<SEC-DOCUMENT>0001753926-22-000273.txt : 20220301
<SEC-HEADER>0001753926-22-000273.hdr.sgml : 20220301
<ACCEPTANCE-DATETIME>20220301162450
ACCESSION NUMBER:		0001753926-22-000273
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		108
CONFORMED PERIOD OF REPORT:	20211231
FILED AS OF DATE:		20220301
DATE AS OF CHANGE:		20220301

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			INTER PARFUMS INC
		CENTRAL INDEX KEY:			0000822663
		STANDARD INDUSTRIAL CLASSIFICATION:	PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS [2844]
		IRS NUMBER:				133275609
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-16469
		FILM NUMBER:		22698464

	BUSINESS ADDRESS:	
		STREET 1:		551 FIFTH AVE
		STREET 2:		STE 1500
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10176
		BUSINESS PHONE:		2129832640

	MAIL ADDRESS:	
		STREET 1:		551 FIFTH AVENUE
		STREET 2:		STE 1500
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10176

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	JEAN PHILIPPE FRAGRANCES INC
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>g082622_10k.htm
<DESCRIPTION>10-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:us-roles="http://fasb.org/us-roles/2021-01-31" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:currency="http://xbrl.sec.gov/currency/2021" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:ipar="http://interparfumsinc.com/20211231">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02C_US%2DGAAP%2D2021_currency -->
<!-- Field: Set; Name: xdx; ID: xdx_035_ipar_interparfumsinc.com_20211231 -->
<!-- Field: Set; Name: xdx; ID: xdx_046_20210101_20211231 -->
<!-- Field: Set; Name: xdx; ID: xdx_052_edei%2D%2DEntityCentralIndexKey_0000822663 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_051_edei%2D%2DDocumentFiscalYearFocus_2021 -->
<!-- Field: Set; Name: xdx; ID: xdx_05A_edei%2D%2DDocumentFiscalPeriodFocus_FY -->
<!-- Field: Set; Name: xdx; ID: xdx_051_edei%2D%2DCurrentFiscalYearEndDate_%2D%2DLS0xMi0zMQ== -->
<!-- Field: Set; Name: xdx; ID: xdx_050_edei%2D%2DTradingSymbol_IPAR -->
<!-- Field: Set; Name: xdx; ID: xdx_076_XDX_Z%2D%2D\XBRL JOB\2022\2022\Q1\02 Feb\Genesis Filings\iXBRL__Inter Parfums, Inc__GFHg082622__31%2D12__10K\In Process\XFR\11\g082622__10k.xdx -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_069_Pure_4_xbrli%2D%2Dpure -->
<!-- Field: Set; Name: xdx; ID: xdx_06C_N_5_Number -->
<!-- Field: Set; Name: xdx; ID: xdx_063_USDEUR_0_iso4217%2D%2DEUR -->
<!-- Field: Set; Name: xdx; ID: xdx_062_USDGBP_0_iso4217%2D%2DGBP -->
<body>
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2021-01-01to2021-12-31" name="dei:EntityCentralIndexKey">0000822663</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2021-01-01to2021-12-31" format="ixt:booleanfalse" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2021-01-01to2021-12-31" name="dei:DocumentFiscalYearFocus">2021</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2021-01-01to2021-12-31" name="dei:DocumentFiscalPeriodFocus">FY</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2021-01-01to2021-12-31" name="dei:CurrentFiscalYearEndDate">--12-31</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2021-01-01to2021-12-31" name="dei:TradingSymbol">IPAR</ix:nonNumeric>
  <ix:nonFraction name="us-gaap:PreferredStockValue" contextRef="AsOf2021-12-31" id="xdx2ixbrl0132" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PreferredStockValue" contextRef="AsOf2020-12-31" id="xdx2ixbrl0133" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ImpairmentOfLeasehold" contextRef="From2020-01-012020-12-31" id="xdx2ixbrl0205" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ImpairmentOfLeasehold" contextRef="From2019-01-012019-12-31" id="xdx2ixbrl0206" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherIncome" contextRef="From2019-01-012019-12-31" id="xdx2ixbrl0230" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" contextRef="From2021-01-01to2021-12-31" id="xdx2ixbrl0296" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2021-01-012021-12-31_us-gaap_TreasuryStockMember" id="xdx2ixbrl0461" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2020-01-012020-12-31_us-gaap_TreasuryStockMember" id="xdx2ixbrl0462" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2019-01-012019-12-31_us-gaap_TreasuryStockMember" id="xdx2ixbrl0463" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncomeLossFromEquityMethodInvestments" contextRef="From2019-01-012019-12-31" id="xdx2ixbrl0564" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PaymentsToAcquireEquityMethodInvestments" contextRef="From2021-01-01to2021-12-31" id="xdx2ixbrl0630" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PaymentsToAcquireEquityMethodInvestments" contextRef="From2019-01-012019-12-31" id="xdx2ixbrl0632" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" contextRef="From2019-01-012019-12-31" id="xdx2ixbrl0648" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PaymentsToMinorityShareholders" contextRef="From2021-01-01to2021-12-31" id="xdx2ixbrl0662" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PaymentsToMinorityShareholders" contextRef="From2020-01-012020-12-31" id="xdx2ixbrl0663" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonNumeric contextRef="From2021-01-012021-12-31_srt_MinimumMember_us-gaap_LicensingAgreementsMember" id="xdx2ixbrl0815" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">P5Y</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2021-01-012021-12-31_srt_MaximumMember_us-gaap_LicensingAgreementsMember" id="xdx2ixbrl0817" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">P15Y</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2021-01-012021-12-31_srt_MinimumMember_us-gaap_LicensingAgreementsMember" id="xdx2ixbrl0819" name="us-gaap:AcquiredFiniteLivedIntangibleAssetWeightedAveragePeriodBeforeRenewalOrExtension">P1Y</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2021-01-012021-12-31_srt_MaximumMember_us-gaap_LicensingAgreementsMember" id="xdx2ixbrl0821" name="us-gaap:AcquiredFiniteLivedIntangibleAssetWeightedAveragePeriodBeforeRenewalOrExtension">P12Y</ix:nonNumeric>
  <ix:nonFraction name="us-gaap:InventoryNet" contextRef="AsOf2021-12-31" id="xdx2ixbrl0863" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">198,914</ix:nonFraction>
  <ix:nonNumeric contextRef="AsOf2021-12-31" id="xdx2ixbrl0880" name="us-gaap:LongTermDebtTerm">P10Y</ix:nonNumeric>
  <ix:nonFraction name="us-gaap:InvestmentsFairValueDisclosure" contextRef="AsOf2021-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel1Member" id="xdx2ixbrl0926" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:InvestmentsFairValueDisclosure" contextRef="AsOf2021-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel3Member" id="xdx2ixbrl0928" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ForeignCurrencyFairValueHedgeAssetAtFairValue" contextRef="AsOf2021-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel1Member" id="xdx2ixbrl0936" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ForeignCurrencyFairValueHedgeAssetAtFairValue" contextRef="AsOf2021-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel3Member" id="xdx2ixbrl0938" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue" contextRef="AsOf2021-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel1Member" id="xdx2ixbrl0941" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue" contextRef="AsOf2021-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel3Member" id="xdx2ixbrl0943" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DerivativeLiabilities" contextRef="AsOf2021-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel1Member" id="xdx2ixbrl0946" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DerivativeLiabilities" contextRef="AsOf2021-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel3Member" id="xdx2ixbrl0948" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2021-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel1Member" id="xdx2ixbrl0951" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2021-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel3Member" id="xdx2ixbrl0953" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:InvestmentsFairValueDisclosure" contextRef="AsOf2020-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel1Member" id="xdx2ixbrl0961" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:InvestmentsFairValueDisclosure" contextRef="AsOf2020-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel3Member" id="xdx2ixbrl0963" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue" contextRef="AsOf2020-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel1Member" id="xdx2ixbrl0966" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue" contextRef="AsOf2020-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel3Member" id="xdx2ixbrl0968" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2020-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel1Member" id="xdx2ixbrl0971" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2020-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel3Member" id="xdx2ixbrl0973" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2020-12-31_us-gaap_BuildingMember" id="xdx2ixbrl0994" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2021-12-31_us-gaap_IndefinitelivedIntangibleAssetsMember" id="xdx2ixbrl1025" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2020-12-31_us-gaap_IndefinitelivedIntangibleAssetsMember" id="xdx2ixbrl1044" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonNumeric contextRef="From2021-01-012021-12-31_us-gaap_TrademarksMember" id="xdx2ixbrl1068" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife">P8Y</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_LicensesMember" id="xdx2ixbrl1069" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife">P15Y</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2021-01-012021-12-31_us-gaap_OtherIntangibleAssetsMember" id="xdx2ixbrl1070" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife">P2Y</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2021-01-01to2021-12-31" id="xdx2ixbrl1071" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife">P14Y</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2021-01-012021-12-31_srt_MinimumMember" id="xdx2ixbrl1086" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife">P3Y</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2021-01-012021-12-31_srt_MaximumMember" id="xdx2ixbrl1088" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife">P20Y</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_LondonInterbankOfferedRateMember_custom_DomesticSubsidiariesMember" format="ixt:dateyearmonthday" id="xdx2ixbrl1126" name="us-gaap:LineOfCreditFacilityExpirationDate1">2022-12-16</ix:nonNumeric>
  <ix:nonFraction name="us-gaap:LongTermDebt" contextRef="AsOf2020-12-31_us-gaap_LoansPayableMember" id="xdx2ixbrl1155" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:LongTermDebt" contextRef="AsOf2020-12-31_custom_LoansPayableTwoMember" id="xdx2ixbrl1170" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:LongTermDebt" contextRef="AsOf2021-12-31_custom_LoansPayableThreeMember" id="xdx2ixbrl1175" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:LongTermDebtCurrent" contextRef="AsOf2020-12-31" id="xdx2ixbrl1182" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">14,570</ix:nonFraction>
  <ix:nonFraction name="us-gaap:LongTermDebtNoncurrent" contextRef="AsOf2020-12-31" id="xdx2ixbrl1185" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">10,136</ix:nonFraction>
  <ix:nonNumeric contextRef="AsOf2021-12-31" id="xdx2ixbrl1199" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1">P6Y1M6D</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2021-01-012021-12-31_srt_MinimumMember_us-gaap_StockOptionMember" id="xdx2ixbrl1263" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">P4Y</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2021-01-012021-12-31_srt_MaximumMember_us-gaap_StockOptionMember" id="xdx2ixbrl1265" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">P5Y</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2021-01-012021-12-31_us-gaap_StockOptionMember39176796" id="xdx2ixbrl1362" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">P5Y</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2021-01-01to2021-12-31" id="xdx2ixbrl1376" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">P5Y</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2020-01-012020-12-31" id="xdx2ixbrl1378" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">P5Y</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2019-01-012019-12-31" id="xdx2ixbrl1380" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">P5Y</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2021-01-012021-12-31_srt_MaximumMember_custom_ExercisePriceRangeOneMember" id="xdx2ixbrl1411" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2">P0Y11M12D</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_ExercisePriceRangeTwoMember" id="xdx2ixbrl1417" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2">P1Y11M8D</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_ExercisePriceRangeThreeMember" id="xdx2ixbrl1422" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2">P3Y0M11D</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_ExercisePriceRangeFourMember" id="xdx2ixbrl1426" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2">P4Y0M0D</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2021-01-01to2021-12-31" id="xdx2ixbrl1429" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2">P2Y9M0D</ix:nonNumeric>
  <ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" contextRef="From2020-01-012020-12-31" id="xdx2ixbrl1497" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">539,009</ix:nonFraction>
  <ix:nonFraction name="us-gaap:DeferredIncomeTaxAssetsNet" contextRef="AsOf2021-12-31_custom_EliminationsMember" id="xdx2ixbrl1600" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" contextRef="From2021-01-01to2021-12-31" id="xdx2ixbrl1662" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">151,019</ix:nonFraction>
  <ix:nonFraction name="ipar:DeferredTaxLiabilitiesBuildingExpenses" contextRef="AsOf2020-12-31" id="xdx2ixbrl1764" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ipar:DeferredTaxLiabilitiesUnrealizedGainOnMarketableEquitySecurities" contextRef="AsOf2020-12-31" id="xdx2ixbrl1770" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DeferredTaxLiabilitiesOther" contextRef="AsOf2020-12-31" id="xdx2ixbrl1773" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" contextRef="AsOf2020-12-31_custom_AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember" id="xdx2ixbrl1818" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" contextRef="AsOf2020-12-31_custom_AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember" id="xdx2ixbrl1832" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesNet" contextRef="From2021-01-01to2021-12-31" id="xdx2ixbrl1866" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesNet" contextRef="From2020-01-012020-12-31" id="xdx2ixbrl1867" unitRef="USD" xs:nil="true"></ix:nonFraction>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="ipar-20211231.xsd" xlink:type="simple" />
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2021-01-01to2021-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-02-25">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-02-25</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_TreasuryStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_TreasuryStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_us-gaap_TreasuryStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_us-gaap_TreasuryStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_us-gaap_TreasuryStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_us-gaap_TreasuryStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_TreasuryStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_MontblancMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ipar:MontblancMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_MontblancMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ipar:MontblancMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_custom_MontblancMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ipar:MontblancMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_JimmyChooMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ipar:JimmyChooMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_JimmyChooMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ipar:JimmyChooMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_custom_JimmyChooMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ipar:JimmyChooMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_CoachMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ipar:CoachMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_CoachMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ipar:CoachMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_custom_CoachMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ipar:CoachMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_GUESSMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ipar:GUESSMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_GUESSMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ipar:GUESSMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_custom_GUESSMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ipar:GUESSMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_InterparfumsSASubsidiaryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:OwnershipAxis">ipar:InterparfumsSASubsidiaryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_MeasurementInputDiscountRateMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_MeasurementInputDiscountRateMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_us-gaap_ShippingAndHandlingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ShippingAndHandlingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_us-gaap_ShippingAndHandlingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ShippingAndHandlingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_us-gaap_ShippingAndHandlingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ShippingAndHandlingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_us-gaap_SalesRevenueNetMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_us-gaap_SalesRevenueNetMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_us-gaap_SalesRevenueNetMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_srt_MinimumMember_us-gaap_LicensingAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_srt_MaximumMember_us-gaap_LicensingAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_InventoryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">ipar:InventoryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_TrademarksMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_OtherAssetMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">ipar:OtherAssetMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_SwissFederalTaxAdministrationFTAMember_currency_EUR_custom_GlobalSettlementAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:SwissFederalTaxAdministrationFTAMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">ipar:GlobalSettlementAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_SwissFederalTaxAdministrationFTAMember_custom_GlobalSettlementAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:SwissFederalTaxAdministrationFTAMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">ipar:GlobalSettlementAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_currency_EUR">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_currency_EUR_us-gaap_SwissFederalTaxAdministrationFTAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:SwissFederalTaxAdministrationFTAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_currency_EUR">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_AnnaSuiCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ipar:AnnaSuiCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_RochasFashionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ipar:RochasFashionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_STDupontMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ipar:STDupontMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_us-gaap_ProductMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_us-gaap_ProductMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_FairValueMeasurementsRecurringMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel3Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_FairValueMeasurementsRecurringMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel3Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_ForeignExchangeContractMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_BuildingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_BuildingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_EquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_EquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_LeaseholdImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_LeaseholdImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_IndefinitelivedIntangibleAssetsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:IndefinitelivedIntangibleAssetsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_FiniteLivedIntangibleAssetsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:FiniteLivedIntangibleAssetsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_LicensesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">ipar:LicensesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_OtherIntangibleAssetsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_SubtotalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">ipar:SubtotalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_IndefinitelivedIntangibleAssetsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:IndefinitelivedIntangibleAssetsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_FiniteLivedIntangibleAssetsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:FiniteLivedIntangibleAssetsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_LicensesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">ipar:LicensesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_OtherIntangibleAssetsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_SubtotalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">ipar:SubtotalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_us-gaap_TrademarksMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_LicensesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">ipar:LicensesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_us-gaap_OtherIntangibleAssetsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_us-gaap_IndefinitelivedIntangibleAssetsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:IndefinitelivedIntangibleAssetsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_MeasurementInputDiscountRateMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_DomesticSubsidiariesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ipar:DomesticSubsidiariesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_LondonInterbankOfferedRateMember_custom_DomesticSubsidiariesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">ipar:LondonInterbankOfferedRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ipar:DomesticSubsidiariesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_LondonInterbankOfferedRateMember_custom_DomesticSubsidiariesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">ipar:LondonInterbankOfferedRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ipar:DomesticSubsidiariesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_ForeignSubsidiariesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ipar:ForeignSubsidiariesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_EuroInterbankOfferedRateMembeMember_custom_ForeignSubsidiariesMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">ipar:EuroInterbankOfferedRateMembeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ipar:ForeignSubsidiariesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_EuroInterbankOfferedRateMembeMember_custom_ForeignSubsidiariesMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">ipar:EuroInterbankOfferedRateMembeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ipar:ForeignSubsidiariesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_EuroInterbankOfferedRateMembeMember_custom_ForeignSubsidiariesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">ipar:EuroInterbankOfferedRateMembeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ipar:ForeignSubsidiariesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_LoansPayableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_us-gaap_LoansPayableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_LoansPayableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_LoansPayableOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ipar:LoansPayableOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_LoansPayableOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ipar:LoansPayableOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_LoansPayableOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ipar:LoansPayableOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_LoansPayableTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ipar:LoansPayableTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_LoansPayableTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ipar:LoansPayableTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_LoansPayableTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ipar:LoansPayableTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_LoansPayableThreeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ipar:LoansPayableThreeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_LoansPayableThreeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ipar:LoansPayableThreeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-04-30_custom_LoansPayableOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ipar:LoansPayableOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_srt_MinimumMember_us-gaap_StockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_srt_MaximumMember_us-gaap_StockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_us-gaap_StockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_us-gaap_StockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_us-gaap_StockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_StockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_StockOptionOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ipar:StockOptionOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_us-gaap_StockOptionMember39176796">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_custom_InterparfumsSASubsidiaryMember_custom_EmployeesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ipar:InterparfumsSASubsidiaryMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">ipar:EmployeesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_custom_InterparfumsSASubsidiaryMember_custom_OfficersAndManagersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ipar:InterparfumsSASubsidiaryMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">ipar:OfficersAndManagersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-03-012020-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-03-01</xbrli:startDate>
        <xbrli:endDate>2020-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-03-31_custom_InterparfumsSASubsidiaryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:OwnershipAxis">ipar:InterparfumsSASubsidiaryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_InterparfumsSASubsidiaryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:OwnershipAxis">ipar:InterparfumsSASubsidiaryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-10-012019-10-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-10-01</xbrli:startDate>
        <xbrli:endDate>2019-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-10-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-02-28_srt_BoardOfDirectorsChairmanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-02-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-03-31_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_us-gaap_OperatingIncomeLossMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OperatingIncomeLossMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_us-gaap_OperatingIncomeLossMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OperatingIncomeLossMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_us-gaap_OperatingIncomeLossMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OperatingIncomeLossMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_srt_MinimumMember_custom_ExercisePriceRangeOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">ipar:ExercisePriceRangeOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_srt_MaximumMember_custom_ExercisePriceRangeOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">ipar:ExercisePriceRangeOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_ExercisePriceRangeOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">ipar:ExercisePriceRangeOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_srt_MaximumMember_custom_ExercisePriceRangeOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">ipar:ExercisePriceRangeOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_srt_MinimumMember_custom_ExercisePriceRangeTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">ipar:ExercisePriceRangeTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_srt_MaximumMember_custom_ExercisePriceRangeThreeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">ipar:ExercisePriceRangeThreeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_ExercisePriceRangeTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">ipar:ExercisePriceRangeTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_ExercisePriceRangeTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">ipar:ExercisePriceRangeTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_srt_MinimumMember_custom_ExercisePriceRangeThreeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">ipar:ExercisePriceRangeThreeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_srt_MaximumMember_custom_ExercisePriceRangeFourMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">ipar:ExercisePriceRangeFourMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_ExercisePriceRangeThreeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">ipar:ExercisePriceRangeThreeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_ExercisePriceRangeThreeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">ipar:ExercisePriceRangeThreeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_ExercisePriceRangeFourMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">ipar:ExercisePriceRangeFourMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_ExercisePriceRangeFourMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">ipar:ExercisePriceRangeFourMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_country_US">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_country_US">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_country_US">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_srt_EuropeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_srt_EuropeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_srt_EuropeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_EliminationsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ipar:EliminationsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_EliminationsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ipar:EliminationsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_custom_EliminationsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ipar:EliminationsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_country_US">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_country_US">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_country_US">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_srt_EuropeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_srt_EuropeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_srt_EuropeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_EliminationsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ipar:EliminationsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_EliminationsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ipar:EliminationsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_EliminationsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ipar:EliminationsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_srt_NorthAmericaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_srt_NorthAmericaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_srt_NorthAmericaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_EuropeCountryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ipar:EuropeCountryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_EuropeCountryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ipar:EuropeCountryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_custom_EuropeCountryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ipar:EuropeCountryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_srt_AsiaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_srt_AsiaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_srt_AsiaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_us-gaap_MiddleEastMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:MiddleEastMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_us-gaap_MiddleEastMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:MiddleEastMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_us-gaap_MiddleEastMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:MiddleEastMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_CentralAndSouthAmericaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ipar:CentralAndSouthAmericaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_CentralAndSouthAmericaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ipar:CentralAndSouthAmericaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_custom_CentralAndSouthAmericaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ipar:CentralAndSouthAmericaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_OtherSegmentCountryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ipar:OtherSegmentCountryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_OtherSegmentCountryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ipar:OtherSegmentCountryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_custom_OtherSegmentCountryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ipar:OtherSegmentCountryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_UnitedStatesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ipar:UnitedStatesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_UnitedStatesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ipar:UnitedStatesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_custom_UnitedStatesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ipar:UnitedStatesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_FranceMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ipar:FranceMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_FranceMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ipar:FranceMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_custom_FranceMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ipar:FranceMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_RussiaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ipar:RussiaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_RussiaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ipar:RussiaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_custom_RussiaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ipar:RussiaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_UnitedKingdomMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ipar:UnitedKingdomMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_UnitedKingdomMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ipar:UnitedKingdomMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_custom_UnitedKingdomMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ipar:UnitedKingdomMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_ForeignDerivedIntangibleIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ipar:ForeignDerivedIntangibleIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_ForeignDerivedIntangibleIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ipar:ForeignDerivedIntangibleIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_custom_ForeignDerivedIntangibleIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ipar:ForeignDerivedIntangibleIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ipar:AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ipar:AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_custom_AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ipar:AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ipar:AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ipar:AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_custom_AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ipar:AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ipar:AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_AccumulatedTranslationAdjustmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_AccumulatedTranslationAdjustmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_us-gaap_AccumulatedTranslationAdjustmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_us-gaap_AccumulatedTranslationAdjustmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_us-gaap_AccumulatedTranslationAdjustmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_us-gaap_AccumulatedTranslationAdjustmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_AccumulatedTranslationAdjustmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <xbrli:unit id="Pure">
      <xbrli:measure>xbrli:pure</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="N">
      <xbrli:measure>ipar:Number</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDEUR">
      <xbrli:measure>iso4217:EUR</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDGBP">
      <xbrli:measure>iso4217:GBP</xbrli:measure>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<!-- Field: Named-Area; Name: Contents -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><b>UNITED STATES</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><b>SECURITIES AND EXCHANGE COMMISSION</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><b>Washington, D.C. 20549</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-size: 14pt"><b>FORM <span id="xdx_90A_edei--DocumentType_c20210101__20211231_zOPNqlYv5pP1"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" name="dei:DocumentType">10-K</ix:nonNumeric></span></b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">(Mark one)</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span id="xdx_902_edei--DocumentAnnualReport_c20210101__20211231_zWna8ySybKGk"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" format="ixt:booleantrue" name="dei:DocumentAnnualReport">&#9746;</ix:nonNumeric></span> <b>Annual Report pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">For the fiscal year ended <span style="text-decoration: underline"><span id="xdx_90F_edei--DocumentPeriodEndDate_dd_c20210101__20211231_zqnZdMp8yyA9"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">December 31, 2021</ix:nonNumeric></span></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">or</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span id="xdx_904_edei--DocumentTransitionReport_c20210101__20211231_z2xS2ziBOufb"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" format="ixt:booleanfalse" name="dei:DocumentTransitionReport">&#9744;</ix:nonNumeric></span> <b>Transition Report pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">For&#160;the&#160;transition&#160;period&#160;from&#160;<span style="text-decoration: underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span>&#160;to&#160;<span style="text-decoration: underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span>.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">Commission file no. <span style="text-decoration: underline"><span id="xdx_90B_edei--EntityFileNumber_c20210101__20211231_zgX9w4Y0G4u6"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" name="dei:EntityFileNumber">0-16469</ix:nonNumeric></span></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-size: 14pt"><b><i><span style="text-decoration: underline"><b><i><span id="xdx_90D_edei--EntityRegistrantName_c20210101__20211231_zCIgwCsACff"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" name="dei:EntityRegistrantName">Inter Parfums, Inc.</ix:nonNumeric></span></i></b></span></i></b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">(Exact name of registrant as specified in its charter)</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<table border="0" cellspacing="0" cellpadding="0" style="width: 100%">

<tr>
<td style="border-bottom: black 1pt none; border-top-style: none; border-right-style: none; border-left-style: none; width: 49%; border-bottom-style: solid; vertical-align: bottom">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span id="xdx_90B_edei--EntityIncorporationStateCountryCode_c20210101__20211231_zedBt1SczQM8"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></p>
</td>
<td style="width: 2%; vertical-align: bottom">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">&#160;</p>
</td>
<td style="border-bottom: black 1pt none; border-top-style: none; border-right-style: none; border-left-style: none; width: 49%; border-bottom-style: solid; vertical-align: bottom">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span id="xdx_90F_edei--EntityTaxIdentificationNumber_c20210101__20211231_zk6bfNL0ptue"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" name="dei:EntityTaxIdentificationNumber">13-3275609</ix:nonNumeric></span></p>
</td>
</tr>
<tr>
<td style="vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">(State or other jurisdiction of incorporation or organization)</p>
</td>
<td style="vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">&#160;</p>
</td>
<td style="vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">(I.R.S. Employer Identification No.)</p>
</td>
</tr>
<tr>
<td style="vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">&#160;</p>
</td>
<td style="vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">&#160;</p>
</td>
<td style="vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">&#160;</p>
</td>
</tr>
<tr>
<td style="border-bottom: black 1pt none; border-top-style: none; border-right-style: none; border-left-style: none; border-bottom-style: solid; vertical-align: bottom">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span id="xdx_90F_edei--EntityAddressAddressLine1_c20210101__20211231_zpfADW7Ymsb8"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" name="dei:EntityAddressAddressLine1">551 Fifth Avenue</ix:nonNumeric></span>, <span id="xdx_90D_edei--EntityAddressCityOrTown_c20210101__20211231_zCXTqTcCSh46"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" name="dei:EntityAddressCityOrTown">New York</ix:nonNumeric></span>, <span id="xdx_90D_edei--EntityAddressStateOrProvince_c20210101__20211231_zKhIaNLwGBok"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince">New York</ix:nonNumeric></span></p>
</td>
<td style="vertical-align: bottom">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">&#160;</p>
</td>
<td style="border-bottom: black 1pt none; border-top-style: none; border-right-style: none; border-left-style: none; border-bottom-style: solid; vertical-align: bottom">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span id="xdx_90C_edei--EntityAddressPostalZipCode_c20210101__20211231_zbbpS2TZr3w5"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" name="dei:EntityAddressPostalZipCode">10176</ix:nonNumeric></span></p>
</td>
</tr>
<tr>
<td style="vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">(Address of Principal Executive Offices)</p>
</td>
<td style="vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">&#160;</p>
</td>
<td style="vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">(Zip Code)</p>
</td>
</tr>

</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">Registrant&#8217;s telephone number, including area code: <span style="text-decoration: underline"><span id="xdx_908_edei--CityAreaCode_c20210101__20211231_zN8beGh2eRBc"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" name="dei:CityAreaCode">212</ix:nonNumeric></span>.<span id="xdx_90D_edei--LocalPhoneNumber_c20210101__20211231_zW1FbGIgkOMi"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" name="dei:LocalPhoneNumber">983.2640</ix:nonNumeric></span></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">Securities registered pursuant to Section 12(b) of the Act:</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<table border="0" cellspacing="0" cellpadding="0" style="width: 100%">

<tr>
<td style="border-bottom: black 1pt none; border-top-style: none; border-right-style: none; border-left-style: none; width: 49%; border-bottom-style: solid; vertical-align: bottom">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">Title of each class</p>
</td>
<td style="width: 2%; vertical-align: bottom">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">&#160;</p>
</td>
<td style="border-bottom: black 1pt none; border-top-style: none; border-right-style: none; border-left-style: none; width: 49%; border-bottom-style: solid; vertical-align: bottom">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">Name of exchange on which registered</p>
</td>
</tr>
<tr>
<td style="background-color: #CCEEFF; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span id="xdx_905_edei--Security12bTitle_c20210101__20211231_zB0N9yHDpT8k"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" name="dei:Security12bTitle">Common Stock, $.001 par value per share</ix:nonNumeric></span></p>
</td>
<td style="background-color: #CCEEFF; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">&#160;</p>
</td>
<td style="background-color: #CCEEFF; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span id="xdx_903_edei--SecurityExchangeName_c20210101__20211231_znm0olUCMGX"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">The Nasdaq Stock Market</ix:nonNumeric></span></p>
</td>
</tr>

</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">Securities registered pursuant to Section 12(g) of the Act:</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<table border="0" cellspacing="0" cellpadding="0" style="width: 100%">

<tr>
<td style="border-bottom: black 1pt none; border-top-style: none; border-right-style: none; border-left-style: none; width: 49%; border-bottom-style: solid; vertical-align: bottom">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">Title of each class</p>
</td>
<td style="width: 2%; vertical-align: bottom">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">&#160;</p>
</td>
<td style="border-bottom: black 1pt none; border-top-style: none; border-right-style: none; border-left-style: none; width: 49%; border-bottom-style: solid; vertical-align: bottom">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">Name of exchange on which registered</p>
</td>
</tr>
<tr>
<td style="background-color: #CCEEFF; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">None</p>
</td>
<td style="background-color: #CCEEFF; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">&#160;</p>
</td>
<td style="background-color: #CCEEFF; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">None</p>
</td>
</tr>

</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">Indicate by check mark whether the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. <span id="xdx_907_edei--EntityWellKnownSeasonedIssuer_c20210101__20211231_zuyzCl9Sp0sh"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" name="dei:EntityWellKnownSeasonedIssuer">Yes</ix:nonNumeric></span>&#160;&#9746; No&#160;&#9744;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Act. Yes&#160;&#9744; <span id="xdx_903_edei--EntityVoluntaryFilers_c20210101__20211231_zds2vsYWG76f"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" name="dei:EntityVoluntaryFilers">No</ix:nonNumeric></span>&#160;&#9746;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days: <span id="xdx_903_edei--EntityCurrentReportingStatus_c20210101__20211231_zePI8xmBqKha"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" name="dei:EntityCurrentReportingStatus">Yes</ix:nonNumeric></span>&#160;&#9746; No&#160;&#9744;&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167; 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). <span id="xdx_90E_edei--EntityInteractiveDataCurrent_c20210101__20211231_z3WSdhGT57m"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" name="dei:EntityInteractiveDataCurrent">Yes</ix:nonNumeric></span>&#160;&#9746; No&#160;&#9744;&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<table border="0" cellspacing="0" cellpadding="0" style="width: 100%">

<tr>
<td style="width: 25%; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_edei--EntityFilerCategory_c20210101__20211231_z3ymufbtPzx5"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory">Large
accelerated filer</ix:nonNumeric></span></span></p>
</td>
<td style="width: 25%; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</span></p>
</td>
<td style="width: 25%; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accelerated
filer</span></p>
</td>
<td style="width: 25%; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td>
</tr>
<tr>
<td style="vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-accelerated
filer</span></p>
</td>
<td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td>
<td style="vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Smaller
reporting company</span></p>
</td>
<td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_edei--EntitySmallBusiness_c20210101__20211231_zfv9ibP5GeKh"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" format="ixt:booleanfalse" name="dei:EntitySmallBusiness">&#9744;</ix:nonNumeric></span></span></td>
</tr>
<tr>
<td colspan="2" style="vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
</td>
<td style="vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging
growth company</span></p>
</td>
<td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_edei--EntityEmergingGrowthCompany_c20210101__20211231_z029uJ5rvIu8"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" format="ixt:booleanfalse" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></span></td>
</tr>

</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#160;&#9744;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant
has filed a report on and attestation to its management&#8217;s assessment of the effectiveness of its internal control over financial
reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared
or issued its audit report.&#160;&#160;<span style="font-family: Segoe UI Symbol,sans-serif"><span id="xdx_90A_edei--IcfrAuditorAttestationFlag_c20210101__20211231_zddiq4o2DZbg"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" format="ixt:booleantrue" name="dei:IcfrAuditorAttestationFlag">&#9746;</ix:nonNumeric></span></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes &#9744; <span id="xdx_90C_edei--EntityShellCompany_c20210101__20211231_zb5DNQkA0vkb"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" format="ixt:booleanfalse" name="dei:EntityShellCompany">No</ix:nonNumeric></span> &#9746;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">State the aggregate market value
of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity
was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant&#8217;s
most recently completed second fiscal quarter. $<span id="xdx_904_edei--EntityPublicFloat_iI_uUSD_c20210630_zi1QU9ytW7x3"><ix:nonFraction name="dei:EntityPublicFloat" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,274,342,976</ix:nonFraction></span> of voting equity and $-0- of non-voting equity.&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">Indicate the number of shares outstanding of the registrant&#8217;s $.001 par value common stock as of the close of business on the latest practicable date February 25, 2022: <span id="xdx_90E_edei--EntityCommonStockSharesOutstanding_iI_pid_uShares_c20220225_zVeRE5lQZWnl"><ix:nonFraction name="dei:EntityCommonStockSharesOutstanding" contextRef="AsOf2022-02-25" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">31,842,225</ix:nonFraction></span>.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">Documents Incorporated by Reference:
None.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt"></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><b>TABLE OF CONTENTS</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<table border="0" cellspacing="0" cellpadding="0" style="margin: 0px; width: 100%; border-collapse: collapse; width: 100%; margin-top: 0px; margin-right: 0px; margin-bottom: 0px; margin-left: 0px">

<tr>
<td style="padding: 0pt; width: 7%; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p>
</td>
<td style="padding: 0pt; width: 87%; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p>
</td>
<td style="border-bottom: black 1pt solid; padding: 0pt; text-align: center; width: 5%; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, serif; margin: 0pt; text-align: center"><b>Page</b></p>
</td>
</tr>
<tr style="background-color: rgb(204,238,255)">
<td colspan="2" style="padding: 0pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="text-decoration: underline"><a href="#a001_v1">Note on Forward Looking Statements</a></span></p>
</td>
<td style="padding: 0pt; text-align: right; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, serif; margin: 0pt; text-align: right">ii</p>
</td>
</tr>
<tr style="background-color: White">
<td style="padding: 0pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p>
</td>
<td style="padding: 0pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p>
</td>
<td style="padding: 0pt; text-align: right; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, serif; margin: 0pt; text-align: right">&#160;</p>
</td>
</tr>
<tr style="background-color: rgb(204,238,255)">
<td style="padding: 0pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><b><span style="text-decoration: underline"><a href="#a002_v1">PART I</a></span></b></p>
</td>
<td style="padding: 0pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p>
</td>
<td style="padding: 0pt; text-align: right; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, serif; margin: 0pt; text-align: right">1</p>
</td>
</tr>
<tr style="background-color: White">
<td style="padding: 0pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p>
</td>
<td style="padding: 0pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p>
</td>
<td style="padding: 0pt; text-align: right; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, serif; margin: 0pt; text-align: right">&#160;</p>
</td>
</tr>
<tr style="background-color: rgb(204,238,255)">
<td style="padding: 0pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="text-decoration: underline"><a href="#a003_v1">Item 1.</a></span></p>
</td>
<td style="padding: 0pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="text-decoration: underline"><a href="#a003_v1">Business</a></span></p>
</td>
<td style="padding: 0pt; text-align: right; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, serif; margin: 0pt; text-align: right">1</p>
</td>
</tr>
<tr style="background-color: White">
<td style="padding: 0pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p>
</td>
<td style="padding: 0pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p>
</td>
<td style="padding: 0pt; text-align: right; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, serif; margin: 0pt; text-align: right">&#160;</p>
</td>
</tr>
<tr style="background-color: rgb(204,238,255)">
<td style="padding: 0pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="text-decoration: underline"><a href="#a004_v1">Item 1A.</a></span></p>
</td>
<td style="padding: 0pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="text-decoration: underline"><a href="#a004_v1">Risk Factors</a></span></p>
</td>
<td style="padding: 0pt; text-align: right; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, serif; margin: 0pt; text-align: right">22</p>
</td>
</tr>
<tr style="background-color: White">
<td style="padding: 0pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p>
</td>
<td style="padding: 0pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p>
</td>
<td style="padding: 0pt; text-align: right; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, serif; margin: 0pt; text-align: right">&#160;</p>
</td>
</tr>
<tr style="background-color: rgb(204,238,255)">
<td style="padding: 0pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="text-decoration: underline"><a href="#a005_v1">Item 1B.</a></span></p>
</td>
<td style="padding: 0pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="text-decoration: underline"><a href="#a005_v1">Unresolved Staff Comments</a></span></p>
</td>
<td style="padding: 0pt; text-align: right; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, serif; margin: 0pt; text-align: right">33</p>
</td>
</tr>
<tr style="background-color: White">
<td style="padding: 0pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p>
</td>
<td style="padding: 0pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p>
</td>
<td style="padding: 0pt; text-align: right; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, serif; margin: 0pt; text-align: right">&#160;</p>
</td>
</tr>
<tr style="background-color: rgb(204,238,255)">
<td style="padding: 0pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="text-decoration: underline"><a href="#a006_v1">Item 2.</a></span></p>
</td>
<td style="padding: 0pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="text-decoration: underline"><a href="#a006_v1">Properties</a></span></p>
</td>
<td style="padding: 0pt; text-align: right; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, serif; margin: 0pt; text-align: right">33</p>
</td>
</tr>
<tr style="background-color: White">
<td style="padding: 0pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p>
</td>
<td style="padding: 0pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p>
</td>
<td style="padding: 0pt; text-align: right; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, serif; margin: 0pt; text-align: right">&#160;</p>
</td>
</tr>
<tr style="background-color: rgb(204,238,255)">
<td style="padding: 0pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="text-decoration: underline"><a href="#a007_v1">Item 3.</a></span></p>
</td>
<td style="padding: 0pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="text-decoration: underline"><a href="#a007_v1">Legal Proceedings</a></span></p>
</td>
<td style="padding: 0pt; text-align: right; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, serif; margin: 0pt; text-align: right">34</p>
</td>
</tr>
<tr style="background-color: White">
<td style="padding: 0pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p>
</td>
<td style="padding: 0pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p>
</td>
<td style="padding: 0pt; text-align: right; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, serif; margin: 0pt; text-align: right">&#160;</p>
</td>
</tr>
<tr style="background-color: rgb(204,238,255)">
<td style="padding: 0pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="text-decoration: underline"><a href="#a008_v1">Item 4.</a></span></p>
</td>
<td style="padding: 0pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="text-decoration: underline"><a href="#a008_v1">Mine Safety Disclosures</a></span></p>
</td>
<td style="padding: 0pt; text-align: right; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, serif; margin: 0pt; text-align: right">34</p>
</td>
</tr>
<tr style="background-color: White">
<td style="padding: 0pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p>
</td>
<td style="padding: 0pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p>
</td>
<td style="padding: 0pt; text-align: right; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, serif; margin: 0pt; text-align: right">&#160;</p>
</td>
</tr>
<tr style="background-color: rgb(204,238,255)">
<td style="padding: 0pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><b><span style="text-decoration: underline"><a href="#a009_v1">PART II</a></span></b></p>
</td>
<td style="padding: 0pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p>
</td>
<td style="padding: 0pt; text-align: right; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, serif; margin: 0pt; text-align: right">35</p>
</td>
</tr>
<tr style="background-color: White">
<td style="padding: 0pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p>
</td>
<td style="padding: 0pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p>
</td>
<td style="padding: 0pt; text-align: right; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, serif; margin: 0pt; text-align: right">&#160;</p>
</td>
</tr>
<tr style="background-color: rgb(204,238,255)">
<td style="padding: 0pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="text-decoration: underline"><a href="#a010_v1">Item 5.</a></span></p>
</td>
<td style="padding: 0pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="text-decoration: underline"><a href="#a010_v1">Market for Registrant&#8217;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</a></span></p>
</td>
<td style="padding: 0pt; text-align: right; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, serif; margin: 0pt; text-align: right">35</p>
</td>
</tr>
<tr style="background-color: White">
<td style="padding: 0pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p>
</td>
<td style="padding: 0pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p>
</td>
<td style="padding: 0pt; text-align: right; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, serif; margin: 0pt; text-align: right">&#160;</p>
</td>
</tr>
<tr style="background-color: rgb(204,238,255)">
<td style="padding: 0pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="text-decoration: underline"><a href="#a011_v1">Item 6.</a></span></p>
</td>
<td style="padding: 0pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><a href="#a011_v1">RESERVED</a></p>
</td>
<td style="padding: 0pt; text-align: right; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, serif; margin: 0pt; text-align: right">37</p>
</td>
</tr>
<tr style="background-color: White">
<td style="padding: 0pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p>
</td>
<td style="padding: 0pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p>
</td>
<td style="padding: 0pt; text-align: right; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, serif; margin: 0pt; text-align: right">&#160;</p>
</td>
</tr>
<tr style="background-color: rgb(204,238,255)">
<td style="padding: 0pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="text-decoration: underline"><a href="#a012_v1">Item 7.</a></span></p>
</td>
<td style="padding: 0pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="text-decoration: underline"><a href="#a012_v1">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></p>
</td>
<td style="padding: 0pt; text-align: right; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, serif; margin: 0pt; text-align: right">37</p>
</td>
</tr>
<tr style="background-color: White">
<td style="padding: 0pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p>
</td>
<td style="padding: 0pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p>
</td>
<td style="padding: 0pt; text-align: right; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, serif; margin: 0pt; text-align: right">&#160;</p>
</td>
</tr>
<tr style="background-color: rgb(204,238,255)">
<td style="padding: 0pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="text-decoration: underline"><a href="#a013_v1">Item 7A.</a></span></p>
</td>
<td style="padding: 0pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="text-decoration: underline"><a href="#a013_v1">Quantitative and Qualitative Disclosures About Market Risk</a></span></p>
</td>
<td style="padding: 0pt; text-align: right; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, serif; margin: 0pt; text-align: right">53</p>
</td>
</tr>
<tr style="background-color: White">
<td style="padding: 0pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p>
</td>
<td style="padding: 0pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p>
</td>
<td style="padding: 0pt; text-align: right; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, serif; margin: 0pt; text-align: right">&#160;</p>
</td>
</tr>
<tr style="background-color: rgb(204,238,255)">
<td style="padding: 0pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="text-decoration: underline"><a href="#a014_v1">Item 8.</a></span></p>
</td>
<td style="padding: 0pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="text-decoration: underline"><a href="#a014_v1">Financial Statements and Supplementary Data</a></span></p>
</td>
<td style="padding: 0pt; text-align: right; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, serif; margin: 0pt; text-align: right">54</p>
</td>
</tr>
<tr style="background-color: White">
<td style="padding: 0pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p>
</td>
<td style="padding: 0pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p>
</td>
<td style="padding: 0pt; text-align: right; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, serif; margin: 0pt; text-align: right">&#160;</p>
</td>
</tr>
<tr style="background-color: rgb(204,238,255)">
<td style="padding: 0pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="text-decoration: underline"><a href="#a015_v1">Item 9.</a></span></p>
</td>
<td style="padding: 0pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="text-decoration: underline"><a href="#a015_v1">Changes in and Disagreements With Accountants on Accounting and Financial Disclosure</a></span></p>
</td>
<td style="padding: 0pt; text-align: right; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, serif; margin: 0pt; text-align: right">54</p>
</td>
</tr>
<tr style="background-color: White">
<td style="padding: 0pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p>
</td>
<td style="padding: 0pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p>
</td>
<td style="padding: 0pt; text-align: right; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, serif; margin: 0pt; text-align: right">&#160;</p>
</td>
</tr>
<tr style="background-color: rgb(204,238,255)">
<td style="padding: 0pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="text-decoration: underline"><a href="#a016_v1">Item 9A.</a></span></p>
</td>
<td style="padding: 0pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="text-decoration: underline"><a href="#a016_v1">Controls and Procedures</a></span></p>
</td>
<td style="padding: 0pt; text-align: right; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, serif; margin: 0pt; text-align: right">54</p>
</td>
</tr>
<tr style="background-color: White">
<td style="padding: 0pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p>
</td>
<td style="padding: 0pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p>
</td>
<td style="padding: 0pt; text-align: right; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, serif; margin: 0pt; text-align: right">&#160;</p>
</td>
</tr>
<tr style="background-color: rgb(204,238,255)">
<td style="padding: 0pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="text-decoration: underline"><a href="#a017_v1">Item 9B.</a></span></p>
</td>
<td style="padding: 0pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="text-decoration: underline"><a href="#a017_v1">Other Information</a></span></p>
</td>
<td style="padding: 0pt; text-align: right; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, serif; margin: 0pt; text-align: right">55</p>
</td>
</tr>
<tr style="background-color: White">
<td style="padding: 0pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p>
</td>
<td style="padding: 0pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p>
</td>
<td style="padding: 0pt; text-align: right; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, serif; margin: 0pt; text-align: right">&#160;</p>
</td>
</tr>
<tr style="background-color: rgb(204,238,255)">
<td style="padding: 0pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><b><span style="text-decoration: underline"><a href="#a018_v1">PART IV</a></span></b></p>
</td>
<td style="padding: 0pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p>
</td>
<td style="padding: 0pt; text-align: right; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, serif; margin: 0pt; text-align: right">86</p>
</td>
</tr>
<tr style="background-color: White">
<td style="padding: 0pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p>
</td>
<td style="padding: 0pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p>
</td>
<td style="padding: 0pt; text-align: right; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, serif; margin: 0pt; text-align: right">&#160;</p>
</td>
</tr>
<tr style="background-color: rgb(204,238,255)">
<td style="padding: 0pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="text-decoration: underline"><a href="#a019_v1">Item 15.</a></span></p>
</td>
<td style="padding: 0pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="text-decoration: underline"><a href="#a019_v1">Exhibits and Financial Statement Schedules</a></span></p>
</td>
<td style="padding: 0pt; text-align: right; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, serif; margin: 0pt; text-align: right">86</p>
</td>
</tr>
<tr style="background-color: White">
<td style="padding: 0pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p>
</td>
<td style="padding: 0pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p>
</td>
<td style="padding: 0pt; text-align: right; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, serif; margin: 0pt; text-align: right">&#160;</p>
</td>
</tr>
<tr style="background-color: rgb(204,238,255)">
<td style="padding: 0pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="text-decoration: underline"><a href="#a020_v1">Item 16.</a></span></p>
</td>
<td style="padding: 0pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="text-decoration: underline"><a href="#a020_v1">Form 10-K Summary</a></span></p>
</td>
<td style="padding: 0pt; text-align: right; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, serif; margin: 0pt; text-align: right">86</p>
</td>
</tr>
<tr style="background-color: White">
<td style="padding: 0pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p>
</td>
<td style="padding: 0pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p>
</td>
<td style="padding: 0pt; text-align: right; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, serif; margin: 0pt; text-align: right">&#160;</p>
</td>
</tr>
<tr style="background-color: rgb(204,238,255)">
<td colspan="2" style="padding: 0pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><b><span style="text-decoration: underline"><a href="#a021_v1">FINANCIAL STATEMENTS</a></span></b></p>
</td>
<td style="padding: 0pt; text-align: right; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, serif; margin: 0pt; text-align: right">F-1</p>
</td>
</tr>
<tr style="background-color: White">
<td style="padding: 0pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p>
</td>
<td style="padding: 0pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p>
</td>
<td style="padding: 0pt; text-align: right; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, serif; margin: 0pt; text-align: right">&#160;</p>
</td>
</tr>
<tr style="background-color: rgb(204,238,255)">
<td colspan="2" style="padding: 0pt; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><b><span style="text-decoration: underline"><a href="#a022_v1">SIGNATURES</a></span></b></p>

</td>
<td style="padding: 0pt; text-align: right; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, serif; margin: 0pt; text-align: right">&#160;</p>
</td>
</tr>

</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;&#160;</p>
<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><b>F<span id="a001_v1"></span>ORWARD LOOKING STATEMENTS</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36pt">This report includes forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, and if incorporated by reference into a registration statement under the Securities Act of 1933, as amended, within the meaning of Section 27A of such act. When used in this report, the words &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;estimate,&#8221; &#8220;will,&#8221; &#8220;should,&#8221; &#8220;could,&#8221; &#8220;may,&#8221; &#8220;intend,&#8221; &#8220;expect,&#8221; &#8220;plan,&#8221; &#8220;predict,&#8221; &#8220;potential,&#8221; or &#8220;continue&#8221; or similar expressions identify certain forward-looking statements. Although we believe that our plans, intentions and expectations reflected in such forward-looking statements are reasonable, we can give no assurance that such plans, intentions or expectations will be achieved.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36pt">Actual results, performance or achievements could differ materially from those contemplated, expressed or implied by the forward-looking statements contained in this report. Important factors that could cause actual results to differ materially from our forward-looking statements are set forth in this report, including under the heading &#8220;Risk Factors&#8221;. Such factors include: The effects of COVID-19 and related governmental mandates; our inability to successfully integrate or manage any future acquisitions; continuation and renewal of existing licenses and similar agreements; potential inability to obtain new licensing, arrangements or agreements for additional brands; potential reduction in sales of our fragrance products due to reduced consumer confidence as the result of a prolonged economic downturn, recession or terrorist attack in the United States, Europe or any of the other countries in which we do significant business; uncertainties and deterioration in global credit markets could negatively impact suppliers, customers and consumers; outbreak of disease, epidemic or pandemic, or similar public health threat, such as the coronavirus; inability to protect our intellectual property rights; our business could be negatively impacted by social impact and sustainability matters; potential liability for infringement of third party brand names; product liability claims; effectiveness of our sales and marketing efforts and product acceptance by consumers; our dependence upon third party manufacturers and distributors; our dependence upon existing management; competition in the fragrance industry; risks related to our foreign operations, currency fluctuation and international tariff and trade barriers; compliance with governmental regulation; changing political conditions could adversely impact our business and financial results; potential hacking and outages of our global information systems; seasonal variability of our business; our ability to operate our business without infringing, and misappropriating or otherwise violating the intellectual property rights of other parties.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36pt">These factors are not intended to represent a complete list of the general or specific factors that may affect us. It should be recognized that other factors, including general economic factors and business strategies, may be significant, and the factors set forth herein may affect us to a greater extent than indicated. All forward-looking statements attributable to us or persons acting on our behalf are expressly qualified in their entirety by the cautionary statements set forth in this report. Except as may be required by law, we undertake no obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<!-- Field: Page; Sequence: 3; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->ii<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><b>P<span id="a002_v1"></span>ART I</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><b>I<span id="a003_v1"></span>tem 1. Business</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><b><i><b><i>General Business Development</i></b></i></b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36pt">Founded in 1982, we operate in the fragrance business, and manufacture, market and distribute a wide array of prestige fragrance, and fragrance related products. Our worldwide headquarters and the office of our wholly-owned United States subsidiaries, Jean Philippe Fragrances, LLC and Inter Parfums USA, LLC, are located at 551 Fifth Avenue, New York, New York 10176, and our telephone number is 212.983.2640. We also have a newly formed, wholly-owned Italian subsidiary, Interparfums Italia srl.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36pt">Our consolidated wholly-owned subsidiary, Inter Parfums Holdings, S.A., and its majority-owned subsidiary, Interparfums SA, maintain executive offices at 4 Rond Point des Champs Elysees, 75008 Paris, France. Our telephone number in Paris is 331.5377.0000. Interparfums SA is the sole owner of two (2) distribution subsidiaries: Inter Parfums srl for Italy and Interparfums Luxury Brands, Inc., a Delaware corporation, for distribution of prestige brands in the United States. Interparfums SA is also the majority owner of Parfums Rochas Spain, SL, a Spanish limited liability company, which specializes in the distribution of Rochas fragrances. In addition, Interparfums SA is also the sole owner of Interparfums (Suisse) SARL, a company formed to hold and manage certain brand names, and Interparfums Asia Pacific Pte., Ltd., an Asian sales and marketing office.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36pt">Our common stock is listed on The Nasdaq Global Select Market under the trading symbol &#8220;IPAR&#8221;. The common shares of our subsidiary, Interparfums SA, are traded on the Euronext Exchange.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36pt">The Securities
and Exchange Commission (&#8220;SEC&#8221;) maintains an internet site at <span style="color: black"><span style="text-decoration: underline">http://www.sec.gov</span></span>
that contains financial reports, proxy and information statements, and other information regarding issuers that file electronically
with the SEC. We maintain our internet website at <span style="color: black"><span style="text-decoration: underline">www.interparfumsinc.com</span></span>, which is linked
to the SEC internet site. You can obtain through our website, free of charge, our annual reports on Form 10-K, quarterly reports
on Form 10-Q, interactive data files, current reports on Form 8-K, beneficial ownership reports (Forms 3, 4 and 5) and amendments
to those reports filed or furnished pursuant to Section 13(a) of the Securities Exchange Act of 1934 as soon as reasonably practicable
after they have been electronically filed with or furnished to the SEC.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36pt"><i>The following information is qualified in its entirety by and should be read together with the more detailed information and audited financial statements, including the related notes, contained or incorporated by reference in this report.</i></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><i>General</i></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36pt">We operate in the fragrance business and manufacture, market and distribute a wide array of fragrance and fragrance related products. We manage our business in two segments, European based operations and United States based operations. Certain prestige fragrance products are produced and marketed by our European operations through our 27% owned subsidiary in Paris, Interparfums SA, which is also a publicly traded company as 73% of Interparfums SA shares trade on the NYSE Euronext.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<!-- Field: Page; Sequence: 4; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36pt">Our business is not capital intensive, and it is important to note that we do not own manufacturing facilities. We act as a general contractor and source our needed components from our suppliers. These components are received at one of our distribution centers and then, based upon production needs, the components are sent to one of several third party fillers which manufacture the finished product for us and deliver them to one of our distribution centers.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36pt">Our fragrance products focus on prestige brands, each with a devoted following. By concentrating in markets where the brands are best known, we have had many successful product launches. We typically launch new fragrance families for our brands every year or two, and more frequently seasonal and limited edition fragrances are introduced as well.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36pt">The creation and marketing of each product family is intimately linked with the brand&#8217;s name, its past and present positioning, customer base and, more generally, the prevailing market atmosphere. Accordingly, we generally study the market for each proposed family of fragrance products for almost a full year before we introduce any new product into the market. This study is intended to define the general position of the fragrance family and more particularly its scent, bottle, packaging and appeal to the buyer. In our opinion, the unity of these four elements of the marketing mix makes for a successful product.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36pt">As with any business, many aspects of our operations are subject to influences outside our control. We believe we have a strong brand portfolio with global reach and potential. As part of our strategy, we plan to continue to make investments behind fast-growing markets and channels to grow market share.&#160;We discuss in greater detail risk factors relating to our business in Item&#160;1A of this Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2021, and the reports that we file from time to time with the SEC.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><i>European Operations</i></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36pt">We produce and distribute our fragrance products primarily under license agreements with brand owners, and fragrance product sales through our European operations represented approximately 75% of net sales for 2021. We have built a portfolio of prestige brands, which include <i>Boucheron, Coach, Jimmy Choo, Karl Lagerfeld, Kate Spade, Lanvin, Moncler, Montblanc, Rochas, S.T. Dupont </i>and <i>Van Cleef &amp; Arpels</i>, whose products are distributed in over 120 countries around the world.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><i>United States Operations</i></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36pt">Prestige brand fragrance products are also produced and marketed through our United States operations, and represented approximately 25% of net sales for the year ended December&#160;31, 2021. These fragrance products are sold under trademarks owned by us or pursuant to license or other agreements with the owners of brands, which include <i>Abercrombie &amp; Fitch, Anna Sui, Dunhill, Ferragamo, Graff, GUESS, Hollister, MCM, Oscar de la Renta and Ungaro</i>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<!-- Field: Page; Sequence: 5; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><b><i><b><i>Recent Developments</i></b></i></b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><i>Salvatore Ferragamo</i></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 36pt">In October 2021, we closed on a transaction agreement with Salvatore Ferragamo S.p.A., whereby an exclusive and worldwide license was granted for the production and distribution of Ferragamo brand perfumes. Our rights under this license are subject to certain minimum advertising expenditures and royalty payments as are customary in our industry. The license is effective from October 2021 and will last for 10 years with a 5-year optional term, subject to certain conditions.&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36pt">With respect to the management and coordination of activities related to the license agreement, the Company will operate through a wholly-owned Italian subsidiary Interparfums Italia srl, which was acquired from Salvatore Ferragamo on October 1, 2021.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><i>Emanuel Ungaro</i></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36pt">In October 2021, we also entered into a 10-year exclusive global licensing agreement a with a 5-year optional
term subject to certain conditions, with Emanuel Ungaro Italia srl, for the creation, development and distribution of fragrances
and fragrance-related products, under the Emanuel Ungaro brand. Our rights under this license are subject to certain minimum advertising
expenditures and royalty payments as are customary in our industry.<b>&#160;</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><i>Donna Karan and DKNY</i></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36pt">In September 2021, we entered into a long-term global licensing agreement for the creation, development and distribution of fragrances and fragrance-related products under the Donna Karan and DKNY brands. Our rights under this license are subject to certain minimum advertising expenditures and royalty payments as are customary in our industry. With this agreement, we are gaining several well-established and valuable fragrance franchises, most notably Donna Karan <i>Cashmere Mist</i> and DKNY <i>Be Delicious</i>, as well as a significant loyal consumer base around the world. The exclusive license is effective July 1, 2022, and we are planning to launch new fragrances under these brands in 2023.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><i>French Tax Settlement </i></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36pt">The French authorities had claimed that the existence of Inter Parfums (Suisse) Sarl, a wholly-owned subsidiary of Interparfums SA, our majority owned Paris-based subsidiary, does not, in and of itself, constitute a permanent establishment, and therefore Interparfums SA should pay French taxes on all or part of the profits of that entity.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36pt">In June 2021, a global settlement agreement was reached with the French Tax Authorities, whereby Interparfums
SA paid in December 2021, &#8364;2.5 million (approximately $2.9 million) effectively lowering the Lanvin brand royalty rate charged
by Inter Parfums (Suisse) Sarl for the periods from 2017 through 2020. Interparfums SA also agreed to apply the lower rate in 2021
through 2025 and to transfer the Lanvin brand from Inter Parfums (Suisse) Sarl to Interparfums SA by December 31, 2025.&#160;&#160;&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<!-- Field: Page; Sequence: 6; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><i></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Land and Building Acquisition - Future
Headquarters in Paris</i></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><i></i></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36pt">In April 2021, Interparfums SA completed the acquisition of its future headquarters at 10 rue de Solf&#233;rino in the 7th arrondissement of Paris from the property developer. This is an office complex combining three buildings connected by two inner courtyards, and consists of approximately 40,000 total sq. ft.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36pt">The $142 million purchase price includes the complete renovation of the site. As of December 31, 2021,
$136.1 million of the purchase price, including approximately $3.1 million of acquisition costs, is included in property, equipment
and leasehold improvements on the accompanying balance sheet as of December 31, 2021. Approximately $8.8 million of cash held in
escrow is included in other assets on the accompanying consolidated balance sheet as of December 31, 2021. In addition, the Company
borrowed $17.0 million pursuant to a short-term loan equal to the VAT credit, and in July 2021, the $17.0 million VAT credit was
reimbursed by the French Tax Authorities and the loan was repaid.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36pt">The acquisition was financed by a 10-year &#8364;120 million (approximately $139 million) bank loan which bears interest at one-month Euribor plus 0.75%. Approximately &#8364;80 million of the variable rate debt was swapped for fixed interest rate debt with a maximum interest rate of 2%.&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36pt">This acquisition is a unique opportunity with benefits to be realized over the long-term. Owning our corporate headquarters in a very prestigious part of Paris, and customizing the complex for our European operations, will enhance our reputation, provide an exceptional work environment, as well as a welcoming and productive atmosphere for our suppliers, distributors and licensors.&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><i>Anna Sui Corp.</i></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36pt">In January 2021, we renewed our license agreement with Anna Sui Corp. for the creation, development and distribution of fragrance products through December&#160;31, 2026, without any material changes in terms and conditions. Our initial 10-year license agreement with Anna Sui Corp. was signed in 2011. The renewal agreement also allows for an additional 5-year term through 2031 at the option of the Company.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><i>Rochas Fashion</i></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36pt">Effective January 1, 2021, we entered into a new license agreement modifying our Rochas fashion business model. The new agreement calls for a reduction in royalties to be received. As a result, in the first quarter of 2021, we took a $2.4 million impairment charge on our Rochas fashion trademark. The new license also contains an option for the licensee to buy-out the Rochas fashion trademarks in June 2025 at its then fair market value.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<!-- Field: Page; Sequence: 7; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><i>S.T. Dupont</i></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36pt">In January 2021, we renewed our license agreement with S.T. Dupont for the creation, development and distribution of fragrance products through December&#160;31, 2022, without any material changes in terms and conditions. Our initial 11-year license agreement with S.T. Dupont was signed in June 1997 and had previously been extended through December 31, 2021.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><i>Origines-Parfums</i></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36pt">In June 2020, the Company through its 73% owned subsidiary, Interparfums SA, and Divabox SAS (&#8220;Divabox&#8221;), owner of the Origines-parfums e-commerce platform for beauty products, signed a strategic agreement and equity investment pursuant to which we acquired a 25% of Divabox capital for $14.0 million, through a capital increase. In connection with the acquisition, the Company entered into a $13.4 million term loan, which was repaid in full in February 2021. As a website of reference for all selective fragrance brands, Origines-parfums is a key French player in the online beauty market recognized for its customer relationship expertise. This agreement should enhance the introduction of dedicated fragrance lines and products designed to address a specific consumer demand for this distribution channel and accelerate our digital development.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><i>Moncler</i></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36pt">In June 2020, the Company entered into an exclusive, 5-year worldwide license agreement with a potential 5-year extension with Moncler for the creation, development and distribution of fragrances under the Moncler brand. Our rights under this license are subject to certain minimum advertising expenditures and royalty payments as are customary in our industry. Moncler was founded at Monestier-de-Clermont, Grenoble, France, in 1952 and is currently headquartered in Italy. Over the years, the brand has combined style with constant technological research assisted by experts in activities linked to the world of the mountain. The Moncler outerwear collections marry the extreme demands of nature with those of city life. Following a successful prelaunch in late 2021, our first fragrance launch for the Moncler brand is rolling out in the first quarter of 2022.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><b><i><b><i>Fragrance Products</i></b></i></b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><i>General</i></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36pt">We are the owner of the Rochas brand, and the Lanvin brand name and trademark for our class of trade. In addition, we have built a portfolio of licensed prestige brands whereby we produce and distribute our prestige fragrance products under license agreements with brand owners. Under license agreements, we obtain the right to use the brand name, create new fragrances and packaging, determine positioning and distribution, and market and sell the licensed products, in exchange for the payment of royalties. Our rights under license agreements are also generally subject to certain minimum sales requirements and advertising expenditures as are customary in our industry.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<!-- Field: Page; Sequence: 8; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36pt">As a percentage of net sales, product sales for the Company&#8217;s largest brands were as follows:</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<table border="0" cellspacing="0" cellpadding="0" style="margin-left: 18.9pt; width: 78%">

<tr>
<td style="vertical-align: bottom"></td>
<td><p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
</td>
<td colspan="10" style="border-bottom: black 1pt solid; border-top-style: none; border-right-style: none; border-left-style: none"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Year
                                         Ended December 31,</b></span></p>
</td>
<td style="vertical-align: bottom"><p style="margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
</td>
</tr>
<tr>
<td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td><p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
</td>
<td colspan="2" style="border-bottom: black 1pt solid; border-top-style: none; border-right-style: none; border-left-style: none"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2021</b></span></p>
</td>
<td style="vertical-align: bottom"><p style="margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
</td>
<td><p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
</td>
<td colspan="2" style="border-bottom: black 1pt solid; border-top-style: none; border-right-style: none; border-left-style: none"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2020</b></span></p>
</td>
<td style="vertical-align: bottom"><p style="margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
</td>
<td><p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
</td>
<td colspan="2" style="border-bottom: black 1pt solid; border-top-style: none; border-right-style: none; border-left-style: none"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2019</b></span></p>
</td>
<td style="vertical-align: bottom"><p style="margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
</td>
</tr>
<tr style="background-color: rgb(204,238,255)">
<td style="width: 42%; vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Montblanc</span></p>
</td>
<td style="width: 2%"><p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
</td>
<td style="width: 1%; vertical-align: bottom"><p style="text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
</td>
<td style="width: 10%; vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">19</span></p>
</td>
<td style="width: 2%; vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></p>
</td>
<td style="width: 1%"><p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
</td>
<td style="width: 1%; vertical-align: bottom"><p style="text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
</td>
<td style="width: 10%; vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">21</span></p>
</td>
<td style="width: 2%; vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></p>
</td>
<td style="width: 1%"><p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
</td>
<td style="width: 1%; vertical-align: bottom"><p style="text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
</td>
<td style="width: 10%; vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">22</span></p>
</td>
<td style="width: 1%; vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></p>
</td>
</tr>
<tr style="background-color: White">
<td style="vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jimmy
                                   Choo</span></p>
</td>
<td><p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
</td>
<td style="vertical-align: bottom"><p style="text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
</td>
<td style="vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">18</span></p>
</td>
<td style="vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></p>
</td>
<td><p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
</td>
<td style="vertical-align: bottom"><p style="text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
</td>
<td style="vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16</span></p>
</td>
<td style="vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></p>
</td>
<td><p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
</td>
<td style="vertical-align: bottom"><p style="text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
</td>
<td style="vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16</span></p>
</td>
<td style="vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></p>
</td>
</tr>
<tr style="background-color: rgb(204,238,255)">
<td style="vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Coach</span></p>
</td>
<td><p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
</td>
<td style="vertical-align: bottom"><p style="text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
</td>
<td style="vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16</span></p>
</td>
<td style="vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></p>
</td>
<td><p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
</td>
<td style="vertical-align: bottom"><p style="text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
</td>
<td style="vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">17</span></p>
</td>
<td style="vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></p>
</td>
<td><p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
</td>
<td style="vertical-align: bottom"><p style="text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
</td>
<td style="vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14</span></p>
</td>
<td style="vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></p>
</td>
</tr>
<tr style="background-color: White">
<td style="vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">GUESS</span></p>
</td>
<td><p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
</td>
<td style="vertical-align: bottom"><p style="text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
</td>
<td style="vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12</span></p>
</td>
<td style="vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></p>
</td>
<td><p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
</td>
<td style="vertical-align: bottom"><p style="text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
</td>
<td style="vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11</span></p>
</td>
<td style="vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></p>
</td>
<td><p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
</td>
<td style="vertical-align: bottom"><p style="text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
</td>
<td style="vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10</span></p>
</td>
<td style="vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></p>
</td>
</tr>

</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36pt">Our licenses expire on the following dates:</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36pt">&#160;</p>
<table border="0" cellspacing="0" cellpadding="0" style="margin: 0px; width: 100%">

<tr>
<td style="border-bottom: black 1pt solid; width: 30%; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><b>Brand Name</b></p>
</td>
<td style="width: 2%; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><b>&#160;</b></p>
</td>
<td style="border-bottom: black 1pt solid; width: 68%; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><b>Expiration Date</b></p>
</td>
</tr>
<tr style="background-color: rgb(204,238,255)">
<td style="width: 30%; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Abercrombie &amp; Fitch</p>
</td>
<td style="width: 2%; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
</td>
<td style="width: 68%; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Extends until either party terminates on 3 years&#8217; notice</p>
</td>
</tr>
<tr style="background-color: White">
<td style="width: 30%; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Anna Sui</p>
</td>
<td style="width: 2%; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
</td>
<td style="width: 68%; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">December 31, 2026, plus one 5-year optional term</p>
</td>
</tr>
<tr style="background-color: rgb(204,238,255)">
<td style="width: 30%; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">bebe Stores</p>
</td>
<td style="width: 2%; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
</td>
<td style="width: 68%; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">June 30, 2023</p>
</td>
</tr>
<tr style="background-color: White">
<td style="width: 30%; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Boucheron</p>
</td>
<td style="width: 2%; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
</td>
<td style="width: 68%; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">December 31, 2025, plus a 5-year optional term if certain sales targets are met</p>
</td>
</tr>
<tr style="background-color: rgb(204,238,255)">
<td style="width: 30%; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Coach</p>
</td>
<td style="width: 2%; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
</td>
<td style="width: 68%; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">June 30, 2026</p>
</td>
</tr>
<tr style="background-color: White">
<td style="width: 30%; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Donna Karan</p>
</td>
<td style="width: 2%; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
</td>
<td style="width: 68%; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">December 31, 2032*, plus a 5-year optional term if certain sales targets are met</p>
</td>
</tr>
<tr style="background-color: rgb(204,238,255)">
<td style="width: 30%; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Dunhill</p>
</td>
<td style="width: 2%; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
</td>
<td style="width: 68%; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">September 30, 2023</p>
</td>
</tr>
<tr style="background-color: White">
<td style="width: 30%; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Emanuel Ungaro</p>
</td>
<td style="width: 2%; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
</td>
<td style="width: 68%; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">December 31, 2031, plus a 5-year optional term if certain sales targets are met</p>
</td>
</tr>
<tr style="background-color: rgb(204,238,255)">
<td style="width: 30%; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">French Connection</p>
</td>
<td style="width: 2%; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
</td>
<td style="width: 68%; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">December 31, 2027, plus a 10-year optional term if certain sales targets are met</p>
</td>
</tr>
<tr style="background-color: White">
<td style="width: 30%; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Graff</p>
</td>
<td style="width: 2%; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
</td>
<td style="width: 68%; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">December 31, 2026, plus 3 optional 3-year terms if certain sales targets are met</p>
</td>
</tr>
<tr style="background-color: rgb(204,238,255)">
<td style="width: 30%; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">GUESS</p>
</td>
<td style="width: 2%; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
</td>
<td style="width: 68%; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">December 31, 2033</p>
</td>
</tr>
<tr style="background-color: White">
<td style="width: 30%; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Hollister</p>
</td>
<td style="width: 2%; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
</td>
<td style="width: 68%; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Extends until either party terminates on 3 years&#8217; notice</p>
</td>
</tr>
<tr style="background-color: rgb(204,238,255)">
<td style="width: 30%; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Kate Spade</p>
</td>
<td style="width: 2%; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
</td>
<td style="width: 68%; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">June 30, 2030</p>
</td>
</tr>
<tr style="background-color: White">
<td style="width: 30%; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Jimmy Choo</p>
</td>
<td style="width: 2%; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
</td>
<td style="width: 68%; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">December 31, 2031</p>
</td>
</tr>
<tr style="background-color: rgb(204,238,255)">
<td style="width: 30%; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Karl Lagerfeld</p>
</td>
<td style="width: 2%; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
</td>
<td style="width: 68%; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">October 31, 2032</p>
</td>
</tr>
<tr style="background-color: White">
<td style="width: 30%; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">MCM</p>
</td>
<td style="width: 2%; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
</td>
<td style="width: 68%; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">December 31, 2030, plus 4 option years</p>
</td>
</tr>
<tr style="background-color: rgb(204,238,255)">
<td style="width: 30%; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Moncler</p>
</td>
<td style="width: 2%; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
</td>
<td style="width: 68%; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">December 31, 2026, plus a 5-year optional term if certain conditions are met</p>
</td>
</tr>
<tr style="background-color: White">
<td style="width: 30%; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Montblanc</p>
</td>
<td style="width: 2%; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
</td>
<td style="width: 68%; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">December 31, 2025</p>
</td>
</tr>
<tr style="background-color: rgb(204,238,255)">
<td style="width: 30%; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Oscar de la Renta</p>
</td>
<td style="width: 2%; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
</td>
<td style="width: 68%; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">December 31, 2031, plus a 5-year optional term if certain sales targets are met</p>
</td>
</tr>
<tr style="background-color: White">
<td style="width: 30%; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Repetto</p>
</td>
<td style="width: 2%; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
</td>
<td style="width: 68%; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">December 31, 2024</p>
</td>
</tr>
<tr style="background-color: rgb(204,238,255)">
<td style="width: 30%; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Salvatore Ferragamo</p>
</td>
<td style="width: 2%; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
</td>
<td style="width: 68%; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">December 31, 2031, plus a 5-year optional term if certain sales targets are met</p>
</td>
</tr>
<tr style="background-color: White">
<td style="width: 30%; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">S.T. Dupont</p>
</td>
<td style="width: 2%; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
</td>
<td style="width: 68%; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">December 31, 2022</p>
</td>
</tr>
<tr style="background-color: rgb(204,238,255)">
<td style="width: 30%; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Van Cleef &amp; Arpels</p>
</td>
<td style="width: 2%; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
</td>
<td style="width: 68%; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">December 31, 2024</p>
</td>
</tr>

</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">* License effective date is July 1, 2022.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<!-- Field: Page; Sequence: 9; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36pt">In connection with the acquisition of the Lanvin brand names and trademarks for our class of trade, we granted the seller the right to repurchase the brand names and trademarks on July 1, 2027 for &#8364;70 million (approximately $79 million) in accordance with an amendment signed in 2021. In connection with such amendment, we also granted a license to the seller to develop and sell cosmetics other than fragrances.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><i>Fragrance Portfolio</i>&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><b>Abercrombie&amp; Fitch &#8212; </b>In 2014, we entered into a worldwide license to create, produce and distribute new fragrances and fragrance related products under the Abercrombie &amp; Fitch brand name. We distribute these fragrances in specialty stores, department stores and duty free shops, and in the U.S., in select Abercrombie &amp; Fitch retail stores. Our initial men&#8217;s scent, <i>First Instinct</i> was launched in 2016 followed by a women&#8217;s version in 2017. Since that time, we unveiled several new fragrances most notably the <i>Authentic </i>and <i>Away </i>duos<i> </i>as well as brand extensions.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36pt">Abercrombie &amp; Fitch Co. is a leading, global, omnichannel specialty retailer of apparel and accessories for men, women and kids. The iconic Abercrombie &amp; Fitch brand was born in 1892 and aims to make every day feel as exceptional as the start of a long weekend.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><b>Anna Sui&#8212;</b>In 2011, we entered into an exclusive worldwide fragrance license to create, produce and distribute fragrances and fragrance related products under the Anna Sui brand. Anna Sui is one of New York&#8217;s most accomplished fashion designers known for creating contemporary clothing inspired by vintage style that capture the brand&#8217;s very sweet feminine girly aspect, combined with touch hipness and rock-and-roll.&#160;Today, Anna Sui has over 50 boutiques and her collection and products are sold in 300 stores in over 30 countries, but her brand is by far most popular and well received throughout Asia.&#160;Over the past decade, we have worked in partnership Anna Sui and her creative team to build upon the brand&#8217;s customer appeal and develop and market a family of fragrances including <i>Fantasia</i>, <i>Sui Dreams</i> and the newest scent, <i>Sky,</i> which was ranked as the second best perfume launch of 2021 by WWD Japan.&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><b>Boucheron&#8212; </b>In 2010, we entered into an exclusive 15-year worldwide license agreement for the creation, development and distribution of fragrances under the Boucheron brand. For over a century, since becoming the first jeweler to open a boutique on Place Vend&#244;me in 1893, Boucheron has embodied very high-end creation, luxury and French know-how. The mysterious and seductive collection of Boucheron fragrances unquestionably continues this prestigious.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36pt">Boucheron legacy scents,<i> Femme</i> and <i>Homme</i>, and the legendary <i>Jaipur</i> perfume form the foundation of brand sales.&#160;Our team has enriched the portfolio with <i>Quatre</i> for men and women, along with several special editions, a growing collection of unique scents aptly named, <i>La Collection</i>, and <i>Serpent Boheme.</i> We have a new Boucheron men&#8217;s fragrance in the works for 2022, as well as still another addition to our Boucheron <i>Collection</i>.&#160;Currently Boucheron operates through over 66 boutiques worldwide as well as an e-commerce site.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<!-- Field: Page; Sequence: 10; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><b>Coach</b>&#8212; In 2015,
we entered into an exclusive 11-year worldwide license to create, produce and distribute new men&#8217;s and women&#8217;s fragrances
and fragrance related products under the Coach brand name. We distribute these fragrances globally to department stores, specialty
stores and duty free shops, as well as in Coach retail stores.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36pt">Founded in 1941, Coach is the ultimate American leather goods brand and has always been renowned for its quality craftsmanship.&#160;Now the luxury brand that best embodies New York&#8217;s casual elegance, Coach also offers collections of ready-to-wear, lifestyle accessories and fragrances. Its contemporary approach to luxury combines authenticity and innovation, exported worldwide thanks to its thoroughly American non-conformist vision.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36pt">In 2016, we launched our first Coach fragrance, a women&#8217;s signature scent, and in 2017, a men&#8217;s scent, both of which became and remain top selling prestige fragrances. Subsequent flankers and extensions have enlarged the Coach fragrance enterprise as have entirely new collections, including <i>Coach Dreams</i> which debuted in early 2020, and its sister scent, <i>Dreams Sunset</i>, debuting in 2021. For 2022, we have a new pillar for men unveiling, and new edition to the Coach women&#8217;s line. Coach is part of the Tapestry house of brands.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><b>Donna Karan&#8212; </b>In September 2021, we entered into a long-term global licensing agreement for the creation, development and distribution of fragrances and fragrance-related products under the Donna Karan and DKNY brands, which takes effect on July 1, 2022. The Donna Karan and DKNY brands, which draw from the energy and attitude of New York City, are powerhouses in fashion and fragrance. These global lifestyle brands will make excellent additions to our portfolio. With this agreement, we are gaining several well-established and valuable fragrance franchises, most notably Donna Karan <i>Cashmere Mist</i> and DKNY <i>Be Delicious</i>, as well as a significant loyal consumer base around the world. Upon joining our portfolio, these brands will rank among our largest. We are planning to launch new fragrances under these brands in 2023.&#160;Donna Karan and DKNY are part of the G-III house of brands.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><b>Dunhill&#8212;</b>Since 2012, we have been the exclusive fragrance licensee whereby we create, produce and distribute fragrances and fragrance related products under the Dunhill brand.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36pt">Founded by Alfred Dunhill in 1893 in London, the brand evolved from a leather harness business to creating accessories for the first motorists. For over 100 years the brand has been recognized as the destination for leather and men&#8217;s luxury goods. Dunhill today continues to create exquisitely designed luxury products - fashion and ingenious accessories for the modern man. The exquisite products are made with the highest level of craftsmanship for the most discerning clients.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36pt">The Dunhill fragrance family encompasses a wide array of men&#8217;s scents and related brand extensions including <i>Century</i>, <i>Icon </i>and <i>Driven</i>. A new fragrance dynasty was born with the Dunhill <i>Signature Collection</i> which since its debut in 2019 has added several new members.&#160;Dunhill is currently owned by Richemont Holdings Limited.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<!-- Field: Page; Sequence: 11; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><b>Emanuel Ungaro&#8212; </b>In October 2021, we also entered into a 10-year exclusive global licensing agreement with Emanuel Ungaro for the creation, development and distribution of fragrances and fragrance-related products, under the Emanuel Ungaro brand.<b>&#160;</b>Founded in 1965 in Paris, the house Emanuel Ungaro is an icon of French refinement and haute couture. Its unique style is expressed through unquestioning sensuality, purity of silhouette, flamboyant prints, and exquisite attention to details. Season after season, Emanuel Ungaro dared to be different,&#160;combining unexpected yet sensual clashes of bright colors&#160;and prints with beautiful draping. Today Ungaro fragrances uphold the same values of audacity and elegance, and the brand is best known and most prized internationally, and such presence will remain our sales focus as we continue to produce and distribute the brand&#8217;s legacy scents, notably <i>Diva. </i>Beginning in 2023, we plan to unveil a new fragrance incorporating disruptive design, driven by creativity, sustainability and authenticity.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><b>Graff</b>&#8212; In 2018, we entered into an exclusive, 8-year worldwide license agreement with London-based Graff for the creation, development and distribution of fragrances under the Graff brand. The 8-year agreement has three 3-year automatic renewal options, potentially extending the license until December 31, 2035.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36pt">Since Laurence Graff OBE founded the company in 1960, Graff has been dedicated to sourcing and crafting diamonds and gemstones of untold beauty and rarity and transforming them into spectacular pieces of jewelry that move the heart and stir the soul. Throughout its rich history, Graff has become the world leader for diamonds of rarity, magnitude and distinction. Each jewelry creation is designed and manufactured in Graff&#8217;s London atelier, where master craftsmen employ techniques to emphasize the beauty of each individual stone. The company remains a family business, overseen by Francois Graff, Chief Executive Officer.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36pt">For Graff, a six-scent collection for women, <i>Lesedi La Rona</i>, debuted exclusively at Harrods beginning in March 2020, which we further extended through 2020 as a result of the mandatory store closings throughout that year. In 2021, a select market rollout began in the Middle East, with limited luxury distribution to only the most exclusive, upmarket retail outlets. In 2021, we added two new scents for the <i>Lesedi La Rona</i> collection.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><b>GUESS</b>&#8212; In 2018, we entered into an exclusive, 15-year worldwide license agreement with GUESS?, Inc. for the creation, development and distribution of fragrances under the GUESS brand.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36pt">Established in 1981, GUESS began as a jeans company and has since successfully grown into a global lifestyle brand.&#160;GUESS?, Inc. designs, markets, distributes and licenses a lifestyle collection of contemporary apparel, denim, handbags, watches, footwear and other related consumer products. GUESS products are distributed through branded GUESS stores as well as better department and specialty stores around the world.&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36pt">We began selling GUESS legacy scents in 2018. In 2019 the GUESS brand quickly became the largest within our U.S. operations, with legacy fragrances dominating the sales mix. In 2019, we began shipments of <i>1981 Los Angeles</i> and <i>Seductive Noir</i>, both flankers of established scents, which accelerated brand growth.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<!-- Field: Page; Sequence: 12; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36pt">Nearly three years in the making, our first new blockbuster scent, <i>Bella Vita</i>, debuted for the GUESS brand both domestically and internationally in 2021. In addition, <i>Effect,</i> a new men&#8217;s grooming line and fragrance collection was launched in 2021. <i>Uomo</i>, a new men&#8217;s fragrance for GUESS, comes to market in 2022.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><b>Hollister&#8212; </b>In 2014, we entered into a worldwide license to create, produce and distribute new fragrances and fragrance related products under the Hollister brand name. We distribute these fragrances in specialty stores, department stores and duty free shops, as well as select Hollister retail stores in the U.S. In 2016 we launched our first men&#8217;s and women&#8217;s fragrance duo, <i>Wave </i>which led to flankers and extensions as did subsequent fragrance families <i>Festival</i> and <i>Canyon Escape</i>.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36pt">The quintessential apparel brand of the global teen consumer, Hollister Co. celebrates the liberating spirit of the endless summer inside everyone. Inspired by California&#8217;s laidback attitude, Hollister&#8217;s clothes are designed to be lived in and made your own, for wherever life takes you.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><b>Jimmy Choo&#8212;</b> In 2009, we entered into an exclusive 12-year worldwide license agreement for the creation, development and distribution of fragrances and fragrance related products under the Jimmy Choo brand, and in 2017, we extended the license agreement which now runs through December 31, 2031.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36pt">Jimmy Choo encompasses a complete luxury accessories brand. Women&#8217;s shoes remain the core of the product offering, alongside handbags, small leather goods, scarves, eyewear, belts, fragrance and men&#8217;s shoes. Jimmy Choo has a global store network encompassing more than 200 stores and is present in the most prestigious department and specialty stores worldwide. Jimmy Choo is part of the Capri Holdings Limited luxury fashion group.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36pt">Our initial Jimmy Choo fragrance was launched in 2011, a signature scent for women.&#160;In the decade that followed, Jimmy Choo has grown to become our second largest brand with new pillars and flankers debuting regularly, both for men and women.&#160;Our newest women&#8217;s fragrance, <i>I Want Choo,</i> was launched in 2021 and for 2022, we have a new <i>Jimmy Choo Man</i> flanker as well as one for <i>I Want Choo</i>.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><b>Karl Lagerfeld&#8212; </b>In 2012, we entered into a 20-year worldwide license agreement with Karl Lagerfeld B.V., the internationally renowned haute couture fashion house, to create, produce and distribute fragrances under the Karl Lagerfeld brand.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36pt">Under the creative direction of the late Karl Lagerfeld, one of the world&#8217;s most influential and iconic designers, the Lagerfeld Portfolio represents a modern approach to distribution, an innovative digital strategy and a global 360 degree vision that reflects the designer&#8217;s own style and soul. Karl Lagerfeld created the first fragrance that bears his name in 1978, and that legacy has expanded to include several growing multi-scent collection, <i>Les Parfums Mati&#232;res </i>and most recently, <i>Karl Cities, </i>a new collection featuring entries for New York,&#160;Paris, Hamburg and Tokyo.&#160;was unveiled.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<!-- Field: Page; Sequence: 13; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><b>Kate Spade&#8212; </b>In 2019, we entered into an exclusive, 11-year worldwide license agreement with Kate Spade to create, produce and distribute new perfumes and fragrance related products under the Kate Spade brand which we distribute globally to department and specialty stores and duty free shops, as well as in Kate Spade retail stores. Our first original scent, <i>Kate Spade New York</i>, debuted in January 2021 and for 2022, we are adding a flanker to our line.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36pt">Since its launch in 1993 with a collection of six essential handbags, Kate Spade has always stood for optimistic femininity. Today, the brand is a global life and style house with handbags, ready-to-wear, jewelry, footwear, gifts, home d&#233;cor and more. Polished ease, thoughtful details and a modern, sophisticated use of color&#8212;Kate Spade&#8217;s founding principles define a unique style synonymous with joy. Under the vision of its creative director, the brand continues to celebrate confident women with a youthful spirit. Kate Spade is part of the Tapestry house of brands.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><b>Lanvin&#8212; </b>In 2007, we acquired the worldwide rights to the Lanvin brand names and international trademarks listed in Class 3, our class of trade. A synonym of luxury and elegance, the Lanvin fashion house, founded in 1889 by Jeanne Lanvin, expanded into fragrances in the 1920s.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36pt">Lanvin fragrances occupy an important position in the selective distribution market in France, Eastern Europe and Asia, and we have several lines currently in distribution, including <i>&#201;clat d&#8217;Arp&#232;ge</i>, <i>Lanvin L&#8217;Homme</i>, <i>Jeanne Lanvin, Modern Princess </i>and<i> A Girl in Capri</i>. The <i>&#201;clat d&#8217;Arp&#232;ge </i>line accounts for almost 50% of brand sales. <i><span style="text-decoration: none; color: windowtext"><i>Les Fleurs de Lanvin</i></span></i><i>, </i>a new floral fragrance collection, was released during the second half 2021. For 2022, we have a new extension unveiling for our <i>&#201;clat d&#8217;Arp&#232;ge</i> line.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><b>MCM&#8212; </b>In 2019, we entered into an exclusive, 10-year worldwide license agreement with German luxury fashion house MCM for the creation, development and distribution of fragrances under the MCM brand.&#160;The agreement has a 4-year automatic renewal option, potentially extending the license until December 31, 2034.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36pt">MCM is a
luxury lifestyle goods and fashion house founded in 1976 with an attitude defined by the cultural Zeitgeist and its German heritage
with a focus on functional innovation, including the use of cutting-edge techniques. Today, through its association with music,
art, travel and technology, MCM embodies the bold, rebellious and aspirational. Always with an eye on the disruptive, the driving
force behind MCM centers on revolutionizing classic design with futuristic materials. MCM&#8217;s millennial and Gen Z audience
is genderless, ageless, empowered and unconstrained by rules and boundaries.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36pt">Following through on our plan to develop extraordinary fragrances that capture the creative spirit of MCM, our first new fragrance, <i>MCM</i>, was released during the first quarter of 2021 to great, and somewhat unexpected success. A flanker is in the pipeline for 2022 along with a limited edition called <i>Graffiti</i>.&#160;Our distribution strategy encompasses MCM stores, high-end department stores and prestige beauty retailers, with a geographic focus on Asia, the Americas and Europe.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<!-- Field: Page; Sequence: 14; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Moncler&#8212; </b>In June 2020, we
entered into an exclusive, 5-year worldwide license agreement with a potential 5-year extension with Moncler for the creation,
development and distribution of fragrances under the Moncler brand. Moncler was founded at Monestier-de-Clermont, Grenoble, France,
in 1952 and is currently headquartered in Italy. Over the years, the brand has combined style with constant technological research
assisted by experts in activities linked to the world of the mountain. The Moncler outerwear collections marry the extreme demands
of nature with those of city life.</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36pt">Our first fragrance for the Moncler brand has a revolutionary LED design, and the flask-shaped bottles of <i>Moncler Pour Femme</i> and <i>Moncler Pour</i> <i>Homme</i> forge a powerful bond with the House Moncler&#8217;s alpine roots and pioneering spirit. This playful and unique innovation enables its owner&#160;to write a personalized note that scrolls in red letters on the screen of the mirror bottle. Our first fragrance was pre-launched in 250 select outlets in the second half of 2021, and was met with an excellent response. A full rollout to approximately 3,000 doors began in early 2022.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><b>Montblanc&#8212;</b>In 2010, we entered into an exclusive license agreement to create, develop and distribute fragrances and fragrance related products under the Montblanc brand. In 2015, we extended the agreement which now runs through December 31, 2025.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36pt">Montblanc has achieved a world-renowned position in the luxury segment and has become a purveyor of exclusive products, which reflect today&#8217;s exacting demands for timeless design, tradition and master craftsmanship. Through its leadership positions in writing instruments, watches and leather goods, promising growth outlook in women&#8217;s jewelry, international retail footprint through its network of more than 600 boutiques, high standards of product design and quality, Montblanc has grown to be our largest fragrance brand.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36pt">In 2011, we launched our first new Montblanc fragrance, <i>Legend, </i>which quickly became our best-selling men&#8217;s line and has given rise to a plethora of flankers including <i>Legend Night</i> and <i>Legend Spirit.</i> In 2014, we launched our second men&#8217;s line, <i>Emblem </i>and like its predecessor, <i>Emblem</i> gave rise to brand extensions. In 2019, we unveiled Montblanc <i>Explorer</i>, which has added flankers, most recently Montblanc <i>Explorer Ultra Blue</i>. The <i>Legend</i> continues, as in 2022, we will be introducing a new flanker, Montblanc <i>Legend Red</i>.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><b>Oscar de la Renta&#8212;</b> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
2013, we entered into an exclusive worldwide license to create, produce and distribute fragrances and fragrance related products
under the Oscar de la Renta brand. In 2019, the agreement was extended through December 31, 2031, with an additional five-year
option potentially extending the agreement through December 31, 2036. After taking over distribution of the brand&#8217;s legacy
fragrances in 2014, we introduced <i>Extraordinary </i>the following year. Oscar de la Renta <i>Bella Blanca</i> debuted in 2018,
followed by <i>Bella Rosa </i>and <i>Bella Essence </i>and soon to join them, <i>Bella Bouquet</i>. Debuting in 2021 was an entirely
new fragrance pillar, <i>Alibi</i> which will welcome a sister scent in 2022.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36pt">Oscar de la Renta is one of the world&#8217;s leading luxury goods firms. The New York-based company was established in 1965, and encompasses a full line of women&#8217;s accessories, bridal, children&#8217;s wear, fragrance, beauty and home goods, in addition to its internationally renowned signature women&#8217;s ready to wear collection. Oscar de la Renta products are sold globally in fine department and specialty stores, www.oscardelarenta.com and through wholesale channels.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<!-- Field: Page; Sequence: 15; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><b>Rochas</b>&#8212; In 2015, we acquired the Rochas brand from The Procter &amp; Gamble Company. Founded by Marcel Rochas in 1925, the brand began as a fashion house and expanded into perfumery in the 1950s under H&#233;l&#232;ne Rochas&#8217; direction.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36pt">Our first new fragrance for Rochas, <i>Mademoiselle Rochas</i>, had a successful launch in 2017 in its traditional markets of France and Spain. Over the next few years, we debuted flankers for legacy scents <i>Eau de Rochas</i> and <i>Mademoiselle Rochas, </i>plus others and in 2018 we launched our first new men&#8217;s line, Rochas <i>Moustache</i>.&#160;<i>Byzance</i> debuted in early 2020 and <i>Rochas Girl</i> in 2021, and the first flanker for both will come to market in 2022 as well as one for <i>L&#8217;Homme Rochas.</i></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><b>Salvatore Ferragamo&#8212; </b>In October 2021, we closed on a transaction agreement with Salvatore Ferragamo S.p.A., whereby an exclusive and worldwide 10-year license was granted for the production and distribution of Ferragamo brand perfumes, with a 5-year optional term if certain conditions are met. Salvatore Ferragamo S.p.A. is the parent company of the Salvatore Ferragamo Group, one of the world&#8217;s leaders in the luxury industry and whose origins date back to 1927. &#160;Named after its founder, the brand still represents and lives by the original values of Salvatore Ferragamo.The uniqueness and exclusivity of its creations, along with the perfect blend of style, creativity and innovation enriched by the quality and superior craftsmanship of the &#8216;Made in Italy&#8217; tradition, have always been the hallmarks of the Salvatore Ferragamo&#8217;s products notably&#160;shoes, leather goods, apparel, silk products and other accessories for men and women.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36pt"><span style="border: windowtext 1pt none; padding: 0pt">The current fragrance lineup includes <i>Storie di Seta,</i> a new collection of four refined, luminous olfactory works of art. Each fragrance is made with rare, sustainable raw materials, and can be worn alone or in combination, creating a personalized multifaceted scent. The genderless collection is comprised of four fragrances in four colors. Four exclusive motifs drawn from the House&#8217;s textile heritage adorn each flacon. Established scents in the Ferragamo portfolio include <i>Ferragamo</i>, a collection of fragrances for men, <i>Signoria</i>, a collection of fragrances for women, the <i>Tuscan Creations</i> series, the <i>Amo</i> series and the <i>Uomo </i>series.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>S.T. Dupont&#8212;</b> In 1997, we signed
an exclusive worldwide license agreement with S.T. Dupont for the creation, manufacture and distribution of S.T. Dupont fragrances.
The license agreement had been renewed several times and is now renewed annually, without any material changes in terms and conditions.
S.T. Dupont is a French luxury goods house founded in 1872, which is known for its fine writing instruments, lighters and leather
goods. S.T. Dupont fragrances include <i>S.T. Dupont pour Femme</i>, <i>S.T. Dupont pour Homme, Pure</i> and <i>S.T. Dupont Collection.</i></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><b>Van Cleef &amp; Arpels&#8212; </b>In 2018, we renewed its license agreement for an additional six years with Van Cleef &amp; Arpels for the creation, development, and distribution of fragrance products through December 2024. Our initial 12-year license agreement with Van Cleef &amp; Arpels was signed in 2006.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<!-- Field: Page; Sequence: 16; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36pt">Van Cleef &amp; Arpels fragrances in current distribution include: <i>First </i>and <i>Collection Extraordinaire. </i>Sales of the <i>Collection Extraordinaire</i> line have experienced continued growth since its debut. We continue to introduce new additions to the Van Cleef &amp; Arpels <i>Collection Extraordinaire</i> assortment annually, including <i>Oud Blanc</i>, in 2020 and <i>R&#233;ve de Matiere </i>in 2021. <i>Patchouli Blanc</i> is the new additions to the <i>Collection Extraordinaire</i>, scheduled for 2022.&#160;Founded in 1896, Van Cleef &amp; Arpels is a French luxury jewelry company owned by Richemont Holdings Limited.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><b><i><b><i>Business Strategy </i></b></i></b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><b>Focus on prestige beauty brands</b>. Prestige beauty brands are expected to contribute significantly to our growth. We focus on developing and launching quality fragrances utilizing internationally renowned brand names. By identifying and concentrating in the most receptive market segments and territories where our brands are known, and executing highly targeted launches that capture the essence of the brand, we have had a history of successful launches. Certain fashion designers and other licensors choose us as a partner, because our Company&#8217;s size enables us to work more closely with them in the product development process as well as our successful track record.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><b>Grow portfolio brands through new product development and marketing</b>. We grow through the creation of fragrance family extensions within the existing brands in our portfolio. Every year or two, we create a new family of fragrances for each brand in our portfolio. We frequently introduce seasonal and limited edition fragrances as well. With new introductions, we leverage our ability and experience to gauge trends in the market and further leverage the brand name into different product families in order to maximize sales and profit potential. We have had success in introducing new fragrance families (sub-brands, flanker brands or flankers) within our brand franchises. Furthermore, we promote the performance of our prestige fragrance operations through knowledge of the market, detailed analysis of the image and potential of each brand name, and a highly professional approach to international distribution channels.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><b>Continue to add new brands to our portfolio,
through new licenses or acquisitions<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></b><span style="font: 10pt Times New Roman, Times, Serif">
Prestige brands are the core of our business, and we intend to add new prestige beauty brands to our portfolio. Over the past
30 years, we have built our portfolio of well-known prestige brands through acquisitions and new license agreements. We intend
to further build on our success in prestige fragrances and pursue new licenses and acquire new brands to strengthen our position
in the prestige beauty market. To that end, in 2020, we signed a new license for the Moncler brand. We also acquired a minority
interest in Divabox, which owns the Origines-parfums online platform. As a website of reference for all selective fragrance brands,
Origines-parfums is a key French player in the online beauty market recognized for its customer relationship expertise. This acquisition
enhances the introduction of dedicated fragrance lines and products designed to address a specific consumer demand for this distribution
channel and accelerate our digital development.&#160;During 2021, we closed on a transaction agreement with Salvatore Ferragamo
S.p.A., whereby an exclusive and worldwide license was granted for the production and distribution of Ferragamo brand perfumes.
In 2021, we also entered into a long-term global licensing agreement for the creation, development and distribution of fragrances
and fragrance-related products under the Donna Karan and DKNY brands. This exclusive license becomes effective on July 1, 2022.
As of December 31, 2021, we had cash, cash equivalents and short-term investments of approximately $320 million, which we believe
should assist us in entering new brand licenses or out-right acquisitions. We identify prestige brands that can be developed and
marketed into a full and varied product families and, with our technical knowledge and practical experience gained over time,
take licensed brand names through all phases of concept, development, manufacturing, marketing and distribution.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<!-- Field: Page; Sequence: 17; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><b>Expand existing portfolio into new categories</b>. We selectively broaden our product offering beyond the fragrance category and offer other fragrance related products and personal care products under some of our existing brands. We believe such product offerings meet customer needs and further strengthen customer loyalty.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Continue to build global distribution
footprint</b>. Our business is a global business, and we intend to continue to build our global distribution footprint. In order
to adapt to changes in the environment and our business, in addition to our arrangements with third party distributors globally,
we are operating distribution subsidiaries or divisions in the major markets of the United States, France and Spain for distribution
of prestige fragrances. We may look into future joint arrangements or acquire distribution companies within other key markets to
distribute certain of our prestige brands. While building a global distribution footprint is part of our long-term strategy, we
may need to make certain decisions based on the short-term needs of the business. We believe that in certain markets, vertical
integration of our distribution network may be one of the keys to future growth of our Company, and ownership of such distribution
should enable us to better serve our customers&#8217; needs in local markets and adapt more quickly as situations may determine.</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><b><i><b><i>Production and Supply</i></b></i></b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">The stages of the development and production process for all fragrances are as follows:</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<table border="0" cellspacing="0" cellpadding="0" style="width: 100%">

<tr>
<td style="width: 36pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#160;</p>
</td>
<td style="width: 18pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#9679;</p>
</td>
<td style="vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">Simultaneous discussions with perfume designers and creators (includes analysis of esthetic and olfactory trends, target clientele and market communication approach)</p>
</td>
</tr>

<tr>
<td style="vertical-align: top"><span style="font-size: 10pt">&#160;</span></td>
<td style="vertical-align: top"><span style="font-size: 10pt">&#160;</span></td>
<td style="vertical-align: top"><span style="font-size: 10pt">&#160;</span></td></tr>
</table>

<table border="0" cellspacing="0" cellpadding="0" style="width: 100%">

<tr>
<td style="width: 36pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#160;</p>
</td>
<td style="width: 18pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#9679;</p>
</td>
<td style="vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">Concept choice</p>
</td>
</tr>

<tr>
<td style="vertical-align: top"><span style="font-size: 10pt">&#160;</span></td>
<td style="vertical-align: top"><span style="font-size: 10pt">&#160;</span></td>
<td style="vertical-align: top"><span style="font-size: 10pt">&#160;</span></td></tr>
</table>

<table border="0" cellspacing="0" cellpadding="0" style="width: 100%">

<tr>
<td style="width: 36pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#160;</p>
</td>
<td style="width: 18pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#9679;</p>
</td>
<td style="vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">Produce mock-ups for final acceptance of bottles and packaging</p>
</td>
</tr>

<tr>
<td style="vertical-align: top"><span style="font-size: 10pt">&#160;</span></td>
<td style="vertical-align: top"><span style="font-size: 10pt">&#160;</span></td>
<td style="vertical-align: top"><span style="font-size: 10pt">&#160;</span></td></tr>
</table>

<table border="0" cellspacing="0" cellpadding="0" style="width: 100%">

<tr>
<td style="width: 36pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#160;</p>
</td>
<td style="width: 18pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#9679;</p>
</td>
<td style="vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">Receive bids from component suppliers (glass makers, plastic processors, printers, etc.) and packaging companies</p>
</td>
</tr>

<tr>
<td style="vertical-align: top"><span style="font-size: 10pt">&#160;</span></td>
<td style="vertical-align: top"><span style="font-size: 10pt">&#160;</span></td>
<td style="vertical-align: top"><span style="font-size: 10pt">&#160;</span></td></tr>
</table>

<table border="0" cellspacing="0" cellpadding="0" style="width: 100%">

<tr>
<td style="width: 36pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#160;</p>
</td>
<td style="width: 18pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#9679;</p>
</td>
<td style="vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">Choose suppliers</p>
</td>
</tr>

<tr>
<td style="vertical-align: top"><span style="font-size: 10pt">&#160;</span></td>
<td style="vertical-align: top"><span style="font-size: 10pt">&#160;</span></td>
<td style="vertical-align: top"><span style="font-size: 10pt">&#160;</span></td></tr>
</table>

<table border="0" cellspacing="0" cellpadding="0" style="width: 100%">

<tr>
<td style="width: 36pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#160;</p>
</td>
<td style="width: 18pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#9679;</p>
</td>
<td style="vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">Schedule production and packaging</p>
</td>
</tr>

</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;&#160;</p>
<!-- Field: Page; Sequence: 18; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<table border="0" cellspacing="0" cellpadding="0" style="width: 100%">

<tr>
<td style="width: 36pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#160;</p>
</td>
<td style="width: 18pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#9679;</p>
</td>
<td style="vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">Issue component purchase orders</p>
</td>
</tr>

</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;&#160;</p>
<table border="0" cellspacing="0" cellpadding="0" style="width: 100%">

<tr>
<td style="width: 36pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#160;</p>
</td>
<td style="width: 18pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#9679;</p>
</td>
<td style="vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">Follow quality control procedures for incoming components; and</p>
</td>
</tr>

</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;&#160;</p>
<table border="0" cellspacing="0" cellpadding="0" style="width: 100%">

<tr>
<td style="width: 36pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#160;</p>
</td>
<td style="width: 18pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#9679;</p>
</td>
<td style="vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">Follow packaging and inventory control procedures.</p>
</td>
</tr>

</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">Suppliers who assist us with product development include, but are not limited to<b>:</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<table border="0" cellspacing="0" cellpadding="0" style="width: 100%">

<tr>
<td style="width: 36pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#160;</p>
</td>
<td style="width: 18pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#9679;</p>
</td>
<td style="vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">Independent perfumery design companies (Aesthete, Carr&#233; Basset, PI Design, Cent Degres)</p>
</td>
</tr>

</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;&#160;</p>
<table border="0" cellspacing="0" cellpadding="0" style="width: 100%">

<tr>
<td style="width: 36pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#160;</p>
</td>
<td style="width: 18pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#9679;</p>
</td>
<td style="vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">Perfumers (IFF, Givaudan, Firmenich,
Robertet, Takasago, Mane) which create a fragrance consistent with our expectations and, that of the fragrance designers and creators</p>
</td>
</tr>
<tr>
<td>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#160;</p>
</td>
<td>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#160;</p>
</td>
<td>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#160;</p>
</td>
</tr>
<tr>
<td style="vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#160;</p>
</td>
<td style="vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#9679;</p>
</td>
<td style="vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">Fillers (Voyant, CPFPI, Omega Packaging, Societe de Diffusion de Produits de Parfumerie, TSM Brands)</p>
</td>
</tr>

</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;&#160;</p>
<table border="0" cellspacing="0" cellpadding="0" style="width: 100%">

<tr>
<td style="width: 36pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#160;</p>
</td>
<td style="width: 18pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#9679;</p>
</td>
<td style="vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">Bottle manufacturers (Pochet du Courval, Verescence, Verreries Brosse, Bormioli Luigi, Stoelzle Masni&#232;res, Heinz), caps (Qualipac, ALBEA, RPC, Codiplas, LF Beauty, Texen Group, S.A.R.L. J3P SBG Packaging Group), Pumps (Silgan Dispensing Systems Thomaston Corp, Rexam) or boxes (Autajon, MMPP, Nortier, Draeger)</p>
</td>
</tr>

</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;&#160;</p>
<table border="0" cellspacing="0" cellpadding="0" style="width: 100%">

<tr>
<td style="width: 36pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#160;</p>
</td>
<td style="width: 18pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#9679;</p>
</td>
<td style="vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">Production specialists who carry out packaging (CCI, Edipar, Jacomo, Societe de Diffusion de Produits de Parfumerie, MF Productions, Biopack) or logistics (Bansard and Bollor&#233; Logistics for storage, order preparation and shipment)</p>
</td>
</tr>

</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36pt">Suppliers&#8217; accounts for our European operations are primarily settled in euro and for our United States operations, suppliers&#8217; accounts are primarily settled in U.S. dollars. For our European operations components for our prestige fragrances are purchased from many suppliers around the world and are primarily manufactured in France.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36pt">For United States operations, components for our prestige fragrances are sourced from many suppliers around the world and are primarily manufactured in the United States. Additionally, we occasionally utilize third party manufacturers in France, China and Turkey.&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><b><i><b><i>Environmental and Social Governance </i></b></i></b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36pt">Both our
U.S. operations and our European operations are good corporate citizens and take our responsibilities seriously. We comply with
all applicable laws, rules and regulations in general, and in particular with regard to chemicals and hazardous materials. From
procurement of components to distribution of finished products, we act as a good corporate citizen and monitor and comply with
all legal requirements.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<!-- Field: Page; Sequence: 19; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36pt">Interparfums SA, our European operations with their headquarters in Paris, has improved its rating in 2021 as the result of improvements in the 2021 Ga&#239;a Index over the past three years:</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<table border="0" cellspacing="0" cellpadding="0" style="border-style: none; margin: 0px; width: 100%">

<tr>
<td style="border: black 1pt solid; width: 40%; vertical-align: top; padding-left: 6pt">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">Year</p>
</td>
<td style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; border-left-style: none; width: 20%; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">2018</p>
</td>
<td style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; border-left-style: none; width: 20%; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">2019</p>
</td>
<td style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; border-left-style: none; width: 20%; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">2020</p>
</td>
</tr>
<tr>
<td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; border-top-style: none; vertical-align: top; padding-left: 6pt">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">ESG Rating</p>
</td>
<td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-top-style: none; border-left-style: none; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">67</p>
</td>
<td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-top-style: none; border-left-style: none; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">71</p>
</td>
<td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-top-style: none; border-left-style: none; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">74</p>
</td>
</tr>

</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">This index assesses the Environmental and Social Governance (&#8220;ESG&#8221;) performance of the top&#160;small and medium enterprises for French companies with revenue between &#8364;150-500 million.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36pt">Interparfums SA also applies a comprehensive approach addressing issues of corporate, environmental and social responsibility and transparency. Interparfums SA complies with IS 22716, International Standards for Good Manufacturing Practices, with all aspects of the manufacturing process, including receiving of raw materials and packaging materials, production and quality control. In this regulatory environment, regular audit campaigns are carried out for all packaging plants by the quality department based on the ISO 22716 standard in place. The ultimate purpose of these audits is to ensure that packaging service providers maintain a good level of traceability for their activities. All plant activities were reviewed: receiving process for raw materials and packaging materials, manufacturing, packaging and quality controls. These reports demonstrated that Interparfums SA&#8217;s subcontractors comply with ISO 22716 Good Manufacturing Practices and in particular traceability requirements for all perfume production operations. It is also in compliance with EU directive entitled Regulation on Registration, Evaluation, Authorization and Restriction of Chemicals (&#8220;REACH&#8221;), which governs and regulates the safe use of chemicals. Although not a manufacturer, per se, Interparfums SA has taken the initiative and monitors its suppliers for compliance with REACH, and has commitments from each of them concerning &#8220;Substances of Very High Concern&#8221; as listed in appendix XIV of REACH. No supplier of Interparfums SA has advised it of any such hazardous materials in any of Interparfums products to date.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36pt">Interparfums SA monitors the outsourcing of the entire production process of its manufacturing partners with expertise and accountable leadership in their respective areas. These include producers of juice, glass, caps and cardboard boxes and packaging companies. We take environmental issues into account at each of these phases, and in particular regarding the choice of materials used for components, waste management and reducing the carbon footprint.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36pt">In addition, Interparfums SA has been equipped with a high environmental quality warehouse since 2011. Its supply chain and operations department is integrating a more &#8220;optimized eco-design&#8221; dimension into its product development process. This process will increase the use of more environmentally friendly materials, reduce weight and size of glass, cardboard and plastics, and replace certain materials with recycled or bio-sourced materials. Interparfums SA intends to build a comprehensive approach based upon the framework provided by the widely used UN Sustainable Development Goals. With these goals in mind, Interparfums SA has established a Corporate Social Responsibility (&#8220;CSR&#8221;) Executive Committee, which is currently working on a strategy in this area that will include 3 or 4 major issues and company related goals.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<!-- Field: Page; Sequence: 20; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36pt">In the U.S. we are also a good corporate citizen. Like our French subsidiary, we are not a true manufacturer, but we regularly monitor our subcontractors, suppliers and fillers for their compliance. In addition, our subcontractors and fillers are subject to inspection and audit from our various licensors for compliance with all aspects of law. One of our largest pump manufacturers is the recipient of a 2021 Gold Medal from EcoVadis for Sustainability and a 2020 Bronze Medal from EcoVadis for its corporate social responsibility rating, and a large glass bottle manufacturer was awarded gold metals from EcoVadis for its corporate social responsibility rating two years in a row. In addition in 2021, a large glass bottle manufacturer received an &#8220;A&#8221; rating for leadership in corporate sustainability by a global environmental non-profit group, ranking &#8216;A&#8217; for tackling water security and &#8216;A-&#8217; for leading effort against climate change.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36pt">In our U.S. operations, we do not use any banned ingredients or components and use sustainable ingredients where practicable. Some componentry (glass/folding cartons) is also recyclable where practicable. For example, our Abercrombie &amp; Fitch <i>Away </i>fragrance uses glass and folding cartons that are 100% recyclable, and the carton liner is 100% recyclable and biodegradable. We are also licensed to use the &#8220;Green Dot&#8221; logo on our packaging, and that licensing fee goes towards packaging recycling efforts of consumer goods. Lastly, our product development team works with our fragrance houses &#8211; all very sustainable in their own right &#8211; to incorporate sustainably sourced ingredients in the fragrance oils used.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36pt">In addition
to our production operations complying with applicable law, our managers, supervisors and traffic coordinators in our New Jersey
distribution center undergo the following training in order for us to comply with Dangerous Goods Regulations. Compliance requires
training and certification to deal in hazardous materials to prevent damage to the environment. The two main certifications are:&#160;&#160;&#160;&#160;&#160;&#160;&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">International Maritime Dangerous Goods (IMDG) Dangerous Goods Training &#8211; 3 year Certification for Ocean Shipment and<span style="text-decoration: underline"> </span>International Air Transport Association (IATA) Dangerous Goods Training &#8211; 2 year Certification for Global Air Shipments.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36pt">Further, our distribution center in New Jersey has in-rack sprinklers to accommodate our hazardous material products. Our fragrances, Class 9 &#8211; Consumer Commodity ID8000, are registered with American Chemistry Council, Inc. (known in the chemicals industry as Chemtrec). Chemtrec has a 24/7 hazardous materials emergency communications center, which provides immediate assistance for incidents involving hazardous materials of any kind.&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><b><i><b><i>Marketing and Distribution</i></b></i></b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36pt">Our products are distributed in over 120 countries around the world through a selective distribution network. For our international distribution, we either contract with independent distribution companies specializing in luxury goods or distribute prestige products through our distribution subsidiaries. In each country, we designate anywhere from one to three distributors on an exclusive basis for one or more of our name brands. We also distribute our products through a variety of duty free operators, such as airports and airlines and select vacation destinations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<!-- Field: Page; Sequence: 21; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36pt">As our business is a global one, we intend to continue to build our global distribution footprint. For distribution of brands within our European based operations we operate through our distribution subsidiaries or divisions in the major markets of the United States, France, Italy and Spain, in addition to our arrangements with third party distributors globally. Our third party distributors vary in size depending on the number of competing brands they represent. This extensive and diverse network together with our own distribution subsidiaries provides us with a significant presence in over 120 countries around the world.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36pt">Over 50% of our European based prestige fragrance net sales are denominated in U.S. dollars. We address certain financial exposures through a controlled program of risk management that includes the use of derivative financial instruments. We primarily enter into foreign currency forward exchange contracts to reduce the effects of fluctuating foreign currency exchange rates.&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36pt">The business of our European operations has become increasingly seasonal due to the timing of shipments by our distribution subsidiaries and divisions to their customers, which are weighted to the second half of the year.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36pt">For our United States operations, we distribute product to retailers and distributors in the United States as well as internationally, including duty free and other travel-related retailers. We utilize our in-house sales team to reach our third party distributors and customers outside the United States. In addition, the business of our United States operations has become increasingly seasonal as shipments are weighted toward the second half of the year.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><b><i><b><i>Competition</i></b></i></b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36pt">The market for prestige fragrance products is highly competitive and sensitive to changing preferences and demands. The prestige fragrance industry is highly concentrated around certain major players with resources far greater than ours. We compete with an original strategy, regular and methodical development of quality fragrances for a growing portfolio of internationally renowned brand names.&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><b><i><b><i>Inventory</i></b></i></b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36pt">We purchase raw materials and component parts from suppliers based on internal estimates of anticipated need for finished goods, which enables us to meet production requirements for finished goods. We generally ship product to customers within 72 hours of the receipt of their orders. Our business is not capital intensive, and it is important to note that we do not own manufacturing facilities. We act as a general contractor and source our needed components from our suppliers. These components are received at one of our distribution centers and then, based upon production needs, the components are sent to one of several third party fillers or directly to one of those third party fillers, which manufacture the finished products for us and then deliver them to one of our distribution centers.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<!-- Field: Page; Sequence: 22; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><b><i><b><i>Product Liability</i></b></i></b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36pt">Our United States operations maintain product liability coverage in an amount of $10.0 million, and our European operations maintain product liability coverage in an amount of &#8364;20 million (approximately $22.7 million). Based upon our experience, we believe this coverage is adequate and covers substantially all of the exposure we may have with respect to our products. We have never been the subject of any material product liability claims.&#160;&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><b><i><b><i>Government Regulation</i></b></i></b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36pt">A fragrance is defined as a &#8220;cosmetic&#8221; under the Federal Food, Drug and Cosmetics Act. A fragrance must comply with the labeling requirements of this FDC Act as well as the Fair Packaging and Labeling Act and its regulations. In addition, various jurisdictions prohibit the use of certain ingredients in fragrances and cosmetics.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36pt">Our fragrance products that are manufactured or sold in Europe are subject to certain regulatory requirements of the European Union, such as Regulation number 1223/2009 on cosmetic products, and products sold in the United Kingdom are also subject to United Kingdom cosmetic regulation, but as of the date of this report, we have not experienced any material difficulties in complying with such requirements.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><b><i><b><i>Trademarks</i></b></i></b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36pt">The market for our products depends to a significant extent upon the value associated with our trademarks and brand names. We have licenses or other rights to use, or own, the material trademark and brand name rights used in connection with the packaging, marketing and distribution of our major products both in the United States and in other countries where such products are principally sold. Therefore, trademark and brand name protection are important to our business. Although most of the brand names we license, use or own are registered in the United States and in certain foreign countries in which we operate, we may not be successful in asserting trademark or brand name protection. In addition, the laws of certain foreign countries may not protect our intellectual property rights to the same extent as the laws of the United States. The costs required to protect our trademarks and brand names may be substantial.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36pt">Under various license and other agreements, we have the right to use certain registered trademarks throughout the world for fragrance products. These registered trademarks include:</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<table border="0" cellspacing="0" cellpadding="0" style="width: 100%">

<tr>
<td style="width: 36pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#160;</p>
</td>
<td style="width: 18pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#9679;</p>
</td>
<td style="vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">Abercrombie &amp; Fitch</p>
</td>
</tr>

</table>
<table border="0" cellspacing="0" cellpadding="0" style="width: 100%">

<tr>
<td style="width: 36pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#160;</p>
</td>
<td style="width: 18pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#9679;</p>
</td>
<td style="vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">Anna Sui</p>
</td>
</tr>

</table>
<table border="0" cellspacing="0" cellpadding="0" style="width: 100%">

<tr>
<td style="width: 36pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#160;</p>
</td>
<td style="width: 18pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#9679;</p>
</td>
<td style="vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">bebe</p>
</td>
</tr>

</table>
<table border="0" cellspacing="0" cellpadding="0" style="width: 100%">

<tr>
<td style="width: 36pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#160;</p>
</td>
<td style="width: 18pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#9679;</p>
</td>
<td style="vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">Boucheron</p>
</td>
</tr>

</table>
<table border="0" cellspacing="0" cellpadding="0" style="width: 100%">

<tr>
<td style="width: 36pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#160;</p>
</td>
<td style="width: 18pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#9679;</p>
</td>
<td style="vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">Coach</p>
</td>
</tr>

</table>
<table border="0" cellspacing="0" cellpadding="0" style="width: 100%">

<tr>
<td style="width: 36pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#160;</p>
</td>
<td style="width: 18pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#9679;</p>
</td>
<td style="vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">Dunhill</p>
</td>
</tr>
<tr>
<td style="width: 36pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#160;</p>
</td>
<td style="width: 18pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#9679;</p>
</td>
<td style="vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">Emanuel Ungaro</p>
</td>
</tr>

</table>
<table border="0" cellspacing="0" cellpadding="0" style="width: 100%">

<tr>
<td style="width: 36pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#160;</p>
</td>
<td style="width: 18pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#9679;</p>
</td>
<td style="vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">French Connection</p>
</td>
</tr>

</table>
<table border="0" cellspacing="0" cellpadding="0" style="width: 100%">

<tr>
<td style="width: 36pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#160;</p>
</td>
<td style="width: 18pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#9679;</p>
</td>
<td style="vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">Graff</p>
</td>
</tr>

</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;&#160;</p>
<!-- Field: Page; Sequence: 23; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<table border="0" cellspacing="0" cellpadding="0" style="width: 100%">

<tr>
<td style="width: 36pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#160;</p>
</td>
<td style="width: 18pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#9679;</p>
</td>
<td style="vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">GUESS</p>
</td>
</tr>

</table>
<table border="0" cellspacing="0" cellpadding="0" style="width: 100%">

<tr>
<td style="width: 36pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#160;</p>
</td>
<td style="width: 18pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#9679;</p>
</td>
<td style="vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">Hollister</p>
</td>
</tr>

</table>
<table border="0" cellspacing="0" cellpadding="0" style="width: 100%">

<tr>
<td style="width: 36pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#160;</p>
</td>
<td style="width: 18pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#9679;</p>
</td>
<td style="vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">Jimmy Choo</p>
</td>
</tr>

</table>
<table border="0" cellspacing="0" cellpadding="0" style="width: 100%">

<tr>
<td style="width: 36pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#160;</p>
</td>
<td style="width: 18pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#9679;</p>
</td>
<td style="vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">Kate Spade</p>
</td>
</tr>

</table>
<table border="0" cellspacing="0" cellpadding="0" style="width: 100%">

<tr>
<td style="width: 36pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#160;</p>
</td>
<td style="width: 18pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#9679;</p>
</td>
<td style="vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">Lily Aldridge</p>
</td>
</tr>

</table>
<table border="0" cellspacing="0" cellpadding="0" style="width: 100%">

<tr>
<td style="width: 36pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#160;</p>
</td>
<td style="width: 18pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#9679;</p>
</td>
<td style="vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">Karl Lagerfeld</p>
</td>
</tr>

</table>
<table border="0" cellspacing="0" cellpadding="0" style="width: 100%">

<tr>
<td style="width: 36pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#160;</p>
</td>
<td style="width: 18pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#9679;</p>
</td>
<td style="vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">MCM</p>
</td>
</tr>

</table>
<table border="0" cellspacing="0" cellpadding="0" style="width: 100%">

<tr>
<td style="width: 36pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#160;</p>
</td>
<td style="width: 18pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#9679;</p>
</td>
<td style="vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">Moncler</p>
</td>
</tr>
<tr>
<td style="vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#160;</p>
</td>
<td style="vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#9679;</p>
</td>
<td style="vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">Montblanc</p>
</td>
</tr>

</table>
<table border="0" cellspacing="0" cellpadding="0" style="width: 100%">

<tr>
<td style="width: 36pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
</td>
<td style="width: 18pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#9679;</p>
</td>
<td style="vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">Oscar de la Renta</p>
</td>
</tr>

</table>
<table border="0" cellspacing="0" cellpadding="0" style="width: 100%">

<tr>
<td style="width: 36pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#160;</p>
</td>
<td style="width: 18pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#9679;</p>
</td>
<td style="vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">Salvatore Ferragamo</p>
</td>
</tr>
<tr>
<td style="width: 36pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#160;</p>
</td>
<td style="width: 18pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#9679;</p>
</td>
<td style="vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">S.T. Dupont</p>
</td>
</tr>

</table>
<table border="0" cellspacing="0" cellpadding="0" style="width: 100%">

<tr>
<td style="width: 36pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#160;</p>
</td>
<td style="width: 18pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#9679;</p>
</td>
<td style="vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">Van Cleef &amp; Arpels</p>
</td>
</tr>

</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36pt">In addition, we are the registered owner of several trademarks for fragrance and beauty products, including:</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<table border="0" cellspacing="0" cellpadding="0" style="width: 100%">

<tr>
<td style="width: 36pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#160;</p>
</td>
<td style="width: 18pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#9679;</p>
</td>
<td style="vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">Rochas</p>
</td>
</tr>

</table>
<table border="0" cellspacing="0" cellpadding="0" style="width: 100%">

<tr>
<td style="width: 36pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#160;</p>
</td>
<td style="width: 18pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#9679;</p>
</td>
<td style="vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">Lanvin</p>
</td>
</tr>

</table>
<table border="0" cellspacing="0" cellpadding="0" style="width: 100%">

<tr>
<td style="width: 36pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#160;</p>
</td>
<td style="width: 18pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#9679;</p>
</td>
<td style="vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">Intimate</p>
</td>
</tr>

</table>
<table border="0" cellspacing="0" cellpadding="0" style="width: 100%">

<tr>
<td style="width: 36pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#160;</p>
</td>
<td style="width: 18pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#9679;</p>
</td>
<td style="vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">Aziza</p>
</td>
</tr>

</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><b><i><b><i>Human Capital</i></b></i></b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36pt">As of January 1, 2022, we had 467 full-time employees worldwide. Of these, 298 are full-time employees of our European operations, with 120 employees engaged in sales activities and 178 in administrative, production and marketing activities. Our United States operations have 169 employees, and of these, 22 were engaged in sales activities and 149 in administrative, production and marketing activities. Other than for the employees of our new wholly-owned subsidiary, Interparfums Italia srl, we do not have collective bargaining agreements relating to any of our employees, and we believe the collective bargaining agreement for our employees of Interparfums Italia Srl will not have a material adverse effect on our operations. We strive to maintain an inclusive environment free from discrimination of any kind, including sexual or other discriminatory harassment and, believe that our relationship with our employees is good.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36pt">Our employees are one of our most valuable assets, and fostering long-term relationships are beneficial to the continuity of our business. After experience and expertise in the respective fields of employment, we look for dedication and loyalty among our employees, as we believe having long-term staff members benefits our company. All of our executive officers have been with us for more than twenty years, and we have several senior and upper level staff members, who have also been with us long term. These long-term executives and employees believe that our company and their co-workers are an extended family. Their efforts and dedication are what allow our company to prosper.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<!-- Field: Page; Sequence: 24; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36pt">The safety of our employees is of paramount importance to us. In the early stages of the COVID-19 pandemic we experienced brief closures at all of our locations, and adapted to working remotely. Upon reopening, we implemented prevention protocols to minimize the spread of COVID-19 in our workplaces. These protocols, which remain in place, are in compliance with the Centers for Disease Control guidelines and state requirements.&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><b><span id="a004_v1"></span>Item 1A. Risk Factors.</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36pt">You should carefully consider these material risk factors before you decide to purchase or sell shares of our common stock. These factors could cause our future results to differ materially from those expressed or implied in forward-looking statements made by us. The trading price of our common stock could decline due to any of these risks, and you may lose all or part of your investment.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<table border="0" cellspacing="0" cellpadding="0" style="margin: 0px; width: 100%">

<tr>
<td style="width: 36pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#9679;</p>
</td>
<td style="vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><b><span style="text-decoration: underline">Fragrance Business, Brand Names and Intellectual Property</span></b></p>
</td>
</tr>

</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><b>We are dependent upon the continuation and renewal of various licenses and other agreements for a significant portion of our sales, and the loss of one or more licenses or agreements could have a material adverse effect on us.</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36pt">All of our rights relating to prestige fragrance brands, other than Lanvin and Rochas, are derived from licenses or other agreements from unaffiliated third parties, and our business is dependent upon the continuation and renewal of such licenses and other agreements on terms favorable to us. Each license or agreement is for a specific term and may have additional optional terms. Generally, each license is subject to us making required royalty payments (which are subject to certain minimums), minimum advertising and promotional expenditures and meeting minimum sales requirements. Other agreements are generally subject to meeting minimum sales requirements. Just as the loss of a license or other significant agreement may have a material adverse effect on us, a renewal on less favorable terms may also negatively impact us.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>If we are unable to acquire or license
additional brands or obtain the required financing for these agreements and arrangements, then the growth of our business could
be impaired. </b></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36pt">Our future expansion through acquisitions or new product license or distribution arrangements, if any, will depend upon the capital resources and working capital available to us. Further, we may be unable to obtain financing or credit that we may require for additional licenses, acquisitions or other transactions. We may be unsuccessful in identifying, negotiating, financing and consummating such acquisitions or arrangements on terms acceptable to us, or at all, which could hinder our ability to increase revenues and build our business. Just as the loss of a license or other significant agreement may have a material adverse effect on us, our failure to acquire rights to new brands may also negatively impact us.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<!-- Field: Page; Sequence: 25; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><b>We may engage in future acquisitions that we may not be able to successfully integrate or manage. These acquisitions may dilute our stockholders and cause us to incur debt and assume contingent liabilities. </b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36pt">We continuously review acquisition prospects that would complement our current product offerings, increase our size and geographic scope of operations or otherwise offer growth and operating efficiency opportunities. The financing, if available, for any of these acquisitions could significantly dilute our stockholders and/or result in an increase in our indebtedness. We may acquire or make investments in businesses or products in the future, and such acquisitions may entail numerous integration risks and impose costs on us, including:</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<table border="0" cellspacing="0" cellpadding="0" style="width: 100%">

<tr>
<td style="width: 36pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#160;</p>
</td>
<td style="width: 18pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#9679;</p>
</td>
<td style="vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">difficulties in assimilating acquired operations or products, including the loss of key employees from acquired businesses</p>
</td>
</tr>

<tr>
<td style="vertical-align: top"><span style="font-size: 10pt">&#160;</span></td>
<td style="vertical-align: top"><span style="font-size: 10pt">&#160;</span></td>
<td style="vertical-align: top"><span style="font-size: 10pt">&#160;</span></td></tr>
</table>

<table border="0" cellspacing="0" cellpadding="0" style="width: 100%">

<tr>
<td style="width: 36pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#160;</p>
</td>
<td style="width: 18pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#9679;</p>
</td>
<td style="vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">diversion of management&#8217;s attention from our core business</p>
</td>
</tr>

<tr>
<td style="vertical-align: top"><span style="font-size: 10pt">&#160;</span></td>
<td style="vertical-align: top"><span style="font-size: 10pt">&#160;</span></td>
<td style="vertical-align: top"><span style="font-size: 10pt">&#160;</span></td></tr>
</table>

<table border="0" cellspacing="0" cellpadding="0" style="width: 100%">

<tr>
<td style="width: 36pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#160;</p>
</td>
<td style="width: 18pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#9679;</p>
</td>
<td style="vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">adverse effects on existing business relationships with suppliers and customers</p>
</td>
</tr>

<tr>
<td style="vertical-align: top"><span style="font-size: 10pt">&#160;</span></td>
<td style="vertical-align: top"><span style="font-size: 10pt">&#160;</span></td>
<td style="vertical-align: top"><span style="font-size: 10pt">&#160;</span></td></tr>
</table>

<table border="0" cellspacing="0" cellpadding="0" style="width: 100%">

<tr>
<td style="width: 36pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#160;</p>
</td>
<td style="width: 18pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#9679;</p>
</td>
<td style="vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">risks of entering markets in which we have no or limited prior experience</p>
</td>
</tr>

<tr>
<td style="vertical-align: top"><span style="font-size: 10pt">&#160;</span></td>
<td style="vertical-align: top"><span style="font-size: 10pt">&#160;</span></td>
<td style="vertical-align: top"><span style="font-size: 10pt">&#160;</span></td></tr>
</table>

<table border="0" cellspacing="0" cellpadding="0" style="width: 100%">

<tr>
<td style="width: 36pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#160;</p>
</td>
<td style="width: 18pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#9679;</p>
</td>
<td style="vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">dilutive issuances of equity securities</p>
</td>
</tr>

<tr>
<td style="vertical-align: top"><span style="font-size: 10pt">&#160;</span></td>
<td style="vertical-align: top"><span style="font-size: 10pt">&#160;</span></td>
<td style="vertical-align: top"><span style="font-size: 10pt">&#160;</span></td></tr>
</table>

<table border="0" cellspacing="0" cellpadding="0" style="width: 100%">

<tr>
<td style="width: 36pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#160;</p>
</td>
<td style="width: 18pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#9679;</p>
</td>
<td style="vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">incurrence of substantial debt</p>
</td>
</tr>

<tr>
<td style="vertical-align: top"><span style="font-size: 10pt">&#160;</span></td>
<td style="vertical-align: top"><span style="font-size: 10pt">&#160;</span></td>
<td style="vertical-align: top"><span style="font-size: 10pt">&#160;</span></td></tr>
</table>

<table border="0" cellspacing="0" cellpadding="0" style="width: 100%">

<tr>
<td style="width: 36pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#160;</p>
</td>
<td style="width: 18pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#9679;</p>
</td>
<td style="vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">assumption of contingent liabilities</p>
</td>
</tr>

<tr>
<td style="vertical-align: top"><span style="font-size: 10pt">&#160;</span></td>
<td style="vertical-align: top"><span style="font-size: 10pt">&#160;</span></td>
<td style="vertical-align: top"><span style="font-size: 10pt">&#160;</span></td></tr>
</table>

<table border="0" cellspacing="0" cellpadding="0" style="width: 100%">

<tr>
<td style="width: 36pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#160;</p>
</td>
<td style="width: 18pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#9679;</p>
</td>
<td style="vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">incurrence of significant amortization expenses related to intangible assets and the potential impairment of acquired assets and</p>
</td>
</tr>

<tr>
<td style="vertical-align: top"><span style="font-size: 10pt">&#160;</span></td>
<td style="vertical-align: top"><span style="font-size: 10pt">&#160;</span></td>
<td style="vertical-align: top"><span style="font-size: 10pt">&#160;</span></td></tr>
</table>

<table border="0" cellspacing="0" cellpadding="0" style="width: 100%">

<tr>
<td style="width: 36pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#160;</p>
</td>
<td style="width: 18pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#9679;</p>
</td>
<td style="vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">incurrence of significant immediate write-offs.</p>
</td>
</tr>

</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36pt">Our failure to successfully complete the integration of any acquired business could have a material adverse effect on our business, financial condition and operating results.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><b>Joint arrangements or strategic alliances in geographic markets in which we have limited, or no prior experience may expose us to additional risks.</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36pt">We review, and from time to time may establish, arrangements and strategic alliances that we believe would complement our current product offerings, increase the size and geographic scope of our operations or otherwise offer growth and operating efficiency opportunities. These business relationships may require us to rely on the local expertise of our partners with respect to market development, sales, local regulatory compliance and other matters. Further, there may be challenges with ensuring that such arrangements or strategic alliances implement the appropriate internal controls to ensure compliance with the various laws and regulations applicable to us as a U.S. public company. Accordingly, in addition to commercial and operational risk, these arrangements and strategic alliances may entail risks such as reputational risk and regulatory compliance risk. In addition, there can be no assurance that we will be able to identify suitable alliance or candidates, that we will be able to consummate any such alliances or arrangements on favorable terms, or that we will realize the anticipated benefits of entering into any such alliances or arrangements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<!-- Field: Page; Sequence: 26; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><b>If we are unable to protect our intellectual property rights, specifically trademarks and brand names, our ability to compete could be negatively impacted.</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36pt">The market for our products depends to a significant extent upon the value associated with trademarks and brand names that we license, use or own. We have licenses or other rights to use, or own the material trademark and brand name rights in connection with the packaging, marketing and distribution of our major products both in the United States and in other countries where such products are principally sold. Therefore, trademark and brand name protection are important to our business. Although most of the brand names we license, use or own are registered in the United States and in certain foreign countries in which we operate, we may not be successful in asserting trademark or brand name protection. In addition, the laws of certain foreign countries may not protect our intellectual property rights to the same extent as the laws of the United States. The costs required to protect our trademarks and brand names may be substantial.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">I<b>f our intangible assets, such as trademarks and licenses, become impaired, we may be required to record a significant non-cash charge to earnings which would negatively impact our results of operations.</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36pt">Under United States generally accepted accounting principles, we review our intangible assets, including our trademarks and licenses, for impairment annually in the fourth quarter of each fiscal year, or more frequently if events or changes in circumstances indicate the carrying value of our intangible assets may not be fully recoverable. The carrying value of our intangible assets may not be recoverable due to factors such as reduced estimates of future cash flows, including those associated with the specific brands to which intangibles relate, or slower growth rates in our industry. Estimates of future cash flows are based on a long-term financial outlook of our operations and the specific brands to which the intangible assets relate. However, actual performance in the near-term or long-term could be materially different from these forecasts, which could impact future estimates and the recorded value of the intangibles. Any significant impairment to our intangible assets would result in a significant charge to earnings in our financial statements during the period in which the impairment is determined to exist.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><b>The illegal distribution and sale by third parties of counterfeit versions of the Company&#8217;s products or the unauthorized diversion by third parties of the Company&#8217;s products could have an adverse effect on the Company&#8217;s revenues and a negative impact on the Company&#8217;s reputation and business.</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36pt">Third parties may illegally distribute and sell counterfeit versions of the Company&#8217;s products. These counterfeit products may be inferior in terms of quality and other characteristics compared to the Company&#8217;s authentic products and/or the counterfeit products could pose safety risks that the Company&#8217;s authentic products would not otherwise present to consumers. Consumers could confuse counterfeit products with the Company&#8217;s authentic products, which could damage or diminish the image, reputation and/or value of the Company&#8217;s brands and cause consumers to refrain from purchasing the Company&#8217;s products in the future. In addition, the sale of the Company&#8217;s prestige products through non-authorized &#8220;grey market&#8221; channels could damage or diminish the image, reputation and/or value of the Company&#8217;s brands and could adversely affect the Company&#8217;s revenues and have a negative impact on the Company&#8217;s reputation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<!-- Field: Page; Sequence: 27; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><b>Our success depends on our ability to operate our business without infringing, misappropriating or otherwise violating the trademarks, patents, copyrights and proprietary rights of other parties.</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36pt">Our commercial success depends at least in part on our ability to operate without infringing, misappropriating or otherwise violating the trademarks, patents, copyrights and other proprietary rights of others. However, we cannot be certain that the conduct of our business does not and will not infringe, misappropriate or otherwise violate such rights. Many companies have employed intellectual property litigation as a way to gain a competitive advantage, and to the extent we gain greater visibility and market exposure, we may also face a greater risk of being the subject of such litigation. For these and other reasons, third parties may allege that our products, services or activities infringe, misappropriate or otherwise violate their trademark, patent, copyright or other proprietary rights. Defending against allegations and litigation could be expensive, take significant time, divert management&#8217;s attention from other business concerns, and delay getting our products to market. In addition, if we are found to be infringing, misappropriating or otherwise violating third party trademark, patent, copyright or other proprietary rights, we may need to obtain a license, which may not be available on commercially reasonable terms or at all, or redesign or rebrand our products, which may not be possible. We may also be required to pay substantial damages or be subject to a court order prohibiting us and our customers from selling certain products or engaging in certain activities. Our inability to operate our business without infringing, misappropriating or otherwise violating the trademarks, patents, copyrights and proprietary rights of others could therefore have a material adverse effect on our business, financial condition and results of operations.&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<table border="0" cellspacing="0" cellpadding="0" style="width: 100%">

<tr>
<td style="width: 36pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><b>&#9679;</b></p>
</td>
<td style="vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><b><span style="text-decoration: underline">COVID-19 Pandemic and Economic Downturn</span></b></p>
</td>
</tr>

</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><b>Although in 2021 we have weathered the COVID-19 pandemic and its effects to date, if the pandemic continues or worsens, it may have a material adverse effect on our business, results of operations, financial condition and cash flows.</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36pt">The public health crisis caused by the&#160;COVID-19 pandemic and the measures being taken by governments, businesses, including us, our suppliers, our distributors, retailers and the public, to limit&#160;COVID-19&#8217;s spread, have had and we expect will continue to have, certain negative impacts on our business including, but not limited to, the following:</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<table border="0" cellspacing="0" cellpadding="0" style="width: 100%">

<tr>
<td style="width: 36pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#160;</p>
</td>
<td style="width: 18pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#9679;</p>
</td>
<td style="vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">In 2020, we experienced an overall decrease in sales of our products in markets around the world that have been affected by the COVID-19 pandemic. In particular, sales of our products were negatively affected by shelter-in-place regulations and closings of retailers around the world. We believe the most significant impact occurred in the second quarter of 2020, as we generated sales increases in the third and fourth quarter as compared to the second quarter of 2020, and had a record year for sales in 2021. However, to date we have experienced issues in our supply chain caused by the COVID-19 pandemic and government imposed mandates. Also, estimates of future sales, even in the short term may be difficult to determine due to the uncertainty created by the COVID-19 variants. In several major markets, such as the United States, the European Union and the United Kingdom, we have seen spikes in infections and increases in hospitalizations, which resulted in governments reimposing certain restrictions on the public. If the COVID-19 pandemic further intensifies, its negative impacts on our sales could be more prolonged and may become more severe.</p>
</td>
</tr>

</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<!-- Field: Page; Sequence: 28; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<table border="0" cellspacing="0" cellpadding="0" style="width: 100%">

<tr>
<td style="width: 36pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#160;</p>
</td>
<td style="width: 18pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#9679;</p>
</td>
<td style="vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">Deteriorating economic and political conditions in many of our major markets affected by the COVID-19 pandemic, such as increased unemployment, decreases in disposable income, declines in consumer confidence, or economic slowdowns could cause a decrease in demand for our products.</p>
</td>
</tr>

<tr>
<td style="vertical-align: top"><span style="font-size: 10pt">&#160;</span></td>
<td style="vertical-align: top"><span style="font-size: 10pt">&#160;</span></td>
<td style="vertical-align: top"><span style="font-size: 10pt">&#160;</span></td></tr>
</table>

<table border="0" cellspacing="0" cellpadding="0" style="width: 100%">

<tr>
<td style="width: 36pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#160;</p>
</td>
<td style="width: 18pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#9679;</p>
</td>
<td style="vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">We may be required to record significant impairment charges with respect to noncurrent assets, including trademarks, licenses and other intangible assets whose fair values may be negatively affected by the effects of the COVID-19 pandemic on our operations.</p>
</td>
</tr>

<tr>
<td style="vertical-align: top"><span style="font-size: 10pt">&#160;</span></td>
<td style="vertical-align: top"><span style="font-size: 10pt">&#160;</span></td>
<td style="vertical-align: top"><span style="font-size: 10pt">&#160;</span></td></tr>
</table>

<table border="0" cellspacing="0" cellpadding="0" style="width: 100%">

<tr>
<td style="width: 36pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#160;</p>
</td>
<td style="width: 18pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#9679;</p>
</td>
<td style="vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">As a result of the COVID-19 pandemic, in all jurisdictions in which we operate we are following guidance as well as requirements from authorities and health officials in allowing our teams to gradually return to our offices, including, requiring personnel to wear masks and other protective clothing as appropriate, and implementing additional cleaning and sanitization routines at our offices and distribution centers. However, we may experience reductions in productivity and disruptions to our business routines while such guidance and restrictions remain in place.</p>
</td>
</tr>

<tr>
<td style="vertical-align: top"><span style="font-size: 10pt">&#160;</span></td>
<td style="vertical-align: top"><span style="font-size: 10pt">&#160;</span></td>
<td style="vertical-align: top"><span style="font-size: 10pt">&#160;</span></td></tr>
</table>

<table border="0" cellspacing="0" cellpadding="0" style="width: 100%">

<tr>
<td style="width: 36pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#160;</p>
</td>
<td style="width: 18pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#9679;</p>
</td>
<td style="vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left">Considerable uncertainty remains regarding this pandemic, including measures being taken by various authorities and others in response to the pandemic. As we continue to monitor COVID-19 developments, including the impacts on our consumers, customers and suppliers, we have taken and will continue to take further measures. Some of the actions we take could adversely impact our business, and there is no certainty that our actions will be sufficient to mitigate the risks and the impacts of COVID-19.</p>
</td>
</tr>

<tr>
<td style="vertical-align: top"><span style="font-size: 10pt">&#160;</span></td>
<td style="vertical-align: top"><span style="font-size: 10pt">&#160;</span></td>
<td style="vertical-align: top"><span style="font-size: 10pt">&#160;</span></td></tr>
</table>

<table border="0" cellspacing="0" cellpadding="0" style="width: 100%">

<tr>
<td style="width: 36pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#160;</p>
</td>
<td style="width: 18pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#9679;</p>
</td>
<td style="vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">Actions we have taken or may take, or decisions on potential actions that we did not take, as a consequence of the COVID-19 pandemic may result in claims or litigation against us.</p>
</td>
</tr>

</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<!-- Field: Page; Sequence: 29; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><b>Consumers may reduce discretionary purchases of our products as a result of a general economic downturn. </b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36pt">We believe that a high degree of global economic uncertainty could have a further negative effect on consumer confidence, demand and spending.&#160;In addition, we believe that consumer spending on beauty products is influenced by general economic conditions and the availability of discretionary income. Accordingly, we may experience sustained periods of declines in sales during periods of economic downturn as it may affect consumer purchasing patterns. In addition, a further general economic downturn may result in further reduced traffic in our customers&#8217; stores which may, in turn, result in reduced net sales to our retail store customers. Any further material reduction in our sales could have a material adverse effect on our business, financial condition and operating results.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><b>An outbreak of any other disease, epidemic or pandemic, or similar public health threat on the scope of COVID-19, could have a material adverse impact on the Company&#8217;s business, operating results and financial condition.</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36pt">An outbreak of disease, epidemic or pandemic, or similar public threat on the scope of COVID-19, or fear of such an event, that negatively impacts consumer spending on our products could have a material adverse impact on the Company&#8217;s business, financial condition and operating results. Like most companies doing business around the globe, ours is being impacted by the coronavirus. There are many unknowns as to the duration and severity of the situation which we are closely monitoring. As a result of the trends starting in 2020 and continuing through today that we have seen, there has been solely a modest increase in air travel and consumer traffic in key shopping and tourist areas from the 2020 pandemic caused lockdowns. The extent and potential short and long-term impact of the coronavirus on the Company&#8217;s operational and financial performance will depend on future developments, including the duration and spread of the outbreak, our customers&#8217; willingness to travel and purchase our products, and the impact on our supply chain and the financial markets, all of which are highly uncertain and cannot be predicted.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<table border="0" cellspacing="0" cellpadding="0" style="width: 100%">

<tr>
<td style="width: 36pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#9679;</p>
</td>
<td style="vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><b><span style="text-decoration: underline">Global Operations</span></b></p>
</td>
</tr>

</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><b>We are subject to risks related to our foreign operations, and a disruption in our operations or supply chain could adversely affect our business and financial results.</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36pt">We operate on a global basis, with a substantial portion of our net sales and net income generated outside the United States, and we anticipate for the foreseeable future that a substantial portion of our net sales and net income will be generated outside the United States. A substantial portion of our cash, cash equivalents and short-term investments that result from these earnings remain outside the United States. As a company engaged in manufacturing and distribution on a global scale, we are subject to many risks and uncertainties, including:</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<table border="0" cellspacing="0" cellpadding="0" style="width: 100%">

<tr>
<td style="width: 36pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#160;</p>
</td>
<td style="width: 18pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#9679;</p>
</td>
<td style="vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">changes in foreign laws, regulations and policies, including restrictions on trade, import and export license requirements, and tariffs and taxes, as well as changes in United States laws and regulations relating to foreign trade and investment; and</p>
</td>
</tr>

<tr>
<td style="vertical-align: top"><span style="font-size: 10pt">&#160;</span></td>
<td style="vertical-align: top"><span style="font-size: 10pt">&#160;</span></td>
<td style="vertical-align: top"><span style="font-size: 10pt">&#160;</span></td></tr>
</table>

<table border="0" cellspacing="0" cellpadding="0" style="width: 100%">

<tr>
<td style="width: 36pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#160;</p>
</td>
<td style="width: 18pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#9679;</p>
</td>
<td style="vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">industrial accidents, environmental events, strikes and other labor disputes, disruptions in supply chain or information technology, loss or impairment of key manufacturing sites or suppliers, product quality control, safety, as well as natural disasters, adverse weather conditions, social, economic and geopolitical conditions, such as terrorist attacks, war or other military action and other external factors over which we have no control.</p>
</td>
</tr>

</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<!-- Field: Page; Sequence: 30; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">These risks could have a material adverse effect on our business, prospects, results of operations and financial condition.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><b>Terrorist attacks, acts of war or military actions, other civil unrest or natural disasters may adversely affect territories in which we operate, and therefore affect our business, financial condition and operating results. </b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36pt">Terrorist attacks such as those that have occurred in Paris, France where we have our European headquarters, amongst other locations, and attempted terrorist attacks, military responses to terrorist attacks, other military actions, or governmental action in response to or in anticipation of a terrorist attack, or civil unrest as occurring in the Middle East, Ukraine and Africa or natural disasters, may adversely affect prevailing economic conditions. These events could result in work stoppages, reduced consumer spending or reduced demand for our products. These developments subject our worldwide operations to increased risks and, depending on their magnitude, could reduce net sales and therefore could have a material adverse effect on our business, financial condition and operating results.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><b>The loss of or disruption in our distribution facilities could have a material adverse effect on our business, financial condition and operating results. </b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36pt">We currently have several distribution facilities in Europe, China and the United States. The loss of any of those facilities, as well as the inventory stored in those facilities, would require us to find replacement facilities and assets. In addition, acts of God, such as extreme weather conditions, natural disasters and the like or terrorist attacks, could disrupt our distribution operations. If we cannot replace our distribution capacity and inventory in a timely, cost-efficient manner, then such failure could have a material adverse effect on our business, financial condition and operating results.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><b>Changes in foreign tax provisions, the adoption of new tax legislation or exposure to additional tax liabilities could affect our profitability and cash flows.</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36pt">In addition to being subject to taxation in the United States, we are subject to income and other taxes in other foreign jurisdictions. Our effective tax rate in the future could be adversely affected by changes to our operating structure, changes in the mix of earnings in countries with differing statutory tax rates, changes in the valuation of deferred tax assets and liabilities, changes in tax laws and the discovery of new information in the course of our tax return preparation process. From time to time, tax proposals are introduced or considered by the United States Congress or the legislative bodies in foreign jurisdictions that could also affect our tax rate, the carrying value of our deferred tax assets, or our other tax liabilities. Our tax liabilities are also affected by the amounts we charge for inventory, services, licenses, funding, cross-jurisdictional transfer pricing, and other items in intercompany transactions. A negative determination or ultimate disposition in any tax audit, changes in tax laws or tax rates, or the ability to utilize our deferred tax assets could materially affect our tax provision, net income and cash flows in future periods.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<!-- Field: Page; Sequence: 31; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><b>The international character of our business renders us subject to fluctuation in foreign currency exchange rates and international trade tariffs, barriers and other restrictions. </b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36pt">A substantial portion of our European operations&#8217; net sales (over 50%) are sold in U.S. dollars. In an effort to reduce our exposure to foreign currency exchange fluctuations, we engage in a controlled program of risk management that includes the use of derivative financial instruments for all major currencies with which we operate. Despite such actions, fluctuations in foreign currency exchange rates for the U.S. dollar, particularly with respect to the euro, could have a material adverse effect on our operating results. Possible import, export, tariff and other trade barriers, which could be imposed by the United States, the European Union or other countries might also have a material adverse effect on our operating results.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><b>Changing political conditions could adversely impact our business and financial results.</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36pt">Changes in the political conditions in markets in which we manufacture, sell or distribute our products may be difficult to predict and may adversely affect our business and financial results. In addition, results of elections, referendums or other political processes in certain markets in which our products are manufactured, sold or distributed could create uncertainty regarding how existing governmental policies, laws and regulations may change, including with respect to sanctions, taxes, the movement of goods, services, capital and people between countries and other matters. The potential implications of such uncertainty, which include, among others, exchange rate fluctuations, tariffs, trade barriers and market contraction, could adversely affect the Company&#8217;s business and financial results.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<table border="0" cellspacing="0" cellpadding="0" style="margin: 0px; width: 100%">

<tr>
<td style="width: 4%; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><b>&#9679;</b></p>
</td>
<td style="width: 96%; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><b><span style="text-decoration: underline">Operational Risks</span></b></p>
</td>
</tr>

</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><b>We are dependent upon Messrs. Jean Madar and Philippe Benacin, and the loss of their services could harm our business.</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36pt">Jean Madar, our Chief Executive Officer, and Philippe Benacin, our President, and Chief Executive Officer of Interparfums SA, are responsible for day-to-day operations as well as major decisions. Termination of their relationships with us, whether through death, incapacity or otherwise, could have a material adverse effect on our operations, and we cannot assure you that qualified replacements can be found.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><b>Our reliance on third party manufacturers could have a material adverse effect on us.</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36pt">We rely on outside sources to manufacture our fragrances and cosmetics. The failure of such third party manufacturers to deliver either compliant, quality components or finished goods on a timely basis could have a material adverse effect on our business. Although we believe there are alternate manufacturers available to supply our requirements, we cannot assure you that current or alternative sources will be able to supply all of our demands on a timely basis. We do not intend to develop our own manufacturing capacity. As these are third parties over whom we have little or no control, the failure of such third parties to provide components or finished goods on a timely basis could have a material adverse effect on our business, financial condition and operating results.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<!-- Field: Page; Sequence: 32; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><b>Our reliance on third party distributors could have a material adverse effect on us.</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36pt">We sell a substantial percentage of our prestige fragrances through independent distributors specializing in luxury goods. Given the growing importance of distribution, we have modified our distribution model by owning a controlling interest in certain of our distributors within key markets. However, we have little or no control over third party distributors and the failure of such third parties to provide services on a timely basis could have a material adverse effect on our business, financial condition and operating results. In addition, if we replace existing third party distributors with new third party distributors or with our own distribution arrangements, then transition issues could have a material adverse effect on our business, financial condition and operating results.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><b>Our business is subject to governmental regulation, which could impact our operations.</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36pt">Fragrance products must comply with the labeling requirements of the Federal Food, Drug and Cosmetics Act as well as the Fair Packaging and Labeling Act and their regulations. In addition, various jurisdictions prohibit the use of certain ingredients in fragrances and cosmetics.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36pt">Our fragrance products that are manufactured or sold in Europe are subject to certain regulatory requirements of the European Union and the United Kingdom, such as the EU Regulation number 1223/2009 on cosmetic products and United Kingdom cosmetic regulations, but as of the date of this report, we have not experienced any material difficulties in complying with such requirements.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36pt">However, we cannot assure you that, should we use proscribed ingredients in our fragrance products that we develop or market, or develop or market fragrance products with different ingredients, or should existing regulations or requirements be revised, we would not in the future experience difficulty in complying with such requirements, which could have a material adverse effect on our results of operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><b>Our business could be negatively impacted by social impact and sustainability matters.</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36pt">There has been continues to be an increased focus from certain investors, customers, consumers, employees, and other stakeholders concerning social impact and environmental matters.&#160;From time to time, we may announce certain initiatives, including goals and commitments, regarding environmental matters, packaging, responsible sourcing and corporate social responsibility.&#160;We could fail, or be perceived to fail, in our achievement of such initiatives, or in accurately reporting our progress on such initiatives.&#160;Such failures could be due to changes in distribution channels, new licenses or other acquisitions. Moreover, the standards by which corporate social responsibility are measured are developing and evolving, and certain areas are subject to assumptions that could change over time. In addition, we could be criticized for the scope of our initiatives or goals or perceived as not acting responsibly in connection with these matters.&#160;Any of such matters could have a material adverse effect on our business.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>


<!-- Field: Page; Sequence: 33; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><b>Our business is subject to seasonal variability.</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36pt">Our business is somewhat seasonal due to the timing of shipments to our customers, which are weighted to the second half of the year. Accordingly, our financial performance, sales, working capital requirements, cash flow and borrowings generally experience variability during the third and fourth quarters.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<table border="0" cellspacing="0" cellpadding="0" style="margin: 0px; width: 100%">

<tr>
<td style="width: 4%; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><b>&#9679;</b></p>
</td>
<td style="width: 96%; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><b><span style="text-decoration: underline">Fragrance Markets</span></b></p>
</td>
</tr>

</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><b>The success of our products is dependent on public taste. </b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36pt">Our revenues are substantially dependent on the success of our products, which depends upon, among other matters, pronounced and rapidly changing public tastes, factors which are difficult to predict and over which we have little, if any, control. In addition, we have to develop successful marketing, promotional and sales programs in order to sell our fragrances and fragrance related products. If we are not able to develop successful marketing, promotional and sales programs, then such failure will have a material adverse effect on our business, financial condition and operating results.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><b>We are subject to extreme competition in the fragrance industry. </b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36pt">The market for fragrance products is highly competitive and sensitive to changing market preferences and demands. Many of our competitors in this market are larger than we are and have greater financial resources than are available to us, potentially allowing them greater operational flexibility. Our success in the prestige fragrance industry is dependent upon our ability to continue to generate original strategies and develop quality products that are in accord with ongoing changes in the market.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36pt">If there is insufficient demand for our existing fragrance products, or if we do not develop future strategies and products that withstand competition or we are unsuccessful in competing on price terms, then we could experience a material adverse effect on our business, financial condition and operating results.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><b>Changes in laws, regulations and policies that affect our business could adversely affect our financial results.&#160;</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36pt">Our business
is subject to numerous laws, regulations and policies. Changes in the laws, regulations and policies, including the interpretation
or enforcement thereof, that affect, or will affect, our business, including changes in accounting standards, tax laws and regulations,
environmental or climate change laws, regulations or accords, trade rules and customs regulations, or increased cosmetics regulation,
and the outcome and expense of legal or regulatory proceedings, and any action we may take as a result could adversely affect
our financial results.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<!-- Field: Page; Sequence: 34; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<table border="0" cellspacing="0" cellpadding="0" style="margin: 0px; width: 100%">

<tr>
<td style="width: 4%; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><b>&#9679;</b></p>
</td>
<td style="width: 96%; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><b><span style="text-decoration: underline">General Risk Factors</span></b></p>
</td>
</tr>

</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><b>Our success depends, in part, on the quality and safety of our products.</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36pt">Our success depends, in part, on the quality and safety of our products. If our products are found to be defective or unsafe, or if they otherwise fail to meet our consumers&#8217; standards, then our relationships with customers or consumers could suffer, the appeal of one or more of our brands could be diminished, and we could lose sales and/or become subject to liability claims, any of which could result in a material adverse effect on our business, results of operations and financial condition.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><b>Our failure to protect our reputation, or the failure of our partners to protect their reputations, could have a material adverse effect on our brand images.</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36pt">Our ability to maintain our reputation is critical to our various brand images. Our reputation could be jeopardized if we fail to maintain high standards for merchandise quality and integrity or if we, or the third parties with whom we do business, do not comply with regulations or accepted practices. Any negative publicity about these types of concerns may reduce demand for our merchandise. Failure to comply with ethical, social, product, labor and environmental standards, or related political considerations, such as animal testing, could also jeopardize our reputation and potentially lead to various adverse consumer actions, including boycotts. Failure to comply with local laws and regulations, including applicable U.S. trade sanctions, to maintain an effective system of internal controls or to provide accurate and timely financial statement information could also hurt our reputation. We are also dependent on the reputations of our brand partners and licensors, which can be affected by matters outside of our control. Damage to our reputation or the reputations of our brand partners or licensors or loss of consumer confidence for any of these or other reasons could have a material adverse effect on our results of operations, financial condition and cash flows, as well as require additional resources to rebuild our reputation.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><b>Our information systems and websites may be susceptible to outages, hacking and other risks.</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36pt">We have information systems that support our business processes, including product development, production, marketing, order processing, sales, distribution, finance and intra-company communications.&#160;We also have Internet websites in the United States and Europe.&#160;These systems may be susceptible to outages due to fire, floods, power loss, telecommunications failures, hacking and similar events.&#160;Despite the implementation of network security measures, our systems may be vulnerable to computer viruses, hacking and similar disruptions from unauthorized tampering.&#160;The occurrence of these or other events could disrupt or damage our information systems and adversely affect our business and results of operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<!-- Field: Page; Sequence: 35; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><b>The trading prices of our securities periodically may rise or fall based on the accuracy of predictions of our earnings or other financial performance.</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36pt">Our business planning process is designed to maximize our long-term strength, growth and profitability, not to achieve an earnings target in any particular fiscal quarter.&#160;We believe that this longer-term focus is in the best interests of our Company and our stockholders.&#160;At the same time, however, we recognize that it may be helpful to provide investors with guidance as to our forecast of annual net sales and diluted earnings per share.&#160;Accordingly, we provide guidance as to our expected annual net sales, and diluted earnings per share, which is updated as appropriate throughout the year.&#160;While we generally provide updates to our guidance when we report our results each fiscal quarter if called for, we assume no responsibility to update any of our forward-looking statements at such times or otherwise.&#160;In addition, longer-term guidance that we may from time to time provide is based on goals that we believe, at the time guidance is given, are reasonably attainable.&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36pt">In all of our public statements when we make, or update, a forward-looking statement about our sales and/or earnings expectations or expectations regarding other initiatives, we accompany such statements directly, or by reference to a public document, with a list of factors that could cause our actual results to differ materially from those we expect. Such a list is included, among other places, in our earnings press releases (by reference to our periodic filings with the Securities and Exchange Commission) and in our periodic filings with the Securities and Exchange Commission (<i>e.g.,</i> in our reports on Form&#160;10-K and Forms&#160;10-Q). These and other factors may make it difficult for outside observers, such as research analysts, to predict what our earnings will be in any given fiscal quarter or year.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36pt">Outside analysts and investors have the right to make their own predictions of our financial results for any future period.&#160;Outside analysts, however, have access to no more material information about our results or plans than any other public investor, and we do not endorse or adopt their predictions as to our future performance.&#160;Nor do we assume any responsibility to correct the predictions of outside analysts or others when they differ from our own internal expectations.&#160;If and when we announce actual results that differ from those that outside analysts or others have been predicting, the market price of our securities could be affected.&#160;Investors who rely on the predictions of outside analysts or others when making investment decisions with respect to our securities do so at their own risk.&#160;We take no responsibility for any losses suffered as a result of such changes in the prices of our securities.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><b>I<span id="a005_v1"></span>tem 1B. Unresolved Staff Comments.</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">None.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><b>I<span id="a006_v1"></span>tem 2. Properties </b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><b>United States Operations</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36pt">We maintain our corporate headquarters and United States operations in approximately 32,000 square feet with a term that expires on December 31, 2029, and have been at the same location in New York City since 1992. We also have a 140,000 square foot distribution center in New Jersey, and this lease expires on October 31, 2025. In addition, we maintain office space in Hong Kong with a lease that expires in June 2023. In August 2019 we opened a small distribution center in Shanghai, China that expires in July 2022, and in October 2021 we leased office space in Florence, Italy with a 6 year term with an option for an additional 6 years for Interparfums Italia srl.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<!-- Field: Page; Sequence: 36; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><b>European Operations</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36pt">Our European
operations maintain their corporate headquarters on the Champs Elysees in Paris France, with leases for various units that expire
from March 2022 to September 2026. We are presently seeking to sublease these offices, due to the planned relocation to the new
Paris headquarters in March 2022 as discussed below. Our European operations also maintains a studio and operations departments
at a second location in Paris with a lease that now expires on March 31, 2022. United States distribution operations for European
operations maintain their headquarters in New York City, with a lease that expires in May 2029. A small office is located Singapore
for Asia-Pacific distribution by European operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 36pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In April 2021, Interparfums SA, completed
the acquisition of its future headquarters at 10 rue de Solf&#233;rino in the 7th arrondissement of Paris from the property developer.
This is an office complex combining three buildings connected by two inner courtyards and consists of approximately 40,000 total
sq. ft. Interparfums SA intends to relocate its operations to its new headquarters by the end of March 2022.</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 36pt"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36pt">European operations maintain an approximately 333,700 square foot distribution center located in Criquebeuf sur Seine, France, with a seven year term that expires May 2027 and an option to extend the term for an additional two years.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36pt">Interparfums SA has several agreements for warehousing and distribution services which are renewed on an annual basis. Fees payable are partially calculated based upon a percentage of sales, which is customary in the industry.&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 36pt">We believe our office and warehouse facilities are satisfactory for our present needs and those for the foreseeable future.&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><b>I<span id="a007_v1"></span>tem 3. Legal Proceedings</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">We are not a party to any material lawsuits.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><b>I<span id="a008_v1"></span>tem 4. Mine Safety Disclosures</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">Not applicable.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<!-- Field: Page; Sequence: 37; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->


<p style="font: 10pt Times New Roman,Times,Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><b>PART II<span id="a009_v1"></span></b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><b><span id="a010_v1"></span>Item 5.&#160;Market for Registrant&#8217;s Common Equity, Related Stockholder Matters</b> <b>and Issuer Purchases of Equity Securities</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><b><i><b><i>The Market for Our Common Stock</i></b></i></b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 36pt">Our Company&#8217;s common stock, $.001 par value per share, is traded on The Nasdaq Global Select Market under the symbol &#8220;IPAR&#8221;.&#160;The following table sets forth in dollars, the range of high and low closing prices for the past two fiscal years for our common stock.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<table border="0" cellspacing="0" cellpadding="0" style="border: Black medium none; margin-left: auto; width: 50%; margin-right: auto">

<tr>
<td style="border: black 1pt solid; width: 20%; vertical-align: top; padding-right: 3pt; padding-left: 3pt">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">Fiscal 2021</p>
</td>
<td style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; border-left-style: none; width: 15%; text-align: center; vertical-align: top; padding-right: 3pt; padding-left: 3pt">
<p style="font: 10pt Times New Roman, Times, serif; margin: 0pt; text-align: center">High Closing Price</p>
</td>
<td style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; border-left-style: none; width: 15%; text-align: center; vertical-align: top; padding-right: 3pt; padding-left: 3pt">
<p style="font: 10pt Times New Roman, Times, serif; margin: 0pt; text-align: center">Low Closing Price</p>
</td>
</tr>
<tr style="background-color: rgb(204,238,255)">
<td style="border-top: black 1pt none; border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; vertical-align: top; padding-right: 3pt; padding-left: 3pt">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">Fourth Quarter</p>
</td>
<td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-top-style: none; border-left-style: none; vertical-align: top; padding-right: 3pt; padding-left: 3pt">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">106.90</p>
</td>
<td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-top-style: none; border-left-style: none; vertical-align: top; padding-right: 3pt; padding-left: 3pt">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">75.89</p>
</td>
</tr>
<tr style="background-color: White">
<td style="border-top: black 1pt none; border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; vertical-align: top; padding-right: 3pt; padding-left: 3pt">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">Third Quarter</p>
</td>
<td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-top-style: none; border-left-style: none; vertical-align: top; padding-right: 3pt; padding-left: 3pt">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">79.42</p>
</td>
<td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-top-style: none; border-left-style: none; vertical-align: top; padding-right: 3pt; padding-left: 3pt">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">67.55</p>
</td>
</tr>
<tr style="background-color: rgb(204,238,255)">
<td style="border-top: black 1pt none; border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; vertical-align: top; padding-right: 3pt; padding-left: 3pt">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">Second Quarter</p>
</td>
<td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-top-style: none; border-left-style: none; vertical-align: top; padding-right: 3pt; padding-left: 3pt">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">77.95</p>
</td>
<td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-top-style: none; border-left-style: none; vertical-align: top; padding-right: 3pt; padding-left: 3pt">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">69.96</p>
</td>
</tr>
<tr style="background-color: White">
<td style="border-top: black 1pt none; border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; vertical-align: top; padding-right: 3pt; padding-left: 3pt">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">First Quarter</p>
</td>
<td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-top-style: none; border-left-style: none; vertical-align: top; padding-right: 3pt; padding-left: 3pt">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">76.75</p>
</td>
<td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-top-style: none; border-left-style: none; vertical-align: top; padding-right: 3pt; padding-left: 3pt">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">59.17</p>
</td>
</tr>

</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<table border="0" cellspacing="0" cellpadding="0" style="border: Black medium none; margin-left: auto; width: 50%; margin-right: auto">

<tr>
<td style="border: black 1pt solid; width: 20%; vertical-align: top; padding-right: 3pt; padding-left: 3pt">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">Fiscal 2020</p>
</td>
<td style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; border-left-style: none; width: 15%; text-align: center; vertical-align: top; padding-right: 3pt; padding-left: 3pt">
<p style="font: 10pt Times New Roman, Times, serif; margin: 0pt; text-align: center">High Closing Price</p>
</td>
<td style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; border-left-style: none; width: 15%; text-align: center; vertical-align: top; padding-right: 3pt; padding-left: 3pt">
<p style="font: 10pt Times New Roman, Times, serif; margin: 0pt; text-align: center">Low Closing Price</p>
</td>
</tr>
<tr style="background-color: rgb(204,238,255)">
<td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; border-top-style: none; vertical-align: top; padding-right: 3pt; padding-left: 3pt">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">Fourth Quarter</p>
</td>
<td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-top-style: none; border-left-style: none; vertical-align: top; padding-right: 3pt; padding-left: 3pt">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">61.08</p>
</td>
<td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-top-style: none; border-left-style: none; vertical-align: top; padding-right: 3pt; padding-left: 3pt">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">36.63</p>
</td>
</tr>
<tr style="background-color: White">
<td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; border-top-style: none; vertical-align: top; padding-right: 3pt; padding-left: 3pt">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">Third Quarter</p>
</td>
<td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-top-style: none; border-left-style: none; vertical-align: top; padding-right: 3pt; padding-left: 3pt">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">49.40</p>
</td>
<td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-top-style: none; border-left-style: none; vertical-align: top; padding-right: 3pt; padding-left: 3pt">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">36.46</p>
</td>
</tr>
<tr style="background-color: rgb(204,238,255)">
<td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; border-top-style: none; vertical-align: top; padding-right: 3pt; padding-left: 3pt">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">Second Quarter</p>
</td>
<td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-top-style: none; border-left-style: none; vertical-align: top; padding-right: 3pt; padding-left: 3pt">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">51.68</p>
</td>
<td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-top-style: none; border-left-style: none; vertical-align: top; padding-right: 3pt; padding-left: 3pt">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">37.63</p>
</td>
</tr>
<tr style="background-color: White">
<td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; border-top-style: none; vertical-align: top; padding-right: 3pt; padding-left: 3pt">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">First Quarter</p>
</td>
<td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-top-style: none; border-left-style: none; vertical-align: top; padding-right: 3pt; padding-left: 3pt">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">75.00</p>
</td>
<td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-top-style: none; border-left-style: none; vertical-align: top; padding-right: 3pt; padding-left: 3pt">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">34.20</p>
</td>
</tr>

</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 36pt">As of February 8, 2022, the number of record holders, which include brokers and broker nominees, etc., of our common stock was 32. We believe there are approximately 15,700 beneficial owners of our common stock.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><b><i><b><i>Corporate Performance Graph</i></b></i></b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 36pt">The following graph compares the performance for the periods indicated in the graph of our common stock with the performance of the Nasdaq Market Index and the average performance of a group of the Company&#8217;s peer corporations consisting of: CCA Industries, Inc., Colgate-Palmolive Co., Est&#233;e Lauder Companies, Inc., Inter Parfums, Inc., Kimberly Clark Corp., Natural Health Trends Corp., Procter &amp; Gamble Co., Revlon, Inc., Stephan Co., Summer Infant, Inc. and United Guardian, Inc. The graph assumes that the value of the investment in our common stock and each index was $100 at the beginning of the period indicated in the graph, and that all dividends were reinvested.</p>

<p style="font: 10pt Times New Roman,Times,Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<!-- Field: Page; Sequence: 38; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>COMPARISON OF 5 YEAR CUMULATIVE TOTAL RETURN*</b></p>
<p style="font: 10pt Times New Roman, Times, serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Among Inter Parfums, Inc., the NASDAQ Composite Index,</p>
<p style="font: 10pt Times New Roman, Times, serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">and a Peer Group</p>
<p style="font: 10pt Times New Roman, Times, serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td colspan="3" style="text-align: center"><img src="img001_v1.jpg" alt="image" /></td></tr>
<tr style="vertical-align: bottom">
    <td style="width: 20%">&#160;</td>
    <td style="width: 60%">&#160;</td>
    <td style="width: 20%">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>*$100 invested on 12/31/16 in stock or index, including reinvestment of dividends. Fiscal year ending December 31.</td>
    <td>&#160;</td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 36pt">Below is the list of the data points for each year&#160;that corresponds to the lines on the above graph.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<table border="0" cellspacing="0" cellpadding="0" style="margin: 0px 0px 0px 0pt; width: 90%">

<tr>
<td style="border-top: black 1pt solid; border-bottom: black 1pt solid; border-left-style: none; border-right-style: none; width: 30%; vertical-align: bottom">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><b>&#160;</b></p>
</td>
<td style="border-top: black 1pt solid; border-bottom: black 1pt solid; border-left-style: none; border-right-style: none; width: 1%; vertical-align: bottom">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><b>&#160;</b></p>
</td>
<td style="border-top: black 1pt solid; border-bottom: black 1pt solid; border-left-style: none; border-right-style: none; width: 10%; vertical-align: bottom">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><b>12/16</b></p>
</td>
<td style="border-top: black 1pt solid; border-bottom: black 1pt solid; border-left-style: none; border-right-style: none; width: 10%; vertical-align: bottom">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><b>12/17</b></p>
</td>
<td style="border-top: black 1pt solid; border-bottom: black 1pt solid; border-left-style: none; border-right-style: none; width: 10%; vertical-align: bottom">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><b>12/18</b></p>
</td>
<td style="border-top: black 1pt solid; border-bottom: black 1pt solid; border-left-style: none; border-right-style: none; width: 10%; vertical-align: bottom">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><b>12/19</b></p>
</td>
<td style="border-top: black 1pt solid; border-bottom: black 1pt solid; border-left-style: none; border-right-style: none; width: 10%; vertical-align: bottom">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><b>12/20</b></p>
</td>
<td style="border-top: black 1pt solid; border-bottom: black 1pt solid; border-left-style: none; border-right-style: none; width: 10%; vertical-align: bottom">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><b>12/21</b></p>
</td>
</tr>
<tr>
<td style="vertical-align: bottom">
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
</td>
<td style="vertical-align: bottom">
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
</td>
<td style="vertical-align: bottom">
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
</td>
<td style="vertical-align: bottom">
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
</td>
<td style="vertical-align: bottom">
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
</td>
<td style="vertical-align: bottom">
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
</td>
<td style="vertical-align: bottom">
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
</td>
<td style="vertical-align: bottom">
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
</td>
</tr>
<tr style="background-color: rgb(204,238,255)">
<td style="vertical-align: bottom">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><b>Inter Parfums, Inc.</b></p>
</td>
<td style="vertical-align: bottom">
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
</td>
<td style="vertical-align: bottom">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><b>100.00</b></p>
</td>
<td style="vertical-align: bottom">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><b>135.07</b></p>
</td>
<td style="vertical-align: bottom">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><b>207.10</b></p>
</td>
<td style="vertical-align: bottom">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><b>233.46</b></p>
</td>
<td style="vertical-align: bottom">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><b>195.51</b></p>
</td>
<td style="vertical-align: bottom">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><b>349.98</b></p>
</td>
</tr>
<tr style="background-color: White">
<td style="vertical-align: bottom">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><b>NASDAQ Composite</b></p>
</td>
<td style="vertical-align: bottom">
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
</td>
<td style="vertical-align: bottom">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><b>100.00</b></p>
</td>
<td style="vertical-align: bottom">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><b>129.64</b></p>
</td>
<td style="vertical-align: bottom">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><b>125.96</b></p>
</td>
<td style="vertical-align: bottom">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><b>172.17</b></p>
</td>
<td style="vertical-align: bottom">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><b>249.51</b></p>
</td>
<td style="vertical-align: bottom">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><b>304.85</b></p>
</td>
</tr>
<tr style="background-color: rgb(204,238,255)">
<td style="vertical-align: bottom">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><b>Peer Group</b></p>
</td>
<td style="vertical-align: bottom">
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
</td>
<td style="vertical-align: bottom">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><b>100.00</b></p>
</td>
<td style="vertical-align: bottom">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><b>117.42</b></p>
</td>
<td style="vertical-align: bottom">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><b>116.63</b></p>
</td>
<td style="vertical-align: bottom">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><b>160.22</b></p>
</td>
<td style="vertical-align: bottom">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><b>186.70</b></p>
</td>
<td style="vertical-align: bottom">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><b>225.46</b></p>
</td>
</tr>

</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><b><i><b><i>Dividends</i></b></i></b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 36pt">In October 2019, our Board of Directors authorized a 20% increase in the annual dividend to $1.32 per share on an annual basis. In April 2020, as a result of the uncertainties raised by the COVID-19 pandemic, the Board of Directors authorized a temporary suspension of the annual cash dividend. In February 2021, our Board of Directors authorized a reinstatement of an annual dividend of $1.00, payable quarterly. In February 2022, our Board of Directors authorized a 100% increase in the annual dividend to $2.00 per share. The next quarterly cash dividend of $0.50 per share is payable on March 31, 2022, to shareholders of record on March 15, 2022.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<!-- Field: Page; Sequence: 39; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><b><i><b><i>Sales of Unregistered Securities </i></b></i></b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: 36pt">In December 2021, our non-employee directors exercised stock options to purchase an aggregate of 2,500 shares of restricted common stock. These transactions were exempt from the registration requirements of Section 5 of the Securities Act under Sections 4(2) and 4(6) of the Securities Act. Each option holder agreed that, if the option is exercised, the option holder would purchase his or her common stock for investment and not for resale to the public. Also, we provide all option holders with all reports we file with the SEC and press releases issued by us.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><b>Item 6.&#160;[RESERVED]<span id="a011_v1"></span> </b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><b>Item 7.&#160;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations<span id="a012_v1"></span></b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><b>Overview</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: 36pt">We operate in the fragrance business, and manufacture, market and distribute a wide array of fragrances and fragrance related products. We manage our business in two segments, European based operations and United States based operations. Certain prestige fragrance products are produced and marketed by our European operations through our 73% owned subsidiary in Paris, Interparfums SA, which is also a publicly traded company as 27% of Interparfums SA shares trade on the NYSE Euronext.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: 36pt">We produce and distribute our European based fragrance products primarily under license agreements with brand owners, and European based fragrance product sales represented approximately 75%, 78% and 76% of net sales for 2021, 2020 and 2019, respectively. We have built a portfolio of prestige brands, which include <i>Boucheron, Coach, Jimmy Choo, Karl Lagerfeld, Kate Spade, Lanvin, Moncler, Montblanc, Rochas, S.T. Dupont </i>and<i> Van Cleef &amp; Arpels</i>, whose products are distributed in over 120 countries around the world.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: 36pt">Through our United States operations, we also market fragrance and fragrance related products. United States operations represented 25%, 22% and 24% of net sales in 2021, 2020 and 2019, respectively. These fragrance products are sold primarily pursuant to license or other agreements with the owners of the <i>Abercrombie &amp; Fitch, Anna Sui, Dunhill, Ferragamo, Graff, GUESS, Hollister, MCM, Oscar de la Renta </i>and<i> Ungaro </i>brands.<i> </i></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: 36pt">Substantially all of our prestige fragrance brands are licensed from unaffiliated third parties, and our business is dependent upon the continuation and renewal of such licenses. With respect to the Company&#8217;s largest brands, we license the Montblanc, Jimmy Choo, Coach and GUESS brand names.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<!-- Field: Page; Sequence: 40; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 36pt">As a percentage of net sales, product sales for the Company&#8217;s largest brands were as follows:</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<table border="0" cellspacing="0" cellpadding="0" style="margin-left: 18.9pt; width: 78%">

<tr>
<td style="vertical-align: bottom"></td>
<td><p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
</td>
<td colspan="10" style="border-bottom: black 1pt solid; border-top-style: none; border-right-style: none; border-left-style: none"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Year
                                         Ended December 31,</b></span></p>
</td>
<td style="vertical-align: bottom"><p style="margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
</td>
</tr>
<tr>
<td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td><p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
</td>
<td colspan="2" style="border-bottom: black 1pt solid; border-top-style: none; border-right-style: none; border-left-style: none"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2021</b></span></p>
</td>
<td style="vertical-align: bottom"><p style="margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
</td>
<td><p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
</td>
<td colspan="2" style="border-bottom: black 1pt solid; border-top-style: none; border-right-style: none; border-left-style: none"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2020</b></span></p>
</td>
<td style="vertical-align: bottom"><p style="margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
</td>
<td><p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
</td>
<td colspan="2" style="border-bottom: black 1pt solid; border-top-style: none; border-right-style: none; border-left-style: none"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2019</b></span></p>
</td>
<td style="vertical-align: bottom"><p style="margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
</td>
</tr>
<tr style="background-color: rgb(204,238,255)">
<td style="width: 42%; vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Montblanc</span></p>
</td>
<td style="width: 2%"><p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
</td>
<td style="width: 1%; vertical-align: bottom"><p style="text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
</td>
<td style="width: 10%; vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">19</span></p>
</td>
<td style="width: 2%; vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></p>
</td>
<td style="width: 1%"><p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
</td>
<td style="width: 1%; vertical-align: bottom"><p style="text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
</td>
<td style="width: 10%; vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">21</span></p>
</td>
<td style="width: 2%; vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></p>
</td>
<td style="width: 1%"><p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
</td>
<td style="width: 1%; vertical-align: bottom"><p style="text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
</td>
<td style="width: 10%; vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">22</span></p>
</td>
<td style="width: 1%; vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></p>
</td>
</tr>
<tr style="background-color: White">
<td style="vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jimmy
                                   Choo</span></p>
</td>
<td><p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
</td>
<td style="vertical-align: bottom"><p style="text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
</td>
<td style="vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">18</span></p>
</td>
<td style="vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></p>
</td>
<td><p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
</td>
<td style="vertical-align: bottom"><p style="text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
</td>
<td style="vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16</span></p>
</td>
<td style="vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></p>
</td>
<td><p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
</td>
<td style="vertical-align: bottom"><p style="text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
</td>
<td style="vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16</span></p>
</td>
<td style="vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></p>
</td>
</tr>
<tr style="background-color: rgb(204,238,255)">
<td style="vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Coach</span></p>
</td>
<td><p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
</td>
<td style="vertical-align: bottom"><p style="text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
</td>
<td style="vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16</span></p>
</td>
<td style="vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></p>
</td>
<td><p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
</td>
<td style="vertical-align: bottom"><p style="text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
</td>
<td style="vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">17</span></p>
</td>
<td style="vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></p>
</td>
<td><p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
</td>
<td style="vertical-align: bottom"><p style="text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
</td>
<td style="vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14</span></p>
</td>
<td style="vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></p>
</td>
</tr>
<tr style="background-color: White">
<td style="vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">GUESS</span></p>
</td>
<td><p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
</td>
<td style="vertical-align: bottom"><p style="text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
</td>
<td style="vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12</span></p>
</td>
<td style="vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></p>
</td>
<td><p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
</td>
<td style="vertical-align: bottom"><p style="text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
</td>
<td style="vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11</span></p>
</td>
<td style="vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></p>
</td>
<td><p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
</td>
<td style="vertical-align: bottom"><p style="text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
</td>
<td style="vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10</span></p>
</td>
<td style="vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></p>
</td>
</tr>

</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: 36pt">Quarterly sales fluctuations are influenced by the timing of new product launches as well as the third and fourth quarter holiday season. In certain markets where we sell directly to retailers, seasonality is more evident. We primarily sell directly to retailers in France and the United States.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: 36pt">We grow our business in two distinct ways. First, we grow by adding new brands to our portfolio, either through new licenses or other arrangements or out-right acquisitions of brands. Second, we grow through the introduction of new products and by supporting new and established products through advertising, merchandising and sampling, as well as by phasing out underperforming products, so we can devote greater resources to those products with greater potential. The economics of developing, producing, launching and supporting products influence our sales and operating performance each year.&#160;The introduction of new products may have some cannibalizing effect on sales of existing products, which we take into account in our business planning.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: 36pt">Our business is not capital intensive, and it is important to note that we do not own manufacturing facilities. We act as a general contractor and source our needed components from our suppliers. These components are received at one of our distribution centers and then, based upon production needs, the components are sent to one of several third party fillers, which manufacture the finished product for us and then deliver them to one of our distribution centers.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: 36pt">As with any global business, many aspects of our operations are subject to influences outside our control. We believe we have a strong brand portfolio with global reach and potential. As part of our strategy, we plan to continue to make investments behind fast-growing markets and channels to grow market share.&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: 36pt">Our reported net sales are impacted
by changes in foreign currency exchange rates. A strong U.S. dollar has a negative impact on our net sales. However, earnings
are positively affected by a strong dollar, because over 50% of net sales of our European operations are denominated in U.S. dollars,
while almost all costs of our European operations are incurred in euro. Conversely, a weak U.S. dollar has a favorable impact
on our net sales while gross margins are negatively affected. We address certain financial exposures through a controlled program
of risk management that includes the use of derivative financial instruments, and primarily enter into foreign currency forward
exchange contracts to reduce the effects of fluctuating foreign currency exchange rates.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<!-- Field: Page; Sequence: 41; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><b>Impact of COVID-19 Pandemic</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: 36pt">A novel strain of coronavirus (&#8220;COVID-19&#8221;) surfaced in late 2019 and has spread around the world, including to the United States and France. In March 2020, the World Health Organization declared COVID-19 a pandemic.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: 36pt">In response to the COVID-19 pandemic various national, state, and local governments where we, our suppliers, and our customers operate initially issued decrees prohibiting certain businesses from continuing to operate and certain classes of workers from reporting to work. In all jurisdictions in which we operate, we have been following guidance from authorities and health officials.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: 36pt">The effects of the COVID-19 pandemic on the beauty industry began in early March 2020. Retail store closings, event cancellations and a shutdown of international air travel brought our sales to a virtual standstill and caused a significant unfavorable impact on our results of operations in 2020.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: 36pt">Business significantly improved in the second half of 2020 and continued to improve throughout 2021, as retail stores reopened, and consumers increased online purchasing. While we expect this trend to continue, as the luxury fragrance industry has shown continued resilience, the introduction of variants of COVID-19 in various parts of the world has caused the temporary re-implementation of governmental restrictions to prevent further spread of the virus. In addition, international air travel has remained curtailed in many jurisdictions due to both governmental restrictions and consumer health concerns. While COVID-19 has significantly restricted international travel in the near-term, we continue to believe that global travel retail will once again be a growth opportunity for the long-term. Lastly, the improved economy has put significant strains on our supply chain causing disruptions affecting the procurement of components, the ability to transport goods, and related cost increases. These disruptions have come at a time when demand for our product lines has never been stronger or more sustained. We have been addressing this issue since the beginning of 2021, by ordering well in advance of need and in larger quantities. Going forward, we aim to carry more inventory overall, source the same components from multiple suppliers and when possible, manufacture products closer to where they are sold. We do not expect the supply chain bottlenecks to begin lifting until later in 2022. Therefore, despite recent business improvement, the impact of the COVID-19 pandemic may have a material adverse effect on our results of our operations, financial position and cash flows through at least the end of 2022.&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><b>Recent Important Events</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: 36pt"><b><i><b><i>Salvatore Ferragamo </i></b></i></b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: 36pt">In October 2021, we closed on
a transaction agreement with Salvatore Ferragamo S.p.A., whereby an exclusive and worldwide license was granted for the production
and distribution of Ferragamo brand perfumes. Our rights under this license are subject to certain minimum advertising expenditures
and royalty payments as are customary in our industry. The license became effective in October 2021 and will last for 10 years
with a 5-year optional term, subject to certain conditions.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<!-- Field: Page; Sequence: 42; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt; margin-right: 0"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt; margin-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt; margin-right: 0"><p style="margin: 0pt 0 0pt 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: 36pt">With respect to the management and coordination of activities related to the license agreement, the Company operates through a wholly-owned Italian subsidiary based in Florence, that was acquired from Salvatore Ferragamo on October 1, 2021. The acquisition together with the license agreement was accounted for as an asset acquisition. The following table summarizes the estimated fair values of the assets acquired and liabilities assumed on October 1, 2021. All amounts have been translated to U.S. dollars at the October 1, 2021 exchange rate.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<table border="0" cellspacing="0" cellpadding="0" style="margin-left: auto; width: 50%; margin-right: auto">

<tr>
<td style="width: 37%; vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(In
                                         thousands)</span></p>
</td>
<td style="width: 1%; vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
</td>
<td style="width: 1%; vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
</td>
<td style="width: 10%; vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
</td>
<td style="width: 1%; vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
</td>
</tr>
<tr>
<td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="background-color: rgb(204,238,255)">
<td style="vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: 7.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventories</span></p>
</td>
<td style="vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
</td>
<td style="vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></p>
</td>
<td style="vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">17,805</span></p>
</td>
<td style="vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
</td>
</tr>
<tr style="background-color: White">
<td style="vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: 7.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trademarks
                                         and licenses</span></p>
</td>
<td style="vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
</td>
<td style="vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
</td>
<td style="vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15,880</span></p>
</td>
<td style="vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
</td>
</tr>
<tr style="background-color: rgb(204,238,255)">
<td style="vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: 7.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
                                         assets</span></p>
</td>
<td style="vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
</td>
<td style="border-bottom: black 1pt solid; border-top-style: none; border-right-style: none; border-left-style: none; vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
</td>
<td style="border-bottom: black 1pt solid; border-top-style: none; border-right-style: none; border-left-style: none; vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,033</span></p>
</td>
<td style="vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
</td>
</tr>
<tr style="background-color: White">
<td style="vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
</td>
<td style="vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
</td>
<td style="border-style: none; vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
</td>
<td style="border-style: none; vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
</td>
<td style="vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
</td>
</tr>
<tr style="background-color: rgb(204,238,255)">
<td style="vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.6pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assets
                                         acquired</span></p>
</td>
<td style="vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
</td>
<td style="border-bottom: black 1pt solid; border-top-style: none; border-right-style: none; border-left-style: none; vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
</td>
<td style="border-bottom: black 1pt solid; border-top-style: none; border-right-style: none; border-left-style: none; vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">36,718</span></p>
</td>
<td style="vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
</td>
</tr>
<tr style="background-color: White">
<td style="vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
</td>
<td style="vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
</td>
<td style="border-style: none; vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
</td>
<td style="border-style: none; vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
</td>
<td style="vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
</td>
</tr>
<tr style="background-color: rgb(204,238,255)">
<td style="vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.6pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Liabilities
                                         assumed</span></p>
</td>
<td style="vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
</td>
<td style="border-bottom: black 1pt solid; border-top-style: none; border-right-style: none; border-left-style: none; vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
</td>
<td style="border-bottom: black 1pt solid; border-top-style: none; border-right-style: none; border-left-style: none; vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(958</span></p>
</td>
<td style="vertical-align: bottom; padding-bottom: 1pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></p>
</td>
</tr>
<tr style="background-color: White">
<td style="vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
</td>
<td style="vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
</td>
<td style="border-bottom: #000000 2.5pt double; border-top-style: none; border-right-style: none; border-left-style: none; vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></p>
</td>
<td style="border-bottom: #000000 2.5pt double; border-top-style: none; border-right-style: none; border-left-style: none; vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">35,760</span></p>
</td>
<td style="vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
</td>
</tr>

</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 36pt"><b><i><b><i>Emanuel Ungaro</i></b></i></b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 36pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In October 2021, we
also entered into a 10-year exclusive global licensing agreement a with a 5-year optional term subject to certain conditions, with
Emanuel Ungaro Italia S.r.l, for the creation, development and distribution of fragrances and fragrance-related products, under
the Emanuel Ungaro brand. Our rights under this license are subject to certain minimum advertising expenditures and royalty payments
as are customary in our industry.</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: 36pt"><b><i><b><i>Donna Karan and DKNY </i></b></i></b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: 36pt">In September 2021, we entered into a long-term global licensing agreement for the creation, development and distribution of fragrances and fragrance-related products under the Donna Karan and DKNY brands. Our rights under this license are subject to certain minimum advertising expenditures and royalty payments as are customary in our industry. With this agreement, we are gaining several well-established and valuable fragrance franchises, most notably Donna Karan <i>Cashmere Mist</i> and DKNY <i>Be Delicious</i>, as well as a significant loyal consumer base around the world. In connection with the grant of license, we issued 65,342 shares of Inter Parfums, Inc. common stock valued at $5.0 million to the licensor. The exclusive license is effective July 1, 2022, and we are planning to launch new fragrances under these brands in 2023.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: 36pt"><b><i><b><i>French Tax Settlement </i></b></i></b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: 36pt">The French authorities had considered that the existence of IP Suisse, a wholly-owned subsidiary of Interparfums SA, does not, in and of itself, constitute a permanent establishment and therefore Interparfums SA should pay French taxes on all or part of the profits of that entity.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<!-- Field: Page; Sequence: 43; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt; margin-right: 0"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt; margin-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt; margin-right: 0"><p style="margin: 0pt 0 0pt 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: 36pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In June 2021, a global settlement agreement
was reached with the French Tax Authorities, whereby Interparfums SA paid in December 2021, &#8364;2.5 million (approximately $2.9
million) effectively lowering the Lanvin brand royalty rate charged by IP Suisse for the periods from 2017 through 2020. Interparfums
SA also agreed to apply the lower rate in 2021 through 2025 and to transfer the Lanvin brand from IP Suisse to Interparfums SA
by December 31, 2025.</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: 36pt"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: 36pt"><b><i><b><i>Land and Building Acquisition - Future Headquarters in Paris</i></b></i></b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: 36pt">In April 2021, Interparfums SA, completed the acquisition of its future headquarters at 10 rue de Solf&#233;rino in the 7th arrondissement of Paris from the property developer. This is an office complex combining three buildings connected by two inner courtyards, and consists of approximately 40,000 total sq. ft.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: 36pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The $142 million purchase price includes
the complete renovation of the site. As of December 31, 2021, $136.1 million of the purchase price, including approximately $3.1
million of acquisition costs, is included in property, equipment and leasehold improvements on the accompanying balance sheet as
of December 31, 2021. Approximately $8.8 million of cash held in escrow is included in other assets on the accompanying balance
sheet as of December 31, 2021. In addition, the Company borrowed $17.0 million pursuant to a short-term loan equal to the VAT credit,
and in July 2021, the $17.0 million VAT credit was reimbursed by the French Tax Authorities and the loan was repaid.</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: 36pt"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 36pt">The acquisition was financed by a 10-year &#8364;120 million (approximately $136 million) bank loan which bears interest at one-month Euribor plus 0.75%. Approximately &#8364;80 million of the variable rate debt was swapped for variable interest rate debt with a maximum rate of 2% per annum.&#160;&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: 36pt"><b><i><b><i>Anna Sui Corp.</i></b></i></b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: 36pt">In January 2021, we renewed our license agreement with Anna Sui Corp. for the creation, development and distribution of fragrance products through December&#160;31, 2026, without any material changes in terms and conditions. Our initial 10-year license agreement with Anna Sui Corp. was signed in 2011. The renewal agreement also allows for an additional 5-year term through 2031 at the option of the Company.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: 36pt"><i></i><b><i><b>Rochas Fashion</b></i></b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: 36pt">Effective January 1, 2021, we entered into a new license agreement modifying our Rochas fashion business model. The new agreement calls for a reduction in royalties to be received. As a result, in the first quarter of 2021, we took a $2.4 million impairment charge on our Rochas fashion trademark. The new license also contains an option for the licensee to buy-out the Rochas fashion trademarks in June 2025 at its then fair market value.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<!-- Field: Page; Sequence: 44; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt; margin-right: 0"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt; margin-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt; margin-right: 0"><p style="margin: 0pt 0 0pt 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: 36pt"><b><i><b>S.T. Dupont</b></i></b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: 36pt">In January 2021, we renewed our license agreement with S.T. Dupont for the creation, development and distribution of fragrance products through December&#160;31, 2022, without any material changes in terms and conditions. Our initial 11-year license agreement with S.T. Dupont was signed in June 1997 and had previously been extended through December 31, 2021.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><b>Discussion of Critical Accounting Policies</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: 36pt">We make estimates and assumptions in the preparation of our financial statements in conformity with accounting principles generally accepted in the United States of America. Actual results could differ significantly from those estimates under different assumptions and conditions. We believe the following discussion addresses our most critical accounting policies, which are those that are most important to the portrayal of our financial condition and results of operations. These accounting policies generally require our management&#8217;s most difficult and subjective judgments, often as a result of the need to make estimates about the effect of matters that are inherently uncertain. Management of the Company has discussed the selection of significant accounting policies and the effect of estimates with the Audit Committee of the Board of Directors.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: 36pt"><b><i><b><i>Long-Lived Assets</i></b></i></b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: 36pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: 36pt">We evaluate indefinite-lived intangible assets for impairment
at least annually during the fourth quarter, or more frequently when events occur or circumstances change, such as an unexpected
decline in sales, that would more likely than not indicate that the carrying value of an indefinite-lived intangible asset may
not be recoverable. When testing indefinite-lived intangible assets for impairment, the evaluation requires a comparison of the
estimated fair value of the asset to the carrying value of the asset. The fair values used in our evaluations are estimated based
upon discounted future cash flow projections using a weighted average cost of capital of 7.47%. The cash flow projections are based
upon a number of assumptions, including, future sales levels and future cost of goods and operating expense levels, as well as
economic conditions, changes to our business model or changes in consumer acceptance of our products which are more subjective
in nature. If the carrying value of an indefinite-lived intangible asset exceeds its fair value, an impairment charge is recorded.</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: 36pt"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<!-- Field: Page; Sequence: 45; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt; margin-right: 0"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt; margin-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt; margin-right: 0"><p style="margin: 0pt 0 0pt 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: 36pt">We believe that the assumptions we have made in projecting future cash flows for the evaluations described above are reasonable. However, if future actual results do not meet our expectations, we may be required to record an impairment charge, the amount of which could be material to our results of operations.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: 36pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">At December 31, 2021 indefinite-lived intangible
assets aggregated $119.7 million. The following table presents the impact a change in the following significant assumptions would
have had on the calculated fair value in 2021 assuming all other assumptions remained constant:</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: 36pt"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 70%; margin-left: 36pt">
<tr style="vertical-align: bottom">
    <td style="font: italic 10pt Times New Roman, Times, Serif">$ in millions</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center">Increase (decrease)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Change</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">to fair value</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 34%">Weighted average cost of capital</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: right"><span style="font-size: 10pt">+10</span></p></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 15%; text-align: right">(11.9</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">Weighted average cost of capital</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-10</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">14.0</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Future sales levels</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: right"><span style="font-size: 10pt">+10</span></p></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">13.3</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Future sales levels</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-10</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(13.3</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: 36pt">Intangible assets subject to amortization are evaluated for impairment testing whenever events or changes in circumstances indicate that the carrying amount of an amortizable intangible asset may not be recoverable. If impairment indicators exist for an amortizable intangible asset, the undiscounted future cash flows associated with the expected service potential of the asset are compared to the carrying value of the asset. If our projection of undiscounted future cash flows is in excess of the carrying value of the intangible asset, no impairment charge is recorded. If our projection of undiscounted future cash flows is less than the carrying value of the intangible asset, an impairment charge would be recorded to reduce the intangible asset to its fair value. The cash flow projections are based upon a number of assumptions, including future sales levels and future cost of goods and operating expense levels, as well as economic conditions, changes to our business model or changes in consumer acceptance of our products which are more subjective in nature. In those cases where we determine that the useful life of long-lived assets should be shortened, we would amortize the net book value in excess of the salvage value (after testing for impairment as described above), over the revised remaining useful life of such asset thereby increasing amortization expense. We believe that the assumptions we have made in projecting future cash flows for the evaluations described above are reasonable.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: 36pt">In determining the useful life of our Lanvin brand names and trademarks, we applied the provisions of ASC topic 350-30-35-3. The only factor that prevented us from determining that the Lanvin brand names and trademarks were indefinite life intangible assets was Item c. &#8220;Any legal, regulatory, or contractual provisions that may limit the useful life.&#8221; The existence of a repurchase option originally in 2025 and amended to 2027, may limit the useful life of the Lanvin brand names and trademarks to the Company. However, this limitation would only take effect if the repurchase option were to be exercised and the repurchase price was paid. If the repurchase option is not exercised, then the Lanvin brand names and trademarks are expected to continue to contribute directly to the future cash flows of our Company and their useful life would be considered to be indefinite.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<!-- Field: Page; Sequence: 46; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt; margin-right: 0"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt; margin-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt; margin-right: 0"><p style="margin: 0pt 0 0pt 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: 36pt">With respect to the application of ASC topic 350-30-35-8, the Lanvin brand names and trademarks would only have a finite life to our Company if the repurchase option were exercised, and in applying ASC topic 350-30-35-8, we assumed that the repurchase option is exercised. When exercised, Lanvin has an obligation to pay the exercise price and the Company would be required to convey the Lanvin brand names and trademarks back to Lanvin. The exercise price to be received (residual value) is well in excess of the carrying value of the Lanvin brand names and trademarks, therefore no amortization is required.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: 36pt"><b><i><b><i>Quantitative Analysis</i></b></i></b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: 36pt">During the three-year period ended December 31, 2021, we have not made any material changes in our assumptions underlying these critical accounting policies or to the related significant estimates. The results of our business underlying these assumptions have not differed significantly from our expectations.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: 36pt">While we believe the estimates we have made are proper and the related results of operations for the period are presented fairly in all material respects, other assumptions could reasonably be justified that would change the amount of reported net sales, cost of sales, and selling, general and administrative expenses as they relate to the provisions for anticipated sales returns, allowance for doubtful accounts and inventory obsolescence reserves. For 2021, had these estimates been changed simultaneously by 5% in either direction, our reported gross profit would have increased or decreased by approximately $0.6 million and selling, general and administrative expenses would have changed by approximately $0.1 million. The collective impact of these changes on 2021 operating income, net income attributable to Inter Parfums, Inc., and net income attributable to Inter Parfums, Inc. per diluted share would be an increase or decrease of approximately $0.6 million, $0.3 million and $0.01, respectively.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><b>Results of Operations</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="font-weight: bold; font-style: italic; text-align: center">Net Sales</td><td style="font-weight: bold">&#160;</td>
    <td colspan="18" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Years ended December 31,</td><td style="font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; text-align: center">(in millions)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">% Change</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">% Change</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 35%; text-align: left">European based product sales</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">663.2</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right">57</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">422.9</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right">(22</td><td style="width: 1%; text-align: left">)%</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">542.1</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">United States based product sales</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">216.4</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">86</td><td style="padding-bottom: 1pt; text-align: left">%</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">116.1</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(32</td><td style="padding-bottom: 1pt; text-align: left">)%</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">171.4</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Total net sales</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">879.6</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">63</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">539.0</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">(24</td><td style="padding-bottom: 2.5pt; text-align: left">)%</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">713.5</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: 36pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Net sales rebounded significantly in 2021,
as compared to 2020 for both European and United States based operations. Even more gratifying, 2021 net sales for European based
operations and United States based operations increased 22% and 26%, respectively, as compared to 2019. At comparable foreign currency
exchange rates, net sales increased 62% in 2021, as compared to 2020 and decreased 26 % in 2020, as compared to 2019. Net sales
in 2020 reflected the negative impacts of the COVID-19 pandemic on the beauty industry. Retail store closings, event cancellations
and a shutdown of international air travel brought our sales to a virtual standstill in early 2020. In the second half of 2020,
business began rebounding thanks to retail stores reopening and a robust e-commerce business conducted by our retail customers.
However, international travel has remained largely curtailed globally due to both government restrictions and consumer health concerns
that continue to adversely impact consumer traffic in most travel retail locations. As 2020 was an outlier for our sales due to
the COVID-19 pandemic and its effects as discussed above, below are sales comparisons for our largest brands in 2021 with 2019.</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: 36pt"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<!-- Field: Page; Sequence: 47; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt; margin-right: 0"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt; margin-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt; margin-right: 0"><p style="margin: 0pt 0 0pt 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: 36pt">For European based operations, our largest brands, Montblanc, Jimmy Choo and Coach grew 2021 sales by 7%, 34% and 41%, respectively, as compared to 2019. There were also significant gains made by our mid-sized brands, including Van Cleef &amp; Arpels and Karl Lagerfeld.&#160;We also welcomed first time sales by our newest brands, notably Kate Spade and Moncler.&#160;&#160;&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: 36pt">In 2021, GUESS became our fourth brand with sales exceeding $100 million. GUESS brand sales increased 41% in 2021, as compared to 2019, contributing to the overall increase in 2021 net sales within U.S. based operations. There were also significant gains made by our mid-sized brands, especially Abercrombie &amp; Fitch, Hollister and Oscar de la Renta. We also welcomed first time sales by our newest brands, MCM and Ferragamo.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: 36pt">A more detailed discussion relating to our sales for 2020 as compared to 2019 can be found in &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; in Part II, Item 7 of our annual report on Form 10-K for the year ended December 2020.&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: 36pt">We are confident in our future as 2022 has begun on a strong note. We have completed the integration of the Ferragamo and Ungaro brands and our new Italian subsidiary is now staffed and fully operational. We have a solid line-up of new product launches in the pipeline for many of our other brands. This includes the roll out of the first Moncler fragrance line in a series of selective points of sale that faithfully respect the brand&#8217;s image. An entirely new men&#8217;s collection for GUESS is scheduled for introduction in the spring. Extensions of the Montblanc <i>Legend</i>, Jimmy Choo <i>Man</i> and Jimmy Choo&#8217;s <i>I Want Choo</i>, debut in the first, second and third quarters, respectively. Also, in the third quarter, we will unveil new men&#8217;s lines for Coach and Boucheron. Brand extensions and flankers are in the works for MCM, Abercrombie &amp; Fitch, Hollister, Anna Sui, and Oscar de la Renta. In addition, we will be adding the Donna Karan and DKNY fragrance brands to our portfolio come this summer. In sum, 2022 has all the earmarks of another superb year as the growth catalysts currently far outweigh the headwinds, most notably limited travel retail business and supply chain disruptions.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: 36pt">As in the past, we hope to benefit from our strong financial position to potentially acquire one or more brands, either on a proprietary basis or as a licensee. However, we cannot assure you that any new license or acquisition agreements will be consummated.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<!-- Field: Page; Sequence: 48; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt; margin-right: 0"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt; margin-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt; margin-right: 0"><p style="margin: 0pt 0 0pt 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 36pt"><b><i><b><i>Net Sales to Customers by Region</i></b></i></b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Years ended December 31,</td><td style="font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="10" style="font-weight: bold; text-align: center; padding-bottom: 8pt">(in millions)</td><td style="font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 61%; text-align: left">North America</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">354.1</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">193.5</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">235.5</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Western Europe</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">202.0</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">147.1</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">185.5</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Asia</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">128.0</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">79.7</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">110.9</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Eastern Europe</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">69.7</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">33.1</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">55.2</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Middle East</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">61.0</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">46.8</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">72.6</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Central and South America</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">56.4</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">32.5</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">46.2</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">Other</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">8.4</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">6.3</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">7.6</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">879.6</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">539.0</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">713.5</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: 36pt">As we did with sales for our largest brands, we are discussing net sales to customers by region using comparisons in 2021 with 2019, as the result of the effects of the COVID-19 pandemic in 2020. Our largest market, North America achieved sales growth of 50% in 2021 compared to 2019, while Western Europe and Asia grew sales by 9% and 15% in 2021, respectively, compared to 2019.&#160;Latin America and Eastern Europe also achieved top line growth of 22% and 26% in 2021, respectively, and only the Middle East had a decline in sales compared to 2019. As of the date of this report, international travel has remained largely curtailed globally due to both government restrictions and consumer health concerns that continue to adversely impact consumer traffic in most travel retail locations.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: 36pt">The impact of the COVID-19 pandemic broadly impacted all regions in 2020, with the steepest declines in the Middle East and Eastern Europe. Travel retail accounted for much of the decline in the Middle East and Asian markets.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: 36pt"><b><i><b><i>Gross Margins</i></b></i></b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Years ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="10" style="font-weight: bold; text-align: center">(in millions)</td><td style="font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">European operations:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 61%; text-align: left">Net sales</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">663.2</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">422.9</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">542.1</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">Cost of sales</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">221.2</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">152.3</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">186.2</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Gross margin</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">442.0</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">270.6</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">355.9</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Gross margin, as a percent of net sales</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">66.7</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">64.0</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">65.7</td><td style="text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">United States operations:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Net sales</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">216.3</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">116.1</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">171.4</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">Cost of sales</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">101.4</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">56.0</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">81.4</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Gross margin</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">114.9</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">60.1</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">90.0</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Gross margin, as a percent of net sales</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">53.1</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">51.8</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">52.5</td><td style="text-align: left">%</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: 36pt">For European based operations, gross profit margin as a percentage of net sales was 66.6%, 64.0% and 65.7% in 2021, 2020 and 2019, respectively. Distribution in the United States for European based operations is handled by a 100% owned subsidiary of Interparfums SA. Therefore, sales are made at a wholesale price rather than at an ex-factory price, resulting in higher gross margins. Net sales of our U.S. distribution subsidiary increased 86% in 2021, as compared to 2020, giving rise to the increase in gross margin in 2021 over both 2020 and 2019. We carefully monitor movements in foreign currency exchange rates as over 50% of our European based operations net sales is denominated in U.S. dollars, while most of our costs are incurred in euro. From a margin standpoint, a strong U.S. dollar has a positive effect on our gross margin while a weak U.S. dollar has a negative effect. The average dollar/euro exchange rate was 1.18 in 2021, 1.15 in 2020, and 1.12 in 2019. The weaker dollar in 2021 partially mitigated the increase in margin referred to above and resulted in a small decline in our gross margins in 2020. Gross margin in 2020 for European operations also included a charge of approximately $2.0 million relating to the assumption of a return liability for products sold by the former licensee of a brand license acquired in 2019.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<!-- Field: Page; Sequence: 49; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt; margin-right: 0"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt; margin-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt; margin-right: 0"><p style="margin: 0pt 0 0pt 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: 36pt">For United States operations, gross profit margin was 53.1%, 51.8% and 52.5% in 2021, 2020 and 2019, respectively. With a decline in sales in 2020, certain expenses such as depreciation of tools and molds together with the distribution of point-of-sale materials exaggerated the decline in gross margin for the year as a percentage of sales. With U.S. based operations net sales up 86% in 2021, as compared to 2020, no such effect was seen in 2021.&#160;&#160;&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: 36pt">Costs relating to purchase with purchase and gift with purchase promotions are reflected in cost of sales, and aggregated $37.6 million, $26.4 million and $38.9 million in 2021, 2020 and 2019, respectively, and represented 4.3%, 4.9% and 5.5% of net sales, respectively.&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: 36pt">Generally, we do not bill customers for shipping and handling costs and such costs, which aggregated $10.1 million, $5.0 million and $7.7 million in 2021, 2020 and 2019, respectively, are included in selling, general and administrative expenses in the consolidated statements of income. As such, our Company&#8217;s gross margins may not be comparable to other companies, which may include these expenses as a component of cost of goods sold.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: 36pt"><b><i><b><i>Selling, General &amp; Administrative Expenses</i></b></i></b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="font-weight: bold; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Years ended December 31,</td><td style="font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: bold; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: bold; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="10" style="font-weight: bold; text-align: center">(in millions)</td><td style="font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-left: 0.125in; text-indent: -0.125in">European Operations</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 61%; text-align: left; padding-left: 0.125in; text-indent: -0.125in">Selling, general &amp; administrative expenses</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">327.5</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">210.6</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">275.3</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Selling, general &amp; administrative expenses as a percent of net sales</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">49.4</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">49.8</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">50.8</td><td style="text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-left: 0.125in; text-indent: -0.125in">United States Operations</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Selling, general &amp; administrative expenses</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">79.0</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">50.1</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">65.9</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Selling, general &amp; administrative expenses as a percent of net sales</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">36.5</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">43.1</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">38.5</td><td style="text-align: left">%</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: 36pt">For European operations, selling, general and administrative expenses increased 55.5% in 2021 and declined 23.6% in 2020, as compared to the corresponding prior year period, and represented 49.4%, 49.8% and 50.8% of sales in 2021, 2020 and 2019, respectively. As discussed in more detail below, the fluctuations which are in line with the fluctuations in sales for European operations, are primarily from variations in promotion and advertising expenditures.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: 36pt">Our operating cost structure, of which variable costs typically account for over two-thirds, had enabled us to minimize the impact of reduced net sales on our bottom line. Due to the effects of the COVID-19 pandemic, a substantial portion of the reduction in selling, general and administrative expenses in 2020 were attributable to the postponement of advertising and promotional expenses to 2021, as nearly all major new product launches were postponed until 2021. In addition, we also undertook several actions with an eye toward minimizing fixed expenses.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<!-- Field: Page; Sequence: 50; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt; margin-right: 0"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt; margin-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt; margin-right: 0"><p style="margin: 0pt 0 0pt 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: 36pt">For United States operations, selling, general and administrative expenses increased 57.8% in 2021 and decreased 24.1% in 2020, as compared to the corresponding prior year period and represented 36.5%, 43.1% and 38.5% of sales in 2021, 2020 and 2019, respectively. Our U.S. operations are significantly smaller than those of our European operations and carry higher fixed costs that could not be leveraged as efficiently as those of our European operations with the decline in 2020 net sales. However, with an 86% increase in 2021 net sales, the opposite effect was realized, and we were able to achieve significant leverage on fixed costs during the year.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: 36pt">Promotion and advertising included in selling, general and administrative expenses aggregated $171.8 million, $91.7 million and $144.6 million in 2021, 2020 and 2019, respectively. Promotion and advertising as a percentage of sales represented 19.5%, 17.0% and 20.3% of net sales in 2021, 2020 and 2019, respectively. Promotion and advertising programs were cut significantly in 2020 in response to market conditions. Throughout 2021, sales rebounded far more rapidly than anticipated causing us to play catchup with promotional and adverting programs and missing our target spend of 21% of annual sales. Promotion and advertising are integral parts of our industry, and we continue to invest heavily in promotional spending to support new product launches and to build brand awareness. We believe that our promotion and advertising efforts have had a beneficial effect on online net sales, causing then to continue to grow strongly on a global basis. All of our brands have benefitted from newly launched and enhanced e-commerce sites in existing markets in collaboration with our retail customers on their e-commerce sites. We also continue to develop and implement omnichannel concepts, the way brick-and-mortar stores and a business&#8217; online operations work in tandem, and compelling content to deliver an integrated consumer experience. We anticipated that on a full year basis, future promotion and advertising expenditures will aggregate approximately 21% of net sales, which is in line with historical averages.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: 36pt">Royalty expense included in selling, general and administrative expenses aggregated $69.0 million, $41.1 million and $53.0 million in 2021, 2020 and 2019, respectively. Royalty expense as a percentage of sales represented 7.8%, 7.6% and 7.4% of net sales in 2021, 2020 and 2019, respectively. The increases in 2021 and 2020, as a percentage of sales, are directly related to new licenses and increased royalty-based product sales. As a result of the COVID-19 pandemic, we reached agreements with most of our licensors to waive or significantly reduce minimum guaranteed royalties for 2020.&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: 36pt">Service fees, which are fees paid within our European operations to third parties relating to the activities of our distribution subsidiaries, aggregated $9.4 million, $6.8 million and $7.5 million in 2021, 2020 and 2019, respectively. The 2021 and 2020 amounts are in line with and directly related to fluctuations in sales within our U.S. distribution subsidiary.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: 36pt"><b><i><b><i>Income from Operations</i></b></i></b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: 0.5in">As a result of the above analysis regarding net sales, gross profit margins and selling, general and administrative expenses, our operating margins aggregated 16.8%, 13.1% and 14.7% for the years ended December 31, 2021, 2020 and 2019, respectively. Lower than expected promotion and adverting expense drove the increase in our operating margin in 2021, while strong cost controls in 2020 enabled us to minimize the impact of the sudden drop in sales resulting from the COVID-19 pandemic.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<!-- Field: Page; Sequence: 51; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt; margin-right: 0"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt; margin-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt; margin-right: 0"><p style="margin: 0pt 0 0pt 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: 36pt"><b><i><b>Other Income and Expenses</b></i></b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 36pt">Traditionally, interest expense was primarily related to the financing of brand and licensing acquisitions. However, in April 2021, we completed the acquisition of the future headquarters of Interparfums SA. The acquisition was financed by a 10-year &#8364;120 million (approximately $136 million) bank loan which bears interest at one-month Euribor plus 0.75%. Also in 2021, approximately &#8364;80 million of the variable rate debt was swapped for fixed interest rate debt. Long-term debt including current maturities aggregated $148.8 million, $24.7 million and $23.1 million as of December 31, 2021, 2020 and 2019, respectively.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: 36pt">We enter into foreign currency forward exchange contracts to manage exposure related to receivables from unaffiliated third parties denominated in a foreign currency and occasionally to manage risks related to future sales expected to be denominated in a foreign currency. Gains and losses on foreign currency transactions have not been significant.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: 36pt">Interest and dividend income represents interest earned on cash and cash equivalents and short-term investments. In 2021, short-term investments include approximately $24.5 million of marketable equity securities of other companies in the luxury goods sector. Interest and dividend income includes approximately $1.8 million of unrealized gains on marketable equity securities.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 36pt"><b><i><b><i>Income Taxes</i></b></i></b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: 36pt">Our effective income tax rate was 27.1%, 27.9% and 27.7% in 2021, 2020 and 2019, respectively.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: 36pt">Income tax expense represents U.S. federal, foreign, state and local income taxes. The effective rate differs from the federal statutory rate primarily due to the effect of state and local income taxes, the tax impact of share-based compensation and the taxation of foreign income including tax settlements. Our effective tax rate will change from year-to-year based on recurring and non-recurring factors including the geographical mix of earnings, enacted tax legislation, state and local income taxes, the tax impact of share-based compensation, the interaction of various global tax strategies and the impact from certain acquisitions.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: 36pt">Our effective income tax rate for European operations was 30.6%, 29.7% and 30.7% in 2021, 2020 and 2019, respectively.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: 36pt">The French authorities had considered
that the existence of IP Suisse, a wholly-owned subsidiary of Interparfums SA, does not, in and of itself, constitute a permanent
establishment and therefore Interparfums SA should pay French taxes on all or part of the profits of that entity. In June 2021,
a global settlement agreement was reached with the French Tax Authorities, whereby Interparfums SA agreed to pay &#8364;2.5 million
(approximately $3.0 million) effectively lowering the Lanvin brand royalty rate charged by IP Suisse for the periods from 2017
through 2020. Interparfums SA also agreed to apply the lower rate in 2021 through 2025 and to transfer the Lanvin brand from IP
Suisse to Interparfums SA by December 31, 2025.&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<!-- Field: Page; Sequence: 52; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt; margin-right: 0"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt; margin-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt; margin-right: 0"><p style="margin: 0pt 0 0pt 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: 36pt">In addition, pursuant to an action plan released by the French Prime Minister, beginning in 2020, the French corporate income tax rate is expected to be cut from approximately 33% to 25% over a three-year period.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: 36pt">Our effective income tax rate for U.S. operations was 15.6%, 16.7% and 17.0% in 2021, 2020 and 2019, respectively.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: 36pt">The Company has determined that it has no tax liability related global intangible low-taxed income (&#8220;GILTI&#8221;) as of December 31, 2021, 2020 and 2019. The Company also estimated the effect of its foreign derived intangible income (&#8220;FDII&#8221;) and recorded a tax benefit of $0.6 million, $0.3 million and $0.9 million as of December 31, 2021, 2020 and 2019, respectively. Share-based compensation resulted in a discrete tax benefit of $1.3 million, $0.4 million and $0.7 million in 2021, 2020 and 2019, respectively.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: 36pt"><b><i><b><i>Net Income</i></b></i></b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<table border="0" cellspacing="0" cellpadding="0" style="width: 100%">

<tr>
<td style="width: 60%; vertical-align: bottom">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt">&#160;</p>
</td>
<td style="width: 2%; vertical-align: bottom">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt">&#160;</p>
</td>
<td colspan="8" style="border-bottom: black 1pt none; border-top-style: none; border-right-style: none; border-left-style: none; width: 37%; border-bottom-style: solid; vertical-align: bottom">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: center"><b>Year ended December 31,</b></p>
</td>
<td style="width: 2%; vertical-align: bottom">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt">&#160;</p>
</td>
</tr>
<tr>
<td style="width: 60%; vertical-align: bottom">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt">&#160;</p>
</td>
<td style="width: 2%; vertical-align: bottom">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt">&#160;</p>
</td>
<td colspan="2" style="border-bottom: black 1pt none; border-top-style: none; border-right-style: none; border-left-style: none; width: 11%; border-bottom-style: solid; vertical-align: bottom">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: center"><b>2021</b></p>
</td>
<td style="border-style: none; width: 2%; vertical-align: bottom">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: center">&#160;</p>
</td>
<td colspan="2" style="border-bottom: black 1pt solid; border-top-style: none; border-left-style: none; border-right-style: none; width: 11%; vertical-align: bottom">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: center"><b>2020</b></p>
</td>
<td style="border-style: none; width: 2%; vertical-align: bottom">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: center">&#160;</p>
</td>
<td colspan="2" style="border-bottom: black 1pt solid; border-top-style: none; border-left-style: none; border-right-style: none; width: 11%; vertical-align: bottom">
<p style="border-style: none; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; padding: 0pt; text-align: center"><b>2019</b></p>
</td>
<td style="width: 2%; vertical-align: bottom">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt">&#160;</p>
</td>
</tr>
<tr>
<td style="width: 60%; vertical-align: bottom">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt">&#160;</p>
</td>
<td style="width: 2%; vertical-align: bottom">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt">&#160;</p>
</td>
<td colspan="8" style="width: 37%; vertical-align: bottom">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: center">(In thousands)</p>
</td>
<td style="width: 2%; vertical-align: bottom">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt">&#160;</p>
</td>
</tr>
<tr>
<td style="width: 60%; vertical-align: bottom">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt">&#160;</p>
</td>
<td style="width: 2%; vertical-align: bottom">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt">&#160;</p>
</td>
<td style="width: 1%; vertical-align: bottom">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt">&#160;</p>
</td>
<td style="width: 10%; vertical-align: bottom">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: right">&#160;</p>
</td>
<td style="width: 2%; vertical-align: bottom">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt">&#160;</p>
</td>
<td style="width: 1%; vertical-align: bottom">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt">&#160;</p>
</td>
<td style="width: 10%; vertical-align: bottom">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: right">&#160;</p>
</td>
<td style="width: 2%; vertical-align: bottom">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt">&#160;</p>
</td>
<td style="width: 1%; vertical-align: bottom">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt">&#160;</p>
</td>
<td style="width: 10%; vertical-align: bottom">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: right">&#160;</p>
</td>
<td style="width: 2%; vertical-align: bottom">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt">&#160;</p>
</td>
</tr>
<tr style="background-color: rgb(204,238,255)">
<td style="width: 60%; vertical-align: bottom">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt">Net income attributable to European operations</p>
</td>
<td style="width: 2%; vertical-align: bottom">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt">&#160;</p>
</td>
<td style="width: 1%; vertical-align: bottom">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt">$</p>
</td>
<td style="width: 10%; vertical-align: bottom">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: right">80,670</p>
</td>
<td style="width: 2%; vertical-align: bottom">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt">&#160;</p>
</td>
<td style="width: 1%; vertical-align: bottom">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt">$</p>
</td>
<td style="width: 10%; vertical-align: bottom">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: right">41,990</p>
</td>
<td style="width: 2%; vertical-align: bottom">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt">&#160;</p>
</td>
<td style="width: 1%; vertical-align: bottom">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt">$</p>
</td>
<td style="width: 10%; vertical-align: bottom">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: right">56,660</p>
</td>
<td style="width: 2%; vertical-align: bottom">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt">&#160;</p>
</td>
</tr>
<tr style="background-color: White">
<td style="width: 60%; vertical-align: bottom">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt">Net income attributable to United States operations</p>
</td>
<td style="width: 2%; vertical-align: bottom">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt">&#160;</p>
</td>
<td style="border-bottom: black 1pt none; border-top-style: none; border-right-style: none; border-left-style: none; width: 1%; border-bottom-style: solid; vertical-align: bottom">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt">&#160;</p>
</td>
<td style="border-bottom: black 1pt none; border-top-style: none; border-right-style: none; border-left-style: none; width: 10%; border-bottom-style: solid; vertical-align: bottom">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: right">29,357</p>
</td>
<td style="width: 2%; vertical-align: bottom">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt">&#160;</p>
</td>
<td style="border-bottom: black 1pt none; border-top-style: none; border-right-style: none; border-left-style: none; width: 1%; border-bottom-style: solid; vertical-align: bottom">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt">&#160;</p>
</td>
<td style="border-bottom: black 1pt none; border-top-style: none; border-right-style: none; border-left-style: none; width: 10%; border-bottom-style: solid; vertical-align: bottom">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: right">7,978</p>
</td>
<td style="width: 2%; vertical-align: bottom">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt">&#160;</p>
</td>
<td style="border-bottom: black 1pt none; border-top-style: none; border-right-style: none; border-left-style: none; width: 1%; border-bottom-style: solid; vertical-align: bottom">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt">&#160;</p>
</td>
<td style="border-bottom: black 1pt none; border-top-style: none; border-right-style: none; border-left-style: none; width: 10%; border-bottom-style: solid; vertical-align: bottom">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: right">19,410</p>
</td>
<td style="width: 2%; vertical-align: bottom">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt">&#160;</p>
</td>
</tr>
<tr style="background-color: rgb(204,238,255)">
<td style="width: 60%; vertical-align: bottom">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt">Net income</p>
</td>
<td style="width: 2%; vertical-align: bottom">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt">&#160;</p>
</td>
<td style="border-style: none; width: 1%; vertical-align: bottom">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt">&#160;</p>
</td>
<td style="border-style: none; width: 10%; vertical-align: bottom">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: right">110,027</p>
</td>
<td style="width: 2%; vertical-align: bottom">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt">&#160;</p>
</td>
<td style="border-style: none; width: 1%; vertical-align: bottom">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt">&#160;</p>
</td>
<td style="border-style: none; width: 10%; vertical-align: bottom">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: right">49,968</p>
</td>
<td style="width: 2%; vertical-align: bottom">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt">&#160;</p>
</td>
<td style="border-style: none; width: 1%; vertical-align: bottom">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt">&#160;</p>
</td>
<td style="border-style: none; width: 10%; vertical-align: bottom">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: right">76,070</p>
</td>
<td style="width: 2%; vertical-align: bottom">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt">&#160;</p>
</td>
</tr>
<tr style="background-color: White">
<td style="width: 60%; vertical-align: bottom">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt">Less: Net income attributable to the noncontrolling interest</p>
</td>
<td style="width: 2%; vertical-align: bottom">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt">&#160;</p>
</td>
<td style="border-bottom: black 1pt none; border-top-style: none; border-right-style: none; border-left-style: none; width: 1%; border-bottom-style: solid; vertical-align: bottom">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt">&#160;</p>
</td>
<td style="border-bottom: black 1pt none; border-top-style: none; border-right-style: none; border-left-style: none; width: 10%; border-bottom-style: solid; vertical-align: bottom">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: right">22,616</p>
</td>
<td style="width: 2%; vertical-align: bottom">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt">&#160;</p>
</td>
<td style="border-bottom: black 1pt none; border-top-style: none; border-right-style: none; border-left-style: none; width: 1%; border-bottom-style: solid; vertical-align: bottom">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt">&#160;</p>
</td>
<td style="border-bottom: black 1pt none; border-top-style: none; border-right-style: none; border-left-style: none; width: 10%; border-bottom-style: solid; vertical-align: bottom">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: right">11,749</p>
</td>
<td style="width: 2%; vertical-align: bottom">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt">&#160;</p>
</td>
<td style="border-bottom: black 1pt none; border-top-style: none; border-right-style: none; border-left-style: none; width: 1%; border-bottom-style: solid; vertical-align: bottom">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt">&#160;</p>
</td>
<td style="border-bottom: black 1pt none; border-top-style: none; border-right-style: none; border-left-style: none; width: 10%; border-bottom-style: solid; vertical-align: bottom">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: right">15,821</p>
</td>
<td style="width: 2%; vertical-align: bottom">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt">&#160;</p>
</td>
</tr>
<tr style="background-color: rgb(204,238,255)">
<td style="width: 60%; border-top-style: none; border-bottom-style: none; vertical-align: bottom">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt">Net income attributable to Inter Parfums, Inc.</p>
</td>
<td style="width: 2%; border-top-style: none; border-bottom-style: none; vertical-align: bottom">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt">&#160;</p>
</td>
<td style="border-bottom: #000000 2.5pt double; border-top-style: none; border-right-style: none; border-left-style: none; width: 1%; vertical-align: bottom">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt">$</p>
</td>
<td style="border-bottom: #000000 2.5pt double; border-top-style: none; border-right-style: none; border-left-style: none; width: 10%; vertical-align: bottom">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: right">87,411</p>
</td>
<td style="border-style: none; width: 2%; vertical-align: bottom">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt">&#160;</p>
</td>
<td style="border-bottom: #000000 2.5pt double; border-top-style: none; border-right-style: none; border-left-style: none; width: 1%; vertical-align: bottom">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt">$</p>
</td>
<td style="border-bottom: #000000 2.5pt double; border-top-style: none; border-right-style: none; border-left-style: none; width: 10%; vertical-align: bottom">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: right">38,219</p>
</td>
<td style="border-style: none; width: 2%; vertical-align: bottom">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt">&#160;</p>
</td>
<td style="border-bottom: #000000 2.5pt double; border-top-style: none; border-right-style: none; border-left-style: none; width: 1%; vertical-align: bottom">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt">$</p>
</td>
<td style="border-bottom: #000000 2.5pt double; border-top-style: none; border-right-style: none; border-left-style: none; width: 10%; vertical-align: bottom">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: right">60,249</p>
</td>
<td style="width: 2%; border-top-style: none; border-bottom-style: none; vertical-align: bottom">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt">&#160;</p>
</td>
</tr>

</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: 36pt">Net income attributable to European operations was $80.7 million, $42.0 million and $56.7 million in 2021, 2020 and 2019, respectively, while net income attributable to United States operations was $29.4 million, $8.0 million and $19.4 million in 2021, 2020 and 2019, respectively. The fluctuations in net income for both European operations and United States operations are directly related to the previous discussions concerning changes in sales, gross profit margins, selling, general and administrative expenses, most of which were caused by the effects of the COVID-19 pandemic beginning in 2020 and the recovery in 2021.&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: 36pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: 36pt">The noncontrolling interest arises primarily from our 73% owned
subsidiary in Paris, Interparfums SA, which is also a publicly traded company as 27% of Interparfums SA shares trade on the NYSE
Euronext. Net income attributable to the noncontrolling interest is directly related to the profitability of our European operations
and aggregated 28.0% of European operations net income in 2021 and 28.1% in 2020 and 2019. Net margins attributable to Inter Parfums,
Inc. aggregated 9.9%, 7.1% and 8.4% in 2021, 2020 and 2019, respectively.</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: 36pt"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><b>Liquidity and Capital Resources</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: 36pt">Our conservative financial tradition has enabled us to amass significant cash balances. As of December 31, 2021, we had $320 million in cash, cash equivalents and short-term investments, most of which are held in euro by our European operations and are readily convertible into U.S. dollars. We have not had any liquidity issues to date, and do not expect any liquidity issues relating to such cash and cash equivalents and short-term investments. As of December&#160;31, 2021, short-term investments include approximately $24.5 million of marketable equity securities.&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<!-- Field: Page; Sequence: 53; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt; margin-right: 0"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt; margin-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt; margin-right: 0"><p style="margin: 0pt 0 0pt 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: 36pt">As of December 31, 2021, working capital aggregated $465 million, and we had a working capital ratio of 2.9 to 1. Approximately 82% of the Company&#8217;s total assets are held by European operations including approximately $171 million of trademarks, licenses and other intangible assets.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: 36pt">The Company is party to a number of license and other agreements for the use of trademarks and rights in connection with the manufacture and sale of its products expiring at various dates through 2033. In connection with certain of these license agreements, the Company is subject to minimum annual advertising commitments, minimum annual royalties and other commitments. <i>See</i> Item 8. Financial Statements and Supplementary Data &#8211; Note 12 &#8211; Commitments in this annual report on Form 10-K. Future advertising commitments are estimated based on planned future sales for the license terms that were in effect at December 31, 2021, without consideration for potential renewal periods and do not reflect the fact that our distributors share our advertising obligations.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: 36pt">The Company hopes to continue to benefit from its strong financial position to potentially acquire one or more brands, either on a proprietary basis or as a licensee. In September 2021, we entered into a long-term global licensing agreement for the creation, development and distribution of fragrances and fragrance-related products under the Donna Karan and DKNY brands. This new license takes effect July 1, 2022.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: 36pt">In October 2021, we closed on a transaction agreement with Salvatore Ferragamo S.p.A., whereby an exclusive and worldwide license was granted for the production and distribution of Ferragamo brand perfumes. The license became effective in October 2021 and will last for 10 years with a 5-year optional term, subject to certain conditions. With respect to the management and coordination of activities related to the license agreement, the Company is operating through a wholly-owned Italian subsidiary based in Florence, that was acquired from Salvatore Ferragamo on October 1, 2021. The acquisition together with the license agreement was accounted for as an asset acquisition. The total cost of the assets acquired net of liabilities assumed aggregated approximately $35.8 million. In connection with this acquisition, we agreed to pay $17.0 million in equal annual installments of $1.7 million including interest imputed at 2.0%.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: 36pt">Opportunities for external growth are regularly examined, with the priority of maintaining the quality and homogeneous nature of our portfolio. However, we cannot assure you that any new license or acquisition agreements will be consummated.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<!-- Field: Page; Sequence: 54; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt; margin-right: 0"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt; margin-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt; margin-right: 0"><p style="margin: 0pt 0 0pt 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: 36pt">Cash provided by operating activities aggregated $119.6 million, $65.0 million, and $76.5 million in 2021, 2020 and 2019, respectively. In 2021, working capital items used $13.7 million in cash from operating activities, as compared to $7.3 million in 2020 and $16.6 million in 2019. Although, from a cash flow perspective, accounts receivable is up approximately 37% from year-end 2020, the balance is reasonable based upon fourth quarter 2021 record sales levels and reflects strong collection activity as day&#8217;s sales outstanding decreased to 61 days in 2021, as compared to 86 days and 69 days in 2020 and 2019, respectively. From a cash flow perspective, inventory levels are up 31% from year-end 2020. However, inventory days on hand declined significantly to 208 days in 2021, as compared to 277 days in 2020, and 224 days in 2019. Although inventories include product needed to support new product launches, the overall balance is lower than historic levels due primarily to the aforementioned supply chain disruptions.&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: 36pt">Cash flows used in investing activities reflect the purchase and sales of short-term investments. These investments consist of certificates of deposit with maturities greater than three months marketable equity securities and other contracts. At December 31, 2021, approximately $45 million of certificates of deposit contain penalties where we would forfeit a portion of the interest earned in the event of early withdrawal.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: 36pt">Our business is not capital intensive as we do not own any manufacturing facilities. On a full year basis, we generally spend less than $5.0 million on capital expenditures including tools and molds needed to support our new product development calendar. Capital expenditures also include amounts for office fixtures, computer equipment and industrial equipment needed at our distribution centers.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: 36pt">In April 2021, Interparfums SA completed the acquisition of its future headquarters at 10 rue de Solf&#233;rino in the 7th arrondissement of Paris from the property developer. This is an office complex combining three buildings connected by two inner courtyards, and consists of approximately 40,000 total sq. ft.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: 36pt">The $142 million purchase price is in line with market value and includes the complete renovation of the site. As of December 31, 2021, $136.1 million of the purchase price, including approximately $3.1 million of acquisition costs, is included in building, equipment and leasehold improvements on the accompanying balance sheet as of December 31, 2021. Approximately $8.8 million of cash held in escrow is included in other assets on the accompanying balance sheet as of December 31, 2021. In addition, the Company borrowed $17.0 million pursuant to a short-term loan equal to the VAT credit, and in July 2021, the $17.0 million VAT credit was reimbursed by the French Tax Authorities and the loan was repaid.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 36pt">The acquisition was financed by a 10-year &#8364;120 million (approximately $136 million) bank loan which bears interest at one-month Euribor plus 0.75%. Approximately &#8364;80 million of the variable rate debt was swapped for variable interest rate debt with a maximum rate of 2% per annum.&#160;&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: 36pt">In June 2020, the Company and
Divabox, owner of the Origines-parfums e-commerce platform for beauty products, signed a strategic agreement and equity investment
pursuant to which we acquired 25% of Divabox capital for $14 million through a capital increase. In connection with the acquisition,
the Company entered into a $13.4 million term loan, which was repaid in full in February 2021.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<!-- Field: Page; Sequence: 55; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt; margin-right: 0"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt; margin-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt; margin-right: 0"><p style="margin: 0pt 0 0pt 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: 36pt">Our short-term financing requirements are expected to be met by available cash on hand at December 31, 2021, cash generated by operations and short-term credit lines provided by domestic and foreign banks. The principal credit facilities for 2021 consist of a $20.0 million unsecured revolving line of credit provided by a domestic commercial bank and approximately $28 million in credit lines provided by a consortium of international financial institutions. There were no balances due from short-term borrowings as of December 31, 2021 and 2020.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: 36pt">In October 2019, our Board authorized a 20% increase in the annual dividend to $1.32 per share. In April 2020, as a result of the uncertainties raised by the COVID-19 pandemic, the Board of Directors authorized a temporary suspension of the quarterly cash dividend. In February 2021, our Board of Directors authorized a reinstatement of an annual dividend of $1.00, payable quarterly and in February 2022, our Board authorized a 100% increase in the annual dividend to $2.00 per share. The next quarterly cash dividend of $0.50 per share is payable on March 31, 2022, to shareholders of record on March 15, 2022. Dividends paid, including dividends paid once per year to noncontrolling stockholders of Interparfums SA, aggregated $41.5 million, $21.1 million and $44.2 million for the years ended December 31, 2021, 2020 and 2019, respectively. The cash dividends to be paid in 2022 are not expected to have any significant impact on our financial position.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: 36pt">We believe that funds provided by or used in operations can be supplemented by our present cash position and available credit facilities, so that they will provide us with sufficient resources to meet all present and reasonably foreseeable future operating needs.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: 36pt">Inflation rates in the U.S. and foreign countries in which we operate did not have a significant impact on operating results for the year ended December 31, 2021.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><b>Item 7A. Quantitative and Qualitative Disclosures About Market Risk.<span id="a013_v1"></span></b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><b><i><b><i>General</i></b></i></b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: 36pt">We address certain financial exposures through a controlled program of risk management that primarily consists of the use of derivative financial instruments. We primarily enter into foreign currency forward exchange contracts in order to reduce the effects of fluctuating foreign currency exchange rates. We do not engage in the trading of foreign currency forward exchange contracts or interest rate swaps.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><b><i><b><i>Foreign Exchange Risk Management </i></b></i></b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: 36pt">A general discussion relating to our policies on foreign exchange risk management can be found in &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; in Part II, Item 7 of our annual report on Form 10-K for the year ended December 2020.&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<!-- Field: Page; Sequence: 56; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt; margin-right: 0"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt; margin-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt; margin-right: 0"><p style="margin: 0pt 0 0pt 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: 36pt">As of December&#160;31, 2021, we had foreign currency contracts in the form of forward exchange contracts with notional amounts of approximately U.S. $64.5&#160;million and GB&#160;&#163;3.5&#160;million which all have maturities of less than one year. We believe that our risk of loss as the result of nonperformance by any of such financial institutions is remote.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><b><i><b><i>Interest Rate Risk Management</i></b></i></b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: 36pt">We mitigate interest rate risk by monitoring interest rates, and then determining whether fixed interest rates should be swapped for floating rate debt, or if floating rate debt should be swapped for fixed rate debt.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>

<!-- Field: /Named-Area; -->

<!-- Field: Named-Area; Name: Contents -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><b>Item 8.&#160;Financial Statements and Supplementary Data<span id="a014_v1"></span></b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: 36pt">The required financial statements commence on page F-1.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><b>Item 9.&#160;Changes in and Disagreements with Accountants on Accounting and&#160;</b><b style="font-size: 10pt">Financial Disclosure<span id="a015_v1"></span></b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: 36pt">None.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><b>Item 9A. Controls and Procedures.<span id="a016_v1"></span>&#160;</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><b><i><b><i>Evaluation of Disclosure Controls and Procedures </i></b></i></b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: 36pt">Our Chief Executive Officer and Chief Financial Officer have reviewed and evaluated the effectiveness of our disclosure controls and procedures (as defined in the Securities Exchange Act of 1934 Rule 13a-15(e)) as of the end of the period covered by this annual report on Form 10-K (the &#8220;Evaluation Date&#8221;).&#160;Based on their review and evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that as of the Evaluation Date, our Company&#8217;s disclosure controls and procedures were effective.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><b><i><b><i>Management&#8217;s Annual Report on Internal Control over Financial Reporting</i></b></i></b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: 36pt">The management of Inter Parfums,
Inc. is responsible for establishing and maintaining adequate internal control over financial reporting as defined in Rule 13(a)-15(f)
under the Securities Exchange Act of 1934. With the participation of the Chief Executive Officer and the Chief Financial Officer,
our management conducted an evaluation of the effectiveness of our internal control over financial reporting based on the framework
and criteria established in <i>Internal Control &#8211; Integrated Framework (2013)</i>, issued by the Committee of Sponsoring
Organizations of the Treadway Commission. Based on this evaluation, our management has concluded that our internal control over
financial reporting was effective as of December 31, 2021.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<!-- Field: Page; Sequence: 57; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt; margin-right: 0"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt; margin-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->54<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt; margin-right: 0"><p style="margin: 0pt 0 0pt 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: 36pt">Our independent auditor, Mazars USA LLP, a registered public accounting firm, has issued its report on its audit of our internal control over financial reporting. This report appears on page F-2.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><b><i><b><i>Changes in Internal Control Over Financial Reporting </i></b></i></b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: 36pt">There has been no change in our internal control over financial reporting (as defined in Rule 13a-15(f) of the Securities Exchange Act of 1934) that occurred during the fourth quarter of 2020 that has materially affected, or is reasonably likely to materially affect, the Company&#8217;s internal control over financial reporting.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><b>Item 9B. &#160;Other Information.<span id="a017_v1"></span></b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: 36pt">None.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<!-- Field: Page; Sequence: 58; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->55<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><b>PART III</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><b>Item 10. Directors, Executive Officers and Corporate Governance</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><b><i><b><i>Executive Officers and Directors</i></b></i></b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36pt">As of the date of this report, our executive officers and directors were as follows:</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<table border="0" cellspacing="0" cellpadding="0" style="width: 100%">

<tr>
<td style="border-bottom: black 1pt none; border-top-style: none; border-right-style: none; border-left-style: none; width: 28%; border-bottom-style: solid; vertical-align: bottom">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><b>Name</b></p>
</td>
<td style="width: 2%; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><b>&#160;</b></p>
</td>
<td style="border-bottom: black 1pt none; border-top-style: none; border-right-style: none; border-left-style: none; width: 70%; border-bottom-style: solid; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><b>Position</b></p>
</td>
</tr>
<tr style="background-color: rgb(204,238,255)">
<td style="vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">Jean Madar</p>
</td>
<td style="vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#160;</p>
</td>
<td style="vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">Chairman of the Board, Chief Executive Officer of Inter Parfums, Inc. and Director General of Interparfums SA</p>
</td>
</tr>
<tr style="background-color: White">
<td style="vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">Philippe Benacin</p>
</td>
<td style="vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#160;</p>
</td>
<td style="vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">Vice Chairman of the Board, President of Inter Parfums, Inc. and Chief Executive Officer of Interparfums SA</p>
</td>
</tr>
<tr style="background-color: rgb(204,238,255)">
<td style="vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">Russell Greenberg</p>
</td>
<td style="vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#160;</p>
</td>
<td style="vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">Director, Executive Vice President and Chief Financial Officer</p>
</td>
</tr>
<tr style="background-color: White">
<td style="vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">Philippe Santi</p>
</td>
<td style="vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#160;</p>
</td>
<td style="vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">Director, Executive Vice President and Chief Financial Officer, Interparfums SA</p>
</td>
</tr>
<tr style="background-color: rgb(204,238,255)">
<td style="vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">Fran&#231;ois Heilbronn</p>
</td>
<td style="vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#160;</p>
</td>
<td style="vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">Director</p>
</td>
</tr>
<tr style="background-color: White">
<td style="vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">Robert Bensoussan</p>
</td>
<td style="vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#160;</p>
</td>
<td style="vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">Director</p>
</td>
</tr>
<tr style="background-color: rgb(204,238,255)">
<td style="vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">Patrick Cho&#235;l</p>
</td>
<td style="vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#160;</p>
</td>
<td style="vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">Director</p>
</td>
</tr>
<tr style="background-color: White">
<td style="vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">Michel Dyens</p>
</td>
<td style="vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#160;</p>
</td>
<td style="vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">Director</p>
</td>
</tr>
<tr style="background-color: rgb(204,238,255)">
<td style="vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">Veronique Gabai-Pinsky</p>
</td>
<td style="vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#160;</p>
</td>
<td style="vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">Director</p>
</td>
</tr>
<tr style="background-color: White">
<td style="vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">Gilbert Harrison</p>
</td>
<td style="vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#160;</p>
</td>
<td style="vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">Director</p>
</td>
</tr>
<tr style="background-color: rgb(204,238,255)">
<td style="vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">Frederic Garcia-Pelayo</p>
</td>
<td style="vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#160;</p>
</td>
<td style="vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">Executive Vice President and Chief Operating Officer of Interparfums SA</p>
</td>
</tr>

</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36pt">Our directors will serve until the next annual meeting of stockholders and thereafter until their successors shall have been elected and qualified. Messrs. Jean Madar and Philippe Benacin have a verbal agreement or understanding to vote their shares and the shares of their respective holding companies in a like manner.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36pt">With the exception of Mr. Benacin, the officers are elected annually by the directors and serve at the discretion of the board of directors. There are no family relationships between executive officers or directors of our Company.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><b><i><b><i>Board of Directors</i></b></i></b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36pt">Our board of directors has the responsibility for establishing broad corporate policies and for the overall performance of our Company. Although certain directors are not involved in day-to-day operating details, members of the board of directors are kept informed of our business by various reports and documents made available to them. Our board of directors held 21 meetings (or executed consents in lieu thereof), including meetings of committees of the full board of directors during 2021, and all of the directors attended at least 75% of the meetings (or executed consents in lieu thereof) of the full board of directors and committees of which they were a member. Our board of directors presently consists of ten (10) directors.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36pt">We have adopted a Code of Business Conduct that applies to our principal executive officer, principal financial officer, principal accounting officer or controller, as well as other persons performing similar functions, and we agree to provide to any person without charge, upon request, a copy of our Code of Business Conduct. Any person who requests a copy of our Code of Business Conduct should provide their name and address in writing to: Inter Parfums, Inc., 551 Fifth Avenue, New York, NY 10176, Att.: Shareholder Relations. In addition, our Code of Conduct is also maintained on our website, at www.interparfumsinc.com.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<!-- Field: Page; Sequence: 59; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->56<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36pt">During 2021, our board of directors had the following standing committees:</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<table border="0" cellspacing="0" cellpadding="0" style="width: 100%">

<tr>
<td style="width: 36pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#160;</p>
</td>
<td style="width: 36pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#9679;</p>
</td>
<td style="vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">Audit Committee &#8211; The Audit Committee has the sole authority and is directly responsible for, the appointment, compensation and oversight of the work of the independent accountants employed by our company which prepare or issue audit reports for our company. During 2021, this committee consisted of Messrs. Heilbronn and Cho&#235;l, and Ms. Gabai-Pinsky. The charter of the Audit Committee is posted on our company&#8217;s website.</p>
</td>
</tr>

</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36pt">The Company does not have an &#8220;audit committee financial expert&#8221; within the definition of the applicable Securities and Exchange Commission rules. Finding qualified nominees to serve as a director of a public company without substantial financial resources has been challenging. In addition, despite the applicable Securities and Exchange Commission rule which states that being named as the audit committee financial expert does not impose any greater duty, obligation or liability, our company has been met with resistance from both present and former directors to being named as such, primarily due to potential additional personal liability. However, as the result of the background, education and experience of the members of the Audit Committee, our board of directors believes that such committee members are fully qualified to fulfill their obligations as members of the Audit Committee.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<table border="0" cellspacing="0" cellpadding="0" style="width: 100%">

<tr>
<td style="width: 36pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#160;</p>
</td>
<td style="width: 36pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#9679;</p>
</td>
<td style="vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">Executive Compensation and Stock Option Committee &#8211; The Executive Compensation and Stock Option Committee oversees the compensation of our company&#8217;s executives and administers our company&#8217;s stock option plans. During 2021, this committee consisted of Messrs. Heilbronn and Cho&#235;l, and Ms. Gabai-Pinsky. The charter of the Executive Compensation and Stock Option Committee is posted on our company&#8217;s website.</p>
</td>
</tr>

</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<table border="0" cellspacing="0" cellpadding="0" style="width: 100%">

<tr>
<td style="width: 36pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#160;</p>
</td>
<td style="width: 36pt; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#9679;</p>
</td>
<td style="vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">Nominating Committee &#8211; During 2021, this committee consisted of Messrs. Heilbronn and Cho&#235;l, and Ms. Gabai-Pinsky. The purpose of the Nominating Committee is to determine and recommend qualified persons to the Board of Directors who will be put forth as management&#8217;s slate of directors for vote of the Corporation&#8217;s stockholders, as well as to fill vacancies in the Board of Directors. The charter of the Nominating Committee is posted on our company&#8217;s website.</p>
</td>
</tr>

</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36pt">We have adopted a board diversity policy, which provides that the selection of candidates for appointment to our board will be based on an overriding emphasis on merit, but the Nominating Committee will seek to fill board vacancies by considering candidates that bring a diversity of background and industry or related expertise to our board. The Nominating Committee is to consider an appropriate level of diversity having regard for factors such as skills, business and other experience, education, gender, age, ethnicity and geographic location. A copy of the board diversity policy is posted on our company&#8217;s website. In addition, Nasdaq has adopted a Board Diversity Rule, which will require Nasdaq listed companies to publicly disclose board-level diversity statistics using a standardized template commencing on the later of August 8, 2022 or the date the filing of a listed company&#8217;s proxy statement for its 2022 annual meeting. In addition, in the following year, we will be required to disclose whether or not we have one director that is diverse under the applicable Nasdaq rule, and if not, then why not. By the 2025 annual meeting, we will be required to disclose whether or not we have two directors that are diverse under the applicable Nasdaq rule, and if not, then why not. We do not foresee any issue in complying with Nasdaq Board Diversity Rule at this time.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<!-- Field: Page; Sequence: 60; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->57<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify"><b><i><b><i>Business Experience</i></b></i></b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 36pt">The following sets forth biographical information as to the business experience of each executive officer and director of our company for at least the past five years.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify"><i>Jean Madar</i></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 36pt">Jean Madar, age 61, a Director, has been the Chairman of the Board since our company&#8217;s inception, and is a co-founder of our company with Mr. Philippe Benacin. From inception until December 1993 he was the President of our company; in January 1994, he became Director General of Interparfums SA, our company&#8217;s subsidiary; and in January 1997, he became Chief Executive Officer of our company. Mr. Madar was previously the managing director of Interparfums SA, from September 1983 until June 1985. At such subsidiary, he had the responsibility of overseeing the marketing operations of its foreign distribution, including market research analysis and actual marketing campaigns. Mr. Madar graduated from The French University for Economic and Commercial Sciences (ESSEC) in 1983. We believe that Mr. Madar&#8217;s skills in guiding, leading and determining the strategic direction of our company since its inception together with Mr. Benacin, in addition to his contacts in the fragrance and cosmetic industry, render him qualified to serve as a member of our board of directors.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify"><i>Philippe Benacin</i></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 36pt">Mr. Benacin, age 63, a Director, is President of our Company and the Chief Executive Officer of Interparfums SA, has been the Vice Chairman of the Board since September 1991, and is a co-founder of our company with Mr. Madar. He was elected the Executive Vice President in September 1991, Senior Vice President in April 1993, and President of the Company in January 1994. In addition, he has been the President of our Company and Chief Executive Officer of Interparfums SA for more than the past five years. Mr. Benacin graduated from The French University for Economic and Commercial Sciences (ESSEC) in 1983. In June 2014 Mr. Benacin was elected as a member of the Supervisory Board of Vivendi, and Chairman of its Corporate Governance, Nominations and Remuneration Committee. We believe that Mr. Benacin&#8217;s skills in guiding, leading and determining the strategic direction of our company since its inception together with Mr. Madar, in addition to his contacts in the fragrance and cosmetic industry, render him qualified to serve as a member of our board of directors.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify"><i>Russell Greenberg</i></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 36pt">Mr. Greenberg, age 65, the Chief Financial Officer, was Vice-President, Finance when he joined the Company in June 1992; became Executive Vice President in April 1993; and was appointed to our board of directors in February 1995. He is a certified public accountant licensed in the State of New York, and is a member of the American Institute of Certified Public Accountants and the New York State Society of Certified Public Accountants. After graduating from The Ohio State University in 1980, he was employed in public accounting until he joined our company in June 1992. We believe that Mr. Greenberg&#8217;s skills in accounting and tax, as well as his knowledge of the fragrance industry and our Company&#8217;s operations, render him qualified to serve as a member of our board of directors.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify"><i>Philippe Santi</i></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 36pt">Philippe Santi, age 59, and a Director since December 1999, is the Executive Vice President and Chief Financial Officer of Interparfums SA. Mr. Santi, who is a Certified Accountant and Statutory Auditor in France, has been the Chief Financial Officer of Interparfums SA since February 1995. Prior to February 1995, Mr. Santi was the Chief Financial Officer for Stryker France and an Audit Manager for Ernst and Young. We believe that Mr. Santi&#8217;s skills in accounting and tax, as well as his knowledge of the fragrance industry and our Company&#8217;s European operations, render him qualified to serve as a member of our board of directors.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<!-- Field: Page; Sequence: 61; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->58<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify"><i>Francois Heilbronn</i></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 36pt">Mr. Heilbronn, age 60, a Director since 1988, an independent director and a member of the Audit Committee, Nominating Committee and the Executive Compensation and Stock Option Committee, is a graduate of Harvard Business School with a Master of Business Administration degree and is currently the managing partner of the consulting firm of M.M. Friedrich, Heilbronn &amp; Fiszer. He was formerly employed by The Boston Consulting Group, Inc. from 1988 through 1992 as a manager. Mr. Heilbronn graduated from Institut d&#8217; Etudes Politiques de Paris in June 1983. From 1984 to 1986, he worked as a financial analyst for Lazard Freres &amp; Co. In addition, during 2009, Mr. Heilbronn became an Associate Professor in Business Strategy at Sciences Po, Paris, France. As the result of his business and financial acumen, as well as his experience as managing partner of a business consulting firm in the area of mergers and acquisitions of large international companies in retail, consumer goods and consumer services throughout the world, we believe Mr. Heilbronn is qualified to serve as a member of our board of directors.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify"><i>Robert Bensoussan</i></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 36pt">Robert Bensoussan, age 63, has been a Director since March 1997, and is also an independent director. Mr. Bensoussan is the founder of Sirius Equity Consultants, a retail and branded luxury goods Investment Company. To date, Mr. Bensoussan remains as an investor in C.A.R.O.L, the AI driven fitness equipment, Hapy Sweet Bee Ltd, natural health food products, Eaglemoss Ltd, UK part-works publisher and Patchwork, a Parisian co-working company.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 36pt">He was previously Chairman of Cama&#239;eu, the French retail conglomerate, a board member of Celio International, the French retail conglomerate and Vivarte representing the GLG hedge fund. In the latter part of 2019, Mr. Bensoussan resigned after 6 years as the only non-North American board member of lululemon athletica Inc. Following the successful sale in 2021, Mr. Bensoussan stepped down from the board of Feelunique.com one of Europe&#8217;s largest online beauty retailer&#8217;s after serving 9 years.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 36pt">He is also a member of the Advisory Board of Pictet Bank Premium Brands Fund and sits on the board of Pronovias, the worldwide leader of wedding dresses owned by BC Partners, Yonderland, Europe&#8217;s largest premium outdoor retailer, SNS, a prominent aspirational streetwear and entertainment hub and Internet Fusion Group, a leading e-commerce site for niche lifestyle products.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 36pt">Previously Mr. Bensoussan was as director of, and had an indirect ownership interest J. Choo Limited until July 2011, and was CEO from 2001 to 2007, and was a member of the Board of Jimmy Choo Ltd, a privately held luxury shoe wholesaler and retailer, from 2001 to 2011.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 36pt">We believe Mr. Bensoussan is qualified to serve as a member of our board of directors due to his business and financial acumen, as well as his experience in the retail and branded luxury goods market.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify"><i>Patrick Cho&#235;l</i></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 36pt">Mr. Cho&#235;l, age 78, was appointed to the board of directors in June 2006 as an independent director, and is a member of the Audit Committee, Nominating Committee and the Executive Compensation and Stock Option Committee. Mr. Cho&#235;l is a director of our majority-owned subsidiary, Interparfums SA, a publicly held company, and Christian Dior and Guerlain, both privately held companies. He is also the manager of Universit&#233; 82, a business consultant and advisor. For approximately 10 years, through March 2004, Mr. Cho&#235;l was the President and CEO of two divisions of LVMH Moet Hennessy Louis Vuitton S.A., first Parfums Christian Dior, a leading world-wide prestige beauty/fragrances business, and later, the LVMH Perfumes and Cosmetics Division, which included such well-known brands as Parfums Christian Dior, Guerlain, and Parfums Givenchy, among others. Prior to such time, for approximately 30 years, he held various executive positions at Unilever, including President and CEO of Elida Faberg&#233; France and President and CEO of Chesebrough Pond&#8217;s USA. Because of this experience, especially in the prestige beauty business, we believe that Mr. Cho&#235;l is qualified to serve as a member of our board of directors.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<!-- Field: Page; Sequence: 62; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->59<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify"><i>Michel Dyens</i></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 36pt">Michel Dyens, age 81 and an independent director, is the Founder, Chairman and Chief Executive Officer of Michel Dyens &amp; Co., which he founded over 25 years ago. With headquarters in New York and Paris, Michel Dyens &amp; Co. is a leading independent investment banking firm focused on mergers and acquisitions. Michel Dyens &amp; Co. has vast experience in luxury goods, beauty, spirits and other premium branded consumer goods in which it has concluded numerous landmark deals. Michel Dyens &amp; Co. has advised in such deals as the sale of the Grey Goose ultra-premium vodka brand to Bacardi, the acquisition of the luxury Swiss watchmaker Hublot by LVMH, the sale of the Harry Winston to Aber Diamond Corporation and Boucheron to Kering. Michel Dyens &amp; Co. represented the owners of Liaigre, the luxury furniture brand, in the sale to Symphony International and Navis Capital, and Casa Dragones, the ultra-premium tequila, in the sale to BDT Partners (Byron Trott).</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 36pt">Michel Dyens &amp; Co. &#160;recently represented the owners of Buly, the luxury French fragrance and beauty brand, in the sale to LVMH and the owners of Blissim, the French leader in beauty subscription e-commerce, and online beauty retail for an investment by Raise Investissement. In addition, he has just sold We11done, the Korean contemporary fashion and lifestyle brand, to Sequoia Capital.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 36pt">Michel Dyens &amp; Co. was the exclusive advisor to Creed in the sale of the ultra-luxury fragrance company Creed BlackRock Long Term Private Capital, and represented Mr. ChinWook Lee, the founder and CEO of Dr. Jart+, in the sale of Have &amp; Be Co. Ltd. to The Est&#233;e Lauder Companies. Michel Dyens &amp; Co. also advised the owner of the ultra-luxury fragrance brand By Kilian, in the sale to Est&#233;e Lauder. Michel Dyens &amp; Co. advised the shareholders of the largest independent hair color and hair care company in Brazil, Niely Cosmeticos in the sale of the company to L&#8217;Or&#233;al, as well as the owner of the super-premium liqueur St-Germain in the sale of the brand to Bacardi, the Colomer Group (American Crew and CND/Shellac brands) in its sale to Revlon, and Sidney Frank Importing Company in the sale of the company to Jaegermeister. Other transactions include the sale of the Essie cosmetics business to L&#8217;Or&#233;al, the sale of TIGI (BedHead and Catwalk brands) to Unilever, the luxury hair care brand Christophe Robin to The Hut Group, the thinning hair brand NIOXIN Research Laboratories to Procter &amp; Gamble, John Frieda Professional Hair Care and Molton Brown to the Kao Corporation, the Svedka vodka brand to Constellation Brands and Chambord liqueur to Brown-Forman.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 36pt">In the mission-driven field, Michel Dyens &amp; Co. recently represented ClimateCare, a prominent UK carbon-offset business, in the sale to Averna Capital and represented the founders of Caboo Paper Products a Vancouver, Canada-based tree-free household paper products brand, for an investment by sustainability-focused venture capital firm Renewal Funds. Among other recent transactions, Michel Dyens &amp; Co.&#160;recently represented the Fairtrade and organic coffee brand Ethical Bean Coffee in the sale to Kraft Heinz, and as well as Alter Eco Americas, a leading organic chocolate brand, which we sold to NextWorld Evergreen.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<!-- Field: Page; Sequence: 63; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->60<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 36pt">In healthy and premium food, Michel Dyens &amp; Co. represented the Fairtrade and organic coffee brand Ethical Bean Coffee in the sale to Kraft Heinz, and as well as Alter Eco Americas, a leading organic chocolate brand, which it sold to NextWorld Evergreen.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 36pt">From April 2004 to September 2014, Mr. Dyens was an independent director of Interparfums SA. We believe Mr. Dyens is qualified to serve as a member of our board of directors thanks to his knowledge of our company&#8217;s luxury business, his business and financial acumen, as well as his experience in the luxury goods market.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify"><i>Veronique Gabai-Pinsky</i></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 36pt">Ms. Gabai-Pinsky, age 56, was elected for the first time to our board in September 2017. She became a director of Interparfums SA in April 2017. She is currently operating a startup specialty fragrance business, and a director of Lifetime Brands (Nasdaq: LCUT), which is in the home goods business. She was President of Vera Wang Group from January 2016 through June 2018, after a year of consulting with the company and she oversaw all product categories and markets. Prior to joining Vera Wang, from 2006 to December 2014 Ms. Gabai-Pinsky was the Global President for Aramis and Designers Fragrances as well as Beauty Bank and Idea Bank at The Est&#233;e Lauder Companies, reporting to the Chief Executive Officer of such company. During her tenure, Ms. Gabai-Pinsky developed and ensured the growth of several beauty and skin care brands, including Lab Series for Men. She was highly instrumental in the evolution of the fragrance category for such company, as she improved its overall business model, globally grew brands such as Donna Karan and Michael Kors, evolved and harmonized the portfolio, divested dilutive brands and brought in Tory Burch, Zegna and Marni under licenses. She ultimately actively participated in the acquisitions of Le Labo, Frederic Malle, and By Kilian and assisted in the transformation of the long-term strategic direction of such company.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 36pt">In the earlier years of her career, Ms. Gabai-Pinsky served as Vice President of Marketing and Communication for Guerlain, a division of LVMH Moet Hennessy Louis Vuitton S.A., where she led the successful re-launch of Shalimar, the introduction of Aqua Allegoria, and contributed to the re-focus of the beauty category around its pillars, Terracotta, Meteorites and Issima, while redesigning all communication strategies and content. She started her career at L&#8217;Or&#233;al, and was also Vice President of Marketing for Giorgio Armani, where she was instrumental in the overall development of its fragrance business by developing the successful Acqua di Gio for men and introducing the Emporio Armani franchise. A graduate from ESSEC Business School in Paris, France, she has received several awards, including Marketer of the Year by Women&#8217;s Wear Daily in December 2013.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 36pt">Ms. Gabai-Pinksy is an independent director, and is a member of the Audit Committee, Executive Compensation and Stock Option Committee and the Nominating Committee of our company. We believe Ms. Gabi-Pinsky is qualified to serve as a member of our board of directors due to her more than 25 years of experience in the luxury, fashion, beauty and fragrance fields, success as a brand builder, creative thinker, business acumen, and a broad understanding of consumers, brands and business models.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify"><i>Gilbert Harrison</i></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 36pt">Mr. Harrison, age 81, an independent director, was appointed to our board in April 2018. Mr. Harrison has more than 50 years of experience in corporate finance and strategic transactions, specializing in the consumer products space. He began his career in 1965 practicing corporate and securities law in New York and Philadelphia. In 1971 he founded Financo, which he grew to become one of the leading independent middle market transaction firms in the country. In 1985, Financo was acquired by Lehman Brothers, where the firm&#8217;s primary efforts were focused on increasing its expertise in retail, apparel and other merchandising transactions of all types. At Lehman, Mr. Harrison was Chairman of the Merchandising Group and on the firm&#8217;s Investment Banking Operating Committee while continuing as Chairman of Financo, which was renamed the Middle Market Group of Lehman. In 1989, he re-acquired Financo from Lehman, re-establishing Financo as one of the leading investment banking firms handling transactions and providing strategic advice in connection with merchandising companies. Mr. Harrison retired as Chairman of Financo in December of 2017, after which he formed the Harrison Group, a firm that provides consulting and financial advisory services to merchandising and products companies.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<!-- Field: Page; Sequence: 64; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->61<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 36pt">Mr. Harrison&#8217;s other activities include his membership on the Advisory Council of the World Retail Congress, Shoptalk and the Financial Times Business of Luxury Summit. Additionally, he has created a course on mergers and acquisitions at The Wharton School and has published various articles and academic studies on the state of retailing and mergers and acquisitions, including a chapter in the book entitled, &#8220;The Mergers and Acquisitions Handbook.&#8221; Mr. Harrison lectures throughout the country, including chairing seminars for Retail Week as well as for the International Council of Shopping Centers, the National Retail Federation, Young President&#8217;s Center, The Wharton Aresty Institute of Executive Education and The President&#8217;s Association of the American Management Association. He also appears frequently on Bloomberg TV and CNBC as an expert on retail and apparel.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 36pt">Mr. Harrison received a Bachelor of Science in Economics from The Wharton School of The University of Pennsylvania in 1962 and his Juris Doctor from The University of Pennsylvania Law School in 1965. He is also Chairman of the Fashion Division of UJA, Treasurer and a Board member of the Southampton Hospital, Director of the Peggy Guggenheim Collection, and former Board member of the Wharton School of the University of Pennsylvania. We believe Mr. Harrison is qualified to serve as a member of our board of directors due to his tremendous depth and breadth of knowledge about the merchandising and consumer industry, and he has a long track record of facilitating value-creating transactions for companies in this sector. Mr. Harrison just finished his autobiography, <i>Deal Junky</i>, which was published in January 2022.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify"><i>Frederic Garcia-Pelayo</i></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 36pt">Frederic Garcia-Pelayo, age 60, has been with Interparfums SA for more than the past 20 years. He is currently the Executive Vice President and Chief Operating Officer of Interparfums SA, and was previously the Director of its Luxury and Fashion division beginning in March 2005. He was also previously the Director of Marketing and Distribution for Perfume and Cosmetics and was first named Executive Vice President in 2004.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify"><b><i><b><i>Section 16(a) Beneficial Ownership Reporting Compliance</i></b></i></b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 36pt">Based solely upon a review of Forms 3, 4 and 5 and any amendments to such forms furnished to us, and written representations from various reporting persons furnished to us, we are not aware of any reporting person who has failed to file the reports required to be filed under Section 16(a) of the Securities Exchange Act of 1934 on a timely basis.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify"><b>Item 11. Executive Compensation</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify"><b><i><b><i>Compensation Discussion and Analysis</i></b></i></b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify"><i>General</i></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 36pt">The executive compensation and stock option committee of our board of directors is comprised entirely of independent directors and oversees all elements of compensation (base salary, annual bonus, long-term incentives and perquisites) of our company&#8217;s executive officers and administers our company&#8217;s stock option plans, other than the non-employee directors stock option plan, which is self-executing.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<!-- Field: Page; Sequence: 65; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->62<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 36pt">The objectives of our compensation program are designed to strike a balance between offering sufficient compensation to either retain existing or attract new executives on the one hand, and maintaining compensation at reasonable levels on the other hand. We do not have the resources comparable to the cosmetic giants in our industry, and, accordingly, cannot afford to pay excessive executive compensation. In furtherance of these objectives, our executive compensation packages generally include a base salary, as well as annual incentives tied to individual performance and long-term incentives tied to our operating performance.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 36pt">Mr. Madar, the Chairman and Chief Executive Officer, takes the initiative after discussions with Mr. Russell Greenberg, Executive Vice President, Chief Financial Officer and a Director, and recommends executive compensation levels for executives for United States operations. Mr. Benacin, the Chief Executive Officer of Interparfums SA, takes the initiative after discussions with Philippe Santi, the Chief Financial Officer of Interparfums SA, and recommends executive compensation levels for executives for European operations. The recommendations are presented to the compensation committee for its consideration, and the compensation committee makes a final determination regarding salary adjustments and annual award amounts to executives, including Jean Madar and Philippe Benacin. Messrs. Madar and Benacin are not present during deliberations or determination of their executive compensation by the compensation committee. Further, Messrs. Madar and Benacin, in addition to being executive officers and directors, are our largest beneficial shareholders, and therefore, their interests are aligned with our shareholder base in keeping executive compensation at a reasonable level.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 36pt">The compensation committee was pleased that the most recent shareholder advisory vote on executive compensation held at our last annual meeting of shareholders in October 2021 overwhelmingly approved the compensation policies and decisions of the compensation committee. The compensation committee has determined to continue its present compensation policies in order to determine similar future decisions.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 36pt">Our compensation committee believes that individual executive compensation is at a level comparable with executives in other companies of similar size and stage of development that operate in the fragrance industry, and takes into account our company&#8217;s performance as well as our own strategic goals. Further, the compensation committee believes that its present policies to date, with its emphasis on rewarding performance, has served to focus the efforts of our executives, which in turn has permitted our company to weather the pandemic and economic and political turmoil in certain parts of the world, which resulted in the Company&#8217;s record results for 2021.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 36pt">During 2021, the members of such committee consisted of Messrs. Heilbronn and Cho&#235;l, and Ms. Gabai-Pinsky.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify"><i>Elements of Compensation</i></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 36pt"><i>General</i></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 36pt">The compensation of our executive officers is generally comprised of base salaries, including a fee paid to the holding companies of each of Messrs. Madar and Benacin, annual cash bonuses and long-term equity incentive awards. In determining specific components of compensation, the compensation committee considers individual performance, level of responsibility, skills and experience, other compensation awards or arrangements and overall company performance. The compensation committee reviews and approves all elements of compensation for all of our executive officers taking into consideration recommendations from the Chief Executive Officer of our company and the Chief Executive Officer of Interparfums SA, as well as information regarding compensation levels at competitors in our industry.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<!-- Field: Page; Sequence: 66; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->63<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 36pt">Our named executive officers have all been with the company for more than the past ten (10) years, with Messrs. Madar and Benacin being founders of the company. As Messrs. Madar and Greenberg for United States operations, and Benacin and Santi for European operations, are most familiar with the individual performance, level of responsibility, skills and experience of each executive officer in their respective operating segments, the compensation committee relies upon the information provided by such executive officers in determining individual performance, level of responsibility, skills and experience of each executive officer.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 36pt">The compensation committee views the competitive marketplace very broadly, which would include executive officers from both public and privately held companies in general, including fashion and beauty companies, but not limited to the peer companies contained in the corporate performance graph contained in our annual report. Generally, rather than tie the compensation committee&#8217;s determination of compensation proposals to any specific peer companies, the members of our committee have used their business experience, judgment and knowledge to review the executive compensation proposals recommended to them by Mr. Madar for United States operations and Mr. Benacin for European operations. As such, as a general rule the compensation committee did not determine the need to &#8220;benchmark&#8221; of any material item of compensation or overall compensation. However, in connection with the salary increase to Mr. Madar that occurred in February 2020, surveys of both peer companies and companies with comparable market capitalizations were used by the compensation committee as one of the factors in reaching such determination.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 36pt">The members of the compensation committee have extensive experience and business acumen and are well qualified in determining the appropriateness of executive compensation levels. Mr. Heilbronn is a managing partner of a business consulting firm in the area of mergers and acquisitions of large international companies in retail, consumer goods and consumer services throughout the world. Mr. Cho&#235;l is presently a business consultant and advisor, who previously worked as President and Chief Executive Officer of two divisions of LVMH Moet Hennessy Louis Vuitton S.A., which included such well-known brands as Parfums Christian Dior, Guerlain, and Parfums Givenchy. Mr. Cho&#235;l has also been President and CEO of both Elida Faberg&#233; France and Chesebrough Ponds USA. Ms. Gabai-Pinsky, the final committee member, has executive experience as the former President of Vera Wang Group, as well as the Global President for Aramis and Designers Fragrances in addition to Beauty Bank and Idea Bank at The Est&#233;e Lauder Companies.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 36pt"><i>Base Salary</i></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 36pt">Base salaries for executive officers are initially determined by evaluating the responsibilities of the position held and the experience of the individual, and by reference to the competitive marketplace for executive talent. Base salaries for executive officers are reviewed on an annual basis, and adjustments are determined by evaluating our operating performance, the performance of each executive officer, as well as whether the nature of the responsibilities of the executive has changed.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 36pt">As stated above, as Messrs. Madar and Greenberg for United States operations, and Benacin and Santi for European operations, are most familiar with the individual performance, level of responsibility, skills and experience of each executive officer in their respective segments, the committee relies upon the information provided by such executive officers in determining individual performance, level of responsibility, skills and experience of each executive officer.&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<!-- Field: Page; Sequence: 67; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->64<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 36pt">For executive officers of United States operations, the bulk of their annual compensation is in base salary including a fee paid to the holding company for Mr. Madar for services rendered outside the United States. However, for executive officers of European operations base salary comprises a smaller percentage of overall compensation. We have paid a lower percentage of overall compensation in the form of base salary to executive officers of European operations for several years, principally because European operations historically have had higher profitability than United States operations, and European operations are run differently from United States operations by the Chief Executive Officer of European operations, Mr. Benacin. As the result of this historically higher profitability, European operations have had the ability to pay higher bonus compensation in addition to base salary. As bonus compensation is and has historically been discretionary, no targets were set in order to maintain flexibility. Further, if results of operations for European operations were not satisfactory (again, no target amounts were set to maintain flexibility), then bonus compensation, as well as overall compensation could be lowered without otherwise affecting base salary. Finally, by keeping annual bonus compensation at a higher percentage of overall compensation and base salary at a lower percentage, our company benefits because the base amount for annual salary adjustments would be smaller.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 36pt"><i>COVID-19 Impact</i></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 36pt">It is important to note that 2020 salary increases and 2019 bonus compensation awards were determined prior to the full impact the global COVID-19 pandemic, the imposition of worldwide governmental lockdowns, and the resultant negative impact on the Company&#8217;s operations. During the balance of the pandemic and related impacts through December 31, 2020, no employees were terminated or furloughed from United States operations. Interparfums SA did avail itself of a small French government plan for unemployment insurance for its employees. For 2020, there were no reductions or deferrals in salaries of any executive officers or employees. For 2021, as the result of the continuing impacts of the COVID-19 pandemic, after the recommendations of Messrs. Madar and Benacin, the compensation committee determined that no executive officer would receive any increase in base salary. In addition, there were no increases in the fees paid to the respective holding companies of Messrs. Madar and Benacin.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 36pt">For 2021, although Mr. Benacin received the same base salary as he did in 2020, his salary was affected by foreign currency conversion rates and was $804,000 for 2021. For 2020, Mr. Benacin received a modest increase in base salary of $14,000 to $789,000, which is comparable to the modest increase in base salary of $13,000 in 2019. Mr. Benacin&#8217;s base salary includes $250,000 paid by the Company&#8217;s United States operations to Mr. Benacin&#8217;s holding company for each of the past three years, in accordance with the consulting agreement with Mr. Benacin&#8217;s holding company, which provides for review on an annual basis of the amount of compensation payable to such company.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 36pt">The compensation committee considered the following salient factors in authorizing payment to Mr. Benacin&#8217;s holding company&#8212; services rendered to United States operations for several years by Mr. Benacin in connection with licensing and distribution of international brands, as well as future services to be performed by Mr. Benacin internationally relating to licensing and distribution of international brands for United States operations.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 36pt">As Mr. Benacin values the services of two named executive officers of Interparfums SA, Mr. Philippe Santi, Executive Vice President and the Chief Financial Officer, and Mr. Frederic Garcia-Pelayo, Executive Vice President and Chief Operating Officer, equally, their base salaries, as well as their bonus compensation discussed below, have been in lockstep. For 2021, the base salary of each of Messrs. Santi and Garcia-Pelayo was &#8364;408,000, as no executive officer received any increase in base salary due the continuing impact of the COVID-19 pandemic. However, the base salaries of Messrs. Santi and Garcia-Pelayo in 2021 were affected by foreign currency conversion rates and were both $483,000 for 2021. For 2020, each of Messrs. Santi and Garcia-Pelayo received an increase in base salary of $14,000 to $470,000. Each of Messrs. Santi and Garcia-Pelayo had received an increase of $13,000 in 2019. Increases in prior years were awarded primarily to reward these two executive officers for their contributions in European Operations achieving increases in both the sales and earnings. The compensation committee considered the recommendations of Mr. Benacin, results of operations for the year, as well as the services performed for European operations by Messrs. Santi and Garcia-Pelayo in authorizing these salary levels.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<!-- Field: Page; Sequence: 68; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->65<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 36pt">A different approach is taken for United States operations as that segment is smaller and less profitable. A more significant base salary is paid in order to attract and retain employees with the skills and talents needed to run the operation with a lesser emphasis placed on bonuses. Neither of the executive officers for United States operations have employment agreements (although Mr. Madar&#8217;s personal holding company has a consulting agreement that provides for review on an annual basis of the amount of compensation payable to such company), as we believe that having flexibility in structuring annual base salary is a benefit, which permits us to act quickly to meet a changing economic environment.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 36pt">As previously reported, from 2013 until 2019 the annual aggregate base salary paid to Mr. Madar individually and fees paid to his holding company remained unchanged at $630,000, which was substantially below the amounts indicated by two surveys of chief executive officer salaries for 2019 (collectively the &#8220;CEO Salary Surveys&#8221;). The CEO Salary Surveys indicated that the annual and median average CEO salaries for peer companies (excluding the Madar salary) were $2,854,656 and $1,540,000, respectively, and $2,604,346 and $1,750,000 for comparable market capitalization companies, respectively. In recognition of the efforts of Mr. Madar and his holding company as one of the prime causes for our substantial increase in net sales and net income, as well as market capitalization from 2014 through 2019, thus substantially increasing shareholder value, on February 4, 2020 the Committees jointly authorized the aggregate annual increase in Mr. Madar&#8217;s base salary by $600,000 to $1.23 million effective as of January 1, 2020. For 2021, Mr. Madar did not receive any increase in base salary.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 36pt">Russell Greenberg, the Executive Vice President and Chief Financial Officer, also did not have any salary increase for 2021, and his base salary remained at $720,000. Previously, he had received the same $30,000 increase in base salary for 2020 and 2019. In connection with the previous increases in salary, the Compensation Committee considered the following material factors in granting Mr. Greenberg his salary increases: his individual performance, level of responsibility, skill and experience, as well as the recommendation of the Chief Executive Officer.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 36pt"><i>Bonus Compensation/Annual Incentives</i></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 36pt">As discussed above, we have paid a higher percentage of overall compensation in the form of bonus compensation to executive officers of European operations for several years, principally because European operations historically have had higher profitability than United States operations. As the result of this historically higher profitability, European operations have had the ability to pay higher bonus compensation in addition to base salary. As bonus compensation is discretionary, no targets were set in order to maintain flexibility. Further, if results of operations for European operations were not satisfactory (again, no target amounts were set to maintain flexibility), then bonus compensation, as well as overall compensation could be lowered without otherwise affecting base salary. Individual performance, level of responsibility, skill and experience, were the salient factors considered by the Compensation Committee in awarding bonus compensation described below.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<!-- Field: Page; Sequence: 69; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->66<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 36pt">In recognition of the Company&#8217;s turnaround from the effects of the COVID-19 pandemic and record results in 2021, and after the recommendations of Messrs. Madar and Benacin, the compensation committee determined that Mr. Benacin receive a bonus of $166,000. For 2020 Mr. Benacin, the chief decision maker for European operations, proposed and the compensation committee concurred in the payment of discretionary bonus compensation of $131,000. For his performance in 2019 Mr. Benacin was paid discretionary bonus compensation of $110,000. The discretionary bonus compensation for Mr. Benacin has been approximately 30% of his base salary in 2021, 17%, of his base salary in 2020 and approximately 14% in 2019. In addition, bonus compensation for Messrs. Santi and Garcia-Pelayo have remained in lockstep, and each was awarded a discretionary bonus of $378,000 in 2021 or 78% of their base salary. This compares to $296,000 and $324,000 in 2020 and 2019, respectively, or approximately 63% and 73% of their base salaries for services performed in 2020 and 2019, respectively.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 36pt">A different approach is taken for United States operations as that segment is smaller and less profitable. As discussed above, a more significant base salary is paid in order to attract and retain employees with the skills and talents needed to run United States operations with a lesser emphasis placed on bonuses. In 2021, although Mr. Greenberg did not receive any increase in base salary due to the continuing impact of the COVID-19 pandemic, he did receive a discretionary bonus of $70,000 based upon the recommendation of the Chief Executive Officer. Mr. Greenberg was paid a discretionary bonus of $35,000 in 2020 and $50,000 in 2019. The Compensation Committee considered the following material factors in granting Mr. Greenberg his bonuses: his individual performance, level of responsibility, skill and experience, as well as the recommendation of the Chief Executive Officer.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 36pt">Mr. Madar, the Chief Executive Officer has not received any cash bonus in the past three years.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 36pt">As required by French law, Interparfums SA maintains its own profit sharing plan for all French employees who have completed three months of service, including executive officers of our European operations other than Mr. Benacin, the Chief Executive Officer of Interparfums SA. Benefits are calculated based upon a percentage of taxable income of Interparfums SA and allocated to employees based upon salary. The maximum amount payable per year per employee is approximately $34,940.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 36pt">Calculation of the total annual benefits contribution is made according to the following formula:</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">67% of (Interparfums SA net income, less 2.5% of shareholders&#8217; equity without net income for the year) times a fraction, the numerator of which is wages, and the denominator of which is net income before tax + wages + taxes (other than income tax) + valuation allowances + amortization expenses + interest expenses.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 36pt">Contribution to individual employees is then made pro rata based upon their individual salaries for the year.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 36pt"><i>Long-Term Incentives</i></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 36pt"><i>Stock Options</i>. In prior years, we have linked long-term incentives with corporate performance through the grant of stock options. However, no options were granted in 2021 or 2020 to either employees of United States operations or European operations, but the compensation committee may choose to do so in the future as part of a review of the executive compensation strategy.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 36pt"><i>Interparfums SA Stock Compensation Plan</i></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 36pt"><i>2019 Plan</i> &#8211; In December 2018, Interparfums SA approved a plan to grant an aggregate of 26,600 shares of its stock to employees with no performance condition requirement, and an aggregate of 133,000 shares to officers and managers, subject to certain corporate performance conditions. The shares, subject to adjustment for stock splits, will be distributed in June 2022. Under this plan in June 2022, Messrs. Benacin, Madar, Garcia Pelayo and Santi are estimated to receive 4,000 shares each, all subject to adjustment for stock splits.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<!-- Field: Page; Sequence: 70; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->67<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 36pt">In June 2020, the performance conditions were modified effecting 96 employees. As of December 31, 2021, the number of shares to be distributed, after forfeited shares and adjusted for stock splits, increased to 172,343. The increase in shares anticipated to be distributed were transferred from treasury shares at the Interparfums SA level. The modification resulted in a revised cost of the grant to approximately $4.6 million.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 36pt">In connection with the 2019 Plan referred to above, an incentive plan was established by Interparfums SA for certain employees of Interparfums Luxury Brands, Inc. (&#8220;IPLB&#8221;), Interparfums Singapore (&#8220;IP Singapore&#8221;) and Inter Parfums, Inc. The proposed incentive plan would not provide shares but rather, would give a cash payment or bonus (&#8220;incentive&#8221; or &#8220;award&#8221;) that mirrors the shares that Interparfums SA employees will receive. An aggregate of 42,140 &#8220;phantom&#8221; shares have been awarded with Mr. Greenberg being awarded 1,000 of such &#8220;phantom&#8221; shares, all subject to adjustment for stock splits.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 36pt"><i>Stock Appreciation Rights</i></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 36pt">Our stock option plans authorize us to grant stock appreciation rights, or SARs. A SAR represents a right to receive the appreciation in value, if any, of our common stock over the base value of the SAR. To date, we have not granted any SARs under our plans. While the compensation committee currently does not plan to grant any SARs under our plans, it may choose to do so in the future as part of a review of the executive compensation strategy.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 36pt"><i>Restricted Stock</i></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 36pt">We have not in the past, and we do not have any future plans to grant restricted stock to our executive officers. However, while the compensation committee currently does not plan to authorize any restricted stock plans, the compensation committee may choose to do so in the future as part of a review of the executive compensation strategy. Our French operating subsidiary, Interparfums, SA, however, has instituted its 2019 Stock Compensation Plans as discussed above.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 36pt"><i>Other Compensation</i></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 36pt">For 2021, each of Messrs. Benacin and Garcia-Pelayo received an automobile allowance of $12,774.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 36pt"><i>No Stock Ownership Guidelines</i></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 36pt">We do not require any minimum level of stock ownership by any of our executive officers. As stated above, Messrs. Madar and Benacin, are our largest beneficial shareholders, which aligns their interests with our shareholder base in keeping executive compensation at a reasonable level.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<!-- Field: Page; Sequence: 71; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->68<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 36pt"><i>Retirement and Pension Plans</i></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 36pt">We maintain a 401(k) plan for United States operations. Commencing in 2021 we started matching the first $6,000 of contribution for each employee, as we have determined that base compensation together with annual bonuses, are sufficient incentives to retain talented employees. Our European operations maintain a pension plan for its employees as required by French law. For each of 2021. 2020 and 2019, each of Messrs. Benacin, Santi and Garcia-Pelayo received an increase of $17,773, $17,500, and $16,789, respectively, in their value of deferred compensation earnings.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify"><b><i><b><i>Compensation Committee Report</i></b></i></b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 36pt">We have reviewed and discussed with management the Compensation Discussion and Analysis provisions to be included in this Annual Report on Form 10-K for fiscal year ended December 31, 2021 and the proxy statement for the upcoming annual meeting of shareholders. Based on this review and discussion, we recommend to the board of directors that the Compensation Discussion and Analysis referred to above be included in this Annual Report on Form 10-K as well as the proxy statement for the upcoming annual meeting of shareholders.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify">Francois Heilbronn</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify">Patrick Cho&#235;l and</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify">Veronique Gabai-Pinsky</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<!-- Field: Page; Sequence: 72; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->69<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->


<p style="margin: 0"></p>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
following table sets forth a summary of all compensation awarded to, earned by or paid to our &#8220;named executive officers,&#8221;
who are our principal executive officer, our principal financial officer, and each of the three most highly compensated executive
officers of our company. This table covers all such compensation during fiscal years ended December 31, 2021, December 31, 2020
and December 31, 2019. For all compensation related matters disclosed in the summary compensation table, and elsewhere where applicable,
all amounts paid in euro have been converted to U.S. dollars at the average rate of exchange in each year.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%">
<tr style="vertical-align: bottom">
    <td colspan="27" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SUMMARY
    COMPENSATION TABLE</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; padding-left: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name
    and Principal Position</b></span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Year</b></span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Salary</b><br />
    <b>($)</b></span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Bonus</b><br />
    <b>($)</b></span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Stock<br />

    Awards</b><br />
    <b>($)</b></span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Option<br />

    Awards</b><br />
    <b>($)(1)</b></span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Non-Equity<br />

    Incentive Plan Compensation</b><br />
    <b>($)(2)</b></span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Change
    in<br />
 Pension Value<br />
 and<br />
 Nonqualified<br />
 Deferred<br />
 Compensation<br />
 Earnings</b><br />
    <b>($)</b></span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>All
    Other<br />
 Compensation</b><br />
    <b>($)(3)</b></span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total</b><br />
    <b>($)</b></span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 19%; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jean Madar,</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 6%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 6%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,230,000</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 6%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 6%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 6%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 6%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,230,000</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chairman and</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2020</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,230,000</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,230,000</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2019</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">630,000</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">138,320</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">353,092</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,121,412</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Russell Greenberg,</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">720,000</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">70,000</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">790,000</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Financial Officer and</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2020</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">720,000</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">35,000</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">755,000</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Executive Vice President</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2019</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">690,000</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50,000</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">34,580</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">353,092</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,127,672</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Philippe Benacin, President Inter</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">803,504</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">165,578</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">17,733</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12,774</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">999,589</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Parfums, Inc., Chief Executive</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2020</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">788,808</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">130,673</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">17,500</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12,434</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">949,415</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Officer of Interparfums SA</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2019</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">760,583</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">109,731</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">138,320</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">353,092</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16,789</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12,093</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,390,608</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Philippe Santi, Executive Vice</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">482,542</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">378,464</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">17,733</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">878,739</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">President and Chief Financial</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2020</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">469,730</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">295,596</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">17,500</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">782,826</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Officer, Interparfums SA</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2019</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">443,401</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">323,593</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">138,320</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">141,237</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">34,028</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16,789</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,097,368</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fr&#233;d&#233;ric Garcia-Pelayo,</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">482,542</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">378,464</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">17,733</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12,774</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">891,513</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Executive Vice President and</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2020</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">469,730</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">295,596</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">17,500</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,980</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">791,806</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Operating Officer Interparfums SA</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2019</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">443,401</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">323,593</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">138,320</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">141,237</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">34,028</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16,789</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,734</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,106,102</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<!-- Field: Page; Sequence: 73; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->70<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin-top: 0; margin-bottom: 0"></p>



<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%">
<tr style="vertical-align: top">

    <td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amounts reflected
    under Option Awards represent the grant date fair values in 2021, 2020 and 2019 based on the fair value of stock option awards
    using a Black-Scholes option pricing model. The assumptions used in this model are detailed in Footnote 13 to the audited
    consolidated financial statements in our Annual Report on Form 10-K for the year ended December 31, 2021 and filed with the
    SEC.</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%">
<tr style="vertical-align: top">

    <td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As required by French
    law, Interparfums SA maintains its own profit sharing plan for all French employees who have completed three months of service,
    including executive officers of our European operations other than Mr. Benacin, the Chief Executive Officer of Interparfums
    SA. Benefits are calculated based upon a percentage of taxable income of Interparfums SA and are allocated to employees based
    upon salary. The maximum amount payable per year is approximately $34,940.</span></td></tr>
</table>
<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Calculation
of total annual benefits contribution is made according to the following formula:</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">67%
of (Interparfums SA net income, less 2.5% of shareholders&#8217; equity without net income for the year) times a fraction, the
numerator of which is wages, and the denominator of which is net income before tax + wages + taxes (other than income tax) + valuation
allowances + amortization expenses + interest expenses.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contribution
to individual employees is then made pro rata based upon their individual salaries for the year.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%">
<tr style="vertical-align: top">

    <td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</span></td>
    <td><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
        following table identifies (i) perquisites and other personal benefits provided to our named executive officers in fiscal
        2021, and quantifies those required by SEC rules to be quantified and (ii) all other compensation that is required by
        SEC rules to be separately identified and quantified.</span></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></td></tr>
</table>
<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%">
<tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name
    and Principal Position</b></span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Perquisites<br />

    and other<br />
 Personal<br />
 Benefits</b><br />
    <b>($)</b></span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Personal<br />

    Automobile<br />
 Expense</b><br />
    <b>($)</b></span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Lodging<br />

    Expense</b><br />
    <b>($)</b></span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total</b><br />
    <b>($)</b></span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 52%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jean Madar, Chairman <br />
    Chief Executive Officer</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Russell Greenberg, Chief Financial<br />
    Officer and Executive Vice<br />
    President</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Philippe Benacin, President of Inter <br />
    Parfums, Inc. and Chief Executive<br />
    Officer of Interparfums SA</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12,774</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12,774</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Philippe Santi, <br />
    Executive Vice President and Chief<br />
    Financial Officer, Interparfums SA</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fr&#233;d&#233;ric Garcia-Pelayo, <br />
    Executive Vice President and <br />
    Chief Operating Officer, <br />
    Interparfums SA</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12,774</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12,774]</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
</table>
<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<!-- Field: Page; Sequence: 74; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->71<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Plan
Based Awards</i></b></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
stock options were granted to the executive officers of our company listed in the Summary Compensation Table during the past fiscal
year.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Interparfums
SA Stock Compensation Plan.</i></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
options were granted by Interparfums SA to the executive officers of our company listed in the Summary Compensation Table during
the past fiscal year.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Interparfums
SA Profit Sharing Plan</i></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Also
as discussed above and required by French law, Inter Parfums, SA maintains its own profit sharing plan for all French employees
who have completed three months of service, including executive officers of our European operations other than Mr. Benacin, the
Chief Executive Officer of Inter Parfums, SA. Benefits are calculated based upon a percentage of taxable income of Interparfums
SA and allocated to employees based upon salary. The maximum amount payable per year per employee is approximately $34,940.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 75; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->72<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Outstanding
Equity Awards at Fiscal Year-End</i></b></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth certain information relating to outstanding equity awards of our Company held by the executive officers
listed in the Summary Compensation Table as of December 31, 2021.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%">
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="17" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Option
    Awards</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number
    of<br />
 Securities<br />
 Underlying<br />
 Unexercised<br />
 Options (#)<br />
 Exercisable<sup>(1)</sup></b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number
    of<br />
 Securities<br />
 Underlying<br />
 Unexercised<br />
 Options (#)<br />
 Unexercisable</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Equity
    Incentive<br />
 Plan Awards:<br />
 Number of<br />
 Securities<br />
 Underlying<br />
 Unexercised<br />
 Unearned<br />
 Options (#)</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Option<br />

    Exercise<br />
 Price ($)</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Option<br />

    Expiration<br />
 Date</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 20%; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jean Madar</span></td>
    <td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">19,000</span></td>
    <td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">32.825</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 12%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12/30/22</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20,000</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>(2)</sup></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,000</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>(2)</sup></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">43.80</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12/29/23</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15,000</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>(2)</sup></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,000</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>(2)</sup></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">65.25</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12/30/24</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,000</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>(2)</sup></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15,000</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>(2)</sup></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">73.09</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12/30/25</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Russell Greenberg</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25,000</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">32.825</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12/30/22</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20,000</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,000</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">43.80</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12/29/23</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15,000</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,000</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">65.25</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12/30/24</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,000</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15,000</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">73.09</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12/30/25</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Philippe Benacin</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">19,000</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">32.825</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12/30/22</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20,000</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>(2)</sup></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,000</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>(2)</sup></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">43.80</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12/29/23</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15,000</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>(2)</sup></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,000</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>(2)</sup></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">65.25</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12/30/24</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,000</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>(2)</sup></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15,000</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>(2)</sup></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">73.09</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12/30/25</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Philippe Santi</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,200</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">32.825</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12/30/22</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,200</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,200</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">43.80</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12/29/23</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,600</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">46.903</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1/18/24</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,000</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,000</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">65.25</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12/30/24</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,000</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,000</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">73.09</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12/30/25</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fr&#233;d&#233;ric Garcia-Pelayo</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,200</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">32.825</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12/30/22</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,200</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,200</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">43.80</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12/29/23</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,600</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">46.903</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1/18/24</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,000</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,000</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">65.25</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12/30/24</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,000</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,000</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">73.09</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12/30/25</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
</table>
<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[<i>Footnotes
from table above</i>]</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All options expire
    6 years from the date of grant, and vest 20% each year commencing one year after the date of grant.</span></td></tr>
</table>
<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Options are held
    in the name of personal holding company.</span></td></tr>
</table>
<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<!-- Field: Page; Sequence: 76; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->73<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets certain information relating to outstanding equity awards granted by Interparfums SA, our majority-owned
French subsidiary which has its shares traded on the NYSE Euronext, held by the executive officers of our company listed in the
Summary Compensation Table as of the end of the past fiscal year.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>OUTSTANDING
EQUITY AWARDS AT FISCAL YEAR-END</b><br />
<b>OF INTERPARFUMS SA</b></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%">
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="17" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Option
    Awards</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="13" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Stock
    Awards</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name</b></span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number
    of Securities Underlying Unexercised Options (#) Exercisable)</b></span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number
    of Securities Underlying Unexercised Options (#) Unexercisable</b></span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Equity
    Incentive Plan Awards: Number of Securities Underlying Unexercised Unearned<br />
 Options (#)</b></span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Option<br />

    Exercise<br />
 Price ($)</b></span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Option
    Expiration<br />
 Date</b></span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number
    of Shares or Units of Stock that Have Not Vested (#)(1)</b></span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Market
    Value of Shares or Units of Stock that Have Not Vested ($)</b></span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Equity
    Incentive Plan Awards: Number of Unearned Shares, Units or Other Rights that Have Not Vested (#)</b></span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Equity
    Incentive Plan Awards: Market or Payout Value of Unearned Shares, Units or Other Rights that Have Not Vested($)</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 13%; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jean Madar</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 7%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 7%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 7%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 7%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 7%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 7%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 7%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 7%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 7%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NA</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Russell Greenberg</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NA</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Philippe Benacin</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,324</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">443,202</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NA</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Philippe Santi</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,324</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">443,202</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NA</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fr&#233;d&#233;ric Garcia-Pelayo</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,324</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">443,202</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NA</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
</table>
<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1
Estimated number of shares are to be issued only to the extent that the performance conditions have been met.</span></p>


<!-- Field: /Named-Area; -->

<!-- Field: Named-Area; Name: Contents -->
<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2
As of December 31, 2021, the closing price of Interparfums SA as reported by Euronext was 73.50 euros, and the exchange rate was
1.1326 U.S. dollars to 1 euro.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 77; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->74<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Option
Exercises and Stock Vested</i></b></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth certain information relating to each option exercise affected during the past fiscal year, and each
vesting of stock, including restricted stock, restricted stock units and similar instruments of our company during the past fiscal
year, for the executive officers of our company listed in the Summary Compensation Table.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>OPTION
EXERCISES AND STOCK VESTED</b></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%">
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="6" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Option
    Awards</b></span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="6" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Stock
    Awards</b></span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name</b></span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number<br />

    of Shares<br />
 Acquired on<br />
 Exercise<br />
 (#)</b></span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Value
    <br />
Realized on<br />
 Exercise<br />
 ($)<sup>1</sup></b></span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number<br />

    of Shares<br />
 Acquired on<br />
 Vesting<br />
 (#)</b></span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Value<br />

    Realized On<br />
 Vesting<br />
 ($)</b></span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 50%; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jean Madar</span></td>
    <td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">19,000</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,375,915</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Russell Greenberg</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25,000</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,460,464</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Philippe Benacin</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">19,000</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,277,297</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Philippe Santi</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16,000</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">440,577</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fr&#233;d&#233;ric Garcia-Pelayo</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16,000</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">452,342</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
</table>
<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[Footnotes
from table above]</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total value realized
    on exercise of options in dollars is based upon the difference between the fair market value of the common stock on the date
    of exercise, and the exercise price of the option.</span></td></tr>
</table>
<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Regarding
Interparfums SA, our majority-owned French subsidiary which has its shares traded on the Euronext, no options were exercised during
the past fiscal year, and there was no vesting of stock, including restricted stock, restricted stock units and similar instruments
during the past fiscal year, for the executive officers of our company listed in the Summary Compensation Table.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Pension
Benefits</i></b></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth certain information relating to payment of benefits in connection with retirement plans during the
past fiscal year, for the executive officers of our company listed in the Summary Compensation Table.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PENSION
BENEFITS</b></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%">
<tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Plan
    Name</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number<br />

    of Years<br />
 Credited<br />
 Service </b><br />
    <b>(#)</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Present</b><br />
    <b>Value of</b><br />
    <b>Accumulated<br />
 Benefit* </b><br />
    <b>($)</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Payments<br />

    During<br />
 Last Fiscal<br />
 Year </b><br />
    <b>($)</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 30%; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jean Madar</span></td>
    <td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NA</span></td>
    <td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 9%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NA</span></td>
    <td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Russell Greenberg</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NA</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NA</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Philippe Benacin</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inter Parfums SA
    Pension Plan</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NA</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">315,233</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">17,733</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Philippe Santi</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inter Parfums SA
    Pension Plan</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NA</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">305,233</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">17,733</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fr&#233;d&#233;ric Garcia-Pelayo</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inter Parfums SA
    Pension Plan</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NA</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">305,233</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">17,733</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
</table>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Does not include
    any contributions made by prior employers, or individually by the recipients as such information is confidential under French
    law.</span></td></tr>
</table>
<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 78; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->75<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Interparfums
SA maintains a pension plan for all of its employees, including all executive officers. The calculation of commitments for severance
benefits involves estimating the probable present value of projected benefit obligations. This projected benefit obligations are
then prorated to take into account seniority of the employees of Interparfums SA on the calculation date.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
calculating benefits, the following assumptions were applied:</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">voluntary retirement
    at age 65;</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a rate of 45% for
    employer payroll contributions for all employees;</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a 4% average annual
    salary increase;</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">an annual rate of
    turnover for all employees under 55 years of age and nil above;</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the TH 00-02 mortality
    table for men and the TF 00-02 mortality table for women;</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a discount rate
    of 2.0%.</span></td></tr>
</table>
<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
normal retirement age is 65 years, but employees, including Messrs. Benacin, Santi and Garcia-Pelayo, can collect reduced benefits
if they retire at age 62.&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Nonqualified
Deferred Compensation</i></b></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
do not maintain any nonqualified deferred compensation plans.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>CEO
Pay Ratio</i></b></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
required by Section 953(b) of the Dodd-Frank Wall Street Reform and Consumer Protection Act, and Item 402(u) of Regulation S-K,
we are providing the following information about the relationship of the annual total compensation of our mean employee and the
annual total compensation of Mr. Jean Madar, Chief Executive Officer (the &#8220;CEO&#8221;):</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
2021, our last completed fiscal year:</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 48px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our median employee&#8217;s
    compensation was $69,673</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 48px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our Chief Executive
    Officer&#8217;s total 2021 compensation was $2,605,915</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 48px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accordingly, our
    2021 CEO to Median Employee Pay Ratio was 37.4 to 1</span></td></tr>
</table>
<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
pay ratio is a reasonable estimate calculated in a manner consistent with SEC rules based on our payroll and employment records.
We identified our median employee using our total employee population as of December 31, 2021 by applying a consistently applied
compensation measure across our global employee population. For our consistently applied compensation measure, we used all compensation,
including actual base salary, bonuses, commissions, and any overtime paid during the 12-month period ending December 31, 2021.
We did not use any material estimates, assumptions, adjustments or statistical sampling to determine the worldwide median employee.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 79; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->76<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
SEC rules for identifying the median compensated employee and calculating the pay ratio based on that employee&#8217;s annual
total compensation allow companies to adopt a variety of methodologies, to apply certain exclusions, and to make reasonable estimates
and assumptions that reflect their compensation practices. As such, the pay ratio reported by other companies may not be comparable
to the pay ratio reported above, as other companies may have different employment and compensation practices and may utilize different
methodologies, exclusions, estimates and assumptions in calculating their own pay ratios.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Employment
and Consulting Agreements</i></b></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
part of our acquisition in 1991 of the controlling interest in Interparfums SA, now a subsidiary, we entered into an employment
agreement with Philippe Benacin. The agreement provides that Mr. Benacin will be employed as Vice Chairman of the Board and President
and Chief Executive Officer of Inter Parfums Holdings and its subsidiary, Interparfums SA. The initial term expired on September
2, 1992, and has subsequently been automatically renewed for additional annual periods. The agreement provides for automatic annual
renewal terms, unless either party terminates the agreement upon 120 days&#8217; notice. For 2021, Mr. Benacin received an annual
salary of approximately $804,000, and automobile expenses of approximately $12,774 which are subject to increase at the discretion
of the board of directors. The agreement also provides for indemnification and a covenant not to compete for one year after termination
of employment.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
2014, we entered into a consulting agreement with Mr. Benacin&#8217;s holding company, Philippe Benacin Holding SAS, which provides
for review on an annual basis of the amount of compensation payable to such company. The agreement also provides for indemnification
for Mr. Benacin and his holding company and a covenant not to compete for one year after termination of the agreement. The agreement
was for one year, with automatic one year renewals unless either party terminates on 120 days&#8217; notice or Mr. Benacin ceases
to be the President of our company. For 2019 through 2021 Mr. Benacin&#8217;s personal holding company received $250,000 each
year for services rendered outside of the United States by Mr. Benacin in his capacity as President. In addition, in December
2018 and December 2019, we granted options to purchase 25,000 shares for the benefit of Mr. Benacin, which were granted to his
personal holding company instead of Mr. Benacin directly.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
2013, we enter into a consulting agreement with Mr. Madar&#8217;s holding company, Jean Madar Holding SAS, which provides for
review on an annual basis of the amount of compensation payable to such company. The agreement also provides for indemnification
for Mr. Madar and his holding company and a covenant not to compete for one year after termination of the agreement. The agreement
was for one year, with automatic one year renewals unless either party terminates on 120 days&#8217; notice or Mr. Madar ceases
to be the Chief Executive Officer of our company. As discussed above, in view of receiving substantially less than the annual
and median average CEO salaries for peer companies and companies with comparable market capitalization, in early February 2020
the Mr. Madar&#8217;s base salary was increased by $600,000 to $1.23 million effective as of January 1, 2020, and allocated so
that the annual base salary for Jean Madar individually was $285,000, and the fees to Jean Madar Holding SAS were $945,000, effective
as of January 1, 2020. For 2021, the compensation to Mr. Madar and the fees paid to Jean Madar Holding SAS were unchanged from
2020. In addition, in December 2018 and December 2019, we granted options to purchase 25,000 shares for the benefit of Mr. Madar,
which were granted to his personal holding company instead of Mr. Madar directly.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 80; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->77<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Compensation
of Directors</i></b></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth certain information relating to the compensation for each of our directors who is not an executive
officer of our Company named in the Summary Compensation Table for the past fiscal year.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%">
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="10" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DIRECTOR
    COMPENSATION</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name</b></span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid"><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fees
Earned or Paid in Cash</b></span></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Stock<br />

    Awards</b><br />
    <b>($)</b></span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Option<br />

    Awards</b><br />
    <b>($)</b></span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Non-Equity
    Incentive Plan Compensation</b><br />
    <b>($)</b></span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Change
    in<br />
 Pension Value<br />
 and Nonqualified Deferred Compensation Earnings</b></span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>All
    Other Compensation</b><br />
    <b>($)<sup>1</sup></b></span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total</b><br />
    <b>($)</b></span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 29%; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Francois Heilbronn<sup>2</sup></span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 7%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20,000</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 7%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 7%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">17,020</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 7%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 7%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 7%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">58,861</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 7%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">95,881</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Robert Bensoussan<sup>3</sup></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12,000</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">17,020</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">36,032</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">65,052</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Patrick Cho&#235;l<sup>4</sup></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20,000</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">17,020</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">39,254</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">76,274</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Michel Dyens<sup>5</sup></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12,000</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">17,020</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">87,095</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">116,115</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Veronique Gabai-Pinsky<sup>6</sup></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20,000</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">17,020</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">37,020</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gilbert Harrison<sup>7</sup></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12,000</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">17,020</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">120,000</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">149,020</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
</table>
<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[Footnotes
from table above]</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents gain from exercise of stock options, except for Mr. Harrison, which consists of a $120,000
payment made in 2021 to the company controlled by Mr. Harrison in connection with the acquisition of the Donna Karan license. See
&#8220;Fee for Director&#8217;s Company&#8221; in Item 13, Certain Relationships and Related Transactions, and Director Independence,
in this annual report on Form 10-K.</span></td></tr>
</table>
<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of the end of
    the last fiscal year, Mr. Heilbronn held options to purchase an aggregate of 5,000 shares of our common stock.</span></td></tr>
</table>
<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of the end of
    the last fiscal year, Mr. Bensoussan held options to purchase an aggregate of 5,000 shares of our common stock.</span></td></tr>
</table>

<!-- Field: /Named-Area; -->

<!-- Field: Named-Area; Name: Contents -->
<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of the end of
    the last fiscal year, Mr. Cho&#235;l held options to purchase an aggregate of 4,500 shares of our common stock.</span></td></tr>
</table>
<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of the end of
    the last fiscal year, Mr. Dyens held options to purchase an aggregate of 5,000 shares of our common stock.</span></td></tr>
</table>
<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of the end of
    the last fiscal year, Ms. Gabai-Pinsky held options to purchase an aggregate of 6.000 shares of our common stock.</span></td></tr>
</table>
<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of the end of
    the last fiscal year, Mr. Harrison held options to purchase an aggregate of 6,000 shares of our common stock.</span></td></tr>
</table>
<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">In
July 2019 and compensation to all nonemployee directors was increased to $6,000 for each board meeting at which they participate
in person, and $3,000 for each meeting held by conference telephone. In addition, effective January 1, 2020 the annual fee for
each member of the audit committee was raised to $8,000. The compensation for the nonemployee directors remained the same for
2021, except for Mr. Harrison. During 2021, a company owned by Mr. Harrison received a fee equal to $300,000, in connection with
the Donna Karan license agreement, which is effective on July 1, 2022. A payment of $120,000 was made in 2021 to Mr. Harrison&#8217;s
company, and the balance will be paid, $120,000 one year later in 2022, and $60,000 two years later in 2023.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 81; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->78<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
maintain stock option plans for our nonemployee directors. The purpose of these plans is to assist us in attracting and retaining
key directors who are responsible for continuing the growth and success of our company. Under such plans, options to purchase
1,500 shares are granted on each February 1st to all nonemployee directors for as long as each is a nonemployee director on such
date. However, if a nonemployee director does not attend certain of the board meetings, then such option grants are reduced according
to a schedule. In addition, options to purchase 2,000 shares are granted to each nonemployee director upon his or her initial
election or appointment to our board, but if such option is granted within six months of the next February 1 automatic grant,
then such nonemployee director would not be eligible to receive that February 1 grant. On February 1, 2021, options to purchase
1,500 shares were granted to all of our nonemployee directors at the exercise price of $62.18 per share under our 2016 Stock Option
Plan. However, our board of directors cancelled the automatic grant of options to the nonemployee directors effective with the
grant that had been scheduled for February 1, 2022.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 82; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->79<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>



<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters </b></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth information with respect to the beneficial ownership of our common stock by (a) each person we know
to be the beneficial owner of more than 5% of our outstanding common stock, (b) our executive officers and directors and (c) all
of our directors and officers as a group. Messrs. Madar and Benacin own 99.99% of their respective personal holding companies.
As of January 26, 2022, we had 31,836,545 shares of common stock outstanding.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%">
<tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name
    and Address of Beneficial Owner</b></span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Amount
    of<br />
 Beneficial<br />
 Ownership<sup>1</sup></b></span></td>
    <td style="text-align: center; padding-bottom: 2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>&#160;</sup></span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Approximate<br />

    Percent of<br />
 Class</b></span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 73%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jean Madar<br />
    c/o Interparfums SA<br />
    4, Rond Point des Champs Elysees<br />
    75008 Paris, France</span></td>
    <td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,109,341</span></td>
    <td style="width: 2%; padding-bottom: 2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>2</sup></span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">22.4</span></td>
    <td style="width: 1%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Philippe Benacin<br />
    c/o Interparfums SA<br />
    4, Rond Point des Champs Elysees<br />
    75008 Paris, France</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,910,064</span></td>
    <td style="padding-bottom: 2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>3</sup></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.7</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Russell Greenberg<br />
    c/o Inter Parfums, Inc.<br />
    551 Fifth Avenue<br />
    New York, NY 10176</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">77,500</span></td>
    <td style="padding-bottom: 2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>4</sup></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less than 1</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Philippe Santi<br />
    Interparfums SA<br />
    4, Rond Point des Champs Elysees<br />
    75008, Paris France</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,200</span></td>
    <td style="padding-bottom: 2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>5</sup></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less than 1</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Francois Heilbronn<br />
    60 Avenue de Breteuil<br />
    75007 Paris, France</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">26,438</span></td>
    <td style="padding-bottom: 2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>6</sup></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less than 1</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Robert Bensoussan<br />
    c/o Sirius Equity LLP<br />
    52 Brook Street<br />
    W1K 5DS London</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9,875</span></td>
    <td style="padding-bottom: 2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>7</sup></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less than 1</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
</table>
<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%">
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 73%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Patrick Cho&#235;l<br />
    140 Rue de Grenelle<br />
    75007, Paris, France</span></td>
    <td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,375</span></td>
    <td style="width: 2%; padding-bottom: 2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>8</sup></span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less than
    1</span></td>
    <td style="width: 1%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Michel Dyens<br />
    Michel Dyens &amp; Co.<br />
    17 Avenue Montaigne<br />
    75008 Paris, France</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,875</span></td>
    <td style="padding-bottom: 2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>9</sup></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less than 1</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Veronique Gabai-Pinsky<br />
    200 East End Avenue<br />
    New York NY 10128</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,875</span></td>
    <td style="padding-bottom: 2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>10</sup></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less than 1</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gilbert Harrison<br />
    Harrison Group<br />
    745 Fifth Avenue, Suite 514<br />
    New York, NY 10151</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,875</span></td>
    <td style="padding-bottom: 2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>11</sup></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less than 1</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Frederic Garcia-Pelayo<br />
    Interparfums SA<br />
    4, Rond Point des Champs Elysees<br />
    75008, Paris, France</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,555</span></td>
    <td style="padding-bottom: 2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>12</sup></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less than 1</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Blackrock, Inc.<br />
    55 East 52<sup>nd</sup> Street<br />
    New York, NY 10055 </span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,662,032</span></p></td>
    <td style="padding-bottom: 2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>13</sup></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.4</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Vanguard Group<br />
    100 Vanguard Blvd.<br />
    Malvern, PA 19355</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,983,427</span></td>
    <td style="padding-bottom: 2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>14</sup></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.2</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ameriprise Financial, Inc. 145<br />
    Ameriprise Financial Center <br />
    Minneapolis, MN 55474 </span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,744,296</span></td>
    <td style="padding-bottom: 2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>15</sup></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.4</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All Directors and Officers<br />
    (As a Group 10 Persons)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14,167,793</span></td>
    <td style="padding-bottom: 2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>16</sup></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">44.2</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
</table>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>



<p style="margin-top: 0; margin-bottom: 0"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>1</sup></span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All shares of common
    stock are directly held with sole voting power and sole power to dispose, unless otherwise stated. Options which are exercisable
    within 60 days are included in beneficial ownership calculations. </span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>2</sup></span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consists of 13,000
    shares held directly, 7,032,341 shares held indirectly through Jean Madar Holding SAS, a personal holding company, and options
    to purchase 64,000 shares.</span></td></tr>
</table>
<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>3</sup></span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consists of 6,846,064
    shares held indirectly through Philippe Benacin Holding SAS, a personal holding company, and options to purchase 64,000 shares.</span></td></tr>
</table>
<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>4</sup></span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consists of shares
    7,500 shares held directly and options to purchase 70,000 shares.</span></td></tr>
</table>
<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>5</sup></span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consists of options
    to purchase shares.</span></td></tr>
</table>
<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>6</sup></span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consists of 24,063
    shares held directly and options to purchase 2,375 shares.</span></td></tr>
</table>
<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>7</sup></span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consists of 7,500
    shares held directly and options to purchase 2,375 shares.</span></td></tr>
</table>
<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>8</sup></span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consists of 4,250
    shares held directly and options to purchase 2,125 shares.</span></td></tr>
</table>
<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>9</sup></span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consists of 4,000
    shares held directly and options to purchase 2,875 shares.</span></td></tr>
</table>
<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>10</sup></span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consists of shares
    of common stock underlying options.</span></td></tr>
</table>
<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>11</sup></span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consists of shares
    of common stock underlying options.</span></td></tr>
</table>
<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>12</sup></span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consists of shares
    of common stock underlying options.</span></td></tr>
</table>
<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>13</sup></span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Information based
    upon Schedule 13G Amendment 6 of Blackrock, Inc. dated February 1, 2022 as filed with the Securities and Exchange Commission.</span></td></tr>
</table>
<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>14</sup></span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Information based
    upon Schedule 13G Amendment 5 of The Vanguard Group, an investment advisor, dated February 9, 2022 as filed with the Securities
    and Exchange Commission.</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Information based
    upon Schedule 13G Amendment 1 of Ameriprise Financial, Inc. (&#8220;AFI&#8221;) dated February 14, 2022 as filed with the
    Securities and Exchange Commission. AFI disclaims beneficial ownership of any shares reported on this Schedule 13G.</span></td></tr>
</table>
<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>15</sup></span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consists of 13,938,718
    shares held directly or indirectly, and options to purchase 229,255 shares.</span></td></tr>
</table>
<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 83; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->80<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
following table sets forth certain information as of the end of our last fiscal year regarding all equity compensation plans that
provide for the award of equity securities or the grant of options, warrants or rights to purchase our equity securities.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Equity
Compensation Plan Information</b></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%">
<tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Plan
    category</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number
    of</b><br />
    <b>securities to</b><br />
    <b>be issued</b><br />
    <b>upon</b><br />
    <b>exercise of</b><br />
    <b>outstanding</b><br />
    <b>options,</b><br />
    <b>warrants and</b><br />
    <b>rights</b><br />
    <b>(a)</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted-average</b><br />
    <b>exercise price of</b><br />
    <b>outstanding</b><br />
    <b>options, warrants</b><br />
    <b>and rights</b><br />
    <b>(b)</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number
    of</b><br />
    <b>securities</b><br />
    <b>remaining</b><br />
    <b>available for</b><br />
    <b>future issuance</b><br />
    <b>under equity</b><br />
    <b>compensation</b><br />
    <b>plans</b><br />
    <b>(excluding</b><br />
    <b>securities</b><br />
    <b>reflected in</b><br />
    <b>column (a)) </b><br />
    <b>(c)</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 60%; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity compensation plans
    approved by security holders</span></td>
    <td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">650,440</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$57.58</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">612,535</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity compensation plans not approved by security
    holders</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 2.5pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 2.5pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 2.5pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
</table>
<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
13. Certain Relationships and Related Transactions, and Director Independence</b></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Transactions
with European Subsidiaries</i></b></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have guaranteed the obligations of our majority-owned, French subsidiary, Interparfums SA under our expired Paul Smith license
agreement. We also provide (or had provided on our behalf) certain financial, accounting and legal services for Interparfums SA,
and during 2021, 2020 and 2019 fees for such services were $443,625, $450,750 and $483,675, respectively.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
2018, Interparfums SA, loaned the Company $10 million. This loan was repayable in ten (10) equal monthly payments of $1 million
of principal plus accrued interest at 2% per annum, with the first payment made on May 31, 2019, and the last payment made on
February 28, 2020.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
March 2020, Interparfums Luxury Brands, Inc., an indirect majority-owned subsidiary of the Company, loaned the Company $10 million,
which was repaid in full, with interest at 2% per annum, in December 2020.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
September 2021, Interparfums Luxury Brands, Inc., an indirect majority-owned subsidiary of the Company, loaned the Company $24
million, which is repayable in 12 equal monthly payments with interest at 2% per annum commencing on January 31, 2022.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
December 2021, Inter Parfums USA, LLC, a United States subsidiary, renewed a license agreement for five years that was initially
signed in 2012 on the same terms with Interparfums Suisse (SARL), a Swiss subsidiary of Interparfums SA, for the right to sell
amenities under the Lanvin brand name to luxury hotels, cruise lines and airlines in return for royalty payments as are customary
in our industry.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 84; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->81<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Fee
for Director&#8217;s Company&#160;</i></b></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the acquisition of the Donna Karan license, which takes effect on July 1, 2022 as discussed above, we agreed to
pay to the company controlled by Mr. Gilbert Harrison, a director, the sum of $300,000, payable over time, with $120,000 being
paid in 2021, and deferred payments of $120,000 one year later and $60,000 two years later.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Consulting
Agreements</i></b></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
2014, we entered into a consulting agreement with Mr. Benacin&#8217;s holding company, Philippe Benacin Holding SAS, which provides
for review on an annual basis of the amount of compensation payable to such company. The agreement also provides for indemnification
for Mr. Benacin and his holding company and a covenant not to compete for one year after termination of the agreement. The agreement
was for one year, with automatic one year renewals unless either party terminates on 120 days&#8217; notice or Mr. Benacin ceases
to be the President of our company. For 2015 through 2021 Mr. Benacin&#8217;s personal holding company received $250,000 each
year for services rendered outside of the United States by Mr. Benacin in his capacity as President. In addition, in December
2018 and December 2019, we granted options to purchase 25,000 shares for the benefit of Mr. Benacin, which were granted to his
personal holding company instead of Mr. Benacin directly.&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
2013, we enter into a consulting agreement with Mr. Madar&#8217;s holding company, Jean Madar Holding SAS, which provides for
review on an annual basis of the amount of compensation payable to such company. The agreement also provides for indemnification
for Mr. Madar and his holding company and a covenant not to compete for one year after termination of the agreement. The agreement
was for one year, with automatic one year renewals unless either party terminates on 120 days&#8217; notice or Mr. Madar ceases
to be the Chief Executive Officer of our company. As discussed above, in view of receiving substantially less than the annual
and median average CEO salaries for peer companies and companies with comparable market capitalization, in early February 2020
the Mr. Madar&#8217;s base salary was increased by $600,000 to $1.23 million effective January 1, 2020, and allocated so that
the annual base salary for Jean Madar individually was $285,000, and the fees to Jean Madar Holding SAS were $945,000. For 2021,
the compensation to Mr. Madar and the fees paid to Jean Madar Holding SAS were unchanged from 2020. In addition, in December 2018
and again in December 2019, we granted options to purchase 25,000 shares for the benefit of Mr. Madar, which were granted to his
personal holding company rather than to Mr. Madar directly.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Procedures
for Approval of Related Person Transactions</i></b></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transactions
between related persons, such as between an executive officer or director and our company, or any company or person controlled
by such officer or director, are required to be approved by our Audit Committee of our board of directors. Our Audit Committee
Charter contains such explicit authority, as required by the applicable rules of The Nasdaq Stock Market.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 85; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->82<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Director
Independence</i></b></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following are our directors who are independent directors within the applicable rules of The Nasdaq Stock Market:</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Francois
Heilbronn&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Robert
Bensoussan&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Patrick
Cho&#235;l&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Michel
Dyens&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Veronique
Gabai-Pinsky&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gilbert
Harrison</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
follow and comply with the independent director definitions as provided by The Nasdaq Stock Market rules in determining the independence
of our directors, which are posted on our company&#8217;s website. In addition, such rules are also available on The Nasdaq Stock
Market&#8217;s website. In addition, The Nasdaq Stock Market maintains more stringent rules relating to director independence
for the members of our Audit Committee, and the members of our Audit Committee, Messrs. Heilbronn and Cho&#235;l, as well as Ms.
Gabai-Pinsky, are independent within the meaning of those rules.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Board
Leadership Structure and Risk Management</i></b></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
more than the past ten (10) years, Jean Madar has held the positions of Chairman of the Board of Directors and Chief Executive
Officer of our company. Almost since inception, Mr. Madar has been allocated the responsibility of overseeing our United States
operations and the operation of Inter Parfums, Inc., as a public company. Philippe Benacin, as Chief Executive Officer of Interparfums
SA, has been allocated the responsibility of overseeing our European operations and its operation as a public company in France.
In addition, Mr. Benacin is also the Vice Chairman of the Board of Directors of our company. Our board of directors is comfortable
with this approach, as the two largest beneficial stockholders of our company are also directly responsible for the operations
of our company&#8217;s two operating segments. Accordingly, our board of directors does not have a &#8220;Lead Director,&#8221;
a non-management director who controls the meetings of our board of directors.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
board of directors manages risk by (i) review of periodic operating reports and discussions with management; (ii) approval of
executive compensation incentive plans through its committee, the Executive Compensation and Stock Option Committee; (iii) approval
of related party transactions through its committee, the Audit Committee; and (iv) approval of material transactions not in the
ordinary course of business. Since our inception, we have never been the subject of any material product liability claims, and
we have had no recent material property damage claims.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Further,
we periodically enter into foreign currency forward exchange contracts to hedge exposure related to receivables denominated in
a foreign currency and to manage risks related to future sales expected to be denominated in a foreign currency. We enter into
these exchange contracts for periods consistent with our identified exposures. The purpose of the hedging activities is to minimize
the effect of foreign exchange rate movements on the receivables and cash flows of Interparfums SA, our French subsidiary, whose
functional currency is the Euro. All foreign currency contracts are denominated in currencies of major industrial countries and
are with large financial institutions, which are rated as strong investment grade<b>.</b></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, we mitigate interest rate risk by continually monitoring interest rates, and then determining whether fixed interest
rates should be swapped for floating rate debt, or if floating rate debt should be swapped for fixed rate debt.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 86; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->83<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
14. Principal Accountant Fees and Services</b></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Fees</i></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following sets forth the fees billed to us by Mazars USA LLP, as well as discusses the services provided for the past two fiscal
years, fiscal years ended December 31, 2021 and December 31, 2020.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Audit
Fees</i></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fees
billed by Mazars USA LLP and its affiliate, Mazars S.A. for audit services and review of the financial statements contained in
our Quarterly Reports on Form 10-Q were $1.2 and $1.1 and million for 2021 and 2020, respectively.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Audit-Related
Fees</i></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mazars
USA LLP did not bill us for any audit-related services during 2021 and 2020.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Tax
Fees</i></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Mazars USA LLP billed
us $49,300 and $34,500 for tax services during 2021 and 2020, respectively.&#160;</p>



<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>All
Other Fees</i></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Mazars S.A. billed
us $3,000 and $3,500 for other services during 2021 and 2020, respectively.</p>



<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Audit
Committee Pre-Approval Policies and Procedures</i></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Audit Committee has the sole authority for the appointment, compensation and oversight of the work of our independent accountants,
who prepare or issue an audit report for us.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the second quarter of 2021, the audit committee authorized the following non-audit services to be performed by Mazars USA LLP.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 48px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We authorized the
    engagement of Mazars USA LLP if deemed necessary to provide tax consultation in the ordinary course of business for fiscal
    year ended December 31, 2021.</span></td></tr>
</table>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 48px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We authorized the
    engagement of Mazars USA LLP if deemed necessary to provide tax consultation as may be required on a project by project basis
    that would not be considered in the ordinary course of business, up to a $10,000 fee limit per project (or &#8364;10,000 in
    the case of Interparfums SA), subject to an aggregate fee limit of $50,000 for fiscal year ended December 31, 2021. If we
    require further tax services from Mazars USA LLP, then the approval of the audit committee must be obtained.</span></td></tr>
</table>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 48px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We authorized the
    engagement of Mazars USA LLP if deemed necessary to provide attestation or other services as may be required on a project
    by project basis that would not be considered in the ordinary course of business, up to a $10,000 fee limit per project (or
    &#8364;10,000 in the case of Interparfums SA), subject to an aggregate fee limit of $50,000 for fiscal year ended December
    31, 2021. If we require further tax services from Mazars USA LLP, then the approval of the audit committee must be obtained.</span></td></tr>
</table>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 48px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If we require other
    services by Mazars USA LLP on an expedited basis such that obtaining pre-approval of the audit committee is not practicable,
    then the Chairman of the Committee has authority to grant the required pre-approvals for all such services.</span></td></tr>
</table>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<!-- Field: Page; Sequence: 87; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->84<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin-top: 0; margin-bottom: 0"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 48px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We imposed a cap
    of $100,000 on the fees that Mazars USA LLP can charge for services on an expedited basis that are approved by the Chairman
    without obtaining full audit committee approval.</span></td></tr>
</table>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 48px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None of the non-audit
    services of either of the Company&#8217;s auditors had the pre-approval requirement waived in accordance with Rule 2-01(c)(7)(i)(C)
    of Regulation S-X.</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0"></p>

<!-- Field: Page; Sequence: 88; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->85<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a018_v1"></span>PART
IV</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a019_v1"></span>Item
15. Exhibits, Financial Statement Schedules</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 91%; text-align: justify; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 8%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>Page</b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">(<b>a)(1)
    Financial Statements annexed hereto</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><a href="#b001_v1">Report of Independent Registered Public Accounting Firm</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">F-2</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Audited
    Financial Statements:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><a href="#b002_v1">Consolidated Balance Sheets as of December 31, 2021 and 2020</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">F-5</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><a href="#b003_v1">Consolidated Statements of Income for each of the years in the three-year period ended December 31, 2021</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">F-6</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><a href="#b004_v1">Consolidated Statements of Comprehensive Income (Loss) for each of the years in the three-year period ended December 31, 2021</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">F-7</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><a href="#b005_v1">Consolidated Statements of Changes in Shareholders&#8217; Equity for each of the years in the three-year period ended December 31, 2021</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">F-8</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><a href="#b006_v1">Consolidated Statements of Cash Flows for each of the years in the three-year period ended December 31, 2021</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">F-9</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><a href="#b007_v1">Notes to Consolidated Financial Statements</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">F-10</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>(a)(2)
    Financial Statement Schedule:</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><a href="#b008_v1">Schedule II &#8211; Valuation and Qualifying Accounts</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">F-33</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>(a)(3)
    Exhibits </b>&#8211; The list of exhibits is contained in the Exhibit Index, which follows the signature page of this report.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="a020_v1"></span>Item
16. Form 10-K Summary</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 89; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->86<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin: 0">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">INTER PARFUMS,
INC. AND SUBSIDIARIES</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="a021_v1"></span>Consolidated Financial Statements and Schedule</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Index</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 95%; padding-left: 0.125in; text-indent: -0.125in"></td><td style="text-align: right; width: 5%; vertical-align: bottom"><b>Page</b></td></tr>
<tr style="vertical-align: top">
<td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="text-align: right; vertical-align: bottom">&#160;</td></tr>

<tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="width: 95%; padding-left: 0.125in; text-indent: -0.125in"><a href="#b001_v1">Report of Independent Registered Public Accounting Firm</a></td>
    <td style="width: 5%; text-align: right; vertical-align: bottom">F-2</td></tr>
<tr style="vertical-align: top; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><p style="margin: 0pt 0">(<i>Mazars USA LLP, New York, New York, PCAOB ID <span id="xdx_900_edei--AuditorFirmId_c20210101__20211231_zVxlT4H2D9i"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" name="dei:AuditorFirmId">339</ix:nonNumeric></span></i>)</p>


</td>
    <td style="text-align: right; vertical-align: bottom">&#160;</td></tr>
<tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td>
    <td style="text-align: right; vertical-align: bottom">&#160;</td></tr>
<tr style="vertical-align: top; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in">Audited Financial Statements:</td>
    <td style="text-align: right; vertical-align: bottom">&#160;</td></tr>
<tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td>
    <td style="text-align: right; vertical-align: bottom">&#160;</td></tr>

<tr style="vertical-align: top; background-color: White">
    <td style="width: 95%; padding-left: 0.25in; text-indent: -0.125in"><a href="#b002_v1">Consolidated Balance Sheets as of December&#160;31, 2021 and 2020</a></td>
    <td style="width: 5%; text-align: right; vertical-align: bottom">F-5</td></tr>

<tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td>
    <td style="text-align: right; vertical-align: bottom">&#160;</td></tr>
<tr style="vertical-align: top; background-color: White">
    <td style="width: 95%; padding-left: 0.25in; text-indent: -0.125in"><a href="#b003_v1">Consolidated Statements of Income for each of the years in the three-year period ended December&#160;31, 2021</a></td>
    <td style="width: 5%; text-align: right; vertical-align: bottom">F-6</td></tr>

<tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td>
    <td style="text-align: right; vertical-align: bottom">&#160;</td></tr>
<tr style="vertical-align: top; background-color: White">
    <td style="width: 95%; padding-left: 0.25in; text-indent: -0.125in"><a href="#b004_v1">Consolidated Statements of Comprehensive Income for each of the years in the three-year period ended December&#160;31, 2021</a></td>
    <td style="width: 5%; text-align: right; vertical-align: bottom">F-7</td></tr>

<tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td>
    <td style="text-align: right; vertical-align: bottom">&#160;</td></tr>
<tr style="vertical-align: top; background-color: White">
    <td style="width: 95%; padding-left: 0.25in; text-indent: -0.125in"><a href="#b005_v1">Consolidated Statements of Changes in Shareholders&#8217; Equity for each of the years in the three-year period ended December&#160;31, 2021</a></td>
    <td style="width: 5%; text-align: right; vertical-align: bottom">F-8</td></tr>

<tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td>
    <td style="text-align: right; vertical-align: bottom">&#160;</td></tr>
<tr style="vertical-align: top; background-color: White">
    <td style="width: 95%; padding-left: 0.25in; text-indent: -0.125in"><a href="#b006_v1">Consolidated Statements of Cash Flows for each of the years in the three-year period ended December&#160;31, 2021</a></td>
    <td style="width: 5%; text-align: right; vertical-align: bottom">F-9</td></tr>

<tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td>
    <td style="text-align: right; vertical-align: bottom">&#160;</td></tr>
<tr style="vertical-align: top; background-color: White">
    <td style="width: 95%; padding-left: 0.125in; text-indent: -0.125in"><a href="#b007_v1">Notes to Consolidated Financial Statements</a></td>
    <td style="width: 5%; text-align: right; vertical-align: bottom">F-10</td></tr>
<tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td>
    <td style="text-align: right; vertical-align: bottom">&#160;</td></tr>
<tr style="vertical-align: top; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><b>Financial Statement Schedule:</b></td>
    <td style="text-align: right; vertical-align: bottom">&#160;</td></tr>
<tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td>
    <td style="text-align: right; vertical-align: bottom">&#160;</td></tr>

<tr style="vertical-align: top; background-color: White">
    <td style="width: 95%; padding-left: 0.125in; text-indent: -0.125in"><a href="#b008_v1">Schedule II &#8211; Valuation and Qualifying Accounts</a></td>
    <td style="width: 5%; text-align: right; vertical-align: bottom">F-33</td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1in 0pt 0.25in; text-indent: -0.25in">&#160;</p>


<!-- Field: Page; Sequence: 90; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #252525">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #252525"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #252525"><b><span id="b001_v1"></span>REPORT OF INDEPENDENT
REGISTERED PUBLIC ACCOUNTING FIRM </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To Shareholders and the Board of Directors
of&#160;Inter Parfums, Inc.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Opinions on the Financial Statements
and Internal Control over Financial Reporting </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have audited the accompanying consolidated
balance sheets of Inter Parfums, Inc. (the &#8220;Company&#8221;) as of December 31, 2021 and 2020, and the related consolidated
statements of income, comprehensive income, shareholders' equity, and cash flows for each of the years in the three-year period
ended December 31, 2021, and the related notes and the schedule listed in the Index in Item 15(a)(2) (collectively referred to
as the &#8220;financial statements&#8221;). We also have audited the Company's internal control over financial reporting as of
December 31, 2021, based on criteria established in Internal Control - Integrated Framework: (2013) issued by the Committee of
Sponsoring Organizations of the Treadway Commission (COSO).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In our opinion, the consolidated financial
statements referred to above present fairly, in all material respects, the financial position of the Company as of December 31,
2021 and 2020, and the results of its operations and its cash flows for each of the years in the three-year period ended December
31, 2021, in conformity with accounting principles generally accepted in the United States of America. Also in our opinion, the
Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2021, based
on criteria established in <i>Internal Control - Integrated Framework: (2013)</i> issued by COSO.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Basis for Opinion </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company&#8217;s management is responsible
for these consolidated financial statements, for maintaining effective internal control over financial reporting, and for its assessment
of the effectiveness of internal control over financial reporting included in the accompanying Management&#8217;s Annual Report
on Internal Control over Financial Reporting. Our responsibility is to express an opinion on the Company&#8217;s consolidated financial
statements and an opinion on the Company&#8217;s internal control over financial reporting based on our audits. We are a public
accounting firm registered with the Public Company Accounting Oversight Board (United States) (&#8220;PCAOB&#8221;) and are required
to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and
regulations of the Securities and Exchange Commission and the PCAOB.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We conducted our audits in accordance with
the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether
the financial statements are free of material misstatement, whether due to error or fraud, and whether effective internal control
over financial reporting was maintained in all material respects.</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #252525"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>


<!-- Field: Page; Sequence: 91; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our audits of the consolidated financial
statements included performing procedures to assess the risks of material misstatement of the consolidated financial statements,
whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a
test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating
the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of
the consolidated financial statements. Our audit of internal control over financial reporting included obtaining an understanding
of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the
design and operating effectiveness of internal control based on the assessed risk. Our audits also included performing such other
procedures as we considered necessary in the circumstances. We believe that our audits provide a reasonable basis for our opinions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Definition and Limitations of Internal
Control over Financial Reporting </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A company&#8217;s internal control over
financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and
the preparation of consolidated financial statements for external purposes in accordance with generally accepted accounting principles.
A company&#8217;s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance
of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company;
(2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of consolidated financial statements
in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only
in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention
or timely detection of unauthorized acquisition, use, or disposition of the company&#8217;s assets that could have a material effect
on the consolidated financial statements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Because of its inherent limitations, internal
control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness
to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree
of compliance with the policies or procedures may deteriorate.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Critical Audit Matter</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The critical audit matter communicated
below is a matter arising from the current period audit of the consolidated financial statements that was communicated or required
to be communicated to the audit committee and that: (1) relates to accounts or disclosures that are material to the consolidated
financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of critical
audit matter does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not,
by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts
or disclosures to which it relates.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As described in Notes 1 and 8 to the consolidated
financial statements, the Company&#8217;s consolidated indefinite and finite &#8212;life intangible assets balance was $214 million
at December 31, 2021. Indefinite lived intangible assets principally consist of trademarks and finite-lived intangible assets represent
fees to acquire, or enter into a license.</p>

<p style="margin: 0pt 0">&#160;</p>

<p style="margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Those intangible assets are
tested for impairment as follows:</span>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in">-</td><td style="text-align: justify">Indefinite &#8211; life intangible assets are tested for impairment at least annually at the reporting
unit level or more frequently when events occur or circumstances change. The evaluation requires a comparison of the estimated
fair value of the asset to the carrying value of the asset. The fair value is estimated based upon discounted future cash flow
projections. If the carrying value of an indefinite-lived intangible asset exceeds its fair value, an impairment charge is recorded.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<!-- Field: Page; Sequence: 92; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in">-</td><td style="text-align: justify">Finite &#8211; life intangible assets are tested for impairment testing whenever events or changes in
circumstances indicate that the carrying amount of the asset may not be recoverable. If impairment indicators exist, the undiscounted
future cash flows associated with the expected service potential of the asset are compared to the carrying value of the asset.
If the projection of undiscounted cash flows is less than the carrying value of a finite-lived intangible asset, an impairment
charge would be recorded.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The determination of the future cash flows
of the intangible assets requires management to make significant estimates and assumptions related to forecasts of future revenues,
operating margins and discount rates. As disclosed by management, changes in these assumptions could have a significant impact
on the future cash flows and therefore, on the amount of any impairment charge. The determination of an impairment indicator on
the finite &#8211; life intangible assets requires management judgments and involves assumptions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We identified the impairment assessment
of intangible assets as a critical audit matter and auditing management&#8217;s judgments regarding the evaluation of impairment
indicators, forecasts of future revenue and operating margin, and the discount rate to be applied involve a high degree of subjectivity.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The primary procedures we performed to
address this critical audit matter included:</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#9658; Reviewing the analysis of the identification of impairment evidence for each indefinite and finite-life
asset based on three indicators (sales analysis, new products launches, payment of minimum guarantees), and then corroborating
that analysis with external information and evidence obtained in other areas of the audit.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#9658; Testing the effectiveness of controls relating to management&#8217;s impairment tests, including controls
over the impairment indicators and determination of the future cash flows.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#9658; In testing management&#8217;s process for determining the future cash flows we evaluated the reasonableness
of management&#8217;s forecasts of future revenue and operating margin by performing a retrospective review in comparing these
forecasts to historical operating results, evaluating whether the assumptions used were reasonable considering current information
as well as future expectations, and using additional evidence obtained in other areas of the audit.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#9658; Utilizing a valuation specialist to assist in auditing the discount rate. It includes evaluating whether
the assumptions used were reasonable by comparing to third party market data.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_908_edei--AuditorName_c20210101__20211231_z7BqhBm8QhA8"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" name="dei:AuditorName">Mazars USA LLP</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>/s/ Mazars USA LLP&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have served as the Company's auditor since 2004.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_906_edei--AuditorLocation_c20210101__20211231_zC3kOQkMY9Uc"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" name="dei:AuditorLocation">New York</ix:nonNumeric></span>, New York&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">March 1, 2022</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<!-- Field: Page; Sequence: 93; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><b>INTER PARFUMS, INC. AND SUBSIDIARIES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><span id="b002_v1"></span>Consolidated Balance Sheets</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">December&#160;31, 2021 and 2020</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(In thousands except share and per share data) &#160;</p>



<p style="margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_303_111_pn3n3_zQ4tsEq24ayh" summary="xdx: Statement - Consolidated Balance Sheets" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="font-weight: bold; padding-left: 0.125in; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49F_20211231_zGrBt8fEetod" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_495_20201231_zLgSEWzv4ide" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr id="xdx_407_eus-gaap--AssetsAbstract_iB_zivrSiRsNuwk" style="vertical-align: bottom">
    <td style="font-weight: bold; padding-left: 0.125in; text-align: center">Assets</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr id="xdx_403_eus-gaap--AssetsCurrentAbstract_i01B_uUSD_z5Npt6aqNHWc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Current assets:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_407_eus-gaap--CashCashEquivalentsAndShortTermInvestments_i02I_uUSD_maCzOtG_maACzqde_zme8UCOln5Jl" style="vertical-align: bottom; background-color: White">
    <td style="width: 72%; text-align: left; padding-left: 0.25in; text-indent: -0.125in">Cash and cash equivalents</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsAndShortTermInvestments" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">159,613</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsAndShortTermInvestments" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">169,681</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--ShortTermInvestments_i02I_uUSD_maCzOtG_maACzqde_zJqwNrhIYX1j" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Short-term investments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShortTermInvestments" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">160,014</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShortTermInvestments" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">126,627</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--AccountsReceivableNetCurrent_i02I_uUSD_maCzOtG_maACzqde_zfhTNLnjDKl7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Accounts receivable, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccountsReceivableNetCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">159,281</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccountsReceivableNetCurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">124,057</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_409_eus-gaap--InventoryNet_i02I_uUSD_maCzOtG_maACzqde_zFDwTcJGekIl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in">Inventories</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:InventoryNet" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">198,914</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:InventoryNet" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">158,822</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_406_eus-gaap--OtherReceivablesNetCurrent_i02I_uUSD_maCzOtG_maACzqde_z8BJJ1tdZut4" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Receivables, other</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OtherReceivablesNetCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">10,308</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OtherReceivablesNetCurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,815</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--OtherAssetsCurrent_i02I_uUSD_maCzOtG_maACzqde_zFKF3zydrAd3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Other current assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OtherAssetsCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">21,375</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OtherAssetsCurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">16,912</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40B_eus-gaap--IncomeTaxesReceivable_i02I_uUSD_maCzOtG_maACzqde_zNG1jvdq5mr4" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.25in; text-indent: -0.125in">Income taxes receivable</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxesReceivable" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">210</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxesReceivable" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,806</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_407_eus-gaap--AssetsCurrent_i01TI_uUSD_maAzaag_mtACzqde_zVJidPHUrvda" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.5in; text-indent: -0.125in">Total current assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">709,715</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">600,720</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_405_eus-gaap--PropertyPlantAndEquipmentNet_i01I_uUSD_maAzaag_zA52tTCkQMHd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Property, equipment and leasehold improvements, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">149,352</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">19,580</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_403_eus-gaap--OperatingLeaseRightOfUseAsset_i01I_uUSD_maCzhzt_maAzaag_zmyzup9MeF8g" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Right-of-use assets, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">33,728</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">24,734</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--IntangibleAssetsNetExcludingGoodwill_i01I_maCzhzt_maAzaag_zHqVzRguQk25" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Trademarks, licenses and other intangible assets, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">214,047</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">214,108</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_409_eus-gaap--DeferredIncomeTaxAssetsNet_i01I_maCzhzt_maAzaag_zyuTThz6noO6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Deferred tax assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredIncomeTaxAssetsNet" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,936</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredIncomeTaxAssetsNet" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8,041</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40E_eus-gaap--OtherAssetsNoncurrent_i01I_maCzhzt_maAzaag_z8q3UV41MYMl" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in">Other assets</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherAssetsNoncurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">30,586</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherAssetsNoncurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">22,962</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--Assets_iTI_mtAzaag_zMXlffkWrZg2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2pt; padding-left: 0.5in; text-indent: -0.125in">Total assets</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td style="border-bottom: Black 2pt double; text-align: right">&#160;&#160;&#160; <ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,145,364</ix:nonFraction></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td style="border-bottom: Black 2pt double; text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">890,145</ix:nonFraction></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
<tr id="xdx_400_eus-gaap--LiabilitiesAndStockholdersEquityAbstract_iB_zTHvxlEAeRg8" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: center; padding-left: 0.125in">Liabilities and Equity</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--LiabilitiesCurrentAbstract_i01B_zcDMZmUy18c5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Current liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_406_eus-gaap--LongTermDebtCurrent_i02I_maCzEz8_zOPqUh3Kqyrc" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Current portion of long-term debt</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:LongTermDebtCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">15,911</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:LongTermDebtCurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">14,570</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--OperatingLeaseLiabilityCurrent_i02I_maCzEz8_zQjibDMIAlAf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Current portion of lease liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,014</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,133</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_408_eus-gaap--AccountsPayableCurrent_i02I_maCzEz8_zAnoApLB6765" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Accounts payable - trade</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">81,980</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableCurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">35,576</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--AccruedLiabilitiesCurrent_i02I_maCzEz8_zpIHohEkzep" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Accrued expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">136,677</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">95,629</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_403_eus-gaap--DividendsPayableCurrent_i02I_maCzEz8_zpaRykq6KmN" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 1pt">Income taxes payable</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:DividendsPayableCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,328</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:DividendsPayableCurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,297</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_40E_eus-gaap--LiabilitiesCurrent_i01TI_mtCzEz8_maCzGK6_maLASEzGLt_zo8EgwVs1Dsf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.5in; text-indent: -0.125in">Total current liabilities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">244,910</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">156,205</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--LongTermDebtNoncurrent_i01I_maLASEzGLt_z9td3eDnu5o4" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in">Long&#8211;term debt, less current portion</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:LongTermDebtNoncurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">132,902</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:LongTermDebtNoncurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">10,136</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_405_eus-gaap--OperatingLeaseLiabilityNoncurrent_i01I_maLASEzGLt_zh4YUjpv0mqk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in">Lease liabilities, less current portion</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">29,220</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">21,354</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--EquityAbstract_i01B_zcWRAS7TFMBg" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in">Equity:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_408_eus-gaap--StockholdersEquityAbstract_i02B_z6gz8qABmmYf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Inter Parfums, Inc. shareholders&#8217; equity:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--PreferredStockValue_i03I_maCz3MP_maSEzHDG_maSEzgL0_zEchidlMR18k" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.375in; text-indent: -0.125in">Preferred stock, $<span id="xdx_907_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pii_uUSDPShares_c20211231_zboxMxis3Is9" title="Preferred stock, par value (in Dollars per share)"><span id="xdx_90A_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pii_uUSDPShares_c20201231_zvGHtaGCZkld" title="Preferred stock, par value (in Dollars per share)"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.001</ix:nonFraction></ix:nonFraction></span></span> par value. Authorized <span id="xdx_906_eus-gaap--PreferredStockSharesAuthorized_iI_pii_uShares_c20211231_zp0zbMifwsJh" title="Preferred stock, authorized"><span id="xdx_90B_eus-gaap--PreferredStockSharesAuthorized_iI_pii_uShares_c20201231_zp2bQ5Lp2Ulh" title="Preferred stock, authorized"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,000,000</ix:nonFraction></ix:nonFraction></span></span> shares; <span id="xdx_904_eus-gaap--PreferredStockSharesIssued_iI_pii_dn_uShares_c20211231_zSFSlQasDt3l" title="Preferred stock, issued"><span id="xdx_901_eus-gaap--PreferredStockSharesIssued_iI_pii_dn_uShares_c20201231_zZ8cmPwl623f" title="Preferred stock, issued"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2021-12-31" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2020-12-31" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares">none</ix:nonFraction></ix:nonFraction></span></span> issued</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0132">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0133">&#8212;</span></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--CommonStockValue_i03I_maCz3MP_maSEzHDG_maSEzgL0_zxQ0jFERrn29" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.375in; text-indent: -0.125in">Common stock, $<span id="xdx_90B_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pii_uUSDPShares_c20211231_z9RE1X8VWI6c" title="Common stock, par value (in Dollars per share)"><span id="xdx_90D_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pii_uUSDPShares_c20201231_zGUx1nYEawve" title="Common stock, par value (in Dollars per share)"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.001</ix:nonFraction></ix:nonFraction></span></span> par value. Authorized <span id="xdx_90F_eus-gaap--CommonStockSharesAuthorized_iI_pii_uShares_c20211231_zbQVL6Zzhugi" title="Common stock, authorized"><span id="xdx_90B_eus-gaap--CommonStockSharesAuthorized_iI_pii_uShares_c20201231_z9RHkzLYmUml" title="Common stock, authorized"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">100,000,000</ix:nonFraction></ix:nonFraction></span></span> shares; outstanding, <span id="xdx_90C_eus-gaap--CommonStockSharesOutstanding_iI_pid_uShares_c20211231_zvlNLAM1BF2" title="Common stock, outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">31,830,420</ix:nonFraction></span> and <span id="xdx_902_eus-gaap--CommonStockSharesOutstanding_iI_pid_uShares_c20201231_zmVOQPT9qGSd" title="Common stock, outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">31,608,588</ix:nonFraction></span> shares at December 31, 2021 and 2020, respectively</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">32</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">32</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_409_eus-gaap--AdditionalPaidInCapital_i03I_maCz7zj_maSEzgL0_zKLrATGrYBQa" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.375in; text-indent: -0.125in">Additional paid-in capital</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">87,132</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">75,708</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_408_eus-gaap--RetainedEarningsAccumulatedDeficit_i03I_maCz7zj_maSEzgL0_zu5yAWlsKYp3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.375in; text-indent: -0.125in">Retained earnings</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">560,663</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">503,567</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_i03I_maCz7zj_maSEzgL0_zhmKz36fjUXg" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.375in; text-indent: -0.125in">Accumulated other comprehensive loss</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">38,432</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">5,997</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr id="xdx_407_eus-gaap--TreasuryStockValue_i03NI_di_msSEzHDG_msSEzgL0_zmav5SVac5ta" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.375in; text-indent: -0.125in">Treasury stock, at cost, <span id="xdx_901_eus-gaap--TreasuryStockShares_iI_pii_uShares_c20211231_zbxp1NvlSBBe"><span id="xdx_90B_eus-gaap--TreasuryStockShares_iI_pii_uShares_c20201231_zADxOS62MTl"><ix:nonFraction name="us-gaap:TreasuryStockShares" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:TreasuryStockShares" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">9,864,805</ix:nonFraction></ix:nonFraction></span></span> common shares at December 31, 2021 and 2020</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:TreasuryStockValue" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">37,475</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:TreasuryStockValue" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">37,475</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr id="xdx_404_eus-gaap--StockholdersEquity_i03TI_mtSEzgL0_maSEIPAz88W_zKmKTT9eg6G6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.5in; text-indent: -0.125in">Total Inter Parfums, Inc. shareholders&#8217; equity</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">571,920</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">535,835</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_409_eus-gaap--MinorityInterest_i03I_maSEIPAz88W_zhG8oCFHXBw5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.25in; text-indent: -0.125in">Noncontrolling interest</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:MinorityInterest" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">166,412</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:MinorityInterest" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">166,615</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_i01TI_mtSEIPAz88W_maLASEzGLt_z7tBCH2lD8mi" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.5in; text-indent: -0.125in">Total equity</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">738,332</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">702,450</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_401_eus-gaap--LiabilitiesAndStockholdersEquity_iTI_mtLASEzGLt_z4fWvXbPL1dd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2pt; padding-left: 0.5in; text-indent: -0.125in">Total liabilities and equity</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td style="border-bottom: Black 2pt double; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,145,364</ix:nonFraction></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td style="border-bottom: Black 2pt double; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">890,145</ix:nonFraction></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
</table>



<p style="margin: 0">&#160;</p>

<p style="margin: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">See accompanying notes to consolidated financial statements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<!-- Field: Page; Sequence: 94; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>INTER PARFUMS, INC. AND SUBSIDIARIES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span id="b003_v1"></span><span style="font-size: 10pt">Consolidated
Statements of Income</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">Years
ended December&#160;31, 2021, 2020, and 2019</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(In thousands except share and per share data) &#160;</p>



<p style="margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_307_113_pn3n3_zgUIcfukL0ej" summary="xdx: Statement - Consolidated Statements of Income" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="text-align: center; vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49F_20210101__20211231_zBqz2rKdYWV2" style="border-bottom: Black 1pt solid; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_496_20200101__20201231_zP4cLd9ZTFpe" style="border-bottom: Black 1pt solid; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_493_20190101__20191231_zFwZOrKejl76" style="border-bottom: Black 1pt solid; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="text-align: center; vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold">2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold">2019</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
<tr id="xdx_402_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_maGPzPk4_zda0cnr9UDYe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left; padding-left: 0.125in; text-indent: -0.125in">Net sales</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">879,516</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">539,009</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">713,514</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_40B_eus-gaap--CostOfGoodsAndServicesSold_msGPzPk4_zDRbvqqWSfJc" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in">Cost of sales</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:CostOfGoodsAndServicesSold" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">322,614</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:CostOfGoodsAndServicesSold" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">208,278</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:CostOfGoodsAndServicesSold" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">267,578</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_408_eus-gaap--GrossProfit_iT_mtGPzPk4_maOILzrkX_zJjnU2lZ7Dbb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.5in; text-indent: -0.125in">Gross margin</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:GrossProfit" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">556,902</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:GrossProfit" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">330,731</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:GrossProfit" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">445,936</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_401_eus-gaap--SellingGeneralAndAdministrativeExpense_msOILzrkX_zmFUNS4RD581" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Selling, general, and administrative expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:SellingGeneralAndAdministrativeExpense" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">406,459</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:SellingGeneralAndAdministrativeExpense" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">260,648</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:SellingGeneralAndAdministrativeExpense" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">341,209</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--ImpairmentOfLeasehold_msOILzrkX_zrFMjLNloshk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in">Impairment loss</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ImpairmentOfLeasehold" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,393</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0205">&#8212;</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0206">&#8212;</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--OperatingIncomeLoss_iT_mtOILzrkX_zLtAXHoCLVue" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.5in; text-indent: -0.125in">Income from operations</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">148,050</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">70,083</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">104,727</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--NonoperatingIncomeExpenseAbstract_iB_zmj5TNU2j4kb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Other expenses (income):</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_406_eus-gaap--InterestExpense_i01_msNIEzbAL_zu8eywPbruBj" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Interest expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <ix:nonFraction name="us-gaap:InterestExpense" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,825</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:InterestExpense" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,970</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:InterestExpense" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,146</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_401_eus-gaap--ForeignCurrencyTransactionGainLossBeforeTax_i01N_di_maNIEzbAL_z0lVqbqRvWdh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">(Gain) loss on foreign currency</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,338</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">2,178</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1,128</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--InvestmentIncomeInterestAndDividend_i01N_di_maNIEzbAL_z2HoaD35Jfcg" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Interest and investment income</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:InvestmentIncomeInterestAndDividend" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,403</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:InvestmentIncomeInterestAndDividend" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,865</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:InvestmentIncomeInterestAndDividend" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,693</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr id="xdx_402_eus-gaap--OtherIncome_i01N_di_maNIEzbAL_zYmZDzbKCwka" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.25in; text-indent: -0.125in">Other income</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:OtherIncome" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">53</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:OtherIncome" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">549</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0230">&#8212;</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_407_eus-gaap--NonoperatingIncomeExpense_i01NT_di_mtNIEzbAL_z3yoW4hk7Pd9" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt"><span style="color: White">&#160;Other expenses (income)</span></td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,969</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">734</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">419</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_407_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_maPLzG2A_zwhGc4qsCvS4" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Income before income taxes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">151,019</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">69,349</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">105,146</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_401_eus-gaap--IncomeTaxExpenseBenefit_msPLzG2A_zZdAQQoobON2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in">Income taxes</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">40,992</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">19,381</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">29,076</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_409_eus-gaap--ProfitLoss_iT_mtPLzG2A_maNILzJnj_zoL5TOBRvLgi" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.5in; text-indent: -0.125in">Net income</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">110,027</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">49,968</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">76,070</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_400_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_msNILzJnj_zVmaZ8DLnYgb" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.5in; text-indent: -0.5in">Less: Net income attributable
    to the noncontrolling interest</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">22,616</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">11,749</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">15,821</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_409_eus-gaap--NetIncomeLoss_iT_mtNILzJnj_zKsKsMj4L0i" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2pt; padding-left: 0.125in; text-indent: -0.125in">Net income attributable to Inter Parfums, Inc.</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td style="border-bottom: Black 2pt double; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">87,411</ix:nonFraction></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td style="border-bottom: Black 2pt double; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">38,219</ix:nonFraction></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td style="border-bottom: Black 2pt double; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">60,249</ix:nonFraction></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
<tr id="xdx_400_eus-gaap--EarningsPerShareBasicAndDilutedAbstract_iB_zBnSi7N0199c" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Net income attributable to Inter Parfums, Inc. common shareholders:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--EarningsPerShareBasic_i01_pid_z1c6Tp9kN8ah" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in">Basic</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">2.76</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.21</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.92</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_408_eus-gaap--EarningsPerShareDiluted_i01_pid_zbBHo74htwv7" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.25in; text-indent: -0.125in">Diluted</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">2.75</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.21</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.90</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40E_eus-gaap--WeightedAverageNumberOfSharesOutstandingAbstract_iB_zoY0iV3kbA75" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">Weighted average number of shares outstanding:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_403_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_i01_pid_z89r13No2zQg" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.25in; text-indent: -0.125in">Basic</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">31,676,796</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">31,536,659</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">31,451,093</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_401_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_i01_pid_zqujiGgdCdni" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in">Diluted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">31,835,408</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">31,654,544</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">31,688,700</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40B_eus-gaap--CommonStockDividendsPerShareDeclared_pid_z0Kd79MDJVia" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">Dividends declared per share</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CommonStockDividendsPerShareDeclared" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.00</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CommonStockDividendsPerShareDeclared" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.33</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CommonStockDividendsPerShareDeclared" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.16</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
</table>



<p style="margin: 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 10pt">See accompanying notes to consolidated financial statements.</span></p>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<!-- Field: Page; Sequence: 95; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>INTER PARFUMS, INC. AND SUBSIDIARIES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="b004_v1"></span>Consolidated Statements
of Comprehensive Income</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Years ended December&#160;31, 2021, 2020,
and 2019</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(In thousands except share and per share
data)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_307_123_pn3n3_ztqwwKMkThdg" summary="xdx: Statement - Consolidated Statements of Comprehensive Income" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="text-align: center; vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49F_20210101__20211231_zKjWxXnIgexl" style="border-bottom: Black 1pt solid; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49C_20200101__20201231_zkKfJYkSvcW" style="border-bottom: Black 1pt solid; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_496_20190101__20191231_zjYexZMPHpdh" style="border-bottom: Black 1pt solid; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="text-align: center; vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold">2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold">2019</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
<tr id="xdx_400_eus-gaap--ProfitLoss_zTkuFBcE6LY4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; font-weight: bold; text-align: left; padding-bottom: 1pt; text-indent: -0.125in; padding-left: 0.125in">Net income</td><td style="width: 1%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 10%; text-align: right"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">110,027</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 10%; text-align: right"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">49,968</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 10%; text-align: right"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">76,070</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; padding-left: 0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_iB_zjIgfieb1NF4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; text-indent: -0.125in; padding-left: 0.125in">Other comprehensive income:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40E_eus-gaap--OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax_i01_znrcRyio5tZ4" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.25in">Net derivative instrument income (loss), net of tax</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1,367</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">19</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">22</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_i01_ziv4Pvah5EX7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.25in">Transfer of OCI into earnings</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0296">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">52</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">136</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr id="xdx_40E_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_i01_zfVUiCz33UW4" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -0.125in; padding-left: 0.25in">Translation adjustments, net of tax</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">42,967</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">47,912</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">8,712</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr id="xdx_40B_eus-gaap--OtherComprehensiveIncomeLossBeforeTax_i01_zQFzx49B5Bod" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td id="xdx_829_z7DPGSGyHPwf" style="padding-bottom: 1pt; text-indent: -0.125in; padding-left: 0.125in; display: none; visibility: hidden">Other Comprehensive Income (Loss), before Tax</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossBeforeTax" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">44,334</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossBeforeTax" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">47,841</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossBeforeTax" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">8,826</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr id="xdx_40B_eus-gaap--ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_i01_maCINOTzXLB_zbLwwdye0D68" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt; text-indent: -0.125in; padding-left: 0.125in">Comprehensive income</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">65,693</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">97,809</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">67,244</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_400_eus-gaap--ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterestAbstract_iB_zJ6Kd17ZhZZa" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; text-indent: -0.125in; padding-left: 0.125in">Comprehensive income attributable to noncontrolling interests:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_407_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_i01_maCINOTzcJ2_zyLtm6Hjr3v6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.25in">Net income</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">22,616</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">11,749</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">15,821</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_409_eus-gaap--OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToNoncontrollingInterest_i01_maCINOTzcJ2_zYbxwH7tFZgh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.25in">Net derivative instrument loss, net of tax</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToNoncontrollingInterest" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">375</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToNoncontrollingInterest" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">19</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToNoncontrollingInterest" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">30</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr id="xdx_401_eus-gaap--OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest_i01_maCINOTzcJ2_zfwqkD22H1x5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -0.125in; padding-left: 0.25in">Translation adjustments, net of tax</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">11,524</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">14,004</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">2,593</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr id="xdx_40B_eus-gaap--ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_i01T_mtCINOTzcJ2_msCINOTzXLB_zFXvj85RONz8" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; text-indent: -0.125in; padding-left: 0.125in; display: none; visibility: hidden">Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">10,717</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">25,734</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">13,198</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_409_eus-gaap--ComprehensiveIncomeNetOfTax_i01T_mtCINOTzXLB_zF3UZye5ZvSh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2pt; text-indent: -0.125in; padding-left: 0.125in">Comprehensive income attributable to Inter Parfums Inc.</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td style="border-bottom: Black 2pt double; text-align: right"><ix:nonFraction name="us-gaap:ComprehensiveIncomeNetOfTax" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">54,976</ix:nonFraction></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td style="border-bottom: Black 2pt double; text-align: right"><ix:nonFraction name="us-gaap:ComprehensiveIncomeNetOfTax" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">72,075</ix:nonFraction></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td style="border-bottom: Black 2pt double; text-align: right"><ix:nonFraction name="us-gaap:ComprehensiveIncomeNetOfTax" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">54,046</ix:nonFraction></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
</table>


<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">See accompanying notes to consolidated financial statements.</p>



<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<!-- Field: Page; Sequence: 96; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><b>INTER
PARFUMS, INC. AND SUBSIDIARIES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span id="b005_v1"></span><span style="font-size: 10pt">Consolidated
Statements of Changes in Shareholders&#8217; Equity</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">Years
ended December&#160;31, 2021, 2020, and 2019</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(In thousands except share and per share data) &#160;</p>



<p style="margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_308_114_pn3n3_zFytyholedo4" summary="xdx: Statement - Consolidated Statements of Changes in Shareholders&apos; Equity" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="text-align: right">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: right">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; font-weight: bold; text-align: left">Common stock, beginning of year</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zGxO9gOQtnI9" title="Beginning Balance" style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2020-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">32</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zERKRq3pON12" title="Beginning Balance" style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2019-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">31</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_c20190101__20191231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zsikd12l1BQ3" title="Beginning Balance" style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2018-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">31</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">&#160;&#160;&#160;&#160;&#160;&#160;Shares issued upon exercise of stock
    options</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--StockIssuedDuringPeriodValueStockOptionsExercised_d0_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zp9LMDiDxCzi" title="Shares issued upon exercise of stock options" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2021-01-012021-12-31_us-gaap_CommonStockMember" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8212;</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--StockIssuedDuringPeriodValueStockOptionsExercised_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zfe1A9alF28i" title="Shares issued upon exercise of stock options" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2020-01-012020-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--StockIssuedDuringPeriodValueStockOptionsExercised_d0_c20190101__20191231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zN2tfA3Wqv11" title="Shares issued upon exercise of stock options" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2019-01-012019-12-31_us-gaap_CommonStockMember" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8212;</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">Common stock, end of year</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iE_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zdhwwUsi1ZYc" title="Ending Balance" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">32</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iE_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zHDEKUmPM1b3" title="Ending Balance" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2020-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">32</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iE_c20190101__20191231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zDNtwc9ix3ja" title="Ending Balance" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2019-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">31</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Additional paid-in capital, beginning of year</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--AdditionalPaidInCapitalMember_znKLdKiADh04" title="Beginning Balance" style="text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2020-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">75,708</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--AdditionalPaidInCapitalMember_zL2mZ7MSNvc8" title="Beginning Balance" style="text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2019-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">70,664</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_pn3n3_c20190101__20191231__us-gaap--StatementEquityComponentsAxis__us-gaap--AdditionalPaidInCapitalMember_zkp0dn4OLka6" title="Beginning Balance" style="text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2018-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">69,970</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in">Shares issued upon exercise of stock options</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--StockIssuedDuringPeriodValueStockOptionsExercised_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--AdditionalPaidInCapitalMember_zqLFIrILlFbi" title="Shares issued upon exercise of stock options" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2021-01-012021-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,393</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--StockIssuedDuringPeriodValueStockOptionsExercised_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--AdditionalPaidInCapitalMember_zE9osLB02HAb" title="Shares issued upon exercise of stock options" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2020-01-012020-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,771</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--StockIssuedDuringPeriodValueStockOptionsExercised_pn3n3_c20190101__20191231__us-gaap--StatementEquityComponentsAxis__us-gaap--AdditionalPaidInCapitalMember_zpo8PzRUGkNh" title="Shares issued upon exercise of stock options" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2019-01-012019-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,458</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; padding-left: 0.125in">Share-based compensation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--StockIssuedDuringPeriodValueShareBasedCompensation_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--AdditionalPaidInCapitalMember_zINZIEAXkpg5" title="Share-based compensation (adjustment)" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2021-01-012021-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,566</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--StockIssuedDuringPeriodValueShareBasedCompensation_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--AdditionalPaidInCapitalMember_zGd1GDkRkyFh" title="Share-based compensation (adjustment)" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2020-01-012020-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,711</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--StockIssuedDuringPeriodValueShareBasedCompensation_pn3n3_c20190101__20191231__us-gaap--StatementEquityComponentsAxis__us-gaap--AdditionalPaidInCapitalMember_z2qsbkw7LKYi" title="Share-based compensation (adjustment)" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2019-01-012019-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,403</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; padding-left: 0.125in">Purchase of subsidiary shares from noncontrolling interests</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance_iN_di0_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--AdditionalPaidInCapitalMember_zFUREfPoKsFd" title="Purchase of subsidiary shares from noncontrolling interests" style="text-align: right"><ix:nonFraction name="us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance" contextRef="From2021-01-012021-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:zerodash" decimals="-3" scale="3" sign="-" unitRef="USD">&#8212;</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance_iN_di0_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--AdditionalPaidInCapitalMember_zhDPevFFX4ak" title="Purchase of subsidiary shares from noncontrolling interests" style="text-align: right"><ix:nonFraction name="us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance" contextRef="From2020-01-012020-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:zerodash" decimals="-3" scale="3" sign="-" unitRef="USD">&#8212;</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance_iN_di_c20190101__20191231__us-gaap--StatementEquityComponentsAxis__us-gaap--AdditionalPaidInCapitalMember_zqNk3j6EaFga" title="Purchase of subsidiary shares from noncontrolling interests" style="text-align: right">(<ix:nonFraction name="us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance" contextRef="From2019-01-012019-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,167</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; padding-left: 0.125in">Shares issued for license acquisition</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--StockIssuedDuringPeriodValueAcquisitions_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--AdditionalPaidInCapitalMember_zudDTJgV26Sa" title="Shares issued for license acquisition" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" contextRef="From2021-01-012021-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--StockIssuedDuringPeriodValueAcquisitions_d0_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--AdditionalPaidInCapitalMember_zW1U3UrqKb9f" title="Shares issued for license acquisition" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" contextRef="From2020-01-012020-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8212;</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--StockIssuedDuringPeriodValueAcquisitions_d0_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--AdditionalPaidInCapitalMember_zPnJhBBIydki" title="Shares issued for license acquisition" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" contextRef="From2020-01-012020-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8212;</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; padding-left: 0.125in">Transfer of subsidiary shares purchased</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_ecustom--TransferOfSubsidiarySharesPurchasedToTreasuryShares_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--AdditionalPaidInCapitalMember_z20SGo1lFMxa" title="Transfer of subsidiary shares purchased" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="ipar:TransferOfSubsidiarySharesPurchasedToTreasuryShares" contextRef="From2021-01-012021-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">535</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_984_ecustom--TransferOfSubsidiarySharesPurchasedToTreasuryShares_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--AdditionalPaidInCapitalMember_zxvjLlK3VCti" title="Transfer of subsidiary shares purchased" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ipar:TransferOfSubsidiarySharesPurchasedToTreasuryShares" contextRef="From2020-01-012020-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">562</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98F_ecustom--TransferOfSubsidiarySharesPurchasedToTreasuryShares_d0_c20190101__20191231__us-gaap--StatementEquityComponentsAxis__us-gaap--AdditionalPaidInCapitalMember_zlUsPUyHb6Uh" title="Transfer of subsidiary shares purchased" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ipar:TransferOfSubsidiarySharesPurchasedToTreasuryShares" contextRef="From2019-01-012019-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8212;</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">Additional paid-in capital, end of year</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iE_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--AdditionalPaidInCapitalMember_z5VoCk3pHGua" title="Ending Balance" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">87,132</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iE_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--AdditionalPaidInCapitalMember_zcrOpdkfXvoc" title="Ending Balance" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2020-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">75,708</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iE_c20190101__20191231__us-gaap--StatementEquityComponentsAxis__us-gaap--AdditionalPaidInCapitalMember_zLdpEBKyQbgj" title="Ending Balance" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2019-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">70,664</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Retained earnings, beginning of year</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember_zHMsXG6FAzXf" title="Beginning Balance" style="text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2020-12-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">503,567</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember_zgyPdwwoRuV3" title="Beginning Balance" style="text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2019-12-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">474,637</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_c20190101__20191231__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember_zCKsMvZvw4Ya" title="Beginning Balance" style="text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2018-12-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">448,731</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt">Net income</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ProfitLoss_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember_zZdEHl7AtYae" title="Net income" style="text-align: right"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2021-01-012021-12-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">87,411</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ProfitLoss_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember_z52pWdAeJw75" title="Net income" style="text-align: right"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2020-01-012020-12-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">38,219</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ProfitLoss_c20190101__20191231__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember_zEsORfnF0gTd" title="Net income" style="text-align: right"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2019-01-012019-12-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">60,249</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt">Dividends</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--DividendsCash_iN_di_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember_zR4RL3NmPSV9" title="Dividends, Cash" style="text-align: right">(<ix:nonFraction name="us-gaap:DividendsCash" contextRef="From2021-01-012021-12-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">31,690</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--DividendsCash_iN_di_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember_zGLR3PgWFoYa" title="Dividends, Cash" style="text-align: right">(<ix:nonFraction name="us-gaap:DividendsCash" contextRef="From2020-01-012020-12-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">10,406</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--DividendsCash_iN_di_c20190101__20191231__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember_zQCqC0VDlHn2" title="Dividends, Cash" style="text-align: right">(<ix:nonFraction name="us-gaap:DividendsCash" contextRef="From2019-01-012019-12-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">36,349</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 10pt">Share-based compensation</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--StockIssuedDuringPeriodValueShareBasedCompensation_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember_zK2W9kpkhSU8" title="Share-based compensation (adjustment)" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2021-01-012021-12-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,375</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--StockIssuedDuringPeriodValueShareBasedCompensation_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember_znmdMDnLx8ga" title="Share-based compensation (adjustment)" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2020-01-012020-12-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,117</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--StockIssuedDuringPeriodValueShareBasedCompensation_c20190101__20191231__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember_z2vnR7HSJcHh" title="Share-based compensation (adjustment)" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2019-01-012019-12-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,006</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">Retained earnings, end of year</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iE_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember_zlVqpFc5GCWi" title="Ending Balance" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-12-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">560,663</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iE_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember_zIgfyq3CKwqj" title="Ending Balance" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2020-12-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">503,567</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iE_c20190101__20191231__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember_zzxEcm01th7c" title="Ending Balance" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2019-12-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">474,637</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; text-indent: -9pt; padding-left: 9pt">Accumulated other comprehensive loss, beginning of year</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedOtherComprehensiveIncomeMember_zGm4d7fMit15" title="Beginning Balance" style="text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2020-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">5,997</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedOtherComprehensiveIncomeMember_zO7F7ppwCb0c" title="Beginning Balance" style="text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2019-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">39,853</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_c20190101__20191231__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedOtherComprehensiveIncomeMember_zBKpaJKgaDNj" title="Beginning Balance" style="text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2018-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">33,650</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; padding-left: 0.125in">Foreign currency translation adjustment, net of tax</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedOtherComprehensiveIncomeMember_zq08VzHt2HU2" title="Foreign currency translation adjustment, net of tax" style="text-align: right">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax" contextRef="From2021-01-012021-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">31,443</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedOtherComprehensiveIncomeMember_zricZZfpm9vh" title="Foreign currency translation adjustment, net of tax" style="text-align: right"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax" contextRef="From2020-01-012020-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">33,908</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax_c20190101__20191231__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedOtherComprehensiveIncomeMember_z114IAIXc317" title="Foreign currency translation adjustment, net of tax" style="text-align: right">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax" contextRef="From2019-01-012019-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">6,119</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; padding-left: 0.125in">Transfer from other comprehensive income into earnings</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax_d0_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedOtherComprehensiveIncomeMember_zWyu8hvYOvij" title="Transfer from other comprehensive income into earnings" style="text-align: right"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax" contextRef="From2021-01-012021-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8212;</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedOtherComprehensiveIncomeMember_zA1B38AtqCPk" title="Transfer from other comprehensive income into earnings" style="text-align: right">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax" contextRef="From2020-01-012020-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">52</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax_c20190101__20191231__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedOtherComprehensiveIncomeMember_zB0WzYdPI4S4" title="Transfer from other comprehensive income into earnings" style="text-align: right">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax" contextRef="From2019-01-012019-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">136</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in">Net derivative instrument gain (loss), net of tax</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToNoncontrollingInterest_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedOtherComprehensiveIncomeMember_z776e02H6NKc" title="Net derivative instrument loss, net of tax" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToNoncontrollingInterest" contextRef="From2021-01-012021-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">992</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToNoncontrollingInterest_d0_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedOtherComprehensiveIncomeMember_zjmkRQGbA053" title="Net derivative instrument loss, net of tax" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToNoncontrollingInterest" contextRef="From2020-01-012020-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8212;</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToNoncontrollingInterest_c20190101__20191231__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedOtherComprehensiveIncomeMember_zdESyZ85lakf" title="Net derivative instrument loss, net of tax" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToNoncontrollingInterest" contextRef="From2019-01-012019-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">52</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt; text-indent: -9pt; padding-left: 9pt">Accumulated other comprehensive loss, end of year</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iE_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedOtherComprehensiveIncomeMember_zSeZsfGiyY2g" title="Ending Balance" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">38,432</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iE_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedOtherComprehensiveIncomeMember_zIDBONEdz0Ue" title="Ending Balance" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2020-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">5,997</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iE_c20190101__20191231__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedOtherComprehensiveIncomeMember_zGkvi7abhpP7" title="Ending Balance" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2019-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">39,853</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255); visibility: hidden">
    <td style="display: none; font-weight: bold; text-align: left; padding-bottom: 1pt; visibility: hidden">Treasury stock, beginning and end of year</td><td style="display: none; padding-bottom: 1pt; visibility: hidden">&#160;</td>
    <td style="border-bottom: Black 1pt solid; display: none; text-align: left; visibility: hidden">&#160;</td><td id="xdx_98B_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--TreasuryStockMember_zAsSu0f1jOib" title="Beginning Balance" style="border-bottom: Black 1pt solid; display: none; text-align: right; visibility: hidden">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2020-12-31_us-gaap_TreasuryStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">37,475</ix:nonFraction></td><td style="display: none; padding-bottom: 1pt; text-align: left; visibility: hidden">)</td><td style="display: none; padding-bottom: 1pt; visibility: hidden">&#160;</td>
    <td style="border-bottom: Black 1pt solid; display: none; text-align: left; visibility: hidden">&#160;</td><td id="xdx_980_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--TreasuryStockMember_zHyjDm6kP3ui" title="Beginning Balance" style="border-bottom: Black 1pt solid; display: none; text-align: right; visibility: hidden">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2019-12-31_us-gaap_TreasuryStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">37,475</ix:nonFraction></td><td style="display: none; padding-bottom: 1pt; text-align: left; visibility: hidden">)</td><td style="display: none; padding-bottom: 1pt; visibility: hidden">&#160;</td>
    <td style="border-bottom: Black 1pt solid; display: none; text-align: left; visibility: hidden">&#160;</td><td id="xdx_984_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_c20190101__20191231__us-gaap--StatementEquityComponentsAxis__us-gaap--TreasuryStockMember_zNJdTxj22D8k" title="Beginning Balance" style="border-bottom: Black 1pt solid; display: none; text-align: right; visibility: hidden">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2018-12-31_us-gaap_TreasuryStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">37,475</ix:nonFraction></td><td style="display: none; padding-bottom: 1pt; text-align: left; visibility: hidden">)</td></tr>
<tr style="display: none; visibility: hidden; vertical-align: bottom; background-color: White">
    <td style="display: none; visibility: hidden; vertical-align: middle; text-align: left">Net income</td><td style="display: none; visibility: hidden">&#160;</td>
    <td style="display: none; visibility: hidden; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ProfitLoss_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--TreasuryStockMember_ziKbN0PLrQya" style="display: none; visibility: hidden; text-align: right">-<span style="-sec-ix-hidden: xdx2ixbrl0461">&#160;</span></td><td style="display: none; visibility: hidden; text-align: left">&#160;</td><td style="display: none; visibility: hidden">&#160;</td>
    <td style="display: none; visibility: hidden; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ProfitLoss_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--TreasuryStockMember_zvlEUCMBSlSf" style="display: none; visibility: hidden; text-align: right">-<span style="-sec-ix-hidden: xdx2ixbrl0462">&#160;</span></td><td style="display: none; visibility: hidden; text-align: left">&#160;</td><td style="display: none; visibility: hidden">&#160;</td>
    <td style="display: none; visibility: hidden; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ProfitLoss_c20190101__20191231__us-gaap--StatementEquityComponentsAxis__us-gaap--TreasuryStockMember_z8FQZ04PqiXc" style="display: none; visibility: hidden; text-align: right">-<span style="-sec-ix-hidden: xdx2ixbrl0463">&#160;</span></td><td style="display: none; visibility: hidden; text-align: left">&#160;</td></tr>
<tr style="visibility: hidden; vertical-align: bottom; background-color: White">
    <td style="visibility: hidden; vertical-align: middle; text-align: left"><b style="visibility: hidden">Treasury stock, beginning and end of year</b></td><td style="visibility: hidden">&#160;</td>
    <td style="visibility: hidden; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iE_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--TreasuryStockMember_zedPFhWdQlta" title="Ending Balance" style="visibility: hidden; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-12-31_us-gaap_TreasuryStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">37,475</ix:nonFraction></td><td style="visibility: hidden; text-align: left">)</td><td style="visibility: hidden">&#160;</td>
    <td style="visibility: hidden; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iE_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--TreasuryStockMember_zBTDFUy8etub" title="Ending Balance" style="visibility: hidden; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2020-12-31_us-gaap_TreasuryStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">37,475</ix:nonFraction></td><td style="visibility: hidden; text-align: left">)</td><td style="visibility: hidden">&#160;</td>
    <td style="visibility: hidden; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iE_c20190101__20191231__us-gaap--StatementEquityComponentsAxis__us-gaap--TreasuryStockMember_zTuvzp1ey7p4" title="Ending Balance" style="visibility: hidden; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2019-12-31_us-gaap_TreasuryStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">37,475</ix:nonFraction></td><td style="visibility: hidden; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Noncontrolling interest, beginning of year</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--NoncontrollingInterestMember_zS6hCCUb9Rj7" title="Beginning Balance" style="text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2020-12-31_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">166,615</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--NoncontrollingInterestMember_zWLc3c2dVbNc" title="Beginning Balance" style="text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2019-12-31_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">140,994</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_c20190101__20191231__us-gaap--StatementEquityComponentsAxis__us-gaap--NoncontrollingInterestMember_zO5mQa4OMZzb" title="Beginning Balance" style="text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2018-12-31_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">138,139</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; padding-left: 0.125in">Net income</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ProfitLoss_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--NoncontrollingInterestMember_zLf9vUD1LX45" title="Net income" style="text-align: right"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2021-01-012021-12-31_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">22,616</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ProfitLoss_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--NoncontrollingInterestMember_zw1UWm3AfiHf" title="Net income" style="text-align: right"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2020-01-012020-12-31_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">11,749</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ProfitLoss_c20190101__20191231__us-gaap--StatementEquityComponentsAxis__us-gaap--NoncontrollingInterestMember_zvWe8MziQoOa" title="Net income" style="text-align: right"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2019-01-012019-12-31_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">15,821</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; padding-left: 0.125in">Foreign currency translation adjustment, net of tax</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--NoncontrollingInterestMember_zCQX2gFsRTch" title="Foreign currency translation adjustment, net of tax" style="text-align: right">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax" contextRef="From2021-01-012021-12-31_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">11,524</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--NoncontrollingInterestMember_zVhXDS6vL81b" title="Foreign currency translation adjustment, net of tax" style="text-align: right"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax" contextRef="From2020-01-012020-12-31_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">14,004</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax_c20190101__20191231__us-gaap--StatementEquityComponentsAxis__us-gaap--NoncontrollingInterestMember_zBUz6lS3u8yk" title="Foreign currency translation adjustment, net of tax" style="text-align: right">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax" contextRef="From2019-01-012019-12-31_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">2,593</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; padding-left: 0.125in">Net derivative instrument loss, net of tax</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToNoncontrollingInterest_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--NoncontrollingInterestMember_zYzvfUzJiDCi" title="Net derivative instrument loss, net of tax" style="text-align: right">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToNoncontrollingInterest" contextRef="From2021-01-012021-12-31_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">375</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToNoncontrollingInterest_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--NoncontrollingInterestMember_zjbP27emCBM2" title="Net derivative instrument loss, net of tax" style="text-align: right">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToNoncontrollingInterest" contextRef="From2020-01-012020-12-31_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">19</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToNoncontrollingInterest_c20190101__20191231__us-gaap--StatementEquityComponentsAxis__us-gaap--NoncontrollingInterestMember_zxaaGnbdKYlk" title="Net derivative instrument loss, net of tax" style="text-align: right">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToNoncontrollingInterest" contextRef="From2019-01-012019-12-31_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">30</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; padding-left: 0.125in">Purchase of subsidiary shares from noncontrolling interests</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance_iN_di0_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--NoncontrollingInterestMember_zwoubxy4s3Q4" title="Purchase of subsidiary shares from noncontrolling interests" style="text-align: right"><ix:nonFraction name="us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance" contextRef="From2021-01-012021-12-31_us-gaap_NoncontrollingInterestMember" format="ixt:zerodash" decimals="-3" scale="3" sign="-" unitRef="USD">&#8212;</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance_iN_di0_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--NoncontrollingInterestMember_zZTYlJgweSq" style="text-align: right"><ix:nonFraction name="us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance" contextRef="From2020-01-012020-12-31_us-gaap_NoncontrollingInterestMember" format="ixt:zerodash" decimals="-3" scale="3" sign="-" unitRef="USD">&#8212;</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance_iN_di0_c20190101__20191231__us-gaap--StatementEquityComponentsAxis__us-gaap--NoncontrollingInterestMember_zxVHYEsJFgSk" style="text-align: right">(<ix:nonFraction name="us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance" contextRef="From2019-01-012019-12-31_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">920</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in">Dividends</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--DividendsCash_iN_di_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--NoncontrollingInterestMember_zgp5mJH8nUMf" title="Dividends" style="text-align: right">(<ix:nonFraction name="us-gaap:DividendsCash" contextRef="From2021-01-012021-12-31_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9,836</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--DividendsCash_iN_di_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--NoncontrollingInterestMember_z9Nt5InvZpwd" title="Dividends" style="text-align: right">(<ix:nonFraction name="us-gaap:DividendsCash" contextRef="From2020-01-012020-12-31_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">324</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--DividendsCash_iN_di_c20190101__20191231__us-gaap--StatementEquityComponentsAxis__us-gaap--NoncontrollingInterestMember_zna3viXOpQi5" title="Dividends" style="text-align: right">(<ix:nonFraction name="us-gaap:DividendsCash" contextRef="From2019-01-012019-12-31_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9,654</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; padding-left: 0.125in">Share-based compensation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--StockIssuedDuringPeriodValueShareBasedCompensation_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--NoncontrollingInterestMember_zwjRPUXyfpk8" title="Share-based compensation (adjustment)" style="text-align: right">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2021-01-012021-12-31_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">293</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--StockIssuedDuringPeriodValueShareBasedCompensation_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--NoncontrollingInterestMember_zuus33PnEmt" title="Share-based compensation (adjustment)" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2020-01-012020-12-31_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">350</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--StockIssuedDuringPeriodValueShareBasedCompensation_c20190101__20191231__us-gaap--StatementEquityComponentsAxis__us-gaap--NoncontrollingInterestMember_zIH477wO4i6b" title="Share-based compensation (adjustment)" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2019-01-012019-12-31_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">231</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; padding-left: 0.125in">Transfer of subsidiary shares purchased</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_ecustom--TransferOfSubsidiarySharesPurchasedToTreasuryShares_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--NoncontrollingInterestMember_zW5vJzxNGi6b" title="Transfer of subsidiary shares purchased" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="ipar:TransferOfSubsidiarySharesPurchasedToTreasuryShares" contextRef="From2021-01-012021-12-31_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">791</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_ecustom--TransferOfSubsidiarySharesPurchasedToTreasuryShares_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--NoncontrollingInterestMember_zyRbcXmWbwFa" title="Transfer of subsidiary shares purchased" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="ipar:TransferOfSubsidiarySharesPurchasedToTreasuryShares" contextRef="From2020-01-012020-12-31_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">139</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_981_ecustom--TransferOfSubsidiarySharesPurchasedToTreasuryShares_d0_c20190101__20191231__us-gaap--StatementEquityComponentsAxis__us-gaap--NoncontrollingInterestMember_zREoQHtuKzE9" title="Transfer of subsidiary shares purchased" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ipar:TransferOfSubsidiarySharesPurchasedToTreasuryShares" contextRef="From2019-01-012019-12-31_us-gaap_NoncontrollingInterestMember" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8212;</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">Noncontrolling interest, end of year</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iE_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--NoncontrollingInterestMember_zgKDRDeWUupl" title="Ending Balance" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-12-31_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">166,412</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iE_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--NoncontrollingInterestMember_znE8m8pZUEqe" title="Ending Balance" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2020-12-31_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">166,615</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iE_c20190101__20191231__us-gaap--StatementEquityComponentsAxis__us-gaap--NoncontrollingInterestMember_zDuqeo4sfcE" title="Ending Balance" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2019-12-31_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">140,994</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="display: none; vertical-align: bottom; background-color: White; visibility: hidden">
    <td style="display: none; visibility: hidden"><b style="display: none; visibility: hidden">Total equity</b></td><td style="display: none; visibility: hidden">&#160;</td>
    <td style="display: none; text-align: left; visibility: hidden">&#160;</td><td id="xdx_98F_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_c20210101__20211231_zu6IGr4PYIog" title="Beginning Balance" style="display: none; text-align: right; visibility: hidden"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">702,450</ix:nonFraction></td><td style="display: none; text-align: left; visibility: hidden">&#160;</td><td style="display: none; visibility: hidden">&#160;</td>
    <td style="display: none; text-align: left; visibility: hidden">&#160;</td><td id="xdx_98D_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_c20200101__20201231_znBjdYAtgLz4" title="Beginning Balance" style="display: none; text-align: right; visibility: hidden"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">608,998</ix:nonFraction></td><td style="display: none; text-align: left; visibility: hidden">&#160;</td><td style="display: none; visibility: hidden">&#160;</td>
    <td style="display: none; text-align: left; visibility: hidden">&#160;</td><td id="xdx_985_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_c20190101__20191231_zNMZn7OlWrw3" title="Beginning Balance" style="display: none; text-align: right; visibility: hidden"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2018-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">585,746</ix:nonFraction></td><td style="display: none; text-align: left; visibility: hidden">&#160;</td></tr>
<tr style="display: none; vertical-align: bottom; background-color: White; visibility: hidden">
    <td style="display: none; visibility: hidden">Net income</td><td style="display: none; visibility: hidden">&#160;</td>
    <td style="display: none; text-align: left; visibility: hidden">&#160;</td><td id="xdx_981_eus-gaap--ProfitLoss_c20210101__20211231_zEUtlr8d8EN2" style="display: none; text-align: right; visibility: hidden"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">110,027</ix:nonFraction></td><td style="display: none; text-align: left; visibility: hidden">&#160;</td><td style="display: none; visibility: hidden">&#160;</td>
    <td style="display: none; text-align: left; visibility: hidden">&#160;</td><td id="xdx_98F_eus-gaap--ProfitLoss_c20200101__20201231_zA32X6w9JxFe" style="display: none; text-align: right; visibility: hidden"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">49,968</ix:nonFraction></td><td style="display: none; text-align: left; visibility: hidden">&#160;</td><td style="display: none; visibility: hidden">&#160;</td>
    <td style="display: none; text-align: left; visibility: hidden">&#160;</td><td id="xdx_984_eus-gaap--ProfitLoss_c20190101__20191231_zX6cezeIINkk" style="display: none; text-align: right; visibility: hidden"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">76,070</ix:nonFraction></td><td style="display: none; text-align: left; visibility: hidden">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2pt; padding-left: 0.25in">Total equity</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iE_c20210101__20211231_zvsMG2lOMvok" title="Ending Balance" style="border-bottom: Black 2pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">738,332</ix:nonFraction></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td id="xdx_987_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iE_c20200101__20201231_zUL6NruJmZSb" title="Ending Balance" style="border-bottom: Black 2pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">702,450</ix:nonFraction></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td id="xdx_98B_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iE_c20190101__20191231_zyfgyDB2ljuk" title="Ending Balance" style="border-bottom: Black 2pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">608,998</ix:nonFraction></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">See accompanying notes to consolidated financial statements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>


<!-- Field: Page; Sequence: 97; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>INTER PARFUMS, INC. AND SUBSIDIARIES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span id="b006_v1"></span>Consolidated Statements of Cash Flows</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">Years ended December&#160;31, 2021, 2020, and 2019</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(In thousands)</p>



<p style="margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_30C_112_pn3n3_zMC3tZHPDBC" summary="xdx: Statement - Consolidated Statements of Cash Flows" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="text-align: right; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_499_20210101__20211231_zgRDphXzzw36" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_498_20200101__20201231_ztjwVtmEKZKi" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49A_20190101__20191231_zQjOlZLbR5x5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: right; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr id="xdx_406_eus-gaap--NetCashProvidedByUsedInOperatingActivitiesAbstract_iB_zqnOelAWneqk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Cash flows from operating activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_408_eus-gaap--ProfitLoss_i01_maNCPBUzlho_zRaP4KlpNZr3" style="vertical-align: bottom; background-color: White">
    <td style="width: 60%; text-align: left; padding-left: 0.25in; text-indent: -0.125in">Net income</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">110,027</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">49,968</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">76,070</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_40B_eus-gaap--AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_i01B_zkkvQnQAi373" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Adjustments to reconcile net income to net cash
    provided by operating activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_401_eus-gaap--OtherDepreciationAndAmortization_i02_maNCPBUzlho_zE1OvTz7KmKb" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.5in; text-indent: -0.125in">Depreciation and amortization including impairment loss</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OtherDepreciationAndAmortization" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">12,698</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OtherDepreciationAndAmortization" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9,067</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OtherDepreciationAndAmortization" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8,729</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_408_eus-gaap--ProvisionForDoubtfulAccounts_i02_maNCPBUzlho_zeXOFW60kBVl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.5in; text-indent: -0.125in">Provision for doubtful accounts</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProvisionForDoubtfulAccounts" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">853</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProvisionForDoubtfulAccounts" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,824</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProvisionForDoubtfulAccounts" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,380</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_406_eus-gaap--ShareBasedCompensation_i02_maNCPBUzlho_zzxYcGmsUv1i" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.5in; text-indent: -0.125in">Noncash stock compensation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,853</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,029</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,394</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--IncomeLossFromEquityMethodInvestments_i02N_di_msNCPBUzlho_zdlOTqYOaoEd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.5in; text-indent: -0.125in">Share of income of equity investment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromEquityMethodInvestments" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">53</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromEquityMethodInvestments" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">549</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0564">&#8212;</span></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_403_eus-gaap--OperatingLeaseImpairmentLoss_i02_maNCPBUzlho_zJxMRYPOOsGb" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.5in; text-indent: -0.125in">Lease expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseImpairmentLoss" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,302</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseImpairmentLoss" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,483</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseImpairmentLoss" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,021</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_409_eus-gaap--DeferredIncomeTaxExpenseBenefit_i02_maNCPBUzlho_znHnRYKcaCvj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.5in; text-indent: -0.125in">Deferred tax expense (benefit)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:DeferredIncomeTaxExpenseBenefit" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">465</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredIncomeTaxExpenseBenefit" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">581</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:DeferredIncomeTaxExpenseBenefit" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">2,330</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr id="xdx_402_eus-gaap--UnrealizedGainLossOnDerivatives_i02N_di_msNCPBUzlho_zOUpHxw5BAT9" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.5in; text-indent: -0.125in">Change in fair value of derivatives</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:UnrealizedGainLossOnDerivatives" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">65</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:UnrealizedGainLossOnDerivatives" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">137</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:UnrealizedGainLossOnDerivatives" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">169</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr id="xdx_407_eus-gaap--IncreaseDecreaseInOperatingCapitalAbstract_i02B_zYgtLMal5rs7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.5in; text-indent: -0.125in">Changes in:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_401_eus-gaap--IncreaseDecreaseInAccountsReceivable_i03N_di_msNCPBUzlho_zZ1FmhyBfdFc" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.625in; text-indent: -0.125in">Accounts receivable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsReceivable" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">45,395</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsReceivable" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">13,157</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsReceivable" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1,124</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_407_eus-gaap--IncreaseDecreaseInInventories_i03N_di_msNCPBUzlho_z79uHHb5xhye" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.625in; text-indent: -0.125in">Inventories</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInInventories" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">49,815</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInInventories" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">19,333</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInInventories" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,925</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr id="xdx_40C_eus-gaap--IncreaseDecreaseInOtherOperatingAssets_i03N_di_msNCPBUzlho_z7epXDj0U6H2" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.625in; text-indent: -0.125in">Other assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">16,725</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1,176</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,945</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr id="xdx_408_eus-gaap--IncreaseDecreaseInOperatingLeaseLiability_i03_maNCPBUzlho_zPlqpVBMKa56" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.625in; text-indent: -0.125in">Operating lease liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">7,503</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">5,421</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">4,953</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr id="xdx_404_eus-gaap--IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_i03_maNCPBUzlho_zSK7Rz8Mp3qi" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.625in; text-indent: -0.125in">Accounts payable and accrued expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">103,046</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">32,239</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">4,960</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr id="xdx_40E_eus-gaap--IncreaseDecreaseInAccruedTaxesPayable_i03_maNCPBUzlho_zA8GlPbxdng" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.625in; text-indent: -0.125in">Income taxes, net</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccruedTaxesPayable" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,698</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccruedTaxesPayable" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">3,279</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccruedTaxesPayable" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,016</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_40E_eus-gaap--NetCashProvidedByUsedInOperatingActivities_i02T_maCCERCzASN_mtNCPBUzlho_z0sdDi1KXhN3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.75in; text-indent: -0.125in">Net cash provided by operating activities</td><td style="padding-bottom: 1pt; padding-left: 0.125in">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">119,586</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">64,993</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">76,452</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_405_eus-gaap--NetCashProvidedByUsedInInvestingActivitiesAbstract_iB_zmK3U5nvnM12" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Cash flows from investing activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--PaymentsToAcquireShortTermInvestments_i01N_di_msNCPBUzV9M_zuCjMswLVFE6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Purchases of short-term investments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:PaymentsToAcquireShortTermInvestments" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">55,691</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:PaymentsToAcquireShortTermInvestments" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,582</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:PaymentsToAcquireShortTermInvestments" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">97,958</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr id="xdx_40C_eus-gaap--ProceedsFromSaleOfShortTermInvestments_i01_maNCPBUzV9M_zdbxG1sjOPTl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Proceeds from sale of short-term investments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromSaleOfShortTermInvestments" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">10,644</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromSaleOfShortTermInvestments" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">11,513</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromSaleOfShortTermInvestments" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">44,814</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_405_eus-gaap--PaymentsToAcquireProductiveAssets_i01N_di_msNCPBUzV9M_zPzXRTF5m3Qa" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Purchase of property, equipment and leasehold improvements</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:PaymentsToAcquireProductiveAssets" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">141,274</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:PaymentsToAcquireProductiveAssets" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">11,011</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:PaymentsToAcquireProductiveAssets" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,427</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr id="xdx_404_eus-gaap--PaymentsToAcquireIntangibleAssets_i01N_di_msNCPBUzV9M_zzLrGR7Ycpm1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Payment for intangible assets acquired</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:PaymentsToAcquireIntangibleAssets" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,545</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:PaymentsToAcquireIntangibleAssets" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,251</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:PaymentsToAcquireIntangibleAssets" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,067</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr id="xdx_40A_eus-gaap--PaymentsToAcquireEquityMethodInvestments_i01N_di_msNCPBUzV9M_zUm3UgRXmkBi" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.25in; text-indent: -0.125in">Purchase of equity investment</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0630">&#8212;</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:PaymentsToAcquireEquityMethodInvestments" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">13,998</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0632">&#8212;</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--NetCashProvidedByUsedInInvestingActivities_i01T_mtNCPBUzV9M_maCCERCzASN_zip1yogtdfx3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.75in; text-indent: -0.125in">Net cash used in investing activities</td><td style="padding-bottom: 1pt; padding-left: 0.125in">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">187,866</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">22,329</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">64,638</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr id="xdx_405_eus-gaap--NetCashProvidedByUsedInFinancingActivitiesAbstract_iB_zDmHkak6hMA6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Cash flows from financing activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--RepaymentsOfLongTermDebt_i01N_di_msNCPBUzZ87_zuMbMqXVXPod" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Repayment of long-term debt</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:RepaymentsOfLongTermDebt" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">43,056</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:RepaymentsOfLongTermDebt" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">13,725</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:RepaymentsOfLongTermDebt" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">22,321</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr id="xdx_40B_eus-gaap--ProceedsFromIssuanceOfLongTermDebt_i01_maNCPBUzZ87_zbYClhGDNEae" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Proceeds from issuance of long-term debt</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">157,382</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">13,438</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0648">&#8212;</span></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_406_eus-gaap--ProceedsFromStockOptionsExercised_i01_maNCPBUzZ87_zHZdKPdzd2K9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in">Proceeds from exercise of options</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromStockOptionsExercised" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,393</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromStockOptionsExercised" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,771</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromStockOptionsExercised" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,458</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_403_eus-gaap--PaymentsOfDividendsCommonStock_i01N_di_msNCPBUzZ87_zsUK7iHjbD3e" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Dividends paid</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:PaymentsOfDividendsCommonStock" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">31,690</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:PaymentsOfDividendsCommonStock" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">20,805</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:PaymentsOfDividendsCommonStock" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">34,579</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr id="xdx_40C_eus-gaap--PaymentsOfDividendsMinorityInterest_i01N_di_msNCPBUzZ87_zbfrGwuzgm2l" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Dividends paid to noncontrolling interests</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:PaymentsOfDividendsMinorityInterest" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9,836</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:PaymentsOfDividendsMinorityInterest" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">324</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:PaymentsOfDividendsMinorityInterest" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9,654</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr id="xdx_401_eus-gaap--PaymentsToMinorityShareholders_i01N_di_msNCPBUzZ87_zevzjvz4MFu5" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.25in; text-indent: -0.125in">Purchase of subsidiary shares from noncontrolling interests</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0662">&#8212;</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0663">&#8212;</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:PaymentsToMinorityShareholders" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,087</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr id="xdx_40D_eus-gaap--NetCashProvidedByUsedInFinancingActivities_i01T_mtNCPBUzZ87_maCCERCzASN_zIBJzChnvx66" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.75in; text-indent: -0.125in">Net cash provided by (used in) financing activities</td><td style="padding-bottom: 1pt; padding-left: 0.125in">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">78,193</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">18,645</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">68,183</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr id="xdx_401_eus-gaap--EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations_maCCERCzASN_zb0SJI1jorzl" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in">Effect of exchange rate changes on cash</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">11,207</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">12,245</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">3,350</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr id="xdx_408_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_iT_mtCCERCzASN_zACmjx7n0Wqe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.75in; text-indent: -0.125in">Net increase (decrease) in cash and cash equivalents</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1,294</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">36,264</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">59,719</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr id="xdx_40C_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iS_zpTMedP7FYqc" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in">Cash and cash equivalents &#8211; beginning of year</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">169,681</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">133,417</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2018-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">193,136</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_401_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iE_z9b8bvQsdGT5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2pt; padding-left: 0.125in; text-indent: -0.125in">Cash and cash equivalents &#8211; end of year</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td style="border-bottom: Black 2pt double; text-align: right"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">168,387</ix:nonFraction></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td style="border-bottom: Black 2pt double; text-align: right"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">169,681</ix:nonFraction></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td style="border-bottom: Black 2pt double; text-align: right"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">133,417</ix:nonFraction></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
<tr id="xdx_401_ecustom--SupplementalDisclosureOfCashFlowInformationAbstract_iB_zFj17NGihTpk" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Supplemental disclosures of cash flow information:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--SupplementalCashFlowInformationAbstract_i01B_zA4h4zSVPdu2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Cash paid for:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_403_eus-gaap--InterestPaidNet_i02_zmMCmlqM258c" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.375in; text-indent: -0.125in">Interest</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:InterestPaidNet" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,468</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:InterestPaidNet" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,105</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:InterestPaidNet" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,764</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--IncomeTaxesPaid_i02_z37Fspzybyf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.375in; text-indent: -0.125in">Income taxes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxesPaid" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">40,497</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxesPaid" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">21,772</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxesPaid" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">26,332</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
</table>


<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 10pt">See accompanying notes to consolidated financial statements.</span></p>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<!-- Field: Page; Sequence: 98; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>INTER PARFUMS, INC. AND SUBSIDIARIES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="b007_v1"></span>Notes to Consolidated Financial Statements</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">December 31, 2021, 2020 and 2019</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(In thousands except share and per share data)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>


<!-- Field: /Named-Area; -->

<!-- Field: Named-Area; Name: Contents -->
<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:SignificantAccountingPoliciesTextBlock"><p id="xdx_80C_eus-gaap--SignificantAccountingPoliciesTextBlock_zEvmGVxK25Pf" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in; text-align: left"><b>(1)</b></td><td style="text-align: justify"><b><span id="xdx_827_zu7dtXIuY5Nk">The Company and its Significant Accounting Policies</span></b></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock"><p id="xdx_84F_eus-gaap--BusinessDescriptionAndAccountingPoliciesTextBlock_zaqQ1CrlHMM9" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_867_zFeuUXnmqXK2">Business of the Company</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Inter Parfums, Inc. and its subsidiaries
(the &#8220;Company&#8221;) are in the fragrance business and manufacture and distribute a wide array of fragrances and fragrance
related products.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock"><p id="xdx_899_eus-gaap--SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_zpcXTUGeaJk8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Substantially all of our prestige
fragrance brands are licensed from unaffiliated third parties, and our business is dependent upon the continuation and renewal
of such licenses. <span>With respect to the Company&#8217;s largest brands, we license the Montblanc, Jimmy Choo, Coach and GUESS brand
names. As a percentage of net sales, product sales for the Company&#8217;s largest brands were as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;<span id="xdx_8BB_zLfZsxXUNYea" style="display: none; visibility: hidden">Schedule of lanvin brand name for our class</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year Ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 55%">Montblanc</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--MontblancMember_zYQdpsEiMHBc" title="Concentration risk percentage" style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2021-01-012021-12-31_custom_MontblancMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">19</ix:nonFraction></td><td style="width: 1%; text-align: left">%</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20200101__20201231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--MontblancMember_zByVvYIo3wEk" style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2020-01-012020-12-31_custom_MontblancMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">21</ix:nonFraction></td><td style="width: 1%; text-align: left">%</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20190101__20191231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--MontblancMember_z8jeCKYz1uF1" title="Concentration risk percentage" style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2019-01-012019-12-31_custom_MontblancMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">22</ix:nonFraction></td><td style="width: 1%; text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Jimmy Choo</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--JimmyChooMember_zQprf6WWuqpb" style="text-align: right"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2021-01-012021-12-31_custom_JimmyChooMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">18</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20200101__20201231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--JimmyChooMember_zS5aVrWrtb99" title="Concentration risk percentage" style="text-align: right"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2020-01-012020-12-31_custom_JimmyChooMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">16</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20190101__20191231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--JimmyChooMember_zKh8Vx48zKxg" style="text-align: right"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2019-01-012019-12-31_custom_JimmyChooMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">16</ix:nonFraction></td><td style="text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Coach</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--CoachMember_zz272R6gNMCg" style="text-align: right"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2021-01-012021-12-31_custom_CoachMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">16</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20200101__20201231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--CoachMember_zoFqBpv49ldh" style="text-align: right"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2020-01-012020-12-31_custom_CoachMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">17</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20190101__20191231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--CoachMember_z8tyQcKDn2p3" style="text-align: right"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2019-01-012019-12-31_custom_CoachMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">14</ix:nonFraction></td><td style="text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>GUESS</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--GUESSMember_zjFmBtriPnHe" style="text-align: right"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2021-01-012021-12-31_custom_GUESSMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">12</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20200101__20201231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--GUESSMember_zs5yKA1qgED6" style="text-align: right"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2020-01-012020-12-31_custom_GUESSMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">11</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20190101__20191231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--GUESSMember_zFSzsWYUIFY7" style="text-align: right"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2019-01-012019-12-31_custom_GUESSMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">10</ix:nonFraction></td><td style="text-align: left">%</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8AB_zhfDGbBby8R8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">No other brand represented 10%
or more of consolidated net sales.</p>

</ix:nonNumeric><p id="xdx_85B_z1C2HfixVkl3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock"><p id="xdx_84E_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zFBXQNTiBWB1" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_864_zsDymlX0yt0e">Basis of Preparation</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-size: 10pt; color: windowtext">The
consolidated financial statements include the accounts of the Company and its subsidiaries, including <span id="xdx_903_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_uPure_c20211231__srt--OwnershipAxis__custom--InterparfumsSASubsidiaryMember_zI2O3snRjMKg" title="Ownership percentage in Interparfums SA"><ix:nonFraction name="us-gaap:MinorityInterestOwnershipPercentageByParent" contextRef="AsOf2021-12-31_custom_InterparfumsSASubsidiaryMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">73</ix:nonFraction></span>% owned Interparfums SA,
a subsidiary whose stock is publicly traded in France.</span> <span style="font-size: 10pt">All material intercompany balances
and transactions have been eliminated</span>.</p>

</ix:nonNumeric><p id="xdx_85F_zTX5GZVARaz9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:UseOfEstimates"><p id="xdx_84D_eus-gaap--UseOfEstimates_zbo5NVG30hw9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><b><i><span id="xdx_862_zrUMUeldlUT8">Management Estimates</span></i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Management makes assumptions
and estimates to prepare financial statements in conformity with accounting principles generally accepted in the United States
of America. Those assumptions and estimates directly affect the amounts reported and disclosures included in the consolidated financial
statements. Actual results could differ from those assumptions and estimates. Significant estimates for which changes in the near
term are considered reasonably possible and that may have a material impact on the financial statements are disclosed in these
notes to the consolidated financial statements.</p>

</ix:nonNumeric><p id="xdx_853_z7CEYu4MNqR3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"><p id="xdx_846_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_zE5MUTGyRm4c" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_86C_z28ilshIsQI2">Foreign Currency Translation</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">For foreign subsidiaries with
operations denominated in a foreign currency, assets and liabilities are translated to U.S. dollars at year-end exchange rates.
Income and expense items are translated at average rates of exchange prevailing during the year. Gains and losses from translation
adjustments are accumulated in a separate component of shareholders&#8217; equity.</p>

</ix:nonNumeric><p id="xdx_858_z96YMstlJoXj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock"><p id="xdx_844_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zEpMocWzPs56" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_86B_zCDC3UyqFj93">Cash and Cash Equivalents
and Short-Term Investments</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">All highly liquid investments
purchased with a maturity of three months or less are considered to be cash equivalents. The Company also has short-term investments
which consist of certificates of deposit and other contracts with maturities greater than three months and available for sale marketable
equity securities. The Company monitors concentrations of credit risk associated with financial institutions with which the Company
conducts significant business. The Company believes its credit risk is minimal, as the Company primarily conducts business with
large, well-established financial institutions. Substantially all cash and cash equivalents are primarily held at financial institutions
outside the United States and are readily convertible into U.S. dollars.</p>

</ix:nonNumeric><p id="xdx_857_z1JRNnU1Mkqb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<ix:exclude><!-- Field: Page; Sequence: 99; Value: 1 -->
    <div id="xdx_232_zuRwhyrrUYRf" style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p id="xdx_234_zks4umNfqfl1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></p></div>
    <div id="xdx_231_z2MuHwzRBQ3c" style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p id="xdx_23A_zDTD1g9RsWN1" style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<ix:exclude><p id="xdx_23B_zupSaAqK3x3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>INTER PARFUMS, INC. AND SUBSIDIARIES</b></p></ix:exclude>

<ix:exclude><p id="xdx_237_z0vE3rc4zWti" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23F_zHLP4HbizPae" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Notes to Consolidated Financial Statements</p></ix:exclude>

<ix:exclude><p id="xdx_231_zgCw9Ukwlt11" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">December 31, 2021, 2020 and 2019</p></ix:exclude>

<ix:exclude><p id="xdx_23F_z4bTqDcegUSg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(In thousands except share and per share data)</p></ix:exclude>

<ix:exclude><p id="xdx_230_zfRtn7hfCnu" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></ix:exclude>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:TradeAndOtherAccountsReceivablePolicy"><p id="xdx_84F_eus-gaap--TradeAndOtherAccountsReceivablePolicy_zOX5N7CtF7sa" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_86C_zRrOsXXviwH7">Accounts Receivable</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Accounts receivable represent
payments due to the Company for previously recognized net sales, reduced by allowances for doubtful accounts or balances which
are estimated to be uncollectible, which aggregated $<span id="xdx_908_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_dm_c20211231_zIjlU4KCWMod" title="Allowances for sales returns and doubtful accounts"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="6" unitRef="USD">2.2</ix:nonFraction> million</span> and $<span id="xdx_907_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_dm_c20201231_zsvFPBrg2MW8" title="Allowances for sales returns and doubtful accounts"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="6" unitRef="USD">5.5</ix:nonFraction> million</span> as of December 31, 2021 and 2020, respectively.
Accounts receivable balances are written-off against the allowance for doubtful accounts when they become uncollectible. Recoveries
of accounts receivable previously recorded against the allowance are recorded in the consolidated statement of income when received.
We generally grant credit based upon our analysis of the customer&#8217;s financial position, as well as previously established
buying patterns.</p>

</ix:nonNumeric><p id="xdx_853_zDGbMdHX287h" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:InventoryPolicyTextBlock"><p id="xdx_84F_eus-gaap--InventoryPolicyTextBlock_ztbdawIs4OD2" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_86C_zNu6STEIHY4i">Inventories</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Inventories, including promotional
merchandise, only include inventory considered saleable or usable in future periods, and are stated at the lower of cost and net
realizable value, with cost being determined on the first-in, first-out method.&#160;Cost components include raw materials, direct
labor and overhead (e.g., indirect labor, utilities, depreciation, purchasing, receiving, inspection and warehousing) as well as
inbound freight.&#160;Promotional merchandise is charged to cost of sales at the time the merchandise is shipped to the Company&#8217;s
customers.</p>

</ix:nonNumeric><p id="xdx_858_z9K5muEB1wti" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:DerivativesPolicyTextBlock"><p id="xdx_84A_eus-gaap--DerivativesPolicyTextBlock_z9baj96Z3Uch" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_865_zEB0CQ2uqAGl">Derivatives</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">All derivative instruments are
recorded as either assets or liabilities and measured at fair value. The Company uses derivative instruments to principally manage
a variety of market risks. For derivatives designated as hedges of the exposure to changes in fair value of the recognized asset
or liability or a firm commitment (referred to as fair value hedges), the gain or loss is recognized in earnings in the period
of change together with the offsetting loss or gain on the hedged item attributable to the risk being hedged. The effect of that
accounting is to include in earnings the extent to which the hedge is not effective in achieving offsetting changes in fair value.
For cash flow hedges, the effective portion of the derivative&#8217;s gain or loss is initially reported in equity (as a component
of accumulated other comprehensive income) and is subsequently reclassified into earnings in the same period or periods during
which the hedged forecasted transaction affects earnings. The ineffective portion of the gain or loss of a cash flow hedge is reported
in earnings immediately. The Company also holds certain instruments for economic purposes that are not designated for hedge accounting
treatment. For these derivative instruments, changes in their fair value are recorded in earnings immediately.</p>

</ix:nonNumeric><p id="xdx_85F_zBTh2OukoYF5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock"><p id="xdx_84E_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zxLXxkQD6l59" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_862_ziePjxIBxEIi">Property, Equipment
and Leasehold Improvements</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Property, equipment and leasehold
improvements are stated at cost less accumulated depreciation and amortization. Depreciation and amortization are provided using
the straight-line method over the estimated useful lives for equipment, which range between three and ten&#160;years and the shorter
of the lease term or estimated useful asset lives for leasehold improvements. Depreciation has not yet begun on property recently
purchased, as it has not yet been put into service. Depreciation provided on equipment used to produce inventory, such as tools
and molds, is included in cost of sales.</p>

</ix:nonNumeric><p id="xdx_851_zsl94Ssv1Lp8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<ix:exclude><!-- Field: Page; Sequence: 100; Value: 1 -->
    <div id="xdx_23C_zsTj3LCBeqZd" style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p id="xdx_23C_zFQ0cwyfKcE8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></p></div>
    <div id="xdx_23F_z4koFGxB6zse" style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p id="xdx_238_zWhk5rVW78xh" style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_237_z4tE9hchE0Wj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_231_zubKrnZuHSz9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>INTER PARFUMS, INC. AND SUBSIDIARIES</b></p></ix:exclude>

<ix:exclude><p id="xdx_231_z4PflFB5z2Bj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_239_zV225lkGnTA5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Notes to Consolidated Financial Statements</p></ix:exclude>

<ix:exclude><p id="xdx_23D_zmycXKhlIog4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">December 31, 2021, 2020 and 2019</p></ix:exclude>

<ix:exclude><p id="xdx_237_zPEzZeptKvdd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(In thousands except share and per share data)</p></ix:exclude>

<ix:exclude><p id="xdx_23C_znJSMF4Q4vCe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></ix:exclude>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock"><p id="xdx_84B_eus-gaap--GoodwillAndIntangibleAssetsPolicyTextBlock_zMLyGXt7t8gg" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_86B_zh41q5d3MFDh">Long-Lived Assets</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Indefinite-lived intangible assets
principally consist of trademarks which are not amortized. The Company evaluates indefinite-lived intangible assets for impairment
at least annually during the fourth quarter, or more frequently when events occur or circumstances change, such as an unexpected
decline in sales, that would more-likely-than-not indicate that the carrying value of an indefinite-lived intangible asset may
not be recoverable. When testing indefinite-lived intangible assets for impairment, the evaluation requires a comparison of the
estimated fair value of the asset to the carrying value of the asset. The fair values used in our evaluations are estimated based
upon discounted future cash flow projections using a weighted average cost of capital of <span id="xdx_905_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_uPure_c20211231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountRateMember_zjI95Q9b1fGj" title="Weighted average cost of capital"><ix:nonFraction name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" contextRef="AsOf2021-12-31_us-gaap_MeasurementInputDiscountRateMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">7.47</ix:nonFraction></span>% and <span id="xdx_906_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_uPure_c20201231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountRateMember_zitEfXDLlzZj" title="Weighted average cost of capital"><ix:nonFraction name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" contextRef="AsOf2020-12-31_us-gaap_MeasurementInputDiscountRateMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">6.99</ix:nonFraction></span>% in 2021 and 2020, respectively.
The cash flow projections are based upon a number of assumptions, including future sales levels, future cost of goods and operating
expense levels, as well as economic conditions, changes to our business model or changes in consumer acceptance of our products
which are more subjective in nature. If the carrying value of an indefinite-lived intangible asset exceeds its fair value, an impairment
charge is recorded.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Intangible assets subject to
amortization are evaluated for impairment testing whenever events or changes in circumstances indicate that the carrying amount
of an amortizable intangible asset may not be recoverable. If impairment indicators exist for an amortizable intangible asset,
the undiscounted future cash flows associated with the expected service potential of the asset are compared to the carrying value
of the asset. If our projection of undiscounted future cash flows is in excess of the carrying value of the intangible asset, no
impairment charge is recorded. If our projection of undiscounted future cash flows is less than the carrying value of the intangible
asset, an impairment charge would be recorded to reduce the intangible asset to its fair value.</p>

</ix:nonNumeric><p id="xdx_859_zvbVB95ePOC6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock"><p id="xdx_846_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_ztLcWRB1tRh4" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_868_zDcPDuMSob3a">Revenue Recognition</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company sells its products
to department stores, perfumeries, specialty stores and domestic and international wholesalers and distributors. Our revenue contracts
represent single performance obligations to sell our products to customers. Sales of such products by our domestic subsidiaries
are denominated in U.S. dollars, and sales of such products by our foreign subsidiaries are primarily denominated in either euro
or U.S. dollars. The Company recognizes revenues when contract terms are met, the price is fixed and determinable, collectability
is reasonably assured, and control of the assets has passed to the customer based on the agreed upon shipping terms. Net sales
are comprised of gross revenues less returns, trade discounts and allowances. The Company does not bill its customers&#8217; freight
and handling charges. All shipping and handling costs, which aggregated $<span id="xdx_903_eus-gaap--CostOfGoodsAndServicesSold_dm_c20210101__20211231__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_z7kiNCO2jrZd" title="Shipping and handling costs"><ix:nonFraction name="us-gaap:CostOfGoodsAndServicesSold" contextRef="From2021-01-012021-12-31_us-gaap_ShippingAndHandlingMember" format="ixt:numdotdecimal" decimals="0" scale="6" unitRef="USD">10.1</ix:nonFraction> million</span>, $<span id="xdx_901_eus-gaap--CostOfGoodsAndServicesSold_dm_c20200101__20201231__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_zYpnjFOqQbrf" title="Shipping and handling costs"><ix:nonFraction name="us-gaap:CostOfGoodsAndServicesSold" contextRef="From2020-01-012020-12-31_us-gaap_ShippingAndHandlingMember" format="ixt:numdotdecimal" decimals="0" scale="6" unitRef="USD">5.0</ix:nonFraction> million</span> and $<span id="xdx_907_eus-gaap--CostOfGoodsAndServicesSold_dm_c20190101__20191231__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_zbv06j8IAt58" title="Shipping and handling costs"><ix:nonFraction name="us-gaap:CostOfGoodsAndServicesSold" contextRef="From2019-01-012019-12-31_us-gaap_ShippingAndHandlingMember" format="ixt:numdotdecimal" decimals="0" scale="6" unitRef="USD">7.7</ix:nonFraction> million</span> in 2021, 2020
and 2019, respectively, are included in selling, general and administrative expenses in the consolidated statements of income.
The Company grants credit to all qualified customers and does not believe it is exposed significantly to any undue concentration
of credit risk. No one customer represented <span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember_zoLUvQ3mRx5b" title="Concentration risk percentage"><span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20200101__20201231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember_zhfXNG5EgFo" title="Concentration risk percentage"><span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20190101__20191231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember_zyOX9TezhAsb" title="Concentration risk percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2021-01-012021-12-31_us-gaap_SalesRevenueNetMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2020-01-012020-12-31_us-gaap_SalesRevenueNetMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2019-01-012019-12-31_us-gaap_SalesRevenueNetMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">10</ix:nonFraction></ix:nonFraction></ix:nonFraction></span></span></span>% or more of net sales in 2021, 2020 or 2019.</p>

</ix:nonNumeric><p id="xdx_857_zyMuc9mPqZY7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:RevenueRecognitionSalesReturns"><p id="xdx_842_eus-gaap--RevenueRecognitionSalesReturns_zRzspxwoKQok" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><b><i><span id="xdx_86A_z8xvPmwjEzX2">Sales Returns</span></i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Generally, the Company does not
permit customers to return their unsold products. However, for U.S. based customers, we allow returns if properly requested, authorized
and approved. The Company regularly reviews and revises, as deemed necessary, its estimate of reserves for future sales returns
based primarily upon historic trends and relevant current data including information provided by retailers regarding their inventory
levels. In addition, as necessary, specific accruals may be established for significant future known or anticipated events. The
types of known or anticipated events that we consider include, but are not limited to, the financial condition of our customers,
store closings by retailers, changes in the retail environment and our decision to continue to support new and existing products.
The Company records its estimate of potential sales returns as a reduction of sales and cost of sales with corresponding entries
to accrued expenses, to record the refund liability, and inventory, for the right to recover goods from the customer. The refund
liability associated with estimated returns was $<span id="xdx_908_eus-gaap--ContractWithCustomerRefundLiability_iI_dm_c20211231_znyf5BtratH3" title="Contract with customer, refund liability"><ix:nonFraction name="us-gaap:ContractWithCustomerRefundLiability" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="6" unitRef="USD">5.1</ix:nonFraction> million</span> and $<span id="xdx_90C_eus-gaap--ContractWithCustomerRefundLiability_iI_dm_c20201231_zRetSX8A8Xf2" title="Contract with customer, refund liability"><ix:nonFraction name="us-gaap:ContractWithCustomerRefundLiability" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="6" unitRef="USD">3.6</ix:nonFraction> million</span> at December 31, 2021 and 2020, respectively, and
the amounts recognized for the rights to recover products was $<span id="xdx_901_eus-gaap--ContractWithCustomerRightToRecoverProduct_iI_dm_c20211231_zeBEEVsuiDj8" title="Contract with customer, right to recover products"><ix:nonFraction name="us-gaap:ContractWithCustomerRightToRecoverProduct" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="6" unitRef="USD">1.9</ix:nonFraction> million</span> and $<span id="xdx_907_eus-gaap--ContractWithCustomerRightToRecoverProduct_iI_dm_c20201231_z0jjHn77u3ra" title="Contract with customer, right to recover products"><ix:nonFraction name="us-gaap:ContractWithCustomerRightToRecoverProduct" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="6" unitRef="USD">1.4</ix:nonFraction> million</span> at December 31, 2021 and 2020, respectively.
The physical condition and marketability of returned products are the major factors we consider in estimating realizable value.
Actual returns, as well as estimated realizable values of returned products, may differ significantly, either favorably or unfavorably,
from our estimates, if factors such as economic conditions, inventory levels or competitive conditions differ from our expectations.</p>

</ix:nonNumeric><p id="xdx_85A_zGHAKYOFyFo4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<ix:exclude><!-- Field: Page; Sequence: 101; Value: 1 -->
    <div id="xdx_231_z01avcqAC0V7" style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p id="xdx_239_zrInipDhyR8f" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></p></div>
    <div id="xdx_23D_zQGbeWbFLyb" style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<ix:exclude><p id="xdx_23C_zPilLJPvTIVl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>INTER PARFUMS, INC. AND SUBSIDIARIES</b></p></ix:exclude>

<ix:exclude><p id="xdx_235_zCPjinMZIC71" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23D_zXAbCtFGh94" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Notes to Consolidated Financial Statements</p></ix:exclude>

<ix:exclude><p id="xdx_235_zVw7hCQbeaWi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">December 31, 2021, 2020 and 2019</p></ix:exclude>

<ix:exclude><p id="xdx_239_zjGMy5q1LUdj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(In thousands except share and per share data)</p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:RevenueRecognitionAllowances"><p id="xdx_848_eus-gaap--RevenueRecognitionAllowances_zIXF944rySMe" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_868_znLVY5SKtDS2">Payments to Customers</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company records revenues
generated from purchase with purchase and gift with purchase promotions as sales and the costs of its purchase with purchase and
gift with purchase promotions as cost of sales. Certain other incentive arrangements require the payment of a fee to customers
based on their attainment of pre-established sales levels.&#160;These fees have been recorded as a reduction of net sales.</p>

</ix:nonNumeric><p id="xdx_852_zWNBQtZ1lOll" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:AdvertisingCostsPolicyTextBlock"><p id="xdx_847_eus-gaap--AdvertisingCostsPolicyTextBlock_zMhsa7dUIP4b" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_86B_zKwixucqi0Wc">Advertising and Promotion</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Advertising and promotional costs
are expensed as incurred and recorded as a component of cost of goods sold (in the case of free goods given to customers) or selling,
general and administrative expenses. Advertising and promotional costs included in selling, general and administrative expenses
were $<span id="xdx_90F_eus-gaap--AdvertisingExpense_dm_c20210101__20211231_zO66CJoHkc5i" title="Advertising costs"><ix:nonFraction name="us-gaap:AdvertisingExpense" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="6" unitRef="USD">171.8</ix:nonFraction> million</span>, $<span id="xdx_900_eus-gaap--AdvertisingExpense_dm_c20200101__20201231_zmbGZy0nheab" title="Advertising costs"><ix:nonFraction name="us-gaap:AdvertisingExpense" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" scale="6" unitRef="USD">91.7</ix:nonFraction> million</span> and $<span id="xdx_906_eus-gaap--AdvertisingExpense_dm_c20190101__20191231_zSBuyQo7SUfj" title="Advertising costs"><ix:nonFraction name="us-gaap:AdvertisingExpense" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="0" scale="6" unitRef="USD">144.6</ix:nonFraction> million</span> for 2021, 2020 and 2019, respectively. Costs relating to purchase with purchase
and gift with purchase promotions that are reflected in cost of sales aggregated $<span id="xdx_90B_eus-gaap--MarketingExpense_dm_c20210101__20211231_zkC5S7wCoKt" title="Customer incentives cost"><ix:nonFraction name="us-gaap:MarketingExpense" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="6" unitRef="USD">37.6</ix:nonFraction> million</span>, $<span id="xdx_907_eus-gaap--MarketingExpense_dm_c20200101__20201231_zIl6u6IHe97g" title="Customer incentives cost"><ix:nonFraction name="us-gaap:MarketingExpense" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" scale="6" unitRef="USD">26.4</ix:nonFraction> million</span> and $<span id="xdx_90B_eus-gaap--MarketingExpense_dm_c20190101__20191231_z8Sfs4W9HSo7" title="Customer incentives cost"><ix:nonFraction name="us-gaap:MarketingExpense" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="0" scale="6" unitRef="USD">38.9</ix:nonFraction> million</span>
in 2021, 2020 and 2019, respectively.</p>

</ix:nonNumeric><p id="xdx_852_zv0TgE5diP73" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:ResearchAndDevelopmentExpensePolicy"><p id="xdx_845_eus-gaap--ResearchAndDevelopmentExpensePolicy_zb6l10DhTTD1" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_86C_zxubFzrB3ag7">Package Development
Costs</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Package development costs associated
with new products and redesigns of existing product packaging are expensed as incurred.</p>

</ix:nonNumeric><p id="xdx_850_zDyjh8VrwLea" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:LessorLeasesPolicyTextBlock"><p id="xdx_84E_eus-gaap--LessorLeasesPolicyTextBlock_zY4OsnzKpcG1" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_864_zSwFQL2unLWj">Operating Leases</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company leases its offices
and warehouses, vehicles, and certain office equipment, substantially all of which are classified as operating leases. The Company
currently has no material financing leases. The Company determines if an arrangement is a lease at inception. Operating lease assets
and obligations are recognized at the lease commencement date based on the present value of lease payments over the lease term.</p>

</ix:nonNumeric><p id="xdx_851_zBCT9dlLM9yb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:CommitmentsAndContingenciesPolicyTextBlock"><p id="xdx_845_eus-gaap--CommitmentsAndContingenciesPolicyTextBlock_zlM20bGen9Pf" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_86A_zpWo2K9IzHBk">License Agreements</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company&#8217;s license agreements
generally provide the Company with worldwide rights to manufacture, market and sell fragrance and fragrance related products using
the licensors&#8217; trademarks.&#160;The licenses typically have an initial term of approximately <span id="xdx_905_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtxL_c20210101__20211231__srt--RangeAxis__srt--MinimumMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_zg5oy7vG2Sig" title="License agreement term::XDX::P5Y"><span style="-sec-ix-hidden: xdx2ixbrl0815">5</span></span> to <span id="xdx_90B_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtxL_c20210101__20211231__srt--RangeAxis__srt--MaximumMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_zH4FMG4euCva" title="License agreement term::XDX::P15Y"><span style="-sec-ix-hidden: xdx2ixbrl0817">15</span></span> years, and are potentially
renewable subject to the Company&#8217;s compliance with the license agreement provisions.&#160;The remaining terms, excluding
potential renewal periods, range from approximately <span id="xdx_900_eus-gaap--AcquiredFiniteLivedIntangibleAssetWeightedAveragePeriodBeforeRenewalOrExtension_dtxL_c20210101__20211231__srt--RangeAxis__srt--MinimumMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_zZBekVhYz7rl" title="License agreement renewal term::XDX::P1Y"><span style="-sec-ix-hidden: xdx2ixbrl0819">1</span></span> to <span id="xdx_90B_eus-gaap--AcquiredFiniteLivedIntangibleAssetWeightedAveragePeriodBeforeRenewalOrExtension_dtxL_c20210101__20211231__srt--RangeAxis__srt--MaximumMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_zPKh8saKEnri" title="License agreement renewal term::XDX::P12Y"><span style="-sec-ix-hidden: xdx2ixbrl0821">12</span></span> years.&#160; Under each license, the Company is required to pay royalties
in the range of <span id="xdx_904_ecustom--RoyaltyExpenseNetSalesPercentage_pid_dp_uPure_c20210101__20211231__srt--RangeAxis__srt--MinimumMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_zLpjMvg6tOsh" title="Royalty expense, percentage of net sales"><ix:nonFraction name="ipar:RoyaltyExpenseNetSalesPercentage" contextRef="From2021-01-012021-12-31_srt_MinimumMember_us-gaap_LicensingAgreementsMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">6</ix:nonFraction></span>% to <span id="xdx_90C_ecustom--RoyaltyExpenseNetSalesPercentage_pid_dp_uPure_c20210101__20211231__srt--RangeAxis__srt--MaximumMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_ziq3WDdigWN5" title="Royalty expense, percentage of net sales"><ix:nonFraction name="ipar:RoyaltyExpenseNetSalesPercentage" contextRef="From2021-01-012021-12-31_srt_MaximumMember_us-gaap_LicensingAgreementsMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">10</ix:nonFraction></span>% to the licensor, at least annually, based on net sales to third parties.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In certain cases, the Company
may pay an entry fee to acquire, or enter into, a license where the licensor or another licensee was operating a pre-existing fragrance
business.&#160; In those cases, the entry fee is capitalized as an intangible asset and amortized over its useful life.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Most license agreements require
minimum royalty payments, incremental royalties based on net sales levels and minimum spending on advertising and promotional activities.&#160;
Royalty expenses are accrued in the period in which net sales are recognized while advertising and promotional expenses are accrued
at the time these costs are incurred.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<ix:exclude><!-- Field: Page; Sequence: 102; Value: 1 -->
    <div id="xdx_239_zbcMZEP2Tlsh" style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p id="xdx_23D_zAxamBEngXZh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></p></div>
    <div id="xdx_232_zF0fjuVtqGn6" style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<ix:exclude><p id="xdx_239_zpc0YZiDazdh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>INTER PARFUMS, INC. AND SUBSIDIARIES</b></p></ix:exclude>

<ix:exclude><p id="xdx_239_zkWl4UnLwg01" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_236_zwNdfXQiS9v3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Notes to Consolidated Financial Statements</p></ix:exclude>

<ix:exclude><p id="xdx_238_z2BJQxuzcv96" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">December 31, 2021, 2020 and 2019</p></ix:exclude>

<ix:exclude><p id="xdx_237_zReku42mHPpc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(In thousands except share and per share data)</p></ix:exclude>

<ix:exclude><p id="xdx_235_zFjdtkNv2Re7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In addition, the Company is exposed
to certain concentration risk. Most of our prestige fragrance brands are licensed from unaffiliated third parties, and our business
is dependent upon the continuation and renewal of such licenses.</p>

</ix:nonNumeric><p id="xdx_851_zS3es4fIsQH4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;&#160;</p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:IncomeTaxPolicyTextBlock"><p id="xdx_848_eus-gaap--IncomeTaxPolicyTextBlock_zfkJH3uH7nI3" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_862_ztuairfRRGmc">Income Taxes</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company accounts for income
taxes using an asset and liability approach that requires the recognition of deferred tax assets and liabilities for the expected
future tax consequences of events that have been recognized in its financial statements or tax returns.&#160;The net deferred tax
assets assume sufficient future earnings for their realization, as well as the continued application of currently enacted tax rates.&#160;Included
in net deferred tax assets is a valuation allowance for deferred tax assets, where management believes it is more-likely-than-not
that the deferred tax assets will not be realized in the relevant jurisdiction.&#160;If the Company determines that a deferred
tax asset will not be realizable, an adjustment to the deferred tax asset will result in a reduction of net earnings at that time.
Accrued interest and penalties are included within the related tax asset or liability in the accompanying financial statements.</p>

</ix:nonNumeric><p id="xdx_858_zgWcCsu0X49f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:ConsolidationSubsidiaryStockIssuancesPolicy"><p id="xdx_84B_eus-gaap--ConsolidationSubsidiaryStockIssuancesPolicy_zNn5UAKH97j9" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_863_z3XeDhRGwgT6">Issuance of Common Stock
by Consolidated Subsidiary</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The difference between the Company&#8217;s
share of the proceeds received by the subsidiary and the carrying amount of the portion of the Company&#8217;s investment deemed
sold, is reflected as an equity adjustment in the consolidated balance sheets.</p>

</ix:nonNumeric><p id="xdx_858_ztrkRACWMHWj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:RepurchaseAgreementsCollateralPolicy"><p id="xdx_845_eus-gaap--RepurchaseAgreementsCollateralPolicy_zgFdiS9Lz6vl" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_86E_zPR2sjlhj6Vi">Treasury Stock</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Board of Directors may authorize
share repurchases of the Company&#8217;s common stock (Share Repurchase Authorizations). Share repurchases under Share Repurchase
Authorizations may be made through open market transactions, negotiated purchase or otherwise, at times and in such amounts within
the parameters authorized by the Board. Shares repurchased under Share Repurchase Authorizations are held in treasury for general
corporate purposes, including issuances under various employee stock option plans. Treasury shares are accounted for under the
cost method and reported as a reduction of equity. Share Repurchase Authorizations may be suspended, limited or terminated at any
time without notice.</p>

</ix:nonNumeric><p id="xdx_85B_zl4btBt8GBfd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock"><p id="xdx_846_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zaV2orbuBuQ3" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_865_zEa8FnNhccEf">Recent Accounting Pronouncements</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In June 2016, the Financial Accounting
Standards Board (&#8220;FASB&#8221;) issued ASU 2016-13, &#8220;Financial Instruments - Credit Losses (Topic 326): Measurement
of Credit Losses on Financial Instruments&#8221;, as updated in 2019 and 2020, which require a financial asset measured at amortized
cost basis to be presented at the net amount expected to be collected. The new rules eliminate the probable initial recognition
threshold and, instead, reflect an entity&#8217;s current estimate of all expected credit losses. The new rules took effect for
the Company in the first quarter of 2020 and there was no material impact on our consolidated financial statements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">There are no other recent accounting
pronouncements issued but not yet adopted that would have a material effect on our consolidated financial statements.</p>

</ix:nonNumeric><p id="xdx_85E_zHyHguiqTzx6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:PriorPeriodReclassificationAdjustmentDescription"><p id="xdx_841_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zOY2dqwXvKZ4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><b><i><span id="xdx_865_zZHMpqe0Xir6">Reclassifications</span></i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Certain prior year&#8217;s amounts
in the accompanying consolidated statements of cash flows have been reclassified to conform to current period presentation.</p>

</ix:nonNumeric><p id="xdx_85C_zIPzerqA9kpk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

</ix:nonNumeric><p id="xdx_819_zATXLV2SQL99" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<!-- Field: Page; Sequence: 103; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>INTER PARFUMS, INC. AND SUBSIDIARIES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Notes to Consolidated Financial Statements</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">December 31, 2021, 2020 and 2019</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(In thousands except share and per share data)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>


<!-- Field: /Named-Area; -->

<!-- Field: Named-Area; Name: Contents -->
<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="ipar:ImpactOfCOVID19PandemicTextBlock"><p id="xdx_802_ecustom--ImpactOfCOVID19PandemicTextBlock_zhjKhOFC7zZf" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in">(2)</td><td><span id="xdx_822_zgXMrxJ4zcsd">Impact of COVID-19 Pandemic</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">A novel strain of coronavirus
(&#8220;COVID-19&#8221;) surfaced in late 2019 and has spread around the world, including to the United States and France. In March
2020, the World Health Organization declared COVID-19 a pandemic.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In response to the COVID-19 pandemic
various national, state, and local governments where we, our suppliers, and our customers operate initially issued decrees prohibiting
certain businesses from continuing to operate and certain classes of workers from reporting to work. In all jurisdictions in which
we operate we have been following guidance from authorities and health officials.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The effects of the COVID-19 pandemic
on the beauty industry began in early March 2020. Retail store closings, event cancellations and a shutdown of international air
travel brought our sales to a virtual standstill and caused a significant unfavorable impact on our results of operations in 2020.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Business significantly improved
in the second half of 2020 and continued to improve throughout 2021, as retail stores reopened, and consumers increased online
purchasing. While we expect this trend to continue, as the luxury fragrance industry has shown continued resilience, the introduction
of variants of COVID-19 in various parts of the world has caused the temporary re-implementation of governmental restrictions to
prevent further spread of the virus. In addition, international air travel has remained curtailed in many jurisdictions due to
both governmental restrictions and consumer health concerns. While COVID-19 has significantly restricted international travel in
the near-term, we continue to believe that global travel retail will once again be a growth opportunity for the long-term. Lastly,
the improved economy has put significant strains on our supply chain causing disruptions affecting the procurement of components,
the ability to transport goods, and related cost increases. These disruptions have come at a time when demand for our product lines
has never been stronger or more sustained. We have been addressing this issue since the beginning of 2021, by ordering well in
advance of need and in larger quantities. Going forward, we aim to carry more inventory overall, source the same components from
multiple suppliers and when possible, manufacture products closer to where they are sold. We do not expect the supply chain bottlenecks
to begin lifting until later in 2022. Therefore, despite recent business improvement, the impact of the COVID-19 pandemic may have
a material adverse effect on our results of our operations, financial position and cash flows through at least the end of 2022.</p>

</ix:nonNumeric><p id="xdx_819_zZuHvJYpLYGi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>


<!-- Field: /Named-Area; -->

<!-- Field: Named-Area; Name: Contents -->
<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:BusinessCombinationDisclosureTextBlock"><p id="xdx_809_eus-gaap--BusinessCombinationDisclosureTextBlock_z9lEmzIUSBA1" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in">(3)</td><td><span id="xdx_82F_zZ584f55AChe">Recent Agreements</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><b><i>Salvatore Ferragamo </i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In October 2021, we closed on
a transaction agreement with Salvatore Ferragamo S.p.A., whereby an exclusive and worldwide license was granted for the production
and distribution of Ferragamo brand perfumes. Our rights under this license are subject to certain minimum advertising expenditures
and royalty payments as are customary in our industry. The license became effective in October 2021 and will last for 10 years
with a 5-year optional term, subject to certain conditions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<ix:exclude><!-- Field: Page; Sequence: 104; Value: 1 -->
    <div id="xdx_23B_z9TCL9C336t2" style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p id="xdx_230_ztIXO9VPANpe" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></p></div>
    <div id="xdx_23F_zYJSXlXRP3Lf" style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p id="xdx_231_z6mh4hPv0hwh" style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23A_zv13WT30IWfc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23C_zESayrsjXNVf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>INTER PARFUMS, INC. AND SUBSIDIARIES</b></p></ix:exclude>

<ix:exclude><p id="xdx_232_zNAqaTyY0hIj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23C_zP9E98Y324Ma" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Notes to Consolidated Financial Statements</p></ix:exclude>

<ix:exclude><p id="xdx_23B_zACHtRShF7yk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">December 31, 2021, 2020 and 2019</p></ix:exclude>

<ix:exclude><p id="xdx_235_zfd6McRHAGXi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(In thousands except share and per share data)</p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="ipar:ScheduleOfInventoryCurrentTableTextBlock1"><p id="xdx_897_ecustom--ScheduleOfInventoryCurrentTableTextBlock1_z2moVF6wOGw9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">With respect to the management
and coordination of activities related to the license agreement, the Company operates through a wholly-owned Italian subsidiary
based in Florence, that was acquired from Salvatore Ferragamo on October 1, 2021. The acquisition together with the license agreement
was accounted for as an asset acquisition. The following table summarizes the estimated fair values of the assets acquired and
liabilities assumed on October 1, 2021. <span id="xdx_8BE_z60afETIDPI2">All amounts have been translated to U.S. dollars at the October 1, 2021 exchange rate.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 40%; margin-right: auto">
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 25%">Inventories</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--InventoryGross_iI_pn3n3_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--InventoryMember_zBSGsFMZ2Kmk" title="Inventories" style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:InventoryGross" contextRef="AsOf2021-12-31_custom_InventoryMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">17,805</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Trademarks and licenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--InventoryGross_iI_pn3n3_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksMember_zjHRtjDVGIv1" style="text-align: right"><ix:nonFraction name="us-gaap:InventoryGross" contextRef="AsOf2021-12-31_us-gaap_TrademarksMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">15,880</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Other assets</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--InventoryGross_iI_pn3n3_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--OtherAssetMember_zqiCMi4rBlte" title="Inventory gross" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:InventoryGross" contextRef="AsOf2021-12-31_custom_OtherAssetMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,033</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in">Assets acquired</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--FairValueOfAssetsAcquired_pn3n3_c20210101__20211231_zc7pMBCM27j7" title="Assets acquired" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:FairValueOfAssetsAcquired" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">36,718</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in">Liabilities assumed</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--LiabilitiesAssumed1_iN_di_c20210101__20211231_zYAilmIsHA5d" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:LiabilitiesAssumed1" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">958</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2pt">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td id="xdx_983_eus-gaap--InventoryNet_iI_pn3n3_dxL_c20211231_znyKJ10w2TWd" title="Inventory net::XDX::198%2C914" style="border-bottom: Black 2pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0863">35,760</span></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
</table>



</ix:nonNumeric><p id="xdx_8A0_zuHLOTPrKK3k" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><b><i>Emanuel Ungaro</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In October 2021, we also entered into a 10-year exclusive global licensing agreement a with a 5-year optional
term subject to certain conditions, with Emanuel Ungaro Italia S.r.l, for the creation, development and distribution of fragrances
and fragrance-related products, under the Emanuel Ungaro brand. Our rights under this license are subject to certain minimum advertising
expenditures and royalty payments as are customary in our industry.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><b><i>Donna Karan and DKNY </i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In September 2021, we entered
into a long-term global licensing agreement for the creation, development and distribution of fragrances and fragrance-related
products under the Donna Karan and DKNY brands. Our rights under this license are subject to certain minimum advertising expenditures
and royalty payments as are customary in our industry. With this agreement, we are gaining several well-established and valuable
fragrance franchises, most notably Donna Karan <i>Cashmere Mist</i> and DKNY <i>Be Delicious</i>, as well as a significant loyal
consumer base around the world. In connection with the grant of license, we issued 65,342 shares of Inter Parfums, Inc. common
stock valued at $5.0 million to the licensor. The exclusive license is effective July 1, 2022, and we are planning to launch new
fragrances under these brands in 2023.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><b><i>French Tax Settlement </i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The French authorities had considered
that the existence of IP Suisse, a wholly-owned subsidiary of Interparfums SA, does not, in and of itself, constitute a permanent
establishment and therefore Interparfums SA should pay French taxes on all or part of the profits of that entity.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In June 2021, a global settlement
agreement was reached with the French Tax Authorities, whereby Interparfums SA paid in December 2021, &#8364;<span id="xdx_907_eus-gaap--TaxesPayableCurrentAndNoncurrent_iI_dm_uUSDEUR_c20211231__us-gaap--IncomeTaxAuthorityNameAxis__us-gaap--SwissFederalTaxAdministrationFTAMember__srt--CurrencyAxis__currency--EUR__us-gaap--TypeOfArrangementAxis__custom--GlobalSettlementAgreementMember_zgRIBUsoyBNa" title="Taxes Payable"><ix:nonFraction name="us-gaap:TaxesPayableCurrentAndNoncurrent" contextRef="AsOf2021-12-31_us-gaap_SwissFederalTaxAdministrationFTAMember_currency_EUR_custom_GlobalSettlementAgreementMember" format="ixt:numdotdecimal" decimals="0" scale="6" unitRef="USDEUR">2.5</ix:nonFraction> million</span> (approximately
$<span id="xdx_904_eus-gaap--TaxesPayableCurrentAndNoncurrent_iI_dm_uUSD_c20211231__us-gaap--IncomeTaxAuthorityNameAxis__us-gaap--SwissFederalTaxAdministrationFTAMember__us-gaap--TypeOfArrangementAxis__custom--GlobalSettlementAgreementMember_zNa45vnyzqeh" title="Taxes Payable"><ix:nonFraction name="us-gaap:TaxesPayableCurrentAndNoncurrent" contextRef="AsOf2021-12-31_us-gaap_SwissFederalTaxAdministrationFTAMember_custom_GlobalSettlementAgreementMember" format="ixt:numdotdecimal" decimals="0" scale="6" unitRef="USD">2.9</ix:nonFraction> million</span>) effectively lowering the Lanvin brand royalty rate charged by IP Suisse for the periods from 2017 through 2020. Interparfums
SA also agreed to apply the lower rate in 2021 through 2025 and to transfer the Lanvin brand from IP Suisse to Interparfums SA
by December 31, 2025.</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><b><i>Land and Building Acquisition
- Future Headquarters in Paris</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In April 2021, Interparfums SA,
completed the acquisition of its future headquarters at 10 rue de Solf&#233;rino in the 7th arrondissement of Paris from the
property developer. This is an office complex combining three buildings connected by two inner courtyards, and consists of approximately
40,000 total sq. ft.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<ix:exclude><!-- Field: Page; Sequence: 105; Value: 1 -->
    <div id="xdx_235_zjPokVuG51vf" style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p id="xdx_239_z44GIrLRKed8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p id="xdx_234_zSzI1fHGEWPf" style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<ix:exclude><p id="xdx_23F_z36RPHIHJIt6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>INTER PARFUMS, INC. AND SUBSIDIARIES</b></p></ix:exclude>

<ix:exclude><p id="xdx_232_z2FoNbBItJ2i" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23D_zcuod11RDsL9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Notes to Consolidated Financial Statements</p></ix:exclude>

<ix:exclude><p id="xdx_235_z6kqxbMKWafd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">December 31, 2021, 2020 and 2019</p></ix:exclude>

<ix:exclude><p id="xdx_23F_zVI5Ks9Fjy2a" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(In thousands except share and per share data)</p></ix:exclude>

<ix:exclude><p id="xdx_23A_z0afGCa7cUE2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The $<span id="xdx_902_eus-gaap--PaymentsForPurchaseOfOtherAssets1_pn6n6_uUSD_c20210101__20211231_zKlent8Ofh4k"><ix:nonFraction name="us-gaap:PaymentsForPurchaseOfOtherAssets1" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-6" scale="6" unitRef="USD">142</ix:nonFraction> million</span> purchase price
includes the complete renovation of the site. As of December 31, 2021, $136.1 million of the purchase price, including approximately
$<span id="xdx_901_eus-gaap--AcquisitionCosts_dm_uUSD_c20210101__20211231__srt--CurrencyAxis__currency--EUR_zGDIfEGVe4h6"><ix:nonFraction name="us-gaap:AcquisitionCosts" contextRef="From2021-01-012021-12-31_currency_EUR" format="ixt:numdotdecimal" decimals="0" scale="6" unitRef="USD">3.1</ix:nonFraction> million</span> of acquisition costs, is included in property, equipment and leasehold improvements on the accompanying balance sheet
as of December 31, 2021. Approximately $<span id="xdx_903_ecustom--CashHeldInEscrow_iI_dm_c20211231_zcXQAcHk90za"><ix:nonFraction name="ipar:CashHeldInEscrow" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="6" unitRef="USD">8.8</ix:nonFraction> million</span> of cash held in escrow is included in other assets on the accompanying balance
sheet as of December 31, 2021. In addition, the Company borrowed $<span id="xdx_901_eus-gaap--IncomeTaxReceivable_iI_dm_c20211231__srt--CurrencyAxis__currency--EUR__us-gaap--IncomeTaxAuthorityNameAxis__us-gaap--SwissFederalTaxAdministrationFTAMember_zJZHWCo7GE88"><ix:nonFraction name="us-gaap:IncomeTaxReceivable" contextRef="AsOf2021-12-31_currency_EUR_us-gaap_SwissFederalTaxAdministrationFTAMember" format="ixt:numdotdecimal" decimals="0" scale="6" unitRef="USD">17.0</ix:nonFraction> million</span> pursuant to a short-term loan equal to the VAT credit,
and in July 2021, the $<span id="xdx_901_eus-gaap--InvestmentTaxCredit_dm_c20210101__20211231__srt--CurrencyAxis__currency--EUR_zykIjumC6No"><ix:nonFraction name="us-gaap:InvestmentTaxCredit" contextRef="From2021-01-012021-12-31_currency_EUR" format="ixt:numdotdecimal" decimals="0" scale="6" unitRef="USD">17.0</ix:nonFraction> million</span> VAT credit was reimbursed by the French Tax Authorities and the loan was repaid.</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The acquisition was financed
by a <span id="xdx_909_eus-gaap--LongTermDebtTerm_iI_dtYxL_c20211231_zEMKWpLnF5X5" title="Long-term Debt, Term::XDX::P10Y"><span style="-sec-ix-hidden: xdx2ixbrl0880">10</span></span>-year &#8364;<span id="xdx_903_eus-gaap--LineOfCredit_iI_pn3n3_uUSDEUR_c20211231__srt--CurrencyAxis__currency--EUR_zznhm4xTa8a2" title="Long-term Line of Credit"><ix:nonFraction name="us-gaap:LineOfCredit" contextRef="AsOf2021-12-31_currency_EUR" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USDEUR">120</ix:nonFraction></span> million (approximately $<span id="xdx_901_eus-gaap--LineOfCredit_iI_pn3n3_c20211231_zvrHR7gWg4Hd" title="Long-term Line of Credit"><ix:nonFraction name="us-gaap:LineOfCredit" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">136</ix:nonFraction></span> million) bank loan which bears interest at <span id="xdx_909_eus-gaap--DebtInstrumentInterestRateTerms_c20210101__20211231_z5oqquTuhvI2" title="Debt Instrument, Interest Rate Terms"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" name="us-gaap:DebtInstrumentInterestRateTerms">one-month Euribor plus 0.75%</ix:nonNumeric></span>. Approximately
&#8364;<span id="xdx_904_eus-gaap--DebtInstrumentFaceAmount_iI_pn3n3_uUSDEUR_c20211231__srt--CurrencyAxis__currency--EUR_zKK7gisjMti" title="Debt Instrument, Face Amount"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2021-12-31_currency_EUR" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USDEUR">80</ix:nonFraction> million</span> of the variable rate debt was swapped for fixed interest rate debt with a maximum interest rate of 2%.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><b><i>Anna Sui Corp.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In January 2021, we renewed our
license agreement with Anna Sui Corp. for the creation, development and distribution of fragrance products through December&#160;31,
2026, without any material changes in terms and conditions. <span id="xdx_903_ecustom--DiscriptionOfRecentAgreement_c20210101__20211231__dei--LegalEntityAxis__custom--AnnaSuiCorpMember_zUsirhIK94Na" title="Discription of recent agreement"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_AnnaSuiCorpMember" name="ipar:DiscriptionOfRecentAgreement">Our initial 10-year license agreement with Anna Sui Corp. was signed
in 2011. The renewal agreement also allows for an additional 5-year term through 2031 at the option of the Company</ix:nonNumeric></span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><b><i>Rochas Fashion</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Effective January 1, 2021, we
entered into a new license agreement modifying our Rochas fashion business model. The new agreement calls for a reduction in royalties
to be received. As a result, in the first quarter of 2021, we took a $<span id="xdx_902_eus-gaap--ImpairmentChargeOnReclassifiedAssets_dm_c20210101__20211231__dei--LegalEntityAxis__custom--RochasFashionMember_zkCLcfrr2KLe" title="Impairment Charge on Reclassified Assets"><ix:nonFraction name="us-gaap:ImpairmentChargeOnReclassifiedAssets" contextRef="From2021-01-012021-12-31_custom_RochasFashionMember" format="ixt:numdotdecimal" decimals="0" scale="6" unitRef="USD">2.4</ix:nonFraction> million</span> impairment charge on our Rochas fashion trademark.
The new license also contains an option for the licensee to buy-out the Rochas fashion trademarks in June 2025 at its then fair
market value.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><b><i>S.T. Dupont</i></b>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In January 2021, <span id="xdx_900_eus-gaap--BusinessAcquisitionDescriptionOfAcquiredEntity_c20210101__20211231__dei--LegalEntityAxis__custom--STDupontMember_zzie8oIqQBaj" title="License agreements, description"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_STDupontMember" name="us-gaap:BusinessAcquisitionDescriptionOfAcquiredEntity">we renewed our
license agreement with S.T. Dupont for the creation, development and distribution of fragrance products through December&#160;31,
2022, without any material changes in terms and conditions. Our initial 11-year license agreement with S.T. Dupont was signed in
June 1997 and had previously been extended through December 31, 2021.</ix:nonNumeric></span></p>

</ix:nonNumeric><p id="xdx_81E_z8bAZjqKPjy9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>


<!-- Field: /Named-Area; -->

<!-- Field: Named-Area; Name: Contents -->
<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:InventoryDisclosureTextBlock"><p id="xdx_80C_eus-gaap--InventoryDisclosureTextBlock_zbIqYjDHdHx4" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in">(4)</td><td><span id="xdx_82A_zPVN2RmbXXAa">Inventories</span></td></tr></table>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock"><p id="xdx_892_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zrRb4nJddiO5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span id="xdx_8B1_z1kNhe6Jw8G8" style="display: none; visibility: hidden">Schedule of inventories</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_49F_20211231_z7oxjyUrNaij" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_492_20201231_zHh7oxh1Rru7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr id="xdx_407_eus-gaap--InventoryRawMaterials_iI_maINz9tx_zpDlqBeKK311" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 70%; text-align: left">Raw materials and component parts</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:InventoryRawMaterials" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">111,312</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:InventoryRawMaterials" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">66,492</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_408_eus-gaap--InventoryFinishedGoods_iI_maINz9tx_zO2JndZo2iN2" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Finished goods</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:InventoryFinishedGoods" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">87,602</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:InventoryFinishedGoods" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">92,330</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--InventoryNet_iI_mtINz9tx_zwskzoITkwre" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="display: none; padding-bottom: 2pt; visibility: hidden">Inventories</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td style="border-bottom: Black 2pt double; text-align: right"><ix:nonFraction name="us-gaap:InventoryNet" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">198,914</ix:nonFraction></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td style="border-bottom: Black 2pt double; text-align: right"><ix:nonFraction name="us-gaap:InventoryNet" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">158,822</ix:nonFraction></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
</table>



</ix:nonNumeric><p id="xdx_8AB_zpl8F1Ipqorb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Overhead included in inventory
aggregated $<span id="xdx_90B_eus-gaap--CostOfGoodsAndServicesSoldOverhead_dm_c20210101__20211231__srt--ProductOrServiceAxis__us-gaap--ProductMember_zUYcASZwXUK5" title="Cost of Goods Sold, Overhead"><ix:nonFraction name="us-gaap:CostOfGoodsAndServicesSoldOverhead" contextRef="From2021-01-012021-12-31_us-gaap_ProductMember" format="ixt:numdotdecimal" decimals="0" scale="6" unitRef="USD">3.7</ix:nonFraction> million</span> and $<span id="xdx_902_eus-gaap--CostOfGoodsAndServicesSoldOverhead_dm_c20200101__20201231__srt--ProductOrServiceAxis__us-gaap--ProductMember_zH75RwMS2Wp3"><ix:nonFraction name="us-gaap:CostOfGoodsAndServicesSoldOverhead" contextRef="From2020-01-012020-12-31_us-gaap_ProductMember" format="ixt:numdotdecimal" decimals="0" scale="6" unitRef="USD">5.4</ix:nonFraction> million</span> as of December 31, 2021 and 2020, respectively. Included in inventories is an inventory
reserve, which represents the difference between the cost of the inventory and its estimated realizable value, based upon sales
forecasts and the physical condition of the inventories. In addition, and as necessary, specific reserves for future known or anticipated
events may be established. Inventory reserves aggregated $<span id="xdx_908_eus-gaap--InventoryValuationReserves_iI_dm_c20211231_z3HCyH8yiTr3" title="Inventory Valuation Reserves"><ix:nonFraction name="us-gaap:InventoryValuationReserves" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="6" unitRef="USD">15.8</ix:nonFraction> million</span> and $<span id="xdx_907_eus-gaap--InventoryValuationReserves_iI_dm_c20201231_zNoSN7RlidSk" title="Inventory Valuation Reserves"><ix:nonFraction name="us-gaap:InventoryValuationReserves" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="6" unitRef="USD">9.4</ix:nonFraction> million</span> as of December 31, 2021 and 2020, respectively.</p>

</ix:nonNumeric><p id="xdx_818_z9YokQxfNd9a" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<!-- Field: Page; Sequence: 106; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>INTER PARFUMS, INC. AND SUBSIDIARIES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Notes to Consolidated Financial Statements</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">December 31, 2021, 2020 and 2019</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(In thousands except share and per share data)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>


<!-- Field: /Named-Area; -->

<!-- Field: Named-Area; Name: Contents -->
<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:FairValueDisclosuresTextBlock"><p id="xdx_806_eus-gaap--FairValueDisclosuresTextBlock_zeSK3KGDx5I1" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in">(5)</td><td><span id="xdx_826_zA9SG9OgExr7">Fair Value of Financial Instruments</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"><p id="xdx_895_eus-gaap--ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_zpUSsX2tZJt1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The following tables present
our financial assets and liabilities that are measured at fair value on a recurring basis and are categorized using the fair value
hierarchy. The fair value hierarchy has three levels based on the reliability of the inputs used to determine fair value.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8B5_z08ZA4b1osk4" style="display: none; visibility: hidden">Schedule of fair value, assets measured on recurring basis</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_499_20211231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zip1pYCzDCQ9" style="font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_49E_20211231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zqW8AlibTaAh" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_498_20211231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zWFQNxn7cvse" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_497_20211231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zcDrb0jEVg1h" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="color: Black">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="color: Black">&#160;</span></td>
    <td colspan="2" style="font-weight: bold"><span style="color: Black">&#160;</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="color: Black">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="color: Black">&#160;</span></td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="color: Black">Fair
    Value Measurements at December 31, 2021</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="color: Black">&#160;</span></td></tr>
<tr style="text-align: center; vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: right"><span style="color: Black">&#160;</span></td><td style="font-weight: bold; text-align: right"><span style="color: Black">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: right"><span style="color: Black">&#160;</span></td><td style="font-weight: bold; text-align: right"><span style="color: Black">&#160;</span></td><td style="font-weight: bold; text-align: right"><span style="color: Black">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: right"><span style="color: Black">Quoted Prices in</span></td><td style="font-weight: bold; text-align: right"><span style="color: Black">&#160;</span></td><td style="font-weight: bold; text-align: right"><span style="color: Black">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: right"><span style="color: Black">Significant Other</span></td><td style="font-weight: bold; text-align: right"><span style="color: Black">&#160;</span></td><td style="font-weight: bold; text-align: right"><span style="color: Black">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: right"><span style="color: Black">Significant</span></td><td style="font-weight: bold; text-align: right"><span style="color: Black">&#160;</span></td></tr>
<tr style="text-align: center; vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: right"><span style="color: Black">&#160;</span></td><td style="font-weight: bold; text-align: right"><span style="color: Black">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: right"><span style="color: Black">&#160;</span></td><td style="font-weight: bold; text-align: right"><span style="color: Black">&#160;</span></td><td style="font-weight: bold; text-align: right"><span style="color: Black">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: right"><span style="color: Black">Active Markets for</span></td><td style="font-weight: bold; text-align: right"><span style="color: Black">&#160;</span></td><td style="font-weight: bold; text-align: right"><span style="color: Black">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: right"><span style="color: Black">Observable</span></td><td style="font-weight: bold; text-align: right"><span style="color: Black">&#160;</span></td><td style="font-weight: bold; text-align: right"><span style="color: Black">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: right"><span style="color: Black">Unobservable</span></td><td style="font-weight: bold; text-align: right"><span style="color: Black">&#160;</span></td></tr>
<tr style="text-align: center; vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: right"><span style="color: Black">&#160;</span></td><td style="font-weight: bold; text-align: right"><span style="color: Black">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: right"><span style="color: Black">&#160;</span></td><td style="font-weight: bold; text-align: right"><span style="color: Black">&#160;</span></td><td style="font-weight: bold; text-align: right"><span style="color: Black">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: right"><span style="color: Black">Identical Assets</span></td><td style="font-weight: bold; text-align: right"><span style="color: Black">&#160;</span></td><td style="font-weight: bold; text-align: right"><span style="color: Black">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: right"><span style="color: Black">Inputs</span></td><td style="font-weight: bold; text-align: right"><span style="color: Black">&#160;</span></td><td style="font-weight: bold; text-align: right"><span style="color: Black">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: right"><span style="color: Black">Inputs</span></td><td style="font-weight: bold; text-align: right"><span style="color: Black">&#160;</span></td></tr>
<tr style="text-align: center; vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: right"><span style="color: Black">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt; text-align: right"><span style="color: Black">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="color: Black">Total</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: right"><span style="color: Black">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt; text-align: right"><span style="color: Black">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="color: Black">(Level 1)</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: right"><span style="color: Black">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt; text-align: right"><span style="color: Black">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="color: Black">(Level 2)</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: right"><span style="color: Black">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt; text-align: right"><span style="color: Black">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="color: Black">(Level 3)</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: right"><span style="color: Black">&#160;</span></td></tr>
<tr id="xdx_406_eus-gaap--AssetsFairValueDisclosureAbstract_iB_zyr2SglTMbYk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="color: Black">Assets:</span></td><td><span style="color: Black">&#160;</span></td>
    <td colspan="2"><span style="color: Black">&#160;</span></td><td><span style="color: Black">&#160;</span></td><td><span style="color: Black">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="color: Black">&#160;</span></td><td><span style="color: Black">&#160;</span></td><td><span style="color: Black">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="color: Black">&#160;</span></td><td><span style="color: Black">&#160;</span></td><td><span style="color: Black">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="color: Black">&#160;</span></td><td><span style="color: Black">&#160;</span></td></tr>
<tr id="xdx_407_eus-gaap--InvestmentsFairValueDisclosure_i01I_zoqxLledHNfl" style="vertical-align: bottom; background-color: White">
    <td style="width: 38%; text-align: left; padding-bottom: 2pt; padding-left: 0.25in; text-indent: -0.125in"><span style="color: Black">Short-term
    investments</span></td><td style="width: 1%; padding-bottom: 2pt"><span style="color: Black">&#160;</span></td>
    <td style="border-bottom: Black 2pt double; width: 1%; text-align: left"><span style="color: Black">$</span></td><td style="border-bottom: Black 2pt double; width: 12%; text-align: right"><span style="color: Black"><ix:nonFraction name="us-gaap:InvestmentsFairValueDisclosure" contextRef="AsOf2021-12-31_us-gaap_FairValueMeasurementsRecurringMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">160,014</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 2pt; text-align: left"><span style="color: Black">&#160;</span></td><td style="width: 1%; padding-bottom: 2pt"><span style="color: Black">&#160;</span></td>
    <td style="border-bottom: Black 2pt double; width: 1%; text-align: left"><span style="color: Black">$</span></td><td style="border-bottom: Black 2pt double; width: 14%; text-align: right"><span style="color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0926">&#8212;</span></span></td><td style="width: 1%; padding-bottom: 2pt; text-align: left"><span style="color: Black">&#160;</span></td><td style="width: 1%; padding-bottom: 2pt"><span style="color: Black">&#160;</span></td>
    <td style="border-bottom: Black 2pt double; width: 1%; text-align: left"><span style="color: Black">$</span></td><td style="border-bottom: Black 2pt double; width: 12%; text-align: right"><span style="color: Black"><ix:nonFraction name="us-gaap:InvestmentsFairValueDisclosure" contextRef="AsOf2021-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel2Member" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">160,014</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 2pt; text-align: left"><span style="color: Black">&#160;</span></td><td style="width: 1%; padding-bottom: 2pt"><span style="color: Black">&#160;</span></td>
    <td style="border-bottom: Black 2pt double; width: 1%; text-align: left"><span style="color: Black">$</span></td><td style="border-bottom: Black 2pt double; width: 12%; text-align: right"><span style="color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0928">&#8212;</span></span></td><td style="width: 1%; padding-bottom: 2pt; text-align: left"><span style="color: Black">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="color: Black">&#160;</span></td><td><span style="color: Black">&#160;</span></td>
    <td style="text-align: left"><span style="color: Black">&#160;</span></td><td style="text-align: right"><span style="color: Black">&#160;</span></td><td style="text-align: left"><span style="color: Black">&#160;</span></td><td><span style="color: Black">&#160;</span></td>
    <td style="text-align: left"><span style="color: Black">&#160;</span></td><td style="text-align: right"><span style="color: Black">&#160;</span></td><td style="text-align: left"><span style="color: Black">&#160;</span></td><td><span style="color: Black">&#160;</span></td>
    <td style="text-align: left"><span style="color: Black">&#160;</span></td><td style="text-align: right"><span style="color: Black">&#160;</span></td><td style="text-align: left"><span style="color: Black">&#160;</span></td><td><span style="color: Black">&#160;</span></td>
    <td style="text-align: left"><span style="color: Black">&#160;</span></td><td style="text-align: right"><span style="color: Black">&#160;</span></td><td style="text-align: left"><span style="color: Black">&#160;</span></td></tr>
<tr id="xdx_402_eus-gaap--LiabilitiesAbstract_iB_zm2i0qxAvay6" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="color: Black">Liabilities:</span></td><td><span style="color: Black">&#160;</span></td>
    <td style="text-align: left"><span style="color: Black">&#160;</span></td><td style="text-align: right"><span style="color: Black">&#160;</span></td><td style="text-align: left"><span style="color: Black">&#160;</span></td><td><span style="color: Black">&#160;</span></td>
    <td style="text-align: left"><span style="color: Black">&#160;</span></td><td style="text-align: right"><span style="color: Black">&#160;</span></td><td style="text-align: left"><span style="color: Black">&#160;</span></td><td><span style="color: Black">&#160;</span></td>
    <td style="text-align: left"><span style="color: Black">&#160;</span></td><td style="text-align: right"><span style="color: Black">&#160;</span></td><td style="text-align: left"><span style="color: Black">&#160;</span></td><td><span style="color: Black">&#160;</span></td>
    <td style="text-align: left"><span style="color: Black">&#160;</span></td><td style="text-align: right"><span style="color: Black">&#160;</span></td><td style="text-align: left"><span style="color: Black">&#160;</span></td></tr>
<tr id="xdx_40C_eus-gaap--ForeignCurrencyFairValueHedgeAssetAtFairValue_i01I_zyZJXYtQXuE5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in"><span style="color: Black">Foreign currency forward
    exchange contracts accounted for using hedge accounting</span></td><td><span style="color: Black">&#160;</span></td>
    <td style="text-align: left"><span style="color: Black">$</span></td><td style="text-align: right"><span style="color: Black"><ix:nonFraction name="us-gaap:ForeignCurrencyFairValueHedgeAssetAtFairValue" contextRef="AsOf2021-12-31_us-gaap_FairValueMeasurementsRecurringMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,982</ix:nonFraction></span></td><td style="text-align: left"><span style="color: Black">&#160;</span></td><td><span style="color: Black">&#160;</span></td>
    <td style="text-align: left"><span style="color: Black">$</span></td><td style="text-align: right"><span style="color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0936">&#8212;</span></span></td><td style="text-align: left"><span style="color: Black">&#160;</span></td><td><span style="color: Black">&#160;</span></td>
    <td style="text-align: left"><span style="color: Black">$</span></td><td style="text-align: right"><span style="color: Black"><ix:nonFraction name="us-gaap:ForeignCurrencyFairValueHedgeAssetAtFairValue" contextRef="AsOf2021-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel2Member" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,982</ix:nonFraction></span></td><td style="text-align: left"><span style="color: Black">&#160;</span></td><td><span style="color: Black">&#160;</span></td>
    <td style="text-align: left"><span style="color: Black">$</span></td><td style="text-align: right"><span style="color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0938">&#8212;</span></span></td><td style="text-align: left"><span style="color: Black">&#160;</span></td></tr>
<tr id="xdx_40D_eus-gaap--ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue_i01I_zeqSL4COBFL7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.375in; text-indent: -0.125in"><span style="color: Black">Foreign currency forward
    exchange contracts not accounted for using hedge accounting</span></td><td><span style="color: Black">&#160;</span></td>
    <td style="text-align: left"><span style="color: Black">&#160;</span></td><td style="text-align: right"><span style="color: Black"><ix:nonFraction name="us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue" contextRef="AsOf2021-12-31_us-gaap_FairValueMeasurementsRecurringMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">63</ix:nonFraction></span></td><td style="text-align: left"><span style="color: Black">&#160;</span></td><td><span style="color: Black">&#160;</span></td>
    <td style="text-align: left"><span style="color: Black">&#160;</span></td><td style="text-align: right"><span style="color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0941">&#8212;</span></span></td><td style="text-align: left"><span style="color: Black">&#160;</span></td><td><span style="color: Black">&#160;</span></td>
    <td style="text-align: left"><span style="color: Black">&#160;</span></td><td style="text-align: right"><span style="color: Black"><ix:nonFraction name="us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue" contextRef="AsOf2021-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel2Member" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">63</ix:nonFraction></span></td><td style="text-align: left"><span style="color: Black">&#160;</span></td><td><span style="color: Black">&#160;</span></td>
    <td style="text-align: left"><span style="color: Black">$&#160;</span></td><td style="text-align: right"><span style="color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0943">&#8212;</span></span></td><td style="text-align: left"><span style="color: Black">&#160;</span></td></tr>
<tr id="xdx_40A_eus-gaap--DerivativeLiabilities_iI_zoek8SC7XOo4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.25in; text-indent: -0.125in"><span style="color: Black">Interest
    rate swaps</span></td><td style="color: #FF0000; padding-bottom: 1pt"><span style="color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; color: #FF0000; text-align: left"><span style="color: Black">&#160;</span></td><td style="border-bottom: Black 1pt solid; color: #FF0000; text-align: right"><span style="color: Black">(<ix:nonFraction name="us-gaap:DerivativeLiabilities" contextRef="AsOf2021-12-31_us-gaap_FairValueMeasurementsRecurringMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">234</ix:nonFraction></span></td><td style="padding-bottom: 1pt; color: #FF0000; text-align: left"><span style="color: Black">)</span></td><td style="padding-bottom: 1pt"><span style="color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="color: Black">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0946">&#8212;</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="color: Black">&#160;</span></td><td style="color: #FF0000; padding-bottom: 1pt"><span style="color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; color: #FF0000; text-align: left"><span style="color: Black">&#160;</span></td><td style="border-bottom: Black 1pt solid; color: #FF0000; text-align: right"><span style="color: Black">(<ix:nonFraction name="us-gaap:DerivativeLiabilities" contextRef="AsOf2021-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel2Member" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">234</ix:nonFraction></span></td><td style="padding-bottom: 1pt; color: #FF0000; text-align: left"><span style="color: Black">)</span></td><td style="padding-bottom: 1pt"><span style="color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="color: Black">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0948">&#8212;</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="color: Black">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="color: Black">&#160;</span></td><td><span style="color: Black">&#160;</span></td>
    <td style="text-align: left"><span style="color: Black">&#160;</span></td><td style="text-align: right"><span style="color: Black">&#160;</span></td><td style="text-align: left"><span style="color: Black">&#160;</span></td><td><span style="color: Black">&#160;</span></td>
    <td style="text-align: left"><span style="color: Black">&#160;</span></td><td style="text-align: right"><span style="color: Black">&#160;</span></td><td style="text-align: left"><span style="color: Black">&#160;</span></td><td><span style="color: Black">&#160;</span></td>
    <td style="text-align: left"><span style="color: Black">&#160;</span></td><td style="text-align: right"><span style="color: Black">&#160;</span></td><td style="text-align: left"><span style="color: Black">&#160;</span></td><td><span style="color: Black">&#160;</span></td>
    <td style="text-align: left"><span style="color: Black">&#160;</span></td><td style="text-align: right"><span style="color: Black">&#160;</span></td><td style="text-align: left"><span style="color: Black">&#160;</span></td></tr>
<tr id="xdx_405_eus-gaap--AssetsFairValueDisclosure_iI_zgWf1xgKXWnd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2pt; padding-left: 0.125in; text-indent: -0.125in"><span style="color: Black">&#160;</span></td><td style="padding-bottom: 2pt"><span style="color: Black">&#160;</span></td>
    <td style="border-bottom: Black 2pt double; text-align: left"><span style="color: Black">$</span></td><td style="border-bottom: Black 2pt double; text-align: right"><span style="color: Black"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2021-12-31_us-gaap_FairValueMeasurementsRecurringMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,811</ix:nonFraction></span></td><td style="padding-bottom: 2pt; text-align: left"><span style="color: Black">&#160;</span></td><td style="padding-bottom: 2pt"><span style="color: Black">&#160;</span></td>
    <td style="border-bottom: Black 2pt double; text-align: left"><span style="color: Black">$</span></td><td style="border-bottom: Black 2pt double; text-align: right"><span style="color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0951">&#8212;</span></span></td><td style="padding-bottom: 2pt; text-align: left"><span style="color: Black">&#160;</span></td><td style="padding-bottom: 2pt"><span style="color: Black">&#160;</span></td>
    <td style="border-bottom: Black 2pt double; text-align: left"><span style="color: Black">$</span></td><td style="border-bottom: Black 2pt double; text-align: right"><span style="color: Black"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2021-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel2Member" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,811</ix:nonFraction></span></td><td style="padding-bottom: 2pt; text-align: left"><span style="color: Black">&#160;</span></td><td style="padding-bottom: 2pt"><span style="color: Black">&#160;</span></td>
    <td style="border-bottom: Black 2pt double; text-align: left"><span style="color: Black">$</span></td><td style="border-bottom: Black 2pt double; text-align: right"><span style="color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0953">&#8212;</span></span></td><td style="padding-bottom: 2pt; text-align: left"><span style="color: Black">&#160;</span></td></tr>
</table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_494_20201231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_z7FyXXMlbJxf" style="font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_49D_20201231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z1vV2kJH9DG3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_490_20201231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zeDZ9U0lgoDj" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_49C_20201231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zDh2rS24njTf" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Fair Value Measurements at December 31, 2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: right; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: right">Quoted Prices in</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: right">Significant Other</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: right">Significant</td><td style="font-weight: bold; text-align: right">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: right; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: right">Active Markets for</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: right">Observable</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: right">Unobservable</td><td style="font-weight: bold; text-align: right">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: right; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: right">Identical Assets</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: right">Inputs</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: right">Inputs</td><td style="font-weight: bold; text-align: right">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: right; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt; text-align: right">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">Total</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt; text-align: right">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(Level 1)</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt; text-align: right">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(Level 2)</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt; text-align: right">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(Level 3)</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: right">&#160;</td></tr>
<tr id="xdx_406_eus-gaap--AssetsFairValueDisclosureAbstract_iB_zPVcHzGl6kc1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">Assets:</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
<tr id="xdx_407_eus-gaap--InvestmentsFairValueDisclosure_i01I_zFWk88u7lgO3" style="vertical-align: bottom; background-color: White">
    <td style="width: 38%; text-align: left; padding-left: 0.25in; text-indent: -0.125in">Short-term investments</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:InvestmentsFairValueDisclosure" contextRef="AsOf2020-12-31_us-gaap_FairValueMeasurementsRecurringMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">126,627</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0961">&#8212;</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:InvestmentsFairValueDisclosure" contextRef="AsOf2020-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel2Member" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">126,627</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0963">&#8212;</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue_i01I_zT4hr1fpmTaj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.25in; text-indent: -0.125in">Foreign currency forward exchange contracts not accounted for using hedge accounting</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue" contextRef="AsOf2020-12-31_us-gaap_FairValueMeasurementsRecurringMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">253</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0966">&#8212;</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue" contextRef="AsOf2020-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel2Member" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">253</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0968">&#8212;</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_403_eus-gaap--AssetsFairValueDisclosure_i01I_zonVrdkYao88" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="display: none; padding-bottom: 2pt; padding-left: 0.125in; text-indent: -0.125in; visibility: hidden">&#160;Total Assets</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td style="border-bottom: Black 2pt double; text-align: right"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2020-12-31_us-gaap_FairValueMeasurementsRecurringMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">126,880</ix:nonFraction></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td style="border-bottom: Black 2pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0971">&#8212;</span></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td style="border-bottom: Black 2pt double; text-align: right"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2020-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel2Member" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">126,880</ix:nonFraction></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td style="border-bottom: Black 2pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0973">&#8212;</span></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
</table>



</ix:nonNumeric><p id="xdx_8A0_zwDNJddXG2Yl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The carrying amount of cash and
cash equivalents including money market funds, short-term investments including marketable equity securities, accounts receivable,
other receivables, accounts payable and accrued expenses approximates fair value due to the short terms to maturity of these instruments.
The carrying amount of loans payable approximates fair value as the variable interest rates on the Company&#8217;s indebtedness
approximate current market rates.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<ix:exclude><!-- Field: Page; Sequence: 107; Value: 1 -->
    <div id="xdx_23B_zEQ7GpbBtcya" style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p id="xdx_23A_zxWlF8QNiXUa" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></p></div>
    <div id="xdx_239_zVL80B1H5NO6" style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_234_zu9f0iKfC1ob" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_238_z5ZGFXM3FfU3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>INTER PARFUMS, INC. AND SUBSIDIARIES</b></p></ix:exclude>

<ix:exclude><p id="xdx_239_zARalx2tbtN9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23A_z8XrN6IvF2q4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Notes to Consolidated Financial Statements</p></ix:exclude>

<ix:exclude><p id="xdx_230_zBOmyly5cmwf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">December 31, 2021, 2020 and 2019</p></ix:exclude>

<ix:exclude><p id="xdx_238_zs9YBMDWMFP4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(In thousands except share and per share data)</p></ix:exclude>

<ix:exclude><p id="xdx_23F_zQ19FvXFtMqc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Foreign currency forward exchange
contracts are valued based on quotations from financial institutions and the value of interest rate swaps are the discounted net
present value of the swaps using third party quotes from financial institutions.</p>

</ix:nonNumeric><p id="xdx_815_zDS7AxuZosPi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>


<!-- Field: /Named-Area; -->

<!-- Field: Named-Area; Name: Contents -->
<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"><p id="xdx_807_eus-gaap--DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_zn5M6Z8fNke4" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in">(6)</td><td><span id="xdx_82E_zfnjnKZXosil">Derivative Financial Instruments</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company enters into foreign
currency forward exchange contracts to hedge exposure related to receivables denominated in a foreign currency and occasionally
to manage risks related to future sales expected to be denominated in a foreign currency. Before entering into a derivative transaction
for hedging purposes, it is determined that a high degree of initial effectiveness exists between the change in value of the hedged
item and the change in the value of the derivative instrument from movement in exchange rates. High effectiveness means that the
change in the cash flows of the derivative instrument will effectively offset the change in the cash flows of the hedged item.
The effectiveness of each hedged item is measured throughout the hedged period and is based on the dollar offset methodology and
excludes the portion of the fair value of the foreign currency forward exchange contract attributable to the change in spot-forward
difference which is reported in current period earnings. Any hedge ineffectiveness is also recognized as a gain or loss on foreign
currency in the income statement. For hedge contracts that are no longer deemed highly effective, hedge accounting is discontinued,
and gains and losses accumulated in other comprehensive income are reclassified to earnings.&#160;If it is probable that the forecasted
transaction will no longer occur, then any gains or losses accumulated in other comprehensive income are reclassified to current-period
earnings.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Gains and losses in derivatives
designated as hedges are accumulated in other comprehensive income (loss) and gains and losses in derivatives not designated as
hedges are included in (gain) loss on foreign currency on the accompanying income statements. Such gains and losses were immaterial
in each of the years in the three-year period ended December 31, 2021. For the year ended December 31, 2021, interest expense
includes a gain of $0.2 million, resulting from an interest rate swap.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">All derivative instruments are
reported as either assets or liabilities on the balance sheet measured at fair value. The valuation of interest rate swap is included
in long-term debt on the accompanying balance sheets. The valuation of foreign currency forward exchange contracts at December
31, 2021 and December 31, 2020, resulted in an asset and is included in other current assets on the accompanying balance sheets.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">At December&#160;31, 2021, the
Company had foreign currency contracts in the form of forward exchange contracts with notional amounts of approximately U.S. $<span id="xdx_902_eus-gaap--ForeignCurrencyContractsLiabilityFairValueDisclosure_iI_dm_uUSD_c20211231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--ForeignExchangeContractMember_zUrDW8nAWuge" title="Foreign currency contracts, liability, fair value disclosure"><ix:nonFraction name="us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure" contextRef="AsOf2021-12-31_us-gaap_ForeignExchangeContractMember" format="ixt:numdotdecimal" decimals="0" scale="6" unitRef="USD">64.5</ix:nonFraction> million</span>
and GB &#163;<span id="xdx_90C_eus-gaap--ForeignCurrencyContractsLiabilityFairValueDisclosure_iI_dm_uUSDGBP_c20211231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--ForeignExchangeContractMember_zJaINp4y5hvi" title="Foreign currency contracts, liability, fair value disclosure"><ix:nonFraction name="us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure" contextRef="AsOf2021-12-31_us-gaap_ForeignExchangeContractMember" format="ixt:numdotdecimal" decimals="0" scale="6" unitRef="USDGBP">3.5</ix:nonFraction> million</span>, which all have maturities of less than one year.</p>

</ix:nonNumeric><p id="xdx_81C_zk6w3QlRaxPh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<!-- Field: Page; Sequence: 108; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>INTER PARFUMS, INC. AND SUBSIDIARIES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Notes to Consolidated Financial Statements</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">December 31, 2021, 2020 and 2019</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(In thousands except share and per share data)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>


<!-- Field: /Named-Area; -->

<!-- Field: Named-Area; Name: Contents -->
<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock"><p id="xdx_805_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_zmpCiBz5yz8l" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in">(7)</td><td><span id="xdx_828_zi19mCmjwIk4">Property, Equipment and Leasehold Improvements</span></td></tr></table>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:PropertyPlantAndEquipmentTextBlock"><p id="xdx_893_eus-gaap--PropertyPlantAndEquipmentTextBlock_z0bRjPUIflOc" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span id="xdx_8B4_zOApWi6icI86" style="display: none; visibility: hidden">Schedule of equipment and leasehold improvements</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 70%; text-align: left">Land and Building (construction in progress)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_zmu1pZyIhen" title="Equipment and leasehold improvements" style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2021-12-31_us-gaap_BuildingMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">136,131</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_zOhwooYlLtD9" title="Equipment and leasehold improvements" style="width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0994">&#8212;</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>Equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_zatqLbXfqFpb" title="Equipment and leasehold improvements" style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2021-12-31_us-gaap_EquipmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">52,036</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_zkNXbvmrPpxj" style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2020-12-31_us-gaap_EquipmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">51,060</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Leasehold improvements</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zvYoPZIRifaa" title="Equipment and leasehold improvements" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2021-12-31_us-gaap_LeaseholdImprovementsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,082</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zsgKJCxMc6Le" title="Equipment and leasehold improvements" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2020-12-31_us-gaap_LeaseholdImprovementsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,989</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20211231_zvVH0RSWRkT8" style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">190,249</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20201231_z3jZry9HRNR7" style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">53,049</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Less accumulated depreciation and amortization</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_c20211231_zDfPC239o3jk" title="Less accumulated depreciation and amortization" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">40,897</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_c20201231_zSdQ2fOjLqy6" title="Less accumulated depreciation and amortization" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">33,469</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2pt">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentNet_iI_c20211231_z5MQFrRc4331" title="Property, Plant and Equipment, Net, Total" style="border-bottom: Black 2pt double; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">149,352</ix:nonFraction></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentNet_iI_c20201231_zDkyy5vp5BN7" title="Property, Plant and Equipment, Net, Total" style="border-bottom: Black 2pt double; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">19,580</ix:nonFraction></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
</table>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Depreciation and amortization
expense was $<span id="xdx_903_eus-gaap--DepreciationDepletionAndAmortization_dm_c20210101__20211231_zWBF7I9UTu97" title="Depreciation and amortization expense"><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="6" unitRef="USD">4.4</ix:nonFraction> million</span>, $<span id="xdx_905_eus-gaap--DepreciationDepletionAndAmortization_dm_c20200101__20201231_znvTPsO5y99e" title="Depreciation and amortization expense"><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" scale="6" unitRef="USD">3.8</ix:nonFraction> million</span> and $<span id="xdx_904_eus-gaap--DepreciationDepletionAndAmortization_dm_c20190101__20191231_zRKLfsHBp3Gd" title="Depreciation and amortization expense"><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="0" scale="6" unitRef="USD">3.7</ix:nonFraction> million</span> in 2021, 2020, and 2019, respectively.</p>

</ix:nonNumeric><p id="xdx_8A8_zZYWZciLiWU7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

</ix:nonNumeric><p id="xdx_816_zZbeDgRcpob2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>


<!-- Field: /Named-Area; -->

<!-- Field: Named-Area; Name: Contents -->
<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:IntangibleAssetsDisclosureTextBlock"><p id="xdx_80C_eus-gaap--IntangibleAssetsDisclosureTextBlock_zASYfjfS08qk" style="margin-top: 0; margin-bottom: 0"></p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in">(8)</td><td><span id="xdx_823_ztId1nKE5Sgb">Trademarks, Licenses and Other Intangible Assets</span></td></tr></table>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:ScheduleOfImpairedIntangibleAssetsTextBlock"><p id="xdx_890_eus-gaap--ScheduleOfImpairedIntangibleAssetsTextBlock_zuBsXwYVrou3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span id="xdx_8B9_zFTNgX7e9xii" style="display: none; visibility: hidden">Schedule of trademarks, licenses and other intangible assets</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: left">2021</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Gross</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Accumulated</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Net Book</td><td style="font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amortization</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Value</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 55%; text-align: left; padding-bottom: 1pt">Trademarks (indefinite lives)</td><td style="width: 1%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--IndefinitelivedIntangibleAssetsMember_zu1V8Hk54jCl" title="Gross Amount" style="border-bottom: Black 1pt solid; width: 12%; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2021-12-31_us-gaap_IndefinitelivedIntangibleAssetsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">119,712</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--IndefinitelivedIntangibleAssetsMember_z4V7kKkHlkBi" title="Accumulated Amortization" style="border-bottom: Black 1pt solid; width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1025">&#8212;</span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--IndefinitelivedIntangibleAssetsMember_zrketUL9HUY7" title="Net Book Value" style="border-bottom: Black 1pt solid; width: 12%; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2021-12-31_us-gaap_IndefinitelivedIntangibleAssetsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">119,712</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Trademarks (finite lives)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--FiniteLivedIntangibleAssetsMember_zZCIY8a9jTg" style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2021-12-31_us-gaap_FiniteLivedIntangibleAssetsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">43,820</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--FiniteLivedIntangibleAssetsMember_zqIUcyJ0BHma" style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2021-12-31_us-gaap_FiniteLivedIntangibleAssetsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">68</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--FiniteLivedIntangibleAssetsMember_zmtxuWrqpXn9" style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2021-12-31_us-gaap_FiniteLivedIntangibleAssetsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">43,752</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Licenses (finite lives)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--LicensesMember_zx0fSCvbMOrb" style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2021-12-31_custom_LicensesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">109,682</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--LicensesMember_z8jsBqvtrboj" style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2021-12-31_custom_LicensesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">62,286</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--LicensesMember_z0VnQSfTgOJ7" style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2021-12-31_custom_LicensesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">47,396</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Other intangible assets (finite lives)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_zjSRkZdrdQo9" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2021-12-31_us-gaap_OtherIntangibleAssetsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">17,775</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_zJrZNrlcE1S6" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2021-12-31_us-gaap_OtherIntangibleAssetsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">14,588</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_ztASP3x639Q5" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2021-12-31_us-gaap_OtherIntangibleAssetsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,187</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; padding-left: 0.125in">Subtotal</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20211231__us-gaap--FairValueByAssetClassAxis__custom--SubtotalMember_zjAApMVnkPLe" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2021-12-31_custom_SubtotalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">171,277</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20211231__us-gaap--FairValueByAssetClassAxis__custom--SubtotalMember_z5aaCPnWhZl8" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2021-12-31_custom_SubtotalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">76,942</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20211231__us-gaap--FairValueByAssetClassAxis__custom--SubtotalMember_zeq888yvAzid" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2021-12-31_custom_SubtotalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">94,335</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2pt; padding-left: 0.25in">Total</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20211231_zd8wUtrQItc6" style="border-bottom: Black 2pt double; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">290,989</ix:nonFraction></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20211231_zzWg0TC4opf" style="border-bottom: Black 2pt double; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">76,942</ix:nonFraction></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20211231_z1ERowanMjXi" style="border-bottom: Black 2pt double; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">214,047</ix:nonFraction></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
</table>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: left">2020</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Gross</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Accumulated</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Net Book</td><td style="font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amortization</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Value</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 55%; text-align: left; padding-bottom: 1pt">Trademarks (indefinite lives)</td><td style="width: 1%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20201231__us-gaap--FairValueByAssetClassAxis__us-gaap--IndefinitelivedIntangibleAssetsMember_zybGBplDjgM9" style="border-bottom: Black 1pt solid; width: 12%; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2020-12-31_us-gaap_IndefinitelivedIntangibleAssetsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">131,962</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20201231__us-gaap--FairValueByAssetClassAxis__us-gaap--IndefinitelivedIntangibleAssetsMember_zFwzKYV0hDvc" style="border-bottom: Black 1pt solid; width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1044">&#8212;</span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20201231__us-gaap--FairValueByAssetClassAxis__us-gaap--IndefinitelivedIntangibleAssetsMember_z69xLvALNKe3" style="border-bottom: Black 1pt solid; width: 12%; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2020-12-31_us-gaap_IndefinitelivedIntangibleAssetsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">131,962</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Trademarks (finite lives)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20201231__us-gaap--FairValueByAssetClassAxis__us-gaap--FiniteLivedIntangibleAssetsMember_ziaV74qg3lCi" style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2020-12-31_us-gaap_FiniteLivedIntangibleAssetsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">47,477</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20201231__us-gaap--FairValueByAssetClassAxis__us-gaap--FiniteLivedIntangibleAssetsMember_zhPRtVWM8tI9" style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2020-12-31_us-gaap_FiniteLivedIntangibleAssetsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">74</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20201231__us-gaap--FairValueByAssetClassAxis__us-gaap--FiniteLivedIntangibleAssetsMember_zq8HaJkzhfVg" style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2020-12-31_us-gaap_FiniteLivedIntangibleAssetsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">47,403</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Licenses (finite lives)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20201231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--LicensesMember_zrAhzOIqgkPe" style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2020-12-31_custom_LicensesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">93,248</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20201231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--LicensesMember_zwz01IMDZW7k" style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2020-12-31_custom_LicensesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">62,262</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20201231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--LicensesMember_zMyp1St5uT12" style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2020-12-31_custom_LicensesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">30,986</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Other intangible assets (finite lives)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20201231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_zGlN5ArnoJh9" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2020-12-31_us-gaap_OtherIntangibleAssetsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">18,194</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20201231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_zlfX60VP3edg" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2020-12-31_us-gaap_OtherIntangibleAssetsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">14,437</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20201231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_zfKTGxO0jFGd" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2020-12-31_us-gaap_OtherIntangibleAssetsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,757</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; padding-left: 0.125in">Subtotal</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20201231__us-gaap--FairValueByAssetClassAxis__custom--SubtotalMember_zWGERQGgcGBg" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2020-12-31_custom_SubtotalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">158,919</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20201231__us-gaap--FairValueByAssetClassAxis__custom--SubtotalMember_zVbjRD3OU4hd" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2020-12-31_custom_SubtotalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">76,773</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20201231__us-gaap--FairValueByAssetClassAxis__custom--SubtotalMember_zoZ4PHhbS7N2" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2020-12-31_custom_SubtotalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">82,146</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2pt; padding-left: 0.25in">Total</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20201231_zlKDRBTRgzJ3" style="border-bottom: Black 2pt double; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">290,881</ix:nonFraction></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20201231_znLLbaAQ7M08" style="border-bottom: Black 2pt double; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">76,773</ix:nonFraction></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20201231_zLiIvgLQitT7" style="border-bottom: Black 2pt double; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">214,108</ix:nonFraction></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
</table>



</ix:nonNumeric><p id="xdx_8AC_zDFVvg2vAF1k" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Amortization expense was $<span id="xdx_909_eus-gaap--AmortizationOfIntangibleAssets_dm_c20210101__20211231_zRzN3UNpNi5e"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="6" unitRef="USD">5.9</ix:nonFraction>
million</span>, $<span id="xdx_90B_eus-gaap--AmortizationOfIntangibleAssets_dm_c20200101__20201231_zPvqgT6L9bEl"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" scale="6" unitRef="USD">5.3</ix:nonFraction> million</span> and $<span id="xdx_906_eus-gaap--AmortizationOfIntangibleAssets_dm_c20190101__20191231_zkalSNE8NOt6"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="0" scale="6" unitRef="USD">5.0</ix:nonFraction> million</span> in 2021, 2020 and 2019, respectively. Amortization expense is expected to approximate $<span id="xdx_90D_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_dm_c20211231_zn6kMfoB5nHe"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="6" unitRef="USD">5.4</ix:nonFraction>
million</span> in 2022, $<span id="xdx_90C_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_dm_c20211231_zYkWq6jGK7U2"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="6" unitRef="USD">4.4</ix:nonFraction> million</span> in 2023, $<span id="xdx_90E_ecustom--FiniteLivedIntangibleAssetsAmortizationExpenseAfterTwoYears_iI_dm_c20211231_zjDLtvIn6nv1"><ix:nonFraction name="ipar:FiniteLivedIntangibleAssetsAmortizationExpenseAfterTwoYears" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="6" unitRef="USD">4.2</ix:nonFraction> million</span> in 2024, 2025 and 2026. The weighted average amortization period for trademarks,
licenses and other intangible assets with finite lives are <span id="xdx_904_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dxL_c20210101__20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksMember_zkGjhOUrG502" title="Amortization period::XDX::P8Y"><span style="-sec-ix-hidden: xdx2ixbrl1068">18</span></span> years, <span id="xdx_906_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dxL_c20210101__20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--LicensesMember_zk26A5A30yn8" title="::XDX::P15Y"><span style="-sec-ix-hidden: xdx2ixbrl1069">15</span></span> years and <span id="xdx_905_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dxL_c20210101__20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_zSXQI9V2pbu2" title="::XDX::P2Y"><span style="-sec-ix-hidden: xdx2ixbrl1070">2</span></span> years, respectively, and <span id="xdx_90F_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dxL_c20210101__20211231_zlBlcV0rOLf2" title="::XDX::P14Y"><span style="-sec-ix-hidden: xdx2ixbrl1071">14</span></span> years on average.</p>

<ix:exclude><p id="xdx_23B_zFJC1VicmNK5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 109; Value: 1 -->
    <div id="xdx_230_zbwTSYSkydJ4" style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p id="xdx_23E_zhFZKf15BKOk" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></p></div>
    <div id="xdx_23C_zfd6SL4wNNLj" style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p id="xdx_236_zaE6vlFQCy77" style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_235_zvmtDkzdL1a3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_237_zylU46RdVj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>INTER PARFUMS, INC. AND SUBSIDIARIES</b></p></ix:exclude>

<ix:exclude><p id="xdx_239_zXQsy2xlp3b" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_232_zBklkXUSugr1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Notes to Consolidated Financial Statements</p></ix:exclude>

<ix:exclude><p id="xdx_230_z5V9XLtvlIP3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">December 31, 2021, 2020 and 2019</p></ix:exclude>

<ix:exclude><p id="xdx_232_zkGnQYcnOzJ3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(In thousands except share and per share data)</p></ix:exclude>

<ix:exclude><p id="xdx_23F_zDuMxFiBBe11" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company reviews intangible
assets with indefinite lives for impairment whenever events or changes in circumstances indicate that the carrying amount may not
be recoverable. There was an impairment charge for trademarks with indefinite useful lives of $<span id="xdx_90E_eus-gaap--AmortizationOfIntangibleAssets_dm_c20210101__20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--IndefinitelivedIntangibleAssetsMember_zwbHZTD4I777"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2021-01-012021-12-31_us-gaap_IndefinitelivedIntangibleAssetsMember" format="ixt:numdotdecimal" decimals="0" scale="6" unitRef="USD">2.4</ix:nonFraction> million</span> in 2021 relating to
our Rochas fashion business. The fair values used in our evaluations are estimated based upon discounted future cash flow projections
using a weighted average cost of capital of <span id="xdx_901_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_dp_c20211231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountRateMember_zygYPPsPyuSc" title="Weighted average cost of capital"><ix:nonFraction name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" contextRef="AsOf2021-12-31_us-gaap_MeasurementInputDiscountRateMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">7.47</ix:nonFraction></span>%, <span id="xdx_904_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_dp_c20201231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountRateMember_zVklY56kLe9c"><ix:nonFraction name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" contextRef="AsOf2020-12-31_us-gaap_MeasurementInputDiscountRateMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">6.99</ix:nonFraction></span>%, and <span id="xdx_904_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_dp_c20191231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountRateMember_zZGJVZLsjdC6"><ix:nonFraction name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" contextRef="AsOf2019-12-31_us-gaap_MeasurementInputDiscountRateMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">7.94</ix:nonFraction></span>% as of December 31, 2021, 2020 and 2019, respectively. The cash
flow projections are based upon a number of assumptions, including, future sales levels and future cost of goods and operating
expense levels, as well as economic conditions, changes to our business model or changes in consumer acceptance of our products
which are more subjective in nature. The Company believes that the assumptions it has made in projecting future cash flows for
the evaluations described above are reasonable and currently no other impairment indicators exist for our indefinite-lived assets.
However, if future actual results do not meet our expectations, the Company may be required to record an impairment charge, the
amount of which could be material to our results of operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The cost of trademarks, licenses
and other intangible assets with finite lives is being amortized by the straight-line method over the term of the respective license
or the intangible assets estimated useful life which range from <span id="xdx_906_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dxL_c20210101__20211231__srt--RangeAxis__srt--MinimumMember_zsFW3oxRvSE8" title="Amortization period::XDX::P3Y"><span style="-sec-ix-hidden: xdx2ixbrl1086">three</span></span> to <span id="xdx_90A_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dxL_c20210101__20211231__srt--RangeAxis__srt--MaximumMember_z50AU7FdbDm" title="Amortization period::XDX::P20Y"><span style="-sec-ix-hidden: xdx2ixbrl1088">twenty years</span></span>. If the residual value of a finite life intangible
asset exceeds its carrying value, then the asset is not amortized. The Company reviews intangible assets with finite lives for
impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Trademarks (finite lives) primarily
represent Lanvin brand names and trademarks and in connection with their purchase, Lanvin was granted the right to repurchase the
brand names and trademarks on July 1, 2027 for &#8364;70 million (approximately $<span id="xdx_905_eus-gaap--IndefiniteLivedLicenseAgreements_iI_pn6n6_c20211231_zDWDHEBoYp44"><ix:nonFraction name="us-gaap:IndefiniteLivedLicenseAgreements" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-6" scale="6" unitRef="USD">79</ix:nonFraction></span> million) (residual value) in accordance with
an amendment signed in 2021. Because the residual value of the intangible asset exceeds its carrying value, the asset is not being
amortized.</p>

</ix:nonNumeric><p id="xdx_819_zVcbvxp4vcL4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>


<!-- Field: /Named-Area; -->

<!-- Field: Named-Area; Name: Contents -->
<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock"><p id="xdx_805_eus-gaap--AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_zkW03kU6fsdd" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in">(9)</td><td><span id="xdx_82F_zYjsMSf8W1Cf">Accrued Expenses</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock"><p id="xdx_893_eus-gaap--ScheduleOfAccruedLiabilitiesTableTextBlock_z2tBzBebFVa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8B3_zfGhPo3W9388">Accrued expenses consist of the
following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_49B_20211231_zOrca3nEmH29" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_49A_20201231_zCaUhWp9ThJh" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--AccruedAdvertisingCurrent_iI_maALCzkev_zryJtF67WKMd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 70%; text-align: left">Advertising liabilities</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:AccruedAdvertisingCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">31,215</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:AccruedAdvertisingCurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">12,164</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--AccruedSalariesCurrent_iI_maALCzkev_z5Ky8tSKulA2" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Salary (including bonus and related taxes)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccruedSalariesCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">19,993</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccruedSalariesCurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">14,605</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_403_eus-gaap--AccruedRoyaltiesCurrent_iI_maALCzkev_zE0TFIWDkX95" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Royalties</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccruedRoyaltiesCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">19,154</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccruedRoyaltiesCurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">16,966</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_403_ecustom--DueVendorsNotYetInvoiced_iI_maALCzkev_zreYzpg8bkA" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Due vendors (not yet invoiced)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ipar:DueVendorsNotYetInvoiced" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">45,707</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ipar:DueVendorsNotYetInvoiced" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">31,698</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrent_iI_maALCzkev_zvE6kTpZLRsk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Retirement reserves</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">10,234</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">11,889</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--CustomerRefundLiabilityCurrent_iI_maALCzkev_zaOmeGtKBpj" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Refund (return) liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CustomerRefundLiabilityCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,128</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CustomerRefundLiabilityCurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,616</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40E_eus-gaap--OtherAccruedLiabilitiesCurrent_iI_maALCzkev_zZcRqnM9d0lg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">Other</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherAccruedLiabilitiesCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,246</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherAccruedLiabilitiesCurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,691</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_400_eus-gaap--AccruedLiabilitiesCurrent_iTI_mtALCzkev_z3kdIpeQpYsb" style="vertical-align: bottom; background-color: White">
    <td style="display: none; padding-bottom: 2pt; visibility: hidden">Accrued expenses</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td style="border-bottom: Black 2pt double; text-align: right"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">136,677</ix:nonFraction></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td style="border-bottom: Black 2pt double; text-align: right"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">95,629</ix:nonFraction></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
</table>



</ix:nonNumeric><p id="xdx_8A2_zhGs4I0UOZy2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

</ix:nonNumeric><p id="xdx_81E_zAv7T8aedgui" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>


<!-- Field: /Named-Area; -->

<!-- Field: Named-Area; Name: Contents -->
<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:DebtDisclosureTextBlock"><p id="xdx_80B_eus-gaap--DebtDisclosureTextBlock_z3so1WY1dNn6" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in">(10)</td><td><span id="xdx_821_zPl2YMX39Ffb">Loans Payable &#8211; Banks</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Loans payable &#8211; banks consist
of the following:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company and its domestic
subsidiaries have available a $<span id="xdx_90A_eus-gaap--LineOfCreditFacilityMaximumBorrowingCapacity_iI_c20211231__dei--LegalEntityAxis__custom--DomesticSubsidiariesMember_zLBYAMwpu2w6" title="Line of credit, maximum borrowing amount"><ix:nonFraction name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" contextRef="AsOf2021-12-31_custom_DomesticSubsidiariesMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">20</ix:nonFraction> million</span> unsecured revolving line of credit due on demand, which bears interest at the daily Secured
Overnight Financing Rate (&#8220;SOFR&#8221;) plus <span id="xdx_90F_eus-gaap--DebtInstrumentBasisSpreadOnVariableRate1_pid_dp_uPure_c20210101__20211231__us-gaap--VariableRateAxis__custom--LondonInterbankOfferedRateMember__dei--LegalEntityAxis__custom--DomesticSubsidiariesMember_zYMwwLZy6vQi" title="Basis spread over variable interest rate"><ix:nonFraction name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" contextRef="From2021-01-012021-12-31_custom_LondonInterbankOfferedRateMember_custom_DomesticSubsidiariesMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">2</ix:nonFraction></span>% (the SOFR was <span id="xdx_90D_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20211231__us-gaap--VariableRateAxis__custom--LondonInterbankOfferedRateMember__dei--LegalEntityAxis__custom--DomesticSubsidiariesMember_zIwllRqe60vg" title="Variable rate"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2021-12-31_custom_LondonInterbankOfferedRateMember_custom_DomesticSubsidiariesMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.05</ix:nonFraction></span>% as of December 31, 2021). The line of credit which has
a maturity date of <span id="xdx_908_eus-gaap--LineOfCreditFacilityExpirationDate1_ddpxL_c20210101__20211231__us-gaap--VariableRateAxis__custom--LondonInterbankOfferedRateMember__dei--LegalEntityAxis__custom--DomesticSubsidiariesMember_zi5y8Aw4Cht7" title="::XDX::2022-12-16"><span style="-sec-ix-hidden: xdx2ixbrl1126">December&#160;16, 2022</span></span>, is expected to be renewed on an annual basis. Borrowings outstanding pursuant to lines
of credit were zero as of December 31, 2021 and 2020.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company&#8217;s foreign subsidiaries
have available credit lines, including several bank overdraft facilities totaling approximately $<span id="xdx_903_eus-gaap--LineOfCreditFacilityMaximumBorrowingCapacity_iI_pn6n6_c20211231__dei--LegalEntityAxis__custom--ForeignSubsidiariesMember_zjSaiZ34pJyk"><ix:nonFraction name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" contextRef="AsOf2021-12-31_custom_ForeignSubsidiariesMember" format="ixt:numdotdecimal" decimals="-6" scale="6" unitRef="USD">28</ix:nonFraction></span> million. These credit lines
bear interest at EURIBOR plus between <span id="xdx_900_eus-gaap--DebtInstrumentBasisSpreadOnVariableRate1_pid_dp_uPure_c20210101__20211231__us-gaap--VariableRateAxis__custom--EuroInterbankOfferedRateMembeMember__dei--LegalEntityAxis__custom--ForeignSubsidiariesMember__srt--RangeAxis__srt--MinimumMember_zxGu8AsBheC3" title="Basis spread over variable interest rate"><ix:nonFraction name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" contextRef="From2021-01-012021-12-31_custom_EuroInterbankOfferedRateMembeMember_custom_ForeignSubsidiariesMember_srt_MinimumMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.5</ix:nonFraction></span>% and <span id="xdx_90C_eus-gaap--DebtInstrumentBasisSpreadOnVariableRate1_pid_dp_uPure_c20210101__20211231__us-gaap--VariableRateAxis__custom--EuroInterbankOfferedRateMembeMember__dei--LegalEntityAxis__custom--ForeignSubsidiariesMember__srt--RangeAxis__srt--MaximumMember_zryWJs2OjWO1" title="Basis spread over variable interest rate"><ix:nonFraction name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" contextRef="From2021-01-012021-12-31_custom_EuroInterbankOfferedRateMembeMember_custom_ForeignSubsidiariesMember_srt_MaximumMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.8</ix:nonFraction></span>% (EURIBOR was minus <span id="xdx_90A_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20211231__us-gaap--VariableRateAxis__custom--EuroInterbankOfferedRateMembeMember__dei--LegalEntityAxis__custom--ForeignSubsidiariesMember_zq65zFAJJ8U7" title="Variable rate"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2021-12-31_custom_EuroInterbankOfferedRateMembeMember_custom_ForeignSubsidiariesMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.570</ix:nonFraction></span>% at December&#160;31, 2021). Borrowings outstanding
pursuant to these bank overdraft facilities were zero as of December 31, 2021 and 2020.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<ix:exclude><!-- Field: Page; Sequence: 110; Value: 1 -->
    <div id="xdx_234_zFgUMc89NK79" style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p id="xdx_23F_zJnWjzrN0k8h" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></p></div>
    <div id="xdx_23F_zDcQyycw0Qaj" style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p id="xdx_23C_zeM3ld06K09b" style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23D_zOz8zekn9wwb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_238_zleRpSHRhv8d" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>INTER PARFUMS, INC. AND SUBSIDIARIES</b></p></ix:exclude>

<ix:exclude><p id="xdx_236_zE9zW4WEutAk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23F_z5P1c5T5QE98" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Notes to Consolidated Financial Statements</p></ix:exclude>

<ix:exclude><p id="xdx_23B_zgSe6mqkkf28" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">December 31, 2021, 2020 and 2019</p></ix:exclude>

<ix:exclude><p id="xdx_237_zrBJ6wnQV7d6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(In thousands except share and per share data)</p></ix:exclude>

<ix:exclude><p id="xdx_23E_zu5hm68eXMX9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">As there were no borrowings outstanding
as of December 31, 2021 and 2010, there is no weighted average interest rate on short-term borrowings as of December 31, 2021 and
2020.</p>

</ix:nonNumeric><p id="xdx_81A_zIChPs4EHnyl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>


<!-- Field: /Named-Area; -->

<!-- Field: Named-Area; Name: Contents -->
<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:LongTermDebtTextBlock"><p id="xdx_80A_eus-gaap--LongTermDebtTextBlock_zeDt996wEdyh" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in">(11)</td><td><span id="xdx_82F_z4DbqKVC28r3">Long-Term Debt</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:ScheduleOfDebtInstrumentsTextBlock"><p id="xdx_897_eus-gaap--ScheduleOfDebtInstrumentsTextBlock_zMA0beScaH04" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span id="xdx_8B8_zDtbLqdGeQz3">Long-term debt consists of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 65%; text-align: left; text-indent: -0.125in; padding-left: 0.125in">$<span id="xdx_901_eus-gaap--DebtInstrumentFaceAmount_iI_dm_c20211231__us-gaap--LongtermDebtTypeAxis__us-gaap--LoansPayableMember_zr2GjGBCW5Ni" title="Loan payable (in Dollars)"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2021-12-31_us-gaap_LoansPayableMember" format="ixt:numdotdecimal" decimals="-3" scale="9" unitRef="USD">135.9</ix:nonFraction> million</span> payable in <span id="xdx_902_ecustom--NumberOfInstallment_iI_pid_uN_c20211231__us-gaap--LongtermDebtTypeAxis__us-gaap--LoansPayableMember_z0VjT2MOZQqa" title="Number of installments"><ix:nonFraction name="ipar:NumberOfInstallment" contextRef="AsOf2021-12-31_us-gaap_LoansPayableMember" format="ixt:numdotdecimal" decimals="INF" unitRef="N">120</ix:nonFraction></span> equal monthly installments of $<span id="xdx_904_eus-gaap--DebtInstrumentPeriodicPayment_dm_c20210101__20211231__us-gaap--LongtermDebtTypeAxis__us-gaap--LoansPayableMember_zFFNifrp7ql4" title="Installment amount (in Dollars)"><ix:nonFraction name="us-gaap:DebtInstrumentPeriodicPayment" contextRef="From2021-01-012021-12-31_us-gaap_LoansPayableMember" format="ixt:numdotdecimal" decimals="-3" scale="9" unitRef="USD">1.1</ix:nonFraction> million</span> beginning in April 2021, bearing interest at one-month Euribor plus <span id="xdx_907_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20211231__us-gaap--LongtermDebtTypeAxis__us-gaap--LoansPayableMember_z8NioIBw61Z2" title="Interest per annum"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2021-12-31_us-gaap_LoansPayableMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.75</ix:nonFraction></span>%</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--LongTermDebt_iI_c20211231__us-gaap--LongtermDebtTypeAxis__us-gaap--LoansPayableMember_zeY3RkgUJ7Z3" title="Loan payable" style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:LongTermDebt" contextRef="AsOf2021-12-31_us-gaap_LoansPayableMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">124,375</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--LongTermDebt_iI_c20201231__us-gaap--LongtermDebtTypeAxis__us-gaap--LoansPayableMember_zyOOVGWYqHbf" style="width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1155">&#8212;</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">$<span id="xdx_902_eus-gaap--DebtInstrumentFaceAmount_iI_pn6n6_c20211231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableOneMember_zc7fR9ruMpj7"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2021-12-31_custom_LoansPayableOneMember" format="ixt:numdotdecimal" decimals="-6" scale="6" unitRef="USD">15</ix:nonFraction></span>.0 million payable in <span id="xdx_90E_ecustom--NumberOfInstallment_iI_pid_uN_c20211231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableOneMember_zls04tXK2V3i" title="Number of installments"><ix:nonFraction name="ipar:NumberOfInstallment" contextRef="AsOf2021-12-31_custom_LoansPayableOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="N">14</ix:nonFraction></span> equal annual installments of $<span id="xdx_90A_eus-gaap--DebtInstrumentPeriodicPayment_dm_c20210101__20211231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableOneMember_zIQI3xg3fbsh"><ix:nonFraction name="us-gaap:DebtInstrumentPeriodicPayment" contextRef="From2021-01-012021-12-31_custom_LoansPayableOneMember" format="ixt:numdotdecimal" decimals="-3" scale="9" unitRef="USD">1.1</ix:nonFraction> million</span> beginning in January 2020 including interest imputed at <span id="xdx_903_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20211231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableOneMember_z7c1VKEfKJcg"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2021-12-31_custom_LoansPayableOneMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">4.1</ix:nonFraction></span>% per annum</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--LongTermDebt_iI_c20211231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableOneMember_zl6ufcRiHPn1" style="text-align: right"><ix:nonFraction name="us-gaap:LongTermDebt" contextRef="AsOf2021-12-31_custom_LoansPayableOneMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">10,569</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--LongTermDebt_iI_c20201231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableOneMember_zHLrPGY0Cis4" style="text-align: right"><ix:nonFraction name="us-gaap:LongTermDebt" contextRef="AsOf2020-12-31_custom_LoansPayableOneMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">11,208</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">$<span id="xdx_90E_eus-gaap--DebtInstrumentFaceAmount_iI_pn6n6_c20211231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableTwoMember_zjWS3GRRDjOc"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2021-12-31_custom_LoansPayableTwoMember" format="ixt:numdotdecimal" decimals="-6" scale="6" unitRef="USD">17</ix:nonFraction></span> million payable in <span id="xdx_900_ecustom--NumberOfInstallment_iI_pid_uN_c20211231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableTwoMember_zhDrCItdpwMc" title="Number of installments"><ix:nonFraction name="ipar:NumberOfInstallment" contextRef="AsOf2021-12-31_custom_LoansPayableTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="N">10</ix:nonFraction></span> equal annual installments of $<span id="xdx_900_eus-gaap--DebtInstrumentPeriodicPayment_dm_c20210101__20211231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableTwoMember_zDQCZr8k366l"><ix:nonFraction name="us-gaap:DebtInstrumentPeriodicPayment" contextRef="From2021-01-012021-12-31_custom_LoansPayableTwoMember" format="ixt:numdotdecimal" decimals="-3" scale="9" unitRef="USD">1.7</ix:nonFraction> million</span> beginning in October 2021 including interest imputed at <span id="xdx_903_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20211231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableTwoMember_zSXZgXMCuGRa" title="Interest per annum"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2021-12-31_custom_LoansPayableTwoMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">2.0</ix:nonFraction></span>% per annum</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--LongTermDebt_iI_c20211231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableTwoMember_zwClsCJGC9Ef" style="text-align: right"><ix:nonFraction name="us-gaap:LongTermDebt" contextRef="AsOf2021-12-31_custom_LoansPayableTwoMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">13,869</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--LongTermDebt_iI_c20201231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableTwoMember_zSb2zFa2pWdg" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1170">&#8212;</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -0.125in; padding-left: 0.125in">$<span id="xdx_903_eus-gaap--DebtInstrumentFaceAmount_iI_dm_c20211231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableThreeMember_zI0tfHx4cvw8"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2021-12-31_custom_LoansPayableThreeMember" format="ixt:numdotdecimal" decimals="-3" scale="9" unitRef="USD">13.4</ix:nonFraction> million</span> term loan amended such that the loan was repaid in February 2021 plus interest at <span id="xdx_90B_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20211231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableThreeMember_zuP7Ddx97nz3" title="Interest per annum"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2021-12-31_custom_LoansPayableThreeMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.85</ix:nonFraction></span>% per annum</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--LongTermDebt_iI_c20211231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableThreeMember_z4H340Co1wo2" title="Loan payable" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1175">&#8212;</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--LongTermDebt_iI_c20201231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableThreeMember_zJKDQUnLn4J" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:LongTermDebt" contextRef="AsOf2020-12-31_custom_LoansPayableThreeMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">13,498</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -0.125in; padding-left: 0.125in">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--LongTermDebt_iI_c20211231_z0zLZRFstio8" style="text-align: right"><ix:nonFraction name="us-gaap:LongTermDebt" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">148,813</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--LongTermDebt_iI_c20201231_zXol4Mlgb4ie" style="text-align: right"><ix:nonFraction name="us-gaap:LongTermDebt" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">24,706</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -0.125in; padding-left: 0.25in">Less current maturities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--LongTermDebtCurrent_iI_c20211231_zFsrVaCUHeEb" title="Less current maturities" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:LongTermDebtCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">15,911</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--LongTermDebtCurrent_iI_dxL_c20201231_zvYm1Uq9Ws7g" title="Less current maturities::XDX::14%2C570" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1182">14,570</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2pt; text-indent: -0.125in; padding-left: 0.375in">Total</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--LongTermDebtNoncurrent_iI_c20211231_zcAIKG3aVVCb" title="Total" style="border-bottom: Black 2pt double; text-align: right"><ix:nonFraction name="us-gaap:LongTermDebtNoncurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">132,902</ix:nonFraction></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--LongTermDebtNoncurrent_iI_dxL_c20201231_z9kcQMiGz5Lc" title="::XDX::10%2C136" style="border-bottom: Black 2pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1185">10,136</span></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
</table>



</ix:nonNumeric><p id="xdx_8A5_zaOBx13pgpvg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In April 2021, to finance the
acquisition of Interparfums SA&#8217;s future corporate headquarters, the Company entered into a $<span id="xdx_908_eus-gaap--DebtInstrumentFaceAmount_iI_dm_c20210430__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableOneMember_zwYKmCgVtDg8"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2021-04-30_custom_LoansPayableOneMember" format="ixt:numdotdecimal" decimals="0" scale="6" unitRef="USD">135.9</ix:nonFraction> million</span> (&#8364;120 million)
ten-year credit agreement. Approximately $90.6 million (&#8364;80.0 million) of the variable rate debt was swapped for variable
interest rate debt with maximum rate of 2% per annum. The swap is a derivative instrument and is therefore recorded at fair value
and changes in fair value are reflected in the accompanying consolidated statements of income.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Maturities of long-term debt
subsequent to December 31, 2021 are approximately $<span id="xdx_903_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_iI_dm_c20211231_zdiE6pGbH5Bg" title="Long-term Debt, Maturities, 2021"><ix:nonFraction name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="6" unitRef="USD">15.9</ix:nonFraction> million</span> in 2022 and $<span id="xdx_903_eus-gaap--LongTermDebtDescription_c20210101__20211231_zwc9NOyQKt6k" title="Long term debt maturity, description"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" name="us-gaap:LongTermDebtDescription">16.4 million per year thereafter through 2033.</ix:nonNumeric></span></p>

</ix:nonNumeric><p id="xdx_81D_z7cBbpttovc1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>


<!-- Field: /Named-Area; -->

<!-- Field: Named-Area; Name: Contents -->
<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock"><p id="xdx_805_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zqgwaM2S2mR7" style="margin-top: 0; margin-bottom: 0"></p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in">(12)</td><td><span id="xdx_825_zyzysgm6ry98">Commitments</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">Leases</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company leases its offices,
warehouses and vehicles, substantially all of which are classified as operating leases. The Company currently has no material financing
leases. The Company determines if an arrangement is a lease at inception. Operating lease assets and obligations are recognized
at the lease commencement date based on the present value of lease payments over the lease term.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In determining lease asset value,
the Company considers fixed or variable payment terms, prepayments, incentives, and options to extend or terminate, depending on
the lease. Renewal, termination or purchase options affect the lease term used for determining lease asset value only if the option
is reasonably certain to be exercised. The Company generally uses its incremental borrowing rate based on information available
at the lease commencement date for the location in which the lease is held in determining the present value of lease payments.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<ix:exclude><!-- Field: Page; Sequence: 111; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<ix:exclude><p id="xdx_234_zlAcH830bZd7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>INTER PARFUMS, INC. AND SUBSIDIARIES</b></p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<ix:exclude><p id="xdx_231_zMD22MYjcUy5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Notes to Consolidated Financial Statements</p></ix:exclude>

<ix:exclude><p id="xdx_23E_zYNqNQzgFdEf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">December 31, 2021, 2020 and 2019</p></ix:exclude>

<ix:exclude><p id="xdx_230_zssOamNgTgbi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(In thousands except share and per share data)</p></ix:exclude>

<ix:exclude><p id="xdx_23F_zd1DNOcTNhAc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">As of December 31, 2021, the
weighted average remaining lease term was <span id="xdx_903_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtxL_c20211231_zXr3RXHM8Vid" title="Weighted average remaining lease term::XDX::P6Y1M6D"><span style="-sec-ix-hidden: xdx2ixbrl1199">6.1</span></span> years and the weighted average discount rate used to determine the operating lease
liability was <span id="xdx_902_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_uPure_c20211231_zGGI7ynjqSoe" title="Operating lease, weighted average discount rate"><ix:nonFraction name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">2.5</ix:nonFraction></span>%. Rental expense related to operating leases was $<span id="xdx_90B_eus-gaap--OperatingLeasesRentExpenseNet_dm_c20210101__20211231_zhzkNfylL7uj" title="Operating lease of related to rental expenses"><ix:nonFraction name="us-gaap:OperatingLeasesRentExpenseNet" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="6" unitRef="USD">8.2</ix:nonFraction> million</span>, $<span id="xdx_904_eus-gaap--OperatingLeasesRentExpenseNet_dm_c20200101__20201231_zgNOlsvEhs37" title="Operating lease of related to rental expenses"><ix:nonFraction name="us-gaap:OperatingLeasesRentExpenseNet" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" scale="6" unitRef="USD">6.2</ix:nonFraction> million</span>, and $<span id="xdx_90F_eus-gaap--OperatingLeasesRentExpenseNet_dm_c20190101__20191231_zN6YTu1GjGah" title="Operating lease of related to rental expenses"><ix:nonFraction name="us-gaap:OperatingLeasesRentExpenseNet" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="0" scale="6" unitRef="USD">7.5</ix:nonFraction> million</span> for the years ended
December 31, 2021, 2020 and 2019, respectively. Operating lease payments included in operating cash flows totaled $<span id="xdx_909_eus-gaap--OperatingLeasePayments_dm_c20210101__20211231_zZKZcRlr63O7" title="Operating lease payments"><ix:nonFraction name="us-gaap:OperatingLeasePayments" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="6" unitRef="USD">7.5</ix:nonFraction> million</span>
and noncash additions to operating lease assets totaled $<span id="xdx_902_eus-gaap--OperatingLeaseCost_dm_c20210101__20211231_zNDAhX6tEV49" title="Noncash additions to operating lease assets"><ix:nonFraction name="us-gaap:OperatingLeaseCost" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="6" unitRef="USD">12.2</ix:nonFraction> million</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock"><p id="xdx_89E_eus-gaap--ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_zyF9BNIMPeU5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8B0_z8Tw1yW0uR54">Maturities of lease liabilities
subsequent to December&#160;31, 2021 are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">(In thousands)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto">
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 85%; text-align: left"><span style="color: Black">2022</span></td><td style="width: 1%"><span style="color: Black">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="color: Black">$</span></td><td id="xdx_980_eus-gaap--OperatingLeasesFutureMinimumPaymentsDueCurrent_iI_c20211231_zgdKcFRfwmI7" title="2022" style="width: 12%; text-align: right"><span style="color: Black"><ix:nonFraction name="us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,541</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="color: Black">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="color: Black">2023</span></td><td><span style="color: Black">&#160;</span></td>
    <td style="text-align: left"><span style="color: Black">&#160;</span></td><td id="xdx_980_eus-gaap--OperatingLeasesFutureMinimumPaymentsDueInTwoYears_iI_c20211231_zKxxjLn9srP2" title="2023" style="text-align: right"><span style="color: Black"><ix:nonFraction name="us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,776</ix:nonFraction></span></td><td style="text-align: left"><span style="color: Black">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="color: Black">2024</span></td><td><span style="color: Black">&#160;</span></td>
    <td style="text-align: left"><span style="color: Black">&#160;</span></td><td id="xdx_98E_eus-gaap--OperatingLeasesFutureMinimumPaymentsDueInThreeYears_iI_c20211231_zyAnOct969U4" title="2024" style="text-align: right"><span style="color: Black"><ix:nonFraction name="us-gaap:OperatingLeasesFutureMinimumPaymentsDueInThreeYears" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,787</ix:nonFraction></span></td><td style="text-align: left"><span style="color: Black">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="color: Black">2025</span></td><td><span style="color: Black">&#160;</span></td>
    <td style="text-align: left"><span style="color: Black">&#160;</span></td><td id="xdx_98B_eus-gaap--OperatingLeasesFutureMinimumPaymentsDueInFourYears_iI_c20211231_zT0E7zKRecuf" title="2025" style="text-align: right"><span style="color: Black"><ix:nonFraction name="us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFourYears" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,704</ix:nonFraction></span></td><td style="text-align: left"><span style="color: Black">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="color: Black">2026</span></td><td><span style="color: Black">&#160;</span></td>
    <td style="text-align: left"><span style="color: Black">&#160;</span></td><td id="xdx_984_eus-gaap--OperatingLeasesFutureMinimumPaymentsDueInFiveYears_iI_c20211231_z1JuVgtQyVeb" title="2026" style="text-align: right"><span style="color: Black"><ix:nonFraction name="us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFiveYears" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,087</ix:nonFraction></span></td><td style="text-align: left"><span style="color: Black">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="color: Black">Thereafter</span></td><td style="padding-bottom: 1pt"><span style="color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="color: Black">&#160;</span></td><td id="xdx_987_eus-gaap--OperatingLeasesFutureMinimumPaymentsDueThereafter_iI_c20211231_zxf5qxdhJLQd" title="Thereafter" style="border-bottom: Black 1pt solid; text-align: right"><span style="color: Black"><ix:nonFraction name="us-gaap:OperatingLeasesFutureMinimumPaymentsDueThereafter" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">10,017</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="color: Black">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="color: Black">&#160;</span></td><td style="padding-bottom: 1pt"><span style="color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="color: Black">&#160;</span></td><td id="xdx_98E_eus-gaap--OperatingLeasesFutureMinimumPaymentsDue_iI_c20211231_zL7HpyRAvjvg" title="Gross Total" style="border-bottom: Black 1pt solid; text-align: right"><span style="color: Black"><ix:nonFraction name="us-gaap:OperatingLeasesFutureMinimumPaymentsDue" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">37,912</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="color: Black">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in"><span style="color: Black">Less imputed interest (based on 2.5%
    weighted-average discount rate)</span></td><td style="color: #FF0000; padding-bottom: 1pt"><span style="color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; color: #FF0000; text-align: left"><span style="color: Black">&#160;</span></td><td id="xdx_98E_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_di_c20211231_zeZogE6qFnNa" title="Less imputed interest (based on 3.0% weighted-average discount rate)" style="border-bottom: Black 1pt solid; color: #FF0000; text-align: right"><span style="color: Black">(<ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,679</ix:nonFraction></span></td><td style="padding-bottom: 1pt; color: #FF0000; text-align: left"><span style="color: Black">)</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="color: Black">&#160;</span></td><td style="padding-bottom: 2pt"><span style="color: Black">&#160;</span></td>
    <td style="border-bottom: Black 2pt double; text-align: left"><span style="color: Black">$</span></td><td id="xdx_983_eus-gaap--OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear_iI_c20211231_zIFiIkcyU5ui" title="Net Total" style="border-bottom: Black 2pt double; text-align: right"><span style="color: Black"><ix:nonFraction name="us-gaap:OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">35,233</ix:nonFraction></span></td><td style="padding-bottom: 2pt; text-align: left"><span style="color: Black">&#160;</span></td></tr>
</table>



</ix:nonNumeric><p id="xdx_8AB_zhNpFQ1yxWP6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&#160;</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">License Agreements</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&#160;</p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="srt:ContractualObligationFiscalYearMaturityScheduleTableTextBlock"><p id="xdx_897_esrt--ContractualObligationFiscalYearMaturityScheduleTableTextBlock_zZ3LS5YZ6ke3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_909_eus-gaap--FiniteLivedIntangibleAssetsIntentOrAbilityToRenewOrExtendArrangement_c20210101__20211231_zG1Kv0UMvD25" title="License agreement, expiration description">The Company is party to a number
of license and other agreements for the use of trademarks and rights in connection with the manufacture and sale of its products
expiring at various dates through 2033.</span> In connection with certain of these license agreements, the Company is subject to minimum
annual advertising commitments, <span id="xdx_8BA_zRoIaXnWGOPf">minimum annual royalties and other commitments as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">(In thousands)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto">
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 85%; text-align: left">2022</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--OtherCommitmentDueInNextTwelveMonths_iI_c20211231_zm45FY8fqk6" title="2021" style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:OtherCommitmentDueInNextTwelveMonths" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">191,422</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">2023</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--OtherCommitmentDueInSecondYear_iI_c20211231_z0dLRXe8E3tk" title="2022" style="text-align: right"><ix:nonFraction name="us-gaap:OtherCommitmentDueInSecondYear" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">206,241</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">2024</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--OtherCommitmentDueInThirdYear_iI_c20211231_zFige0sVO4d6" title="2023" style="text-align: right"><ix:nonFraction name="us-gaap:OtherCommitmentDueInThirdYear" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">202,774</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">2025</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--OtherCommitmentDueInFourthYear_iI_c20211231_zaqJgioDS9k9" title="2024" style="text-align: right"><ix:nonFraction name="us-gaap:OtherCommitmentDueInFourthYear" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">199,770</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">2026</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--OtherCommitmentDueInFifthYear_iI_c20211231_zccCQ2llkBg1" title="2025" style="text-align: right"><ix:nonFraction name="us-gaap:OtherCommitmentDueInFifthYear" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">136,776</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Thereafter</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--OtherCommitmentDueAfterFifthYear_iI_c20211231_zX6A7AQu8all" title="Thereafter" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherCommitmentDueAfterFifthYear" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">702,780</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--OtherCommitment_iI_c20211231_zYIIHzBGGK3" title="Total" style="border-bottom: Black 2pt double; text-align: right"><ix:nonFraction name="us-gaap:OtherCommitment" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,639,763</ix:nonFraction></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
</table>



</ix:nonNumeric><p id="xdx_8A1_zZwkZ0mXFns" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Future advertising commitments
are estimated based on planned future sales for the license terms that were in effect at December 31, 2021, without consideration
for potential renewal periods. The above figures do not reflect the fact that our distributors share our advertising obligations.
Royalty expense included in selling, general, and administrative expenses, aggregated $<span id="xdx_905_eus-gaap--RoyaltyExpense_dm_c20210101__20211231_zv0zwDjibcWk" title="Royalty expense"><ix:nonFraction name="us-gaap:RoyaltyExpense" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="6" unitRef="USD">69.0</ix:nonFraction> million</span>, $<span id="xdx_902_eus-gaap--RoyaltyExpense_dm_c20200101__20201231_zRA9yVRRt4Ke" title="Royalty expense"><ix:nonFraction name="us-gaap:RoyaltyExpense" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" scale="6" unitRef="USD">41.1</ix:nonFraction> million</span> and $<span id="xdx_90D_eus-gaap--RoyaltyExpense_dm_c20190101__20191231_zNxscyQ0Iszc" title="Royalty expense"><ix:nonFraction name="us-gaap:RoyaltyExpense" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="0" scale="6" unitRef="USD">53.0</ix:nonFraction> million</span>,
in 2021, 2020 and 2019, respectively, and represented <span id="xdx_906_ecustom--RoyaltyExpenseNetSalesPercentage_pid_dp_uPure_c20210101__20211231_zUsXEeOJLdje" title="Royalty expense, percentage of net sales"><ix:nonFraction name="ipar:RoyaltyExpenseNetSalesPercentage" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">7.8</ix:nonFraction></span>%, <span id="xdx_906_ecustom--RoyaltyExpenseNetSalesPercentage_pid_dp_uPure_c20200101__20201231_zr0biWr1Ldh8" title="Royalty expense, percentage of net sales"><ix:nonFraction name="ipar:RoyaltyExpenseNetSalesPercentage" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">7.6</ix:nonFraction></span>% and <span id="xdx_90F_ecustom--RoyaltyExpenseNetSalesPercentage_pid_dp_uPure_c20190101__20191231_zlmhlWfFkpe9" title="Royalty expense, percentage of net sales"><ix:nonFraction name="ipar:RoyaltyExpenseNetSalesPercentage" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">7.4</ix:nonFraction></span>% of net sales for the years ended December 31, 2021, 2020
and 2019, respectively.</p>

</ix:nonNumeric><p id="xdx_81C_zXu4IRn3vcQ1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<!-- Field: Page; Sequence: 112; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>INTER PARFUMS, INC. AND SUBSIDIARIES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Notes to Consolidated Financial Statements</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">December 31, 2021, 2020 and 2019</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(In thousands except share and per share data)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>


<!-- Field: /Named-Area; -->

<!-- Field: Named-Area; Name: Contents -->
<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock"><p id="xdx_803_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zlyxrfluMVOi" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in">(13)</td><td><span id="xdx_824_zVmjzl1ySt49">Equity</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">Share-Based Payments</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company maintains
a stock option program for key employees, executives and directors. The plans, all of which have been approved by
shareholder vote, provide for the granting of both nonqualified and incentive options. Options granted under the plans
typically have a six-year term and vest over a <span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_dtxL_c20210101__20211231__srt--RangeAxis__srt--MinimumMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zUGDlh0a2WU6" title="Share-based compensation arrangement by share-based payment award, award vesting period::XDX::P4Y"><span style="-sec-ix-hidden: xdx2ixbrl1263">four</span></span>
to <span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_dtxL_c20210101__20211231__srt--RangeAxis__srt--MaximumMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zE2tSj3P95Be" title="Share-based compensation arrangement by share-based payment award, award vesting period::XDX::P5Y"><span style="-sec-ix-hidden: xdx2ixbrl1265">five-year</span></span>
period. The fair value of shares vested aggregated $<span id="xdx_90E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_dm_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zfs2A3ks61kd"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" contextRef="From2021-01-012021-12-31_us-gaap_StockOptionMember" format="ixt:numdotdecimal" decimals="0" scale="6" unitRef="USD">1.4</ix:nonFraction>
million</span>, $<span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_dm_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zi9jTldEHxY" title="Fair value of shares vested"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" contextRef="From2020-01-012020-12-31_us-gaap_StockOptionMember" format="ixt:numdotdecimal" decimals="0" scale="6" unitRef="USD">1.7</ix:nonFraction>
million</span> and $<span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_dm_c20190101__20191231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zCCezxtDy292"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" contextRef="From2019-01-012019-12-31_us-gaap_StockOptionMember" format="ixt:numdotdecimal" decimals="0" scale="6" unitRef="USD">1.4</ix:nonFraction> million</span> in 2021, 2020 and 2019, respectively. <span style="font-family: Times New Roman, Times, Serif">Compensation
cost, net of estimated forfeitures, is recognized on a straight-line basis over the requisite service period for the
entire award. Forfeitures are estimated based on historic trends. </span>It is generally the Company&#8217;s policy to issue
new shares upon exercise of stock options.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock"><p id="xdx_897_eus-gaap--ScheduleOfNonvestedShareActivityTableTextBlock_z8ZrifFxP0t3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8BC_zMWGswiSqs1h">The following table sets forth
information with respect to nonvested options for 2021:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Number of Shares</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Weighted Average<br />
 Grant Date<br />
Fair Value</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">Nonvested options &#8211; beginning of year</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iS_pid_uShares_c20210101__20211231_zvGsbl79ra63" title="Nonvested options - beginning of year" style="width: 15%; text-align: right"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">353,790</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iS_pid_uUSDPShares_c20210101__20211231_zf4XtRrTRhY1" title="Weighted Average Grant Date Fair Value, beginning of year" style="width: 15%; text-align: right"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">12.96</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Nonvested options granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_uShares_c20210101__20211231_zbm3MQRNZLj7" title="Nonvested options granted" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">9,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_uUSDPShares_c20210101__20211231_zvj55yTKFDL8" title="Weighted Average Grant Date Fair Value, granted" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">11.35</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Nonvested options vested or forfeited</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_iN_pid_di_uShares_c20210101__20211231_zHoNAdPd7gk1" title="Nonvested options vested or forfeited" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">153,280</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_pid_uUSDPShares_c20210101__20211231_zaOodMpx1m63" title="Weighted Average Grant Date Fair Value, vested or forfeited" style="text-align: right"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">12.19</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2pt">Nonvested options &#8211; end of year</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iE_pid_uShares_c20210101__20211231_zfPUrQ8OE2u2" title="Nonvested options - end of year" style="border-bottom: Black 2pt double; text-align: right"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">209,510</ix:nonFraction></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iE_pid_uUSDPShares_c20210101__20211231_zK1Iv0XltGv5" title="Weighted Average Grant Date Fair Value, end of year" style="text-align: right"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">13.45</ix:nonFraction></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8A8_z9G0XLBK20a4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock"><p id="xdx_89D_eus-gaap--ScheduleOfShareBasedCompensationActivityTableTextBlock_zvleNI06rDEk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8BB_zB9k0ntXSjdd">The effect of share-based payment
expenses decreased income statement line items as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year Ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 55%; text-align: left">Income before income taxes</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_c20210101__20211231__us-gaap--IncomeStatementLocationAxis__us-gaap--OperatingIncomeLossMember_zPf8FbwkipRc" title="Income before income taxes" style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" contextRef="From2021-01-012021-12-31_us-gaap_OperatingIncomeLossMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,850</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_c20200101__20201231__us-gaap--IncomeStatementLocationAxis__us-gaap--OperatingIncomeLossMember_zM3RXe1Uzlx5" style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" contextRef="From2020-01-012020-12-31_us-gaap_OperatingIncomeLossMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,030</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_c20190101__20191231__us-gaap--IncomeStatementLocationAxis__us-gaap--OperatingIncomeLossMember_zLGXk9Bchomf" style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" contextRef="From2019-01-012019-12-31_us-gaap_OperatingIncomeLossMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,390</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Net income attributable to Inter Parfums, Inc.</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--NetIncomeLoss_c20210101__20211231__us-gaap--IncomeStatementLocationAxis__us-gaap--OperatingIncomeLossMember_zio92kKlNDG1" title="Net income attributable to Inter Parfums, Inc." style="text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-01-012021-12-31_us-gaap_OperatingIncomeLossMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,880</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--NetIncomeLoss_c20200101__20201231__us-gaap--IncomeStatementLocationAxis__us-gaap--OperatingIncomeLossMember_zk1fIhwSyAQ8" style="text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-01-012020-12-31_us-gaap_OperatingIncomeLossMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,040</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--NetIncomeLoss_c20190101__20191231__us-gaap--IncomeStatementLocationAxis__us-gaap--OperatingIncomeLossMember_znsBRLKCuWb5" style="text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2019-01-012019-12-31_us-gaap_OperatingIncomeLossMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,060</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Diluted earnings per share attributable to Inter Parfums, Inc.</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--EarningsPerShareDiluted_pid_uUSDPShares_c20210101__20211231__us-gaap--IncomeStatementLocationAxis__us-gaap--OperatingIncomeLossMember_zxDcEGuXrfEg" title="Diluted earnings per share attributable to Inter Parfums, Inc" style="text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2021-01-012021-12-31_us-gaap_OperatingIncomeLossMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.06</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--EarningsPerShareDiluted_pid_uUSDPShares_c20200101__20201231__us-gaap--IncomeStatementLocationAxis__us-gaap--OperatingIncomeLossMember_zRLGYRITWUa" style="text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2020-01-012020-12-31_us-gaap_OperatingIncomeLossMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.06</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--EarningsPerShareDiluted_pid_uUSDPShares_c20190101__20191231__us-gaap--IncomeStatementLocationAxis__us-gaap--OperatingIncomeLossMember_zBLJMsKKNzV8" style="text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2019-01-012019-12-31_us-gaap_OperatingIncomeLossMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.07</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
</table>


</ix:nonNumeric><p id="xdx_8AE_z0DOdvvSAml7" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"><p id="xdx_89E_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zDcEFm9k7uh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8B8_zD54LK3lVHI8">The following table summarizes stock option activity and related information for the years ended December 31, 2021, 2020 and
2019:</span></p>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="22" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Options</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Weighted</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Average</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Exercise</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Price</b></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Options</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Weighted</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Average</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Exercise</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Price</b></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Options</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Weighted</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Average</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Exercise</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Price</b></p></td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 28%; text-align: left; text-indent: -0.125in; padding-left: 0.125in">Shares under option - beginning of year</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_uShares_c20210101__20211231_zA8543b6APh9" title="Options shares under option - beginning of year" style="width: 9%; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">713,210</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_uUSDPShares_c20210101__20211231_zC8vapGuY9i" title="Weighted average exercise price shares under option - beginning of year" style="width: 9%; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">52.74</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_uShares_c20200101__20201231_z5u6iR8WYkrl" style="width: 9%; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">815,800</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_uUSDPShares_c20200101__20201231_zcP0CPxAKP8j" style="width: 9%; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">49.89</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_uShares_c20190101__20191231_zU6ybomZKya4" style="width: 9%; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2018-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">776,171</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_uUSDPShares_c20190101__20191231_zUrKgGW5UtFl" style="width: 9%; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2018-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">41.33</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Options granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_uShares_c20210101__20211231_zWaGWhA3y089" title="Options granted" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">9,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_uUSDPShares_c20210101__20211231_ztWooTqug7se" title="Weighted average exercise price options granted" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">62.18</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_uShares_c20200101__20201231_zdZYrk8MSQec" title="Options granted" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">9,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_uUSDPShares_c20200101__20201231_zcTcxSHfjHQe" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">69.11</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_uShares_c20190101__20191231_zwbAPKXMgHzb" title="Options granted" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">194,050</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_uUSDPShares_c20190101__20191231_zWRSpCGy5fB4" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">72.89</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Options exercised</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pid_di_uShares_c20210101__20211231_z8jozSWC3XAb" title="Options exercised" style="text-align: right">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">156,490</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_uUSDPShares_c20210101__20211231_zn6fcE5Pg9Hj" title="Weighted average exercise price options exercised" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">34.46</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pid_di_uShares_c20200101__20201231_zKMFxZ3Jpyx" title="Options exercised" style="text-align: right">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">95,570</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_uUSDPShares_c20200101__20201231_zt5HTMbsLwL2" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">28.99</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pid_di_uShares_c20190101__20191231_z2UEaolQPkd8" title="Options exercised" style="text-align: right">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">130,891</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_uUSDPShares_c20190101__20191231_zUqWAhlDcou9" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">34.06</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -0.125in; padding-left: 0.125in">Options forfeited</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_pid_di_uShares_c20210101__20211231_z0823ZeqZ2A6" title="Options forfeited" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">40,820</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_uUSDPShares_c20210101__20211231_zgN5rdvufK9b" title="Weighted average exercise price options forfeited" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">62.57</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_pid_di_uShares_c20200101__20201231_zzKTz6JvbIZc" title="Options forfeited" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">16,020</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_uUSDPShares_c20200101__20201231_zjEgBkjyNEn1" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">58.38</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_pid_di_uShares_c20190101__20191231_zZTaSwGKkgOd" title="Options forfeited" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">23,530</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_uUSDPShares_c20190101__20191231_zyiZ3TVFZLNk" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">45.48</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2pt; text-indent: -0.125in; padding-left: 0.125in">Shares under option - end of year</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_uShares_c20210101__20211231_zLmY6iaWJ20g" title="Options shares under option - end of year" style="border-bottom: Black 2pt double; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">524,900</ix:nonFraction></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_uUSDPShares_c20210101__20211231_zVLAtyPYEs4j" title="Weighted average exercise price shares under option - end of year" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">57.58</ix:nonFraction></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_uShares_c20200101__20201231_zB9SYPBYrZPg" style="border-bottom: Black 2pt double; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">713,210</ix:nonFraction></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_uUSDPShares_c20200101__20201231_zuA5T05mo1V9" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">52.74</ix:nonFraction></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_uShares_c20190101__20191231_zHnm84lXJmT" style="border-bottom: Black 2pt double; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">815,800</ix:nonFraction></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_uUSDPShares_c20190101__20191231_zkHyldwmhiGg" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">49.89</ix:nonFraction></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8AB_zhbOaxUnAgCa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<ix:exclude><!-- Field: Page; Sequence: 113; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<ix:exclude><p id="xdx_237_zsiCDlFUgbN2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>INTER PARFUMS, INC. AND SUBSIDIARIES</b></p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<ix:exclude><p id="xdx_23A_zPa0TfneKpe2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Notes to Consolidated Financial Statements</p></ix:exclude>

<ix:exclude><p id="xdx_238_zQLiqUWnNTPh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">December 31, 2021, 2020 and 2019</p></ix:exclude>

<ix:exclude><p id="xdx_237_zmb9E17jrSk1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(In thousands except share and per share data)</p></ix:exclude>

<ix:exclude><p id="xdx_236_zzOlYtISy9Oh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">At December 31, 2021, options
for <span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_pid_uShares_c20211231__us-gaap--DebtInstrumentAxis__us-gaap--StockOptionMember_zmZy7NvXvfW3" title="Number of shares available for grant (in Shares)"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" contextRef="AsOf2021-12-31_us-gaap_StockOptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">612,535</ix:nonFraction></span> shares were available for future grant under the plans. The aggregate intrinsic value of options outstanding is $<span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_dm_c20211231__us-gaap--DebtInstrumentAxis__us-gaap--StockOptionMember_zQUIKP2LH6u1" title="Aggregate intrinsic value of options outstanding"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" contextRef="AsOf2021-12-31_us-gaap_StockOptionMember" format="ixt:numdotdecimal" decimals="0" scale="6" unitRef="USD">25.9</ix:nonFraction>
million</span> as of December 31, 2021 and unrecognized compensation cost related to stock options outstanding aggregated $<span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_dm_c20211231__us-gaap--DebtInstrumentAxis__custom--StockOptionOneMember_zy9caq77DwYb" title="Aggregate intrinsic value of options outstanding"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" contextRef="AsOf2021-12-31_custom_StockOptionOneMember" format="ixt:numdotdecimal" decimals="0" scale="6" unitRef="USD">2.9</ix:nonFraction> million</span>,
which will be recognized over the next <span id="xdx_90F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_dxL_c20210101__20211231__us-gaap--DebtInstrumentAxis__us-gaap--StockOptionMember_z2LEBgvlwLGi" title="Term::XDX::P5Y"><span style="-sec-ix-hidden: xdx2ixbrl1362">five years</span></span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The weighted average fair values
of options granted by Inter Parfums, Inc. during 2021, 2020 and 2019 were $<span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z9ZXJRC5TbIl" title="Weighted average grant date fair value (in Dollars per share)"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="From2021-01-012021-12-31_us-gaap_StockOptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">11.35</ix:nonFraction></span>, $<span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z0o2Go7rFK5h" title="Weighted average grant date fair value (in Dollars per share)"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="From2020-01-012020-12-31_us-gaap_StockOptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">12.16</ix:nonFraction></span> and $<span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20190101__20191231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_ztP81MAKJyY9" title="Weighted average grant date fair value (in Dollars per share)"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="From2019-01-012019-12-31_us-gaap_StockOptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">14.14</ix:nonFraction></span> per share, respectively, on
the date of grant using the Black-Scholes option pricing model to calculate the fair value.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"><p id="xdx_894_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zojQBpKqAPSe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8B8_zqp2yAmXZsBb">The assumptions used in the Black-Scholes
pricing model are set forth in the following table:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_494_20210101__20211231_zAj1yLhUcnl6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_498_20200101__20201231_zvfM12Hn0mB7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_498_20190101__20191231_zWvzMZGTPlzj" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year Ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr id="xdx_40E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pii_dp_uPure_zJuwuMc5Ckni" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 55%; text-align: left">Weighted-average expected stock-price volatility</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">25</ix:nonFraction></td><td style="width: 1%; text-align: left">%</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">25</ix:nonFraction></td><td style="width: 1%; text-align: left">%</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">25</ix:nonFraction></td><td style="width: 1%; text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Weighted-average expected option life</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dxL_c20210101__20211231_zn4UR0StrNI4" title="Weighted-average expected option life::XDX::P5Y" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1376">5.0 years</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dxL_c20200101__20201231_zJXLlFaOMDM7" title="Weighted-average expected option life::XDX::P5Y" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1378">5.0 years</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtxL_c20190101__20191231_zI1qfZ5JrH9l" title="Weighted-average expected option life::XDX::P5Y" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1380">5.0 years</span></span></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pii_dp_uPure_zX0zKk2ffFX8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Weighted-average risk-free interest rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.4</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">1.4</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">1.7</ix:nonFraction></td><td style="text-align: left">%</td></tr>
<tr id="xdx_400_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pii_dp_uPure_z7juvhVvP4ri" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Weighted-average dividend yield</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">1.6</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">2.5</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">2.0</ix:nonFraction></td><td style="text-align: left">%</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8A3_z4RQRU2Koug" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Expected volatility is estimated
based on historic volatility of the Company&#8217;s common stock. The expected term of the option is estimated based on historic
data. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of the grant of the option and the dividend
yield reflects the assumption that the dividend payout as authorized by the Board of Directors would maintain its current payout
ratio as a percentage of earnings.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:CashProceedsReceivedAndTaxBenefitFromShareBasedPaymentAwardsTableTextBlock"><p id="xdx_897_eus-gaap--CashProceedsReceivedAndTaxBenefitFromShareBasedPaymentAwardsTableTextBlock_zk2DUKzD1fS5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8BA_zJjz1GHhyJ9h">Proceeds, tax benefits and intrinsic
value related to stock options exercised were as follows</span>:<span style="font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_49C_20210101__20211231_zIBswFHmbfIg" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_498_20200101__20201231_zRtiSmREtAr9" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td colspan="3" id="xdx_49C_20190101__20191231_zMnqljIvkn5e" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year Ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr id="xdx_40B_eus-gaap--ProceedsFromStockOptionsExercised_z6Rw9FEBmt6h" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 55%; text-align: left; text-indent: -8.1pt; padding-left: 8.1pt">Proceeds from stock options exercised</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromStockOptionsExercised" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,393</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromStockOptionsExercised" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,771</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromStockOptionsExercised" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,458</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_406_eus-gaap--DeferredTaxExpenseFromStockOptionsExercised_zBKEGaJCuyba" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Tax benefits</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxExpenseFromStockOptionsExercised" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,300</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxExpenseFromStockOptionsExercised" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">400</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxExpenseFromStockOptionsExercised" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">690</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_409_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_zQ1YtC1ZC4T5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Intrinsic value of stock options exercised</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,800</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,873</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,520</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8AF_zJo8QVZzWam8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<ix:exclude><!-- Field: Page; Sequence: 114; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>INTER PARFUMS, INC. AND SUBSIDIARIES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Notes to Consolidated Financial Statements</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">December 31, 2021, 2020 and 2019</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(In thousands except share and per share data)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock"><p id="xdx_89D_eus-gaap--ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_z2AzDnAS4v3g" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8B3_zD7zIDewqjl9">The following table summarizes
additional stock option information as of December&#160;31, 2021:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Exercise prices</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Options<br /> outstanding</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Options outstanding<br /> weighted average remaining<br /> contractual life</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Options<br /> exercisable</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 25%; text-align: center">&#160;$<span id="xdx_904_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20211231__srt--RangeAxis__srt--MinimumMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_z0SmNLp1UKW8"><ix:nonFraction name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" contextRef="AsOf2021-12-31_srt_MinimumMember_custom_ExercisePriceRangeOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">32.83</ix:nonFraction></span> - $<span id="xdx_90C_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20211231__srt--RangeAxis__srt--MaximumMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zxkEFLWonQRc" title="Exercise price range (in Dollars per share)"><ix:nonFraction name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" contextRef="AsOf2021-12-31_srt_MaximumMember_custom_ExercisePriceRangeOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">33.95</ix:nonFraction></span>&#160;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_uShares_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zghQWgYFZpQ4" title="Options outstanding" style="width: 15%; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" contextRef="AsOf2021-12-31_custom_ExercisePriceRangeOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">81,190</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 32%; text-align: center"><span id="xdx_907_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtxL_c20210101__20211231__srt--RangeAxis__srt--MaximumMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zbT0vgHJK6z3" title="Options outstanding weighted average remaining contractual life::XDX::P0Y11M12D"><span style="-sec-ix-hidden: xdx2ixbrl1411">0.99</span></span> years</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_uShares_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zq3UMvD8Cs77" title="Options exercisable" style="width: 15%; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" contextRef="AsOf2021-12-31_custom_ExercisePriceRangeOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">81,190</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">&#160;$<span id="xdx_901_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20211231__srt--RangeAxis__srt--MinimumMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zSK2Hc2JHOs5"><ix:nonFraction name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" contextRef="AsOf2021-12-31_srt_MinimumMember_custom_ExercisePriceRangeTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">40.15</ix:nonFraction></span> - $<span id="xdx_90B_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20211231__srt--RangeAxis__srt--MaximumMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_zZl4qG4E9RKk"><ix:nonFraction name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" contextRef="AsOf2021-12-31_srt_MaximumMember_custom_ExercisePriceRangeThreeMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">46.90</ix:nonFraction></span>&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_uShares_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zo23alIyc0ei" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" contextRef="AsOf2021-12-31_custom_ExercisePriceRangeTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">123,130</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center"><span id="xdx_90D_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtxL_c20210101__20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zGo3mr7UDwb2" title="::XDX::P1Y11M8D"><span style="-sec-ix-hidden: xdx2ixbrl1417">1.94</span></span> years</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_uShares_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zrOVZVdmeJVf" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" contextRef="AsOf2021-12-31_custom_ExercisePriceRangeTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">90,790</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center">&#160;$<span id="xdx_90B_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20211231__srt--RangeAxis__srt--MinimumMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_z7PS3EwbWBze"><ix:nonFraction name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" contextRef="AsOf2021-12-31_srt_MinimumMember_custom_ExercisePriceRangeThreeMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">65.18</ix:nonFraction></span> - $<span id="xdx_901_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20211231__srt--RangeAxis__srt--MaximumMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_z5DcuTr6jQOk"><ix:nonFraction name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" contextRef="AsOf2021-12-31_srt_MaximumMember_custom_ExercisePriceRangeFourMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">69.11</ix:nonFraction></span>&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_uShares_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_z0rt4wLXWj34" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" contextRef="AsOf2021-12-31_custom_ExercisePriceRangeThreeMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">164,940</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center"><span id="xdx_901_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtxL_c20210101__20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_zGFPaLhucRG9" title="::XDX::P3Y0M11D"><span style="-sec-ix-hidden: xdx2ixbrl1422">3.03</span></span> years</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_uShares_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_zJm6RHjgp7t7" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" contextRef="AsOf2021-12-31_custom_ExercisePriceRangeThreeMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">84,790</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">$<span id="xdx_90B_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_z1viWAr5GRFa"><ix:nonFraction name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" contextRef="AsOf2021-12-31_custom_ExercisePriceRangeFourMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">73.09</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_uShares_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_zuMRwU8NixE8" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" contextRef="AsOf2021-12-31_custom_ExercisePriceRangeFourMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">155,640</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1pt"><span id="xdx_906_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtxL_c20210101__20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_zabrABTe8d59" title="::XDX::P4Y0M0D"><span style="-sec-ix-hidden: xdx2ixbrl1426">4.00</span></span> years</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_uShares_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_zq5xHhHAiRNd" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" contextRef="AsOf2021-12-31_custom_ExercisePriceRangeFourMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">58,620</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center">&#160;Totals&#160;</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_uShares_c20211231_zZWPcpK3imjl" style="border-bottom: Black 2pt double; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">524,900</ix:nonFraction></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 2pt"><span id="xdx_907_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtxL_c20210101__20211231_z43En5xnVYij" title="::XDX::P2Y9M0D"><span style="-sec-ix-hidden: xdx2ixbrl1429">2.75</span></span> years</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_uShares_c20211231_zoOydnZgWk87" style="border-bottom: Black 2pt double; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">315,390</ix:nonFraction></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
</table>



</ix:nonNumeric><p id="xdx_8A8_zfHmFJMSTkk5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">As of December 31, 2021, the
weighted average exercise price of options exercisable was $52.23 and the weighted average remaining contractual life of options
exercisable is 2.35 years. The aggregate intrinsic value of options exercisable at December 31, 2021 is $17.2 million.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In December 2018, Interparfums
SA approved a plan to grant an aggregate of <span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_iI_pid_c20181231__srt--ConsolidatedEntitiesAxis__custom--InterparfumsSASubsidiaryMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_zmeIjpsfFm22" title="Adjusted for stock splits (in Shares)"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" contextRef="AsOf2018-12-31_custom_InterparfumsSASubsidiaryMember_custom_EmployeesMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">26,600</ix:nonFraction></span> shares of its stock to employees with no performance condition requirement,
and an aggregate of <span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_pid_c20181231__srt--ConsolidatedEntitiesAxis__custom--InterparfumsSASubsidiaryMember__srt--TitleOfIndividualAxis__custom--OfficersAndManagersMember_zFYVOvSAnHy9" title="Aggregate intrinsic value of options outstanding"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" contextRef="AsOf2018-12-31_custom_InterparfumsSASubsidiaryMember_custom_OfficersAndManagersMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">133,000</ix:nonFraction></span> shares to officers and managers, subject to certain corporate performance conditions. The shares, subject
to adjustment for stock splits, will be distributed in June 2022.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In March 2020, <span id="xdx_900_ecustom--Covid19Description_c20200301__20200331_z6z0qEPsMxh9" title="Covid 19, description"><ix:nonNumeric contextRef="From2020-03-012020-03-31" name="ipar:Covid19Description">due to the potential
impact on future net sales and operating results resulting from the COVID-19 pandemic, the estimated number of shares to be distributed,
after forfeited shares, was reduced from&#160;142,571&#160;to&#160;82,162. As the Company had already purchased shares in contemplation
of the higher anticipated distribution, shares purchased in excess of the reduced anticipated distribution were transferred to
treasury shares at the Interparfums SA level.</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The fair value of the grant had
been determined based on the quoted stock price of Interparfums SA shares as reported by the NYSE Euronext on the date of grant.&#160;<span id="xdx_90E_ecustom--RevaluationResultedInReductionOfCostDescription_c20200101__20200331__srt--OwnershipAxis__custom--InterparfumsSASubsidiaryMember_z9QGz33uRcDa" title="Revaluation resulted in reduction of cost, description"><ix:nonNumeric contextRef="From2020-01-012020-03-31_custom_InterparfumsSASubsidiaryMember" name="ipar:RevaluationResultedInReductionOfCostDescription">The
original cost of the grant was approximately $4.4&#160;million, and the March 2020 revaluation resulted in a reduction of the cost,
to approximately $2.5 million.&#160;</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In June 2020, the performance
conditions were modified affecting 96 employees. As of December 31, 2021, the number of shares to be distributed, after forfeited
shares, increased to&#160;<span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_iI_pid_c20211231__srt--OwnershipAxis__custom--InterparfumsSASubsidiaryMember_zU6v2gsi8Bo3" title="Adjusted for stock splits (in Shares)"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" contextRef="AsOf2021-12-31_custom_InterparfumsSASubsidiaryMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">172,343</ix:nonFraction></span>. The increase in shares anticipated to be distributed were transferred from treasury shares at
the Interparfums SA level. The modification resulted in a revised cost of the grant to approximately $<span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost_dm_c20210101__20211231__srt--OwnershipAxis__custom--InterparfumsSASubsidiaryMember_zNxJlL9c4Lw7" title="Modification resulted revised cost"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" contextRef="From2021-01-012021-12-31_custom_InterparfumsSASubsidiaryMember" format="ixt:numdotdecimal" decimals="0" scale="6" unitRef="USD">4.6</ix:nonFraction> million</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In order to avoid dilution of
the Company&#8217;s ownership of Interparfums SA, all shares distributed or to be distributed pursuant to these plans are pre-existing
shares of Interparfums SA, purchased in the open market by Interparfums SA.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">All share purchases and issuances
have been classified as equity transactions on the accompanying balance sheet.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">Dividends</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In October 2019, our Board of
Directors authorized a <span id="xdx_90B_ecustom--PercentageOfIncreaseInAnnualDividend_pid_dp_c20191001__20191031_ztVsbdUeAaGk" title="Percentage of increase in annual dividend"><ix:nonFraction name="ipar:PercentageOfIncreaseInAnnualDividend" contextRef="From2019-10-012019-10-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">20</ix:nonFraction></span>% increase in the annual dividend to $<span id="xdx_90F_eus-gaap--DividendsPayableAmountPerShare_iI_pid_c20191031_zxw6vw9fs8a1"><ix:nonFraction name="us-gaap:DividendsPayableAmountPerShare" contextRef="AsOf2019-10-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.32</ix:nonFraction></span> per share on an annual basis. In April 2020, as a result of
the uncertainties raised by the COVID-19 pandemic, the Board of Directors authorized a temporary suspension of the annual cash
dividend. In February 2021, the Board of Directors authorized a reinstatement of an annual dividend of $1.00 payable quarterly.
In February 2022, the Board of Directors authorized a 100% increase in the annual dividend to $<span id="xdx_907_eus-gaap--DividendsPayableAmountPerShare_iI_pid_c20210228__srt--TitleOfIndividualAxis__srt--BoardOfDirectorsChairmanMember_zb9fHsHC1Kq1" title="Dividends payable, amount per share (in Dollars per share)"><ix:nonFraction name="us-gaap:DividendsPayableAmountPerShare" contextRef="AsOf2021-02-28_srt_BoardOfDirectorsChairmanMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">2.00</ix:nonFraction></span> per share. The next quarterly
cash dividend of $<span id="xdx_90B_eus-gaap--DividendsPayableAmountPerShare_iI_pid_c20220331__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zouOfKzEDI9d" title="Dividends payable, amount per share (in Dollars per share)"><ix:nonFraction name="us-gaap:DividendsPayableAmountPerShare" contextRef="AsOf2022-03-31_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.50</ix:nonFraction></span> per share is payable on March 31, 2022 to shareholders of record on March 15, 2022.</p>

</ix:nonNumeric><p id="xdx_815_zbNsvoYMPdM5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<!-- Field: Page; Sequence: 115; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>INTER PARFUMS, INC. AND SUBSIDIARIES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Notes to Consolidated Financial Statements</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">December 31, 2021, 2020 and 2019</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(In thousands except share and per share data)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>


<!-- Field: /Named-Area; -->

<!-- Field: Named-Area; Name: Contents -->
<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:EarningsPerShareTextBlock"><p id="xdx_800_eus-gaap--EarningsPerShareTextBlock_zpFzO0SNYxZj" style="margin-top: 0; margin-bottom: 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"><b>(14)</b></td><td style="text-align: justify"><b><span id="xdx_82B_zJMHuSWwwFd5">Net Income Attributable to Inter Parfums, Inc. Common Shareholders</span></b></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Net income attributable to Inter
Parfums, Inc. per common share (&#8220;basic EPS&#8221;) is computed by dividing net income attributable to Inter Parfums, Inc.
by the weighted average number of shares outstanding.&#160;Net income attributable to Inter Parfums, Inc. per share assuming dilution
(&#8220;diluted EPS&#8221;), is computed using the weighted average number of shares outstanding, plus the incremental shares outstanding
assuming the exercise of dilutive stock options using the treasury stock method.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"><p id="xdx_89D_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zlJjlIepIwr5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8BA_zfyefk7NQKP4">The reconciliation between the
numerators and denominators of the basic and diluted EPS computations is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 55%; text-align: left; padding-bottom: 2pt; padding-left: 0.125in; text-indent: -0.125in">Numerator for diluted earnings per share</td><td style="width: 1%; padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--NetIncomeLoss_c20210101__20211231_zEWwdTlz5Vt2" title="Numerator for diluted earnings per share (in Dollars)" style="border-bottom: Black 2pt double; width: 12%; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">87,411</ix:nonFraction></td><td style="width: 1%; padding-bottom: 2pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--NetIncomeLoss_c20200101__20201231_zNxMkoLkjqxj" style="border-bottom: Black 2pt double; width: 12%; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">38,219</ix:nonFraction></td><td style="width: 1%; padding-bottom: 2pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--NetIncomeLoss_c20190101__20191231_zDE6DZYY3Mae" style="border-bottom: Black 2pt double; width: 12%; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">60,249</ix:nonFraction></td><td style="width: 1%; padding-bottom: 2pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in">Denominator:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in">Weighted average shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20210101__20211231_z3w9K3ErW8cl" title="Weighted average shares" style="text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">31,676,796</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20200101__20201231_zno5RniMDrQ6" style="text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">31,536,659</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20190101__20191231_zENCLkBFGux6" style="text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">31,451,093</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Effect of dilutive securities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.375in; text-indent: -0.125in">Stock options</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pid_c20210101__20211231_z92ryuDbpvDg" title="Weighted Average Number Diluted Shares Outstanding Adjustment" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">158,612</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pid_c20200101__20201231_zLjAwq7ESuw6" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">117,885</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pid_c20190101__20191231_zkH1TMDFadK7" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">237,607</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2pt; padding-left: 0.125in; text-indent: -0.125in">Denominator for diluted earnings per share</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20210101__20211231_zhHhLvmWNm7k" title="Denominator for diluted earnings per share" style="border-bottom: Black 2pt double; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">31,835,408</ix:nonFraction></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20200101__20201231_zaHD7YnDhgK" style="border-bottom: Black 2pt double; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">31,654,544</ix:nonFraction></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20190101__20191231_zFHcdezmXLJ9" style="border-bottom: Black 2pt double; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">31,688,700</ix:nonFraction></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">Earnings per share:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Net income attributable to Inter Parfums, Inc. common shareholders:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.5in; text-indent: -0.125in">Basic</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--EarningsPerShareBasic_pid_uUSDPShares_c20210101__20211231_zOAESjXbsdb" title="Basic (in Dollars per share)" style="text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">2.76</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--EarningsPerShareBasic_pid_uUSDPShares_c20200101__20201231_zYb8TsiOd9sh" style="text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.21</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--EarningsPerShareBasic_pid_uUSDPShares_c20190101__20191231_ztYCFe9bVaud" style="text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.92</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.5in; text-indent: -0.125in">Diluted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--EarningsPerShareDiluted_pid_uUSDPShares_c20210101__20211231_zwl2wHaUR5d5" title="Diluted (in Dollars per share)" style="text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">2.75</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--EarningsPerShareDiluted_pid_uUSDPShares_c20200101__20201231_zugRmgPcyZuh" style="text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.21</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--EarningsPerShareDiluted_pid_uUSDPShares_c20190101__20191231_zqFshltCql7" style="text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.90</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
</table>



</ix:nonNumeric><p id="xdx_8A9_z9egu375NYqk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Not included in the above computations
is the effect of anti-dilutive potential common shares, which consist of outstanding options to purchase <span id="xdx_901_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210101__20211231_zOBp8fkF9WTe" title="Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">175,000</ix:nonFraction></span>, <span id="xdx_904_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20200101__20201231_z2DnMDmdyJ4j"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">450,000</ix:nonFraction></span>, and
<span id="xdx_90E_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20190101__20191231_zT5RFzadOjRc"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">183,000</ix:nonFraction></span> shares of common stock for 2021, 2020, and 2019, respectively.</p>

</ix:nonNumeric><p id="xdx_81F_zNkaLinD4Gci" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>


<!-- Field: /Named-Area; -->

<!-- Field: Named-Area; Name: Contents -->
<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:SegmentReportingDisclosureTextBlock"><p id="xdx_809_eus-gaap--SegmentReportingDisclosureTextBlock_zTDjhJtKdnf" style="margin-top: 0; margin-bottom: 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"><b>(15)</b></td><td style="text-align: justify"><b><span id="xdx_82F_zfV26WYAai8k">Segments and Geographic Areas</span></b></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company <span style="font-family: Times New Roman, Times, Serif">manufactures
and distributes one product line, fragrances and fragrance related products. The Company</span> manages its business in two segments,
European based operations and United States based operations. The European assets are located, and operations are primarily conducted,
in France. Both European and United States operations primarily represent the sale of prestige brand name fragrances.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<ix:exclude><!-- Field: Page; Sequence: 116; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>INTER PARFUMS, INC. AND SUBSIDIARIES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Notes to Consolidated Financial Statements</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">December 31, 2021, 2020 and 2019</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(In thousands except share and per share data)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock"><p id="xdx_899_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_zxd4NvECI4qf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span><span id="xdx_8B5_zkDY8ZZkiM0h">Information on the Company&#8217;s
operations by segments is as follows:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="visibility: visible; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; visibility: visible; font-weight: bold; text-align: center">Year ended December 31,</td><td style="visibility: visible; padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="visibility: visible; vertical-align: bottom">
    <td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; visibility: visible; font-weight: bold; text-align: center">2021</td><td style="visibility: visible; padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="visibility: visible; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; visibility: visible; font-weight: bold; text-align: center">2020</td><td style="visibility: visible; padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="visibility: visible; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; visibility: visible; font-weight: bold; text-align: center">2019</td><td style="visibility: visible; padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="visibility: visible; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="visibility: visible; text-align: left">Net sales:</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible; text-align: right">&#160;</td><td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible; text-align: right">&#160;</td><td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible; text-align: right">&#160;</td><td style="visibility: visible; text-align: left">&#160;</td></tr>
<tr style="visibility: visible; vertical-align: bottom; background-color: White">
    <td style="visibility: visible; width: 55%; text-align: left">&#160;&#160;&#160;&#160;United States</td><td style="visibility: visible; width: 1%">&#160;</td>
    <td style="visibility: visible; width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20210101__20211231__srt--StatementGeographicalAxis__country--US_z5r4PcNAeks3" style="visibility: visible; width: 12%; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" contextRef="From2021-01-012021-12-31_country_US" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">216,559</ix:nonFraction></td><td style="visibility: visible; width: 1%; text-align: left">&#160;</td><td style="visibility: visible; width: 1%">&#160;</td>
    <td style="visibility: visible; width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20200101__20201231__srt--StatementGeographicalAxis__country--US_zCfrzosskOG7" style="visibility: visible; width: 12%; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" contextRef="From2020-01-012020-12-31_country_US" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">117,489</ix:nonFraction></td><td style="visibility: visible; width: 1%; text-align: left">&#160;</td><td style="visibility: visible; width: 1%">&#160;</td>
    <td style="visibility: visible; width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20190101__20191231__srt--StatementGeographicalAxis__country--US_zWIdVteHZ4Hi" style="visibility: visible; width: 12%; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" contextRef="From2019-01-012019-12-31_country_US" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">173,522</ix:nonFraction></td><td style="visibility: visible; width: 1%; text-align: left">&#160;</td></tr>
<tr style="visibility: visible; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="visibility: visible; text-align: left">&#160;&#160;&#160;&#160;Europe</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20210101__20211231__srt--StatementGeographicalAxis__srt--EuropeMember_zmO13RpnEfAk" style="visibility: visible; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" contextRef="From2021-01-012021-12-31_srt_EuropeMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">663,290</ix:nonFraction></td><td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20200101__20201231__srt--StatementGeographicalAxis__srt--EuropeMember_ztyL8g0DCNCg" style="visibility: visible; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" contextRef="From2020-01-012020-12-31_srt_EuropeMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">422,947</ix:nonFraction></td><td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20190101__20191231__srt--StatementGeographicalAxis__srt--EuropeMember_ztcgUX0XX4o3" style="visibility: visible; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" contextRef="From2019-01-012019-12-31_srt_EuropeMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">542,226</ix:nonFraction></td><td style="visibility: visible; text-align: left">&#160;</td></tr>
<tr style="visibility: visible; vertical-align: bottom; background-color: White">
    <td style="visibility: visible; text-align: left; padding-bottom: 1pt">&#160;&#160;&#160;&#160;Eliminations of intercompany sales</td><td style="visibility: visible; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; visibility: visible; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20210101__20211231__srt--StatementGeographicalAxis__custom--EliminationsMember_zwlEf11aFZM2" style="border-bottom: Black 1pt solid; visibility: visible; text-align: right">(<ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" contextRef="From2021-01-012021-12-31_custom_EliminationsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">333</ix:nonFraction></td><td style="visibility: visible; padding-bottom: 1pt; text-align: left">)</td><td style="visibility: visible; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; visibility: visible; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20200101__20201231__srt--StatementGeographicalAxis__custom--EliminationsMember_z5ym2Cf1wVOj" style="border-bottom: Black 1pt solid; visibility: visible; text-align: right">(<ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" contextRef="From2020-01-012020-12-31_custom_EliminationsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1,427</ix:nonFraction></td><td style="visibility: visible; padding-bottom: 1pt; text-align: left">)</td><td style="visibility: visible; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; visibility: visible; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20190101__20191231__srt--StatementGeographicalAxis__custom--EliminationsMember_zicOjvimpE4k" style="border-bottom: Black 1pt solid; visibility: visible; text-align: right">(<ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" contextRef="From2019-01-012019-12-31_custom_EliminationsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">2,234</ix:nonFraction></td><td style="visibility: visible; padding-bottom: 1pt; text-align: left">)</td></tr>
<tr style="visibility: visible; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="visibility: visible; text-align: left; padding-bottom: 2pt">&#160;</td><td style="visibility: visible; padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; visibility: visible; text-align: left">$</td><td id="xdx_988_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20210101__20211231_zjyV2OjP8sa3" style="border-bottom: Black 2pt double; visibility: visible; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">879,516</ix:nonFraction></td><td style="visibility: visible; padding-bottom: 2pt; text-align: left">&#160;</td><td style="visibility: visible; padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; visibility: visible; text-align: left">$</td><td id="xdx_98C_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20200101__20201231_zeUtsjBlkcec" style="border-bottom: Black 2pt double; visibility: visible; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">539,009</ix:nonFraction></td><td style="visibility: visible; padding-bottom: 2pt; text-align: left">&#160;</td><td style="visibility: visible; padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; visibility: visible; text-align: left">$</td><td id="xdx_984_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_dxL_c20200101__20201231_zrpOASipOcL" title="::XDX::539%2C009" style="border-bottom: Black 2pt double; visibility: visible; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1497">713,514</span></td><td style="visibility: visible; padding-bottom: 2pt; text-align: left">&#160;</td></tr>
<tr style="visibility: visible; vertical-align: bottom; background-color: White">
    <td style="visibility: visible; text-align: left">Net income attributable to Inter Parfums, Inc.:</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible; text-align: right">&#160;</td><td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible; text-align: right">&#160;</td><td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible; text-align: right">&#160;</td><td style="visibility: visible; text-align: left">&#160;</td></tr>
<tr style="visibility: visible; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="visibility: visible; text-align: left">&#160;&#160;&#160;&#160;United States</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">$</td><td id="xdx_982_eus-gaap--NetIncomeLoss_c20210101__20211231__srt--StatementGeographicalAxis__country--US_zJrsX1vBTKh1" style="visibility: visible; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-01-012021-12-31_country_US" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">29,359</ix:nonFraction></td><td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">$</td><td id="xdx_986_eus-gaap--NetIncomeLoss_c20200101__20201231__srt--StatementGeographicalAxis__country--US_zukMU1UqRBab" style="visibility: visible; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-01-012020-12-31_country_US" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,942</ix:nonFraction></td><td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">$</td><td id="xdx_98D_eus-gaap--NetIncomeLoss_c20190101__20191231__srt--StatementGeographicalAxis__country--US_zfoS7lQBSpQ7" style="visibility: visible; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2019-01-012019-12-31_country_US" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">19,365</ix:nonFraction></td><td style="visibility: visible; text-align: left">&#160;</td></tr>
<tr style="visibility: visible; vertical-align: bottom; background-color: White">
    <td style="visibility: visible; text-align: left">&#160;&#160;&#160;&#160;Europe</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--NetIncomeLoss_c20210101__20211231__srt--StatementGeographicalAxis__srt--EuropeMember_z5kifDjPeta6" style="visibility: visible; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-01-012021-12-31_srt_EuropeMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">57,869</ix:nonFraction></td><td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--NetIncomeLoss_c20200101__20201231__srt--StatementGeographicalAxis__srt--EuropeMember_zytAdG8vtrri" style="visibility: visible; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-01-012020-12-31_srt_EuropeMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">30,241</ix:nonFraction></td><td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--NetIncomeLoss_c20190101__20191231__srt--StatementGeographicalAxis__srt--EuropeMember_ztQNOn4IdHg8" style="visibility: visible; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2019-01-012019-12-31_srt_EuropeMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">40,840</ix:nonFraction></td><td style="visibility: visible; text-align: left">&#160;</td></tr>
<tr style="visibility: visible; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="visibility: visible; text-align: left; padding-bottom: 1pt">&#160;&#160;&#160;&#160;Eliminations</td><td style="visibility: visible; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; visibility: visible; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--NetIncomeLoss_c20210101__20211231__srt--StatementGeographicalAxis__custom--EliminationsMember_zg9MaKYb0dsc" style="border-bottom: Black 1pt solid; visibility: visible; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-01-012021-12-31_custom_EliminationsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">183</ix:nonFraction></td><td style="visibility: visible; padding-bottom: 1pt; text-align: left">&#160;</td><td style="visibility: visible; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; visibility: visible; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--NetIncomeLoss_c20200101__20201231__srt--StatementGeographicalAxis__custom--EliminationsMember_zNVbvBEIifob" style="border-bottom: Black 1pt solid; visibility: visible; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-01-012020-12-31_custom_EliminationsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">36</ix:nonFraction></td><td style="visibility: visible; padding-bottom: 1pt; text-align: left">&#160;</td><td style="visibility: visible; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; visibility: visible; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--NetIncomeLoss_c20190101__20191231__srt--StatementGeographicalAxis__custom--EliminationsMember_zykwKqHurgGd" style="border-bottom: Black 1pt solid; visibility: visible; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2019-01-012019-12-31_custom_EliminationsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">44</ix:nonFraction></td><td style="visibility: visible; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="visibility: visible; vertical-align: bottom; background-color: White">
    <td style="visibility: visible; text-align: left; padding-bottom: 2pt">&#160;</td><td style="visibility: visible; padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; visibility: visible; text-align: left">$</td><td id="xdx_981_eus-gaap--NetIncomeLoss_c20210101__20211231_znQ0YUnY32X3" style="border-bottom: Black 2pt double; visibility: visible; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">87,411</ix:nonFraction></td><td style="visibility: visible; padding-bottom: 2pt; text-align: left">&#160;</td><td style="visibility: visible; padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; visibility: visible; text-align: left">$</td><td id="xdx_986_eus-gaap--NetIncomeLoss_c20200101__20201231_zyP62IcvJVSh" style="border-bottom: Black 2pt double; visibility: visible; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">38,219</ix:nonFraction></td><td style="visibility: visible; padding-bottom: 2pt; text-align: left">&#160;</td><td style="visibility: visible; padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; visibility: visible; text-align: left">$</td><td id="xdx_98B_eus-gaap--NetIncomeLoss_c20190101__20191231_z997kfuIqlMf" style="border-bottom: Black 2pt double; visibility: visible; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">60,249</ix:nonFraction></td><td style="visibility: visible; padding-bottom: 2pt; text-align: left">&#160;</td></tr>
<tr style="visibility: visible; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="visibility: visible; text-align: left; text-indent: -7.75pt; padding-left: 7.75pt">Depreciation and amortization expense including impairment loss:</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible; text-align: right">&#160;</td><td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible; text-align: right">&#160;</td><td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible; text-align: right">&#160;</td><td style="visibility: visible; text-align: left">&#160;</td></tr>
<tr style="visibility: visible; vertical-align: bottom; background-color: White">
    <td style="visibility: visible; text-align: left">&#160;&#160;&#160;&#160;United States</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">$</td><td id="xdx_98C_eus-gaap--DepreciationAndAmortization_c20210101__20211231__srt--StatementGeographicalAxis__country--US_zkF7xuK0rol4" style="visibility: visible; text-align: right"><ix:nonFraction name="us-gaap:DepreciationAndAmortization" contextRef="From2021-01-012021-12-31_country_US" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,835</ix:nonFraction></td><td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">$</td><td id="xdx_982_eus-gaap--DepreciationAndAmortization_c20200101__20201231__srt--StatementGeographicalAxis__country--US_zyOCWL2HUBxa" style="visibility: visible; text-align: right"><ix:nonFraction name="us-gaap:DepreciationAndAmortization" contextRef="From2020-01-012020-12-31_country_US" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,354</ix:nonFraction></td><td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">$</td><td id="xdx_985_eus-gaap--DepreciationAndAmortization_c20190101__20191231__srt--StatementGeographicalAxis__country--US_zUUVLjx2cPk" style="visibility: visible; text-align: right"><ix:nonFraction name="us-gaap:DepreciationAndAmortization" contextRef="From2019-01-012019-12-31_country_US" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,088</ix:nonFraction></td><td style="visibility: visible; text-align: left">&#160;</td></tr>
<tr style="visibility: visible; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="visibility: visible; text-align: left; padding-bottom: 1pt">&#160;&#160;&#160;&#160;Europe</td><td style="visibility: visible; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; visibility: visible; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--DepreciationAndAmortization_c20210101__20211231__srt--StatementGeographicalAxis__srt--EuropeMember_zt8Xwpmj0roa" style="border-bottom: Black 1pt solid; visibility: visible; text-align: right"><ix:nonFraction name="us-gaap:DepreciationAndAmortization" contextRef="From2021-01-012021-12-31_srt_EuropeMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8,863</ix:nonFraction></td><td style="visibility: visible; padding-bottom: 1pt; text-align: left">&#160;</td><td style="visibility: visible; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; visibility: visible; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--DepreciationAndAmortization_c20200101__20201231__srt--StatementGeographicalAxis__srt--EuropeMember_zioukoB7Vgtj" style="border-bottom: Black 1pt solid; visibility: visible; text-align: right"><ix:nonFraction name="us-gaap:DepreciationAndAmortization" contextRef="From2020-01-012020-12-31_srt_EuropeMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,713</ix:nonFraction></td><td style="visibility: visible; padding-bottom: 1pt; text-align: left">&#160;</td><td style="visibility: visible; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; visibility: visible; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--DepreciationAndAmortization_c20190101__20191231__srt--StatementGeographicalAxis__srt--EuropeMember_z70leSOFQKH9" style="border-bottom: Black 1pt solid; visibility: visible; text-align: right"><ix:nonFraction name="us-gaap:DepreciationAndAmortization" contextRef="From2019-01-012019-12-31_srt_EuropeMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,641</ix:nonFraction></td><td style="visibility: visible; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="visibility: visible; vertical-align: bottom; background-color: White">
    <td style="visibility: visible; text-align: left; padding-bottom: 2pt">&#160;</td><td style="visibility: visible; padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; visibility: visible; text-align: left">$</td><td id="xdx_988_eus-gaap--DepreciationAndAmortization_c20210101__20211231_zDXjtc4WPOAg" style="border-bottom: Black 2pt double; visibility: visible; text-align: right"><ix:nonFraction name="us-gaap:DepreciationAndAmortization" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">12,698</ix:nonFraction></td><td style="visibility: visible; padding-bottom: 2pt; text-align: left">&#160;</td><td style="visibility: visible; padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; visibility: visible; text-align: left">$</td><td id="xdx_987_eus-gaap--DepreciationAndAmortization_c20200101__20201231_zqTLCmXoJIdd" style="border-bottom: Black 2pt double; visibility: visible; text-align: right"><ix:nonFraction name="us-gaap:DepreciationAndAmortization" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9,067</ix:nonFraction></td><td style="visibility: visible; padding-bottom: 2pt; text-align: left">&#160;</td><td style="visibility: visible; padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; visibility: visible; text-align: left">$</td><td id="xdx_983_eus-gaap--DepreciationAndAmortization_c20190101__20191231_z7wvpw82L6q3" style="border-bottom: Black 2pt double; visibility: visible; text-align: right"><ix:nonFraction name="us-gaap:DepreciationAndAmortization" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8,729</ix:nonFraction></td><td style="visibility: visible; padding-bottom: 2pt; text-align: left">&#160;</td></tr>
<tr style="visibility: visible; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="visibility: visible; text-align: left">Interest and investment income:</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible; text-align: right">&#160;</td><td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible; text-align: right">&#160;</td><td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible; text-align: right">&#160;</td><td style="visibility: visible; text-align: left">&#160;</td></tr>
<tr style="visibility: visible; vertical-align: bottom; background-color: White">
    <td style="visibility: visible; text-align: left">&#160;&#160;&#160;&#160;United States</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">$</td><td id="xdx_988_eus-gaap--InvestmentIncomeInterestAndDividend_c20210101__20211231__srt--StatementGeographicalAxis__country--US_zGHaHth6AQv7" style="visibility: visible; text-align: right"><ix:nonFraction name="us-gaap:InvestmentIncomeInterestAndDividend" contextRef="From2021-01-012021-12-31_country_US" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3</ix:nonFraction></td><td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">$</td><td id="xdx_982_eus-gaap--InvestmentIncomeInterestAndDividend_c20200101__20201231__srt--StatementGeographicalAxis__country--US_z7dyBRe90bJ8" style="visibility: visible; text-align: right"><ix:nonFraction name="us-gaap:InvestmentIncomeInterestAndDividend" contextRef="From2020-01-012020-12-31_country_US" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">24</ix:nonFraction></td><td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">$</td><td id="xdx_984_eus-gaap--InvestmentIncomeInterestAndDividend_c20190101__20191231__srt--StatementGeographicalAxis__country--US_za0FpXMf1CW8" style="visibility: visible; text-align: right"><ix:nonFraction name="us-gaap:InvestmentIncomeInterestAndDividend" contextRef="From2019-01-012019-12-31_country_US" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">345</ix:nonFraction></td><td style="visibility: visible; text-align: left">&#160;</td></tr>
<tr style="visibility: visible; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="visibility: visible; text-align: left">&#160;&#160;&#160;&#160;Europe</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--InvestmentIncomeInterestAndDividend_c20210101__20211231__srt--StatementGeographicalAxis__srt--EuropeMember_zoRhTydjQQed" style="visibility: visible; text-align: right"><ix:nonFraction name="us-gaap:InvestmentIncomeInterestAndDividend" contextRef="From2021-01-012021-12-31_srt_EuropeMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,526</ix:nonFraction></td><td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--InvestmentIncomeInterestAndDividend_c20200101__20201231__srt--StatementGeographicalAxis__srt--EuropeMember_zP5BNsiY3o85" style="visibility: visible; text-align: right"><ix:nonFraction name="us-gaap:InvestmentIncomeInterestAndDividend" contextRef="From2020-01-012020-12-31_srt_EuropeMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,971</ix:nonFraction></td><td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--InvestmentIncomeInterestAndDividend_c20190101__20191231__srt--StatementGeographicalAxis__srt--EuropeMember_zWzfeijv0RZe" style="visibility: visible; text-align: right"><ix:nonFraction name="us-gaap:InvestmentIncomeInterestAndDividend" contextRef="From2019-01-012019-12-31_srt_EuropeMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,501</ix:nonFraction></td><td style="visibility: visible; text-align: left">&#160;</td></tr>
<tr style="visibility: visible; vertical-align: bottom; background-color: White">
    <td style="visibility: visible; text-align: left; padding-bottom: 1pt">&#160;&#160;&#160;&#160;Eliminations</td><td style="visibility: visible; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; visibility: visible; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--InvestmentIncomeInterestAndDividend_c20210101__20211231__srt--StatementGeographicalAxis__custom--EliminationsMember_zJm2O7dCPjhc" style="border-bottom: Black 1pt solid; visibility: visible; text-align: right">(<ix:nonFraction name="us-gaap:InvestmentIncomeInterestAndDividend" contextRef="From2021-01-012021-12-31_custom_EliminationsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">126</ix:nonFraction></td><td style="visibility: visible; padding-bottom: 1pt; text-align: left">)</td><td style="visibility: visible; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; visibility: visible; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--InvestmentIncomeInterestAndDividend_c20200101__20201231__srt--StatementGeographicalAxis__custom--EliminationsMember_zOPX0UarbiWc" style="border-bottom: Black 1pt solid; visibility: visible; text-align: right">(<ix:nonFraction name="us-gaap:InvestmentIncomeInterestAndDividend" contextRef="From2020-01-012020-12-31_custom_EliminationsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">130</ix:nonFraction></td><td style="visibility: visible; padding-bottom: 1pt; text-align: left">)</td><td style="visibility: visible; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; visibility: visible; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--InvestmentIncomeInterestAndDividend_c20190101__20191231__srt--StatementGeographicalAxis__custom--EliminationsMember_zt62G18GMYZ" style="border-bottom: Black 1pt solid; visibility: visible; text-align: right">(<ix:nonFraction name="us-gaap:InvestmentIncomeInterestAndDividend" contextRef="From2019-01-012019-12-31_custom_EliminationsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">153</ix:nonFraction></td><td style="visibility: visible; padding-bottom: 1pt; text-align: left">)</td></tr>
<tr style="visibility: visible; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="visibility: visible; text-align: left; padding-bottom: 2pt">&#160;</td><td style="visibility: visible; padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; visibility: visible; text-align: left">$</td><td id="xdx_98F_eus-gaap--InvestmentIncomeInterestAndDividend_c20210101__20211231_z1Scsi8xKcu8" style="border-bottom: Black 2pt double; visibility: visible; text-align: right"><ix:nonFraction name="us-gaap:InvestmentIncomeInterestAndDividend" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,403</ix:nonFraction></td><td style="visibility: visible; padding-bottom: 2pt; text-align: left">&#160;</td><td style="visibility: visible; padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; visibility: visible; text-align: left">$</td><td id="xdx_986_eus-gaap--InvestmentIncomeInterestAndDividend_c20200101__20201231_zqQDKSCvhSI9" style="border-bottom: Black 2pt double; visibility: visible; text-align: right"><ix:nonFraction name="us-gaap:InvestmentIncomeInterestAndDividend" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,865</ix:nonFraction></td><td style="visibility: visible; padding-bottom: 2pt; text-align: left">&#160;</td><td style="visibility: visible; padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; visibility: visible; text-align: left">$</td><td id="xdx_98E_eus-gaap--InvestmentIncomeInterestAndDividend_c20190101__20191231_zEOKYG3INDt8" style="border-bottom: Black 2pt double; visibility: visible; text-align: right"><ix:nonFraction name="us-gaap:InvestmentIncomeInterestAndDividend" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,693</ix:nonFraction></td><td style="visibility: visible; padding-bottom: 2pt; text-align: left">&#160;</td></tr>
<tr style="visibility: visible; vertical-align: bottom; background-color: White">
    <td style="visibility: visible; text-align: left">Interest expense:</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible; text-align: right">&#160;</td><td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible; text-align: right">&#160;</td><td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible; text-align: right">&#160;</td><td style="visibility: visible; text-align: left">&#160;</td></tr>
<tr style="visibility: visible; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="visibility: visible; text-align: left">&#160;&#160;&#160;&#160;United States</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">$</td><td id="xdx_987_eus-gaap--InterestExpense_c20210101__20211231__srt--StatementGeographicalAxis__country--US_zYxsoG4QjcUa" style="visibility: visible; text-align: right"><ix:nonFraction name="us-gaap:InterestExpense" contextRef="From2021-01-012021-12-31_country_US" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">636</ix:nonFraction></td><td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">$</td><td id="xdx_989_eus-gaap--InterestExpense_c20200101__20201231__srt--StatementGeographicalAxis__country--US_z2Ybx7IJsKC3" style="visibility: visible; text-align: right"><ix:nonFraction name="us-gaap:InterestExpense" contextRef="From2020-01-012020-12-31_country_US" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">604</ix:nonFraction></td><td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">$</td><td id="xdx_98B_eus-gaap--InterestExpense_c20190101__20191231__srt--StatementGeographicalAxis__country--US_zY8KBHWYMCk1" style="visibility: visible; text-align: right"><ix:nonFraction name="us-gaap:InterestExpense" contextRef="From2019-01-012019-12-31_country_US" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">673</ix:nonFraction></td><td style="visibility: visible; text-align: left">&#160;</td></tr>
<tr style="visibility: visible; vertical-align: bottom; background-color: White">
    <td style="visibility: visible; text-align: left">&#160;&#160;&#160;&#160;Europe</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--InterestExpense_c20210101__20211231__srt--StatementGeographicalAxis__srt--EuropeMember_zHgsSFDcKVIf" title="Interest expense" style="visibility: visible; text-align: right"><ix:nonFraction name="us-gaap:InterestExpense" contextRef="From2021-01-012021-12-31_srt_EuropeMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,315</ix:nonFraction></td><td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--InterestExpense_c20200101__20201231__srt--StatementGeographicalAxis__srt--EuropeMember_zLmvKN23VR57" title="Interest expense" style="visibility: visible; text-align: right"><ix:nonFraction name="us-gaap:InterestExpense" contextRef="From2020-01-012020-12-31_srt_EuropeMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,496</ix:nonFraction></td><td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--InterestExpense_c20190101__20191231__srt--StatementGeographicalAxis__srt--EuropeMember_zNSXrgeFTNAg" title="Interest expense" style="visibility: visible; text-align: right"><ix:nonFraction name="us-gaap:InterestExpense" contextRef="From2019-01-012019-12-31_srt_EuropeMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,626</ix:nonFraction></td><td style="visibility: visible; text-align: left">&#160;</td></tr>
<tr style="visibility: visible; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="visibility: visible; text-align: left; padding-bottom: 1pt">&#160;&#160;&#160;&#160;Eliminations</td><td style="visibility: visible; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; visibility: visible; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--InterestExpense_c20210101__20211231__srt--StatementGeographicalAxis__custom--EliminationsMember_zcrfn5F85JL7" title="Interest expense" style="border-bottom: Black 1pt solid; visibility: visible; text-align: right">(<ix:nonFraction name="us-gaap:InterestExpense" contextRef="From2021-01-012021-12-31_custom_EliminationsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">126</ix:nonFraction></td><td style="visibility: visible; padding-bottom: 1pt; text-align: left">)</td><td style="visibility: visible; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; visibility: visible; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--InterestExpense_c20200101__20201231__srt--StatementGeographicalAxis__custom--EliminationsMember_zYBXzVtL8SH1" title="Interest expense" style="border-bottom: Black 1pt solid; visibility: visible; text-align: right">(<ix:nonFraction name="us-gaap:InterestExpense" contextRef="From2020-01-012020-12-31_custom_EliminationsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">130</ix:nonFraction></td><td style="visibility: visible; padding-bottom: 1pt; text-align: left">)</td><td style="visibility: visible; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; visibility: visible; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--InterestExpense_c20190101__20191231__srt--StatementGeographicalAxis__custom--EliminationsMember_zSMQsNKpvAO2" title="Interest expense" style="border-bottom: Black 1pt solid; visibility: visible; text-align: right">(<ix:nonFraction name="us-gaap:InterestExpense" contextRef="From2019-01-012019-12-31_custom_EliminationsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">153</ix:nonFraction></td><td style="visibility: visible; padding-bottom: 1pt; text-align: left">)</td></tr>
<tr style="visibility: visible; vertical-align: bottom; background-color: White">
    <td style="visibility: visible; text-align: left; padding-bottom: 2pt">&#160;</td><td style="visibility: visible; padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; visibility: visible; text-align: left">$</td><td id="xdx_98D_eus-gaap--InterestExpense_c20210101__20211231_zYwDrdtfE7qj" title="Interest expense" style="border-bottom: Black 2pt double; visibility: visible; text-align: right"><ix:nonFraction name="us-gaap:InterestExpense" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,825</ix:nonFraction></td><td style="visibility: visible; padding-bottom: 2pt; text-align: left">&#160;</td><td style="visibility: visible; padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; visibility: visible; text-align: left">$</td><td id="xdx_980_eus-gaap--InterestExpense_c20200101__20201231_zNXV6WHw0F3b" title="Interest expense" style="border-bottom: Black 2pt double; visibility: visible; text-align: right"><ix:nonFraction name="us-gaap:InterestExpense" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,970</ix:nonFraction></td><td style="visibility: visible; padding-bottom: 2pt; text-align: left">&#160;</td><td style="visibility: visible; padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; visibility: visible; text-align: left">$</td><td id="xdx_981_eus-gaap--InterestExpense_c20190101__20191231_zI8X8gzlNi8c" title="Interest expense" style="border-bottom: Black 2pt double; visibility: visible; text-align: right"><ix:nonFraction name="us-gaap:InterestExpense" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,146</ix:nonFraction></td><td style="visibility: visible; padding-bottom: 2pt; text-align: left">&#160;</td></tr>
<tr style="visibility: visible; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="visibility: visible; text-align: left">Income tax expense:</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible; text-align: right">&#160;</td><td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible; text-align: right">&#160;</td><td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible; text-align: right">&#160;</td><td style="visibility: visible; text-align: left">&#160;</td></tr>
<tr style="visibility: visible; vertical-align: bottom; background-color: White">
    <td style="visibility: visible; text-align: left">&#160;&#160;&#160;&#160;United States</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">$</td><td id="xdx_985_eus-gaap--IncomeTaxExpenseBenefit_c20210101__20211231__srt--StatementGeographicalAxis__country--US_zPqN12BQMkL1" style="visibility: visible; text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2021-01-012021-12-31_country_US" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,336</ix:nonFraction></td><td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">$</td><td id="xdx_983_eus-gaap--IncomeTaxExpenseBenefit_c20200101__20201231__srt--StatementGeographicalAxis__country--US_zHU559TDBHrb" style="visibility: visible; text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2020-01-012020-12-31_country_US" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,590</ix:nonFraction></td><td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">$</td><td id="xdx_986_eus-gaap--IncomeTaxExpenseBenefit_c20190101__20191231__srt--StatementGeographicalAxis__country--US_ztUs8eqesh7k" style="visibility: visible; text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2019-01-012019-12-31_country_US" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,945</ix:nonFraction></td><td style="visibility: visible; text-align: left">&#160;</td></tr>
<tr style="visibility: visible; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="visibility: visible; text-align: left">&#160;&#160;&#160;&#160;Europe</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--IncomeTaxExpenseBenefit_c20210101__20211231__srt--StatementGeographicalAxis__srt--EuropeMember_z0bXvJdCA9qa" style="visibility: visible; text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2021-01-012021-12-31_srt_EuropeMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">35,607</ix:nonFraction></td><td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--IncomeTaxExpenseBenefit_c20200101__20201231__srt--StatementGeographicalAxis__srt--EuropeMember_z6N7TqsQJgVf" style="visibility: visible; text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2020-01-012020-12-31_srt_EuropeMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">17,782</ix:nonFraction></td><td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--IncomeTaxExpenseBenefit_c20190101__20191231__srt--StatementGeographicalAxis__srt--EuropeMember_zyNgRnvX3AHa" style="visibility: visible; text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2019-01-012019-12-31_srt_EuropeMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">25,101</ix:nonFraction></td><td style="visibility: visible; text-align: left">&#160;</td></tr>
<tr style="visibility: visible; vertical-align: bottom; background-color: White">
    <td style="visibility: visible; text-align: left; padding-bottom: 1pt">&#160;&#160;&#160;&#160;Eliminations</td><td style="visibility: visible; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; visibility: visible; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--IncomeTaxExpenseBenefit_c20210101__20211231__srt--StatementGeographicalAxis__custom--EliminationsMember_zsxwiXhlQHTb" style="border-bottom: Black 1pt solid; visibility: visible; text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2021-01-012021-12-31_custom_EliminationsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">49</ix:nonFraction></td><td style="visibility: visible; padding-bottom: 1pt; text-align: left">&#160;</td><td style="visibility: visible; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; visibility: visible; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--IncomeTaxExpenseBenefit_c20200101__20201231__srt--StatementGeographicalAxis__custom--EliminationsMember_zAQ2F8H0iw26" style="border-bottom: Black 1pt solid; visibility: visible; text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2020-01-012020-12-31_custom_EliminationsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9</ix:nonFraction></td><td style="visibility: visible; padding-bottom: 1pt; text-align: left">&#160;</td><td style="visibility: visible; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; visibility: visible; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--IncomeTaxExpenseBenefit_c20190101__20191231__srt--StatementGeographicalAxis__custom--EliminationsMember_zsfPjVbPoZq9" style="border-bottom: Black 1pt solid; visibility: visible; text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2019-01-012019-12-31_custom_EliminationsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">30</ix:nonFraction></td><td style="visibility: visible; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="visibility: visible; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="visibility: visible; text-align: left; padding-bottom: 2pt">&#160;</td><td style="visibility: visible; padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; visibility: visible; text-align: left">$</td><td id="xdx_985_eus-gaap--IncomeTaxExpenseBenefit_c20210101__20211231_zYuwcNGNDjxe" style="border-bottom: Black 2pt double; visibility: visible; text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">40,992</ix:nonFraction></td><td style="visibility: visible; padding-bottom: 2pt; text-align: left">&#160;</td><td style="visibility: visible; padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; visibility: visible; text-align: left">$</td><td id="xdx_988_eus-gaap--IncomeTaxExpenseBenefit_c20200101__20201231_zK5CansaJlHa" style="border-bottom: Black 2pt double; visibility: visible; text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">19,381</ix:nonFraction></td><td style="visibility: visible; padding-bottom: 2pt; text-align: left">&#160;</td><td style="visibility: visible; padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; visibility: visible; text-align: left">$</td><td id="xdx_982_eus-gaap--IncomeTaxExpenseBenefit_c20190101__20191231_ziS0Mw2aThV8" style="border-bottom: Black 2pt double; visibility: visible; text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">29,076</ix:nonFraction></td><td style="visibility: visible; padding-bottom: 2pt; text-align: left">&#160;</td></tr>
</table>

<p style="margin: 0; visibility: visible">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in">
<tr style="text-align: center; vertical-align: bottom">
    <td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>December 31,</b></span></td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="text-align: center; vertical-align: bottom">
    <td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold">2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold">2019</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; width: 55%">Total assets:</td><td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td style="text-align: right; width: 12%">&#160;</td><td style="text-align: left; width: 1%">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td style="text-align: right; width: 12%">&#160;</td><td style="text-align: left; width: 1%">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td style="text-align: right; width: 12%">&#160;</td><td style="text-align: left; width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;&#160;&#160;&#160;United States</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--Assets_iI_c20211231__srt--StatementGeographicalAxis__country--US_z8zLIQYvfsd3" style="text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2021-12-31_country_US" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">247,703</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--Assets_iI_c20201231__srt--StatementGeographicalAxis__country--US_z1a1mVWhWgJa" style="text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2020-12-31_country_US" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">141,316</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_983_eus-gaap--Assets_iI_c20191231__srt--StatementGeographicalAxis__country--US_ze4scNtgijPj" style="text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2019-12-31_country_US" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">166,180</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;&#160;&#160;&#160;Europe</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--Assets_iI_c20211231__srt--StatementGeographicalAxis__srt--EuropeMember_zFKpIBUvOgqk" style="text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2021-12-31_srt_EuropeMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">931,735</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--Assets_iI_c20201231__srt--StatementGeographicalAxis__srt--EuropeMember_zLoIkfHcmMR6" style="text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2020-12-31_srt_EuropeMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">758,812</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--Assets_iI_c20191231__srt--StatementGeographicalAxis__srt--EuropeMember_zHhR8uZ68Vdi" style="text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2019-12-31_srt_EuropeMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">670,657</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">&#160;&#160;&#160;&#160;Eliminations</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--Assets_iI_c20211231__srt--StatementGeographicalAxis__custom--EliminationsMember_ziJx0D2ajuXj" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2021-12-31_custom_EliminationsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">34,074</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--Assets_iI_c20201231__srt--StatementGeographicalAxis__custom--EliminationsMember_zW0wHylpiVnf" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2020-12-31_custom_EliminationsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">9,983</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--Assets_iI_c20191231__srt--StatementGeographicalAxis__custom--EliminationsMember_ztZSf6TnJ691" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2019-12-31_custom_EliminationsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">8,005</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2pt">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td id="xdx_984_eus-gaap--Assets_iI_c20211231_zDp748Hon1k2" style="border-bottom: Black 2pt double; text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,145,364</ix:nonFraction></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--Assets_iI_c20201231_zF0HVpqB8clf" style="border-bottom: Black 2pt double; text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">890,145</ix:nonFraction></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--Assets_iI_c20191231_zKV32bgh58nd" style="border-bottom: Black 2pt double; text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">828,832</ix:nonFraction></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Additions to long-lived assets:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;&#160;&#160;&#160;United States</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--AdditionsToOtherAssetsAmount_c20210101__20211231__srt--StatementGeographicalAxis__country--US_zwbljiC2D0T2" style="text-align: right"><ix:nonFraction name="us-gaap:AdditionsToOtherAssetsAmount" contextRef="From2021-01-012021-12-31_country_US" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,711</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--AdditionsToOtherAssetsAmount_c20200101__20201231__srt--StatementGeographicalAxis__country--US_zDQwlX504Fj9" style="text-align: right"><ix:nonFraction name="us-gaap:AdditionsToOtherAssetsAmount" contextRef="From2020-01-012020-12-31_country_US" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,004</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--AdditionsToOtherAssetsAmount_c20190101__20191231__srt--StatementGeographicalAxis__country--US_zyaItO2G8at2" style="text-align: right"><ix:nonFraction name="us-gaap:AdditionsToOtherAssetsAmount" contextRef="From2019-01-012019-12-31_country_US" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,851</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">&#160;&#160;&#160;&#160;Europe</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--AdditionsToOtherAssetsAmount_c20210101__20211231__srt--StatementGeographicalAxis__srt--EuropeMember_zhE9PE1o3qA5" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:AdditionsToOtherAssetsAmount" contextRef="From2021-01-012021-12-31_srt_EuropeMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">138,563</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--AdditionsToOtherAssetsAmount_c20200101__20201231__srt--StatementGeographicalAxis__srt--EuropeMember_z7bZHUpdAPbg" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:AdditionsToOtherAssetsAmount" contextRef="From2020-01-012020-12-31_srt_EuropeMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">11,259</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--AdditionsToOtherAssetsAmount_c20190101__20191231__srt--StatementGeographicalAxis__srt--EuropeMember_znS4FO2uM4K6" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:AdditionsToOtherAssetsAmount" contextRef="From2019-01-012019-12-31_srt_EuropeMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,643</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2pt">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--AdditionsToOtherAssetsAmount_c20210101__20211231_zHfls6HDBu4k" style="border-bottom: Black 2pt double; text-align: right"><ix:nonFraction name="us-gaap:AdditionsToOtherAssetsAmount" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">141,274</ix:nonFraction></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td id="xdx_987_eus-gaap--AdditionsToOtherAssetsAmount_c20200101__20201231_zcl7DDjE2QR5" style="border-bottom: Black 2pt double; text-align: right"><ix:nonFraction name="us-gaap:AdditionsToOtherAssetsAmount" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">12,263</ix:nonFraction></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td id="xdx_983_eus-gaap--AdditionsToOtherAssetsAmount_c20190101__20191231_zXeSTYOabnB4" style="border-bottom: Black 2pt double; text-align: right"><ix:nonFraction name="us-gaap:AdditionsToOtherAssetsAmount" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">11,494</ix:nonFraction></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Total long-lived assets:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;&#160;&#160;&#160;United States</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--NoncurrentAssets_iI_c20211231__srt--StatementGeographicalAxis__country--US_zQKQz1a0vcYc" style="text-align: right"><ix:nonFraction name="us-gaap:NoncurrentAssets" contextRef="AsOf2021-12-31_country_US" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">63,094</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--NoncurrentAssets_iI_c20201231__srt--StatementGeographicalAxis__country--US_zN6R5bz6TMr6" style="text-align: right"><ix:nonFraction name="us-gaap:NoncurrentAssets" contextRef="AsOf2020-12-31_country_US" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">40,656</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--NoncurrentAssets_iI_c20191231__srt--StatementGeographicalAxis__country--US_zofVpONNxiv8" style="text-align: right"><ix:nonFraction name="us-gaap:NoncurrentAssets" contextRef="AsOf2019-12-31_country_US" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">44,473</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">&#160;&#160;&#160;&#160;Europe</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--NoncurrentAssets_iI_c20211231__srt--StatementGeographicalAxis__srt--EuropeMember_zr7C4Q02H059" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NoncurrentAssets" contextRef="AsOf2021-12-31_srt_EuropeMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">334,033</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--NoncurrentAssets_iI_c20201231__srt--StatementGeographicalAxis__srt--EuropeMember_zgqJ58AYQgJ" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NoncurrentAssets" contextRef="AsOf2020-12-31_srt_EuropeMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">217,766</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--NoncurrentAssets_iI_c20191231__srt--StatementGeographicalAxis__srt--EuropeMember_z9wKjWDm19Zg" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NoncurrentAssets" contextRef="AsOf2019-12-31_srt_EuropeMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">196,976</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2pt">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--NoncurrentAssets_iI_c20211231_z6hxmiTCgKSi" style="border-bottom: Black 2pt double; text-align: right"><ix:nonFraction name="us-gaap:NoncurrentAssets" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">397,127</ix:nonFraction></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td id="xdx_984_eus-gaap--NoncurrentAssets_iI_c20201231_zJnLsw2O7mc3" style="border-bottom: Black 2pt double; text-align: right"><ix:nonFraction name="us-gaap:NoncurrentAssets" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">258,422</ix:nonFraction></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td id="xdx_980_eus-gaap--NoncurrentAssets_iI_c20191231_zGz0VhTFM3Yh" style="border-bottom: Black 2pt double; text-align: right"><ix:nonFraction name="us-gaap:NoncurrentAssets" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">241,449</ix:nonFraction></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Deferred tax assets:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;&#160;&#160;&#160;United States</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20211231__srt--StatementGeographicalAxis__country--US_zkvJfows7qFd" style="text-align: right"><ix:nonFraction name="us-gaap:DeferredIncomeTaxAssetsNet" contextRef="AsOf2021-12-31_country_US" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">870</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20201231__srt--StatementGeographicalAxis__country--US_zP0BCCuOPxBf" style="text-align: right"><ix:nonFraction name="us-gaap:DeferredIncomeTaxAssetsNet" contextRef="AsOf2020-12-31_country_US" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">886</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20191231__srt--StatementGeographicalAxis__country--US_zVZLmXviCsil" style="text-align: right"><ix:nonFraction name="us-gaap:DeferredIncomeTaxAssetsNet" contextRef="AsOf2019-12-31_country_US" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">705</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;&#160;&#160;&#160;Europe</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20211231__srt--StatementGeographicalAxis__srt--EuropeMember_z0lncOo7cgB7" style="text-align: right"><ix:nonFraction name="us-gaap:DeferredIncomeTaxAssetsNet" contextRef="AsOf2021-12-31_srt_EuropeMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,066</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20201231__srt--StatementGeographicalAxis__srt--EuropeMember_zrlbuGWF38d" style="text-align: right"><ix:nonFraction name="us-gaap:DeferredIncomeTaxAssetsNet" contextRef="AsOf2020-12-31_srt_EuropeMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,106</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20191231__srt--StatementGeographicalAxis__srt--EuropeMember_zVMP9IkRSMu4" style="text-align: right"><ix:nonFraction name="us-gaap:DeferredIncomeTaxAssetsNet" contextRef="AsOf2019-12-31_srt_EuropeMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,241</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">&#160;&#160;&#160;&#160;Eliminations</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20211231__srt--StatementGeographicalAxis__custom--EliminationsMember_zJs36H0Si6he" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1600">&#8212;</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20201231__srt--StatementGeographicalAxis__custom--EliminationsMember_znLmrvdF8f1k" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:DeferredIncomeTaxAssetsNet" contextRef="AsOf2020-12-31_custom_EliminationsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">49</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20191231__srt--StatementGeographicalAxis__custom--EliminationsMember_zAodDoksCThk" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:DeferredIncomeTaxAssetsNet" contextRef="AsOf2019-12-31_custom_EliminationsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">58</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2pt">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20211231_zEpnN8QYHkOa" style="border-bottom: Black 2pt double; text-align: right"><ix:nonFraction name="us-gaap:DeferredIncomeTaxAssetsNet" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,936</ix:nonFraction></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td id="xdx_987_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20201231_zkqsKHMhcTOl" style="border-bottom: Black 2pt double; text-align: right"><ix:nonFraction name="us-gaap:DeferredIncomeTaxAssetsNet" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8,041</ix:nonFraction></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20191231_zisQbqIbzlz4" style="border-bottom: Black 2pt double; text-align: right"><ix:nonFraction name="us-gaap:DeferredIncomeTaxAssetsNet" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8,004</ix:nonFraction></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8AE_zwGI3qP3PxX8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<ix:exclude><!-- Field: Page; Sequence: 117; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>INTER PARFUMS, INC. AND SUBSIDIARIES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Notes to Consolidated Financial Statements</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">December 31, 2021, 2020 and 2019</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(In thousands except share and per share data)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock"><p id="xdx_89E_eus-gaap--ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_zqqPoAQ24U2i" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">United States export sales were
approximately $<span id="xdx_901_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_dm_c20210101__20211231_zOKOIecfTgs">126.2 million</span>, $<span id="xdx_909_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_dm_c20200101__20201231_zgHZ9LnNqMH7">71.5 million</span> and $<span id="xdx_900_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20190101__20191231_zmGNh1bB8Dsd">112.0</span> million in 2021, 2020 and 2019, respectively. <span id="xdx_8BB_z8EKIkonq9Dc">Consolidated net sales to
customers by region are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 55%; text-align: left">North America</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--Revenues_c20210101__20211231__srt--StatementGeographicalAxis__srt--NorthAmericaMember_zAne2nd7s9qb" title="Net sales" style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2021-01-012021-12-31_srt_NorthAmericaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">354,100</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--Revenues_c20200101__20201231__srt--StatementGeographicalAxis__srt--NorthAmericaMember_zGLPNa5KiEji" style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2020-01-012020-12-31_srt_NorthAmericaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">193,500</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--Revenues_c20190101__20191231__srt--StatementGeographicalAxis__srt--NorthAmericaMember_zY4PXJenVjHl" style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2019-01-012019-12-31_srt_NorthAmericaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">235,500</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>Europe</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--Revenues_c20210101__20211231__srt--StatementGeographicalAxis__custom--EuropeCountryMember_z4Kj9Q2LPdmi" style="text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2021-01-012021-12-31_custom_EuropeCountryMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">271,600</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--Revenues_c20200101__20201231__srt--StatementGeographicalAxis__custom--EuropeCountryMember_z9cC9M7ZndHh" style="text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2020-01-012020-12-31_custom_EuropeCountryMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">180,200</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--Revenues_c20190101__20191231__srt--StatementGeographicalAxis__custom--EuropeCountryMember_zgb1sHloeFD6" style="text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2019-01-012019-12-31_custom_EuropeCountryMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">240,800</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Asia</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--Revenues_c20210101__20211231__srt--StatementGeographicalAxis__srt--AsiaMember_zW7Z1YghAqd3" style="text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2021-01-012021-12-31_srt_AsiaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">128,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--Revenues_c20200101__20201231__srt--StatementGeographicalAxis__srt--AsiaMember_zRNOQ20XH2E3" style="text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2020-01-012020-12-31_srt_AsiaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">79,700</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--Revenues_c20190101__20191231__srt--StatementGeographicalAxis__srt--AsiaMember_zV1AsVZ6BVC7" style="text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2019-01-012019-12-31_srt_AsiaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">110,900</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Middle East</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--Revenues_c20210101__20211231__srt--StatementGeographicalAxis__us-gaap--MiddleEastMember_zBqHf1TKVNzl" style="text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2021-01-012021-12-31_us-gaap_MiddleEastMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">61,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--Revenues_c20200101__20201231__srt--StatementGeographicalAxis__us-gaap--MiddleEastMember_zPX5D2V6erWl" style="text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2020-01-012020-12-31_us-gaap_MiddleEastMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">46,800</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--Revenues_c20190101__20191231__srt--StatementGeographicalAxis__us-gaap--MiddleEastMember_z2SSTGEiiOpk" style="text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2019-01-012019-12-31_us-gaap_MiddleEastMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">72,600</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Central and South America</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--Revenues_c20210101__20211231__srt--StatementGeographicalAxis__custom--CentralAndSouthAmericaMember_zQ82bJLnqLmc" style="text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2021-01-012021-12-31_custom_CentralAndSouthAmericaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">56,400</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--Revenues_c20200101__20201231__srt--StatementGeographicalAxis__custom--CentralAndSouthAmericaMember_zaQPC0bZbpRd" style="text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2020-01-012020-12-31_custom_CentralAndSouthAmericaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">32,500</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--Revenues_c20190101__20191231__srt--StatementGeographicalAxis__custom--CentralAndSouthAmericaMember_zug9hg2oF66d" style="text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2019-01-012019-12-31_custom_CentralAndSouthAmericaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">46,200</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">Other</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--Revenues_c20210101__20211231__srt--StatementGeographicalAxis__custom--OtherSegmentCountryMember_zTIQ1CRJkQvb" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2021-01-012021-12-31_custom_OtherSegmentCountryMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8,400</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--Revenues_c20200101__20201231__srt--StatementGeographicalAxis__custom--OtherSegmentCountryMember_zwuHA6VcULmb" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2020-01-012020-12-31_custom_OtherSegmentCountryMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,300</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--Revenues_c20190101__20191231__srt--StatementGeographicalAxis__custom--OtherSegmentCountryMember_zf5C59wEliX7" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2019-01-012019-12-31_custom_OtherSegmentCountryMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,500</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2pt">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td id="xdx_984_eus-gaap--Revenues_c20210101__20211231_zuLPyqTHRiEf" style="border-bottom: Black 2pt double; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">879,500</ix:nonFraction></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td id="xdx_988_eus-gaap--Revenues_c20200101__20201231_za3KlQTe5Msg" style="border-bottom: Black 2pt double; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">539,000</ix:nonFraction></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td id="xdx_984_eus-gaap--Revenues_c20190101__20191231_zdyljZT1FLch" style="border-bottom: Black 2pt double; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">713,500</ix:nonFraction></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8A2_zI94YqJMxfll" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&#160;</p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock"><p id="xdx_898_eus-gaap--ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock_zuUa5YDa2a4h" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span id="xdx_8BA_zqXnHQ8BJT6k">Consolidated net sales to customers in major countries
are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year Ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 55%; text-align: left">United States</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20210101__20211231__us-gaap--StatementBusinessSegmentsAxis__custom--UnitedStatesMember_zEKymJV57Qvl" title="Revenue from Contract with Customer, Including Assessed Tax" style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" contextRef="From2021-01-012021-12-31_custom_UnitedStatesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">351,300</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20200101__20201231__us-gaap--StatementBusinessSegmentsAxis__custom--UnitedStatesMember_zxYvGQoLkVMk" style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" contextRef="From2020-01-012020-12-31_custom_UnitedStatesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">187,300</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20190101__20191231__us-gaap--StatementBusinessSegmentsAxis__custom--UnitedStatesMember_ztuDf4UXZh8e" style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" contextRef="From2019-01-012019-12-31_custom_UnitedStatesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">225,300</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>France</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20210101__20211231__us-gaap--StatementBusinessSegmentsAxis__custom--FranceMember_zCRsWORMslv7" style="text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" contextRef="From2021-01-012021-12-31_custom_FranceMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">44,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20200101__20201231__us-gaap--StatementBusinessSegmentsAxis__custom--FranceMember_zbAfAETODHKk" style="text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" contextRef="From2020-01-012020-12-31_custom_FranceMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">37,600</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20190101__20191231__us-gaap--StatementBusinessSegmentsAxis__custom--FranceMember_zkP4BXithRv5" style="text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" contextRef="From2019-01-012019-12-31_custom_FranceMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">43,500</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Russia</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20210101__20211231__us-gaap--StatementBusinessSegmentsAxis__custom--RussiaMember_zcXrJAGJdL37" style="text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" contextRef="From2021-01-012021-12-31_custom_RussiaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">43,400</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20200101__20201231__us-gaap--StatementBusinessSegmentsAxis__custom--RussiaMember_zYkELQ8N448i" style="text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" contextRef="From2020-01-012020-12-31_custom_RussiaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">14,100</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20190101__20191231__us-gaap--StatementBusinessSegmentsAxis__custom--RussiaMember_zMwJcPbEQXTj" style="text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" contextRef="From2019-01-012019-12-31_custom_RussiaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">36,800</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">United Kingdom</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20210101__20211231__us-gaap--StatementBusinessSegmentsAxis__custom--UnitedKingdomMember_z7NvoMSPPB0e" style="text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" contextRef="From2021-01-012021-12-31_custom_UnitedKingdomMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">38,500</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20200101__20201231__us-gaap--StatementBusinessSegmentsAxis__custom--UnitedKingdomMember_zmsscOTv6ur1" style="text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" contextRef="From2020-01-012020-12-31_custom_UnitedKingdomMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">24,600</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20190101__20191231__us-gaap--StatementBusinessSegmentsAxis__custom--UnitedKingdomMember_zmPhy1xPPQR" style="text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" contextRef="From2019-01-012019-12-31_custom_UnitedKingdomMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">35,800</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8AD_zXT9PNXVEmLi" style="margin-top: 0; margin-bottom: 0">&#160;</p>

</ix:nonNumeric><p id="xdx_81A_z9WVtcCkDDt3" style="margin-top: 0; margin-bottom: 0">&#160;</p>


<!-- Field: /Named-Area; -->

<!-- Field: Named-Area; Name: Contents -->
<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:IncomeTaxDisclosureTextBlock"><p id="xdx_80D_eus-gaap--IncomeTaxDisclosureTextBlock_zBeljCq3QZd5" style="margin-top: 0; margin-bottom: 0"></p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in">(16)</td><td><span id="xdx_829_zi73uunWhwN8">Income Taxes</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company and its subsidiaries
file income tax returns in the U.S. federal, and various states and foreign jurisdictions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company assessed its uncertain
tax positions and determined that it has no material uncertain tax position at December 31, 2021.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"><p id="xdx_89C_eus-gaap--ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_zP7KWJTx3xN4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8B8_zek4eMr6vwDe">The components of income before
income taxes consist of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 55%; text-align: left">U.S. operations</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_c20210101__20211231_zzpNfdpkgazi" title="U.S. operations" style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">34,742</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_c20200101__20201231_zGARqmS1frAk" title="U.S. operations" style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9,577</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_c20190101__20191231_zQnEOBvTAa7i" title="U.S. operations" style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">23,384</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Foreign operations</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_c20210101__20211231_zRdQmkhIgTYa" title="Foreign operations" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">116,277</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_c20200101__20201231_z51CEqt2q3F9" title="Foreign operations" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">59,772</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_c20190101__20191231_zIeZ60GanUl9" title="Foreign operations" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">81,762</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2pt">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_dxL_c20210101__20211231_zrOnVOV5dMj8" title="Income before income taxes::XDX::151%2C019" style="border-bottom: Black 2pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1662">151,019</span></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_c20200101__20201231_z3T85frJ6MZ8" title="Income before income taxes" style="border-bottom: Black 2pt double; text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">69,349</ix:nonFraction></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_c20190101__20191231_zXCUYLNbH8Ei" title="Income before income taxes" style="border-bottom: Black 2pt double; text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">105,146</ix:nonFraction></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8A9_zWk3IgxaIIF5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<ix:exclude><!-- Field: Page; Sequence: 118; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<ix:exclude><p id="xdx_239_zDhHfYhJUWHd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>INTER PARFUMS, INC. AND SUBSIDIARIES</b></p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<ix:exclude><p id="xdx_230_z0cAaFhNprz8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Notes to Consolidated Financial Statements</p></ix:exclude>

<ix:exclude><p id="xdx_23B_zeuoTPygJa01" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">December 31, 2021, 2020 and 2019</p></ix:exclude>

<ix:exclude><p id="xdx_23B_zcvAUXa51jvk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(In thousands except share and per share data)</p></ix:exclude>

<p id="xdx_00A" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"><p id="xdx_896_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zUGiZ2T49aRh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8BA_zwqhkU3uzkwj">The provision for current and
deferred income tax expense (benefit) consists of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td><span style="color: Black">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="color: Black">&#160;</span></td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="color: Black">Year
    ended December 31,</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="color: Black">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td><span style="color: Black">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="color: Black">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="color: Black">2021</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="color: Black">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="color: Black">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="color: Black">2020</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="color: Black">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="color: Black">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="color: Black">2019</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="color: Black">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="color: Black">Current:</span></td><td><span style="color: Black">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="color: Black">&#160;</span></td><td><span style="color: Black">&#160;</span></td><td><span style="color: Black">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="color: Black">&#160;</span></td><td><span style="color: Black">&#160;</span></td><td><span style="color: Black">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="color: Black">&#160;</span></td><td><span style="color: Black">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 55%; padding-left: 0.125in"><span style="color: Black">Federal</span></td><td style="width: 1%"><span style="color: Black">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="color: Black">$</span></td><td id="xdx_98C_eus-gaap--CurrentFederalTaxExpenseBenefit_c20210101__20211231_zyccVXsRAWgb" title="Federal" style="width: 12%; text-align: right"><span style="color: Black"><ix:nonFraction name="us-gaap:CurrentFederalTaxExpenseBenefit" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,825</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="color: Black">&#160;</span></td><td style="width: 1%"><span style="color: Black">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="color: Black">$</span></td><td id="xdx_98C_eus-gaap--CurrentFederalTaxExpenseBenefit_c20200101__20201231_zQoZuV1w3Dt3" title="Federal" style="width: 12%; text-align: right"><span style="color: Black"><ix:nonFraction name="us-gaap:CurrentFederalTaxExpenseBenefit" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,685</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="color: Black">&#160;</span></td><td style="width: 1%"><span style="color: Black">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="color: Black">$</span></td><td id="xdx_98D_eus-gaap--CurrentFederalTaxExpenseBenefit_c20190101__20191231_zYITiginS8Pj" title="Federal" style="width: 12%; text-align: right"><span style="color: Black"><ix:nonFraction name="us-gaap:CurrentFederalTaxExpenseBenefit" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,280</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="color: Black">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.125in"><span style="color: Black">State and local</span></td><td><span style="color: Black">&#160;</span></td>
    <td style="text-align: left"><span style="color: Black">&#160;</span></td><td id="xdx_98B_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_c20210101__20211231_zeZQt1nhP2qf" title="State and local" style="text-align: right"><span style="color: Black"><ix:nonFraction name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">518</ix:nonFraction></span></td><td style="text-align: left"><span style="color: Black">&#160;</span></td><td><span style="color: Black">&#160;</span></td>
    <td style="text-align: left"><span style="color: Black">&#160;</span></td><td id="xdx_983_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_c20200101__20201231_zIJtWwL6AOM1" title="State and local" style="text-align: right"><span style="color: Black"><ix:nonFraction name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">90</ix:nonFraction></span></td><td style="text-align: left"><span style="color: Black">&#160;</span></td><td><span style="color: Black">&#160;</span></td>
    <td style="text-align: left"><span style="color: Black">&#160;</span></td><td id="xdx_98E_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_c20190101__20191231_zuaogGZmmemj" title="State and local" style="text-align: right"><span style="color: Black"><ix:nonFraction name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">713</ix:nonFraction></span></td><td style="text-align: left"><span style="color: Black">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; padding-left: 0.125in"><span style="color: Black">Foreign</span></td><td style="padding-bottom: 1pt"><span style="color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="color: Black">&#160;</span></td><td id="xdx_989_eus-gaap--CurrentForeignTaxExpenseBenefit_c20210101__20211231_zl83A7KS5Ufe" title="Foreign" style="border-bottom: Black 1pt solid; text-align: right"><span style="color: Black"><ix:nonFraction name="us-gaap:CurrentForeignTaxExpenseBenefit" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">36,164</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="color: Black">&#160;</span></td><td style="padding-bottom: 1pt"><span style="color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="color: Black">&#160;</span></td><td id="xdx_98D_eus-gaap--CurrentForeignTaxExpenseBenefit_c20200101__20201231_zkZBFCc887yb" title="Foreign" style="border-bottom: Black 1pt solid; text-align: right"><span style="color: Black"><ix:nonFraction name="us-gaap:CurrentForeignTaxExpenseBenefit" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">17,024</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="color: Black">&#160;</span></td><td style="padding-bottom: 1pt"><span style="color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="color: Black">&#160;</span></td><td id="xdx_988_eus-gaap--CurrentForeignTaxExpenseBenefit_c20190101__20191231_zQAipynMaS1f" title="Foreign" style="border-bottom: Black 1pt solid; text-align: right"><span style="color: Black"><ix:nonFraction name="us-gaap:CurrentForeignTaxExpenseBenefit" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">27,412</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="color: Black">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; padding-left: 0.125in"><span style="color: Black">&#160;</span></td><td style="padding-bottom: 1pt"><span style="color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="color: Black">&#160;</span></td><td id="xdx_98D_eus-gaap--CurrentIncomeTaxExpenseBenefit_c20210101__20211231_zeEvwTxGaul2" title="Current income tax expense" style="border-bottom: Black 1pt solid; text-align: right"><span style="color: Black"><ix:nonFraction name="us-gaap:CurrentIncomeTaxExpenseBenefit" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">41,507</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="color: Black">&#160;</span></td><td style="padding-bottom: 1pt"><span style="color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="color: Black">&#160;</span></td><td id="xdx_985_eus-gaap--CurrentIncomeTaxExpenseBenefit_c20200101__20201231_zB7H8NO70fik" title="Current income tax expense" style="border-bottom: Black 1pt solid; text-align: right"><span style="color: Black"><ix:nonFraction name="us-gaap:CurrentIncomeTaxExpenseBenefit" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">18,799</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="color: Black">&#160;</span></td><td style="padding-bottom: 1pt"><span style="color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="color: Black">&#160;</span></td><td id="xdx_98A_eus-gaap--CurrentIncomeTaxExpenseBenefit_c20190101__20191231_zBWsVBhDhPxd" title="Current income tax expense" style="border-bottom: Black 1pt solid; text-align: right"><span style="color: Black"><ix:nonFraction name="us-gaap:CurrentIncomeTaxExpenseBenefit" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">31,405</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="color: Black">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0in"><span style="color: Black">Deferred:</span></td><td><span style="color: Black">&#160;</span></td>
    <td style="text-align: left"><span style="color: Black">&#160;</span></td><td style="text-align: right"><span style="color: Black">&#160;</span></td><td style="text-align: left"><span style="color: Black">&#160;</span></td><td><span style="color: Black">&#160;</span></td>
    <td style="text-align: left"><span style="color: Black">&#160;</span></td><td style="text-align: right"><span style="color: Black">&#160;</span></td><td style="text-align: left"><span style="color: Black">&#160;</span></td><td><span style="color: Black">&#160;</span></td>
    <td style="text-align: left"><span style="color: Black">&#160;</span></td><td style="text-align: right"><span style="color: Black">&#160;</span></td><td style="text-align: left"><span style="color: Black">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in"><span style="color: Black">Federal</span></td><td><span style="color: Black">&#160;</span></td>
    <td style="text-align: left"><span style="color: Black">&#160;</span></td><td id="xdx_98C_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_c20210101__20211231_ze6HlfWY8uA8" title="Federal" style="text-align: right"><span style="color: Black"><ix:nonFraction name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4</ix:nonFraction></span></td><td style="text-align: left"><span style="color: Black">&#160;</span></td><td style="color: #FF0000"><span style="color: Black">&#160;</span></td>
    <td style="color: #FF0000; text-align: left"><span style="color: Black">&#160;</span></td><td id="xdx_988_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_c20200101__20201231_zUhelWURYQZc" title="Federal" style="color: #FF0000; text-align: right"><span style="color: Black">(<ix:nonFraction name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">215</ix:nonFraction></span></td><td style="color: #FF0000; text-align: left"><span style="color: Black">)</span></td><td style="color: #FF0000"><span style="color: Black">&#160;</span></td>
    <td style="color: #FF0000; text-align: left"><span style="color: Black">&#160;</span></td><td id="xdx_986_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_c20190101__20191231_ziUn6oUD2Zyj" title="Federal" style="color: #FF0000; text-align: right"><span style="color: Black">(<ix:nonFraction name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">3</ix:nonFraction></span></td><td style="color: #FF0000; text-align: left"><span style="color: Black">)</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.125in"><span style="color: Black">State and local</span></td><td><span style="color: Black">&#160;</span></td>
    <td style="text-align: left"><span style="color: Black">&#160;</span></td><td id="xdx_988_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_c20210101__20211231_zd2QCvpKnETk" title="State and local" style="text-align: right"><span style="color: Black"><ix:nonFraction name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">11</ix:nonFraction></span></td><td style="text-align: left"><span style="color: Black">&#160;</span></td><td><span style="color: Black">&#160;</span></td>
    <td style="text-align: left"><span style="color: Black">&#160;</span></td><td id="xdx_986_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_c20200101__20201231_zFRLVE8qtbpg" title="State and local" style="text-align: right"><span style="color: Black"><ix:nonFraction name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">44</ix:nonFraction></span></td><td style="text-align: left"><span style="color: Black">&#160;</span></td><td style="color: #FF0000"><span style="color: Black">&#160;</span></td>
    <td style="color: #FF0000; text-align: left"><span style="color: Black">&#160;</span></td><td id="xdx_98F_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_c20190101__20191231_zyiKjpMXNJpf" title="State and local" style="color: #FF0000; text-align: right"><span style="color: Black">(<ix:nonFraction name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">22</ix:nonFraction></span></td><td style="color: #FF0000; text-align: left"><span style="color: Black">)</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; padding-left: 0.125in"><span style="color: Black">Foreign</span></td><td style="color: #FF0000; padding-bottom: 1pt"><span style="color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; color: #FF0000; text-align: left"><span style="color: Black">&#160;</span></td><td id="xdx_982_eus-gaap--DeferredForeignIncomeTaxExpenseBenefit_c20210101__20211231_ziURehu430v9" title="Foreign" style="border-bottom: Black 1pt solid; color: #FF0000; text-align: right"><span style="color: Black">(<ix:nonFraction name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">530</ix:nonFraction></span></td><td style="padding-bottom: 1pt; color: #FF0000; text-align: left"><span style="color: Black">)</span></td><td style="padding-bottom: 1pt"><span style="color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="color: Black">&#160;</span></td><td id="xdx_989_eus-gaap--DeferredForeignIncomeTaxExpenseBenefit_c20200101__20201231_zop73MEig7uh" title="Foreign" style="border-bottom: Black 1pt solid; text-align: right"><span style="color: Black"><ix:nonFraction name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">753</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="color: Black">&#160;</span></td><td style="color: #FF0000; padding-bottom: 1pt"><span style="color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; color: #FF0000; text-align: left"><span style="color: Black">&#160;</span></td><td id="xdx_98F_eus-gaap--DeferredForeignIncomeTaxExpenseBenefit_c20190101__20191231_z8JMNNKenST5" title="Foreign" style="border-bottom: Black 1pt solid; color: #FF0000; text-align: right"><span style="color: Black">(<ix:nonFraction name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">2,304</ix:nonFraction></span></td><td style="padding-bottom: 1pt; color: #FF0000; text-align: left"><span style="color: Black">)</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; padding-left: 0.125in"><span style="color: Black">&#160;</span></td><td style="color: #FF0000; padding-bottom: 1pt"><span style="color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; color: #FF0000; text-align: left"><span style="color: Black">&#160;</span></td><td id="xdx_983_eus-gaap--DeferredIncomeTaxesAndTaxCredits_c20210101__20211231_z5wYD0xIO3L2" title="Deferred income tax expense" style="border-bottom: Black 1pt solid; color: #FF0000; text-align: right"><span style="color: Black">(<ix:nonFraction name="us-gaap:DeferredIncomeTaxesAndTaxCredits" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">515</ix:nonFraction></span></td><td style="padding-bottom: 1pt; color: #FF0000; text-align: left"><span style="color: Black">)</span></td><td style="padding-bottom: 1pt"><span style="color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="color: Black">&#160;</span></td><td id="xdx_983_eus-gaap--DeferredIncomeTaxesAndTaxCredits_c20200101__20201231_zBOX09o1nzye" title="Deferred income tax expense" style="border-bottom: Black 1pt solid; text-align: right"><span style="color: Black"><ix:nonFraction name="us-gaap:DeferredIncomeTaxesAndTaxCredits" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">582</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="color: Black">&#160;</span></td><td style="color: #FF0000; padding-bottom: 1pt"><span style="color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; color: #FF0000; text-align: left"><span style="color: Black">&#160;</span></td><td id="xdx_98B_eus-gaap--DeferredIncomeTaxesAndTaxCredits_c20190101__20191231_zysV537hiDga" title="Deferred income tax expense" style="border-bottom: Black 1pt solid; color: #FF0000; text-align: right"><span style="color: Black">(<ix:nonFraction name="us-gaap:DeferredIncomeTaxesAndTaxCredits" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">2,329</ix:nonFraction></span></td><td style="padding-bottom: 1pt; color: #FF0000; text-align: left"><span style="color: Black">)</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2pt; padding-left: 0.25in"><span style="color: Black">Total income tax expense</span></td><td style="padding-bottom: 2pt"><span style="color: Black">&#160;</span></td>
    <td style="border-bottom: Black 2pt double; text-align: left"><span style="color: Black">$</span></td><td id="xdx_98D_eus-gaap--IncomeTaxExpenseBenefit_c20210101__20211231_zYRwkxqLQOXc" title="Total income tax expense" style="border-bottom: Black 2pt double; text-align: right"><span style="color: Black"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">40,992</ix:nonFraction></span></td><td style="padding-bottom: 2pt; text-align: left"><span style="color: Black">&#160;</span></td><td style="padding-bottom: 2pt"><span style="color: Black">&#160;</span></td>
    <td style="border-bottom: Black 2pt double; text-align: left"><span style="color: Black">$</span></td><td id="xdx_98C_eus-gaap--IncomeTaxExpenseBenefit_c20200101__20201231_zxFb4ctKogba" title="Total income tax expense" style="border-bottom: Black 2pt double; text-align: right"><span style="color: Black"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">19,381</ix:nonFraction></span></td><td style="padding-bottom: 2pt; text-align: left"><span style="color: Black">&#160;</span></td><td style="padding-bottom: 2pt"><span style="color: Black">&#160;</span></td>
    <td style="border-bottom: Black 2pt double; text-align: left"><span style="color: Black">$</span></td><td id="xdx_989_eus-gaap--IncomeTaxExpenseBenefit_c20190101__20191231_zkeNHgSLd1P2" title="Total income tax expense" style="border-bottom: Black 2pt double; text-align: right"><span style="color: Black"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">29,076</ix:nonFraction></span></td><td style="padding-bottom: 2pt; text-align: left"><span style="color: Black">&#160;</span></td></tr>
</table>



</ix:nonNumeric><p id="xdx_8AB_zYpwPMqPmny1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"><p id="xdx_897_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_z8HkKCVmb7g4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8B2_zHg3EdUCGBhc">The tax effects of temporary
differences that give rise to significant portions of the deferred tax assets and deferred tax liabilities are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td style="color: Black">&#160;</td><td style="color: Black; font-weight: bold">&#160;</td>
    <td style="color: Black; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_499_20211231_zi4394cUJWsb" style="color: Black; font-weight: bold; text-align: center">&#160;</td>
    <td style="color: Black; font-weight: bold; text-align: center">&#160;</td>
    <td style="color: Black; font-weight: bold; text-align: center">&#160;</td>
    <td style="color: Black; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_490_20201231_zkjjpzRc39bb" style="color: Black; font-weight: bold; text-align: center">&#160;</td><td style="color: Black; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="color: Black">&#160;</td><td style="color: Black; font-weight: bold">&#160;</td>
    <td colspan="6" style="color: Black; font-weight: bold; text-align: center">December 31,</td><td style="color: Black; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="color: Black">&#160;</td><td style="color: Black; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; color: Black; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; color: Black; font-weight: bold">&#160;</td><td style="color: Black; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; color: Black; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; color: Black; font-weight: bold">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--DeferredTaxAssetsNetAbstract_iB_zK1nWOL8gmL2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="color: Black; text-align: left">Net deferred tax assets:</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right">&#160;</td><td style="color: Black; text-align: left">&#160;</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right">&#160;</td><td style="color: Black; text-align: left">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsForeign_iI_maDTAGzmCT_zmRBKDLHHch3" style="vertical-align: bottom; background-color: White">
    <td style="width: 70%; color: Black; text-align: left; padding-left: 0.125in">Foreign net operating loss carry-forwards</td><td style="width: 1%; color: Black">&#160;</td>
    <td style="width: 1%; color: Black; text-align: left">$</td><td style="width: 12%; color: Black; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,292</ix:nonFraction></td><td style="width: 1%; color: Black; text-align: left">&#160;</td><td style="width: 1%; color: Black">&#160;</td>
    <td style="width: 1%; color: Black; text-align: left">$</td><td style="width: 12%; color: Black; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">360</ix:nonFraction></td><td style="width: 1%; color: Black; text-align: left">&#160;</td></tr>
<tr id="xdx_40F_ecustom--DeferredTaxAssetsInventoryAndAccountsReceivable_maDTAGzmCT_z1s4JlqTUHm6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="color: Black; text-align: left; padding-left: 0.125in">Inventory and accounts receivable</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right"><ix:nonFraction name="ipar:DeferredTaxAssetsInventoryAndAccountsReceivable" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,508</ix:nonFraction></td><td style="color: Black; text-align: left">&#160;</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right"><ix:nonFraction name="ipar:DeferredTaxAssetsInventoryAndAccountsReceivable" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,928</ix:nonFraction></td><td style="color: Black; text-align: left">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--DeferredTaxAssetsDeferredIncome_iI_maDTAGzmCT_zhDcLYc2jnL1" style="vertical-align: bottom; background-color: White">
    <td style="color: Black; text-align: left; padding-left: 0.125in">Profit sharing</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsDeferredIncome" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,787</ix:nonFraction></td><td style="color: Black; text-align: left">&#160;</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsDeferredIncome" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,936</ix:nonFraction></td><td style="color: Black; text-align: left">&#160;</td></tr>
<tr id="xdx_400_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_iI_maDTAGzmCT_zNImAMKYjB2c" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="color: Black; text-align: left; padding-left: 0.125in">Stock option compensation</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">732</ix:nonFraction></td><td style="color: Black; text-align: left">&#160;</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">718</ix:nonFraction></td><td style="color: Black; text-align: left">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--DeferredTaxAssetsInventory_iI_maDTAGzmCT_z9f3UtCJGMCk" style="vertical-align: bottom; background-color: White">
    <td style="color: Black; text-align: left; padding-left: 0.125in">Effect of inventory profit elimination</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsInventory" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,112</ix:nonFraction></td><td style="color: Black; text-align: left">&#160;</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsInventory" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,443</ix:nonFraction></td><td style="color: Black; text-align: left">&#160;</td></tr>
<tr id="xdx_408_eus-gaap--DeferredTaxAssetsOther_iI_maDTAGzmCT_z1TnN3770nd4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="color: Black; padding-bottom: 1pt; padding-left: 0.125in">Other</td><td style="color: Black; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; color: Black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; color: Black; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsOther" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">407</ix:nonFraction></td><td style="padding-bottom: 1pt; color: Black; text-align: left">&#160;</td><td style="color: Black; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; color: Black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; color: Black; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsOther" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">910</ix:nonFraction></td><td style="padding-bottom: 1pt; color: Black; text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--DeferredTaxAssetsGross_iTI_mtDTAGzmCT_maDTANzIZJ_zghQxM5cOPla" style="vertical-align: bottom; background-color: White">
    <td style="color: Black; text-align: left; padding-left: 0.25in">Total gross deferred tax assets, net</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsGross" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">15,838</ix:nonFraction></td><td style="color: Black; text-align: left">&#160;</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsGross" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">11,295</ix:nonFraction></td><td style="color: Black; text-align: left">&#160;</td></tr>
<tr id="xdx_408_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_di_msDTANzIZJ_zETuZe2V2e2j" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="color: Black; text-align: left; padding-bottom: 1pt; padding-left: 0.25in">Valuation allowance</td><td style="color: Black; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; color: Black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; color: Black; text-align: right">(<ix:nonFraction name="us-gaap:DeferredTaxAssetsValuationAllowance" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,582</ix:nonFraction></td><td style="padding-bottom: 1pt; color: Black; text-align: left">)</td><td style="color: Black; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; color: Black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; color: Black; text-align: right">(<ix:nonFraction name="us-gaap:DeferredTaxAssetsValuationAllowance" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">360</ix:nonFraction></td><td style="padding-bottom: 1pt; color: Black; text-align: left">)</td></tr>
<tr id="xdx_40A_eus-gaap--DeferredTaxAssetsNet_iTI_mtDTANzIZJ_zGngeMWftMQd" style="vertical-align: bottom; background-color: White">
    <td style="color: Black; text-align: left; padding-bottom: 1pt; padding-left: 0.25in">Net deferred tax assets</td><td style="color: Black; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; color: Black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; color: Black; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsNet" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">12,256</ix:nonFraction></td><td style="padding-bottom: 1pt; color: Black; text-align: left">&#160;</td><td style="color: Black; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; color: Black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; color: Black; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsNet" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">10,935</ix:nonFraction></td><td style="padding-bottom: 1pt; color: Black; text-align: left">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--DeferredTaxLiabilitiesNetAbstract_iB_z5kogWajN939" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="color: Black; text-align: left">Deferred tax liabilities (long-term):</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right">&#160;</td><td style="color: Black; text-align: left">&#160;</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right">&#160;</td><td style="color: Black; text-align: left">&#160;</td></tr>
<tr id="xdx_40C_ecustom--DeferredTaxLiabilitiesBuildingExpenses_i01I_zsHnfG6XNNjj" style="vertical-align: bottom; background-color: White">
    <td style="color: Black; text-align: left; padding-left: 0.125in">Building expenses</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right">(<ix:nonFraction name="ipar:DeferredTaxLiabilitiesBuildingExpenses" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1,082</ix:nonFraction></td><td style="color: Black; text-align: left">)</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1764">&#8212;</span></td><td style="color: Black; text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--DeferredTaxLiabilitiesOtherFiniteLivedAssets_i01NI_di_zSa24pNuTUQh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="color: Black; text-align: left; padding-left: 0.125in">Trademarks and licenses</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right">(<ix:nonFraction name="us-gaap:DeferredTaxLiabilitiesOtherFiniteLivedAssets" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,551</ix:nonFraction></td><td style="color: Black; text-align: left">)</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right">(<ix:nonFraction name="us-gaap:DeferredTaxLiabilitiesOtherFiniteLivedAssets" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,894</ix:nonFraction></td><td style="color: Black; text-align: left">)</td></tr>
<tr id="xdx_40B_ecustom--DeferredTaxLiabilitiesUnrealizedGainOnMarketableEquitySecurities_i01I_zebaeX8IqmS" style="vertical-align: bottom; background-color: White">
    <td style="color: Black; text-align: left; padding-left: 0.125in">Unrealized gain on marketable equity securities</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right">(<ix:nonFraction name="ipar:DeferredTaxLiabilitiesUnrealizedGainOnMarketableEquitySecurities" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">436</ix:nonFraction></td><td style="color: Black; text-align: left">)</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1770">&#8212;</span></td><td style="color: Black; text-align: left">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--DeferredTaxLiabilitiesOther_i01I_zdjodKSLJgG6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="color: Black; padding-bottom: 1pt; padding-left: 0.125in">Other</td><td style="color: Black; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; color: Black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; color: Black; text-align: right">(<ix:nonFraction name="us-gaap:DeferredTaxLiabilitiesOther" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">251</ix:nonFraction></td><td style="padding-bottom: 1pt; color: Black; text-align: left">)</td><td style="color: Black; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; color: Black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; color: Black; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1773">&#8212;</span></td><td style="padding-bottom: 1pt; color: Black; text-align: left">&#160;</td></tr>
<tr id="xdx_400_eus-gaap--DeferredIncomeTaxLiabilities_i01NI_di_zd5vwLFRfw42" style="vertical-align: bottom; background-color: White">
    <td style="color: Black; text-align: left; padding-bottom: 1pt; padding-left: 0.25in">Total deferred tax liabilities</td><td style="color: Black; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; color: Black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; color: Black; text-align: right">(<ix:nonFraction name="us-gaap:DeferredIncomeTaxLiabilities" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,320</ix:nonFraction></td><td style="padding-bottom: 1pt; color: Black; text-align: left">)</td><td style="color: Black; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; color: Black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; color: Black; text-align: right">(<ix:nonFraction name="us-gaap:DeferredIncomeTaxLiabilities" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,894</ix:nonFraction></td><td style="padding-bottom: 1pt; color: Black; text-align: left">)</td></tr>
<tr id="xdx_407_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iI_zL18h8AAz5ue" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="color: Black; text-align: left; padding-bottom: 2pt; padding-left: 0.25in">Net deferred tax assets</td><td style="color: Black; padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; color: Black; text-align: left">$</td><td style="border-bottom: Black 2pt double; color: Black; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsLiabilitiesNet" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,936</ix:nonFraction></td><td style="padding-bottom: 2pt; color: Black; text-align: left">&#160;</td><td style="color: Black; padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; color: Black; text-align: left">$</td><td style="border-bottom: Black 2pt double; color: Black; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsLiabilitiesNet" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8,041</ix:nonFraction></td><td style="padding-bottom: 2pt; color: Black; text-align: left">&#160;</td></tr>
</table>



</ix:nonNumeric><p id="xdx_8A0_zTf7XmPVN5Q5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Valuation allowances have been
provided for deferred tax assets relating to foreign net operating loss carry-forwards and reserves acquired in connection with
the acquisition of Interparfums Italia srl, as future profitable operations from certain foreign subsidiaries might not be sufficient
to realize the full amount of the deferred tax assets.</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<ix:exclude><!-- Field: Page; Sequence: 119; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>INTER PARFUMS, INC. AND SUBSIDIARIES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Notes to Consolidated Financial Statements</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">December 31, 2021, 2020 and 2019</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(In thousands except share and per share data)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">No other valuation allowances
have been provided as management believes that it is more likely than not that the asset will be realized in the reduction of future
taxable income.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company estimated of the
effect of global intangible low-taxed income (&#8220;GILTI&#8221;) and has determined that it has no tax liability related to
GILTI as of December 31, 2021, 2020 and 2019. The Company also estimated the effect of foreign derived intangible income (&#8220;FDII&#8221;)
and recorded a tax benefit of approximately $<span id="xdx_90B_eus-gaap--DeferredForeignIncomeTaxExpenseBenefit_dm_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ForeignDerivedIntangibleIncomeMember_zePfhbys0nCd"><ix:nonFraction name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" contextRef="From2021-01-012021-12-31_custom_ForeignDerivedIntangibleIncomeMember" format="ixt:numdotdecimal" decimals="0" scale="6" unitRef="USD">0.9</ix:nonFraction> million</span>, $<span id="xdx_90C_eus-gaap--DeferredForeignIncomeTaxExpenseBenefit_dm_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ForeignDerivedIntangibleIncomeMember_zwK5bpy5kvgk"><ix:nonFraction name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" contextRef="From2020-01-012020-12-31_custom_ForeignDerivedIntangibleIncomeMember" format="ixt:numdotdecimal" decimals="0" scale="6" unitRef="USD">0.3</ix:nonFraction> million</span> and $<span id="xdx_909_eus-gaap--DeferredForeignIncomeTaxExpenseBenefit_dm_c20190101__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ForeignDerivedIntangibleIncomeMember_zexQD05FbtX4"><ix:nonFraction name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" contextRef="From2019-01-012019-12-31_custom_ForeignDerivedIntangibleIncomeMember" format="ixt:numdotdecimal" decimals="0" scale="6" unitRef="USD">0.9</ix:nonFraction> million</span> as of December&#160;31, 2021, 2020 and
2019, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><b><i>French Tax Settlement</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The French authorities had considered
that the existence of IP Suisse, a wholly-owned subsidiary of Interparfums SA, does not, in and of itself, constitute a permanent
establishment and therefore Interparfums, SA should pay French taxes on all or part of the profits of that entity. In June 2021,
a global settlement agreement was reached with the French Tax Authority whereby Interparfums SA paid in December 2021, &#8364;2.5
million (approximately $2.9 million) effectively lowering the Lanvin brand royalty rate charged by IP Suisse for the periods from
2017 through 2020. Interparfums SA also agreed to apply the lower rate in 2021 through 2025 and to transfer the Lanvin brand from
IP Suisse to Interparfums, SA by December 31, 2025.</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company is no longer subject
to U.S. federal, state, and local income tax examinations by tax authorities for years before 2017.</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"><p id="xdx_89F_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zuxB3yl6LAej" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8BC_zKFhEewEOfMj">Differences between the United
States federal statutory income tax rate and the effective income tax rate were as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td style="color: Black">&#160;</td><td style="color: Black; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; color: Black; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_49B_20210101__20211231_zKfaQdCfQ1tj" style="border-bottom: Black 1pt solid; color: Black; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; color: Black; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; color: Black; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; color: Black; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_498_20200101__20201231_zCryRnAsh2Gc" style="border-bottom: Black 1pt solid; color: Black; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; color: Black; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; color: Black; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; color: Black; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_49A_20190101__20191231_zzD1b1MT4mt6" style="border-bottom: Black 1pt solid; color: Black; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; color: Black; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="color: Black">&#160;</td><td style="color: Black; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; color: Black; font-weight: bold; text-align: center">Year ended December 31,</td><td style="padding-bottom: 1pt; color: Black; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="color: Black">&#160;</td><td style="color: Black; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; color: Black; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; color: Black; font-weight: bold">&#160;</td><td style="color: Black; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; color: Black; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; color: Black; font-weight: bold">&#160;</td><td style="color: Black; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; color: Black; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1pt; color: Black; font-weight: bold">&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_uPure_zUn273ToAdQi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 55%; color: Black; text-align: left">Statutory rates</td><td style="width: 1%; color: Black">&#160;</td>
    <td style="width: 1%; color: Black; text-align: left">&#160;</td><td style="width: 12%; color: Black; text-align: right"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">21.0</ix:nonFraction></td><td style="width: 1%; color: Black; text-align: left">%</td><td style="width: 1%; color: Black">&#160;</td>
    <td style="width: 1%; color: Black; text-align: left">&#160;</td><td style="width: 12%; color: Black; text-align: right"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">21.0</ix:nonFraction></td><td style="width: 1%; color: Black; text-align: left">%</td><td style="width: 1%; color: Black">&#160;</td>
    <td style="width: 1%; color: Black; text-align: left">&#160;</td><td style="width: 12%; color: Black; text-align: right"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">21.0</ix:nonFraction></td><td style="width: 1%; color: Black; text-align: left">%</td></tr>
<tr id="xdx_40D_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_pid_dp_uPure_z3TsOQpSz64d" style="vertical-align: bottom; background-color: White">
    <td style="color: Black; text-align: left">State and local taxes, net of Federal benefit</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.3</ix:nonFraction></td><td style="color: Black; text-align: left">&#160;</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.2</ix:nonFraction></td><td style="color: Black; text-align: left">&#160;</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.6</ix:nonFraction></td><td style="color: Black; text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--EffectiveIncomeTaxRateReconciliationDeductionsEmployeeStockOwnershipPlanDividends_pid_dp_uPure_zsvSNwGdE5Yg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="color: Black; text-align: left">Windfall benefit from exercise of stock options</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right">(<ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationDeductionsEmployeeStockOwnershipPlanDividends" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Pure">0.9</ix:nonFraction></td><td style="color: Black; text-align: left">)</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right">(<ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationDeductionsEmployeeStockOwnershipPlanDividends" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Pure">0.6</ix:nonFraction></td><td style="color: Black; text-align: left">)</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right">(<ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationDeductionsEmployeeStockOwnershipPlanDividends" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Pure">0.7</ix:nonFraction></td><td style="color: Black; text-align: left">)</td></tr>
<tr id="xdx_407_eus-gaap--EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_pid_dp_uPure_zQNyQrvXODyf" style="vertical-align: bottom; background-color: White">
    <td style="color: Black; text-align: left">Benefit of Foreign Derived Intangible Income</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right">(<ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Pure">0.6</ix:nonFraction></td><td style="color: Black; text-align: left">)</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right">(<ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Pure">0.4</ix:nonFraction></td><td style="color: Black; text-align: left">)</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right">(<ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Pure">0.9</ix:nonFraction></td><td style="color: Black; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="color: Black; text-align: left">Effect of foreign taxes greater than</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right">&#160;</td><td style="color: Black; text-align: left">&#160;</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right">&#160;</td><td style="color: Black; text-align: left">&#160;</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right">&#160;</td><td style="color: Black; text-align: left">&#160;</td></tr>
<tr id="xdx_408_ecustom--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate1_pid_dp_uPure_z0tNlUfNQ9Yk" style="vertical-align: bottom; background-color: White">
    <td style="color: Black; text-align: left; padding-left: 0.125in">U.S. statutory rates</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right"><ix:nonFraction name="ipar:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate1" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">7.4</ix:nonFraction></td><td style="color: Black; text-align: left">&#160;</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right"><ix:nonFraction name="ipar:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate1" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">7.5</ix:nonFraction></td><td style="color: Black; text-align: left">&#160;</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right"><ix:nonFraction name="ipar:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate1" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">7.5</ix:nonFraction></td><td style="color: Black; text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherAdjustments_pid_dp_zswJ8pulXbZ7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="color: Black; padding-bottom: 1pt">Other</td><td style="color: Black; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; color: Black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; color: Black; text-align: right">(<ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Pure">0.1</ix:nonFraction></td><td style="padding-bottom: 1pt; color: Black; text-align: left">)</td><td style="color: Black; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; color: Black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; color: Black; text-align: right"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.2</ix:nonFraction></td><td style="padding-bottom: 1pt; color: Black; text-align: left">&#160;</td><td style="color: Black; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; color: Black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; color: Black; text-align: right"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.1</ix:nonFraction></td><td style="padding-bottom: 1pt; color: Black; text-align: left">&#160;</td></tr>
<tr id="xdx_401_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_pid_dp_zZMCFfSnrETc" style="vertical-align: bottom; background-color: White">
    <td style="color: Black; text-align: left; padding-bottom: 2pt; padding-left: 0.25in">Effective rates</td><td style="color: Black; padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; color: Black; text-align: left">&#160;</td><td style="border-bottom: Black 2pt double; color: Black; text-align: right"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">27.1</ix:nonFraction></td><td style="padding-bottom: 2pt; color: Black; text-align: left">%</td><td style="color: Black; padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; color: Black; text-align: left">&#160;</td><td style="border-bottom: Black 2pt double; color: Black; text-align: right"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">27.9</ix:nonFraction></td><td style="padding-bottom: 2pt; color: Black; text-align: left">%</td><td style="color: Black; padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; color: Black; text-align: left">&#160;</td><td style="border-bottom: Black 2pt double; color: Black; text-align: right"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">27.6</ix:nonFraction></td><td style="padding-bottom: 2pt; color: Black; text-align: left">%</td></tr>
</table>



</ix:nonNumeric><p id="xdx_8AB_zdd6uejOfoTi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<ix:exclude><!-- Field: Page; Sequence: 120; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>INTER PARFUMS, INC. AND SUBSIDIARIES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Notes to Consolidated Financial Statements</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">December 31, 2021, 2020 and 2019</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(In thousands except share and per share data)</p>

</ix:nonNumeric><p id="xdx_81A_zYFvboJ8ceTa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>


<!-- Field: /Named-Area; -->

<!-- Field: Named-Area; Name: Contents -->
<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:ComprehensiveIncomeNoteTextBlock"><p id="xdx_801_eus-gaap--ComprehensiveIncomeNoteTextBlock_zekB4W6nwU4d" style="margin-top: 0; margin-bottom: 0"></p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in">(17)</td><td><span id="xdx_82A_zMDiheg1qEY">Accumulated Other Comprehensive Loss</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"><p id="xdx_891_eus-gaap--ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_zT2ahtPkK5pg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_8BD_z2018wLiyWrk">The components of accumulated other
comprehensive loss consist of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td style="color: Black">&#160;</td><td style="color: Black; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; color: Black; font-weight: bold; text-align: center">Year ended December 31,</td><td style="padding-bottom: 1pt; color: Black; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="color: Black">&#160;</td><td style="color: Black; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; color: Black; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; color: Black; font-weight: bold">&#160;</td><td style="color: Black; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; color: Black; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; color: Black; font-weight: bold">&#160;</td><td style="color: Black; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; color: Black; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1pt; color: Black; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="color: Black">&#160;</td><td style="color: Black; font-weight: bold">&#160;</td>
    <td colspan="2" style="color: Black; font-weight: bold; text-align: center">&#160;</td><td style="color: Black; font-weight: bold">&#160;</td><td style="color: Black; font-weight: bold">&#160;</td>
    <td colspan="2" style="color: Black; font-weight: bold; text-align: center">&#160;</td><td style="color: Black; font-weight: bold">&#160;</td><td style="color: Black; font-weight: bold">&#160;</td>
    <td colspan="2" style="color: Black; font-weight: bold; text-align: center">&#160;</td><td style="color: Black; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 55%; color: Black; text-align: left">Net derivative instruments, beginning of year</td><td style="width: 1%; color: Black">&#160;</td>
    <td style="width: 1%; color: Black; text-align: left">$</td><td id="xdx_98A_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iS_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember_z8NwCIV0OFgi" title="Net derivative instruments, beginning of year" style="width: 12%; color: Black; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1818">&#8212;</span></td><td style="width: 1%; color: Black; text-align: left">&#160;</td><td style="width: 1%; color: Black">&#160;</td>
    <td style="width: 1%; color: Black; text-align: left">$</td><td id="xdx_985_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iS_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__custom--AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember_zVLnjObU6Ota" title="Net derivative instruments, beginning of year" style="width: 12%; color: Black; text-align: right"><ix:nonFraction name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" contextRef="AsOf2019-12-31_custom_AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">52</ix:nonFraction></td><td style="width: 1%; color: Black; text-align: left">&#160;</td><td style="width: 1%; color: Black">&#160;</td>
    <td style="width: 1%; color: Black; text-align: left">$</td><td id="xdx_984_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iS_c20190101__20191231__us-gaap--StatementEquityComponentsAxis__custom--AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember_zcO40Katkn9e" title="Net derivative instruments, beginning of year" style="width: 12%; color: Black; text-align: right"><ix:nonFraction name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" contextRef="AsOf2018-12-31_custom_AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">136</ix:nonFraction></td><td style="width: 1%; color: Black; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="color: Black; text-align: left; padding-bottom: 1pt">Net derivative instrument loss, net of tax</td><td style="color: Black; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; color: Black; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember_znaE0XRI0M8i" title="Net derivative instrument gain (loss), net of tax" style="border-bottom: Black 1pt solid; color: Black; text-align: right">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent" contextRef="From2021-01-012021-12-31_custom_AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">992</ix:nonFraction></td><td style="padding-bottom: 1pt; color: Black; text-align: left">)</td><td style="color: Black; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; color: Black; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__custom--AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember_zpWsCwwmm9K5" title="Net derivative instrument gain (loss), net of tax" style="border-bottom: Black 1pt solid; color: Black; text-align: right">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent" contextRef="From2020-01-012020-12-31_custom_AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">52</ix:nonFraction></td><td style="padding-bottom: 1pt; color: Black; text-align: left">)</td><td style="color: Black; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; color: Black; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent_c20190101__20191231__us-gaap--StatementEquityComponentsAxis__custom--AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember_zulD6iHEI5a6" title="Net derivative instrument gain (loss), net of tax" style="border-bottom: Black 1pt solid; color: Black; text-align: right">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent" contextRef="From2019-01-012019-12-31_custom_AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">84</ix:nonFraction></td><td style="padding-bottom: 1pt; color: Black; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="color: Black; text-align: left; padding-bottom: 1pt">Net derivative instruments, end of year</td><td style="color: Black; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; color: Black; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iE_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember_zi0dEX2OAb1e" title="Net derivative instruments, end of year" style="border-bottom: Black 1pt solid; color: Black; text-align: right">(<ix:nonFraction name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" contextRef="AsOf2021-12-31_custom_AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">992</ix:nonFraction></td><td style="padding-bottom: 1pt; color: Black; text-align: left">)</td><td style="color: Black; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; color: Black; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iE_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__custom--AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember_zmSt4N8sPGl2" title="Net derivative instruments, end of year" style="border-bottom: Black 1pt solid; color: Black; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1832">&#8212;</span></td><td style="padding-bottom: 1pt; color: Black; text-align: left">&#160;</td><td style="color: Black; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; color: Black; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iE_c20190101__20191231__us-gaap--StatementEquityComponentsAxis__custom--AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember_zlAFjDVhRoaa" title="Net derivative instruments, end of year" style="border-bottom: Black 1pt solid; color: Black; text-align: right"><ix:nonFraction name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" contextRef="AsOf2019-12-31_custom_AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">52</ix:nonFraction></td><td style="padding-bottom: 1pt; color: Black; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="color: Black">&#160;</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right">&#160;</td><td style="color: Black; text-align: left">&#160;</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right">&#160;</td><td style="color: Black; text-align: left">&#160;</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right">&#160;</td><td style="color: Black; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="color: Black; text-align: left">Cumulative translation adjustments, beginning of year</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iS_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedTranslationAdjustmentMember_zZtL9OD2C5Tg" title="Cumulative translation adjustments, beginning of year" style="color: Black; text-align: right">(<ix:nonFraction name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" contextRef="AsOf2020-12-31_us-gaap_AccumulatedTranslationAdjustmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">5,997</ix:nonFraction></td><td style="color: Black; text-align: left">)</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iS_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedTranslationAdjustmentMember_zx08Us77Xpv" title="Cumulative translation adjustments, beginning of year" style="color: Black; text-align: right">(<ix:nonFraction name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" contextRef="AsOf2019-12-31_us-gaap_AccumulatedTranslationAdjustmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">39,905</ix:nonFraction></td><td style="color: Black; text-align: left">)</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iS_c20190101__20191231__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedTranslationAdjustmentMember_zEaBJn0ox5Ja" title="Cumulative translation adjustments, beginning of year" style="color: Black; text-align: right">(<ix:nonFraction name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" contextRef="AsOf2018-12-31_us-gaap_AccumulatedTranslationAdjustmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">33,786</ix:nonFraction></td><td style="color: Black; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="color: Black; text-align: left; padding-bottom: 1pt">Translation adjustments</td><td style="color: Black; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; color: Black; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedTranslationAdjustmentMember_zVfsua6Vt5c5" title="Translation adjustments" style="border-bottom: Black 1pt solid; color: Black; text-align: right">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" contextRef="From2021-01-012021-12-31_us-gaap_AccumulatedTranslationAdjustmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">31,443</ix:nonFraction></td><td style="padding-bottom: 1pt; color: Black; text-align: left">)</td><td style="color: Black; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; color: Black; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedTranslationAdjustmentMember_z2zWJIkxmuT9" title="Translation adjustments" style="border-bottom: Black 1pt solid; color: Black; text-align: right"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" contextRef="From2020-01-012020-12-31_us-gaap_AccumulatedTranslationAdjustmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">33,908</ix:nonFraction></td><td style="padding-bottom: 1pt; color: Black; text-align: left">&#160;</td><td style="color: Black; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; color: Black; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_c20190101__20191231__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedTranslationAdjustmentMember_zsSrjNLPOCfl" title="Translation adjustments" style="border-bottom: Black 1pt solid; color: Black; text-align: right">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" contextRef="From2019-01-012019-12-31_us-gaap_AccumulatedTranslationAdjustmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">6,119</ix:nonFraction></td><td style="padding-bottom: 1pt; color: Black; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="color: Black; text-align: left; padding-bottom: 1pt">Cumulative translation adjustments, end of year</td><td style="color: Black; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; color: Black; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iE_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedTranslationAdjustmentMember_zRPbbUho5b1l" title="Cumulative translation adjustments, end of year" style="border-bottom: Black 1pt solid; color: Black; text-align: right">(<ix:nonFraction name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" contextRef="AsOf2021-12-31_us-gaap_AccumulatedTranslationAdjustmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">37,440</ix:nonFraction></td><td style="padding-bottom: 1pt; color: Black; text-align: left">)</td><td style="color: Black; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; color: Black; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iE_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedTranslationAdjustmentMember_zMO8dc2L7wp6" title="Cumulative translation adjustments, end of year" style="border-bottom: Black 1pt solid; color: Black; text-align: right">(<ix:nonFraction name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" contextRef="AsOf2020-12-31_us-gaap_AccumulatedTranslationAdjustmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">5,997</ix:nonFraction></td><td style="padding-bottom: 1pt; color: Black; text-align: left">)</td><td style="color: Black; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; color: Black; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iE_c20190101__20191231__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedTranslationAdjustmentMember_zxkqgm5CvTZ1" title="Cumulative translation adjustments, end of year" style="border-bottom: Black 1pt solid; color: Black; text-align: right">(<ix:nonFraction name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" contextRef="AsOf2019-12-31_us-gaap_AccumulatedTranslationAdjustmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">39,905</ix:nonFraction></td><td style="padding-bottom: 1pt; color: Black; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="color: Black">&#160;</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right">&#160;</td><td style="color: Black; text-align: left">&#160;</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right">&#160;</td><td style="color: Black; text-align: left">&#160;</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right">&#160;</td><td style="color: Black; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="color: Black; text-align: left; padding-bottom: 2pt">Accumulated other comprehensive loss</td><td style="color: Black; padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; color: Black; text-align: left">$</td><td id="xdx_98A_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iI_c20211231_z9lfBa14i2V1" title="Accumulated other comprehensive loss" style="border-bottom: Black 2pt double; color: Black; text-align: right">(<ix:nonFraction name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">38,432</ix:nonFraction></td><td style="padding-bottom: 2pt; color: Black; text-align: left">)</td><td style="color: Black; padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; color: Black; text-align: left">$</td><td id="xdx_986_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iI_c20201231_zrepYmMBCj0k" style="border-bottom: Black 2pt double; color: Black; text-align: right">(<ix:nonFraction name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">5,997</ix:nonFraction></td><td style="padding-bottom: 2pt; color: Black; text-align: left">)</td><td style="color: Black; padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; color: Black; text-align: left">$</td><td id="xdx_98D_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iI_c20191231_zXZBNJmdo7Of" style="border-bottom: Black 2pt double; color: Black; text-align: right">(<ix:nonFraction name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">39,853</ix:nonFraction></td><td style="padding-bottom: 2pt; color: Black; text-align: left">)</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8A0_zE2lWp6Gzvc7" style="margin-top: 0; margin-bottom: 0">&#160;</p>



</ix:nonNumeric><p id="xdx_81A_zQqzegih9Gy5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&#160;</p>


<!-- Field: /Named-Area; -->

<!-- Field: Named-Area; Name: Contents -->
<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:MinorityInterestDisclosureTextBlock"><p id="xdx_806_eus-gaap--MinorityInterestDisclosureTextBlock_zByigvtYnxki" style="margin-top: 0; margin-bottom: 0"></p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in">(18)</td><td><span id="xdx_826_zfNvBoYHth0k">Net Income Attributable to Inter Parfums, Inc. and Transfers from the Noncontrolling Interest</span></td></tr></table>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock"><p id="xdx_892_eus-gaap--ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock_z6bQSfK2HVW7" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span id="xdx_8B3_zT1VWmcDFA85" style="display: none; visibility: hidden">Schedule of net income attributable to transfers from the noncontrolling interest</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_494_20210101__20211231_zmj7rP5v3rye" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_492_20200101__20201231_zwVHY0pR8ec5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_499_20190101__20191231_z0DwhBQWU0dk" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="color: Black">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="color: Black">&#160;</span></td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="color: Black">Year
    ended December 31,</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="color: Black">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="color: Black">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="color: Black">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="color: Black">2021</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="color: Black">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="color: Black">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="color: Black">2020</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="color: Black">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="color: Black">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="color: Black">2019</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="color: Black">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="color: Black">&#160;</span></td><td style="font-weight: bold"><span style="color: Black">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="color: Black">&#160;</span></td><td style="font-weight: bold"><span style="color: Black">&#160;</span></td><td style="font-weight: bold"><span style="color: Black">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="color: Black">&#160;</span></td><td style="font-weight: bold"><span style="color: Black">&#160;</span></td><td style="font-weight: bold"><span style="color: Black">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="color: Black">&#160;</span></td><td style="font-weight: bold"><span style="color: Black">&#160;</span></td></tr>
<tr id="xdx_407_eus-gaap--NetIncomeLoss_z7p5PdToESgh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 55%; text-align: left; padding-left: 0.125in; text-indent: -0.125in"><span style="color: Black">Net income attributable to Inter Parfums, Inc.</span></td><td style="width: 1%"><span style="color: Black">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="color: Black">$</span></td><td style="width: 12%; text-align: right"><span style="color: Black"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">87,411</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="color: Black">&#160;</span></td><td style="width: 1%"><span style="color: Black">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="color: Black">$</span></td><td style="width: 12%; text-align: right"><span style="color: Black"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">38,219</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="color: Black">&#160;</span></td><td style="width: 1%"><span style="color: Black">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="color: Black">$</span></td><td style="width: 12%; text-align: right"><span style="color: Black"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">60,249</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="color: Black">&#160;</span></td></tr>
<tr id="xdx_402_eus-gaap--ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesNet_z6sJRoHhgHQ2" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in"><span style="color: Black">Decrease in Inter Parfums, Inc.&#8217;s additional
    paid-in capital for subsidiary share transactions</span></td><td style="padding-bottom: 1pt"><span style="color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="color: Black">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="color: Black"><span style="-sec-ix-hidden: xdx2ixbrl1866">&#8212;</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="color: Black">&#160;</span></td><td style="padding-bottom: 1pt"><span style="color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="color: Black">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="color: Black"><span style="-sec-ix-hidden: xdx2ixbrl1867">&#8212;</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="color: Black">&#160;</span></td><td style="color: #FF0000; padding-bottom: 1pt"><span style="color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; color: #FF0000; text-align: left"><span style="color: Black">&#160;</span></td><td style="border-bottom: Black 1pt solid; color: #FF0000; text-align: right"><span style="color: Black">(<ix:nonFraction name="us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesNet" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">5,167</ix:nonFraction></span></td><td style="padding-bottom: 1pt; color: #FF0000; text-align: left"><span style="color: Black">)</span></td></tr>
<tr id="xdx_400_eus-gaap--ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNet_z88EJYfrzncb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2pt; padding-left: 0.125in; text-indent: -0.125in"><p style="margin-top: 0; margin-bottom: 0"></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">&#160;<span style="color: Black">Change from net income attributable to Inter Parfums, Inc. and transfers from noncontrolling interest</span></p></td><td style="padding-bottom: 2pt"><span style="color: Black">&#160;</span></td>
    <td style="border-bottom: Black 2pt double; text-align: left"><span style="color: Black">$</span></td><td style="border-bottom: Black 2pt double; text-align: right"><span style="color: Black"><ix:nonFraction name="us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNet" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">87,411</ix:nonFraction></span></td><td style="padding-bottom: 2pt; text-align: left"><span style="color: Black">&#160;</span></td><td style="padding-bottom: 2pt"><span style="color: Black">&#160;</span></td>
    <td style="border-bottom: Black 2pt double; text-align: left"><span style="color: Black">$</span></td><td style="border-bottom: Black 2pt double; text-align: right"><span style="color: Black"><ix:nonFraction name="us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNet" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">38,219</ix:nonFraction></span></td><td style="padding-bottom: 2pt; text-align: left"><span style="color: Black">&#160;</span></td><td style="padding-bottom: 2pt"><span style="color: Black">&#160;</span></td>
    <td style="border-bottom: Black 2pt double; text-align: left"><span style="color: Black">$</span></td><td style="border-bottom: Black 2pt double; text-align: right"><span style="color: Black"><ix:nonFraction name="us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNet" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">55,082</ix:nonFraction></span></td><td style="padding-bottom: 2pt; text-align: left"><span style="color: Black">&#160;</span></td></tr>
</table>



</ix:nonNumeric><p id="xdx_8AD_zGaZYBR2EsGg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

</ix:nonNumeric><p id="xdx_810_zpQKoJr8dnFg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>


<!-- Field: /Named-Area; -->

<!-- Field: Named-Area; Name: Contents -->
<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="ipar:ReconciliationOfCashAndCashEquivalentsToTheStatementOfCashFlowsTextBlock"><p id="xdx_80D_ecustom--ReconciliationOfCashAndCashEquivalentsToTheStatementOfCashFlowsTextBlock_z3A1PtU4iC4e" style="margin-top: 0; margin-bottom: 0"></p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in">(19)</td><td><span id="xdx_828_zwupbeSFx0qk">Reconciliation of Cash and Cash Equivalents to the Statement of Cash Flows</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock"><p id="xdx_893_eus-gaap--ScheduleOfCashAndCashEquivalentsTableTextBlock_zp6EmKT6Xtp4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8BD_zpQue6aL6gP9">The following table summarizes
cash and cash equivalents as of December 31, 2021:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td style="font-family: Courier New, Courier, Monospace; text-align: justify">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49D_20211231_zPehRo7p78A2" style="border-bottom: Black 1pt solid; text-align: center">December 31, 2021</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: justify">&#160;</td><td>&#160;</td></tr>
<tr id="xdx_409_eus-gaap--CashCashEquivalentsAndShortTermInvestments_iI_zX1rKjbN7Yn5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 85%; text-align: left">Cash and cash equivalents per balance sheet</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsAndShortTermInvestments" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">159,613</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_40E_ecustom--CashHeldInEscrowIncludedInOtherAssets_iI_zgfaoIKvSPUl" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Cash held in escrow included in other assets (see note 3)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ipar:CashHeldInEscrowIncludedInOtherAssets" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8,774</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40C_ecustom--CashAndCashEquivalentsPerStatementOfCashFlows_iI_z3NGxqJWTH9i" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2pt">Cash and cash equivalents per statement of cash flows</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td style="border-bottom: Black 2pt double; text-align: right"><ix:nonFraction name="ipar:CashAndCashEquivalentsPerStatementOfCashFlows" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">168,387</ix:nonFraction></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8AE_zUUhc8uvTUeg" style="margin-top: 0; margin-bottom: 0">&#160;</p>

</ix:nonNumeric><p id="xdx_81E_zA86cBQ7mCtb" style="margin-top: 0; margin-bottom: 0">&#160;</p>


<!-- Field: Page; Sequence: 121; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><b><span id="b008_v1"></span>Schedule II</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><b>INTER PARFUMS, INC. AND SUBSIDIARIES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">Valuation and Qualifying Accounts</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">(In
thousands)</span></p>



<p style="margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center; padding-left: 0.125in; text-indent: -0.125in">Column A</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Column B</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Column C</td>
    <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Column D</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Column E</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: right; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Additions</td>
    <td style="text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="text-align: center; vertical-align: bottom">
    <td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold">(1)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold">(2)</td>
    <td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="text-align: center; vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold; padding-left: 0.125in; text-indent: -0.125in">Description</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold"><span style="font-size: 10pt"><b>Balance at</b></span><br /> <span style="font-size: 10pt"><b>beginning of</b></span><br /> <span style="font-size: 10pt"><b>period</b></span></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold"><span style="font-size: 10pt"><b>Charged to</b></span><br /> <span style="font-size: 10pt"><b>costs and</b></span><br /> <span style="font-size: 10pt"><b>expenses</b></span></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold"><span style="font-size: 10pt"><b>Charged to</b></span><br /> <span style="font-size: 10pt"><b>other</b></span><br /> <span style="font-size: 10pt"><b>accounts &#8211; </b></span><br /> <span style="font-size: 10pt"><b>describe</b></span></td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold"><span style="font-size: 10pt"><b>Deductions </b></span><br /> <span style="font-size: 10pt"><b>describe</b></span></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold"><span style="font-size: 10pt"><b>Balance at</b></span><br /> <span style="font-size: 10pt"><b>end of period</b></span></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; width: 35%; padding-left: 0.125in; text-indent: -0.125in">Allowance for doubtful accounts:</td><td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td style="text-align: right; width: 9%">&#160;</td><td style="text-align: left; width: 1%">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td style="text-align: right; width: 9%">&#160;</td><td style="text-align: left; width: 1%">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td style="text-align: right; width: 9%">&#160;</td>
    <td style="text-align: left; width: 4%">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td style="text-align: right; width: 9%">&#160;</td><td style="text-align: left; width: 3%">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td style="text-align: right; width: 9%">&#160;</td><td style="text-align: left; width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.375in; text-indent: -0.125in">Year ended December 31, 2021</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">5,550</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">877</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(843</td>
    <td style="text-align: left"><span style="font-size: 10pt">)(d)</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,336</td><td style="text-align: left">(a)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,247</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.375in; text-indent: -0.125in">Year ended December 31, 2020</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">2,452</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,824</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">381</td>
    <td style="text-align: left"><span style="font-size: 10pt">(d)</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,107</td><td style="text-align: left">(a)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,550</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.375in; text-indent: -0.125in">Year ended December 31, 2019</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">2,602</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,380</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(41</td>
    <td style="text-align: left"><span style="font-size: 10pt">)(d)</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,489</td><td style="text-align: left">(a)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,452</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Allowance for sales returns, net of inventory:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.375in; text-indent: -0.125in">Year ended December 31, 2021</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">2,242</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,042</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td>
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,042</td><td style="text-align: left">(b)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,242</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.375in; text-indent: -0.125in">Year ended December 31, 2020</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">2,587</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,978</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td>
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,323</td><td style="text-align: left">(b)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,242</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.375in; text-indent: -0.125in">Year ended December 31, 2019</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1,379</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,387</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td>
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,179</td><td style="text-align: left">(b)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,587</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Inventory reserve:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.375in; text-indent: -0.125in">Year ended December 31, 2021</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">9,371</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,217</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7,041</td>
    <td style="text-align: left"><span style="font-size: 10pt">(d)(e)</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,852</td><td style="text-align: left">(c)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">15,777</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.375in; text-indent: -0.125in">Year ended December 31, 2020</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">4,909</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7,212</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">616</td>
    <td style="text-align: left"><span style="font-size: 10pt">(d)</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,366</td><td style="text-align: left">(c)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,371</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.375in; text-indent: -0.125in">Year ended December 31, 2019</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">4,854</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,321</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(70</td>
    <td style="text-align: left"><span style="font-size: 10pt">)(d)</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,196</td><td style="text-align: left">(c)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,909</td><td style="text-align: left">&#160;</td></tr>
</table>



<p style="margin: 0">&#160;</p>

<p style="margin: 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left">(a)</td><td style="text-align: justify">Write-off of bad debts.</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left">(b)</td><td style="text-align: justify">Write-off of sales returns.</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left">(c)</td><td style="text-align: justify">Disposal of inventory</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left">(d)</td><td style="text-align: justify">Foreign currency translation adjustment</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left">(e)</td><td style="text-align: justify">Inventory reserves acquired of $7,639</td>
</tr></table>



<p style="margin: 0"></p>

<p style="margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">See accompanying reports of independent registered public accounting
firm.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<!-- Field: Page; Sequence: 122; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="a022_v1"></span>SIGNATURES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of Section 13 or 15 (d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report
to be signed on its behalf by the undersigned, thereunto duly authorized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inter Parfums, Inc.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 55%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By: </span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 42%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;/s/ Jean Madar&#160;&#160;&#160;&#160;&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jean Madar, Chief Executive Officer</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date: March 1, 2022</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf
of the Registrant and in the capacities and on the dates indicated:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 30%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signature</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 40%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 25%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;/s/ Jean Madar</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chairman of the Board of Directors</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jean Madar</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and Chief Executive Officer</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">March 1, 2022</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;/s/ Russell Greenberg</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Russell Greenberg</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Financial and Accounting Officer and Director</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">March 1, 2022</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;/s/ Philippe Benacin</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Philippe Benacin</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">February 25, 2022</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;/s/ Philippe Santi</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Philippe Santi</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">February 25, 2022</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;/s/ Fran&#231;ois Heilbronn</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fran&#231;ois Heilbronn</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">February 28, 2022</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/&#160;Robert Bensoussan</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Robert Bensoussan</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">February 25, 2022</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/&#160;Patrick Cho&#235;l</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Patrick Cho&#235;l</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">February 28, 2022</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;/s/ Michel Dyens</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Michel Dyens</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">February 25, 2022</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Veronique Gabai-Pinsky</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Veronique Gabai-Pinsky</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">February 28, 2022</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Gilbert Harrison</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gilbert Harrison</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">February 25, 2022</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>
<!-- Field: Page; Sequence: 125; Value: 87 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->87<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span style="text-decoration: underline">Exhibit
Index</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following documents previously filed with the Commission are incorporated by reference to the Company&#8217;s Annual Report on
Form 10-K for the fiscal year ended December 31, 2017:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit
    <br />
No.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description</b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.166</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 91%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/822663/000161577418001852/s109206_ex10-166.htm">Form
    of Option Agreement for Options Granted to Executive Officers on December 29, 2017 with Schedule of Option Holders and Options
    Granted</a></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.167</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/822663/000161577418001852/s109206_ex10-167.htm">Form
    of Option Agreement for Options Granted to Executive Officers on January 19, 2018 with Schedule of Option Holders and Options
    Granted</a></span></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following documents previously filed with the Commission are incorporated by reference to the Company&#8217;s Annual Report on
Form 10-K for the fiscal year ended December 31, 2018:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit
<br />
No.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description</b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.156</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/822663/000161577419003459/s116268_ex10-156.htm">Consulting
    Agreement with Jean Madar Holding SAS</a></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 8%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.168</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 91%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/822663/000161577419003459/s116268_ex10-168.htm">Eighth
    Modification of Lease for portions of 551 5<sup>th</sup> Avenue, New York, NY</a></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.168.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/822663/000161577419003459/s116268_ex10-1681.htm">Exhibits
    to Eighth Modification of Lease for portions of 551 5<sup>th</sup> Avenue, New York, NY</a></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.169</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/822663/000161577419003459/s116268_ex10-169.htm">Fourth
    Amendment to Lease for 60 Stults Road, South Brunswick, NJ</a></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.171</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/822663/000161577419003459/s116268_ex10-171.htm">Form
    of Option Agreement for Options Granted to Executive Officers on December 31, 2018 with Schedule of Option Holders and Options
    Granted</a></span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following document previously filed with the Commission is incorporated by reference to the Company&#8217;s Current Report on
Form 8-K as filed on February 7, 2020:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 8%; text-align: left; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit&#160;No.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 91%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description</b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.171</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/822663/000121390020002946/f8k020420ex10-171_inter.htm">Form
    of Amendment to Consulting Agreement for Jean Madar Holding SAS</a></span></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 123; Options: NewSection; Value: 87 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->88<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following documents previously filed with the Commission are incorporated by reference to the Company&#8217;s Annual Report on
Form 10-K for the fiscal year ended December 31, 2019:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit<br />

    No.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 91%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description</b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.160</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/822663/000121390020005153/f10k2019ex10-160_interpar.htm">Consulting
    Agreement with Philippe Benacin Holding SAS</a></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/822663/000121390020005153/f10k2019ex3-1i_interpar.htm">Restated
    Certificate of Incorporation dated September 3, 1987</a></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1.2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/822663/000121390020005153/f10k2019ex3-1ii_interpar.htm">Amendment
    to Restated Certificate of Incorporation dated July 31, 1992</a></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1.3</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/822663/000121390020005153/f10k2019ex3-1iii_interpar.htm">Amendment
    to Restated Certificate of Incorporation dated July 9, 1993</a></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1.4</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/822663/000121390020005153/f10k2019ex3-1iv_interpar.htm">Amendment
    to Restated Certificate of Incorporation, as amended, dated July 13, 1999</a></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1.5</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/822663/000121390020005153/f10k2019ex3-1v_interpar.htm">Amendment
    to Restated Certificate of Incorporation, as amended, dated July 12, 2000</a></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1.6</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/822663/000121390020005153/f10k2019ex3-1vi_interpar.htm">Amendment
    to Restated Certificate of Incorporation dated August 6, 2004</a></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160; </span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.3</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/822663/000121390020005153/f10k2019ex3-3_interpar.htm">Articles
    of Incorporation of Inter Parfums Holdings, S.A.</a></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.3.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/822663/000121390020005153/f10k2019ex3-3i_interpar.htm">Articles
    of Incorporation of Inter Parfums Holdings, S.A. (English translation)</a></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.4</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/822663/000121390020005153/f10k2019ex3-4_interpar.htm">Articles
    of Incorporation of Interparfums SA</a></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.4.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/822663/000121390020005153/f10k2019ex3-4i_interpar.htm">Articles
    of Incorporation of Interparfums SA (English translation)</a></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.25</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/822663/000121390020005153/f10k2019ex10-25_interpar.htm">Employment
    Agreement between the Company and Philippe Benacin dated July 29, 1991</a></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.26</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/822663/000121390020005153/f10k2019ex10-26_interpar.htm">Lease
    for portion of 15th Floor, 551 Fifth Avenue, New York, New York</a></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.61</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/822663/000121390020005153/f10k2019ex10-61_interpar.htm">Lease
    for 60 Stults Road, South Brunswick, NJ between Forsgate Industrial Complex, LP, and Jean Philippe Fragrances, Inc. dated
    July 10, 1995</a></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.61.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/822663/000121390020005153/f10k2019ex10-61i_interpar.htm">Third
    Amendment to Lease for 60 Stults Road, South Brunswick, NJ</a></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.172</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/822663/000121390020005153/f10k2019ex10-172_interpar.htm">Form
    of Option Agreement for Options Granted to Executive Officers on December 31, 2019 with Schedule of Option Holders and Options
    Granted</a></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.173</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/822663/000121390020005153/f10k2019ex10-173_inter.htm">Lease
    for Interparfums SA Distribution Center</a> <span style="color: blue"><i><span style="text-decoration: underline">(confidential information in this exhibit was omitted)</span></i></span></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/822663/000121390020005153/f10k2019ex31-1_interpar.htm">Certification Required by Rule 13a-14 of Chief Executive Officer</a></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31.2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/822663/000121390020005153/f10k2019ex31-2_interpar.htm">Certification Required by Rule 13a-14 of Chief Financial Officer</a></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">32.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/822663/000121390020005153/f10k2019ex32-1_interpar.htm">Certification Required by Section 906 of the Sarbanes-Oxley Act by Chief Executive Officer</a></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">32.2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/822663/000121390020005153/f10k2019ex32-2_interpar.htm">Certification Required by Section 906 of the Sarbanes-Oxley Act by Chief Executive Officer</a></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interactive data
    files</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following documents previously filed with the Commission are incorporated by reference to the Company&#8217;s Annual Report on
Form 10-K for the fiscal year ended December 31, 2020:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 9%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit
    <br />
No.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 89%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description</b></span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/822663/000121390021012513/f10k2020ex3-1_inter.htm">Interparfums Singapore Pte. Ltd Memorandum and Articles of Association</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/822663/000121390021012513/f10k2020ex3-2_inter.htm">Interparfums Luxury Brands, Inc. Certificate of Incorporation</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/822663/000161577419003459/s116268_ex23.htm">Consent
    of Mazars USA LLP</a></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/822663/000161577419003459/s116268_ex31-1.htm">Certification
    Required by Rule 13a-14 of Chief Executive Officer</a></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31.2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/822663/000161577419003459/s116268_ex31-2.htm">Certification
    Required by Rule 13a-14 of Chief Financial Officer</a></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">32.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/822663/000161577419003459/s116268_ex32-1.htm">Certification
    Required by Section 906 of the Sarbanes-Oxley Act by Chief Executive Officer</a></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">32.2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/822663/000161577419003459/s116268_ex32-2.htm">Certification
    Required by Section 906 of the Sarbanes-Oxley Act by Chief Executive Officer</a></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interactive
data files&#160;</span></p></td></tr>
</table>

<p style="margin: 0">&#160;</p>


<!-- Field: Page; Sequence: 124; Value: 87 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->89<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
following documents previously filed with the Commission are incorporated by reference to the Company&#8217;s Annual Report on
Form 10-K for the fiscal year ended December 31, 2016:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit
    <br />
No.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description</b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.6</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 91%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/822663/000114420417014248/v460761_ex3-6.htm">Organizational
    Document of Inter Parfums (Suisse) Sarl (French original)</a></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.6.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/822663/000114420417014248/v460761_ex3-6x1.htm">Organizational
    Document of Inter Parfums (Suisse) Sarl (English translation)</a></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.9</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/822663/000114420417014248/v460761_ex3-2.htm">Amended
    and Restated By-laws</a> <a href="http://www.sec.gov/Archives/edgar/data/822663/000114420417014248/v460761_ex3-2.htm"><i>(correction
    to name only)</i></a></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.165</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/822663/000114420417014248/v460761_ex10-165.htm">Form
    of Option Agreement for Options Granted to Executive Officers on December 31, 2016 with Schedule of Option Holders and Options
    Granted</a></span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibits
Filed and Attached to this report:</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following document previously filed with the Commission more than five years ago is incorporated by reference to the Company&#8217;s
Quarterly Report on Form 10-Q for the period ended March 31, 2016:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit
    <br />
No.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 82%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description</b></span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 8%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Page
    No.</b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.8</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="g082622_ex3-8.htm">Articles of Association of Parfums Rochas Spain, Limited Liability Company (Spanish with English translation)</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">127</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following document previously filed with the Commission more than five years ago is incorporated by reference to the Company&#8217;s
Quarterly Report on Form 10-Q for the period ended June 30, 2016:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 82%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.33</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="g082622_ex4-33.htm">2016 Stock Option Plan</a> &#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">158</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;The
following documents are filed with this report:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left; width: 8%; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit&#160;No.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 82%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 8%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Page
    <br />
Nos.</b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.10</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="g082622_ex3-10.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interparfums Italia srl (formerly Parfums Italia srl) Incorporation Deed dated September 8, 2021 (Italian language)</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">128</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.10.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="g082622_ex3-101.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interparfums Italia srl (formerly Parfums Italia srl) Incorporation Deed dated September 8, 2021 (English translation)</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">131</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.10.2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="g082622_ex3-102.htm"><span style="font: 10pt Times New Roman, Times, Serif">Interparfums Italia srl (formerly Parfums Italia srl) Amendment to Certificate of Organization dated October 1, 2021 (Italian language)</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">134</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.10.3</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="g082622_ex3-103.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interparfums Italia srl (formerly Parfums Italia srl) Amendment to Certificate of Organization dated October 1, 2021 (English translation)</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">137</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">21</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="g082622_ex21.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">List of Subsidiaries</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">168</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="g082622_ex23.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consent of Mazars USA LLP</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">169</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="g082622_ex31-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certification Required by Rule 13a-14 of Chief Executive Officer</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">170</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31.2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="g082622_ex31-2.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certification Required by Rule 13a-14 of Chief Financial Officer</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">172</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">32.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="g082622_ex32-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certification Required by Section 906 of the Sarbanes-Oxley Act by Chief Executive Officer</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">174</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">32.2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="g082622_ex32-2.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certification Required by Section 906 of the Sarbanes-Oxley Act by Chief Executive Officer</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">175</span></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>






<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<!-- Field: Page; Sequence: 126; Value: 87 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->90<!-- Field: /Sequence --></p></div>

    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>


<!-- Field: /Named-Area; -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.10
<SEQUENCE>2
<FILENAME>g082622_ex3-10.htm
<DESCRIPTION>EXHIBIT 3.10
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
3.10</B></FONT></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Repertorio
n. 82.061 Raccolta n.26.643</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ATTO
COSTITUTIVO DI SOCIETA&rsquo; A RESPONSABILITA&rsquo; LIMITATA</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">R
E P U B B L I C A I T A L I A N A</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-
8 settembre 2021 -</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Il
giorno otto settembre duemilaventuno.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
Firenze, via Tornabuoni n. 2.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Davanti
a me dott. Francesco STEIDL, Notaio in Firenze,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iscritto
al Collegio Notarile dei Distretti Riuniti di</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Firenze
Pistoia e Prato</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">sono
comparsi i signori</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-
<B>Francesco PERGOLINI, </B>impiegato, nato a Firenze (FI) il</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">giorno
11 ottobre 1970, residente a Sesto Fiorentino (FI),</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">via
Cagliari n. 10 int. 2, codice fiscale dichiarato PRG FNC</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">70R11
D612I;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-
Dott. Michele Norsa, nato a Lecco (LC) il giorno 12 agosto</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1948
domiciliato ove infra per la carica, il quale dichiara</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">di
intervenire al presente atto nella qualit&agrave; di Vice</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Presidente
del Consiglio di Amministrazione e legale</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">rappresentante
della societ&agrave;, costituita in Italia,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;SALVATORE
FERRAGAMO S.P.A.&rdquo;</B>, con sede in Firenze (FI), via</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tornabuoni
n. 2, con capitale sociale di euro 16.879.000,00</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(sedicimilioniottocentosettantanovemila
virgola zero zero),</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">interamente
versato, codice fiscale, partita I.V.A. e numero</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">di
iscrizione al Registro delle Imprese di Firenze</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">02175200480,
R.E.A. numero FI-464724, in forza dei poteri</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">attribuiti
con deliberazione del Consiglio di</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amministrazione
in data 20 luglio 2021, che in estratto</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">autentico
si allega al presente atto <B>sub A)</B>, omessa la</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">lettura
per dispensa avutane dai comparenti.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Detti
comparenti, di cittadinanza italiana, della cui</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">identit&agrave;
personale io notaio sono certo, mi richiedono di</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ricevere
il presente atto con il quale si conviene e stipula</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">quanto
segue.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ART.
1) CONSENSO</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">E&rsquo;
costituita da &ldquo;SALVATORE FERRAGAMO S.P.A.&rdquo; una societ&agrave; a</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">responsabilit&agrave;
limitata unipersonale sotto la denominazione</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">sociale
&ldquo;<B>PARFUMS ITALIA SRL</B>&rdquo;.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ART.
2) SEDE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">La
sede della societ&agrave; &egrave; fissata in Firenze (FI).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ai
soli fini dell&rsquo;art. 111 <I>ter </I>disp. att. cod. civ., le</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">parti
dichiarano che l&rsquo;indirizzo ove &egrave; posta la sede della</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">societ&agrave;
&egrave; in via Maggio n. 7.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ART.
3) DURATA</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">La
societ&agrave; avr&agrave; durata compresa tra il giorno della sua</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">legale
costituzione e il giorno trentuno dicembre</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">duemilacento,
e pu&ograve; essere prorogata o anticipatamente</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">sciolta
con deliberazione dell&rsquo;assemblea dei soci.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ART.
4) ORGANO AMMINISTRATIVO</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fino
a nuova determinazione dei soci, la societ&agrave; sar&agrave;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">gestita
e amministrata da un Amministratore unico, che dura</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
carica a tempo indeterminato, nella persona del signor</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Francesco
PERGOLINI</B>, come sopra costituito, il quale,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">presente,
accetta dichiarando che a proprio carico non</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">sussistono
cause di ineleggibilit&agrave; o decadenza previste</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">dalla
legge.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ART.
5) CAPITALE SOCIALE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Il
capitale sociale &egrave; fissato in euro 10.000,00 (diecimila</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">virgola
zero zero) e viene interamente sottoscritto e</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">versato
in denaro dall&rsquo;unico socio in data odierna come</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">subito
appresso indicato.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Il
signor Francesco PERGOLINI, nella sua qualit&agrave; di</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amministratore
unico, come sopra nominato e costituito,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">dichiara
di ricevere e prendere in custodia la somma</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">rappresentante
l&rsquo;intero capitale sociale e si obbliga ad</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">aprire
un conto corrente bancario intestato alla societ&agrave; una</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">volta
che la stessa sia stata iscritta nel competente</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Registro
delle Imprese e a versare il citato importo su</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">detto
conto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ai
sensi dell&rsquo;art. 2464, comma 4, cod. civ., copia dei mezzi</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">di
pagamento dei conferimenti in denaro si allega al</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">presente
atto <B>sub B)</B>, omessa la lettura per dispensa avutane</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">dai
comparenti.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ART.
6) NORME RELATIVE AL FUNZIONAMENTO DELLA SOCIETA&rsquo; E</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>OGGETTO
SOCIALE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Le
norme relative al funzionamento della societ&agrave; sono</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">stabilite
nello statuto sociale, che viene approvato</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">dall&rsquo;unico
socio nel testo che si allega al presente atto</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>sub
C), </B>previa lettura da me datane ai comparenti<B>.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Si
allega inoltre <B>sub D)</B>, e per una migliore sua</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">comprensione
da parte di chi non comprende la lingua</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">italiana,
il testo dello statuto con traduzione a fronte in</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">lingua
inglese effettuata da me notaio<B>, </B>che comprendo la</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">lingua
inglese, omessa la lettura per dispensa avutane dai</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">comparenti.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">La
societ&agrave; ha per oggetto lo svolgimento delle attivit&agrave;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">connesse
alla commercializzazione all&rsquo;ingrosso di fragranze</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e
cosmetici e quant&rsquo;altro previsto nell&rsquo;art. 4 dello statuto</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">sociale
come sopra allegato.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ART.
7) PRIMO ESERCIZIO</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Il
primo esercizio sociale si chiuder&agrave; il giorno 31 dicembre</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ART.
8) PRIVACY</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ai
sensi del reg. UE n. 2016/679 (regolamento generale sulla</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">protezione
dei dati), i comparenti, ricevuta la debita</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">informativa
su finalit&agrave;, conservazione, tempi, diritti</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">dell&rsquo;interessato,
destinatari e destinazioni, in virt&ugrave; della</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">funzione
e degli adempimenti di legge connessi al loro</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">utilizzo,
nella consapevolezza dell&rsquo;importanza del servizio,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">autorizzano
il notaio rogante in quanto pubblico ufficiale e</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">il
suo ufficio al trattamento dei dati personali sensibili</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">esplicitati
nel presente atto; il consenso &egrave; reso a tempo</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">indefinito
in quanto connesso ad atto notarile avente</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">validit&agrave;
non limitata nel tempo.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ART.
9) NORMATIVA ANTIRICICLAGGIO</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
comparenti, ciascuno per quanto di propria spettanza e</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">sotto
la rispettiva personale responsabilit&agrave;, consapevoli</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">della
rilevanza penale del loro comportamento ai sensi</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">dell&rsquo;art.
55 d.lgs. n. 231 del 2007, dichiarano:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-
di essere a conoscenza che le informazioni e gli altri</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">dati
forniti in occasione dell&rsquo;istruttoria e della stipula</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">del
presente atto saranno impiegati dal notaio rogante ai</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">fini
degli adempimenti previsti dal citato d.lgs.;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-
che tali informazioni e dati sono aggiornati.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ART.
10) SPESE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Le
spese e competenze inerenti e conseguenti al presente</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">atto,
ammontanti approssimativamente a euro 2.000,00</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(duemila
virgola zero zero), sono a carico della societ&agrave;.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Del
presente atto ho dato lettura alle parti comparenti che</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">lo
approvano e confermano.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Scritto
da persona di mia fiducia e completato da me notaio</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">su
un foglio per tre pagine.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sottoscritto
alle ore dodici e venti.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All&rsquo;originale
firmato: Michele Norsa - Francesco Pergolini -</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Francesco
Steidl Notaio</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[Signature
and Seal]</FONT></P>



<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>

    <!-- Field: /Page -->

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.10.1
<SEQUENCE>3
<FILENAME>g082622_ex3-101.htm
<DESCRIPTION>EXHIBIT 3.10.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
3.10.1</B></FONT></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Repertoire
n. 82.061 Collection n.26.643</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>DEED
OF INCORPORATION OF LIMITED LIABILITY COMPANIES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">R
E P U B B L I C A I T A L I A N A</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-
8 September 2021 -</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
the eighth day of September two thousand twenty-one.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
Florence, via Tornabuoni n. 2.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
front of me dr. Francesco STEIDL, Notary in Florence,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">member
of the Notarial College of the Districts of</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Florence
Pistoia and Prato</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
gentlemen have appeared</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-
<B>Francesco PERGOLINI, </B>clerk, born in Florence (FI) on</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11
October 1970, resident in Sesto Fiorentino (FI),</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">via
Cagliari n. 10 int. 2, tax code declared PRG FNC</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">70R11
D612I;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-
Dr. Michele Norsa, born in Lecco (LC) on August 12th</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1948
domiciled if infra for the office, which declares</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
intervene in this Act in his capacity as Deputy</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chairman
of the Board of Directors and Legal</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">representative
of the company, incorporated in Italy,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;SALVATORE
FERRAGAMO S.P.A.&rdquo; </B>, based in Florence (FI), via</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tornabuoni
n. 2, with share capital of &euro; 16,879,000.00</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(sixteen
million, eight hundred and seventy-nine thousand zero point zero),</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">fully
paid, tax code, VAT number and number</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">registration
in the Register of Companies of Florence</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">02175200480,
R.E.A. number FI-464724, by virtue of the powers</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">assigned
by resolution of the Council of</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Administration
on July 20 , 2021, which in extract</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">authentic
is attached to this act <B>under A)</B> omitted the</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">reading
for dispensation had by the participants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Said
applicants, of Italian nationality, of which</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">personal
identity I notary I am sure, they ask me to</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">receive
this act with which it is agreed and stipulated</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
following.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ART.
1) CONSENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
is established by &ldquo;SALVATORE FERRAGAMO S.P.A.&rdquo; a company in</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">single-person
limited liability under the name</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">social
&ldquo;<B>PARFUMS ITALIA SRL</B>&rdquo;.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ART.
2) HEADQUARTERS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
company&rsquo;s headquarters are located in Florence (FI).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the sole purposes of Article 111b of the Civil Code, the</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">parties
declare that the address where the seat of the</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">company
is in via Maggio n. 7.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ART.
3) DURATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
company will last between the day of its</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">legal
constitution and the day thirty-one December</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">two
thousand hundred, and can be extended or in advance</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">dissolved
by resolution of the shareholders&rsquo; meeting .</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ART.
4) ADMINISTRATIVE BODY</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Until
further determination of the shareholders, the company will be</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">managed
and administered by a Sole Director, which lasts</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
office for an indefinite period, in the person of Mr</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Francesco
PERGOLINI</B>, as constituted above, who,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">present,
accepts declaring that at his own expense not</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">there
are grounds for ineligibility or forfeiture provided for</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">by
law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ART.
5) SOCIAL CAPITAL</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
share capital is fixed at &euro; 10,000.00 (ten thousand</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">zero
point zero) and is fully subscribed to and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">paid
in cash by the sole shareholder today as</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">immediately
indicated below.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Francesco PERGOLINI, in his capacity as</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sole
Director, as appointed and constituted above,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">declares
to receive and take into custody the sum</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">representing
the entire share capital and undertakes to</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">open
a bank account in the name of the company a</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">once
the same has been registered in the competent</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Register
of Companies and to pay the aforementioned amount on</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">said
account.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to Article 2464, paragraph 4, of the Italian Civil Code, copy of the means</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">payment
of cash contributions is attached to the</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">this
Act <B>(B)</B>, omitted reading for dispensation had</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">by
the comparants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ART.
6) RULES RELATING TO THE FUNCTIONING OF THE COMPANY AND</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>COMPANY
OBJECT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
rules relating to the operation of the company are</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">established
in the articles of association, which are approved</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">by
the sole member in the text annexed to this act</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>sub
C), </B>after reading by me given to the participants<B>.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
is also attached <B>sub D)</B>, and for a better its</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">comprehension
by those who do not understand the language</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Italian,
the text of the statute with translation in front in</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">English
language made by me notary<B>, </B>which I understand the</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">English
language, omitted reading for dispensation had by the</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">comparenti.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
object of the company is to carry out its activities</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">related
to the wholesale marketing of fragrances</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">and
cosmetics and anything else provided for in Article 4 of the Statute</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">social
as attached above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ART.
7) FIRST FINANCIAL YEAR</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
first financial year will close on December 31st</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ART.
8) PRIVACY</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to Reg. EU no. 2016/679 (general regulation on</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">data
protection), the applicants, received the due</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">information
on purpose, conservation, timing, rights</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">of
the interested party, recipients and destinations, by virtue of the</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">function
and legal obligations related to their</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">use,
in the awareness of the importance of the service,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">authorize
the notary public as a public official and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">your
office to the processing of sensitive personal data</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">made
explicit in this act; consent is given in time</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">indefinite
as it is connected to a notarial deed having</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">validity
not limited in time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ART.
9) ANTI-MONEY LAUNDERING LEGISLATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
participants, each to the extent to which it is their responsibility and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">under
their respective personal responsibility, aware</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
criminal relevance of their conduct pursuant to</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">of
Article 55 of Legislative Decree no. 231 of 2007, declare:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-
to be aware that the information and others</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">data
provided during the investigation and stipulation</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">of
this deed will be used by the notary public to the</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">purposes
of the obligations provided for by the aforementioned d.lgs.;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-
that such information and data are up to date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ART.
10) EXPENSES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
expenses and competences inherent and consequential to the present</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">deed,
amounting approximately to &euro; 2,000.00</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(two
thousand comma zero zero), are the responsibility of the company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Of
this Act I have read to the appearing parts that</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">they
approve and confirm it.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Written
by a person of my trust and completed by me a notary</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">on
a sheet for three pages.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signed
at twelve and twenty o&rsquo;clock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
the original signed: Michele Norsa - Francesco Pergolini -</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Francesco
Steidl Notary</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[signature
and seal]</FONT></P>



<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>

    <!-- Field: /Page -->

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.10.2
<SEQUENCE>4
<FILENAME>g082622_ex3-102.htm
<DESCRIPTION>EXHIBIT 3.10.2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
3.10.2</B></FONT></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Dott.
Francesco STEIDL</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Notaio</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>C
E R T I F I C A Z I O N E</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Io
sottoscritto Dr. Francesco STEIDL, Notaio in Firenze, iscritto al</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Collegio
dei Distretti Notarili Riuniti di Firenze, Pistoia e Prato,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CERTIFICO</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">che
con atto autenticato dame notaio in data odierna tra :</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-
<B>&ldquo;SALVATORE FERRAGAMO S . P.A.&rdquo; , </B>con sede in Firenze (FI), via Tornabuoni</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">n.
2 , con capitale sociale di euro 16 .8 79.000 ,00, interamente versato,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">codice
fiscale , partita I.V.A . e numero di iscrizione al Registro delle</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Imprese
di Firenze 02175200480, R. E. A. numero FI-464724;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;INTER
PARFUMS, Inc .&rdquo;, </B>societa regolata dalla legge del Delaware</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(U.S.A.)
con sede al n. 551 Fifth Avenue, New York N. Y. 10176 (U . S .A.)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">con
Numero Identificativo dell&rsquo;Agenzia delle Entrate 13-3275609;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">premesso
che</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;SALVATORE
FERRAGAMO S. P .A.&rdquo; e proprietaria dell&rsquo; intero capitale</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">sociale
della societa <B>&ldquo;PARFUMS ITALIA S.R.L .&rdquo; </B>unipersonale, societa di</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">diritto
italiano con sede a Firenze via Maggio n. 7, capitale sociale di</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">euro
17.138.000,00 (diciassettemilionicentotrentottomila virgola zero</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">zero)
interamente versato, numero di iscrizione nel Registro delle</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Imprese
di Firenze codice fiscale e Partita IVA 07122680486, R. E.A. di</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Firenze
FI 681202;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">tanto
premesso</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">la
societa &ldquo;SALVATORE FERRAGAMO s . p .A.&rdquo; ha venduto alla societa &ldquo;INTER</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PARFUMS
Inc .&rdquo;, l&rsquo; intera quota di sua proprieta pari al 100% (cento per</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">cento)
del capitale sociale nella societa <B>&ldquo;PARFUMS ITALIA S.R.L.&rdquo;, </B>al</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">prezzo
di euro 17 . 138 . 000,00 (diciassettemilionicentotrentottomila</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">virgola
zero zero).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">La
presente dichiarazione si rilascia per gli usi consentiti dalla legge.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Firenze,
1&deg; ottobre 2021</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[signature
and seal]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dott.
Francesco STEIDL</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notaio</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CERTIFICAZIONE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Io
sottoscritto Dott. Francesco Steidl, Notaio in</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Collegio
dei Distretti Notarili riuniti <I>di </I>Firenze,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">certifico:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Firenze,
iscritto al</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pistoia
e Prato,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">che
con decisione del socio unico, SALVATORE FERRAGAMO S.P.A. (in</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">esecuzione
<I>di </I>precedenti accordi assunti con INTER PARFUMS, INC. che ha,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
data odierna, acquisi to l&rsquo; intero capi tale sociale dell a societa, con</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">atto
da me notaio autenticato, in corso <I>di </I>registrazione e <I>di </I>deposito</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">presso
<I>il </I>competente Registro delle Imprese), dame verbalizzata in data</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">odierna,
la societa a responsabilita limitata denominata:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;PARFUMS
ITALIA SRL&rdquo;, </B>con sede in Firenze (FI) , <I>via </I>Maggio n. 7, con</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">capitale
sociale <I>di </I>euro 17.138.000,00= interamente versato, codice</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">fiscale,
partita I.V.A. e numero <I>di </I>iscrizione al Registro delle Imprese</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>di
</I>Firenze 07122680486, R.E.A. numero FI-681202,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ha
deliberato quanto segue:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&ldquo;a)
sul <B>prim.o </B>punto all&rsquo;ordine del giorno:</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-
<I>di accettare le dimissioni dell&rsquo;Amministratore unico </I>e, <I>ringraziandolo</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>per
la fattiva opera svolta a favore della societa;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>di
ratificare ed approvare </I>e, <I>conseguentemente, di rinunciare</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>all
&rsquo;esercizio di qualunque azione, anche di responsabilita (ivi inclusa</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>l&rsquo;azione
di cui agli artt. 2476 </I>e <I>2497 del codice civile) nei confronti</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>di
Francesco Pergolini in relazione a </I>- <I>l&rsquo;operato dallo stesso svolto</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>quale
Amministratore Unico della societa, per tutto</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>permanenza
nella carica </I>e <I>fino alla data di cessazione</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>il
tempo di</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>della
stessa</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>inclusa,
con riferimento a tutte le operazioni paste in essere,</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>confermando
l &rsquo;assemblea all&rsquo; unanimi ta di es sere pienamen te informa ta al</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>riguardo;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-
<I>che la ratifica, le rinunce all&rsquo;esercizio di azioni di responsabilita,</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>nonche
tutto quanta previsto nella presente delibera, non troveranno</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>applicazione
per qualsiasi azione </I>e/o <I>omissione pasta in essere dal</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>precedente
amministratore unico con dolo </I>e/o <I>colpa grave;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>b)
sul <B>secondo </B>punto all&rsquo;ordine del giorno:</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>di
nominare quale Amministratore Unico il signor <B>Gregory Joseph Serge</B></I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>REZNIK,
</I></B><I>nato a Parigi (Francia) il 12 luglio 1977, domiciliato per la</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>carica
presso la sede sociale, codice fiscale dichiarato RZN GGR 77&pound;12</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>ZllOW,
cittadino francese, il quale durera in carica fino a revoca o</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>dimissioni;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>c)
sul </I><B>terzo </B><I>punto all&rsquo;ordine del giorno:</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>di
modificare la denominazione in <B>&ldquo;INTERPARFUMS ITALIA SRL&rdquo; con</B></I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>conseguente
dello statuto costituita odifica dell &rsquo;art. 1)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>come
segue: &ldquo;E una societa a responsabilita <B>&ldquo;INTERPARFUMS ITALIA SRL&rdquo; </B></I>&rdquo;;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>limitata
denominata</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>d)
s ul </I><B>quarto </B><I>punto all&rsquo;ordine del giorno:</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-
<I>di t r as ferire la sede legale della societa nell &rsquo;ambi to dello stesso</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>c
om une e cioe da Via Maggio n. </I>7, <I>Firenze a Piazza della Repubblica n.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>6,
Fi r e n z e ;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>e)
sul <B>quinto </B>pun to all&rsquo;ordine del giorno:</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-
<I>di ridurre il capitale sociale, ai sensi dell &rsquo; art. di <B>euro</B>1 </I>7. <I>138 . 000, 00</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>dall
&rsquo;importo attuale 2482 cod . civ., 1 </I>7. <I>138 . 000, 00</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(diciassettemilionicentotrentottomila/00)
all &rsquo;importo di euro 100.000,00</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(centomila/00)
e, quindi, per euro 17.038.000,00</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(diciassettemilionitrentottomila/00),
mediante accan tonamen to del</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>corrispondente
importo ad apposita riserva disponibile;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-
<I>di prendere atto che la presente delibera di riduzione del capitale</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>potra
es sere eseguita sol tan to dopo novanta giorni dall &rsquo; iscrizione della</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>stessa
nel Registro delle Imprese, purche, entro tale termine, nessun</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>creditore
sociale anteriore all &rsquo; iscrizione abbia fatto opposizione;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>di
dare mandato al nuovo Amministratore unico di provvedere al</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>deposito
del nuovo testo dello statuto sociale, quale risultante dal</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>testo
esibito dal Presidente e approvato in questa sede dall &rsquo;assemblea e</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>recante
la modifica dell &rsquo;art. 5) relativo al capita le sociale,</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>subordina
</I>tamente <I>all a defini ti va efficacia della presente delibera.&rdquo;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Si
rilascia per gli usi consentiti dalla legge.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Firenze,
1&deg; ottobre 2021</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[signature
&amp; seal]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>



<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>

    <!-- Field: /Page -->

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.10.3
<SEQUENCE>5
<FILENAME>g082622_ex3-103.htm
<DESCRIPTION>EXHIBIT 3.10.3
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
3.10.3</B></FONT></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Dott.
Francesco STEIDL</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Notary</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>C
E R T I F I C A Z I O N E</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
undersigned Dr. Francesco STEIDL, Notary in Florence, registered with the</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">College
of the Notary Districts of Florence, Pistoia and Prato,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CERTIFY</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">that
with deed authenticated dame notary today between:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-
<B>&ldquo;SALVATORE FERRAGAMO S . P.A.&rdquo;, </B>based in Florence (FI), via Tornabuoni</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">n.
2 , with share capital of &euro; 16.8 79,000.00, fully paid-up,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">tax
code, VAT number. and registration number in the Register of</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Imprese
di Firenze 02175200480, R. E. A. number FI-464724;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;INTER
PARFUMS, Inc.&rdquo;, </B>a company governed by Delaware law</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(U.S.A.)
con sede al n. 551 Fifth Avenue, New York N. Y. 10176 (U . S .A.)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">with
Identification Number of the Revenue Agency 13-3275609;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">given
that</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;SALVATORE
FERRAGAMO S. P.A.&rdquo; and owner of the entire capital</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">social
of the company <B>&ldquo;PARFUMS ITALIA S.R.L.&rdquo; </B> unipersonale, a company of</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Italian
law with registered office in Florence via Maggio n. 7, share capital of</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&euro;
17,138,000.00 (seventeen million one hundred and thirty-eight thousand point zero</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">zero)
fully paid, registration number in the Register of</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Companies
of Florence tax code and VAT number 07122680486, R. E.A. of</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Florence
FI 681202;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">so
much premise</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
company &ldquo;SALVATORE FERRAGAMO s . p.A.&rdquo; sold to the company &ldquo;INTER</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PARFUMS
Inc .&rdquo;, the entire share of his property equal to 100% (one hundred for</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">cento)
of the share capital in the company <B>&ldquo;PARFUMS ITALIA S.R.L.&rdquo;, </B>to the</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">price
of euro 17 . 138 . 000.00 (seventeen million one hundred and thirty-eight thousand</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">zero
point zero).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
statement is made for the uses permitted by law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Florence,
1 October 2021</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[signature
and seal]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dott.
Francesco STEIDL</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notary</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CERTIFICATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
undersigned Dr. Francesco Steidl, Notary in</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">College
of the Notary Districts <I>of </I>Florence,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certify:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Florence,
member of the</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pistoia
and Prato,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">and
by decision of the sole shareholder, SALVATORE FERRAGAMO S.P.A. (in</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">execution
<I>of </I>previous agreements entered into with INTER PARFUMS, INC. which has,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Today,
acquired the entire corporate capital of the company, with</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">deed
notary notarized by me, in the process <I>of </I>registration and deposit</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">at
<I>the </I>competent Register of Companies), dame recorded on</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">today,
the limited liability company called:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;PARFUMS
ITALIA SRL&rdquo;, </B>with registered office in Florence (FI), <I>via </I>Maggio n. 7, with</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">share
capital <I>of </I>&euro; 17,138,000.00 = fully paid-up, code</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">tax,
VAT number and registration <I>number </I>in the Register of Companies</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>of
</I>Florence 07122680486, R.E.A. number FI-681202,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>has
decided as follows:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&ldquo;(a)
on <B>the first</B> item on the agenda:</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-
<I>to accept the resignation of the Sole Director</I> and, <I>thanking him</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>for
the active work carried out in favor of the company;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>to
ratify and approve</I> and, <I>consequently, to renounce</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>the
exercise of any action, including responsibility (including</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>the
action referred to in Articles. 2476 </I>and <I>2497 of the Civil Code)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>by
Francesco Pergolini in relation to </I>- <I>the work carried out by the same</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>as
Sole Director of the company, for everything</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>stay
in office</I> and <I>until the date of termination</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>the
time of</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>of
the same</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>included,
with reference to all existing paste operations,</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>confirming
the assembly unanimously and fully informed to the</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>regard;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-
<I>ratification, renunciation of the exercise of actions of responsibility,</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>as
well as everything provided for in this resolution, they will not find</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>application
for any action </I>and / or <I>omission paste in place since</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>previous
sole director with intent</I> and / or <I>gross negligence;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(b)
on the <B>second </B>item on the agenda:</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>to
appoint Mr <B>Gregory Joseph Serge</B></I> as Sole Director</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>REZNIK,
</I></B><I>born in Paris (France) on 12 July 1977, domiciled in</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>office
at the registered office, tax code declared RZN GGR 77&pound;12</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>ZllOW,
French national, who will remain in office until revoked or</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>resignation;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(c)
on the</I> <B>third</B> <I>item on the agenda:</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>to
change the name to <B>&ldquo;INTERPARFUMS ITALIA SRL&rdquo; with</B></I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>consequential
of the statute constituted odifica of art. 1)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>as
follows: &ldquo;And a company with responsibility <B>&ldquo;INTERPARFUMS ITALIA SRL&rdquo; </B></I>&rdquo;;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>limited
named</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(d)
the </I><B>fourth </B><I>item on the agenda:</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-
<I>to transfer the registered office of the company within the scope of the same</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>c
om une e cioe from Via Maggio n. </I>7, <I>Florence to Piazza della Repubblica n.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>6,
Fi r e n z e ;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(c)
</I>on <I>the fifth item on the agenda:</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-
<I>to reduce the share capital, in accordance with Article 1 of euro<B>1</B></I> 7. <I>138 . 000, 00</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>from
the current amount 2482 cod . civ., 1 </I>7. <I>138 . 000, 00</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(seventeen
million one hundred and thirty-eight thousand/00) to the amount of &euro; 100,000.00</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(one
hundred thousand/00) and, therefore, for &euro; 17,038,000.00</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(diciassettemilionitrentottomila/00),
by accan tonamen to del</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>corresponding
amount to a specific reserve available;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-
<I>to take note that this resolution on the reduction of capital</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>may
be performed only after ninety days from the registration of the</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>itself
in the Register of Companies, provided that, within that period, no</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>social
creditor prior to registration has objected;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>to
give a mandate to the new Sole Director to provide for the</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>filing
of the new text of the Articles of Association, as resulting from the</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>text
presented by the President and approved here by the Assembly and</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>amending
art. 5) relating to the social capita le,</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>subject
to the definitive effectiveness of this resolution.&rdquo;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
is released for uses permitted by law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Florence,
1 October 2021</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[signature
&amp; seal]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>



<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>

    <!-- Field: /Page -->

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.8
<SEQUENCE>6
<FILENAME>g082622_ex3-8.htm
<DESCRIPTION>EXHIBIT 3.8
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXHIBIT
3.8</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 4.8pt 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 4.8pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; text-align: center; padding-right: 5.4pt; padding-left: 5.4pt; border-right: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ESTATUTOS SOCIALES DE
    PARFUMS ROCHAS SPAIN, SOCIEDAD LIMITADA.</B></FONT></TD>
    <TD STYLE="width: 50%; text-align: center; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLES OF ASSOCIATION
    OF PARFUMS ROCHAS SPAIN, LIMITED LIABILITY COMPANY.</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-right: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-right: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>T&Iacute;TULO I.- DENOMINACI&Oacute;N, OBJETO,
    DOMICILIO Y DURACI&Oacute;N</B></FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>TITLE I.- NAME, PURPOSE, REGISTERED OFFICE
    AND TERM OF EXISTANCE</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-right: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-right: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Art&iacute;culo 1.- Denominaci&oacute;n.
    </B>La Sociedad se denomina PARFUMS ROCHAS SPAIN, SOCIEDAD LIMITADA.</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Article 1.- Name.</B> The name of the Company
    is PARFUMS ROCHAS SPAIN, LIMITED LIABILITY COMPANY.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-right: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-right: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Esta Sociedad es de car&aacute;cter mercantil
    y adopta la forma de Sociedad de Responsabilidad Limitada, que se regir&aacute; por las normas contenidas en los presentes
    Estatutos Sociales, por el Real Decreto Legislativo 1/2010 de 2 de julio por el que se aprueba el texto refundido de la Ley
    de Sociedades de Capital (&ldquo;LSC&rdquo;), por el Real Decreto 1784/1996 de 19 de julio por el que se aprueba el Reglamento
    del Registro Mercantil (&ldquo;RRM&rdquo;) y por las dem&aacute;s normas legales vigentes en cada momento que le sean aplicables.</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This Company is of mercantile nature and has
    adopted a Limited Liability Form. It will be governed by the present Articles of Association, as well as by the Royal Legislative
    Decree 1/2010 dated the 2<SUP>nd</SUP> of July, by which the law regarding the Capital Companies Law is approved (&ldquo;LSC&rdquo;),
    and by Royal Decree 1784/1996 dated the 19<SUP>th</SUP> of July by which the Rules of the Companies House is approved (&ldquo;RRM&rdquo;)
    and by any other applicable legal disposition.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-right: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-right: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Art&iacute;culo 2.- Objeto.</B> El objeto
    social de la Sociedad es:</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Article 2.- Purpose.</B> The purpose of the
    Company is</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-right: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 0.625in; text-indent: -0.25in; border-right: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-&nbsp;&nbsp;&nbsp;
    &nbsp;&nbsp;La fabricaci&oacute;n, venta, comercializaci&oacute;n y representaci&oacute;n de productos de perfumer&iacute;a y
    cosm&eacute;tica     y objetos de lujo ya sean nacionales o extranjeros. </FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-&nbsp;&nbsp;&nbsp;The
manufacture</FONT>, sale, marketing <FONT STYLE="color: #222222">and representation of perfumes and cosmetics and luxury items
whether national or foreign</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-right: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-right: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">La Sociedad puede igualmente, desarrollar, en
    general, cualquier otra actividad de licito comercio que sea antecedente, complemento o accesoria, o consecuencia de las anteriormente
    citadas o principales.</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #222222">The Company may also develop,
    in general, any other lawful activity of trade that is complement or accessory, or a result of the above.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-right: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-right: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Las actividades integrantes del objeto social
    pueden ser desarrolladas por la Sociedad total o parcialmente de modo directo o indirecto, mediante la titularidad de acciones
    o participaciones en sociedad.</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The above activities can be performed by the
    Company partially or in full, by means of owning shares or stocks of any company with an identical or similar purpose.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-right: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-right: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">El c&oacute;digo que mejor describe su actividad
    principal, por referencia al CNAE, es el 4645 (Comercio al por mayor de productos de perfumer&iacute;a y droguer&iacute;a).</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Tax Code (CNAE) that best describes the
    corporate purpose is the 4645 (Wholesale of perfume and drugstore).</FONT></TD></TR>
</TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Art&iacute;culo 3.- Domicilio.
    </B>La Sociedad tendr&aacute; su domicilio en Madrid (Espa&ntilde;a), Isla de Java, 28034 Madrid.</FONT></TD>
    <TD STYLE="width: 50%; padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Article 3.- Registered
    Address.</B> The registered office of the Company shall be in Madrid (Spain), Isla de Java, 33, 28034 Madrid.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">El &oacute;rgano de administraci&oacute;n de
    la Sociedad es el competente para cambiar el domicilio social dentro del mismo t&eacute;rmino municipal, as&iacute; como para
    acordar la creaci&oacute;n, supresi&oacute;n o el traslado de sucursales, delegaciones y agencias en cualquier lugar del territorio
    nacional o del extranjero.</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The administration body is authorized to change
    the Registered Office within the same municipality, as well as to create, eliminate or transfer branches, local offices and
    agencies in Spain or abroad.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Art&iacute;culo 4.- Duraci&oacute;n e inicio
    de operaciones.</B> La duraci&oacute;n de la Sociedad se establece por tiempo indefinido y dar&aacute; comienzo en sus operaciones
    sociales el d&iacute;a del otorgamiento de la escritura fundacional.</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Article 4.- Term of existence and starting
    of activities.</B> The Company shall exist for an indefinite period and it will start its corporate activities from the day
    in which the incorporation Public Deed is granted.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>T&Iacute;TULO II.- CAPITAL - PARTICIPACIONES
    SOCIALES</B></FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>TITLE II.- SHARE <FONT STYLE="text-transform: uppercase">Capital
    - shares of the Company</FONT></B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Art&iacute;culo 5.- Capital Social.</B> El
    capital social de la Sociedad es de QUINIENTOS MIL EUROS (500.000 &euro;).</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Article 5.- Share Capital.</B> The share
    capital of the Company shall amount to FIVE HUNDRED THOUSAND EURO (Eur. 500,000).</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dicho capital estar&aacute; representado por
    QUINCIENTOS MIL (500.000) participaciones sociales, de UN EURO (1 &euro;) de valor nominal cada una de ellas, indivisibles
    y acumulables, numeradas correlativamente para su debida identificaci&oacute;n de la UNO (1) a la QUINIENTOS MIL (500.000),
    ambas inclusive. Las participaciones sociales est&aacute;n totalmente asumidas y desembolsadas.</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company's share capital shall be divided
    into FIVE HUNDRED THOUSAND (500,000) shares of ONE EURO (1 &euro;) of nominal value each, numbered ONE (1) to FIVE HUNDRED
    THOUSAND (500,000), both inclusive. These shares are cumulative and non divisible and the share capital is fully subscribed
    and disbursed.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Art&iacute;culo 6.- Participaciones sociales.
    </B>Las participaciones sociales no tendr&aacute;n el car&aacute;cter de valores, no podr&aacute;n estar representadas por
    medio de t&iacute;tulos o de anotaciones en cuenta, ni denominarse acciones.</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Article 6.- Shares.</B> Company&rsquo; shares
    shall not be considered securities and may not be represented by certificates or book entries and they cannot be called stocks.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tampoco podr&aacute;n emitirse resguardos provisionales
    acreditativos de la propiedad de una o varias participaciones sociales. El &uacute;nico t&iacute;tulo de propiedad est&aacute;
    constituido por la escritura de constituci&oacute;n y, en su caso, por las escrituras de modificaci&oacute;n del capital social
    y por los dem&aacute;s documentos p&uacute;blicos que pudieran otorgarse. En caso de adquisici&oacute;n por transmisi&oacute;n
    &ldquo;inter vivos&rdquo; o &ldquo;mortis causa&rdquo;, por el documento p&uacute;blico correspondiente.</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No temporary shares voucher shall be issued.
    The incorporation Public Deed shall be the only property deed and, if applicable, the public deed of modification of the share
    capital or by other public documents that could be granted. In case of &ldquo;inter vivos&rdquo; or &ldquo;mortis causa&rdquo;
    share transfer, this shall be registered into a public document.</FONT></TD></TR>
</TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Las participaciones atribuyen
    a los socios los mismos derechos, con las excepciones estatutarias y legales.</FONT></TD>
    <TD STYLE="width: 50%; padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares shall grant the same
    rights to all members, with exceptions expressly set forth in these Articles of Association and in the Law.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">En ning&uacute;n caso podr&aacute;n ser objeto
    de aportaci&oacute;n el trabajo o los servicios.</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In any case the Shareholder&rsquo;s contribution
    to the Company may consist in rendering labour or services.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Art&iacute;culo 7.- Libro Registro de socios.
    </B>La Sociedad llevar&aacute; un Libro Registro de socios, en el que se har&aacute; constar la titularidad originaria y las
    sucesivas transmisiones, voluntarias o forzosas, de las participaciones sociales, as&iacute; como la constituci&oacute;n de
    derechos reales y otros grav&aacute;menes sobre las mismas.</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Article 7.- <FONT STYLE="text-transform: uppercase">S</FONT>hareholders&rsquo;
    Registry Book<FONT STYLE="text-transform: uppercase">.</FONT></B> The Company shall have a Shareholders&rsquo; Registry Book,
    which will contain the original ownership and consecutive transfers of the shares, whether voluntary or forced, as well as
    the incorporation of real property rights and other encumbrances on the shares.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">La Sociedad s&oacute;lo reputar&aacute; socio
    a quien se halle inscrito en dicho libro.</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company will only consider as Shareholder
    whoever is registered in referred Book.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">En cada anotaci&oacute;n se indicar&aacute;
    la identidad y domicilio del titular de la participaci&oacute;n o del derecho o gravamen constituido sobre aquella.</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In each annotation the identity and the address
    of the titleholder of the share or the titleholder of the right or encumbrance will be indicated.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">La Sociedad s&oacute;lo podr&aacute; rectificar
    el contenido del Libro Registro de socios si los interesados no se hubieran opuesto a la rectificaci&oacute;n en el plazo
    de un (1) mes desde la notificaci&oacute;n fehaciente del prop&oacute;sito de proceder a la misma.</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company may only modify the contents of
    the Shareholders Registry Book if the interested parties do not oppose the modification within one (1) month after receiving
    due notification of the intention to modify the registry.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cualquier socio podr&aacute; examinar el Libro
    Registro de socios, cuya llevanza y custodia corresponde al &oacute;rgano de administraci&oacute;n.</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any Shareholder will be able to revise the Shareholders
    Registry Book, which will be kept by the Administrative Body.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">El socio y los titulares de derechos reales
    o grav&aacute;menes sobre las participaciones sociales, tienen derecho a obtener certificaci&oacute;n de las participaciones,
    derechos y grav&aacute;menes registrados a su nombre.</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Shareholder or the titleholders of real
    property rights will be able to obtain certificates containing the rights and encumbrances registered in their name.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Los datos personales de los socios podr&aacute;n
    modificarse a su instancia, no surtiendo entre tanto efectos frente a la Sociedad.</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Personal details of the Shareholders will be
    modified upon Shareholders&rsquo; request, not taking effect before the Company prior the request.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Art&iacute;culo 8.- Copropiedad de participaciones.
    </B>En caso de copropiedad sobre una o varias participaciones sociales los copropietarios habr&aacute;n de designar una sola
    persona para el ejercicio de los derechos de socio, y responder&aacute;n solidariamente frente a la Sociedad de cuantas obligaciones
    se deriven de esta condici&oacute;n. La misma regla se aplicar&aacute; a los dem&aacute;s supuestos de cotitularidad de derechos
    sobre las participaciones.</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Article 8.- Joint ownership of shares.</B>
    Joint owners of the Company shares shall appoint one person to exercise the Shareholder&rsquo;s rights and both shall be jointly
    and severally liable to the Company for any obligation derived from their condition of Shareholders. The same rule shall apply
    to any other case of joint ownership of rights over the shares.</FONT></TD></TR>
</TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; padding-right: 5.4pt; padding-left: 5.4pt; border-right: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Art&iacute;culo 9.- Usufructo
    de participaciones.</B> En caso de usufructo de participaciones la cualidad de socio reside en el nudo propietario, pero el
    usufructuario tendr&aacute; derecho en todo caso a los dividendos acordados por la Sociedad durante el usufructo. El ejercicio
    de los dem&aacute;s derechos del socio corresponde al nudo propietario.</FONT></TD>
    <TD STYLE="width: 50%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Article 9.- Rights of
    usufruct over Company shares. </B>In cases of usufruct, the legal owner of the share shall be considered Shareholder. However,
    the usufruct holder shall have the right, in all cases, to receive any dividends declared by the Company during the term of
    the usufruct. The exercise of all other rights shall correspond to the legal owner.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-right: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-right: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">El usufructuario queda obligado a facilitar
    al nudo propietario el ejercicio de estos derechos.</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The usufruct holder is subject to facilitate
    to the legal owner of the shares the execution of its rights.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-right: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-right: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">En las relaciones entre el usufructuario y el
    nudo propietario regir&aacute; lo que determine el t&iacute;tulo constitutivo del usufructo y, en su defecto, lo previsto
    en esta Ley y, supletoriamente, lo dispuesto en el C&oacute;digo Civil.</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The title establishing the usufruct and in its
    default the law provisions and additionally the Civil Code shall govern the relationship between the usufruct holder and the
    legal owner of the shares.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-right: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-right: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Art&iacute;culo 10.- Prenda y embargo de
    participaciones.</B> En caso de prenda de participaciones sociales corresponder&aacute; al propietario de &eacute;stas el
    ejercicio de los derechos de socio.</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Article 10.- Pledge and seizure of Company
    Shares. </B>The owner of the shares which have been subject to pledge shall exercise the rights of the Shareholder.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-right: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-right: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">El acreedor pignoraticio queda obligado a facilitar
    el ejercicio de estos derechos.</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The pledge creditor is subject to facilitate
    to the owner of the shares the executions of its rights.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-right: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-right: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">En caso de ejecuci&oacute;n de la prenda de
    participaciones se aplicar&aacute;n las reglas previstas para el caso de transmisi&oacute;n forzosa por el art&iacute;culo
    109 de la LSC.</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In the event of execution of the pledge, provisions
    on forced transfer contained in the article 109 of the LSC will be applicable.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-right: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-right: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">El derecho real de prenda deber&aacute; constar
    siempre en documento p&uacute;blico.</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pledge of shares shall be executed into public
    document.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-right: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-right: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">En caso de embargo de participaciones, se observar&aacute;n
    las mismas reglas siempre que sean compatibles con el r&eacute;gimen espec&iacute;fico del embargo.</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In the event of the seizure of the Company&rsquo;s
    shares, the rules established for the pledge shall govern, provided that they are compatible with the specific nature of the
    seizure.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-right: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-right: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Art&iacute;culo 11.- R&eacute;gimen general
    de transmisi&oacute;n de participaciones.</B> Ser&aacute; libre la transmisi&oacute;n voluntaria de participaciones por actos
    inter vivos entre socios, as&iacute; como la realizada a favor del c&oacute;nyuge, ascendiente del socio o en a favor de sociedades
    pertenecientes al mismo grupo que la transmitente. En otros casos, cualquier transmisi&oacute;n de participaciones sociales
    se realizar&aacute; de conformidad con lo previsto en el art&iacute;culo 107.2 de la LSC. </FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Article 11.- General transfer rules of shares.
    </B>The transfer of shares shall be limited to other shareholders, its spouses, ascendants and descendents, or in favour of
    companies in the same group as the transferor, and subject to limitations according to the Spanish Law regulations (LSC) in
    the remaining cases. Any transfer of shares shall be carried out pursuant to provisions of article 107.2 of the LSC.</FONT></TD></TR>
</TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Art&iacute;culo 12.- Transmisi&oacute;n
    forzosa de participaciones sociales.</B> En el caso de embargo de participaciones sociales en cualquier procedimiento de apremio,
    y en tanto no adquieran firmeza, los socios y, en su defecto, la Sociedad, podr&aacute;n subrogarse en lugar del rematante
    o, en su caso, del acreedor, siendo aplicable lo dispuesto en el art&iacute;culo 109 y concordantes de la LSC.</FONT></TD>
    <TD STYLE="width: 50%; padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Article 12.- Forced transfer
    rules. </B>Should there be a seizure of Company&rsquo;s shares, in any type of judicial collection proceedings, during the
    execution or when the adjudication is not finalized, the Shareholders and, if applicable, the Company, may substitute the
    creditors being applicable what is established in article 109 and following articles of the LSC.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Art&iacute;culo 13.- Transmisi&oacute;n mortis
    causa de participaciones sociales.</B> El mismo derecho de adquisici&oacute;n preferente de participaciones de la Sociedad
    tendr&aacute; lugar en el caso de transmisi&oacute;n mortis causa o a t&iacute;tulo gratuito o lucrativo de las participaciones.
    Los herederos o legatarios y, en su caso, los donatarios, comunicar&aacute;n la adquisici&oacute;n al &oacute;rgano de administraci&oacute;n,
    aplic&aacute;ndose a partir de ese momento las reglas del anterior art&iacute;culo 11&ordm; en cuanto a plazos de ejercicio
    del derecho.</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Article 13.- Rules regarding <I>mortis causa
    </I>transfers. </B>The Shareholders will have the same preferential acquisition right in cases of &ldquo;mortis causa&rdquo;
    or free transfer of shares. Heirs, beneficiaries and donors shall notify the acquisition to the Administrative Body and the
    rules established in Article 11 will be applicable regarding the terms applicable to execute this right.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>T&Iacute;TULO III.- &Oacute;RGANOS DE LA
    SOCIEDAD</B></FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>TITLE III.- COMPANY ORGANIZATION</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Art&iacute;culo 14.- &Oacute;rganos de la
    Sociedad.</B> <FONT STYLE="font-weight: normal">Los &oacute;rganos sociales de la Sociedad son los siguientes:</FONT></FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Article 14.- Company organization. </B>The
    Company is made of the following governing bodies:</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A) La Junta General.</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A) The General Shareholders&rsquo; Meeting.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">B) El &oacute;rgano de administraci&oacute;n
    (o &ldquo;Administradores&rdquo;).</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">B) The Administrative Body (also referred to
    as &ldquo;Directors&rdquo;).</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>A. JUNTA GENERAL DE SOCIOS</B></FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>A. GENERAL SHAREHOLDERS MEETING</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Art&iacute;culo 15.- Junta General de socios.
    </B>Los socios, reunidos en Junta General debidamente convocada y constituida, decidir&aacute;n por la mayor&iacute;a legal
    establecida en estos Estatutos, en los asuntos propios de la competencia de la Junta.</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Article 15.- General Shareholders&rsquo;
    Meeting.</B> The Shareholders, assembled at a duly called general Shareholders&rsquo; Meeting, shall decide, by a majority
    vote as determined by these Articles of Association, those matters that fall within the competence of the Meeting.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Las Juntas Generales podr&aacute;n ser Ordinarias
    o Extraordinarias.</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">General Shareholders&rsquo; Meeting can be either
    Ordinary or Extraordinary.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Junta Ordinaria es la que debe reunirse dentro
    de los seis (6) primeros meses de cada ejercicio para censurar la gesti&oacute;n social, aprobar, en su caso, las cuentas
    del ejercicio anterior y resolver sobre la aplicaci&oacute;n del resultado. Junta Extraordinaria es cualquier otra que no
    sea la ordinaria anual.</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ordinary Shareholders&rsquo; Meeting must take
    place within the first six (6) months of each financial year in order to review the Company&rsquo;s management, approve in
    its case, the annual accounts of the previous financial year and decide regarding the allocation of the results. Extraordinary
    Shareholders&rsquo; Meeting is any other Meeting besides de Ordinary Meeting.</FONT></TD></TR>
</TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Todos los socios, incluso
    los disidentes y los que no hayan participado en la reuni&oacute;n, quedan sometidos a los acuerdos de la Junta General.</FONT></TD>
    <TD STYLE="width: 50%; padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All members, including dissenting
    and non-attending members, shall be bound by the resolutions passed at General Meetings.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No se permite la adopci&oacute;n de acuerdos
    fuera de Junta General de socios.</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Resolutions adopted outside the General Shareholder&rsquo;s
    Meeting shall not be binding.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Es competencia de la Junta General deliberar
    y acordar los asuntos referidos en el art&iacute;culo 160 de la LSC.</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The scope of powers to the General Shareholders&rsquo;
    Meeting shall be those referred in article 160 of LSC.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Art&iacute;culo 16.- Emisi&oacute;n de votos.
    </B>Cada participaci&oacute;n da derecho a un (1) voto.</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Article 16.- Right to vote</B>. Each share
    in the Company shall give the holder a right to one (1) vote.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Art&iacute;culo 17.- Adopci&oacute;n de acuerdos
    en Junta General.</B> Los acuerdos sociales se adoptar&aacute;n por mayor&iacute;a de los votos v&aacute;lidamente emitidos,
    siempre que representen al menos un tercio (1/3) de los votos correspondientes a las participaciones sociales en que se divide
    el capital social. No se computar&aacute;n los votos en blanco.</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Article 17.- Resolutions of the Company</B>.
    Resolutions of the Company shall be approved by a majority of votes validly issued, provided that such votes represent at
    least one third (1/3) of Company&rsquo;s shares. Abstentions shall not be counted.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Por excepci&oacute;n a lo dispuesto en el apartado
    anterior:</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following exceptions to the above rule shall
    be applicable:</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a) El aumento o reducci&oacute;n de capital
    y cualquier otra modificaci&oacute;n de los Estatutos Sociales para la que no se exija mayor&iacute;a cualificada, y la opci&oacute;n
    por cualesquiera de las formas de administraci&oacute;n que en su caso se fijen en los Estatutos, requerir&aacute; el voto
    favorable de al menos dos tercios (2/3) de los votos correspondientes a las participaciones en que se haya dividido el capital
    social.</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a) An increase or decrease of the Company&rsquo;s
    capital or any other modification of the Articles of Association not requiring a qualified majority, and the change of the
    structure of the Administrative Body shall require the favourable vote of more than 2/3 of the votes corresponding to the
    shares in which the capital of the Company is divided.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b) La transformaci&oacute;n, la fusi&oacute;n,
    la escisi&oacute;n y la cesi&oacute;n global de activo y pasivo de la Sociedad, as&iacute; como el traslado del domicilio
    al extranjero y la supresi&oacute;n del derecho de preferencia en los aumentos de capital, la exclusi&oacute;n de socios y
    la autorizaci&oacute;n para que los Administradores puedan dedicarse por cuenta propia o ajena al mismo, an&aacute;logo o
    complementario g&eacute;nero de actividad que constituya el objeto social, requerir&aacute; el voto favorable de al menos
    dos tercios (2/3) de los votos correspondientes a las participaciones en que se divida el capital social.</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b) Reorganization, merger or split-off and the
    global transfer of the assets and liabilities of the Company, as well as transfer of the Registered Office to a foreign country,
    waiver of pre-emptive rights in capital increases, exclusion of Shareholders from the Company and the authorization for the
    Directors to act on their own behalf or on third parties behalf in activities similar or complementary to the corporate purpose,
    will require a favourable vote of at least two thirds (2/3) of the votes of the corresponding shares in which the Share capital
    of the Company is divided.</FONT></TD></TR>
</TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No obstante, cuando la legislaci&oacute;n
    exija cualesquiera otros requisitos para la convocatoria (su forma y contenido), modo de deliberar y adoptar acuerdos, mayor&iacute;as,
    derechos de los socios, constituci&oacute;n de la Junta y de su mesa, conflicto de intereses y documentaci&oacute;n de los
    acuerdos para casos especiales y concretos, se estar&aacute; a lo que dicha legislaci&oacute;n establezca, como en el caso
    del traslado del domicilio al extranjero.</FONT></TD>
    <TD STYLE="width: 50%; padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">However, when the legislation
    requires any other requirements for the call (form and content), deliberations and adopt resolutions, majorities rights of
    members, constitution of Shareholders&rsquo; Meeting, conflict of interest and documentation for special and specific cases,
    it will be to what that legislation provides, as in the case of transfer of residence abroad.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Para el c&oacute;mputo de la mayor&iacute;a
    de votos que en cada caso sea necesaria se deducir&aacute;n del capital social las participaciones del socio que se encuentre
    en las situaciones de conflicto de intereses previstas en el art&iacute;culo 190 de la LSC.</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">When applicable, the shares of Shareholders
    in a conflict of interest situation, foreseen in article 190 of LSC, shall be subtracted from the Company&rsquo;s capital
    for the determination of the majority of votes&rsquo; purposes.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">De conformidad con lo dispuesto en el art&iacute;culo
    197 bis LSC, en la Junta General, deber&aacute;n votarse separadamente aquellos asuntos que sean sustancialmente independientes.
    En todo caso, aunque figuren en el mismo punto del orden del d&iacute;a, deber&aacute;n votarse de forma separada:</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #222222">In accordance with article 197
    bis LSC, the General </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shareholders&rsquo;
    Meeting <FONT STYLE="color: #222222">must vote separately on matters that are substantially independent. In any case, even
    appearing at the same point on the agenda, should be voted on separately:</FONT></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a) el nombramiento, la ratificaci&oacute;n,
    la reelecci&oacute;n o la separaci&oacute;n de cada administrador.</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #222222">a) appointment, ratification,
    re-election or removal of each administrator.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b) en la modificaci&oacute;n de estatutos sociales,
    la de cada art&iacute;culo o grupo de art&iacute;culos que tengan autonom&iacute;a propia.</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #222222">b) modifying bylaws.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Art&iacute;culo 18.- Adopci&oacute;n de acuerdos
    en Junta General por unanimidad.</B> Quedan a salvo de la norma establecida en el art&iacute;culo anterior los supuestos en
    los que la LSC exija el consentimiento de todos los socios.</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Article 18.- General Meeting with unanimous
    consent. </B>The abovementioned rules shall not be applicable in those cases where the applicable LSC require an unanimous
    consent on the resolution of a matter.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Art&iacute;culo 19.- R&eacute;gimen general
    de convocatoria de Junta General.</B> La Junta General Ordinaria o Extraordinaria ser&aacute; convocada por el &oacute;rgano
    de administraci&oacute;n y, en su caso, por los Liquidadores de la Sociedad, sin perjuicio de lo mencionado en los p&aacute;rrafos
    siguientes.</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Article 19.- Rules for calling of the General
    Meeting. </B>The Ordinary or Extraordinary General Shareholders&rsquo; Meeting shall be announced by the Administrative Body,
    or, when the Company is in liquidation, by the Company&rsquo;s liquidators.</FONT></TD></TR>
</TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; padding-right: 5.4pt; padding-left: 5.4pt; border-right: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">El &oacute;rgano de administraci&oacute;n
    convocar&aacute; la Junta General Ordinaria para su celebraci&oacute;n dentro de los seis (6) primeros meses de cada ejercicio,
    con el fin de censurar la gesti&oacute;n social, aprobar, en su caso, las cuentas del ejercicio anterior y resolver sobre
    la aplicaci&oacute;n del resultado. En este anuncio de convocatoria se har&aacute; constar expresamente que cualquier socio
    puede obtener de la Sociedad, de forma inmediata y gratuita, los documentos que han de ser sometidos a la aprobaci&oacute;n
    de la misma, as&iacute; como, en su caso, el informe de Gesti&oacute;n y el informe de los Auditores de Cuentas. Si estas
    Juntas no fueran convocadas dentro del plazo legal, podr&aacute;n serlo por el Juez de lo mercantil del domicilio social,
    a solicitud de cualquier socio y previa audiencia del &oacute;rgano de administraci&oacute;n.</FONT></TD>
    <TD STYLE="width: 50%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Likewise, the Administrative
    Body shall call the General Ordinary Meeting within the first six (6) months of each financial year for the purpose of reviewing
    the Company&rsquo;s management, approving the Company&rsquo;s annual accounts, financial statements and applications of the
    results. In the announcement it will be detailed that all Shareholders have the right to obtain immediately, and without cost,
    the documents that will be subject to the Shareholders&rsquo; approval, as well as if applicable, the Management Report and
    the Auditors&rsquo; Report. Should the Meeting not be called in the abovementioned time the Mercantile Court corresponding
    to the Company&rsquo;s Registered Office shall call the Meeting upon the request of any of the Shareholders, having already
    informed the Administrative Body.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-right: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-right: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">El &oacute;rgano de administraci&oacute;n convocar&aacute;
    asimismo la Junta General Extraordinaria cuando lo considere necesario o conveniente y cuando lo soliciten uno o varios socios
    que representen al menos el cinco (5) por ciento del capital social, expresando en la solicitud los asuntos a tratar en la
    Junta. En este &uacute;ltimo caso, la Junta General deber&aacute; ser convocada para su celebraci&oacute;n dentro de los dos
    meses siguientes a la fecha en que se hubiera requerido notarialmente al &oacute;rgano de administraci&oacute;n para convocarla,
    debiendo incluirse necesariamente en el Orden del D&iacute;a los asuntos que hubiesen sido objeto de la solicitud.</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Administrative Body shall call an Extraordinary
    General Meeting any time they deem it necessary or advisable, or when requested by one or more Shareholders, representing
    at least five (5) percent of the Company&rsquo;s capital, who shall state in their request the matters to be placed on the
    Meeting&rsquo;s agenda. In the latter case, the General Meeting must be called within two (2) months after receipt of Notary's
    notification requiring them to call the Meeting. The notice calling for the Meeting must include the agenda for the Meeting,
    including the matters specified in the request for the Meeting.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-right: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-right: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Si el &oacute;rgano de administraci&oacute;n
    no atiende oportunamente a la solicitud mencionada, podr&aacute; realizarse la convocatoria por el Juez de lo mercantil del
    domicilio social, si lo solicita el porcentaje del capital social a que se refiere el p&aacute;rrafo anterior y previa audiencia
    del &oacute;rgano de administraci&oacute;n.</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If the Administrative Body do not properly respond
    to the request, the call of a Meeting may be made by the Mercantile Court corresponding to where the Company has its Registered
    Office, who may call a Meeting at the request of Shareholders holding the shares percentage referred to in the previous paragraph,
    and after having already informed the Administrative Body.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-right: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-right: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Igualmente, en caso de muerte o de cese del
    administrador &uacute;nico, de todos los administradores solidarios, de alguno de los administradores mancomunados, o de la
    mayor&iacute;a de los miembros del &oacute;rgano de administraci&oacute;n, sin que existan suplentes, cualquier socio podr&aacute;
    solicitar del Juez de lo mercantil del domicilio social la convocatoria de Junta General para el nombramiento de los Administradores.
    Adem&aacute;s, cualquiera de los Administradores que permanezca en el ejercicio del cargo podr&aacute; convocar la Junta General
    con este &uacute;nico objeto.</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In the event of death or resignation of the
    Sole Director, all of the joint and several directors, any of the joint directors or the majority of the members of the Board
    of Directors, any Shareholder may request to the Mercantile Court corresponding to the Company&rsquo;s Registered Office to
    call the General Meeting for the purpose of appointing new Directors. Also, any remaining Director may call a General Meeting
    for this sole purpose.</FONT></TD></TR>
</TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Art&iacute;culo 20.- Forma
    de la convocatoria.</B> La convocatoria se realizar&aacute; por carta certificada o telegrama con acuse de recibo dirigido
    personalmente a cada socio al domicilio designado que conste al efecto en el Libro Registro de socios. Con car&aacute;cter
    adicional, la convocatoria tambi&eacute;n podr&aacute; publicarse en uno de los diarios de mayor circulaci&oacute;n en la
    provincia en que est&eacute; situado el domicilio social. </FONT></TD>
    <TD STYLE="width: 50%; padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Article 20.- Contents
    of the notice of the Meeting. </B>The Meeting will be called through notification send by certified letter, with acknowledgement
    of receipt, personally addressed to all Shareholders to their domicile contained in the Shareholders&rsquo; Registration Book.
    Furthermore, the meeting can also be notified by means of its publication in a high-circulation newspaper of the province
    in which the Company has its registered office.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Art&iacute;culo 21.- Plazos y contenido de
    la convocatoria. Derecho de informaci&oacute;n.</B> Entre la convocatoria y la fecha prevista para la celebraci&oacute;n de
    la reuni&oacute;n, deber&aacute; existir un plazo de, al menos, quince (15) d&iacute;as, que se computar&aacute;, en los casos
    de convocatoria individual, a partir de la fecha en que hubiera sido remitido el anuncio al &uacute;ltimo de los socios. En
    los casos de fusi&oacute;n y escisi&oacute;n, la antelaci&oacute;n deber&aacute; ser de al menos un (1) mes.</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Article 21.- Periods and contents of the
    notice of the Meeting. Information right. </B>A period of at least fifteen (15) days must pass from the calling of the Meeting
    to the date of the Meeting. In the event of individual notification to each Shareholder, the period shall be calculated from
    the time the last Shareholder receives the notification. In merger and split off of the Company the period will be of at least
    one (1) month.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">En todo caso, la convocatoria expresar&aacute;
    el nombre de la Sociedad, la fecha y hora de la reuni&oacute;n y el Orden del D&iacute;a en el que figurar&aacute;n los asuntos
    a tratar, as&iacute; como el nombre de la persona o personas que realicen la comunicaci&oacute;n. En todo caso se har&aacute;n
    constar las menciones obligatorias que en cada caso exija la LSC en relaci&oacute;n con los temas a tratar.</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In any case, the notice of the Meeting shall
    include the name of the Company, the date and time for the Meeting, and the agenda of the matters to be discussed, as well
    as the name of the person or people who make the communication. In any case it will be necessary to include those obligatory
    mentions required by the LSC regarding the matters to be discussed.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Los socios podr&aacute;n solicitar por escrito,
    con anterioridad a la reuni&oacute;n de la Junta General o verbalmente durante la misma, los informes o aclaraciones que estimen
    precisos acerca de los asuntos comprendidos en el Orden del D&iacute;a. El &oacute;rgano de administraci&oacute;n estar&aacute;
    obligado a proporcion&aacute;rselos en la forma prevista en la LSC, salvo en los casos en que, a juicio del propio &oacute;rgano,
    la publicidad de &eacute;sta perjudique los intereses sociales. Esta excepci&oacute;n no proceder&aacute; cuando la solicitud
    est&eacute; apoyada por socios que representen, al menos, el veinticinco por ciento (25%) del capital social.</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If the Shareholders deem it necessary, they
    may require in writing before the Meeting or verbally during the Meeting information or clarifications of the matters included
    on the agenda. The Administrative Body shall provide such information in the form established in LSC, except in those cases
    where the Administrative Body deems that the disclosure of the information requested may be harmful to the Company&rsquo;s
    interests. This exception shall not be applicable if the request is supported by Shareholders representing at least twenty-five
    (25%) percent of the Company&rsquo;s capital.</FONT></TD></TR>
</TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Art&iacute;culo 22.- Junta
    universal.</B> La Junta General quedar&aacute; v&aacute;lidamente constituida para tratar cualquier asunto, sin necesidad
    de previa convocatoria, siempre que est&eacute; presente o representado la totalidad del capital social y los concurrentes
    acepten por unanimidad la celebraci&oacute;n de la reuni&oacute;n y el Orden del D&iacute;a de la misma.</FONT></TD>
    <TD STYLE="width: 50%; padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Article 22.- Universal
    Meetings. </B>The General Meeting shall be validly held to consider any matter and without prior calling when Shareholders
    representing the entire capital or their representatives are present at the Meeting and those present unanimously agree to
    hold the Meeting and agree on its agenda.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Art&iacute;culo 23.- Lugar de celebraci&oacute;n
    de la Junta General.</B> <FONT STYLE="font-weight: normal">La Junta General se celebrar&aacute; en cualquier lugar del t&eacute;rmino
    municipal del domicilio social. Si en la convocatoria no figurase el lugar de celebraci&oacute;n, se entender&aacute; que
    la Junta ha sido convocada para su celebraci&oacute;n en el domicilio social. Por excepci&oacute;n, la Junta Universal a la
    que se ha hecho menci&oacute;n en el art&iacute;culo 22&ordm; anterior, podr&aacute; reunirse en cualquier lugar del territorio
    nacional o del extranjero.</FONT></FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Article 23.- Place of the Meeting.</B> The
    General Meeting shall be held in the municipality corresponding to the Company&rsquo;s Registered Office. If the notice of
    the Meeting does not state the place where it is to be held, it shall be understood that the Meeting is to be held at the
    Company&rsquo;s Registered Office. A Universal Meeting, as described in the aforementioned Article 22, may take place at any
    place either in national or foreign territory.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Art&iacute;culo 24.- Mesa de la Junta General.
    </B><FONT STYLE="font-weight: normal">Las Juntas Generales de socios ser&aacute;n presididas y ejercer&aacute; de Secretario
    las personas que designe la propia Junta en el mismo acto. En el supuesto de que exista un Consejo de Administraci&oacute;n,
    la Junta ser&aacute; presidida por el Presidente del Consejo de Administraci&oacute;n o, en su caso, por el Vicepresidente
    del mismo y actuar&aacute; de Secretario el que lo sea del Consejo de Administraci&oacute;n o, en su caso, el Vicesecretario
    del mismo. Lo anterior se entiende sin perjuicio de las facultades que asisten a la propia Junta General para designar el
    socio que haya de presidirlas y la persona, sea o no socio, que haya de actuar como Secretario.</FONT></FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Article 24.- Chairing of the General Meeting.
    </B>General Shareholders&rsquo; Meetings will be chaired by a Chairman and the Secretary will be appointed by the own Meeting
    at the same occasion. Should there exist a Board of Directors, the General Shareholders&rsquo; Meeting will be chaired by
    the Chairman, or the Vicechairman of the Board of Directors, and the Secretary, or the Vicesecretary of the Board of Directors
    will hold the same position in the General Meeting. Notwithstanding the abovementioned, the General Meeting will be able to
    appoint the Chairman or the Secretary (even in cases where the latter is not a Shareholder) for the purposes of the Meeting.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Art&iacute;culo 25.- Direcci&oacute;n de
    la Junta y constancia en acta de los acuerdos.</B> Corresponde al Presidente de la Junta dirigir las sesiones, conceder la
    palabra a los socios y organizar los debates as&iacute; como comprobar la realidad de la adopci&oacute;n de los acuerdos.</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Article 25.- Minutes of the Meetings. </B>Meetings
    will be chaired by the Chairman who will have the faculty to give the right to speak, to moderate and to check the fulfilment
    of the adopted agreements.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Todos los acuerdos sociales deber&aacute;n constar
    en acta. El acta incluir&aacute; necesariamente la lista de asistentes y deber&aacute; ser aprobada por la propia Junta al
    final de la reuni&oacute;n o, en su defecto, y dentro del plazo de quince (15) d&iacute;as, por el Presidente de la Junta
    General y dos (2) socios interventores, uno en representaci&oacute;n de la mayor&iacute;a y otro en representaci&oacute;n
    de la minor&iacute;a. El acta tendr&aacute; fuerza ejecutiva a partir de la fecha de su aprobaci&oacute;n.</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All resolutions of the Company must be reflected
    in the Minutes of the Meeting. The Minutes shall include a list of attendees and must be approved by the attendees at the
    end of the Meeting, or in its default, it has to be approved within fifteen (15) days by the Chairman and two (2) supervising
    Shareholders, one representing the majority and the other the minority. The Minutes shall have legal effect from the date
    of their approval.</FONT></TD></TR>
</TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; padding-right: 5.4pt; padding-left: 5.4pt; border-right: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">El &oacute;rgano de administraci&oacute;n
    podr&aacute; requerir la presencia de un Notario para que levante acta de la Junta y estar&aacute; obligado a hacerlo siempre
    que con cinco (5) d&iacute;as de antelaci&oacute;n al previsto para la celebraci&oacute;n de la Junta, lo soliciten socios
    que representen, al menos, el cinco (5) por ciento del capital social. En este &uacute;ltimo caso, los acuerdos s&oacute;lo
    ser&aacute;n eficaces si constan en acta notarial. El acta notarial no se someter&aacute; a tr&aacute;mite de aprobaci&oacute;n,
    tendr&aacute; la consideraci&oacute;n de acta de la Junta y fuerza ejecutiva desde la fecha de su cierre, siendo sus honorarios
    de cargo de la Sociedad.</FONT></TD>
    <TD STYLE="width: 50%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Administrative Body may
    require the presence of a Public Notary to draw up the minutes. The Administrative Body will be obliged to do so when Shareholders
    representing at least five (5) percent of the Company shares require the Notary&rsquo;s presence with at least five (5) days
    notice before the scheduled Meeting. In this case, resolutions shall only be valid if reflected in the Minutes drawn up by
    the Notary. Minutes drawn up by a Notary shall not be subject to approval and shall be considered as the correct Minutes and
    shall have legal effect from the date of execution. The Notary&rsquo;s fees shall be charged to the Company.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-right: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-right: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Art&iacute;culo 26.- Asistencia y representaci&oacute;n
    en Junta General.</B> Todos los socios tienen derecho a asistir personalmente a la Junta General o hacerse representar en
    dichas reuniones por medio de otro socio, su c&oacute;nyuge, ascendientes o descendientes, o persona que ostente poder general
    conferido en documento p&uacute;blico con facultades para administrar todo el patrimonio que el representado tuviera en territorio
    nacional.</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Article 26.- Attendance and representation.
    </B>All Shareholders shall have the right to attend the General Meeting. Shareholders may be represented at General Meetings
    by other Shareholders, spouse, ascendants, descendants or any other person with general powers of attorney executed in a public
    document with the faculties to administer all the property of the represented person within the national territory.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-right: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-right: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">La representaci&oacute;n comprender&aacute;
    la totalidad de las participaciones de las que sea titular el socio representado y si no constara en documento p&uacute;blico,
    deber&aacute; ser escrita y con car&aacute;cter especial para cada Junta.</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Representation by proxy shall include all shares
    held by represented Shareholders and must be issued in writing for each Meeting unless the proxy is contained in a document
    executed before a Notary.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-right: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-right: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>B. &Oacute;RGANO DE ADMINISTRACI&Oacute;N</B></FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>B. <FONT STYLE="text-transform: uppercase">The
    ADMINiSTRATIVE Body</FONT></B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-right: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-right: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Art&iacute;culo 27.- &Oacute;rgano de administraci&oacute;n.
    </B>La Sociedad estar&aacute; regida y administrada por un Administrador &uacute;nico, dos (2) mancomunados, varios solidarios,
    con un m&iacute;nimo de dos (2) y un m&aacute;ximo de cuatro (4), o un Consejo de Administraci&oacute;n.</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Article 27.- Administrative Body.</B> The
    management of the Company may be entrusted to a sole Director, to two (2) joint Directors or to several joint and several
    Directors with a minimum of two (2) and a maximum of four (4), or to a Board of Directors.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-right: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-right: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">En el supuesto de Consejo de Administraci&oacute;n,
    &eacute;ste estar&aacute; integrado por un m&iacute;nimo de tres (3) y un m&aacute;ximo de doce (12) miembros. Al Consejo
    de Administraci&oacute;n, en forma colegiada, le corresponden todas las facultades del &oacute;rgano de administraci&oacute;n
    que resultan de la LSC y de estos Estatutos, sin perjuicio de la posibilidad de poder delegar todas o algunas de dichas facultades
    en una Comisi&oacute;n Ejecutiva o en uno o varios Consejeros Delegados. Tambi&eacute;n le corresponde la representaci&oacute;n
    de la Sociedad, en juicio y fuera de &eacute;l, en forma colegiada.</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Board of Directors shall be made up of a minimum
    of three (3) and a maximum of twelve (12) Directors. The Board of Directors acting jointly will have all the powers established
    in the LSC and in these Articles of Association. It will also have the power to grant any of its powers to an executive committee
    or to several Managing Directors. The Board of Directors will also hold the representation of the Company inside or outside
    trials.</FONT></TD></TR>
</TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Art&iacute;culo 28.- Competencia
    para el nombramiento y separaci&oacute;n de los miembros del &oacute;rgano de administraci&oacute;n.</B> La Competencia para
    el nombramiento y separaci&oacute;n de los miembros del &oacute;rgano de administraci&oacute;n corresponde exclusivamente
    a la Junta General, la cual determinar&aacute; tambi&eacute;n el n&uacute;mero concreto de miembros dentro de los m&iacute;nimos
    y m&aacute;ximos se&ntilde;alados en estos Estatutos Sociales. Los Administradores nombrados podr&aacute;n ser separados de
    su cargo por la Junta General, aun cuando la separaci&oacute;n no conste en el Orden del D&iacute;a.</FONT></TD>
    <TD STYLE="width: 50%; padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Article 28.- Appointment
    and removal of members of the Administrative Body. </B>The General Meeting shall have the exclusive power to appoint and remove
    the members from the Administrative Body and to establish the number of members, within the minimum and maximum numbers established
    in the Articles of Association of the Company. Directors may be removed from office by the General Meeting, even if the removal
    is not on the agenda.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Art&iacute;culo 29.- &Aacute;mbito de representaci&oacute;n.
    </B>La representaci&oacute;n del &oacute;rgano de administraci&oacute;n se extiende a todos los actos comprendidos en el objeto
    social, sin m&aacute;s excepci&oacute;n que la de aquellos asuntos que legalmente sean competencia de la Junta General.</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Article 29.- Scope of representation.</B>
    The scope of representation shall extend to all the activities included in the purpose of the Company, except those matters
    belonging to the scope of Competence of the General Shareholders Meeting.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cualquier limitaci&oacute;n de las facultades
    representativas del &oacute;rgano de administraci&oacute;n, tanto si viene impuesta por los Estatutos como por decisiones
    de la Junta General, ser&aacute;n ineficaces frente a terceros, sin perjuicio de su validez y de la responsabilidad en que
    incurren los Administradores frente a la Sociedad en caso de extralimitaci&oacute;n o abuso de facultades o por la realizaci&oacute;n
    de actos no comprendidos en el objeto social que obliguen a la Sociedad en virtud de lo dispuesto en la LSC.</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any limitation to the representation powers
    of the Administrative Body, whether imposed by the Articles of Association or by the decisions of the Shareholders&rsquo;
    Meeting, will be ineffective before third parties, notwithstanding its validity and the responsibility in which the Directors
    may incur before the Company due to the extra limitation or abuse of their powers or by taking actions in matters which are
    not part of the corporate purpose of the Company by virtue of what is established in the LSC.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Art&iacute;culo 30.- Condiciones para ser
    nombrado Administrador.</B> Para ser nombrado Administrador no se requiere la condici&oacute;n de socio.</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Article 30.- Conditions for being appointed
    Director. </B>It shall not be necessary to be a Shareholder in the Company in order to be appointed Director.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No podr&aacute;n ser
    Administradores ni ocupar cargos en la Sociedad los menores de edad no emancipados, los judicialmente incapacitados, las personas
    inhabilitadas conforme a la Ley Concursal mientras no haya concluido el per&iacute;odo de inhabilitaci&oacute;n fijado en
    la sentencia de calificaci&oacute;n del concurso y los condenados por delitos contra la libertad, contra el patrimonio o contra
    el orden socioecon&oacute;mico, contra la seguridad colectiva, contra la Administraci&oacute;n de Justicia o por cualquier
    clase de falsedad, as&iacute; como aqu&eacute;llos que por raz&oacute;n de su cargo no puedan ejercer el comercio. </FONT></TD>
    <TD STYLE="text-align: justify; padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">People who cannot be
    appointed Directors include minors, any individual without legal capacity, those who have been declared bankrupt or insolvent
    but not discharged, and those convicted of crimes with sentences prohibiting the exercise of public office, those who have
    been convicted of serious breaches of labour laws or regulations, and those who, due to their position, cannot engage in business
    activities.</FONT></TD></TR>
</TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tampoco pueden serlo los
    funcionarios al servicio de la Administraci&oacute;n con funciones a su cargo que se relacionen con las actividades propias
    de la Sociedad, ni quienes se hallen incursos en causa legal de incompatibilidad, en la medida y condiciones que en cada caso
    se establezcan.</FONT></TD>
    <TD STYLE="width: 50%; padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neither public servants working
    for the administration with duties in their charge linked with the activities of the Company nor those people incurring in
    a cause of incompatibility.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">El nombramiento de los Administradores surtir&aacute;
    efecto desde el momento de su aceptaci&oacute;n.</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The appointment of the Directors will be effective
    from the date of its acceptance.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Art&iacute;culo 31.- Administradores suplentes.
    </B>La Junta General est&aacute; facultada para nombrar Administradores suplentes para el caso de que cesen por cualquier
    causa uno o varios de ellos. El nombramiento y aceptaci&oacute;n de los suplentes como administradores se inscribir&aacute;
    en el Registro Mercantil una vez producido en cese del anterior. El nombramiento del suplente se entender&aacute; efectuado
    por el periodo pendiente de cumplir por la persona cuya vacante se cubra.</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Article 31.- Substitute Directors. </B>Substitute
    Directors may be appointed by the General Meeting to take office in the event of the removal of a Director for whatever reason.
    The appointment and acceptance of substitute Directors shall be registered at the Companies House upon removal of the prior
    Director. The appointment of a substitute Director shall be understood to be subject to the term of the replaced Director.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">El nombramiento de los Administradores suplentes
    surtir&aacute; efecto desde el momento de su aceptaci&oacute;n.</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The appointment of substitute Directors shall
    have effect upon acceptance.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Art&iacute;culo 32.- Duraci&oacute;n del
    cargo de Administrador.</B> Los Administradores ejercer&aacute;n su cargo por tiempo indefinido.</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Article 32.- Term of the office</B>. Directors
    shall serve for an indefinite period.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Art&iacute;culo 33.- Responsabilidad de los
    Administradores.</B> En todo lo relativo a la responsabilidad de los Administradores, acciones de responsabilidad y de impugnaci&oacute;n
    de acuerdos adoptados por ellos, se estar&aacute; a lo dispuesto en la LSC, con excepci&oacute;n del acuerdo de Junta General
    que decida sobre el ejercicio de la acci&oacute;n de responsabilidad que se podr&aacute; adoptar por mayor&iacute;a ordinaria
    por imperativo legal.</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Article 33.- Liability of Directors. </B>Liability
    of Directors as well as the challenging of their decisions will be governed by the applicable LSC, with exception of the General
    Meeting Agreement which decides over the responsibility action against the Directors which will have to be adopted by ordinary
    majority as established in Law.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Art&iacute;culo 34.- Retribuci&oacute;n de
    los Administradores.</B> El cargo de Administrador ser&aacute; gratuito. </FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Article 34.- Payment of Directors.</B> The
    position of Director shall not be remunerated.</FONT></TD></TR>
</TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Si alguno de los Administradores
    prestase a la Sociedad servicios por cargos para los que hubiese sido nombrado, como Director General, Director Gerente o
    por trabajos profesionales o de cualquier &iacute;ndole que para la misma realice, la remuneraci&oacute;n que por este concepto
    reciba lo ser&aacute; en funci&oacute;n del trabajo que desarrolle y no por su car&aacute;cter de Administrador, que es totalmente
    independiente.</FONT></TD>
    <TD STYLE="width: 50%; padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Should any Director render
    services to the Company due to a post of General Director, General Manager or to any professional service contract, the remuneration
    for this concept will be considered according to the services rendered. This remuneration shall be considered independent
    from the post held by the individual as Director.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Art&iacute;culo 35.- Nombramiento de Presidente
    y Vicepresidente y Secretario y Vicesecretario del Consejo de Administraci&oacute;n.</B> En el caso de que exista, el Consejo
    de Administraci&oacute;n nombrar&aacute; de su seno un Presidente y, si lo considera oportuno, un Vicepresidente. Asimismo
    nombrar&aacute; libremente a la persona que haya de desempe&ntilde;ar el cargo de Secretario y, si lo estima conveniente,
    un Vicesecretario. El Secretario y el Vicesecretario podr&aacute;n no ser Consejeros.</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Article 35.- Chairman, Vicechairman, Secretary
    and Vicesecretary appointment. </B>Should there be a Board of Directors, the Board shall appoint a Chairman and if necessary
    a Vicechairman, as well as a Secretary and if necessary a Vicesecretary. Neither Secretary nor Vicesecretary has to be members
    of the Board of Directors.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">El Vicepresidente y Vicesecretario actuar&aacute;n
    en los casos de imposibilidad f&iacute;sica o jur&iacute;dica de los cargos que suplan.</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Vicechairman and Vicesecretary will act
    in case of physical or legal impossibility of the Director or Secretary to attend the meeting.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Art&iacute;culo 36.- Convocatoria y modo
    de celebraci&oacute;n de reuniones por el Consejo de Administraci&oacute;n. Votaci&oacute;n por escrito y sin sesi&oacute;n.
    </B>En el caso de que exista Consejo de Administraci&oacute;n, la convocatoria del mismo se har&aacute; por el Presidente,
    o a falta de &eacute;ste, por el Vicepresidente, por medio de carta certificada o por telegrama, con acuse de recibo, o por
    e-mail dirigido personalmente a cada Consejero, con una antelaci&oacute;n m&iacute;nima de siete (7) d&iacute;as y quedar&aacute;
    v&aacute;lidamente constituido cuando concurran a la reuni&oacute;n, presentes o representados, un n&uacute;mero de &eacute;stos
    que superen la mitad aritm&eacute;tica del n&uacute;mero de miembros que lo integran. La representaci&oacute;n y voto para
    las reuniones del Consejo podr&aacute; conferirse a favor de cualquier otro Consejero, comunic&aacute;ndolo por carta dirigida
    al Presidente o a falta de &eacute;ste, al Vicepresidente. Esta representaci&oacute;n, adem&aacute;s de escrita, habr&aacute;
    de ser especial para cada sesi&oacute;n.</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Article 36.- Notice and holding of the Meeting.
    Written vote with no Meeting. </B>Should the Administrative Body be a Board of Directors, the Meeting of the Board will be
    announced by its Chairman or, when applicable, the Vicechairman, by way of a certified letter or telegram with acknowledgment
    of receipt, or by email, sent to all Directors individually at least seven (7) days in advance. The Meeting will be validly
    called when members or their representatives representing at least half of the members of the Board of Directors are present.
    Representation and voting rights for the Meetings can be conferred to another Board member through a letter addressed to the
    Chairman or Vicechairman. This proxy will have to be put into writing and in a separate document for each Meeting.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">El Presidente, o a falta de &eacute;ste, el
    Vicepresidente, dirigir&aacute; las sesiones, conceder&aacute; la palabra a los Consejeros y ordenar&aacute; los debates,
    fijar&aacute; el orden de las intervenciones y las propuestas de resoluci&oacute;n.</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Chairman or the Vicechairman, in its case,
    shall lead the Meetings, will give the right to speak to the Directors and will establish the participation order and the
    proposals for the resolution of matters.</FONT></TD></TR>
</TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">El Consejo de Administraci&oacute;n
    deber&aacute; reunirse, al menos, una vez al trimestre. As&iacute; mismo, el Consejo de Administraci&oacute;n se reunir&aacute;
    en los d&iacute;as que el mismo acuerde y siempre que lo disponga su Presidente, o a falta de &eacute;ste, el Vicepresidente
    o lo pidan dos (2) de sus componentes, en cuyo caso se convocar&aacute; por aqu&eacute;l para reunirse dentro de los quince
    (15) d&iacute;as siguientes a la petici&oacute;n. </FONT></TD>
    <TD STYLE="width: 50%; padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Board of Directors shall
    be held, at least, once a quarter. Additionally, Board of Directors shall be held for the dates established by the Chairman
    or, when applicable, by the Vicechairman or the date requested by two (2) members. The Meeting will be held fifteen (15) days
    after the request.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Se permitir&aacute; la participaci&oacute;n
    por medio de tel&eacute;fono o videoconferencia, siempre que todos los consejeros puedan o&iacute;r y ser o&iacute;dos por
    los dem&aacute;s</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Participation by means of telephone or videoconference
    will be allowed, provided all Directors can hear and be heard by each other.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ser&aacute; v&aacute;lida la reuni&oacute;n
    del Consejo sin necesidad de previa convocatoria, cuando, estando reunidos todos sus miembros, decidan por unanimidad celebrar
    la sesi&oacute;n.</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Board of Directors shall be validly called
    without a prior call when members representing all the Board of Directors unanimously agree to hold the Meeting.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">La votaci&oacute;n por escrito y sin sesi&oacute;n
    s&oacute;lo ser&aacute; admitida cuando ning&uacute;n Consejero se oponga a este procedimiento. El Presidente, o a falta de
    &eacute;ste, el Vicepresidente o el Secretario o a falta de &eacute;ste, el Vicesecretario del Consejo de Administraci&oacute;n,
    deber&aacute;n dirigirse por carta certificada o telegrama, con acuse de recibo, a todos los Consejeros, comunic&aacute;ndoles
    el contenido de los acuerdos que se proponen al Consejo para su deliberaci&oacute;n. Los Consejeros, por escrito y bajo su
    firma, otorgar&aacute;n su voto a la propuesta de acuerdos dentro de los diez (10) d&iacute;as siguientes a la fecha en que
    se hubiere remitido la comunicaci&oacute;n al &uacute;ltimo Consejero. Dicha comunicaci&oacute;n previa no ser&aacute; necesaria
    cuando conste, por escrito y bajo su firma, el voto de todos los Consejeros.</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The agreements taken in a written form and without
    holding a meeting will only be valid when no Directors object the procedure. Chairman or, when applicable, Vicechairman, or
    Secretary or, when applicable, Vicesecretary shall communicate to all members of the Board of Directors by certified letter
    or telegram, with acknowledgement of receipt, informing them about the contents of the agreements subject to consideration
    by the Board of Directors. The vote shall be issued in a written and signed form by all the Directors within ten (10) days
    after the last notification has been sent to the last Director. This procedure shall not be necessary when there is a written
    and signed vote of all the Directors.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Art&iacute;culo 37.- Adopci&oacute;n de acuerdos
    por el Consejo de Administraci&oacute;n y delegaci&oacute;n de facultades.</B></FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Article 37.- Board of Directors agreements
    and delegations of powers.</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">En el caso de existir Consejo de Administraci&oacute;n,
    los acuerdos se adoptar&aacute;n por mayor&iacute;a absoluta de los Consejeros presentes y representados en la sesi&oacute;n.</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Should there be a Board of Directors, all the
    agreements will be adopted by all the present and represented Directors following the majority rules.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">El Consejo de Administraci&oacute;n, mediante
    acuerdo con el voto favorable de las dos terceras (2/3) partes de sus componentes, podr&aacute; delegar permanentemente alguna
    o todas sus facultades en una Comisi&oacute;n Ejecutiva o en uno o varios Consejeros Delegados, indicando en el nombramiento
    el r&eacute;gimen de actuaci&oacute;n y fijando sus facultades con cumplimiento de los l&iacute;mites legales.</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Board of Directors will be able to delegate
    permanently some of its Powers to the Executive Committee or to one or more Managing Directors establishing the rules and
    content of the delegation. For this delegation the agreement of two thirds (2/3) of the members of the Board will be necessary.</FONT></TD></TR>
</TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; padding-right: 5.4pt; padding-left: 5.4pt; border-right: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dicha delegaci&oacute;n y
    nombramiento no producir&aacute;n efecto alguno hasta su inscripci&oacute;n en el Registro Mercantil.</FONT></TD>
    <TD STYLE="width: 50%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This delegation shall not
    be effective until recorded in the Trade Register.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-right: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-right: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cuando un miembro del consejo de administraci&oacute;n
    sea nombrado consejero delegado o se le atribuyan funciones ejecutivas en virtud de otro t&iacute;tulo, ser&aacute; necesario
    que se celebre un contrato entre este y la sociedad que deber&aacute; ser aprobado previamente por el consejo de administraci&oacute;n
    con el voto favorable de las dos terceras partes de sus miembros. El consejero afectado deber&aacute; abstenerse de asistir
    a la deliberaci&oacute;n y de participar en la votaci&oacute;n. El contrato deber&aacute; incorporarse como anejo al acta
    de la sesi&oacute;n.</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #222222">When a member of the Board of
    Directors is appointed CEO or executive functions assigned to him under another title, it will require a contract between
    him and the company which must be approved by the Board of Directors with the favorable vote of two-thirds of its members.
    The director shall not attend the discussion and participate in the vote. The contract shall be incorporated as an annex to
    the minutes of the session.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-right: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-right: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Art&iacute;culo 38.- Constancia en acta de
    los acuerdos del Consejo de Administraci&oacute;n.</B> En el supuesto de existir Consejo de Administraci&oacute;n, las discusiones
    y acuerdos del mismo se llevar&aacute;n a un Libro de Actas en el que constar&aacute;n los acuerdos adoptados con expresi&oacute;n
    de los datos relativos a la convocatoria y a la constituci&oacute;n del Consejo, un resumen de los asuntos debatidos, las
    intervenciones de los que se haya solicitado constancia y los resultados de las votaciones. Dicho Libro de Actas ser&aacute;
    firmado por el Secretario o, en su caso, el Vicesecretario, con el visto bueno del Presidente o, en su caso, el Vicepresidente.</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Article 38.- Minutes of the Board of Directors.
    </B>The agreements taken by the Board of Directors will be included in a Minutes Book. The Minutes Book will contain all the
    details regarding the calling of the Meeting, agreements adopted, the incorporation of the Board, the summary of the discussed
    issues, the participation of the attendants, the recording of the matters requested by attendants and the results of the voting
    process and it will be signed by the Secretary or by the Vicesecretary with the Chairman&rsquo;s or Vicechairman&rsquo;s approval.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-right: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-right: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>T&Iacute;TULO IV.- EJERCICIO SOCIAL</B></FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>TITLE IV.- FINANCIAL YEAR</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-right: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-right: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Art&iacute;culo 39.- Ejercicio social.</B>
    El ejercicio social empieza el 1 de enero y termina el 31 de diciembre.</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Article 39.- Financial year. </B>The financial
    year shall begin on 1 January and end on 31<SUP>st</SUP> of December.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-right: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-right: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Art&iacute;culo 40.- Formulaci&oacute;n de
    las Cuentas Anuales.</B> Los Administradores est&aacute;n obligados a formular en el plazo m&aacute;ximo de tres (3) meses,
    contados a partir del cierre del ejercicio social, las Cuentas Anuales, el Informe de Gesti&oacute;n y la propuesta de aplicaci&oacute;n
    del resultado, as&iacute; como, en su caso, las Cuentas y el Informe de Gesti&oacute;n consolidados. Las Cuentas Anuales comprender&aacute;n
    el Balance, la Cuenta de P&eacute;rdidas y Ganancias, la Memoria, el estado que refleje los cambios en el patrimonio neto
    del ejercicio y en su caso el estado de flujo de efectivo. Estos documentos, que forman una unidad, deber&aacute;n ser redactados
    con claridad y mostrar la imagen fiel del patrimonio, de la situaci&oacute;n financiera y de los resultados de la Sociedad,
    de acuerdo con lo establecido en la legislaci&oacute;n aplicable.</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Article 40.- Preparation of Annual Accounts.
    </B>Directors shall prepare the Annual Accounts, financial statements, the management report, the proposed distribution of
    income or loss, and, where applicable, the consolidated financial statements and consolidated management report within a maximum
    period of three (3) months counted from the close of the financial year. The financial statements shall consist of a balance
    sheet, profit and loss statements, notes on the financial statements, the state which reflects the changes in the net equity
    of the financial year, and in its case the state of effective flow. These documents, will be considered as a single report,
    must be clearly presented and give a true and correct view of the Company&rsquo;s net equity, financial position and income
    or loss, in accordance with the Law and any other applicable provision.</FONT></TD></TR>
</TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Las Cuentas Anuales y el
    Informe de Gesti&oacute;n deber&aacute;n estar firmadas por todos los Administradores. Si faltare la firma de alguno de ellos
    se se&ntilde;alar&aacute; en cada uno de los documentos que falte, con expresa indicaci&oacute;n de la causa.</FONT></TD>
    <TD STYLE="width: 50%; padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The financial statements
    and the management report must be signed by all the Directors. Where a Director&rsquo;s signature is missing, this fact together
    with the reason for its absence shall be expressly pointed out on each document where such signature is lacking.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">En materia de auditor&iacute;a de cuentas se
    aplicar&aacute; lo previsto en la legislaci&oacute;n vigente.</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Regarding the auditing of the accounts it will
    be enforceable the applicable legislation.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Art&iacute;culo 41.- Derecho de informaci&oacute;n
    y examen de contabilidad.</B> A partir de la convocatoria de la Junta General, cualquier socio podr&aacute; obtener de la
    Sociedad, de forma inmediata y gratuita los documentos que han de ser sometidos a la aprobaci&oacute;n de la misma, as&iacute;
    como, en su caso, el Informe de Gesti&oacute;n y el Informe de los Auditores de Cuentas. En la propia convocatoria se deber&aacute;
    hacer menci&oacute;n de este derecho.</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Article 41.- Right to access to information
    and examination of accounts. </B>From the date of the calling of the Shareholders&rsquo; General Meeting, any Shareholder
    has the right to obtain from the Company, immediately and free of charge, the documents that are to be approved during the
    Meeting. This includes the Management Report and Auditors&rsquo; Report, if applicable. This right must be mentioned in the
    calling of the Meeting.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Durante el mismo plazo, el socio o socios que
    representen el cinco (5) por ciento del capital podr&aacute;n examinar en el domicilio social, por s&iacute; o en uni&oacute;n
    de experto contable, los documentos que sirvan de soporte y de antecedente de las Cuentas Anuales, sin que ello impida el
    derecho de la minor&iacute;a a que se nombre un auditor de cuentas con cargo a la Sociedad.</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the same period, the Shareholder/s who
    represent a five (5) percent or more of the Share Capital, may consult, in the Registered Office of the Company, independently
    or accompanied by an accounting expert, the documents which serve as a support and background for the preparation of the Annual
    Accounts. This does not have any effect on the fact that the minority has a right to elect an independent Auditor of the Annual
    Accounts, whose cost will be charged to the Company.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Art&iacute;culo 42.- Distribuci&oacute;n
    de dividendos.</B> La distribuci&oacute;n de dividendos a los socios, se realizar&aacute; en proporci&oacute;n a su participaci&oacute;n
    en el capital social.</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Article 42.- Distribution of dividends</B>.
    The payment of dividends on ordinary shares shall be made in proportion to the capital paid-in on those shares.</FONT></TD></TR>
</TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>T&Iacute;TULO V.- DISOLUCI&Oacute;N
    Y LIQUIDACI&Oacute;N</B></FONT></TD>
    <TD STYLE="width: 50%; padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>TITLE V.- WINDING UP AND
    LIQUIDATION</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Art&iacute;culo 43.- Causas de disoluci&oacute;n.
    </B>La Sociedad se disolver&aacute; por las causas previstas en la LSC.</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Article 43.- Causes of dissolution. </B>The
    Company shall be wound up for any of the reasons set forth in the LSC.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Art&iacute;culo 44.- Cese de Administradores
    y nombramiento de Liquidadores.</B> Con la apertura del periodo de liquidaci&oacute;n cesar&aacute;n en sus cargos los Administradores
    quienes de forma autom&aacute;tica quedar&aacute;n convertidos en Liquidadores.</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Article 44.- Resignation of Directors and
    appointment of Liquidators. </B>The Company&rsquo;s Directors&rsquo; posts shall terminate when the liquidation process starts.
    Directors at the time of dissolution shall become liquidators.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">La Sociedad disuelta conservar&aacute; su personalidad
    jur&iacute;dica mientras la liquidaci&oacute;n se realiza. Durante ese tiempo deber&aacute; a&ntilde;adir a su denominaci&oacute;n
    la expresi&oacute;n &ldquo;en liquidaci&oacute;n&rdquo;.</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The dissolved Company shall maintain its status
    as legal entity during the liquidation process. During this time it shall add to its Company name the words &ldquo;in liquidation&rdquo;.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Art&iacute;culo 45.- Duraci&oacute;n del
    cargo de Liquidador.</B> Los Liquidadores ejercer&aacute;n su cargo por tiempo indefinido.</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Article 45.- Term of office of Liquidators.
    </B>Liquidators shall serve for an undetermined period of time.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Art&iacute;culo 46.- &Aacute;mbito de representaci&oacute;n.
    </B>El poder de representaci&oacute;n de los Liquidadores ser&aacute; ejercido de forma individual. La representaci&oacute;n
    de los Liquidadores se extiende a todas aquellas operaciones que sean necesarias para la liquidaci&oacute;n de la Sociedad.</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Article 46.- Representative authority. </B>Each
    liquidator shall have individual representative authority. The liquidators&rsquo; representative authority shall extend to
    all transactions necessary for the liquidation.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Art&iacute;culo 47.- C&aacute;lculo de la
    cuota de liquidaci&oacute;n.</B> La cuota de liquidaci&oacute;n que corresponde a cada socio ser&aacute; proporcional a su
    participaci&oacute;n en el capital social.</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Article 47.- Distribution of the liquidation
    payout. </B>The payout distributed between the Shareholders shall be in proportion to their participation in the Company&rsquo;s
    share capital.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Los Liquidadores no podr&aacute;n satisfacer
    la cuota de liquidaci&oacute;n sin la previa satisfacci&oacute;n a los acreedores de sus cr&eacute;ditos o sin consignarlos
    en una entidad de cr&eacute;dito del t&eacute;rmino municipal del domicilio social.</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Liquidators may not satisfy liquidation
    payout until all creditors have been fully paid or the amounts of their credits have been deposited in escrow in a financial
    institution within the municipal limits of the Company&rsquo;s Registered Office.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Art&iacute;culo 48.- Forma de pago de la
    cuota de liquidaci&oacute;n.</B> Los socios tendr&aacute;n derecho a percibir en dinero la cuota resultante de la liquidaci&oacute;n,
    salvo que por acuerdo un&aacute;nime se acuerde otra cosa.</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Article 48.- Payment of liquidation payout.
    </B>Unless all Shareholders unanimously agree otherwise, the Shareholders shall have the right to receive the liquidation
    payout in cash.</FONT></TD></TR>
</TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->



<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.33
<SEQUENCE>7
<FILENAME>g082622_ex4-33.htm
<DESCRIPTION>EXHIBIT 4.33
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit 4.33</B></FONT></P>

<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2016
STOCK OPTION PLAN</B>&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>OF</B>&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>INTER
PARFUMS, INC. </U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;Purposes of The Plan.</B> This stock option plan (the &quot;Plan&quot;) is designed to provide an incentive to
key employees, officers, directors and consultants of Inter Parfums, Inc., a Delaware corporation (the &quot;Company&quot;),
and its present and future subsidiary corporations, as defined in Paragraph 17 (&quot;Subsidiaries&quot;), and to offer an
additional inducement in obtaining the services of such individuals. The Plan provides for the grant of &quot;incentive stock
options,&quot; within the meaning of Section 422 of the Internal Revenue Code of 1986, as amended (the &quot;Code&quot;),
nonqualified stock options and stock appreciation rights (&quot;SARs&quot;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;Shares Subject to The Plan.</B> The aggregate number of shares of Common Stock, $.001 par value per share,
of the Company (&quot;Common Stock&quot;) for which options or SARs may be granted under the Plan shall not exceed 1,000,000,
and the Company hereby reserves 50,000 shares of Common Stock to be available solely for issuance to Nonemployee Directors,
as hereinafter defined, upon options to be granted under 2016 Option Plan. Such shares may, in the discretion of the Board of
Directors, consist either in whole or in part of authorized but unissued shares of Common Stock or shares of Common Stock
held in the treasury of the Company. The Company shall at all times during the term of the Plan reserve and keep available
such number of shares of Common Stock as will be sufficient to satisfy the requirements of the Plan. Subject to the
provisions of Paragraph 14, any shares subject to an option or SAR which for any reason expire, are canceled or are
terminated unexercised (other than those which expire, are canceled or terminated pursuant to the exercise of a tandem SAR or
option) shall again become available for the granting of options or SARs under the Plan. The number of shares of Common Stock
underlying that portion of an option or SAR which is exercised (regardless of the number of shares actually issued) shall <I>not </I>again
become available for grant under the Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;Administration of The Plan.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Plan shall be administered by the Board of Directors, or if appointed, by a committee consisting of not less than two (2) members
of the Board of Directors, each of whom shall be a &ldquo;Nonemployee Director&rdquo; within the meaning of Rule 16b-3 promulgated
by the Securities and Exchange Commission. (The group administering the plan is referred to as the &ldquo;Committee&rdquo;). The
failure of any of the Committee members to qualify as a Nonemployee Director shall not otherwise affect the validity of the grant
of any option or SAR, or the issuance of shares of Common Stock otherwise validly issued upon exercise of any such option. A majority
of the members of the Committee shall constitute a quorum, and the acts of a majority of the members present at any meeting at
which a quorum is present, and any acts approved in writing by all members without a meeting, shall be the acts of the Committee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Subject
to the express provisions of the Plan, the Committee shall have the authority, in its sole discretion, to determine the individuals
who shall receive options and SARS; the times when they shall receive them; whether an option shall be an incentive or a nonqualified
stock option; whether an SAR shall be granted separately, in tandem with or in addition to an option; the number of shares to
be subject to each option and SAR; the term of each option and SAR; the date each option and SAR shall become exercisable; whether
an option or SAR shall be exercisable in whole, in part or in installments, and if in installments, the number of shares to be
subject to each installment; whether the installments shall be cumulative, the date each installment shall become exercisable
and the term of each installment; whether to accelerate the date of exercise of any installment; whether shares may be issued
on exercise of an option as partly paid, and, if so, the dates when future installments of the exercise price shall become due
and the amounts of such installments; the exercise price of each option and the base price of each SAR; the form of payment of
the exercise price; the form of payment by the Company upon the optionee's exercise of an SAR; whether to require that the optionee
remain in the employ of, or in association with, the Company or its Subsidiaries for a period of time from and after the date
the option or SAR is granted to him; the amount necessary to satisfy the Company's obligation to withhold taxes; whether to restrict
the sale or other disposition of the shares of Common Stock acquired upon the exercise of an option or SAR and to waive any such
restriction; to subject the exercise of all or any portion of an option or SAR to the fulfillment of contingencies as specified
in the Contract (as described in Paragraph 12), including without limitations, contingencies relating to financial objectives
(such as, but not limited to, earnings per share, cash flow return, return on investment or growth in sales) for a specified period
for the Company, a division, a product line or other category, and/or the period of continued employment of the optionee with
the Company or its Subsidiaries, and to determine whether such contingencies have been met; to construe the respective Contracts
and the Plan; with the consent of the optionee, to cancel or modify an option or SAR, provided such option or SAR as modified
would be permitted to be granted on such date under the terms of the Plan; and to make all other determinations necessary or advisable
for administering the Plan. The determinations of the Committee on the matters referred to in this Paragraph 3 shall be conclusive.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Subject
to the express provisions of the Plan and solely with respect to employees or consultants of the Company who are not executive
officers or directors of the Company, the Committee hereby delegates to the Chief Executive Officer, and to act in place and on
behalf of the Committee, the authority to grant nonqualified options and SARs to such employees or consultants; to determine the
term of such nonqualified options and SARs; to determine whether an option or SAR shall be exercisable in whole, in part or in
installments; to determine whether to require that the optionee remain in the employ of, or association with, the Company or its
Subsidiaries for a period of time from and after the date the option or SAR is granted to such person; and to subject the exercise
of all or any portion of an option or SAR to the fulfillment of contingencies as specified in the Contract. Any such action by
the Chief Executive Officer shall be promptly reduced to writing and provided to the Committee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;With
regard to option grants to Nonemployee Directors, the Plan shall be self-executing. However, subject to the express provisions
of the Plan, with regard to Nonemployee Directors, the Committee have the power to interpret the Plan; correct any defect, supply
any omission or reconcile any inconsistency in the Plan; prescribe, amend and rescind rules and regulations relating to the Plan;
and make all other determinations necessary or advisable for the administration of the Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Eligibility.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Committee may, consistent with the purposes of the Plan, grant incentive stock options to key employees (including officers and
directors who are employees) and nonqualified stock options and SARs to key employees, officers, directors and consultants of
the Company or any of its Subsidiaries from time to time, but not to Nonemployee Directors, who are to receive automatic grants
of nonqualified stock options without discretion of the Committee, as hereinafter set forth, within ten (10) years from the date
of adoption of the Plan by the Board of Directors, covering such number of shares of Common Stock as the Committee may determine;
<I>provided that, </I>the aggregate market value (determined at the time the stock option is granted) of the shares for which
any eligible person may be granted incentive stock options under the Plan or any plan of the Company, or of a Parent or a Subsidiary
of the Company which are exercisable for the first time by such optionee during any calendar year shall not exceed $100,000. Any
option (or portion thereof) granted in excess of such amount shall be treated as a nonqualified stock option.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Notwithstanding
any other provision of the Plan, if the Committee determines that at the time a person is granted an option or SAR, such person
is then, or is likely to become, a Covered Person (as hereinafter defined), then the Committee may provide that this Section 4(b)
is applicable to such grant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.4in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Notwithstanding
any provision of this Plan, no person eligible to receive a grant of an option or SAR under this Plan shall be granted options
to purchase or an SAR in excess of 150,000 shares of common stock in any one fiscal year. Such 150,000 maximum number shall be
appropriately adjusted for stock splits, stock dividends and the like.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.4in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Notwithstanding
any provision of this Plan, the exercise price for all options and the base price for all SARs to be granted under the Plan, shall
not be less than the Fair Market Value (as hereinafter defined) at the time of grant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.4in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
term &ldquo;Covered Person&rdquo; shall mean a &ldquo;covered employee&rdquo; within the meaning of Code Section 162(m)(3) or
any successor provision thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Nonemployee
Directors shall not be eligible to receive a stock option or SAR grant in the discretion of the Committee. In lieu of such discretionary
grants, each Nonemployee Director shall receive the following option grants:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.85in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
(i) &nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;Each individual who becomes a Nonemployee Director, shall on the date of his initial
election or appointment to the Board be granted an option to purchase 2,000 shares of Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.85in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> (ii) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each
Nonemployee Director shall be granted an option to purchase 1,000 shares of Common Stock commencing on the next February 1st,
and each succeeding February 1st throughout the term of this Plan for so long as such person is a Nonemployee Director. Notwithstanding
the foregoing, no option shall be granted on such February 1st grant date to any Nonemployee Director who first becomes a Nonemployee
Director within six (6) months prior to such February 1st grant date. Notwithstanding the foregoing, if a Nonemployee Director
did not attend one of the two in-person board meetings that are usually held the prior June-July and December-January, then the
option to be granted on the following February 1, under this Plan would be reduced by 50%; and if such Nonemployee Director did
not attend both of such meetings, then such Nonemployee Director would not receive any option grant on the following February
1.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.85in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> (iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If
a sufficient number of shares of Common Stock reserved for issuance upon proper exercise of options to be granted to Nonemployee
Directors on the February 1st grant date does not exist, then the aggregate remaining number of shares shall be prorated equally
among options to be granted to all Nonemployee Directors at such February 1st grant date, and options shall be granted to purchase
such reduced number of shares. Notwithstanding the foregoing, if a sufficient number of shares of Common Stock reserved for issuance
upon proper exercise of options to be granted to Nonemployee Directors on the February 1st grant date does not exist, then options
shall be granted under any pre-existing Nonemployee Director plan in order to satisfy such deficiency, if, and to the extent available.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.85in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
(iv) &nbsp;&nbsp; &nbsp;&nbsp;All options that may be granted from time to time under the Plan to Nonemployee Directors shall
vest and become exercisable to purchase shares of Common Stock as follows: 25% one year after the date of grant, and then 25%
on each of the second, third and fourth consecutive years from the date of grant on a cumulative basis, so that each option
shall become fully vested and exercisable on the fourth year from the date of grant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.85in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
(v) &nbsp;&nbsp;&nbsp; &nbsp;&nbsp;It is the express intent that options to be granted to Nonemployee Directors shall be
first made under the 2004 Nonemployee Director Stock Option Plan, as amended (the &ldquo;2004 Nonemployee Director
Plan&rdquo;), until all shares of Common Stock under that plan have been exhausted. Upon no further shares of Common Stock
being available for grant under the 2004 Nonemployee Director Plan, then options to purchase Common Stock to Nonemployee
Directors are to be granted under this Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.85in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
(vi) &nbsp;&nbsp; &nbsp;&nbsp;All grants under this Plan to Nonemployee Directors shall be in lieu of any other option grants
that a Nonemployee Director may have been entitled to under any other plan of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Exercise
Price and Base Price.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
exercise price of the shares of Common Stock under each option and the base price for each SAR shall be determined by the Committee;
<I>provided that,</I> in the case of</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.85in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
(i) &nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;Nonemployee Directors, all options granted under this Plan shall have an exercise
price equal to one hundred percent (100%) of the fair market value of the Common Stock as hereinafter determined (&ldquo;Fair
Market Value&rdquo;) on the date of grant, and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.85in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
(ii) &nbsp;&nbsp;&nbsp; &nbsp;&nbsp;an incentive stock option, the exercise price shall not be less than 100% of the Fair
Market Value on the date of grant, and further provided, that if, at the time an incentive stock option is granted, the
optionee owns (or is deemed to own) stock possessing more than ten percent (10%) of the total combined voting power of all
classes of stock of the Company, of any of its Subsidiaries or of a Parent, then the exercise price shall not be less than
110% of the Fair Market Value subject to the option at the time of the granting of such option.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Fair Market Value on the date of grant shall be: (i) If the principal market for the Common stock is a national securities exchange,
then the closing price of the Common Stock on the last trading day immediately preceding the date of grant as reported by such
exchange; or (ii) if the principal market for the Common Stock is not a national securities exchange, then the Fair Market Value
shall be determined by the Committee by any method consistent with United States generally accepted accounting principles. The
determination of the Committee shall be conclusive in determining Fair Market Value.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Term.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Except
as otherwise provided in this Plan, the term of each option and SAR granted pursuant to the Plan shall be as established by the
Committee, in its sole discretion. The term of each incentive stock option granted pursuant to the Plan shall be for a period
not exceeding ten (10) years from the date of grant thereof; <I>provided that</I>, if, at the time an incentive stock option is
granted, the optionee owns (or is deemed to own) stock possessing more than ten percent (10%) of the total combined voting power
of all classes of stock of the Company, of any of its Subsidiaries or of a Parent, then the term of the incentive stock option
shall be for a period not exceeding five (5) years.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;For
options granted to Nonemployee Directors, the term of each option shall be five (5) years.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Options shall be subject to earlier termination as hereinafter provided.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Exercise.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;An
option or SAR (or any part or installment thereof) shall be exercised by giving written notice to the Company at its principal
office (at present 551 Fifth Avenue, New York, NY 10176) stating whether an incentive or nonqualified stock option or SAR is being
exercised, specifying the number of shares as to which such option or SAR is being exercised, and in the case of an option, accompanied
by payment in full of the aggregate exercise price therefor (or the amount due on exercise if the Contract permits installment
payments) in the discretion of the Committee (i) in cash, by certified check or by wire transfer of funds through the Federal
Reserve System, (ii) with previously acquired shares of Common Stock having an aggregate fair market value, on the date of exercise,
equal to the aggregate exercise price of all options being exercised, or (iii) any combination thereof. In addition, upon the
exercise of a nonqualified stock option or SAR, the Company may withhold cash and/or shares of Common Stock to be issued with
respect thereto having an aggregate fair market value equal to the amount which it determined is necessary to satisfy its obligation
to withhold Federal, state and local income taxes or other taxes incurred by reason of such exercise. Alternatively, the Company
may require the holder to pay to the Company such amount, in cash, promptly upon demand. The Company shall not be required to
issue any shares pursuant to any such option or SAR until all required payments have been made. Fair market value of the shares
shall be determined in accordance with Paragraph 5.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A
person entitled to receive Common Stock upon the exercise of an option or SAR shall not have the rights of a shareholder with
respect to such shares until the date of issuance of such shares<I>; provided that,</I> until such shares are issued, any option
holder using previously acquired shares in payment of an option exercise price shall have the rights of a shareholder with respect
to such previously acquired shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
no case may a fraction of a share be purchased or issued under the Plan. Any option granted in tandem with an SAR shall no longer
be exercisable to the extent the SAR is exercised, and the exercise of the related option shall cancel the SAR to the extent of
such exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Stock
Appreciation Rights.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;An
SAR may be granted separately, in tandem with or in addition to any option, and may be granted before, simultaneously with or
after the grant of an option hereunder. In addition, the holder of an option may, in lieu of making the payment required at the
time of exercise under Paragraph 7, include in the written notice referred to therein an &quot;election&quot; to exercise the
option as an SAR. In such case, the Committee shall have fifteen (15) days from the receipt of notice of the election to decide,
in its sole discretion, whether or not to accept the election and notify the option holder of its decision. If the Committee consents,
then such exercise shall be treated as the exercise of an SAR with a base price equal to the exercise price.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Upon
the exercise of an SAR, the holder shall be entitled to receive an amount equal to the excess of the Fair Market Value on the
date of exercise over the base price of the SAR. Such amount shall be paid, in the discretion of the Committee, in cash, Common
Stock having a Fair Market Value on the date of payment equal to such amount, or a combination thereof. For purposes of this Paragraph
8, Fair Market Value shall be determined in accordance with Paragraph 5.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Termination
of Association with the Company (Other Than Death or Permanent Disability).</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Any
holder of an incentive option whose association with the Company (and its Subsidiaries) has terminated for any reason other than
his death or permanent and total disability as defined in Section 22(e)(3) of the Code (&ldquo;Permanent Disability&rdquo;) may
exercise such option, to the extent exercisable on the date of such termination, at any time within three (3) months after the
date of termination, but in no event after the expiration of the term of the option; <I>provided that</I>, if such association
shall be terminated either (i) for cause, or (ii) without the consent of the Company, then said option shall terminate immediately.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Except
with regard to stock options granted to Nonemployee Directors, any and all nonqualified stock options or SARs granted under the
Plan shall terminate simultaneously with the termination of association of the holder of such nonqualified option or SAR with
the Company (and its Subsidiaries) for any reason other than the death or Permanent Disability of such holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Options
and SARs granted under the Plan shall not be affected by any change in the status of an optionee so long as he continues to be
associated with the Company or any of the Subsidiaries.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Nothing
in the Plan or in any option or SAR granted under the Plan shall confer on any individual any right to continue to be associated
with the Company or any of its Subsidiaries, or interfere in any way with the right of the Company or any of its Subsidiaries
to terminate the holder's association at any time for any reason whatsoever without liability to the Company or any of its Subsidiaries.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
If a Nonemployee Director to whom an option has been granted under the Plan shall cease to serve on the Board, otherwise than
by reason of death or Permanent Disability, then such option may be exercised (to the extent that the Nonemployee Director was
entitled to do so at the time of cessation of service) at any time within three (3) months after such cessation of service but
not thereafter, and in no event after the date on which, except for such cessation of service, the option would otherwise expire.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Death
or Permanent Disability of An Optionee.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Except
with regard to options held by Nonemployee Directors, if an optionee dies while he is associated with the Company or any of its
Subsidiaries, or within three (3) months after such termination for the holder of an incentive option (unless such termination
was for cause or without the consent of the Company), then the remaining unexercised portion of the option or SAR may be exercised
in whole or in part (notwithstanding that the option or SAR had not yet become exercisable with respect to all or part of such
shares at the date of death, <I>i.e.,</I> all vesting requirements shall lapse) by such person&rsquo;s executor, administrator
or other person at the time entitled by law to the decedent&rsquo;s rights under the option or SAR, at any time within one (1)
year after death, but in no event after the expiration of the term of the option or SAR.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
a Nonemployee Director to whom an option has been granted under the Plan shall die while he is serving on the Board, or within
three (3) months after cessation of service on the Board, then the remaining unexercised portion of the option may be exercised
in whole or in part (notwithstanding that the option had not yet become exercisable with respect to all or part of such shares
at the date of such death, <I>i.e.,</I> all vesting requirements shall lapse) by such person&rsquo;s executor, administrator or
other person at the time entitled by law to the decedent&rsquo;s rights, at any time within one (1) year after his death, but
in no event after the date on which, except for such death, the option would otherwise expire.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Except
with regard to options held by Nonemployee Directors, any holder whose association with the Company or its Subsidiaries has terminated
by reason of a Permanent Disability may exercise his option or SAR, to the extent exercisable upon the effective date of such
termination, at any time within one (1) year after such date, but in no event after the expiration of the term of the option or
SAR.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
If a Nonemployee Director to whom an option has been granted under the Plan shall cease to serve on the Board by reason of a Permanent
Disability, then the remaining unexercised portion of the option may be exercised in whole or in part by the Nonemployee Director
(notwithstanding that the option had not yet become exercisable with respect to all or part of such shares at the date of such
Permanent Disability <I>i.e.,</I> all vesting requirements shall lapse) at any time within one (1) year after such Permanent Disability,
but not thereafter, and in no event after the date on which, except for such Permanent Disability, the option would otherwise
expire.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>11.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Compliance
With Securities Laws.</B> The Committee may require, in its discretion, as a condition to the exercise of an option or SAR that
either (a) a registration statement under the Securities Act of 1933, as amended (the &quot;Securities Act&quot;), with respect
to such shares shall be effective at the time of exercise or (b) there is an exemption from registration under the Securities
Act for the issuance of shares of Common Stock upon such exercise. Nothing herein shall be construed as requiring the Company
to register shares subject to any option or SAR under the Securities Act. In addition, if at any time the Committee shall determine
in its discretion that the listing or qualification of the shares subject to such option or SAR on any securities exchange or
under any applicable law, or the consent or approval of any governmental regulatory body, is necessary or desirable as a condition
of, or in connection with, the granting of an option or SAR, or the issue of shares thereunder, then such option or SAR may not
be exercised in whole or in part unless such listing, qualification, consent or approval shall have been effected or obtained
free of any conditions not acceptable to the Committee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>12.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Stock
Option and SAR Contracts.</B> Each option and SAR shall be evidenced by an appropriate Contract which shall be duly executed by
the Company and the optionee, and shall contain such terms and conditions not inconsistent herewith as may be determined by the
Committee, and which shall provide, among other things, (i) that the optionee agrees that he will remain in the employ of or association
with the Company or its Subsidiaries, at the election of the Company, for the later of (A) the period of time determined by the
Committee at or before the time of grant or (B) the date to which such optionee is then contractually obligated to remain associated
with the Company or its Subsidiaries, (ii) that in the event of the exercise of an option or an SAR which is paid with Common
stock, unless the shares of Common Stock received upon such exercise shall have been registered under an effective registration
statement under the Securities Act, such shares will be acquired for investment and not with a view to distribution thereof, and
that such shares may not be sold except in compliance with the applicable provisions of the Securities Act, and (iii) that in
the event of any disposition of the shares of Common Stock acquired upon the exercise of an incentive stock option within two
(2) years from the date of grant of the option or one (1) year from the date of transfer of such shares to him, the optionee will
notify the Company thereof in writing within 30 days after such disposition, pay the Company, on demand, in cash an amount necessary
to satisfy its obligation, if any, to withhold any Federal, state and local income taxes or other taxes by reason of such disqualifying
disposition and provide the Company, on demand, with such information as the Company shall reasonably request to determine such
obligation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>13.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Adjustment
of and Changes in Common Stock. </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
the outstanding shares of the Common Stock are increased, decreased, changed into, or exchanged for a different number or kind
of shares or securities of the Corporation through reorganization, recapitalization, reclassification, stock dividend, stock split,
reverse stock split or the like, then an appropriate and proportionate adjustment shall be made in the (i) aggregate number and
kind of securities available under the Plan, and (ii) number and kind of securities issuable upon the exercise of all outstanding
options and SARs granted under the Plan, without change in the total price applicable to the unexercised portion of such options
or SARs, but with a corresponding adjustment in the exercise price or base price for each unit of any security covered by such
options or SARs.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Upon
the dissolution or liquidation of the Corporation, or upon a reorganization, merger or consolidation of the Corporation with one
or more corporations as a result of which the Corporation is not the surviving corporation, or upon the sale of substantially
all of the assets of the Corporation, the Committee shall provide in writing in connection with such transaction for one or more
of the following alternatives, separately or in combination: (i) the assumption by the successor entity of the options theretofore
granted or the substitution by such entity for such options of new options or SARs covering the stock of the successor entity,
or a parent or subsidiary thereof, with appropriate adjustments as to the number and kind of shares and prices; or (ii) the continuance
of such option agreements by such successor entity in which such options shall remain in full force and effect under the terms
so provided.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Any
adjustments under this Section 13 shall be made by the Committee, whose good faith determination as to what adjustments shall
be made, and the extent thereof, shall be final, binding and conclusive.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>14.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amendments
and Termination of The Plan.</B> The Plan was adopted by the Board of Directors on June 28, 2016. No options may be granted under
the Plan after June 27, 2026. The Board of Directors, without further approval of the Company's stockholders, may at any time
suspend or terminate the Plan, in whole or in part, or amend it from time to time in such respects as it may deem advisable, including,
without limitation, in order that incentive stock options granted hereunder meet the requirements for &quot;incentive stock options&quot;
under the Code, or any comparable provisions thereafter enacted and conform to any change in applicable law or to regulations
or rulings of administrative agencies; <I>provided that,</I> no amendment shall be effective without the prior or subsequent approval
of a majority of the Company's outstanding stock entitled to vote thereon which would (a) except as contemplated in Paragraph
13, increase the maximum number of shares for which options may be granted under the Plan, (b) materially increase the benefits
to participants under the Plan or (c) change the eligibility requirements for individuals entitled to receive options hereunder.
No termination, suspension or amendment of the Plan shall, without the consent of the holder of an existing option affected thereby,
adversely affect his rights under such option.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>15.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Nontransferability
of Options.</B> No option or SAR granted under the Plan shall be transferable otherwise than by will or the laws of descent and
distribution, or qualified domestic relations order as defined in the Code or Title I of the Employee Retirement Income Security
Act, and options and SARs may be exercised, during the lifetime of the holder thereof, only by him or his legal representatives.
Except to the extent provided above, options and SARs may not be assigned, transferred, pledged, hypothecated or disposed of in
any way (whether by operation of law or otherwise) and shall not subject to execution, attachment or similar process.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>16.
Substitutions and Assumptions of Options of Certain Constituent Corporations.</B> Anything in this Plan to the contrary notwithstanding,
the Board of directors may, without further approval by the stockholders, substitute new options for prior options and new SARs
for prior SARs of a Constituent Corporation (as defined in Paragraph 17) or assume the prior options or SARs of such Constituent
Corporation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>17.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Certain
Definitions.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
term &quot;Subsidiary&quot; shall have the same definition as &quot;subsidiary corporation&quot; in Section 424(f) of the Code.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
term &quot;Parent&quot; shall have the same definition as &quot;parent corporation&quot; in Section 424(e) of the Code.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
term &quot;Constituent Corporation&quot; shall mean any corporation which engages with the Company, its Parent or Subsidiary,
in a transaction to which section 424(a) of the Code applies (or would apply if the option or SAR assumed or substituted were
an incentive stock option), or any Parent or any Subsidiary of such corporation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>18.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Conditions Precedent.</B> The Plan shall be subject to approval by the holders of a majority of shares of the Company's capital
stock outstanding and entitled to vote thereon at the next meeting of its stockholders, or the written consent of the holders
of a majority of shares that would have been entitled to vote thereon, and no options or SARs granted hereunder may be exercised
prior to such approval, provided that the date of grant of any options granted hereunder shall be determined as if the Plan had
not been subject to such approval.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21
<SEQUENCE>8
<FILENAME>g082622_ex21.htm
<DESCRIPTION>EXHIBIT 21
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
21</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <B>LIST
OF SUBSIDIARIES </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 50%; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Name</B></FONT></TD>
    <TD STYLE="width: 50%; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Jurisdiction</B></FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inter
    Parfums Holdings, S.A.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">France</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interparfums
    SA</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">France</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jean
    Philippe Fragrances, LLC</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
    York</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inter
    Parfums USA, LLC</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
    York</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IP
    Beauty, Inc.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Delaware</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inter
    Parfums srl</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Italy</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Parfums
    Rochas Spain, SL</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Spain</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inter
    Parfums (Suisse) Sarl</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Switzerland</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interparfums
    Luxury Brands, Inc.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Delaware</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interparfums
    Singapore Pte.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Republic
    of Singapore</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inter
    Parfums USA Hong Kong Limited</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hong
    Kong</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interstellar
    Brands LLC</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
    York</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Divabox
    SAS</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">France</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interparfums
    Italia Srl</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Italy</FONT></TD></TR>
</TABLE>


<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>

    <!-- Field: /Page -->

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23
<SEQUENCE>9
<FILENAME>g082622_ex23.htm
<DESCRIPTION>EXHIBIT 23
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
23</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CONSENT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
consent to the incorporation by reference in the Registration Statements on Form S-8 (No. 333-136988 and No. 333-216705) under
the Securities Act of 1933 of Inter Parfums, Inc. and subsidiaries of our report dated March 1, 2022 on the consolidated balance
sheets of Inter Parfums, Inc. and subsidiaries as of December 31, 2021 and 2020, and the related consolidated statements of income,
comprehensive income (loss), changes in shareholders&rsquo; equity and cash flows and the schedule listed in the Index in Item
15(a)(2) for each of the years in the three-year period ended December 31, 2021 and on the effectiveness of the Inter Parfums,
Inc. maintenance of internal controls over financial reporting as of December 31, 2021. This report appears in the December 31,
2021 Annual Report on Form 10-K of Inter Parfums, Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 35%; font: 10pt Times New Roman, Times, Serif; text-align: justify; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Mazars USA LLP</FONT></TD>
    <TD STYLE="width: 65%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mazars
    USA LLP</FONT></TD>
    <TD>&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
York, New York</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">March
1, 2022</FONT></P>



<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>

    <!-- Field: /Page -->

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>10
<FILENAME>g082622_ex31-1.htm
<DESCRIPTION>EXHIBIT 31.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
31.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>CERTIFICATIONS</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I,
Jean Madar, certify that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
I have reviewed this annual report on Form 10-K of Inter Parfums, Inc.;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary
to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect
to the period covered by this report;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.
Based on my knowledge, the financial statements, and other financial information included in this annual report, fairly present
in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods
presented in this report;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.
The registrant&rsquo;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures
(as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange
Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision,
to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by
others within those entities, particularly during the period in which this report is being prepared;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
Designed such internal control over financial reporting, or caused such control over financial reporting to be designed under
our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial
statements for external purposes in accordance with generally accepted accounting principles;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
Evaluated the effectiveness of the registrant&rsquo;s disclosure controls and procedures and presented in this report our conclusions
about the effectiveness of the disclosure controls and procedures as of the end of the period covered by this report based upon
such evaluation; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
Disclosed in this report any change in the registrant&rsquo;s internal control over financial reporting that occurred during the
registrant&rsquo;s most recent fiscal quarter (the registrant&rsquo;s fourth quarter in case of an annual report) that has materially
affected, or is reasonably likely to materially affect, the registrant&rsquo;s internal control over financial reporting; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.
The registrant&rsquo;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over
financial reporting, to the registrant&rsquo;s auditors and the audit committee of registrant&rsquo;s board of directors (or persons performing
the equivalent functions):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
all significant deficiencies and material weaknesses in the design or operation of internal controls over financial reporting
which are reasonably likely to adversely affect the registrant&rsquo;s ability to record, process, summarize and report financial information;
and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&rsquo;s
internal control over financial reporting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
March 1, 2022</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 35%; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s
    /Jean Madar</FONT></TD>
    <TD STYLE="width: 65%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jean
    Madar, Chief Executive Officer</FONT></TD>
    <TD>&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>

    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>11
<FILENAME>g082622_ex31-2.htm
<DESCRIPTION>EXHIBIT 31.2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
31.2</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I,
Russell Greenberg, certify that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
I have reviewed this annual report on Form 10-K of Inter Parfums, Inc.;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary
to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect
to the period covered by this report;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.
Based on my knowledge, the financial statements, and other financial information included in this annual report, fairly present
in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods
presented in this report;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.
The registrant&rsquo;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures
(as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange
Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision,
to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by
others within those entities, particularly during the period in which this report is being prepared;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
Designed such internal control over financial reporting, or caused such control over financial reporting to be designed under
our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial
statements for external purposes in accordance with generally accepted accounting principles;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
Evaluated the effectiveness of the registrant&rsquo;s disclosure controls and procedures and presented in this report our conclusions
about the effectiveness of the disclosure controls and procedures as of the end of the period covered by this report based upon
such evaluation; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
Disclosed in this report any change in the registrant&rsquo;s internal control over financial reporting that occurred during the
registrant&rsquo;s most recent fiscal quarter (the registrant&rsquo;s fourth quarter in case of an annual report) that has materially
affected, or is reasonably likely to materially affect, the registrant&rsquo;s internal control over financial reporting; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.
The registrant&rsquo;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over
financial reporting, to the registrant&rsquo;s auditors and the audit committee of registrant&rsquo;s board of directors (or persons performing
the equivalent functions):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
all significant deficiencies and material weaknesses in the design or operation of internal controls over financial reporting
which are reasonably likely to adversely affect the registrant&rsquo;s ability to record, process, summarize and report financial information;
and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&rsquo;s
internal control over financial reporting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
March 1, 2022</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 35%; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s
    /Russell Greenberg</FONT></TD>
    <TD STYLE="width: 65%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Russell
    Greenberg <BR>
Chief Financial Officer and <BR>
Principal
Accounting Officer</FONT></TD>
    <TD>&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>

    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>12
<FILENAME>g082622_ex32-1.htm
<DESCRIPTION>EXHIBIT 32.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
32.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CERTIFICATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned hereby certifies, in accordance with 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act
of 2002, in his capacity as an officer of Inter Parfums, Inc., that the Annual Report of Inter Parfums, Inc. on Form 10-K for
the year ended December 31, 2021, fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934
and that the information contained in such report fairly presents, in all material respects, the financial condition and results
of operation of Inter Parfums, Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 50%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
    March 1, 2022</FONT></TD>
    <TD STYLE="width: 5%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="width: 45%; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Jean Madar</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jean
    Madar,</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
signed original of this written statement required by Section 906 has been provided to Inter Parfums, Inc. and will be retained
by Inter Parfums, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>

    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>13
<FILENAME>g082622_ex32-2.htm
<DESCRIPTION>EXHIBIT 32.2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
32.2</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CERTIFICATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned hereby certifies, in accordance with 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act
of 2002, in his capacity as an officer of Inter Parfums, Inc., that the Annual Report of Inter Parfums, Inc. on Form 10-K for
the year ended December 31, 2021, fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934
and that the information contained in such report fairly presents, in all material respects, the financial condition and results
of operation of Inter Parfums, Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 50%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
    March 1, 2022</FONT></TD>
    <TD STYLE="width: 5%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="width: 45%; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Russell Greenberg</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Russell
    Greenberg,</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Executive
    Vice President, <BR>
Chief
    Financial Officer and <BR>
Principal
    Accounting Officer</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
signed original of this written statement required by Section 906 has been provided to Inter Parfums, Inc. and will be retained
by Inter Parfums, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>

    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>img001_v1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img001_v1.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@!3@(M P$1  (1 0,1 ?_$ *   0 " P$! 0$!
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MCX_RP_I$RY4/9/+ & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@#
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M@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# &
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M6DLS3"Q"QW-,LS=(Z?+-,RT_K,S,S\R0XZ _O@\?'^6'](F7*Y*3RP!@# &
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M & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & ,
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MR D%,-VI#J8N*]Z7M;L:H7;*$BVB2HM$E:&$W1HMZ%JF?"R+ & , 8 P!@#
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MII)15J-D<J[I.$3^0*^M;'LAP8'.N&-I>6IN:B!)T3_"F "5*6D2Z3X!ZIL
M8 P#!G1F-J)&WS%1'F,^7-+,ZQUJE)S2@-D;9'WU8T.+XQ-[X-.)S1,SRX,"
M ]6E+-"0H.1)QF!$(DO8?2.U2VK7,JMWC\D1\19X?)XN_I_EXO-=X^[KV>6S
MMZ=[=3_N0BV?DM;,R1/SVLT0K,O7_&66(5ICI,Q$1/Q!G,\@8 P"!O0']\'C
MX_RP_I$RX!/+ & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & ,
M 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# (W=)]@\Q
M\?15FF?3%UP6GF"2OFXO%C94YCTYRV3Z3B5?AN(1UN(7R*5R$2</JTA;DJE4
M+6]?0&][U]0*M^V/*;>[%TFU>.;B7EF=S#K.ZX&5(*IO2RU<+9^>(#$'%M:U
MTAOV6,+?*':VE5;5HA<S2-J7%A:$3O*TH&1(:I4FA ,#X>1/$1=M><>**!O_
M +%G,-M&==$2#H*_+BX<<G:GK+Z!5RUG2%RF-79><]332T)BY2"0;4'*9!'
MP164W!2H&Y,VITI8= 6P1GDSFR)V^/H=JI2NCNACXBS059?[Q%VI^NU?%6)B
M11M$SK;2>$RV:G)3F9N))5:^9KYGMZ$?[@M?7 )#X P!@# & , 8 P!@# (&
M] ?WP>/C_+#^D3+@$\L 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@#
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M](F7*AZ)Y8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@#
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M*EFPF%!T3LL/J#NJ>BR' & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8
MP!@# & , 8 P!@# & , 8 P!@$?UW67+#8M6-KETOS^WN+>J4(5Z!=<M=)%J
M%:D-&0J1K$I\C+/3*DQY8@&%C"$8!AWK>M;U@'7HI+XG.V%!*H/*([,HPZ:/
MVV2.*/3;(F%QTE4G(E6T#PT*5C>KTF6)S"C/;,%Z#0"#OZ"#O6@-BP!@# &
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M'T[A7FUNDPL<DO#A/AB,J?9&8ST_5-E=DVVB(^28)43_ ##MF1495B5P.1:
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M(G()K*BX<&/ 5P.GH%*KBMEU7R]W3L$4;&*LZ^;'V6+5$@>50""#AIRD9?\
MJ,./*) 88$#C#2?VS=-H498[6YPKFCE%96S;++2HRPH"IDO8,CG4F9GXI37$
MCE,=GZJJZ<:848L;%0UC,?)7-6M3J$_K3%[ 9H#IW+''7/G&4+?830,+61Y/
M,).NF\_E4GEDNL>RK+FKE_I62VR+.L)\DT\G+^(@(2"CW%P4?%2%EIR-%$%E
MEA D]@# & , 8!!KM+ONGN,&^&1U[0R*V>B+D6+F+G7E6JDY#_=]ZRA&G&<H
M2Q>.Z,U]GB+(#7O/<E<=IV1B1Z$>K/#H.@B X#RMP_:TLM]G[L\BSW&[(ZX1
M)G75(5!%%"Q?S]PK$I0UH6]XAE.(5QYA,RMIX1)?:DMAK2ON2\1IR1MTA:Q;
M(. MCP!@# & 8.12:-Q!H5R"6R!CB["@!LQ<]R)V0,C0B+UK8MF*W)S4)D:<
M&@AWOZC'K7TU@$!6'RT^.V;7-%N?JLZA@]XVW+I.@B2&+\^H)7?J=G<G!4:B
M"LFLHIZ/S6(5_'4:DD05;J]KV]N1_3ZG'%ZUO> ;UU):'=T7D\9AO'7*526^
ME>F(]RD=OWMT?_)JNH.Z?-4HTL?%$XC6]JV?,' 1!0%9IB= B1 (," *@9WK
M 6!7Q=_'_EUN:)LE@6CU)R1.)73=HU#T)6O'=8\WJ832=ASRDK-C5E,T0G'0
M%N3*U+/;3' B/F(VE[;6II^TNYI#D:0<$C2<('4KKLKHKO"$1+F:(\8=#\[(
MYQ-ZP?.@[9Z.2UQ&XI34%K>Q8/8LL8H(? [3ECE;=I2X,>&T1U2P^ZQH3S1.
M2Q<6!,!,I N1P!@# *7VGRH3R>^5>7>/JHN?FR<PFEV!P*OV6J;*88K<$4>%
M;54$B9+(C]:RP;"V/-'MR"T"D!J@MP.>GM?I4:W)/8:A!<I?7*VYOA.3]@L6
M5XW+=--+(RLRZ*FY!&IU5MVM7.RS%*9&26BKK3;IZ4:VMQ??:87UZSBL-+>7
ME]ZI<];1*1.:WMB'S//XW/FB?-KZRM:IUIJ=]:Q19D)OY9%_.LUFT7[2YU(Y
M[+0<PWCUK F>,7A'KPLM95]"/;.RR=KMR)Q>&L<+K2<2<4B1&Q].Q2J<-*_7
MR"CG)*H3B)'5SN^KB=;Y5\_L^+^*A\E7RC6<S?.3'17H>*^NA-<11J5J5IK[
MUMSWZJ>KQ>G \\MBSHRKP6[?MRUZK/PGK@HG7=IFA>^?J/E1[ZFFR-/;XTOR
M47/-:_.I\M:V+,$[B5DT TQKJ5EL+E2NH!1L>N5?+8C.7+M<TX%!+W:V%-.Q
MAZAJ!(!L<Q3+TQ%T-C^F=7M"!Z#\82G53B]6O91Q/&-59R[<SR7&7=[,F>O1
MQ/'IRNVQ+E2Q[<OT75\]K44V6VSXK**/EXQ,O)\?.9^9Y)KLWKD\!1S%5GC[
M[WRZ=C\?50U'<M:[IVQ52U*Z;*%C12_VIB7A)U\=]/D=5UA(Y:LB*>OYY6UM
MVE0UNP1!*=3EGBEJT]*UL3EJ&.37<?B*B6Q1<:F*7-3BH:&A6J;U9(U"%&?[
MB<N&RO%;QV#F^*M>_AN3QQIH=TBJSM\EM%E=M</8JV4Z*+J7A++$EJ^Y+&1H
MF;5RW8^7W<%L\<<A@MI6SQM+I*Z<F;=0ZLR5M^>;72S1*1*62]?5NWNGG70'
M]\'CX_RP_I$RY5/1/+ & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8!^1
MYY*8DY2I.*3ITY1AYYYY@"B2"2@;,-..-,V$!918 [$(0MZUK6OKO /.OY3O
M(YX^+&;*\Y60:;^_9PDZ<H)VL7EB@ZQ3]3A?6A@L!"H.@\Z))1.%*,;U)7()
M2) V2MZ; *E>_P#5Z2R3S2@(3]7\:V1+^=;4M"I_"_XK_&[$(LRMTECMDVE5
ME*V7V2T&MTC91MKO%8%S= V.N:IE(E6O>(4CL9X4HB @]Q.%2:82C M^_P#B
M14W"I"Z=X=W]H=C"- ,*RLT%E;Y+YO$$T\*@TC5,<J%UHL?D>_; 4$$D?Y",
M*<'H]>]FJ!G@3NYZXOY'Y,;!M',W-5(T6F.V(2U165;16*.[J8,DM.-0]OS6
MV$/CZK&G) 6(Y8H/-$6 (=B](=:T!)G & , 8 P!@# & , 8 P!@# & 5:][
M\D<$3PF2= 7/$7^%]!5G %\U9;QY5-EL1[?01>)G?0@,$<Z6)';%B-Z1V7@(
M(9E21Y9C5:@(#D@M"W@%:3!)O/U#*OHZTJO6.G1'-^IRFE%A5=T%3-,TOY;=
M5"S3->CW#EJ,-A%\A2,^2Q)"6N"K4E1N9EMZHLHQ'IW";H0$Q?'OT+XHVJW+
MBBE'LYG,?:%U2Y?-K^J3JYFF]8]BS61*7YU5IBW=3>;@ME-GQ*/N+ZI3,8(V
M[O<:;DXA)V\1998P! NRP!@# & 1)OOOCB/EB7-D Z4ZUYVH:<O,<2S!IA]M
M6]!H%)7&)KG-W94,E1LLE>FYQ4,:QX8%R4I4$O9)BA&>6$6Q%#T$#X:8\AG!
M_1;Y(HS0O8W,]PR&(0]SL&5,M<W57TN<XW V1:UMKS,WQ&RORL]KBS0X/:,E
M4O.T!*G-5DA&,.S :V!!>5^2ZS^OY$\TOXA(/'+V/;G(4>L3O2Q0/*#A^EQ[
MV:0X'0.2($7R>M;&:-@]1;%$3_LI8Q $O>4P-Z 8!*?C#QY5SR<ZRJW99-)?
MTSV':J8)5T]@71IK7VI,TWR=+2H7$D;:E2QVHJ=8U(0A:HE'2$;6E*)*V=I2
M>7[^P+!< QCP],T=;5;S('9L8V= 5LY<ZO"]*V-J,D/_ (C5:Y::0E3E:_[Q
M#%K6 5CSKS0^.&*213!(9T$1TG9:94:A,K'CJ#V!UW.2EI)IJ<Y,N:N>8Q8:
M=D&4I)$2(3@>D+T?KVO5[F]!P"5?2$VZL::VC3MQW3-46K8TC>&XEP:>@K6E
M-&1B%Q=>S+UILC=!QVKK.DST[-[H!(F-90(T)WH/-,VH",C1)H$,&#F?ROVE
M)H])>B/(G65(1=I?&][74SPUS0QHDSV0B<"5NXY([OZ9=K=E3LSFIR?C'C;8
M]'S501C'O16MA* !,SHOB;DKKQP@#CU%SW5U_#JX]]4P-!:\7135ACRB2@:R
MWTXF,O85<=6&.1;*E"9M2E.WZ20ZU]-?7Z@=R@]=5]6+&1&:U@L-KV-IM "F
MCT'C#)$V-.$L/I $AI84+>@*T ._IK02]?36 ;C@# & , 8 P#SY=B>-CJ#I
MKR<<\]'(&'FB&5_1AR:<Q'J"!ER*#=,-B:'S2I9$FH*P4>P2-1/B)TD9Y*SE
M/R=P3L:.+R1T)/9 +"2/O,WJ6F[UW7R?-JE4<J^=D6KN:,W(3;EY?-77H14F
M::ZIU8+]MCSHLMLP9)R0OD?Z$GM7;S7K^+U_-99]5[^EK61#688BS-=9JRSW
MI%MCM1,9JHC/X;79[K;D7I9RNGO$CU[9J3R#J/("3SO*[K[\K"R*N>NK*NZ6
MMVQGVFJW<!';J.B*<YZG7(]51R%U-"3E 5;D<":GKWA<FT<H*-$9KV/.68XO
MU#)Q'#M%7.X^2P\K9;8GE7DN4PZJ]-=NUU>JRK,D5Q53GJBR*JF=$E9F&6[;
MO2_W>OV'12MG!54WXJ,T--<X^/TT-5H\3=MD6[-#3#6WOXEEI[U2)BQ=';7K
MQ=="6,X3[HF?N5%1_JDJV.&K(J^#Q2>61(J-6)N#A/H8TSS6?NE6Q>:L9MT$
M3-\TN.1Q=UU$_E)?: ^[1F"6:&;E&XOD*.:X^KRZVY_F>3OIL?L18YKAZ^%L
MRUWJEDV?5HK70FEL]/V+NM;9Z*Y[HYNOA\^SC9]:Y:^U>%J]9R<15=2BS:S8
M^4_EUVOG=H58MTUYJGQQJ?MHJL[-GDNB:[%^"^9)9S'5=AH[%6Q53:-Y=#7=
MTQ9:"".CV^P6,2VZIDJDAD+B$ADC'%7V2L</9PHV\+HJ:6@YT-3F*MH4?O:3
M%593!@X/B?6N*:VSCN)P?76RU52RUGT:-=]LUJ]D5PVC3;XZ_+9*50BS8[1+
M3HZGLY#V'D_8[JUJOY&[-/C5YLA$Q\?CXVK\Y2ON9ZL26OT186RQD7N58:=$
MNJ'Q]B[]X?DK8D4DO,P,Z<-D"@UU=UI"L;-338E;]IF]<O4MK5HDA0/0M)"2
M-&[WH1GJ%K6]53T6,8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P#F=N714
M5 P5XLZ\;/@50UW'RO=>9M9$L9(;&&_6];V64>\OZU A^4H$'TDDZ'LTX>]
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M1+9V4Z-13-()0H<D 5JD_P"&42:J&/>B@ %Z- =0@5;5U5<?21.L(#"JXBJ
MHHA#&8%%F*'Q]&20#VB"4C-'D#<W)RB2]>D 0%ZT$/\ #7\, W7 & , 8 P!
M@# & , 8 P!@# & 0-Z _O@\?'^6'](F7 )Y8 P!@# & , 8 P!@# & , 8
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MD1IBM;WO12=,G 6227K>_P#PA#K6 ?7@# & , 8 P!@# & , 8 P!@# & ,
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MMY/#.Z$N\4STTT:8KRV:;)FM<].K(]+S97=5L]>Z(W!4\*G'0T-M[+&T6_\
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M@%L80Z#K00ZT$(=:"$(=:UH.M:^FM:UK^&M:U@']P!@# & , 8 P!@# & ,
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M(5N(DM/M!:42]246$Y8),68()>S!"] 1;UKZ:WE4]%@. , 8 P!@# & , 8
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M!@# & , 8 P!@# & , C+T-V=RGR>T1A\Z-OZLJA03=]5Q>%!E\F1)'&8R-
M8C*<&*)LJ<2EYDCLWF.*?1Z=$G/-)V>#UZ#ZP_4#3C^K9@_7?/Z&K;E/HQ[6
M0N&O3LGOB?0]+5/+;S-@PYHE,0A+99$G<1SB4$2)2]%(%;O&XH_M[2L)4$G"
M$>G.) !#[HVP>I(AQ>]6?W'U5!/'(X-]G->GN2\2Q=TZ3D6H!)--L8A=3L+O
M<=-R!V?[:F$W= EZ51^##/$,PA&A*&/UJC (?-$BD=]=),W6W'?B(NJX;T:X
MVT06/=O>36SGKE>!QR/((5N#NDCIZEY>CLVV8PKF3*X'IGH^-5="B9#HQ6H/
M4'@VG"K N;Z-Y9/Z/K^%5L7?-^<V11C<2EDN;>4YLSU.Z3EFTS*6X4$53LJ(
MKYU%8F4J4:.".-+6%Q'HO0=J Z^F@@<UYR\7/!/*TA+GE2<VP7=N>\<K6WS9
M&G6Y>@G9>I4$JE*]TO*VG&:6BI4&J$Q6PATZ!)) 2442 LHHH  )^8 P!@#
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MH-#- (>O5@$M\ 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8
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M@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# &
M, @;T!_?!X^/\L/Z1,N 3RP!@# & , 8 P!@# & , 8 P!@# & , 8 P!@#
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M.!C\B->&A<1+0+*:;#7 Q,V(3S')GTT'E@*%I6 O9VS-"+^H=;WE,^%C& ,
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MK269IA8A8[FF69ND=/EFF9:?UF9F9^9(<= ?WP>/C_+#^D3+E<E)Y8 P!@#
M& , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8
M P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@$
M#>@/[X/'Q_EA_2)EP">6 , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!
M@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# &
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MF59>L=?E6B8:/UB8F)^8(<= ?WP>/C_+#^D3+E<E)Y8 P!@# & , 8 P!@#
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M2,\H?R5IU\F(TC@RPF+P)*2T%D(TYZ=&8SQ),88$XQ0/:D9@M#"#82P ;O\
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MA-4PI2.'HFMDKJ#P-M 3N8)R'HI>>7$Q&'EBV<7H0M# 9]!^T4!)7 & , 8
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ML::;LE.ED693)?OS1LQ5:);MGKIS/78CU+;2C6U4W6U7V)4T^LA)Q@# & ,
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M?@\V37<LS,<AOJT:WLW=S=MMD?6LS4K?HJIU7=C1?7VUTS%LN91JC & , 8
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M99=$7/,US#)X]%>TUKX_.A8UT_4<-<(&L34O2/DKZC\B1'0PY;79\5FL9O\
MK^SV^.4\U0E+*3+8;K-CDXM(TIS,6Q]/'?LS<%2F=3U2G:%/4]/T5\9@XY^0
MZUZ^%]/Y#@T3IU^S9KY*NVG37*]ZK0F%6:_S-3<NR5IJINHZZ"][;??RF[EE
MQU0^?GN9X3>SP_2,B\5@R4:*K5959[;M6-?K+3%M<Y[9>ZZJVOPV>A3*)[&
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M@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# &
M, 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P
M!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# &
M , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8
MP!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@#
M& , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8
M P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@#
M & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & ,
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M7#'&Z*NQL[67%+OYML<3:&2K*?C9<!:K7*>OMPVAHVRCV8;MN/,1>QH %B.
M5^>5"+<MS7@'I.+]J61-*BY?=X@U$6[8U>(5CG,XLP@ET=/1+6)"@@5GJU"D
MY]*2$BT!A<=Z*-%OVPZULP%;I3_.\);UG^2KY_CGR)_ZV[4U5MEILGI\5VW0
MJ/,M7$+,S-M?^4;G 6<C5IT3QE:673QN];(:>D+G;%>NEX_)?RKSS8Z1UF9=
M8B$>?P:&EFU]XQ'ORF<YO:B\IW#_ ")LG$UC1ZN(A7K0X*EDOYV?8L]HPSJ<
MJ?Y/2ED33&&-Q;BJCA*ET:U1IQAFMMZXO11(?NM(MGW[M:RJ-/&37S?BZS&1
M/L9G:[-\/W:IGZM317]EO#XI\43TL.7H^G5Q7HJW=EF#-RD6<--O2)U/&.U/
M#H_QE<C5>>WJ\9D\T70ML-Y*RN9%6W_2[N''M1UM7_0/+C%-4[U2S97O05:,
MM(G>55?:33:L7.B<B=&5)23QTB"TY-.TI)3^!;""=EH5*C:A*D1:V,KIL=VZ
M_P!SX3;ZQ513N3;BLR9^/F)Q6*M,371>U3V5QCLI^-4W7I$3+>:ZN[K,2[NS
M/Q?L">U^6^I\_+KR#<CY(T)Y&TQK>KR>.^=%#M9.**%=Y[*OKI<DK#VC=?4M
MS5)X5V7.>BNN>\:ZY,8F@!?8]-2N-2-=SQ,XZDBC;MY/K5TN#F.=6JEA[HRB
M(TX:H:5M+.%T";Z DN?ROKR]<\?GHQ:N3C/?Q;\Q_P!:G7VQ":YV1%<6S/CU
MSF73*-1]^U\/@6.SKA\D-K85Y6[>F+A&MJ]@KX]>[15VS-F>,[2T,KP_'Q?-
M"VKH\-%>ONL;S=-$4RF+!07)]D]M/\IY@[=Z1Y_O9)PMS^A?ZVYLB=%O-<.?
M'B*23912SPP+[KY$NQ&68[N"AP()#&7].\!3$$["03K99AFMICDLR^T:.9F_
M1EGV%'YBJSNAHY&,73Q]:/'K_/*KLTYK)Z.[=+%LBM4YS//#Z./]8S\1%-%<
M<'I7B+:_F)P-HS^5^EWDS_A?.:%C37$S"QU1D\LSPRSH=X+C(CXY9)T!:T#(
MYCC"?HUFYC@'4#<3OE:Q+'= &!MZ6=$+>@ZV.:T-YQUU0NHD1<U>V):-[6./
MMHU2\/T(@A\R^P/;<F-N2N]3Q+D1_%XZ.'5L#YGXR9F$EGIG!4T5-=?&.%GL
M1//9.G>FB>)U4P]T45>WWOR#U?\ +=R\_P DEM6V*UF8SK=.ZWJJ59/,M438
MU?UJY_E6P_P2)6/R6RVB+5J]QY@D5:T@T=@5AS4W-(.0X(J:VZ0?RZE-*N'.
ME;H$*R^9&-5KY!<,D+R_@>$[?Z$:5RVF]W[5&Y?7,F>9TMEM]P5^.M;O^S5R
M_;QJ)3@CI%DU>2,-JS%=M/F9XBWL\]<24SE;VBFW-&%>7J]<T+I3_K^&[C)M
MVO;9RLO,U0JU_>JZ:GJ_Z7EF4:KI8?'&J!XEB?DOY]DS]W-V)8_7'XG&^5=7
MG2]</JNDC_DT,[DN<&:5T4YPI&HVCI5%0RP@W;E(WQRM0IH2)].?S"A^@=[U
MQMF??R5?'K7?I7C^238WXJ[TOJP_:MQ,DKG6BGDJ\S:EXVF<MDW::[DAY2W-
MC\U55?PG'VW6Z*.%G5@;,BPS5*R6;)S5[8E6T-%M;ZDQSR%RO7;7GLSM,*].
MFTGL**<\S>><PQBP;-GM/=(NL^FA')%BTV@$YV_&Y9_+YY%8ZQG0N-?6E7Q\
M&_ >C0ONILQ+X=Z]HOE@^9]OWK(P576\U=_$6S5S"\3<VCMBJ>[CHTY)N2WS
M(]?C;5]2*YCMT>;M^JZOW2;NBQ:^!MGD:ZK.$G=EB._K$KNF+_JMG[&6[[*U
M_:G]GK_U?M>=6R^>"-MQ5UR/':4F\#ZQOKL">*-]/<_HTMU7.SVZCGP>HU$D
MA@>?G7F)JA%,0RF?4BEOV\7IJZ);AVUGS/O))F_N6LM8_/LW<)7P'3)SWV]J
MX73MG5YHR:(W/=&SS-X&Q_:EHUK_ !_UYM^NBU?$>'A\F7E+.6FO5P_\-#;%
ML\<9_H3>\UI/UHJ7[*72BK-;?ROD7'WNUGUFF/-_4]XU&R#],U]T_P!5WG(;
M717[PT[]0WG+8ZV$= .\O0V3%GCC>+'-%=<W,=9%4\\24@#4F,A\.2L(3#G0
M:E80YZ<5@+7 7N_*^NZ?7*:U;/[;?.6I9?QZ><7 JZ8US;9-BN^*:;([K,]$
M4K1&64H[4:ASM/3AN8IYZUYQW^G6K;9,)WYN$;5=Y'S16D0SIJB[RPR7ZI>5
M^PCQX.F-Z>JOQ7/(_*3_ #DZ4NN)BFG1'!CKV?J/L3PIU4EK1G=4_P#&:,U[
M[% R7[DR6'M"R?>#"/Q. CYAWN*VST[]BIZK-E"^L?PL1=%/O^R_C^_X\_--
MX/L8[>O9TSITK[6GPK/=/34__K<]BZVV\U/*_M/9_7#4:^WY\7 ]>5Z[4Z=_
M75^>W\(\C?LU_P#4^8\L/HU7_,DJNKSB2#L*\+JK7EJ(>02B%]Y0>.M(U]*6
MFQ#IRA 0AEM56&H)_*&^-DSCXPGD<5>(X?M%[/WT\37[>L]^F]M/J'J.JO\
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=V^*.$C=9$4),QY^V>2F6ME+IY/[,4^2Z(\2S_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>15
<FILENAME>ipar-20211231.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.12a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 9qw5o7xRiXgen8uEZ3ZcSauJuaOdz511+ZlBtWl+HblKLy4jqZAJByLXQJkmwfgM -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:srt-types="http://fasb.org/srt-types/2021-01-31" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:ipar="http://interparfumsinc.com/20211231" elementFormDefault="qualified" targetNamespace="http://interparfumsinc.com/20211231">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://interparfumsinc.com/role/Cover" id="Cover">
	  <link:definition>00000001 - Document - Cover</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/BalanceSheets" id="BalanceSheets">
	  <link:definition>00000002 - Statement - Consolidated Balance Sheets</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/BalanceSheetsParenthetical" id="BalanceSheetsParenthetical">
	  <link:definition>00000003 - Statement - Consolidated Balance Sheets (Parenthetical)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/StatementsOfIncome" id="StatementsOfIncome">
	  <link:definition>00000004 - Statement - Consolidated Statements of Income</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/StatementsOfComprehensiveIncome" id="StatementsOfComprehensiveIncome">
	  <link:definition>00000005 - Statement - Consolidated Statements of Comprehensive Income</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/StatementsOfChangesInShareholdersEquity" id="StatementsOfChangesInShareholdersEquity">
	  <link:definition>00000006 - Statement - Consolidated Statements of Changes in Shareholders' Equity</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/StatementsOfCashFlows" id="StatementsOfCashFlows">
	  <link:definition>00000007 - Statement - Consolidated Statements of Cash Flows</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPolicies" id="CompanyAndItsSignificantAccountingPolicies">
	  <link:definition>00000008 - Disclosure - The Company and its Significant Accounting Policies</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/ImpactOfCovid-19Pandemic" id="ImpactOfCovid-19Pandemic">
	  <link:definition>00000009 - Disclosure - Impact of COVID-19 Pandemic</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/RecentAgreements" id="RecentAgreements">
	  <link:definition>00000010 - Disclosure - Recent Agreements</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/Inventories" id="Inventories">
	  <link:definition>00000011 - Disclosure - Inventories</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/FairValueOfFinancialInstruments" id="FairValueOfFinancialInstruments">
	  <link:definition>00000012 - Disclosure - Fair Value of Financial Instruments</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/DerivativeFinancialInstruments" id="DerivativeFinancialInstruments">
	  <link:definition>00000013 - Disclosure - Derivative Financial Instruments</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/PropertyEquipmentAndLeaseholdImprovements" id="PropertyEquipmentAndLeaseholdImprovements">
	  <link:definition>00000014 - Disclosure - Property, Equipment and Leasehold Improvements</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssets" id="TrademarksLicensesAndOtherIntangibleAssets">
	  <link:definition>00000015 - Disclosure - Trademarks, Licenses and Other Intangible Assets</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/AccruedExpenses" id="AccruedExpenses">
	  <link:definition>00000016 - Disclosure - Accrued Expenses</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/LoansPayableBanks" id="LoansPayableBanks">
	  <link:definition>00000017 - Disclosure - Loans Payable &#8211; Banks</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/Long-termDebt" id="Long-termDebt">
	  <link:definition>00000018 - Disclosure - Long-Term Debt</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/Commitments" id="Commitments">
	  <link:definition>00000019 - Disclosure - Commitments</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/Equity" id="Equity">
	  <link:definition>00000020 - Disclosure - Equity</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.CommonShareholders" id="NetIncomeAttributableToInterParfumsInc.CommonShareholders">
	  <link:definition>00000021 - Disclosure - Net Income Attributable to Inter Parfums, Inc. Common Shareholders</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/SegmentsAndGeographicAreas" id="SegmentsAndGeographicAreas">
	  <link:definition>00000022 - Disclosure - Segments and Geographic Areas</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/IncomeTaxes" id="IncomeTaxes">
	  <link:definition>00000023 - Disclosure - Income Taxes</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/AccumulatedOtherComprehensiveLoss" id="AccumulatedOtherComprehensiveLoss">
	  <link:definition>00000024 - Disclosure - Accumulated Other Comprehensive Loss</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.AndTransfersFromNoncontrollingInterest" id="NetIncomeAttributableToInterParfumsInc.AndTransfersFromNoncontrollingInterest">
	  <link:definition>00000025 - Disclosure - Net Income Attributable to Inter Parfums, Inc. and Transfers from the Noncontrolling Interest</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/ReconciliationOfCashAndCashEquivalentsToStatementOfCashFlows" id="ReconciliationOfCashAndCashEquivalentsToStatementOfCashFlows">
	  <link:definition>00000026 - Disclosure - Reconciliation of Cash and Cash Equivalents to the Statement of Cash Flows</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesPolicies" id="CompanyAndItsSignificantAccountingPoliciesPolicies">
	  <link:definition>00000027 - Disclosure - The Company and its Significant Accounting Policies (Policies)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesTables" id="CompanyAndItsSignificantAccountingPoliciesTables">
	  <link:definition>00000028 - Disclosure - The Company and its Significant Accounting Policies (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/RecentAgreementsTables" id="RecentAgreementsTables">
	  <link:definition>00000029 - Disclosure - Recent Agreements (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/InventoriesTables" id="InventoriesTables">
	  <link:definition>00000030 - Disclosure - Inventories (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/FairValueOfFinancialInstrumentsTables" id="FairValueOfFinancialInstrumentsTables">
	  <link:definition>00000031 - Disclosure - Fair Value of Financial Instruments (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/PropertyEquipmentAndLeaseholdImprovementsTables" id="PropertyEquipmentAndLeaseholdImprovementsTables">
	  <link:definition>00000032 - Disclosure - Property, Equipment and Leasehold Improvements (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssetsTables" id="TrademarksLicensesAndOtherIntangibleAssetsTables">
	  <link:definition>00000033 - Disclosure - Trademarks, Licenses and Other Intangible Assets (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/AccruedExpensesTables" id="AccruedExpensesTables">
	  <link:definition>00000034 - Disclosure - Accrued Expenses (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/Long-termDebtTables" id="Long-termDebtTables">
	  <link:definition>00000035 - Disclosure - Long-Term Debt (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/CommitmentsTables" id="CommitmentsTables">
	  <link:definition>00000036 - Disclosure - Commitments (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/EquityTables" id="EquityTables">
	  <link:definition>00000037 - Disclosure - Equity (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.CommonShareholdersTables" id="NetIncomeAttributableToInterParfumsInc.CommonShareholdersTables">
	  <link:definition>00000038 - Disclosure - Net Income Attributable to Inter Parfums, Inc. Common Shareholders (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/SegmentsAndGeographicAreasTables" id="SegmentsAndGeographicAreasTables">
	  <link:definition>00000039 - Disclosure - Segments and Geographic Areas (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/IncomeTaxesTables" id="IncomeTaxesTables">
	  <link:definition>00000040 - Disclosure - Income Taxes (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/AccumulatedOtherComprehensiveLossTables" id="AccumulatedOtherComprehensiveLossTables">
	  <link:definition>00000041 - Disclosure - Accumulated Other Comprehensive Loss (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.AndTransfersFromNoncontrollingInterestTables" id="NetIncomeAttributableToInterParfumsInc.AndTransfersFromNoncontrollingInterestTables">
	  <link:definition>00000042 - Disclosure - Net Income Attributable to Inter Parfums, Inc. and Transfers from the Noncontrolling Interest (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/ReconciliationOfCashAndCashEquivalentsToStatementOfCashFlowsTables" id="ReconciliationOfCashAndCashEquivalentsToStatementOfCashFlowsTables">
	  <link:definition>00000043 - Disclosure - Reconciliation of Cash and Cash Equivalents to the Statement of Cash Flows (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/ScheduleOfLanvinBrandNameForOurClassDetails" id="ScheduleOfLanvinBrandNameForOurClassDetails">
	  <link:definition>00000044 - Disclosure - Schedule of lanvin brand name for our class (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesDetailsNarrative" id="CompanyAndItsSignificantAccountingPoliciesDetailsNarrative">
	  <link:definition>00000045 - Disclosure - The Company and its Significant Accounting Policies (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/AllAmountsHaveBeenTranslatedToU.s.DollarsAtOctober12021ExchangeRate.Details" id="AllAmountsHaveBeenTranslatedToU.s.DollarsAtOctober12021ExchangeRate.Details">
	  <link:definition>00000046 - Disclosure - All amounts have been translated to U.S. dollars at the October 1, 2021 exchange rate. (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative" id="RecentAgreementsDetailsNarrative">
	  <link:definition>00000047 - Disclosure - Recent Agreements (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/ScheduleOfInventoriesDetails" id="ScheduleOfInventoriesDetails">
	  <link:definition>00000048 - Disclosure - Schedule of inventories (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/InventoriesDetailsNarrative" id="InventoriesDetailsNarrative">
	  <link:definition>00000049 - Disclosure - Inventories (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/ScheduleOfFairValueAssetsMeasuredOnRecurringBasisDetails" id="ScheduleOfFairValueAssetsMeasuredOnRecurringBasisDetails">
	  <link:definition>00000050 - Disclosure - Schedule of fair value, assets measured on recurring basis (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/DerivativeFinancialInstrumentsDetailsNarrative" id="DerivativeFinancialInstrumentsDetailsNarrative">
	  <link:definition>00000051 - Disclosure - Derivative Financial Instruments (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/ScheduleOfEquipmentAndLeaseholdImprovementsDetails" id="ScheduleOfEquipmentAndLeaseholdImprovementsDetails">
	  <link:definition>00000052 - Disclosure - Schedule of equipment and leasehold improvements (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/PropertyEquipmentAndLeaseholdImprovementsDetailsNarrative" id="PropertyEquipmentAndLeaseholdImprovementsDetailsNarrative">
	  <link:definition>00000053 - Disclosure - Property, Equipment and Leasehold Improvements (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/ScheduleOfTrademarksLicensesAndOtherIntangibleAssetsDetails" id="ScheduleOfTrademarksLicensesAndOtherIntangibleAssetsDetails">
	  <link:definition>00000054 - Disclosure - Schedule of trademarks, licenses and other intangible assets (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssetsDetailsNarrative" id="TrademarksLicensesAndOtherIntangibleAssetsDetailsNarrative">
	  <link:definition>00000055 - Disclosure - Trademarks, Licenses and Other Intangible Assets (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/AccruedExpensesConsistOfFollowingDetails" id="AccruedExpensesConsistOfFollowingDetails">
	  <link:definition>00000056 - Disclosure - Accrued expenses consist of the following: (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/Long-termDebtConsistsOfFollowingDetails" id="Long-termDebtConsistsOfFollowingDetails">
	  <link:definition>00000057 - Disclosure - Long-term debt consists of the following: (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/LoansPayableBanksDetailsNarrative" id="LoansPayableBanksDetailsNarrative">
	  <link:definition>00000058 - Disclosure - Loans Payable &#8211; Banks (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/Long-termDebtDetailsNarrative" id="Long-termDebtDetailsNarrative">
	  <link:definition>00000059 - Disclosure - Long-Term Debt (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/MaturitiesOfLeaseLiabilitiesSubsequentToDecember312021AreAsFollowsDetails" id="MaturitiesOfLeaseLiabilitiesSubsequentToDecember312021AreAsFollowsDetails">
	  <link:definition>00000060 - Disclosure - Maturities of lease liabilities subsequent to December 31, 2021 are as follows: (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/MinimumAnnualRoyaltiesAndOtherCommitmentsAsFollowsDetails" id="MinimumAnnualRoyaltiesAndOtherCommitmentsAsFollowsDetails">
	  <link:definition>00000061 - Disclosure - minimum annual royalties and other commitments as follows: (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/CommitmentsDetailsNarrative" id="CommitmentsDetailsNarrative">
	  <link:definition>00000062 - Disclosure - Commitments (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/FollowingTableSetsForthInformationWithRespectToNonvestedOptionsFor2021Details" id="FollowingTableSetsForthInformationWithRespectToNonvestedOptionsFor2021Details">
	  <link:definition>00000063 - Disclosure - The following table sets forth information with respect to nonvested options for 2021: (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/EffectOfShare-basedPaymentExpensesDecreasedIncomeStatementLineItemsAsFollowsDetails" id="EffectOfShare-basedPaymentExpensesDecreasedIncomeStatementLineItemsAsFollowsDetails">
	  <link:definition>00000064 - Disclosure - The effect of share-based payment expenses decreased income statement line items as follows: (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/FollowingTableSummarizesStockOptionActivityAndRelatedInformationForYearsEndedDecember3120212020And2019Details" id="FollowingTableSummarizesStockOptionActivityAndRelatedInformationForYearsEndedDecember3120212020And2019Details">
	  <link:definition>00000065 - Disclosure - The following table summarizes stock option activity and related information for the years ended December 31, 2021, 2020 and 2019: (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/AssumptionsUsedInBlack-scholesPricingModelAreSetForthInFollowingTableDetails" id="AssumptionsUsedInBlack-scholesPricingModelAreSetForthInFollowingTableDetails">
	  <link:definition>00000066 - Disclosure - The assumptions used in the Black-Scholes pricing model are set forth in the following table: (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/ProceedsTaxBenefitsAndIntrinsicValueRelatedToStockOptionsExercisedWereAsFollowsDetails" id="ProceedsTaxBenefitsAndIntrinsicValueRelatedToStockOptionsExercisedWereAsFollowsDetails">
	  <link:definition>00000067 - Disclosure - Proceeds, tax benefits and intrinsic value related to stock options exercised were as follows (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/FollowingTableSummarizesAdditionalStockOptionInformationAsOfDecember312021Details" id="FollowingTableSummarizesAdditionalStockOptionInformationAsOfDecember312021Details">
	  <link:definition>00000068 - Disclosure - The following table summarizes additional stock option information as of December 31, 2021: (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/EquityDetailsNarrative" id="EquityDetailsNarrative">
	  <link:definition>00000069 - Disclosure - Equity (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/ReconciliationBetweenNumeratorsAndDenominatorsOfBasicAndDilutedEpsComputationsIsAsFollowsDetails" id="ReconciliationBetweenNumeratorsAndDenominatorsOfBasicAndDilutedEpsComputationsIsAsFollowsDetails">
	  <link:definition>00000070 - Disclosure - The reconciliation between the numerators and denominators of the basic and diluted EPS computations is as follows: (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.CommonShareholdersDetailsNarrative" id="NetIncomeAttributableToInterParfumsInc.CommonShareholdersDetailsNarrative">
	  <link:definition>00000071 - Disclosure - Net Income Attributable to Inter Parfums, Inc. Common Shareholders (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/InformationOnCompanysOperationsBySegmentsIsAsFollowsDetails" id="InformationOnCompanysOperationsBySegmentsIsAsFollowsDetails">
	  <link:definition>00000072 - Disclosure - Information on the Company&#8217;s operations by segments is as follows: (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/NetSalesToCustomersByRegionAreAsFollowsDetails" id="NetSalesToCustomersByRegionAreAsFollowsDetails">
	  <link:definition>00000073 - Disclosure - Consolidated net sales to customers by region are as follows: (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/NetSalesToCustomersInMajorCountriesAreAsFollowsDetails" id="NetSalesToCustomersInMajorCountriesAreAsFollowsDetails">
	  <link:definition>00000074 - Disclosure - Consolidated net sales to customers in major countries are as follows: (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/ComponentsOfIncomeBeforeIncomeTaxesConsistOfFollowingDetails" id="ComponentsOfIncomeBeforeIncomeTaxesConsistOfFollowingDetails">
	  <link:definition>00000075 - Disclosure - The components of income before income taxes consist of the following: (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/ProvisionForCurrentAndDeferredIncomeTaxExpenseBenefitConsistsOfFollowingDetails" id="ProvisionForCurrentAndDeferredIncomeTaxExpenseBenefitConsistsOfFollowingDetails">
	  <link:definition>00000076 - Disclosure - The provision for current and deferred income tax expense (benefit) consists of the following: (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/TaxEffectsOfTemporaryDifferencesThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndDeferredTaxLiabilitiesAreAsFollowsDetails" id="TaxEffectsOfTemporaryDifferencesThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndDeferredTaxLiabilitiesAreAsFollowsDetails">
	  <link:definition>00000077 - Disclosure - The tax effects of temporary differences that give rise to significant portions of the deferred tax assets and deferred tax liabilities are as follows: (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/DifferencesBetweenUnitedStatesFederalStatutoryIncomeTaxRateAndEffectiveIncomeTaxRateWereAsFollowsDetails" id="DifferencesBetweenUnitedStatesFederalStatutoryIncomeTaxRateAndEffectiveIncomeTaxRateWereAsFollowsDetails">
	  <link:definition>00000078 - Disclosure - Differences between the United States federal statutory income tax rate and the effective income tax rate were as follows: (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/IncomeTaxesDetailsNarrative" id="IncomeTaxesDetailsNarrative">
	  <link:definition>00000079 - Disclosure - Income Taxes (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/ComponentsOfAccumulatedOtherComprehensiveLossConsistOfFollowingDetails" id="ComponentsOfAccumulatedOtherComprehensiveLossConsistOfFollowingDetails">
	  <link:definition>00000080 - Disclosure - The components of accumulated other comprehensive loss consist of the following: (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/ScheduleOfNetIncomeAttributableToTransfersFromNoncontrollingInterestDetails" id="ScheduleOfNetIncomeAttributableToTransfersFromNoncontrollingInterestDetails">
	  <link:definition>00000081 - Disclosure - Schedule of net income attributable to transfers from the noncontrolling interest (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/FollowingTableSummarizesCashAndCashEquivalentsAsOfDecember312021Details" id="FollowingTableSummarizesCashAndCashEquivalentsAsOfDecember312021Details">
	  <link:definition>00000082 - Disclosure - The following table summarizes cash and cash equivalents as of December 31, 2021: (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="ipar-20211231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="ipar-20211231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="ipar-20211231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Calculation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="ipar-20211231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2021q4" schemaLocation="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd" />
    <import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd" />
    <import namespace="http://fasb.org/us-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2021" schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd" />
    <import namespace="http://xbrl.sec.gov/currency/2021" schemaLocation="https://xbrl.sec.gov/currency/2021/currency-2021.xsd" />
    <import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd" />
    <import namespace="http://fasb.org/srt-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd" />
    <element id="ipar_MontblancMember" name="MontblancMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_JimmyChooMember" name="JimmyChooMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_CoachMember" name="CoachMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_GUESSMember" name="GUESSMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_InterparfumsSASubsidiaryMember" name="InterparfumsSASubsidiaryMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_InventoryMember" name="InventoryMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_OtherAssetMember" name="OtherAssetMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_GlobalSettlementAgreementMember" name="GlobalSettlementAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_AnnaSuiCorpMember" name="AnnaSuiCorpMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_RochasFashionMember" name="RochasFashionMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_STDupontMember" name="STDupontMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_LicensesMember" name="LicensesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_SubtotalMember" name="SubtotalMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_DomesticSubsidiariesMember" name="DomesticSubsidiariesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_LondonInterbankOfferedRateMember" name="LondonInterbankOfferedRateMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_ForeignSubsidiariesMember" name="ForeignSubsidiariesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_EuroInterbankOfferedRateMembeMember" name="EuroInterbankOfferedRateMembeMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_LoansPayableOneMember" name="LoansPayableOneMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_LoansPayableTwoMember" name="LoansPayableTwoMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_LoansPayableThreeMember" name="LoansPayableThreeMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_StockOptionOneMember" name="StockOptionOneMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_EmployeesMember" name="EmployeesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_OfficersAndManagersMember" name="OfficersAndManagersMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_ExercisePriceRangeOneMember" name="ExercisePriceRangeOneMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_ExercisePriceRangeTwoMember" name="ExercisePriceRangeTwoMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_ExercisePriceRangeThreeMember" name="ExercisePriceRangeThreeMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_ExercisePriceRangeFourMember" name="ExercisePriceRangeFourMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_EliminationsMember" name="EliminationsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_EuropeCountryMember" name="EuropeCountryMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_CentralAndSouthAmericaMember" name="CentralAndSouthAmericaMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_OtherSegmentCountryMember" name="OtherSegmentCountryMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_UnitedStatesMember" name="UnitedStatesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_FranceMember" name="FranceMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_RussiaMember" name="RussiaMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_UnitedKingdomMember" name="UnitedKingdomMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_ForeignDerivedIntangibleIncomeMember" name="ForeignDerivedIntangibleIncomeMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember" name="AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_TransferOfSubsidiarySharesPurchasedToTreasuryShares" name="TransferOfSubsidiarySharesPurchasedToTreasuryShares" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_SupplementalDisclosureOfCashFlowInformationAbstract" name="SupplementalDisclosureOfCashFlowInformationAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_DisclosureImpactOfCovid19PandemicAbstract" name="DisclosureImpactOfCovid19PandemicAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_ImpactOfCOVID19PandemicTextBlock" name="ImpactOfCOVID19PandemicTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_DisclosureReconciliationOfCashAndCashEquivalentsToStatementOfCashFlowsAbstract" name="DisclosureReconciliationOfCashAndCashEquivalentsToStatementOfCashFlowsAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_ReconciliationOfCashAndCashEquivalentsToTheStatementOfCashFlowsTextBlock" name="ReconciliationOfCashAndCashEquivalentsToTheStatementOfCashFlowsTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_ScheduleOfInventoryCurrentTableTextBlock1" name="ScheduleOfInventoryCurrentTableTextBlock1" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_RoyaltyExpenseNetSalesPercentage" name="RoyaltyExpenseNetSalesPercentage" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_CashHeldInEscrow" name="CashHeldInEscrow" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_DiscriptionOfRecentAgreement" name="DiscriptionOfRecentAgreement" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_FiniteLivedIntangibleAssetsAmortizationExpenseAfterTwoYears" name="FiniteLivedIntangibleAssetsAmortizationExpenseAfterTwoYears" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_DueVendorsNotYetInvoiced" name="DueVendorsNotYetInvoiced" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_NumberOfInstallment" name="NumberOfInstallment" nillable="true" xbrli:periodType="instant" type="xbrli:integerItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_Covid19Description" name="Covid19Description" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_RevaluationResultedInReductionOfCostDescription" name="RevaluationResultedInReductionOfCostDescription" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_PercentageOfIncreaseInAnnualDividend" name="PercentageOfIncreaseInAnnualDividend" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_DeferredTaxAssetsInventoryAndAccountsReceivable" name="DeferredTaxAssetsInventoryAndAccountsReceivable" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_DeferredTaxLiabilitiesBuildingExpenses" name="DeferredTaxLiabilitiesBuildingExpenses" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_DeferredTaxLiabilitiesUnrealizedGainOnMarketableEquitySecurities" name="DeferredTaxLiabilitiesUnrealizedGainOnMarketableEquitySecurities" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate1" name="EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate1" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_CashHeldInEscrowIncludedInOtherAssets" name="CashHeldInEscrowIncludedInOtherAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_CashAndCashEquivalentsPerStatementOfCashFlows" name="CashAndCashEquivalentsPerStatementOfCashFlows" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_ExercisePriceRangeFiveMember" name="ExercisePriceRangeFiveMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_OperatingLeasesFutureMinimumPaymentsDueInSixYears" name="OperatingLeasesFutureMinimumPaymentsDueInSixYears" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_EURMember" name="EURMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_USDMember" name="USDMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>16
<FILENAME>ipar-20211231_cal.xml
<DESCRIPTION>XBRL CALCULATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.12a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://interparfumsinc.com/role/Cover" xlink:href="ipar-20211231.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/BalanceSheets" xlink:href="ipar-20211231.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/BalanceSheetsParenthetical" xlink:href="ipar-20211231.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/StatementsOfIncome" xlink:href="ipar-20211231.xsd#StatementsOfIncome" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/StatementsOfComprehensiveIncome" xlink:href="ipar-20211231.xsd#StatementsOfComprehensiveIncome" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/StatementsOfChangesInShareholdersEquity" xlink:href="ipar-20211231.xsd#StatementsOfChangesInShareholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/StatementsOfCashFlows" xlink:href="ipar-20211231.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPolicies" xlink:href="ipar-20211231.xsd#CompanyAndItsSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/ImpactOfCovid-19Pandemic" xlink:href="ipar-20211231.xsd#ImpactOfCovid-19Pandemic" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/RecentAgreements" xlink:href="ipar-20211231.xsd#RecentAgreements" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/Inventories" xlink:href="ipar-20211231.xsd#Inventories" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/FairValueOfFinancialInstruments" xlink:href="ipar-20211231.xsd#FairValueOfFinancialInstruments" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/DerivativeFinancialInstruments" xlink:href="ipar-20211231.xsd#DerivativeFinancialInstruments" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/PropertyEquipmentAndLeaseholdImprovements" xlink:href="ipar-20211231.xsd#PropertyEquipmentAndLeaseholdImprovements" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssets" xlink:href="ipar-20211231.xsd#TrademarksLicensesAndOtherIntangibleAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/AccruedExpenses" xlink:href="ipar-20211231.xsd#AccruedExpenses" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/LoansPayableBanks" xlink:href="ipar-20211231.xsd#LoansPayableBanks" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/Long-termDebt" xlink:href="ipar-20211231.xsd#Long-termDebt" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/Commitments" xlink:href="ipar-20211231.xsd#Commitments" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/Equity" xlink:href="ipar-20211231.xsd#Equity" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.CommonShareholders" xlink:href="ipar-20211231.xsd#NetIncomeAttributableToInterParfumsInc.CommonShareholders" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/SegmentsAndGeographicAreas" xlink:href="ipar-20211231.xsd#SegmentsAndGeographicAreas" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/IncomeTaxes" xlink:href="ipar-20211231.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/AccumulatedOtherComprehensiveLoss" xlink:href="ipar-20211231.xsd#AccumulatedOtherComprehensiveLoss" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.AndTransfersFromNoncontrollingInterest" xlink:href="ipar-20211231.xsd#NetIncomeAttributableToInterParfumsInc.AndTransfersFromNoncontrollingInterest" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/ReconciliationOfCashAndCashEquivalentsToStatementOfCashFlows" xlink:href="ipar-20211231.xsd#ReconciliationOfCashAndCashEquivalentsToStatementOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesPolicies" xlink:href="ipar-20211231.xsd#CompanyAndItsSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesTables" xlink:href="ipar-20211231.xsd#CompanyAndItsSignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/RecentAgreementsTables" xlink:href="ipar-20211231.xsd#RecentAgreementsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/InventoriesTables" xlink:href="ipar-20211231.xsd#InventoriesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/FairValueOfFinancialInstrumentsTables" xlink:href="ipar-20211231.xsd#FairValueOfFinancialInstrumentsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/PropertyEquipmentAndLeaseholdImprovementsTables" xlink:href="ipar-20211231.xsd#PropertyEquipmentAndLeaseholdImprovementsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssetsTables" xlink:href="ipar-20211231.xsd#TrademarksLicensesAndOtherIntangibleAssetsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/AccruedExpensesTables" xlink:href="ipar-20211231.xsd#AccruedExpensesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/Long-termDebtTables" xlink:href="ipar-20211231.xsd#Long-termDebtTables" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/CommitmentsTables" xlink:href="ipar-20211231.xsd#CommitmentsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/EquityTables" xlink:href="ipar-20211231.xsd#EquityTables" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.CommonShareholdersTables" xlink:href="ipar-20211231.xsd#NetIncomeAttributableToInterParfumsInc.CommonShareholdersTables" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/SegmentsAndGeographicAreasTables" xlink:href="ipar-20211231.xsd#SegmentsAndGeographicAreasTables" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/IncomeTaxesTables" xlink:href="ipar-20211231.xsd#IncomeTaxesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/AccumulatedOtherComprehensiveLossTables" xlink:href="ipar-20211231.xsd#AccumulatedOtherComprehensiveLossTables" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.AndTransfersFromNoncontrollingInterestTables" xlink:href="ipar-20211231.xsd#NetIncomeAttributableToInterParfumsInc.AndTransfersFromNoncontrollingInterestTables" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/ReconciliationOfCashAndCashEquivalentsToStatementOfCashFlowsTables" xlink:href="ipar-20211231.xsd#ReconciliationOfCashAndCashEquivalentsToStatementOfCashFlowsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/ScheduleOfLanvinBrandNameForOurClassDetails" xlink:href="ipar-20211231.xsd#ScheduleOfLanvinBrandNameForOurClassDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesDetailsNarrative" xlink:href="ipar-20211231.xsd#CompanyAndItsSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/AllAmountsHaveBeenTranslatedToU.s.DollarsAtOctober12021ExchangeRate.Details" xlink:href="ipar-20211231.xsd#AllAmountsHaveBeenTranslatedToU.s.DollarsAtOctober12021ExchangeRate.Details" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative" xlink:href="ipar-20211231.xsd#RecentAgreementsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/ScheduleOfInventoriesDetails" xlink:href="ipar-20211231.xsd#ScheduleOfInventoriesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/InventoriesDetailsNarrative" xlink:href="ipar-20211231.xsd#InventoriesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/ScheduleOfFairValueAssetsMeasuredOnRecurringBasisDetails" xlink:href="ipar-20211231.xsd#ScheduleOfFairValueAssetsMeasuredOnRecurringBasisDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/DerivativeFinancialInstrumentsDetailsNarrative" xlink:href="ipar-20211231.xsd#DerivativeFinancialInstrumentsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/ScheduleOfEquipmentAndLeaseholdImprovementsDetails" xlink:href="ipar-20211231.xsd#ScheduleOfEquipmentAndLeaseholdImprovementsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/PropertyEquipmentAndLeaseholdImprovementsDetailsNarrative" xlink:href="ipar-20211231.xsd#PropertyEquipmentAndLeaseholdImprovementsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/ScheduleOfTrademarksLicensesAndOtherIntangibleAssetsDetails" xlink:href="ipar-20211231.xsd#ScheduleOfTrademarksLicensesAndOtherIntangibleAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssetsDetailsNarrative" xlink:href="ipar-20211231.xsd#TrademarksLicensesAndOtherIntangibleAssetsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/AccruedExpensesConsistOfFollowingDetails" xlink:href="ipar-20211231.xsd#AccruedExpensesConsistOfFollowingDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/Long-termDebtConsistsOfFollowingDetails" xlink:href="ipar-20211231.xsd#Long-termDebtConsistsOfFollowingDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/LoansPayableBanksDetailsNarrative" xlink:href="ipar-20211231.xsd#LoansPayableBanksDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/Long-termDebtDetailsNarrative" xlink:href="ipar-20211231.xsd#Long-termDebtDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/MaturitiesOfLeaseLiabilitiesSubsequentToDecember312021AreAsFollowsDetails" xlink:href="ipar-20211231.xsd#MaturitiesOfLeaseLiabilitiesSubsequentToDecember312021AreAsFollowsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/MinimumAnnualRoyaltiesAndOtherCommitmentsAsFollowsDetails" xlink:href="ipar-20211231.xsd#MinimumAnnualRoyaltiesAndOtherCommitmentsAsFollowsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/CommitmentsDetailsNarrative" xlink:href="ipar-20211231.xsd#CommitmentsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/FollowingTableSetsForthInformationWithRespectToNonvestedOptionsFor2021Details" xlink:href="ipar-20211231.xsd#FollowingTableSetsForthInformationWithRespectToNonvestedOptionsFor2021Details" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/EffectOfShare-basedPaymentExpensesDecreasedIncomeStatementLineItemsAsFollowsDetails" xlink:href="ipar-20211231.xsd#EffectOfShare-basedPaymentExpensesDecreasedIncomeStatementLineItemsAsFollowsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/FollowingTableSummarizesStockOptionActivityAndRelatedInformationForYearsEndedDecember3120212020And2019Details" xlink:href="ipar-20211231.xsd#FollowingTableSummarizesStockOptionActivityAndRelatedInformationForYearsEndedDecember3120212020And2019Details" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/AssumptionsUsedInBlack-scholesPricingModelAreSetForthInFollowingTableDetails" xlink:href="ipar-20211231.xsd#AssumptionsUsedInBlack-scholesPricingModelAreSetForthInFollowingTableDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/ProceedsTaxBenefitsAndIntrinsicValueRelatedToStockOptionsExercisedWereAsFollowsDetails" xlink:href="ipar-20211231.xsd#ProceedsTaxBenefitsAndIntrinsicValueRelatedToStockOptionsExercisedWereAsFollowsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/FollowingTableSummarizesAdditionalStockOptionInformationAsOfDecember312021Details" xlink:href="ipar-20211231.xsd#FollowingTableSummarizesAdditionalStockOptionInformationAsOfDecember312021Details" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/EquityDetailsNarrative" xlink:href="ipar-20211231.xsd#EquityDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/ReconciliationBetweenNumeratorsAndDenominatorsOfBasicAndDilutedEpsComputationsIsAsFollowsDetails" xlink:href="ipar-20211231.xsd#ReconciliationBetweenNumeratorsAndDenominatorsOfBasicAndDilutedEpsComputationsIsAsFollowsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.CommonShareholdersDetailsNarrative" xlink:href="ipar-20211231.xsd#NetIncomeAttributableToInterParfumsInc.CommonShareholdersDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/InformationOnCompanysOperationsBySegmentsIsAsFollowsDetails" xlink:href="ipar-20211231.xsd#InformationOnCompanysOperationsBySegmentsIsAsFollowsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/NetSalesToCustomersByRegionAreAsFollowsDetails" xlink:href="ipar-20211231.xsd#NetSalesToCustomersByRegionAreAsFollowsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/NetSalesToCustomersInMajorCountriesAreAsFollowsDetails" xlink:href="ipar-20211231.xsd#NetSalesToCustomersInMajorCountriesAreAsFollowsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/ComponentsOfIncomeBeforeIncomeTaxesConsistOfFollowingDetails" xlink:href="ipar-20211231.xsd#ComponentsOfIncomeBeforeIncomeTaxesConsistOfFollowingDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/ProvisionForCurrentAndDeferredIncomeTaxExpenseBenefitConsistsOfFollowingDetails" xlink:href="ipar-20211231.xsd#ProvisionForCurrentAndDeferredIncomeTaxExpenseBenefitConsistsOfFollowingDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/TaxEffectsOfTemporaryDifferencesThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndDeferredTaxLiabilitiesAreAsFollowsDetails" xlink:href="ipar-20211231.xsd#TaxEffectsOfTemporaryDifferencesThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndDeferredTaxLiabilitiesAreAsFollowsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/DifferencesBetweenUnitedStatesFederalStatutoryIncomeTaxRateAndEffectiveIncomeTaxRateWereAsFollowsDetails" xlink:href="ipar-20211231.xsd#DifferencesBetweenUnitedStatesFederalStatutoryIncomeTaxRateAndEffectiveIncomeTaxRateWereAsFollowsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/IncomeTaxesDetailsNarrative" xlink:href="ipar-20211231.xsd#IncomeTaxesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/ComponentsOfAccumulatedOtherComprehensiveLossConsistOfFollowingDetails" xlink:href="ipar-20211231.xsd#ComponentsOfAccumulatedOtherComprehensiveLossConsistOfFollowingDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/ScheduleOfNetIncomeAttributableToTransfersFromNoncontrollingInterestDetails" xlink:href="ipar-20211231.xsd#ScheduleOfNetIncomeAttributableToTransfersFromNoncontrollingInterestDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/FollowingTableSummarizesCashAndCashEquivalentsAsOfDecember312021Details" xlink:href="ipar-20211231.xsd#FollowingTableSummarizesCashAndCashEquivalentsAsOfDecember312021Details" xlink:type="simple" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/Cover" xlink:title="00000001 - Document - Cover" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/BalanceSheets" xlink:title="00000002 - Statement - Consolidated Balance Sheets">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:label="loc_us-gaapCashCashEquivalentsAndShortTermInvestments" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapCashCashEquivalentsAndShortTermInvestments" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermInvestments" xlink:label="loc_us-gaapShortTermInvestments" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapShortTermInvestments" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaapAccountsReceivableNetCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapAccountsReceivableNetCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapInventoryNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherReceivablesNetCurrent" xlink:label="loc_us-gaapOtherReceivablesNetCurrent" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapOtherReceivablesNetCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsCurrent" xlink:label="loc_us-gaapOtherAssetsCurrent" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapOtherAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesReceivable" xlink:label="loc_us-gaapIncomeTaxesReceivable" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapIncomeTaxesReceivable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet" xlink:label="loc_us-gaapDeferredIncomeTaxAssetsNet" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapDeferredIncomeTaxAssetsNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="loc_us-gaapOtherAssetsNoncurrent" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapOtherAssetsNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent" xlink:label="loc_us-gaapLongTermDebtCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapLongTermDebtCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapOperatingLeaseLiabilityCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccruedLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsPayableCurrent" xlink:label="loc_us-gaapDividendsPayableCurrent" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapDividendsPayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValue" xlink:label="loc_us-gaapTreasuryStockValue" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapTreasuryStockValue" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest" xlink:label="loc_us-gaapMinorityInterest" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="loc_us-gaapMinorityInterest" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="loc_us-gaapLongTermDebtNoncurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapLongTermDebtNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityNoncurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapOperatingLeaseLiabilityNoncurrent" xlink:type="arc" weight="1" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Consolidated Balance Sheets (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/StatementsOfIncome" xlink:title="00000004 - Statement - Consolidated Statements of Income">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaapGrossProfit" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:label="loc_us-gaapRevenueFromContractWithCustomerIncludingAssessedTax" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapGrossProfit" xlink:to="loc_us-gaapRevenueFromContractWithCustomerIncludingAssessedTax" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="loc_us-gaapCostOfGoodsAndServicesSold" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapGrossProfit" xlink:to="loc_us-gaapCostOfGoodsAndServicesSold" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapGrossProfit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaapSellingGeneralAndAdministrativeExpense" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapSellingGeneralAndAdministrativeExpense" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfLeasehold" xlink:label="loc_us-gaapImpairmentOfLeasehold" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapImpairmentOfLeasehold" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaapInterestExpense" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapInterestExpense" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:label="loc_us-gaapForeignCurrencyTransactionGainLossBeforeTax" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapForeignCurrencyTransactionGainLossBeforeTax" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInterestAndDividend" xlink:label="loc_us-gaapInvestmentIncomeInterestAndDividend" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapInvestmentIncomeInterestAndDividend" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIncome" xlink:label="loc_us-gaapOtherIncome" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapOtherIncome" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapProfitLoss" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapProfitLoss" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapProfitLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/StatementsOfComprehensiveIncome" xlink:title="00000005 - Statement - Consolidated Statements of Comprehensive Income">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:to="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapOtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToNoncontrollingInterest" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:to="loc_us-gaapOtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToNoncontrollingInterest" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapOtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:to="loc_us-gaapOtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="loc_us-gaapComprehensiveIncomeNetOfTax" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapComprehensiveIncomeNetOfTax" xlink:to="loc_us-gaapComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapComprehensiveIncomeNetOfTax" xlink:to="loc_us-gaapComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/StatementsOfChangesInShareholdersEquity" xlink:title="00000006 - Statement - Consolidated Statements of Changes in Shareholders&apos; Equity" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/StatementsOfCashFlows" xlink:title="00000007 - Statement - Consolidated Statements of Cash Flows">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapProfitLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherDepreciationAndAmortization" xlink:label="loc_us-gaapOtherDepreciationAndAmortization" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapOtherDepreciationAndAmortization" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="loc_us-gaapProvisionForDoubtfulAccounts" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapProvisionForDoubtfulAccounts" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments" xlink:label="loc_us-gaapIncomeLossFromEquityMethodInvestments" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncomeLossFromEquityMethodInvestments" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseImpairmentLoss" xlink:label="loc_us-gaapOperatingLeaseImpairmentLoss" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapOperatingLeaseImpairmentLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredIncomeTaxExpenseBenefit" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapDeferredIncomeTaxExpenseBenefit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrealizedGainLossOnDerivatives" xlink:label="loc_us-gaapUnrealizedGainLossOnDerivatives" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapUnrealizedGainLossOnDerivatives" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsReceivable" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsReceivable" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaapIncreaseDecreaseInInventories" />
      <link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInInventories" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:label="loc_us-gaapIncreaseDecreaseInOtherOperatingAssets" />
      <link:calculationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInOtherOperatingAssets" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingLeaseLiability" />
      <link:calculationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingLeaseLiability" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
      <link:calculationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedTaxesPayable" xlink:label="loc_us-gaapIncreaseDecreaseInAccruedTaxesPayable" />
      <link:calculationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccruedTaxesPayable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireShortTermInvestments" xlink:label="loc_us-gaapPaymentsToAcquireShortTermInvestments" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsToAcquireShortTermInvestments" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfShortTermInvestments" xlink:label="loc_us-gaapProceedsFromSaleOfShortTermInvestments" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapProceedsFromSaleOfShortTermInvestments" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireProductiveAssets" xlink:label="loc_us-gaapPaymentsToAcquireProductiveAssets" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsToAcquireProductiveAssets" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="loc_us-gaapPaymentsToAcquireIntangibleAssets" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsToAcquireIntangibleAssets" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:label="loc_us-gaapPaymentsToAcquireEquityMethodInvestments" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsToAcquireEquityMethodInvestments" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt" xlink:label="loc_us-gaapRepaymentsOfLongTermDebt" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapRepaymentsOfLongTermDebt" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:label="loc_us-gaapProceedsFromIssuanceOfLongTermDebt" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromIssuanceOfLongTermDebt" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="loc_us-gaapProceedsFromStockOptionsExercised" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromStockOptionsExercised" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividendsCommonStock" xlink:label="loc_us-gaapPaymentsOfDividendsCommonStock" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapPaymentsOfDividendsCommonStock" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividendsMinorityInterest" xlink:label="loc_us-gaapPaymentsOfDividendsMinorityInterest" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapPaymentsOfDividendsMinorityInterest" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToMinorityShareholders" xlink:label="loc_us-gaapPaymentsToMinorityShareholders" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapPaymentsToMinorityShareholders" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations" xlink:label="loc_us-gaapEffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapEffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPolicies" xlink:title="00000008 - Disclosure - The Company and its Significant Accounting Policies" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/ImpactOfCovid-19Pandemic" xlink:title="00000009 - Disclosure - Impact of COVID-19 Pandemic" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/RecentAgreements" xlink:title="00000010 - Disclosure - Recent Agreements" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/Inventories" xlink:title="00000011 - Disclosure - Inventories" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/FairValueOfFinancialInstruments" xlink:title="00000012 - Disclosure - Fair Value of Financial Instruments" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/DerivativeFinancialInstruments" xlink:title="00000013 - Disclosure - Derivative Financial Instruments" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/PropertyEquipmentAndLeaseholdImprovements" xlink:title="00000014 - Disclosure - Property, Equipment and Leasehold Improvements" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssets" xlink:title="00000015 - Disclosure - Trademarks, Licenses and Other Intangible Assets" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/AccruedExpenses" xlink:title="00000016 - Disclosure - Accrued Expenses" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/LoansPayableBanks" xlink:title="00000017 - Disclosure - Loans Payable &#8211; Banks" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/Long-termDebt" xlink:title="00000018 - Disclosure - Long-Term Debt" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/Commitments" xlink:title="00000019 - Disclosure - Commitments" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/Equity" xlink:title="00000020 - Disclosure - Equity" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.CommonShareholders" xlink:title="00000021 - Disclosure - Net Income Attributable to Inter Parfums, Inc. Common Shareholders" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/SegmentsAndGeographicAreas" xlink:title="00000022 - Disclosure - Segments and Geographic Areas" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/IncomeTaxes" xlink:title="00000023 - Disclosure - Income Taxes" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/AccumulatedOtherComprehensiveLoss" xlink:title="00000024 - Disclosure - Accumulated Other Comprehensive Loss" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.AndTransfersFromNoncontrollingInterest" xlink:title="00000025 - Disclosure - Net Income Attributable to Inter Parfums, Inc. and Transfers from the Noncontrolling Interest" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/ReconciliationOfCashAndCashEquivalentsToStatementOfCashFlows" xlink:title="00000026 - Disclosure - Reconciliation of Cash and Cash Equivalents to the Statement of Cash Flows" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesPolicies" xlink:title="00000027 - Disclosure - The Company and its Significant Accounting Policies (Policies)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesTables" xlink:title="00000028 - Disclosure - The Company and its Significant Accounting Policies (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/RecentAgreementsTables" xlink:title="00000029 - Disclosure - Recent Agreements (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/InventoriesTables" xlink:title="00000030 - Disclosure - Inventories (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/FairValueOfFinancialInstrumentsTables" xlink:title="00000031 - Disclosure - Fair Value of Financial Instruments (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/PropertyEquipmentAndLeaseholdImprovementsTables" xlink:title="00000032 - Disclosure - Property, Equipment and Leasehold Improvements (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssetsTables" xlink:title="00000033 - Disclosure - Trademarks, Licenses and Other Intangible Assets (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/AccruedExpensesTables" xlink:title="00000034 - Disclosure - Accrued Expenses (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/Long-termDebtTables" xlink:title="00000035 - Disclosure - Long-Term Debt (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/CommitmentsTables" xlink:title="00000036 - Disclosure - Commitments (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/EquityTables" xlink:title="00000037 - Disclosure - Equity (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.CommonShareholdersTables" xlink:title="00000038 - Disclosure - Net Income Attributable to Inter Parfums, Inc. Common Shareholders (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/SegmentsAndGeographicAreasTables" xlink:title="00000039 - Disclosure - Segments and Geographic Areas (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/IncomeTaxesTables" xlink:title="00000040 - Disclosure - Income Taxes (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/AccumulatedOtherComprehensiveLossTables" xlink:title="00000041 - Disclosure - Accumulated Other Comprehensive Loss (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.AndTransfersFromNoncontrollingInterestTables" xlink:title="00000042 - Disclosure - Net Income Attributable to Inter Parfums, Inc. and Transfers from the Noncontrolling Interest (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/ReconciliationOfCashAndCashEquivalentsToStatementOfCashFlowsTables" xlink:title="00000043 - Disclosure - Reconciliation of Cash and Cash Equivalents to the Statement of Cash Flows (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/ScheduleOfLanvinBrandNameForOurClassDetails" xlink:title="00000044 - Disclosure - Schedule of lanvin brand name for our class (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesDetailsNarrative" xlink:title="00000045 - Disclosure - The Company and its Significant Accounting Policies (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/AllAmountsHaveBeenTranslatedToU.s.DollarsAtOctober12021ExchangeRate.Details" xlink:title="00000046 - Disclosure - All amounts have been translated to U.S. dollars at the October 1, 2021 exchange rate. (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative" xlink:title="00000047 - Disclosure - Recent Agreements (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/ScheduleOfInventoriesDetails" xlink:title="00000048 - Disclosure - Schedule of inventories (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRawMaterials" xlink:label="loc_us-gaapInventoryRawMaterials" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapInventoryNet" xlink:to="loc_us-gaapInventoryRawMaterials" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoods" xlink:label="loc_us-gaapInventoryFinishedGoods" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapInventoryNet" xlink:to="loc_us-gaapInventoryFinishedGoods" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/InventoriesDetailsNarrative" xlink:title="00000049 - Disclosure - Inventories (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/ScheduleOfFairValueAssetsMeasuredOnRecurringBasisDetails" xlink:title="00000050 - Disclosure - Schedule of fair value, assets measured on recurring basis (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/DerivativeFinancialInstrumentsDetailsNarrative" xlink:title="00000051 - Disclosure - Derivative Financial Instruments (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/ScheduleOfEquipmentAndLeaseholdImprovementsDetails" xlink:title="00000052 - Disclosure - Schedule of equipment and leasehold improvements (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/PropertyEquipmentAndLeaseholdImprovementsDetailsNarrative" xlink:title="00000053 - Disclosure - Property, Equipment and Leasehold Improvements (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/ScheduleOfTrademarksLicensesAndOtherIntangibleAssetsDetails" xlink:title="00000054 - Disclosure - Schedule of trademarks, licenses and other intangible assets (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssetsDetailsNarrative" xlink:title="00000055 - Disclosure - Trademarks, Licenses and Other Intangible Assets (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/AccruedExpensesConsistOfFollowingDetails" xlink:title="00000056 - Disclosure - Accrued expenses consist of the following: (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedAdvertisingCurrent" xlink:label="loc_us-gaapAccruedAdvertisingCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccruedLiabilitiesCurrent" xlink:to="loc_us-gaapAccruedAdvertisingCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedSalariesCurrent" xlink:label="loc_us-gaapAccruedSalariesCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccruedLiabilitiesCurrent" xlink:to="loc_us-gaapAccruedSalariesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedRoyaltiesCurrent" xlink:label="loc_us-gaapAccruedRoyaltiesCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccruedLiabilitiesCurrent" xlink:to="loc_us-gaapAccruedRoyaltiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_DueVendorsNotYetInvoiced" xlink:label="loc_iparDueVendorsNotYetInvoiced" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccruedLiabilitiesCurrent" xlink:to="loc_iparDueVendorsNotYetInvoiced" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrent" xlink:label="loc_us-gaapPensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrent" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccruedLiabilitiesCurrent" xlink:to="loc_us-gaapPensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRefundLiabilityCurrent" xlink:label="loc_us-gaapCustomerRefundLiabilityCurrent" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccruedLiabilitiesCurrent" xlink:to="loc_us-gaapCustomerRefundLiabilityCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapOtherAccruedLiabilitiesCurrent" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccruedLiabilitiesCurrent" xlink:to="loc_us-gaapOtherAccruedLiabilitiesCurrent" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/Long-termDebtConsistsOfFollowingDetails" xlink:title="00000057 - Disclosure - Long-term debt consists of the following: (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/LoansPayableBanksDetailsNarrative" xlink:title="00000058 - Disclosure - Loans Payable &#8211; Banks (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/Long-termDebtDetailsNarrative" xlink:title="00000059 - Disclosure - Long-Term Debt (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/MaturitiesOfLeaseLiabilitiesSubsequentToDecember312021AreAsFollowsDetails" xlink:title="00000060 - Disclosure - Maturities of lease liabilities subsequent to December 31, 2021 are as follows: (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/MinimumAnnualRoyaltiesAndOtherCommitmentsAsFollowsDetails" xlink:title="00000061 - Disclosure - minimum annual royalties and other commitments as follows: (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/CommitmentsDetailsNarrative" xlink:title="00000062 - Disclosure - Commitments (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/FollowingTableSetsForthInformationWithRespectToNonvestedOptionsFor2021Details" xlink:title="00000063 - Disclosure - The following table sets forth information with respect to nonvested options for 2021: (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/EffectOfShare-basedPaymentExpensesDecreasedIncomeStatementLineItemsAsFollowsDetails" xlink:title="00000064 - Disclosure - The effect of share-based payment expenses decreased income statement line items as follows: (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/FollowingTableSummarizesStockOptionActivityAndRelatedInformationForYearsEndedDecember3120212020And2019Details" xlink:title="00000065 - Disclosure - The following table summarizes stock option activity and related information for the years ended December 31, 2021, 2020 and 2019: (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/AssumptionsUsedInBlack-scholesPricingModelAreSetForthInFollowingTableDetails" xlink:title="00000066 - Disclosure - The assumptions used in the Black-Scholes pricing model are set forth in the following table: (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/ProceedsTaxBenefitsAndIntrinsicValueRelatedToStockOptionsExercisedWereAsFollowsDetails" xlink:title="00000067 - Disclosure - Proceeds, tax benefits and intrinsic value related to stock options exercised were as follows (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/FollowingTableSummarizesAdditionalStockOptionInformationAsOfDecember312021Details" xlink:title="00000068 - Disclosure - The following table summarizes additional stock option information as of December 31, 2021: (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/EquityDetailsNarrative" xlink:title="00000069 - Disclosure - Equity (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/ReconciliationBetweenNumeratorsAndDenominatorsOfBasicAndDilutedEpsComputationsIsAsFollowsDetails" xlink:title="00000070 - Disclosure - The reconciliation between the numerators and denominators of the basic and diluted EPS computations is as follows: (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.CommonShareholdersDetailsNarrative" xlink:title="00000071 - Disclosure - Net Income Attributable to Inter Parfums, Inc. Common Shareholders (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/InformationOnCompanysOperationsBySegmentsIsAsFollowsDetails" xlink:title="00000072 - Disclosure - Information on the Company&#8217;s operations by segments is as follows: (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/NetSalesToCustomersByRegionAreAsFollowsDetails" xlink:title="00000073 - Disclosure - Consolidated net sales to customers by region are as follows: (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/NetSalesToCustomersInMajorCountriesAreAsFollowsDetails" xlink:title="00000074 - Disclosure - Consolidated net sales to customers in major countries are as follows: (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/ComponentsOfIncomeBeforeIncomeTaxesConsistOfFollowingDetails" xlink:title="00000075 - Disclosure - The components of income before income taxes consist of the following: (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/ProvisionForCurrentAndDeferredIncomeTaxExpenseBenefitConsistsOfFollowingDetails" xlink:title="00000076 - Disclosure - The provision for current and deferred income tax expense (benefit) consists of the following: (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/TaxEffectsOfTemporaryDifferencesThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndDeferredTaxLiabilitiesAreAsFollowsDetails" xlink:title="00000077 - Disclosure - The tax effects of temporary differences that give rise to significant portions of the deferred tax assets and deferred tax liabilities are as follows: (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="loc_us-gaapDeferredTaxAssetsGross" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:label="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwardsForeign" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_DeferredTaxAssetsInventoryAndAccountsReceivable" xlink:label="loc_iparDeferredTaxAssetsInventoryAndAccountsReceivable" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_iparDeferredTaxAssetsInventoryAndAccountsReceivable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsDeferredIncome" xlink:label="loc_us-gaapDeferredTaxAssetsDeferredIncome" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_us-gaapDeferredTaxAssetsDeferredIncome" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsInventory" xlink:label="loc_us-gaapDeferredTaxAssetsInventory" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_us-gaapDeferredTaxAssetsInventory" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOther" xlink:label="loc_us-gaapDeferredTaxAssetsOther" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_us-gaapDeferredTaxAssetsOther" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="loc_us-gaapDeferredTaxAssetsNet" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsNet" xlink:to="loc_us-gaapDeferredTaxAssetsGross" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapDeferredTaxAssetsValuationAllowance" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsNet" xlink:to="loc_us-gaapDeferredTaxAssetsValuationAllowance" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/DifferencesBetweenUnitedStatesFederalStatutoryIncomeTaxRateAndEffectiveIncomeTaxRateWereAsFollowsDetails" xlink:title="00000078 - Disclosure - Differences between the United States federal statutory income tax rate and the effective income tax rate were as follows: (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/IncomeTaxesDetailsNarrative" xlink:title="00000079 - Disclosure - Income Taxes (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/ComponentsOfAccumulatedOtherComprehensiveLossConsistOfFollowingDetails" xlink:title="00000080 - Disclosure - The components of accumulated other comprehensive loss consist of the following: (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/ScheduleOfNetIncomeAttributableToTransfersFromNoncontrollingInterestDetails" xlink:title="00000081 - Disclosure - Schedule of net income attributable to transfers from the noncontrolling interest (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/FollowingTableSummarizesCashAndCashEquivalentsAsOfDecember312021Details" xlink:title="00000082 - Disclosure - The following table summarizes cash and cash equivalents as of December 31, 2021: (Details)" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>17
<FILENAME>ipar-20211231_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.12a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://interparfumsinc.com/role/Cover" xlink:href="ipar-20211231.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/BalanceSheets" xlink:href="ipar-20211231.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/BalanceSheetsParenthetical" xlink:href="ipar-20211231.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/StatementsOfIncome" xlink:href="ipar-20211231.xsd#StatementsOfIncome" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/StatementsOfComprehensiveIncome" xlink:href="ipar-20211231.xsd#StatementsOfComprehensiveIncome" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/StatementsOfChangesInShareholdersEquity" xlink:href="ipar-20211231.xsd#StatementsOfChangesInShareholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/StatementsOfCashFlows" xlink:href="ipar-20211231.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPolicies" xlink:href="ipar-20211231.xsd#CompanyAndItsSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/ImpactOfCovid-19Pandemic" xlink:href="ipar-20211231.xsd#ImpactOfCovid-19Pandemic" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/RecentAgreements" xlink:href="ipar-20211231.xsd#RecentAgreements" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/Inventories" xlink:href="ipar-20211231.xsd#Inventories" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/FairValueOfFinancialInstruments" xlink:href="ipar-20211231.xsd#FairValueOfFinancialInstruments" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/DerivativeFinancialInstruments" xlink:href="ipar-20211231.xsd#DerivativeFinancialInstruments" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/PropertyEquipmentAndLeaseholdImprovements" xlink:href="ipar-20211231.xsd#PropertyEquipmentAndLeaseholdImprovements" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssets" xlink:href="ipar-20211231.xsd#TrademarksLicensesAndOtherIntangibleAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/AccruedExpenses" xlink:href="ipar-20211231.xsd#AccruedExpenses" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/LoansPayableBanks" xlink:href="ipar-20211231.xsd#LoansPayableBanks" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/Long-termDebt" xlink:href="ipar-20211231.xsd#Long-termDebt" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/Commitments" xlink:href="ipar-20211231.xsd#Commitments" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/Equity" xlink:href="ipar-20211231.xsd#Equity" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.CommonShareholders" xlink:href="ipar-20211231.xsd#NetIncomeAttributableToInterParfumsInc.CommonShareholders" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/SegmentsAndGeographicAreas" xlink:href="ipar-20211231.xsd#SegmentsAndGeographicAreas" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/IncomeTaxes" xlink:href="ipar-20211231.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/AccumulatedOtherComprehensiveLoss" xlink:href="ipar-20211231.xsd#AccumulatedOtherComprehensiveLoss" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.AndTransfersFromNoncontrollingInterest" xlink:href="ipar-20211231.xsd#NetIncomeAttributableToInterParfumsInc.AndTransfersFromNoncontrollingInterest" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/ReconciliationOfCashAndCashEquivalentsToStatementOfCashFlows" xlink:href="ipar-20211231.xsd#ReconciliationOfCashAndCashEquivalentsToStatementOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesPolicies" xlink:href="ipar-20211231.xsd#CompanyAndItsSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesTables" xlink:href="ipar-20211231.xsd#CompanyAndItsSignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/RecentAgreementsTables" xlink:href="ipar-20211231.xsd#RecentAgreementsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/InventoriesTables" xlink:href="ipar-20211231.xsd#InventoriesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/FairValueOfFinancialInstrumentsTables" xlink:href="ipar-20211231.xsd#FairValueOfFinancialInstrumentsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/PropertyEquipmentAndLeaseholdImprovementsTables" xlink:href="ipar-20211231.xsd#PropertyEquipmentAndLeaseholdImprovementsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssetsTables" xlink:href="ipar-20211231.xsd#TrademarksLicensesAndOtherIntangibleAssetsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/AccruedExpensesTables" xlink:href="ipar-20211231.xsd#AccruedExpensesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/Long-termDebtTables" xlink:href="ipar-20211231.xsd#Long-termDebtTables" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/CommitmentsTables" xlink:href="ipar-20211231.xsd#CommitmentsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/EquityTables" xlink:href="ipar-20211231.xsd#EquityTables" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.CommonShareholdersTables" xlink:href="ipar-20211231.xsd#NetIncomeAttributableToInterParfumsInc.CommonShareholdersTables" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/SegmentsAndGeographicAreasTables" xlink:href="ipar-20211231.xsd#SegmentsAndGeographicAreasTables" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/IncomeTaxesTables" xlink:href="ipar-20211231.xsd#IncomeTaxesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/AccumulatedOtherComprehensiveLossTables" xlink:href="ipar-20211231.xsd#AccumulatedOtherComprehensiveLossTables" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.AndTransfersFromNoncontrollingInterestTables" xlink:href="ipar-20211231.xsd#NetIncomeAttributableToInterParfumsInc.AndTransfersFromNoncontrollingInterestTables" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/ReconciliationOfCashAndCashEquivalentsToStatementOfCashFlowsTables" xlink:href="ipar-20211231.xsd#ReconciliationOfCashAndCashEquivalentsToStatementOfCashFlowsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/ScheduleOfLanvinBrandNameForOurClassDetails" xlink:href="ipar-20211231.xsd#ScheduleOfLanvinBrandNameForOurClassDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesDetailsNarrative" xlink:href="ipar-20211231.xsd#CompanyAndItsSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/AllAmountsHaveBeenTranslatedToU.s.DollarsAtOctober12021ExchangeRate.Details" xlink:href="ipar-20211231.xsd#AllAmountsHaveBeenTranslatedToU.s.DollarsAtOctober12021ExchangeRate.Details" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative" xlink:href="ipar-20211231.xsd#RecentAgreementsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/ScheduleOfInventoriesDetails" xlink:href="ipar-20211231.xsd#ScheduleOfInventoriesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/InventoriesDetailsNarrative" xlink:href="ipar-20211231.xsd#InventoriesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/ScheduleOfFairValueAssetsMeasuredOnRecurringBasisDetails" xlink:href="ipar-20211231.xsd#ScheduleOfFairValueAssetsMeasuredOnRecurringBasisDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/DerivativeFinancialInstrumentsDetailsNarrative" xlink:href="ipar-20211231.xsd#DerivativeFinancialInstrumentsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/ScheduleOfEquipmentAndLeaseholdImprovementsDetails" xlink:href="ipar-20211231.xsd#ScheduleOfEquipmentAndLeaseholdImprovementsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/PropertyEquipmentAndLeaseholdImprovementsDetailsNarrative" xlink:href="ipar-20211231.xsd#PropertyEquipmentAndLeaseholdImprovementsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/ScheduleOfTrademarksLicensesAndOtherIntangibleAssetsDetails" xlink:href="ipar-20211231.xsd#ScheduleOfTrademarksLicensesAndOtherIntangibleAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssetsDetailsNarrative" xlink:href="ipar-20211231.xsd#TrademarksLicensesAndOtherIntangibleAssetsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/AccruedExpensesConsistOfFollowingDetails" xlink:href="ipar-20211231.xsd#AccruedExpensesConsistOfFollowingDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/Long-termDebtConsistsOfFollowingDetails" xlink:href="ipar-20211231.xsd#Long-termDebtConsistsOfFollowingDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/LoansPayableBanksDetailsNarrative" xlink:href="ipar-20211231.xsd#LoansPayableBanksDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/Long-termDebtDetailsNarrative" xlink:href="ipar-20211231.xsd#Long-termDebtDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/MaturitiesOfLeaseLiabilitiesSubsequentToDecember312021AreAsFollowsDetails" xlink:href="ipar-20211231.xsd#MaturitiesOfLeaseLiabilitiesSubsequentToDecember312021AreAsFollowsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/MinimumAnnualRoyaltiesAndOtherCommitmentsAsFollowsDetails" xlink:href="ipar-20211231.xsd#MinimumAnnualRoyaltiesAndOtherCommitmentsAsFollowsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/CommitmentsDetailsNarrative" xlink:href="ipar-20211231.xsd#CommitmentsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/FollowingTableSetsForthInformationWithRespectToNonvestedOptionsFor2021Details" xlink:href="ipar-20211231.xsd#FollowingTableSetsForthInformationWithRespectToNonvestedOptionsFor2021Details" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/EffectOfShare-basedPaymentExpensesDecreasedIncomeStatementLineItemsAsFollowsDetails" xlink:href="ipar-20211231.xsd#EffectOfShare-basedPaymentExpensesDecreasedIncomeStatementLineItemsAsFollowsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/FollowingTableSummarizesStockOptionActivityAndRelatedInformationForYearsEndedDecember3120212020And2019Details" xlink:href="ipar-20211231.xsd#FollowingTableSummarizesStockOptionActivityAndRelatedInformationForYearsEndedDecember3120212020And2019Details" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/AssumptionsUsedInBlack-scholesPricingModelAreSetForthInFollowingTableDetails" xlink:href="ipar-20211231.xsd#AssumptionsUsedInBlack-scholesPricingModelAreSetForthInFollowingTableDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/ProceedsTaxBenefitsAndIntrinsicValueRelatedToStockOptionsExercisedWereAsFollowsDetails" xlink:href="ipar-20211231.xsd#ProceedsTaxBenefitsAndIntrinsicValueRelatedToStockOptionsExercisedWereAsFollowsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/FollowingTableSummarizesAdditionalStockOptionInformationAsOfDecember312021Details" xlink:href="ipar-20211231.xsd#FollowingTableSummarizesAdditionalStockOptionInformationAsOfDecember312021Details" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/EquityDetailsNarrative" xlink:href="ipar-20211231.xsd#EquityDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/ReconciliationBetweenNumeratorsAndDenominatorsOfBasicAndDilutedEpsComputationsIsAsFollowsDetails" xlink:href="ipar-20211231.xsd#ReconciliationBetweenNumeratorsAndDenominatorsOfBasicAndDilutedEpsComputationsIsAsFollowsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.CommonShareholdersDetailsNarrative" xlink:href="ipar-20211231.xsd#NetIncomeAttributableToInterParfumsInc.CommonShareholdersDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/InformationOnCompanysOperationsBySegmentsIsAsFollowsDetails" xlink:href="ipar-20211231.xsd#InformationOnCompanysOperationsBySegmentsIsAsFollowsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/NetSalesToCustomersByRegionAreAsFollowsDetails" xlink:href="ipar-20211231.xsd#NetSalesToCustomersByRegionAreAsFollowsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/NetSalesToCustomersInMajorCountriesAreAsFollowsDetails" xlink:href="ipar-20211231.xsd#NetSalesToCustomersInMajorCountriesAreAsFollowsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/ComponentsOfIncomeBeforeIncomeTaxesConsistOfFollowingDetails" xlink:href="ipar-20211231.xsd#ComponentsOfIncomeBeforeIncomeTaxesConsistOfFollowingDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/ProvisionForCurrentAndDeferredIncomeTaxExpenseBenefitConsistsOfFollowingDetails" xlink:href="ipar-20211231.xsd#ProvisionForCurrentAndDeferredIncomeTaxExpenseBenefitConsistsOfFollowingDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/TaxEffectsOfTemporaryDifferencesThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndDeferredTaxLiabilitiesAreAsFollowsDetails" xlink:href="ipar-20211231.xsd#TaxEffectsOfTemporaryDifferencesThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndDeferredTaxLiabilitiesAreAsFollowsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/DifferencesBetweenUnitedStatesFederalStatutoryIncomeTaxRateAndEffectiveIncomeTaxRateWereAsFollowsDetails" xlink:href="ipar-20211231.xsd#DifferencesBetweenUnitedStatesFederalStatutoryIncomeTaxRateAndEffectiveIncomeTaxRateWereAsFollowsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/IncomeTaxesDetailsNarrative" xlink:href="ipar-20211231.xsd#IncomeTaxesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/ComponentsOfAccumulatedOtherComprehensiveLossConsistOfFollowingDetails" xlink:href="ipar-20211231.xsd#ComponentsOfAccumulatedOtherComprehensiveLossConsistOfFollowingDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/ScheduleOfNetIncomeAttributableToTransfersFromNoncontrollingInterestDetails" xlink:href="ipar-20211231.xsd#ScheduleOfNetIncomeAttributableToTransfersFromNoncontrollingInterestDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/FollowingTableSummarizesCashAndCashEquivalentsAsOfDecember312021Details" xlink:href="ipar-20211231.xsd#FollowingTableSummarizesCashAndCashEquivalentsAsOfDecember312021Details" xlink:type="simple" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/Cover" xlink:title="00000001 - Document - Cover" />
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/BalanceSheets" xlink:title="00000002 - Statement - Consolidated Balance Sheets" />
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Consolidated Balance Sheets (Parenthetical)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/StatementsOfIncome" xlink:title="00000004 - Statement - Consolidated Statements of Income" />
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/StatementsOfComprehensiveIncome" xlink:title="00000005 - Statement - Consolidated Statements of Comprehensive Income" />
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/StatementsOfChangesInShareholdersEquity" xlink:title="00000006 - Statement - Consolidated Statements of Changes in Shareholders&apos; Equity">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapRetainedEarningsMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember" xlink:label="loc_us-gaapTreasuryStockMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapTreasuryStockMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestMember" xlink:label="loc_us-gaapNoncontrollingInterestMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapNoncontrollingInterestMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_80" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueStockOptionsExercised_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueStockOptionsExercised_80" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueShareBasedCompensation_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueShareBasedCompensation_80" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance" xlink:label="loc_us-gaapNoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance_80" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueAcquisitions_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueAcquisitions_80" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_TransferOfSubsidiarySharesPurchasedToTreasuryShares" xlink:label="loc_iparTransferOfSubsidiarySharesPurchasedToTreasuryShares_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_iparTransferOfSubsidiarySharesPurchasedToTreasuryShares_80" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProfitLoss_80" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsCash" xlink:label="loc_us-gaapDividendsCash_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDividendsCash_80" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax" xlink:label="loc_us-gaapOtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax_80" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax_80" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapOtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToNoncontrollingInterest_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToNoncontrollingInterest_80" xlink:type="arc" order="11" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/StatementsOfCashFlows" xlink:title="00000007 - Statement - Consolidated Statements of Cash Flows" />
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPolicies" xlink:title="00000008 - Disclosure - The Company and its Significant Accounting Policies" />
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/ImpactOfCovid-19Pandemic" xlink:title="00000009 - Disclosure - Impact of COVID-19 Pandemic" />
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/RecentAgreements" xlink:title="00000010 - Disclosure - Recent Agreements" />
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/Inventories" xlink:title="00000011 - Disclosure - Inventories" />
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/FairValueOfFinancialInstruments" xlink:title="00000012 - Disclosure - Fair Value of Financial Instruments" />
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/DerivativeFinancialInstruments" xlink:title="00000013 - Disclosure - Derivative Financial Instruments" />
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/PropertyEquipmentAndLeaseholdImprovements" xlink:title="00000014 - Disclosure - Property, Equipment and Leasehold Improvements" />
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssets" xlink:title="00000015 - Disclosure - Trademarks, Licenses and Other Intangible Assets" />
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/AccruedExpenses" xlink:title="00000016 - Disclosure - Accrued Expenses" />
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/LoansPayableBanks" xlink:title="00000017 - Disclosure - Loans Payable &#8211; Banks" />
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/Long-termDebt" xlink:title="00000018 - Disclosure - Long-Term Debt" />
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/Commitments" xlink:title="00000019 - Disclosure - Commitments" />
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/Equity" xlink:title="00000020 - Disclosure - Equity" />
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.CommonShareholders" xlink:title="00000021 - Disclosure - Net Income Attributable to Inter Parfums, Inc. Common Shareholders" />
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/SegmentsAndGeographicAreas" xlink:title="00000022 - Disclosure - Segments and Geographic Areas" />
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/IncomeTaxes" xlink:title="00000023 - Disclosure - Income Taxes" />
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/AccumulatedOtherComprehensiveLoss" xlink:title="00000024 - Disclosure - Accumulated Other Comprehensive Loss" />
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.AndTransfersFromNoncontrollingInterest" xlink:title="00000025 - Disclosure - Net Income Attributable to Inter Parfums, Inc. and Transfers from the Noncontrolling Interest" />
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/ReconciliationOfCashAndCashEquivalentsToStatementOfCashFlows" xlink:title="00000026 - Disclosure - Reconciliation of Cash and Cash Equivalents to the Statement of Cash Flows" />
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesPolicies" xlink:title="00000027 - Disclosure - The Company and its Significant Accounting Policies (Policies)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesTables" xlink:title="00000028 - Disclosure - The Company and its Significant Accounting Policies (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/RecentAgreementsTables" xlink:title="00000029 - Disclosure - Recent Agreements (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/InventoriesTables" xlink:title="00000030 - Disclosure - Inventories (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/FairValueOfFinancialInstrumentsTables" xlink:title="00000031 - Disclosure - Fair Value of Financial Instruments (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/PropertyEquipmentAndLeaseholdImprovementsTables" xlink:title="00000032 - Disclosure - Property, Equipment and Leasehold Improvements (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssetsTables" xlink:title="00000033 - Disclosure - Trademarks, Licenses and Other Intangible Assets (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/AccruedExpensesTables" xlink:title="00000034 - Disclosure - Accrued Expenses (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/Long-termDebtTables" xlink:title="00000035 - Disclosure - Long-Term Debt (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/CommitmentsTables" xlink:title="00000036 - Disclosure - Commitments (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/EquityTables" xlink:title="00000037 - Disclosure - Equity (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.CommonShareholdersTables" xlink:title="00000038 - Disclosure - Net Income Attributable to Inter Parfums, Inc. Common Shareholders (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/SegmentsAndGeographicAreasTables" xlink:title="00000039 - Disclosure - Segments and Geographic Areas (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/IncomeTaxesTables" xlink:title="00000040 - Disclosure - Income Taxes (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/AccumulatedOtherComprehensiveLossTables" xlink:title="00000041 - Disclosure - Accumulated Other Comprehensive Loss (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.AndTransfersFromNoncontrollingInterestTables" xlink:title="00000042 - Disclosure - Net Income Attributable to Inter Parfums, Inc. and Transfers from the Noncontrolling Interest (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/ReconciliationOfCashAndCashEquivalentsToStatementOfCashFlowsTables" xlink:title="00000043 - Disclosure - Reconciliation of Cash and Cash Equivalents to the Statement of Cash Flows (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/ScheduleOfLanvinBrandNameForOurClassDetails" xlink:title="00000044 - Disclosure - Schedule of lanvin brand name for our class (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductInformationLineItems" xlink:label="loc_us-gaapProductInformationLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfProductInformationTable" xlink:label="loc_us-gaapScheduleOfProductInformationTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapScheduleOfProductInformationTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaapConcentrationRiskByBenchmarkAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_MontblancMember" xlink:label="loc_iparMontblancMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_iparMontblancMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_JimmyChooMember" xlink:label="loc_iparJimmyChooMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_iparJimmyChooMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_CoachMember" xlink:label="loc_iparCoachMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_iparCoachMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_GUESSMember" xlink:label="loc_iparGUESSMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_iparGUESSMember_90" xlink:type="arc" order="91" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaapConcentrationRiskPercentage1_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapConcentrationRiskPercentage1_130" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesDetailsNarrative" xlink:title="00000045 - Disclosure - The Company and its Significant Accounting Policies (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductInformationLineItems" xlink:label="loc_us-gaapProductInformationLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfProductInformationTable" xlink:label="loc_us-gaapScheduleOfProductInformationTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapScheduleOfProductInformationTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipAxis" xlink:label="loc_srtOwnershipAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_srtOwnershipAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain" xlink:label="loc_srtOwnershipDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtOwnershipAxis" xlink:to="loc_srtOwnershipDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain" xlink:label="loc_srtOwnershipDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtOwnershipAxis" xlink:to="loc_srtOwnershipDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_InterparfumsSASubsidiaryMember" xlink:label="loc_iparInterparfumsSASubsidiaryMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtOwnershipDomain" xlink:to="loc_iparInterparfumsSASubsidiaryMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="loc_us-gaapMeasurementInputTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapMeasurementInputTypeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaapMeasurementInputTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapMeasurementInputTypeAxis" xlink:to="loc_us-gaapMeasurementInputTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaapMeasurementInputTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapMeasurementInputTypeAxis" xlink:to="loc_us-gaapMeasurementInputTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputDiscountRateMember" xlink:label="loc_us-gaapMeasurementInputDiscountRateMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputDiscountRateMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srtProductOrServiceAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_srtProductOrServiceAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShippingAndHandlingMember" xlink:label="loc_us-gaapShippingAndHandlingMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_us-gaapShippingAndHandlingMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaapConcentrationRiskByBenchmarkAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesRevenueNetMember" xlink:label="loc_us-gaapSalesRevenueNetMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_us-gaapSalesRevenueNetMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember_140" xlink:type="arc" order="141" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_150" xlink:type="arc" order="151" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LicensingAgreementsMember" xlink:label="loc_us-gaapLicensingAgreementsMember_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapLicensingAgreementsMember_140" xlink:type="arc" order="142" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:label="loc_us-gaapMinorityInterestOwnershipPercentageByParent_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapMinorityInterestOwnershipPercentageByParent_170" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:label="loc_us-gaapAllowanceForDoubtfulAccountsReceivableCurrent_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapAllowanceForDoubtfulAccountsReceivableCurrent_170" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="loc_us-gaapOperatingLeaseWeightedAverageDiscountRatePercent_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapOperatingLeaseWeightedAverageDiscountRatePercent_170" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="loc_us-gaapCostOfGoodsAndServicesSold_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapCostOfGoodsAndServicesSold_170" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaapConcentrationRiskPercentage1_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapConcentrationRiskPercentage1_170" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerRefundLiability" xlink:label="loc_us-gaapContractWithCustomerRefundLiability_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapContractWithCustomerRefundLiability_170" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerRightToRecoverProduct" xlink:label="loc_us-gaapContractWithCustomerRightToRecoverProduct_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapContractWithCustomerRightToRecoverProduct_170" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdvertisingExpense" xlink:label="loc_us-gaapAdvertisingExpense_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapAdvertisingExpense_170" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketingExpense" xlink:label="loc_us-gaapMarketingExpense_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapMarketingExpense_170" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:label="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_170" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetWeightedAveragePeriodBeforeRenewalOrExtension" xlink:label="loc_us-gaapAcquiredFiniteLivedIntangibleAssetWeightedAveragePeriodBeforeRenewalOrExtension_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapAcquiredFiniteLivedIntangibleAssetWeightedAveragePeriodBeforeRenewalOrExtension_170" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_RoyaltyExpenseNetSalesPercentage" xlink:label="loc_iparRoyaltyExpenseNetSalesPercentage_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_iparRoyaltyExpenseNetSalesPercentage_170" xlink:type="arc" order="11" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/AllAmountsHaveBeenTranslatedToU.s.DollarsAtOctober12021ExchangeRate.Details" xlink:title="00000046 - Disclosure - All amounts have been translated to U.S. dollars at the October 1, 2021 exchange rate. (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_InventoryMember" xlink:label="loc_iparInventoryMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_iparInventoryMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TrademarksMember" xlink:label="loc_us-gaapTrademarksMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapTrademarksMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_OtherAssetMember" xlink:label="loc_iparOtherAssetMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_iparOtherAssetMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryGross" xlink:label="loc_us-gaapInventoryGross_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapInventoryGross_60" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueOfAssetsAcquired" xlink:label="loc_us-gaapFairValueOfAssetsAcquired_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFairValueOfAssetsAcquired_60" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAssumed1" xlink:label="loc_us-gaapLiabilitiesAssumed1_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapLiabilitiesAssumed1_60" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapInventoryNet_60" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative" xlink:title="00000047 - Disclosure - Recent Agreements (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityNameAxis" xlink:label="loc_us-gaapIncomeTaxAuthorityNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapIncomeTaxAuthorityNameAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityNameDomain" xlink:label="loc_us-gaapIncomeTaxAuthorityNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapIncomeTaxAuthorityNameAxis" xlink:to="loc_us-gaapIncomeTaxAuthorityNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityNameDomain" xlink:label="loc_us-gaapIncomeTaxAuthorityNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapIncomeTaxAuthorityNameAxis" xlink:to="loc_us-gaapIncomeTaxAuthorityNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SwissFederalTaxAdministrationFTAMember" xlink:label="loc_us-gaapSwissFederalTaxAdministrationFTAMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeTaxAuthorityNameDomain" xlink:to="loc_us-gaapSwissFederalTaxAdministrationFTAMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CurrencyAxis" xlink:label="loc_srtCurrencyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtCurrencyAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_AllCurrenciesDomain" xlink:label="loc_currencyAllCurrenciesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtCurrencyAxis" xlink:to="loc_currencyAllCurrenciesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_AllCurrenciesDomain" xlink:label="loc_currencyAllCurrenciesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtCurrencyAxis" xlink:to="loc_currencyAllCurrenciesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_EUR" xlink:label="loc_currencyEUR_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currencyAllCurrenciesDomain" xlink:to="loc_currencyEUR_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_GlobalSettlementAgreementMember" xlink:label="loc_iparGlobalSettlementAgreementMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_iparGlobalSettlementAgreementMember_0" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_AnnaSuiCorpMember" xlink:label="loc_iparAnnaSuiCorpMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_iparAnnaSuiCorpMember_70" xlink:type="arc" order="71" />
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_RochasFashionMember" xlink:label="loc_iparRochasFashionMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_iparRochasFashionMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_STDupontMember" xlink:label="loc_iparSTDupontMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_iparSTDupontMember_90" xlink:type="arc" order="91" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxesPayableCurrentAndNoncurrent" xlink:label="loc_us-gaapTaxesPayableCurrentAndNoncurrent_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTaxesPayableCurrentAndNoncurrent_110" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForPurchaseOfOtherAssets1" xlink:label="loc_us-gaapPaymentsForPurchaseOfOtherAssets1_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPaymentsForPurchaseOfOtherAssets1_110" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcquisitionCosts" xlink:label="loc_us-gaapAcquisitionCosts_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAcquisitionCosts_110" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_CashHeldInEscrow" xlink:label="loc_iparCashHeldInEscrow_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_iparCashHeldInEscrow_110" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReceivable" xlink:label="loc_us-gaapIncomeTaxReceivable_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeTaxReceivable_110" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTaxCredit" xlink:label="loc_us-gaapInvestmentTaxCredit_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapInvestmentTaxCredit_110" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtTerm" xlink:label="loc_us-gaapLongTermDebtTerm_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLongTermDebtTerm_110" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCredit" xlink:label="loc_us-gaapLineOfCredit_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLineOfCredit_110" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateTerms" xlink:label="loc_us-gaapDebtInstrumentInterestRateTerms_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateTerms_110" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount_110" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_DiscriptionOfRecentAgreement" xlink:label="loc_iparDiscriptionOfRecentAgreement_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_iparDiscriptionOfRecentAgreement_110" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentChargeOnReclassifiedAssets" xlink:label="loc_us-gaapImpairmentChargeOnReclassifiedAssets_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapImpairmentChargeOnReclassifiedAssets_110" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionDescriptionOfAcquiredEntity" xlink:label="loc_us-gaapBusinessAcquisitionDescriptionOfAcquiredEntity_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapBusinessAcquisitionDescriptionOfAcquiredEntity_110" xlink:type="arc" order="12" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/ScheduleOfInventoriesDetails" xlink:title="00000048 - Disclosure - Schedule of inventories (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/InventoriesDetailsNarrative" xlink:title="00000049 - Disclosure - Inventories (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srtProductOrServiceAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtProductOrServiceAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductMember" xlink:label="loc_us-gaapProductMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_us-gaapProductMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSoldOverhead" xlink:label="loc_us-gaapCostOfGoodsAndServicesSoldOverhead_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCostOfGoodsAndServicesSoldOverhead_50" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryValuationReserves" xlink:label="loc_us-gaapInventoryValuationReserves_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapInventoryValuationReserves_50" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/ScheduleOfFairValueAssetsMeasuredOnRecurringBasisDetails" xlink:title="00000050 - Disclosure - Schedule of fair value, assets measured on recurring basis (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="loc_us-gaapFairValueByMeasurementFrequencyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_us-gaapFairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaapFairValueMeasurementFrequencyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFairValueByMeasurementFrequencyAxis" xlink:to="loc_us-gaapFairValueMeasurementFrequencyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaapFairValueMeasurementFrequencyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFairValueByMeasurementFrequencyAxis" xlink:to="loc_us-gaapFairValueMeasurementFrequencyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="loc_us-gaapFairValueMeasurementsRecurringMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueMeasurementFrequencyDomain" xlink:to="loc_us-gaapFairValueMeasurementsRecurringMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaapFairValueInputsLevel1Member_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel1Member_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaapFairValueInputsLevel2Member_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel2Member_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaapFairValueInputsLevel3Member_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel3Member_30" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosureAbstract" xlink:label="loc_us-gaapAssetsFairValueDisclosureAbstract_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapAssetsFairValueDisclosureAbstract_90" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsFairValueDisclosure" xlink:label="loc_us-gaapInvestmentsFairValueDisclosure_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsFairValueDisclosureAbstract_90" xlink:to="loc_us-gaapInvestmentsFairValueDisclosure_90" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAbstract" xlink:label="loc_us-gaapLiabilitiesAbstract_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapLiabilitiesAbstract_90" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyFairValueHedgeAssetAtFairValue" xlink:label="loc_us-gaapForeignCurrencyFairValueHedgeAssetAtFairValue_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAbstract_90" xlink:to="loc_us-gaapForeignCurrencyFairValueHedgeAssetAtFairValue_90" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue" xlink:label="loc_us-gaapForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAbstract_90" xlink:to="loc_us-gaapForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue_90" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilities" xlink:label="loc_us-gaapDerivativeLiabilities_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapDerivativeLiabilities_90" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="loc_us-gaapAssetsFairValueDisclosure_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapAssetsFairValueDisclosure_90" xlink:type="arc" order="6" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/DerivativeFinancialInstrumentsDetailsNarrative" xlink:title="00000051 - Disclosure - Derivative Financial Instruments (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:label="loc_us-gaapDerivativeInstrumentsGainLossLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:label="loc_us-gaapDerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDerivativeInstrumentsGainLossLineItems" xlink:to="loc_us-gaapDerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_us-gaapDerivativeInstrumentRiskAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapDerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:to="loc_us-gaapDerivativeInstrumentRiskAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaapDerivativeContractTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapDerivativeInstrumentRiskAxis" xlink:to="loc_us-gaapDerivativeContractTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaapDerivativeContractTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDerivativeInstrumentRiskAxis" xlink:to="loc_us-gaapDerivativeContractTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember" xlink:label="loc_us-gaapForeignExchangeContractMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_us-gaapForeignExchangeContractMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure" xlink:label="loc_us-gaapForeignCurrencyContractsLiabilityFairValueDisclosure_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDerivativeInstrumentsGainLossLineItems" xlink:to="loc_us-gaapForeignCurrencyContractsLiabilityFairValueDisclosure_20" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/ScheduleOfEquipmentAndLeaseholdImprovementsDetails" xlink:title="00000052 - Disclosure - Schedule of equipment and leasehold improvements (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BuildingMember" xlink:label="loc_us-gaapBuildingMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapBuildingMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquipmentMember" xlink:label="loc_us-gaapEquipmentMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapEquipmentMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="loc_us-gaapLeaseholdImprovementsMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapLeaseholdImprovementsMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaapPropertyPlantAndEquipmentGross_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentGross_90" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_90" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet_90" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/PropertyEquipmentAndLeaseholdImprovementsDetailsNarrative" xlink:title="00000053 - Disclosure - Property, Equipment and Leasehold Improvements (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/ScheduleOfTrademarksLicensesAndOtherIntangibleAssetsDetails" xlink:title="00000054 - Disclosure - Schedule of trademarks, licenses and other intangible assets (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByAssetClassAxis" xlink:label="loc_us-gaapFairValueByAssetClassAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFairValueByAssetClassAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:label="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFairValueByAssetClassAxis" xlink:to="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:label="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFairValueByAssetClassAxis" xlink:to="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefinitelivedIntangibleAssetsMember" xlink:label="loc_us-gaapIndefinitelivedIntangibleAssetsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="loc_us-gaapIndefinitelivedIntangibleAssetsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMember" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_SubtotalMember" xlink:label="loc_iparSubtotalMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="loc_iparSubtotalMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_LicensesMember" xlink:label="loc_iparLicensesMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_iparLicensesMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIntangibleAssetsMember" xlink:label="loc_us-gaapOtherIntangibleAssetsMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapOtherIntangibleAssetsMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsGross_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsGross_130" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization_130" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsNet_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsNet_130" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssetsDetailsNarrative" xlink:title="00000055 - Disclosure - Trademarks, Licenses and Other Intangible Assets (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TrademarksMember" xlink:label="loc_us-gaapTrademarksMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapTrademarksMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_LicensesMember" xlink:label="loc_iparLicensesMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_iparLicensesMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIntangibleAssetsMember" xlink:label="loc_us-gaapOtherIntangibleAssetsMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapOtherIntangibleAssetsMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByAssetClassAxis" xlink:label="loc_us-gaapFairValueByAssetClassAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFairValueByAssetClassAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:label="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFairValueByAssetClassAxis" xlink:to="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:label="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFairValueByAssetClassAxis" xlink:to="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefinitelivedIntangibleAssetsMember" xlink:label="loc_us-gaapIndefinitelivedIntangibleAssetsMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="loc_us-gaapIndefinitelivedIntangibleAssetsMember_70" xlink:type="arc" order="71" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="loc_us-gaapMeasurementInputTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapMeasurementInputTypeAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaapMeasurementInputTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapMeasurementInputTypeAxis" xlink:to="loc_us-gaapMeasurementInputTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaapMeasurementInputTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapMeasurementInputTypeAxis" xlink:to="loc_us-gaapMeasurementInputTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputDiscountRateMember" xlink:label="loc_us-gaapMeasurementInputDiscountRateMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputDiscountRateMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember_110" xlink:type="arc" order="111" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_120" xlink:type="arc" order="121" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaapAmortizationOfIntangibleAssets_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapAmortizationOfIntangibleAssets_140" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_140" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_140" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_FiniteLivedIntangibleAssetsAmortizationExpenseAfterTwoYears" xlink:label="loc_iparFiniteLivedIntangibleAssetsAmortizationExpenseAfterTwoYears_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_iparFiniteLivedIntangibleAssetsAmortizationExpenseAfterTwoYears_140" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetUsefulLife_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetUsefulLife_140" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="loc_us-gaapOperatingLeaseWeightedAverageDiscountRatePercent_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapOperatingLeaseWeightedAverageDiscountRatePercent_140" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedLicenseAgreements" xlink:label="loc_us-gaapIndefiniteLivedLicenseAgreements_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapIndefiniteLivedLicenseAgreements_140" xlink:type="arc" order="6" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/AccruedExpensesConsistOfFollowingDetails" xlink:title="00000056 - Disclosure - Accrued expenses consist of the following: (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/Long-termDebtConsistsOfFollowingDetails" xlink:title="00000057 - Disclosure - Long-term debt consists of the following: (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaapDebtInstrumentLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaapDebtInstrumentTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaapLongtermDebtTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_us-gaapLongtermDebtTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaapLongtermDebtTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapLongtermDebtTypeAxis" xlink:to="loc_us-gaapLongtermDebtTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaapLongtermDebtTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapLongtermDebtTypeAxis" xlink:to="loc_us-gaapLongtermDebtTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LoansPayableMember" xlink:label="loc_us-gaapLoansPayableMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_us-gaapLoansPayableMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_LoansPayableOneMember" xlink:label="loc_iparLoansPayableOneMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_iparLoansPayableOneMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_LoansPayableTwoMember" xlink:label="loc_iparLoansPayableTwoMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_iparLoansPayableTwoMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_LoansPayableThreeMember" xlink:label="loc_iparLoansPayableThreeMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_iparLoansPayableThreeMember_90" xlink:type="arc" order="91" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount_140" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_NumberOfInstallment" xlink:label="loc_iparNumberOfInstallment_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_iparNumberOfInstallment_140" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentPeriodicPayment" xlink:label="loc_us-gaapDebtInstrumentPeriodicPayment_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentPeriodicPayment_140" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateStatedPercentage_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateStatedPercentage_140" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt" xlink:label="loc_us-gaapLongTermDebt_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapLongTermDebt_140" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent" xlink:label="loc_us-gaapLongTermDebtCurrent_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapLongTermDebtCurrent_140" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="loc_us-gaapLongTermDebtNoncurrent_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapLongTermDebtNoncurrent_140" xlink:type="arc" order="6" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/LoansPayableBanksDetailsNarrative" xlink:title="00000058 - Disclosure - Loans Payable &#8211; Banks (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaapDebtInstrumentLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaapDebtInstrumentTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_DomesticSubsidiariesMember" xlink:label="loc_iparDomesticSubsidiariesMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_iparDomesticSubsidiariesMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_ForeignSubsidiariesMember" xlink:label="loc_iparForeignSubsidiariesMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_iparForeignSubsidiariesMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis" xlink:label="loc_us-gaapVariableRateAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_us-gaapVariableRateAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain" xlink:label="loc_us-gaapVariableRateDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapVariableRateAxis" xlink:to="loc_us-gaapVariableRateDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain" xlink:label="loc_us-gaapVariableRateDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapVariableRateAxis" xlink:to="loc_us-gaapVariableRateDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_LondonInterbankOfferedRateMember" xlink:label="loc_iparLondonInterbankOfferedRateMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapVariableRateDomain" xlink:to="loc_iparLondonInterbankOfferedRateMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_EuroInterbankOfferedRateMembeMember" xlink:label="loc_iparEuroInterbankOfferedRateMembeMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapVariableRateDomain" xlink:to="loc_iparEuroInterbankOfferedRateMembeMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember_40" xlink:type="arc" order="43" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_50" xlink:type="arc" order="53" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="loc_us-gaapLineOfCreditFacilityMaximumBorrowingCapacity_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapLineOfCreditFacilityMaximumBorrowingCapacity_80" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:label="loc_us-gaapDebtInstrumentBasisSpreadOnVariableRate1_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentBasisSpreadOnVariableRate1_80" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateStatedPercentage_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateStatedPercentage_80" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityExpirationDate1" xlink:label="loc_us-gaapLineOfCreditFacilityExpirationDate1_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapLineOfCreditFacilityExpirationDate1_80" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/Long-termDebtDetailsNarrative" xlink:title="00000059 - Disclosure - Long-Term Debt (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaapDebtInstrumentLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaapDebtInstrumentTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaapLongtermDebtTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_us-gaapLongtermDebtTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaapLongtermDebtTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapLongtermDebtTypeAxis" xlink:to="loc_us-gaapLongtermDebtTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaapLongtermDebtTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapLongtermDebtTypeAxis" xlink:to="loc_us-gaapLongtermDebtTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_LoansPayableOneMember" xlink:label="loc_iparLoansPayableOneMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_iparLoansPayableOneMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:label="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_40" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtDescription" xlink:label="loc_us-gaapLongTermDebtDescription_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapLongTermDebtDescription_40" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/MaturitiesOfLeaseLiabilitiesSubsequentToDecember312021AreAsFollowsDetails" xlink:title="00000060 - Disclosure - Maturities of lease liabilities subsequent to December 31, 2021 are as follows: (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/MinimumAnnualRoyaltiesAndOtherCommitmentsAsFollowsDetails" xlink:title="00000061 - Disclosure - minimum annual royalties and other commitments as follows: (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/CommitmentsDetailsNarrative" xlink:title="00000062 - Disclosure - Commitments (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/FollowingTableSetsForthInformationWithRespectToNonvestedOptionsFor2021Details" xlink:title="00000063 - Disclosure - The following table sets forth information with respect to nonvested options for 2021: (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/EffectOfShare-basedPaymentExpensesDecreasedIncomeStatementLineItemsAsFollowsDetails" xlink:title="00000064 - Disclosure - The effect of share-based payment expenses decreased income statement line items as follows: (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaapIncomeStatementLocationAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapIncomeStatementLocationAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLossMember" xlink:label="loc_us-gaapOperatingIncomeLossMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_us-gaapOperatingIncomeLossMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss_40" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaapEarningsPerShareDiluted_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareDiluted_40" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/FollowingTableSummarizesStockOptionActivityAndRelatedInformationForYearsEndedDecember3120212020And2019Details" xlink:title="00000065 - Disclosure - The following table summarizes stock option activity and related information for the years ended December 31, 2021, 2020 and 2019: (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/AssumptionsUsedInBlack-scholesPricingModelAreSetForthInFollowingTableDetails" xlink:title="00000066 - Disclosure - The assumptions used in the Black-Scholes pricing model are set forth in the following table: (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/ProceedsTaxBenefitsAndIntrinsicValueRelatedToStockOptionsExercisedWereAsFollowsDetails" xlink:title="00000067 - Disclosure - Proceeds, tax benefits and intrinsic value related to stock options exercised were as follows (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/FollowingTableSummarizesAdditionalStockOptionInformationAsOfDecember312021Details" xlink:title="00000068 - Disclosure - The following table summarizes additional stock option information as of December 31, 2021: (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_ExercisePriceRangeOneMember" xlink:label="loc_iparExercisePriceRangeOneMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_iparExercisePriceRangeOneMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_ExercisePriceRangeTwoMember" xlink:label="loc_iparExercisePriceRangeTwoMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_iparExercisePriceRangeTwoMember_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_ExercisePriceRangeThreeMember" xlink:label="loc_iparExercisePriceRangeThreeMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_iparExercisePriceRangeThreeMember_50" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_ExercisePriceRangeFourMember" xlink:label="loc_iparExercisePriceRangeFourMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_iparExercisePriceRangeFourMember_90" xlink:type="arc" order="92" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:label="loc_us-gaapSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_170" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_170" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_170" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_170" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/EquityDetailsNarrative" xlink:title="00000069 - Disclosure - Equity (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems" xlink:label="loc_us-gaapSubsidiaryOrEquityMethodInvesteeLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable" xlink:label="loc_us-gaapScheduleOfSubsidiaryOrEquityMethodInvesteeTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeLineItems" xlink:to="loc_us-gaapScheduleOfSubsidiaryOrEquityMethodInvesteeTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfSubsidiaryOrEquityMethodInvesteeTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_us-gaapDerivativeInstrumentRiskAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfSubsidiaryOrEquityMethodInvesteeTable" xlink:to="loc_us-gaapDerivativeInstrumentRiskAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaapDerivativeContractTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapDerivativeInstrumentRiskAxis" xlink:to="loc_us-gaapDerivativeContractTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaapDerivativeContractTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDerivativeInstrumentRiskAxis" xlink:to="loc_us-gaapDerivativeContractTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockOptionMember" xlink:label="loc_us-gaapStockOptionMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_us-gaapStockOptionMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfSubsidiaryOrEquityMethodInvesteeTable" xlink:to="loc_us-gaapDebtInstrumentAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockOptionMember" xlink:label="loc_us-gaapStockOptionMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_us-gaapStockOptionMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_StockOptionOneMember" xlink:label="loc_iparStockOptionOneMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_iparStockOptionOneMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="loc_srtConsolidatedEntitiesAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfSubsidiaryOrEquityMethodInvesteeTable" xlink:to="loc_srtConsolidatedEntitiesAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="loc_srtConsolidatedEntitiesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtConsolidatedEntitiesAxis" xlink:to="loc_srtConsolidatedEntitiesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="loc_srtConsolidatedEntitiesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtConsolidatedEntitiesAxis" xlink:to="loc_srtConsolidatedEntitiesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_InterparfumsSASubsidiaryMember" xlink:label="loc_iparInterparfumsSASubsidiaryMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtConsolidatedEntitiesDomain" xlink:to="loc_iparInterparfumsSASubsidiaryMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfSubsidiaryOrEquityMethodInvesteeTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_EmployeesMember" xlink:label="loc_iparEmployeesMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_iparEmployeesMember_80" xlink:type="arc" order="82" />
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_OfficersAndManagersMember" xlink:label="loc_iparOfficersAndManagersMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_iparOfficersAndManagersMember_90" xlink:type="arc" order="92" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_BoardOfDirectorsChairmanMember" xlink:label="loc_srtBoardOfDirectorsChairmanMember_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_srtBoardOfDirectorsChairmanMember_160" xlink:type="arc" order="161" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipAxis" xlink:label="loc_srtOwnershipAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfSubsidiaryOrEquityMethodInvesteeTable" xlink:to="loc_srtOwnershipAxis" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain" xlink:label="loc_srtOwnershipDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtOwnershipAxis" xlink:to="loc_srtOwnershipDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain" xlink:label="loc_srtOwnershipDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtOwnershipAxis" xlink:to="loc_srtOwnershipDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_InterparfumsSASubsidiaryMember" xlink:label="loc_iparInterparfumsSASubsidiaryMember_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtOwnershipDomain" xlink:to="loc_iparInterparfumsSASubsidiaryMember_110" xlink:type="arc" order="111" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfSubsidiaryOrEquityMethodInvesteeTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember_170" xlink:type="arc" order="171" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_190" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_190" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_190" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_190" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_190" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_190" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_190" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_Covid19Description" xlink:label="loc_iparCovid19Description_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeLineItems" xlink:to="loc_iparCovid19Description_190" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_RevaluationResultedInReductionOfCostDescription" xlink:label="loc_iparRevaluationResultedInReductionOfCostDescription_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeLineItems" xlink:to="loc_iparRevaluationResultedInReductionOfCostDescription_190" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost_190" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_PercentageOfIncreaseInAnnualDividend" xlink:label="loc_iparPercentageOfIncreaseInAnnualDividend_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeLineItems" xlink:to="loc_iparPercentageOfIncreaseInAnnualDividend_190" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsPayableAmountPerShare" xlink:label="loc_us-gaapDividendsPayableAmountPerShare_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeLineItems" xlink:to="loc_us-gaapDividendsPayableAmountPerShare_190" xlink:type="arc" order="11" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/ReconciliationBetweenNumeratorsAndDenominatorsOfBasicAndDilutedEpsComputationsIsAsFollowsDetails" xlink:title="00000070 - Disclosure - The reconciliation between the numerators and denominators of the basic and diluted EPS computations is as follows: (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.CommonShareholdersDetailsNarrative" xlink:title="00000071 - Disclosure - Net Income Attributable to Inter Parfums, Inc. Common Shareholders (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/InformationOnCompanysOperationsBySegmentsIsAsFollowsDetails" xlink:title="00000072 - Disclosure - Information on the Company&#8217;s operations by segments is as follows: (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:label="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:label="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srtStatementGeographicalAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:to="loc_srtStatementGeographicalAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srtSegmentGeographicalDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtStatementGeographicalAxis" xlink:to="loc_srtSegmentGeographicalDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srtSegmentGeographicalDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtStatementGeographicalAxis" xlink:to="loc_srtSegmentGeographicalDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US" xlink:label="loc_countryUS_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryUS_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EuropeMember" xlink:label="loc_srtEuropeMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_srtEuropeMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_EliminationsMember" xlink:label="loc_iparEliminationsMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_iparEliminationsMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:label="loc_us-gaapRevenueFromContractWithCustomerIncludingAssessedTax_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="loc_us-gaapRevenueFromContractWithCustomerIncludingAssessedTax_250" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="loc_us-gaapNetIncomeLoss_250" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationAndAmortization" xlink:label="loc_us-gaapDepreciationAndAmortization_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="loc_us-gaapDepreciationAndAmortization_250" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInterestAndDividend" xlink:label="loc_us-gaapInvestmentIncomeInterestAndDividend_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="loc_us-gaapInvestmentIncomeInterestAndDividend_250" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaapInterestExpense_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="loc_us-gaapInterestExpense_250" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit_250" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="loc_us-gaapAssets_250" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionsToOtherAssetsAmount" xlink:label="loc_us-gaapAdditionsToOtherAssetsAmount_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="loc_us-gaapAdditionsToOtherAssetsAmount_250" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncurrentAssets" xlink:label="loc_us-gaapNoncurrentAssets_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="loc_us-gaapNoncurrentAssets_250" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet" xlink:label="loc_us-gaapDeferredIncomeTaxAssetsNet_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="loc_us-gaapDeferredIncomeTaxAssetsNet_250" xlink:type="arc" order="9" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/NetSalesToCustomersByRegionAreAsFollowsDetails" xlink:title="00000073 - Disclosure - Consolidated net sales to customers by region are as follows: (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:label="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:label="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srtStatementGeographicalAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:to="loc_srtStatementGeographicalAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srtSegmentGeographicalDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtStatementGeographicalAxis" xlink:to="loc_srtSegmentGeographicalDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srtSegmentGeographicalDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtStatementGeographicalAxis" xlink:to="loc_srtSegmentGeographicalDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NorthAmericaMember" xlink:label="loc_srtNorthAmericaMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_srtNorthAmericaMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_EuropeCountryMember" xlink:label="loc_iparEuropeCountryMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_iparEuropeCountryMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_AsiaMember" xlink:label="loc_srtAsiaMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_srtAsiaMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MiddleEastMember" xlink:label="loc_us-gaapMiddleEastMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_us-gaapMiddleEastMember_90" xlink:type="arc" order="91" />
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_CentralAndSouthAmericaMember" xlink:label="loc_iparCentralAndSouthAmericaMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_iparCentralAndSouthAmericaMember_120" xlink:type="arc" order="121" />
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_OtherSegmentCountryMember" xlink:label="loc_iparOtherSegmentCountryMember_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_iparOtherSegmentCountryMember_150" xlink:type="arc" order="151" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="loc_us-gaapRevenues_220" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/NetSalesToCustomersInMajorCountriesAreAsFollowsDetails" xlink:title="00000074 - Disclosure - Consolidated net sales to customers in major countries are as follows: (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems" xlink:label="loc_us-gaapSegmentReportingInformationLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:label="loc_us-gaapScheduleOfSegmentReportingInformationBySegmentTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSegmentReportingInformationLineItems" xlink:to="loc_us-gaapScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaapStatementBusinessSegmentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="loc_us-gaapStatementBusinessSegmentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaapSegmentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementBusinessSegmentsAxis" xlink:to="loc_us-gaapSegmentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaapSegmentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementBusinessSegmentsAxis" xlink:to="loc_us-gaapSegmentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_UnitedStatesMember" xlink:label="loc_iparUnitedStatesMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSegmentDomain" xlink:to="loc_iparUnitedStatesMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_FranceMember" xlink:label="loc_iparFranceMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSegmentDomain" xlink:to="loc_iparFranceMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_RussiaMember" xlink:label="loc_iparRussiaMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSegmentDomain" xlink:to="loc_iparRussiaMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_UnitedKingdomMember" xlink:label="loc_iparUnitedKingdomMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSegmentDomain" xlink:to="loc_iparUnitedKingdomMember_90" xlink:type="arc" order="91" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:label="loc_us-gaapRevenueFromContractWithCustomerIncludingAssessedTax_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSegmentReportingInformationLineItems" xlink:to="loc_us-gaapRevenueFromContractWithCustomerIncludingAssessedTax_130" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/ComponentsOfIncomeBeforeIncomeTaxesConsistOfFollowingDetails" xlink:title="00000075 - Disclosure - The components of income before income taxes consist of the following: (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/ProvisionForCurrentAndDeferredIncomeTaxExpenseBenefitConsistsOfFollowingDetails" xlink:title="00000076 - Disclosure - The provision for current and deferred income tax expense (benefit) consists of the following: (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/TaxEffectsOfTemporaryDifferencesThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndDeferredTaxLiabilitiesAreAsFollowsDetails" xlink:title="00000077 - Disclosure - The tax effects of temporary differences that give rise to significant portions of the deferred tax assets and deferred tax liabilities are as follows: (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/DifferencesBetweenUnitedStatesFederalStatutoryIncomeTaxRateAndEffectiveIncomeTaxRateWereAsFollowsDetails" xlink:title="00000078 - Disclosure - Differences between the United States federal statutory income tax rate and the effective income tax rate were as follows: (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/IncomeTaxesDetailsNarrative" xlink:title="00000079 - Disclosure - Income Taxes (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:label="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:label="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_ForeignDerivedIntangibleIncomeMember" xlink:label="loc_iparForeignDerivedIntangibleIncomeMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_iparForeignDerivedIntangibleIncomeMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredForeignIncomeTaxExpenseBenefit_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapDeferredForeignIncomeTaxExpenseBenefit_40" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/ComponentsOfAccumulatedOtherComprehensiveLossConsistOfFollowingDetails" xlink:title="00000080 - Disclosure - The components of accumulated other comprehensive loss consist of the following: (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember" xlink:label="loc_iparAccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_iparAccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember" xlink:label="loc_us-gaapAccumulatedTranslationAdjustmentMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapAccumulatedTranslationAdjustmentMember_70" xlink:type="arc" order="71" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax_180" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent" xlink:label="loc_us-gaapOtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapOtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent_180" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_180" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/ScheduleOfNetIncomeAttributableToTransfersFromNoncontrollingInterestDetails" xlink:title="00000081 - Disclosure - Schedule of net income attributable to transfers from the noncontrolling interest (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/FollowingTableSummarizesCashAndCashEquivalentsAsOfDecember312021Details" xlink:title="00000082 - Disclosure - The following table summarizes cash and cash equivalents as of December 31, 2021: (Details)" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>18
<FILENAME>ipar-20211231_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.12a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xml:lang="en-US">Equity Components [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockMember_lbl" xml:lang="en-US">Common Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsMember_lbl" xml:lang="en-US">Retained Earnings [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember" xlink:label="us-gaap_TreasuryStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TreasuryStockMember" xlink:to="us-gaap_TreasuryStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TreasuryStockMember_lbl" xml:lang="en-US">Treasury Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestMember" xlink:label="us-gaap_NoncontrollingInterestMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncontrollingInterestMember" xlink:to="us-gaap_NoncontrollingInterestMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NoncontrollingInterestMember_lbl" xml:lang="en-US">Noncontrolling Interest [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskByBenchmarkAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis_lbl" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_MontblancMember" xlink:label="ipar_MontblancMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_MontblancMember" xlink:to="ipar_MontblancMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ipar_MontblancMember_lbl" xml:lang="en-US">Montblanc [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_JimmyChooMember" xlink:label="ipar_JimmyChooMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_JimmyChooMember" xlink:to="ipar_JimmyChooMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ipar_JimmyChooMember_lbl" xml:lang="en-US">Jimmy Choo [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_CoachMember" xlink:label="ipar_CoachMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_CoachMember" xlink:to="ipar_CoachMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ipar_CoachMember_lbl" xml:lang="en-US">Coach [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_GUESSMember" xlink:label="ipar_GUESSMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_GUESSMember" xlink:to="ipar_GUESSMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ipar_GUESSMember_lbl" xml:lang="en-US">G U E S S [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipAxis" xlink:label="srt_OwnershipAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_OwnershipAxis" xlink:to="srt_OwnershipAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_OwnershipAxis_lbl" xml:lang="en-US">Ownership [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_InterparfumsSASubsidiaryMember" xlink:label="ipar_InterparfumsSASubsidiaryMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_InterparfumsSASubsidiaryMember" xlink:to="ipar_InterparfumsSASubsidiaryMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ipar_InterparfumsSASubsidiaryMember_lbl" xml:lang="en-US">Interparfums S A Subsidiary [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="us-gaap_MeasurementInputTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputTypeAxis" xlink:to="us-gaap_MeasurementInputTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputTypeAxis_lbl" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputDiscountRateMember" xlink:label="us-gaap_MeasurementInputDiscountRateMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputDiscountRateMember" xlink:to="us-gaap_MeasurementInputDiscountRateMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputDiscountRateMember_lbl" xml:lang="en-US">Measurement Input, Discount Rate [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="srt_ProductOrServiceAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductOrServiceAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ProductOrServiceAxis_lbl" xml:lang="en-US">Product and Service [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShippingAndHandlingMember" xlink:label="us-gaap_ShippingAndHandlingMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShippingAndHandlingMember" xlink:to="us-gaap_ShippingAndHandlingMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShippingAndHandlingMember_lbl" xml:lang="en-US">Shipping and Handling [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesRevenueNetMember" xlink:label="us-gaap_SalesRevenueNetMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalesRevenueNetMember" xlink:to="us-gaap_SalesRevenueNetMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SalesRevenueNetMember_lbl" xml:lang="en-US">Revenue Benchmark [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeAxis" xlink:to="srt_RangeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_RangeAxis_lbl" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MinimumMember" xlink:to="srt_MinimumMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MinimumMember_lbl" xml:lang="en-US">Minimum [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LicensingAgreementsMember" xlink:label="us-gaap_LicensingAgreementsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LicensingAgreementsMember" xlink:to="us-gaap_LicensingAgreementsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LicensingAgreementsMember_lbl" xml:lang="en-US">Licensing Agreements [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MaximumMember" xlink:to="srt_MaximumMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MaximumMember_lbl" xml:lang="en-US">Maximum [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_InventoryMember" xlink:label="ipar_InventoryMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_InventoryMember" xlink:to="ipar_InventoryMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ipar_InventoryMember_lbl" xml:lang="en-US">Inventory [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TrademarksMember" xlink:label="us-gaap_TrademarksMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TrademarksMember" xlink:to="us-gaap_TrademarksMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TrademarksMember_lbl" xml:lang="en-US">Trademarks [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_OtherAssetMember" xlink:label="ipar_OtherAssetMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_OtherAssetMember" xlink:to="ipar_OtherAssetMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ipar_OtherAssetMember_lbl" xml:lang="en-US">Other Asset [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityNameAxis" xlink:label="us-gaap_IncomeTaxAuthorityNameAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxAuthorityNameAxis" xlink:to="us-gaap_IncomeTaxAuthorityNameAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxAuthorityNameAxis_lbl" xml:lang="en-US">Income Tax Authority, Name [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SwissFederalTaxAdministrationFTAMember" xlink:label="us-gaap_SwissFederalTaxAdministrationFTAMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SwissFederalTaxAdministrationFTAMember" xlink:to="us-gaap_SwissFederalTaxAdministrationFTAMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SwissFederalTaxAdministrationFTAMember_lbl" xml:lang="en-US">Swiss Federal Tax Administration (FTA) [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CurrencyAxis" xlink:label="srt_CurrencyAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_CurrencyAxis" xlink:to="srt_CurrencyAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_CurrencyAxis_lbl" xml:lang="en-US">Currency [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_EUR" xlink:label="currency_EUR" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="currency_EUR" xlink:to="currency_EUR_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="currency_EUR_lbl" xml:lang="en-US">Euro Member Countries, Euro</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_TypeOfArrangementAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TypeOfArrangementAxis_lbl" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_GlobalSettlementAgreementMember" xlink:label="ipar_GlobalSettlementAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_GlobalSettlementAgreementMember" xlink:to="ipar_GlobalSettlementAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ipar_GlobalSettlementAgreementMember_lbl" xml:lang="en-US">Global Settlement Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LegalEntityAxis" xlink:to="dei_LegalEntityAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LegalEntityAxis_lbl" xml:lang="en-US">Legal Entity [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_AnnaSuiCorpMember" xlink:label="ipar_AnnaSuiCorpMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_AnnaSuiCorpMember" xlink:to="ipar_AnnaSuiCorpMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ipar_AnnaSuiCorpMember_lbl" xml:lang="en-US">Anna Sui Corp [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_RochasFashionMember" xlink:label="ipar_RochasFashionMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_RochasFashionMember" xlink:to="ipar_RochasFashionMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ipar_RochasFashionMember_lbl" xml:lang="en-US">Rochas Fashion [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_STDupontMember" xlink:label="ipar_STDupontMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_STDupontMember" xlink:to="ipar_STDupontMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ipar_STDupontMember_lbl" xml:lang="en-US">S T Dupont [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductMember" xlink:label="us-gaap_ProductMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProductMember" xlink:to="us-gaap_ProductMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProductMember_lbl" xml:lang="en-US">Product [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueByMeasurementFrequencyAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis_lbl" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="us-gaap_FairValueMeasurementsRecurringMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementsRecurringMember" xlink:to="us-gaap_FairValueMeasurementsRecurringMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementsRecurringMember_lbl" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="us-gaap_FairValueInputsLevel1Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel1Member" xlink:to="us-gaap_FairValueInputsLevel1Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueInputsLevel1Member_lbl" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="us-gaap_FairValueInputsLevel2Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel2Member" xlink:to="us-gaap_FairValueInputsLevel2Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueInputsLevel2Member_lbl" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="us-gaap_FairValueInputsLevel3Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel3Member" xlink:to="us-gaap_FairValueInputsLevel3Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueInputsLevel3Member_lbl" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="us-gaap_DerivativeInstrumentRiskAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeInstrumentRiskAxis" xlink:to="us-gaap_DerivativeInstrumentRiskAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeInstrumentRiskAxis_lbl" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember" xlink:label="us-gaap_ForeignExchangeContractMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignExchangeContractMember" xlink:to="us-gaap_ForeignExchangeContractMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ForeignExchangeContractMember_lbl" xml:lang="en-US">Foreign Exchange Contract [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BuildingMember" xlink:label="us-gaap_BuildingMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BuildingMember" xlink:to="us-gaap_BuildingMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BuildingMember_lbl" xml:lang="en-US">Building [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquipmentMember" xlink:label="us-gaap_EquipmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquipmentMember" xlink:to="us-gaap_EquipmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquipmentMember_lbl" xml:lang="en-US">Equipment [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="us-gaap_LeaseholdImprovementsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseholdImprovementsMember" xlink:to="us-gaap_LeaseholdImprovementsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseholdImprovementsMember_lbl" xml:lang="en-US">Leasehold Improvements [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByAssetClassAxis" xlink:label="us-gaap_FairValueByAssetClassAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByAssetClassAxis" xlink:to="us-gaap_FairValueByAssetClassAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueByAssetClassAxis_lbl" xml:lang="en-US">Asset Class [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefinitelivedIntangibleAssetsMember" xlink:label="us-gaap_IndefinitelivedIntangibleAssetsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IndefinitelivedIntangibleAssetsMember" xlink:to="us-gaap_IndefinitelivedIntangibleAssetsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IndefinitelivedIntangibleAssetsMember_lbl" xml:lang="en-US">Indefinite-lived Intangible Assets [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMember" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMember" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMember_lbl" xml:lang="en-US">Finite-Lived Intangible Assets [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_LicensesMember" xlink:label="ipar_LicensesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_LicensesMember" xlink:to="ipar_LicensesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ipar_LicensesMember_lbl" xml:lang="en-US">Licenses [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIntangibleAssetsMember" xlink:label="us-gaap_OtherIntangibleAssetsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherIntangibleAssetsMember" xlink:to="us-gaap_OtherIntangibleAssetsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherIntangibleAssetsMember_lbl" xml:lang="en-US">Other Intangible Assets [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_SubtotalMember" xlink:label="ipar_SubtotalMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_SubtotalMember" xlink:to="ipar_SubtotalMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ipar_SubtotalMember_lbl" xml:lang="en-US">Subtotal [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_DomesticSubsidiariesMember" xlink:label="ipar_DomesticSubsidiariesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_DomesticSubsidiariesMember" xlink:to="ipar_DomesticSubsidiariesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ipar_DomesticSubsidiariesMember_lbl" xml:lang="en-US">Domestic Subsidiaries [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis" xlink:label="us-gaap_VariableRateAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VariableRateAxis" xlink:to="us-gaap_VariableRateAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_VariableRateAxis_lbl" xml:lang="en-US">Variable Rate [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_LondonInterbankOfferedRateMember" xlink:label="ipar_LondonInterbankOfferedRateMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_LondonInterbankOfferedRateMember" xlink:to="ipar_LondonInterbankOfferedRateMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ipar_LondonInterbankOfferedRateMember_lbl" xml:lang="en-US">London Interbank Offered Rate [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_ForeignSubsidiariesMember" xlink:label="ipar_ForeignSubsidiariesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_ForeignSubsidiariesMember" xlink:to="ipar_ForeignSubsidiariesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ipar_ForeignSubsidiariesMember_lbl" xml:lang="en-US">Foreign Subsidiaries [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_EuroInterbankOfferedRateMembeMember" xlink:label="ipar_EuroInterbankOfferedRateMembeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_EuroInterbankOfferedRateMembeMember" xlink:to="ipar_EuroInterbankOfferedRateMembeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ipar_EuroInterbankOfferedRateMembeMember_lbl" xml:lang="en-US">Euro Interbank Offered Rate Membe [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="us-gaap_LongtermDebtTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongtermDebtTypeAxis_lbl" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LoansPayableMember" xlink:label="us-gaap_LoansPayableMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LoansPayableMember" xlink:to="us-gaap_LoansPayableMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LoansPayableMember_lbl" xml:lang="en-US">Loans Payable [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_LoansPayableOneMember" xlink:label="ipar_LoansPayableOneMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_LoansPayableOneMember" xlink:to="ipar_LoansPayableOneMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ipar_LoansPayableOneMember_lbl" xml:lang="en-US">Loans Payable One [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_LoansPayableTwoMember" xlink:label="ipar_LoansPayableTwoMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_LoansPayableTwoMember" xlink:to="ipar_LoansPayableTwoMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ipar_LoansPayableTwoMember_lbl" xml:lang="en-US">Loans Payable Two [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_LoansPayableThreeMember" xlink:label="ipar_LoansPayableThreeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_LoansPayableThreeMember" xlink:to="ipar_LoansPayableThreeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ipar_LoansPayableThreeMember_lbl" xml:lang="en-US">Loans Payable Three [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockOptionMember" xlink:label="us-gaap_StockOptionMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockOptionMember" xlink:to="us-gaap_StockOptionMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockOptionMember_lbl" xml:lang="en-US">Equity Option [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentAxis_lbl" xml:lang="en-US">Debt Instrument [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_StockOptionOneMember" xlink:label="ipar_StockOptionOneMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_StockOptionOneMember" xlink:to="ipar_StockOptionOneMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ipar_StockOptionOneMember_lbl" xml:lang="en-US">Stock Option One [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="srt_ConsolidatedEntitiesAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ConsolidatedEntitiesAxis_lbl" xml:lang="en-US">Consolidated Entities [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="srt_TitleOfIndividualAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_TitleOfIndividualAxis_lbl" xml:lang="en-US">Title of Individual [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_EmployeesMember" xlink:label="ipar_EmployeesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_EmployeesMember" xlink:to="ipar_EmployeesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ipar_EmployeesMember_lbl" xml:lang="en-US">Employees [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_OfficersAndManagersMember" xlink:label="ipar_OfficersAndManagersMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_OfficersAndManagersMember" xlink:to="ipar_OfficersAndManagersMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ipar_OfficersAndManagersMember_lbl" xml:lang="en-US">Officers And Managers [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_BoardOfDirectorsChairmanMember" xlink:label="srt_BoardOfDirectorsChairmanMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_BoardOfDirectorsChairmanMember" xlink:to="srt_BoardOfDirectorsChairmanMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_BoardOfDirectorsChairmanMember_lbl" xml:lang="en-US">Board of Directors Chairman [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTypeAxis_lbl" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventMember" xlink:to="us-gaap_SubsequentEventMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventMember_lbl" xml:lang="en-US">Subsequent Event [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementLocationAxis_lbl" xml:lang="en-US">Income Statement Location [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLossMember" xlink:label="us-gaap_OperatingIncomeLossMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLossMember" xlink:to="us-gaap_OperatingIncomeLossMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingIncomeLossMember_lbl" xml:lang="en-US">Operating Income (Loss) [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_lbl" xml:lang="en-US">Exercise Price Range [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_ExercisePriceRangeOneMember" xlink:label="ipar_ExercisePriceRangeOneMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_ExercisePriceRangeOneMember" xlink:to="ipar_ExercisePriceRangeOneMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ipar_ExercisePriceRangeOneMember_lbl" xml:lang="en-US">Exercise Price Range One [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_ExercisePriceRangeTwoMember" xlink:label="ipar_ExercisePriceRangeTwoMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_ExercisePriceRangeTwoMember" xlink:to="ipar_ExercisePriceRangeTwoMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ipar_ExercisePriceRangeTwoMember_lbl" xml:lang="en-US">Exercise Price Range Two [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_ExercisePriceRangeThreeMember" xlink:label="ipar_ExercisePriceRangeThreeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_ExercisePriceRangeThreeMember" xlink:to="ipar_ExercisePriceRangeThreeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ipar_ExercisePriceRangeThreeMember_lbl" xml:lang="en-US">Exercise Price Range Three [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_ExercisePriceRangeFourMember" xlink:label="ipar_ExercisePriceRangeFourMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_ExercisePriceRangeFourMember" xlink:to="ipar_ExercisePriceRangeFourMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ipar_ExercisePriceRangeFourMember_lbl" xml:lang="en-US">Exercise Price Range Four [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis" xlink:label="srt_StatementGeographicalAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_StatementGeographicalAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_StatementGeographicalAxis_lbl" xml:lang="en-US">Geographical [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US" xlink:label="country_US" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_US" xlink:to="country_US_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="country_US_lbl" xml:lang="en-US">UNITED STATES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EuropeMember" xlink:label="srt_EuropeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_EuropeMember" xlink:to="srt_EuropeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_EuropeMember_lbl" xml:lang="en-US">Europe [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_EliminationsMember" xlink:label="ipar_EliminationsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_EliminationsMember" xlink:to="ipar_EliminationsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ipar_EliminationsMember_lbl" xml:lang="en-US">Eliminations [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NorthAmericaMember" xlink:label="srt_NorthAmericaMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_NorthAmericaMember" xlink:to="srt_NorthAmericaMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_NorthAmericaMember_lbl" xml:lang="en-US">North America [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_EuropeCountryMember" xlink:label="ipar_EuropeCountryMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_EuropeCountryMember" xlink:to="ipar_EuropeCountryMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ipar_EuropeCountryMember_lbl" xml:lang="en-US">Europe Country [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_AsiaMember" xlink:label="srt_AsiaMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_AsiaMember" xlink:to="srt_AsiaMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_AsiaMember_lbl" xml:lang="en-US">Asia [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MiddleEastMember" xlink:label="us-gaap_MiddleEastMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MiddleEastMember" xlink:to="us-gaap_MiddleEastMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MiddleEastMember_lbl" xml:lang="en-US">Middle East [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_CentralAndSouthAmericaMember" xlink:label="ipar_CentralAndSouthAmericaMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_CentralAndSouthAmericaMember" xlink:to="ipar_CentralAndSouthAmericaMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ipar_CentralAndSouthAmericaMember_lbl" xml:lang="en-US">Central And South America [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_OtherSegmentCountryMember" xlink:label="ipar_OtherSegmentCountryMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_OtherSegmentCountryMember" xlink:to="ipar_OtherSegmentCountryMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ipar_OtherSegmentCountryMember_lbl" xml:lang="en-US">Other Segment Country [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="us-gaap_StatementBusinessSegmentsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="us-gaap_StatementBusinessSegmentsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementBusinessSegmentsAxis_lbl" xml:lang="en-US">Segments [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_UnitedStatesMember" xlink:label="ipar_UnitedStatesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_UnitedStatesMember" xlink:to="ipar_UnitedStatesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ipar_UnitedStatesMember_lbl" xml:lang="en-US">United States [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_FranceMember" xlink:label="ipar_FranceMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_FranceMember" xlink:to="ipar_FranceMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ipar_FranceMember_lbl" xml:lang="en-US">France [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_RussiaMember" xlink:label="ipar_RussiaMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_RussiaMember" xlink:to="ipar_RussiaMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ipar_RussiaMember_lbl" xml:lang="en-US">Russia [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_UnitedKingdomMember" xlink:label="ipar_UnitedKingdomMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_UnitedKingdomMember" xlink:to="ipar_UnitedKingdomMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ipar_UnitedKingdomMember_lbl" xml:lang="en-US">United Kingdom [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xml:lang="en-US">Related Party [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_ForeignDerivedIntangibleIncomeMember" xlink:label="ipar_ForeignDerivedIntangibleIncomeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_ForeignDerivedIntangibleIncomeMember" xlink:to="ipar_ForeignDerivedIntangibleIncomeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ipar_ForeignDerivedIntangibleIncomeMember_lbl" xml:lang="en-US">Foreign Derived Intangible Income [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember" xlink:label="ipar_AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember" xlink:to="ipar_AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ipar_AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember_lbl" xml:lang="en-US">Accumulated Defined Benefit Plans Net Derivative Instruments [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember" xlink:label="us-gaap_AccumulatedTranslationAdjustmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedTranslationAdjustmentMember" xlink:to="us-gaap_AccumulatedTranslationAdjustmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedTranslationAdjustmentMember_lbl" xml:lang="en-US">Accumulated Foreign Currency Adjustment Attributable to Parent [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="dei_IcfrAuditorAttestationFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_IcfrAuditorAttestationFlag" xlink:to="dei_IcfrAuditorAttestationFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_IcfrAuditorAttestationFlag_lbl" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorFirmId" xlink:label="dei_AuditorFirmId" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorFirmId" xlink:to="dei_AuditorFirmId_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditorFirmId_lbl" xml:lang="en-US">Auditor Firm ID</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorName" xlink:label="dei_AuditorName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorName" xlink:to="dei_AuditorName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditorName_lbl" xml:lang="en-US">Auditor Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorLocation" xlink:label="dei_AuditorLocation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorLocation" xlink:to="dei_AuditorLocation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditorLocation_lbl" xml:lang="en-US">Auditor Location</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsAbstract_lbl" xml:lang="en-US">Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xml:lang="en-US">Current assets:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:label="us-gaap_CashCashEquivalentsAndShortTermInvestments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:to="us-gaap_CashCashEquivalentsAndShortTermInvestments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsAndShortTermInvestments_lbl" xml:lang="en-US">Cash and cash equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermInvestments" xlink:label="us-gaap_ShortTermInvestments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermInvestments" xlink:to="us-gaap_ShortTermInvestments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShortTermInvestments_lbl" xml:lang="en-US">Short-term investments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="us-gaap_AccountsReceivableNetCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableNetCurrent" xlink:to="us-gaap_AccountsReceivableNetCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsReceivableNetCurrent_lbl" xml:lang="en-US">Accounts receivable, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet" xlink:label="us-gaap_InventoryNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryNet" xlink:to="us-gaap_InventoryNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryNet_lbl" xml:lang="en-US">Inventories</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherReceivablesNetCurrent" xlink:label="us-gaap_OtherReceivablesNetCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherReceivablesNetCurrent" xlink:to="us-gaap_OtherReceivablesNetCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherReceivablesNetCurrent_lbl" xml:lang="en-US">Receivables, other</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsCurrent" xlink:label="us-gaap_OtherAssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsCurrent" xlink:to="us-gaap_OtherAssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAssetsCurrent_lbl" xml:lang="en-US">Other current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesReceivable" xlink:label="us-gaap_IncomeTaxesReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxesReceivable" xlink:to="us-gaap_IncomeTaxesReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxesReceivable_lbl" xml:lang="en-US">Income taxes receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsCurrent_lbl" xml:lang="en-US">Total current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xml:lang="en-US">Property, equipment and leasehold improvements, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xml:lang="en-US">Right-of-use assets, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl" xml:lang="en-US">Trademarks, licenses and other intangible assets, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet" xlink:label="us-gaap_DeferredIncomeTaxAssetsNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxAssetsNet" xlink:to="us-gaap_DeferredIncomeTaxAssetsNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredIncomeTaxAssetsNet_lbl" xml:lang="en-US">Deferred tax assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="us-gaap_OtherAssetsNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsNoncurrent" xlink:to="us-gaap_OtherAssetsNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAssetsNoncurrent_lbl" xml:lang="en-US">Other assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Assets_lbl" xml:lang="en-US">Total assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xml:lang="en-US">Liabilities and Equity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xml:lang="en-US">Current liabilities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent" xlink:label="us-gaap_LongTermDebtCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtCurrent" xlink:to="us-gaap_LongTermDebtCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtCurrent_lbl" xml:lang="en-US">Current portion of long-term debt</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xml:lang="en-US">Current portion of lease liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xml:lang="en-US">Accounts payable - trade</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl" xml:lang="en-US">Accrued expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsPayableCurrent" xlink:label="us-gaap_DividendsPayableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DividendsPayableCurrent" xlink:to="us-gaap_DividendsPayableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DividendsPayableCurrent_lbl" xml:lang="en-US">Income taxes payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xml:lang="en-US">Total current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="us-gaap_LongTermDebtNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtNoncurrent" xlink:to="us-gaap_LongTermDebtNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtNoncurrent_lbl" xml:lang="en-US">Long&#8211;term debt, less current portion</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xml:lang="en-US">Lease liabilities, less current portion</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_EquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityAbstract_lbl" xml:lang="en-US">Equity:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xml:lang="en-US">Inter Parfums, Inc. shareholders&#8217; equity:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockValue_lbl" xml:lang="en-US">Preferred stock, $0.001 par value. Authorized 1,000,000 shares; none issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockValue_lbl" xml:lang="en-US">Common stock, $0.001 par value. Authorized 100,000,000 shares; outstanding, 31,830,420 and 31,608,588 shares at December 31, 2021 and 2020, respectively</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xml:lang="en-US">Additional paid-in capital</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xml:lang="en-US">Retained earnings</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValue" xlink:label="us-gaap_TreasuryStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TreasuryStockValue" xlink:to="us-gaap_TreasuryStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_TreasuryStockValue_lbl" xml:lang="en-US">Treasury stock, at cost, 9,864,805 common shares at December 31, 2021 and 2020</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US">Total Inter Parfums, Inc. shareholders&#8217; equity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest" xlink:label="us-gaap_MinorityInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinorityInterest" xlink:to="us-gaap_MinorityInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MinorityInterest_lbl" xml:lang="en-US">Noncontrolling interest</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl" xml:lang="en-US">Total equity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xml:lang="en-US">Total liabilities and equity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Preferred stock, par value (in Dollars per share)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xml:lang="en-US">Preferred stock, authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xml:lang="en-US">Preferred stock, issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Common stock, par value (in Dollars per share)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xml:lang="en-US">Common stock, authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US">Common stock, outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockShares" xlink:label="us-gaap_TreasuryStockShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TreasuryStockShares" xlink:to="us-gaap_TreasuryStockShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TreasuryStockShares_lbl" xml:lang="en-US">Treasury Stock, Shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xml:lang="en-US">Income Statement [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:to="us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_lbl" xml:lang="en-US">Net sales</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="us-gaap_CostOfGoodsAndServicesSold" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfGoodsAndServicesSold" xlink:to="us-gaap_CostOfGoodsAndServicesSold_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostOfGoodsAndServicesSold_lbl" xml:lang="en-US">Cost of sales</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit" xlink:label="us-gaap_GrossProfit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_GrossProfit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_GrossProfit_lbl" xml:lang="en-US">Gross margin</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense_lbl" xml:lang="en-US">Selling, general, and administrative expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfLeasehold" xlink:label="us-gaap_ImpairmentOfLeasehold" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOfLeasehold" xlink:to="us-gaap_ImpairmentOfLeasehold_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ImpairmentOfLeasehold_lbl" xml:lang="en-US">Impairment loss</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xml:lang="en-US">Income from operations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_NonoperatingIncomeExpenseAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract_lbl" xml:lang="en-US">Other expenses (income):</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_InterestExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpense" xlink:to="us-gaap_InterestExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestExpense_lbl" xml:lang="en-US">Interest expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:to="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_lbl" xml:lang="en-US">(Gain) loss on foreign currency</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInterestAndDividend" xlink:label="us-gaap_InvestmentIncomeInterestAndDividend" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentIncomeInterestAndDividend" xlink:to="us-gaap_InvestmentIncomeInterestAndDividend_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_InvestmentIncomeInterestAndDividend_lbl" xml:lang="en-US">Interest and investment income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIncome" xlink:label="us-gaap_OtherIncome" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherIncome" xlink:to="us-gaap_OtherIncome_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_OtherIncome_lbl" xml:lang="en-US">Other income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="us-gaap_NonoperatingIncomeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:label="us-gaap_NonoperatingIncomeExpense_lbl" xml:lang="en-US">&#160;Other expenses (income)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_lbl" xml:lang="en-US">Income before income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_ProfitLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_ProfitLoss_lbl" xml:lang="en-US">Net income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_lbl" xml:lang="en-US">Less: Net income attributable to the noncontrolling interest</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US">Net income attributable to Inter Parfums, Inc.</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:label="us-gaap_EarningsPerShareBasicAndDilutedAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:to="us-gaap_EarningsPerShareBasicAndDilutedAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasicAndDilutedAbstract_lbl" xml:lang="en-US">Net income attributable to Inter Parfums, Inc. common shareholders:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xml:lang="en-US">Basic</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xml:lang="en-US">Diluted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_lbl" xml:lang="en-US">Weighted average number of shares outstanding:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xml:lang="en-US">Basic</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xml:lang="en-US">Diluted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared" xlink:label="us-gaap_CommonStockDividendsPerShareDeclared" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockDividendsPerShareDeclared" xlink:to="us-gaap_CommonStockDividendsPerShareDeclared_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockDividendsPerShareDeclared_lbl" xml:lang="en-US">Dividends declared per share</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_ProfitLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProfitLoss_2_lbl" xml:lang="en-US">Net income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_lbl" xml:lang="en-US">Other comprehensive income:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax_lbl" xml:lang="en-US">Net derivative instrument income (loss), net of tax</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:label="us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:to="us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_lbl" xml:lang="en-US">Transfer of OCI into earnings</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_lbl" xml:lang="en-US">Translation adjustments, net of tax</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossBeforeTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossBeforeTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossBeforeTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeLossBeforeTax_lbl" xml:lang="en-US">Other Comprehensive Income (Loss), before Tax</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:label="us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_lbl" xml:lang="en-US">Comprehensive income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterestAbstract" xlink:label="us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterestAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterestAbstract" xlink:to="us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterestAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterestAbstract_lbl" xml:lang="en-US">Comprehensive income attributable to noncontrolling interests:</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_2_lbl" xml:lang="en-US">Net income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToNoncontrollingInterest" xlink:label="us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToNoncontrollingInterest_lbl" xml:lang="en-US">Net derivative instrument loss, net of tax</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest" xlink:label="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest_lbl" xml:lang="en-US">Translation adjustments, net of tax</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:label="us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:to="us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_lbl" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax_lbl" xml:lang="en-US">Comprehensive income attributable to Inter Parfums Inc.</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2_lbl" xml:lang="en-US">Beginning Balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xml:lang="en-US">Shares issued upon exercise of stock options</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:label="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_lbl" xml:lang="en-US">Share-based compensation (adjustment)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance" xlink:label="us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance" xlink:to="us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance_lbl" xml:lang="en-US">Purchase of subsidiary shares from noncontrolling interests</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:label="us-gaap_StockIssuedDuringPeriodValueAcquisitions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:to="us-gaap_StockIssuedDuringPeriodValueAcquisitions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueAcquisitions_lbl" xml:lang="en-US">Shares issued for license acquisition</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_TransferOfSubsidiarySharesPurchasedToTreasuryShares" xlink:label="ipar_TransferOfSubsidiarySharesPurchasedToTreasuryShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_TransferOfSubsidiarySharesPurchasedToTreasuryShares" xlink:to="ipar_TransferOfSubsidiarySharesPurchasedToTreasuryShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ipar_TransferOfSubsidiarySharesPurchasedToTreasuryShares_lbl" xml:lang="en-US">Transfer of subsidiary shares purchased</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsCash" xlink:label="us-gaap_DividendsCash" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DividendsCash" xlink:to="us-gaap_DividendsCash_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DividendsCash_lbl" xml:lang="en-US">Dividends</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax" xlink:label="us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax" xlink:to="us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax_lbl" xml:lang="en-US">Foreign currency translation adjustment, net of tax</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax_lbl" xml:lang="en-US">Transfer from other comprehensive income into earnings</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3_lbl" xml:lang="en-US">Ending Balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Cash flows from operating activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Adjustments to reconcile net income to net cash provided by operating activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherDepreciationAndAmortization" xlink:label="us-gaap_OtherDepreciationAndAmortization" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherDepreciationAndAmortization" xlink:to="us-gaap_OtherDepreciationAndAmortization_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherDepreciationAndAmortization_lbl" xml:lang="en-US">Depreciation and amortization including impairment loss</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="us-gaap_ProvisionForDoubtfulAccounts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProvisionForDoubtfulAccounts" xlink:to="us-gaap_ProvisionForDoubtfulAccounts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProvisionForDoubtfulAccounts_lbl" xml:lang="en-US">Provision for doubtful accounts</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensation_lbl" xml:lang="en-US">Noncash stock compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments" xlink:label="us-gaap_IncomeLossFromEquityMethodInvestments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromEquityMethodInvestments" xlink:to="us-gaap_IncomeLossFromEquityMethodInvestments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncomeLossFromEquityMethodInvestments_lbl" xml:lang="en-US">Share of income of equity investment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseImpairmentLoss" xlink:label="us-gaap_OperatingLeaseImpairmentLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseImpairmentLoss" xlink:to="us-gaap_OperatingLeaseImpairmentLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseImpairmentLoss_lbl" xml:lang="en-US">Lease expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Deferred tax expense (benefit)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrealizedGainLossOnDerivatives" xlink:label="us-gaap_UnrealizedGainLossOnDerivatives" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrealizedGainLossOnDerivatives" xlink:to="us-gaap_UnrealizedGainLossOnDerivatives_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_UnrealizedGainLossOnDerivatives_lbl" xml:lang="en-US">Change in fair value of derivatives</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xml:lang="en-US">Changes in:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xml:lang="en-US">Accounts receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="us-gaap_IncreaseDecreaseInInventories" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInventories" xlink:to="us-gaap_IncreaseDecreaseInInventories_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInInventories_lbl" xml:lang="en-US">Inventories</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets_lbl" xml:lang="en-US">Other assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:label="us-gaap_IncreaseDecreaseInOperatingLeaseLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:to="us-gaap_IncreaseDecreaseInOperatingLeaseLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingLeaseLiability_lbl" xml:lang="en-US">Operating lease liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl" xml:lang="en-US">Accounts payable and accrued expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedTaxesPayable" xlink:label="us-gaap_IncreaseDecreaseInAccruedTaxesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccruedTaxesPayable" xlink:to="us-gaap_IncreaseDecreaseInAccruedTaxesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccruedTaxesPayable_lbl" xml:lang="en-US">Income taxes, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xml:lang="en-US">Net cash provided by operating activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xml:lang="en-US">Cash flows from investing activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireShortTermInvestments" xlink:label="us-gaap_PaymentsToAcquireShortTermInvestments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireShortTermInvestments" xlink:to="us-gaap_PaymentsToAcquireShortTermInvestments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquireShortTermInvestments_lbl" xml:lang="en-US">Purchases of short-term investments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfShortTermInvestments" xlink:label="us-gaap_ProceedsFromSaleOfShortTermInvestments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSaleOfShortTermInvestments" xlink:to="us-gaap_ProceedsFromSaleOfShortTermInvestments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromSaleOfShortTermInvestments_lbl" xml:lang="en-US">Proceeds from sale of short-term investments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireProductiveAssets" xlink:label="us-gaap_PaymentsToAcquireProductiveAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireProductiveAssets" xlink:to="us-gaap_PaymentsToAcquireProductiveAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquireProductiveAssets_lbl" xml:lang="en-US">Purchase of property, equipment and leasehold improvements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireIntangibleAssets" xlink:to="us-gaap_PaymentsToAcquireIntangibleAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets_lbl" xml:lang="en-US">Payment for intangible assets acquired</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:label="us-gaap_PaymentsToAcquireEquityMethodInvestments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:to="us-gaap_PaymentsToAcquireEquityMethodInvestments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquireEquityMethodInvestments_lbl" xml:lang="en-US">Purchase of equity investment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xml:lang="en-US">Net cash used in investing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xml:lang="en-US">Cash flows from financing activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt" xlink:label="us-gaap_RepaymentsOfLongTermDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfLongTermDebt" xlink:to="us-gaap_RepaymentsOfLongTermDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_RepaymentsOfLongTermDebt_lbl" xml:lang="en-US">Repayment of long-term debt</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:label="us-gaap_ProceedsFromIssuanceOfLongTermDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:to="us-gaap_ProceedsFromIssuanceOfLongTermDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfLongTermDebt_lbl" xml:lang="en-US">Proceeds from issuance of long-term debt</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromStockOptionsExercised" xlink:to="us-gaap_ProceedsFromStockOptionsExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromStockOptionsExercised_lbl" xml:lang="en-US">Proceeds from exercise of options</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividendsCommonStock" xlink:label="us-gaap_PaymentsOfDividendsCommonStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfDividendsCommonStock" xlink:to="us-gaap_PaymentsOfDividendsCommonStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsOfDividendsCommonStock_lbl" xml:lang="en-US">Dividends paid</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividendsMinorityInterest" xlink:label="us-gaap_PaymentsOfDividendsMinorityInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfDividendsMinorityInterest" xlink:to="us-gaap_PaymentsOfDividendsMinorityInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsOfDividendsMinorityInterest_lbl" xml:lang="en-US">Dividends paid to noncontrolling interests</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToMinorityShareholders" xlink:label="us-gaap_PaymentsToMinorityShareholders" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToMinorityShareholders" xlink:to="us-gaap_PaymentsToMinorityShareholders_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToMinorityShareholders_lbl" xml:lang="en-US">Purchase of subsidiary shares from noncontrolling interests</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xml:lang="en-US">Net cash provided by (used in) financing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations" xlink:label="us-gaap_EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations" xlink:to="us-gaap_EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations_lbl" xml:lang="en-US">Effect of exchange rate changes on cash</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xml:lang="en-US">Net increase (decrease) in cash and cash equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xml:lang="en-US">Cash and cash equivalents &#8211; beginning of year</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_2_lbl" xml:lang="en-US">Cash and cash equivalents &#8211; end of year</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_SupplementalDisclosureOfCashFlowInformationAbstract" xlink:label="ipar_SupplementalDisclosureOfCashFlowInformationAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_SupplementalDisclosureOfCashFlowInformationAbstract" xlink:to="ipar_SupplementalDisclosureOfCashFlowInformationAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ipar_SupplementalDisclosureOfCashFlowInformationAbstract_lbl" xml:lang="en-US">Supplemental disclosures of cash flow information:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xml:lang="en-US">Cash paid for:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet" xlink:label="us-gaap_InterestPaidNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPaidNet" xlink:to="us-gaap_InterestPaidNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestPaidNet_lbl" xml:lang="en-US">Interest</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaid" xlink:label="us-gaap_IncomeTaxesPaid" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxesPaid" xlink:to="us-gaap_IncomeTaxesPaid_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncomeTaxesPaid_lbl" xml:lang="en-US">Income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xml:lang="en-US">The Company and its Significant Accounting Policies</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_DisclosureImpactOfCovid19PandemicAbstract" xlink:label="ipar_DisclosureImpactOfCovid19PandemicAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_DisclosureImpactOfCovid19PandemicAbstract" xlink:to="ipar_DisclosureImpactOfCovid19PandemicAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ipar_DisclosureImpactOfCovid19PandemicAbstract_lbl" xml:lang="en-US">Impact Of Covid-19 Pandemic</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_ImpactOfCOVID19PandemicTextBlock" xlink:label="ipar_ImpactOfCOVID19PandemicTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_ImpactOfCOVID19PandemicTextBlock" xlink:to="ipar_ImpactOfCOVID19PandemicTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ipar_ImpactOfCOVID19PandemicTextBlock_lbl" xml:lang="en-US">Impact of COVID-19 Pandemic</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:label="us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:to="us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_lbl" xml:lang="en-US">Business Combination and Asset Acquisition [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock" xlink:label="us-gaap_BusinessCombinationDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="us-gaap_BusinessCombinationDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationDisclosureTextBlock_lbl" xml:lang="en-US">Recent Agreements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="us-gaap_InventoryDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryDisclosureAbstract" xlink:to="us-gaap_InventoryDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryDisclosureAbstract_lbl" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureTextBlock" xlink:label="us-gaap_InventoryDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryDisclosureTextBlock" xlink:to="us-gaap_InventoryDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_InventoryDisclosureTextBlock_lbl" xml:lang="en-US">Inventories</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueDisclosuresAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueDisclosuresAbstract_lbl" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="us-gaap_FairValueDisclosuresTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosuresTextBlock" xlink:to="us-gaap_FairValueDisclosuresTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueDisclosuresTextBlock_lbl" xml:lang="en-US">Fair Value of Financial Instruments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:label="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_lbl" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:label="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:to="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_lbl" xml:lang="en-US">Derivative Financial Instruments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xml:lang="en-US">Property, Equipment and Leasehold Improvements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:label="us-gaap_IntangibleAssetsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:to="us-gaap_IntangibleAssetsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IntangibleAssetsDisclosureTextBlock_lbl" xml:lang="en-US">Trademarks, Licenses and Other Intangible Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="us-gaap_PayablesAndAccrualsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_PayablesAndAccrualsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PayablesAndAccrualsAbstract_lbl" xml:lang="en-US">Payables and Accruals [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl" xml:lang="en-US">Accrued Expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtDisclosureAbstract_lbl" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="us-gaap_DebtDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureTextBlock" xlink:to="us-gaap_DebtDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtDisclosureTextBlock_lbl" xml:lang="en-US">Loans Payable &#8211; Banks</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtTextBlock" xlink:label="us-gaap_LongTermDebtTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtTextBlock" xlink:to="us-gaap_LongTermDebtTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtTextBlock_lbl" xml:lang="en-US">Long-Term Debt</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xml:lang="en-US">Commitments</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_EquityAbstract_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EquityAbstract_2_lbl" xml:lang="en-US">Equity [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xml:lang="en-US">Equity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareAbstract_lbl" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="us-gaap_EarningsPerShareTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareTextBlock" xlink:to="us-gaap_EarningsPerShareTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareTextBlock_lbl" xml:lang="en-US">Net Income Attributable to Inter Parfums, Inc. Common Shareholders</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="us-gaap_SegmentReportingAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_SegmentReportingAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SegmentReportingAbstract_lbl" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="us-gaap_SegmentReportingDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock_lbl" xml:lang="en-US">Segments and Geographic Areas</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureAbstract_lbl" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xml:lang="en-US">Income Taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:label="us-gaap_ComprehensiveIncomeNoteTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:to="us-gaap_ComprehensiveIncomeNoteTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ComprehensiveIncomeNoteTextBlock_lbl" xml:lang="en-US">Accumulated Other Comprehensive Loss</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestAbstract" xlink:label="us-gaap_NoncontrollingInterestAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncontrollingInterestAbstract" xlink:to="us-gaap_NoncontrollingInterestAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NoncontrollingInterestAbstract_lbl" xml:lang="en-US">Noncontrolling Interest [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestDisclosureTextBlock" xlink:label="us-gaap_MinorityInterestDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinorityInterestDisclosureTextBlock" xlink:to="us-gaap_MinorityInterestDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MinorityInterestDisclosureTextBlock_lbl" xml:lang="en-US">Net Income Attributable to Inter Parfums, Inc. and Transfers from the Noncontrolling Interest</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_DisclosureReconciliationOfCashAndCashEquivalentsToStatementOfCashFlowsAbstract" xlink:label="ipar_DisclosureReconciliationOfCashAndCashEquivalentsToStatementOfCashFlowsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_DisclosureReconciliationOfCashAndCashEquivalentsToStatementOfCashFlowsAbstract" xlink:to="ipar_DisclosureReconciliationOfCashAndCashEquivalentsToStatementOfCashFlowsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ipar_DisclosureReconciliationOfCashAndCashEquivalentsToStatementOfCashFlowsAbstract_lbl" xml:lang="en-US">Reconciliation Of Cash And Cash Equivalents To Statement Of Cash Flows</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_ReconciliationOfCashAndCashEquivalentsToTheStatementOfCashFlowsTextBlock" xlink:label="ipar_ReconciliationOfCashAndCashEquivalentsToTheStatementOfCashFlowsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_ReconciliationOfCashAndCashEquivalentsToTheStatementOfCashFlowsTextBlock" xlink:to="ipar_ReconciliationOfCashAndCashEquivalentsToTheStatementOfCashFlowsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ipar_ReconciliationOfCashAndCashEquivalentsToTheStatementOfCashFlowsTextBlock_lbl" xml:lang="en-US">Reconciliation of Cash and Cash Equivalents to the Statement of Cash Flows</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock" xlink:label="us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock" xlink:to="us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock_lbl" xml:lang="en-US">Business of the Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xml:lang="en-US">Basis of Preparation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UseOfEstimates_lbl" xml:lang="en-US">Management Estimates</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_lbl" xml:lang="en-US">Foreign Currency Translation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xml:lang="en-US">Cash and Cash Equivalents and Short-Term Investments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:label="us-gaap_TradeAndOtherAccountsReceivablePolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:to="us-gaap_TradeAndOtherAccountsReceivablePolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TradeAndOtherAccountsReceivablePolicy_lbl" xml:lang="en-US">Accounts Receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryPolicyTextBlock" xlink:label="us-gaap_InventoryPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryPolicyTextBlock" xlink:to="us-gaap_InventoryPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_InventoryPolicyTextBlock_lbl" xml:lang="en-US">Inventories</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativesPolicyTextBlock" xlink:label="us-gaap_DerivativesPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativesPolicyTextBlock" xlink:to="us-gaap_DerivativesPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativesPolicyTextBlock_lbl" xml:lang="en-US">Derivatives</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xml:lang="en-US">Property, Equipment and Leasehold Improvements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:label="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:to="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_lbl" xml:lang="en-US">Long-Lived Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:label="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_lbl" xml:lang="en-US">Revenue Recognition</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRecognitionSalesReturns" xlink:label="us-gaap_RevenueRecognitionSalesReturns" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRecognitionSalesReturns" xlink:to="us-gaap_RevenueRecognitionSalesReturns_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueRecognitionSalesReturns_lbl" xml:lang="en-US">Sales Returns</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRecognitionAllowances" xlink:label="us-gaap_RevenueRecognitionAllowances" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRecognitionAllowances" xlink:to="us-gaap_RevenueRecognitionAllowances_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueRecognitionAllowances_lbl" xml:lang="en-US">Payments to Customers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdvertisingCostsPolicyTextBlock" xlink:label="us-gaap_AdvertisingCostsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdvertisingCostsPolicyTextBlock" xlink:to="us-gaap_AdvertisingCostsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdvertisingCostsPolicyTextBlock_lbl" xml:lang="en-US">Advertising and Promotion</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" xml:lang="en-US">Package Development Costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LessorLeasesPolicyTextBlock" xlink:label="us-gaap_LessorLeasesPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LessorLeasesPolicyTextBlock" xlink:to="us-gaap_LessorLeasesPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LessorLeasesPolicyTextBlock_lbl" xml:lang="en-US">Operating Leases</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesPolicyTextBlock_lbl" xml:lang="en-US">License Agreements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xml:lang="en-US">Income Taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationSubsidiaryStockIssuancesPolicy" xlink:label="us-gaap_ConsolidationSubsidiaryStockIssuancesPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConsolidationSubsidiaryStockIssuancesPolicy" xlink:to="us-gaap_ConsolidationSubsidiaryStockIssuancesPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConsolidationSubsidiaryStockIssuancesPolicy_lbl" xml:lang="en-US">Issuance of Common Stock by Consolidated Subsidiary</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepurchaseAgreementsCollateralPolicy" xlink:label="us-gaap_RepurchaseAgreementsCollateralPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepurchaseAgreementsCollateralPolicy" xlink:to="us-gaap_RepurchaseAgreementsCollateralPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RepurchaseAgreementsCollateralPolicy_lbl" xml:lang="en-US">Treasury Stock</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xml:lang="en-US">Recent Accounting Pronouncements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:label="us-gaap_PriorPeriodReclassificationAdjustmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:to="us-gaap_PriorPeriodReclassificationAdjustmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PriorPeriodReclassificationAdjustmentDescription_lbl" xml:lang="en-US">Reclassifications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:label="us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:to="us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_lbl" xml:lang="en-US">Schedule of lanvin brand name for our class</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_ScheduleOfInventoryCurrentTableTextBlock1" xlink:label="ipar_ScheduleOfInventoryCurrentTableTextBlock1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_ScheduleOfInventoryCurrentTableTextBlock1" xlink:to="ipar_ScheduleOfInventoryCurrentTableTextBlock1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ipar_ScheduleOfInventoryCurrentTableTextBlock1_lbl" xml:lang="en-US">All amounts have been translated to U.S. dollars at the October 1, 2021 exchange rate.</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl" xml:lang="en-US">Schedule of inventories</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:label="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_lbl" xml:lang="en-US">Schedule of fair value, assets measured on recurring basis</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xml:lang="en-US">Schedule of equipment and leasehold improvements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfImpairedIntangibleAssetsTextBlock" xlink:label="us-gaap_ScheduleOfImpairedIntangibleAssetsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfImpairedIntangibleAssetsTextBlock" xlink:to="us-gaap_ScheduleOfImpairedIntangibleAssetsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfImpairedIntangibleAssetsTextBlock_lbl" xml:lang="en-US">Schedule of trademarks, licenses and other intangible assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl" xml:lang="en-US">Accrued expenses consist of the following:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:label="us-gaap_ScheduleOfDebtInstrumentsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:to="us-gaap_ScheduleOfDebtInstrumentsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDebtInstrumentsTextBlock_lbl" xml:lang="en-US">Long-term debt consists of the following:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:label="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:to="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_lbl" xml:lang="en-US">Maturities of lease liabilities subsequent to December 31, 2021 are as follows:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock" xlink:label="srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock" xlink:to="srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock_lbl" xml:lang="en-US">minimum annual royalties and other commitments as follows:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock_lbl" xml:lang="en-US">The following table sets forth information with respect to nonvested options for 2021:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_lbl" xml:lang="en-US">The effect of share-based payment expenses decreased income statement line items as follows:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xml:lang="en-US">The following table summarizes stock option activity and related information for the years ended December 31, 2021, 2020 and 2019:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xml:lang="en-US">The assumptions used in the Black-Scholes pricing model are set forth in the following table:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashProceedsReceivedAndTaxBenefitFromShareBasedPaymentAwardsTableTextBlock" xlink:label="us-gaap_CashProceedsReceivedAndTaxBenefitFromShareBasedPaymentAwardsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashProceedsReceivedAndTaxBenefitFromShareBasedPaymentAwardsTableTextBlock" xlink:to="us-gaap_CashProceedsReceivedAndTaxBenefitFromShareBasedPaymentAwardsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashProceedsReceivedAndTaxBenefitFromShareBasedPaymentAwardsTableTextBlock_lbl" xml:lang="en-US">Proceeds, tax benefits and intrinsic value related to stock options exercised were as follows</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_lbl" xml:lang="en-US">The following table summarizes additional stock option information as of December 31, 2021:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xml:lang="en-US">The reconciliation between the numerators and denominators of the basic and diluted EPS computations is as follows:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_lbl" xml:lang="en-US">Information on the Company&#8217;s operations by segments is as follows:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:label="us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:to="us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_lbl" xml:lang="en-US">Consolidated net sales to customers by region are as follows:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock" xlink:label="us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock" xlink:to="us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock_lbl" xml:lang="en-US">Consolidated net sales to customers in major countries are as follows:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:label="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:to="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_lbl" xml:lang="en-US">The components of income before income taxes consist of the following:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl" xml:lang="en-US">The provision for current and deferred income tax expense (benefit) consists of the following:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xml:lang="en-US">The tax effects of temporary differences that give rise to significant portions of the deferred tax assets and deferred tax liabilities are as follows:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xml:lang="en-US">Differences between the United States federal statutory income tax rate and the effective income tax rate were as follows:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:label="us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_lbl" xml:lang="en-US">The components of accumulated other comprehensive loss consist of the following:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock" xlink:label="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock" xlink:to="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock_lbl" xml:lang="en-US">Schedule of net income attributable to transfers from the noncontrolling interest</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:label="us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:to="us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_lbl" xml:lang="en-US">The following table summarizes cash and cash equivalents as of December 31, 2021:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfProductInformationTable" xlink:label="us-gaap_ScheduleOfProductInformationTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfProductInformationTable" xlink:to="us-gaap_ScheduleOfProductInformationTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfProductInformationTable_lbl" xml:lang="en-US">Schedule of Product Information [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductInformationLineItems" xlink:label="us-gaap_ProductInformationLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProductInformationLineItems" xlink:to="us-gaap_ProductInformationLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProductInformationLineItems_lbl" xml:lang="en-US">Product Information [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="us-gaap_ConcentrationRiskPercentage1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskPercentage1" xlink:to="us-gaap_ConcentrationRiskPercentage1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskPercentage1_lbl" xml:lang="en-US">Concentration risk percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:label="us-gaap_MinorityInterestOwnershipPercentageByParent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:to="us-gaap_MinorityInterestOwnershipPercentageByParent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MinorityInterestOwnershipPercentageByParent_lbl" xml:lang="en-US">Ownership percentage in Interparfums SA</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_lbl" xml:lang="en-US">Allowances for sales returns and doubtful accounts</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl" xml:lang="en-US">Weighted average cost of capital</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfGoodsAndServicesSold" xlink:to="us-gaap_CostOfGoodsAndServicesSold_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CostOfGoodsAndServicesSold_2_lbl" xml:lang="en-US">Shipping and handling costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerRefundLiability" xlink:label="us-gaap_ContractWithCustomerRefundLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractWithCustomerRefundLiability" xlink:to="us-gaap_ContractWithCustomerRefundLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ContractWithCustomerRefundLiability_lbl" xml:lang="en-US">Contract with customer, refund liability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerRightToRecoverProduct" xlink:label="us-gaap_ContractWithCustomerRightToRecoverProduct" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractWithCustomerRightToRecoverProduct" xlink:to="us-gaap_ContractWithCustomerRightToRecoverProduct_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ContractWithCustomerRightToRecoverProduct_lbl" xml:lang="en-US">Contract with customer, right to recover products</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdvertisingExpense" xlink:label="us-gaap_AdvertisingExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdvertisingExpense" xlink:to="us-gaap_AdvertisingExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdvertisingExpense_lbl" xml:lang="en-US">Advertising costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketingExpense" xlink:label="us-gaap_MarketingExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketingExpense" xlink:to="us-gaap_MarketingExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MarketingExpense_lbl" xml:lang="en-US">Customer incentives cost</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:label="us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:to="us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_lbl" xml:lang="en-US">License agreement term</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetWeightedAveragePeriodBeforeRenewalOrExtension" xlink:label="us-gaap_AcquiredFiniteLivedIntangibleAssetWeightedAveragePeriodBeforeRenewalOrExtension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AcquiredFiniteLivedIntangibleAssetWeightedAveragePeriodBeforeRenewalOrExtension" xlink:to="us-gaap_AcquiredFiniteLivedIntangibleAssetWeightedAveragePeriodBeforeRenewalOrExtension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AcquiredFiniteLivedIntangibleAssetWeightedAveragePeriodBeforeRenewalOrExtension_lbl" xml:lang="en-US">License agreement renewal term</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_RoyaltyExpenseNetSalesPercentage" xlink:label="ipar_RoyaltyExpenseNetSalesPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_RoyaltyExpenseNetSalesPercentage" xlink:to="ipar_RoyaltyExpenseNetSalesPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ipar_RoyaltyExpenseNetSalesPercentage_lbl" xml:lang="en-US">Royalty expense, percentage of net sales</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable_lbl" xml:lang="en-US">Finite-Lived Intangible Assets Acquired as Part of Business Combination [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:label="us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_lbl" xml:lang="en-US">Acquired Finite-Lived Intangible Assets [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryGross" xlink:label="us-gaap_InventoryGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryGross" xlink:to="us-gaap_InventoryGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryGross_lbl" xml:lang="en-US">Inventory gross</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueOfAssetsAcquired" xlink:label="us-gaap_FairValueOfAssetsAcquired" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueOfAssetsAcquired" xlink:to="us-gaap_FairValueOfAssetsAcquired_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueOfAssetsAcquired_lbl" xml:lang="en-US">Assets acquired</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAssumed1" xlink:label="us-gaap_LiabilitiesAssumed1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAssumed1" xlink:to="us-gaap_LiabilitiesAssumed1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_LiabilitiesAssumed1_lbl" xml:lang="en-US">Liabilities Assumed</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryNet" xlink:to="us-gaap_InventoryNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_InventoryNet_2_lbl" xml:lang="en-US">Inventory net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxesPayableCurrentAndNoncurrent" xlink:label="us-gaap_TaxesPayableCurrentAndNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TaxesPayableCurrentAndNoncurrent" xlink:to="us-gaap_TaxesPayableCurrentAndNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TaxesPayableCurrentAndNoncurrent_lbl" xml:lang="en-US">Taxes Payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForPurchaseOfOtherAssets1" xlink:label="us-gaap_PaymentsForPurchaseOfOtherAssets1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForPurchaseOfOtherAssets1" xlink:to="us-gaap_PaymentsForPurchaseOfOtherAssets1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsForPurchaseOfOtherAssets1_lbl" xml:lang="en-US">Payments for Purchase of Other Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcquisitionCosts" xlink:label="us-gaap_AcquisitionCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AcquisitionCosts" xlink:to="us-gaap_AcquisitionCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AcquisitionCosts_lbl" xml:lang="en-US">Acquisition Costs, Period Cost</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_CashHeldInEscrow" xlink:label="ipar_CashHeldInEscrow" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_CashHeldInEscrow" xlink:to="ipar_CashHeldInEscrow_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ipar_CashHeldInEscrow_lbl" xml:lang="en-US">[custom:CashHeldInEscrow-0]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReceivable" xlink:label="us-gaap_IncomeTaxReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReceivable" xlink:to="us-gaap_IncomeTaxReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReceivable_lbl" xml:lang="en-US">Income Taxes Receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTaxCredit" xlink:label="us-gaap_InvestmentTaxCredit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentTaxCredit" xlink:to="us-gaap_InvestmentTaxCredit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentTaxCredit_lbl" xml:lang="en-US">Investment Tax Credit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtTerm" xlink:label="us-gaap_LongTermDebtTerm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtTerm" xlink:to="us-gaap_LongTermDebtTerm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtTerm_lbl" xml:lang="en-US">Long-term Debt, Term</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCredit" xlink:label="us-gaap_LineOfCredit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCredit" xlink:to="us-gaap_LineOfCredit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LineOfCredit_lbl" xml:lang="en-US">Long-term Line of Credit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateTerms" xlink:label="us-gaap_DebtInstrumentInterestRateTerms" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateTerms" xlink:to="us-gaap_DebtInstrumentInterestRateTerms_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentInterestRateTerms_lbl" xml:lang="en-US">Debt Instrument, Interest Rate Terms</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentFaceAmount" xlink:to="us-gaap_DebtInstrumentFaceAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentFaceAmount_lbl" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_DiscriptionOfRecentAgreement" xlink:label="ipar_DiscriptionOfRecentAgreement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_DiscriptionOfRecentAgreement" xlink:to="ipar_DiscriptionOfRecentAgreement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ipar_DiscriptionOfRecentAgreement_lbl" xml:lang="en-US">Discription of recent agreement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentChargeOnReclassifiedAssets" xlink:label="us-gaap_ImpairmentChargeOnReclassifiedAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentChargeOnReclassifiedAssets" xlink:to="us-gaap_ImpairmentChargeOnReclassifiedAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ImpairmentChargeOnReclassifiedAssets_lbl" xml:lang="en-US">Impairment Charge on Reclassified Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionDescriptionOfAcquiredEntity" xlink:label="us-gaap_BusinessAcquisitionDescriptionOfAcquiredEntity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionDescriptionOfAcquiredEntity" xlink:to="us-gaap_BusinessAcquisitionDescriptionOfAcquiredEntity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionDescriptionOfAcquiredEntity_lbl" xml:lang="en-US">License agreements, description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRawMaterials" xlink:label="us-gaap_InventoryRawMaterials" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryRawMaterials" xlink:to="us-gaap_InventoryRawMaterials_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryRawMaterials_lbl" xml:lang="en-US">Raw materials and component parts</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoods" xlink:label="us-gaap_InventoryFinishedGoods" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryFinishedGoods" xlink:to="us-gaap_InventoryFinishedGoods_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryFinishedGoods_lbl" xml:lang="en-US">Finished goods</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSoldOverhead" xlink:label="us-gaap_CostOfGoodsAndServicesSoldOverhead" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfGoodsAndServicesSoldOverhead" xlink:to="us-gaap_CostOfGoodsAndServicesSoldOverhead_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostOfGoodsAndServicesSoldOverhead_lbl" xml:lang="en-US">Cost of Goods Sold, Overhead</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryValuationReserves" xlink:label="us-gaap_InventoryValuationReserves" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryValuationReserves" xlink:to="us-gaap_InventoryValuationReserves_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryValuationReserves_lbl" xml:lang="en-US">Inventory Valuation Reserves</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosureAbstract" xlink:label="us-gaap_AssetsFairValueDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsFairValueDisclosureAbstract" xlink:to="us-gaap_AssetsFairValueDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsFairValueDisclosureAbstract_lbl" xml:lang="en-US">Assets:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsFairValueDisclosure" xlink:label="us-gaap_InvestmentsFairValueDisclosure" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentsFairValueDisclosure" xlink:to="us-gaap_InvestmentsFairValueDisclosure_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_InvestmentsFairValueDisclosure_lbl" xml:lang="en-US">Short-term investments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAbstract" xlink:label="us-gaap_LiabilitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAbstract" xlink:to="us-gaap_LiabilitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAbstract_lbl" xml:lang="en-US">Liabilities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyFairValueHedgeAssetAtFairValue" xlink:label="us-gaap_ForeignCurrencyFairValueHedgeAssetAtFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyFairValueHedgeAssetAtFairValue" xlink:to="us-gaap_ForeignCurrencyFairValueHedgeAssetAtFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ForeignCurrencyFairValueHedgeAssetAtFairValue_lbl" xml:lang="en-US">Foreign currency forward exchange contracts accounted for using hedge accounting</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue" xlink:label="us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue" xlink:to="us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue_lbl" xml:lang="en-US">Foreign currency forward exchange contracts not accounted for using hedge accounting</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilities" xlink:label="us-gaap_DerivativeLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeLiabilities" xlink:to="us-gaap_DerivativeLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeLiabilities_lbl" xml:lang="en-US">Interest rate swaps</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="us-gaap_AssetsFairValueDisclosure" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsFairValueDisclosure" xlink:to="us-gaap_AssetsFairValueDisclosure_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsFairValueDisclosure_lbl" xml:lang="en-US">&#160;Total Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:label="us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:to="us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_lbl" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:label="us-gaap_DerivativeInstrumentsGainLossLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:to="us-gaap_DerivativeInstrumentsGainLossLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeInstrumentsGainLossLineItems_lbl" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure" xlink:label="us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure" xlink:to="us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_lbl" xml:lang="en-US">Foreign currency contracts, liability, fair value disclosure</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentGross" xlink:to="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xml:lang="en-US">Equipment and leasehold improvements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xml:lang="en-US">Less accumulated depreciation and amortization</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_2_lbl" xml:lang="en-US">Property, Plant and Equipment, Net, Total</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="us-gaap_DepreciationDepletionAndAmortization" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationDepletionAndAmortization" xlink:to="us-gaap_DepreciationDepletionAndAmortization_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DepreciationDepletionAndAmortization_lbl" xml:lang="en-US">Depreciation and amortization expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_lbl" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="us-gaap_FiniteLivedIntangibleAssetsLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsLineItems_lbl" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="us-gaap_FiniteLivedIntangibleAssetsGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross_lbl" xml:lang="en-US">Gross Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl" xml:lang="en-US">Accumulated Amortization</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet_lbl" xml:lang="en-US">Net Book Value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="us-gaap_AmortizationOfIntangibleAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfIntangibleAssets" xlink:to="us-gaap_AmortizationOfIntangibleAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AmortizationOfIntangibleAssets_lbl" xml:lang="en-US">Amortization of Intangible Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_lbl" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_lbl" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Two</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_FiniteLivedIntangibleAssetsAmortizationExpenseAfterTwoYears" xlink:label="ipar_FiniteLivedIntangibleAssetsAmortizationExpenseAfterTwoYears" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_FiniteLivedIntangibleAssetsAmortizationExpenseAfterTwoYears" xlink:to="ipar_FiniteLivedIntangibleAssetsAmortizationExpenseAfterTwoYears_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ipar_FiniteLivedIntangibleAssetsAmortizationExpenseAfterTwoYears_lbl" xml:lang="en-US">[custom:FiniteLivedIntangibleAssetsAmortizationExpenseAfterTwoYears-0]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl" xml:lang="en-US">Amortization period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedLicenseAgreements" xlink:label="us-gaap_IndefiniteLivedLicenseAgreements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IndefiniteLivedLicenseAgreements" xlink:to="us-gaap_IndefiniteLivedLicenseAgreements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IndefiniteLivedLicenseAgreements_lbl" xml:lang="en-US">Indefinite-Lived License Agreements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedAdvertisingCurrent" xlink:label="us-gaap_AccruedAdvertisingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedAdvertisingCurrent" xlink:to="us-gaap_AccruedAdvertisingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedAdvertisingCurrent_lbl" xml:lang="en-US">Advertising liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedSalariesCurrent" xlink:label="us-gaap_AccruedSalariesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedSalariesCurrent" xlink:to="us-gaap_AccruedSalariesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedSalariesCurrent_lbl" xml:lang="en-US">Salary (including bonus and related taxes)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedRoyaltiesCurrent" xlink:label="us-gaap_AccruedRoyaltiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedRoyaltiesCurrent" xlink:to="us-gaap_AccruedRoyaltiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedRoyaltiesCurrent_lbl" xml:lang="en-US">Royalties</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_DueVendorsNotYetInvoiced" xlink:label="ipar_DueVendorsNotYetInvoiced" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_DueVendorsNotYetInvoiced" xlink:to="ipar_DueVendorsNotYetInvoiced_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ipar_DueVendorsNotYetInvoiced_lbl" xml:lang="en-US">Due vendors (not yet invoiced)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrent" xlink:label="us-gaap_PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrent" xlink:to="us-gaap_PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrent_lbl" xml:lang="en-US">Retirement reserves</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRefundLiabilityCurrent" xlink:label="us-gaap_CustomerRefundLiabilityCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CustomerRefundLiabilityCurrent" xlink:to="us-gaap_CustomerRefundLiabilityCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CustomerRefundLiabilityCurrent_lbl" xml:lang="en-US">Refund (return) liability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xml:lang="en-US">Other</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AccruedLiabilitiesCurrent_2_lbl" xml:lang="en-US">Accrued expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="us-gaap_DebtInstrumentTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentTable_lbl" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="us-gaap_DebtInstrumentLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentLineItems_lbl" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentFaceAmount" xlink:to="us-gaap_DebtInstrumentFaceAmount_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DebtInstrumentFaceAmount_2_lbl" xml:lang="en-US">Loan payable (in Dollars)</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_NumberOfInstallment" xlink:label="ipar_NumberOfInstallment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_NumberOfInstallment" xlink:to="ipar_NumberOfInstallment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ipar_NumberOfInstallment_lbl" xml:lang="en-US">Number of installments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentPeriodicPayment" xlink:label="us-gaap_DebtInstrumentPeriodicPayment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentPeriodicPayment" xlink:to="us-gaap_DebtInstrumentPeriodicPayment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentPeriodicPayment_lbl" xml:lang="en-US">Installment amount (in Dollars)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" xml:lang="en-US">Interest per annum</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt" xlink:label="us-gaap_LongTermDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebt" xlink:to="us-gaap_LongTermDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebt_lbl" xml:lang="en-US">Loan payable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtCurrent" xlink:to="us-gaap_LongTermDebtCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LongTermDebtCurrent_2_lbl" xml:lang="en-US">Less current maturities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtNoncurrent" xlink:to="us-gaap_LongTermDebtNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LongTermDebtNoncurrent_2_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_lbl" xml:lang="en-US">Line of credit, maximum borrowing amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:label="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_lbl" xml:lang="en-US">Basis spread over variable interest rate</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage_2_lbl" xml:lang="en-US">Variable rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityExpirationDate1" xlink:label="us-gaap_LineOfCreditFacilityExpirationDate1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityExpirationDate1" xlink:to="us-gaap_LineOfCreditFacilityExpirationDate1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LineOfCreditFacilityExpirationDate1_lbl" xml:lang="en-US">Line of Credit Facility, Expiration Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_lbl" xml:lang="en-US">Long-term Debt, Maturities, 2021</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtDescription" xlink:label="us-gaap_LongTermDebtDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtDescription" xlink:to="us-gaap_LongTermDebtDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtDescription_lbl" xml:lang="en-US">Long term debt maturity, description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_lbl" xml:lang="en-US">2022</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_lbl" xml:lang="en-US">2023</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_lbl" xml:lang="en-US">2024</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_lbl" xml:lang="en-US">2025</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_lbl" xml:lang="en-US">2026</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter_lbl" xml:lang="en-US">Thereafter</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDue_lbl" xml:lang="en-US">Gross Total</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl" xml:lang="en-US">Less imputed interest (based on 3.0% weighted-average discount rate)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear_lbl" xml:lang="en-US">Net Total</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCommitmentDueInNextTwelveMonths" xlink:label="us-gaap_OtherCommitmentDueInNextTwelveMonths" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherCommitmentDueInNextTwelveMonths" xlink:to="us-gaap_OtherCommitmentDueInNextTwelveMonths_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherCommitmentDueInNextTwelveMonths_lbl" xml:lang="en-US">2021</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCommitmentDueInSecondYear" xlink:label="us-gaap_OtherCommitmentDueInSecondYear" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherCommitmentDueInSecondYear" xlink:to="us-gaap_OtherCommitmentDueInSecondYear_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OtherCommitmentDueInSecondYear_lbl" xml:lang="en-US">2022</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCommitmentDueInThirdYear" xlink:label="us-gaap_OtherCommitmentDueInThirdYear" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherCommitmentDueInThirdYear" xlink:to="us-gaap_OtherCommitmentDueInThirdYear_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OtherCommitmentDueInThirdYear_lbl" xml:lang="en-US">2023</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCommitmentDueInFourthYear" xlink:label="us-gaap_OtherCommitmentDueInFourthYear" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherCommitmentDueInFourthYear" xlink:to="us-gaap_OtherCommitmentDueInFourthYear_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OtherCommitmentDueInFourthYear_lbl" xml:lang="en-US">2024</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCommitmentDueInFifthYear" xlink:label="us-gaap_OtherCommitmentDueInFifthYear" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherCommitmentDueInFifthYear" xlink:to="us-gaap_OtherCommitmentDueInFifthYear_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OtherCommitmentDueInFifthYear_lbl" xml:lang="en-US">2025</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCommitmentDueAfterFifthYear" xlink:label="us-gaap_OtherCommitmentDueAfterFifthYear" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherCommitmentDueAfterFifthYear" xlink:to="us-gaap_OtherCommitmentDueAfterFifthYear_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OtherCommitmentDueAfterFifthYear_lbl" xml:lang="en-US">Thereafter</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCommitment" xlink:label="us-gaap_OtherCommitment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherCommitment" xlink:to="us-gaap_OtherCommitment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherCommitment_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" xml:lang="en-US">Weighted average remaining lease term</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_2_lbl" xml:lang="en-US">Operating lease, weighted average discount rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesRentExpenseNet" xlink:label="us-gaap_OperatingLeasesRentExpenseNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesRentExpenseNet" xlink:to="us-gaap_OperatingLeasesRentExpenseNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasesRentExpenseNet_lbl" xml:lang="en-US">Operating lease of related to rental expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasePayments" xlink:label="us-gaap_OperatingLeasePayments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasePayments" xlink:to="us-gaap_OperatingLeasePayments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasePayments_lbl" xml:lang="en-US">Operating lease payments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseCost" xlink:label="us-gaap_OperatingLeaseCost" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseCost" xlink:to="us-gaap_OperatingLeaseCost_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseCost_lbl" xml:lang="en-US">Noncash additions to operating lease assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RoyaltyExpense" xlink:label="us-gaap_RoyaltyExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RoyaltyExpense" xlink:to="us-gaap_RoyaltyExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RoyaltyExpense_lbl" xml:lang="en-US">Royalty expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_lbl" xml:lang="en-US">Nonvested options - beginning of year</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US">Weighted Average Grant Date Fair Value, beginning of year</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xml:lang="en-US">Nonvested options granted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US">Weighted Average Grant Date Fair Value, granted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_lbl" xml:lang="en-US">Nonvested options vested or forfeited</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US">Weighted Average Grant Date Fair Value, vested or forfeited</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_2_lbl" xml:lang="en-US">Nonvested options - end of year</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_2_lbl" xml:lang="en-US">Weighted Average Grant Date Fair Value, end of year</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLoss_2_lbl" xml:lang="en-US">Net income attributable to Inter Parfums, Inc.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EarningsPerShareDiluted_2_lbl" xml:lang="en-US">Diluted earnings per share attributable to Inter Parfums, Inc</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xml:lang="en-US">Options shares under option - beginning of year</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted average exercise price shares under option - beginning of year</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_lbl" xml:lang="en-US">Options granted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted average exercise price options granted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xml:lang="en-US">Options exercised</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted average exercise price options exercised</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xml:lang="en-US">Options forfeited</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted average exercise price options forfeited</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2_lbl" xml:lang="en-US">Options shares under option - end of year</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2_lbl" xml:lang="en-US">Weighted average exercise price shares under option - end of year</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xml:lang="en-US">Weighted-average expected stock-price volatility</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xml:lang="en-US">Weighted-average expected option life</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xml:lang="en-US">Weighted-average risk-free interest rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xml:lang="en-US">Weighted-average dividend yield</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromStockOptionsExercised" xlink:to="us-gaap_ProceedsFromStockOptionsExercised_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProceedsFromStockOptionsExercised_2_lbl" xml:lang="en-US">Proceeds from stock options exercised</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxExpenseFromStockOptionsExercised" xlink:label="us-gaap_DeferredTaxExpenseFromStockOptionsExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxExpenseFromStockOptionsExercised" xlink:to="us-gaap_DeferredTaxExpenseFromStockOptionsExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxExpenseFromStockOptionsExercised_lbl" xml:lang="en-US">Tax benefits</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_lbl" xml:lang="en-US">Intrinsic value of stock options exercised</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_lbl" xml:lang="en-US">Exercise price range (in Dollars per share)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_lbl" xml:lang="en-US">Options outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_lbl" xml:lang="en-US">Options outstanding weighted average remaining contractual life</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_lbl" xml:lang="en-US">Options exercisable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable" xlink:label="us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable" xlink:to="us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable_lbl" xml:lang="en-US">Schedule of Subsidiary or Equity Method Investee [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems" xlink:label="us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems" xlink:to="us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_lbl" xml:lang="en-US">Subsidiary or Equity Method Investee [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl" xml:lang="en-US">Share-based compensation arrangement by share-based payment award, award vesting period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_lbl" xml:lang="en-US">Fair value of shares vested</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" xml:lang="en-US">Number of shares available for grant (in Shares)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xml:lang="en-US">Aggregate intrinsic value of options outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl" xml:lang="en-US">Term</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_2_lbl" xml:lang="en-US">Weighted average grant date fair value (in Dollars per share)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl" xml:lang="en-US">Adjusted for stock splits (in Shares)</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_Covid19Description" xlink:label="ipar_Covid19Description" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_Covid19Description" xlink:to="ipar_Covid19Description_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ipar_Covid19Description_lbl" xml:lang="en-US">Covid 19, description</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_RevaluationResultedInReductionOfCostDescription" xlink:label="ipar_RevaluationResultedInReductionOfCostDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_RevaluationResultedInReductionOfCostDescription" xlink:to="ipar_RevaluationResultedInReductionOfCostDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ipar_RevaluationResultedInReductionOfCostDescription_lbl" xml:lang="en-US">Revaluation resulted in reduction of cost, description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost_lbl" xml:lang="en-US">Modification resulted revised cost</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_PercentageOfIncreaseInAnnualDividend" xlink:label="ipar_PercentageOfIncreaseInAnnualDividend" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_PercentageOfIncreaseInAnnualDividend" xlink:to="ipar_PercentageOfIncreaseInAnnualDividend_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ipar_PercentageOfIncreaseInAnnualDividend_lbl" xml:lang="en-US">Percentage of increase in annual dividend</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsPayableAmountPerShare" xlink:label="us-gaap_DividendsPayableAmountPerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DividendsPayableAmountPerShare" xlink:to="us-gaap_DividendsPayableAmountPerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DividendsPayableAmountPerShare_lbl" xml:lang="en-US">Dividends payable, amount per share (in Dollars per share)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_NetIncomeLoss_3_lbl" xml:lang="en-US">Numerator for diluted earnings per share (in Dollars)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2_lbl" xml:lang="en-US">Weighted average shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:label="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:to="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_lbl" xml:lang="en-US">Weighted Average Number Diluted Shares Outstanding Adjustment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2_lbl" xml:lang="en-US">Denominator for diluted earnings per share</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EarningsPerShareBasic_2_lbl" xml:lang="en-US">Basic (in Dollars per share)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EarningsPerShareDiluted_3_lbl" xml:lang="en-US">Diluted (in Dollars per share)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:label="us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:to="us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_lbl" xml:lang="en-US">Schedule of Revenues from External Customers and Long-Lived Assets [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:label="us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_lbl" xml:lang="en-US">Revenues from External Customers and Long-Lived Assets [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:to="us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_2_lbl" xml:lang="en-US">Revenue from Contract with Customer, Including Assessed Tax</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetIncomeLoss_4_lbl" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationAndAmortization" xlink:label="us-gaap_DepreciationAndAmortization" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationAndAmortization" xlink:to="us-gaap_DepreciationAndAmortization_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DepreciationAndAmortization_lbl" xml:lang="en-US">Depreciation, Depletion and Amortization, Nonproduction</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentIncomeInterestAndDividend" xlink:to="us-gaap_InvestmentIncomeInterestAndDividend_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentIncomeInterestAndDividend_2_lbl" xml:lang="en-US">Investment Income, Interest and Dividend</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncomeTaxExpenseBenefit_2_lbl" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_Assets_2_lbl" xml:lang="en-US">Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionsToOtherAssetsAmount" xlink:label="us-gaap_AdditionsToOtherAssetsAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionsToOtherAssetsAmount" xlink:to="us-gaap_AdditionsToOtherAssetsAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionsToOtherAssetsAmount_lbl" xml:lang="en-US">Additions to Other Assets, Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncurrentAssets" xlink:label="us-gaap_NoncurrentAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncurrentAssets" xlink:to="us-gaap_NoncurrentAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_NoncurrentAssets_lbl" xml:lang="en-US">Long-Lived Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxAssetsNet" xlink:to="us-gaap_DeferredIncomeTaxAssetsNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DeferredIncomeTaxAssetsNet_2_lbl" xml:lang="en-US">Deferred Income Tax Assets, Net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues" xlink:label="us-gaap_Revenues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_Revenues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_Revenues_lbl" xml:lang="en-US">Net sales</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_lbl" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems" xlink:label="us-gaap_SegmentReportingInformationLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_SegmentReportingInformationLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SegmentReportingInformationLineItems_lbl" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_lbl" xml:lang="en-US">U.S. operations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_lbl" xml:lang="en-US">Foreign operations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentFederalTaxExpenseBenefit" xlink:to="us-gaap_CurrentFederalTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit_lbl" xml:lang="en-US">Federal</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:to="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl" xml:lang="en-US">State and local</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit" xlink:label="us-gaap_CurrentForeignTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentForeignTaxExpenseBenefit" xlink:to="us-gaap_CurrentForeignTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CurrentForeignTaxExpenseBenefit_lbl" xml:lang="en-US">Foreign</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Current income tax expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Federal</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl" xml:lang="en-US">State and local</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredForeignIncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredForeignIncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DeferredForeignIncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Foreign</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:label="us-gaap_DeferredIncomeTaxesAndTaxCredits" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:to="us-gaap_DeferredIncomeTaxesAndTaxCredits_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredIncomeTaxesAndTaxCredits_lbl" xml:lang="en-US">Deferred income tax expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeTaxExpenseBenefit_3_lbl" xml:lang="en-US">Total income tax expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsNetAbstract" xlink:label="us-gaap_DeferredTaxAssetsNetAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNetAbstract" xlink:to="us-gaap_DeferredTaxAssetsNetAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsNetAbstract_lbl" xml:lang="en-US">Net deferred tax assets:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign_lbl" xml:lang="en-US">Foreign net operating loss carry-forwards</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_DeferredTaxAssetsInventoryAndAccountsReceivable" xlink:label="ipar_DeferredTaxAssetsInventoryAndAccountsReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_DeferredTaxAssetsInventoryAndAccountsReceivable" xlink:to="ipar_DeferredTaxAssetsInventoryAndAccountsReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ipar_DeferredTaxAssetsInventoryAndAccountsReceivable_lbl" xml:lang="en-US">Inventory and accounts receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsDeferredIncome" xlink:label="us-gaap_DeferredTaxAssetsDeferredIncome" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsDeferredIncome" xlink:to="us-gaap_DeferredTaxAssetsDeferredIncome_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsDeferredIncome_lbl" xml:lang="en-US">Profit sharing</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_lbl" xml:lang="en-US">Stock option compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsInventory" xlink:label="us-gaap_DeferredTaxAssetsInventory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsInventory" xlink:to="us-gaap_DeferredTaxAssetsInventory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsInventory_lbl" xml:lang="en-US">Effect of inventory profit elimination</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOther" xlink:label="us-gaap_DeferredTaxAssetsOther" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOther" xlink:to="us-gaap_DeferredTaxAssetsOther_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DeferredTaxAssetsOther_lbl" xml:lang="en-US">Other</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="us-gaap_DeferredTaxAssetsGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_DeferredTaxAssetsGross_lbl" xml:lang="en-US">Total gross deferred tax assets, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US">Valuation allowance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="us-gaap_DeferredTaxAssetsNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_DeferredTaxAssetsNet_lbl" xml:lang="en-US">Net deferred tax assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesNetAbstract" xlink:label="us-gaap_DeferredTaxLiabilitiesNetAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesNetAbstract" xlink:to="us-gaap_DeferredTaxLiabilitiesNetAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxLiabilitiesNetAbstract_lbl" xml:lang="en-US">Deferred tax liabilities (long-term):</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_DeferredTaxLiabilitiesBuildingExpenses" xlink:label="ipar_DeferredTaxLiabilitiesBuildingExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_DeferredTaxLiabilitiesBuildingExpenses" xlink:to="ipar_DeferredTaxLiabilitiesBuildingExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ipar_DeferredTaxLiabilitiesBuildingExpenses_lbl" xml:lang="en-US">Building expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets" xlink:label="us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets" xlink:to="us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets_lbl" xml:lang="en-US">Trademarks and licenses</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_DeferredTaxLiabilitiesUnrealizedGainOnMarketableEquitySecurities" xlink:label="ipar_DeferredTaxLiabilitiesUnrealizedGainOnMarketableEquitySecurities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_DeferredTaxLiabilitiesUnrealizedGainOnMarketableEquitySecurities" xlink:to="ipar_DeferredTaxLiabilitiesUnrealizedGainOnMarketableEquitySecurities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ipar_DeferredTaxLiabilitiesUnrealizedGainOnMarketableEquitySecurities_lbl" xml:lang="en-US">Unrealized gain on marketable equity securities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesOther" xlink:label="us-gaap_DeferredTaxLiabilitiesOther" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesOther" xlink:to="us-gaap_DeferredTaxLiabilitiesOther_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DeferredTaxLiabilitiesOther_lbl" xml:lang="en-US">Other</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities" xlink:label="us-gaap_DeferredIncomeTaxLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxLiabilities" xlink:to="us-gaap_DeferredIncomeTaxLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DeferredIncomeTaxLiabilities_lbl" xml:lang="en-US">Total deferred tax liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl" xml:lang="en-US">Net deferred tax assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xml:lang="en-US">Statutory rates</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl" xml:lang="en-US">State and local taxes, net of Federal benefit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsEmployeeStockOwnershipPlanDividends" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsEmployeeStockOwnershipPlanDividends" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsEmployeeStockOwnershipPlanDividends" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsEmployeeStockOwnershipPlanDividends_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsEmployeeStockOwnershipPlanDividends_lbl" xml:lang="en-US">Windfall benefit from exercise of stock options</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_lbl" xml:lang="en-US">Benefit of Foreign Derived Intangible Income</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate1" xlink:label="ipar_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate1" xlink:to="ipar_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ipar_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate1_lbl" xml:lang="en-US">U.S. statutory rates</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_lbl" xml:lang="en-US">Other</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xml:lang="en-US">Effective rates</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:label="us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_lbl" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:label="us-gaap_DefinedBenefitPlanDisclosureLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:to="us-gaap_DefinedBenefitPlanDisclosureLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DefinedBenefitPlanDisclosureLineItems_lbl" xml:lang="en-US">Defined Benefit Plan Disclosure [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredForeignIncomeTaxExpenseBenefit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredForeignIncomeTaxExpenseBenefit_2_lbl" xml:lang="en-US">Deferred Foreign Income Tax Expense (Benefit)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_lbl" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_lbl" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_2_lbl" xml:lang="en-US">Cumulative translation adjustments, beginning of year</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent" xlink:label="us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent" xlink:to="us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent_lbl" xml:lang="en-US">Net derivative instrument gain (loss), net of tax</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_3_lbl" xml:lang="en-US">Cumulative translation adjustments, end of year</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_lbl" xml:lang="en-US">Translation adjustments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesNet" xlink:label="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesNet" xlink:to="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesNet_lbl" xml:lang="en-US">Decrease in Inter Parfums, Inc.&#8217;s additional paid-in capital for subsidiary share transactions</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNet" xlink:label="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNet" xlink:to="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNet_lbl" xml:lang="en-US">&#160;Change from net income attributable to Inter Parfums, Inc. and transfers from noncontrolling interest</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_DisclosureReconciliationOfCashAndCashEquivalentsToStatementOfCashFlowsAbstract" xlink:to="ipar_DisclosureReconciliationOfCashAndCashEquivalentsToStatementOfCashFlowsAbstract_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ipar_DisclosureReconciliationOfCashAndCashEquivalentsToStatementOfCashFlowsAbstract_2_lbl" xml:lang="en-US">Following Table Summarizes Cash And Cash Equivalents As Of December 31 2021</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:to="us-gaap_CashCashEquivalentsAndShortTermInvestments_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CashCashEquivalentsAndShortTermInvestments_2_lbl" xml:lang="en-US">Cash and cash equivalents per balance sheet</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_CashHeldInEscrowIncludedInOtherAssets" xlink:label="ipar_CashHeldInEscrowIncludedInOtherAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_CashHeldInEscrowIncludedInOtherAssets" xlink:to="ipar_CashHeldInEscrowIncludedInOtherAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ipar_CashHeldInEscrowIncludedInOtherAssets_lbl" xml:lang="en-US">Cash held in escrow included in other assets (see note 3)</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_CashAndCashEquivalentsPerStatementOfCashFlows" xlink:label="ipar_CashAndCashEquivalentsPerStatementOfCashFlows" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_CashAndCashEquivalentsPerStatementOfCashFlows" xlink:to="ipar_CashAndCashEquivalentsPerStatementOfCashFlows_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ipar_CashAndCashEquivalentsPerStatementOfCashFlows_lbl" xml:lang="en-US">Cash and cash equivalents per statement of cash flows</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_ReconciliationOfCashAndCashEquivalentsToTheStatementOfCashFlowsTextBlock" xlink:to="ipar_ReconciliationOfCashAndCashEquivalentsToTheStatementOfCashFlowsTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_ReconciliationOfCashAndCashEquivalentsToTheStatementOfCashFlowsTextBlock_doc" xml:lang="en-US">The entire disclosure for reconciliation of cash and cash equivalents to the statement of cash flows.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_MontblancMember" xlink:to="ipar_MontblancMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_MontblancMember_doc" xml:lang="en-US">The member montblanc.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_JimmyChooMember" xlink:to="ipar_JimmyChooMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_JimmyChooMember_doc" xml:lang="en-US">The member jimmy choo.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_CoachMember" xlink:to="ipar_CoachMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_CoachMember_doc" xml:lang="en-US">The member coach.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_GUESSMember" xlink:to="ipar_GUESSMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_GUESSMember_doc" xml:lang="en-US">The member GUESS.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_InterparfumsSASubsidiaryMember" xlink:to="ipar_InterparfumsSASubsidiaryMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_InterparfumsSASubsidiaryMember_doc" xml:lang="en-US">The member interparfums s a subsidiary.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_CashHeldInEscrowIncludedInOtherAssets" xlink:to="ipar_CashHeldInEscrowIncludedInOtherAssets_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_CashHeldInEscrowIncludedInOtherAssets_doc" xml:lang="en-US">Cash held in escrow included in other assets.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_CashAndCashEquivalentsPerStatementOfCashFlows" xlink:to="ipar_CashAndCashEquivalentsPerStatementOfCashFlows_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_CashAndCashEquivalentsPerStatementOfCashFlows_doc" xml:lang="en-US">Cash and cash equivalents per statement of cash flows.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_RoyaltyExpenseNetSalesPercentage" xlink:to="ipar_RoyaltyExpenseNetSalesPercentage_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_RoyaltyExpenseNetSalesPercentage_doc" xml:lang="en-US">Royalty expense net sales percentage.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_ImpactOfCOVID19PandemicTextBlock" xlink:to="ipar_ImpactOfCOVID19PandemicTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_ImpactOfCOVID19PandemicTextBlock_doc" xml:lang="en-US">The entire disclosure for impact of COVID 19 pandemic.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember" xlink:to="ipar_AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember_doc" xml:lang="en-US">The member accumulated defined benefit plans net derivative instruments.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_DiscriptionOfRecentAgreement" xlink:to="ipar_DiscriptionOfRecentAgreement_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_DiscriptionOfRecentAgreement_doc" xml:lang="en-US">Discription of recent agreement.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_AnnaSuiCorpMember" xlink:to="ipar_AnnaSuiCorpMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_AnnaSuiCorpMember_doc" xml:lang="en-US">This member stans for anna SuiCorp.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_RochasFashionMember" xlink:to="ipar_RochasFashionMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_RochasFashionMember_doc" xml:lang="en-US">This member stans for rochas fashion.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_CashHeldInEscrow" xlink:to="ipar_CashHeldInEscrow_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_CashHeldInEscrow_doc" xml:lang="en-US">Cash held in escrow.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_STDupontMember" xlink:to="ipar_STDupontMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_STDupontMember_doc" xml:lang="en-US">The member stand for STDupont.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_GlobalSettlementAgreementMember" xlink:to="ipar_GlobalSettlementAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_GlobalSettlementAgreementMember_doc" xml:lang="en-US">This member stans for global settlement agreement.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_DeferredTaxAssetsInventoryAndAccountsReceivable" xlink:to="ipar_DeferredTaxAssetsInventoryAndAccountsReceivable_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_DeferredTaxAssetsInventoryAndAccountsReceivable_doc" xml:lang="en-US">Deferred tax assets inventory and accounts receivable.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_DueVendorsNotYetInvoiced" xlink:to="ipar_DueVendorsNotYetInvoiced_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_DueVendorsNotYetInvoiced_doc" xml:lang="en-US">Due vendors not yet invoiced.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_ForeignDerivedIntangibleIncomeMember" xlink:to="ipar_ForeignDerivedIntangibleIncomeMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_ForeignDerivedIntangibleIncomeMember_doc" xml:lang="en-US">This member stans for foreign derived intangible income.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_DomesticSubsidiariesMember" xlink:to="ipar_DomesticSubsidiariesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_DomesticSubsidiariesMember_doc" xml:lang="en-US">This member stans for domestic subsidiaries.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_LondonInterbankOfferedRateMember" xlink:to="ipar_LondonInterbankOfferedRateMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_LondonInterbankOfferedRateMember_doc" xml:lang="en-US">This member stans for london interbank offered rate.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_ForeignSubsidiariesMember" xlink:to="ipar_ForeignSubsidiariesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_ForeignSubsidiariesMember_doc" xml:lang="en-US">This member stans for foreign subsidiaries.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_EuroInterbankOfferedRateMembeMember" xlink:to="ipar_EuroInterbankOfferedRateMembeMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_EuroInterbankOfferedRateMembeMember_doc" xml:lang="en-US">This member stans for euro interbank offered rate membe.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_EliminationsMember" xlink:to="ipar_EliminationsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_EliminationsMember_doc" xml:lang="en-US">This member stans for eliminations.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_TransferOfSubsidiarySharesPurchasedToTreasuryShares" xlink:to="ipar_TransferOfSubsidiarySharesPurchasedToTreasuryShares_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_TransferOfSubsidiarySharesPurchasedToTreasuryShares_doc" xml:lang="en-US">Transfer of subsidiary shares purchased to treasury shares.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_LoansPayableOneMember" xlink:to="ipar_LoansPayableOneMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_LoansPayableOneMember_doc" xml:lang="en-US">This member stans for loans payable one.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_LoansPayableTwoMember" xlink:to="ipar_LoansPayableTwoMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_LoansPayableTwoMember_doc" xml:lang="en-US">This member stans for loans payable two.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_LoansPayableThreeMember" xlink:to="ipar_LoansPayableThreeMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_LoansPayableThreeMember_doc" xml:lang="en-US">This member stans for loans payable three.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_NumberOfInstallment" xlink:to="ipar_NumberOfInstallment_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_NumberOfInstallment_doc" xml:lang="en-US">Number of installment.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_EuropeCountryMember" xlink:to="ipar_EuropeCountryMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_EuropeCountryMember_doc" xml:lang="en-US">This member stans for europe country.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_CentralAndSouthAmericaMember" xlink:to="ipar_CentralAndSouthAmericaMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_CentralAndSouthAmericaMember_doc" xml:lang="en-US">This member stans for central and south america.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_OtherSegmentCountryMember" xlink:to="ipar_OtherSegmentCountryMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_OtherSegmentCountryMember_doc" xml:lang="en-US">This member stans for other segment country.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_UnitedStatesMember" xlink:to="ipar_UnitedStatesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_UnitedStatesMember_doc" xml:lang="en-US">This member stans for united states.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_FranceMember" xlink:to="ipar_FranceMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_FranceMember_doc" xml:lang="en-US">This member stans for france.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_RussiaMember" xlink:to="ipar_RussiaMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_RussiaMember_doc" xml:lang="en-US">This member stans for russia.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_UnitedKingdomMember" xlink:to="ipar_UnitedKingdomMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_UnitedKingdomMember_doc" xml:lang="en-US">This member stans for united kingdom.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_ExercisePriceRangeOneMember" xlink:to="ipar_ExercisePriceRangeOneMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_ExercisePriceRangeOneMember_doc" xml:lang="en-US">This member stans for exercise price range one.</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_ExercisePriceRangeFiveMember" xlink:label="ipar_ExercisePriceRangeFiveMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_ExercisePriceRangeFiveMember" xlink:to="ipar_ExercisePriceRangeFiveMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_ExercisePriceRangeFiveMember_doc" xml:lang="en-US">This member stans for exercise price range five.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_ExercisePriceRangeThreeMember" xlink:to="ipar_ExercisePriceRangeThreeMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_ExercisePriceRangeThreeMember_doc" xml:lang="en-US">This member stans for exercise price range three.</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_OperatingLeasesFutureMinimumPaymentsDueInSixYears" xlink:label="ipar_OperatingLeasesFutureMinimumPaymentsDueInSixYears" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_OperatingLeasesFutureMinimumPaymentsDueInSixYears" xlink:to="ipar_OperatingLeasesFutureMinimumPaymentsDueInSixYears_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_OperatingLeasesFutureMinimumPaymentsDueInSixYears_doc" xml:lang="en-US">Operating leases future minimum payments due in six years.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_EmployeesMember" xlink:to="ipar_EmployeesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_EmployeesMember_doc" xml:lang="en-US">This member stans for employees.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_OfficersAndManagersMember" xlink:to="ipar_OfficersAndManagersMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_OfficersAndManagersMember_doc" xml:lang="en-US">This member stans for officers and managers.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_Covid19Description" xlink:to="ipar_Covid19Description_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_Covid19Description_doc" xml:lang="en-US">Covid 19 description.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_RevaluationResultedInReductionOfCostDescription" xlink:to="ipar_RevaluationResultedInReductionOfCostDescription_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_RevaluationResultedInReductionOfCostDescription_doc" xml:lang="en-US">Revaluation resulted in reduction of cost description.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_PercentageOfIncreaseInAnnualDividend" xlink:to="ipar_PercentageOfIncreaseInAnnualDividend_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_PercentageOfIncreaseInAnnualDividend_doc" xml:lang="en-US">Percentage of increase in annual dividend.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_StockOptionOneMember" xlink:to="ipar_StockOptionOneMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_StockOptionOneMember_doc" xml:lang="en-US">This member stans for stock option one.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_DeferredTaxLiabilitiesUnrealizedGainOnMarketableEquitySecurities" xlink:to="ipar_DeferredTaxLiabilitiesUnrealizedGainOnMarketableEquitySecurities_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_DeferredTaxLiabilitiesUnrealizedGainOnMarketableEquitySecurities_doc" xml:lang="en-US">Deferred tax liabilities unrealized gain on marketable equity securities.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_DeferredTaxLiabilitiesBuildingExpenses" xlink:to="ipar_DeferredTaxLiabilitiesBuildingExpenses_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_DeferredTaxLiabilitiesBuildingExpenses_doc" xml:lang="en-US">Deferred tax liabilities building expenses.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_LicensesMember" xlink:to="ipar_LicensesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_LicensesMember_doc" xml:lang="en-US">This member stans for licenses.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_SubtotalMember" xlink:to="ipar_SubtotalMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_SubtotalMember_doc" xml:lang="en-US">This member stans for subtotal.</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_EURMember" xlink:label="ipar_EURMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_EURMember" xlink:to="ipar_EURMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_EURMember_doc" xml:lang="en-US">This member stans for EUR.</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_USDMember" xlink:label="ipar_USDMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_USDMember" xlink:to="ipar_USDMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_USDMember_doc" xml:lang="en-US">This member stans for USD.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_InventoryMember" xlink:to="ipar_InventoryMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_InventoryMember_doc" xml:lang="en-US">This member stans for inventory.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_OtherAssetMember" xlink:to="ipar_OtherAssetMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_OtherAssetMember_doc" xml:lang="en-US">This member stans for other asset.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_ScheduleOfInventoryCurrentTableTextBlock1" xlink:to="ipar_ScheduleOfInventoryCurrentTableTextBlock1_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_ScheduleOfInventoryCurrentTableTextBlock1_doc" xml:lang="en-US">Tabular disclosure of inventory current table text block1.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate1" xlink:to="ipar_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate1_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate1_doc" xml:lang="en-US">Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_FiniteLivedIntangibleAssetsAmortizationExpenseAfterTwoYears" xlink:to="ipar_FiniteLivedIntangibleAssetsAmortizationExpenseAfterTwoYears_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_FiniteLivedIntangibleAssetsAmortizationExpenseAfterTwoYears_doc" xml:lang="en-US">The amount finite lived intangible assets amortization expense after two years.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrent_2_lbl" xml:lang="en-US">Assets, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Assets_3_lbl" xml:lang="en-US">Assets [Default Label]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrent_2_lbl" xml:lang="en-US">Liabilities, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TreasuryStockValue" xlink:to="us-gaap_TreasuryStockValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TreasuryStockValue_2_lbl" xml:lang="en-US">Treasury Stock, Value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquity_2_lbl" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_4_lbl" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xml:lang="en-US">Liabilities and Equity [Default Label]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_GrossProfit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GrossProfit_2_lbl" xml:lang="en-US">Gross Profit</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingIncomeLoss_2_lbl" xml:lang="en-US">Operating Income (Loss)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:to="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_2_lbl" xml:lang="en-US">Foreign Currency Transaction Gain (Loss), before Tax</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherIncome" xlink:to="us-gaap_OtherIncome_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherIncome_2_lbl" xml:lang="en-US">Other Income</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NonoperatingIncomeExpense_2_lbl" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest_2_lbl" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Noncontrolling Interest</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:to="us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_2_lbl" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax_2_lbl" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance" xlink:to="us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance_2_lbl" xml:lang="en-US">Noncontrolling Interest, Increase from Subsidiary Equity Issuance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DividendsCash" xlink:to="us-gaap_DividendsCash_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DividendsCash_2_lbl" xml:lang="en-US">Dividends, Cash</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromEquityMethodInvestments" xlink:to="us-gaap_IncomeLossFromEquityMethodInvestments_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromEquityMethodInvestments_2_lbl" xml:lang="en-US">Income (Loss) from Equity Method Investments</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrealizedGainLossOnDerivatives" xlink:to="us-gaap_UnrealizedGainLossOnDerivatives_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UnrealizedGainLossOnDerivatives_2_lbl" xml:lang="en-US">Unrealized Gain (Loss) on Derivatives</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_2_lbl" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInventories" xlink:to="us-gaap_IncreaseDecreaseInInventories_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInInventories_2_lbl" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets_2_lbl" xml:lang="en-US">Increase (Decrease) in Other Operating Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireShortTermInvestments" xlink:to="us-gaap_PaymentsToAcquireShortTermInvestments_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireShortTermInvestments_2_lbl" xml:lang="en-US">Payments to Acquire Short-term Investments</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireProductiveAssets" xlink:to="us-gaap_PaymentsToAcquireProductiveAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireProductiveAssets_2_lbl" xml:lang="en-US">Payments to Acquire Productive Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireIntangibleAssets" xlink:to="us-gaap_PaymentsToAcquireIntangibleAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets_2_lbl" xml:lang="en-US">Payments to Acquire Intangible Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:to="us-gaap_PaymentsToAcquireEquityMethodInvestments_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireEquityMethodInvestments_2_lbl" xml:lang="en-US">Payments to Acquire Equity Method Investments</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfLongTermDebt" xlink:to="us-gaap_RepaymentsOfLongTermDebt_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RepaymentsOfLongTermDebt_2_lbl" xml:lang="en-US">Repayments of Long-term Debt</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfDividendsCommonStock" xlink:to="us-gaap_PaymentsOfDividendsCommonStock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsOfDividendsCommonStock_2_lbl" xml:lang="en-US">Payments of Ordinary Dividends, Common Stock</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfDividendsMinorityInterest" xlink:to="us-gaap_PaymentsOfDividendsMinorityInterest_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsOfDividendsMinorityInterest_2_lbl" xml:lang="en-US">Payments of Ordinary Dividends, Noncontrolling Interest</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToMinorityShareholders" xlink:to="us-gaap_PaymentsToMinorityShareholders_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToMinorityShareholders_2_lbl" xml:lang="en-US">Payments to Noncontrolling Interests</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_lbl" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_3_lbl" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxesPaid" xlink:to="us-gaap_IncomeTaxesPaid_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxesPaid_2_lbl" xml:lang="en-US">Income Taxes Paid</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryDisclosureTextBlock" xlink:to="us-gaap_InventoryDisclosureTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryDisclosureTextBlock_2_lbl" xml:lang="en-US">Inventory Disclosure [Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryPolicyTextBlock" xlink:to="us-gaap_InventoryPolicyTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryPolicyTextBlock_2_lbl" xml:lang="en-US">Inventory, Policy [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_2_lbl" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_2_lbl" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAssumed1" xlink:to="us-gaap_LiabilitiesAssumed1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAssumed1_2_lbl" xml:lang="en-US">Liabilities Assumed</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentsFairValueDisclosure" xlink:to="us-gaap_InvestmentsFairValueDisclosure_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentsFairValueDisclosure_2_lbl" xml:lang="en-US">Investments, Fair Value Disclosure</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_2_lbl" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherCommitmentDueInSecondYear" xlink:to="us-gaap_OtherCommitmentDueInSecondYear_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherCommitmentDueInSecondYear_2_lbl" xml:lang="en-US">Other Commitment, to be Paid, Year Two</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherCommitmentDueInThirdYear" xlink:to="us-gaap_OtherCommitmentDueInThirdYear_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherCommitmentDueInThirdYear_2_lbl" xml:lang="en-US">Other Commitment, to be Paid, Year Three</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherCommitmentDueInFourthYear" xlink:to="us-gaap_OtherCommitmentDueInFourthYear_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherCommitmentDueInFourthYear_2_lbl" xml:lang="en-US">Other Commitment, to be Paid, Year Four</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherCommitmentDueInFifthYear" xlink:to="us-gaap_OtherCommitmentDueInFifthYear_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherCommitmentDueInFifthYear_2_lbl" xml:lang="en-US">Other Commitment, to be Paid, Year Five</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherCommitmentDueAfterFifthYear" xlink:to="us-gaap_OtherCommitmentDueAfterFifthYear_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherCommitmentDueAfterFifthYear_2_lbl" xml:lang="en-US">Other Commitment, to be Paid, after Year Five</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_3_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_3_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_2_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Number of Shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_3_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_2_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_2_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncurrentAssets" xlink:to="us-gaap_NoncurrentAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NoncurrentAssets_2_lbl" xml:lang="en-US">Long-Lived Assets [Default Label]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_Revenues_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Revenues_2_lbl" xml:lang="en-US">Revenues</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_2_lbl" xml:lang="en-US">Deferred Federal Income Tax Expense (Benefit)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_2_lbl" xml:lang="en-US">Deferred State and Local Income Tax Expense (Benefit)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOther" xlink:to="us-gaap_DeferredTaxAssetsOther_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsOther_2_lbl" xml:lang="en-US">Deferred Tax Assets, Other</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsGross_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsGross_2_lbl" xml:lang="en-US">Deferred Tax Assets, Gross</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_2_lbl" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsNet_2_lbl" xml:lang="en-US">Deferred Tax Assets, Net of Valuation Allowance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets" xlink:to="us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets_2_lbl" xml:lang="en-US">Deferred Tax Liabilities, Other Finite-Lived Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesOther" xlink:to="us-gaap_DeferredTaxLiabilitiesOther_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxLiabilitiesOther_2_lbl" xml:lang="en-US">Deferred Tax Liabilities, Other</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxLiabilities" xlink:to="us-gaap_DeferredIncomeTaxLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredIncomeTaxLiabilities_2_lbl" xml:lang="en-US">Deferred Tax Liabilities, Gross</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_2_lbl" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Other Adjustments, Percent</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>19
<FILENAME>ipar-20211231_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.12a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://interparfumsinc.com/role/Cover" xlink:href="ipar-20211231.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/BalanceSheets" xlink:href="ipar-20211231.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/BalanceSheetsParenthetical" xlink:href="ipar-20211231.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/StatementsOfIncome" xlink:href="ipar-20211231.xsd#StatementsOfIncome" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/StatementsOfComprehensiveIncome" xlink:href="ipar-20211231.xsd#StatementsOfComprehensiveIncome" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/StatementsOfChangesInShareholdersEquity" xlink:href="ipar-20211231.xsd#StatementsOfChangesInShareholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/StatementsOfCashFlows" xlink:href="ipar-20211231.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPolicies" xlink:href="ipar-20211231.xsd#CompanyAndItsSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/ImpactOfCovid-19Pandemic" xlink:href="ipar-20211231.xsd#ImpactOfCovid-19Pandemic" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/RecentAgreements" xlink:href="ipar-20211231.xsd#RecentAgreements" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/Inventories" xlink:href="ipar-20211231.xsd#Inventories" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/FairValueOfFinancialInstruments" xlink:href="ipar-20211231.xsd#FairValueOfFinancialInstruments" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/DerivativeFinancialInstruments" xlink:href="ipar-20211231.xsd#DerivativeFinancialInstruments" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/PropertyEquipmentAndLeaseholdImprovements" xlink:href="ipar-20211231.xsd#PropertyEquipmentAndLeaseholdImprovements" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssets" xlink:href="ipar-20211231.xsd#TrademarksLicensesAndOtherIntangibleAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/AccruedExpenses" xlink:href="ipar-20211231.xsd#AccruedExpenses" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/LoansPayableBanks" xlink:href="ipar-20211231.xsd#LoansPayableBanks" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/Long-termDebt" xlink:href="ipar-20211231.xsd#Long-termDebt" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/Commitments" xlink:href="ipar-20211231.xsd#Commitments" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/Equity" xlink:href="ipar-20211231.xsd#Equity" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.CommonShareholders" xlink:href="ipar-20211231.xsd#NetIncomeAttributableToInterParfumsInc.CommonShareholders" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/SegmentsAndGeographicAreas" xlink:href="ipar-20211231.xsd#SegmentsAndGeographicAreas" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/IncomeTaxes" xlink:href="ipar-20211231.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/AccumulatedOtherComprehensiveLoss" xlink:href="ipar-20211231.xsd#AccumulatedOtherComprehensiveLoss" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.AndTransfersFromNoncontrollingInterest" xlink:href="ipar-20211231.xsd#NetIncomeAttributableToInterParfumsInc.AndTransfersFromNoncontrollingInterest" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/ReconciliationOfCashAndCashEquivalentsToStatementOfCashFlows" xlink:href="ipar-20211231.xsd#ReconciliationOfCashAndCashEquivalentsToStatementOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesPolicies" xlink:href="ipar-20211231.xsd#CompanyAndItsSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesTables" xlink:href="ipar-20211231.xsd#CompanyAndItsSignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/RecentAgreementsTables" xlink:href="ipar-20211231.xsd#RecentAgreementsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/InventoriesTables" xlink:href="ipar-20211231.xsd#InventoriesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/FairValueOfFinancialInstrumentsTables" xlink:href="ipar-20211231.xsd#FairValueOfFinancialInstrumentsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/PropertyEquipmentAndLeaseholdImprovementsTables" xlink:href="ipar-20211231.xsd#PropertyEquipmentAndLeaseholdImprovementsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssetsTables" xlink:href="ipar-20211231.xsd#TrademarksLicensesAndOtherIntangibleAssetsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/AccruedExpensesTables" xlink:href="ipar-20211231.xsd#AccruedExpensesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/Long-termDebtTables" xlink:href="ipar-20211231.xsd#Long-termDebtTables" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/CommitmentsTables" xlink:href="ipar-20211231.xsd#CommitmentsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/EquityTables" xlink:href="ipar-20211231.xsd#EquityTables" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.CommonShareholdersTables" xlink:href="ipar-20211231.xsd#NetIncomeAttributableToInterParfumsInc.CommonShareholdersTables" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/SegmentsAndGeographicAreasTables" xlink:href="ipar-20211231.xsd#SegmentsAndGeographicAreasTables" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/IncomeTaxesTables" xlink:href="ipar-20211231.xsd#IncomeTaxesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/AccumulatedOtherComprehensiveLossTables" xlink:href="ipar-20211231.xsd#AccumulatedOtherComprehensiveLossTables" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.AndTransfersFromNoncontrollingInterestTables" xlink:href="ipar-20211231.xsd#NetIncomeAttributableToInterParfumsInc.AndTransfersFromNoncontrollingInterestTables" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/ReconciliationOfCashAndCashEquivalentsToStatementOfCashFlowsTables" xlink:href="ipar-20211231.xsd#ReconciliationOfCashAndCashEquivalentsToStatementOfCashFlowsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/ScheduleOfLanvinBrandNameForOurClassDetails" xlink:href="ipar-20211231.xsd#ScheduleOfLanvinBrandNameForOurClassDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesDetailsNarrative" xlink:href="ipar-20211231.xsd#CompanyAndItsSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/AllAmountsHaveBeenTranslatedToU.s.DollarsAtOctober12021ExchangeRate.Details" xlink:href="ipar-20211231.xsd#AllAmountsHaveBeenTranslatedToU.s.DollarsAtOctober12021ExchangeRate.Details" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative" xlink:href="ipar-20211231.xsd#RecentAgreementsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/ScheduleOfInventoriesDetails" xlink:href="ipar-20211231.xsd#ScheduleOfInventoriesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/InventoriesDetailsNarrative" xlink:href="ipar-20211231.xsd#InventoriesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/ScheduleOfFairValueAssetsMeasuredOnRecurringBasisDetails" xlink:href="ipar-20211231.xsd#ScheduleOfFairValueAssetsMeasuredOnRecurringBasisDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/DerivativeFinancialInstrumentsDetailsNarrative" xlink:href="ipar-20211231.xsd#DerivativeFinancialInstrumentsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/ScheduleOfEquipmentAndLeaseholdImprovementsDetails" xlink:href="ipar-20211231.xsd#ScheduleOfEquipmentAndLeaseholdImprovementsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/PropertyEquipmentAndLeaseholdImprovementsDetailsNarrative" xlink:href="ipar-20211231.xsd#PropertyEquipmentAndLeaseholdImprovementsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/ScheduleOfTrademarksLicensesAndOtherIntangibleAssetsDetails" xlink:href="ipar-20211231.xsd#ScheduleOfTrademarksLicensesAndOtherIntangibleAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssetsDetailsNarrative" xlink:href="ipar-20211231.xsd#TrademarksLicensesAndOtherIntangibleAssetsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/AccruedExpensesConsistOfFollowingDetails" xlink:href="ipar-20211231.xsd#AccruedExpensesConsistOfFollowingDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/Long-termDebtConsistsOfFollowingDetails" xlink:href="ipar-20211231.xsd#Long-termDebtConsistsOfFollowingDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/LoansPayableBanksDetailsNarrative" xlink:href="ipar-20211231.xsd#LoansPayableBanksDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/Long-termDebtDetailsNarrative" xlink:href="ipar-20211231.xsd#Long-termDebtDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/MaturitiesOfLeaseLiabilitiesSubsequentToDecember312021AreAsFollowsDetails" xlink:href="ipar-20211231.xsd#MaturitiesOfLeaseLiabilitiesSubsequentToDecember312021AreAsFollowsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/MinimumAnnualRoyaltiesAndOtherCommitmentsAsFollowsDetails" xlink:href="ipar-20211231.xsd#MinimumAnnualRoyaltiesAndOtherCommitmentsAsFollowsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/CommitmentsDetailsNarrative" xlink:href="ipar-20211231.xsd#CommitmentsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/FollowingTableSetsForthInformationWithRespectToNonvestedOptionsFor2021Details" xlink:href="ipar-20211231.xsd#FollowingTableSetsForthInformationWithRespectToNonvestedOptionsFor2021Details" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/EffectOfShare-basedPaymentExpensesDecreasedIncomeStatementLineItemsAsFollowsDetails" xlink:href="ipar-20211231.xsd#EffectOfShare-basedPaymentExpensesDecreasedIncomeStatementLineItemsAsFollowsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/FollowingTableSummarizesStockOptionActivityAndRelatedInformationForYearsEndedDecember3120212020And2019Details" xlink:href="ipar-20211231.xsd#FollowingTableSummarizesStockOptionActivityAndRelatedInformationForYearsEndedDecember3120212020And2019Details" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/AssumptionsUsedInBlack-scholesPricingModelAreSetForthInFollowingTableDetails" xlink:href="ipar-20211231.xsd#AssumptionsUsedInBlack-scholesPricingModelAreSetForthInFollowingTableDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/ProceedsTaxBenefitsAndIntrinsicValueRelatedToStockOptionsExercisedWereAsFollowsDetails" xlink:href="ipar-20211231.xsd#ProceedsTaxBenefitsAndIntrinsicValueRelatedToStockOptionsExercisedWereAsFollowsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/FollowingTableSummarizesAdditionalStockOptionInformationAsOfDecember312021Details" xlink:href="ipar-20211231.xsd#FollowingTableSummarizesAdditionalStockOptionInformationAsOfDecember312021Details" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/EquityDetailsNarrative" xlink:href="ipar-20211231.xsd#EquityDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/ReconciliationBetweenNumeratorsAndDenominatorsOfBasicAndDilutedEpsComputationsIsAsFollowsDetails" xlink:href="ipar-20211231.xsd#ReconciliationBetweenNumeratorsAndDenominatorsOfBasicAndDilutedEpsComputationsIsAsFollowsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.CommonShareholdersDetailsNarrative" xlink:href="ipar-20211231.xsd#NetIncomeAttributableToInterParfumsInc.CommonShareholdersDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/InformationOnCompanysOperationsBySegmentsIsAsFollowsDetails" xlink:href="ipar-20211231.xsd#InformationOnCompanysOperationsBySegmentsIsAsFollowsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/NetSalesToCustomersByRegionAreAsFollowsDetails" xlink:href="ipar-20211231.xsd#NetSalesToCustomersByRegionAreAsFollowsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/NetSalesToCustomersInMajorCountriesAreAsFollowsDetails" xlink:href="ipar-20211231.xsd#NetSalesToCustomersInMajorCountriesAreAsFollowsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/ComponentsOfIncomeBeforeIncomeTaxesConsistOfFollowingDetails" xlink:href="ipar-20211231.xsd#ComponentsOfIncomeBeforeIncomeTaxesConsistOfFollowingDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/ProvisionForCurrentAndDeferredIncomeTaxExpenseBenefitConsistsOfFollowingDetails" xlink:href="ipar-20211231.xsd#ProvisionForCurrentAndDeferredIncomeTaxExpenseBenefitConsistsOfFollowingDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/TaxEffectsOfTemporaryDifferencesThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndDeferredTaxLiabilitiesAreAsFollowsDetails" xlink:href="ipar-20211231.xsd#TaxEffectsOfTemporaryDifferencesThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndDeferredTaxLiabilitiesAreAsFollowsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/DifferencesBetweenUnitedStatesFederalStatutoryIncomeTaxRateAndEffectiveIncomeTaxRateWereAsFollowsDetails" xlink:href="ipar-20211231.xsd#DifferencesBetweenUnitedStatesFederalStatutoryIncomeTaxRateAndEffectiveIncomeTaxRateWereAsFollowsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/IncomeTaxesDetailsNarrative" xlink:href="ipar-20211231.xsd#IncomeTaxesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/ComponentsOfAccumulatedOtherComprehensiveLossConsistOfFollowingDetails" xlink:href="ipar-20211231.xsd#ComponentsOfAccumulatedOtherComprehensiveLossConsistOfFollowingDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/ScheduleOfNetIncomeAttributableToTransfersFromNoncontrollingInterestDetails" xlink:href="ipar-20211231.xsd#ScheduleOfNetIncomeAttributableToTransfersFromNoncontrollingInterestDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/FollowingTableSummarizesCashAndCashEquivalentsAsOfDecember312021Details" xlink:href="ipar-20211231.xsd#FollowingTableSummarizesCashAndCashEquivalentsAsOfDecember312021Details" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="loc_deiIcfrAuditorAttestationFlag" />
      <link:presentationArc order="580" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiIcfrAuditorAttestationFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorFirmId" xlink:label="loc_deiAuditorFirmId" />
      <link:presentationArc order="590" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditorFirmId" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorName" xlink:label="loc_deiAuditorName" />
      <link:presentationArc order="600" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditorName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorLocation" xlink:label="loc_deiAuditorLocation" />
      <link:presentationArc order="610" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditorLocation" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/BalanceSheets" xlink:title="00000002 - Statement - Consolidated Balance Sheets">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaapAssetsAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapAssetsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaapAssetsCurrentAbstract" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssetsCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:label="loc_us-gaapCashCashEquivalentsAndShortTermInvestments" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapCashCashEquivalentsAndShortTermInvestments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermInvestments" xlink:label="loc_us-gaapShortTermInvestments" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapShortTermInvestments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaapAccountsReceivableNetCurrent" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapAccountsReceivableNetCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapInventoryNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherReceivablesNetCurrent" xlink:label="loc_us-gaapOtherReceivablesNetCurrent" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapOtherReceivablesNetCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsCurrent" xlink:label="loc_us-gaapOtherAssetsCurrent" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapOtherAssetsCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesReceivable" xlink:label="loc_us-gaapIncomeTaxesReceivable" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapIncomeTaxesReceivable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet" xlink:label="loc_us-gaapDeferredIncomeTaxAssetsNet" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapDeferredIncomeTaxAssetsNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="loc_us-gaapOtherAssetsNoncurrent" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapOtherAssetsNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaapLiabilitiesCurrentAbstract" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent" xlink:label="loc_us-gaapLongTermDebtCurrent" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapLongTermDebtCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityCurrent" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapOperatingLeaseLiabilityCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrent" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapAccruedLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsPayableCurrent" xlink:label="loc_us-gaapDividendsPayableCurrent" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapDividendsPayableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="loc_us-gaapLongTermDebtNoncurrent" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLongTermDebtNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityNoncurrent" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapOperatingLeaseLiabilityNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaapStockholdersEquityAbstract" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValue" xlink:label="loc_us-gaapTreasuryStockValue" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapTreasuryStockValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest" xlink:label="loc_us-gaapMinorityInterest" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapMinorityInterest" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Consolidated Balance Sheets (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapPreferredStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaapPreferredStockSharesIssued" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapPreferredStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockShares" xlink:label="loc_us-gaapTreasuryStockShares" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapTreasuryStockShares" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/StatementsOfIncome" xlink:title="00000004 - Statement - Consolidated Statements of Income">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaapIncomeStatementAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:label="loc_us-gaapRevenueFromContractWithCustomerIncludingAssessedTax" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapRevenueFromContractWithCustomerIncludingAssessedTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="loc_us-gaapCostOfGoodsAndServicesSold" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapCostOfGoodsAndServicesSold" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaapGrossProfit" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapGrossProfit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaapSellingGeneralAndAdministrativeExpense" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapSellingGeneralAndAdministrativeExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfLeasehold" xlink:label="loc_us-gaapImpairmentOfLeasehold" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapImpairmentOfLeasehold" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="loc_us-gaapNonoperatingIncomeExpenseAbstract" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaapInterestExpense" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapInterestExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:label="loc_us-gaapForeignCurrencyTransactionGainLossBeforeTax" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapForeignCurrencyTransactionGainLossBeforeTax" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInterestAndDividend" xlink:label="loc_us-gaapInvestmentIncomeInterestAndDividend" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapInvestmentIncomeInterestAndDividend" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIncome" xlink:label="loc_us-gaapOtherIncome" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapOtherIncome" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapNonoperatingIncomeExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapProfitLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:label="loc_us-gaapEarningsPerShareBasicAndDilutedAbstract" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapEarningsPerShareBasicAndDilutedAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaapEarningsPerShareBasic" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareBasicAndDilutedAbstract" xlink:to="loc_us-gaapEarningsPerShareBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaapEarningsPerShareDiluted" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareBasicAndDilutedAbstract" xlink:to="loc_us-gaapEarningsPerShareDiluted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingAbstract" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapWeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapWeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared" xlink:label="loc_us-gaapCommonStockDividendsPerShareDeclared" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapCommonStockDividendsPerShareDeclared" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/StatementsOfComprehensiveIncome" xlink:title="00000005 - Statement - Consolidated Statements of Comprehensive Income">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaapIncomeStatementAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapProfitLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:label="loc_us-gaapReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="loc_us-gaapReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTax" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossBeforeTax" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossBeforeTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="loc_us-gaapComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterestAbstract" xlink:label="loc_us-gaapComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterestAbstract" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterestAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterestAbstract" xlink:to="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapOtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToNoncontrollingInterest" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterestAbstract" xlink:to="loc_us-gaapOtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToNoncontrollingInterest" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapOtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterestAbstract" xlink:to="loc_us-gaapOtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterestAbstract" xlink:to="loc_us-gaapComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="loc_us-gaapComprehensiveIncomeNetOfTax" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterestAbstract" xlink:to="loc_us-gaapComprehensiveIncomeNetOfTax" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/StatementsOfChangesInShareholdersEquity" xlink:title="00000006 - Statement - Consolidated Statements of Changes in Shareholders&apos; Equity">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaapStatementOfStockholdersEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfStockholdersEquityAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="70" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapRetainedEarningsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember" xlink:label="loc_us-gaapTreasuryStockMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapTreasuryStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestMember" xlink:label="loc_us-gaapNoncontrollingInterestMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapNoncontrollingInterestMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueStockOptionsExercised" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueShareBasedCompensation" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueShareBasedCompensation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance" xlink:label="loc_us-gaapNoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueAcquisitions" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueAcquisitions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_TransferOfSubsidiarySharesPurchasedToTreasuryShares" xlink:label="loc_iparTransferOfSubsidiarySharesPurchasedToTreasuryShares" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_iparTransferOfSubsidiarySharesPurchasedToTreasuryShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProfitLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsCash" xlink:label="loc_us-gaapDividendsCash" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDividendsCash" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax" xlink:label="loc_us-gaapOtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapOtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToNoncontrollingInterest" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToNoncontrollingInterest" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/StatementsOfCashFlows" xlink:title="00000007 - Statement - Consolidated Statements of Cash Flows">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaapStatementOfCashFlowsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapProfitLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherDepreciationAndAmortization" xlink:label="loc_us-gaapOtherDepreciationAndAmortization" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapOtherDepreciationAndAmortization" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="loc_us-gaapProvisionForDoubtfulAccounts" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapProvisionForDoubtfulAccounts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments" xlink:label="loc_us-gaapIncomeLossFromEquityMethodInvestments" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncomeLossFromEquityMethodInvestments" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseImpairmentLoss" xlink:label="loc_us-gaapOperatingLeaseImpairmentLoss" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapOperatingLeaseImpairmentLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredIncomeTaxExpenseBenefit" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapDeferredIncomeTaxExpenseBenefit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrealizedGainLossOnDerivatives" xlink:label="loc_us-gaapUnrealizedGainLossOnDerivatives" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapUnrealizedGainLossOnDerivatives" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsReceivable" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsReceivable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaapIncreaseDecreaseInInventories" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInInventories" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:label="loc_us-gaapIncreaseDecreaseInOtherOperatingAssets" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOtherOperatingAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingLeaseLiability" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingLeaseLiability" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedTaxesPayable" xlink:label="loc_us-gaapIncreaseDecreaseInAccruedTaxesPayable" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccruedTaxesPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireShortTermInvestments" xlink:label="loc_us-gaapPaymentsToAcquireShortTermInvestments" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsToAcquireShortTermInvestments" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfShortTermInvestments" xlink:label="loc_us-gaapProceedsFromSaleOfShortTermInvestments" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromSaleOfShortTermInvestments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireProductiveAssets" xlink:label="loc_us-gaapPaymentsToAcquireProductiveAssets" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsToAcquireProductiveAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="loc_us-gaapPaymentsToAcquireIntangibleAssets" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsToAcquireIntangibleAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:label="loc_us-gaapPaymentsToAcquireEquityMethodInvestments" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsToAcquireEquityMethodInvestments" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt" xlink:label="loc_us-gaapRepaymentsOfLongTermDebt" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapRepaymentsOfLongTermDebt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:label="loc_us-gaapProceedsFromIssuanceOfLongTermDebt" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromIssuanceOfLongTermDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="loc_us-gaapProceedsFromStockOptionsExercised" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromStockOptionsExercised" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividendsCommonStock" xlink:label="loc_us-gaapPaymentsOfDividendsCommonStock" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsOfDividendsCommonStock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividendsMinorityInterest" xlink:label="loc_us-gaapPaymentsOfDividendsMinorityInterest" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsOfDividendsMinorityInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToMinorityShareholders" xlink:label="loc_us-gaapPaymentsToMinorityShareholders" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsToMinorityShareholders" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations" xlink:label="loc_us-gaapEffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapEffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue_2" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_SupplementalDisclosureOfCashFlowInformationAbstract" xlink:label="loc_iparSupplementalDisclosureOfCashFlowInformationAbstract" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_iparSupplementalDisclosureOfCashFlowInformationAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="loc_us-gaapSupplementalCashFlowInformationAbstract" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iparSupplementalDisclosureOfCashFlowInformationAbstract" xlink:to="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet" xlink:label="loc_us-gaapInterestPaidNet" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:to="loc_us-gaapInterestPaidNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaid" xlink:label="loc_us-gaapIncomeTaxesPaid" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:to="loc_us-gaapIncomeTaxesPaid" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPolicies" xlink:title="00000008 - Disclosure - The Company and its Significant Accounting Policies">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaapSignificantAccountingPoliciesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapSignificantAccountingPoliciesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/ImpactOfCovid-19Pandemic" xlink:title="00000009 - Disclosure - Impact of COVID-19 Pandemic">
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_DisclosureImpactOfCovid19PandemicAbstract" xlink:label="loc_iparDisclosureImpactOfCovid19PandemicAbstract" />
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_ImpactOfCOVID19PandemicTextBlock" xlink:label="loc_iparImpactOfCOVID19PandemicTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iparDisclosureImpactOfCovid19PandemicAbstract" xlink:to="loc_iparImpactOfCOVID19PandemicTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/RecentAgreements" xlink:title="00000010 - Disclosure - Recent Agreements">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:label="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock" xlink:label="loc_us-gaapBusinessCombinationDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_us-gaapBusinessCombinationDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/Inventories" xlink:title="00000011 - Disclosure - Inventories">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaapInventoryDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureTextBlock" xlink:label="loc_us-gaapInventoryDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryDisclosureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/FairValueOfFinancialInstruments" xlink:title="00000012 - Disclosure - Fair Value of Financial Instruments">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaapFairValueDisclosuresAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="loc_us-gaapFairValueDisclosuresTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueDisclosuresAbstract" xlink:to="loc_us-gaapFairValueDisclosuresTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/DerivativeFinancialInstruments" xlink:title="00000013 - Disclosure - Derivative Financial Instruments">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:label="loc_us-gaapDerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:label="loc_us-gaapDerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="loc_us-gaapDerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/PropertyEquipmentAndLeaseholdImprovements" xlink:title="00000014 - Disclosure - Property, Equipment and Leasehold Improvements">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="loc_us-gaapPropertyPlantAndEquipmentDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssets" xlink:title="00000015 - Disclosure - Trademarks, Licenses and Other Intangible Assets">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:label="loc_us-gaapIntangibleAssetsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapIntangibleAssetsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/AccruedExpenses" xlink:title="00000016 - Disclosure - Accrued Expenses">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaapPayablesAndAccrualsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/LoansPayableBanks" xlink:title="00000017 - Disclosure - Loans Payable &#8211; Banks">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="loc_us-gaapDebtDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapDebtDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/Long-termDebt" xlink:title="00000018 - Disclosure - Long-Term Debt">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtTextBlock" xlink:label="loc_us-gaapLongTermDebtTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapLongTermDebtTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/Commitments" xlink:title="00000019 - Disclosure - Commitments">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapCommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/Equity" xlink:title="00000020 - Disclosure - Equity">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="loc_us-gaapStockholdersEquityNoteDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapStockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.CommonShareholders" xlink:title="00000021 - Disclosure - Net Income Attributable to Inter Parfums, Inc. Common Shareholders">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaapEarningsPerShareAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="loc_us-gaapEarningsPerShareTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapEarningsPerShareTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/SegmentsAndGeographicAreas" xlink:title="00000022 - Disclosure - Segments and Geographic Areas">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaapSegmentReportingAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="loc_us-gaapSegmentReportingDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_us-gaapSegmentReportingDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/IncomeTaxes" xlink:title="00000023 - Disclosure - Income Taxes">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="loc_us-gaapIncomeTaxDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/AccumulatedOtherComprehensiveLoss" xlink:title="00000024 - Disclosure - Accumulated Other Comprehensive Loss">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:label="loc_us-gaapComprehensiveIncomeNoteTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapComprehensiveIncomeNoteTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.AndTransfersFromNoncontrollingInterest" xlink:title="00000025 - Disclosure - Net Income Attributable to Inter Parfums, Inc. and Transfers from the Noncontrolling Interest">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestAbstract" xlink:label="loc_us-gaapNoncontrollingInterestAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestDisclosureTextBlock" xlink:label="loc_us-gaapMinorityInterestDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncontrollingInterestAbstract" xlink:to="loc_us-gaapMinorityInterestDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/ReconciliationOfCashAndCashEquivalentsToStatementOfCashFlows" xlink:title="00000026 - Disclosure - Reconciliation of Cash and Cash Equivalents to the Statement of Cash Flows">
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_DisclosureReconciliationOfCashAndCashEquivalentsToStatementOfCashFlowsAbstract" xlink:label="loc_iparDisclosureReconciliationOfCashAndCashEquivalentsToStatementOfCashFlowsAbstract" />
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_ReconciliationOfCashAndCashEquivalentsToTheStatementOfCashFlowsTextBlock" xlink:label="loc_iparReconciliationOfCashAndCashEquivalentsToTheStatementOfCashFlowsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iparDisclosureReconciliationOfCashAndCashEquivalentsToStatementOfCashFlowsAbstract" xlink:to="loc_iparReconciliationOfCashAndCashEquivalentsToTheStatementOfCashFlowsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesPolicies" xlink:title="00000027 - Disclosure - The Company and its Significant Accounting Policies (Policies)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock" xlink:label="loc_us-gaapBusinessDescriptionAndAccountingPoliciesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="loc_us-gaapBasisOfAccountingPolicyPolicyTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapBasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="loc_us-gaapUseOfEstimates" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapUseOfEstimates" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:label="loc_us-gaapForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="loc_us-gaapCashAndCashEquivalentsPolicyTextBlock" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:label="loc_us-gaapTradeAndOtherAccountsReceivablePolicy" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapTradeAndOtherAccountsReceivablePolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryPolicyTextBlock" xlink:label="loc_us-gaapInventoryPolicyTextBlock" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapInventoryPolicyTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativesPolicyTextBlock" xlink:label="loc_us-gaapDerivativesPolicyTextBlock" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapDerivativesPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="loc_us-gaapPropertyPlantAndEquipmentPolicyTextBlock" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsPolicyTextBlock" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapGoodwillAndIntangibleAssetsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:label="loc_us-gaapRevenueFromContractWithCustomerPolicyTextBlock" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapRevenueFromContractWithCustomerPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRecognitionSalesReturns" xlink:label="loc_us-gaapRevenueRecognitionSalesReturns" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapRevenueRecognitionSalesReturns" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRecognitionAllowances" xlink:label="loc_us-gaapRevenueRecognitionAllowances" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapRevenueRecognitionAllowances" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdvertisingCostsPolicyTextBlock" xlink:label="loc_us-gaapAdvertisingCostsPolicyTextBlock" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapAdvertisingCostsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="loc_us-gaapResearchAndDevelopmentExpensePolicy" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapResearchAndDevelopmentExpensePolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LessorLeasesPolicyTextBlock" xlink:label="loc_us-gaapLessorLeasesPolicyTextBlock" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapLessorLeasesPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:label="loc_us-gaapCommitmentsAndContingenciesPolicyTextBlock" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapCommitmentsAndContingenciesPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="loc_us-gaapIncomeTaxPolicyTextBlock" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapIncomeTaxPolicyTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationSubsidiaryStockIssuancesPolicy" xlink:label="loc_us-gaapConsolidationSubsidiaryStockIssuancesPolicy" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapConsolidationSubsidiaryStockIssuancesPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepurchaseAgreementsCollateralPolicy" xlink:label="loc_us-gaapRepurchaseAgreementsCollateralPolicy" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapRepurchaseAgreementsCollateralPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:label="loc_us-gaapPriorPeriodReclassificationAdjustmentDescription" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapPriorPeriodReclassificationAdjustmentDescription" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesTables" xlink:title="00000028 - Disclosure - The Company and its Significant Accounting Policies (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:label="loc_us-gaapSchedulesOfConcentrationOfRiskByRiskFactorTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapSchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/RecentAgreementsTables" xlink:title="00000029 - Disclosure - Recent Agreements (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:label="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" />
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_ScheduleOfInventoryCurrentTableTextBlock1" xlink:label="loc_iparScheduleOfInventoryCurrentTableTextBlock1" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_iparScheduleOfInventoryCurrentTableTextBlock1" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/InventoriesTables" xlink:title="00000030 - Disclosure - Inventories (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaapInventoryDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:label="loc_us-gaapScheduleOfInventoryCurrentTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/FairValueOfFinancialInstrumentsTables" xlink:title="00000031 - Disclosure - Fair Value of Financial Instruments (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaapFairValueDisclosuresAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:label="loc_us-gaapScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueDisclosuresAbstract" xlink:to="loc_us-gaapScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/PropertyEquipmentAndLeaseholdImprovementsTables" xlink:title="00000032 - Disclosure - Property, Equipment and Leasehold Improvements (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssetsTables" xlink:title="00000033 - Disclosure - Trademarks, Licenses and Other Intangible Assets (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfImpairedIntangibleAssetsTextBlock" xlink:label="loc_us-gaapScheduleOfImpairedIntangibleAssetsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfImpairedIntangibleAssetsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/AccruedExpensesTables" xlink:title="00000034 - Disclosure - Accrued Expenses (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaapPayablesAndAccrualsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:label="loc_us-gaapScheduleOfAccruedLiabilitiesTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapScheduleOfAccruedLiabilitiesTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/Long-termDebtTables" xlink:title="00000035 - Disclosure - Long-Term Debt (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:label="loc_us-gaapScheduleOfDebtInstrumentsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfDebtInstrumentsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/CommitmentsTables" xlink:title="00000036 - Disclosure - Commitments (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:label="loc_us-gaapScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock" xlink:label="loc_srtContractualObligationFiscalYearMaturityScheduleTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_srtContractualObligationFiscalYearMaturityScheduleTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/EquityTables" xlink:title="00000037 - Disclosure - Equity (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xlink:label="loc_us-gaapScheduleOfNonvestedShareActivityTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapScheduleOfNonvestedShareActivityTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationActivityTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="loc_us-gaapScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashProceedsReceivedAndTaxBenefitFromShareBasedPaymentAwardsTableTextBlock" xlink:label="loc_us-gaapCashProceedsReceivedAndTaxBenefitFromShareBasedPaymentAwardsTableTextBlock" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapCashProceedsReceivedAndTaxBenefitFromShareBasedPaymentAwardsTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.CommonShareholdersTables" xlink:title="00000038 - Disclosure - Net Income Attributable to Inter Parfums, Inc. Common Shareholders (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaapEarningsPerShareAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="loc_us-gaapScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/SegmentsAndGeographicAreasTables" xlink:title="00000039 - Disclosure - Segments and Geographic Areas (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaapSegmentReportingAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:label="loc_us-gaapScheduleOfSegmentReportingInformationBySegmentTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_us-gaapScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:label="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock" xlink:label="loc_us-gaapScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_us-gaapScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/IncomeTaxesTables" xlink:title="00000040 - Disclosure - Income Taxes (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:label="loc_us-gaapScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:label="loc_us-gaapScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="loc_us-gaapScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="loc_us-gaapScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/AccumulatedOtherComprehensiveLossTables" xlink:title="00000041 - Disclosure - Accumulated Other Comprehensive Loss (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:label="loc_us-gaapScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.AndTransfersFromNoncontrollingInterestTables" xlink:title="00000042 - Disclosure - Net Income Attributable to Inter Parfums, Inc. and Transfers from the Noncontrolling Interest (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestAbstract" xlink:label="loc_us-gaapNoncontrollingInterestAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock" xlink:label="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncontrollingInterestAbstract" xlink:to="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/ReconciliationOfCashAndCashEquivalentsToStatementOfCashFlowsTables" xlink:title="00000043 - Disclosure - Reconciliation of Cash and Cash Equivalents to the Statement of Cash Flows (Tables)">
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_DisclosureReconciliationOfCashAndCashEquivalentsToStatementOfCashFlowsAbstract" xlink:label="loc_iparDisclosureReconciliationOfCashAndCashEquivalentsToStatementOfCashFlowsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:label="loc_us-gaapScheduleOfCashAndCashEquivalentsTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iparDisclosureReconciliationOfCashAndCashEquivalentsToStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/ScheduleOfLanvinBrandNameForOurClassDetails" xlink:title="00000044 - Disclosure - Schedule of lanvin brand name for our class (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfProductInformationTable" xlink:label="loc_us-gaapScheduleOfProductInformationTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfProductInformationTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductInformationLineItems" xlink:label="loc_us-gaapProductInformationLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapProductInformationLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaapConcentrationRiskByBenchmarkAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapConcentrationRiskByBenchmarkAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_MontblancMember" xlink:label="loc_iparMontblancMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_iparMontblancMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_JimmyChooMember" xlink:label="loc_iparJimmyChooMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_iparJimmyChooMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_CoachMember" xlink:label="loc_iparCoachMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_iparCoachMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_GUESSMember" xlink:label="loc_iparGUESSMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_iparGUESSMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaapConcentrationRiskPercentage1" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapConcentrationRiskPercentage1" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesDetailsNarrative" xlink:title="00000045 - Disclosure - The Company and its Significant Accounting Policies (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfProductInformationTable" xlink:label="loc_us-gaapScheduleOfProductInformationTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfProductInformationTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductInformationLineItems" xlink:label="loc_us-gaapProductInformationLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapProductInformationLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipAxis" xlink:label="loc_srtOwnershipAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_srtOwnershipAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain" xlink:label="loc_srtOwnershipDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtOwnershipAxis" xlink:to="loc_srtOwnershipDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_InterparfumsSASubsidiaryMember" xlink:label="loc_iparInterparfumsSASubsidiaryMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtOwnershipDomain" xlink:to="loc_iparInterparfumsSASubsidiaryMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="loc_us-gaapMeasurementInputTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapMeasurementInputTypeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaapMeasurementInputTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeAxis" xlink:to="loc_us-gaapMeasurementInputTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputDiscountRateMember" xlink:label="loc_us-gaapMeasurementInputDiscountRateMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputDiscountRateMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srtProductOrServiceAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_srtProductOrServiceAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShippingAndHandlingMember" xlink:label="loc_us-gaapShippingAndHandlingMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_us-gaapShippingAndHandlingMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaapConcentrationRiskByBenchmarkAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapConcentrationRiskByBenchmarkAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesRevenueNetMember" xlink:label="loc_us-gaapSalesRevenueNetMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_us-gaapSalesRevenueNetMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_srtRangeAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" order="60" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LicensingAgreementsMember" xlink:label="loc_us-gaapLicensingAgreementsMember" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapLicensingAgreementsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:label="loc_us-gaapMinorityInterestOwnershipPercentageByParent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapMinorityInterestOwnershipPercentageByParent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:label="loc_us-gaapAllowanceForDoubtfulAccountsReceivableCurrent" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapAllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="loc_us-gaapOperatingLeaseWeightedAverageDiscountRatePercent" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapOperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="loc_us-gaapCostOfGoodsAndServicesSold" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapCostOfGoodsAndServicesSold" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaapConcentrationRiskPercentage1" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapConcentrationRiskPercentage1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerRefundLiability" xlink:label="loc_us-gaapContractWithCustomerRefundLiability" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapContractWithCustomerRefundLiability" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerRightToRecoverProduct" xlink:label="loc_us-gaapContractWithCustomerRightToRecoverProduct" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapContractWithCustomerRightToRecoverProduct" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdvertisingExpense" xlink:label="loc_us-gaapAdvertisingExpense" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapAdvertisingExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketingExpense" xlink:label="loc_us-gaapMarketingExpense" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapMarketingExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:label="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetWeightedAveragePeriodBeforeRenewalOrExtension" xlink:label="loc_us-gaapAcquiredFiniteLivedIntangibleAssetWeightedAveragePeriodBeforeRenewalOrExtension" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapAcquiredFiniteLivedIntangibleAssetWeightedAveragePeriodBeforeRenewalOrExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_RoyaltyExpenseNetSalesPercentage" xlink:label="loc_iparRoyaltyExpenseNetSalesPercentage" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_iparRoyaltyExpenseNetSalesPercentage" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/AllAmountsHaveBeenTranslatedToU.s.DollarsAtOctober12021ExchangeRate.Details" xlink:title="00000046 - Disclosure - All amounts have been translated to U.S. dollars at the October 1, 2021 exchange rate. (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:label="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable" xlink:to="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_InventoryMember" xlink:label="loc_iparInventoryMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_iparInventoryMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TrademarksMember" xlink:label="loc_us-gaapTrademarksMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapTrademarksMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_OtherAssetMember" xlink:label="loc_iparOtherAssetMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_iparOtherAssetMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryGross" xlink:label="loc_us-gaapInventoryGross" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapInventoryGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueOfAssetsAcquired" xlink:label="loc_us-gaapFairValueOfAssetsAcquired" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFairValueOfAssetsAcquired" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAssumed1" xlink:label="loc_us-gaapLiabilitiesAssumed1" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapLiabilitiesAssumed1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapInventoryNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative" xlink:title="00000047 - Disclosure - Recent Agreements (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:label="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityNameAxis" xlink:label="loc_us-gaapIncomeTaxAuthorityNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapIncomeTaxAuthorityNameAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityNameDomain" xlink:label="loc_us-gaapIncomeTaxAuthorityNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxAuthorityNameAxis" xlink:to="loc_us-gaapIncomeTaxAuthorityNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SwissFederalTaxAdministrationFTAMember" xlink:label="loc_us-gaapSwissFederalTaxAdministrationFTAMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxAuthorityNameDomain" xlink:to="loc_us-gaapSwissFederalTaxAdministrationFTAMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CurrencyAxis" xlink:label="loc_srtCurrencyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtCurrencyAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_AllCurrenciesDomain" xlink:label="loc_currencyAllCurrenciesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtCurrencyAxis" xlink:to="loc_currencyAllCurrenciesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_EUR" xlink:label="loc_currencyEUR" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currencyAllCurrenciesDomain" xlink:to="loc_currencyEUR" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_GlobalSettlementAgreementMember" xlink:label="loc_iparGlobalSettlementAgreementMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_iparGlobalSettlementAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_AnnaSuiCorpMember" xlink:label="loc_iparAnnaSuiCorpMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_iparAnnaSuiCorpMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_RochasFashionMember" xlink:label="loc_iparRochasFashionMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_iparRochasFashionMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_STDupontMember" xlink:label="loc_iparSTDupontMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_iparSTDupontMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxesPayableCurrentAndNoncurrent" xlink:label="loc_us-gaapTaxesPayableCurrentAndNoncurrent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTaxesPayableCurrentAndNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForPurchaseOfOtherAssets1" xlink:label="loc_us-gaapPaymentsForPurchaseOfOtherAssets1" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPaymentsForPurchaseOfOtherAssets1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcquisitionCosts" xlink:label="loc_us-gaapAcquisitionCosts" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAcquisitionCosts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_CashHeldInEscrow" xlink:label="loc_iparCashHeldInEscrow" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_iparCashHeldInEscrow" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReceivable" xlink:label="loc_us-gaapIncomeTaxReceivable" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeTaxReceivable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTaxCredit" xlink:label="loc_us-gaapInvestmentTaxCredit" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapInvestmentTaxCredit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtTerm" xlink:label="loc_us-gaapLongTermDebtTerm" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLongTermDebtTerm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCredit" xlink:label="loc_us-gaapLineOfCredit" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLineOfCredit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateTerms" xlink:label="loc_us-gaapDebtInstrumentInterestRateTerms" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateTerms" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_DiscriptionOfRecentAgreement" xlink:label="loc_iparDiscriptionOfRecentAgreement" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_iparDiscriptionOfRecentAgreement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentChargeOnReclassifiedAssets" xlink:label="loc_us-gaapImpairmentChargeOnReclassifiedAssets" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapImpairmentChargeOnReclassifiedAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionDescriptionOfAcquiredEntity" xlink:label="loc_us-gaapBusinessAcquisitionDescriptionOfAcquiredEntity" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapBusinessAcquisitionDescriptionOfAcquiredEntity" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/ScheduleOfInventoriesDetails" xlink:title="00000048 - Disclosure - Schedule of inventories (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaapInventoryDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRawMaterials" xlink:label="loc_us-gaapInventoryRawMaterials" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryRawMaterials" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoods" xlink:label="loc_us-gaapInventoryFinishedGoods" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryFinishedGoods" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryNet" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/InventoriesDetailsNarrative" xlink:title="00000049 - Disclosure - Inventories (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaapInventoryDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srtProductOrServiceAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtProductOrServiceAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductMember" xlink:label="loc_us-gaapProductMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_us-gaapProductMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSoldOverhead" xlink:label="loc_us-gaapCostOfGoodsAndServicesSoldOverhead" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCostOfGoodsAndServicesSoldOverhead" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryValuationReserves" xlink:label="loc_us-gaapInventoryValuationReserves" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapInventoryValuationReserves" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/ScheduleOfFairValueAssetsMeasuredOnRecurringBasisDetails" xlink:title="00000050 - Disclosure - Schedule of fair value, assets measured on recurring basis (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaapFairValueDisclosuresAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueDisclosuresAbstract" xlink:to="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="loc_us-gaapFairValueByMeasurementFrequencyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_us-gaapFairValueByMeasurementFrequencyAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaapFairValueMeasurementFrequencyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueByMeasurementFrequencyAxis" xlink:to="loc_us-gaapFairValueMeasurementFrequencyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="loc_us-gaapFairValueMeasurementsRecurringMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueMeasurementFrequencyDomain" xlink:to="loc_us-gaapFairValueMeasurementsRecurringMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaapFairValueInputsLevel1Member" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel1Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaapFairValueInputsLevel2Member" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel2Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaapFairValueInputsLevel3Member" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel3Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosureAbstract" xlink:label="loc_us-gaapAssetsFairValueDisclosureAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapAssetsFairValueDisclosureAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsFairValueDisclosure" xlink:label="loc_us-gaapInvestmentsFairValueDisclosure" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsFairValueDisclosureAbstract" xlink:to="loc_us-gaapInvestmentsFairValueDisclosure" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAbstract" xlink:label="loc_us-gaapLiabilitiesAbstract" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapLiabilitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyFairValueHedgeAssetAtFairValue" xlink:label="loc_us-gaapForeignCurrencyFairValueHedgeAssetAtFairValue" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAbstract" xlink:to="loc_us-gaapForeignCurrencyFairValueHedgeAssetAtFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue" xlink:label="loc_us-gaapForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAbstract" xlink:to="loc_us-gaapForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilities" xlink:label="loc_us-gaapDerivativeLiabilities" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapDerivativeLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="loc_us-gaapAssetsFairValueDisclosure" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapAssetsFairValueDisclosure" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/DerivativeFinancialInstrumentsDetailsNarrative" xlink:title="00000051 - Disclosure - Derivative Financial Instruments (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:label="loc_us-gaapDerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:label="loc_us-gaapDerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="loc_us-gaapDerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:label="loc_us-gaapDerivativeInstrumentsGainLossLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:to="loc_us-gaapDerivativeInstrumentsGainLossLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_us-gaapDerivativeInstrumentRiskAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:to="loc_us-gaapDerivativeInstrumentRiskAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaapDerivativeContractTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeInstrumentRiskAxis" xlink:to="loc_us-gaapDerivativeContractTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember" xlink:label="loc_us-gaapForeignExchangeContractMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_us-gaapForeignExchangeContractMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure" xlink:label="loc_us-gaapForeignCurrencyContractsLiabilityFairValueDisclosure" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeInstrumentsGainLossLineItems" xlink:to="loc_us-gaapForeignCurrencyContractsLiabilityFairValueDisclosure" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/ScheduleOfEquipmentAndLeaseholdImprovementsDetails" xlink:title="00000052 - Disclosure - Schedule of equipment and leasehold improvements (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BuildingMember" xlink:label="loc_us-gaapBuildingMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapBuildingMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquipmentMember" xlink:label="loc_us-gaapEquipmentMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="loc_us-gaapLeaseholdImprovementsMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapLeaseholdImprovementsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaapPropertyPlantAndEquipmentGross" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/PropertyEquipmentAndLeaseholdImprovementsDetailsNarrative" xlink:title="00000053 - Disclosure - Property, Equipment and Leasehold Improvements (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaapDepreciationDepletionAndAmortization" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapDepreciationDepletionAndAmortization" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/ScheduleOfTrademarksLicensesAndOtherIntangibleAssetsDetails" xlink:title="00000054 - Disclosure - Schedule of trademarks, licenses and other intangible assets (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByAssetClassAxis" xlink:label="loc_us-gaapFairValueByAssetClassAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFairValueByAssetClassAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:label="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueByAssetClassAxis" xlink:to="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefinitelivedIntangibleAssetsMember" xlink:label="loc_us-gaapIndefinitelivedIntangibleAssetsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="loc_us-gaapIndefinitelivedIntangibleAssetsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMember" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_SubtotalMember" xlink:label="loc_iparSubtotalMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="loc_iparSubtotalMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_LicensesMember" xlink:label="loc_iparLicensesMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_iparLicensesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIntangibleAssetsMember" xlink:label="loc_us-gaapOtherIntangibleAssetsMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapOtherIntangibleAssetsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsGross" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsNet" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsNet" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssetsDetailsNarrative" xlink:title="00000055 - Disclosure - Trademarks, Licenses and Other Intangible Assets (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TrademarksMember" xlink:label="loc_us-gaapTrademarksMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapTrademarksMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_LicensesMember" xlink:label="loc_iparLicensesMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_iparLicensesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIntangibleAssetsMember" xlink:label="loc_us-gaapOtherIntangibleAssetsMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapOtherIntangibleAssetsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByAssetClassAxis" xlink:label="loc_us-gaapFairValueByAssetClassAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFairValueByAssetClassAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:label="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueByAssetClassAxis" xlink:to="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefinitelivedIntangibleAssetsMember" xlink:label="loc_us-gaapIndefinitelivedIntangibleAssetsMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="loc_us-gaapIndefinitelivedIntangibleAssetsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="loc_us-gaapMeasurementInputTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapMeasurementInputTypeAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaapMeasurementInputTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeAxis" xlink:to="loc_us-gaapMeasurementInputTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputDiscountRateMember" xlink:label="loc_us-gaapMeasurementInputDiscountRateMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputDiscountRateMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_srtRangeAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaapAmortizationOfIntangibleAssets" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapAmortizationOfIntangibleAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_FiniteLivedIntangibleAssetsAmortizationExpenseAfterTwoYears" xlink:label="loc_iparFiniteLivedIntangibleAssetsAmortizationExpenseAfterTwoYears" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_iparFiniteLivedIntangibleAssetsAmortizationExpenseAfterTwoYears" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetUsefulLife" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetUsefulLife" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="loc_us-gaapOperatingLeaseWeightedAverageDiscountRatePercent" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapOperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedLicenseAgreements" xlink:label="loc_us-gaapIndefiniteLivedLicenseAgreements" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapIndefiniteLivedLicenseAgreements" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/AccruedExpensesConsistOfFollowingDetails" xlink:title="00000056 - Disclosure - Accrued expenses consist of the following: (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaapPayablesAndAccrualsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedAdvertisingCurrent" xlink:label="loc_us-gaapAccruedAdvertisingCurrent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccruedAdvertisingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedSalariesCurrent" xlink:label="loc_us-gaapAccruedSalariesCurrent" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccruedSalariesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedRoyaltiesCurrent" xlink:label="loc_us-gaapAccruedRoyaltiesCurrent" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccruedRoyaltiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_DueVendorsNotYetInvoiced" xlink:label="loc_iparDueVendorsNotYetInvoiced" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_iparDueVendorsNotYetInvoiced" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrent" xlink:label="loc_us-gaapPensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrent" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapPensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRefundLiabilityCurrent" xlink:label="loc_us-gaapCustomerRefundLiabilityCurrent" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapCustomerRefundLiabilityCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapOtherAccruedLiabilitiesCurrent" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapOtherAccruedLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrent" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccruedLiabilitiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/Long-termDebtConsistsOfFollowingDetails" xlink:title="00000057 - Disclosure - Long-term debt consists of the following: (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaapDebtInstrumentTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapDebtInstrumentTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaapDebtInstrumentLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_us-gaapDebtInstrumentLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaapLongtermDebtTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_us-gaapLongtermDebtTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaapLongtermDebtTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongtermDebtTypeAxis" xlink:to="loc_us-gaapLongtermDebtTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LoansPayableMember" xlink:label="loc_us-gaapLoansPayableMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_us-gaapLoansPayableMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_LoansPayableOneMember" xlink:label="loc_iparLoansPayableOneMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_iparLoansPayableOneMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_LoansPayableTwoMember" xlink:label="loc_iparLoansPayableTwoMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_iparLoansPayableTwoMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_LoansPayableThreeMember" xlink:label="loc_iparLoansPayableThreeMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_iparLoansPayableThreeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_NumberOfInstallment" xlink:label="loc_iparNumberOfInstallment" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_iparNumberOfInstallment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentPeriodicPayment" xlink:label="loc_us-gaapDebtInstrumentPeriodicPayment" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentPeriodicPayment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateStatedPercentage" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateStatedPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt" xlink:label="loc_us-gaapLongTermDebt" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapLongTermDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent" xlink:label="loc_us-gaapLongTermDebtCurrent" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapLongTermDebtCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="loc_us-gaapLongTermDebtNoncurrent" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapLongTermDebtNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/LoansPayableBanksDetailsNarrative" xlink:title="00000058 - Disclosure - Loans Payable &#8211; Banks (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaapDebtInstrumentTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapDebtInstrumentTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaapDebtInstrumentLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_us-gaapDebtInstrumentLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_deiLegalEntityAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_DomesticSubsidiariesMember" xlink:label="loc_iparDomesticSubsidiariesMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_iparDomesticSubsidiariesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_ForeignSubsidiariesMember" xlink:label="loc_iparForeignSubsidiariesMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_iparForeignSubsidiariesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis" xlink:label="loc_us-gaapVariableRateAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_us-gaapVariableRateAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain" xlink:label="loc_us-gaapVariableRateDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapVariableRateAxis" xlink:to="loc_us-gaapVariableRateDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_LondonInterbankOfferedRateMember" xlink:label="loc_iparLondonInterbankOfferedRateMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapVariableRateDomain" xlink:to="loc_iparLondonInterbankOfferedRateMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_EuroInterbankOfferedRateMembeMember" xlink:label="loc_iparEuroInterbankOfferedRateMembeMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapVariableRateDomain" xlink:to="loc_iparEuroInterbankOfferedRateMembeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_srtRangeAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="loc_us-gaapLineOfCreditFacilityMaximumBorrowingCapacity" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapLineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:label="loc_us-gaapDebtInstrumentBasisSpreadOnVariableRate1" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentBasisSpreadOnVariableRate1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateStatedPercentage" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateStatedPercentage" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityExpirationDate1" xlink:label="loc_us-gaapLineOfCreditFacilityExpirationDate1" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapLineOfCreditFacilityExpirationDate1" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/Long-termDebtDetailsNarrative" xlink:title="00000059 - Disclosure - Long-Term Debt (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaapDebtInstrumentTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapDebtInstrumentTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaapDebtInstrumentLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_us-gaapDebtInstrumentLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaapLongtermDebtTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_us-gaapLongtermDebtTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaapLongtermDebtTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongtermDebtTypeAxis" xlink:to="loc_us-gaapLongtermDebtTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_LoansPayableOneMember" xlink:label="loc_iparLoansPayableOneMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_iparLoansPayableOneMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:label="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtDescription" xlink:label="loc_us-gaapLongTermDebtDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapLongTermDebtDescription" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/MaturitiesOfLeaseLiabilitiesSubsequentToDecember312021AreAsFollowsDetails" xlink:title="00000060 - Disclosure - Maturities of lease liabilities subsequent to December 31, 2021 are as follows: (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueCurrent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInTwoYears" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInThreeYears" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInFourYears" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInFiveYears" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueThereafter" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueThereafter" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDue" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityUndiscountedExcessAmount" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapOperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/MinimumAnnualRoyaltiesAndOtherCommitmentsAsFollowsDetails" xlink:title="00000061 - Disclosure - minimum annual royalties and other commitments as follows: (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCommitmentDueInNextTwelveMonths" xlink:label="loc_us-gaapOtherCommitmentDueInNextTwelveMonths" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapOtherCommitmentDueInNextTwelveMonths" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCommitmentDueInSecondYear" xlink:label="loc_us-gaapOtherCommitmentDueInSecondYear" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapOtherCommitmentDueInSecondYear" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCommitmentDueInThirdYear" xlink:label="loc_us-gaapOtherCommitmentDueInThirdYear" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapOtherCommitmentDueInThirdYear" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCommitmentDueInFourthYear" xlink:label="loc_us-gaapOtherCommitmentDueInFourthYear" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapOtherCommitmentDueInFourthYear" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCommitmentDueInFifthYear" xlink:label="loc_us-gaapOtherCommitmentDueInFifthYear" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapOtherCommitmentDueInFifthYear" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCommitmentDueAfterFifthYear" xlink:label="loc_us-gaapOtherCommitmentDueAfterFifthYear" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapOtherCommitmentDueAfterFifthYear" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCommitment" xlink:label="loc_us-gaapOtherCommitment" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapOtherCommitment" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/CommitmentsDetailsNarrative" xlink:title="00000062 - Disclosure - Commitments (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="loc_us-gaapOperatingLeaseWeightedAverageRemainingLeaseTerm1" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapOperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="loc_us-gaapOperatingLeaseWeightedAverageDiscountRatePercent" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapOperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesRentExpenseNet" xlink:label="loc_us-gaapOperatingLeasesRentExpenseNet" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapOperatingLeasesRentExpenseNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasePayments" xlink:label="loc_us-gaapOperatingLeasePayments" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapOperatingLeasePayments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseCost" xlink:label="loc_us-gaapOperatingLeaseCost" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapOperatingLeaseCost" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RoyaltyExpense" xlink:label="loc_us-gaapRoyaltyExpense" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapRoyaltyExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_RoyaltyExpenseNetSalesPercentage" xlink:label="loc_iparRoyaltyExpenseNetSalesPercentage" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_iparRoyaltyExpenseNetSalesPercentage" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/FollowingTableSetsForthInformationWithRespectToNonvestedOptionsFor2021Details" xlink:title="00000063 - Disclosure - The following table sets forth information with respect to nonvested options for 2021: (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_2" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_2" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/EffectOfShare-basedPaymentExpensesDecreasedIncomeStatementLineItemsAsFollowsDetails" xlink:title="00000064 - Disclosure - The effect of share-based payment expenses decreased income statement line items as follows: (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaapIncomeStatementLocationAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapIncomeStatementLocationAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLossMember" xlink:label="loc_us-gaapOperatingIncomeLossMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_us-gaapOperatingIncomeLossMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaapEarningsPerShareDiluted" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareDiluted" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/FollowingTableSummarizesStockOptionActivityAndRelatedInformationForYearsEndedDecember3120212020And2019Details" xlink:title="00000065 - Disclosure - The following table summarizes stock option activity and related information for the years ended December 31, 2021, 2020 and 2019: (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/AssumptionsUsedInBlack-scholesPricingModelAreSetForthInFollowingTableDetails" xlink:title="00000066 - Disclosure - The assumptions used in the Black-Scholes pricing model are set forth in the following table: (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/ProceedsTaxBenefitsAndIntrinsicValueRelatedToStockOptionsExercisedWereAsFollowsDetails" xlink:title="00000067 - Disclosure - Proceeds, tax benefits and intrinsic value related to stock options exercised were as follows (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="loc_us-gaapProceedsFromStockOptionsExercised" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapProceedsFromStockOptionsExercised" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxExpenseFromStockOptionsExercised" xlink:label="loc_us-gaapDeferredTaxExpenseFromStockOptionsExercised" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapDeferredTaxExpenseFromStockOptionsExercised" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/FollowingTableSummarizesAdditionalStockOptionInformationAsOfDecember312021Details" xlink:title="00000068 - Disclosure - The following table summarizes additional stock option information as of December 31, 2021: (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRangeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_ExercisePriceRangeOneMember" xlink:label="loc_iparExercisePriceRangeOneMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_iparExercisePriceRangeOneMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_ExercisePriceRangeTwoMember" xlink:label="loc_iparExercisePriceRangeTwoMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_iparExercisePriceRangeTwoMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_ExercisePriceRangeThreeMember" xlink:label="loc_iparExercisePriceRangeThreeMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_iparExercisePriceRangeThreeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_ExercisePriceRangeFourMember" xlink:label="loc_iparExercisePriceRangeFourMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_iparExercisePriceRangeFourMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:label="loc_us-gaapSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/EquityDetailsNarrative" xlink:title="00000069 - Disclosure - Equity (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable" xlink:label="loc_us-gaapScheduleOfSubsidiaryOrEquityMethodInvesteeTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapScheduleOfSubsidiaryOrEquityMethodInvesteeTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems" xlink:label="loc_us-gaapSubsidiaryOrEquityMethodInvesteeLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfSubsidiaryOrEquityMethodInvesteeTable" xlink:to="loc_us-gaapSubsidiaryOrEquityMethodInvesteeLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfSubsidiaryOrEquityMethodInvesteeTable" xlink:to="loc_srtRangeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_us-gaapDerivativeInstrumentRiskAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfSubsidiaryOrEquityMethodInvesteeTable" xlink:to="loc_us-gaapDerivativeInstrumentRiskAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaapDerivativeContractTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeInstrumentRiskAxis" xlink:to="loc_us-gaapDerivativeContractTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockOptionMember" xlink:label="loc_us-gaapStockOptionMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_us-gaapStockOptionMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfSubsidiaryOrEquityMethodInvesteeTable" xlink:to="loc_us-gaapDebtInstrumentAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockOptionMember" xlink:label="loc_us-gaapStockOptionMember_2" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_us-gaapStockOptionMember_2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_StockOptionOneMember" xlink:label="loc_iparStockOptionOneMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_iparStockOptionOneMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="loc_srtConsolidatedEntitiesAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfSubsidiaryOrEquityMethodInvesteeTable" xlink:to="loc_srtConsolidatedEntitiesAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="loc_srtConsolidatedEntitiesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtConsolidatedEntitiesAxis" xlink:to="loc_srtConsolidatedEntitiesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_InterparfumsSASubsidiaryMember" xlink:label="loc_iparInterparfumsSASubsidiaryMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtConsolidatedEntitiesDomain" xlink:to="loc_iparInterparfumsSASubsidiaryMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfSubsidiaryOrEquityMethodInvesteeTable" xlink:to="loc_srtTitleOfIndividualAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_EmployeesMember" xlink:label="loc_iparEmployeesMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_iparEmployeesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_OfficersAndManagersMember" xlink:label="loc_iparOfficersAndManagersMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_iparOfficersAndManagersMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_BoardOfDirectorsChairmanMember" xlink:label="loc_srtBoardOfDirectorsChairmanMember" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_srtBoardOfDirectorsChairmanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipAxis" xlink:label="loc_srtOwnershipAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfSubsidiaryOrEquityMethodInvesteeTable" xlink:to="loc_srtOwnershipAxis" order="60" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain" xlink:label="loc_srtOwnershipDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtOwnershipAxis" xlink:to="loc_srtOwnershipDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_InterparfumsSASubsidiaryMember" xlink:label="loc_iparInterparfumsSASubsidiaryMember_2" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtOwnershipDomain" xlink:to="loc_iparInterparfumsSASubsidiaryMember_2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfSubsidiaryOrEquityMethodInvesteeTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" order="70" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_Covid19Description" xlink:label="loc_iparCovid19Description" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeLineItems" xlink:to="loc_iparCovid19Description" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_RevaluationResultedInReductionOfCostDescription" xlink:label="loc_iparRevaluationResultedInReductionOfCostDescription" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeLineItems" xlink:to="loc_iparRevaluationResultedInReductionOfCostDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_PercentageOfIncreaseInAnnualDividend" xlink:label="loc_iparPercentageOfIncreaseInAnnualDividend" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeLineItems" xlink:to="loc_iparPercentageOfIncreaseInAnnualDividend" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsPayableAmountPerShare" xlink:label="loc_us-gaapDividendsPayableAmountPerShare" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeLineItems" xlink:to="loc_us-gaapDividendsPayableAmountPerShare" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/ReconciliationBetweenNumeratorsAndDenominatorsOfBasicAndDilutedEpsComputationsIsAsFollowsDetails" xlink:title="00000070 - Disclosure - The reconciliation between the numerators and denominators of the basic and diluted EPS computations is as follows: (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaapEarningsPerShareAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:label="loc_us-gaapWeightedAverageNumberDilutedSharesOutstandingAdjustment" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapWeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaapEarningsPerShareBasic" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapEarningsPerShareBasic" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaapEarningsPerShareDiluted" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapEarningsPerShareDiluted" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.CommonShareholdersDetailsNarrative" xlink:title="00000071 - Disclosure - Net Income Attributable to Inter Parfums, Inc. Common Shareholders (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaapEarningsPerShareAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/InformationOnCompanysOperationsBySegmentsIsAsFollowsDetails" xlink:title="00000072 - Disclosure - Information on the Company&#8217;s operations by segments is as follows: (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaapSegmentReportingAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:label="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:label="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:to="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srtStatementGeographicalAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:to="loc_srtStatementGeographicalAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srtSegmentGeographicalDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtStatementGeographicalAxis" xlink:to="loc_srtSegmentGeographicalDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US" xlink:label="loc_countryUS" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryUS" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EuropeMember" xlink:label="loc_srtEuropeMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_srtEuropeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_EliminationsMember" xlink:label="loc_iparEliminationsMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_iparEliminationsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:label="loc_us-gaapRevenueFromContractWithCustomerIncludingAssessedTax" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="loc_us-gaapRevenueFromContractWithCustomerIncludingAssessedTax" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationAndAmortization" xlink:label="loc_us-gaapDepreciationAndAmortization" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="loc_us-gaapDepreciationAndAmortization" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInterestAndDividend" xlink:label="loc_us-gaapInvestmentIncomeInterestAndDividend" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="loc_us-gaapInvestmentIncomeInterestAndDividend" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaapInterestExpense" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="loc_us-gaapInterestExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="loc_us-gaapAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionsToOtherAssetsAmount" xlink:label="loc_us-gaapAdditionsToOtherAssetsAmount" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="loc_us-gaapAdditionsToOtherAssetsAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncurrentAssets" xlink:label="loc_us-gaapNoncurrentAssets" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="loc_us-gaapNoncurrentAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet" xlink:label="loc_us-gaapDeferredIncomeTaxAssetsNet" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="loc_us-gaapDeferredIncomeTaxAssetsNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/NetSalesToCustomersByRegionAreAsFollowsDetails" xlink:title="00000073 - Disclosure - Consolidated net sales to customers by region are as follows: (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaapSegmentReportingAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:label="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:label="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:to="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srtStatementGeographicalAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:to="loc_srtStatementGeographicalAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srtSegmentGeographicalDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtStatementGeographicalAxis" xlink:to="loc_srtSegmentGeographicalDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NorthAmericaMember" xlink:label="loc_srtNorthAmericaMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_srtNorthAmericaMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_EuropeCountryMember" xlink:label="loc_iparEuropeCountryMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_iparEuropeCountryMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_AsiaMember" xlink:label="loc_srtAsiaMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_srtAsiaMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MiddleEastMember" xlink:label="loc_us-gaapMiddleEastMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_us-gaapMiddleEastMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_CentralAndSouthAmericaMember" xlink:label="loc_iparCentralAndSouthAmericaMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_iparCentralAndSouthAmericaMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_OtherSegmentCountryMember" xlink:label="loc_iparOtherSegmentCountryMember" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_iparOtherSegmentCountryMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="loc_us-gaapRevenues" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/NetSalesToCustomersInMajorCountriesAreAsFollowsDetails" xlink:title="00000074 - Disclosure - Consolidated net sales to customers in major countries are as follows: (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaapSegmentReportingAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:label="loc_us-gaapScheduleOfSegmentReportingInformationBySegmentTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_us-gaapScheduleOfSegmentReportingInformationBySegmentTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems" xlink:label="loc_us-gaapSegmentReportingInformationLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="loc_us-gaapSegmentReportingInformationLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaapStatementBusinessSegmentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="loc_us-gaapStatementBusinessSegmentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaapSegmentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementBusinessSegmentsAxis" xlink:to="loc_us-gaapSegmentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_UnitedStatesMember" xlink:label="loc_iparUnitedStatesMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentDomain" xlink:to="loc_iparUnitedStatesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_FranceMember" xlink:label="loc_iparFranceMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentDomain" xlink:to="loc_iparFranceMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_RussiaMember" xlink:label="loc_iparRussiaMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentDomain" xlink:to="loc_iparRussiaMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_UnitedKingdomMember" xlink:label="loc_iparUnitedKingdomMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentDomain" xlink:to="loc_iparUnitedKingdomMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:label="loc_us-gaapRevenueFromContractWithCustomerIncludingAssessedTax" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingInformationLineItems" xlink:to="loc_us-gaapRevenueFromContractWithCustomerIncludingAssessedTax" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/ComponentsOfIncomeBeforeIncomeTaxesConsistOfFollowingDetails" xlink:title="00000075 - Disclosure - The components of income before income taxes consist of the following: (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/ProvisionForCurrentAndDeferredIncomeTaxExpenseBenefitConsistsOfFollowingDetails" xlink:title="00000076 - Disclosure - The provision for current and deferred income tax expense (benefit) consists of the following: (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="loc_us-gaapCurrentFederalTaxExpenseBenefit" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapCurrentFederalTaxExpenseBenefit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="loc_us-gaapCurrentStateAndLocalTaxExpenseBenefit" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapCurrentStateAndLocalTaxExpenseBenefit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit" xlink:label="loc_us-gaapCurrentForeignTaxExpenseBenefit" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapCurrentForeignTaxExpenseBenefit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapCurrentIncomeTaxExpenseBenefit" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapCurrentIncomeTaxExpenseBenefit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredFederalIncomeTaxExpenseBenefit" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredFederalIncomeTaxExpenseBenefit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredStateAndLocalIncomeTaxExpenseBenefit" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredForeignIncomeTaxExpenseBenefit" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredForeignIncomeTaxExpenseBenefit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:label="loc_us-gaapDeferredIncomeTaxesAndTaxCredits" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredIncomeTaxesAndTaxCredits" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/TaxEffectsOfTemporaryDifferencesThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndDeferredTaxLiabilitiesAreAsFollowsDetails" xlink:title="00000077 - Disclosure - The tax effects of temporary differences that give rise to significant portions of the deferred tax assets and deferred tax liabilities are as follows: (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsNetAbstract" xlink:label="loc_us-gaapDeferredTaxAssetsNetAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsNetAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:label="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwardsForeign" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_DeferredTaxAssetsInventoryAndAccountsReceivable" xlink:label="loc_iparDeferredTaxAssetsInventoryAndAccountsReceivable" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_iparDeferredTaxAssetsInventoryAndAccountsReceivable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsDeferredIncome" xlink:label="loc_us-gaapDeferredTaxAssetsDeferredIncome" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsDeferredIncome" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsInventory" xlink:label="loc_us-gaapDeferredTaxAssetsInventory" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsInventory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOther" xlink:label="loc_us-gaapDeferredTaxAssetsOther" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsOther" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="loc_us-gaapDeferredTaxAssetsGross" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsGross" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapDeferredTaxAssetsValuationAllowance" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsValuationAllowance" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="loc_us-gaapDeferredTaxAssetsNet" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesNetAbstract" xlink:label="loc_us-gaapDeferredTaxLiabilitiesNetAbstract" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxLiabilitiesNetAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_DeferredTaxLiabilitiesBuildingExpenses" xlink:label="loc_iparDeferredTaxLiabilitiesBuildingExpenses" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredTaxLiabilitiesNetAbstract" xlink:to="loc_iparDeferredTaxLiabilitiesBuildingExpenses" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets" xlink:label="loc_us-gaapDeferredTaxLiabilitiesOtherFiniteLivedAssets" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredTaxLiabilitiesNetAbstract" xlink:to="loc_us-gaapDeferredTaxLiabilitiesOtherFiniteLivedAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_DeferredTaxLiabilitiesUnrealizedGainOnMarketableEquitySecurities" xlink:label="loc_iparDeferredTaxLiabilitiesUnrealizedGainOnMarketableEquitySecurities" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredTaxLiabilitiesNetAbstract" xlink:to="loc_iparDeferredTaxLiabilitiesUnrealizedGainOnMarketableEquitySecurities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesOther" xlink:label="loc_us-gaapDeferredTaxLiabilitiesOther" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredTaxLiabilitiesNetAbstract" xlink:to="loc_us-gaapDeferredTaxLiabilitiesOther" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities" xlink:label="loc_us-gaapDeferredIncomeTaxLiabilities" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredTaxLiabilitiesNetAbstract" xlink:to="loc_us-gaapDeferredIncomeTaxLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="loc_us-gaapDeferredTaxAssetsLiabilitiesNet" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsLiabilitiesNet" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/DifferencesBetweenUnitedStatesFederalStatutoryIncomeTaxRateAndEffectiveIncomeTaxRateWereAsFollowsDetails" xlink:title="00000078 - Disclosure - Differences between the United States federal statutory income tax rate and the effective income tax rate were as follows: (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsEmployeeStockOwnershipPlanDividends" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationDeductionsEmployeeStockOwnershipPlanDividends" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationDeductionsEmployeeStockOwnershipPlanDividends" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate1" xlink:label="loc_iparEffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate1" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_iparEffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationOtherAdjustments" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/IncomeTaxesDetailsNarrative" xlink:title="00000079 - Disclosure - Income Taxes (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:label="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:label="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_ForeignDerivedIntangibleIncomeMember" xlink:label="loc_iparForeignDerivedIntangibleIncomeMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_iparForeignDerivedIntangibleIncomeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredForeignIncomeTaxExpenseBenefit" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapDeferredForeignIncomeTaxExpenseBenefit" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/ComponentsOfAccumulatedOtherComprehensiveLossConsistOfFollowingDetails" xlink:title="00000080 - Disclosure - The components of accumulated other comprehensive loss consist of the following: (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember" xlink:label="loc_iparAccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_iparAccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember" xlink:label="loc_us-gaapAccumulatedTranslationAdjustmentMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapAccumulatedTranslationAdjustmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent" xlink:label="loc_us-gaapOtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapOtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax_2" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax_3" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax_3" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/ScheduleOfNetIncomeAttributableToTransfersFromNoncontrollingInterestDetails" xlink:title="00000081 - Disclosure - Schedule of net income attributable to transfers from the noncontrolling interest (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestAbstract" xlink:label="loc_us-gaapNoncontrollingInterestAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncontrollingInterestAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesNet" xlink:label="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesNet" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncontrollingInterestAbstract" xlink:to="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNet" xlink:label="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNet" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncontrollingInterestAbstract" xlink:to="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNet" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/FollowingTableSummarizesCashAndCashEquivalentsAsOfDecember312021Details" xlink:title="00000082 - Disclosure - The following table summarizes cash and cash equivalents as of December 31, 2021: (Details)">
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_DisclosureReconciliationOfCashAndCashEquivalentsToStatementOfCashFlowsAbstract" xlink:label="loc_iparDisclosureReconciliationOfCashAndCashEquivalentsToStatementOfCashFlowsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:label="loc_us-gaapCashCashEquivalentsAndShortTermInvestments" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iparDisclosureReconciliationOfCashAndCashEquivalentsToStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashCashEquivalentsAndShortTermInvestments" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_CashHeldInEscrowIncludedInOtherAssets" xlink:label="loc_iparCashHeldInEscrowIncludedInOtherAssets" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iparDisclosureReconciliationOfCashAndCashEquivalentsToStatementOfCashFlowsAbstract" xlink:to="loc_iparCashHeldInEscrowIncludedInOtherAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ipar-20211231.xsd#ipar_CashAndCashEquivalentsPerStatementOfCashFlows" xlink:label="loc_iparCashAndCashEquivalentsPerStatementOfCashFlows" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iparDisclosureReconciliationOfCashAndCashEquivalentsToStatementOfCashFlowsAbstract" xlink:to="loc_iparCashAndCashEquivalentsPerStatementOfCashFlows" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139983549699464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Feb. 25, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">0-16469<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Inter Parfums, Inc.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000822663<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">13-3275609<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">551 Fifth Avenue<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">New York<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">10176<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">212<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">983.2640<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $.001 par value per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">IPAR<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,274,342,976<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31,842,225<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">339<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">Mazars USA LLP<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">New York<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139983549837064">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsAndShortTermInvestments', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 159,613<span></span>
</td>
<td class="nump">$ 169,681<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Short-term investments</a></td>
<td class="nump">160,014<span></span>
</td>
<td class="nump">126,627<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net</a></td>
<td class="nump">159,281<span></span>
</td>
<td class="nump">124,057<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">198,914<span></span>
</td>
<td class="nump">158,822<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherReceivablesNetCurrent', window );">Receivables, other</a></td>
<td class="nump">10,308<span></span>
</td>
<td class="nump">1,815<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other current assets</a></td>
<td class="nump">21,375<span></span>
</td>
<td class="nump">16,912<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesReceivable', window );">Income taxes receivable</a></td>
<td class="nump">210<span></span>
</td>
<td class="nump">2,806<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">709,715<span></span>
</td>
<td class="nump">600,720<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, equipment and leasehold improvements, net</a></td>
<td class="nump">149,352<span></span>
</td>
<td class="nump">19,580<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right-of-use assets, net</a></td>
<td class="nump">33,728<span></span>
</td>
<td class="nump">24,734<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Trademarks, licenses and other intangible assets, net</a></td>
<td class="nump">214,047<span></span>
</td>
<td class="nump">214,108<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Deferred tax assets</a></td>
<td class="nump">7,936<span></span>
</td>
<td class="nump">8,041<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">30,586<span></span>
</td>
<td class="nump">22,962<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">1,145,364<span></span>
</td>
<td class="nump">890,145<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current portion of long-term debt</a></td>
<td class="nump">15,911<span></span>
</td>
<td class="nump">14,570<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current portion of lease liabilities</a></td>
<td class="nump">6,014<span></span>
</td>
<td class="nump">5,133<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable - trade</a></td>
<td class="nump">81,980<span></span>
</td>
<td class="nump">35,576<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">136,677<span></span>
</td>
<td class="nump">95,629<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPayableCurrent', window );">Income taxes payable</a></td>
<td class="nump">4,328<span></span>
</td>
<td class="nump">5,297<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">244,910<span></span>
</td>
<td class="nump">156,205<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long&#8211;term debt, less current portion</a></td>
<td class="nump">132,902<span></span>
</td>
<td class="nump">10,136<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Lease liabilities, less current portion</a></td>
<td class="nump">29,220<span></span>
</td>
<td class="nump">21,354<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Inter Parfums, Inc. shareholders&#8217; equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $0.001 par value. Authorized 1,000,000 shares; none issued</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.001 par value. Authorized 100,000,000 shares; outstanding, 31,830,420 and 31,608,588 shares at December 31, 2021 and 2020, respectively</a></td>
<td class="nump">32<span></span>
</td>
<td class="nump">32<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">87,132<span></span>
</td>
<td class="nump">75,708<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">560,663<span></span>
</td>
<td class="nump">503,567<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(38,432)<span></span>
</td>
<td class="num">(5,997)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury stock, at cost, 9,864,805 common shares at December 31, 2021 and 2020</a></td>
<td class="num">(37,475)<span></span>
</td>
<td class="num">(37,475)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Inter Parfums, Inc. shareholders&#8217; equity</a></td>
<td class="nump">571,920<span></span>
</td>
<td class="nump">535,835<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interest</a></td>
<td class="nump">166,412<span></span>
</td>
<td class="nump">166,615<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total equity</a></td>
<td class="nump">738,332<span></span>
</td>
<td class="nump">702,450<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and equity</a></td>
<td class="nump">$ 1,145,364<span></span>
</td>
<td class="nump">$ 890,145<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsAndShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the customer may deposit additional funds at any time and effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid Investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Short-term investments, exclusive of cash equivalents, generally consist of marketable securities intended to be sold within one year (or the normal operating cycle if longer) and may include trading securities, available-for-sale securities, or held-to-maturity securities (if maturing within one year), as applicable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsAndShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount due within one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.5(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.10)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(g))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 24: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568447-111683<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(03)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139983556015720">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in Dollars per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, authorized</a></td>
<td class="nump">1,000,000<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in Dollars per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, authorized</a></td>
<td class="nump">100,000,000<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, outstanding</a></td>
<td class="nump">31,830,420<span></span>
</td>
<td class="nump">31,608,588<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury Stock, Shares</a></td>
<td class="nump">9,864,805<span></span>
</td>
<td class="nump">9,864,805<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139983549718696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Income - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 879,516<span></span>
</td>
<td class="nump">$ 539,009<span></span>
</td>
<td class="nump">$ 713,514<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of sales</a></td>
<td class="nump">322,614<span></span>
</td>
<td class="nump">208,278<span></span>
</td>
<td class="nump">267,578<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross margin</a></td>
<td class="nump">556,902<span></span>
</td>
<td class="nump">330,731<span></span>
</td>
<td class="nump">445,936<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general, and administrative expenses</a></td>
<td class="nump">406,459<span></span>
</td>
<td class="nump">260,648<span></span>
</td>
<td class="nump">341,209<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfLeasehold', window );">Impairment loss</a></td>
<td class="nump">2,393<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income from operations</a></td>
<td class="nump">148,050<span></span>
</td>
<td class="nump">70,083<span></span>
</td>
<td class="nump">104,727<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other expenses (income):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="nump">2,825<span></span>
</td>
<td class="nump">1,970<span></span>
</td>
<td class="nump">2,146<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax', window );">(Gain) loss on foreign currency</a></td>
<td class="num">(2,338)<span></span>
</td>
<td class="nump">2,178<span></span>
</td>
<td class="nump">1,128<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterestAndDividend', window );">Interest and investment income</a></td>
<td class="num">(3,403)<span></span>
</td>
<td class="num">(2,865)<span></span>
</td>
<td class="num">(3,693)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIncome', window );">Other income</a></td>
<td class="num">(53)<span></span>
</td>
<td class="num">(549)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">&#160;Other expenses (income)</a></td>
<td class="num">(2,969)<span></span>
</td>
<td class="nump">734<span></span>
</td>
<td class="num">(419)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income before income taxes</a></td>
<td class="nump">151,019<span></span>
</td>
<td class="nump">69,349<span></span>
</td>
<td class="nump">105,146<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income taxes</a></td>
<td class="nump">40,992<span></span>
</td>
<td class="nump">19,381<span></span>
</td>
<td class="nump">29,076<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">110,027<span></span>
</td>
<td class="nump">49,968<span></span>
</td>
<td class="nump">76,070<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Less: Net income attributable to the noncontrolling interest</a></td>
<td class="nump">22,616<span></span>
</td>
<td class="nump">11,749<span></span>
</td>
<td class="nump">15,821<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to Inter Parfums, Inc.</a></td>
<td class="nump">$ 87,411<span></span>
</td>
<td class="nump">$ 38,219<span></span>
</td>
<td class="nump">$ 60,249<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract', window );"><strong>Net income attributable to Inter Parfums, Inc. common shareholders:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic</a></td>
<td class="nump">$ 2.76<span></span>
</td>
<td class="nump">$ 1.21<span></span>
</td>
<td class="nump">$ 1.92<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted</a></td>
<td class="nump">$ 2.75<span></span>
</td>
<td class="nump">$ 1.21<span></span>
</td>
<td class="nump">$ 1.90<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted average number of shares outstanding:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic</a></td>
<td class="nump">31,676,796<span></span>
</td>
<td class="nump">31,536,659<span></span>
</td>
<td class="nump">31,451,093<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted</a></td>
<td class="nump">31,835,408<span></span>
</td>
<td class="nump">31,654,544<span></span>
</td>
<td class="nump">31,688,700<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Dividends declared per share</a></td>
<td class="nump">$ 1.00<span></span>
</td>
<td class="nump">$ 0.33<span></span>
</td>
<td class="nump">$ 1.16<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=125521441&amp;loc=d3e30690-110894<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 35<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123602790&amp;loc=d3e30226-110892<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=120253306&amp;loc=d3e28228-110885<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124440516&amp;loc=d3e30840-110895<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionGainLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfLeasehold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The adjustment to reduce the value of existing agreements that specify the lessee's rights to use the leased property. This expense is charged when the estimates of future profits generated by the leased property are reduced.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2420-110228<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfLeasehold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterestAndDividend">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income and dividend income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(a),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterestAndDividend</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue and income classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139983549817992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Comprehensive Income - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">$ 110,027<span></span>
</td>
<td class="nump">$ 49,968<span></span>
</td>
<td class="nump">$ 76,070<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive income:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax', window );">Net derivative instrument income (loss), net of tax</a></td>
<td class="num">(1,367)<span></span>
</td>
<td class="num">(19)<span></span>
</td>
<td class="nump">22<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent', window );">Transfer of OCI into earnings</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(52)<span></span>
</td>
<td class="num">(136)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Translation adjustments, net of tax</a></td>
<td class="num">(42,967)<span></span>
</td>
<td class="nump">47,912<span></span>
</td>
<td class="num">(8,712)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeTax', window );">Other Comprehensive Income (Loss), before Tax</a></td>
<td class="num">(44,334)<span></span>
</td>
<td class="nump">47,841<span></span>
</td>
<td class="num">(8,826)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">Comprehensive income</a></td>
<td class="nump">65,693<span></span>
</td>
<td class="nump">97,809<span></span>
</td>
<td class="nump">67,244<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterestAbstract', window );"><strong>Comprehensive income attributable to noncontrolling interests:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net income</a></td>
<td class="nump">22,616<span></span>
</td>
<td class="nump">11,749<span></span>
</td>
<td class="nump">15,821<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToNoncontrollingInterest', window );">Net derivative instrument loss, net of tax</a></td>
<td class="num">(375)<span></span>
</td>
<td class="num">(19)<span></span>
</td>
<td class="num">(30)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest', window );">Translation adjustments, net of tax</a></td>
<td class="num">(11,524)<span></span>
</td>
<td class="nump">14,004<span></span>
</td>
<td class="num">(2,593)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest', window );">Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest</a></td>
<td class="nump">10,717<span></span>
</td>
<td class="nump">25,734<span></span>
</td>
<td class="nump">13,198<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income attributable to Inter Parfums Inc.</a></td>
<td class="nump">$ 54,976<span></span>
</td>
<td class="nump">$ 72,075<span></span>
</td>
<td class="nump">$ 54,046<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4613674-111683<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569643-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments, of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss), attributable to noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569643-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569643-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax, after reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33775-111570<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments, of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustments of other comprehensive income (loss) attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139983481325400">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Changes in Shareholders' Equity - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Common Stock [Member]</div></th>
<th class="th"><div>Additional Paid-in Capital [Member]</div></th>
<th class="th"><div>Retained Earnings [Member]</div></th>
<th class="th"><div>AOCI Attributable to Parent [Member]</div></th>
<th class="th"><div>Treasury Stock [Member]</div></th>
<th class="th"><div>Noncontrolling Interest [Member]</div></th>
<th class="th"><div>Total</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning Balance at Dec. 31, 2018</a></td>
<td class="nump">$ 31<span></span>
</td>
<td class="nump">$ 69,970<span></span>
</td>
<td class="nump">$ 448,731<span></span>
</td>
<td class="num">$ (33,650)<span></span>
</td>
<td class="num">$ (37,475)<span></span>
</td>
<td class="nump">$ 138,139<span></span>
</td>
<td class="nump">$ 585,746<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Shares issued upon exercise of stock options</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">4,458<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Share-based compensation (adjustment)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,403<span></span>
</td>
<td class="nump">2,006<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">231<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance', window );">Purchase of subsidiary shares from noncontrolling interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,167)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(920)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ipar_TransferOfSubsidiarySharesPurchasedToTreasuryShares', window );">Transfer of subsidiary shares purchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60,249<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">15,821<span></span>
</td>
<td class="nump">76,070<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCash', window );">Dividends</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(36,349)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9,654)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax', window );">Foreign currency translation adjustment, net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,119)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,593)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax', window );">Transfer from other comprehensive income into earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(136)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToNoncontrollingInterest', window );">Net derivative instrument loss, net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">52<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(30)<span></span>
</td>
<td class="num">(30)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending Balance at Dec. 31, 2019</a></td>
<td class="nump">31<span></span>
</td>
<td class="nump">70,664<span></span>
</td>
<td class="nump">474,637<span></span>
</td>
<td class="num">(39,853)<span></span>
</td>
<td class="num">(37,475)<span></span>
</td>
<td class="nump">140,994<span></span>
</td>
<td class="nump">608,998<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Shares issued upon exercise of stock options</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">2,771<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Share-based compensation (adjustment)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,711<span></span>
</td>
<td class="nump">1,117<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">350<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance', window );">Purchase of subsidiary shares from noncontrolling interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions', window );">Shares issued for license acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ipar_TransferOfSubsidiarySharesPurchasedToTreasuryShares', window );">Transfer of subsidiary shares purchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">562<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(139)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38,219<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">11,749<span></span>
</td>
<td class="nump">49,968<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCash', window );">Dividends</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10,406)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(324)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax', window );">Foreign currency translation adjustment, net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,908<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,004<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax', window );">Transfer from other comprehensive income into earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(52)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToNoncontrollingInterest', window );">Net derivative instrument loss, net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(19)<span></span>
</td>
<td class="num">(19)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending Balance at Dec. 31, 2020</a></td>
<td class="nump">32<span></span>
</td>
<td class="nump">75,708<span></span>
</td>
<td class="nump">503,567<span></span>
</td>
<td class="num">(5,997)<span></span>
</td>
<td class="num">(37,475)<span></span>
</td>
<td class="nump">166,615<span></span>
</td>
<td class="nump">702,450<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Shares issued upon exercise of stock options</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">5,393<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Share-based compensation (adjustment)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,566<span></span>
</td>
<td class="nump">1,375<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(293)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance', window );">Purchase of subsidiary shares from noncontrolling interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions', window );">Shares issued for license acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ipar_TransferOfSubsidiarySharesPurchasedToTreasuryShares', window );">Transfer of subsidiary shares purchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(535)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(791)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">87,411<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">22,616<span></span>
</td>
<td class="nump">110,027<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCash', window );">Dividends</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(31,690)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9,836)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax', window );">Foreign currency translation adjustment, net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(31,443)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(11,524)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax', window );">Transfer from other comprehensive income into earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToNoncontrollingInterest', window );">Net derivative instrument loss, net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(992)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(375)<span></span>
</td>
<td class="num">(375)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending Balance at Dec. 31, 2021</a></td>
<td class="nump">$ 32<span></span>
</td>
<td class="nump">$ 87,132<span></span>
</td>
<td class="nump">$ 560,663<span></span>
</td>
<td class="num">$ (38,432)<span></span>
</td>
<td class="num">$ (37,475)<span></span>
</td>
<td class="nump">$ 166,412<span></span>
</td>
<td class="nump">$ 738,332<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ipar_TransferOfSubsidiarySharesPurchasedToTreasuryShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Transfer of subsidiary shares purchased to treasury shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ipar_TransferOfSubsidiarySharesPurchasedToTreasuryShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ipar_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid cash dividends declared for classes of stock, for example, but not limited to, common and preferred.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 405<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6957935&amp;loc=d3e64057-112817<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in noncontrolling interest from subsidiary issuance of equity interests to noncontrolling interest holders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569655-111683<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments, of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss), attributable to noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569643-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit), before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=120253306&amp;loc=d3e28129-110885<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32262-110900<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e640-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=125521441&amp;loc=d3e30755-110894<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustment from accumulated other comprehensive income of accumulated gain (loss) realized from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's deferred hedging gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph c<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41638-113959<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL34724391-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e689-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued pursuant to acquisitions during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 24: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568447-111683<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(03)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139983550544952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">$ 110,027<span></span>
</td>
<td class="nump">$ 49,968<span></span>
</td>
<td class="nump">$ 76,070<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherDepreciationAndAmortization', window );">Depreciation and amortization including impairment loss</a></td>
<td class="nump">12,698<span></span>
</td>
<td class="nump">9,067<span></span>
</td>
<td class="nump">8,729<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Provision for doubtful accounts</a></td>
<td class="nump">853<span></span>
</td>
<td class="nump">4,824<span></span>
</td>
<td class="nump">1,380<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Noncash stock compensation</a></td>
<td class="nump">2,853<span></span>
</td>
<td class="nump">3,029<span></span>
</td>
<td class="nump">3,394<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Share of income of equity investment</a></td>
<td class="num">(53)<span></span>
</td>
<td class="num">(549)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseImpairmentLoss', window );">Lease expense</a></td>
<td class="nump">7,302<span></span>
</td>
<td class="nump">5,483<span></span>
</td>
<td class="nump">6,021<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred tax expense (benefit)</a></td>
<td class="num">(465)<span></span>
</td>
<td class="nump">581<span></span>
</td>
<td class="num">(2,330)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnDerivatives', window );">Change in fair value of derivatives</a></td>
<td class="nump">65<span></span>
</td>
<td class="num">(137)<span></span>
</td>
<td class="num">(169)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="num">(45,395)<span></span>
</td>
<td class="nump">13,157<span></span>
</td>
<td class="nump">1,124<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="num">(49,815)<span></span>
</td>
<td class="nump">19,333<span></span>
</td>
<td class="num">(5,925)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets', window );">Other assets</a></td>
<td class="num">(16,725)<span></span>
</td>
<td class="nump">1,176<span></span>
</td>
<td class="num">(4,945)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability', window );">Operating lease liabilities</a></td>
<td class="num">(7,503)<span></span>
</td>
<td class="num">(5,421)<span></span>
</td>
<td class="num">(4,953)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable and accrued expenses</a></td>
<td class="nump">103,046<span></span>
</td>
<td class="num">(32,239)<span></span>
</td>
<td class="num">(4,960)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedTaxesPayable', window );">Income taxes, net</a></td>
<td class="nump">2,698<span></span>
</td>
<td class="num">(3,279)<span></span>
</td>
<td class="nump">3,016<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">119,586<span></span>
</td>
<td class="nump">64,993<span></span>
</td>
<td class="nump">76,452<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireShortTermInvestments', window );">Purchases of short-term investments</a></td>
<td class="num">(55,691)<span></span>
</td>
<td class="num">(7,582)<span></span>
</td>
<td class="num">(97,958)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfShortTermInvestments', window );">Proceeds from sale of short-term investments</a></td>
<td class="nump">10,644<span></span>
</td>
<td class="nump">11,513<span></span>
</td>
<td class="nump">44,814<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Purchase of property, equipment and leasehold improvements</a></td>
<td class="num">(141,274)<span></span>
</td>
<td class="num">(11,011)<span></span>
</td>
<td class="num">(5,427)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireIntangibleAssets', window );">Payment for intangible assets acquired</a></td>
<td class="num">(1,545)<span></span>
</td>
<td class="num">(1,251)<span></span>
</td>
<td class="num">(6,067)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireEquityMethodInvestments', window );">Purchase of equity investment</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(13,998)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(187,866)<span></span>
</td>
<td class="num">(22,329)<span></span>
</td>
<td class="num">(64,638)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Repayment of long-term debt</a></td>
<td class="num">(43,056)<span></span>
</td>
<td class="num">(13,725)<span></span>
</td>
<td class="num">(22,321)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Proceeds from issuance of long-term debt</a></td>
<td class="nump">157,382<span></span>
</td>
<td class="nump">13,438<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from exercise of options</a></td>
<td class="nump">5,393<span></span>
</td>
<td class="nump">2,771<span></span>
</td>
<td class="nump">4,458<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDividendsCommonStock', window );">Dividends paid</a></td>
<td class="num">(31,690)<span></span>
</td>
<td class="num">(20,805)<span></span>
</td>
<td class="num">(34,579)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDividendsMinorityInterest', window );">Dividends paid to noncontrolling interests</a></td>
<td class="num">(9,836)<span></span>
</td>
<td class="num">(324)<span></span>
</td>
<td class="num">(9,654)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToMinorityShareholders', window );">Purchase of subsidiary shares from noncontrolling interests</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(6,087)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by (used in) financing activities</a></td>
<td class="nump">78,193<span></span>
</td>
<td class="num">(18,645)<span></span>
</td>
<td class="num">(68,183)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations', window );">Effect of exchange rate changes on cash</a></td>
<td class="num">(11,207)<span></span>
</td>
<td class="nump">12,245<span></span>
</td>
<td class="num">(3,350)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase (decrease) in cash and cash equivalents</a></td>
<td class="num">(1,294)<span></span>
</td>
<td class="nump">36,264<span></span>
</td>
<td class="num">(59,719)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents &#8211; beginning of year</a></td>
<td class="nump">169,681<span></span>
</td>
<td class="nump">133,417<span></span>
</td>
<td class="nump">193,136<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents &#8211; end of year</a></td>
<td class="nump">168,387<span></span>
</td>
<td class="nump">169,681<span></span>
</td>
<td class="nump">133,417<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Cash paid for:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest</a></td>
<td class="nump">2,468<span></span>
</td>
<td class="nump">1,105<span></span>
</td>
<td class="nump">1,764<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaid', window );">Income taxes</a></td>
<td class="nump">$ 40,497<span></span>
</td>
<td class="nump">$ 21,772<span></span>
</td>
<td class="nump">$ 26,332<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The effect of exchange rate changes on cash balances in continuing operations held in foreign currencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedTaxesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period of all taxes owed but not paid, including income, property and other taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedTaxesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from impairment of right-of-use asset from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 25<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123399704&amp;loc=SL77918431-209957<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense charged against earnings to allocate the cost of tangible and intangible assets over their remaining economic lives, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividendsCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividendsCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividendsMinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow in the form of ordinary dividends provided by the non-wholly owned subsidiary to noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividendsMinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireProductiveAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 30<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123362884&amp;loc=d3e9212-128498<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 30<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123362884&amp;loc=d3e9215-128498<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123385561&amp;loc=d3e9135-128495<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireProductiveAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for securities or other assets acquired, which qualify for treatment as an investing activity and are to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToMinorityShareholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to a noncontrolling interest. Includes, but not limited to, reduction of noncontrolling interest ownership. Excludes dividends paid to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToMinorityShareholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from sales of all investments, including securities and other assets, having ready marketability and intended by management to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrealizedGainLossOnDerivatives">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net change in the difference between the fair value and the carrying value, or in the comparative fair values, of derivative instruments, including options, swaps, futures, and forward contracts, held at each balance sheet date, that was included in earnings for the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrealizedGainLossOnDerivatives</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139983555817368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>The Company and its Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">The Company and its Significant Accounting Policies</a></td>
<td class="text"><p id="xdx_80C_eus-gaap--SignificantAccountingPoliciesTextBlock_zEvmGVxK25Pf" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in; text-align: left"><b>(1)</b></td><td style="text-align: justify"><b><span id="xdx_827_zu7dtXIuY5Nk">The Company and its Significant Accounting Policies</span></b></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p id="xdx_84F_eus-gaap--BusinessDescriptionAndAccountingPoliciesTextBlock_zaqQ1CrlHMM9" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_867_zFeuUXnmqXK2">Business of the Company</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Inter Parfums, Inc. and its subsidiaries
(the &#8220;Company&#8221;) are in the fragrance business and manufacture and distribute a wide array of fragrances and fragrance
related products.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p id="xdx_899_eus-gaap--SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_zpcXTUGeaJk8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Substantially all of our prestige
fragrance brands are licensed from unaffiliated third parties, and our business is dependent upon the continuation and renewal
of such licenses. <span>With respect to the Company&#8217;s largest brands, we license the Montblanc, Jimmy Choo, Coach and GUESS brand
names. As a percentage of net sales, product sales for the Company&#8217;s largest brands were as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;<span id="xdx_8BB_zLfZsxXUNYea" style="display: none; visibility: hidden">Schedule of lanvin brand name for our class</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year Ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 55%">Montblanc</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--MontblancMember_zYQdpsEiMHBc" style="width: 12%; text-align: right" title="Concentration risk percentage">19</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20200101__20201231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--MontblancMember_zByVvYIo3wEk" style="width: 12%; text-align: right">21</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20190101__20191231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--MontblancMember_z8jeCKYz1uF1" style="width: 12%; text-align: right" title="Concentration risk percentage">22</td><td style="width: 1%; text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Jimmy Choo</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--JimmyChooMember_zQprf6WWuqpb" style="text-align: right">18</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20200101__20201231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--JimmyChooMember_zS5aVrWrtb99" style="text-align: right" title="Concentration risk percentage">16</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20190101__20191231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--JimmyChooMember_zKh8Vx48zKxg" style="text-align: right">16</td><td style="text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Coach</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--CoachMember_zz272R6gNMCg" style="text-align: right">16</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20200101__20201231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--CoachMember_zoFqBpv49ldh" style="text-align: right">17</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20190101__20191231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--CoachMember_z8tyQcKDn2p3" style="text-align: right">14</td><td style="text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>GUESS</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--GUESSMember_zjFmBtriPnHe" style="text-align: right">12</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20200101__20201231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--GUESSMember_zs5yKA1qgED6" style="text-align: right">11</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20190101__20191231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--GUESSMember_zFSzsWYUIFY7" style="text-align: right">10</td><td style="text-align: left">%</td></tr>
</table>

<p id="xdx_8AB_zhfDGbBby8R8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">No other brand represented 10%
or more of consolidated net sales.</p>

<p id="xdx_85B_z1C2HfixVkl3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p id="xdx_84E_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zFBXQNTiBWB1" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_864_zsDymlX0yt0e">Basis of Preparation</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-size: 10pt; color: windowtext">The
consolidated financial statements include the accounts of the Company and its subsidiaries, including <span id="xdx_903_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_uPure_c20211231__srt--OwnershipAxis__custom--InterparfumsSASubsidiaryMember_zI2O3snRjMKg" title="Ownership percentage in Interparfums SA">73</span>% owned Interparfums SA,
a subsidiary whose stock is publicly traded in France.</span> <span style="font-size: 10pt">All material intercompany balances
and transactions have been eliminated</span>.</p>

<p id="xdx_85F_zTX5GZVARaz9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p id="xdx_84D_eus-gaap--UseOfEstimates_zbo5NVG30hw9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><b><i><span id="xdx_862_zrUMUeldlUT8">Management Estimates</span></i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Management makes assumptions
and estimates to prepare financial statements in conformity with accounting principles generally accepted in the United States
of America. Those assumptions and estimates directly affect the amounts reported and disclosures included in the consolidated financial
statements. Actual results could differ from those assumptions and estimates. Significant estimates for which changes in the near
term are considered reasonably possible and that may have a material impact on the financial statements are disclosed in these
notes to the consolidated financial statements.</p>

<p id="xdx_853_z7CEYu4MNqR3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p id="xdx_846_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_zE5MUTGyRm4c" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_86C_z28ilshIsQI2">Foreign Currency Translation</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">For foreign subsidiaries with
operations denominated in a foreign currency, assets and liabilities are translated to U.S. dollars at year-end exchange rates.
Income and expense items are translated at average rates of exchange prevailing during the year. Gains and losses from translation
adjustments are accumulated in a separate component of shareholders&#8217; equity.</p>

<p id="xdx_858_z96YMstlJoXj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p id="xdx_844_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zEpMocWzPs56" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_86B_zCDC3UyqFj93">Cash and Cash Equivalents
and Short-Term Investments</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">All highly liquid investments
purchased with a maturity of three months or less are considered to be cash equivalents. The Company also has short-term investments
which consist of certificates of deposit and other contracts with maturities greater than three months and available for sale marketable
equity securities. The Company monitors concentrations of credit risk associated with financial institutions with which the Company
conducts significant business. The Company believes its credit risk is minimal, as the Company primarily conducts business with
large, well-established financial institutions. Substantially all cash and cash equivalents are primarily held at financial institutions
outside the United States and are readily convertible into U.S. dollars.</p>

<p id="xdx_857_z1JRNnU1Mkqb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>













<p id="xdx_84F_eus-gaap--TradeAndOtherAccountsReceivablePolicy_zOX5N7CtF7sa" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_86C_zRrOsXXviwH7">Accounts Receivable</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Accounts receivable represent
payments due to the Company for previously recognized net sales, reduced by allowances for doubtful accounts or balances which
are estimated to be uncollectible, which aggregated $<span id="xdx_908_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_dm_c20211231_zIjlU4KCWMod" title="Allowances for sales returns and doubtful accounts">2.2 million</span> and $<span id="xdx_907_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_dm_c20201231_zsvFPBrg2MW8" title="Allowances for sales returns and doubtful accounts">5.5 million</span> as of December 31, 2021 and 2020, respectively.
Accounts receivable balances are written-off against the allowance for doubtful accounts when they become uncollectible. Recoveries
of accounts receivable previously recorded against the allowance are recorded in the consolidated statement of income when received.
We generally grant credit based upon our analysis of the customer&#8217;s financial position, as well as previously established
buying patterns.</p>

<p id="xdx_853_zDGbMdHX287h" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p id="xdx_84F_eus-gaap--InventoryPolicyTextBlock_ztbdawIs4OD2" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_86C_zNu6STEIHY4i">Inventories</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Inventories, including promotional
merchandise, only include inventory considered saleable or usable in future periods, and are stated at the lower of cost and net
realizable value, with cost being determined on the first-in, first-out method.&#160;Cost components include raw materials, direct
labor and overhead (e.g., indirect labor, utilities, depreciation, purchasing, receiving, inspection and warehousing) as well as
inbound freight.&#160;Promotional merchandise is charged to cost of sales at the time the merchandise is shipped to the Company&#8217;s
customers.</p>

<p id="xdx_858_z9K5muEB1wti" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p id="xdx_84A_eus-gaap--DerivativesPolicyTextBlock_z9baj96Z3Uch" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_865_zEB0CQ2uqAGl">Derivatives</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">All derivative instruments are
recorded as either assets or liabilities and measured at fair value. The Company uses derivative instruments to principally manage
a variety of market risks. For derivatives designated as hedges of the exposure to changes in fair value of the recognized asset
or liability or a firm commitment (referred to as fair value hedges), the gain or loss is recognized in earnings in the period
of change together with the offsetting loss or gain on the hedged item attributable to the risk being hedged. The effect of that
accounting is to include in earnings the extent to which the hedge is not effective in achieving offsetting changes in fair value.
For cash flow hedges, the effective portion of the derivative&#8217;s gain or loss is initially reported in equity (as a component
of accumulated other comprehensive income) and is subsequently reclassified into earnings in the same period or periods during
which the hedged forecasted transaction affects earnings. The ineffective portion of the gain or loss of a cash flow hedge is reported
in earnings immediately. The Company also holds certain instruments for economic purposes that are not designated for hedge accounting
treatment. For these derivative instruments, changes in their fair value are recorded in earnings immediately.</p>

<p id="xdx_85F_zBTh2OukoYF5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p id="xdx_84E_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zxLXxkQD6l59" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_862_ziePjxIBxEIi">Property, Equipment
and Leasehold Improvements</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Property, equipment and leasehold
improvements are stated at cost less accumulated depreciation and amortization. Depreciation and amortization are provided using
the straight-line method over the estimated useful lives for equipment, which range between three and ten&#160;years and the shorter
of the lease term or estimated useful asset lives for leasehold improvements. Depreciation has not yet begun on property recently
purchased, as it has not yet been put into service. Depreciation provided on equipment used to produce inventory, such as tools
and molds, is included in cost of sales.</p>

<p id="xdx_851_zsl94Ssv1Lp8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

















<p id="xdx_84B_eus-gaap--GoodwillAndIntangibleAssetsPolicyTextBlock_zMLyGXt7t8gg" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_86B_zh41q5d3MFDh">Long-Lived Assets</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Indefinite-lived intangible assets
principally consist of trademarks which are not amortized. The Company evaluates indefinite-lived intangible assets for impairment
at least annually during the fourth quarter, or more frequently when events occur or circumstances change, such as an unexpected
decline in sales, that would more-likely-than-not indicate that the carrying value of an indefinite-lived intangible asset may
not be recoverable. When testing indefinite-lived intangible assets for impairment, the evaluation requires a comparison of the
estimated fair value of the asset to the carrying value of the asset. The fair values used in our evaluations are estimated based
upon discounted future cash flow projections using a weighted average cost of capital of <span id="xdx_905_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_uPure_c20211231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountRateMember_zjI95Q9b1fGj" title="Weighted average cost of capital">7.47</span>% and <span id="xdx_906_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_uPure_c20201231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountRateMember_zitEfXDLlzZj" title="Weighted average cost of capital">6.99</span>% in 2021 and 2020, respectively.
The cash flow projections are based upon a number of assumptions, including future sales levels, future cost of goods and operating
expense levels, as well as economic conditions, changes to our business model or changes in consumer acceptance of our products
which are more subjective in nature. If the carrying value of an indefinite-lived intangible asset exceeds its fair value, an impairment
charge is recorded.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Intangible assets subject to
amortization are evaluated for impairment testing whenever events or changes in circumstances indicate that the carrying amount
of an amortizable intangible asset may not be recoverable. If impairment indicators exist for an amortizable intangible asset,
the undiscounted future cash flows associated with the expected service potential of the asset are compared to the carrying value
of the asset. If our projection of undiscounted future cash flows is in excess of the carrying value of the intangible asset, no
impairment charge is recorded. If our projection of undiscounted future cash flows is less than the carrying value of the intangible
asset, an impairment charge would be recorded to reduce the intangible asset to its fair value.</p>

<p id="xdx_859_zvbVB95ePOC6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p id="xdx_846_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_ztLcWRB1tRh4" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_868_zDcPDuMSob3a">Revenue Recognition</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company sells its products
to department stores, perfumeries, specialty stores and domestic and international wholesalers and distributors. Our revenue contracts
represent single performance obligations to sell our products to customers. Sales of such products by our domestic subsidiaries
are denominated in U.S. dollars, and sales of such products by our foreign subsidiaries are primarily denominated in either euro
or U.S. dollars. The Company recognizes revenues when contract terms are met, the price is fixed and determinable, collectability
is reasonably assured, and control of the assets has passed to the customer based on the agreed upon shipping terms. Net sales
are comprised of gross revenues less returns, trade discounts and allowances. The Company does not bill its customers&#8217; freight
and handling charges. All shipping and handling costs, which aggregated $<span id="xdx_903_eus-gaap--CostOfGoodsAndServicesSold_dm_c20210101__20211231__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_z7kiNCO2jrZd" title="Shipping and handling costs">10.1 million</span>, $<span id="xdx_901_eus-gaap--CostOfGoodsAndServicesSold_dm_c20200101__20201231__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_zYpnjFOqQbrf" title="Shipping and handling costs">5.0 million</span> and $<span id="xdx_907_eus-gaap--CostOfGoodsAndServicesSold_dm_c20190101__20191231__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_zbv06j8IAt58" title="Shipping and handling costs">7.7 million</span> in 2021, 2020
and 2019, respectively, are included in selling, general and administrative expenses in the consolidated statements of income.
The Company grants credit to all qualified customers and does not believe it is exposed significantly to any undue concentration
of credit risk. No one customer represented <span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember_zoLUvQ3mRx5b" title="Concentration risk percentage"><span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20200101__20201231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember_zhfXNG5EgFo" title="Concentration risk percentage"><span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20190101__20191231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember_zyOX9TezhAsb" title="Concentration risk percentage">10</span></span></span>% or more of net sales in 2021, 2020 or 2019.</p>

<p id="xdx_857_zyMuc9mPqZY7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p id="xdx_842_eus-gaap--RevenueRecognitionSalesReturns_zRzspxwoKQok" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><b><i><span id="xdx_86A_z8xvPmwjEzX2">Sales Returns</span></i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Generally, the Company does not
permit customers to return their unsold products. However, for U.S. based customers, we allow returns if properly requested, authorized
and approved. The Company regularly reviews and revises, as deemed necessary, its estimate of reserves for future sales returns
based primarily upon historic trends and relevant current data including information provided by retailers regarding their inventory
levels. In addition, as necessary, specific accruals may be established for significant future known or anticipated events. The
types of known or anticipated events that we consider include, but are not limited to, the financial condition of our customers,
store closings by retailers, changes in the retail environment and our decision to continue to support new and existing products.
The Company records its estimate of potential sales returns as a reduction of sales and cost of sales with corresponding entries
to accrued expenses, to record the refund liability, and inventory, for the right to recover goods from the customer. The refund
liability associated with estimated returns was $<span id="xdx_908_eus-gaap--ContractWithCustomerRefundLiability_iI_dm_c20211231_znyf5BtratH3" title="Contract with customer, refund liability">5.1 million</span> and $<span id="xdx_90C_eus-gaap--ContractWithCustomerRefundLiability_iI_dm_c20201231_zRetSX8A8Xf2" title="Contract with customer, refund liability">3.6 million</span> at December 31, 2021 and 2020, respectively, and
the amounts recognized for the rights to recover products was $<span id="xdx_901_eus-gaap--ContractWithCustomerRightToRecoverProduct_iI_dm_c20211231_zeBEEVsuiDj8" title="Contract with customer, right to recover products">1.9 million</span> and $<span id="xdx_907_eus-gaap--ContractWithCustomerRightToRecoverProduct_iI_dm_c20201231_z0jjHn77u3ra" title="Contract with customer, right to recover products">1.4 million</span> at December 31, 2021 and 2020, respectively.
The physical condition and marketability of returned products are the major factors we consider in estimating realizable value.
Actual returns, as well as estimated realizable values of returned products, may differ significantly, either favorably or unfavorably,
from our estimates, if factors such as economic conditions, inventory levels or competitive conditions differ from our expectations.</p>

<p id="xdx_85A_zGHAKYOFyFo4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>











<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p id="xdx_848_eus-gaap--RevenueRecognitionAllowances_zIXF944rySMe" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_868_znLVY5SKtDS2">Payments to Customers</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company records revenues
generated from purchase with purchase and gift with purchase promotions as sales and the costs of its purchase with purchase and
gift with purchase promotions as cost of sales. Certain other incentive arrangements require the payment of a fee to customers
based on their attainment of pre-established sales levels.&#160;These fees have been recorded as a reduction of net sales.</p>

<p id="xdx_852_zWNBQtZ1lOll" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p id="xdx_847_eus-gaap--AdvertisingCostsPolicyTextBlock_zMhsa7dUIP4b" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_86B_zKwixucqi0Wc">Advertising and Promotion</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Advertising and promotional costs
are expensed as incurred and recorded as a component of cost of goods sold (in the case of free goods given to customers) or selling,
general and administrative expenses. Advertising and promotional costs included in selling, general and administrative expenses
were $<span id="xdx_90F_eus-gaap--AdvertisingExpense_dm_c20210101__20211231_zO66CJoHkc5i" title="Advertising costs">171.8 million</span>, $<span id="xdx_900_eus-gaap--AdvertisingExpense_dm_c20200101__20201231_zmbGZy0nheab" title="Advertising costs">91.7 million</span> and $<span id="xdx_906_eus-gaap--AdvertisingExpense_dm_c20190101__20191231_zSBuyQo7SUfj" title="Advertising costs">144.6 million</span> for 2021, 2020 and 2019, respectively. Costs relating to purchase with purchase
and gift with purchase promotions that are reflected in cost of sales aggregated $<span id="xdx_90B_eus-gaap--MarketingExpense_dm_c20210101__20211231_zkC5S7wCoKt" title="Customer incentives cost">37.6 million</span>, $<span id="xdx_907_eus-gaap--MarketingExpense_dm_c20200101__20201231_zIl6u6IHe97g" title="Customer incentives cost">26.4 million</span> and $<span id="xdx_90B_eus-gaap--MarketingExpense_dm_c20190101__20191231_z8Sfs4W9HSo7" title="Customer incentives cost">38.9 million</span>
in 2021, 2020 and 2019, respectively.</p>

<p id="xdx_852_zv0TgE5diP73" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p id="xdx_845_eus-gaap--ResearchAndDevelopmentExpensePolicy_zb6l10DhTTD1" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_86C_zxubFzrB3ag7">Package Development
Costs</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Package development costs associated
with new products and redesigns of existing product packaging are expensed as incurred.</p>

<p id="xdx_850_zDyjh8VrwLea" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p id="xdx_84E_eus-gaap--LessorLeasesPolicyTextBlock_zY4OsnzKpcG1" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_864_zSwFQL2unLWj">Operating Leases</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company leases its offices
and warehouses, vehicles, and certain office equipment, substantially all of which are classified as operating leases. The Company
currently has no material financing leases. The Company determines if an arrangement is a lease at inception. Operating lease assets
and obligations are recognized at the lease commencement date based on the present value of lease payments over the lease term.</p>

<p id="xdx_851_zBCT9dlLM9yb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p id="xdx_845_eus-gaap--CommitmentsAndContingenciesPolicyTextBlock_zlM20bGen9Pf" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_86A_zpWo2K9IzHBk">License Agreements</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company&#8217;s license agreements
generally provide the Company with worldwide rights to manufacture, market and sell fragrance and fragrance related products using
the licensors&#8217; trademarks.&#160;The licenses typically have an initial term of approximately <span id="xdx_905_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtxL_c20210101__20211231__srt--RangeAxis__srt--MinimumMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_zg5oy7vG2Sig" title="License agreement term::XDX::P5Y"><span style="-sec-ix-hidden: xdx2ixbrl0815">5</span></span> to <span id="xdx_90B_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtxL_c20210101__20211231__srt--RangeAxis__srt--MaximumMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_zH4FMG4euCva" title="License agreement term::XDX::P15Y"><span style="-sec-ix-hidden: xdx2ixbrl0817">15</span></span> years, and are potentially
renewable subject to the Company&#8217;s compliance with the license agreement provisions.&#160;The remaining terms, excluding
potential renewal periods, range from approximately <span id="xdx_900_eus-gaap--AcquiredFiniteLivedIntangibleAssetWeightedAveragePeriodBeforeRenewalOrExtension_dtxL_c20210101__20211231__srt--RangeAxis__srt--MinimumMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_zZBekVhYz7rl" title="License agreement renewal term::XDX::P1Y"><span style="-sec-ix-hidden: xdx2ixbrl0819">1</span></span> to <span id="xdx_90B_eus-gaap--AcquiredFiniteLivedIntangibleAssetWeightedAveragePeriodBeforeRenewalOrExtension_dtxL_c20210101__20211231__srt--RangeAxis__srt--MaximumMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_zPKh8saKEnri" title="License agreement renewal term::XDX::P12Y"><span style="-sec-ix-hidden: xdx2ixbrl0821">12</span></span> years.&#160; Under each license, the Company is required to pay royalties
in the range of <span id="xdx_904_ecustom--RoyaltyExpenseNetSalesPercentage_pid_dp_uPure_c20210101__20211231__srt--RangeAxis__srt--MinimumMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_zLpjMvg6tOsh" title="Royalty expense, percentage of net sales">6</span>% to <span id="xdx_90C_ecustom--RoyaltyExpenseNetSalesPercentage_pid_dp_uPure_c20210101__20211231__srt--RangeAxis__srt--MaximumMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_ziq3WDdigWN5" title="Royalty expense, percentage of net sales">10</span>% to the licensor, at least annually, based on net sales to third parties.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In certain cases, the Company
may pay an entry fee to acquire, or enter into, a license where the licensor or another licensee was operating a pre-existing fragrance
business.&#160; In those cases, the entry fee is capitalized as an intangible asset and amortized over its useful life.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Most license agreements require
minimum royalty payments, incremental royalties based on net sales levels and minimum spending on advertising and promotional activities.&#160;
Royalty expenses are accrued in the period in which net sales are recognized while advertising and promotional expenses are accrued
at the time these costs are incurred.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>













<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In addition, the Company is exposed
to certain concentration risk. Most of our prestige fragrance brands are licensed from unaffiliated third parties, and our business
is dependent upon the continuation and renewal of such licenses.</p>

<p id="xdx_851_zS3es4fIsQH4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;&#160;</p>

<p id="xdx_848_eus-gaap--IncomeTaxPolicyTextBlock_zfkJH3uH7nI3" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_862_ztuairfRRGmc">Income Taxes</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company accounts for income
taxes using an asset and liability approach that requires the recognition of deferred tax assets and liabilities for the expected
future tax consequences of events that have been recognized in its financial statements or tax returns.&#160;The net deferred tax
assets assume sufficient future earnings for their realization, as well as the continued application of currently enacted tax rates.&#160;Included
in net deferred tax assets is a valuation allowance for deferred tax assets, where management believes it is more-likely-than-not
that the deferred tax assets will not be realized in the relevant jurisdiction.&#160;If the Company determines that a deferred
tax asset will not be realizable, an adjustment to the deferred tax asset will result in a reduction of net earnings at that time.
Accrued interest and penalties are included within the related tax asset or liability in the accompanying financial statements.</p>

<p id="xdx_858_zgWcCsu0X49f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p id="xdx_84B_eus-gaap--ConsolidationSubsidiaryStockIssuancesPolicy_zNn5UAKH97j9" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_863_z3XeDhRGwgT6">Issuance of Common Stock
by Consolidated Subsidiary</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The difference between the Company&#8217;s
share of the proceeds received by the subsidiary and the carrying amount of the portion of the Company&#8217;s investment deemed
sold, is reflected as an equity adjustment in the consolidated balance sheets.</p>

<p id="xdx_858_ztrkRACWMHWj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p id="xdx_845_eus-gaap--RepurchaseAgreementsCollateralPolicy_zgFdiS9Lz6vl" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_86E_zPR2sjlhj6Vi">Treasury Stock</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Board of Directors may authorize
share repurchases of the Company&#8217;s common stock (Share Repurchase Authorizations). Share repurchases under Share Repurchase
Authorizations may be made through open market transactions, negotiated purchase or otherwise, at times and in such amounts within
the parameters authorized by the Board. Shares repurchased under Share Repurchase Authorizations are held in treasury for general
corporate purposes, including issuances under various employee stock option plans. Treasury shares are accounted for under the
cost method and reported as a reduction of equity. Share Repurchase Authorizations may be suspended, limited or terminated at any
time without notice.</p>

<p id="xdx_85B_zl4btBt8GBfd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p id="xdx_846_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zaV2orbuBuQ3" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_865_zEa8FnNhccEf">Recent Accounting Pronouncements</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In June 2016, the Financial Accounting
Standards Board (&#8220;FASB&#8221;) issued ASU 2016-13, &#8220;Financial Instruments - Credit Losses (Topic 326): Measurement
of Credit Losses on Financial Instruments&#8221;, as updated in 2019 and 2020, which require a financial asset measured at amortized
cost basis to be presented at the net amount expected to be collected. The new rules eliminate the probable initial recognition
threshold and, instead, reflect an entity&#8217;s current estimate of all expected credit losses. The new rules took effect for
the Company in the first quarter of 2020 and there was no material impact on our consolidated financial statements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">There are no other recent accounting
pronouncements issued but not yet adopted that would have a material effect on our consolidated financial statements.</p>

<p id="xdx_85E_zHyHguiqTzx6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p id="xdx_841_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zOY2dqwXvKZ4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><b><i><span id="xdx_865_zZHMpqe0Xir6">Reclassifications</span></i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Certain prior year&#8217;s amounts
in the accompanying consolidated statements of cash flows have been reclassified to conform to current period presentation.</p>

<p id="xdx_85C_zIPzerqA9kpk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18726-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139983555970840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Impact of COVID-19 Pandemic<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ipar_DisclosureImpactOfCovid19PandemicAbstract', window );"><strong>Impact Of Covid-19 Pandemic</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ipar_ImpactOfCOVID19PandemicTextBlock', window );">Impact of COVID-19 Pandemic</a></td>
<td class="text"><p id="xdx_802_ecustom--ImpactOfCOVID19PandemicTextBlock_zhjKhOFC7zZf" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in">(2)</td><td><span id="xdx_822_zgXMrxJ4zcsd">Impact of COVID-19 Pandemic</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">A novel strain of coronavirus
(&#8220;COVID-19&#8221;) surfaced in late 2019 and has spread around the world, including to the United States and France. In March
2020, the World Health Organization declared COVID-19 a pandemic.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In response to the COVID-19 pandemic
various national, state, and local governments where we, our suppliers, and our customers operate initially issued decrees prohibiting
certain businesses from continuing to operate and certain classes of workers from reporting to work. In all jurisdictions in which
we operate we have been following guidance from authorities and health officials.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The effects of the COVID-19 pandemic
on the beauty industry began in early March 2020. Retail store closings, event cancellations and a shutdown of international air
travel brought our sales to a virtual standstill and caused a significant unfavorable impact on our results of operations in 2020.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Business significantly improved
in the second half of 2020 and continued to improve throughout 2021, as retail stores reopened, and consumers increased online
purchasing. While we expect this trend to continue, as the luxury fragrance industry has shown continued resilience, the introduction
of variants of COVID-19 in various parts of the world has caused the temporary re-implementation of governmental restrictions to
prevent further spread of the virus. In addition, international air travel has remained curtailed in many jurisdictions due to
both governmental restrictions and consumer health concerns. While COVID-19 has significantly restricted international travel in
the near-term, we continue to believe that global travel retail will once again be a growth opportunity for the long-term. Lastly,
the improved economy has put significant strains on our supply chain causing disruptions affecting the procurement of components,
the ability to transport goods, and related cost increases. These disruptions have come at a time when demand for our product lines
has never been stronger or more sustained. We have been addressing this issue since the beginning of 2021, by ordering well in
advance of need and in larger quantities. Going forward, we aim to carry more inventory overall, source the same components from
multiple suppliers and when possible, manufacture products closer to where they are sold. We do not expect the supply chain bottlenecks
to begin lifting until later in 2022. Therefore, despite recent business improvement, the impact of the COVID-19 pandemic may have
a material adverse effect on our results of our operations, financial position and cash flows through at least the end of 2022.</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ipar_DisclosureImpactOfCovid19PandemicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ipar_DisclosureImpactOfCovid19PandemicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ipar_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ipar_ImpactOfCOVID19PandemicTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for impact of COVID 19 pandemic.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ipar_ImpactOfCOVID19PandemicTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ipar_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139983555811608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Recent Agreements<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">Recent Agreements</a></td>
<td class="text"><p id="xdx_809_eus-gaap--BusinessCombinationDisclosureTextBlock_z9lEmzIUSBA1" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in">(3)</td><td><span id="xdx_82F_zZ584f55AChe">Recent Agreements</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><b><i>Salvatore Ferragamo </i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In October 2021, we closed on
a transaction agreement with Salvatore Ferragamo S.p.A., whereby an exclusive and worldwide license was granted for the production
and distribution of Ferragamo brand perfumes. Our rights under this license are subject to certain minimum advertising expenditures
and royalty payments as are customary in our industry. The license became effective in October 2021 and will last for 10 years
with a 5-year optional term, subject to certain conditions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>















<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p id="xdx_897_ecustom--ScheduleOfInventoryCurrentTableTextBlock1_z2moVF6wOGw9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">With respect to the management
and coordination of activities related to the license agreement, the Company operates through a wholly-owned Italian subsidiary
based in Florence, that was acquired from Salvatore Ferragamo on October 1, 2021. The acquisition together with the license agreement
was accounted for as an asset acquisition. The following table summarizes the estimated fair values of the assets acquired and
liabilities assumed on October 1, 2021. <span id="xdx_8BE_z60afETIDPI2">All amounts have been translated to U.S. dollars at the October 1, 2021 exchange rate.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 40%; margin-right: auto">
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 25%">Inventories</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--InventoryGross_iI_pn3n3_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--InventoryMember_zBSGsFMZ2Kmk" style="width: 12%; text-align: right" title="Inventories">17,805</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Trademarks and licenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--InventoryGross_iI_pn3n3_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksMember_zjHRtjDVGIv1" style="text-align: right">15,880</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Other assets</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--InventoryGross_iI_pn3n3_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--OtherAssetMember_zqiCMi4rBlte" style="border-bottom: Black 1pt solid; text-align: right" title="Inventory gross">3,033</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in">Assets acquired</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--FairValueOfAssetsAcquired_pn3n3_c20210101__20211231_zc7pMBCM27j7" style="border-bottom: Black 1pt solid; text-align: right" title="Assets acquired">36,718</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in">Liabilities assumed</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--LiabilitiesAssumed1_iN_di_c20210101__20211231_zYAilmIsHA5d" style="border-bottom: Black 1pt solid; text-align: right">(958</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2pt">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td id="xdx_983_eus-gaap--InventoryNet_iI_pn3n3_dxL_c20211231_znyKJ10w2TWd" style="border-bottom: Black 2pt double; text-align: right" title="Inventory net::XDX::198%2C914"><span style="-sec-ix-hidden: xdx2ixbrl0863">35,760</span></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
</table>



<p id="xdx_8A0_zuHLOTPrKK3k" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><b><i>Emanuel Ungaro</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In October 2021, we also entered into a 10-year exclusive global licensing agreement a with a 5-year optional
term subject to certain conditions, with Emanuel Ungaro Italia S.r.l, for the creation, development and distribution of fragrances
and fragrance-related products, under the Emanuel Ungaro brand. Our rights under this license are subject to certain minimum advertising
expenditures and royalty payments as are customary in our industry.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><b><i>Donna Karan and DKNY </i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In September 2021, we entered
into a long-term global licensing agreement for the creation, development and distribution of fragrances and fragrance-related
products under the Donna Karan and DKNY brands. Our rights under this license are subject to certain minimum advertising expenditures
and royalty payments as are customary in our industry. With this agreement, we are gaining several well-established and valuable
fragrance franchises, most notably Donna Karan <i>Cashmere Mist</i> and DKNY <i>Be Delicious</i>, as well as a significant loyal
consumer base around the world. In connection with the grant of license, we issued 65,342 shares of Inter Parfums, Inc. common
stock valued at $5.0 million to the licensor. The exclusive license is effective July 1, 2022, and we are planning to launch new
fragrances under these brands in 2023.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><b><i>French Tax Settlement </i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The French authorities had considered
that the existence of IP Suisse, a wholly-owned subsidiary of Interparfums SA, does not, in and of itself, constitute a permanent
establishment and therefore Interparfums SA should pay French taxes on all or part of the profits of that entity.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In June 2021, a global settlement
agreement was reached with the French Tax Authorities, whereby Interparfums SA paid in December 2021, &#8364;<span id="xdx_907_eus-gaap--TaxesPayableCurrentAndNoncurrent_iI_dm_uUSDEUR_c20211231__us-gaap--IncomeTaxAuthorityNameAxis__us-gaap--SwissFederalTaxAdministrationFTAMember__srt--CurrencyAxis__currency--EUR__us-gaap--TypeOfArrangementAxis__custom--GlobalSettlementAgreementMember_zgRIBUsoyBNa" title="Taxes Payable">2.5 million</span> (approximately
$<span id="xdx_904_eus-gaap--TaxesPayableCurrentAndNoncurrent_iI_dm_uUSD_c20211231__us-gaap--IncomeTaxAuthorityNameAxis__us-gaap--SwissFederalTaxAdministrationFTAMember__us-gaap--TypeOfArrangementAxis__custom--GlobalSettlementAgreementMember_zNa45vnyzqeh" title="Taxes Payable">2.9 million</span>) effectively lowering the Lanvin brand royalty rate charged by IP Suisse for the periods from 2017 through 2020. Interparfums
SA also agreed to apply the lower rate in 2021 through 2025 and to transfer the Lanvin brand from IP Suisse to Interparfums SA
by December 31, 2025.</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><b><i>Land and Building Acquisition
- Future Headquarters in Paris</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In April 2021, Interparfums SA,
completed the acquisition of its future headquarters at 10 rue de Solf&#233;rino in the 7th arrondissement of Paris from the
property developer. This is an office complex combining three buildings connected by two inner courtyards, and consists of approximately
40,000 total sq. ft.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>













<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The $<span id="xdx_902_eus-gaap--PaymentsForPurchaseOfOtherAssets1_pn6n6_uUSD_c20210101__20211231_zKlent8Ofh4k">142 million</span> purchase price
includes the complete renovation of the site. As of December 31, 2021, $136.1 million of the purchase price, including approximately
$<span id="xdx_901_eus-gaap--AcquisitionCosts_dm_uUSD_c20210101__20211231__srt--CurrencyAxis__currency--EUR_zGDIfEGVe4h6">3.1 million</span> of acquisition costs, is included in property, equipment and leasehold improvements on the accompanying balance sheet
as of December 31, 2021. Approximately $<span id="xdx_903_ecustom--CashHeldInEscrow_iI_dm_c20211231_zcXQAcHk90za">8.8 million</span> of cash held in escrow is included in other assets on the accompanying balance
sheet as of December 31, 2021. In addition, the Company borrowed $<span id="xdx_901_eus-gaap--IncomeTaxReceivable_iI_dm_c20211231__srt--CurrencyAxis__currency--EUR__us-gaap--IncomeTaxAuthorityNameAxis__us-gaap--SwissFederalTaxAdministrationFTAMember_zJZHWCo7GE88">17.0 million</span> pursuant to a short-term loan equal to the VAT credit,
and in July 2021, the $<span id="xdx_901_eus-gaap--InvestmentTaxCredit_dm_c20210101__20211231__srt--CurrencyAxis__currency--EUR_zykIjumC6No">17.0 million</span> VAT credit was reimbursed by the French Tax Authorities and the loan was repaid.</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The acquisition was financed
by a <span id="xdx_909_eus-gaap--LongTermDebtTerm_iI_dtYxL_c20211231_zEMKWpLnF5X5" title="Long-term Debt, Term::XDX::P10Y"><span style="-sec-ix-hidden: xdx2ixbrl0880">10</span></span>-year &#8364;<span id="xdx_903_eus-gaap--LineOfCredit_iI_pn3n3_uUSDEUR_c20211231__srt--CurrencyAxis__currency--EUR_zznhm4xTa8a2" title="Long-term Line of Credit">120</span> million (approximately $<span id="xdx_901_eus-gaap--LineOfCredit_iI_pn3n3_c20211231_zvrHR7gWg4Hd" title="Long-term Line of Credit">136</span> million) bank loan which bears interest at <span id="xdx_909_eus-gaap--DebtInstrumentInterestRateTerms_c20210101__20211231_z5oqquTuhvI2" title="Debt Instrument, Interest Rate Terms">one-month Euribor plus 0.75%</span>. Approximately
&#8364;<span id="xdx_904_eus-gaap--DebtInstrumentFaceAmount_iI_pn3n3_uUSDEUR_c20211231__srt--CurrencyAxis__currency--EUR_zKK7gisjMti" title="Debt Instrument, Face Amount">80 million</span> of the variable rate debt was swapped for fixed interest rate debt with a maximum interest rate of 2%.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><b><i>Anna Sui Corp.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In January 2021, we renewed our
license agreement with Anna Sui Corp. for the creation, development and distribution of fragrance products through December&#160;31,
2026, without any material changes in terms and conditions. <span id="xdx_903_ecustom--DiscriptionOfRecentAgreement_c20210101__20211231__dei--LegalEntityAxis__custom--AnnaSuiCorpMember_zUsirhIK94Na" title="Discription of recent agreement">Our initial 10-year license agreement with Anna Sui Corp. was signed
in 2011. The renewal agreement also allows for an additional 5-year term through 2031 at the option of the Company</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><b><i>Rochas Fashion</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Effective January 1, 2021, we
entered into a new license agreement modifying our Rochas fashion business model. The new agreement calls for a reduction in royalties
to be received. As a result, in the first quarter of 2021, we took a $<span id="xdx_902_eus-gaap--ImpairmentChargeOnReclassifiedAssets_dm_c20210101__20211231__dei--LegalEntityAxis__custom--RochasFashionMember_zkCLcfrr2KLe" title="Impairment Charge on Reclassified Assets">2.4 million</span> impairment charge on our Rochas fashion trademark.
The new license also contains an option for the licensee to buy-out the Rochas fashion trademarks in June 2025 at its then fair
market value.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><b><i>S.T. Dupont</i></b>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In January 2021, <span id="xdx_900_eus-gaap--BusinessAcquisitionDescriptionOfAcquiredEntity_c20210101__20211231__dei--LegalEntityAxis__custom--STDupontMember_zzie8oIqQBaj" title="License agreements, description">we renewed our
license agreement with S.T. Dupont for the creation, development and distribution of fragrance products through December&#160;31,
2022, without any material changes in terms and conditions. Our initial 11-year license agreement with S.T. Dupont was signed in
June 1997 and had previously been extended through December 31, 2021.</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI http://asc.fasb.org/topic&amp;trid=2303972<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139983574811720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventories<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureTextBlock', window );">Inventories</a></td>
<td class="text"><p id="xdx_80C_eus-gaap--InventoryDisclosureTextBlock_zbIqYjDHdHx4" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in">(4)</td><td><span id="xdx_82A_zPVN2RmbXXAa">Inventories</span></td></tr></table>

<p id="xdx_892_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zrRb4nJddiO5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span id="xdx_8B1_z1kNhe6Jw8G8" style="display: none; visibility: hidden">Schedule of inventories</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_49F_20211231_z7oxjyUrNaij" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_492_20201231_zHh7oxh1Rru7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr id="xdx_407_eus-gaap--InventoryRawMaterials_iI_maINz9tx_zpDlqBeKK311" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 70%; text-align: left">Raw materials and component parts</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">111,312</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">66,492</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_408_eus-gaap--InventoryFinishedGoods_iI_maINz9tx_zO2JndZo2iN2" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Finished goods</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">87,602</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">92,330</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--InventoryNet_iI_mtINz9tx_zwskzoITkwre" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="display: none; padding-bottom: 2pt; visibility: hidden">Inventories</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td style="border-bottom: Black 2pt double; text-align: right">198,914</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td style="border-bottom: Black 2pt double; text-align: right">158,822</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
</table>



<p id="xdx_8AB_zpl8F1Ipqorb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Overhead included in inventory
aggregated $<span id="xdx_90B_eus-gaap--CostOfGoodsAndServicesSoldOverhead_dm_c20210101__20211231__srt--ProductOrServiceAxis__us-gaap--ProductMember_zUYcASZwXUK5" title="Cost of Goods Sold, Overhead">3.7 million</span> and $<span id="xdx_902_eus-gaap--CostOfGoodsAndServicesSoldOverhead_dm_c20200101__20201231__srt--ProductOrServiceAxis__us-gaap--ProductMember_zH75RwMS2Wp3">5.4 million</span> as of December 31, 2021 and 2020, respectively. Included in inventories is an inventory
reserve, which represents the difference between the cost of the inventory and its estimated realizable value, based upon sales
forecasts and the physical condition of the inventories. In addition, and as necessary, specific reserves for future known or anticipated
events may be established. Inventory reserves aggregated $<span id="xdx_908_eus-gaap--InventoryValuationReserves_iI_dm_c20211231_z3HCyH8yiTr3" title="Inventory Valuation Reserves">15.8 million</span> and $<span id="xdx_907_eus-gaap--InventoryValuationReserves_iI_dm_c20201231_zNoSN7RlidSk" title="Inventory Valuation Reserves">9.4 million</span> as of December 31, 2021 and 2020, respectively.</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI http://asc.fasb.org/topic&amp;trid=2126998<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139983555886120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value of Financial Instruments<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value of Financial Instruments</a></td>
<td class="text"><p id="xdx_806_eus-gaap--FairValueDisclosuresTextBlock_zeSK3KGDx5I1" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in">(5)</td><td><span id="xdx_826_zA9SG9OgExr7">Fair Value of Financial Instruments</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p id="xdx_895_eus-gaap--ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_zpUSsX2tZJt1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The following tables present
our financial assets and liabilities that are measured at fair value on a recurring basis and are categorized using the fair value
hierarchy. The fair value hierarchy has three levels based on the reliability of the inputs used to determine fair value.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8B5_z08ZA4b1osk4" style="display: none; visibility: hidden">Schedule of fair value, assets measured on recurring basis</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_499_20211231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zip1pYCzDCQ9" style="font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_49E_20211231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zqW8AlibTaAh" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_498_20211231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zWFQNxn7cvse" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_497_20211231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zcDrb0jEVg1h" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="color: Black">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="color: Black">&#160;</span></td>
    <td colspan="2" style="font-weight: bold"><span style="color: Black">&#160;</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="color: Black">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="color: Black">&#160;</span></td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="color: Black">Fair
    Value Measurements at December 31, 2021</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="color: Black">&#160;</span></td></tr>
<tr style="text-align: center; vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: right"><span style="color: Black">&#160;</span></td><td style="font-weight: bold; text-align: right"><span style="color: Black">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: right"><span style="color: Black">&#160;</span></td><td style="font-weight: bold; text-align: right"><span style="color: Black">&#160;</span></td><td style="font-weight: bold; text-align: right"><span style="color: Black">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: right"><span style="color: Black">Quoted Prices in</span></td><td style="font-weight: bold; text-align: right"><span style="color: Black">&#160;</span></td><td style="font-weight: bold; text-align: right"><span style="color: Black">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: right"><span style="color: Black">Significant Other</span></td><td style="font-weight: bold; text-align: right"><span style="color: Black">&#160;</span></td><td style="font-weight: bold; text-align: right"><span style="color: Black">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: right"><span style="color: Black">Significant</span></td><td style="font-weight: bold; text-align: right"><span style="color: Black">&#160;</span></td></tr>
<tr style="text-align: center; vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: right"><span style="color: Black">&#160;</span></td><td style="font-weight: bold; text-align: right"><span style="color: Black">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: right"><span style="color: Black">&#160;</span></td><td style="font-weight: bold; text-align: right"><span style="color: Black">&#160;</span></td><td style="font-weight: bold; text-align: right"><span style="color: Black">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: right"><span style="color: Black">Active Markets for</span></td><td style="font-weight: bold; text-align: right"><span style="color: Black">&#160;</span></td><td style="font-weight: bold; text-align: right"><span style="color: Black">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: right"><span style="color: Black">Observable</span></td><td style="font-weight: bold; text-align: right"><span style="color: Black">&#160;</span></td><td style="font-weight: bold; text-align: right"><span style="color: Black">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: right"><span style="color: Black">Unobservable</span></td><td style="font-weight: bold; text-align: right"><span style="color: Black">&#160;</span></td></tr>
<tr style="text-align: center; vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: right"><span style="color: Black">&#160;</span></td><td style="font-weight: bold; text-align: right"><span style="color: Black">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: right"><span style="color: Black">&#160;</span></td><td style="font-weight: bold; text-align: right"><span style="color: Black">&#160;</span></td><td style="font-weight: bold; text-align: right"><span style="color: Black">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: right"><span style="color: Black">Identical Assets</span></td><td style="font-weight: bold; text-align: right"><span style="color: Black">&#160;</span></td><td style="font-weight: bold; text-align: right"><span style="color: Black">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: right"><span style="color: Black">Inputs</span></td><td style="font-weight: bold; text-align: right"><span style="color: Black">&#160;</span></td><td style="font-weight: bold; text-align: right"><span style="color: Black">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: right"><span style="color: Black">Inputs</span></td><td style="font-weight: bold; text-align: right"><span style="color: Black">&#160;</span></td></tr>
<tr style="text-align: center; vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: right"><span style="color: Black">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt; text-align: right"><span style="color: Black">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="color: Black">Total</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: right"><span style="color: Black">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt; text-align: right"><span style="color: Black">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="color: Black">(Level 1)</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: right"><span style="color: Black">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt; text-align: right"><span style="color: Black">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="color: Black">(Level 2)</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: right"><span style="color: Black">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt; text-align: right"><span style="color: Black">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="color: Black">(Level 3)</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: right"><span style="color: Black">&#160;</span></td></tr>
<tr id="xdx_406_eus-gaap--AssetsFairValueDisclosureAbstract_iB_zyr2SglTMbYk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="color: Black">Assets:</span></td><td><span style="color: Black">&#160;</span></td>
    <td colspan="2"><span style="color: Black">&#160;</span></td><td><span style="color: Black">&#160;</span></td><td><span style="color: Black">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="color: Black">&#160;</span></td><td><span style="color: Black">&#160;</span></td><td><span style="color: Black">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="color: Black">&#160;</span></td><td><span style="color: Black">&#160;</span></td><td><span style="color: Black">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="color: Black">&#160;</span></td><td><span style="color: Black">&#160;</span></td></tr>
<tr id="xdx_407_eus-gaap--InvestmentsFairValueDisclosure_i01I_zoqxLledHNfl" style="vertical-align: bottom; background-color: White">
    <td style="width: 38%; text-align: left; padding-bottom: 2pt; padding-left: 0.25in; text-indent: -0.125in"><span style="color: Black">Short-term
    investments</span></td><td style="width: 1%; padding-bottom: 2pt"><span style="color: Black">&#160;</span></td>
    <td style="border-bottom: Black 2pt double; width: 1%; text-align: left"><span style="color: Black">$</span></td><td style="border-bottom: Black 2pt double; width: 12%; text-align: right"><span style="color: Black">160,014</span></td><td style="width: 1%; padding-bottom: 2pt; text-align: left"><span style="color: Black">&#160;</span></td><td style="width: 1%; padding-bottom: 2pt"><span style="color: Black">&#160;</span></td>
    <td style="border-bottom: Black 2pt double; width: 1%; text-align: left"><span style="color: Black">$</span></td><td style="border-bottom: Black 2pt double; width: 14%; text-align: right"><span style="color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0926">&#8212;</span></span></td><td style="width: 1%; padding-bottom: 2pt; text-align: left"><span style="color: Black">&#160;</span></td><td style="width: 1%; padding-bottom: 2pt"><span style="color: Black">&#160;</span></td>
    <td style="border-bottom: Black 2pt double; width: 1%; text-align: left"><span style="color: Black">$</span></td><td style="border-bottom: Black 2pt double; width: 12%; text-align: right"><span style="color: Black">160,014</span></td><td style="width: 1%; padding-bottom: 2pt; text-align: left"><span style="color: Black">&#160;</span></td><td style="width: 1%; padding-bottom: 2pt"><span style="color: Black">&#160;</span></td>
    <td style="border-bottom: Black 2pt double; width: 1%; text-align: left"><span style="color: Black">$</span></td><td style="border-bottom: Black 2pt double; width: 12%; text-align: right"><span style="color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0928">&#8212;</span></span></td><td style="width: 1%; padding-bottom: 2pt; text-align: left"><span style="color: Black">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="color: Black">&#160;</span></td><td><span style="color: Black">&#160;</span></td>
    <td style="text-align: left"><span style="color: Black">&#160;</span></td><td style="text-align: right"><span style="color: Black">&#160;</span></td><td style="text-align: left"><span style="color: Black">&#160;</span></td><td><span style="color: Black">&#160;</span></td>
    <td style="text-align: left"><span style="color: Black">&#160;</span></td><td style="text-align: right"><span style="color: Black">&#160;</span></td><td style="text-align: left"><span style="color: Black">&#160;</span></td><td><span style="color: Black">&#160;</span></td>
    <td style="text-align: left"><span style="color: Black">&#160;</span></td><td style="text-align: right"><span style="color: Black">&#160;</span></td><td style="text-align: left"><span style="color: Black">&#160;</span></td><td><span style="color: Black">&#160;</span></td>
    <td style="text-align: left"><span style="color: Black">&#160;</span></td><td style="text-align: right"><span style="color: Black">&#160;</span></td><td style="text-align: left"><span style="color: Black">&#160;</span></td></tr>
<tr id="xdx_402_eus-gaap--LiabilitiesAbstract_iB_zm2i0qxAvay6" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="color: Black">Liabilities:</span></td><td><span style="color: Black">&#160;</span></td>
    <td style="text-align: left"><span style="color: Black">&#160;</span></td><td style="text-align: right"><span style="color: Black">&#160;</span></td><td style="text-align: left"><span style="color: Black">&#160;</span></td><td><span style="color: Black">&#160;</span></td>
    <td style="text-align: left"><span style="color: Black">&#160;</span></td><td style="text-align: right"><span style="color: Black">&#160;</span></td><td style="text-align: left"><span style="color: Black">&#160;</span></td><td><span style="color: Black">&#160;</span></td>
    <td style="text-align: left"><span style="color: Black">&#160;</span></td><td style="text-align: right"><span style="color: Black">&#160;</span></td><td style="text-align: left"><span style="color: Black">&#160;</span></td><td><span style="color: Black">&#160;</span></td>
    <td style="text-align: left"><span style="color: Black">&#160;</span></td><td style="text-align: right"><span style="color: Black">&#160;</span></td><td style="text-align: left"><span style="color: Black">&#160;</span></td></tr>
<tr id="xdx_40C_eus-gaap--ForeignCurrencyFairValueHedgeAssetAtFairValue_i01I_zyZJXYtQXuE5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in"><span style="color: Black">Foreign currency forward
    exchange contracts accounted for using hedge accounting</span></td><td><span style="color: Black">&#160;</span></td>
    <td style="text-align: left"><span style="color: Black">$</span></td><td style="text-align: right"><span style="color: Black">1,982</span></td><td style="text-align: left"><span style="color: Black">&#160;</span></td><td><span style="color: Black">&#160;</span></td>
    <td style="text-align: left"><span style="color: Black">$</span></td><td style="text-align: right"><span style="color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0936">&#8212;</span></span></td><td style="text-align: left"><span style="color: Black">&#160;</span></td><td><span style="color: Black">&#160;</span></td>
    <td style="text-align: left"><span style="color: Black">$</span></td><td style="text-align: right"><span style="color: Black">1,982</span></td><td style="text-align: left"><span style="color: Black">&#160;</span></td><td><span style="color: Black">&#160;</span></td>
    <td style="text-align: left"><span style="color: Black">$</span></td><td style="text-align: right"><span style="color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0938">&#8212;</span></span></td><td style="text-align: left"><span style="color: Black">&#160;</span></td></tr>
<tr id="xdx_40D_eus-gaap--ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue_i01I_zeqSL4COBFL7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.375in; text-indent: -0.125in"><span style="color: Black">Foreign currency forward
    exchange contracts not accounted for using hedge accounting</span></td><td><span style="color: Black">&#160;</span></td>
    <td style="text-align: left"><span style="color: Black">&#160;</span></td><td style="text-align: right"><span style="color: Black">63</span></td><td style="text-align: left"><span style="color: Black">&#160;</span></td><td><span style="color: Black">&#160;</span></td>
    <td style="text-align: left"><span style="color: Black">&#160;</span></td><td style="text-align: right"><span style="color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0941">&#8212;</span></span></td><td style="text-align: left"><span style="color: Black">&#160;</span></td><td><span style="color: Black">&#160;</span></td>
    <td style="text-align: left"><span style="color: Black">&#160;</span></td><td style="text-align: right"><span style="color: Black">63</span></td><td style="text-align: left"><span style="color: Black">&#160;</span></td><td><span style="color: Black">&#160;</span></td>
    <td style="text-align: left"><span style="color: Black">$&#160;</span></td><td style="text-align: right"><span style="color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0943">&#8212;</span></span></td><td style="text-align: left"><span style="color: Black">&#160;</span></td></tr>
<tr id="xdx_40A_eus-gaap--DerivativeLiabilities_iI_zoek8SC7XOo4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.25in; text-indent: -0.125in"><span style="color: Black">Interest
    rate swaps</span></td><td style="color: #FF0000; padding-bottom: 1pt"><span style="color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; color: #FF0000; text-align: left"><span style="color: Black">&#160;</span></td><td style="border-bottom: Black 1pt solid; color: #FF0000; text-align: right"><span style="color: Black">(234</span></td><td style="padding-bottom: 1pt; color: #FF0000; text-align: left"><span style="color: Black">)</span></td><td style="padding-bottom: 1pt"><span style="color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="color: Black">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0946">&#8212;</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="color: Black">&#160;</span></td><td style="color: #FF0000; padding-bottom: 1pt"><span style="color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; color: #FF0000; text-align: left"><span style="color: Black">&#160;</span></td><td style="border-bottom: Black 1pt solid; color: #FF0000; text-align: right"><span style="color: Black">(234</span></td><td style="padding-bottom: 1pt; color: #FF0000; text-align: left"><span style="color: Black">)</span></td><td style="padding-bottom: 1pt"><span style="color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="color: Black">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0948">&#8212;</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="color: Black">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="color: Black">&#160;</span></td><td><span style="color: Black">&#160;</span></td>
    <td style="text-align: left"><span style="color: Black">&#160;</span></td><td style="text-align: right"><span style="color: Black">&#160;</span></td><td style="text-align: left"><span style="color: Black">&#160;</span></td><td><span style="color: Black">&#160;</span></td>
    <td style="text-align: left"><span style="color: Black">&#160;</span></td><td style="text-align: right"><span style="color: Black">&#160;</span></td><td style="text-align: left"><span style="color: Black">&#160;</span></td><td><span style="color: Black">&#160;</span></td>
    <td style="text-align: left"><span style="color: Black">&#160;</span></td><td style="text-align: right"><span style="color: Black">&#160;</span></td><td style="text-align: left"><span style="color: Black">&#160;</span></td><td><span style="color: Black">&#160;</span></td>
    <td style="text-align: left"><span style="color: Black">&#160;</span></td><td style="text-align: right"><span style="color: Black">&#160;</span></td><td style="text-align: left"><span style="color: Black">&#160;</span></td></tr>
<tr id="xdx_405_eus-gaap--AssetsFairValueDisclosure_iI_zgWf1xgKXWnd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2pt; padding-left: 0.125in; text-indent: -0.125in"><span style="color: Black">&#160;</span></td><td style="padding-bottom: 2pt"><span style="color: Black">&#160;</span></td>
    <td style="border-bottom: Black 2pt double; text-align: left"><span style="color: Black">$</span></td><td style="border-bottom: Black 2pt double; text-align: right"><span style="color: Black">1,811</span></td><td style="padding-bottom: 2pt; text-align: left"><span style="color: Black">&#160;</span></td><td style="padding-bottom: 2pt"><span style="color: Black">&#160;</span></td>
    <td style="border-bottom: Black 2pt double; text-align: left"><span style="color: Black">$</span></td><td style="border-bottom: Black 2pt double; text-align: right"><span style="color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0951">&#8212;</span></span></td><td style="padding-bottom: 2pt; text-align: left"><span style="color: Black">&#160;</span></td><td style="padding-bottom: 2pt"><span style="color: Black">&#160;</span></td>
    <td style="border-bottom: Black 2pt double; text-align: left"><span style="color: Black">$</span></td><td style="border-bottom: Black 2pt double; text-align: right"><span style="color: Black">1,811</span></td><td style="padding-bottom: 2pt; text-align: left"><span style="color: Black">&#160;</span></td><td style="padding-bottom: 2pt"><span style="color: Black">&#160;</span></td>
    <td style="border-bottom: Black 2pt double; text-align: left"><span style="color: Black">$</span></td><td style="border-bottom: Black 2pt double; text-align: right"><span style="color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0953">&#8212;</span></span></td><td style="padding-bottom: 2pt; text-align: left"><span style="color: Black">&#160;</span></td></tr>
</table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_494_20201231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_z7FyXXMlbJxf" style="font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_49D_20201231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z1vV2kJH9DG3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_490_20201231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zeDZ9U0lgoDj" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_49C_20201231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zDh2rS24njTf" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Fair Value Measurements at December 31, 2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: right; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: right">Quoted Prices in</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: right">Significant Other</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: right">Significant</td><td style="font-weight: bold; text-align: right">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: right; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: right">Active Markets for</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: right">Observable</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: right">Unobservable</td><td style="font-weight: bold; text-align: right">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: right; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: right">Identical Assets</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: right">Inputs</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: right">Inputs</td><td style="font-weight: bold; text-align: right">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: right; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt; text-align: right">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">Total</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt; text-align: right">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(Level 1)</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt; text-align: right">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(Level 2)</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt; text-align: right">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(Level 3)</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: right">&#160;</td></tr>
<tr id="xdx_406_eus-gaap--AssetsFairValueDisclosureAbstract_iB_zPVcHzGl6kc1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">Assets:</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
<tr id="xdx_407_eus-gaap--InvestmentsFairValueDisclosure_i01I_zFWk88u7lgO3" style="vertical-align: bottom; background-color: White">
    <td style="width: 38%; text-align: left; padding-left: 0.25in; text-indent: -0.125in">Short-term investments</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">126,627</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0961">&#8212;</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">126,627</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0963">&#8212;</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue_i01I_zT4hr1fpmTaj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.25in; text-indent: -0.125in">Foreign currency forward exchange contracts not accounted for using hedge accounting</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">253</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0966">&#8212;</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">253</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0968">&#8212;</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_403_eus-gaap--AssetsFairValueDisclosure_i01I_zonVrdkYao88" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="display: none; padding-bottom: 2pt; padding-left: 0.125in; text-indent: -0.125in; visibility: hidden">&#160;Total Assets</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td style="border-bottom: Black 2pt double; text-align: right">126,880</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td style="border-bottom: Black 2pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0971">&#8212;</span></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td style="border-bottom: Black 2pt double; text-align: right">126,880</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td style="border-bottom: Black 2pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0973">&#8212;</span></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
</table>



<p id="xdx_8A0_zwDNJddXG2Yl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The carrying amount of cash and
cash equivalents including money market funds, short-term investments including marketable equity securities, accounts receivable,
other receivables, accounts payable and accrued expenses approximates fair value due to the short terms to maturity of these instruments.
The carrying amount of loans payable approximates fair value as the variable interest rates on the Company&#8217;s indebtedness
approximate current market rates.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

















<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Foreign currency forward exchange
contracts are valued based on quotations from financial institutions and the value of interest rate swaps are the discounted net
present value of the swaps using third party quotes from financial institutions.</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139983555938728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Financial Instruments<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock', window );">Derivative Financial Instruments</a></td>
<td class="text"><p id="xdx_807_eus-gaap--DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_zn5M6Z8fNke4" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in">(6)</td><td><span id="xdx_82E_zfnjnKZXosil">Derivative Financial Instruments</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company enters into foreign
currency forward exchange contracts to hedge exposure related to receivables denominated in a foreign currency and occasionally
to manage risks related to future sales expected to be denominated in a foreign currency. Before entering into a derivative transaction
for hedging purposes, it is determined that a high degree of initial effectiveness exists between the change in value of the hedged
item and the change in the value of the derivative instrument from movement in exchange rates. High effectiveness means that the
change in the cash flows of the derivative instrument will effectively offset the change in the cash flows of the hedged item.
The effectiveness of each hedged item is measured throughout the hedged period and is based on the dollar offset methodology and
excludes the portion of the fair value of the foreign currency forward exchange contract attributable to the change in spot-forward
difference which is reported in current period earnings. Any hedge ineffectiveness is also recognized as a gain or loss on foreign
currency in the income statement. For hedge contracts that are no longer deemed highly effective, hedge accounting is discontinued,
and gains and losses accumulated in other comprehensive income are reclassified to earnings.&#160;If it is probable that the forecasted
transaction will no longer occur, then any gains or losses accumulated in other comprehensive income are reclassified to current-period
earnings.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Gains and losses in derivatives
designated as hedges are accumulated in other comprehensive income (loss) and gains and losses in derivatives not designated as
hedges are included in (gain) loss on foreign currency on the accompanying income statements. Such gains and losses were immaterial
in each of the years in the three-year period ended December 31, 2021. For the year ended December 31, 2021, interest expense
includes a gain of $0.2 million, resulting from an interest rate swap.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">All derivative instruments are
reported as either assets or liabilities on the balance sheet measured at fair value. The valuation of interest rate swap is included
in long-term debt on the accompanying balance sheets. The valuation of foreign currency forward exchange contracts at December
31, 2021 and December 31, 2020, resulted in an asset and is included in other current assets on the accompanying balance sheets.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">At December&#160;31, 2021, the
Company had foreign currency contracts in the form of forward exchange contracts with notional amounts of approximately U.S. $<span id="xdx_902_eus-gaap--ForeignCurrencyContractsLiabilityFairValueDisclosure_iI_dm_uUSD_c20211231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--ForeignExchangeContractMember_zUrDW8nAWuge" title="Foreign currency contracts, liability, fair value disclosure">64.5 million</span>
and GB &#163;<span id="xdx_90C_eus-gaap--ForeignCurrencyContractsLiabilityFairValueDisclosure_iI_dm_uUSDGBP_c20211231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--ForeignExchangeContractMember_zJaINp4y5hvi" title="Foreign currency contracts, liability, fair value disclosure">3.5 million</span>, which all have maturities of less than one year.</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -URI http://asc.fasb.org/topic&amp;trid=2229140<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123477628&amp;loc=d3e90205-114008<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139983556278280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, Equipment and Leasehold Improvements<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">Property, Equipment and Leasehold Improvements</a></td>
<td class="text"><p id="xdx_805_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_zmpCiBz5yz8l" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in">(7)</td><td><span id="xdx_828_zi19mCmjwIk4">Property, Equipment and Leasehold Improvements</span></td></tr></table>

<p id="xdx_893_eus-gaap--PropertyPlantAndEquipmentTextBlock_z0bRjPUIflOc" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span id="xdx_8B4_zOApWi6icI86" style="display: none; visibility: hidden">Schedule of equipment and leasehold improvements</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 70%; text-align: left">Land and Building (construction in progress)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_zmu1pZyIhen" style="width: 12%; text-align: right" title="Equipment and leasehold improvements">136,131</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_zOhwooYlLtD9" style="width: 12%; text-align: right" title="Equipment and leasehold improvements"><span style="-sec-ix-hidden: xdx2ixbrl0994">&#8212;</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>Equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_zatqLbXfqFpb" style="text-align: right" title="Equipment and leasehold improvements">52,036</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_zkNXbvmrPpxj" style="text-align: right">51,060</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Leasehold improvements</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zvYoPZIRifaa" style="border-bottom: Black 1pt solid; text-align: right" title="Equipment and leasehold improvements">2,082</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zsgKJCxMc6Le" style="border-bottom: Black 1pt solid; text-align: right" title="Equipment and leasehold improvements">1,989</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20211231_zvVH0RSWRkT8" style="text-align: right">190,249</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20201231_z3jZry9HRNR7" style="text-align: right">53,049</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Less accumulated depreciation and amortization</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_c20211231_zDfPC239o3jk" style="border-bottom: Black 1pt solid; text-align: right" title="Less accumulated depreciation and amortization">40,897</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_c20201231_zSdQ2fOjLqy6" style="border-bottom: Black 1pt solid; text-align: right" title="Less accumulated depreciation and amortization">33,469</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2pt">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentNet_iI_c20211231_z5MQFrRc4331" style="border-bottom: Black 2pt double; text-align: right" title="Property, Plant and Equipment, Net, Total">149,352</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentNet_iI_c20201231_zDkyy5vp5BN7" style="border-bottom: Black 2pt double; text-align: right" title="Property, Plant and Equipment, Net, Total">19,580</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
</table>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Depreciation and amortization
expense was $<span id="xdx_903_eus-gaap--DepreciationDepletionAndAmortization_dm_c20210101__20211231_zWBF7I9UTu97" title="Depreciation and amortization expense">4.4 million</span>, $<span id="xdx_905_eus-gaap--DepreciationDepletionAndAmortization_dm_c20200101__20201231_znvTPsO5y99e" title="Depreciation and amortization expense">3.8 million</span> and $<span id="xdx_904_eus-gaap--DepreciationDepletionAndAmortization_dm_c20190101__20191231_zRKLfsHBp3Gd" title="Depreciation and amortization expense">3.7 million</span> in 2021, 2020, and 2019, respectively.</p>

<p id="xdx_8A8_zZYWZciLiWU7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99893-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI http://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=SL120174063-112916<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99779-112916<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139983555837944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Trademarks, Licenses and Other Intangible Assets<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsDisclosureTextBlock', window );">Trademarks, Licenses and Other Intangible Assets</a></td>
<td class="text"><p id="xdx_80C_eus-gaap--IntangibleAssetsDisclosureTextBlock_zASYfjfS08qk" style="margin-top: 0; margin-bottom: 0"/>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in">(8)</td><td><span id="xdx_823_ztId1nKE5Sgb">Trademarks, Licenses and Other Intangible Assets</span></td></tr></table>

<p id="xdx_890_eus-gaap--ScheduleOfImpairedIntangibleAssetsTextBlock_zuBsXwYVrou3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span id="xdx_8B9_zFTNgX7e9xii" style="display: none; visibility: hidden">Schedule of trademarks, licenses and other intangible assets</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: left">2021</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Gross</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Accumulated</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Net Book</td><td style="font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amortization</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Value</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 55%; text-align: left; padding-bottom: 1pt">Trademarks (indefinite lives)</td><td style="width: 1%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--IndefinitelivedIntangibleAssetsMember_zu1V8Hk54jCl" style="border-bottom: Black 1pt solid; width: 12%; text-align: right" title="Gross Amount">119,712</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--IndefinitelivedIntangibleAssetsMember_z4V7kKkHlkBi" style="border-bottom: Black 1pt solid; width: 12%; text-align: right" title="Accumulated Amortization"><span style="-sec-ix-hidden: xdx2ixbrl1025">&#8212;</span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--IndefinitelivedIntangibleAssetsMember_zrketUL9HUY7" style="border-bottom: Black 1pt solid; width: 12%; text-align: right" title="Net Book Value">119,712</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Trademarks (finite lives)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--FiniteLivedIntangibleAssetsMember_zZCIY8a9jTg" style="text-align: right">43,820</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--FiniteLivedIntangibleAssetsMember_zqIUcyJ0BHma" style="text-align: right">68</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--FiniteLivedIntangibleAssetsMember_zmtxuWrqpXn9" style="text-align: right">43,752</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Licenses (finite lives)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--LicensesMember_zx0fSCvbMOrb" style="text-align: right">109,682</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--LicensesMember_z8jsBqvtrboj" style="text-align: right">62,286</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--LicensesMember_z0VnQSfTgOJ7" style="text-align: right">47,396</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Other intangible assets (finite lives)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_zjSRkZdrdQo9" style="border-bottom: Black 1pt solid; text-align: right">17,775</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_zJrZNrlcE1S6" style="border-bottom: Black 1pt solid; text-align: right">14,588</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_ztASP3x639Q5" style="border-bottom: Black 1pt solid; text-align: right">3,187</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; padding-left: 0.125in">Subtotal</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20211231__us-gaap--FairValueByAssetClassAxis__custom--SubtotalMember_zjAApMVnkPLe" style="border-bottom: Black 1pt solid; text-align: right">171,277</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20211231__us-gaap--FairValueByAssetClassAxis__custom--SubtotalMember_z5aaCPnWhZl8" style="border-bottom: Black 1pt solid; text-align: right">76,942</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20211231__us-gaap--FairValueByAssetClassAxis__custom--SubtotalMember_zeq888yvAzid" style="border-bottom: Black 1pt solid; text-align: right">94,335</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2pt; padding-left: 0.25in">Total</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20211231_zd8wUtrQItc6" style="border-bottom: Black 2pt double; text-align: right">290,989</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20211231_zzWg0TC4opf" style="border-bottom: Black 2pt double; text-align: right">76,942</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20211231_z1ERowanMjXi" style="border-bottom: Black 2pt double; text-align: right">214,047</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
</table>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: left">2020</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Gross</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Accumulated</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Net Book</td><td style="font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amortization</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Value</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 55%; text-align: left; padding-bottom: 1pt">Trademarks (indefinite lives)</td><td style="width: 1%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20201231__us-gaap--FairValueByAssetClassAxis__us-gaap--IndefinitelivedIntangibleAssetsMember_zybGBplDjgM9" style="border-bottom: Black 1pt solid; width: 12%; text-align: right">131,962</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20201231__us-gaap--FairValueByAssetClassAxis__us-gaap--IndefinitelivedIntangibleAssetsMember_zFwzKYV0hDvc" style="border-bottom: Black 1pt solid; width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1044">&#8212;</span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20201231__us-gaap--FairValueByAssetClassAxis__us-gaap--IndefinitelivedIntangibleAssetsMember_z69xLvALNKe3" style="border-bottom: Black 1pt solid; width: 12%; text-align: right">131,962</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Trademarks (finite lives)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20201231__us-gaap--FairValueByAssetClassAxis__us-gaap--FiniteLivedIntangibleAssetsMember_ziaV74qg3lCi" style="text-align: right">47,477</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20201231__us-gaap--FairValueByAssetClassAxis__us-gaap--FiniteLivedIntangibleAssetsMember_zhPRtVWM8tI9" style="text-align: right">74</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20201231__us-gaap--FairValueByAssetClassAxis__us-gaap--FiniteLivedIntangibleAssetsMember_zq8HaJkzhfVg" style="text-align: right">47,403</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Licenses (finite lives)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20201231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--LicensesMember_zrAhzOIqgkPe" style="text-align: right">93,248</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20201231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--LicensesMember_zwz01IMDZW7k" style="text-align: right">62,262</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20201231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--LicensesMember_zMyp1St5uT12" style="text-align: right">30,986</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Other intangible assets (finite lives)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20201231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_zGlN5ArnoJh9" style="border-bottom: Black 1pt solid; text-align: right">18,194</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20201231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_zlfX60VP3edg" style="border-bottom: Black 1pt solid; text-align: right">14,437</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20201231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_zfKTGxO0jFGd" style="border-bottom: Black 1pt solid; text-align: right">3,757</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; padding-left: 0.125in">Subtotal</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20201231__us-gaap--FairValueByAssetClassAxis__custom--SubtotalMember_zWGERQGgcGBg" style="border-bottom: Black 1pt solid; text-align: right">158,919</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20201231__us-gaap--FairValueByAssetClassAxis__custom--SubtotalMember_zVbjRD3OU4hd" style="border-bottom: Black 1pt solid; text-align: right">76,773</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20201231__us-gaap--FairValueByAssetClassAxis__custom--SubtotalMember_zoZ4PHhbS7N2" style="border-bottom: Black 1pt solid; text-align: right">82,146</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2pt; padding-left: 0.25in">Total</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20201231_zlKDRBTRgzJ3" style="border-bottom: Black 2pt double; text-align: right">290,881</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20201231_znLLbaAQ7M08" style="border-bottom: Black 2pt double; text-align: right">76,773</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20201231_zLiIvgLQitT7" style="border-bottom: Black 2pt double; text-align: right">214,108</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
</table>



<p id="xdx_8AC_zDFVvg2vAF1k" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Amortization expense was $<span id="xdx_909_eus-gaap--AmortizationOfIntangibleAssets_dm_c20210101__20211231_zRzN3UNpNi5e">5.9
million</span>, $<span id="xdx_90B_eus-gaap--AmortizationOfIntangibleAssets_dm_c20200101__20201231_zPvqgT6L9bEl">5.3 million</span> and $<span id="xdx_906_eus-gaap--AmortizationOfIntangibleAssets_dm_c20190101__20191231_zkalSNE8NOt6">5.0 million</span> in 2021, 2020 and 2019, respectively. Amortization expense is expected to approximate $<span id="xdx_90D_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_dm_c20211231_zn6kMfoB5nHe">5.4
million</span> in 2022, $<span id="xdx_90C_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_dm_c20211231_zYkWq6jGK7U2">4.4 million</span> in 2023, $<span id="xdx_90E_ecustom--FiniteLivedIntangibleAssetsAmortizationExpenseAfterTwoYears_iI_dm_c20211231_zjDLtvIn6nv1">4.2 million</span> in 2024, 2025 and 2026. The weighted average amortization period for trademarks,
licenses and other intangible assets with finite lives are <span id="xdx_904_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dxL_c20210101__20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksMember_zkGjhOUrG502" title="Amortization period::XDX::P8Y"><span style="-sec-ix-hidden: xdx2ixbrl1068">18</span></span> years, <span id="xdx_906_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dxL_c20210101__20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--LicensesMember_zk26A5A30yn8" title="::XDX::P15Y"><span style="-sec-ix-hidden: xdx2ixbrl1069">15</span></span> years and <span id="xdx_905_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dxL_c20210101__20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_zSXQI9V2pbu2" title="::XDX::P2Y"><span style="-sec-ix-hidden: xdx2ixbrl1070">2</span></span> years, respectively, and <span id="xdx_90F_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dxL_c20210101__20211231_zlBlcV0rOLf2" title="::XDX::P14Y"><span style="-sec-ix-hidden: xdx2ixbrl1071">14</span></span> years on average.</p>



















<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company reviews intangible
assets with indefinite lives for impairment whenever events or changes in circumstances indicate that the carrying amount may not
be recoverable. There was an impairment charge for trademarks with indefinite useful lives of $<span id="xdx_90E_eus-gaap--AmortizationOfIntangibleAssets_dm_c20210101__20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--IndefinitelivedIntangibleAssetsMember_zwbHZTD4I777">2.4 million</span> in 2021 relating to
our Rochas fashion business. The fair values used in our evaluations are estimated based upon discounted future cash flow projections
using a weighted average cost of capital of <span id="xdx_901_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_dp_c20211231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountRateMember_zygYPPsPyuSc" title="Weighted average cost of capital">7.47</span>%, <span id="xdx_904_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_dp_c20201231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountRateMember_zVklY56kLe9c">6.99</span>%, and <span id="xdx_904_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_dp_c20191231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountRateMember_zZGJVZLsjdC6">7.94</span>% as of December 31, 2021, 2020 and 2019, respectively. The cash
flow projections are based upon a number of assumptions, including, future sales levels and future cost of goods and operating
expense levels, as well as economic conditions, changes to our business model or changes in consumer acceptance of our products
which are more subjective in nature. The Company believes that the assumptions it has made in projecting future cash flows for
the evaluations described above are reasonable and currently no other impairment indicators exist for our indefinite-lived assets.
However, if future actual results do not meet our expectations, the Company may be required to record an impairment charge, the
amount of which could be material to our results of operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The cost of trademarks, licenses
and other intangible assets with finite lives is being amortized by the straight-line method over the term of the respective license
or the intangible assets estimated useful life which range from <span id="xdx_906_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dxL_c20210101__20211231__srt--RangeAxis__srt--MinimumMember_zsFW3oxRvSE8" title="Amortization period::XDX::P3Y"><span style="-sec-ix-hidden: xdx2ixbrl1086">three</span></span> to <span id="xdx_90A_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dxL_c20210101__20211231__srt--RangeAxis__srt--MaximumMember_z50AU7FdbDm" title="Amortization period::XDX::P20Y"><span style="-sec-ix-hidden: xdx2ixbrl1088">twenty years</span></span>. If the residual value of a finite life intangible
asset exceeds its carrying value, then the asset is not amortized. The Company reviews intangible assets with finite lives for
impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Trademarks (finite lives) primarily
represent Lanvin brand names and trademarks and in connection with their purchase, Lanvin was granted the right to repurchase the
brand names and trademarks on July 1, 2027 for &#8364;70 million (approximately $<span id="xdx_905_eus-gaap--IndefiniteLivedLicenseAgreements_iI_pn6n6_c20211231_zDWDHEBoYp44">79</span> million) (residual value) in accordance with
an amendment signed in 2021. Because the residual value of the intangible asset exceeds its carrying value, the asset is not being
amortized.</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all or part of the information related to intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI http://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139983555925528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued Expenses<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock', window );">Accrued Expenses</a></td>
<td class="text"><p id="xdx_805_eus-gaap--AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_zkW03kU6fsdd" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in">(9)</td><td><span id="xdx_82F_zYjsMSf8W1Cf">Accrued Expenses</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p id="xdx_893_eus-gaap--ScheduleOfAccruedLiabilitiesTableTextBlock_z2tBzBebFVa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8B3_zfGhPo3W9388">Accrued expenses consist of the
following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_49B_20211231_zOrca3nEmH29" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_49A_20201231_zCaUhWp9ThJh" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--AccruedAdvertisingCurrent_iI_maALCzkev_zryJtF67WKMd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 70%; text-align: left">Advertising liabilities</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">31,215</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">12,164</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--AccruedSalariesCurrent_iI_maALCzkev_z5Ky8tSKulA2" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Salary (including bonus and related taxes)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">19,993</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">14,605</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_403_eus-gaap--AccruedRoyaltiesCurrent_iI_maALCzkev_zE0TFIWDkX95" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Royalties</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">19,154</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">16,966</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_403_ecustom--DueVendorsNotYetInvoiced_iI_maALCzkev_zreYzpg8bkA" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Due vendors (not yet invoiced)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">45,707</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">31,698</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrent_iI_maALCzkev_zvE6kTpZLRsk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Retirement reserves</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,234</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">11,889</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--CustomerRefundLiabilityCurrent_iI_maALCzkev_zaOmeGtKBpj" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Refund (return) liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,128</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,616</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40E_eus-gaap--OtherAccruedLiabilitiesCurrent_iI_maALCzkev_zZcRqnM9d0lg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">Other</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">5,246</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">4,691</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_400_eus-gaap--AccruedLiabilitiesCurrent_iTI_mtALCzkev_z3kdIpeQpYsb" style="vertical-align: bottom; background-color: White">
    <td style="display: none; padding-bottom: 2pt; visibility: hidden">Accrued expenses</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td style="border-bottom: Black 2pt double; text-align: right">136,677</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td style="border-bottom: Black 2pt double; text-align: right">95,629</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
</table>



<p id="xdx_8A2_zhGs4I0UOZy2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a),20,24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139983555875992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Loans Payable &#8211; Banks<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Loans Payable &#8211; Banks</a></td>
<td class="text"><p id="xdx_80B_eus-gaap--DebtDisclosureTextBlock_z3so1WY1dNn6" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in">(10)</td><td><span id="xdx_821_zPl2YMX39Ffb">Loans Payable &#8211; Banks</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Loans payable &#8211; banks consist
of the following:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company and its domestic
subsidiaries have available a $<span id="xdx_90A_eus-gaap--LineOfCreditFacilityMaximumBorrowingCapacity_iI_c20211231__dei--LegalEntityAxis__custom--DomesticSubsidiariesMember_zLBYAMwpu2w6" title="Line of credit, maximum borrowing amount">20 million</span> unsecured revolving line of credit due on demand, which bears interest at the daily Secured
Overnight Financing Rate (&#8220;SOFR&#8221;) plus <span id="xdx_90F_eus-gaap--DebtInstrumentBasisSpreadOnVariableRate1_pid_dp_uPure_c20210101__20211231__us-gaap--VariableRateAxis__custom--LondonInterbankOfferedRateMember__dei--LegalEntityAxis__custom--DomesticSubsidiariesMember_zYMwwLZy6vQi" title="Basis spread over variable interest rate">2</span>% (the SOFR was <span id="xdx_90D_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20211231__us-gaap--VariableRateAxis__custom--LondonInterbankOfferedRateMember__dei--LegalEntityAxis__custom--DomesticSubsidiariesMember_zIwllRqe60vg" title="Variable rate">0.05</span>% as of December 31, 2021). The line of credit which has
a maturity date of <span id="xdx_908_eus-gaap--LineOfCreditFacilityExpirationDate1_ddpxL_c20210101__20211231__us-gaap--VariableRateAxis__custom--LondonInterbankOfferedRateMember__dei--LegalEntityAxis__custom--DomesticSubsidiariesMember_zi5y8Aw4Cht7" title="::XDX::2022-12-16"><span style="-sec-ix-hidden: xdx2ixbrl1126">December&#160;16, 2022</span></span>, is expected to be renewed on an annual basis. Borrowings outstanding pursuant to lines
of credit were zero as of December 31, 2021 and 2020.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company&#8217;s foreign subsidiaries
have available credit lines, including several bank overdraft facilities totaling approximately $<span id="xdx_903_eus-gaap--LineOfCreditFacilityMaximumBorrowingCapacity_iI_pn6n6_c20211231__dei--LegalEntityAxis__custom--ForeignSubsidiariesMember_zjSaiZ34pJyk">28</span> million. These credit lines
bear interest at EURIBOR plus between <span id="xdx_900_eus-gaap--DebtInstrumentBasisSpreadOnVariableRate1_pid_dp_uPure_c20210101__20211231__us-gaap--VariableRateAxis__custom--EuroInterbankOfferedRateMembeMember__dei--LegalEntityAxis__custom--ForeignSubsidiariesMember__srt--RangeAxis__srt--MinimumMember_zxGu8AsBheC3" title="Basis spread over variable interest rate">0.5</span>% and <span id="xdx_90C_eus-gaap--DebtInstrumentBasisSpreadOnVariableRate1_pid_dp_uPure_c20210101__20211231__us-gaap--VariableRateAxis__custom--EuroInterbankOfferedRateMembeMember__dei--LegalEntityAxis__custom--ForeignSubsidiariesMember__srt--RangeAxis__srt--MaximumMember_zryWJs2OjWO1" title="Basis spread over variable interest rate">0.8</span>% (EURIBOR was minus <span id="xdx_90A_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20211231__us-gaap--VariableRateAxis__custom--EuroInterbankOfferedRateMembeMember__dei--LegalEntityAxis__custom--ForeignSubsidiariesMember_zq65zFAJJ8U7" title="Variable rate">0.570</span>% at December&#160;31, 2021). Borrowings outstanding
pursuant to these bank overdraft facilities were zero as of December 31, 2021 and 2020.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

















<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">As there were no borrowings outstanding
as of December 31, 2021 and 2010, there is no weighted average interest rate on short-term borrowings as of December 31, 2021 and
2020.</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139983555991176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Debt<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtTextBlock', window );">Long-Term Debt</a></td>
<td class="text"><p id="xdx_80A_eus-gaap--LongTermDebtTextBlock_zeDt996wEdyh" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in">(11)</td><td><span id="xdx_82F_z4DbqKVC28r3">Long-Term Debt</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p id="xdx_897_eus-gaap--ScheduleOfDebtInstrumentsTextBlock_zMA0beScaH04" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span id="xdx_8B8_zDtbLqdGeQz3">Long-term debt consists of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 65%; text-align: left; text-indent: -0.125in; padding-left: 0.125in">$<span id="xdx_901_eus-gaap--DebtInstrumentFaceAmount_iI_dm_c20211231__us-gaap--LongtermDebtTypeAxis__us-gaap--LoansPayableMember_zr2GjGBCW5Ni" title="Loan payable (in Dollars)">135.9 million</span> payable in <span id="xdx_902_ecustom--NumberOfInstallment_iI_pid_uN_c20211231__us-gaap--LongtermDebtTypeAxis__us-gaap--LoansPayableMember_z0VjT2MOZQqa" title="Number of installments">120</span> equal monthly installments of $<span id="xdx_904_eus-gaap--DebtInstrumentPeriodicPayment_dm_c20210101__20211231__us-gaap--LongtermDebtTypeAxis__us-gaap--LoansPayableMember_zFFNifrp7ql4" title="Installment amount (in Dollars)">1.1 million</span> beginning in April 2021, bearing interest at one-month Euribor plus <span id="xdx_907_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20211231__us-gaap--LongtermDebtTypeAxis__us-gaap--LoansPayableMember_z8NioIBw61Z2" title="Interest per annum">0.75</span>%</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--LongTermDebt_iI_c20211231__us-gaap--LongtermDebtTypeAxis__us-gaap--LoansPayableMember_zeY3RkgUJ7Z3" style="width: 12%; text-align: right" title="Loan payable">124,375</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--LongTermDebt_iI_c20201231__us-gaap--LongtermDebtTypeAxis__us-gaap--LoansPayableMember_zyOOVGWYqHbf" style="width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1155">&#8212;</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">$<span id="xdx_902_eus-gaap--DebtInstrumentFaceAmount_iI_pn6n6_c20211231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableOneMember_zc7fR9ruMpj7">15</span>.0 million payable in <span id="xdx_90E_ecustom--NumberOfInstallment_iI_pid_uN_c20211231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableOneMember_zls04tXK2V3i" title="Number of installments">14</span> equal annual installments of $<span id="xdx_90A_eus-gaap--DebtInstrumentPeriodicPayment_dm_c20210101__20211231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableOneMember_zIQI3xg3fbsh">1.1 million</span> beginning in January 2020 including interest imputed at <span id="xdx_903_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20211231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableOneMember_z7c1VKEfKJcg">4.1</span>% per annum</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--LongTermDebt_iI_c20211231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableOneMember_zl6ufcRiHPn1" style="text-align: right">10,569</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--LongTermDebt_iI_c20201231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableOneMember_zHLrPGY0Cis4" style="text-align: right">11,208</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">$<span id="xdx_90E_eus-gaap--DebtInstrumentFaceAmount_iI_pn6n6_c20211231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableTwoMember_zjWS3GRRDjOc">17</span> million payable in <span id="xdx_900_ecustom--NumberOfInstallment_iI_pid_uN_c20211231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableTwoMember_zhDrCItdpwMc" title="Number of installments">10</span> equal annual installments of $<span id="xdx_900_eus-gaap--DebtInstrumentPeriodicPayment_dm_c20210101__20211231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableTwoMember_zDQCZr8k366l">1.7 million</span> beginning in October 2021 including interest imputed at <span id="xdx_903_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20211231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableTwoMember_zSXZgXMCuGRa" title="Interest per annum">2.0</span>% per annum</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--LongTermDebt_iI_c20211231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableTwoMember_zwClsCJGC9Ef" style="text-align: right">13,869</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--LongTermDebt_iI_c20201231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableTwoMember_zSb2zFa2pWdg" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1170">&#8212;</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -0.125in; padding-left: 0.125in">$<span id="xdx_903_eus-gaap--DebtInstrumentFaceAmount_iI_dm_c20211231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableThreeMember_zI0tfHx4cvw8">13.4 million</span> term loan amended such that the loan was repaid in February 2021 plus interest at <span id="xdx_90B_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20211231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableThreeMember_zuP7Ddx97nz3" title="Interest per annum">0.85</span>% per annum</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--LongTermDebt_iI_c20211231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableThreeMember_z4H340Co1wo2" style="border-bottom: Black 1pt solid; text-align: right" title="Loan payable"><span style="-sec-ix-hidden: xdx2ixbrl1175">&#8212;</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--LongTermDebt_iI_c20201231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableThreeMember_zJKDQUnLn4J" style="border-bottom: Black 1pt solid; text-align: right">13,498</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -0.125in; padding-left: 0.125in">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--LongTermDebt_iI_c20211231_z0zLZRFstio8" style="text-align: right">148,813</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--LongTermDebt_iI_c20201231_zXol4Mlgb4ie" style="text-align: right">24,706</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -0.125in; padding-left: 0.25in">Less current maturities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--LongTermDebtCurrent_iI_c20211231_zFsrVaCUHeEb" style="border-bottom: Black 1pt solid; text-align: right" title="Less current maturities">15,911</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--LongTermDebtCurrent_iI_dxL_c20201231_zvYm1Uq9Ws7g" style="border-bottom: Black 1pt solid; text-align: right" title="Less current maturities::XDX::14%2C570"><span style="-sec-ix-hidden: xdx2ixbrl1182">14,570</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2pt; text-indent: -0.125in; padding-left: 0.375in">Total</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--LongTermDebtNoncurrent_iI_c20211231_zcAIKG3aVVCb" style="border-bottom: Black 2pt double; text-align: right" title="Total">132,902</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--LongTermDebtNoncurrent_iI_dxL_c20201231_z9kcQMiGz5Lc" style="border-bottom: Black 2pt double; text-align: right" title="::XDX::10%2C136"><span style="-sec-ix-hidden: xdx2ixbrl1185">10,136</span></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
</table>



<p id="xdx_8A5_zaOBx13pgpvg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In April 2021, to finance the
acquisition of Interparfums SA&#8217;s future corporate headquarters, the Company entered into a $<span id="xdx_908_eus-gaap--DebtInstrumentFaceAmount_iI_dm_c20210430__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableOneMember_zwYKmCgVtDg8">135.9 million</span> (&#8364;120 million)
ten-year credit agreement. Approximately $90.6 million (&#8364;80.0 million) of the variable rate debt was swapped for variable
interest rate debt with maximum rate of 2% per annum. The swap is a derivative instrument and is therefore recorded at fair value
and changes in fair value are reflected in the accompanying consolidated statements of income.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Maturities of long-term debt
subsequent to December 31, 2021 are approximately $<span id="xdx_903_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_iI_dm_c20211231_zdiE6pGbH5Bg" title="Long-term Debt, Maturities, 2021">15.9 million</span> in 2022 and $<span id="xdx_903_eus-gaap--LongTermDebtDescription_c20210101__20211231_zwc9NOyQKt6k" title="Long term debt maturity, description">16.4 million per year thereafter through 2033.</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139983558739448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments</a></td>
<td class="text"><p id="xdx_805_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zqgwaM2S2mR7" style="margin-top: 0; margin-bottom: 0"/>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in">(12)</td><td><span id="xdx_825_zyzysgm6ry98">Commitments</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">Leases</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company leases its offices,
warehouses and vehicles, substantially all of which are classified as operating leases. The Company currently has no material financing
leases. The Company determines if an arrangement is a lease at inception. Operating lease assets and obligations are recognized
at the lease commencement date based on the present value of lease payments over the lease term.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In determining lease asset value,
the Company considers fixed or variable payment terms, prepayments, incentives, and options to extend or terminate, depending on
the lease. Renewal, termination or purchase options affect the lease term used for determining lease asset value only if the option
is reasonably certain to be exercised. The Company generally uses its incremental borrowing rate based on information available
at the lease commencement date for the location in which the lease is held in determining the present value of lease payments.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>









<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">As of December 31, 2021, the
weighted average remaining lease term was <span id="xdx_903_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtxL_c20211231_zXr3RXHM8Vid" title="Weighted average remaining lease term::XDX::P6Y1M6D"><span style="-sec-ix-hidden: xdx2ixbrl1199">6.1</span></span> years and the weighted average discount rate used to determine the operating lease
liability was <span id="xdx_902_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_uPure_c20211231_zGGI7ynjqSoe" title="Operating lease, weighted average discount rate">2.5</span>%. Rental expense related to operating leases was $<span id="xdx_90B_eus-gaap--OperatingLeasesRentExpenseNet_dm_c20210101__20211231_zhzkNfylL7uj" title="Operating lease of related to rental expenses">8.2 million</span>, $<span id="xdx_904_eus-gaap--OperatingLeasesRentExpenseNet_dm_c20200101__20201231_zgNOlsvEhs37" title="Operating lease of related to rental expenses">6.2 million</span>, and $<span id="xdx_90F_eus-gaap--OperatingLeasesRentExpenseNet_dm_c20190101__20191231_zN6YTu1GjGah" title="Operating lease of related to rental expenses">7.5 million</span> for the years ended
December 31, 2021, 2020 and 2019, respectively. Operating lease payments included in operating cash flows totaled $<span id="xdx_909_eus-gaap--OperatingLeasePayments_dm_c20210101__20211231_zZKZcRlr63O7" title="Operating lease payments">7.5 million</span>
and noncash additions to operating lease assets totaled $<span id="xdx_902_eus-gaap--OperatingLeaseCost_dm_c20210101__20211231_zNDAhX6tEV49" title="Noncash additions to operating lease assets">12.2 million</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p id="xdx_89E_eus-gaap--ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_zyF9BNIMPeU5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8B0_z8Tw1yW0uR54">Maturities of lease liabilities
subsequent to December&#160;31, 2021 are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">(In thousands)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto">
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 85%; text-align: left"><span style="color: Black">2022</span></td><td style="width: 1%"><span style="color: Black">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="color: Black">$</span></td><td id="xdx_980_eus-gaap--OperatingLeasesFutureMinimumPaymentsDueCurrent_iI_c20211231_zgdKcFRfwmI7" style="width: 12%; text-align: right" title="2022"><span style="color: Black">6,541</span></td><td style="width: 1%; text-align: left"><span style="color: Black">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="color: Black">2023</span></td><td><span style="color: Black">&#160;</span></td>
    <td style="text-align: left"><span style="color: Black">&#160;</span></td><td id="xdx_980_eus-gaap--OperatingLeasesFutureMinimumPaymentsDueInTwoYears_iI_c20211231_zKxxjLn9srP2" style="text-align: right" title="2023"><span style="color: Black">6,776</span></td><td style="text-align: left"><span style="color: Black">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="color: Black">2024</span></td><td><span style="color: Black">&#160;</span></td>
    <td style="text-align: left"><span style="color: Black">&#160;</span></td><td id="xdx_98E_eus-gaap--OperatingLeasesFutureMinimumPaymentsDueInThreeYears_iI_c20211231_zyAnOct969U4" style="text-align: right" title="2024"><span style="color: Black">5,787</span></td><td style="text-align: left"><span style="color: Black">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="color: Black">2025</span></td><td><span style="color: Black">&#160;</span></td>
    <td style="text-align: left"><span style="color: Black">&#160;</span></td><td id="xdx_98B_eus-gaap--OperatingLeasesFutureMinimumPaymentsDueInFourYears_iI_c20211231_zT0E7zKRecuf" style="text-align: right" title="2025"><span style="color: Black">4,704</span></td><td style="text-align: left"><span style="color: Black">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="color: Black">2026</span></td><td><span style="color: Black">&#160;</span></td>
    <td style="text-align: left"><span style="color: Black">&#160;</span></td><td id="xdx_984_eus-gaap--OperatingLeasesFutureMinimumPaymentsDueInFiveYears_iI_c20211231_z1JuVgtQyVeb" style="text-align: right" title="2026"><span style="color: Black">4,087</span></td><td style="text-align: left"><span style="color: Black">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="color: Black">Thereafter</span></td><td style="padding-bottom: 1pt"><span style="color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="color: Black">&#160;</span></td><td id="xdx_987_eus-gaap--OperatingLeasesFutureMinimumPaymentsDueThereafter_iI_c20211231_zxf5qxdhJLQd" style="border-bottom: Black 1pt solid; text-align: right" title="Thereafter"><span style="color: Black">10,017</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="color: Black">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="color: Black">&#160;</span></td><td style="padding-bottom: 1pt"><span style="color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="color: Black">&#160;</span></td><td id="xdx_98E_eus-gaap--OperatingLeasesFutureMinimumPaymentsDue_iI_c20211231_zL7HpyRAvjvg" style="border-bottom: Black 1pt solid; text-align: right" title="Gross Total"><span style="color: Black">37,912</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="color: Black">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in"><span style="color: Black">Less imputed interest (based on 2.5%
    weighted-average discount rate)</span></td><td style="color: #FF0000; padding-bottom: 1pt"><span style="color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; color: #FF0000; text-align: left"><span style="color: Black">&#160;</span></td><td id="xdx_98E_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_di_c20211231_zeZogE6qFnNa" style="border-bottom: Black 1pt solid; color: #FF0000; text-align: right" title="Less imputed interest (based on 3.0% weighted-average discount rate)"><span style="color: Black">(2,679</span></td><td style="padding-bottom: 1pt; color: #FF0000; text-align: left"><span style="color: Black">)</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="color: Black">&#160;</span></td><td style="padding-bottom: 2pt"><span style="color: Black">&#160;</span></td>
    <td style="border-bottom: Black 2pt double; text-align: left"><span style="color: Black">$</span></td><td id="xdx_983_eus-gaap--OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear_iI_c20211231_zIFiIkcyU5ui" style="border-bottom: Black 2pt double; text-align: right" title="Net Total"><span style="color: Black">35,233</span></td><td style="padding-bottom: 2pt; text-align: left"><span style="color: Black">&#160;</span></td></tr>
</table>



<p id="xdx_8AB_zhNpFQ1yxWP6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&#160;</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">License Agreements</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&#160;</p>

<p id="xdx_897_esrt--ContractualObligationFiscalYearMaturityScheduleTableTextBlock_zZ3LS5YZ6ke3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_909_eus-gaap--FiniteLivedIntangibleAssetsIntentOrAbilityToRenewOrExtendArrangement_c20210101__20211231_zG1Kv0UMvD25" title="License agreement, expiration description">The Company is party to a number
of license and other agreements for the use of trademarks and rights in connection with the manufacture and sale of its products
expiring at various dates through 2033.</span> In connection with certain of these license agreements, the Company is subject to minimum
annual advertising commitments, <span id="xdx_8BA_zRoIaXnWGOPf">minimum annual royalties and other commitments as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">(In thousands)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto">
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 85%; text-align: left">2022</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--OtherCommitmentDueInNextTwelveMonths_iI_c20211231_zm45FY8fqk6" style="width: 12%; text-align: right" title="2021">191,422</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">2023</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--OtherCommitmentDueInSecondYear_iI_c20211231_z0dLRXe8E3tk" style="text-align: right" title="2022">206,241</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">2024</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--OtherCommitmentDueInThirdYear_iI_c20211231_zFige0sVO4d6" style="text-align: right" title="2023">202,774</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">2025</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--OtherCommitmentDueInFourthYear_iI_c20211231_zaqJgioDS9k9" style="text-align: right" title="2024">199,770</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">2026</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--OtherCommitmentDueInFifthYear_iI_c20211231_zccCQ2llkBg1" style="text-align: right" title="2025">136,776</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Thereafter</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--OtherCommitmentDueAfterFifthYear_iI_c20211231_zX6A7AQu8all" style="border-bottom: Black 1pt solid; text-align: right" title="Thereafter">702,780</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--OtherCommitment_iI_c20211231_zYIIHzBGGK3" style="border-bottom: Black 2pt double; text-align: right" title="Total">1,639,763</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
</table>



<p id="xdx_8A1_zZwkZ0mXFns" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Future advertising commitments
are estimated based on planned future sales for the license terms that were in effect at December 31, 2021, without consideration
for potential renewal periods. The above figures do not reflect the fact that our distributors share our advertising obligations.
Royalty expense included in selling, general, and administrative expenses, aggregated $<span id="xdx_905_eus-gaap--RoyaltyExpense_dm_c20210101__20211231_zv0zwDjibcWk" title="Royalty expense">69.0 million</span>, $<span id="xdx_902_eus-gaap--RoyaltyExpense_dm_c20200101__20201231_zRA9yVRRt4Ke" title="Royalty expense">41.1 million</span> and $<span id="xdx_90D_eus-gaap--RoyaltyExpense_dm_c20190101__20191231_zNxscyQ0Iszc" title="Royalty expense">53.0 million</span>,
in 2021, 2020 and 2019, respectively, and represented <span id="xdx_906_ecustom--RoyaltyExpenseNetSalesPercentage_pid_dp_uPure_c20210101__20211231_zUsXEeOJLdje" title="Royalty expense, percentage of net sales">7.8</span>%, <span id="xdx_906_ecustom--RoyaltyExpenseNetSalesPercentage_pid_dp_uPure_c20200101__20201231_zr0biWr1Ldh8" title="Royalty expense, percentage of net sales">7.6</span>% and <span id="xdx_90F_ecustom--RoyaltyExpenseNetSalesPercentage_pid_dp_uPure_c20190101__20191231_zlmhlWfFkpe9" title="Royalty expense, percentage of net sales">7.4</span>% of net sales for the years ended December 31, 2021, 2020
and 2019, respectively.</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139983555846312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Equity</a></td>
<td class="text"><p id="xdx_803_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zlyxrfluMVOi" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in">(13)</td><td><span id="xdx_824_zVmjzl1ySt49">Equity</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">Share-Based Payments</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company maintains
a stock option program for key employees, executives and directors. The plans, all of which have been approved by
shareholder vote, provide for the granting of both nonqualified and incentive options. Options granted under the plans
typically have a six-year term and vest over a <span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_dtxL_c20210101__20211231__srt--RangeAxis__srt--MinimumMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zUGDlh0a2WU6" title="Share-based compensation arrangement by share-based payment award, award vesting period::XDX::P4Y"><span style="-sec-ix-hidden: xdx2ixbrl1263">four</span></span>
to <span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_dtxL_c20210101__20211231__srt--RangeAxis__srt--MaximumMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zE2tSj3P95Be" title="Share-based compensation arrangement by share-based payment award, award vesting period::XDX::P5Y"><span style="-sec-ix-hidden: xdx2ixbrl1265">five-year</span></span>
period. The fair value of shares vested aggregated $<span id="xdx_90E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_dm_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zfs2A3ks61kd">1.4
million</span>, $<span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_dm_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zi9jTldEHxY" title="Fair value of shares vested">1.7
million</span> and $<span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_dm_c20190101__20191231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zCCezxtDy292">1.4 million</span> in 2021, 2020 and 2019, respectively. <span style="font-family: Times New Roman, Times, Serif">Compensation
cost, net of estimated forfeitures, is recognized on a straight-line basis over the requisite service period for the
entire award. Forfeitures are estimated based on historic trends. </span>It is generally the Company&#8217;s policy to issue
new shares upon exercise of stock options.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p id="xdx_897_eus-gaap--ScheduleOfNonvestedShareActivityTableTextBlock_z8ZrifFxP0t3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8BC_zMWGswiSqs1h">The following table sets forth
information with respect to nonvested options for 2021:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Number of Shares</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Weighted Average<br/>
 Grant Date<br/>
Fair Value</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">Nonvested options &#8211; beginning of year</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iS_pid_uShares_c20210101__20211231_zvGsbl79ra63" style="width: 15%; text-align: right" title="Nonvested options - beginning of year">353,790</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iS_pid_uUSDPShares_c20210101__20211231_zf4XtRrTRhY1" style="width: 15%; text-align: right" title="Weighted Average Grant Date Fair Value, beginning of year">12.96</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Nonvested options granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_uShares_c20210101__20211231_zbm3MQRNZLj7" style="text-align: right" title="Nonvested options granted">9,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_uUSDPShares_c20210101__20211231_zvj55yTKFDL8" style="text-align: right" title="Weighted Average Grant Date Fair Value, granted">11.35</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Nonvested options vested or forfeited</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_iN_pid_di_uShares_c20210101__20211231_zHoNAdPd7gk1" style="border-bottom: Black 1pt solid; text-align: right" title="Nonvested options vested or forfeited">(153,280</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_pid_uUSDPShares_c20210101__20211231_zaOodMpx1m63" style="text-align: right" title="Weighted Average Grant Date Fair Value, vested or forfeited">12.19</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2pt">Nonvested options &#8211; end of year</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iE_pid_uShares_c20210101__20211231_zfPUrQ8OE2u2" style="border-bottom: Black 2pt double; text-align: right" title="Nonvested options - end of year">209,510</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iE_pid_uUSDPShares_c20210101__20211231_zK1Iv0XltGv5" style="text-align: right" title="Weighted Average Grant Date Fair Value, end of year">13.45</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
</table>

<p id="xdx_8A8_z9G0XLBK20a4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p id="xdx_89D_eus-gaap--ScheduleOfShareBasedCompensationActivityTableTextBlock_zvleNI06rDEk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8BB_zB9k0ntXSjdd">The effect of share-based payment
expenses decreased income statement line items as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year Ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 55%; text-align: left">Income before income taxes</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_c20210101__20211231__us-gaap--IncomeStatementLocationAxis__us-gaap--OperatingIncomeLossMember_zPf8FbwkipRc" style="width: 12%; text-align: right" title="Income before income taxes">2,850</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_c20200101__20201231__us-gaap--IncomeStatementLocationAxis__us-gaap--OperatingIncomeLossMember_zM3RXe1Uzlx5" style="width: 12%; text-align: right">3,030</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_c20190101__20191231__us-gaap--IncomeStatementLocationAxis__us-gaap--OperatingIncomeLossMember_zLGXk9Bchomf" style="width: 12%; text-align: right">3,390</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Net income attributable to Inter Parfums, Inc.</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--NetIncomeLoss_c20210101__20211231__us-gaap--IncomeStatementLocationAxis__us-gaap--OperatingIncomeLossMember_zio92kKlNDG1" style="text-align: right" title="Net income attributable to Inter Parfums, Inc.">1,880</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--NetIncomeLoss_c20200101__20201231__us-gaap--IncomeStatementLocationAxis__us-gaap--OperatingIncomeLossMember_zk1fIhwSyAQ8" style="text-align: right">2,040</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--NetIncomeLoss_c20190101__20191231__us-gaap--IncomeStatementLocationAxis__us-gaap--OperatingIncomeLossMember_znsBRLKCuWb5" style="text-align: right">2,060</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Diluted earnings per share attributable to Inter Parfums, Inc.</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--EarningsPerShareDiluted_pid_uUSDPShares_c20210101__20211231__us-gaap--IncomeStatementLocationAxis__us-gaap--OperatingIncomeLossMember_zxDcEGuXrfEg" style="text-align: right" title="Diluted earnings per share attributable to Inter Parfums, Inc">0.06</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--EarningsPerShareDiluted_pid_uUSDPShares_c20200101__20201231__us-gaap--IncomeStatementLocationAxis__us-gaap--OperatingIncomeLossMember_zRLGYRITWUa" style="text-align: right">0.06</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--EarningsPerShareDiluted_pid_uUSDPShares_c20190101__20191231__us-gaap--IncomeStatementLocationAxis__us-gaap--OperatingIncomeLossMember_zBLJMsKKNzV8" style="text-align: right">0.07</td><td style="text-align: left">&#160;</td></tr>
</table>


<p id="xdx_8AE_z0DOdvvSAml7" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p id="xdx_89E_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zDcEFm9k7uh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8B8_zD54LK3lVHI8">The following table summarizes stock option activity and related information for the years ended December 31, 2021, 2020 and
2019:</span></p>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="22" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Options</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Weighted</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Average</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Exercise</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Price</b></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Options</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Weighted</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Average</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Exercise</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Price</b></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Options</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Weighted</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Average</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Exercise</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Price</b></p></td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 28%; text-align: left; text-indent: -0.125in; padding-left: 0.125in">Shares under option - beginning of year</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_uShares_c20210101__20211231_zA8543b6APh9" style="width: 9%; text-align: right" title="Options shares under option - beginning of year">713,210</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_uUSDPShares_c20210101__20211231_zC8vapGuY9i" style="width: 9%; text-align: right" title="Weighted average exercise price shares under option - beginning of year">52.74</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_uShares_c20200101__20201231_z5u6iR8WYkrl" style="width: 9%; text-align: right">815,800</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_uUSDPShares_c20200101__20201231_zcP0CPxAKP8j" style="width: 9%; text-align: right">49.89</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_uShares_c20190101__20191231_zU6ybomZKya4" style="width: 9%; text-align: right">776,171</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_uUSDPShares_c20190101__20191231_zUrKgGW5UtFl" style="width: 9%; text-align: right">41.33</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Options granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_uShares_c20210101__20211231_zWaGWhA3y089" style="text-align: right" title="Options granted">9,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_uUSDPShares_c20210101__20211231_ztWooTqug7se" style="text-align: right" title="Weighted average exercise price options granted">62.18</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_uShares_c20200101__20201231_zdZYrk8MSQec" style="text-align: right" title="Options granted">9,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_uUSDPShares_c20200101__20201231_zcTcxSHfjHQe" style="text-align: right">69.11</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_uShares_c20190101__20191231_zwbAPKXMgHzb" style="text-align: right" title="Options granted">194,050</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_uUSDPShares_c20190101__20191231_zWRSpCGy5fB4" style="text-align: right">72.89</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Options exercised</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pid_di_uShares_c20210101__20211231_z8jozSWC3XAb" style="text-align: right" title="Options exercised">(156,490</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_uUSDPShares_c20210101__20211231_zn6fcE5Pg9Hj" style="text-align: right" title="Weighted average exercise price options exercised">34.46</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pid_di_uShares_c20200101__20201231_zKMFxZ3Jpyx" style="text-align: right" title="Options exercised">(95,570</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_uUSDPShares_c20200101__20201231_zt5HTMbsLwL2" style="text-align: right">28.99</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pid_di_uShares_c20190101__20191231_z2UEaolQPkd8" style="text-align: right" title="Options exercised">(130,891</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_uUSDPShares_c20190101__20191231_zUqWAhlDcou9" style="text-align: right">34.06</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -0.125in; padding-left: 0.125in">Options forfeited</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_pid_di_uShares_c20210101__20211231_z0823ZeqZ2A6" style="border-bottom: Black 1pt solid; text-align: right" title="Options forfeited">(40,820</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_uUSDPShares_c20210101__20211231_zgN5rdvufK9b" style="text-align: right" title="Weighted average exercise price options forfeited">62.57</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_pid_di_uShares_c20200101__20201231_zzKTz6JvbIZc" style="border-bottom: Black 1pt solid; text-align: right" title="Options forfeited">(16,020</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_uUSDPShares_c20200101__20201231_zjEgBkjyNEn1" style="text-align: right">58.38</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_pid_di_uShares_c20190101__20191231_zZTaSwGKkgOd" style="border-bottom: Black 1pt solid; text-align: right" title="Options forfeited">(23,530</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_uUSDPShares_c20190101__20191231_zyiZ3TVFZLNk" style="text-align: right">45.48</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2pt; text-indent: -0.125in; padding-left: 0.125in">Shares under option - end of year</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_uShares_c20210101__20211231_zLmY6iaWJ20g" style="border-bottom: Black 2pt double; text-align: right" title="Options shares under option - end of year">524,900</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_uUSDPShares_c20210101__20211231_zVLAtyPYEs4j" style="text-align: right" title="Weighted average exercise price shares under option - end of year">57.58</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_uShares_c20200101__20201231_zB9SYPBYrZPg" style="border-bottom: Black 2pt double; text-align: right">713,210</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_uUSDPShares_c20200101__20201231_zuA5T05mo1V9" style="text-align: right">52.74</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_uShares_c20190101__20191231_zHnm84lXJmT" style="border-bottom: Black 2pt double; text-align: right">815,800</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_uUSDPShares_c20190101__20191231_zkHyldwmhiGg" style="text-align: right">49.89</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
</table>

<p id="xdx_8AB_zhbOaxUnAgCa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>









<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">At December 31, 2021, options
for <span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_pid_uShares_c20211231__us-gaap--DebtInstrumentAxis__us-gaap--StockOptionMember_zmZy7NvXvfW3" title="Number of shares available for grant (in Shares)">612,535</span> shares were available for future grant under the plans. The aggregate intrinsic value of options outstanding is $<span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_dm_c20211231__us-gaap--DebtInstrumentAxis__us-gaap--StockOptionMember_zQUIKP2LH6u1" title="Aggregate intrinsic value of options outstanding">25.9
million</span> as of December 31, 2021 and unrecognized compensation cost related to stock options outstanding aggregated $<span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_dm_c20211231__us-gaap--DebtInstrumentAxis__custom--StockOptionOneMember_zy9caq77DwYb" title="Aggregate intrinsic value of options outstanding">2.9 million</span>,
which will be recognized over the next <span id="xdx_90F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_dxL_c20210101__20211231__us-gaap--DebtInstrumentAxis__us-gaap--StockOptionMember_z2LEBgvlwLGi" title="Term::XDX::P5Y"><span style="-sec-ix-hidden: xdx2ixbrl1362">five years</span></span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The weighted average fair values
of options granted by Inter Parfums, Inc. during 2021, 2020 and 2019 were $<span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z9ZXJRC5TbIl" title="Weighted average grant date fair value (in Dollars per share)">11.35</span>, $<span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z0o2Go7rFK5h" title="Weighted average grant date fair value (in Dollars per share)">12.16</span> and $<span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20190101__20191231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_ztP81MAKJyY9" title="Weighted average grant date fair value (in Dollars per share)">14.14</span> per share, respectively, on
the date of grant using the Black-Scholes option pricing model to calculate the fair value.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p id="xdx_894_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zojQBpKqAPSe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8B8_zqp2yAmXZsBb">The assumptions used in the Black-Scholes
pricing model are set forth in the following table:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_494_20210101__20211231_zAj1yLhUcnl6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_498_20200101__20201231_zvfM12Hn0mB7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_498_20190101__20191231_zWvzMZGTPlzj" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year Ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr id="xdx_40E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pii_dp_uPure_zJuwuMc5Ckni" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 55%; text-align: left">Weighted-average expected stock-price volatility</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">25</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">25</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">25</td><td style="width: 1%; text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Weighted-average expected option life</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dxL_c20210101__20211231_zn4UR0StrNI4" style="text-align: right" title="Weighted-average expected option life::XDX::P5Y"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1376">5.0 years</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dxL_c20200101__20201231_zJXLlFaOMDM7" style="text-align: right" title="Weighted-average expected option life::XDX::P5Y"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1378">5.0 years</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtxL_c20190101__20191231_zI1qfZ5JrH9l" style="text-align: right" title="Weighted-average expected option life::XDX::P5Y"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1380">5.0 years</span></span></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pii_dp_uPure_zX0zKk2ffFX8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Weighted-average risk-free interest rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.4</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1.4</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1.7</td><td style="text-align: left">%</td></tr>
<tr id="xdx_400_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pii_dp_uPure_z7juvhVvP4ri" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Weighted-average dividend yield</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1.6</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2.5</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2.0</td><td style="text-align: left">%</td></tr>
</table>

<p id="xdx_8A3_z4RQRU2Koug" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Expected volatility is estimated
based on historic volatility of the Company&#8217;s common stock. The expected term of the option is estimated based on historic
data. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of the grant of the option and the dividend
yield reflects the assumption that the dividend payout as authorized by the Board of Directors would maintain its current payout
ratio as a percentage of earnings.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p id="xdx_897_eus-gaap--CashProceedsReceivedAndTaxBenefitFromShareBasedPaymentAwardsTableTextBlock_zk2DUKzD1fS5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8BA_zJjz1GHhyJ9h">Proceeds, tax benefits and intrinsic
value related to stock options exercised were as follows</span>:<span style="font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_49C_20210101__20211231_zIBswFHmbfIg" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_498_20200101__20201231_zRtiSmREtAr9" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td colspan="3" id="xdx_49C_20190101__20191231_zMnqljIvkn5e" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year Ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr id="xdx_40B_eus-gaap--ProceedsFromStockOptionsExercised_z6Rw9FEBmt6h" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 55%; text-align: left; text-indent: -8.1pt; padding-left: 8.1pt">Proceeds from stock options exercised</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">5,393</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">2,771</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">4,458</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_406_eus-gaap--DeferredTaxExpenseFromStockOptionsExercised_zBKEGaJCuyba" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Tax benefits</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1,300</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">400</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">690</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_409_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_zQ1YtC1ZC4T5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Intrinsic value of stock options exercised</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">7,800</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">2,873</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">4,520</td><td style="text-align: left">&#160;</td></tr>
</table>

<p id="xdx_8AF_zJo8QVZzWam8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>INTER PARFUMS, INC. AND SUBSIDIARIES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Notes to Consolidated Financial Statements</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">December 31, 2021, 2020 and 2019</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(In thousands except share and per share data)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p id="xdx_89D_eus-gaap--ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_z2AzDnAS4v3g" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8B3_zD7zIDewqjl9">The following table summarizes
additional stock option information as of December&#160;31, 2021:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Exercise prices</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Options<br/> outstanding</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Options outstanding<br/> weighted average remaining<br/> contractual life</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Options<br/> exercisable</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 25%; text-align: center">&#160;$<span id="xdx_904_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20211231__srt--RangeAxis__srt--MinimumMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_z0SmNLp1UKW8">32.83</span> - $<span id="xdx_90C_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20211231__srt--RangeAxis__srt--MaximumMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zxkEFLWonQRc" title="Exercise price range (in Dollars per share)">33.95</span>&#160;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_uShares_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zghQWgYFZpQ4" style="width: 15%; text-align: right" title="Options outstanding">81,190</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 32%; text-align: center"><span id="xdx_907_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtxL_c20210101__20211231__srt--RangeAxis__srt--MaximumMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zbT0vgHJK6z3" title="Options outstanding weighted average remaining contractual life::XDX::P0Y11M12D"><span style="-sec-ix-hidden: xdx2ixbrl1411">0.99</span></span> years</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_uShares_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zq3UMvD8Cs77" style="width: 15%; text-align: right" title="Options exercisable">81,190</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">&#160;$<span id="xdx_901_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20211231__srt--RangeAxis__srt--MinimumMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zSK2Hc2JHOs5">40.15</span> - $<span id="xdx_90B_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20211231__srt--RangeAxis__srt--MaximumMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_zZl4qG4E9RKk">46.90</span>&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_uShares_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zo23alIyc0ei" style="text-align: right">123,130</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center"><span id="xdx_90D_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtxL_c20210101__20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zGo3mr7UDwb2" title="::XDX::P1Y11M8D"><span style="-sec-ix-hidden: xdx2ixbrl1417">1.94</span></span> years</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_uShares_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zrOVZVdmeJVf" style="text-align: right">90,790</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center">&#160;$<span id="xdx_90B_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20211231__srt--RangeAxis__srt--MinimumMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_z7PS3EwbWBze">65.18</span> - $<span id="xdx_901_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20211231__srt--RangeAxis__srt--MaximumMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_z5DcuTr6jQOk">69.11</span>&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_uShares_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_z0rt4wLXWj34" style="text-align: right">164,940</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center"><span id="xdx_901_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtxL_c20210101__20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_zGFPaLhucRG9" title="::XDX::P3Y0M11D"><span style="-sec-ix-hidden: xdx2ixbrl1422">3.03</span></span> years</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_uShares_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_zJm6RHjgp7t7" style="text-align: right">84,790</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">$<span id="xdx_90B_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_z1viWAr5GRFa">73.09</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_uShares_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_zuMRwU8NixE8" style="border-bottom: Black 1pt solid; text-align: right">155,640</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1pt"><span id="xdx_906_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtxL_c20210101__20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_zabrABTe8d59" title="::XDX::P4Y0M0D"><span style="-sec-ix-hidden: xdx2ixbrl1426">4.00</span></span> years</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_uShares_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_zq5xHhHAiRNd" style="border-bottom: Black 1pt solid; text-align: right">58,620</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center">&#160;Totals&#160;</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_uShares_c20211231_zZWPcpK3imjl" style="border-bottom: Black 2pt double; text-align: right">524,900</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 2pt"><span id="xdx_907_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtxL_c20210101__20211231_z43En5xnVYij" title="::XDX::P2Y9M0D"><span style="-sec-ix-hidden: xdx2ixbrl1429">2.75</span></span> years</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_uShares_c20211231_zoOydnZgWk87" style="border-bottom: Black 2pt double; text-align: right">315,390</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
</table>



<p id="xdx_8A8_zfHmFJMSTkk5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">As of December 31, 2021, the
weighted average exercise price of options exercisable was $52.23 and the weighted average remaining contractual life of options
exercisable is 2.35 years. The aggregate intrinsic value of options exercisable at December 31, 2021 is $17.2 million.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In December 2018, Interparfums
SA approved a plan to grant an aggregate of <span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_iI_pid_c20181231__srt--ConsolidatedEntitiesAxis__custom--InterparfumsSASubsidiaryMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_zmeIjpsfFm22" title="Adjusted for stock splits (in Shares)">26,600</span> shares of its stock to employees with no performance condition requirement,
and an aggregate of <span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_pid_c20181231__srt--ConsolidatedEntitiesAxis__custom--InterparfumsSASubsidiaryMember__srt--TitleOfIndividualAxis__custom--OfficersAndManagersMember_zFYVOvSAnHy9" title="Aggregate intrinsic value of options outstanding">133,000</span> shares to officers and managers, subject to certain corporate performance conditions. The shares, subject
to adjustment for stock splits, will be distributed in June 2022.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In March 2020, <span id="xdx_900_ecustom--Covid19Description_c20200301__20200331_z6z0qEPsMxh9" title="Covid 19, description">due to the potential
impact on future net sales and operating results resulting from the COVID-19 pandemic, the estimated number of shares to be distributed,
after forfeited shares, was reduced from&#160;142,571&#160;to&#160;82,162. As the Company had already purchased shares in contemplation
of the higher anticipated distribution, shares purchased in excess of the reduced anticipated distribution were transferred to
treasury shares at the Interparfums SA level.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The fair value of the grant had
been determined based on the quoted stock price of Interparfums SA shares as reported by the NYSE Euronext on the date of grant.&#160;<span id="xdx_90E_ecustom--RevaluationResultedInReductionOfCostDescription_c20200101__20200331__srt--OwnershipAxis__custom--InterparfumsSASubsidiaryMember_z9QGz33uRcDa" title="Revaluation resulted in reduction of cost, description">The
original cost of the grant was approximately $4.4&#160;million, and the March 2020 revaluation resulted in a reduction of the cost,
to approximately $2.5 million.&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In June 2020, the performance
conditions were modified affecting 96 employees. As of December 31, 2021, the number of shares to be distributed, after forfeited
shares, increased to&#160;<span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_iI_pid_c20211231__srt--OwnershipAxis__custom--InterparfumsSASubsidiaryMember_zU6v2gsi8Bo3" title="Adjusted for stock splits (in Shares)">172,343</span>. The increase in shares anticipated to be distributed were transferred from treasury shares at
the Interparfums SA level. The modification resulted in a revised cost of the grant to approximately $<span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost_dm_c20210101__20211231__srt--OwnershipAxis__custom--InterparfumsSASubsidiaryMember_zNxJlL9c4Lw7" title="Modification resulted revised cost">4.6 million</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In order to avoid dilution of
the Company&#8217;s ownership of Interparfums SA, all shares distributed or to be distributed pursuant to these plans are pre-existing
shares of Interparfums SA, purchased in the open market by Interparfums SA.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">All share purchases and issuances
have been classified as equity transactions on the accompanying balance sheet.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">Dividends</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In October 2019, our Board of
Directors authorized a <span id="xdx_90B_ecustom--PercentageOfIncreaseInAnnualDividend_pid_dp_c20191001__20191031_ztVsbdUeAaGk" title="Percentage of increase in annual dividend">20</span>% increase in the annual dividend to $<span id="xdx_90F_eus-gaap--DividendsPayableAmountPerShare_iI_pid_c20191031_zxw6vw9fs8a1">1.32</span> per share on an annual basis. In April 2020, as a result of
the uncertainties raised by the COVID-19 pandemic, the Board of Directors authorized a temporary suspension of the annual cash
dividend. In February 2021, the Board of Directors authorized a reinstatement of an annual dividend of $1.00 payable quarterly.
In February 2022, the Board of Directors authorized a 100% increase in the annual dividend to $<span id="xdx_907_eus-gaap--DividendsPayableAmountPerShare_iI_pid_c20210228__srt--TitleOfIndividualAxis__srt--BoardOfDirectorsChairmanMember_zb9fHsHC1Kq1" title="Dividends payable, amount per share (in Dollars per share)">2.00</span> per share. The next quarterly
cash dividend of $<span id="xdx_90B_eus-gaap--DividendsPayableAmountPerShare_iI_pid_c20220331__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zouOfKzEDI9d" title="Dividends payable, amount per share (in Dollars per share)">0.50</span> per share is payable on March 31, 2022 to shareholders of record on March 15, 2022.</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139983555887240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income Attributable to Inter Parfums, Inc. Common Shareholders<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Net Income Attributable to Inter Parfums, Inc. Common Shareholders</a></td>
<td class="text"><p id="xdx_800_eus-gaap--EarningsPerShareTextBlock_zpFzO0SNYxZj" style="margin-top: 0; margin-bottom: 0"/>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"><b>(14)</b></td><td style="text-align: justify"><b><span id="xdx_82B_zJMHuSWwwFd5">Net Income Attributable to Inter Parfums, Inc. Common Shareholders</span></b></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Net income attributable to Inter
Parfums, Inc. per common share (&#8220;basic EPS&#8221;) is computed by dividing net income attributable to Inter Parfums, Inc.
by the weighted average number of shares outstanding.&#160;Net income attributable to Inter Parfums, Inc. per share assuming dilution
(&#8220;diluted EPS&#8221;), is computed using the weighted average number of shares outstanding, plus the incremental shares outstanding
assuming the exercise of dilutive stock options using the treasury stock method.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p id="xdx_89D_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zlJjlIepIwr5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8BA_zfyefk7NQKP4">The reconciliation between the
numerators and denominators of the basic and diluted EPS computations is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 55%; text-align: left; padding-bottom: 2pt; padding-left: 0.125in; text-indent: -0.125in">Numerator for diluted earnings per share</td><td style="width: 1%; padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--NetIncomeLoss_c20210101__20211231_zEWwdTlz5Vt2" style="border-bottom: Black 2pt double; width: 12%; text-align: right" title="Numerator for diluted earnings per share (in Dollars)">87,411</td><td style="width: 1%; padding-bottom: 2pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--NetIncomeLoss_c20200101__20201231_zNxMkoLkjqxj" style="border-bottom: Black 2pt double; width: 12%; text-align: right">38,219</td><td style="width: 1%; padding-bottom: 2pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--NetIncomeLoss_c20190101__20191231_zDE6DZYY3Mae" style="border-bottom: Black 2pt double; width: 12%; text-align: right">60,249</td><td style="width: 1%; padding-bottom: 2pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in">Denominator:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in">Weighted average shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20210101__20211231_z3w9K3ErW8cl" style="text-align: right" title="Weighted average shares">31,676,796</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20200101__20201231_zno5RniMDrQ6" style="text-align: right">31,536,659</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20190101__20191231_zENCLkBFGux6" style="text-align: right">31,451,093</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Effect of dilutive securities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.375in; text-indent: -0.125in">Stock options</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pid_c20210101__20211231_z92ryuDbpvDg" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Number Diluted Shares Outstanding Adjustment">158,612</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pid_c20200101__20201231_zLjAwq7ESuw6" style="border-bottom: Black 1pt solid; text-align: right">117,885</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pid_c20190101__20191231_zkH1TMDFadK7" style="border-bottom: Black 1pt solid; text-align: right">237,607</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2pt; padding-left: 0.125in; text-indent: -0.125in">Denominator for diluted earnings per share</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20210101__20211231_zhHhLvmWNm7k" style="border-bottom: Black 2pt double; text-align: right" title="Denominator for diluted earnings per share">31,835,408</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20200101__20201231_zaHD7YnDhgK" style="border-bottom: Black 2pt double; text-align: right">31,654,544</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20190101__20191231_zFHcdezmXLJ9" style="border-bottom: Black 2pt double; text-align: right">31,688,700</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">Earnings per share:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Net income attributable to Inter Parfums, Inc. common shareholders:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.5in; text-indent: -0.125in">Basic</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--EarningsPerShareBasic_pid_uUSDPShares_c20210101__20211231_zOAESjXbsdb" style="text-align: right" title="Basic (in Dollars per share)">2.76</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--EarningsPerShareBasic_pid_uUSDPShares_c20200101__20201231_zYb8TsiOd9sh" style="text-align: right">1.21</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--EarningsPerShareBasic_pid_uUSDPShares_c20190101__20191231_ztYCFe9bVaud" style="text-align: right">1.92</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.5in; text-indent: -0.125in">Diluted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--EarningsPerShareDiluted_pid_uUSDPShares_c20210101__20211231_zwl2wHaUR5d5" style="text-align: right" title="Diluted (in Dollars per share)">2.75</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--EarningsPerShareDiluted_pid_uUSDPShares_c20200101__20201231_zugRmgPcyZuh" style="text-align: right">1.21</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--EarningsPerShareDiluted_pid_uUSDPShares_c20190101__20191231_zqFshltCql7" style="text-align: right">1.90</td><td style="text-align: left">&#160;</td></tr>
</table>



<p id="xdx_8A9_z9egu375NYqk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Not included in the above computations
is the effect of anti-dilutive potential common shares, which consist of outstanding options to purchase <span id="xdx_901_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210101__20211231_zOBp8fkF9WTe" title="Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount">175,000</span>, <span id="xdx_904_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20200101__20201231_z2DnMDmdyJ4j">450,000</span>, and
<span id="xdx_90E_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20190101__20191231_zT5RFzadOjRc">183,000</span> shares of common stock for 2021, 2020, and 2019, respectively.</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139983555911352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segments and Geographic Areas<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segments and Geographic Areas</a></td>
<td class="text"><p id="xdx_809_eus-gaap--SegmentReportingDisclosureTextBlock_zTDjhJtKdnf" style="margin-top: 0; margin-bottom: 0"/>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"><b>(15)</b></td><td style="text-align: justify"><b><span id="xdx_82F_zfV26WYAai8k">Segments and Geographic Areas</span></b></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company <span style="font-family: Times New Roman, Times, Serif">manufactures
and distributes one product line, fragrances and fragrance related products. The Company</span> manages its business in two segments,
European based operations and United States based operations. The European assets are located, and operations are primarily conducted,
in France. Both European and United States operations primarily represent the sale of prestige brand name fragrances.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>INTER PARFUMS, INC. AND SUBSIDIARIES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Notes to Consolidated Financial Statements</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">December 31, 2021, 2020 and 2019</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(In thousands except share and per share data)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p id="xdx_899_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_zxd4NvECI4qf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span><span id="xdx_8B5_zkDY8ZZkiM0h">Information on the Company&#8217;s
operations by segments is as follows:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="visibility: visible; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; visibility: visible; font-weight: bold; text-align: center">Year ended December 31,</td><td style="visibility: visible; padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="visibility: visible; vertical-align: bottom">
    <td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; visibility: visible; font-weight: bold; text-align: center">2021</td><td style="visibility: visible; padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="visibility: visible; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; visibility: visible; font-weight: bold; text-align: center">2020</td><td style="visibility: visible; padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="visibility: visible; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; visibility: visible; font-weight: bold; text-align: center">2019</td><td style="visibility: visible; padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="visibility: visible; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="visibility: visible; text-align: left">Net sales:</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible; text-align: right">&#160;</td><td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible; text-align: right">&#160;</td><td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible; text-align: right">&#160;</td><td style="visibility: visible; text-align: left">&#160;</td></tr>
<tr style="visibility: visible; vertical-align: bottom; background-color: White">
    <td style="visibility: visible; width: 55%; text-align: left">&#160;&#160;&#160;&#160;United States</td><td style="visibility: visible; width: 1%">&#160;</td>
    <td style="visibility: visible; width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20210101__20211231__srt--StatementGeographicalAxis__country--US_z5r4PcNAeks3" style="visibility: visible; width: 12%; text-align: right">216,559</td><td style="visibility: visible; width: 1%; text-align: left">&#160;</td><td style="visibility: visible; width: 1%">&#160;</td>
    <td style="visibility: visible; width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20200101__20201231__srt--StatementGeographicalAxis__country--US_zCfrzosskOG7" style="visibility: visible; width: 12%; text-align: right">117,489</td><td style="visibility: visible; width: 1%; text-align: left">&#160;</td><td style="visibility: visible; width: 1%">&#160;</td>
    <td style="visibility: visible; width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20190101__20191231__srt--StatementGeographicalAxis__country--US_zWIdVteHZ4Hi" style="visibility: visible; width: 12%; text-align: right">173,522</td><td style="visibility: visible; width: 1%; text-align: left">&#160;</td></tr>
<tr style="visibility: visible; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="visibility: visible; text-align: left">&#160;&#160;&#160;&#160;Europe</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20210101__20211231__srt--StatementGeographicalAxis__srt--EuropeMember_zmO13RpnEfAk" style="visibility: visible; text-align: right">663,290</td><td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20200101__20201231__srt--StatementGeographicalAxis__srt--EuropeMember_ztyL8g0DCNCg" style="visibility: visible; text-align: right">422,947</td><td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20190101__20191231__srt--StatementGeographicalAxis__srt--EuropeMember_ztcgUX0XX4o3" style="visibility: visible; text-align: right">542,226</td><td style="visibility: visible; text-align: left">&#160;</td></tr>
<tr style="visibility: visible; vertical-align: bottom; background-color: White">
    <td style="visibility: visible; text-align: left; padding-bottom: 1pt">&#160;&#160;&#160;&#160;Eliminations of intercompany sales</td><td style="visibility: visible; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; visibility: visible; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20210101__20211231__srt--StatementGeographicalAxis__custom--EliminationsMember_zwlEf11aFZM2" style="border-bottom: Black 1pt solid; visibility: visible; text-align: right">(333</td><td style="visibility: visible; padding-bottom: 1pt; text-align: left">)</td><td style="visibility: visible; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; visibility: visible; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20200101__20201231__srt--StatementGeographicalAxis__custom--EliminationsMember_z5ym2Cf1wVOj" style="border-bottom: Black 1pt solid; visibility: visible; text-align: right">(1,427</td><td style="visibility: visible; padding-bottom: 1pt; text-align: left">)</td><td style="visibility: visible; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; visibility: visible; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20190101__20191231__srt--StatementGeographicalAxis__custom--EliminationsMember_zicOjvimpE4k" style="border-bottom: Black 1pt solid; visibility: visible; text-align: right">(2,234</td><td style="visibility: visible; padding-bottom: 1pt; text-align: left">)</td></tr>
<tr style="visibility: visible; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="visibility: visible; text-align: left; padding-bottom: 2pt">&#160;</td><td style="visibility: visible; padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; visibility: visible; text-align: left">$</td><td id="xdx_988_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20210101__20211231_zjyV2OjP8sa3" style="border-bottom: Black 2pt double; visibility: visible; text-align: right">879,516</td><td style="visibility: visible; padding-bottom: 2pt; text-align: left">&#160;</td><td style="visibility: visible; padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; visibility: visible; text-align: left">$</td><td id="xdx_98C_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20200101__20201231_zeUtsjBlkcec" style="border-bottom: Black 2pt double; visibility: visible; text-align: right">539,009</td><td style="visibility: visible; padding-bottom: 2pt; text-align: left">&#160;</td><td style="visibility: visible; padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; visibility: visible; text-align: left">$</td><td id="xdx_984_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_dxL_c20200101__20201231_zrpOASipOcL" style="border-bottom: Black 2pt double; visibility: visible; text-align: right" title="::XDX::539%2C009"><span style="-sec-ix-hidden: xdx2ixbrl1497">713,514</span></td><td style="visibility: visible; padding-bottom: 2pt; text-align: left">&#160;</td></tr>
<tr style="visibility: visible; vertical-align: bottom; background-color: White">
    <td style="visibility: visible; text-align: left">Net income attributable to Inter Parfums, Inc.:</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible; text-align: right">&#160;</td><td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible; text-align: right">&#160;</td><td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible; text-align: right">&#160;</td><td style="visibility: visible; text-align: left">&#160;</td></tr>
<tr style="visibility: visible; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="visibility: visible; text-align: left">&#160;&#160;&#160;&#160;United States</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">$</td><td id="xdx_982_eus-gaap--NetIncomeLoss_c20210101__20211231__srt--StatementGeographicalAxis__country--US_zJrsX1vBTKh1" style="visibility: visible; text-align: right">29,359</td><td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">$</td><td id="xdx_986_eus-gaap--NetIncomeLoss_c20200101__20201231__srt--StatementGeographicalAxis__country--US_zukMU1UqRBab" style="visibility: visible; text-align: right">7,942</td><td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">$</td><td id="xdx_98D_eus-gaap--NetIncomeLoss_c20190101__20191231__srt--StatementGeographicalAxis__country--US_zfoS7lQBSpQ7" style="visibility: visible; text-align: right">19,365</td><td style="visibility: visible; text-align: left">&#160;</td></tr>
<tr style="visibility: visible; vertical-align: bottom; background-color: White">
    <td style="visibility: visible; text-align: left">&#160;&#160;&#160;&#160;Europe</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--NetIncomeLoss_c20210101__20211231__srt--StatementGeographicalAxis__srt--EuropeMember_z5kifDjPeta6" style="visibility: visible; text-align: right">57,869</td><td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--NetIncomeLoss_c20200101__20201231__srt--StatementGeographicalAxis__srt--EuropeMember_zytAdG8vtrri" style="visibility: visible; text-align: right">30,241</td><td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--NetIncomeLoss_c20190101__20191231__srt--StatementGeographicalAxis__srt--EuropeMember_ztQNOn4IdHg8" style="visibility: visible; text-align: right">40,840</td><td style="visibility: visible; text-align: left">&#160;</td></tr>
<tr style="visibility: visible; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="visibility: visible; text-align: left; padding-bottom: 1pt">&#160;&#160;&#160;&#160;Eliminations</td><td style="visibility: visible; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; visibility: visible; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--NetIncomeLoss_c20210101__20211231__srt--StatementGeographicalAxis__custom--EliminationsMember_zg9MaKYb0dsc" style="border-bottom: Black 1pt solid; visibility: visible; text-align: right">183</td><td style="visibility: visible; padding-bottom: 1pt; text-align: left">&#160;</td><td style="visibility: visible; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; visibility: visible; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--NetIncomeLoss_c20200101__20201231__srt--StatementGeographicalAxis__custom--EliminationsMember_zNVbvBEIifob" style="border-bottom: Black 1pt solid; visibility: visible; text-align: right">36</td><td style="visibility: visible; padding-bottom: 1pt; text-align: left">&#160;</td><td style="visibility: visible; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; visibility: visible; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--NetIncomeLoss_c20190101__20191231__srt--StatementGeographicalAxis__custom--EliminationsMember_zykwKqHurgGd" style="border-bottom: Black 1pt solid; visibility: visible; text-align: right">44</td><td style="visibility: visible; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="visibility: visible; vertical-align: bottom; background-color: White">
    <td style="visibility: visible; text-align: left; padding-bottom: 2pt">&#160;</td><td style="visibility: visible; padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; visibility: visible; text-align: left">$</td><td id="xdx_981_eus-gaap--NetIncomeLoss_c20210101__20211231_znQ0YUnY32X3" style="border-bottom: Black 2pt double; visibility: visible; text-align: right">87,411</td><td style="visibility: visible; padding-bottom: 2pt; text-align: left">&#160;</td><td style="visibility: visible; padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; visibility: visible; text-align: left">$</td><td id="xdx_986_eus-gaap--NetIncomeLoss_c20200101__20201231_zyP62IcvJVSh" style="border-bottom: Black 2pt double; visibility: visible; text-align: right">38,219</td><td style="visibility: visible; padding-bottom: 2pt; text-align: left">&#160;</td><td style="visibility: visible; padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; visibility: visible; text-align: left">$</td><td id="xdx_98B_eus-gaap--NetIncomeLoss_c20190101__20191231_z997kfuIqlMf" style="border-bottom: Black 2pt double; visibility: visible; text-align: right">60,249</td><td style="visibility: visible; padding-bottom: 2pt; text-align: left">&#160;</td></tr>
<tr style="visibility: visible; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="visibility: visible; text-align: left; text-indent: -7.75pt; padding-left: 7.75pt">Depreciation and amortization expense including impairment loss:</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible; text-align: right">&#160;</td><td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible; text-align: right">&#160;</td><td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible; text-align: right">&#160;</td><td style="visibility: visible; text-align: left">&#160;</td></tr>
<tr style="visibility: visible; vertical-align: bottom; background-color: White">
    <td style="visibility: visible; text-align: left">&#160;&#160;&#160;&#160;United States</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">$</td><td id="xdx_98C_eus-gaap--DepreciationAndAmortization_c20210101__20211231__srt--StatementGeographicalAxis__country--US_zkF7xuK0rol4" style="visibility: visible; text-align: right">3,835</td><td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">$</td><td id="xdx_982_eus-gaap--DepreciationAndAmortization_c20200101__20201231__srt--StatementGeographicalAxis__country--US_zyOCWL2HUBxa" style="visibility: visible; text-align: right">3,354</td><td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">$</td><td id="xdx_985_eus-gaap--DepreciationAndAmortization_c20190101__20191231__srt--StatementGeographicalAxis__country--US_zUUVLjx2cPk" style="visibility: visible; text-align: right">3,088</td><td style="visibility: visible; text-align: left">&#160;</td></tr>
<tr style="visibility: visible; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="visibility: visible; text-align: left; padding-bottom: 1pt">&#160;&#160;&#160;&#160;Europe</td><td style="visibility: visible; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; visibility: visible; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--DepreciationAndAmortization_c20210101__20211231__srt--StatementGeographicalAxis__srt--EuropeMember_zt8Xwpmj0roa" style="border-bottom: Black 1pt solid; visibility: visible; text-align: right">8,863</td><td style="visibility: visible; padding-bottom: 1pt; text-align: left">&#160;</td><td style="visibility: visible; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; visibility: visible; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--DepreciationAndAmortization_c20200101__20201231__srt--StatementGeographicalAxis__srt--EuropeMember_zioukoB7Vgtj" style="border-bottom: Black 1pt solid; visibility: visible; text-align: right">5,713</td><td style="visibility: visible; padding-bottom: 1pt; text-align: left">&#160;</td><td style="visibility: visible; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; visibility: visible; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--DepreciationAndAmortization_c20190101__20191231__srt--StatementGeographicalAxis__srt--EuropeMember_z70leSOFQKH9" style="border-bottom: Black 1pt solid; visibility: visible; text-align: right">5,641</td><td style="visibility: visible; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="visibility: visible; vertical-align: bottom; background-color: White">
    <td style="visibility: visible; text-align: left; padding-bottom: 2pt">&#160;</td><td style="visibility: visible; padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; visibility: visible; text-align: left">$</td><td id="xdx_988_eus-gaap--DepreciationAndAmortization_c20210101__20211231_zDXjtc4WPOAg" style="border-bottom: Black 2pt double; visibility: visible; text-align: right">12,698</td><td style="visibility: visible; padding-bottom: 2pt; text-align: left">&#160;</td><td style="visibility: visible; padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; visibility: visible; text-align: left">$</td><td id="xdx_987_eus-gaap--DepreciationAndAmortization_c20200101__20201231_zqTLCmXoJIdd" style="border-bottom: Black 2pt double; visibility: visible; text-align: right">9,067</td><td style="visibility: visible; padding-bottom: 2pt; text-align: left">&#160;</td><td style="visibility: visible; padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; visibility: visible; text-align: left">$</td><td id="xdx_983_eus-gaap--DepreciationAndAmortization_c20190101__20191231_z7wvpw82L6q3" style="border-bottom: Black 2pt double; visibility: visible; text-align: right">8,729</td><td style="visibility: visible; padding-bottom: 2pt; text-align: left">&#160;</td></tr>
<tr style="visibility: visible; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="visibility: visible; text-align: left">Interest and investment income:</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible; text-align: right">&#160;</td><td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible; text-align: right">&#160;</td><td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible; text-align: right">&#160;</td><td style="visibility: visible; text-align: left">&#160;</td></tr>
<tr style="visibility: visible; vertical-align: bottom; background-color: White">
    <td style="visibility: visible; text-align: left">&#160;&#160;&#160;&#160;United States</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">$</td><td id="xdx_988_eus-gaap--InvestmentIncomeInterestAndDividend_c20210101__20211231__srt--StatementGeographicalAxis__country--US_zGHaHth6AQv7" style="visibility: visible; text-align: right">3</td><td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">$</td><td id="xdx_982_eus-gaap--InvestmentIncomeInterestAndDividend_c20200101__20201231__srt--StatementGeographicalAxis__country--US_z7dyBRe90bJ8" style="visibility: visible; text-align: right">24</td><td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">$</td><td id="xdx_984_eus-gaap--InvestmentIncomeInterestAndDividend_c20190101__20191231__srt--StatementGeographicalAxis__country--US_za0FpXMf1CW8" style="visibility: visible; text-align: right">345</td><td style="visibility: visible; text-align: left">&#160;</td></tr>
<tr style="visibility: visible; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="visibility: visible; text-align: left">&#160;&#160;&#160;&#160;Europe</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--InvestmentIncomeInterestAndDividend_c20210101__20211231__srt--StatementGeographicalAxis__srt--EuropeMember_zoRhTydjQQed" style="visibility: visible; text-align: right">3,526</td><td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--InvestmentIncomeInterestAndDividend_c20200101__20201231__srt--StatementGeographicalAxis__srt--EuropeMember_zP5BNsiY3o85" style="visibility: visible; text-align: right">2,971</td><td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--InvestmentIncomeInterestAndDividend_c20190101__20191231__srt--StatementGeographicalAxis__srt--EuropeMember_zWzfeijv0RZe" style="visibility: visible; text-align: right">3,501</td><td style="visibility: visible; text-align: left">&#160;</td></tr>
<tr style="visibility: visible; vertical-align: bottom; background-color: White">
    <td style="visibility: visible; text-align: left; padding-bottom: 1pt">&#160;&#160;&#160;&#160;Eliminations</td><td style="visibility: visible; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; visibility: visible; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--InvestmentIncomeInterestAndDividend_c20210101__20211231__srt--StatementGeographicalAxis__custom--EliminationsMember_zJm2O7dCPjhc" style="border-bottom: Black 1pt solid; visibility: visible; text-align: right">(126</td><td style="visibility: visible; padding-bottom: 1pt; text-align: left">)</td><td style="visibility: visible; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; visibility: visible; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--InvestmentIncomeInterestAndDividend_c20200101__20201231__srt--StatementGeographicalAxis__custom--EliminationsMember_zOPX0UarbiWc" style="border-bottom: Black 1pt solid; visibility: visible; text-align: right">(130</td><td style="visibility: visible; padding-bottom: 1pt; text-align: left">)</td><td style="visibility: visible; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; visibility: visible; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--InvestmentIncomeInterestAndDividend_c20190101__20191231__srt--StatementGeographicalAxis__custom--EliminationsMember_zt62G18GMYZ" style="border-bottom: Black 1pt solid; visibility: visible; text-align: right">(153</td><td style="visibility: visible; padding-bottom: 1pt; text-align: left">)</td></tr>
<tr style="visibility: visible; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="visibility: visible; text-align: left; padding-bottom: 2pt">&#160;</td><td style="visibility: visible; padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; visibility: visible; text-align: left">$</td><td id="xdx_98F_eus-gaap--InvestmentIncomeInterestAndDividend_c20210101__20211231_z1Scsi8xKcu8" style="border-bottom: Black 2pt double; visibility: visible; text-align: right">3,403</td><td style="visibility: visible; padding-bottom: 2pt; text-align: left">&#160;</td><td style="visibility: visible; padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; visibility: visible; text-align: left">$</td><td id="xdx_986_eus-gaap--InvestmentIncomeInterestAndDividend_c20200101__20201231_zqQDKSCvhSI9" style="border-bottom: Black 2pt double; visibility: visible; text-align: right">2,865</td><td style="visibility: visible; padding-bottom: 2pt; text-align: left">&#160;</td><td style="visibility: visible; padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; visibility: visible; text-align: left">$</td><td id="xdx_98E_eus-gaap--InvestmentIncomeInterestAndDividend_c20190101__20191231_zEOKYG3INDt8" style="border-bottom: Black 2pt double; visibility: visible; text-align: right">3,693</td><td style="visibility: visible; padding-bottom: 2pt; text-align: left">&#160;</td></tr>
<tr style="visibility: visible; vertical-align: bottom; background-color: White">
    <td style="visibility: visible; text-align: left">Interest expense:</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible; text-align: right">&#160;</td><td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible; text-align: right">&#160;</td><td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible; text-align: right">&#160;</td><td style="visibility: visible; text-align: left">&#160;</td></tr>
<tr style="visibility: visible; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="visibility: visible; text-align: left">&#160;&#160;&#160;&#160;United States</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">$</td><td id="xdx_987_eus-gaap--InterestExpense_c20210101__20211231__srt--StatementGeographicalAxis__country--US_zYxsoG4QjcUa" style="visibility: visible; text-align: right">636</td><td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">$</td><td id="xdx_989_eus-gaap--InterestExpense_c20200101__20201231__srt--StatementGeographicalAxis__country--US_z2Ybx7IJsKC3" style="visibility: visible; text-align: right">604</td><td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">$</td><td id="xdx_98B_eus-gaap--InterestExpense_c20190101__20191231__srt--StatementGeographicalAxis__country--US_zY8KBHWYMCk1" style="visibility: visible; text-align: right">673</td><td style="visibility: visible; text-align: left">&#160;</td></tr>
<tr style="visibility: visible; vertical-align: bottom; background-color: White">
    <td style="visibility: visible; text-align: left">&#160;&#160;&#160;&#160;Europe</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--InterestExpense_c20210101__20211231__srt--StatementGeographicalAxis__srt--EuropeMember_zHgsSFDcKVIf" style="visibility: visible; text-align: right" title="Interest expense">2,315</td><td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--InterestExpense_c20200101__20201231__srt--StatementGeographicalAxis__srt--EuropeMember_zLmvKN23VR57" style="visibility: visible; text-align: right" title="Interest expense">1,496</td><td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--InterestExpense_c20190101__20191231__srt--StatementGeographicalAxis__srt--EuropeMember_zNSXrgeFTNAg" style="visibility: visible; text-align: right" title="Interest expense">1,626</td><td style="visibility: visible; text-align: left">&#160;</td></tr>
<tr style="visibility: visible; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="visibility: visible; text-align: left; padding-bottom: 1pt">&#160;&#160;&#160;&#160;Eliminations</td><td style="visibility: visible; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; visibility: visible; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--InterestExpense_c20210101__20211231__srt--StatementGeographicalAxis__custom--EliminationsMember_zcrfn5F85JL7" style="border-bottom: Black 1pt solid; visibility: visible; text-align: right" title="Interest expense">(126</td><td style="visibility: visible; padding-bottom: 1pt; text-align: left">)</td><td style="visibility: visible; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; visibility: visible; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--InterestExpense_c20200101__20201231__srt--StatementGeographicalAxis__custom--EliminationsMember_zYBXzVtL8SH1" style="border-bottom: Black 1pt solid; visibility: visible; text-align: right" title="Interest expense">(130</td><td style="visibility: visible; padding-bottom: 1pt; text-align: left">)</td><td style="visibility: visible; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; visibility: visible; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--InterestExpense_c20190101__20191231__srt--StatementGeographicalAxis__custom--EliminationsMember_zSMQsNKpvAO2" style="border-bottom: Black 1pt solid; visibility: visible; text-align: right" title="Interest expense">(153</td><td style="visibility: visible; padding-bottom: 1pt; text-align: left">)</td></tr>
<tr style="visibility: visible; vertical-align: bottom; background-color: White">
    <td style="visibility: visible; text-align: left; padding-bottom: 2pt">&#160;</td><td style="visibility: visible; padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; visibility: visible; text-align: left">$</td><td id="xdx_98D_eus-gaap--InterestExpense_c20210101__20211231_zYwDrdtfE7qj" style="border-bottom: Black 2pt double; visibility: visible; text-align: right" title="Interest expense">2,825</td><td style="visibility: visible; padding-bottom: 2pt; text-align: left">&#160;</td><td style="visibility: visible; padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; visibility: visible; text-align: left">$</td><td id="xdx_980_eus-gaap--InterestExpense_c20200101__20201231_zNXV6WHw0F3b" style="border-bottom: Black 2pt double; visibility: visible; text-align: right" title="Interest expense">1,970</td><td style="visibility: visible; padding-bottom: 2pt; text-align: left">&#160;</td><td style="visibility: visible; padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; visibility: visible; text-align: left">$</td><td id="xdx_981_eus-gaap--InterestExpense_c20190101__20191231_zI8X8gzlNi8c" style="border-bottom: Black 2pt double; visibility: visible; text-align: right" title="Interest expense">2,146</td><td style="visibility: visible; padding-bottom: 2pt; text-align: left">&#160;</td></tr>
<tr style="visibility: visible; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="visibility: visible; text-align: left">Income tax expense:</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible; text-align: right">&#160;</td><td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible; text-align: right">&#160;</td><td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible; text-align: right">&#160;</td><td style="visibility: visible; text-align: left">&#160;</td></tr>
<tr style="visibility: visible; vertical-align: bottom; background-color: White">
    <td style="visibility: visible; text-align: left">&#160;&#160;&#160;&#160;United States</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">$</td><td id="xdx_985_eus-gaap--IncomeTaxExpenseBenefit_c20210101__20211231__srt--StatementGeographicalAxis__country--US_zPqN12BQMkL1" style="visibility: visible; text-align: right">5,336</td><td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">$</td><td id="xdx_983_eus-gaap--IncomeTaxExpenseBenefit_c20200101__20201231__srt--StatementGeographicalAxis__country--US_zHU559TDBHrb" style="visibility: visible; text-align: right">1,590</td><td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">$</td><td id="xdx_986_eus-gaap--IncomeTaxExpenseBenefit_c20190101__20191231__srt--StatementGeographicalAxis__country--US_ztUs8eqesh7k" style="visibility: visible; text-align: right">3,945</td><td style="visibility: visible; text-align: left">&#160;</td></tr>
<tr style="visibility: visible; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="visibility: visible; text-align: left">&#160;&#160;&#160;&#160;Europe</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--IncomeTaxExpenseBenefit_c20210101__20211231__srt--StatementGeographicalAxis__srt--EuropeMember_z0bXvJdCA9qa" style="visibility: visible; text-align: right">35,607</td><td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--IncomeTaxExpenseBenefit_c20200101__20201231__srt--StatementGeographicalAxis__srt--EuropeMember_z6N7TqsQJgVf" style="visibility: visible; text-align: right">17,782</td><td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--IncomeTaxExpenseBenefit_c20190101__20191231__srt--StatementGeographicalAxis__srt--EuropeMember_zyNgRnvX3AHa" style="visibility: visible; text-align: right">25,101</td><td style="visibility: visible; text-align: left">&#160;</td></tr>
<tr style="visibility: visible; vertical-align: bottom; background-color: White">
    <td style="visibility: visible; text-align: left; padding-bottom: 1pt">&#160;&#160;&#160;&#160;Eliminations</td><td style="visibility: visible; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; visibility: visible; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--IncomeTaxExpenseBenefit_c20210101__20211231__srt--StatementGeographicalAxis__custom--EliminationsMember_zsxwiXhlQHTb" style="border-bottom: Black 1pt solid; visibility: visible; text-align: right">49</td><td style="visibility: visible; padding-bottom: 1pt; text-align: left">&#160;</td><td style="visibility: visible; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; visibility: visible; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--IncomeTaxExpenseBenefit_c20200101__20201231__srt--StatementGeographicalAxis__custom--EliminationsMember_zAQ2F8H0iw26" style="border-bottom: Black 1pt solid; visibility: visible; text-align: right">9</td><td style="visibility: visible; padding-bottom: 1pt; text-align: left">&#160;</td><td style="visibility: visible; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; visibility: visible; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--IncomeTaxExpenseBenefit_c20190101__20191231__srt--StatementGeographicalAxis__custom--EliminationsMember_zsfPjVbPoZq9" style="border-bottom: Black 1pt solid; visibility: visible; text-align: right">30</td><td style="visibility: visible; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="visibility: visible; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="visibility: visible; text-align: left; padding-bottom: 2pt">&#160;</td><td style="visibility: visible; padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; visibility: visible; text-align: left">$</td><td id="xdx_985_eus-gaap--IncomeTaxExpenseBenefit_c20210101__20211231_zYuwcNGNDjxe" style="border-bottom: Black 2pt double; visibility: visible; text-align: right">40,992</td><td style="visibility: visible; padding-bottom: 2pt; text-align: left">&#160;</td><td style="visibility: visible; padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; visibility: visible; text-align: left">$</td><td id="xdx_988_eus-gaap--IncomeTaxExpenseBenefit_c20200101__20201231_zK5CansaJlHa" style="border-bottom: Black 2pt double; visibility: visible; text-align: right">19,381</td><td style="visibility: visible; padding-bottom: 2pt; text-align: left">&#160;</td><td style="visibility: visible; padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; visibility: visible; text-align: left">$</td><td id="xdx_982_eus-gaap--IncomeTaxExpenseBenefit_c20190101__20191231_ziS0Mw2aThV8" style="border-bottom: Black 2pt double; visibility: visible; text-align: right">29,076</td><td style="visibility: visible; padding-bottom: 2pt; text-align: left">&#160;</td></tr>
</table>

<p style="margin: 0; visibility: visible">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in">
<tr style="text-align: center; vertical-align: bottom">
    <td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>December 31,</b></span></td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="text-align: center; vertical-align: bottom">
    <td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold">2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold">2019</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; width: 55%">Total assets:</td><td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td style="text-align: right; width: 12%">&#160;</td><td style="text-align: left; width: 1%">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td style="text-align: right; width: 12%">&#160;</td><td style="text-align: left; width: 1%">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td style="text-align: right; width: 12%">&#160;</td><td style="text-align: left; width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;&#160;&#160;&#160;United States</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--Assets_iI_c20211231__srt--StatementGeographicalAxis__country--US_z8zLIQYvfsd3" style="text-align: right">247,703</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--Assets_iI_c20201231__srt--StatementGeographicalAxis__country--US_z1a1mVWhWgJa" style="text-align: right">141,316</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_983_eus-gaap--Assets_iI_c20191231__srt--StatementGeographicalAxis__country--US_ze4scNtgijPj" style="text-align: right">166,180</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;&#160;&#160;&#160;Europe</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--Assets_iI_c20211231__srt--StatementGeographicalAxis__srt--EuropeMember_zFKpIBUvOgqk" style="text-align: right">931,735</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--Assets_iI_c20201231__srt--StatementGeographicalAxis__srt--EuropeMember_zLoIkfHcmMR6" style="text-align: right">758,812</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--Assets_iI_c20191231__srt--StatementGeographicalAxis__srt--EuropeMember_zHhR8uZ68Vdi" style="text-align: right">670,657</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">&#160;&#160;&#160;&#160;Eliminations</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--Assets_iI_c20211231__srt--StatementGeographicalAxis__custom--EliminationsMember_ziJx0D2ajuXj" style="border-bottom: Black 1pt solid; text-align: right">(34,074</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--Assets_iI_c20201231__srt--StatementGeographicalAxis__custom--EliminationsMember_zW0wHylpiVnf" style="border-bottom: Black 1pt solid; text-align: right">(9,983</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--Assets_iI_c20191231__srt--StatementGeographicalAxis__custom--EliminationsMember_ztZSf6TnJ691" style="border-bottom: Black 1pt solid; text-align: right">(8,005</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2pt">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td id="xdx_984_eus-gaap--Assets_iI_c20211231_zDp748Hon1k2" style="border-bottom: Black 2pt double; text-align: right">1,145,364</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--Assets_iI_c20201231_zF0HVpqB8clf" style="border-bottom: Black 2pt double; text-align: right">890,145</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--Assets_iI_c20191231_zKV32bgh58nd" style="border-bottom: Black 2pt double; text-align: right">828,832</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Additions to long-lived assets:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;&#160;&#160;&#160;United States</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--AdditionsToOtherAssetsAmount_c20210101__20211231__srt--StatementGeographicalAxis__country--US_zwbljiC2D0T2" style="text-align: right">2,711</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--AdditionsToOtherAssetsAmount_c20200101__20201231__srt--StatementGeographicalAxis__country--US_zDQwlX504Fj9" style="text-align: right">1,004</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--AdditionsToOtherAssetsAmount_c20190101__20191231__srt--StatementGeographicalAxis__country--US_zyaItO2G8at2" style="text-align: right">5,851</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">&#160;&#160;&#160;&#160;Europe</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--AdditionsToOtherAssetsAmount_c20210101__20211231__srt--StatementGeographicalAxis__srt--EuropeMember_zhE9PE1o3qA5" style="border-bottom: Black 1pt solid; text-align: right">138,563</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--AdditionsToOtherAssetsAmount_c20200101__20201231__srt--StatementGeographicalAxis__srt--EuropeMember_z7bZHUpdAPbg" style="border-bottom: Black 1pt solid; text-align: right">11,259</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--AdditionsToOtherAssetsAmount_c20190101__20191231__srt--StatementGeographicalAxis__srt--EuropeMember_znS4FO2uM4K6" style="border-bottom: Black 1pt solid; text-align: right">5,643</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2pt">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--AdditionsToOtherAssetsAmount_c20210101__20211231_zHfls6HDBu4k" style="border-bottom: Black 2pt double; text-align: right">141,274</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td id="xdx_987_eus-gaap--AdditionsToOtherAssetsAmount_c20200101__20201231_zcl7DDjE2QR5" style="border-bottom: Black 2pt double; text-align: right">12,263</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td id="xdx_983_eus-gaap--AdditionsToOtherAssetsAmount_c20190101__20191231_zXeSTYOabnB4" style="border-bottom: Black 2pt double; text-align: right">11,494</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Total long-lived assets:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;&#160;&#160;&#160;United States</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--NoncurrentAssets_iI_c20211231__srt--StatementGeographicalAxis__country--US_zQKQz1a0vcYc" style="text-align: right">63,094</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--NoncurrentAssets_iI_c20201231__srt--StatementGeographicalAxis__country--US_zN6R5bz6TMr6" style="text-align: right">40,656</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--NoncurrentAssets_iI_c20191231__srt--StatementGeographicalAxis__country--US_zofVpONNxiv8" style="text-align: right">44,473</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">&#160;&#160;&#160;&#160;Europe</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--NoncurrentAssets_iI_c20211231__srt--StatementGeographicalAxis__srt--EuropeMember_zr7C4Q02H059" style="border-bottom: Black 1pt solid; text-align: right">334,033</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--NoncurrentAssets_iI_c20201231__srt--StatementGeographicalAxis__srt--EuropeMember_zgqJ58AYQgJ" style="border-bottom: Black 1pt solid; text-align: right">217,766</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--NoncurrentAssets_iI_c20191231__srt--StatementGeographicalAxis__srt--EuropeMember_z9wKjWDm19Zg" style="border-bottom: Black 1pt solid; text-align: right">196,976</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2pt">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--NoncurrentAssets_iI_c20211231_z6hxmiTCgKSi" style="border-bottom: Black 2pt double; text-align: right">397,127</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td id="xdx_984_eus-gaap--NoncurrentAssets_iI_c20201231_zJnLsw2O7mc3" style="border-bottom: Black 2pt double; text-align: right">258,422</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td id="xdx_980_eus-gaap--NoncurrentAssets_iI_c20191231_zGz0VhTFM3Yh" style="border-bottom: Black 2pt double; text-align: right">241,449</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Deferred tax assets:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;&#160;&#160;&#160;United States</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20211231__srt--StatementGeographicalAxis__country--US_zkvJfows7qFd" style="text-align: right">870</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20201231__srt--StatementGeographicalAxis__country--US_zP0BCCuOPxBf" style="text-align: right">886</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20191231__srt--StatementGeographicalAxis__country--US_zVZLmXviCsil" style="text-align: right">705</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;&#160;&#160;&#160;Europe</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20211231__srt--StatementGeographicalAxis__srt--EuropeMember_z0lncOo7cgB7" style="text-align: right">7,066</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20201231__srt--StatementGeographicalAxis__srt--EuropeMember_zrlbuGWF38d" style="text-align: right">7,106</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20191231__srt--StatementGeographicalAxis__srt--EuropeMember_zVMP9IkRSMu4" style="text-align: right">7,241</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">&#160;&#160;&#160;&#160;Eliminations</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20211231__srt--StatementGeographicalAxis__custom--EliminationsMember_zJs36H0Si6he" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1600">&#8212;</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20201231__srt--StatementGeographicalAxis__custom--EliminationsMember_znLmrvdF8f1k" style="border-bottom: Black 1pt solid; text-align: right">49</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20191231__srt--StatementGeographicalAxis__custom--EliminationsMember_zAodDoksCThk" style="border-bottom: Black 1pt solid; text-align: right">58</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2pt">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20211231_zEpnN8QYHkOa" style="border-bottom: Black 2pt double; text-align: right">7,936</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td id="xdx_987_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20201231_zkqsKHMhcTOl" style="border-bottom: Black 2pt double; text-align: right">8,041</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20191231_zisQbqIbzlz4" style="border-bottom: Black 2pt double; text-align: right">8,004</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
</table>

<p id="xdx_8AE_zwGI3qP3PxX8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>INTER PARFUMS, INC. AND SUBSIDIARIES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Notes to Consolidated Financial Statements</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">December 31, 2021, 2020 and 2019</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(In thousands except share and per share data)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p id="xdx_89E_eus-gaap--ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_zqqPoAQ24U2i" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">United States export sales were
approximately $<span id="xdx_901_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_dm_c20210101__20211231_zOKOIecfTgs">126.2 million</span>, $<span id="xdx_909_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_dm_c20200101__20201231_zgHZ9LnNqMH7">71.5 million</span> and $<span id="xdx_900_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20190101__20191231_zmGNh1bB8Dsd">112.0</span> million in 2021, 2020 and 2019, respectively. <span id="xdx_8BB_z8EKIkonq9Dc">Consolidated net sales to
customers by region are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 55%; text-align: left">North America</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--Revenues_c20210101__20211231__srt--StatementGeographicalAxis__srt--NorthAmericaMember_zAne2nd7s9qb" style="width: 12%; text-align: right" title="Net sales">354,100</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--Revenues_c20200101__20201231__srt--StatementGeographicalAxis__srt--NorthAmericaMember_zGLPNa5KiEji" style="width: 12%; text-align: right">193,500</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--Revenues_c20190101__20191231__srt--StatementGeographicalAxis__srt--NorthAmericaMember_zY4PXJenVjHl" style="width: 12%; text-align: right">235,500</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>Europe</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--Revenues_c20210101__20211231__srt--StatementGeographicalAxis__custom--EuropeCountryMember_z4Kj9Q2LPdmi" style="text-align: right">271,600</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--Revenues_c20200101__20201231__srt--StatementGeographicalAxis__custom--EuropeCountryMember_z9cC9M7ZndHh" style="text-align: right">180,200</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--Revenues_c20190101__20191231__srt--StatementGeographicalAxis__custom--EuropeCountryMember_zgb1sHloeFD6" style="text-align: right">240,800</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Asia</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--Revenues_c20210101__20211231__srt--StatementGeographicalAxis__srt--AsiaMember_zW7Z1YghAqd3" style="text-align: right">128,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--Revenues_c20200101__20201231__srt--StatementGeographicalAxis__srt--AsiaMember_zRNOQ20XH2E3" style="text-align: right">79,700</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--Revenues_c20190101__20191231__srt--StatementGeographicalAxis__srt--AsiaMember_zV1AsVZ6BVC7" style="text-align: right">110,900</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Middle East</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--Revenues_c20210101__20211231__srt--StatementGeographicalAxis__us-gaap--MiddleEastMember_zBqHf1TKVNzl" style="text-align: right">61,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--Revenues_c20200101__20201231__srt--StatementGeographicalAxis__us-gaap--MiddleEastMember_zPX5D2V6erWl" style="text-align: right">46,800</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--Revenues_c20190101__20191231__srt--StatementGeographicalAxis__us-gaap--MiddleEastMember_z2SSTGEiiOpk" style="text-align: right">72,600</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Central and South America</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--Revenues_c20210101__20211231__srt--StatementGeographicalAxis__custom--CentralAndSouthAmericaMember_zQ82bJLnqLmc" style="text-align: right">56,400</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--Revenues_c20200101__20201231__srt--StatementGeographicalAxis__custom--CentralAndSouthAmericaMember_zaQPC0bZbpRd" style="text-align: right">32,500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--Revenues_c20190101__20191231__srt--StatementGeographicalAxis__custom--CentralAndSouthAmericaMember_zug9hg2oF66d" style="text-align: right">46,200</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">Other</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--Revenues_c20210101__20211231__srt--StatementGeographicalAxis__custom--OtherSegmentCountryMember_zTIQ1CRJkQvb" style="border-bottom: Black 1pt solid; text-align: right">8,400</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--Revenues_c20200101__20201231__srt--StatementGeographicalAxis__custom--OtherSegmentCountryMember_zwuHA6VcULmb" style="border-bottom: Black 1pt solid; text-align: right">6,300</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--Revenues_c20190101__20191231__srt--StatementGeographicalAxis__custom--OtherSegmentCountryMember_zf5C59wEliX7" style="border-bottom: Black 1pt solid; text-align: right">7,500</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2pt">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td id="xdx_984_eus-gaap--Revenues_c20210101__20211231_zuLPyqTHRiEf" style="border-bottom: Black 2pt double; text-align: right">879,500</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td id="xdx_988_eus-gaap--Revenues_c20200101__20201231_za3KlQTe5Msg" style="border-bottom: Black 2pt double; text-align: right">539,000</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td id="xdx_984_eus-gaap--Revenues_c20190101__20191231_zdyljZT1FLch" style="border-bottom: Black 2pt double; text-align: right">713,500</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
</table>

<p id="xdx_8A2_zI94YqJMxfll" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&#160;</p>

<p id="xdx_898_eus-gaap--ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock_zuUa5YDa2a4h" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span id="xdx_8BA_zqXnHQ8BJT6k">Consolidated net sales to customers in major countries
are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year Ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 55%; text-align: left">United States</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20210101__20211231__us-gaap--StatementBusinessSegmentsAxis__custom--UnitedStatesMember_zEKymJV57Qvl" style="width: 12%; text-align: right" title="Revenue from Contract with Customer, Including Assessed Tax">351,300</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20200101__20201231__us-gaap--StatementBusinessSegmentsAxis__custom--UnitedStatesMember_zxYvGQoLkVMk" style="width: 12%; text-align: right">187,300</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20190101__20191231__us-gaap--StatementBusinessSegmentsAxis__custom--UnitedStatesMember_ztuDf4UXZh8e" style="width: 12%; text-align: right">225,300</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>France</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20210101__20211231__us-gaap--StatementBusinessSegmentsAxis__custom--FranceMember_zCRsWORMslv7" style="text-align: right">44,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20200101__20201231__us-gaap--StatementBusinessSegmentsAxis__custom--FranceMember_zbAfAETODHKk" style="text-align: right">37,600</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20190101__20191231__us-gaap--StatementBusinessSegmentsAxis__custom--FranceMember_zkP4BXithRv5" style="text-align: right">43,500</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Russia</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20210101__20211231__us-gaap--StatementBusinessSegmentsAxis__custom--RussiaMember_zcXrJAGJdL37" style="text-align: right">43,400</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20200101__20201231__us-gaap--StatementBusinessSegmentsAxis__custom--RussiaMember_zYkELQ8N448i" style="text-align: right">14,100</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20190101__20191231__us-gaap--StatementBusinessSegmentsAxis__custom--RussiaMember_zMwJcPbEQXTj" style="text-align: right">36,800</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">United Kingdom</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20210101__20211231__us-gaap--StatementBusinessSegmentsAxis__custom--UnitedKingdomMember_z7NvoMSPPB0e" style="text-align: right">38,500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20200101__20201231__us-gaap--StatementBusinessSegmentsAxis__custom--UnitedKingdomMember_zmsscOTv6ur1" style="text-align: right">24,600</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20190101__20191231__us-gaap--StatementBusinessSegmentsAxis__custom--UnitedKingdomMember_zmPhy1xPPQR" style="text-align: right">35,800</td><td style="text-align: left">&#160;</td></tr>
</table>

<p id="xdx_8AD_zXT9PNXVEmLi" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI http://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139983555929672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text"><p id="xdx_80D_eus-gaap--IncomeTaxDisclosureTextBlock_zBeljCq3QZd5" style="margin-top: 0; margin-bottom: 0"/>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in">(16)</td><td><span id="xdx_829_zi73uunWhwN8">Income Taxes</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company and its subsidiaries
file income tax returns in the U.S. federal, and various states and foreign jurisdictions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company assessed its uncertain
tax positions and determined that it has no material uncertain tax position at December 31, 2021.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p id="xdx_89C_eus-gaap--ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_zP7KWJTx3xN4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8B8_zek4eMr6vwDe">The components of income before
income taxes consist of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 55%; text-align: left">U.S. operations</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_c20210101__20211231_zzpNfdpkgazi" style="width: 12%; text-align: right" title="U.S. operations">34,742</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_c20200101__20201231_zGARqmS1frAk" style="width: 12%; text-align: right" title="U.S. operations">9,577</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_c20190101__20191231_zQnEOBvTAa7i" style="width: 12%; text-align: right" title="U.S. operations">23,384</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Foreign operations</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_c20210101__20211231_zRdQmkhIgTYa" style="border-bottom: Black 1pt solid; text-align: right" title="Foreign operations">116,277</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_c20200101__20201231_z51CEqt2q3F9" style="border-bottom: Black 1pt solid; text-align: right" title="Foreign operations">59,772</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_c20190101__20191231_zIeZ60GanUl9" style="border-bottom: Black 1pt solid; text-align: right" title="Foreign operations">81,762</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2pt">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_dxL_c20210101__20211231_zrOnVOV5dMj8" style="border-bottom: Black 2pt double; text-align: right" title="Income before income taxes::XDX::151%2C019"><span style="-sec-ix-hidden: xdx2ixbrl1662">151,019</span></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_c20200101__20201231_z3T85frJ6MZ8" style="border-bottom: Black 2pt double; text-align: right" title="Income before income taxes">69,349</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_c20190101__20191231_zXCUYLNbH8Ei" style="border-bottom: Black 2pt double; text-align: right" title="Income before income taxes">105,146</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
</table>

<p id="xdx_8A9_zWk3IgxaIIF5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>







<p id="xdx_00A" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p id="xdx_896_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zUGiZ2T49aRh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8BA_zwqhkU3uzkwj">The provision for current and
deferred income tax expense (benefit) consists of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td><span style="color: Black">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="color: Black">&#160;</span></td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="color: Black">Year
    ended December 31,</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="color: Black">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td><span style="color: Black">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="color: Black">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="color: Black">2021</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="color: Black">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="color: Black">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="color: Black">2020</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="color: Black">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="color: Black">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="color: Black">2019</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="color: Black">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="color: Black">Current:</span></td><td><span style="color: Black">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="color: Black">&#160;</span></td><td><span style="color: Black">&#160;</span></td><td><span style="color: Black">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="color: Black">&#160;</span></td><td><span style="color: Black">&#160;</span></td><td><span style="color: Black">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="color: Black">&#160;</span></td><td><span style="color: Black">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 55%; padding-left: 0.125in"><span style="color: Black">Federal</span></td><td style="width: 1%"><span style="color: Black">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="color: Black">$</span></td><td id="xdx_98C_eus-gaap--CurrentFederalTaxExpenseBenefit_c20210101__20211231_zyccVXsRAWgb" style="width: 12%; text-align: right" title="Federal"><span style="color: Black">4,825</span></td><td style="width: 1%; text-align: left"><span style="color: Black">&#160;</span></td><td style="width: 1%"><span style="color: Black">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="color: Black">$</span></td><td id="xdx_98C_eus-gaap--CurrentFederalTaxExpenseBenefit_c20200101__20201231_zQoZuV1w3Dt3" style="width: 12%; text-align: right" title="Federal"><span style="color: Black">1,685</span></td><td style="width: 1%; text-align: left"><span style="color: Black">&#160;</span></td><td style="width: 1%"><span style="color: Black">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="color: Black">$</span></td><td id="xdx_98D_eus-gaap--CurrentFederalTaxExpenseBenefit_c20190101__20191231_zYITiginS8Pj" style="width: 12%; text-align: right" title="Federal"><span style="color: Black">3,280</span></td><td style="width: 1%; text-align: left"><span style="color: Black">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.125in"><span style="color: Black">State and local</span></td><td><span style="color: Black">&#160;</span></td>
    <td style="text-align: left"><span style="color: Black">&#160;</span></td><td id="xdx_98B_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_c20210101__20211231_zeZQt1nhP2qf" style="text-align: right" title="State and local"><span style="color: Black">518</span></td><td style="text-align: left"><span style="color: Black">&#160;</span></td><td><span style="color: Black">&#160;</span></td>
    <td style="text-align: left"><span style="color: Black">&#160;</span></td><td id="xdx_983_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_c20200101__20201231_zIJtWwL6AOM1" style="text-align: right" title="State and local"><span style="color: Black">90</span></td><td style="text-align: left"><span style="color: Black">&#160;</span></td><td><span style="color: Black">&#160;</span></td>
    <td style="text-align: left"><span style="color: Black">&#160;</span></td><td id="xdx_98E_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_c20190101__20191231_zuaogGZmmemj" style="text-align: right" title="State and local"><span style="color: Black">713</span></td><td style="text-align: left"><span style="color: Black">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; padding-left: 0.125in"><span style="color: Black">Foreign</span></td><td style="padding-bottom: 1pt"><span style="color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="color: Black">&#160;</span></td><td id="xdx_989_eus-gaap--CurrentForeignTaxExpenseBenefit_c20210101__20211231_zl83A7KS5Ufe" style="border-bottom: Black 1pt solid; text-align: right" title="Foreign"><span style="color: Black">36,164</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="color: Black">&#160;</span></td><td style="padding-bottom: 1pt"><span style="color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="color: Black">&#160;</span></td><td id="xdx_98D_eus-gaap--CurrentForeignTaxExpenseBenefit_c20200101__20201231_zkZBFCc887yb" style="border-bottom: Black 1pt solid; text-align: right" title="Foreign"><span style="color: Black">17,024</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="color: Black">&#160;</span></td><td style="padding-bottom: 1pt"><span style="color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="color: Black">&#160;</span></td><td id="xdx_988_eus-gaap--CurrentForeignTaxExpenseBenefit_c20190101__20191231_zQAipynMaS1f" style="border-bottom: Black 1pt solid; text-align: right" title="Foreign"><span style="color: Black">27,412</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="color: Black">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; padding-left: 0.125in"><span style="color: Black">&#160;</span></td><td style="padding-bottom: 1pt"><span style="color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="color: Black">&#160;</span></td><td id="xdx_98D_eus-gaap--CurrentIncomeTaxExpenseBenefit_c20210101__20211231_zeEvwTxGaul2" style="border-bottom: Black 1pt solid; text-align: right" title="Current income tax expense"><span style="color: Black">41,507</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="color: Black">&#160;</span></td><td style="padding-bottom: 1pt"><span style="color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="color: Black">&#160;</span></td><td id="xdx_985_eus-gaap--CurrentIncomeTaxExpenseBenefit_c20200101__20201231_zB7H8NO70fik" style="border-bottom: Black 1pt solid; text-align: right" title="Current income tax expense"><span style="color: Black">18,799</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="color: Black">&#160;</span></td><td style="padding-bottom: 1pt"><span style="color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="color: Black">&#160;</span></td><td id="xdx_98A_eus-gaap--CurrentIncomeTaxExpenseBenefit_c20190101__20191231_zBWsVBhDhPxd" style="border-bottom: Black 1pt solid; text-align: right" title="Current income tax expense"><span style="color: Black">31,405</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="color: Black">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0in"><span style="color: Black">Deferred:</span></td><td><span style="color: Black">&#160;</span></td>
    <td style="text-align: left"><span style="color: Black">&#160;</span></td><td style="text-align: right"><span style="color: Black">&#160;</span></td><td style="text-align: left"><span style="color: Black">&#160;</span></td><td><span style="color: Black">&#160;</span></td>
    <td style="text-align: left"><span style="color: Black">&#160;</span></td><td style="text-align: right"><span style="color: Black">&#160;</span></td><td style="text-align: left"><span style="color: Black">&#160;</span></td><td><span style="color: Black">&#160;</span></td>
    <td style="text-align: left"><span style="color: Black">&#160;</span></td><td style="text-align: right"><span style="color: Black">&#160;</span></td><td style="text-align: left"><span style="color: Black">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in"><span style="color: Black">Federal</span></td><td><span style="color: Black">&#160;</span></td>
    <td style="text-align: left"><span style="color: Black">&#160;</span></td><td id="xdx_98C_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_c20210101__20211231_ze6HlfWY8uA8" style="text-align: right" title="Federal"><span style="color: Black">4</span></td><td style="text-align: left"><span style="color: Black">&#160;</span></td><td style="color: #FF0000"><span style="color: Black">&#160;</span></td>
    <td style="color: #FF0000; text-align: left"><span style="color: Black">&#160;</span></td><td id="xdx_988_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_c20200101__20201231_zUhelWURYQZc" style="color: #FF0000; text-align: right" title="Federal"><span style="color: Black">(215</span></td><td style="color: #FF0000; text-align: left"><span style="color: Black">)</span></td><td style="color: #FF0000"><span style="color: Black">&#160;</span></td>
    <td style="color: #FF0000; text-align: left"><span style="color: Black">&#160;</span></td><td id="xdx_986_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_c20190101__20191231_ziUn6oUD2Zyj" style="color: #FF0000; text-align: right" title="Federal"><span style="color: Black">(3</span></td><td style="color: #FF0000; text-align: left"><span style="color: Black">)</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.125in"><span style="color: Black">State and local</span></td><td><span style="color: Black">&#160;</span></td>
    <td style="text-align: left"><span style="color: Black">&#160;</span></td><td id="xdx_988_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_c20210101__20211231_zd2QCvpKnETk" style="text-align: right" title="State and local"><span style="color: Black">11</span></td><td style="text-align: left"><span style="color: Black">&#160;</span></td><td><span style="color: Black">&#160;</span></td>
    <td style="text-align: left"><span style="color: Black">&#160;</span></td><td id="xdx_986_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_c20200101__20201231_zFRLVE8qtbpg" style="text-align: right" title="State and local"><span style="color: Black">44</span></td><td style="text-align: left"><span style="color: Black">&#160;</span></td><td style="color: #FF0000"><span style="color: Black">&#160;</span></td>
    <td style="color: #FF0000; text-align: left"><span style="color: Black">&#160;</span></td><td id="xdx_98F_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_c20190101__20191231_zyiKjpMXNJpf" style="color: #FF0000; text-align: right" title="State and local"><span style="color: Black">(22</span></td><td style="color: #FF0000; text-align: left"><span style="color: Black">)</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; padding-left: 0.125in"><span style="color: Black">Foreign</span></td><td style="color: #FF0000; padding-bottom: 1pt"><span style="color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; color: #FF0000; text-align: left"><span style="color: Black">&#160;</span></td><td id="xdx_982_eus-gaap--DeferredForeignIncomeTaxExpenseBenefit_c20210101__20211231_ziURehu430v9" style="border-bottom: Black 1pt solid; color: #FF0000; text-align: right" title="Foreign"><span style="color: Black">(530</span></td><td style="padding-bottom: 1pt; color: #FF0000; text-align: left"><span style="color: Black">)</span></td><td style="padding-bottom: 1pt"><span style="color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="color: Black">&#160;</span></td><td id="xdx_989_eus-gaap--DeferredForeignIncomeTaxExpenseBenefit_c20200101__20201231_zop73MEig7uh" style="border-bottom: Black 1pt solid; text-align: right" title="Foreign"><span style="color: Black">753</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="color: Black">&#160;</span></td><td style="color: #FF0000; padding-bottom: 1pt"><span style="color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; color: #FF0000; text-align: left"><span style="color: Black">&#160;</span></td><td id="xdx_98F_eus-gaap--DeferredForeignIncomeTaxExpenseBenefit_c20190101__20191231_z8JMNNKenST5" style="border-bottom: Black 1pt solid; color: #FF0000; text-align: right" title="Foreign"><span style="color: Black">(2,304</span></td><td style="padding-bottom: 1pt; color: #FF0000; text-align: left"><span style="color: Black">)</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; padding-left: 0.125in"><span style="color: Black">&#160;</span></td><td style="color: #FF0000; padding-bottom: 1pt"><span style="color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; color: #FF0000; text-align: left"><span style="color: Black">&#160;</span></td><td id="xdx_983_eus-gaap--DeferredIncomeTaxesAndTaxCredits_c20210101__20211231_z5wYD0xIO3L2" style="border-bottom: Black 1pt solid; color: #FF0000; text-align: right" title="Deferred income tax expense"><span style="color: Black">(515</span></td><td style="padding-bottom: 1pt; color: #FF0000; text-align: left"><span style="color: Black">)</span></td><td style="padding-bottom: 1pt"><span style="color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="color: Black">&#160;</span></td><td id="xdx_983_eus-gaap--DeferredIncomeTaxesAndTaxCredits_c20200101__20201231_zBOX09o1nzye" style="border-bottom: Black 1pt solid; text-align: right" title="Deferred income tax expense"><span style="color: Black">582</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="color: Black">&#160;</span></td><td style="color: #FF0000; padding-bottom: 1pt"><span style="color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; color: #FF0000; text-align: left"><span style="color: Black">&#160;</span></td><td id="xdx_98B_eus-gaap--DeferredIncomeTaxesAndTaxCredits_c20190101__20191231_zysV537hiDga" style="border-bottom: Black 1pt solid; color: #FF0000; text-align: right" title="Deferred income tax expense"><span style="color: Black">(2,329</span></td><td style="padding-bottom: 1pt; color: #FF0000; text-align: left"><span style="color: Black">)</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2pt; padding-left: 0.25in"><span style="color: Black">Total income tax expense</span></td><td style="padding-bottom: 2pt"><span style="color: Black">&#160;</span></td>
    <td style="border-bottom: Black 2pt double; text-align: left"><span style="color: Black">$</span></td><td id="xdx_98D_eus-gaap--IncomeTaxExpenseBenefit_c20210101__20211231_zYRwkxqLQOXc" style="border-bottom: Black 2pt double; text-align: right" title="Total income tax expense"><span style="color: Black">40,992</span></td><td style="padding-bottom: 2pt; text-align: left"><span style="color: Black">&#160;</span></td><td style="padding-bottom: 2pt"><span style="color: Black">&#160;</span></td>
    <td style="border-bottom: Black 2pt double; text-align: left"><span style="color: Black">$</span></td><td id="xdx_98C_eus-gaap--IncomeTaxExpenseBenefit_c20200101__20201231_zxFb4ctKogba" style="border-bottom: Black 2pt double; text-align: right" title="Total income tax expense"><span style="color: Black">19,381</span></td><td style="padding-bottom: 2pt; text-align: left"><span style="color: Black">&#160;</span></td><td style="padding-bottom: 2pt"><span style="color: Black">&#160;</span></td>
    <td style="border-bottom: Black 2pt double; text-align: left"><span style="color: Black">$</span></td><td id="xdx_989_eus-gaap--IncomeTaxExpenseBenefit_c20190101__20191231_zkeNHgSLd1P2" style="border-bottom: Black 2pt double; text-align: right" title="Total income tax expense"><span style="color: Black">29,076</span></td><td style="padding-bottom: 2pt; text-align: left"><span style="color: Black">&#160;</span></td></tr>
</table>



<p id="xdx_8AB_zYpwPMqPmny1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p id="xdx_897_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_z8HkKCVmb7g4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8B2_zHg3EdUCGBhc">The tax effects of temporary
differences that give rise to significant portions of the deferred tax assets and deferred tax liabilities are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td style="color: Black">&#160;</td><td style="color: Black; font-weight: bold">&#160;</td>
    <td style="color: Black; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_499_20211231_zi4394cUJWsb" style="color: Black; font-weight: bold; text-align: center">&#160;</td>
    <td style="color: Black; font-weight: bold; text-align: center">&#160;</td>
    <td style="color: Black; font-weight: bold; text-align: center">&#160;</td>
    <td style="color: Black; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_490_20201231_zkjjpzRc39bb" style="color: Black; font-weight: bold; text-align: center">&#160;</td><td style="color: Black; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="color: Black">&#160;</td><td style="color: Black; font-weight: bold">&#160;</td>
    <td colspan="6" style="color: Black; font-weight: bold; text-align: center">December 31,</td><td style="color: Black; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="color: Black">&#160;</td><td style="color: Black; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; color: Black; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; color: Black; font-weight: bold">&#160;</td><td style="color: Black; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; color: Black; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; color: Black; font-weight: bold">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--DeferredTaxAssetsNetAbstract_iB_zK1nWOL8gmL2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="color: Black; text-align: left">Net deferred tax assets:</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right">&#160;</td><td style="color: Black; text-align: left">&#160;</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right">&#160;</td><td style="color: Black; text-align: left">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsForeign_iI_maDTAGzmCT_zmRBKDLHHch3" style="vertical-align: bottom; background-color: White">
    <td style="width: 70%; color: Black; text-align: left; padding-left: 0.125in">Foreign net operating loss carry-forwards</td><td style="width: 1%; color: Black">&#160;</td>
    <td style="width: 1%; color: Black; text-align: left">$</td><td style="width: 12%; color: Black; text-align: right">1,292</td><td style="width: 1%; color: Black; text-align: left">&#160;</td><td style="width: 1%; color: Black">&#160;</td>
    <td style="width: 1%; color: Black; text-align: left">$</td><td style="width: 12%; color: Black; text-align: right">360</td><td style="width: 1%; color: Black; text-align: left">&#160;</td></tr>
<tr id="xdx_40F_ecustom--DeferredTaxAssetsInventoryAndAccountsReceivable_maDTAGzmCT_z1s4JlqTUHm6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="color: Black; text-align: left; padding-left: 0.125in">Inventory and accounts receivable</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right">4,508</td><td style="color: Black; text-align: left">&#160;</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right">1,928</td><td style="color: Black; text-align: left">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--DeferredTaxAssetsDeferredIncome_iI_maDTAGzmCT_zhDcLYc2jnL1" style="vertical-align: bottom; background-color: White">
    <td style="color: Black; text-align: left; padding-left: 0.125in">Profit sharing</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right">3,787</td><td style="color: Black; text-align: left">&#160;</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right">2,936</td><td style="color: Black; text-align: left">&#160;</td></tr>
<tr id="xdx_400_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_iI_maDTAGzmCT_zNImAMKYjB2c" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="color: Black; text-align: left; padding-left: 0.125in">Stock option compensation</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right">732</td><td style="color: Black; text-align: left">&#160;</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right">718</td><td style="color: Black; text-align: left">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--DeferredTaxAssetsInventory_iI_maDTAGzmCT_z9f3UtCJGMCk" style="vertical-align: bottom; background-color: White">
    <td style="color: Black; text-align: left; padding-left: 0.125in">Effect of inventory profit elimination</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right">5,112</td><td style="color: Black; text-align: left">&#160;</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right">4,443</td><td style="color: Black; text-align: left">&#160;</td></tr>
<tr id="xdx_408_eus-gaap--DeferredTaxAssetsOther_iI_maDTAGzmCT_z1TnN3770nd4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="color: Black; padding-bottom: 1pt; padding-left: 0.125in">Other</td><td style="color: Black; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; color: Black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; color: Black; text-align: right">407</td><td style="padding-bottom: 1pt; color: Black; text-align: left">&#160;</td><td style="color: Black; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; color: Black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; color: Black; text-align: right">910</td><td style="padding-bottom: 1pt; color: Black; text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--DeferredTaxAssetsGross_iTI_mtDTAGzmCT_maDTANzIZJ_zghQxM5cOPla" style="vertical-align: bottom; background-color: White">
    <td style="color: Black; text-align: left; padding-left: 0.25in">Total gross deferred tax assets, net</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right">15,838</td><td style="color: Black; text-align: left">&#160;</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right">11,295</td><td style="color: Black; text-align: left">&#160;</td></tr>
<tr id="xdx_408_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_di_msDTANzIZJ_zETuZe2V2e2j" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="color: Black; text-align: left; padding-bottom: 1pt; padding-left: 0.25in">Valuation allowance</td><td style="color: Black; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; color: Black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; color: Black; text-align: right">(3,582</td><td style="padding-bottom: 1pt; color: Black; text-align: left">)</td><td style="color: Black; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; color: Black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; color: Black; text-align: right">(360</td><td style="padding-bottom: 1pt; color: Black; text-align: left">)</td></tr>
<tr id="xdx_40A_eus-gaap--DeferredTaxAssetsNet_iTI_mtDTANzIZJ_zGngeMWftMQd" style="vertical-align: bottom; background-color: White">
    <td style="color: Black; text-align: left; padding-bottom: 1pt; padding-left: 0.25in">Net deferred tax assets</td><td style="color: Black; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; color: Black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; color: Black; text-align: right">12,256</td><td style="padding-bottom: 1pt; color: Black; text-align: left">&#160;</td><td style="color: Black; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; color: Black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; color: Black; text-align: right">10,935</td><td style="padding-bottom: 1pt; color: Black; text-align: left">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--DeferredTaxLiabilitiesNetAbstract_iB_z5kogWajN939" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="color: Black; text-align: left">Deferred tax liabilities (long-term):</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right">&#160;</td><td style="color: Black; text-align: left">&#160;</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right">&#160;</td><td style="color: Black; text-align: left">&#160;</td></tr>
<tr id="xdx_40C_ecustom--DeferredTaxLiabilitiesBuildingExpenses_i01I_zsHnfG6XNNjj" style="vertical-align: bottom; background-color: White">
    <td style="color: Black; text-align: left; padding-left: 0.125in">Building expenses</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right">(1,082</td><td style="color: Black; text-align: left">)</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1764">&#8212;</span></td><td style="color: Black; text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--DeferredTaxLiabilitiesOtherFiniteLivedAssets_i01NI_di_zSa24pNuTUQh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="color: Black; text-align: left; padding-left: 0.125in">Trademarks and licenses</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right">(2,551</td><td style="color: Black; text-align: left">)</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right">(2,894</td><td style="color: Black; text-align: left">)</td></tr>
<tr id="xdx_40B_ecustom--DeferredTaxLiabilitiesUnrealizedGainOnMarketableEquitySecurities_i01I_zebaeX8IqmS" style="vertical-align: bottom; background-color: White">
    <td style="color: Black; text-align: left; padding-left: 0.125in">Unrealized gain on marketable equity securities</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right">(436</td><td style="color: Black; text-align: left">)</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1770">&#8212;</span></td><td style="color: Black; text-align: left">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--DeferredTaxLiabilitiesOther_i01I_zdjodKSLJgG6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="color: Black; padding-bottom: 1pt; padding-left: 0.125in">Other</td><td style="color: Black; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; color: Black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; color: Black; text-align: right">(251</td><td style="padding-bottom: 1pt; color: Black; text-align: left">)</td><td style="color: Black; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; color: Black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; color: Black; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1773">&#8212;</span></td><td style="padding-bottom: 1pt; color: Black; text-align: left">&#160;</td></tr>
<tr id="xdx_400_eus-gaap--DeferredIncomeTaxLiabilities_i01NI_di_zd5vwLFRfw42" style="vertical-align: bottom; background-color: White">
    <td style="color: Black; text-align: left; padding-bottom: 1pt; padding-left: 0.25in">Total deferred tax liabilities</td><td style="color: Black; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; color: Black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; color: Black; text-align: right">(4,320</td><td style="padding-bottom: 1pt; color: Black; text-align: left">)</td><td style="color: Black; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; color: Black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; color: Black; text-align: right">(2,894</td><td style="padding-bottom: 1pt; color: Black; text-align: left">)</td></tr>
<tr id="xdx_407_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iI_zL18h8AAz5ue" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="color: Black; text-align: left; padding-bottom: 2pt; padding-left: 0.25in">Net deferred tax assets</td><td style="color: Black; padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; color: Black; text-align: left">$</td><td style="border-bottom: Black 2pt double; color: Black; text-align: right">7,936</td><td style="padding-bottom: 2pt; color: Black; text-align: left">&#160;</td><td style="color: Black; padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; color: Black; text-align: left">$</td><td style="border-bottom: Black 2pt double; color: Black; text-align: right">8,041</td><td style="padding-bottom: 2pt; color: Black; text-align: left">&#160;</td></tr>
</table>



<p id="xdx_8A0_zTf7XmPVN5Q5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Valuation allowances have been
provided for deferred tax assets relating to foreign net operating loss carry-forwards and reserves acquired in connection with
the acquisition of Interparfums Italia srl, as future profitable operations from certain foreign subsidiaries might not be sufficient
to realize the full amount of the deferred tax assets.</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>INTER PARFUMS, INC. AND SUBSIDIARIES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Notes to Consolidated Financial Statements</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">December 31, 2021, 2020 and 2019</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(In thousands except share and per share data)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">No other valuation allowances
have been provided as management believes that it is more likely than not that the asset will be realized in the reduction of future
taxable income.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company estimated of the
effect of global intangible low-taxed income (&#8220;GILTI&#8221;) and has determined that it has no tax liability related to
GILTI as of December 31, 2021, 2020 and 2019. The Company also estimated the effect of foreign derived intangible income (&#8220;FDII&#8221;)
and recorded a tax benefit of approximately $<span id="xdx_90B_eus-gaap--DeferredForeignIncomeTaxExpenseBenefit_dm_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ForeignDerivedIntangibleIncomeMember_zePfhbys0nCd">0.9 million</span>, $<span id="xdx_90C_eus-gaap--DeferredForeignIncomeTaxExpenseBenefit_dm_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ForeignDerivedIntangibleIncomeMember_zwK5bpy5kvgk">0.3 million</span> and $<span id="xdx_909_eus-gaap--DeferredForeignIncomeTaxExpenseBenefit_dm_c20190101__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ForeignDerivedIntangibleIncomeMember_zexQD05FbtX4">0.9 million</span> as of December&#160;31, 2021, 2020 and
2019, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><b><i>French Tax Settlement</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The French authorities had considered
that the existence of IP Suisse, a wholly-owned subsidiary of Interparfums SA, does not, in and of itself, constitute a permanent
establishment and therefore Interparfums, SA should pay French taxes on all or part of the profits of that entity. In June 2021,
a global settlement agreement was reached with the French Tax Authority whereby Interparfums SA paid in December 2021, &#8364;2.5
million (approximately $2.9 million) effectively lowering the Lanvin brand royalty rate charged by IP Suisse for the periods from
2017 through 2020. Interparfums SA also agreed to apply the lower rate in 2021 through 2025 and to transfer the Lanvin brand from
IP Suisse to Interparfums, SA by December 31, 2025.</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company is no longer subject
to U.S. federal, state, and local income tax examinations by tax authorities for years before 2017.</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p id="xdx_89F_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zuxB3yl6LAej" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8BC_zKFhEewEOfMj">Differences between the United
States federal statutory income tax rate and the effective income tax rate were as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td style="color: Black">&#160;</td><td style="color: Black; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; color: Black; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_49B_20210101__20211231_zKfaQdCfQ1tj" style="border-bottom: Black 1pt solid; color: Black; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; color: Black; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; color: Black; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; color: Black; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_498_20200101__20201231_zCryRnAsh2Gc" style="border-bottom: Black 1pt solid; color: Black; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; color: Black; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; color: Black; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; color: Black; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_49A_20190101__20191231_zzD1b1MT4mt6" style="border-bottom: Black 1pt solid; color: Black; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; color: Black; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="color: Black">&#160;</td><td style="color: Black; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; color: Black; font-weight: bold; text-align: center">Year ended December 31,</td><td style="padding-bottom: 1pt; color: Black; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="color: Black">&#160;</td><td style="color: Black; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; color: Black; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; color: Black; font-weight: bold">&#160;</td><td style="color: Black; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; color: Black; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; color: Black; font-weight: bold">&#160;</td><td style="color: Black; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; color: Black; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1pt; color: Black; font-weight: bold">&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_uPure_zUn273ToAdQi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 55%; color: Black; text-align: left">Statutory rates</td><td style="width: 1%; color: Black">&#160;</td>
    <td style="width: 1%; color: Black; text-align: left">&#160;</td><td style="width: 12%; color: Black; text-align: right">21.0</td><td style="width: 1%; color: Black; text-align: left">%</td><td style="width: 1%; color: Black">&#160;</td>
    <td style="width: 1%; color: Black; text-align: left">&#160;</td><td style="width: 12%; color: Black; text-align: right">21.0</td><td style="width: 1%; color: Black; text-align: left">%</td><td style="width: 1%; color: Black">&#160;</td>
    <td style="width: 1%; color: Black; text-align: left">&#160;</td><td style="width: 12%; color: Black; text-align: right">21.0</td><td style="width: 1%; color: Black; text-align: left">%</td></tr>
<tr id="xdx_40D_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_pid_dp_uPure_z3TsOQpSz64d" style="vertical-align: bottom; background-color: White">
    <td style="color: Black; text-align: left">State and local taxes, net of Federal benefit</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right">0.3</td><td style="color: Black; text-align: left">&#160;</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right">0.2</td><td style="color: Black; text-align: left">&#160;</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right">0.6</td><td style="color: Black; text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--EffectiveIncomeTaxRateReconciliationDeductionsEmployeeStockOwnershipPlanDividends_pid_dp_uPure_zsvSNwGdE5Yg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="color: Black; text-align: left">Windfall benefit from exercise of stock options</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right">(0.9</td><td style="color: Black; text-align: left">)</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right">(0.6</td><td style="color: Black; text-align: left">)</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right">(0.7</td><td style="color: Black; text-align: left">)</td></tr>
<tr id="xdx_407_eus-gaap--EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_pid_dp_uPure_zQNyQrvXODyf" style="vertical-align: bottom; background-color: White">
    <td style="color: Black; text-align: left">Benefit of Foreign Derived Intangible Income</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right">(0.6</td><td style="color: Black; text-align: left">)</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right">(0.4</td><td style="color: Black; text-align: left">)</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right">(0.9</td><td style="color: Black; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="color: Black; text-align: left">Effect of foreign taxes greater than</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right">&#160;</td><td style="color: Black; text-align: left">&#160;</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right">&#160;</td><td style="color: Black; text-align: left">&#160;</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right">&#160;</td><td style="color: Black; text-align: left">&#160;</td></tr>
<tr id="xdx_408_ecustom--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate1_pid_dp_uPure_z0tNlUfNQ9Yk" style="vertical-align: bottom; background-color: White">
    <td style="color: Black; text-align: left; padding-left: 0.125in">U.S. statutory rates</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right">7.4</td><td style="color: Black; text-align: left">&#160;</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right">7.5</td><td style="color: Black; text-align: left">&#160;</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right">7.5</td><td style="color: Black; text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherAdjustments_pid_dp_zswJ8pulXbZ7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="color: Black; padding-bottom: 1pt">Other</td><td style="color: Black; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; color: Black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; color: Black; text-align: right">(0.1</td><td style="padding-bottom: 1pt; color: Black; text-align: left">)</td><td style="color: Black; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; color: Black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; color: Black; text-align: right">0.2</td><td style="padding-bottom: 1pt; color: Black; text-align: left">&#160;</td><td style="color: Black; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; color: Black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; color: Black; text-align: right">0.1</td><td style="padding-bottom: 1pt; color: Black; text-align: left">&#160;</td></tr>
<tr id="xdx_401_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_pid_dp_zZMCFfSnrETc" style="vertical-align: bottom; background-color: White">
    <td style="color: Black; text-align: left; padding-bottom: 2pt; padding-left: 0.25in">Effective rates</td><td style="color: Black; padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; color: Black; text-align: left">&#160;</td><td style="border-bottom: Black 2pt double; color: Black; text-align: right">27.1</td><td style="padding-bottom: 2pt; color: Black; text-align: left">%</td><td style="color: Black; padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; color: Black; text-align: left">&#160;</td><td style="border-bottom: Black 2pt double; color: Black; text-align: right">27.9</td><td style="padding-bottom: 2pt; color: Black; text-align: left">%</td><td style="color: Black; padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; color: Black; text-align: left">&#160;</td><td style="border-bottom: Black 2pt double; color: Black; text-align: right">27.6</td><td style="padding-bottom: 2pt; color: Black; text-align: left">%</td></tr>
</table>



<p id="xdx_8AB_zdd6uejOfoTi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>INTER PARFUMS, INC. AND SUBSIDIARIES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Notes to Consolidated Financial Statements</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">December 31, 2021, 2020 and 2019</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(In thousands except share and per share data)</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139983555870872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated Other Comprehensive Loss<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNoteTextBlock', window );">Accumulated Other Comprehensive Loss</a></td>
<td class="text"><p id="xdx_801_eus-gaap--ComprehensiveIncomeNoteTextBlock_zekB4W6nwU4d" style="margin-top: 0; margin-bottom: 0"/>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in">(17)</td><td><span id="xdx_82A_zMDiheg1qEY">Accumulated Other Comprehensive Loss</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p id="xdx_891_eus-gaap--ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_zT2ahtPkK5pg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_8BD_z2018wLiyWrk">The components of accumulated other
comprehensive loss consist of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td style="color: Black">&#160;</td><td style="color: Black; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; color: Black; font-weight: bold; text-align: center">Year ended December 31,</td><td style="padding-bottom: 1pt; color: Black; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="color: Black">&#160;</td><td style="color: Black; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; color: Black; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; color: Black; font-weight: bold">&#160;</td><td style="color: Black; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; color: Black; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; color: Black; font-weight: bold">&#160;</td><td style="color: Black; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; color: Black; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1pt; color: Black; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="color: Black">&#160;</td><td style="color: Black; font-weight: bold">&#160;</td>
    <td colspan="2" style="color: Black; font-weight: bold; text-align: center">&#160;</td><td style="color: Black; font-weight: bold">&#160;</td><td style="color: Black; font-weight: bold">&#160;</td>
    <td colspan="2" style="color: Black; font-weight: bold; text-align: center">&#160;</td><td style="color: Black; font-weight: bold">&#160;</td><td style="color: Black; font-weight: bold">&#160;</td>
    <td colspan="2" style="color: Black; font-weight: bold; text-align: center">&#160;</td><td style="color: Black; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 55%; color: Black; text-align: left">Net derivative instruments, beginning of year</td><td style="width: 1%; color: Black">&#160;</td>
    <td style="width: 1%; color: Black; text-align: left">$</td><td id="xdx_98A_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iS_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember_z8NwCIV0OFgi" style="width: 12%; color: Black; text-align: right" title="Net derivative instruments, beginning of year"><span style="-sec-ix-hidden: xdx2ixbrl1818">&#8212;</span></td><td style="width: 1%; color: Black; text-align: left">&#160;</td><td style="width: 1%; color: Black">&#160;</td>
    <td style="width: 1%; color: Black; text-align: left">$</td><td id="xdx_985_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iS_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__custom--AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember_zVLnjObU6Ota" style="width: 12%; color: Black; text-align: right" title="Net derivative instruments, beginning of year">52</td><td style="width: 1%; color: Black; text-align: left">&#160;</td><td style="width: 1%; color: Black">&#160;</td>
    <td style="width: 1%; color: Black; text-align: left">$</td><td id="xdx_984_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iS_c20190101__20191231__us-gaap--StatementEquityComponentsAxis__custom--AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember_zcO40Katkn9e" style="width: 12%; color: Black; text-align: right" title="Net derivative instruments, beginning of year">136</td><td style="width: 1%; color: Black; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="color: Black; text-align: left; padding-bottom: 1pt">Net derivative instrument loss, net of tax</td><td style="color: Black; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; color: Black; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember_znaE0XRI0M8i" style="border-bottom: Black 1pt solid; color: Black; text-align: right" title="Net derivative instrument gain (loss), net of tax">(992</td><td style="padding-bottom: 1pt; color: Black; text-align: left">)</td><td style="color: Black; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; color: Black; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__custom--AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember_zpWsCwwmm9K5" style="border-bottom: Black 1pt solid; color: Black; text-align: right" title="Net derivative instrument gain (loss), net of tax">(52</td><td style="padding-bottom: 1pt; color: Black; text-align: left">)</td><td style="color: Black; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; color: Black; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent_c20190101__20191231__us-gaap--StatementEquityComponentsAxis__custom--AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember_zulD6iHEI5a6" style="border-bottom: Black 1pt solid; color: Black; text-align: right" title="Net derivative instrument gain (loss), net of tax">(84</td><td style="padding-bottom: 1pt; color: Black; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="color: Black; text-align: left; padding-bottom: 1pt">Net derivative instruments, end of year</td><td style="color: Black; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; color: Black; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iE_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember_zi0dEX2OAb1e" style="border-bottom: Black 1pt solid; color: Black; text-align: right" title="Net derivative instruments, end of year">(992</td><td style="padding-bottom: 1pt; color: Black; text-align: left">)</td><td style="color: Black; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; color: Black; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iE_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__custom--AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember_zmSt4N8sPGl2" style="border-bottom: Black 1pt solid; color: Black; text-align: right" title="Net derivative instruments, end of year"><span style="-sec-ix-hidden: xdx2ixbrl1832">&#8212;</span></td><td style="padding-bottom: 1pt; color: Black; text-align: left">&#160;</td><td style="color: Black; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; color: Black; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iE_c20190101__20191231__us-gaap--StatementEquityComponentsAxis__custom--AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember_zlAFjDVhRoaa" style="border-bottom: Black 1pt solid; color: Black; text-align: right" title="Net derivative instruments, end of year">52</td><td style="padding-bottom: 1pt; color: Black; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="color: Black">&#160;</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right">&#160;</td><td style="color: Black; text-align: left">&#160;</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right">&#160;</td><td style="color: Black; text-align: left">&#160;</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right">&#160;</td><td style="color: Black; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="color: Black; text-align: left">Cumulative translation adjustments, beginning of year</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iS_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedTranslationAdjustmentMember_zZtL9OD2C5Tg" style="color: Black; text-align: right" title="Cumulative translation adjustments, beginning of year">(5,997</td><td style="color: Black; text-align: left">)</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iS_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedTranslationAdjustmentMember_zx08Us77Xpv" style="color: Black; text-align: right" title="Cumulative translation adjustments, beginning of year">(39,905</td><td style="color: Black; text-align: left">)</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iS_c20190101__20191231__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedTranslationAdjustmentMember_zEaBJn0ox5Ja" style="color: Black; text-align: right" title="Cumulative translation adjustments, beginning of year">(33,786</td><td style="color: Black; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="color: Black; text-align: left; padding-bottom: 1pt">Translation adjustments</td><td style="color: Black; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; color: Black; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedTranslationAdjustmentMember_zVfsua6Vt5c5" style="border-bottom: Black 1pt solid; color: Black; text-align: right" title="Translation adjustments">(31,443</td><td style="padding-bottom: 1pt; color: Black; text-align: left">)</td><td style="color: Black; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; color: Black; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedTranslationAdjustmentMember_z2zWJIkxmuT9" style="border-bottom: Black 1pt solid; color: Black; text-align: right" title="Translation adjustments">33,908</td><td style="padding-bottom: 1pt; color: Black; text-align: left">&#160;</td><td style="color: Black; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; color: Black; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_c20190101__20191231__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedTranslationAdjustmentMember_zsSrjNLPOCfl" style="border-bottom: Black 1pt solid; color: Black; text-align: right" title="Translation adjustments">(6,119</td><td style="padding-bottom: 1pt; color: Black; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="color: Black; text-align: left; padding-bottom: 1pt">Cumulative translation adjustments, end of year</td><td style="color: Black; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; color: Black; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iE_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedTranslationAdjustmentMember_zRPbbUho5b1l" style="border-bottom: Black 1pt solid; color: Black; text-align: right" title="Cumulative translation adjustments, end of year">(37,440</td><td style="padding-bottom: 1pt; color: Black; text-align: left">)</td><td style="color: Black; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; color: Black; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iE_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedTranslationAdjustmentMember_zMO8dc2L7wp6" style="border-bottom: Black 1pt solid; color: Black; text-align: right" title="Cumulative translation adjustments, end of year">(5,997</td><td style="padding-bottom: 1pt; color: Black; text-align: left">)</td><td style="color: Black; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; color: Black; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iE_c20190101__20191231__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedTranslationAdjustmentMember_zxkqgm5CvTZ1" style="border-bottom: Black 1pt solid; color: Black; text-align: right" title="Cumulative translation adjustments, end of year">(39,905</td><td style="padding-bottom: 1pt; color: Black; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="color: Black">&#160;</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right">&#160;</td><td style="color: Black; text-align: left">&#160;</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right">&#160;</td><td style="color: Black; text-align: left">&#160;</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right">&#160;</td><td style="color: Black; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="color: Black; text-align: left; padding-bottom: 2pt">Accumulated other comprehensive loss</td><td style="color: Black; padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; color: Black; text-align: left">$</td><td id="xdx_98A_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iI_c20211231_z9lfBa14i2V1" style="border-bottom: Black 2pt double; color: Black; text-align: right" title="Accumulated other comprehensive loss">(38,432</td><td style="padding-bottom: 2pt; color: Black; text-align: left">)</td><td style="color: Black; padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; color: Black; text-align: left">$</td><td id="xdx_986_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iI_c20201231_zrepYmMBCj0k" style="border-bottom: Black 2pt double; color: Black; text-align: right">(5,997</td><td style="padding-bottom: 2pt; color: Black; text-align: left">)</td><td style="color: Black; padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; color: Black; text-align: left">$</td><td id="xdx_98D_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iI_c20191231_zXZBNJmdo7Of" style="border-bottom: Black 2pt double; color: Black; text-align: right">(39,853</td><td style="padding-bottom: 2pt; color: Black; text-align: left">)</td></tr>
</table>

<p id="xdx_8A0_zE2lWp6Gzvc7" style="margin-top: 0; margin-bottom: 0">&#160;</p>



<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNoteTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -URI http://asc.fasb.org/topic&amp;trid=2134417<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNoteTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139983556294568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income Attributable to Inter Parfums, Inc. and Transfers from the Noncontrolling Interest<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestAbstract', window );"><strong>Noncontrolling Interest [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDisclosureTextBlock', window );">Net Income Attributable to Inter Parfums, Inc. and Transfers from the Noncontrolling Interest</a></td>
<td class="text"><p id="xdx_806_eus-gaap--MinorityInterestDisclosureTextBlock_zByigvtYnxki" style="margin-top: 0; margin-bottom: 0"/>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in">(18)</td><td><span id="xdx_826_zfNvBoYHth0k">Net Income Attributable to Inter Parfums, Inc. and Transfers from the Noncontrolling Interest</span></td></tr></table>

<p id="xdx_892_eus-gaap--ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock_z6bQSfK2HVW7" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span id="xdx_8B3_zT1VWmcDFA85" style="display: none; visibility: hidden">Schedule of net income attributable to transfers from the noncontrolling interest</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_494_20210101__20211231_zmj7rP5v3rye" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_492_20200101__20201231_zwVHY0pR8ec5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_499_20190101__20191231_z0DwhBQWU0dk" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="color: Black">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="color: Black">&#160;</span></td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="color: Black">Year
    ended December 31,</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="color: Black">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="color: Black">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="color: Black">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="color: Black">2021</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="color: Black">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="color: Black">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="color: Black">2020</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="color: Black">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="color: Black">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="color: Black">2019</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="color: Black">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="color: Black">&#160;</span></td><td style="font-weight: bold"><span style="color: Black">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="color: Black">&#160;</span></td><td style="font-weight: bold"><span style="color: Black">&#160;</span></td><td style="font-weight: bold"><span style="color: Black">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="color: Black">&#160;</span></td><td style="font-weight: bold"><span style="color: Black">&#160;</span></td><td style="font-weight: bold"><span style="color: Black">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="color: Black">&#160;</span></td><td style="font-weight: bold"><span style="color: Black">&#160;</span></td></tr>
<tr id="xdx_407_eus-gaap--NetIncomeLoss_z7p5PdToESgh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 55%; text-align: left; padding-left: 0.125in; text-indent: -0.125in"><span style="color: Black">Net income attributable to Inter Parfums, Inc.</span></td><td style="width: 1%"><span style="color: Black">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="color: Black">$</span></td><td style="width: 12%; text-align: right"><span style="color: Black">87,411</span></td><td style="width: 1%; text-align: left"><span style="color: Black">&#160;</span></td><td style="width: 1%"><span style="color: Black">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="color: Black">$</span></td><td style="width: 12%; text-align: right"><span style="color: Black">38,219</span></td><td style="width: 1%; text-align: left"><span style="color: Black">&#160;</span></td><td style="width: 1%"><span style="color: Black">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="color: Black">$</span></td><td style="width: 12%; text-align: right"><span style="color: Black">60,249</span></td><td style="width: 1%; text-align: left"><span style="color: Black">&#160;</span></td></tr>
<tr id="xdx_402_eus-gaap--ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesNet_z6sJRoHhgHQ2" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in"><span style="color: Black">Decrease in Inter Parfums, Inc.&#8217;s additional
    paid-in capital for subsidiary share transactions</span></td><td style="padding-bottom: 1pt"><span style="color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="color: Black">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="color: Black"><span style="-sec-ix-hidden: xdx2ixbrl1866">&#8212;</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="color: Black">&#160;</span></td><td style="padding-bottom: 1pt"><span style="color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="color: Black">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="color: Black"><span style="-sec-ix-hidden: xdx2ixbrl1867">&#8212;</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="color: Black">&#160;</span></td><td style="color: #FF0000; padding-bottom: 1pt"><span style="color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; color: #FF0000; text-align: left"><span style="color: Black">&#160;</span></td><td style="border-bottom: Black 1pt solid; color: #FF0000; text-align: right"><span style="color: Black">(5,167</span></td><td style="padding-bottom: 1pt; color: #FF0000; text-align: left"><span style="color: Black">)</span></td></tr>
<tr id="xdx_400_eus-gaap--ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNet_z88EJYfrzncb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2pt; padding-left: 0.125in; text-indent: -0.125in"><p style="margin-top: 0; margin-bottom: 0"/>
                                                                                <p style="margin-top: 0; margin-bottom: 0">&#160;<span style="color: Black">Change from net income attributable to Inter Parfums, Inc. and transfers from noncontrolling interest</span></p></td><td style="padding-bottom: 2pt"><span style="color: Black">&#160;</span></td>
    <td style="border-bottom: Black 2pt double; text-align: left"><span style="color: Black">$</span></td><td style="border-bottom: Black 2pt double; text-align: right"><span style="color: Black">87,411</span></td><td style="padding-bottom: 2pt; text-align: left"><span style="color: Black">&#160;</span></td><td style="padding-bottom: 2pt"><span style="color: Black">&#160;</span></td>
    <td style="border-bottom: Black 2pt double; text-align: left"><span style="color: Black">$</span></td><td style="border-bottom: Black 2pt double; text-align: right"><span style="color: Black">38,219</span></td><td style="padding-bottom: 2pt; text-align: left"><span style="color: Black">&#160;</span></td><td style="padding-bottom: 2pt"><span style="color: Black">&#160;</span></td>
    <td style="border-bottom: Black 2pt double; text-align: left"><span style="color: Black">$</span></td><td style="border-bottom: Black 2pt double; text-align: right"><span style="color: Black">55,082</span></td><td style="padding-bottom: 2pt; text-align: left"><span style="color: Black">&#160;</span></td></tr>
</table>



<p id="xdx_8AD_zGaZYBR2EsGg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for noncontrolling interest in consolidated subsidiaries, which could include the name of the subsidiary, the ownership percentage held by the parent, the ownership percentage held by the noncontrolling owners, the amount of the noncontrolling interest, the location of this amount on the balance sheet (when not reported separately), an explanation of the increase or decrease in the amount of the noncontrolling interest, the noncontrolling interest share of the net Income or Loss of the subsidiary, the location of this amount on the income statement (when not reported separately), the nature of the noncontrolling interest such as background information and terms, the amount of the noncontrolling interest represented by preferred stock, a description of the preferred stock, and the dividend requirements of the preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI http://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139983555835480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Reconciliation of Cash and Cash Equivalents to the Statement of Cash Flows<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ipar_DisclosureReconciliationOfCashAndCashEquivalentsToStatementOfCashFlowsAbstract', window );"><strong>Reconciliation Of Cash And Cash Equivalents To Statement Of Cash Flows</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ipar_ReconciliationOfCashAndCashEquivalentsToTheStatementOfCashFlowsTextBlock', window );">Reconciliation of Cash and Cash Equivalents to the Statement of Cash Flows</a></td>
<td class="text"><p id="xdx_80D_ecustom--ReconciliationOfCashAndCashEquivalentsToTheStatementOfCashFlowsTextBlock_z3A1PtU4iC4e" style="margin-top: 0; margin-bottom: 0"/>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in">(19)</td><td><span id="xdx_828_zwupbeSFx0qk">Reconciliation of Cash and Cash Equivalents to the Statement of Cash Flows</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p id="xdx_893_eus-gaap--ScheduleOfCashAndCashEquivalentsTableTextBlock_zp6EmKT6Xtp4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8BD_zpQue6aL6gP9">The following table summarizes
cash and cash equivalents as of December 31, 2021:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td style="font-family: Courier New, Courier, Monospace; text-align: justify">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49D_20211231_zPehRo7p78A2" style="border-bottom: Black 1pt solid; text-align: center">December 31, 2021</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: justify">&#160;</td><td>&#160;</td></tr>
<tr id="xdx_409_eus-gaap--CashCashEquivalentsAndShortTermInvestments_iI_zX1rKjbN7Yn5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 85%; text-align: left">Cash and cash equivalents per balance sheet</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">159,613</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_40E_ecustom--CashHeldInEscrowIncludedInOtherAssets_iI_zgfaoIKvSPUl" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Cash held in escrow included in other assets (see note 3)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">8,774</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40C_ecustom--CashAndCashEquivalentsPerStatementOfCashFlows_iI_z3NGxqJWTH9i" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2pt">Cash and cash equivalents per statement of cash flows</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td style="border-bottom: Black 2pt double; text-align: right">168,387</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
</table>

<p id="xdx_8AE_zUUhc8uvTUeg" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ipar_DisclosureReconciliationOfCashAndCashEquivalentsToStatementOfCashFlowsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ipar_DisclosureReconciliationOfCashAndCashEquivalentsToStatementOfCashFlowsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ipar_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ipar_ReconciliationOfCashAndCashEquivalentsToTheStatementOfCashFlowsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reconciliation of cash and cash equivalents to the statement of cash flows.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ipar_ReconciliationOfCashAndCashEquivalentsToTheStatementOfCashFlowsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ipar_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139983549857448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>The Company and its Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock', window );">Business of the Company</a></td>
<td class="text"><p id="xdx_84F_eus-gaap--BusinessDescriptionAndAccountingPoliciesTextBlock_zaqQ1CrlHMM9" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_867_zFeuUXnmqXK2">Business of the Company</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Inter Parfums, Inc. and its subsidiaries
(the &#8220;Company&#8221;) are in the fragrance business and manufacture and distribute a wide array of fragrances and fragrance
related products.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p id="xdx_899_eus-gaap--SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_zpcXTUGeaJk8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Substantially all of our prestige
fragrance brands are licensed from unaffiliated third parties, and our business is dependent upon the continuation and renewal
of such licenses. <span>With respect to the Company&#8217;s largest brands, we license the Montblanc, Jimmy Choo, Coach and GUESS brand
names. As a percentage of net sales, product sales for the Company&#8217;s largest brands were as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;<span id="xdx_8BB_zLfZsxXUNYea" style="display: none; visibility: hidden">Schedule of lanvin brand name for our class</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year Ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 55%">Montblanc</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--MontblancMember_zYQdpsEiMHBc" style="width: 12%; text-align: right" title="Concentration risk percentage">19</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20200101__20201231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--MontblancMember_zByVvYIo3wEk" style="width: 12%; text-align: right">21</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20190101__20191231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--MontblancMember_z8jeCKYz1uF1" style="width: 12%; text-align: right" title="Concentration risk percentage">22</td><td style="width: 1%; text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Jimmy Choo</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--JimmyChooMember_zQprf6WWuqpb" style="text-align: right">18</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20200101__20201231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--JimmyChooMember_zS5aVrWrtb99" style="text-align: right" title="Concentration risk percentage">16</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20190101__20191231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--JimmyChooMember_zKh8Vx48zKxg" style="text-align: right">16</td><td style="text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Coach</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--CoachMember_zz272R6gNMCg" style="text-align: right">16</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20200101__20201231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--CoachMember_zoFqBpv49ldh" style="text-align: right">17</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20190101__20191231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--CoachMember_z8tyQcKDn2p3" style="text-align: right">14</td><td style="text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>GUESS</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--GUESSMember_zjFmBtriPnHe" style="text-align: right">12</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20200101__20201231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--GUESSMember_zs5yKA1qgED6" style="text-align: right">11</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20190101__20191231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--GUESSMember_zFSzsWYUIFY7" style="text-align: right">10</td><td style="text-align: left">%</td></tr>
</table>

<p id="xdx_8AB_zhfDGbBby8R8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">No other brand represented 10%
or more of consolidated net sales.</p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Preparation</a></td>
<td class="text"><p id="xdx_84E_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zFBXQNTiBWB1" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_864_zsDymlX0yt0e">Basis of Preparation</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-size: 10pt; color: windowtext">The
consolidated financial statements include the accounts of the Company and its subsidiaries, including <span id="xdx_903_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_uPure_c20211231__srt--OwnershipAxis__custom--InterparfumsSASubsidiaryMember_zI2O3snRjMKg" title="Ownership percentage in Interparfums SA">73</span>% owned Interparfums SA,
a subsidiary whose stock is publicly traded in France.</span> <span style="font-size: 10pt">All material intercompany balances
and transactions have been eliminated</span>.</p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Management Estimates</a></td>
<td class="text"><p id="xdx_84D_eus-gaap--UseOfEstimates_zbo5NVG30hw9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><b><i><span id="xdx_862_zrUMUeldlUT8">Management Estimates</span></i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Management makes assumptions
and estimates to prepare financial statements in conformity with accounting principles generally accepted in the United States
of America. Those assumptions and estimates directly affect the amounts reported and disclosures included in the consolidated financial
statements. Actual results could differ from those assumptions and estimates. Significant estimates for which changes in the near
term are considered reasonably possible and that may have a material impact on the financial statements are disclosed in these
notes to the consolidated financial statements.</p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">Foreign Currency Translation</a></td>
<td class="text"><p id="xdx_846_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_zE5MUTGyRm4c" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_86C_z28ilshIsQI2">Foreign Currency Translation</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">For foreign subsidiaries with
operations denominated in a foreign currency, assets and liabilities are translated to U.S. dollars at year-end exchange rates.
Income and expense items are translated at average rates of exchange prevailing during the year. Gains and losses from translation
adjustments are accumulated in a separate component of shareholders&#8217; equity.</p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents and Short-Term Investments</a></td>
<td class="text"><p id="xdx_844_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zEpMocWzPs56" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_86B_zCDC3UyqFj93">Cash and Cash Equivalents
and Short-Term Investments</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">All highly liquid investments
purchased with a maturity of three months or less are considered to be cash equivalents. The Company also has short-term investments
which consist of certificates of deposit and other contracts with maturities greater than three months and available for sale marketable
equity securities. The Company monitors concentrations of credit risk associated with financial institutions with which the Company
conducts significant business. The Company believes its credit risk is minimal, as the Company primarily conducts business with
large, well-established financial institutions. Substantially all cash and cash equivalents are primarily held at financial institutions
outside the United States and are readily convertible into U.S. dollars.</p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TradeAndOtherAccountsReceivablePolicy', window );">Accounts Receivable</a></td>
<td class="text"><p id="xdx_84F_eus-gaap--TradeAndOtherAccountsReceivablePolicy_zOX5N7CtF7sa" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_86C_zRrOsXXviwH7">Accounts Receivable</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Accounts receivable represent
payments due to the Company for previously recognized net sales, reduced by allowances for doubtful accounts or balances which
are estimated to be uncollectible, which aggregated $<span id="xdx_908_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_dm_c20211231_zIjlU4KCWMod" title="Allowances for sales returns and doubtful accounts">2.2 million</span> and $<span id="xdx_907_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_dm_c20201231_zsvFPBrg2MW8" title="Allowances for sales returns and doubtful accounts">5.5 million</span> as of December 31, 2021 and 2020, respectively.
Accounts receivable balances are written-off against the allowance for doubtful accounts when they become uncollectible. Recoveries
of accounts receivable previously recorded against the allowance are recorded in the consolidated statement of income when received.
We generally grant credit based upon our analysis of the customer&#8217;s financial position, as well as previously established
buying patterns.</p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryPolicyTextBlock', window );">Inventories</a></td>
<td class="text"><p id="xdx_84F_eus-gaap--InventoryPolicyTextBlock_ztbdawIs4OD2" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_86C_zNu6STEIHY4i">Inventories</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Inventories, including promotional
merchandise, only include inventory considered saleable or usable in future periods, and are stated at the lower of cost and net
realizable value, with cost being determined on the first-in, first-out method.&#160;Cost components include raw materials, direct
labor and overhead (e.g., indirect labor, utilities, depreciation, purchasing, receiving, inspection and warehousing) as well as
inbound freight.&#160;Promotional merchandise is charged to cost of sales at the time the merchandise is shipped to the Company&#8217;s
customers.</p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesPolicyTextBlock', window );">Derivatives</a></td>
<td class="text"><p id="xdx_84A_eus-gaap--DerivativesPolicyTextBlock_z9baj96Z3Uch" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_865_zEB0CQ2uqAGl">Derivatives</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">All derivative instruments are
recorded as either assets or liabilities and measured at fair value. The Company uses derivative instruments to principally manage
a variety of market risks. For derivatives designated as hedges of the exposure to changes in fair value of the recognized asset
or liability or a firm commitment (referred to as fair value hedges), the gain or loss is recognized in earnings in the period
of change together with the offsetting loss or gain on the hedged item attributable to the risk being hedged. The effect of that
accounting is to include in earnings the extent to which the hedge is not effective in achieving offsetting changes in fair value.
For cash flow hedges, the effective portion of the derivative&#8217;s gain or loss is initially reported in equity (as a component
of accumulated other comprehensive income) and is subsequently reclassified into earnings in the same period or periods during
which the hedged forecasted transaction affects earnings. The ineffective portion of the gain or loss of a cash flow hedge is reported
in earnings immediately. The Company also holds certain instruments for economic purposes that are not designated for hedge accounting
treatment. For these derivative instruments, changes in their fair value are recorded in earnings immediately.</p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property, Equipment and Leasehold Improvements</a></td>
<td class="text"><p id="xdx_84E_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zxLXxkQD6l59" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_862_ziePjxIBxEIi">Property, Equipment
and Leasehold Improvements</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Property, equipment and leasehold
improvements are stated at cost less accumulated depreciation and amortization. Depreciation and amortization are provided using
the straight-line method over the estimated useful lives for equipment, which range between three and ten&#160;years and the shorter
of the lease term or estimated useful asset lives for leasehold improvements. Depreciation has not yet begun on property recently
purchased, as it has not yet been put into service. Depreciation provided on equipment used to produce inventory, such as tools
and molds, is included in cost of sales.</p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock', window );">Long-Lived Assets</a></td>
<td class="text"><p id="xdx_84B_eus-gaap--GoodwillAndIntangibleAssetsPolicyTextBlock_zMLyGXt7t8gg" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_86B_zh41q5d3MFDh">Long-Lived Assets</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Indefinite-lived intangible assets
principally consist of trademarks which are not amortized. The Company evaluates indefinite-lived intangible assets for impairment
at least annually during the fourth quarter, or more frequently when events occur or circumstances change, such as an unexpected
decline in sales, that would more-likely-than-not indicate that the carrying value of an indefinite-lived intangible asset may
not be recoverable. When testing indefinite-lived intangible assets for impairment, the evaluation requires a comparison of the
estimated fair value of the asset to the carrying value of the asset. The fair values used in our evaluations are estimated based
upon discounted future cash flow projections using a weighted average cost of capital of <span id="xdx_905_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_uPure_c20211231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountRateMember_zjI95Q9b1fGj" title="Weighted average cost of capital">7.47</span>% and <span id="xdx_906_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_uPure_c20201231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountRateMember_zitEfXDLlzZj" title="Weighted average cost of capital">6.99</span>% in 2021 and 2020, respectively.
The cash flow projections are based upon a number of assumptions, including future sales levels, future cost of goods and operating
expense levels, as well as economic conditions, changes to our business model or changes in consumer acceptance of our products
which are more subjective in nature. If the carrying value of an indefinite-lived intangible asset exceeds its fair value, an impairment
charge is recorded.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Intangible assets subject to
amortization are evaluated for impairment testing whenever events or changes in circumstances indicate that the carrying amount
of an amortizable intangible asset may not be recoverable. If impairment indicators exist for an amortizable intangible asset,
the undiscounted future cash flows associated with the expected service potential of the asset are compared to the carrying value
of the asset. If our projection of undiscounted future cash flows is in excess of the carrying value of the intangible asset, no
impairment charge is recorded. If our projection of undiscounted future cash flows is less than the carrying value of the intangible
asset, an impairment charge would be recorded to reduce the intangible asset to its fair value.</p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text"><p id="xdx_846_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_ztLcWRB1tRh4" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_868_zDcPDuMSob3a">Revenue Recognition</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company sells its products
to department stores, perfumeries, specialty stores and domestic and international wholesalers and distributors. Our revenue contracts
represent single performance obligations to sell our products to customers. Sales of such products by our domestic subsidiaries
are denominated in U.S. dollars, and sales of such products by our foreign subsidiaries are primarily denominated in either euro
or U.S. dollars. The Company recognizes revenues when contract terms are met, the price is fixed and determinable, collectability
is reasonably assured, and control of the assets has passed to the customer based on the agreed upon shipping terms. Net sales
are comprised of gross revenues less returns, trade discounts and allowances. The Company does not bill its customers&#8217; freight
and handling charges. All shipping and handling costs, which aggregated $<span id="xdx_903_eus-gaap--CostOfGoodsAndServicesSold_dm_c20210101__20211231__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_z7kiNCO2jrZd" title="Shipping and handling costs">10.1 million</span>, $<span id="xdx_901_eus-gaap--CostOfGoodsAndServicesSold_dm_c20200101__20201231__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_zYpnjFOqQbrf" title="Shipping and handling costs">5.0 million</span> and $<span id="xdx_907_eus-gaap--CostOfGoodsAndServicesSold_dm_c20190101__20191231__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_zbv06j8IAt58" title="Shipping and handling costs">7.7 million</span> in 2021, 2020
and 2019, respectively, are included in selling, general and administrative expenses in the consolidated statements of income.
The Company grants credit to all qualified customers and does not believe it is exposed significantly to any undue concentration
of credit risk. No one customer represented <span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember_zoLUvQ3mRx5b" title="Concentration risk percentage"><span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20200101__20201231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember_zhfXNG5EgFo" title="Concentration risk percentage"><span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20190101__20191231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember_zyOX9TezhAsb" title="Concentration risk percentage">10</span></span></span>% or more of net sales in 2021, 2020 or 2019.</p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRecognitionSalesReturns', window );">Sales Returns</a></td>
<td class="text"><p id="xdx_842_eus-gaap--RevenueRecognitionSalesReturns_zRzspxwoKQok" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><b><i><span id="xdx_86A_z8xvPmwjEzX2">Sales Returns</span></i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Generally, the Company does not
permit customers to return their unsold products. However, for U.S. based customers, we allow returns if properly requested, authorized
and approved. The Company regularly reviews and revises, as deemed necessary, its estimate of reserves for future sales returns
based primarily upon historic trends and relevant current data including information provided by retailers regarding their inventory
levels. In addition, as necessary, specific accruals may be established for significant future known or anticipated events. The
types of known or anticipated events that we consider include, but are not limited to, the financial condition of our customers,
store closings by retailers, changes in the retail environment and our decision to continue to support new and existing products.
The Company records its estimate of potential sales returns as a reduction of sales and cost of sales with corresponding entries
to accrued expenses, to record the refund liability, and inventory, for the right to recover goods from the customer. The refund
liability associated with estimated returns was $<span id="xdx_908_eus-gaap--ContractWithCustomerRefundLiability_iI_dm_c20211231_znyf5BtratH3" title="Contract with customer, refund liability">5.1 million</span> and $<span id="xdx_90C_eus-gaap--ContractWithCustomerRefundLiability_iI_dm_c20201231_zRetSX8A8Xf2" title="Contract with customer, refund liability">3.6 million</span> at December 31, 2021 and 2020, respectively, and
the amounts recognized for the rights to recover products was $<span id="xdx_901_eus-gaap--ContractWithCustomerRightToRecoverProduct_iI_dm_c20211231_zeBEEVsuiDj8" title="Contract with customer, right to recover products">1.9 million</span> and $<span id="xdx_907_eus-gaap--ContractWithCustomerRightToRecoverProduct_iI_dm_c20201231_z0jjHn77u3ra" title="Contract with customer, right to recover products">1.4 million</span> at December 31, 2021 and 2020, respectively.
The physical condition and marketability of returned products are the major factors we consider in estimating realizable value.
Actual returns, as well as estimated realizable values of returned products, may differ significantly, either favorably or unfavorably,
from our estimates, if factors such as economic conditions, inventory levels or competitive conditions differ from our expectations.</p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRecognitionAllowances', window );">Payments to Customers</a></td>
<td class="text"><p id="xdx_848_eus-gaap--RevenueRecognitionAllowances_zIXF944rySMe" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_868_znLVY5SKtDS2">Payments to Customers</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company records revenues
generated from purchase with purchase and gift with purchase promotions as sales and the costs of its purchase with purchase and
gift with purchase promotions as cost of sales. Certain other incentive arrangements require the payment of a fee to customers
based on their attainment of pre-established sales levels.&#160;These fees have been recorded as a reduction of net sales.</p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdvertisingCostsPolicyTextBlock', window );">Advertising and Promotion</a></td>
<td class="text"><p id="xdx_847_eus-gaap--AdvertisingCostsPolicyTextBlock_zMhsa7dUIP4b" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_86B_zKwixucqi0Wc">Advertising and Promotion</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Advertising and promotional costs
are expensed as incurred and recorded as a component of cost of goods sold (in the case of free goods given to customers) or selling,
general and administrative expenses. Advertising and promotional costs included in selling, general and administrative expenses
were $<span id="xdx_90F_eus-gaap--AdvertisingExpense_dm_c20210101__20211231_zO66CJoHkc5i" title="Advertising costs">171.8 million</span>, $<span id="xdx_900_eus-gaap--AdvertisingExpense_dm_c20200101__20201231_zmbGZy0nheab" title="Advertising costs">91.7 million</span> and $<span id="xdx_906_eus-gaap--AdvertisingExpense_dm_c20190101__20191231_zSBuyQo7SUfj" title="Advertising costs">144.6 million</span> for 2021, 2020 and 2019, respectively. Costs relating to purchase with purchase
and gift with purchase promotions that are reflected in cost of sales aggregated $<span id="xdx_90B_eus-gaap--MarketingExpense_dm_c20210101__20211231_zkC5S7wCoKt" title="Customer incentives cost">37.6 million</span>, $<span id="xdx_907_eus-gaap--MarketingExpense_dm_c20200101__20201231_zIl6u6IHe97g" title="Customer incentives cost">26.4 million</span> and $<span id="xdx_90B_eus-gaap--MarketingExpense_dm_c20190101__20191231_z8Sfs4W9HSo7" title="Customer incentives cost">38.9 million</span>
in 2021, 2020 and 2019, respectively.</p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Package Development Costs</a></td>
<td class="text"><p id="xdx_845_eus-gaap--ResearchAndDevelopmentExpensePolicy_zb6l10DhTTD1" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_86C_zxubFzrB3ag7">Package Development
Costs</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Package development costs associated
with new products and redesigns of existing product packaging are expensed as incurred.</p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LessorLeasesPolicyTextBlock', window );">Operating Leases</a></td>
<td class="text"><p id="xdx_84E_eus-gaap--LessorLeasesPolicyTextBlock_zY4OsnzKpcG1" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_864_zSwFQL2unLWj">Operating Leases</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company leases its offices
and warehouses, vehicles, and certain office equipment, substantially all of which are classified as operating leases. The Company
currently has no material financing leases. The Company determines if an arrangement is a lease at inception. Operating lease assets
and obligations are recognized at the lease commencement date based on the present value of lease payments over the lease term.</p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesPolicyTextBlock', window );">License Agreements</a></td>
<td class="text"><p id="xdx_845_eus-gaap--CommitmentsAndContingenciesPolicyTextBlock_zlM20bGen9Pf" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_86A_zpWo2K9IzHBk">License Agreements</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company&#8217;s license agreements
generally provide the Company with worldwide rights to manufacture, market and sell fragrance and fragrance related products using
the licensors&#8217; trademarks.&#160;The licenses typically have an initial term of approximately <span id="xdx_905_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtxL_c20210101__20211231__srt--RangeAxis__srt--MinimumMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_zg5oy7vG2Sig" title="License agreement term::XDX::P5Y"><span style="-sec-ix-hidden: xdx2ixbrl0815">5</span></span> to <span id="xdx_90B_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtxL_c20210101__20211231__srt--RangeAxis__srt--MaximumMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_zH4FMG4euCva" title="License agreement term::XDX::P15Y"><span style="-sec-ix-hidden: xdx2ixbrl0817">15</span></span> years, and are potentially
renewable subject to the Company&#8217;s compliance with the license agreement provisions.&#160;The remaining terms, excluding
potential renewal periods, range from approximately <span id="xdx_900_eus-gaap--AcquiredFiniteLivedIntangibleAssetWeightedAveragePeriodBeforeRenewalOrExtension_dtxL_c20210101__20211231__srt--RangeAxis__srt--MinimumMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_zZBekVhYz7rl" title="License agreement renewal term::XDX::P1Y"><span style="-sec-ix-hidden: xdx2ixbrl0819">1</span></span> to <span id="xdx_90B_eus-gaap--AcquiredFiniteLivedIntangibleAssetWeightedAveragePeriodBeforeRenewalOrExtension_dtxL_c20210101__20211231__srt--RangeAxis__srt--MaximumMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_zPKh8saKEnri" title="License agreement renewal term::XDX::P12Y"><span style="-sec-ix-hidden: xdx2ixbrl0821">12</span></span> years.&#160; Under each license, the Company is required to pay royalties
in the range of <span id="xdx_904_ecustom--RoyaltyExpenseNetSalesPercentage_pid_dp_uPure_c20210101__20211231__srt--RangeAxis__srt--MinimumMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_zLpjMvg6tOsh" title="Royalty expense, percentage of net sales">6</span>% to <span id="xdx_90C_ecustom--RoyaltyExpenseNetSalesPercentage_pid_dp_uPure_c20210101__20211231__srt--RangeAxis__srt--MaximumMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_ziq3WDdigWN5" title="Royalty expense, percentage of net sales">10</span>% to the licensor, at least annually, based on net sales to third parties.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In certain cases, the Company
may pay an entry fee to acquire, or enter into, a license where the licensor or another licensee was operating a pre-existing fragrance
business.&#160; In those cases, the entry fee is capitalized as an intangible asset and amortized over its useful life.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Most license agreements require
minimum royalty payments, incremental royalties based on net sales levels and minimum spending on advertising and promotional activities.&#160;
Royalty expenses are accrued in the period in which net sales are recognized while advertising and promotional expenses are accrued
at the time these costs are incurred.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>













<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In addition, the Company is exposed
to certain concentration risk. Most of our prestige fragrance brands are licensed from unaffiliated third parties, and our business
is dependent upon the continuation and renewal of such licenses.</p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><p id="xdx_848_eus-gaap--IncomeTaxPolicyTextBlock_zfkJH3uH7nI3" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_862_ztuairfRRGmc">Income Taxes</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company accounts for income
taxes using an asset and liability approach that requires the recognition of deferred tax assets and liabilities for the expected
future tax consequences of events that have been recognized in its financial statements or tax returns.&#160;The net deferred tax
assets assume sufficient future earnings for their realization, as well as the continued application of currently enacted tax rates.&#160;Included
in net deferred tax assets is a valuation allowance for deferred tax assets, where management believes it is more-likely-than-not
that the deferred tax assets will not be realized in the relevant jurisdiction.&#160;If the Company determines that a deferred
tax asset will not be realizable, an adjustment to the deferred tax asset will result in a reduction of net earnings at that time.
Accrued interest and penalties are included within the related tax asset or liability in the accompanying financial statements.</p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationSubsidiaryStockIssuancesPolicy', window );">Issuance of Common Stock by Consolidated Subsidiary</a></td>
<td class="text"><p id="xdx_84B_eus-gaap--ConsolidationSubsidiaryStockIssuancesPolicy_zNn5UAKH97j9" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_863_z3XeDhRGwgT6">Issuance of Common Stock
by Consolidated Subsidiary</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The difference between the Company&#8217;s
share of the proceeds received by the subsidiary and the carrying amount of the portion of the Company&#8217;s investment deemed
sold, is reflected as an equity adjustment in the consolidated balance sheets.</p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepurchaseAgreementsCollateralPolicy', window );">Treasury Stock</a></td>
<td class="text"><p id="xdx_845_eus-gaap--RepurchaseAgreementsCollateralPolicy_zgFdiS9Lz6vl" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_86E_zPR2sjlhj6Vi">Treasury Stock</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Board of Directors may authorize
share repurchases of the Company&#8217;s common stock (Share Repurchase Authorizations). Share repurchases under Share Repurchase
Authorizations may be made through open market transactions, negotiated purchase or otherwise, at times and in such amounts within
the parameters authorized by the Board. Shares repurchased under Share Repurchase Authorizations are held in treasury for general
corporate purposes, including issuances under various employee stock option plans. Treasury shares are accounted for under the
cost method and reported as a reduction of equity. Share Repurchase Authorizations may be suspended, limited or terminated at any
time without notice.</p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Accounting Pronouncements</a></td>
<td class="text"><p id="xdx_846_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zaV2orbuBuQ3" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_865_zEa8FnNhccEf">Recent Accounting Pronouncements</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In June 2016, the Financial Accounting
Standards Board (&#8220;FASB&#8221;) issued ASU 2016-13, &#8220;Financial Instruments - Credit Losses (Topic 326): Measurement
of Credit Losses on Financial Instruments&#8221;, as updated in 2019 and 2020, which require a financial asset measured at amortized
cost basis to be presented at the net amount expected to be collected. The new rules eliminate the probable initial recognition
threshold and, instead, reflect an entity&#8217;s current estimate of all expected credit losses. The new rules took effect for
the Company in the first quarter of 2020 and there was no material impact on our consolidated financial statements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">There are no other recent accounting
pronouncements issued but not yet adopted that would have a material effect on our consolidated financial statements.</p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription', window );">Reclassifications</a></td>
<td class="text"><p id="xdx_841_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zOY2dqwXvKZ4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><b><i><span id="xdx_865_zZHMpqe0Xir6">Reclassifications</span></i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Certain prior year&#8217;s amounts
in the accompanying consolidated statements of cash flows have been reclassified to conform to current period presentation.</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvertisingCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for advertising cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 720<br> -SubTopic 35<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6420018&amp;loc=d3e36677-107848<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvertisingCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the business description and accounting policies concepts.  Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Accounting policies describe all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI http://asc.fasb.org/topic&amp;trid=2134479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4273-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123368208&amp;loc=d3e12565-110249<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 450<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6491354&amp;loc=d3e6049-115624<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationSubsidiaryStockIssuancesPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569655-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569618-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationSubsidiaryStockIssuancesPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its derivative instruments and hedging activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41620-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41638-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41675-113959<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(n))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579240-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -URI http://asc.fasb.org/topic&amp;trid=2175825<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32847-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32840-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL116659661-227067<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32280-109318<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4556-108314<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 330<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6471895&amp;loc=d3e55923-109411<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4492-108314<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124437754&amp;loc=d3e543-108305<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI http://asc.fasb.org/topic&amp;trid=2126998<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LessorLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangements entered into by lessor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL117410129-209981<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL77919352-209981<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL117410129-209981<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL119206284-209981<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LessorLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429488&amp;loc=d3e326-107755<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PriorPeriodReclassificationAdjustmentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99779-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99893-112916<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepurchaseAgreementsCollateralPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy with regard to collateral required and collateral rights on securities sold under agreements to repurchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109249958&amp;loc=SL6224234-111729<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepurchaseAgreementsCollateralPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130561-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130563-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130563-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130564-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionAllowances">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue recognition for sales allowances.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionAllowances</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionSalesReturns">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for sales returns.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionSalesReturns</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TradeAndOtherAccountsReceivablePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e4975-111524<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5212-111524<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=SL6953423-111524<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5093-111524<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5033-111524<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10133-111534<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TradeAndOtherAccountsReceivablePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139983558674360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>The Company and its Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock', window );">Schedule of lanvin brand name for our class</a></td>
<td class="text"><p id="xdx_899_eus-gaap--SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_zpcXTUGeaJk8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Substantially all of our prestige
fragrance brands are licensed from unaffiliated third parties, and our business is dependent upon the continuation and renewal
of such licenses. <span>With respect to the Company&#8217;s largest brands, we license the Montblanc, Jimmy Choo, Coach and GUESS brand
names. As a percentage of net sales, product sales for the Company&#8217;s largest brands were as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;<span id="xdx_8BB_zLfZsxXUNYea" style="display: none; visibility: hidden">Schedule of lanvin brand name for our class</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year Ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 55%">Montblanc</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--MontblancMember_zYQdpsEiMHBc" style="width: 12%; text-align: right" title="Concentration risk percentage">19</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20200101__20201231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--MontblancMember_zByVvYIo3wEk" style="width: 12%; text-align: right">21</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20190101__20191231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--MontblancMember_z8jeCKYz1uF1" style="width: 12%; text-align: right" title="Concentration risk percentage">22</td><td style="width: 1%; text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Jimmy Choo</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--JimmyChooMember_zQprf6WWuqpb" style="text-align: right">18</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20200101__20201231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--JimmyChooMember_zS5aVrWrtb99" style="text-align: right" title="Concentration risk percentage">16</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20190101__20191231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--JimmyChooMember_zKh8Vx48zKxg" style="text-align: right">16</td><td style="text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Coach</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--CoachMember_zz272R6gNMCg" style="text-align: right">16</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20200101__20201231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--CoachMember_zoFqBpv49ldh" style="text-align: right">17</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20190101__20191231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--CoachMember_z8tyQcKDn2p3" style="text-align: right">14</td><td style="text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>GUESS</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--GUESSMember_zjFmBtriPnHe" style="text-align: right">12</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20200101__20201231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--GUESSMember_zs5yKA1qgED6" style="text-align: right">11</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20190101__20191231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--GUESSMember_zFSzsWYUIFY7" style="text-align: right">10</td><td style="text-align: left">%</td></tr>
</table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13531-108611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6327-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6442-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139983555938728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Recent Agreements (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ipar_ScheduleOfInventoryCurrentTableTextBlock1', window );">All amounts have been translated to U.S. dollars at the October 1, 2021 exchange rate.</a></td>
<td class="text"><p id="xdx_897_ecustom--ScheduleOfInventoryCurrentTableTextBlock1_z2moVF6wOGw9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">With respect to the management
and coordination of activities related to the license agreement, the Company operates through a wholly-owned Italian subsidiary
based in Florence, that was acquired from Salvatore Ferragamo on October 1, 2021. The acquisition together with the license agreement
was accounted for as an asset acquisition. The following table summarizes the estimated fair values of the assets acquired and
liabilities assumed on October 1, 2021. <span id="xdx_8BE_z60afETIDPI2">All amounts have been translated to U.S. dollars at the October 1, 2021 exchange rate.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 40%; margin-right: auto">
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 25%">Inventories</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--InventoryGross_iI_pn3n3_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--InventoryMember_zBSGsFMZ2Kmk" style="width: 12%; text-align: right" title="Inventories">17,805</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Trademarks and licenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--InventoryGross_iI_pn3n3_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksMember_zjHRtjDVGIv1" style="text-align: right">15,880</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Other assets</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--InventoryGross_iI_pn3n3_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--OtherAssetMember_zqiCMi4rBlte" style="border-bottom: Black 1pt solid; text-align: right" title="Inventory gross">3,033</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in">Assets acquired</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--FairValueOfAssetsAcquired_pn3n3_c20210101__20211231_zc7pMBCM27j7" style="border-bottom: Black 1pt solid; text-align: right" title="Assets acquired">36,718</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in">Liabilities assumed</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--LiabilitiesAssumed1_iN_di_c20210101__20211231_zYAilmIsHA5d" style="border-bottom: Black 1pt solid; text-align: right">(958</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2pt">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td id="xdx_983_eus-gaap--InventoryNet_iI_pn3n3_dxL_c20211231_znyKJ10w2TWd" style="border-bottom: Black 2pt double; text-align: right" title="Inventory net::XDX::198%2C914"><span style="-sec-ix-hidden: xdx2ixbrl0863">35,760</span></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
</table>



<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ipar_ScheduleOfInventoryCurrentTableTextBlock1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of inventory current table text block1.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ipar_ScheduleOfInventoryCurrentTableTextBlock1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ipar_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139983555878680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventories (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Schedule of inventories</a></td>
<td class="text"><p id="xdx_892_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zrRb4nJddiO5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span id="xdx_8B1_z1kNhe6Jw8G8" style="display: none; visibility: hidden">Schedule of inventories</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_49F_20211231_z7oxjyUrNaij" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_492_20201231_zHh7oxh1Rru7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr id="xdx_407_eus-gaap--InventoryRawMaterials_iI_maINz9tx_zpDlqBeKK311" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 70%; text-align: left">Raw materials and component parts</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">111,312</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">66,492</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_408_eus-gaap--InventoryFinishedGoods_iI_maINz9tx_zO2JndZo2iN2" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Finished goods</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">87,602</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">92,330</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--InventoryNet_iI_mtINz9tx_zwskzoITkwre" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="display: none; padding-bottom: 2pt; visibility: hidden">Inventories</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td style="border-bottom: Black 2pt double; text-align: right">198,914</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td style="border-bottom: Black 2pt double; text-align: right">158,822</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
</table>



<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139983556278840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value of Financial Instruments (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Schedule of fair value, assets measured on recurring basis</a></td>
<td class="text"><p id="xdx_895_eus-gaap--ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_zpUSsX2tZJt1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The following tables present
our financial assets and liabilities that are measured at fair value on a recurring basis and are categorized using the fair value
hierarchy. The fair value hierarchy has three levels based on the reliability of the inputs used to determine fair value.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8B5_z08ZA4b1osk4" style="display: none; visibility: hidden">Schedule of fair value, assets measured on recurring basis</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_499_20211231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zip1pYCzDCQ9" style="font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_49E_20211231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zqW8AlibTaAh" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_498_20211231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zWFQNxn7cvse" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_497_20211231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zcDrb0jEVg1h" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="color: Black">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="color: Black">&#160;</span></td>
    <td colspan="2" style="font-weight: bold"><span style="color: Black">&#160;</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="color: Black">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="color: Black">&#160;</span></td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="color: Black">Fair
    Value Measurements at December 31, 2021</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="color: Black">&#160;</span></td></tr>
<tr style="text-align: center; vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: right"><span style="color: Black">&#160;</span></td><td style="font-weight: bold; text-align: right"><span style="color: Black">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: right"><span style="color: Black">&#160;</span></td><td style="font-weight: bold; text-align: right"><span style="color: Black">&#160;</span></td><td style="font-weight: bold; text-align: right"><span style="color: Black">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: right"><span style="color: Black">Quoted Prices in</span></td><td style="font-weight: bold; text-align: right"><span style="color: Black">&#160;</span></td><td style="font-weight: bold; text-align: right"><span style="color: Black">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: right"><span style="color: Black">Significant Other</span></td><td style="font-weight: bold; text-align: right"><span style="color: Black">&#160;</span></td><td style="font-weight: bold; text-align: right"><span style="color: Black">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: right"><span style="color: Black">Significant</span></td><td style="font-weight: bold; text-align: right"><span style="color: Black">&#160;</span></td></tr>
<tr style="text-align: center; vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: right"><span style="color: Black">&#160;</span></td><td style="font-weight: bold; text-align: right"><span style="color: Black">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: right"><span style="color: Black">&#160;</span></td><td style="font-weight: bold; text-align: right"><span style="color: Black">&#160;</span></td><td style="font-weight: bold; text-align: right"><span style="color: Black">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: right"><span style="color: Black">Active Markets for</span></td><td style="font-weight: bold; text-align: right"><span style="color: Black">&#160;</span></td><td style="font-weight: bold; text-align: right"><span style="color: Black">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: right"><span style="color: Black">Observable</span></td><td style="font-weight: bold; text-align: right"><span style="color: Black">&#160;</span></td><td style="font-weight: bold; text-align: right"><span style="color: Black">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: right"><span style="color: Black">Unobservable</span></td><td style="font-weight: bold; text-align: right"><span style="color: Black">&#160;</span></td></tr>
<tr style="text-align: center; vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: right"><span style="color: Black">&#160;</span></td><td style="font-weight: bold; text-align: right"><span style="color: Black">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: right"><span style="color: Black">&#160;</span></td><td style="font-weight: bold; text-align: right"><span style="color: Black">&#160;</span></td><td style="font-weight: bold; text-align: right"><span style="color: Black">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: right"><span style="color: Black">Identical Assets</span></td><td style="font-weight: bold; text-align: right"><span style="color: Black">&#160;</span></td><td style="font-weight: bold; text-align: right"><span style="color: Black">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: right"><span style="color: Black">Inputs</span></td><td style="font-weight: bold; text-align: right"><span style="color: Black">&#160;</span></td><td style="font-weight: bold; text-align: right"><span style="color: Black">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: right"><span style="color: Black">Inputs</span></td><td style="font-weight: bold; text-align: right"><span style="color: Black">&#160;</span></td></tr>
<tr style="text-align: center; vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: right"><span style="color: Black">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt; text-align: right"><span style="color: Black">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="color: Black">Total</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: right"><span style="color: Black">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt; text-align: right"><span style="color: Black">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="color: Black">(Level 1)</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: right"><span style="color: Black">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt; text-align: right"><span style="color: Black">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="color: Black">(Level 2)</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: right"><span style="color: Black">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt; text-align: right"><span style="color: Black">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="color: Black">(Level 3)</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: right"><span style="color: Black">&#160;</span></td></tr>
<tr id="xdx_406_eus-gaap--AssetsFairValueDisclosureAbstract_iB_zyr2SglTMbYk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="color: Black">Assets:</span></td><td><span style="color: Black">&#160;</span></td>
    <td colspan="2"><span style="color: Black">&#160;</span></td><td><span style="color: Black">&#160;</span></td><td><span style="color: Black">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="color: Black">&#160;</span></td><td><span style="color: Black">&#160;</span></td><td><span style="color: Black">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="color: Black">&#160;</span></td><td><span style="color: Black">&#160;</span></td><td><span style="color: Black">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="color: Black">&#160;</span></td><td><span style="color: Black">&#160;</span></td></tr>
<tr id="xdx_407_eus-gaap--InvestmentsFairValueDisclosure_i01I_zoqxLledHNfl" style="vertical-align: bottom; background-color: White">
    <td style="width: 38%; text-align: left; padding-bottom: 2pt; padding-left: 0.25in; text-indent: -0.125in"><span style="color: Black">Short-term
    investments</span></td><td style="width: 1%; padding-bottom: 2pt"><span style="color: Black">&#160;</span></td>
    <td style="border-bottom: Black 2pt double; width: 1%; text-align: left"><span style="color: Black">$</span></td><td style="border-bottom: Black 2pt double; width: 12%; text-align: right"><span style="color: Black">160,014</span></td><td style="width: 1%; padding-bottom: 2pt; text-align: left"><span style="color: Black">&#160;</span></td><td style="width: 1%; padding-bottom: 2pt"><span style="color: Black">&#160;</span></td>
    <td style="border-bottom: Black 2pt double; width: 1%; text-align: left"><span style="color: Black">$</span></td><td style="border-bottom: Black 2pt double; width: 14%; text-align: right"><span style="color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0926">&#8212;</span></span></td><td style="width: 1%; padding-bottom: 2pt; text-align: left"><span style="color: Black">&#160;</span></td><td style="width: 1%; padding-bottom: 2pt"><span style="color: Black">&#160;</span></td>
    <td style="border-bottom: Black 2pt double; width: 1%; text-align: left"><span style="color: Black">$</span></td><td style="border-bottom: Black 2pt double; width: 12%; text-align: right"><span style="color: Black">160,014</span></td><td style="width: 1%; padding-bottom: 2pt; text-align: left"><span style="color: Black">&#160;</span></td><td style="width: 1%; padding-bottom: 2pt"><span style="color: Black">&#160;</span></td>
    <td style="border-bottom: Black 2pt double; width: 1%; text-align: left"><span style="color: Black">$</span></td><td style="border-bottom: Black 2pt double; width: 12%; text-align: right"><span style="color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0928">&#8212;</span></span></td><td style="width: 1%; padding-bottom: 2pt; text-align: left"><span style="color: Black">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="color: Black">&#160;</span></td><td><span style="color: Black">&#160;</span></td>
    <td style="text-align: left"><span style="color: Black">&#160;</span></td><td style="text-align: right"><span style="color: Black">&#160;</span></td><td style="text-align: left"><span style="color: Black">&#160;</span></td><td><span style="color: Black">&#160;</span></td>
    <td style="text-align: left"><span style="color: Black">&#160;</span></td><td style="text-align: right"><span style="color: Black">&#160;</span></td><td style="text-align: left"><span style="color: Black">&#160;</span></td><td><span style="color: Black">&#160;</span></td>
    <td style="text-align: left"><span style="color: Black">&#160;</span></td><td style="text-align: right"><span style="color: Black">&#160;</span></td><td style="text-align: left"><span style="color: Black">&#160;</span></td><td><span style="color: Black">&#160;</span></td>
    <td style="text-align: left"><span style="color: Black">&#160;</span></td><td style="text-align: right"><span style="color: Black">&#160;</span></td><td style="text-align: left"><span style="color: Black">&#160;</span></td></tr>
<tr id="xdx_402_eus-gaap--LiabilitiesAbstract_iB_zm2i0qxAvay6" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="color: Black">Liabilities:</span></td><td><span style="color: Black">&#160;</span></td>
    <td style="text-align: left"><span style="color: Black">&#160;</span></td><td style="text-align: right"><span style="color: Black">&#160;</span></td><td style="text-align: left"><span style="color: Black">&#160;</span></td><td><span style="color: Black">&#160;</span></td>
    <td style="text-align: left"><span style="color: Black">&#160;</span></td><td style="text-align: right"><span style="color: Black">&#160;</span></td><td style="text-align: left"><span style="color: Black">&#160;</span></td><td><span style="color: Black">&#160;</span></td>
    <td style="text-align: left"><span style="color: Black">&#160;</span></td><td style="text-align: right"><span style="color: Black">&#160;</span></td><td style="text-align: left"><span style="color: Black">&#160;</span></td><td><span style="color: Black">&#160;</span></td>
    <td style="text-align: left"><span style="color: Black">&#160;</span></td><td style="text-align: right"><span style="color: Black">&#160;</span></td><td style="text-align: left"><span style="color: Black">&#160;</span></td></tr>
<tr id="xdx_40C_eus-gaap--ForeignCurrencyFairValueHedgeAssetAtFairValue_i01I_zyZJXYtQXuE5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in"><span style="color: Black">Foreign currency forward
    exchange contracts accounted for using hedge accounting</span></td><td><span style="color: Black">&#160;</span></td>
    <td style="text-align: left"><span style="color: Black">$</span></td><td style="text-align: right"><span style="color: Black">1,982</span></td><td style="text-align: left"><span style="color: Black">&#160;</span></td><td><span style="color: Black">&#160;</span></td>
    <td style="text-align: left"><span style="color: Black">$</span></td><td style="text-align: right"><span style="color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0936">&#8212;</span></span></td><td style="text-align: left"><span style="color: Black">&#160;</span></td><td><span style="color: Black">&#160;</span></td>
    <td style="text-align: left"><span style="color: Black">$</span></td><td style="text-align: right"><span style="color: Black">1,982</span></td><td style="text-align: left"><span style="color: Black">&#160;</span></td><td><span style="color: Black">&#160;</span></td>
    <td style="text-align: left"><span style="color: Black">$</span></td><td style="text-align: right"><span style="color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0938">&#8212;</span></span></td><td style="text-align: left"><span style="color: Black">&#160;</span></td></tr>
<tr id="xdx_40D_eus-gaap--ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue_i01I_zeqSL4COBFL7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.375in; text-indent: -0.125in"><span style="color: Black">Foreign currency forward
    exchange contracts not accounted for using hedge accounting</span></td><td><span style="color: Black">&#160;</span></td>
    <td style="text-align: left"><span style="color: Black">&#160;</span></td><td style="text-align: right"><span style="color: Black">63</span></td><td style="text-align: left"><span style="color: Black">&#160;</span></td><td><span style="color: Black">&#160;</span></td>
    <td style="text-align: left"><span style="color: Black">&#160;</span></td><td style="text-align: right"><span style="color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0941">&#8212;</span></span></td><td style="text-align: left"><span style="color: Black">&#160;</span></td><td><span style="color: Black">&#160;</span></td>
    <td style="text-align: left"><span style="color: Black">&#160;</span></td><td style="text-align: right"><span style="color: Black">63</span></td><td style="text-align: left"><span style="color: Black">&#160;</span></td><td><span style="color: Black">&#160;</span></td>
    <td style="text-align: left"><span style="color: Black">$&#160;</span></td><td style="text-align: right"><span style="color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0943">&#8212;</span></span></td><td style="text-align: left"><span style="color: Black">&#160;</span></td></tr>
<tr id="xdx_40A_eus-gaap--DerivativeLiabilities_iI_zoek8SC7XOo4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.25in; text-indent: -0.125in"><span style="color: Black">Interest
    rate swaps</span></td><td style="color: #FF0000; padding-bottom: 1pt"><span style="color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; color: #FF0000; text-align: left"><span style="color: Black">&#160;</span></td><td style="border-bottom: Black 1pt solid; color: #FF0000; text-align: right"><span style="color: Black">(234</span></td><td style="padding-bottom: 1pt; color: #FF0000; text-align: left"><span style="color: Black">)</span></td><td style="padding-bottom: 1pt"><span style="color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="color: Black">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0946">&#8212;</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="color: Black">&#160;</span></td><td style="color: #FF0000; padding-bottom: 1pt"><span style="color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; color: #FF0000; text-align: left"><span style="color: Black">&#160;</span></td><td style="border-bottom: Black 1pt solid; color: #FF0000; text-align: right"><span style="color: Black">(234</span></td><td style="padding-bottom: 1pt; color: #FF0000; text-align: left"><span style="color: Black">)</span></td><td style="padding-bottom: 1pt"><span style="color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="color: Black">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0948">&#8212;</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="color: Black">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="color: Black">&#160;</span></td><td><span style="color: Black">&#160;</span></td>
    <td style="text-align: left"><span style="color: Black">&#160;</span></td><td style="text-align: right"><span style="color: Black">&#160;</span></td><td style="text-align: left"><span style="color: Black">&#160;</span></td><td><span style="color: Black">&#160;</span></td>
    <td style="text-align: left"><span style="color: Black">&#160;</span></td><td style="text-align: right"><span style="color: Black">&#160;</span></td><td style="text-align: left"><span style="color: Black">&#160;</span></td><td><span style="color: Black">&#160;</span></td>
    <td style="text-align: left"><span style="color: Black">&#160;</span></td><td style="text-align: right"><span style="color: Black">&#160;</span></td><td style="text-align: left"><span style="color: Black">&#160;</span></td><td><span style="color: Black">&#160;</span></td>
    <td style="text-align: left"><span style="color: Black">&#160;</span></td><td style="text-align: right"><span style="color: Black">&#160;</span></td><td style="text-align: left"><span style="color: Black">&#160;</span></td></tr>
<tr id="xdx_405_eus-gaap--AssetsFairValueDisclosure_iI_zgWf1xgKXWnd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2pt; padding-left: 0.125in; text-indent: -0.125in"><span style="color: Black">&#160;</span></td><td style="padding-bottom: 2pt"><span style="color: Black">&#160;</span></td>
    <td style="border-bottom: Black 2pt double; text-align: left"><span style="color: Black">$</span></td><td style="border-bottom: Black 2pt double; text-align: right"><span style="color: Black">1,811</span></td><td style="padding-bottom: 2pt; text-align: left"><span style="color: Black">&#160;</span></td><td style="padding-bottom: 2pt"><span style="color: Black">&#160;</span></td>
    <td style="border-bottom: Black 2pt double; text-align: left"><span style="color: Black">$</span></td><td style="border-bottom: Black 2pt double; text-align: right"><span style="color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0951">&#8212;</span></span></td><td style="padding-bottom: 2pt; text-align: left"><span style="color: Black">&#160;</span></td><td style="padding-bottom: 2pt"><span style="color: Black">&#160;</span></td>
    <td style="border-bottom: Black 2pt double; text-align: left"><span style="color: Black">$</span></td><td style="border-bottom: Black 2pt double; text-align: right"><span style="color: Black">1,811</span></td><td style="padding-bottom: 2pt; text-align: left"><span style="color: Black">&#160;</span></td><td style="padding-bottom: 2pt"><span style="color: Black">&#160;</span></td>
    <td style="border-bottom: Black 2pt double; text-align: left"><span style="color: Black">$</span></td><td style="border-bottom: Black 2pt double; text-align: right"><span style="color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0953">&#8212;</span></span></td><td style="padding-bottom: 2pt; text-align: left"><span style="color: Black">&#160;</span></td></tr>
</table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_494_20201231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_z7FyXXMlbJxf" style="font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_49D_20201231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z1vV2kJH9DG3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_490_20201231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zeDZ9U0lgoDj" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_49C_20201231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zDh2rS24njTf" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Fair Value Measurements at December 31, 2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: right; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: right">Quoted Prices in</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: right">Significant Other</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: right">Significant</td><td style="font-weight: bold; text-align: right">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: right; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: right">Active Markets for</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: right">Observable</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: right">Unobservable</td><td style="font-weight: bold; text-align: right">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: right; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: right">Identical Assets</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: right">Inputs</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: right">Inputs</td><td style="font-weight: bold; text-align: right">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: right; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt; text-align: right">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">Total</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt; text-align: right">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(Level 1)</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt; text-align: right">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(Level 2)</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt; text-align: right">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(Level 3)</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: right">&#160;</td></tr>
<tr id="xdx_406_eus-gaap--AssetsFairValueDisclosureAbstract_iB_zPVcHzGl6kc1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">Assets:</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
<tr id="xdx_407_eus-gaap--InvestmentsFairValueDisclosure_i01I_zFWk88u7lgO3" style="vertical-align: bottom; background-color: White">
    <td style="width: 38%; text-align: left; padding-left: 0.25in; text-indent: -0.125in">Short-term investments</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">126,627</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0961">&#8212;</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">126,627</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0963">&#8212;</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue_i01I_zT4hr1fpmTaj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.25in; text-indent: -0.125in">Foreign currency forward exchange contracts not accounted for using hedge accounting</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">253</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0966">&#8212;</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">253</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0968">&#8212;</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_403_eus-gaap--AssetsFairValueDisclosure_i01I_zonVrdkYao88" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="display: none; padding-bottom: 2pt; padding-left: 0.125in; text-indent: -0.125in; visibility: hidden">&#160;Total Assets</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td style="border-bottom: Black 2pt double; text-align: right">126,880</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td style="border-bottom: Black 2pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0971">&#8212;</span></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td style="border-bottom: Black 2pt double; text-align: right">126,880</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td style="border-bottom: Black 2pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0973">&#8212;</span></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
</table>



<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139983555878680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, Equipment and Leasehold Improvements (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of equipment and leasehold improvements</a></td>
<td class="text"><p id="xdx_893_eus-gaap--PropertyPlantAndEquipmentTextBlock_z0bRjPUIflOc" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span id="xdx_8B4_zOApWi6icI86" style="display: none; visibility: hidden">Schedule of equipment and leasehold improvements</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 70%; text-align: left">Land and Building (construction in progress)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_zmu1pZyIhen" style="width: 12%; text-align: right" title="Equipment and leasehold improvements">136,131</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_zOhwooYlLtD9" style="width: 12%; text-align: right" title="Equipment and leasehold improvements"><span style="-sec-ix-hidden: xdx2ixbrl0994">&#8212;</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>Equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_zatqLbXfqFpb" style="text-align: right" title="Equipment and leasehold improvements">52,036</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_zkNXbvmrPpxj" style="text-align: right">51,060</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Leasehold improvements</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zvYoPZIRifaa" style="border-bottom: Black 1pt solid; text-align: right" title="Equipment and leasehold improvements">2,082</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zsgKJCxMc6Le" style="border-bottom: Black 1pt solid; text-align: right" title="Equipment and leasehold improvements">1,989</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20211231_zvVH0RSWRkT8" style="text-align: right">190,249</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20201231_z3jZry9HRNR7" style="text-align: right">53,049</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Less accumulated depreciation and amortization</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_c20211231_zDfPC239o3jk" style="border-bottom: Black 1pt solid; text-align: right" title="Less accumulated depreciation and amortization">40,897</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_c20201231_zSdQ2fOjLqy6" style="border-bottom: Black 1pt solid; text-align: right" title="Less accumulated depreciation and amortization">33,469</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2pt">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentNet_iI_c20211231_z5MQFrRc4331" style="border-bottom: Black 2pt double; text-align: right" title="Property, Plant and Equipment, Net, Total">149,352</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentNet_iI_c20201231_zDkyy5vp5BN7" style="border-bottom: Black 2pt double; text-align: right" title="Property, Plant and Equipment, Net, Total">19,580</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
</table>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Depreciation and amortization
expense was $<span id="xdx_903_eus-gaap--DepreciationDepletionAndAmortization_dm_c20210101__20211231_zWBF7I9UTu97" title="Depreciation and amortization expense">4.4 million</span>, $<span id="xdx_905_eus-gaap--DepreciationDepletionAndAmortization_dm_c20200101__20201231_znvTPsO5y99e" title="Depreciation and amortization expense">3.8 million</span> and $<span id="xdx_904_eus-gaap--DepreciationDepletionAndAmortization_dm_c20190101__20191231_zRKLfsHBp3Gd" title="Depreciation and amortization expense">3.7 million</span> in 2021, 2020, and 2019, respectively.</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139983555936232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Trademarks, Licenses and Other Intangible Assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfImpairedIntangibleAssetsTextBlock', window );">Schedule of trademarks, licenses and other intangible assets</a></td>
<td class="text"><p id="xdx_890_eus-gaap--ScheduleOfImpairedIntangibleAssetsTextBlock_zuBsXwYVrou3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span id="xdx_8B9_zFTNgX7e9xii" style="display: none; visibility: hidden">Schedule of trademarks, licenses and other intangible assets</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: left">2021</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Gross</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Accumulated</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Net Book</td><td style="font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amortization</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Value</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 55%; text-align: left; padding-bottom: 1pt">Trademarks (indefinite lives)</td><td style="width: 1%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--IndefinitelivedIntangibleAssetsMember_zu1V8Hk54jCl" style="border-bottom: Black 1pt solid; width: 12%; text-align: right" title="Gross Amount">119,712</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--IndefinitelivedIntangibleAssetsMember_z4V7kKkHlkBi" style="border-bottom: Black 1pt solid; width: 12%; text-align: right" title="Accumulated Amortization"><span style="-sec-ix-hidden: xdx2ixbrl1025">&#8212;</span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--IndefinitelivedIntangibleAssetsMember_zrketUL9HUY7" style="border-bottom: Black 1pt solid; width: 12%; text-align: right" title="Net Book Value">119,712</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Trademarks (finite lives)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--FiniteLivedIntangibleAssetsMember_zZCIY8a9jTg" style="text-align: right">43,820</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--FiniteLivedIntangibleAssetsMember_zqIUcyJ0BHma" style="text-align: right">68</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--FiniteLivedIntangibleAssetsMember_zmtxuWrqpXn9" style="text-align: right">43,752</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Licenses (finite lives)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--LicensesMember_zx0fSCvbMOrb" style="text-align: right">109,682</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--LicensesMember_z8jsBqvtrboj" style="text-align: right">62,286</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--LicensesMember_z0VnQSfTgOJ7" style="text-align: right">47,396</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Other intangible assets (finite lives)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_zjSRkZdrdQo9" style="border-bottom: Black 1pt solid; text-align: right">17,775</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_zJrZNrlcE1S6" style="border-bottom: Black 1pt solid; text-align: right">14,588</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_ztASP3x639Q5" style="border-bottom: Black 1pt solid; text-align: right">3,187</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; padding-left: 0.125in">Subtotal</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20211231__us-gaap--FairValueByAssetClassAxis__custom--SubtotalMember_zjAApMVnkPLe" style="border-bottom: Black 1pt solid; text-align: right">171,277</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20211231__us-gaap--FairValueByAssetClassAxis__custom--SubtotalMember_z5aaCPnWhZl8" style="border-bottom: Black 1pt solid; text-align: right">76,942</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20211231__us-gaap--FairValueByAssetClassAxis__custom--SubtotalMember_zeq888yvAzid" style="border-bottom: Black 1pt solid; text-align: right">94,335</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2pt; padding-left: 0.25in">Total</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20211231_zd8wUtrQItc6" style="border-bottom: Black 2pt double; text-align: right">290,989</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20211231_zzWg0TC4opf" style="border-bottom: Black 2pt double; text-align: right">76,942</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20211231_z1ERowanMjXi" style="border-bottom: Black 2pt double; text-align: right">214,047</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
</table>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: left">2020</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Gross</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Accumulated</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Net Book</td><td style="font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amortization</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Value</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 55%; text-align: left; padding-bottom: 1pt">Trademarks (indefinite lives)</td><td style="width: 1%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20201231__us-gaap--FairValueByAssetClassAxis__us-gaap--IndefinitelivedIntangibleAssetsMember_zybGBplDjgM9" style="border-bottom: Black 1pt solid; width: 12%; text-align: right">131,962</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20201231__us-gaap--FairValueByAssetClassAxis__us-gaap--IndefinitelivedIntangibleAssetsMember_zFwzKYV0hDvc" style="border-bottom: Black 1pt solid; width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1044">&#8212;</span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20201231__us-gaap--FairValueByAssetClassAxis__us-gaap--IndefinitelivedIntangibleAssetsMember_z69xLvALNKe3" style="border-bottom: Black 1pt solid; width: 12%; text-align: right">131,962</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Trademarks (finite lives)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20201231__us-gaap--FairValueByAssetClassAxis__us-gaap--FiniteLivedIntangibleAssetsMember_ziaV74qg3lCi" style="text-align: right">47,477</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20201231__us-gaap--FairValueByAssetClassAxis__us-gaap--FiniteLivedIntangibleAssetsMember_zhPRtVWM8tI9" style="text-align: right">74</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20201231__us-gaap--FairValueByAssetClassAxis__us-gaap--FiniteLivedIntangibleAssetsMember_zq8HaJkzhfVg" style="text-align: right">47,403</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Licenses (finite lives)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20201231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--LicensesMember_zrAhzOIqgkPe" style="text-align: right">93,248</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20201231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--LicensesMember_zwz01IMDZW7k" style="text-align: right">62,262</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20201231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--LicensesMember_zMyp1St5uT12" style="text-align: right">30,986</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Other intangible assets (finite lives)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20201231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_zGlN5ArnoJh9" style="border-bottom: Black 1pt solid; text-align: right">18,194</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20201231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_zlfX60VP3edg" style="border-bottom: Black 1pt solid; text-align: right">14,437</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20201231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_zfKTGxO0jFGd" style="border-bottom: Black 1pt solid; text-align: right">3,757</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; padding-left: 0.125in">Subtotal</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20201231__us-gaap--FairValueByAssetClassAxis__custom--SubtotalMember_zWGERQGgcGBg" style="border-bottom: Black 1pt solid; text-align: right">158,919</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20201231__us-gaap--FairValueByAssetClassAxis__custom--SubtotalMember_zVbjRD3OU4hd" style="border-bottom: Black 1pt solid; text-align: right">76,773</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20201231__us-gaap--FairValueByAssetClassAxis__custom--SubtotalMember_zoZ4PHhbS7N2" style="border-bottom: Black 1pt solid; text-align: right">82,146</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2pt; padding-left: 0.25in">Total</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20201231_zlKDRBTRgzJ3" style="border-bottom: Black 2pt double; text-align: right">290,881</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20201231_znLLbaAQ7M08" style="border-bottom: Black 2pt double; text-align: right">76,773</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20201231_zLiIvgLQitT7" style="border-bottom: Black 2pt double; text-align: right">214,108</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
</table>



<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfImpairedIntangibleAssetsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of impaired intangible assets excluding goodwill. This may include a description of the facts and circumstances leading to the recording of impairment charges of intangible assets in the period, the amount of the impairment charges, the methods of determining fair value of the associated assets, the caption in the income statement in which the impairment losses are aggregated, and the segment in which the impaired intangible assets are reported.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfImpairedIntangibleAssetsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139983555939288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued Expenses (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock', window );">Accrued expenses consist of the following:</a></td>
<td class="text"><p id="xdx_893_eus-gaap--ScheduleOfAccruedLiabilitiesTableTextBlock_z2tBzBebFVa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8B3_zfGhPo3W9388">Accrued expenses consist of the
following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_49B_20211231_zOrca3nEmH29" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_49A_20201231_zCaUhWp9ThJh" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--AccruedAdvertisingCurrent_iI_maALCzkev_zryJtF67WKMd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 70%; text-align: left">Advertising liabilities</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">31,215</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">12,164</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--AccruedSalariesCurrent_iI_maALCzkev_z5Ky8tSKulA2" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Salary (including bonus and related taxes)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">19,993</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">14,605</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_403_eus-gaap--AccruedRoyaltiesCurrent_iI_maALCzkev_zE0TFIWDkX95" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Royalties</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">19,154</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">16,966</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_403_ecustom--DueVendorsNotYetInvoiced_iI_maALCzkev_zreYzpg8bkA" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Due vendors (not yet invoiced)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">45,707</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">31,698</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrent_iI_maALCzkev_zvE6kTpZLRsk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Retirement reserves</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,234</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">11,889</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--CustomerRefundLiabilityCurrent_iI_maALCzkev_zaOmeGtKBpj" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Refund (return) liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,128</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,616</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40E_eus-gaap--OtherAccruedLiabilitiesCurrent_iI_maALCzkev_zZcRqnM9d0lg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">Other</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">5,246</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">4,691</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_400_eus-gaap--AccruedLiabilitiesCurrent_iTI_mtALCzkev_z3kdIpeQpYsb" style="vertical-align: bottom; background-color: White">
    <td style="display: none; padding-bottom: 2pt; visibility: hidden">Accrued expenses</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td style="border-bottom: Black 2pt double; text-align: right">136,677</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td style="border-bottom: Black 2pt double; text-align: right">95,629</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
</table>



<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139983556277528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Debt (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock', window );">Long-term debt consists of the following:</a></td>
<td class="text"><p id="xdx_897_eus-gaap--ScheduleOfDebtInstrumentsTextBlock_zMA0beScaH04" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span id="xdx_8B8_zDtbLqdGeQz3">Long-term debt consists of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 65%; text-align: left; text-indent: -0.125in; padding-left: 0.125in">$<span id="xdx_901_eus-gaap--DebtInstrumentFaceAmount_iI_dm_c20211231__us-gaap--LongtermDebtTypeAxis__us-gaap--LoansPayableMember_zr2GjGBCW5Ni" title="Loan payable (in Dollars)">135.9 million</span> payable in <span id="xdx_902_ecustom--NumberOfInstallment_iI_pid_uN_c20211231__us-gaap--LongtermDebtTypeAxis__us-gaap--LoansPayableMember_z0VjT2MOZQqa" title="Number of installments">120</span> equal monthly installments of $<span id="xdx_904_eus-gaap--DebtInstrumentPeriodicPayment_dm_c20210101__20211231__us-gaap--LongtermDebtTypeAxis__us-gaap--LoansPayableMember_zFFNifrp7ql4" title="Installment amount (in Dollars)">1.1 million</span> beginning in April 2021, bearing interest at one-month Euribor plus <span id="xdx_907_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20211231__us-gaap--LongtermDebtTypeAxis__us-gaap--LoansPayableMember_z8NioIBw61Z2" title="Interest per annum">0.75</span>%</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--LongTermDebt_iI_c20211231__us-gaap--LongtermDebtTypeAxis__us-gaap--LoansPayableMember_zeY3RkgUJ7Z3" style="width: 12%; text-align: right" title="Loan payable">124,375</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--LongTermDebt_iI_c20201231__us-gaap--LongtermDebtTypeAxis__us-gaap--LoansPayableMember_zyOOVGWYqHbf" style="width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1155">&#8212;</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">$<span id="xdx_902_eus-gaap--DebtInstrumentFaceAmount_iI_pn6n6_c20211231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableOneMember_zc7fR9ruMpj7">15</span>.0 million payable in <span id="xdx_90E_ecustom--NumberOfInstallment_iI_pid_uN_c20211231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableOneMember_zls04tXK2V3i" title="Number of installments">14</span> equal annual installments of $<span id="xdx_90A_eus-gaap--DebtInstrumentPeriodicPayment_dm_c20210101__20211231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableOneMember_zIQI3xg3fbsh">1.1 million</span> beginning in January 2020 including interest imputed at <span id="xdx_903_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20211231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableOneMember_z7c1VKEfKJcg">4.1</span>% per annum</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--LongTermDebt_iI_c20211231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableOneMember_zl6ufcRiHPn1" style="text-align: right">10,569</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--LongTermDebt_iI_c20201231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableOneMember_zHLrPGY0Cis4" style="text-align: right">11,208</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">$<span id="xdx_90E_eus-gaap--DebtInstrumentFaceAmount_iI_pn6n6_c20211231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableTwoMember_zjWS3GRRDjOc">17</span> million payable in <span id="xdx_900_ecustom--NumberOfInstallment_iI_pid_uN_c20211231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableTwoMember_zhDrCItdpwMc" title="Number of installments">10</span> equal annual installments of $<span id="xdx_900_eus-gaap--DebtInstrumentPeriodicPayment_dm_c20210101__20211231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableTwoMember_zDQCZr8k366l">1.7 million</span> beginning in October 2021 including interest imputed at <span id="xdx_903_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20211231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableTwoMember_zSXZgXMCuGRa" title="Interest per annum">2.0</span>% per annum</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--LongTermDebt_iI_c20211231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableTwoMember_zwClsCJGC9Ef" style="text-align: right">13,869</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--LongTermDebt_iI_c20201231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableTwoMember_zSb2zFa2pWdg" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1170">&#8212;</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -0.125in; padding-left: 0.125in">$<span id="xdx_903_eus-gaap--DebtInstrumentFaceAmount_iI_dm_c20211231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableThreeMember_zI0tfHx4cvw8">13.4 million</span> term loan amended such that the loan was repaid in February 2021 plus interest at <span id="xdx_90B_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20211231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableThreeMember_zuP7Ddx97nz3" title="Interest per annum">0.85</span>% per annum</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--LongTermDebt_iI_c20211231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableThreeMember_z4H340Co1wo2" style="border-bottom: Black 1pt solid; text-align: right" title="Loan payable"><span style="-sec-ix-hidden: xdx2ixbrl1175">&#8212;</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--LongTermDebt_iI_c20201231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableThreeMember_zJKDQUnLn4J" style="border-bottom: Black 1pt solid; text-align: right">13,498</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -0.125in; padding-left: 0.125in">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--LongTermDebt_iI_c20211231_z0zLZRFstio8" style="text-align: right">148,813</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--LongTermDebt_iI_c20201231_zXol4Mlgb4ie" style="text-align: right">24,706</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -0.125in; padding-left: 0.25in">Less current maturities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--LongTermDebtCurrent_iI_c20211231_zFsrVaCUHeEb" style="border-bottom: Black 1pt solid; text-align: right" title="Less current maturities">15,911</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--LongTermDebtCurrent_iI_dxL_c20201231_zvYm1Uq9Ws7g" style="border-bottom: Black 1pt solid; text-align: right" title="Less current maturities::XDX::14%2C570"><span style="-sec-ix-hidden: xdx2ixbrl1182">14,570</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2pt; text-indent: -0.125in; padding-left: 0.375in">Total</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--LongTermDebtNoncurrent_iI_c20211231_zcAIKG3aVVCb" style="border-bottom: Black 2pt double; text-align: right" title="Total">132,902</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--LongTermDebtNoncurrent_iI_dxL_c20201231_z9kcQMiGz5Lc" style="border-bottom: Black 2pt double; text-align: right" title="::XDX::10%2C136"><span style="-sec-ix-hidden: xdx2ixbrl1185">10,136</span></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
</table>



<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21506-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21521-112644<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21538-112644<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123599511&amp;loc=d3e64711-112823<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139983555933384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock', window );">Maturities of lease liabilities subsequent to December 31, 2021 are as follows:</a></td>
<td class="text"><p id="xdx_89E_eus-gaap--ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_zyF9BNIMPeU5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8B0_z8Tw1yW0uR54">Maturities of lease liabilities
subsequent to December&#160;31, 2021 are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">(In thousands)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto">
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 85%; text-align: left"><span style="color: Black">2022</span></td><td style="width: 1%"><span style="color: Black">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="color: Black">$</span></td><td id="xdx_980_eus-gaap--OperatingLeasesFutureMinimumPaymentsDueCurrent_iI_c20211231_zgdKcFRfwmI7" style="width: 12%; text-align: right" title="2022"><span style="color: Black">6,541</span></td><td style="width: 1%; text-align: left"><span style="color: Black">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="color: Black">2023</span></td><td><span style="color: Black">&#160;</span></td>
    <td style="text-align: left"><span style="color: Black">&#160;</span></td><td id="xdx_980_eus-gaap--OperatingLeasesFutureMinimumPaymentsDueInTwoYears_iI_c20211231_zKxxjLn9srP2" style="text-align: right" title="2023"><span style="color: Black">6,776</span></td><td style="text-align: left"><span style="color: Black">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="color: Black">2024</span></td><td><span style="color: Black">&#160;</span></td>
    <td style="text-align: left"><span style="color: Black">&#160;</span></td><td id="xdx_98E_eus-gaap--OperatingLeasesFutureMinimumPaymentsDueInThreeYears_iI_c20211231_zyAnOct969U4" style="text-align: right" title="2024"><span style="color: Black">5,787</span></td><td style="text-align: left"><span style="color: Black">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="color: Black">2025</span></td><td><span style="color: Black">&#160;</span></td>
    <td style="text-align: left"><span style="color: Black">&#160;</span></td><td id="xdx_98B_eus-gaap--OperatingLeasesFutureMinimumPaymentsDueInFourYears_iI_c20211231_zT0E7zKRecuf" style="text-align: right" title="2025"><span style="color: Black">4,704</span></td><td style="text-align: left"><span style="color: Black">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="color: Black">2026</span></td><td><span style="color: Black">&#160;</span></td>
    <td style="text-align: left"><span style="color: Black">&#160;</span></td><td id="xdx_984_eus-gaap--OperatingLeasesFutureMinimumPaymentsDueInFiveYears_iI_c20211231_z1JuVgtQyVeb" style="text-align: right" title="2026"><span style="color: Black">4,087</span></td><td style="text-align: left"><span style="color: Black">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="color: Black">Thereafter</span></td><td style="padding-bottom: 1pt"><span style="color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="color: Black">&#160;</span></td><td id="xdx_987_eus-gaap--OperatingLeasesFutureMinimumPaymentsDueThereafter_iI_c20211231_zxf5qxdhJLQd" style="border-bottom: Black 1pt solid; text-align: right" title="Thereafter"><span style="color: Black">10,017</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="color: Black">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="color: Black">&#160;</span></td><td style="padding-bottom: 1pt"><span style="color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="color: Black">&#160;</span></td><td id="xdx_98E_eus-gaap--OperatingLeasesFutureMinimumPaymentsDue_iI_c20211231_zL7HpyRAvjvg" style="border-bottom: Black 1pt solid; text-align: right" title="Gross Total"><span style="color: Black">37,912</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="color: Black">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in"><span style="color: Black">Less imputed interest (based on 2.5%
    weighted-average discount rate)</span></td><td style="color: #FF0000; padding-bottom: 1pt"><span style="color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; color: #FF0000; text-align: left"><span style="color: Black">&#160;</span></td><td id="xdx_98E_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_di_c20211231_zeZogE6qFnNa" style="border-bottom: Black 1pt solid; color: #FF0000; text-align: right" title="Less imputed interest (based on 3.0% weighted-average discount rate)"><span style="color: Black">(2,679</span></td><td style="padding-bottom: 1pt; color: #FF0000; text-align: left"><span style="color: Black">)</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="color: Black">&#160;</span></td><td style="padding-bottom: 2pt"><span style="color: Black">&#160;</span></td>
    <td style="border-bottom: Black 2pt double; text-align: left"><span style="color: Black">$</span></td><td id="xdx_983_eus-gaap--OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear_iI_c20211231_zIFiIkcyU5ui" style="border-bottom: Black 2pt double; text-align: right" title="Net Total"><span style="color: Black">35,233</span></td><td style="padding-bottom: 2pt; text-align: left"><span style="color: Black">&#160;</span></td></tr>
</table>



<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock', window );">minimum annual royalties and other commitments as follows:</a></td>
<td class="text"><p id="xdx_897_esrt--ContractualObligationFiscalYearMaturityScheduleTableTextBlock_zZ3LS5YZ6ke3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_909_eus-gaap--FiniteLivedIntangibleAssetsIntentOrAbilityToRenewOrExtendArrangement_c20210101__20211231_zG1Kv0UMvD25" title="License agreement, expiration description">The Company is party to a number
of license and other agreements for the use of trademarks and rights in connection with the manufacture and sale of its products
expiring at various dates through 2033.</span> In connection with certain of these license agreements, the Company is subject to minimum
annual advertising commitments, <span id="xdx_8BA_zRoIaXnWGOPf">minimum annual royalties and other commitments as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">(In thousands)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto">
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 85%; text-align: left">2022</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--OtherCommitmentDueInNextTwelveMonths_iI_c20211231_zm45FY8fqk6" style="width: 12%; text-align: right" title="2021">191,422</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">2023</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--OtherCommitmentDueInSecondYear_iI_c20211231_z0dLRXe8E3tk" style="text-align: right" title="2022">206,241</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">2024</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--OtherCommitmentDueInThirdYear_iI_c20211231_zFige0sVO4d6" style="text-align: right" title="2023">202,774</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">2025</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--OtherCommitmentDueInFourthYear_iI_c20211231_zaqJgioDS9k9" style="text-align: right" title="2024">199,770</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">2026</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--OtherCommitmentDueInFifthYear_iI_c20211231_zccCQ2llkBg1" style="text-align: right" title="2025">136,776</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Thereafter</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--OtherCommitmentDueAfterFifthYear_iI_c20211231_zX6A7AQu8all" style="border-bottom: Black 1pt solid; text-align: right" title="Thereafter">702,780</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--OtherCommitment_iI_c20211231_zYIIHzBGGK3" style="border-bottom: Black 2pt double; text-align: right" title="Total">1,639,763</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
</table>



<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of contractual obligation by timing of payment due. Includes, but is not limited to, long-term debt obligation, lease obligation, and purchase obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher SEC<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 303<br> -Paragraph (a)<br> -Subparagraph (5)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of future minimum payments required in the aggregate and for each of the five succeeding fiscal years for operating leases having initial or remaining noncancelable lease terms in excess of one year and the total minimum rentals to be received in the future under noncancelable subleases as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123406913&amp;loc=d3e41502-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139983558838312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock', window );">The following table sets forth information with respect to nonvested options for 2021:</a></td>
<td class="text"><p id="xdx_897_eus-gaap--ScheduleOfNonvestedShareActivityTableTextBlock_z8ZrifFxP0t3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8BC_zMWGswiSqs1h">The following table sets forth
information with respect to nonvested options for 2021:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Number of Shares</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Weighted Average<br/>
 Grant Date<br/>
Fair Value</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">Nonvested options &#8211; beginning of year</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iS_pid_uShares_c20210101__20211231_zvGsbl79ra63" style="width: 15%; text-align: right" title="Nonvested options - beginning of year">353,790</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iS_pid_uUSDPShares_c20210101__20211231_zf4XtRrTRhY1" style="width: 15%; text-align: right" title="Weighted Average Grant Date Fair Value, beginning of year">12.96</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Nonvested options granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_uShares_c20210101__20211231_zbm3MQRNZLj7" style="text-align: right" title="Nonvested options granted">9,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_uUSDPShares_c20210101__20211231_zvj55yTKFDL8" style="text-align: right" title="Weighted Average Grant Date Fair Value, granted">11.35</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Nonvested options vested or forfeited</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_iN_pid_di_uShares_c20210101__20211231_zHoNAdPd7gk1" style="border-bottom: Black 1pt solid; text-align: right" title="Nonvested options vested or forfeited">(153,280</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_pid_uUSDPShares_c20210101__20211231_zaOodMpx1m63" style="text-align: right" title="Weighted Average Grant Date Fair Value, vested or forfeited">12.19</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2pt">Nonvested options &#8211; end of year</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iE_pid_uShares_c20210101__20211231_zfPUrQ8OE2u2" style="border-bottom: Black 2pt double; text-align: right" title="Nonvested options - end of year">209,510</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iE_pid_uUSDPShares_c20210101__20211231_zK1Iv0XltGv5" style="text-align: right" title="Weighted Average Grant Date Fair Value, end of year">13.45</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
</table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock', window );">The effect of share-based payment expenses decreased income statement line items as follows:</a></td>
<td class="text"><p id="xdx_89D_eus-gaap--ScheduleOfShareBasedCompensationActivityTableTextBlock_zvleNI06rDEk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8BB_zB9k0ntXSjdd">The effect of share-based payment
expenses decreased income statement line items as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year Ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 55%; text-align: left">Income before income taxes</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_c20210101__20211231__us-gaap--IncomeStatementLocationAxis__us-gaap--OperatingIncomeLossMember_zPf8FbwkipRc" style="width: 12%; text-align: right" title="Income before income taxes">2,850</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_c20200101__20201231__us-gaap--IncomeStatementLocationAxis__us-gaap--OperatingIncomeLossMember_zM3RXe1Uzlx5" style="width: 12%; text-align: right">3,030</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_c20190101__20191231__us-gaap--IncomeStatementLocationAxis__us-gaap--OperatingIncomeLossMember_zLGXk9Bchomf" style="width: 12%; text-align: right">3,390</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Net income attributable to Inter Parfums, Inc.</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--NetIncomeLoss_c20210101__20211231__us-gaap--IncomeStatementLocationAxis__us-gaap--OperatingIncomeLossMember_zio92kKlNDG1" style="text-align: right" title="Net income attributable to Inter Parfums, Inc.">1,880</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--NetIncomeLoss_c20200101__20201231__us-gaap--IncomeStatementLocationAxis__us-gaap--OperatingIncomeLossMember_zk1fIhwSyAQ8" style="text-align: right">2,040</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--NetIncomeLoss_c20190101__20191231__us-gaap--IncomeStatementLocationAxis__us-gaap--OperatingIncomeLossMember_znsBRLKCuWb5" style="text-align: right">2,060</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Diluted earnings per share attributable to Inter Parfums, Inc.</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--EarningsPerShareDiluted_pid_uUSDPShares_c20210101__20211231__us-gaap--IncomeStatementLocationAxis__us-gaap--OperatingIncomeLossMember_zxDcEGuXrfEg" style="text-align: right" title="Diluted earnings per share attributable to Inter Parfums, Inc">0.06</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--EarningsPerShareDiluted_pid_uUSDPShares_c20200101__20201231__us-gaap--IncomeStatementLocationAxis__us-gaap--OperatingIncomeLossMember_zRLGYRITWUa" style="text-align: right">0.06</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--EarningsPerShareDiluted_pid_uUSDPShares_c20190101__20191231__us-gaap--IncomeStatementLocationAxis__us-gaap--OperatingIncomeLossMember_zBLJMsKKNzV8" style="text-align: right">0.07</td><td style="text-align: left">&#160;</td></tr>
</table>


<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">The following table summarizes stock option activity and related information for the years ended December 31, 2021, 2020 and 2019:</a></td>
<td class="text"><p id="xdx_89E_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zDcEFm9k7uh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8B8_zD54LK3lVHI8">The following table summarizes stock option activity and related information for the years ended December 31, 2021, 2020 and
2019:</span></p>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="22" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Options</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Weighted</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Average</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Exercise</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Price</b></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Options</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Weighted</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Average</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Exercise</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Price</b></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Options</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Weighted</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Average</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Exercise</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Price</b></p></td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 28%; text-align: left; text-indent: -0.125in; padding-left: 0.125in">Shares under option - beginning of year</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_uShares_c20210101__20211231_zA8543b6APh9" style="width: 9%; text-align: right" title="Options shares under option - beginning of year">713,210</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_uUSDPShares_c20210101__20211231_zC8vapGuY9i" style="width: 9%; text-align: right" title="Weighted average exercise price shares under option - beginning of year">52.74</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_uShares_c20200101__20201231_z5u6iR8WYkrl" style="width: 9%; text-align: right">815,800</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_uUSDPShares_c20200101__20201231_zcP0CPxAKP8j" style="width: 9%; text-align: right">49.89</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_uShares_c20190101__20191231_zU6ybomZKya4" style="width: 9%; text-align: right">776,171</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_uUSDPShares_c20190101__20191231_zUrKgGW5UtFl" style="width: 9%; text-align: right">41.33</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Options granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_uShares_c20210101__20211231_zWaGWhA3y089" style="text-align: right" title="Options granted">9,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_uUSDPShares_c20210101__20211231_ztWooTqug7se" style="text-align: right" title="Weighted average exercise price options granted">62.18</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_uShares_c20200101__20201231_zdZYrk8MSQec" style="text-align: right" title="Options granted">9,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_uUSDPShares_c20200101__20201231_zcTcxSHfjHQe" style="text-align: right">69.11</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_uShares_c20190101__20191231_zwbAPKXMgHzb" style="text-align: right" title="Options granted">194,050</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_uUSDPShares_c20190101__20191231_zWRSpCGy5fB4" style="text-align: right">72.89</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Options exercised</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pid_di_uShares_c20210101__20211231_z8jozSWC3XAb" style="text-align: right" title="Options exercised">(156,490</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_uUSDPShares_c20210101__20211231_zn6fcE5Pg9Hj" style="text-align: right" title="Weighted average exercise price options exercised">34.46</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pid_di_uShares_c20200101__20201231_zKMFxZ3Jpyx" style="text-align: right" title="Options exercised">(95,570</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_uUSDPShares_c20200101__20201231_zt5HTMbsLwL2" style="text-align: right">28.99</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pid_di_uShares_c20190101__20191231_z2UEaolQPkd8" style="text-align: right" title="Options exercised">(130,891</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_uUSDPShares_c20190101__20191231_zUqWAhlDcou9" style="text-align: right">34.06</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -0.125in; padding-left: 0.125in">Options forfeited</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_pid_di_uShares_c20210101__20211231_z0823ZeqZ2A6" style="border-bottom: Black 1pt solid; text-align: right" title="Options forfeited">(40,820</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_uUSDPShares_c20210101__20211231_zgN5rdvufK9b" style="text-align: right" title="Weighted average exercise price options forfeited">62.57</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_pid_di_uShares_c20200101__20201231_zzKTz6JvbIZc" style="border-bottom: Black 1pt solid; text-align: right" title="Options forfeited">(16,020</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_uUSDPShares_c20200101__20201231_zjEgBkjyNEn1" style="text-align: right">58.38</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_pid_di_uShares_c20190101__20191231_zZTaSwGKkgOd" style="border-bottom: Black 1pt solid; text-align: right" title="Options forfeited">(23,530</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_uUSDPShares_c20190101__20191231_zyiZ3TVFZLNk" style="text-align: right">45.48</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2pt; text-indent: -0.125in; padding-left: 0.125in">Shares under option - end of year</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_uShares_c20210101__20211231_zLmY6iaWJ20g" style="border-bottom: Black 2pt double; text-align: right" title="Options shares under option - end of year">524,900</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_uUSDPShares_c20210101__20211231_zVLAtyPYEs4j" style="text-align: right" title="Weighted average exercise price shares under option - end of year">57.58</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_uShares_c20200101__20201231_zB9SYPBYrZPg" style="border-bottom: Black 2pt double; text-align: right">713,210</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_uUSDPShares_c20200101__20201231_zuA5T05mo1V9" style="text-align: right">52.74</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_uShares_c20190101__20191231_zHnm84lXJmT" style="border-bottom: Black 2pt double; text-align: right">815,800</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_uUSDPShares_c20190101__20191231_zkHyldwmhiGg" style="text-align: right">49.89</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
</table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">The assumptions used in the Black-Scholes pricing model are set forth in the following table:</a></td>
<td class="text"><p id="xdx_894_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zojQBpKqAPSe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8B8_zqp2yAmXZsBb">The assumptions used in the Black-Scholes
pricing model are set forth in the following table:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_494_20210101__20211231_zAj1yLhUcnl6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_498_20200101__20201231_zvfM12Hn0mB7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_498_20190101__20191231_zWvzMZGTPlzj" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year Ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr id="xdx_40E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pii_dp_uPure_zJuwuMc5Ckni" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 55%; text-align: left">Weighted-average expected stock-price volatility</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">25</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">25</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">25</td><td style="width: 1%; text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Weighted-average expected option life</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dxL_c20210101__20211231_zn4UR0StrNI4" style="text-align: right" title="Weighted-average expected option life::XDX::P5Y"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1376">5.0 years</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dxL_c20200101__20201231_zJXLlFaOMDM7" style="text-align: right" title="Weighted-average expected option life::XDX::P5Y"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1378">5.0 years</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtxL_c20190101__20191231_zI1qfZ5JrH9l" style="text-align: right" title="Weighted-average expected option life::XDX::P5Y"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1380">5.0 years</span></span></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pii_dp_uPure_zX0zKk2ffFX8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Weighted-average risk-free interest rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.4</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1.4</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1.7</td><td style="text-align: left">%</td></tr>
<tr id="xdx_400_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pii_dp_uPure_z7juvhVvP4ri" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Weighted-average dividend yield</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1.6</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2.5</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2.0</td><td style="text-align: left">%</td></tr>
</table>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashProceedsReceivedAndTaxBenefitFromShareBasedPaymentAwardsTableTextBlock', window );">Proceeds, tax benefits and intrinsic value related to stock options exercised were as follows</a></td>
<td class="text"><p id="xdx_897_eus-gaap--CashProceedsReceivedAndTaxBenefitFromShareBasedPaymentAwardsTableTextBlock_zk2DUKzD1fS5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8BA_zJjz1GHhyJ9h">Proceeds, tax benefits and intrinsic
value related to stock options exercised were as follows</span>:<span style="font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_49C_20210101__20211231_zIBswFHmbfIg" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_498_20200101__20201231_zRtiSmREtAr9" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td colspan="3" id="xdx_49C_20190101__20191231_zMnqljIvkn5e" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year Ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr id="xdx_40B_eus-gaap--ProceedsFromStockOptionsExercised_z6Rw9FEBmt6h" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 55%; text-align: left; text-indent: -8.1pt; padding-left: 8.1pt">Proceeds from stock options exercised</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">5,393</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">2,771</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">4,458</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_406_eus-gaap--DeferredTaxExpenseFromStockOptionsExercised_zBKEGaJCuyba" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Tax benefits</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1,300</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">400</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">690</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_409_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_zQ1YtC1ZC4T5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Intrinsic value of stock options exercised</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">7,800</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">2,873</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">4,520</td><td style="text-align: left">&#160;</td></tr>
</table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock', window );">The following table summarizes additional stock option information as of December 31, 2021:</a></td>
<td class="text"><p id="xdx_89D_eus-gaap--ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_z2AzDnAS4v3g" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8B3_zD7zIDewqjl9">The following table summarizes
additional stock option information as of December&#160;31, 2021:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Exercise prices</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Options<br/> outstanding</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Options outstanding<br/> weighted average remaining<br/> contractual life</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Options<br/> exercisable</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 25%; text-align: center">&#160;$<span id="xdx_904_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20211231__srt--RangeAxis__srt--MinimumMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_z0SmNLp1UKW8">32.83</span> - $<span id="xdx_90C_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20211231__srt--RangeAxis__srt--MaximumMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zxkEFLWonQRc" title="Exercise price range (in Dollars per share)">33.95</span>&#160;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_uShares_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zghQWgYFZpQ4" style="width: 15%; text-align: right" title="Options outstanding">81,190</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 32%; text-align: center"><span id="xdx_907_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtxL_c20210101__20211231__srt--RangeAxis__srt--MaximumMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zbT0vgHJK6z3" title="Options outstanding weighted average remaining contractual life::XDX::P0Y11M12D"><span style="-sec-ix-hidden: xdx2ixbrl1411">0.99</span></span> years</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_uShares_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zq3UMvD8Cs77" style="width: 15%; text-align: right" title="Options exercisable">81,190</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">&#160;$<span id="xdx_901_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20211231__srt--RangeAxis__srt--MinimumMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zSK2Hc2JHOs5">40.15</span> - $<span id="xdx_90B_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20211231__srt--RangeAxis__srt--MaximumMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_zZl4qG4E9RKk">46.90</span>&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_uShares_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zo23alIyc0ei" style="text-align: right">123,130</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center"><span id="xdx_90D_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtxL_c20210101__20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zGo3mr7UDwb2" title="::XDX::P1Y11M8D"><span style="-sec-ix-hidden: xdx2ixbrl1417">1.94</span></span> years</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_uShares_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zrOVZVdmeJVf" style="text-align: right">90,790</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center">&#160;$<span id="xdx_90B_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20211231__srt--RangeAxis__srt--MinimumMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_z7PS3EwbWBze">65.18</span> - $<span id="xdx_901_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20211231__srt--RangeAxis__srt--MaximumMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_z5DcuTr6jQOk">69.11</span>&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_uShares_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_z0rt4wLXWj34" style="text-align: right">164,940</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center"><span id="xdx_901_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtxL_c20210101__20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_zGFPaLhucRG9" title="::XDX::P3Y0M11D"><span style="-sec-ix-hidden: xdx2ixbrl1422">3.03</span></span> years</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_uShares_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_zJm6RHjgp7t7" style="text-align: right">84,790</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">$<span id="xdx_90B_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_z1viWAr5GRFa">73.09</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_uShares_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_zuMRwU8NixE8" style="border-bottom: Black 1pt solid; text-align: right">155,640</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1pt"><span id="xdx_906_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtxL_c20210101__20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_zabrABTe8d59" title="::XDX::P4Y0M0D"><span style="-sec-ix-hidden: xdx2ixbrl1426">4.00</span></span> years</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_uShares_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_zq5xHhHAiRNd" style="border-bottom: Black 1pt solid; text-align: right">58,620</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center">&#160;Totals&#160;</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_uShares_c20211231_zZWPcpK3imjl" style="border-bottom: Black 2pt double; text-align: right">524,900</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 2pt"><span id="xdx_907_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtxL_c20210101__20211231_z43En5xnVYij" title="::XDX::P2Y9M0D"><span style="-sec-ix-hidden: xdx2ixbrl1429">2.75</span></span> years</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_uShares_c20211231_zoOydnZgWk87" style="border-bottom: Black 2pt double; text-align: right">315,390</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
</table>



<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashProceedsReceivedAndTaxBenefitFromShareBasedPaymentAwardsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of cash received from exercise of stock options and similar instruments granted under share-based payment arrangements and tax benefit from exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashProceedsReceivedAndTaxBenefitFromShareBasedPaymentAwardsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in outstanding nonvested shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of activity for award under share-based payment arrangement. Includes, but is not limited to, outstanding award at beginning and end of year, granted, exercised, forfeited, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139983555939288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income Attributable to Inter Parfums, Inc. Common Shareholders (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">The reconciliation between the numerators and denominators of the basic and diluted EPS computations is as follows:</a></td>
<td class="text"><p id="xdx_89D_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zlJjlIepIwr5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8BA_zfyefk7NQKP4">The reconciliation between the
numerators and denominators of the basic and diluted EPS computations is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 55%; text-align: left; padding-bottom: 2pt; padding-left: 0.125in; text-indent: -0.125in">Numerator for diluted earnings per share</td><td style="width: 1%; padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--NetIncomeLoss_c20210101__20211231_zEWwdTlz5Vt2" style="border-bottom: Black 2pt double; width: 12%; text-align: right" title="Numerator for diluted earnings per share (in Dollars)">87,411</td><td style="width: 1%; padding-bottom: 2pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--NetIncomeLoss_c20200101__20201231_zNxMkoLkjqxj" style="border-bottom: Black 2pt double; width: 12%; text-align: right">38,219</td><td style="width: 1%; padding-bottom: 2pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--NetIncomeLoss_c20190101__20191231_zDE6DZYY3Mae" style="border-bottom: Black 2pt double; width: 12%; text-align: right">60,249</td><td style="width: 1%; padding-bottom: 2pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in">Denominator:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in">Weighted average shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20210101__20211231_z3w9K3ErW8cl" style="text-align: right" title="Weighted average shares">31,676,796</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20200101__20201231_zno5RniMDrQ6" style="text-align: right">31,536,659</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20190101__20191231_zENCLkBFGux6" style="text-align: right">31,451,093</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Effect of dilutive securities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.375in; text-indent: -0.125in">Stock options</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pid_c20210101__20211231_z92ryuDbpvDg" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Number Diluted Shares Outstanding Adjustment">158,612</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pid_c20200101__20201231_zLjAwq7ESuw6" style="border-bottom: Black 1pt solid; text-align: right">117,885</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pid_c20190101__20191231_zkH1TMDFadK7" style="border-bottom: Black 1pt solid; text-align: right">237,607</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2pt; padding-left: 0.125in; text-indent: -0.125in">Denominator for diluted earnings per share</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20210101__20211231_zhHhLvmWNm7k" style="border-bottom: Black 2pt double; text-align: right" title="Denominator for diluted earnings per share">31,835,408</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20200101__20201231_zaHD7YnDhgK" style="border-bottom: Black 2pt double; text-align: right">31,654,544</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20190101__20191231_zFHcdezmXLJ9" style="border-bottom: Black 2pt double; text-align: right">31,688,700</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">Earnings per share:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Net income attributable to Inter Parfums, Inc. common shareholders:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.5in; text-indent: -0.125in">Basic</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--EarningsPerShareBasic_pid_uUSDPShares_c20210101__20211231_zOAESjXbsdb" style="text-align: right" title="Basic (in Dollars per share)">2.76</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--EarningsPerShareBasic_pid_uUSDPShares_c20200101__20201231_zYb8TsiOd9sh" style="text-align: right">1.21</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--EarningsPerShareBasic_pid_uUSDPShares_c20190101__20191231_ztYCFe9bVaud" style="text-align: right">1.92</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.5in; text-indent: -0.125in">Diluted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--EarningsPerShareDiluted_pid_uUSDPShares_c20210101__20211231_zwl2wHaUR5d5" style="text-align: right" title="Diluted (in Dollars per share)">2.75</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--EarningsPerShareDiluted_pid_uUSDPShares_c20200101__20201231_zugRmgPcyZuh" style="text-align: right">1.21</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--EarningsPerShareDiluted_pid_uUSDPShares_c20190101__20191231_zqFshltCql7" style="text-align: right">1.90</td><td style="text-align: left">&#160;</td></tr>
</table>



<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139983549605720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segments and Geographic Areas (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Information on the Company&#8217;s operations by segments is as follows:</a></td>
<td class="text"><p id="xdx_899_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_zxd4NvECI4qf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span><span id="xdx_8B5_zkDY8ZZkiM0h">Information on the Company&#8217;s
operations by segments is as follows:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="visibility: visible; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; visibility: visible; font-weight: bold; text-align: center">Year ended December 31,</td><td style="visibility: visible; padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="visibility: visible; vertical-align: bottom">
    <td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; visibility: visible; font-weight: bold; text-align: center">2021</td><td style="visibility: visible; padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="visibility: visible; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; visibility: visible; font-weight: bold; text-align: center">2020</td><td style="visibility: visible; padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="visibility: visible; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; visibility: visible; font-weight: bold; text-align: center">2019</td><td style="visibility: visible; padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="visibility: visible; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="visibility: visible; text-align: left">Net sales:</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible; text-align: right">&#160;</td><td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible; text-align: right">&#160;</td><td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible; text-align: right">&#160;</td><td style="visibility: visible; text-align: left">&#160;</td></tr>
<tr style="visibility: visible; vertical-align: bottom; background-color: White">
    <td style="visibility: visible; width: 55%; text-align: left">&#160;&#160;&#160;&#160;United States</td><td style="visibility: visible; width: 1%">&#160;</td>
    <td style="visibility: visible; width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20210101__20211231__srt--StatementGeographicalAxis__country--US_z5r4PcNAeks3" style="visibility: visible; width: 12%; text-align: right">216,559</td><td style="visibility: visible; width: 1%; text-align: left">&#160;</td><td style="visibility: visible; width: 1%">&#160;</td>
    <td style="visibility: visible; width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20200101__20201231__srt--StatementGeographicalAxis__country--US_zCfrzosskOG7" style="visibility: visible; width: 12%; text-align: right">117,489</td><td style="visibility: visible; width: 1%; text-align: left">&#160;</td><td style="visibility: visible; width: 1%">&#160;</td>
    <td style="visibility: visible; width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20190101__20191231__srt--StatementGeographicalAxis__country--US_zWIdVteHZ4Hi" style="visibility: visible; width: 12%; text-align: right">173,522</td><td style="visibility: visible; width: 1%; text-align: left">&#160;</td></tr>
<tr style="visibility: visible; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="visibility: visible; text-align: left">&#160;&#160;&#160;&#160;Europe</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20210101__20211231__srt--StatementGeographicalAxis__srt--EuropeMember_zmO13RpnEfAk" style="visibility: visible; text-align: right">663,290</td><td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20200101__20201231__srt--StatementGeographicalAxis__srt--EuropeMember_ztyL8g0DCNCg" style="visibility: visible; text-align: right">422,947</td><td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20190101__20191231__srt--StatementGeographicalAxis__srt--EuropeMember_ztcgUX0XX4o3" style="visibility: visible; text-align: right">542,226</td><td style="visibility: visible; text-align: left">&#160;</td></tr>
<tr style="visibility: visible; vertical-align: bottom; background-color: White">
    <td style="visibility: visible; text-align: left; padding-bottom: 1pt">&#160;&#160;&#160;&#160;Eliminations of intercompany sales</td><td style="visibility: visible; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; visibility: visible; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20210101__20211231__srt--StatementGeographicalAxis__custom--EliminationsMember_zwlEf11aFZM2" style="border-bottom: Black 1pt solid; visibility: visible; text-align: right">(333</td><td style="visibility: visible; padding-bottom: 1pt; text-align: left">)</td><td style="visibility: visible; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; visibility: visible; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20200101__20201231__srt--StatementGeographicalAxis__custom--EliminationsMember_z5ym2Cf1wVOj" style="border-bottom: Black 1pt solid; visibility: visible; text-align: right">(1,427</td><td style="visibility: visible; padding-bottom: 1pt; text-align: left">)</td><td style="visibility: visible; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; visibility: visible; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20190101__20191231__srt--StatementGeographicalAxis__custom--EliminationsMember_zicOjvimpE4k" style="border-bottom: Black 1pt solid; visibility: visible; text-align: right">(2,234</td><td style="visibility: visible; padding-bottom: 1pt; text-align: left">)</td></tr>
<tr style="visibility: visible; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="visibility: visible; text-align: left; padding-bottom: 2pt">&#160;</td><td style="visibility: visible; padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; visibility: visible; text-align: left">$</td><td id="xdx_988_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20210101__20211231_zjyV2OjP8sa3" style="border-bottom: Black 2pt double; visibility: visible; text-align: right">879,516</td><td style="visibility: visible; padding-bottom: 2pt; text-align: left">&#160;</td><td style="visibility: visible; padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; visibility: visible; text-align: left">$</td><td id="xdx_98C_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20200101__20201231_zeUtsjBlkcec" style="border-bottom: Black 2pt double; visibility: visible; text-align: right">539,009</td><td style="visibility: visible; padding-bottom: 2pt; text-align: left">&#160;</td><td style="visibility: visible; padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; visibility: visible; text-align: left">$</td><td id="xdx_984_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_dxL_c20200101__20201231_zrpOASipOcL" style="border-bottom: Black 2pt double; visibility: visible; text-align: right" title="::XDX::539%2C009"><span style="-sec-ix-hidden: xdx2ixbrl1497">713,514</span></td><td style="visibility: visible; padding-bottom: 2pt; text-align: left">&#160;</td></tr>
<tr style="visibility: visible; vertical-align: bottom; background-color: White">
    <td style="visibility: visible; text-align: left">Net income attributable to Inter Parfums, Inc.:</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible; text-align: right">&#160;</td><td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible; text-align: right">&#160;</td><td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible; text-align: right">&#160;</td><td style="visibility: visible; text-align: left">&#160;</td></tr>
<tr style="visibility: visible; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="visibility: visible; text-align: left">&#160;&#160;&#160;&#160;United States</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">$</td><td id="xdx_982_eus-gaap--NetIncomeLoss_c20210101__20211231__srt--StatementGeographicalAxis__country--US_zJrsX1vBTKh1" style="visibility: visible; text-align: right">29,359</td><td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">$</td><td id="xdx_986_eus-gaap--NetIncomeLoss_c20200101__20201231__srt--StatementGeographicalAxis__country--US_zukMU1UqRBab" style="visibility: visible; text-align: right">7,942</td><td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">$</td><td id="xdx_98D_eus-gaap--NetIncomeLoss_c20190101__20191231__srt--StatementGeographicalAxis__country--US_zfoS7lQBSpQ7" style="visibility: visible; text-align: right">19,365</td><td style="visibility: visible; text-align: left">&#160;</td></tr>
<tr style="visibility: visible; vertical-align: bottom; background-color: White">
    <td style="visibility: visible; text-align: left">&#160;&#160;&#160;&#160;Europe</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--NetIncomeLoss_c20210101__20211231__srt--StatementGeographicalAxis__srt--EuropeMember_z5kifDjPeta6" style="visibility: visible; text-align: right">57,869</td><td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--NetIncomeLoss_c20200101__20201231__srt--StatementGeographicalAxis__srt--EuropeMember_zytAdG8vtrri" style="visibility: visible; text-align: right">30,241</td><td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--NetIncomeLoss_c20190101__20191231__srt--StatementGeographicalAxis__srt--EuropeMember_ztQNOn4IdHg8" style="visibility: visible; text-align: right">40,840</td><td style="visibility: visible; text-align: left">&#160;</td></tr>
<tr style="visibility: visible; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="visibility: visible; text-align: left; padding-bottom: 1pt">&#160;&#160;&#160;&#160;Eliminations</td><td style="visibility: visible; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; visibility: visible; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--NetIncomeLoss_c20210101__20211231__srt--StatementGeographicalAxis__custom--EliminationsMember_zg9MaKYb0dsc" style="border-bottom: Black 1pt solid; visibility: visible; text-align: right">183</td><td style="visibility: visible; padding-bottom: 1pt; text-align: left">&#160;</td><td style="visibility: visible; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; visibility: visible; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--NetIncomeLoss_c20200101__20201231__srt--StatementGeographicalAxis__custom--EliminationsMember_zNVbvBEIifob" style="border-bottom: Black 1pt solid; visibility: visible; text-align: right">36</td><td style="visibility: visible; padding-bottom: 1pt; text-align: left">&#160;</td><td style="visibility: visible; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; visibility: visible; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--NetIncomeLoss_c20190101__20191231__srt--StatementGeographicalAxis__custom--EliminationsMember_zykwKqHurgGd" style="border-bottom: Black 1pt solid; visibility: visible; text-align: right">44</td><td style="visibility: visible; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="visibility: visible; vertical-align: bottom; background-color: White">
    <td style="visibility: visible; text-align: left; padding-bottom: 2pt">&#160;</td><td style="visibility: visible; padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; visibility: visible; text-align: left">$</td><td id="xdx_981_eus-gaap--NetIncomeLoss_c20210101__20211231_znQ0YUnY32X3" style="border-bottom: Black 2pt double; visibility: visible; text-align: right">87,411</td><td style="visibility: visible; padding-bottom: 2pt; text-align: left">&#160;</td><td style="visibility: visible; padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; visibility: visible; text-align: left">$</td><td id="xdx_986_eus-gaap--NetIncomeLoss_c20200101__20201231_zyP62IcvJVSh" style="border-bottom: Black 2pt double; visibility: visible; text-align: right">38,219</td><td style="visibility: visible; padding-bottom: 2pt; text-align: left">&#160;</td><td style="visibility: visible; padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; visibility: visible; text-align: left">$</td><td id="xdx_98B_eus-gaap--NetIncomeLoss_c20190101__20191231_z997kfuIqlMf" style="border-bottom: Black 2pt double; visibility: visible; text-align: right">60,249</td><td style="visibility: visible; padding-bottom: 2pt; text-align: left">&#160;</td></tr>
<tr style="visibility: visible; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="visibility: visible; text-align: left; text-indent: -7.75pt; padding-left: 7.75pt">Depreciation and amortization expense including impairment loss:</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible; text-align: right">&#160;</td><td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible; text-align: right">&#160;</td><td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible; text-align: right">&#160;</td><td style="visibility: visible; text-align: left">&#160;</td></tr>
<tr style="visibility: visible; vertical-align: bottom; background-color: White">
    <td style="visibility: visible; text-align: left">&#160;&#160;&#160;&#160;United States</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">$</td><td id="xdx_98C_eus-gaap--DepreciationAndAmortization_c20210101__20211231__srt--StatementGeographicalAxis__country--US_zkF7xuK0rol4" style="visibility: visible; text-align: right">3,835</td><td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">$</td><td id="xdx_982_eus-gaap--DepreciationAndAmortization_c20200101__20201231__srt--StatementGeographicalAxis__country--US_zyOCWL2HUBxa" style="visibility: visible; text-align: right">3,354</td><td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">$</td><td id="xdx_985_eus-gaap--DepreciationAndAmortization_c20190101__20191231__srt--StatementGeographicalAxis__country--US_zUUVLjx2cPk" style="visibility: visible; text-align: right">3,088</td><td style="visibility: visible; text-align: left">&#160;</td></tr>
<tr style="visibility: visible; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="visibility: visible; text-align: left; padding-bottom: 1pt">&#160;&#160;&#160;&#160;Europe</td><td style="visibility: visible; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; visibility: visible; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--DepreciationAndAmortization_c20210101__20211231__srt--StatementGeographicalAxis__srt--EuropeMember_zt8Xwpmj0roa" style="border-bottom: Black 1pt solid; visibility: visible; text-align: right">8,863</td><td style="visibility: visible; padding-bottom: 1pt; text-align: left">&#160;</td><td style="visibility: visible; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; visibility: visible; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--DepreciationAndAmortization_c20200101__20201231__srt--StatementGeographicalAxis__srt--EuropeMember_zioukoB7Vgtj" style="border-bottom: Black 1pt solid; visibility: visible; text-align: right">5,713</td><td style="visibility: visible; padding-bottom: 1pt; text-align: left">&#160;</td><td style="visibility: visible; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; visibility: visible; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--DepreciationAndAmortization_c20190101__20191231__srt--StatementGeographicalAxis__srt--EuropeMember_z70leSOFQKH9" style="border-bottom: Black 1pt solid; visibility: visible; text-align: right">5,641</td><td style="visibility: visible; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="visibility: visible; vertical-align: bottom; background-color: White">
    <td style="visibility: visible; text-align: left; padding-bottom: 2pt">&#160;</td><td style="visibility: visible; padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; visibility: visible; text-align: left">$</td><td id="xdx_988_eus-gaap--DepreciationAndAmortization_c20210101__20211231_zDXjtc4WPOAg" style="border-bottom: Black 2pt double; visibility: visible; text-align: right">12,698</td><td style="visibility: visible; padding-bottom: 2pt; text-align: left">&#160;</td><td style="visibility: visible; padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; visibility: visible; text-align: left">$</td><td id="xdx_987_eus-gaap--DepreciationAndAmortization_c20200101__20201231_zqTLCmXoJIdd" style="border-bottom: Black 2pt double; visibility: visible; text-align: right">9,067</td><td style="visibility: visible; padding-bottom: 2pt; text-align: left">&#160;</td><td style="visibility: visible; padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; visibility: visible; text-align: left">$</td><td id="xdx_983_eus-gaap--DepreciationAndAmortization_c20190101__20191231_z7wvpw82L6q3" style="border-bottom: Black 2pt double; visibility: visible; text-align: right">8,729</td><td style="visibility: visible; padding-bottom: 2pt; text-align: left">&#160;</td></tr>
<tr style="visibility: visible; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="visibility: visible; text-align: left">Interest and investment income:</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible; text-align: right">&#160;</td><td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible; text-align: right">&#160;</td><td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible; text-align: right">&#160;</td><td style="visibility: visible; text-align: left">&#160;</td></tr>
<tr style="visibility: visible; vertical-align: bottom; background-color: White">
    <td style="visibility: visible; text-align: left">&#160;&#160;&#160;&#160;United States</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">$</td><td id="xdx_988_eus-gaap--InvestmentIncomeInterestAndDividend_c20210101__20211231__srt--StatementGeographicalAxis__country--US_zGHaHth6AQv7" style="visibility: visible; text-align: right">3</td><td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">$</td><td id="xdx_982_eus-gaap--InvestmentIncomeInterestAndDividend_c20200101__20201231__srt--StatementGeographicalAxis__country--US_z7dyBRe90bJ8" style="visibility: visible; text-align: right">24</td><td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">$</td><td id="xdx_984_eus-gaap--InvestmentIncomeInterestAndDividend_c20190101__20191231__srt--StatementGeographicalAxis__country--US_za0FpXMf1CW8" style="visibility: visible; text-align: right">345</td><td style="visibility: visible; text-align: left">&#160;</td></tr>
<tr style="visibility: visible; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="visibility: visible; text-align: left">&#160;&#160;&#160;&#160;Europe</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--InvestmentIncomeInterestAndDividend_c20210101__20211231__srt--StatementGeographicalAxis__srt--EuropeMember_zoRhTydjQQed" style="visibility: visible; text-align: right">3,526</td><td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--InvestmentIncomeInterestAndDividend_c20200101__20201231__srt--StatementGeographicalAxis__srt--EuropeMember_zP5BNsiY3o85" style="visibility: visible; text-align: right">2,971</td><td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--InvestmentIncomeInterestAndDividend_c20190101__20191231__srt--StatementGeographicalAxis__srt--EuropeMember_zWzfeijv0RZe" style="visibility: visible; text-align: right">3,501</td><td style="visibility: visible; text-align: left">&#160;</td></tr>
<tr style="visibility: visible; vertical-align: bottom; background-color: White">
    <td style="visibility: visible; text-align: left; padding-bottom: 1pt">&#160;&#160;&#160;&#160;Eliminations</td><td style="visibility: visible; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; visibility: visible; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--InvestmentIncomeInterestAndDividend_c20210101__20211231__srt--StatementGeographicalAxis__custom--EliminationsMember_zJm2O7dCPjhc" style="border-bottom: Black 1pt solid; visibility: visible; text-align: right">(126</td><td style="visibility: visible; padding-bottom: 1pt; text-align: left">)</td><td style="visibility: visible; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; visibility: visible; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--InvestmentIncomeInterestAndDividend_c20200101__20201231__srt--StatementGeographicalAxis__custom--EliminationsMember_zOPX0UarbiWc" style="border-bottom: Black 1pt solid; visibility: visible; text-align: right">(130</td><td style="visibility: visible; padding-bottom: 1pt; text-align: left">)</td><td style="visibility: visible; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; visibility: visible; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--InvestmentIncomeInterestAndDividend_c20190101__20191231__srt--StatementGeographicalAxis__custom--EliminationsMember_zt62G18GMYZ" style="border-bottom: Black 1pt solid; visibility: visible; text-align: right">(153</td><td style="visibility: visible; padding-bottom: 1pt; text-align: left">)</td></tr>
<tr style="visibility: visible; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="visibility: visible; text-align: left; padding-bottom: 2pt">&#160;</td><td style="visibility: visible; padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; visibility: visible; text-align: left">$</td><td id="xdx_98F_eus-gaap--InvestmentIncomeInterestAndDividend_c20210101__20211231_z1Scsi8xKcu8" style="border-bottom: Black 2pt double; visibility: visible; text-align: right">3,403</td><td style="visibility: visible; padding-bottom: 2pt; text-align: left">&#160;</td><td style="visibility: visible; padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; visibility: visible; text-align: left">$</td><td id="xdx_986_eus-gaap--InvestmentIncomeInterestAndDividend_c20200101__20201231_zqQDKSCvhSI9" style="border-bottom: Black 2pt double; visibility: visible; text-align: right">2,865</td><td style="visibility: visible; padding-bottom: 2pt; text-align: left">&#160;</td><td style="visibility: visible; padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; visibility: visible; text-align: left">$</td><td id="xdx_98E_eus-gaap--InvestmentIncomeInterestAndDividend_c20190101__20191231_zEOKYG3INDt8" style="border-bottom: Black 2pt double; visibility: visible; text-align: right">3,693</td><td style="visibility: visible; padding-bottom: 2pt; text-align: left">&#160;</td></tr>
<tr style="visibility: visible; vertical-align: bottom; background-color: White">
    <td style="visibility: visible; text-align: left">Interest expense:</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible; text-align: right">&#160;</td><td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible; text-align: right">&#160;</td><td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible; text-align: right">&#160;</td><td style="visibility: visible; text-align: left">&#160;</td></tr>
<tr style="visibility: visible; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="visibility: visible; text-align: left">&#160;&#160;&#160;&#160;United States</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">$</td><td id="xdx_987_eus-gaap--InterestExpense_c20210101__20211231__srt--StatementGeographicalAxis__country--US_zYxsoG4QjcUa" style="visibility: visible; text-align: right">636</td><td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">$</td><td id="xdx_989_eus-gaap--InterestExpense_c20200101__20201231__srt--StatementGeographicalAxis__country--US_z2Ybx7IJsKC3" style="visibility: visible; text-align: right">604</td><td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">$</td><td id="xdx_98B_eus-gaap--InterestExpense_c20190101__20191231__srt--StatementGeographicalAxis__country--US_zY8KBHWYMCk1" style="visibility: visible; text-align: right">673</td><td style="visibility: visible; text-align: left">&#160;</td></tr>
<tr style="visibility: visible; vertical-align: bottom; background-color: White">
    <td style="visibility: visible; text-align: left">&#160;&#160;&#160;&#160;Europe</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--InterestExpense_c20210101__20211231__srt--StatementGeographicalAxis__srt--EuropeMember_zHgsSFDcKVIf" style="visibility: visible; text-align: right" title="Interest expense">2,315</td><td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--InterestExpense_c20200101__20201231__srt--StatementGeographicalAxis__srt--EuropeMember_zLmvKN23VR57" style="visibility: visible; text-align: right" title="Interest expense">1,496</td><td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--InterestExpense_c20190101__20191231__srt--StatementGeographicalAxis__srt--EuropeMember_zNSXrgeFTNAg" style="visibility: visible; text-align: right" title="Interest expense">1,626</td><td style="visibility: visible; text-align: left">&#160;</td></tr>
<tr style="visibility: visible; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="visibility: visible; text-align: left; padding-bottom: 1pt">&#160;&#160;&#160;&#160;Eliminations</td><td style="visibility: visible; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; visibility: visible; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--InterestExpense_c20210101__20211231__srt--StatementGeographicalAxis__custom--EliminationsMember_zcrfn5F85JL7" style="border-bottom: Black 1pt solid; visibility: visible; text-align: right" title="Interest expense">(126</td><td style="visibility: visible; padding-bottom: 1pt; text-align: left">)</td><td style="visibility: visible; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; visibility: visible; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--InterestExpense_c20200101__20201231__srt--StatementGeographicalAxis__custom--EliminationsMember_zYBXzVtL8SH1" style="border-bottom: Black 1pt solid; visibility: visible; text-align: right" title="Interest expense">(130</td><td style="visibility: visible; padding-bottom: 1pt; text-align: left">)</td><td style="visibility: visible; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; visibility: visible; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--InterestExpense_c20190101__20191231__srt--StatementGeographicalAxis__custom--EliminationsMember_zSMQsNKpvAO2" style="border-bottom: Black 1pt solid; visibility: visible; text-align: right" title="Interest expense">(153</td><td style="visibility: visible; padding-bottom: 1pt; text-align: left">)</td></tr>
<tr style="visibility: visible; vertical-align: bottom; background-color: White">
    <td style="visibility: visible; text-align: left; padding-bottom: 2pt">&#160;</td><td style="visibility: visible; padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; visibility: visible; text-align: left">$</td><td id="xdx_98D_eus-gaap--InterestExpense_c20210101__20211231_zYwDrdtfE7qj" style="border-bottom: Black 2pt double; visibility: visible; text-align: right" title="Interest expense">2,825</td><td style="visibility: visible; padding-bottom: 2pt; text-align: left">&#160;</td><td style="visibility: visible; padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; visibility: visible; text-align: left">$</td><td id="xdx_980_eus-gaap--InterestExpense_c20200101__20201231_zNXV6WHw0F3b" style="border-bottom: Black 2pt double; visibility: visible; text-align: right" title="Interest expense">1,970</td><td style="visibility: visible; padding-bottom: 2pt; text-align: left">&#160;</td><td style="visibility: visible; padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; visibility: visible; text-align: left">$</td><td id="xdx_981_eus-gaap--InterestExpense_c20190101__20191231_zI8X8gzlNi8c" style="border-bottom: Black 2pt double; visibility: visible; text-align: right" title="Interest expense">2,146</td><td style="visibility: visible; padding-bottom: 2pt; text-align: left">&#160;</td></tr>
<tr style="visibility: visible; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="visibility: visible; text-align: left">Income tax expense:</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible; text-align: right">&#160;</td><td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible; text-align: right">&#160;</td><td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible; text-align: right">&#160;</td><td style="visibility: visible; text-align: left">&#160;</td></tr>
<tr style="visibility: visible; vertical-align: bottom; background-color: White">
    <td style="visibility: visible; text-align: left">&#160;&#160;&#160;&#160;United States</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">$</td><td id="xdx_985_eus-gaap--IncomeTaxExpenseBenefit_c20210101__20211231__srt--StatementGeographicalAxis__country--US_zPqN12BQMkL1" style="visibility: visible; text-align: right">5,336</td><td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">$</td><td id="xdx_983_eus-gaap--IncomeTaxExpenseBenefit_c20200101__20201231__srt--StatementGeographicalAxis__country--US_zHU559TDBHrb" style="visibility: visible; text-align: right">1,590</td><td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">$</td><td id="xdx_986_eus-gaap--IncomeTaxExpenseBenefit_c20190101__20191231__srt--StatementGeographicalAxis__country--US_ztUs8eqesh7k" style="visibility: visible; text-align: right">3,945</td><td style="visibility: visible; text-align: left">&#160;</td></tr>
<tr style="visibility: visible; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="visibility: visible; text-align: left">&#160;&#160;&#160;&#160;Europe</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--IncomeTaxExpenseBenefit_c20210101__20211231__srt--StatementGeographicalAxis__srt--EuropeMember_z0bXvJdCA9qa" style="visibility: visible; text-align: right">35,607</td><td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--IncomeTaxExpenseBenefit_c20200101__20201231__srt--StatementGeographicalAxis__srt--EuropeMember_z6N7TqsQJgVf" style="visibility: visible; text-align: right">17,782</td><td style="visibility: visible; text-align: left">&#160;</td><td style="visibility: visible">&#160;</td>
    <td style="visibility: visible; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--IncomeTaxExpenseBenefit_c20190101__20191231__srt--StatementGeographicalAxis__srt--EuropeMember_zyNgRnvX3AHa" style="visibility: visible; text-align: right">25,101</td><td style="visibility: visible; text-align: left">&#160;</td></tr>
<tr style="visibility: visible; vertical-align: bottom; background-color: White">
    <td style="visibility: visible; text-align: left; padding-bottom: 1pt">&#160;&#160;&#160;&#160;Eliminations</td><td style="visibility: visible; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; visibility: visible; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--IncomeTaxExpenseBenefit_c20210101__20211231__srt--StatementGeographicalAxis__custom--EliminationsMember_zsxwiXhlQHTb" style="border-bottom: Black 1pt solid; visibility: visible; text-align: right">49</td><td style="visibility: visible; padding-bottom: 1pt; text-align: left">&#160;</td><td style="visibility: visible; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; visibility: visible; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--IncomeTaxExpenseBenefit_c20200101__20201231__srt--StatementGeographicalAxis__custom--EliminationsMember_zAQ2F8H0iw26" style="border-bottom: Black 1pt solid; visibility: visible; text-align: right">9</td><td style="visibility: visible; padding-bottom: 1pt; text-align: left">&#160;</td><td style="visibility: visible; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; visibility: visible; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--IncomeTaxExpenseBenefit_c20190101__20191231__srt--StatementGeographicalAxis__custom--EliminationsMember_zsfPjVbPoZq9" style="border-bottom: Black 1pt solid; visibility: visible; text-align: right">30</td><td style="visibility: visible; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="visibility: visible; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="visibility: visible; text-align: left; padding-bottom: 2pt">&#160;</td><td style="visibility: visible; padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; visibility: visible; text-align: left">$</td><td id="xdx_985_eus-gaap--IncomeTaxExpenseBenefit_c20210101__20211231_zYuwcNGNDjxe" style="border-bottom: Black 2pt double; visibility: visible; text-align: right">40,992</td><td style="visibility: visible; padding-bottom: 2pt; text-align: left">&#160;</td><td style="visibility: visible; padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; visibility: visible; text-align: left">$</td><td id="xdx_988_eus-gaap--IncomeTaxExpenseBenefit_c20200101__20201231_zK5CansaJlHa" style="border-bottom: Black 2pt double; visibility: visible; text-align: right">19,381</td><td style="visibility: visible; padding-bottom: 2pt; text-align: left">&#160;</td><td style="visibility: visible; padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; visibility: visible; text-align: left">$</td><td id="xdx_982_eus-gaap--IncomeTaxExpenseBenefit_c20190101__20191231_ziS0Mw2aThV8" style="border-bottom: Black 2pt double; visibility: visible; text-align: right">29,076</td><td style="visibility: visible; padding-bottom: 2pt; text-align: left">&#160;</td></tr>
</table>

<p style="margin: 0; visibility: visible">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in">
<tr style="text-align: center; vertical-align: bottom">
    <td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>December 31,</b></span></td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="text-align: center; vertical-align: bottom">
    <td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold">2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold">2019</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; width: 55%">Total assets:</td><td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td style="text-align: right; width: 12%">&#160;</td><td style="text-align: left; width: 1%">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td style="text-align: right; width: 12%">&#160;</td><td style="text-align: left; width: 1%">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td style="text-align: right; width: 12%">&#160;</td><td style="text-align: left; width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;&#160;&#160;&#160;United States</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--Assets_iI_c20211231__srt--StatementGeographicalAxis__country--US_z8zLIQYvfsd3" style="text-align: right">247,703</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--Assets_iI_c20201231__srt--StatementGeographicalAxis__country--US_z1a1mVWhWgJa" style="text-align: right">141,316</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_983_eus-gaap--Assets_iI_c20191231__srt--StatementGeographicalAxis__country--US_ze4scNtgijPj" style="text-align: right">166,180</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;&#160;&#160;&#160;Europe</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--Assets_iI_c20211231__srt--StatementGeographicalAxis__srt--EuropeMember_zFKpIBUvOgqk" style="text-align: right">931,735</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--Assets_iI_c20201231__srt--StatementGeographicalAxis__srt--EuropeMember_zLoIkfHcmMR6" style="text-align: right">758,812</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--Assets_iI_c20191231__srt--StatementGeographicalAxis__srt--EuropeMember_zHhR8uZ68Vdi" style="text-align: right">670,657</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">&#160;&#160;&#160;&#160;Eliminations</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--Assets_iI_c20211231__srt--StatementGeographicalAxis__custom--EliminationsMember_ziJx0D2ajuXj" style="border-bottom: Black 1pt solid; text-align: right">(34,074</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--Assets_iI_c20201231__srt--StatementGeographicalAxis__custom--EliminationsMember_zW0wHylpiVnf" style="border-bottom: Black 1pt solid; text-align: right">(9,983</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--Assets_iI_c20191231__srt--StatementGeographicalAxis__custom--EliminationsMember_ztZSf6TnJ691" style="border-bottom: Black 1pt solid; text-align: right">(8,005</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2pt">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td id="xdx_984_eus-gaap--Assets_iI_c20211231_zDp748Hon1k2" style="border-bottom: Black 2pt double; text-align: right">1,145,364</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--Assets_iI_c20201231_zF0HVpqB8clf" style="border-bottom: Black 2pt double; text-align: right">890,145</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--Assets_iI_c20191231_zKV32bgh58nd" style="border-bottom: Black 2pt double; text-align: right">828,832</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Additions to long-lived assets:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;&#160;&#160;&#160;United States</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--AdditionsToOtherAssetsAmount_c20210101__20211231__srt--StatementGeographicalAxis__country--US_zwbljiC2D0T2" style="text-align: right">2,711</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--AdditionsToOtherAssetsAmount_c20200101__20201231__srt--StatementGeographicalAxis__country--US_zDQwlX504Fj9" style="text-align: right">1,004</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--AdditionsToOtherAssetsAmount_c20190101__20191231__srt--StatementGeographicalAxis__country--US_zyaItO2G8at2" style="text-align: right">5,851</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">&#160;&#160;&#160;&#160;Europe</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--AdditionsToOtherAssetsAmount_c20210101__20211231__srt--StatementGeographicalAxis__srt--EuropeMember_zhE9PE1o3qA5" style="border-bottom: Black 1pt solid; text-align: right">138,563</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--AdditionsToOtherAssetsAmount_c20200101__20201231__srt--StatementGeographicalAxis__srt--EuropeMember_z7bZHUpdAPbg" style="border-bottom: Black 1pt solid; text-align: right">11,259</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--AdditionsToOtherAssetsAmount_c20190101__20191231__srt--StatementGeographicalAxis__srt--EuropeMember_znS4FO2uM4K6" style="border-bottom: Black 1pt solid; text-align: right">5,643</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2pt">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--AdditionsToOtherAssetsAmount_c20210101__20211231_zHfls6HDBu4k" style="border-bottom: Black 2pt double; text-align: right">141,274</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td id="xdx_987_eus-gaap--AdditionsToOtherAssetsAmount_c20200101__20201231_zcl7DDjE2QR5" style="border-bottom: Black 2pt double; text-align: right">12,263</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td id="xdx_983_eus-gaap--AdditionsToOtherAssetsAmount_c20190101__20191231_zXeSTYOabnB4" style="border-bottom: Black 2pt double; text-align: right">11,494</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Total long-lived assets:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;&#160;&#160;&#160;United States</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--NoncurrentAssets_iI_c20211231__srt--StatementGeographicalAxis__country--US_zQKQz1a0vcYc" style="text-align: right">63,094</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--NoncurrentAssets_iI_c20201231__srt--StatementGeographicalAxis__country--US_zN6R5bz6TMr6" style="text-align: right">40,656</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--NoncurrentAssets_iI_c20191231__srt--StatementGeographicalAxis__country--US_zofVpONNxiv8" style="text-align: right">44,473</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">&#160;&#160;&#160;&#160;Europe</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--NoncurrentAssets_iI_c20211231__srt--StatementGeographicalAxis__srt--EuropeMember_zr7C4Q02H059" style="border-bottom: Black 1pt solid; text-align: right">334,033</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--NoncurrentAssets_iI_c20201231__srt--StatementGeographicalAxis__srt--EuropeMember_zgqJ58AYQgJ" style="border-bottom: Black 1pt solid; text-align: right">217,766</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--NoncurrentAssets_iI_c20191231__srt--StatementGeographicalAxis__srt--EuropeMember_z9wKjWDm19Zg" style="border-bottom: Black 1pt solid; text-align: right">196,976</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2pt">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--NoncurrentAssets_iI_c20211231_z6hxmiTCgKSi" style="border-bottom: Black 2pt double; text-align: right">397,127</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td id="xdx_984_eus-gaap--NoncurrentAssets_iI_c20201231_zJnLsw2O7mc3" style="border-bottom: Black 2pt double; text-align: right">258,422</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td id="xdx_980_eus-gaap--NoncurrentAssets_iI_c20191231_zGz0VhTFM3Yh" style="border-bottom: Black 2pt double; text-align: right">241,449</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Deferred tax assets:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;&#160;&#160;&#160;United States</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20211231__srt--StatementGeographicalAxis__country--US_zkvJfows7qFd" style="text-align: right">870</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20201231__srt--StatementGeographicalAxis__country--US_zP0BCCuOPxBf" style="text-align: right">886</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20191231__srt--StatementGeographicalAxis__country--US_zVZLmXviCsil" style="text-align: right">705</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;&#160;&#160;&#160;Europe</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20211231__srt--StatementGeographicalAxis__srt--EuropeMember_z0lncOo7cgB7" style="text-align: right">7,066</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20201231__srt--StatementGeographicalAxis__srt--EuropeMember_zrlbuGWF38d" style="text-align: right">7,106</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20191231__srt--StatementGeographicalAxis__srt--EuropeMember_zVMP9IkRSMu4" style="text-align: right">7,241</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">&#160;&#160;&#160;&#160;Eliminations</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20211231__srt--StatementGeographicalAxis__custom--EliminationsMember_zJs36H0Si6he" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1600">&#8212;</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20201231__srt--StatementGeographicalAxis__custom--EliminationsMember_znLmrvdF8f1k" style="border-bottom: Black 1pt solid; text-align: right">49</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20191231__srt--StatementGeographicalAxis__custom--EliminationsMember_zAodDoksCThk" style="border-bottom: Black 1pt solid; text-align: right">58</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2pt">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20211231_zEpnN8QYHkOa" style="border-bottom: Black 2pt double; text-align: right">7,936</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td id="xdx_987_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20201231_zkqsKHMhcTOl" style="border-bottom: Black 2pt double; text-align: right">8,041</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20191231_zisQbqIbzlz4" style="border-bottom: Black 2pt double; text-align: right">8,004</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
</table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock', window );">Consolidated net sales to customers by region are as follows:</a></td>
<td class="text"><p id="xdx_89E_eus-gaap--ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_zqqPoAQ24U2i" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">United States export sales were
approximately $<span id="xdx_901_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_dm_c20210101__20211231_zOKOIecfTgs">126.2 million</span>, $<span id="xdx_909_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_dm_c20200101__20201231_zgHZ9LnNqMH7">71.5 million</span> and $<span id="xdx_900_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20190101__20191231_zmGNh1bB8Dsd">112.0</span> million in 2021, 2020 and 2019, respectively. <span id="xdx_8BB_z8EKIkonq9Dc">Consolidated net sales to
customers by region are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 55%; text-align: left">North America</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--Revenues_c20210101__20211231__srt--StatementGeographicalAxis__srt--NorthAmericaMember_zAne2nd7s9qb" style="width: 12%; text-align: right" title="Net sales">354,100</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--Revenues_c20200101__20201231__srt--StatementGeographicalAxis__srt--NorthAmericaMember_zGLPNa5KiEji" style="width: 12%; text-align: right">193,500</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--Revenues_c20190101__20191231__srt--StatementGeographicalAxis__srt--NorthAmericaMember_zY4PXJenVjHl" style="width: 12%; text-align: right">235,500</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>Europe</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--Revenues_c20210101__20211231__srt--StatementGeographicalAxis__custom--EuropeCountryMember_z4Kj9Q2LPdmi" style="text-align: right">271,600</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--Revenues_c20200101__20201231__srt--StatementGeographicalAxis__custom--EuropeCountryMember_z9cC9M7ZndHh" style="text-align: right">180,200</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--Revenues_c20190101__20191231__srt--StatementGeographicalAxis__custom--EuropeCountryMember_zgb1sHloeFD6" style="text-align: right">240,800</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Asia</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--Revenues_c20210101__20211231__srt--StatementGeographicalAxis__srt--AsiaMember_zW7Z1YghAqd3" style="text-align: right">128,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--Revenues_c20200101__20201231__srt--StatementGeographicalAxis__srt--AsiaMember_zRNOQ20XH2E3" style="text-align: right">79,700</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--Revenues_c20190101__20191231__srt--StatementGeographicalAxis__srt--AsiaMember_zV1AsVZ6BVC7" style="text-align: right">110,900</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Middle East</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--Revenues_c20210101__20211231__srt--StatementGeographicalAxis__us-gaap--MiddleEastMember_zBqHf1TKVNzl" style="text-align: right">61,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--Revenues_c20200101__20201231__srt--StatementGeographicalAxis__us-gaap--MiddleEastMember_zPX5D2V6erWl" style="text-align: right">46,800</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--Revenues_c20190101__20191231__srt--StatementGeographicalAxis__us-gaap--MiddleEastMember_z2SSTGEiiOpk" style="text-align: right">72,600</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Central and South America</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--Revenues_c20210101__20211231__srt--StatementGeographicalAxis__custom--CentralAndSouthAmericaMember_zQ82bJLnqLmc" style="text-align: right">56,400</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--Revenues_c20200101__20201231__srt--StatementGeographicalAxis__custom--CentralAndSouthAmericaMember_zaQPC0bZbpRd" style="text-align: right">32,500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--Revenues_c20190101__20191231__srt--StatementGeographicalAxis__custom--CentralAndSouthAmericaMember_zug9hg2oF66d" style="text-align: right">46,200</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">Other</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--Revenues_c20210101__20211231__srt--StatementGeographicalAxis__custom--OtherSegmentCountryMember_zTIQ1CRJkQvb" style="border-bottom: Black 1pt solid; text-align: right">8,400</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--Revenues_c20200101__20201231__srt--StatementGeographicalAxis__custom--OtherSegmentCountryMember_zwuHA6VcULmb" style="border-bottom: Black 1pt solid; text-align: right">6,300</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--Revenues_c20190101__20191231__srt--StatementGeographicalAxis__custom--OtherSegmentCountryMember_zf5C59wEliX7" style="border-bottom: Black 1pt solid; text-align: right">7,500</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2pt">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td id="xdx_984_eus-gaap--Revenues_c20210101__20211231_zuLPyqTHRiEf" style="border-bottom: Black 2pt double; text-align: right">879,500</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td id="xdx_988_eus-gaap--Revenues_c20200101__20201231_za3KlQTe5Msg" style="border-bottom: Black 2pt double; text-align: right">539,000</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td id="xdx_984_eus-gaap--Revenues_c20190101__20191231_zdyljZT1FLch" style="border-bottom: Black 2pt double; text-align: right">713,500</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
</table>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock', window );">Consolidated net sales to customers in major countries are as follows:</a></td>
<td class="text"><p id="xdx_898_eus-gaap--ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock_zuUa5YDa2a4h" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span id="xdx_8BA_zqXnHQ8BJT6k">Consolidated net sales to customers in major countries
are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year Ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 55%; text-align: left">United States</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20210101__20211231__us-gaap--StatementBusinessSegmentsAxis__custom--UnitedStatesMember_zEKymJV57Qvl" style="width: 12%; text-align: right" title="Revenue from Contract with Customer, Including Assessed Tax">351,300</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20200101__20201231__us-gaap--StatementBusinessSegmentsAxis__custom--UnitedStatesMember_zxYvGQoLkVMk" style="width: 12%; text-align: right">187,300</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20190101__20191231__us-gaap--StatementBusinessSegmentsAxis__custom--UnitedStatesMember_ztuDf4UXZh8e" style="width: 12%; text-align: right">225,300</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>France</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20210101__20211231__us-gaap--StatementBusinessSegmentsAxis__custom--FranceMember_zCRsWORMslv7" style="text-align: right">44,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20200101__20201231__us-gaap--StatementBusinessSegmentsAxis__custom--FranceMember_zbAfAETODHKk" style="text-align: right">37,600</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20190101__20191231__us-gaap--StatementBusinessSegmentsAxis__custom--FranceMember_zkP4BXithRv5" style="text-align: right">43,500</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Russia</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20210101__20211231__us-gaap--StatementBusinessSegmentsAxis__custom--RussiaMember_zcXrJAGJdL37" style="text-align: right">43,400</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20200101__20201231__us-gaap--StatementBusinessSegmentsAxis__custom--RussiaMember_zYkELQ8N448i" style="text-align: right">14,100</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20190101__20191231__us-gaap--StatementBusinessSegmentsAxis__custom--RussiaMember_zMwJcPbEQXTj" style="text-align: right">36,800</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">United Kingdom</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20210101__20211231__us-gaap--StatementBusinessSegmentsAxis__custom--UnitedKingdomMember_z7NvoMSPPB0e" style="text-align: right">38,500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20200101__20201231__us-gaap--StatementBusinessSegmentsAxis__custom--UnitedKingdomMember_zmsscOTv6ur1" style="text-align: right">24,600</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20190101__20191231__us-gaap--StatementBusinessSegmentsAxis__custom--UnitedKingdomMember_zmPhy1xPPQR" style="text-align: right">35,800</td><td style="text-align: left">&#160;</td></tr>
</table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the extent of the entity's reliance on its major customers, if revenues from transactions with a single external customer amount to 10 percent or more of entity revenues, including the disclosure of that fact, the total amount of revenues from each such customer, and the identity of the reportable segment or segments reporting the revenues. The entity need not disclose the identity of a major customer or the amount of revenues that each segment reports from that customer. For these purposes, a group of companies known to the entity to be under common control is considered a single customer, and the federal government, a state government, a local government such as a county or municipality, or a foreign government is each considered a single customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information concerning material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material.  An entity may also provide subtotals of geographic information about groups of countries.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139983549552840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock', window );">The components of income before income taxes consist of the following:</a></td>
<td class="text"><p id="xdx_89C_eus-gaap--ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_zP7KWJTx3xN4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8B8_zek4eMr6vwDe">The components of income before
income taxes consist of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 55%; text-align: left">U.S. operations</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_c20210101__20211231_zzpNfdpkgazi" style="width: 12%; text-align: right" title="U.S. operations">34,742</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_c20200101__20201231_zGARqmS1frAk" style="width: 12%; text-align: right" title="U.S. operations">9,577</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_c20190101__20191231_zQnEOBvTAa7i" style="width: 12%; text-align: right" title="U.S. operations">23,384</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Foreign operations</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_c20210101__20211231_zRdQmkhIgTYa" style="border-bottom: Black 1pt solid; text-align: right" title="Foreign operations">116,277</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_c20200101__20201231_z51CEqt2q3F9" style="border-bottom: Black 1pt solid; text-align: right" title="Foreign operations">59,772</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_c20190101__20191231_zIeZ60GanUl9" style="border-bottom: Black 1pt solid; text-align: right" title="Foreign operations">81,762</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2pt">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_dxL_c20210101__20211231_zrOnVOV5dMj8" style="border-bottom: Black 2pt double; text-align: right" title="Income before income taxes::XDX::151%2C019"><span style="-sec-ix-hidden: xdx2ixbrl1662">151,019</span></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_c20200101__20201231_z3T85frJ6MZ8" style="border-bottom: Black 2pt double; text-align: right" title="Income before income taxes">69,349</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_c20190101__20191231_zXCUYLNbH8Ei" style="border-bottom: Black 2pt double; text-align: right" title="Income before income taxes">105,146</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
</table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">The provision for current and deferred income tax expense (benefit) consists of the following:</a></td>
<td class="text"><p id="xdx_896_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zUGiZ2T49aRh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8BA_zwqhkU3uzkwj">The provision for current and
deferred income tax expense (benefit) consists of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td><span style="color: Black">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="color: Black">&#160;</span></td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="color: Black">Year
    ended December 31,</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="color: Black">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td><span style="color: Black">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="color: Black">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="color: Black">2021</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="color: Black">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="color: Black">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="color: Black">2020</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="color: Black">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="color: Black">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="color: Black">2019</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="color: Black">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="color: Black">Current:</span></td><td><span style="color: Black">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="color: Black">&#160;</span></td><td><span style="color: Black">&#160;</span></td><td><span style="color: Black">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="color: Black">&#160;</span></td><td><span style="color: Black">&#160;</span></td><td><span style="color: Black">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="color: Black">&#160;</span></td><td><span style="color: Black">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 55%; padding-left: 0.125in"><span style="color: Black">Federal</span></td><td style="width: 1%"><span style="color: Black">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="color: Black">$</span></td><td id="xdx_98C_eus-gaap--CurrentFederalTaxExpenseBenefit_c20210101__20211231_zyccVXsRAWgb" style="width: 12%; text-align: right" title="Federal"><span style="color: Black">4,825</span></td><td style="width: 1%; text-align: left"><span style="color: Black">&#160;</span></td><td style="width: 1%"><span style="color: Black">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="color: Black">$</span></td><td id="xdx_98C_eus-gaap--CurrentFederalTaxExpenseBenefit_c20200101__20201231_zQoZuV1w3Dt3" style="width: 12%; text-align: right" title="Federal"><span style="color: Black">1,685</span></td><td style="width: 1%; text-align: left"><span style="color: Black">&#160;</span></td><td style="width: 1%"><span style="color: Black">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="color: Black">$</span></td><td id="xdx_98D_eus-gaap--CurrentFederalTaxExpenseBenefit_c20190101__20191231_zYITiginS8Pj" style="width: 12%; text-align: right" title="Federal"><span style="color: Black">3,280</span></td><td style="width: 1%; text-align: left"><span style="color: Black">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.125in"><span style="color: Black">State and local</span></td><td><span style="color: Black">&#160;</span></td>
    <td style="text-align: left"><span style="color: Black">&#160;</span></td><td id="xdx_98B_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_c20210101__20211231_zeZQt1nhP2qf" style="text-align: right" title="State and local"><span style="color: Black">518</span></td><td style="text-align: left"><span style="color: Black">&#160;</span></td><td><span style="color: Black">&#160;</span></td>
    <td style="text-align: left"><span style="color: Black">&#160;</span></td><td id="xdx_983_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_c20200101__20201231_zIJtWwL6AOM1" style="text-align: right" title="State and local"><span style="color: Black">90</span></td><td style="text-align: left"><span style="color: Black">&#160;</span></td><td><span style="color: Black">&#160;</span></td>
    <td style="text-align: left"><span style="color: Black">&#160;</span></td><td id="xdx_98E_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_c20190101__20191231_zuaogGZmmemj" style="text-align: right" title="State and local"><span style="color: Black">713</span></td><td style="text-align: left"><span style="color: Black">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; padding-left: 0.125in"><span style="color: Black">Foreign</span></td><td style="padding-bottom: 1pt"><span style="color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="color: Black">&#160;</span></td><td id="xdx_989_eus-gaap--CurrentForeignTaxExpenseBenefit_c20210101__20211231_zl83A7KS5Ufe" style="border-bottom: Black 1pt solid; text-align: right" title="Foreign"><span style="color: Black">36,164</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="color: Black">&#160;</span></td><td style="padding-bottom: 1pt"><span style="color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="color: Black">&#160;</span></td><td id="xdx_98D_eus-gaap--CurrentForeignTaxExpenseBenefit_c20200101__20201231_zkZBFCc887yb" style="border-bottom: Black 1pt solid; text-align: right" title="Foreign"><span style="color: Black">17,024</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="color: Black">&#160;</span></td><td style="padding-bottom: 1pt"><span style="color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="color: Black">&#160;</span></td><td id="xdx_988_eus-gaap--CurrentForeignTaxExpenseBenefit_c20190101__20191231_zQAipynMaS1f" style="border-bottom: Black 1pt solid; text-align: right" title="Foreign"><span style="color: Black">27,412</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="color: Black">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; padding-left: 0.125in"><span style="color: Black">&#160;</span></td><td style="padding-bottom: 1pt"><span style="color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="color: Black">&#160;</span></td><td id="xdx_98D_eus-gaap--CurrentIncomeTaxExpenseBenefit_c20210101__20211231_zeEvwTxGaul2" style="border-bottom: Black 1pt solid; text-align: right" title="Current income tax expense"><span style="color: Black">41,507</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="color: Black">&#160;</span></td><td style="padding-bottom: 1pt"><span style="color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="color: Black">&#160;</span></td><td id="xdx_985_eus-gaap--CurrentIncomeTaxExpenseBenefit_c20200101__20201231_zB7H8NO70fik" style="border-bottom: Black 1pt solid; text-align: right" title="Current income tax expense"><span style="color: Black">18,799</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="color: Black">&#160;</span></td><td style="padding-bottom: 1pt"><span style="color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="color: Black">&#160;</span></td><td id="xdx_98A_eus-gaap--CurrentIncomeTaxExpenseBenefit_c20190101__20191231_zBWsVBhDhPxd" style="border-bottom: Black 1pt solid; text-align: right" title="Current income tax expense"><span style="color: Black">31,405</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="color: Black">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0in"><span style="color: Black">Deferred:</span></td><td><span style="color: Black">&#160;</span></td>
    <td style="text-align: left"><span style="color: Black">&#160;</span></td><td style="text-align: right"><span style="color: Black">&#160;</span></td><td style="text-align: left"><span style="color: Black">&#160;</span></td><td><span style="color: Black">&#160;</span></td>
    <td style="text-align: left"><span style="color: Black">&#160;</span></td><td style="text-align: right"><span style="color: Black">&#160;</span></td><td style="text-align: left"><span style="color: Black">&#160;</span></td><td><span style="color: Black">&#160;</span></td>
    <td style="text-align: left"><span style="color: Black">&#160;</span></td><td style="text-align: right"><span style="color: Black">&#160;</span></td><td style="text-align: left"><span style="color: Black">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in"><span style="color: Black">Federal</span></td><td><span style="color: Black">&#160;</span></td>
    <td style="text-align: left"><span style="color: Black">&#160;</span></td><td id="xdx_98C_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_c20210101__20211231_ze6HlfWY8uA8" style="text-align: right" title="Federal"><span style="color: Black">4</span></td><td style="text-align: left"><span style="color: Black">&#160;</span></td><td style="color: #FF0000"><span style="color: Black">&#160;</span></td>
    <td style="color: #FF0000; text-align: left"><span style="color: Black">&#160;</span></td><td id="xdx_988_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_c20200101__20201231_zUhelWURYQZc" style="color: #FF0000; text-align: right" title="Federal"><span style="color: Black">(215</span></td><td style="color: #FF0000; text-align: left"><span style="color: Black">)</span></td><td style="color: #FF0000"><span style="color: Black">&#160;</span></td>
    <td style="color: #FF0000; text-align: left"><span style="color: Black">&#160;</span></td><td id="xdx_986_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_c20190101__20191231_ziUn6oUD2Zyj" style="color: #FF0000; text-align: right" title="Federal"><span style="color: Black">(3</span></td><td style="color: #FF0000; text-align: left"><span style="color: Black">)</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.125in"><span style="color: Black">State and local</span></td><td><span style="color: Black">&#160;</span></td>
    <td style="text-align: left"><span style="color: Black">&#160;</span></td><td id="xdx_988_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_c20210101__20211231_zd2QCvpKnETk" style="text-align: right" title="State and local"><span style="color: Black">11</span></td><td style="text-align: left"><span style="color: Black">&#160;</span></td><td><span style="color: Black">&#160;</span></td>
    <td style="text-align: left"><span style="color: Black">&#160;</span></td><td id="xdx_986_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_c20200101__20201231_zFRLVE8qtbpg" style="text-align: right" title="State and local"><span style="color: Black">44</span></td><td style="text-align: left"><span style="color: Black">&#160;</span></td><td style="color: #FF0000"><span style="color: Black">&#160;</span></td>
    <td style="color: #FF0000; text-align: left"><span style="color: Black">&#160;</span></td><td id="xdx_98F_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_c20190101__20191231_zyiKjpMXNJpf" style="color: #FF0000; text-align: right" title="State and local"><span style="color: Black">(22</span></td><td style="color: #FF0000; text-align: left"><span style="color: Black">)</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; padding-left: 0.125in"><span style="color: Black">Foreign</span></td><td style="color: #FF0000; padding-bottom: 1pt"><span style="color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; color: #FF0000; text-align: left"><span style="color: Black">&#160;</span></td><td id="xdx_982_eus-gaap--DeferredForeignIncomeTaxExpenseBenefit_c20210101__20211231_ziURehu430v9" style="border-bottom: Black 1pt solid; color: #FF0000; text-align: right" title="Foreign"><span style="color: Black">(530</span></td><td style="padding-bottom: 1pt; color: #FF0000; text-align: left"><span style="color: Black">)</span></td><td style="padding-bottom: 1pt"><span style="color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="color: Black">&#160;</span></td><td id="xdx_989_eus-gaap--DeferredForeignIncomeTaxExpenseBenefit_c20200101__20201231_zop73MEig7uh" style="border-bottom: Black 1pt solid; text-align: right" title="Foreign"><span style="color: Black">753</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="color: Black">&#160;</span></td><td style="color: #FF0000; padding-bottom: 1pt"><span style="color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; color: #FF0000; text-align: left"><span style="color: Black">&#160;</span></td><td id="xdx_98F_eus-gaap--DeferredForeignIncomeTaxExpenseBenefit_c20190101__20191231_z8JMNNKenST5" style="border-bottom: Black 1pt solid; color: #FF0000; text-align: right" title="Foreign"><span style="color: Black">(2,304</span></td><td style="padding-bottom: 1pt; color: #FF0000; text-align: left"><span style="color: Black">)</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; padding-left: 0.125in"><span style="color: Black">&#160;</span></td><td style="color: #FF0000; padding-bottom: 1pt"><span style="color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; color: #FF0000; text-align: left"><span style="color: Black">&#160;</span></td><td id="xdx_983_eus-gaap--DeferredIncomeTaxesAndTaxCredits_c20210101__20211231_z5wYD0xIO3L2" style="border-bottom: Black 1pt solid; color: #FF0000; text-align: right" title="Deferred income tax expense"><span style="color: Black">(515</span></td><td style="padding-bottom: 1pt; color: #FF0000; text-align: left"><span style="color: Black">)</span></td><td style="padding-bottom: 1pt"><span style="color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="color: Black">&#160;</span></td><td id="xdx_983_eus-gaap--DeferredIncomeTaxesAndTaxCredits_c20200101__20201231_zBOX09o1nzye" style="border-bottom: Black 1pt solid; text-align: right" title="Deferred income tax expense"><span style="color: Black">582</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="color: Black">&#160;</span></td><td style="color: #FF0000; padding-bottom: 1pt"><span style="color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; color: #FF0000; text-align: left"><span style="color: Black">&#160;</span></td><td id="xdx_98B_eus-gaap--DeferredIncomeTaxesAndTaxCredits_c20190101__20191231_zysV537hiDga" style="border-bottom: Black 1pt solid; color: #FF0000; text-align: right" title="Deferred income tax expense"><span style="color: Black">(2,329</span></td><td style="padding-bottom: 1pt; color: #FF0000; text-align: left"><span style="color: Black">)</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2pt; padding-left: 0.25in"><span style="color: Black">Total income tax expense</span></td><td style="padding-bottom: 2pt"><span style="color: Black">&#160;</span></td>
    <td style="border-bottom: Black 2pt double; text-align: left"><span style="color: Black">$</span></td><td id="xdx_98D_eus-gaap--IncomeTaxExpenseBenefit_c20210101__20211231_zYRwkxqLQOXc" style="border-bottom: Black 2pt double; text-align: right" title="Total income tax expense"><span style="color: Black">40,992</span></td><td style="padding-bottom: 2pt; text-align: left"><span style="color: Black">&#160;</span></td><td style="padding-bottom: 2pt"><span style="color: Black">&#160;</span></td>
    <td style="border-bottom: Black 2pt double; text-align: left"><span style="color: Black">$</span></td><td id="xdx_98C_eus-gaap--IncomeTaxExpenseBenefit_c20200101__20201231_zxFb4ctKogba" style="border-bottom: Black 2pt double; text-align: right" title="Total income tax expense"><span style="color: Black">19,381</span></td><td style="padding-bottom: 2pt; text-align: left"><span style="color: Black">&#160;</span></td><td style="padding-bottom: 2pt"><span style="color: Black">&#160;</span></td>
    <td style="border-bottom: Black 2pt double; text-align: left"><span style="color: Black">$</span></td><td id="xdx_989_eus-gaap--IncomeTaxExpenseBenefit_c20190101__20191231_zkeNHgSLd1P2" style="border-bottom: Black 2pt double; text-align: right" title="Total income tax expense"><span style="color: Black">29,076</span></td><td style="padding-bottom: 2pt; text-align: left"><span style="color: Black">&#160;</span></td></tr>
</table>



<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">The tax effects of temporary differences that give rise to significant portions of the deferred tax assets and deferred tax liabilities are as follows:</a></td>
<td class="text"><p id="xdx_897_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_z8HkKCVmb7g4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8B2_zHg3EdUCGBhc">The tax effects of temporary
differences that give rise to significant portions of the deferred tax assets and deferred tax liabilities are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td style="color: Black">&#160;</td><td style="color: Black; font-weight: bold">&#160;</td>
    <td style="color: Black; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_499_20211231_zi4394cUJWsb" style="color: Black; font-weight: bold; text-align: center">&#160;</td>
    <td style="color: Black; font-weight: bold; text-align: center">&#160;</td>
    <td style="color: Black; font-weight: bold; text-align: center">&#160;</td>
    <td style="color: Black; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_490_20201231_zkjjpzRc39bb" style="color: Black; font-weight: bold; text-align: center">&#160;</td><td style="color: Black; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="color: Black">&#160;</td><td style="color: Black; font-weight: bold">&#160;</td>
    <td colspan="6" style="color: Black; font-weight: bold; text-align: center">December 31,</td><td style="color: Black; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="color: Black">&#160;</td><td style="color: Black; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; color: Black; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; color: Black; font-weight: bold">&#160;</td><td style="color: Black; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; color: Black; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; color: Black; font-weight: bold">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--DeferredTaxAssetsNetAbstract_iB_zK1nWOL8gmL2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="color: Black; text-align: left">Net deferred tax assets:</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right">&#160;</td><td style="color: Black; text-align: left">&#160;</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right">&#160;</td><td style="color: Black; text-align: left">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsForeign_iI_maDTAGzmCT_zmRBKDLHHch3" style="vertical-align: bottom; background-color: White">
    <td style="width: 70%; color: Black; text-align: left; padding-left: 0.125in">Foreign net operating loss carry-forwards</td><td style="width: 1%; color: Black">&#160;</td>
    <td style="width: 1%; color: Black; text-align: left">$</td><td style="width: 12%; color: Black; text-align: right">1,292</td><td style="width: 1%; color: Black; text-align: left">&#160;</td><td style="width: 1%; color: Black">&#160;</td>
    <td style="width: 1%; color: Black; text-align: left">$</td><td style="width: 12%; color: Black; text-align: right">360</td><td style="width: 1%; color: Black; text-align: left">&#160;</td></tr>
<tr id="xdx_40F_ecustom--DeferredTaxAssetsInventoryAndAccountsReceivable_maDTAGzmCT_z1s4JlqTUHm6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="color: Black; text-align: left; padding-left: 0.125in">Inventory and accounts receivable</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right">4,508</td><td style="color: Black; text-align: left">&#160;</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right">1,928</td><td style="color: Black; text-align: left">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--DeferredTaxAssetsDeferredIncome_iI_maDTAGzmCT_zhDcLYc2jnL1" style="vertical-align: bottom; background-color: White">
    <td style="color: Black; text-align: left; padding-left: 0.125in">Profit sharing</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right">3,787</td><td style="color: Black; text-align: left">&#160;</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right">2,936</td><td style="color: Black; text-align: left">&#160;</td></tr>
<tr id="xdx_400_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_iI_maDTAGzmCT_zNImAMKYjB2c" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="color: Black; text-align: left; padding-left: 0.125in">Stock option compensation</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right">732</td><td style="color: Black; text-align: left">&#160;</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right">718</td><td style="color: Black; text-align: left">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--DeferredTaxAssetsInventory_iI_maDTAGzmCT_z9f3UtCJGMCk" style="vertical-align: bottom; background-color: White">
    <td style="color: Black; text-align: left; padding-left: 0.125in">Effect of inventory profit elimination</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right">5,112</td><td style="color: Black; text-align: left">&#160;</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right">4,443</td><td style="color: Black; text-align: left">&#160;</td></tr>
<tr id="xdx_408_eus-gaap--DeferredTaxAssetsOther_iI_maDTAGzmCT_z1TnN3770nd4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="color: Black; padding-bottom: 1pt; padding-left: 0.125in">Other</td><td style="color: Black; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; color: Black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; color: Black; text-align: right">407</td><td style="padding-bottom: 1pt; color: Black; text-align: left">&#160;</td><td style="color: Black; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; color: Black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; color: Black; text-align: right">910</td><td style="padding-bottom: 1pt; color: Black; text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--DeferredTaxAssetsGross_iTI_mtDTAGzmCT_maDTANzIZJ_zghQxM5cOPla" style="vertical-align: bottom; background-color: White">
    <td style="color: Black; text-align: left; padding-left: 0.25in">Total gross deferred tax assets, net</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right">15,838</td><td style="color: Black; text-align: left">&#160;</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right">11,295</td><td style="color: Black; text-align: left">&#160;</td></tr>
<tr id="xdx_408_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_di_msDTANzIZJ_zETuZe2V2e2j" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="color: Black; text-align: left; padding-bottom: 1pt; padding-left: 0.25in">Valuation allowance</td><td style="color: Black; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; color: Black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; color: Black; text-align: right">(3,582</td><td style="padding-bottom: 1pt; color: Black; text-align: left">)</td><td style="color: Black; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; color: Black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; color: Black; text-align: right">(360</td><td style="padding-bottom: 1pt; color: Black; text-align: left">)</td></tr>
<tr id="xdx_40A_eus-gaap--DeferredTaxAssetsNet_iTI_mtDTANzIZJ_zGngeMWftMQd" style="vertical-align: bottom; background-color: White">
    <td style="color: Black; text-align: left; padding-bottom: 1pt; padding-left: 0.25in">Net deferred tax assets</td><td style="color: Black; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; color: Black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; color: Black; text-align: right">12,256</td><td style="padding-bottom: 1pt; color: Black; text-align: left">&#160;</td><td style="color: Black; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; color: Black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; color: Black; text-align: right">10,935</td><td style="padding-bottom: 1pt; color: Black; text-align: left">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--DeferredTaxLiabilitiesNetAbstract_iB_z5kogWajN939" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="color: Black; text-align: left">Deferred tax liabilities (long-term):</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right">&#160;</td><td style="color: Black; text-align: left">&#160;</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right">&#160;</td><td style="color: Black; text-align: left">&#160;</td></tr>
<tr id="xdx_40C_ecustom--DeferredTaxLiabilitiesBuildingExpenses_i01I_zsHnfG6XNNjj" style="vertical-align: bottom; background-color: White">
    <td style="color: Black; text-align: left; padding-left: 0.125in">Building expenses</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right">(1,082</td><td style="color: Black; text-align: left">)</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1764">&#8212;</span></td><td style="color: Black; text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--DeferredTaxLiabilitiesOtherFiniteLivedAssets_i01NI_di_zSa24pNuTUQh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="color: Black; text-align: left; padding-left: 0.125in">Trademarks and licenses</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right">(2,551</td><td style="color: Black; text-align: left">)</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right">(2,894</td><td style="color: Black; text-align: left">)</td></tr>
<tr id="xdx_40B_ecustom--DeferredTaxLiabilitiesUnrealizedGainOnMarketableEquitySecurities_i01I_zebaeX8IqmS" style="vertical-align: bottom; background-color: White">
    <td style="color: Black; text-align: left; padding-left: 0.125in">Unrealized gain on marketable equity securities</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right">(436</td><td style="color: Black; text-align: left">)</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1770">&#8212;</span></td><td style="color: Black; text-align: left">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--DeferredTaxLiabilitiesOther_i01I_zdjodKSLJgG6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="color: Black; padding-bottom: 1pt; padding-left: 0.125in">Other</td><td style="color: Black; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; color: Black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; color: Black; text-align: right">(251</td><td style="padding-bottom: 1pt; color: Black; text-align: left">)</td><td style="color: Black; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; color: Black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; color: Black; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1773">&#8212;</span></td><td style="padding-bottom: 1pt; color: Black; text-align: left">&#160;</td></tr>
<tr id="xdx_400_eus-gaap--DeferredIncomeTaxLiabilities_i01NI_di_zd5vwLFRfw42" style="vertical-align: bottom; background-color: White">
    <td style="color: Black; text-align: left; padding-bottom: 1pt; padding-left: 0.25in">Total deferred tax liabilities</td><td style="color: Black; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; color: Black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; color: Black; text-align: right">(4,320</td><td style="padding-bottom: 1pt; color: Black; text-align: left">)</td><td style="color: Black; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; color: Black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; color: Black; text-align: right">(2,894</td><td style="padding-bottom: 1pt; color: Black; text-align: left">)</td></tr>
<tr id="xdx_407_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iI_zL18h8AAz5ue" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="color: Black; text-align: left; padding-bottom: 2pt; padding-left: 0.25in">Net deferred tax assets</td><td style="color: Black; padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; color: Black; text-align: left">$</td><td style="border-bottom: Black 2pt double; color: Black; text-align: right">7,936</td><td style="padding-bottom: 2pt; color: Black; text-align: left">&#160;</td><td style="color: Black; padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; color: Black; text-align: left">$</td><td style="border-bottom: Black 2pt double; color: Black; text-align: right">8,041</td><td style="padding-bottom: 2pt; color: Black; text-align: left">&#160;</td></tr>
</table>



<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Differences between the United States federal statutory income tax rate and the effective income tax rate were as follows:</a></td>
<td class="text"><p id="xdx_89F_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zuxB3yl6LAej" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8BC_zKFhEewEOfMj">Differences between the United
States federal statutory income tax rate and the effective income tax rate were as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td style="color: Black">&#160;</td><td style="color: Black; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; color: Black; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_49B_20210101__20211231_zKfaQdCfQ1tj" style="border-bottom: Black 1pt solid; color: Black; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; color: Black; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; color: Black; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; color: Black; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_498_20200101__20201231_zCryRnAsh2Gc" style="border-bottom: Black 1pt solid; color: Black; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; color: Black; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; color: Black; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; color: Black; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_49A_20190101__20191231_zzD1b1MT4mt6" style="border-bottom: Black 1pt solid; color: Black; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; color: Black; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="color: Black">&#160;</td><td style="color: Black; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; color: Black; font-weight: bold; text-align: center">Year ended December 31,</td><td style="padding-bottom: 1pt; color: Black; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="color: Black">&#160;</td><td style="color: Black; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; color: Black; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; color: Black; font-weight: bold">&#160;</td><td style="color: Black; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; color: Black; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; color: Black; font-weight: bold">&#160;</td><td style="color: Black; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; color: Black; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1pt; color: Black; font-weight: bold">&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_uPure_zUn273ToAdQi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 55%; color: Black; text-align: left">Statutory rates</td><td style="width: 1%; color: Black">&#160;</td>
    <td style="width: 1%; color: Black; text-align: left">&#160;</td><td style="width: 12%; color: Black; text-align: right">21.0</td><td style="width: 1%; color: Black; text-align: left">%</td><td style="width: 1%; color: Black">&#160;</td>
    <td style="width: 1%; color: Black; text-align: left">&#160;</td><td style="width: 12%; color: Black; text-align: right">21.0</td><td style="width: 1%; color: Black; text-align: left">%</td><td style="width: 1%; color: Black">&#160;</td>
    <td style="width: 1%; color: Black; text-align: left">&#160;</td><td style="width: 12%; color: Black; text-align: right">21.0</td><td style="width: 1%; color: Black; text-align: left">%</td></tr>
<tr id="xdx_40D_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_pid_dp_uPure_z3TsOQpSz64d" style="vertical-align: bottom; background-color: White">
    <td style="color: Black; text-align: left">State and local taxes, net of Federal benefit</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right">0.3</td><td style="color: Black; text-align: left">&#160;</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right">0.2</td><td style="color: Black; text-align: left">&#160;</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right">0.6</td><td style="color: Black; text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--EffectiveIncomeTaxRateReconciliationDeductionsEmployeeStockOwnershipPlanDividends_pid_dp_uPure_zsvSNwGdE5Yg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="color: Black; text-align: left">Windfall benefit from exercise of stock options</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right">(0.9</td><td style="color: Black; text-align: left">)</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right">(0.6</td><td style="color: Black; text-align: left">)</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right">(0.7</td><td style="color: Black; text-align: left">)</td></tr>
<tr id="xdx_407_eus-gaap--EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_pid_dp_uPure_zQNyQrvXODyf" style="vertical-align: bottom; background-color: White">
    <td style="color: Black; text-align: left">Benefit of Foreign Derived Intangible Income</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right">(0.6</td><td style="color: Black; text-align: left">)</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right">(0.4</td><td style="color: Black; text-align: left">)</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right">(0.9</td><td style="color: Black; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="color: Black; text-align: left">Effect of foreign taxes greater than</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right">&#160;</td><td style="color: Black; text-align: left">&#160;</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right">&#160;</td><td style="color: Black; text-align: left">&#160;</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right">&#160;</td><td style="color: Black; text-align: left">&#160;</td></tr>
<tr id="xdx_408_ecustom--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate1_pid_dp_uPure_z0tNlUfNQ9Yk" style="vertical-align: bottom; background-color: White">
    <td style="color: Black; text-align: left; padding-left: 0.125in">U.S. statutory rates</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right">7.4</td><td style="color: Black; text-align: left">&#160;</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right">7.5</td><td style="color: Black; text-align: left">&#160;</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right">7.5</td><td style="color: Black; text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherAdjustments_pid_dp_zswJ8pulXbZ7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="color: Black; padding-bottom: 1pt">Other</td><td style="color: Black; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; color: Black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; color: Black; text-align: right">(0.1</td><td style="padding-bottom: 1pt; color: Black; text-align: left">)</td><td style="color: Black; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; color: Black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; color: Black; text-align: right">0.2</td><td style="padding-bottom: 1pt; color: Black; text-align: left">&#160;</td><td style="color: Black; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; color: Black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; color: Black; text-align: right">0.1</td><td style="padding-bottom: 1pt; color: Black; text-align: left">&#160;</td></tr>
<tr id="xdx_401_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_pid_dp_zZMCFfSnrETc" style="vertical-align: bottom; background-color: White">
    <td style="color: Black; text-align: left; padding-bottom: 2pt; padding-left: 0.25in">Effective rates</td><td style="color: Black; padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; color: Black; text-align: left">&#160;</td><td style="border-bottom: Black 2pt double; color: Black; text-align: right">27.1</td><td style="padding-bottom: 2pt; color: Black; text-align: left">%</td><td style="color: Black; padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; color: Black; text-align: left">&#160;</td><td style="border-bottom: Black 2pt double; color: Black; text-align: right">27.9</td><td style="padding-bottom: 2pt; color: Black; text-align: left">%</td><td style="color: Black; padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; color: Black; text-align: left">&#160;</td><td style="border-bottom: Black 2pt double; color: Black; text-align: right">27.6</td><td style="padding-bottom: 2pt; color: Black; text-align: left">%</td></tr>
</table>



<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of income before income tax between domestic and foreign jurisdictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139983556263832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated Other Comprehensive Loss (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">The components of accumulated other comprehensive loss consist of the following:</a></td>
<td class="text"><p id="xdx_891_eus-gaap--ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_zT2ahtPkK5pg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_8BD_z2018wLiyWrk">The components of accumulated other
comprehensive loss consist of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td style="color: Black">&#160;</td><td style="color: Black; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; color: Black; font-weight: bold; text-align: center">Year ended December 31,</td><td style="padding-bottom: 1pt; color: Black; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="color: Black">&#160;</td><td style="color: Black; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; color: Black; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; color: Black; font-weight: bold">&#160;</td><td style="color: Black; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; color: Black; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; color: Black; font-weight: bold">&#160;</td><td style="color: Black; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; color: Black; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1pt; color: Black; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="color: Black">&#160;</td><td style="color: Black; font-weight: bold">&#160;</td>
    <td colspan="2" style="color: Black; font-weight: bold; text-align: center">&#160;</td><td style="color: Black; font-weight: bold">&#160;</td><td style="color: Black; font-weight: bold">&#160;</td>
    <td colspan="2" style="color: Black; font-weight: bold; text-align: center">&#160;</td><td style="color: Black; font-weight: bold">&#160;</td><td style="color: Black; font-weight: bold">&#160;</td>
    <td colspan="2" style="color: Black; font-weight: bold; text-align: center">&#160;</td><td style="color: Black; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 55%; color: Black; text-align: left">Net derivative instruments, beginning of year</td><td style="width: 1%; color: Black">&#160;</td>
    <td style="width: 1%; color: Black; text-align: left">$</td><td id="xdx_98A_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iS_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember_z8NwCIV0OFgi" style="width: 12%; color: Black; text-align: right" title="Net derivative instruments, beginning of year"><span style="-sec-ix-hidden: xdx2ixbrl1818">&#8212;</span></td><td style="width: 1%; color: Black; text-align: left">&#160;</td><td style="width: 1%; color: Black">&#160;</td>
    <td style="width: 1%; color: Black; text-align: left">$</td><td id="xdx_985_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iS_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__custom--AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember_zVLnjObU6Ota" style="width: 12%; color: Black; text-align: right" title="Net derivative instruments, beginning of year">52</td><td style="width: 1%; color: Black; text-align: left">&#160;</td><td style="width: 1%; color: Black">&#160;</td>
    <td style="width: 1%; color: Black; text-align: left">$</td><td id="xdx_984_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iS_c20190101__20191231__us-gaap--StatementEquityComponentsAxis__custom--AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember_zcO40Katkn9e" style="width: 12%; color: Black; text-align: right" title="Net derivative instruments, beginning of year">136</td><td style="width: 1%; color: Black; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="color: Black; text-align: left; padding-bottom: 1pt">Net derivative instrument loss, net of tax</td><td style="color: Black; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; color: Black; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember_znaE0XRI0M8i" style="border-bottom: Black 1pt solid; color: Black; text-align: right" title="Net derivative instrument gain (loss), net of tax">(992</td><td style="padding-bottom: 1pt; color: Black; text-align: left">)</td><td style="color: Black; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; color: Black; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__custom--AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember_zpWsCwwmm9K5" style="border-bottom: Black 1pt solid; color: Black; text-align: right" title="Net derivative instrument gain (loss), net of tax">(52</td><td style="padding-bottom: 1pt; color: Black; text-align: left">)</td><td style="color: Black; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; color: Black; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent_c20190101__20191231__us-gaap--StatementEquityComponentsAxis__custom--AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember_zulD6iHEI5a6" style="border-bottom: Black 1pt solid; color: Black; text-align: right" title="Net derivative instrument gain (loss), net of tax">(84</td><td style="padding-bottom: 1pt; color: Black; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="color: Black; text-align: left; padding-bottom: 1pt">Net derivative instruments, end of year</td><td style="color: Black; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; color: Black; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iE_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember_zi0dEX2OAb1e" style="border-bottom: Black 1pt solid; color: Black; text-align: right" title="Net derivative instruments, end of year">(992</td><td style="padding-bottom: 1pt; color: Black; text-align: left">)</td><td style="color: Black; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; color: Black; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iE_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__custom--AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember_zmSt4N8sPGl2" style="border-bottom: Black 1pt solid; color: Black; text-align: right" title="Net derivative instruments, end of year"><span style="-sec-ix-hidden: xdx2ixbrl1832">&#8212;</span></td><td style="padding-bottom: 1pt; color: Black; text-align: left">&#160;</td><td style="color: Black; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; color: Black; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iE_c20190101__20191231__us-gaap--StatementEquityComponentsAxis__custom--AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember_zlAFjDVhRoaa" style="border-bottom: Black 1pt solid; color: Black; text-align: right" title="Net derivative instruments, end of year">52</td><td style="padding-bottom: 1pt; color: Black; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="color: Black">&#160;</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right">&#160;</td><td style="color: Black; text-align: left">&#160;</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right">&#160;</td><td style="color: Black; text-align: left">&#160;</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right">&#160;</td><td style="color: Black; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="color: Black; text-align: left">Cumulative translation adjustments, beginning of year</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iS_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedTranslationAdjustmentMember_zZtL9OD2C5Tg" style="color: Black; text-align: right" title="Cumulative translation adjustments, beginning of year">(5,997</td><td style="color: Black; text-align: left">)</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iS_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedTranslationAdjustmentMember_zx08Us77Xpv" style="color: Black; text-align: right" title="Cumulative translation adjustments, beginning of year">(39,905</td><td style="color: Black; text-align: left">)</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iS_c20190101__20191231__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedTranslationAdjustmentMember_zEaBJn0ox5Ja" style="color: Black; text-align: right" title="Cumulative translation adjustments, beginning of year">(33,786</td><td style="color: Black; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="color: Black; text-align: left; padding-bottom: 1pt">Translation adjustments</td><td style="color: Black; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; color: Black; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedTranslationAdjustmentMember_zVfsua6Vt5c5" style="border-bottom: Black 1pt solid; color: Black; text-align: right" title="Translation adjustments">(31,443</td><td style="padding-bottom: 1pt; color: Black; text-align: left">)</td><td style="color: Black; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; color: Black; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedTranslationAdjustmentMember_z2zWJIkxmuT9" style="border-bottom: Black 1pt solid; color: Black; text-align: right" title="Translation adjustments">33,908</td><td style="padding-bottom: 1pt; color: Black; text-align: left">&#160;</td><td style="color: Black; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; color: Black; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_c20190101__20191231__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedTranslationAdjustmentMember_zsSrjNLPOCfl" style="border-bottom: Black 1pt solid; color: Black; text-align: right" title="Translation adjustments">(6,119</td><td style="padding-bottom: 1pt; color: Black; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="color: Black; text-align: left; padding-bottom: 1pt">Cumulative translation adjustments, end of year</td><td style="color: Black; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; color: Black; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iE_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedTranslationAdjustmentMember_zRPbbUho5b1l" style="border-bottom: Black 1pt solid; color: Black; text-align: right" title="Cumulative translation adjustments, end of year">(37,440</td><td style="padding-bottom: 1pt; color: Black; text-align: left">)</td><td style="color: Black; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; color: Black; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iE_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedTranslationAdjustmentMember_zMO8dc2L7wp6" style="border-bottom: Black 1pt solid; color: Black; text-align: right" title="Cumulative translation adjustments, end of year">(5,997</td><td style="padding-bottom: 1pt; color: Black; text-align: left">)</td><td style="color: Black; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; color: Black; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iE_c20190101__20191231__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedTranslationAdjustmentMember_zxkqgm5CvTZ1" style="border-bottom: Black 1pt solid; color: Black; text-align: right" title="Cumulative translation adjustments, end of year">(39,905</td><td style="padding-bottom: 1pt; color: Black; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="color: Black">&#160;</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right">&#160;</td><td style="color: Black; text-align: left">&#160;</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right">&#160;</td><td style="color: Black; text-align: left">&#160;</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right">&#160;</td><td style="color: Black; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="color: Black; text-align: left; padding-bottom: 2pt">Accumulated other comprehensive loss</td><td style="color: Black; padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; color: Black; text-align: left">$</td><td id="xdx_98A_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iI_c20211231_z9lfBa14i2V1" style="border-bottom: Black 2pt double; color: Black; text-align: right" title="Accumulated other comprehensive loss">(38,432</td><td style="padding-bottom: 2pt; color: Black; text-align: left">)</td><td style="color: Black; padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; color: Black; text-align: left">$</td><td id="xdx_986_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iI_c20201231_zrepYmMBCj0k" style="border-bottom: Black 2pt double; color: Black; text-align: right">(5,997</td><td style="padding-bottom: 2pt; color: Black; text-align: left">)</td><td style="color: Black; padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; color: Black; text-align: left">$</td><td id="xdx_98D_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iI_c20191231_zXZBNJmdo7Of" style="border-bottom: Black 2pt double; color: Black; text-align: right">(39,853</td><td style="padding-bottom: 2pt; color: Black; text-align: left">)</td></tr>
</table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139983555865688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income Attributable to Inter Parfums, Inc. and Transfers from the Noncontrolling Interest (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestAbstract', window );"><strong>Noncontrolling Interest [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock', window );">Schedule of net income attributable to transfers from the noncontrolling interest</a></td>
<td class="text"><p id="xdx_892_eus-gaap--ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock_z6bQSfK2HVW7" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span id="xdx_8B3_zT1VWmcDFA85" style="display: none; visibility: hidden">Schedule of net income attributable to transfers from the noncontrolling interest</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_494_20210101__20211231_zmj7rP5v3rye" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_492_20200101__20201231_zwVHY0pR8ec5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_499_20190101__20191231_z0DwhBQWU0dk" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="color: Black">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="color: Black">&#160;</span></td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="color: Black">Year
    ended December 31,</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="color: Black">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="color: Black">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="color: Black">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="color: Black">2021</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="color: Black">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="color: Black">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="color: Black">2020</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="color: Black">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="color: Black">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="color: Black">2019</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="color: Black">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="color: Black">&#160;</span></td><td style="font-weight: bold"><span style="color: Black">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="color: Black">&#160;</span></td><td style="font-weight: bold"><span style="color: Black">&#160;</span></td><td style="font-weight: bold"><span style="color: Black">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="color: Black">&#160;</span></td><td style="font-weight: bold"><span style="color: Black">&#160;</span></td><td style="font-weight: bold"><span style="color: Black">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="color: Black">&#160;</span></td><td style="font-weight: bold"><span style="color: Black">&#160;</span></td></tr>
<tr id="xdx_407_eus-gaap--NetIncomeLoss_z7p5PdToESgh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 55%; text-align: left; padding-left: 0.125in; text-indent: -0.125in"><span style="color: Black">Net income attributable to Inter Parfums, Inc.</span></td><td style="width: 1%"><span style="color: Black">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="color: Black">$</span></td><td style="width: 12%; text-align: right"><span style="color: Black">87,411</span></td><td style="width: 1%; text-align: left"><span style="color: Black">&#160;</span></td><td style="width: 1%"><span style="color: Black">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="color: Black">$</span></td><td style="width: 12%; text-align: right"><span style="color: Black">38,219</span></td><td style="width: 1%; text-align: left"><span style="color: Black">&#160;</span></td><td style="width: 1%"><span style="color: Black">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="color: Black">$</span></td><td style="width: 12%; text-align: right"><span style="color: Black">60,249</span></td><td style="width: 1%; text-align: left"><span style="color: Black">&#160;</span></td></tr>
<tr id="xdx_402_eus-gaap--ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesNet_z6sJRoHhgHQ2" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in"><span style="color: Black">Decrease in Inter Parfums, Inc.&#8217;s additional
    paid-in capital for subsidiary share transactions</span></td><td style="padding-bottom: 1pt"><span style="color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="color: Black">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="color: Black"><span style="-sec-ix-hidden: xdx2ixbrl1866">&#8212;</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="color: Black">&#160;</span></td><td style="padding-bottom: 1pt"><span style="color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="color: Black">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="color: Black"><span style="-sec-ix-hidden: xdx2ixbrl1867">&#8212;</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="color: Black">&#160;</span></td><td style="color: #FF0000; padding-bottom: 1pt"><span style="color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; color: #FF0000; text-align: left"><span style="color: Black">&#160;</span></td><td style="border-bottom: Black 1pt solid; color: #FF0000; text-align: right"><span style="color: Black">(5,167</span></td><td style="padding-bottom: 1pt; color: #FF0000; text-align: left"><span style="color: Black">)</span></td></tr>
<tr id="xdx_400_eus-gaap--ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNet_z88EJYfrzncb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2pt; padding-left: 0.125in; text-indent: -0.125in"><p style="margin-top: 0; margin-bottom: 0"/>
                                                                                <p style="margin-top: 0; margin-bottom: 0">&#160;<span style="color: Black">Change from net income attributable to Inter Parfums, Inc. and transfers from noncontrolling interest</span></p></td><td style="padding-bottom: 2pt"><span style="color: Black">&#160;</span></td>
    <td style="border-bottom: Black 2pt double; text-align: left"><span style="color: Black">$</span></td><td style="border-bottom: Black 2pt double; text-align: right"><span style="color: Black">87,411</span></td><td style="padding-bottom: 2pt; text-align: left"><span style="color: Black">&#160;</span></td><td style="padding-bottom: 2pt"><span style="color: Black">&#160;</span></td>
    <td style="border-bottom: Black 2pt double; text-align: left"><span style="color: Black">$</span></td><td style="border-bottom: Black 2pt double; text-align: right"><span style="color: Black">38,219</span></td><td style="padding-bottom: 2pt; text-align: left"><span style="color: Black">&#160;</span></td><td style="padding-bottom: 2pt"><span style="color: Black">&#160;</span></td>
    <td style="border-bottom: Black 2pt double; text-align: left"><span style="color: Black">$</span></td><td style="border-bottom: Black 2pt double; text-align: right"><span style="color: Black">55,082</span></td><td style="padding-bottom: 2pt; text-align: left"><span style="color: Black">&#160;</span></td></tr>
</table>



<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The tabular disclosure of the effects of any changes in a parent's ownership interest in a subsidiary on the equity attributable to the parent if the ownership interests in a subsidiary changes during the period. The changes represented by this element did not result in the deconsolidation of the subsidiary.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4M<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591554-111686<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139983556277528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Reconciliation of Cash and Cash Equivalents to the Statement of Cash Flows (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ipar_DisclosureReconciliationOfCashAndCashEquivalentsToStatementOfCashFlowsAbstract', window );"><strong>Reconciliation Of Cash And Cash Equivalents To Statement Of Cash Flows</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock', window );">The following table summarizes cash and cash equivalents as of December 31, 2021:</a></td>
<td class="text"><p id="xdx_893_eus-gaap--ScheduleOfCashAndCashEquivalentsTableTextBlock_zp6EmKT6Xtp4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8BD_zpQue6aL6gP9">The following table summarizes
cash and cash equivalents as of December 31, 2021:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td style="font-family: Courier New, Courier, Monospace; text-align: justify">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49D_20211231_zPehRo7p78A2" style="border-bottom: Black 1pt solid; text-align: center">December 31, 2021</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: justify">&#160;</td><td>&#160;</td></tr>
<tr id="xdx_409_eus-gaap--CashCashEquivalentsAndShortTermInvestments_iI_zX1rKjbN7Yn5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 85%; text-align: left">Cash and cash equivalents per balance sheet</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">159,613</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_40E_ecustom--CashHeldInEscrowIncludedInOtherAssets_iI_zgfaoIKvSPUl" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Cash held in escrow included in other assets (see note 3)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">8,774</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40C_ecustom--CashAndCashEquivalentsPerStatementOfCashFlows_iI_z3NGxqJWTH9i" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2pt">Cash and cash equivalents per statement of cash flows</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td style="border-bottom: Black 2pt double; text-align: right">168,387</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
</table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ipar_DisclosureReconciliationOfCashAndCashEquivalentsToStatementOfCashFlowsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ipar_DisclosureReconciliationOfCashAndCashEquivalentsToStatementOfCashFlowsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ipar_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of cash and cash equivalents.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139983549863320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule of lanvin brand name for our class (Details)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=ipar_MontblancMember', window );">Montblanc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="nump">19.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">22.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=ipar_JimmyChooMember', window );">Jimmy Choo [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="nump">18.00%<span></span>
</td>
<td class="nump">16.00%<span></span>
</td>
<td class="nump">16.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=ipar_CoachMember', window );">Coach [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="nump">16.00%<span></span>
</td>
<td class="nump">17.00%<span></span>
</td>
<td class="nump">14.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=ipar_GUESSMember', window );">G U E S S [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="nump">12.00%<span></span>
</td>
<td class="nump">11.00%<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=ipar_MontblancMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=ipar_MontblancMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=ipar_JimmyChooMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=ipar_JimmyChooMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=ipar_CoachMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=ipar_CoachMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=ipar_GUESSMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=ipar_GUESSMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139983481517992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>The Company and its Significant Accounting Policies (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Allowances for sales returns and doubtful accounts</a></td>
<td class="nump">$ 2,200,000<span></span>
</td>
<td class="nump">$ 5,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted average cost of capital</a></td>
<td class="nump">2.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Shipping and handling costs</a></td>
<td class="nump">$ 322,614,000<span></span>
</td>
<td class="nump">208,278,000<span></span>
</td>
<td class="nump">$ 267,578,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerRefundLiability', window );">Contract with customer, refund liability</a></td>
<td class="nump">5,100,000<span></span>
</td>
<td class="nump">3,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerRightToRecoverProduct', window );">Contract with customer, right to recover products</a></td>
<td class="nump">1,900,000<span></span>
</td>
<td class="nump">1,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdvertisingExpense', window );">Advertising costs</a></td>
<td class="nump">171,800,000<span></span>
</td>
<td class="nump">91,700,000<span></span>
</td>
<td class="nump">144,600,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketingExpense', window );">Customer incentives cost</a></td>
<td class="nump">$ 37,600,000<span></span>
</td>
<td class="nump">$ 26,400,000<span></span>
</td>
<td class="nump">$ 38,900,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ipar_RoyaltyExpenseNetSalesPercentage', window );">Royalty expense, percentage of net sales</a></td>
<td class="nump">7.80%<span></span>
</td>
<td class="nump">7.60%<span></span>
</td>
<td class="nump">7.40%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Licensing Agreements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">License agreement term</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetWeightedAveragePeriodBeforeRenewalOrExtension', window );">License agreement renewal term</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ipar_RoyaltyExpenseNetSalesPercentage', window );">Royalty expense, percentage of net sales</a></td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Licensing Agreements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">License agreement term</a></td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetWeightedAveragePeriodBeforeRenewalOrExtension', window );">License agreement renewal term</a></td>
<td class="text">12 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ipar_RoyaltyExpenseNetSalesPercentage', window );">Royalty expense, percentage of net sales</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">Revenue Benchmark [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ShippingAndHandlingMember', window );">Shipping and Handling [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Shipping and handling costs</a></td>
<td class="nump">$ 10,100,000<span></span>
</td>
<td class="nump">$ 5,000,000.0<span></span>
</td>
<td class="nump">$ 7,700,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember', window );">Measurement Input, Discount Rate [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted average cost of capital</a></td>
<td class="nump">7.47%<span></span>
</td>
<td class="nump">6.99%<span></span>
</td>
<td class="nump">7.94%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_OwnershipAxis=ipar_InterparfumsSASubsidiaryMember', window );">Interparfums S A Subsidiary [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByParent', window );">Ownership percentage in Interparfums SA</a></td>
<td class="nump">73.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ipar_RoyaltyExpenseNetSalesPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Royalty expense net sales percentage.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ipar_RoyaltyExpenseNetSalesPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ipar_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetWeightedAveragePeriodBeforeRenewalOrExtension">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average period before the next renewal or extension for intangible assets with renewal or extension terms, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetWeightedAveragePeriodBeforeRenewalOrExtension</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvertisingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 720<br> -SubTopic 35<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6420018&amp;loc=d3e36677-107848<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvertisingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerRefundLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability for consideration received or receivable from customer which is not included in transaction price, when consideration is expected to be refunded to customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 55<br> -Paragraph 27<br> -URI http://asc.fasb.org/extlink&amp;oid=123410239&amp;loc=SL49130611-203046-203046<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerRefundLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerRightToRecoverProduct">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of right to recover product from customer on settling refund liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 55<br> -Paragraph 27<br> -URI http://asc.fasb.org/extlink&amp;oid=123410239&amp;loc=SL49130611-203046-203046<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerRightToRecoverProduct</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expenditures for planning and executing the conception, pricing, promotion, and distribution of ideas, goods, and services. Costs of public relations and corporate promotions are typically considered to be marketing costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestOwnershipPercentageByParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The parent entity's interest in net assets of the subsidiary, expressed as a percentage.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestOwnershipPercentageByParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ShippingAndHandlingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ShippingAndHandlingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=ipar_InterparfumsSASubsidiaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=ipar_InterparfumsSASubsidiaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139983549864904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>All amounts have been translated to U.S. dollars at the October 1, 2021 exchange rate. (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOfAssetsAcquired', window );">Assets acquired</a></td>
<td class="nump">$ 36,718<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAssumed1', window );">Liabilities Assumed</a></td>
<td class="num">(958)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventory net</a></td>
<td class="nump">198,914<span></span>
</td>
<td class="nump">$ 158,822<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=ipar_InventoryMember', window );">Inventory [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryGross', window );">Inventory gross</a></td>
<td class="nump">17,805<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember', window );">Trademarks [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryGross', window );">Inventory gross</a></td>
<td class="nump">15,880<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=ipar_OtherAssetMember', window );">Other Asset [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryGross', window );">Inventory gross</a></td>
<td class="nump">$ 3,033<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfAssetsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fair value of assets acquired in noncash investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4313-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4332-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfAssetsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross amount, as of the balance sheet date, of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAssumed1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fair value of liabilities assumed in noncash investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4304-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4332-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4313-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAssumed1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=ipar_InventoryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=ipar_InventoryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=ipar_OtherAssetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=ipar_OtherAssetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139983481106520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Recent Agreements (Details Narrative)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>EUR (&#8364;)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForPurchaseOfOtherAssets1', window );">Payments for Purchase of Other Assets</a></td>
<td class="nump">$ 142,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ipar_CashHeldInEscrow', window );">[custom:CashHeldInEscrow-0]</a></td>
<td class="nump">$ 8,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtTerm', window );">Long-term Debt, Term</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Long-term Line of Credit</a></td>
<td class="nump">$ 136,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateTerms', window );">Debt Instrument, Interest Rate Terms</a></td>
<td class="text">one-month Euribor plus 0.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=ipar_AnnaSuiCorpMember', window );">Anna Sui Corp [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ipar_DiscriptionOfRecentAgreement', window );">Discription of recent agreement</a></td>
<td class="text">Our initial 10-year license agreement with Anna Sui Corp. was signed
in 2011. The renewal agreement also allows for an additional 5-year term through 2031 at the option of the Company<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=ipar_RochasFashionMember', window );">Rochas Fashion [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentChargeOnReclassifiedAssets', window );">Impairment Charge on Reclassified Assets</a></td>
<td class="nump">$ 2,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=ipar_STDupontMember', window );">S T Dupont [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionDescriptionOfAcquiredEntity', window );">License agreements, description</a></td>
<td class="text">we renewed our
license agreement with S.T. Dupont for the creation, development and distribution of fragrance products through December&#160;31,
2022, without any material changes in terms and conditions. Our initial 11-year license agreement with S.T. Dupont was signed in
June 1997 and had previously been extended through December 31, 2021.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CurrencyAxis=currency_EUR', window );">Euro Member Countries, Euro</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquisitionCosts', window );">Acquisition Costs, Period Cost</a></td>
<td class="nump">$ 3,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTaxCredit', window );">Investment Tax Credit</a></td>
<td class="nump">17,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Long-term Line of Credit | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 120,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt Instrument, Face Amount | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_SwissFederalTaxAdministrationFTAMember', window );">Swiss Federal Tax Administration (FTA) [Member] | Global Settlement Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxesPayableCurrentAndNoncurrent', window );">Taxes Payable</a></td>
<td class="nump">2,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_SwissFederalTaxAdministrationFTAMember', window );">Swiss Federal Tax Administration (FTA) [Member] | Euro Member Countries, Euro</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReceivable', window );">Income Taxes Receivable</a></td>
<td class="nump">$ 17,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_SwissFederalTaxAdministrationFTAMember', window );">Swiss Federal Tax Administration (FTA) [Member] | Euro Member Countries, Euro | Global Settlement Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxesPayableCurrentAndNoncurrent', window );">Taxes Payable | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 2,500,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ipar_CashHeldInEscrow">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash held in escrow.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ipar_CashHeldInEscrow</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ipar_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ipar_DiscriptionOfRecentAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Discription of recent agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ipar_DiscriptionOfRecentAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ipar_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquisitionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The capitalized costs incurred during the period (excluded from amortization) to purchase, lease or otherwise acquire an unproved property, including costs of lease bonuses and options to purchase or lease properties, the portion of costs applicable to minerals when land including mineral rights is purchased in fee, brokers' fees, recording fees, legal costs, and other costs incurred in acquiring properties.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 932<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-10(c)(7)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=123726172&amp;loc=d3e511914-122862<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 932<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-10(c)(3)(ii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=123726172&amp;loc=d3e511914-122862<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquisitionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionDescriptionOfAcquiredEntity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>With respect to a business combination completed during the period, this element provides a description of the business, other than the name, which may include the industry, size, products and other important information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionDescriptionOfAcquiredEntity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateTerms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of the interest rate as being fixed or variable, and, if variable, identification of the index or rate on which the interest rate is based and the number of points or percentage added to that index or rate to set the rate, and other pertinent information, such as frequency of rate resets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateTerms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentChargeOnReclassifiedAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the asset that is reclassified back to held and used from held-for-sale, the amount of impairment charge that is recognized on the reclassification date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 35<br> -Paragraph 44<br> -URI http://asc.fasb.org/extlink&amp;oid=29634951&amp;loc=d3e1756-110224<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2459-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentChargeOnReclassifiedAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of income taxes previously overpaid to tax authorities (such as U.S. Federal, state and local tax authorities) representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes. Also called income tax refund receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTaxCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount deducted from an entities' taxes, reflecting a percentage of an amount invested in certain assets spread over the useful life of those assets; includes deferred investment tax credits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTaxCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period between issuance and maturity of long-term debt, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForPurchaseOfOtherAssets1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid to purchase other assets as part of operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3367-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForPurchaseOfOtherAssets1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxesPayableCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxesPayableCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=ipar_AnnaSuiCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=ipar_AnnaSuiCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=ipar_RochasFashionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=ipar_RochasFashionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=ipar_STDupontMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=ipar_STDupontMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_EUR">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_EUR</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_SwissFederalTaxAdministrationFTAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_SwissFederalTaxAdministrationFTAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=ipar_GlobalSettlementAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=ipar_GlobalSettlementAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139983549913080">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Schedule of inventories (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryRawMaterials', window );">Raw materials and component parts</a></td>
<td class="nump">$ 111,312<span></span>
</td>
<td class="nump">$ 66,492<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoods', window );">Finished goods</a></td>
<td class="nump">87,602<span></span>
</td>
<td class="nump">92,330<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">$ 198,914<span></span>
</td>
<td class="nump">$ 158,822<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterials">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterials</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139983556283384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventories (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryValuationReserves', window );">Inventory Valuation Reserves</a></td>
<td class="nump">$ 15,800,000<span></span>
</td>
<td class="nump">$ 9,400,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductMember', window );">Product [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSoldOverhead', window );">Cost of Goods Sold, Overhead</a></td>
<td class="nump">$ 3,700,000<span></span>
</td>
<td class="nump">$ 5,400,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSoldOverhead">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indirect cost incurred related to good produced and service rendered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSoldOverhead</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryValuationReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of valuation reserve for inventory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryValuationReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139983480457880">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Schedule of fair value, assets measured on recurring basis (Details) - Fair Value, Recurring [Member] - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Short-term investments</a></td>
<td class="nump">$ 160,014<span></span>
</td>
<td class="nump">$ 126,627<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyFairValueHedgeAssetAtFairValue', window );">Foreign currency forward exchange contracts accounted for using hedge accounting</a></td>
<td class="nump">1,982<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue', window );">Foreign currency forward exchange contracts not accounted for using hedge accounting</a></td>
<td class="nump">63<span></span>
</td>
<td class="nump">253<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Interest rate swaps</a></td>
<td class="num">(234)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">&#160;Total Assets</a></td>
<td class="nump">1,811<span></span>
</td>
<td class="nump">126,880<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Inputs, Level 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Short-term investments</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyFairValueHedgeAssetAtFairValue', window );">Foreign currency forward exchange contracts accounted for using hedge accounting</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue', window );">Foreign currency forward exchange contracts not accounted for using hedge accounting</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Interest rate swaps</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">&#160;Total Assets</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Inputs, Level 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Short-term investments</a></td>
<td class="nump">160,014<span></span>
</td>
<td class="nump">126,627<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyFairValueHedgeAssetAtFairValue', window );">Foreign currency forward exchange contracts accounted for using hedge accounting</a></td>
<td class="nump">1,982<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue', window );">Foreign currency forward exchange contracts not accounted for using hedge accounting</a></td>
<td class="nump">63<span></span>
</td>
<td class="nump">253<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Interest rate swaps</a></td>
<td class="num">(234)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">&#160;Total Assets</a></td>
<td class="nump">1,811<span></span>
</td>
<td class="nump">126,880<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Inputs, Level 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Short-term investments</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyFairValueHedgeAssetAtFairValue', window );">Foreign currency forward exchange contracts accounted for using hedge accounting</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue', window );">Foreign currency forward exchange contracts not accounted for using hedge accounting</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Interest rate swaps</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">&#160;Total Assets</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value as of the balance sheet date of all foreign currency derivative liabilities not designated as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyFairValueHedgeAssetAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value as of the balance sheet date of all derivative assets designated as foreign currency fair value hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyFairValueHedgeAssetAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139983557399976">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Derivative Financial Instruments (Details Narrative) - Dec. 31, 2021<br></strong></div></th>
<th class="th"><div>USD ($)</div></th>
<th class="th"><div>GBP (&#163;)</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Foreign Exchange Contract [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure', window );">Foreign currency contracts, liability, fair value disclosure</a></td>
<td class="nump">$ 64,500,000<span></span>
</td>
<td class="nump">&#163; 3,500,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of liability contracts related to the exchange of different currencies, including, but not limited to, foreign currency options, forward (delivery or nondelivery) contracts, and swaps entered into.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139983549595864">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Schedule of equipment and leasehold improvements (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Equipment and leasehold improvements</a></td>
<td class="nump">$ 190,249<span></span>
</td>
<td class="nump">$ 53,049<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less accumulated depreciation and amortization</a></td>
<td class="nump">40,897<span></span>
</td>
<td class="nump">33,469<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, Plant and Equipment, Net, Total</a></td>
<td class="nump">149,352<span></span>
</td>
<td class="nump">19,580<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember', window );">Building [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Equipment and leasehold improvements</a></td>
<td class="nump">136,131<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember', window );">Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Equipment and leasehold improvements</a></td>
<td class="nump">52,036<span></span>
</td>
<td class="nump">51,060<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold Improvements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Equipment and leasehold improvements</a></td>
<td class="nump">$ 2,082<span></span>
</td>
<td class="nump">$ 1,989<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139983558575736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, Equipment and Leasehold Improvements (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization expense</a></td>
<td class="nump">$ 4,400,000<span></span>
</td>
<td class="nump">$ 3,800,000<span></span>
</td>
<td class="nump">$ 3,700,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139983481101320">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Schedule of trademarks, licenses and other intangible assets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Amount</a></td>
<td class="nump">$ 290,989<span></span>
</td>
<td class="nump">$ 290,881<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">76,942<span></span>
</td>
<td class="nump">76,773<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Book Value</a></td>
<td class="nump">214,047<span></span>
</td>
<td class="nump">214,108<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=ipar_LicensesMember', window );">Licenses [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Amount</a></td>
<td class="nump">109,682<span></span>
</td>
<td class="nump">93,248<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">62,286<span></span>
</td>
<td class="nump">62,262<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Book Value</a></td>
<td class="nump">47,396<span></span>
</td>
<td class="nump">30,986<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember', window );">Other Intangible Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Amount</a></td>
<td class="nump">17,775<span></span>
</td>
<td class="nump">18,194<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">14,588<span></span>
</td>
<td class="nump">14,437<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Book Value</a></td>
<td class="nump">3,187<span></span>
</td>
<td class="nump">3,757<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_IndefinitelivedIntangibleAssetsMember', window );">Indefinite-lived Intangible Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Amount</a></td>
<td class="nump">119,712<span></span>
</td>
<td class="nump">131,962<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Book Value</a></td>
<td class="nump">119,712<span></span>
</td>
<td class="nump">131,962<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_FiniteLivedIntangibleAssetsMember', window );">Finite-Lived Intangible Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Amount</a></td>
<td class="nump">43,820<span></span>
</td>
<td class="nump">47,477<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">68<span></span>
</td>
<td class="nump">74<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Book Value</a></td>
<td class="nump">43,752<span></span>
</td>
<td class="nump">47,403<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=ipar_SubtotalMember', window );">Subtotal [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Amount</a></td>
<td class="nump">171,277<span></span>
</td>
<td class="nump">158,919<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">76,942<span></span>
</td>
<td class="nump">76,773<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Book Value</a></td>
<td class="nump">$ 94,335<span></span>
</td>
<td class="nump">$ 82,146<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=ipar_LicensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=ipar_LicensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_IndefinitelivedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_IndefinitelivedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_FiniteLivedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_FiniteLivedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=ipar_SubtotalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=ipar_SubtotalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139983481570312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Trademarks, Licenses and Other Intangible Assets (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of Intangible Assets</a></td>
<td class="nump">$ 5,900,000<span></span>
</td>
<td class="nump">$ 5,300,000<span></span>
</td>
<td class="nump">$ 5,000,000.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">Finite-Lived Intangible Asset, Expected Amortization, Year One</a></td>
<td class="nump">5,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">Finite-Lived Intangible Asset, Expected Amortization, Year Two</a></td>
<td class="nump">4,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ipar_FiniteLivedIntangibleAssetsAmortizationExpenseAfterTwoYears', window );">[custom:FiniteLivedIntangibleAssetsAmortizationExpenseAfterTwoYears-0]</a></td>
<td class="nump">$ 4,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Amortization period</a></td>
<td class="text">14 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted average cost of capital</a></td>
<td class="nump">2.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedLicenseAgreements', window );">Indefinite-Lived License Agreements</a></td>
<td class="nump">$ 79,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Amortization period</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Amortization period</a></td>
<td class="text">20 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember', window );">Measurement Input, Discount Rate [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted average cost of capital</a></td>
<td class="nump">7.47%<span></span>
</td>
<td class="nump">6.99%<span></span>
</td>
<td class="nump">7.94%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_IndefinitelivedIntangibleAssetsMember', window );">Indefinite-lived Intangible Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of Intangible Assets</a></td>
<td class="nump">$ 2,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember', window );">Trademarks [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Amortization period</a></td>
<td class="text">8 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=ipar_LicensesMember', window );">Licenses [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Amortization period</a></td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember', window );">Other Intangible Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Amortization period</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ipar_FiniteLivedIntangibleAssetsAmortizationExpenseAfterTwoYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount finite lived intangible assets amortization expense after two years.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ipar_FiniteLivedIntangibleAssetsAmortizationExpenseAfterTwoYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ipar_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedLicenseAgreements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (original costs adjusted for previously recognized amortization and impairment) as of the balance sheet date for the capitalized costs to acquire rights under a license arrangement (for example, to sell specified products in a specified territory) having an indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedLicenseAgreements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_IndefinitelivedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_IndefinitelivedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=ipar_LicensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=ipar_LicensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139983549679912">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Accrued expenses consist of the following: (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedAdvertisingCurrent', window );">Advertising liabilities</a></td>
<td class="nump">$ 31,215<span></span>
</td>
<td class="nump">$ 12,164<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedSalariesCurrent', window );">Salary (including bonus and related taxes)</a></td>
<td class="nump">19,993<span></span>
</td>
<td class="nump">14,605<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedRoyaltiesCurrent', window );">Royalties</a></td>
<td class="nump">19,154<span></span>
</td>
<td class="nump">16,966<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ipar_DueVendorsNotYetInvoiced', window );">Due vendors (not yet invoiced)</a></td>
<td class="nump">45,707<span></span>
</td>
<td class="nump">31,698<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrent', window );">Retirement reserves</a></td>
<td class="nump">10,234<span></span>
</td>
<td class="nump">11,889<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CustomerRefundLiabilityCurrent', window );">Refund (return) liability</a></td>
<td class="nump">5,128<span></span>
</td>
<td class="nump">3,616<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other</a></td>
<td class="nump">5,246<span></span>
</td>
<td class="nump">4,691<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">$ 136,677<span></span>
</td>
<td class="nump">$ 95,629<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ipar_DueVendorsNotYetInvoiced">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Due vendors not yet invoiced.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ipar_DueVendorsNotYetInvoiced</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ipar_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedAdvertisingCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for advertising of the entity's goods and services. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e7054-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedAdvertisingCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedRoyaltiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for royalties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedRoyaltiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedSalariesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of the obligations incurred through that date and payable for employees' services provided. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedSalariesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CustomerRefundLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Current regulatory liabilities generally represent obligations to make refunds to customers for various reasons including overpayment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CustomerRefundLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e7018-107765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability, recognized in statement of financial position, for pension, other postretirement and postemployment benefits, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1731-114919<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1703-114919<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139983480453640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-term debt consists of the following: (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>Number</div>
</th>
<th class="th">
<div>Apr. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Loan payable</a></td>
<td class="nump">$ 148,813,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 24,706,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Less current maturities</a></td>
<td class="nump">15,911,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,570,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Total</a></td>
<td class="nump">132,902,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,136,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember', window );">Loans Payable [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Loan payable (in Dollars)</a></td>
<td class="nump">$ 135,900,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ipar_NumberOfInstallment', window );">Number of installments | Number</a></td>
<td class="nump">120<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPayment', window );">Installment amount (in Dollars)</a></td>
<td class="nump">$ 1,100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest per annum</a></td>
<td class="nump">0.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Loan payable</a></td>
<td class="nump">$ 124,375,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=ipar_LoansPayableOneMember', window );">Loans Payable One [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Loan payable (in Dollars)</a></td>
<td class="nump">$ 15,000,000<span></span>
</td>
<td class="nump">$ 135,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ipar_NumberOfInstallment', window );">Number of installments | Number</a></td>
<td class="nump">14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPayment', window );">Installment amount (in Dollars)</a></td>
<td class="nump">$ 1,100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest per annum</a></td>
<td class="nump">4.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Loan payable</a></td>
<td class="nump">$ 10,569,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,208,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=ipar_LoansPayableTwoMember', window );">Loans Payable Two [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Loan payable (in Dollars)</a></td>
<td class="nump">$ 17,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ipar_NumberOfInstallment', window );">Number of installments | Number</a></td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPayment', window );">Installment amount (in Dollars)</a></td>
<td class="nump">$ 1,700,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest per annum</a></td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Loan payable</a></td>
<td class="nump">$ 13,869,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=ipar_LoansPayableThreeMember', window );">Loans Payable Three [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Loan payable (in Dollars)</a></td>
<td class="nump">$ 13,400,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest per annum</a></td>
<td class="nump">0.85%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Loan payable</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,498,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ipar_NumberOfInstallment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of installment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ipar_NumberOfInstallment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ipar_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentPeriodicPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the required periodic payments including both interest and principal payments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123599511&amp;loc=d3e64711-112823<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentPeriodicPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=ipar_LoansPayableOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=ipar_LoansPayableOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=ipar_LoansPayableTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=ipar_LoansPayableTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=ipar_LoansPayableThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=ipar_LoansPayableThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139983481497032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Loans Payable &#8211; Banks (Details Narrative)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=ipar_DomesticSubsidiariesMember', window );">Domestic Subsidiaries [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of credit, maximum borrowing amount</a></td>
<td class="nump">$ 20<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=ipar_DomesticSubsidiariesMember', window );">Domestic Subsidiaries [Member] | London Interbank Offered Rate [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread over variable interest rate</a></td>
<td class="nump">2.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Variable rate</a></td>
<td class="nump">0.05%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityExpirationDate1', window );">Line of Credit Facility, Expiration Date</a></td>
<td class="text">Dec. 16,  2022<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=ipar_ForeignSubsidiariesMember', window );">Foreign Subsidiaries [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of credit, maximum borrowing amount</a></td>
<td class="nump">$ 28,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=ipar_ForeignSubsidiariesMember', window );">Foreign Subsidiaries [Member] | Euro Interbank Offered Rate Membe [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Variable rate</a></td>
<td class="nump">0.57%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=ipar_ForeignSubsidiariesMember', window );">Foreign Subsidiaries [Member] | Euro Interbank Offered Rate Membe [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread over variable interest rate</a></td>
<td class="nump">0.50%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=ipar_ForeignSubsidiariesMember', window );">Foreign Subsidiaries [Member] | Euro Interbank Offered Rate Membe [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread over variable interest rate</a></td>
<td class="nump">0.80%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityExpirationDate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date the credit facility terminates, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityExpirationDate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=ipar_DomesticSubsidiariesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=ipar_DomesticSubsidiariesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=ipar_LondonInterbankOfferedRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=ipar_LondonInterbankOfferedRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=ipar_ForeignSubsidiariesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=ipar_ForeignSubsidiariesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=ipar_EuroInterbankOfferedRateMembeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=ipar_EuroInterbankOfferedRateMembeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139983549642488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Debt (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Apr. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">Long-term Debt, Maturities, 2021</a></td>
<td class="nump">$ 15,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtDescription', window );">Long term debt maturity, description</a></td>
<td class="text">16.4 million per year thereafter through 2033.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=ipar_LoansPayableOneMember', window );">Loans Payable One [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt Instrument, Face Amount</a></td>
<td class="nump">$ 15,000,000<span></span>
</td>
<td class="nump">$ 135,900,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of long-term debt arrangements, which are debt arrangements that originally require full repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer, and disclosures pertaining to the underlying arrangements, including repayment terms, conversion features, interest rates, restrictions on assets and activities, debt covenants, and other matters important to users of the financial statements. Types of long-term debt arrangements include borrowing under notes payable, bonds payable, debentures, term loans, and other contractual obligations for payment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=ipar_LoansPayableOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=ipar_LoansPayableOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139983549886920">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Maturities of lease liabilities subsequent to December 31, 2021 are as follows: (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent', window );">2022</a></td>
<td class="nump">$ 6,541<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears', window );">2023</a></td>
<td class="nump">6,776<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears', window );">2024</a></td>
<td class="nump">5,787<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears', window );">2025</a></td>
<td class="nump">4,704<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears', window );">2026</a></td>
<td class="nump">4,087<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter', window );">Thereafter</a></td>
<td class="nump">10,017<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDue', window );">Gross Total</a></td>
<td class="nump">37,912<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less imputed interest (based on 3.0% weighted-average discount rate)</a></td>
<td class="num">(2,679)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear', window );">Net Total</a></td>
<td class="nump">$ 35,233<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for leases having an initial or remaining non-cancelable letter-terms in excess of one year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406913&amp;loc=d3e41502-112717<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123403562&amp;loc=d3e38371-112697<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406913&amp;loc=d3e41502-112717<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123403562&amp;loc=d3e38371-112697<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406913&amp;loc=d3e41502-112717<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123403562&amp;loc=d3e38371-112697<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406913&amp;loc=d3e41502-112717<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123403562&amp;loc=d3e38371-112697<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123403562&amp;loc=d3e38371-112697<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406913&amp;loc=d3e41502-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406913&amp;loc=d3e41502-112717<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123403562&amp;loc=d3e38371-112697<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due after the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123403562&amp;loc=d3e38371-112697<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406913&amp;loc=d3e41502-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the remainder of the fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139983549699592">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>minimum annual royalties and other commitments as follows: (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCommitmentDueInNextTwelveMonths', window );">2021</a></td>
<td class="nump">$ 191,422<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCommitmentDueInSecondYear', window );">2022</a></td>
<td class="nump">206,241<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCommitmentDueInThirdYear', window );">2023</a></td>
<td class="nump">202,774<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCommitmentDueInFourthYear', window );">2024</a></td>
<td class="nump">199,770<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCommitmentDueInFifthYear', window );">2025</a></td>
<td class="nump">136,776<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCommitmentDueAfterFifthYear', window );">Thereafter</a></td>
<td class="nump">702,780<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCommitment', window );">Total</a></td>
<td class="nump">$ 1,639,763<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Minimum amount of other commitment not otherwise specified in the taxonomy. Excludes commitments explicitly modeled in the taxonomy, including but not limited to, long-term and short-term purchase commitments, recorded and unrecorded purchase obligations, supply commitments, registration payment arrangements, leases, debt, product warranties, guarantees, environmental remediation obligations, and pensions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitmentDueAfterFifthYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of commitment classified as other to be paid after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitmentDueAfterFifthYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitmentDueInFifthYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of commitment classified as other to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitmentDueInFifthYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitmentDueInFourthYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of commitment classified as other to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitmentDueInFourthYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitmentDueInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of commitment classified as other to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitmentDueInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitmentDueInSecondYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of commitment classified as other to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitmentDueInSecondYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitmentDueInThirdYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of commitment classified as other to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitmentDueInThirdYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139983481500808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted average remaining lease term</a></td>
<td class="text">6 years 1 month 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Operating lease, weighted average discount rate</a></td>
<td class="nump">2.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesRentExpenseNet', window );">Operating lease of related to rental expenses</a></td>
<td class="nump">$ 8,200,000<span></span>
</td>
<td class="nump">$ 6,200,000<span></span>
</td>
<td class="nump">$ 7,500,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating lease payments</a></td>
<td class="nump">7,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Noncash additions to operating lease assets</a></td>
<td class="nump">12,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RoyaltyExpense', window );">Royalty expense</a></td>
<td class="nump">$ 69,000,000.0<span></span>
</td>
<td class="nump">$ 41,100,000<span></span>
</td>
<td class="nump">$ 53,000,000.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ipar_RoyaltyExpenseNetSalesPercentage', window );">Royalty expense, percentage of net sales</a></td>
<td class="nump">7.80%<span></span>
</td>
<td class="nump">7.60%<span></span>
</td>
<td class="nump">7.40%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ipar_RoyaltyExpenseNetSalesPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Royalty expense net sales percentage.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ipar_RoyaltyExpenseNetSalesPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ipar_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesRentExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Rental expense for the reporting period incurred under operating leases, including minimum and any contingent rent expense, net of related sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123406913&amp;loc=d3e41499-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesRentExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RoyaltyExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense related to royalty payments under a contractual arrangement such as payment for mineral and drilling rights and use of technology or intellectual property.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RoyaltyExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139983549421896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>The following table sets forth information with respect to nonvested options for 2021: (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares', window );">Nonvested options - beginning of year</a></td>
<td class="nump">353,790<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted Average Grant Date Fair Value, beginning of year</a></td>
<td class="nump">$ 12.96<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Nonvested options granted</a></td>
<td class="nump">9,000<span></span>
</td>
<td class="nump">9,000<span></span>
</td>
<td class="nump">194,050<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted Average Grant Date Fair Value, granted</a></td>
<td class="nump">$ 11.35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares', window );">Nonvested options vested or forfeited</a></td>
<td class="num">(153,280)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue', window );">Weighted Average Grant Date Fair Value, vested or forfeited</a></td>
<td class="nump">$ 12.19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares', window );">Nonvested options - end of year</a></td>
<td class="nump">209,510<span></span>
</td>
<td class="nump">353,790<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted Average Grant Date Fair Value, end of year</a></td>
<td class="nump">$ 13.45<span></span>
</td>
<td class="nump">$ 12.96<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of non-vested options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of non-vested options forfeited.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average grant-date fair value of non-vested options forfeited.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average grant-date fair value of non-vested options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139983549596856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>The effect of share-based payment expenses decreased income statement line items as follows: (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income before income taxes</a></td>
<td class="nump">$ 151,019<span></span>
</td>
<td class="nump">$ 69,349<span></span>
</td>
<td class="nump">$ 105,146<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to Inter Parfums, Inc.</a></td>
<td class="nump">$ 87,411<span></span>
</td>
<td class="nump">$ 38,219<span></span>
</td>
<td class="nump">$ 60,249<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted earnings per share attributable to Inter Parfums, Inc</a></td>
<td class="nump">$ 2.75<span></span>
</td>
<td class="nump">$ 1.21<span></span>
</td>
<td class="nump">$ 1.90<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OperatingIncomeLossMember', window );">Operating Income (Loss) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income before income taxes</a></td>
<td class="nump">$ 2,850<span></span>
</td>
<td class="nump">$ 3,030<span></span>
</td>
<td class="nump">$ 3,390<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to Inter Parfums, Inc.</a></td>
<td class="nump">$ 1,880<span></span>
</td>
<td class="nump">$ 2,040<span></span>
</td>
<td class="nump">$ 2,060<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted earnings per share attributable to Inter Parfums, Inc</a></td>
<td class="nump">$ 0.06<span></span>
</td>
<td class="nump">$ 0.06<span></span>
</td>
<td class="nump">$ 0.07<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OperatingIncomeLossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_OperatingIncomeLossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139983573113352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>The following table summarizes stock option activity and related information for the years ended December 31, 2021, 2020 and 2019: (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options shares under option - beginning of year</a></td>
<td class="nump">713,210<span></span>
</td>
<td class="nump">815,800<span></span>
</td>
<td class="nump">776,171<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted average exercise price shares under option - beginning of year</a></td>
<td class="nump">$ 52.74<span></span>
</td>
<td class="nump">$ 49.89<span></span>
</td>
<td class="nump">$ 41.33<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Options granted</a></td>
<td class="nump">9,000<span></span>
</td>
<td class="nump">9,000<span></span>
</td>
<td class="nump">194,050<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Weighted average exercise price options granted</a></td>
<td class="nump">$ 62.18<span></span>
</td>
<td class="nump">$ 69.11<span></span>
</td>
<td class="nump">$ 72.89<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Options exercised</a></td>
<td class="num">(156,490)<span></span>
</td>
<td class="num">(95,570)<span></span>
</td>
<td class="num">(130,891)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Weighted average exercise price options exercised</a></td>
<td class="nump">$ 34.46<span></span>
</td>
<td class="nump">$ 28.99<span></span>
</td>
<td class="nump">$ 34.06<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Options forfeited</a></td>
<td class="num">(40,820)<span></span>
</td>
<td class="num">(16,020)<span></span>
</td>
<td class="num">(23,530)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Weighted average exercise price options forfeited</a></td>
<td class="nump">$ 62.57<span></span>
</td>
<td class="nump">$ 58.38<span></span>
</td>
<td class="nump">$ 45.48<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options shares under option - end of year</a></td>
<td class="nump">524,900<span></span>
</td>
<td class="nump">713,210<span></span>
</td>
<td class="nump">815,800<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted average exercise price shares under option - end of year</a></td>
<td class="nump">$ 57.58<span></span>
</td>
<td class="nump">$ 52.74<span></span>
</td>
<td class="nump">$ 49.89<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139983481223544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>The assumptions used in the Black-Scholes pricing model are set forth in the following table: (Details)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Weighted-average expected stock-price volatility</a></td>
<td class="nump">25.00%<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Weighted-average expected option life</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Weighted-average risk-free interest rate</a></td>
<td class="nump">0.40%<span></span>
</td>
<td class="nump">1.40%<span></span>
</td>
<td class="nump">1.70%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Weighted-average dividend yield</a></td>
<td class="nump">1.60%<span></span>
</td>
<td class="nump">2.50%<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139983549708488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Proceeds, tax benefits and intrinsic value related to stock options exercised were as follows (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from stock options exercised</a></td>
<td class="nump">$ 5,393<span></span>
</td>
<td class="nump">$ 2,771<span></span>
</td>
<td class="nump">$ 4,458<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxExpenseFromStockOptionsExercised', window );">Tax benefits</a></td>
<td class="nump">1,300<span></span>
</td>
<td class="nump">400<span></span>
</td>
<td class="nump">690<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Intrinsic value of stock options exercised</a></td>
<td class="nump">$ 7,800<span></span>
</td>
<td class="nump">$ 2,873<span></span>
</td>
<td class="nump">$ 4,520<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxExpenseFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax expense from write-off of the deferred tax asset related to deductible stock options at exercise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxExpenseFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139983481052072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>The following table summarizes additional stock option information as of December 31, 2021: (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2021 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Options outstanding</a></td>
<td class="nump">524,900<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Options outstanding weighted average remaining contractual life</a></td>
<td class="text">2 years 9 months<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Options exercisable</a></td>
<td class="nump">315,390<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=ipar_ExercisePriceRangeOneMember', window );">Exercise Price Range One [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Options outstanding</a></td>
<td class="nump">81,190<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Options exercisable</a></td>
<td class="nump">81,190<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=ipar_ExercisePriceRangeTwoMember', window );">Exercise Price Range Two [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Options outstanding</a></td>
<td class="nump">123,130<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Options outstanding weighted average remaining contractual life</a></td>
<td class="text">1 year 11 months 8 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Options exercisable</a></td>
<td class="nump">90,790<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=ipar_ExercisePriceRangeThreeMember', window );">Exercise Price Range Three [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Options outstanding</a></td>
<td class="nump">164,940<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Options outstanding weighted average remaining contractual life</a></td>
<td class="text">3 years 11 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Options exercisable</a></td>
<td class="nump">84,790<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=ipar_ExercisePriceRangeFourMember', window );">Exercise Price Range Four [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1', window );">Exercise price range (in Dollars per share) | $ / shares</a></td>
<td class="nump">$ 73.09<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Options outstanding</a></td>
<td class="nump">155,640<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Options outstanding weighted average remaining contractual life</a></td>
<td class="text">4 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Options exercisable</a></td>
<td class="nump">58,620<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Exercise Price Range One [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1', window );">Exercise price range (in Dollars per share) | $ / shares</a></td>
<td class="nump">$ 32.83<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Exercise Price Range Two [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1', window );">Exercise price range (in Dollars per share) | $ / shares</a></td>
<td class="nump">40.15<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Exercise Price Range Three [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1', window );">Exercise price range (in Dollars per share) | $ / shares</a></td>
<td class="nump">65.18<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Exercise Price Range One [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1', window );">Exercise price range (in Dollars per share) | $ / shares</a></td>
<td class="nump">$ 33.95<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Options outstanding weighted average remaining contractual life</a></td>
<td class="text">11 months 12 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Exercise Price Range Three [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1', window );">Exercise price range (in Dollars per share) | $ / shares</a></td>
<td class="nump">$ 46.90<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Exercise Price Range Four [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1', window );">Exercise price range (in Dollars per share) | $ / shares</a></td>
<td class="nump">$ 69.11<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares reserved for issuance pertaining to the outstanding stock options as of the balance sheet date for all option plans in the customized range of exercise prices.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average exercise price as of the balance sheet date for those equity-based payment arrangements exercisable and outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term of outstanding stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=ipar_ExercisePriceRangeOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=ipar_ExercisePriceRangeOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=ipar_ExercisePriceRangeTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=ipar_ExercisePriceRangeTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=ipar_ExercisePriceRangeThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=ipar_ExercisePriceRangeThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=ipar_ExercisePriceRangeFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=ipar_ExercisePriceRangeFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139983476927144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Oct. 31, 2019</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Feb. 28, 2021</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems', window );"><strong>Subsidiary or Equity Method Investee [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average grant date fair value (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11.35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ipar_Covid19Description', window );">Covid 19, description</a></td>
<td class="text">due to the potential
impact on future net sales and operating results resulting from the COVID-19 pandemic, the estimated number of shares to be distributed,
after forfeited shares, was reduced from&#160;142,571&#160;to&#160;82,162. As the Company had already purchased shares in contemplation
of the higher anticipated distribution, shares purchased in excess of the reduced anticipated distribution were transferred to
treasury shares at the Interparfums SA level.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ipar_PercentageOfIncreaseInAnnualDividend', window );">Percentage of increase in annual dividend</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPayableAmountPerShare', window );">Dividends payable, amount per share (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.32<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems', window );"><strong>Subsidiary or Equity Method Investee [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPayableAmountPerShare', window );">Dividends payable, amount per share (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_OwnershipAxis=ipar_InterparfumsSASubsidiaryMember', window );">Interparfums S A Subsidiary [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems', window );"><strong>Subsidiary or Equity Method Investee [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Adjusted for stock splits (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">172,343<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ipar_RevaluationResultedInReductionOfCostDescription', window );">Revaluation resulted in reduction of cost, description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The
original cost of the grant was approximately $4.4&#160;million, and the March 2020 revaluation resulted in a reduction of the cost,
to approximately $2.5 million.&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost', window );">Modification resulted revised cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=srt_BoardOfDirectorsChairmanMember', window );">Board of Directors Chairman [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems', window );"><strong>Subsidiary or Equity Method Investee [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPayableAmountPerShare', window );">Dividends payable, amount per share (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ipar_InterparfumsSASubsidiaryMember', window );">Interparfums S A Subsidiary [Member] | Employees [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems', window );"><strong>Subsidiary or Equity Method Investee [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Adjusted for stock splits (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26,600<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ipar_InterparfumsSASubsidiaryMember', window );">Interparfums S A Subsidiary [Member] | Officers And Managers [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems', window );"><strong>Subsidiary or Equity Method Investee [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate intrinsic value of options outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 133,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=us-gaap_StockOptionMember', window );">Equity Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems', window );"><strong>Subsidiary or Equity Method Investee [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Number of shares available for grant (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">612,535<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate intrinsic value of options outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ipar_StockOptionOneMember', window );">Stock Option One [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems', window );"><strong>Subsidiary or Equity Method Investee [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate intrinsic value of options outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_StockOptionMember', window );">Equity Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems', window );"><strong>Subsidiary or Equity Method Investee [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1', window );">Fair value of shares vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,400,000<span></span>
</td>
<td class="nump">$ 1,700,000<span></span>
</td>
<td class="nump">$ 1,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average grant date fair value (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11.35<span></span>
</td>
<td class="nump">$ 12.16<span></span>
</td>
<td class="nump">$ 14.14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Equity Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems', window );"><strong>Subsidiary or Equity Method Investee [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Share-based compensation arrangement by share-based payment award, award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Equity Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems', window );"><strong>Subsidiary or Equity Method Investee [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Share-based compensation arrangement by share-based payment award, award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ipar_Covid19Description">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Covid 19 description.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ipar_Covid19Description</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ipar_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ipar_PercentageOfIncreaseInAnnualDividend">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of increase in annual dividend.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ipar_PercentageOfIncreaseInAnnualDividend</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ipar_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ipar_RevaluationResultedInReductionOfCostDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Revaluation resulted in reduction of cost description.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ipar_RevaluationResultedInReductionOfCostDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ipar_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPayableAmountPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The per share amount of a dividend declared, but not paid, as of the financial reporting date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPayableAmountPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>An excess of the fair value of the modified award over the fair value of the award immediately before the modification.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=ipar_InterparfumsSASubsidiaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=ipar_InterparfumsSASubsidiaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_BoardOfDirectorsChairmanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_BoardOfDirectorsChairmanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=ipar_InterparfumsSASubsidiaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=ipar_InterparfumsSASubsidiaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=ipar_EmployeesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=ipar_EmployeesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=ipar_OfficersAndManagersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=ipar_OfficersAndManagersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=us-gaap_StockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=us-gaap_StockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ipar_StockOptionOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ipar_StockOptionOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_StockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_StockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139983549584616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>The reconciliation between the numerators and denominators of the basic and diluted EPS computations is as follows: (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Numerator for diluted earnings per share (in Dollars)</a></td>
<td class="nump">$ 87,411<span></span>
</td>
<td class="nump">$ 38,219<span></span>
</td>
<td class="nump">$ 60,249<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average shares</a></td>
<td class="nump">31,676,796<span></span>
</td>
<td class="nump">31,536,659<span></span>
</td>
<td class="nump">31,451,093<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment', window );">Weighted Average Number Diluted Shares Outstanding Adjustment</a></td>
<td class="nump">158,612<span></span>
</td>
<td class="nump">117,885<span></span>
</td>
<td class="nump">237,607<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Denominator for diluted earnings per share</a></td>
<td class="nump">31,835,408<span></span>
</td>
<td class="nump">31,654,544<span></span>
</td>
<td class="nump">31,688,700<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (in Dollars per share)</a></td>
<td class="nump">$ 2.76<span></span>
</td>
<td class="nump">$ 1.21<span></span>
</td>
<td class="nump">$ 1.92<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (in Dollars per share)</a></td>
<td class="nump">$ 2.75<span></span>
</td>
<td class="nump">$ 1.21<span></span>
</td>
<td class="nump">$ 1.90<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139983481274520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income Attributable to Inter Parfums, Inc. Common Shareholders (Details Narrative) - shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</a></td>
<td class="nump">175,000<span></span>
</td>
<td class="nump">450,000<span></span>
</td>
<td class="nump">183,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139983480890152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Information on the Company&#8217;s operations by segments is as follows: (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Revenue from Contract with Customer, Including Assessed Tax</a></td>
<td class="nump">$ 879,516<span></span>
</td>
<td class="nump">$ 539,009<span></span>
</td>
<td class="nump">$ 713,514<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss) Attributable to Parent</a></td>
<td class="nump">87,411<span></span>
</td>
<td class="nump">38,219<span></span>
</td>
<td class="nump">60,249<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation, Depletion and Amortization, Nonproduction</a></td>
<td class="nump">12,698<span></span>
</td>
<td class="nump">9,067<span></span>
</td>
<td class="nump">8,729<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterestAndDividend', window );">Investment Income, Interest and Dividend</a></td>
<td class="nump">3,403<span></span>
</td>
<td class="nump">2,865<span></span>
</td>
<td class="nump">3,693<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="nump">2,825<span></span>
</td>
<td class="nump">1,970<span></span>
</td>
<td class="nump">2,146<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income Tax Expense (Benefit)</a></td>
<td class="nump">40,992<span></span>
</td>
<td class="nump">19,381<span></span>
</td>
<td class="nump">29,076<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Assets</a></td>
<td class="nump">1,145,364<span></span>
</td>
<td class="nump">890,145<span></span>
</td>
<td class="nump">828,832<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionsToOtherAssetsAmount', window );">Additions to Other Assets, Amount</a></td>
<td class="nump">141,274<span></span>
</td>
<td class="nump">12,263<span></span>
</td>
<td class="nump">11,494<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Long-Lived Assets</a></td>
<td class="nump">397,127<span></span>
</td>
<td class="nump">258,422<span></span>
</td>
<td class="nump">241,449<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Deferred Income Tax Assets, Net</a></td>
<td class="nump">7,936<span></span>
</td>
<td class="nump">8,041<span></span>
</td>
<td class="nump">8,004<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">UNITED STATES</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Revenue from Contract with Customer, Including Assessed Tax</a></td>
<td class="nump">216,559<span></span>
</td>
<td class="nump">117,489<span></span>
</td>
<td class="nump">173,522<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss) Attributable to Parent</a></td>
<td class="nump">29,359<span></span>
</td>
<td class="nump">7,942<span></span>
</td>
<td class="nump">19,365<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation, Depletion and Amortization, Nonproduction</a></td>
<td class="nump">3,835<span></span>
</td>
<td class="nump">3,354<span></span>
</td>
<td class="nump">3,088<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterestAndDividend', window );">Investment Income, Interest and Dividend</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">24<span></span>
</td>
<td class="nump">345<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="nump">636<span></span>
</td>
<td class="nump">604<span></span>
</td>
<td class="nump">673<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income Tax Expense (Benefit)</a></td>
<td class="nump">5,336<span></span>
</td>
<td class="nump">1,590<span></span>
</td>
<td class="nump">3,945<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Assets</a></td>
<td class="nump">247,703<span></span>
</td>
<td class="nump">141,316<span></span>
</td>
<td class="nump">166,180<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionsToOtherAssetsAmount', window );">Additions to Other Assets, Amount</a></td>
<td class="nump">2,711<span></span>
</td>
<td class="nump">1,004<span></span>
</td>
<td class="nump">5,851<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Long-Lived Assets</a></td>
<td class="nump">63,094<span></span>
</td>
<td class="nump">40,656<span></span>
</td>
<td class="nump">44,473<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Deferred Income Tax Assets, Net</a></td>
<td class="nump">870<span></span>
</td>
<td class="nump">886<span></span>
</td>
<td class="nump">705<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_EuropeMember', window );">Europe [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Revenue from Contract with Customer, Including Assessed Tax</a></td>
<td class="nump">663,290<span></span>
</td>
<td class="nump">422,947<span></span>
</td>
<td class="nump">542,226<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss) Attributable to Parent</a></td>
<td class="nump">57,869<span></span>
</td>
<td class="nump">30,241<span></span>
</td>
<td class="nump">40,840<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation, Depletion and Amortization, Nonproduction</a></td>
<td class="nump">8,863<span></span>
</td>
<td class="nump">5,713<span></span>
</td>
<td class="nump">5,641<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterestAndDividend', window );">Investment Income, Interest and Dividend</a></td>
<td class="nump">3,526<span></span>
</td>
<td class="nump">2,971<span></span>
</td>
<td class="nump">3,501<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="nump">2,315<span></span>
</td>
<td class="nump">1,496<span></span>
</td>
<td class="nump">1,626<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income Tax Expense (Benefit)</a></td>
<td class="nump">35,607<span></span>
</td>
<td class="nump">17,782<span></span>
</td>
<td class="nump">25,101<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Assets</a></td>
<td class="nump">931,735<span></span>
</td>
<td class="nump">758,812<span></span>
</td>
<td class="nump">670,657<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionsToOtherAssetsAmount', window );">Additions to Other Assets, Amount</a></td>
<td class="nump">138,563<span></span>
</td>
<td class="nump">11,259<span></span>
</td>
<td class="nump">5,643<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Long-Lived Assets</a></td>
<td class="nump">334,033<span></span>
</td>
<td class="nump">217,766<span></span>
</td>
<td class="nump">196,976<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Deferred Income Tax Assets, Net</a></td>
<td class="nump">7,066<span></span>
</td>
<td class="nump">7,106<span></span>
</td>
<td class="nump">7,241<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=ipar_EliminationsMember', window );">Eliminations [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Revenue from Contract with Customer, Including Assessed Tax</a></td>
<td class="num">(333)<span></span>
</td>
<td class="num">(1,427)<span></span>
</td>
<td class="num">(2,234)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss) Attributable to Parent</a></td>
<td class="nump">183<span></span>
</td>
<td class="nump">36<span></span>
</td>
<td class="nump">44<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterestAndDividend', window );">Investment Income, Interest and Dividend</a></td>
<td class="num">(126)<span></span>
</td>
<td class="num">(130)<span></span>
</td>
<td class="num">(153)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(126)<span></span>
</td>
<td class="num">(130)<span></span>
</td>
<td class="num">(153)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income Tax Expense (Benefit)</a></td>
<td class="nump">49<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="nump">30<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Assets</a></td>
<td class="num">(34,074)<span></span>
</td>
<td class="num">(9,983)<span></span>
</td>
<td class="num">(8,005)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Deferred Income Tax Assets, Net</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 49<span></span>
</td>
<td class="nump">$ 58<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionsToOtherAssetsAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of significant additions in the period in other assets (current, noncurrent, or unclassified).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionsToOtherAssetsAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterestAndDividend">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income and dividend income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(a),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterestAndDividend</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_EuropeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_EuropeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=ipar_EliminationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=ipar_EliminationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139983550289944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated net sales to customers by region are as follows: (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="nump">$ 879,500<span></span>
</td>
<td class="nump">$ 539,000<span></span>
</td>
<td class="nump">$ 713,500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_NorthAmericaMember', window );">North America [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="nump">354,100<span></span>
</td>
<td class="nump">193,500<span></span>
</td>
<td class="nump">235,500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=ipar_EuropeCountryMember', window );">Europe Country [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="nump">271,600<span></span>
</td>
<td class="nump">180,200<span></span>
</td>
<td class="nump">240,800<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_AsiaMember', window );">Asia [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="nump">128,000<span></span>
</td>
<td class="nump">79,700<span></span>
</td>
<td class="nump">110,900<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=us-gaap_MiddleEastMember', window );">Middle East [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="nump">61,000<span></span>
</td>
<td class="nump">46,800<span></span>
</td>
<td class="nump">72,600<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=ipar_CentralAndSouthAmericaMember', window );">Central And South America [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="nump">56,400<span></span>
</td>
<td class="nump">32,500<span></span>
</td>
<td class="nump">46,200<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=ipar_OtherSegmentCountryMember', window );">Other Segment Country [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="nump">$ 8,400<span></span>
</td>
<td class="nump">$ 6,300<span></span>
</td>
<td class="nump">$ 7,500<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_NorthAmericaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_NorthAmericaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=ipar_EuropeCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=ipar_EuropeCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_AsiaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_AsiaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=us-gaap_MiddleEastMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=us-gaap_MiddleEastMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=ipar_CentralAndSouthAmericaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=ipar_CentralAndSouthAmericaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=ipar_OtherSegmentCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=ipar_OtherSegmentCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139983550167464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated net sales to customers in major countries are as follows: (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Revenue from Contract with Customer, Including Assessed Tax</a></td>
<td class="nump">$ 879,516<span></span>
</td>
<td class="nump">$ 539,009<span></span>
</td>
<td class="nump">$ 713,514<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ipar_UnitedStatesMember', window );">United States [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Revenue from Contract with Customer, Including Assessed Tax</a></td>
<td class="nump">351,300<span></span>
</td>
<td class="nump">187,300<span></span>
</td>
<td class="nump">225,300<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ipar_FranceMember', window );">France [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Revenue from Contract with Customer, Including Assessed Tax</a></td>
<td class="nump">44,000<span></span>
</td>
<td class="nump">37,600<span></span>
</td>
<td class="nump">43,500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ipar_RussiaMember', window );">Russia [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Revenue from Contract with Customer, Including Assessed Tax</a></td>
<td class="nump">43,400<span></span>
</td>
<td class="nump">14,100<span></span>
</td>
<td class="nump">36,800<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ipar_UnitedKingdomMember', window );">United Kingdom [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Revenue from Contract with Customer, Including Assessed Tax</a></td>
<td class="nump">$ 38,500<span></span>
</td>
<td class="nump">$ 24,600<span></span>
</td>
<td class="nump">$ 35,800<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=ipar_UnitedStatesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=ipar_UnitedStatesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=ipar_FranceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=ipar_FranceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=ipar_RussiaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=ipar_RussiaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=ipar_UnitedKingdomMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=ipar_UnitedKingdomMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139983481256600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>The components of income before income taxes consist of the following: (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic', window );">U.S. operations</a></td>
<td class="nump">$ 34,742<span></span>
</td>
<td class="nump">$ 9,577<span></span>
</td>
<td class="nump">$ 23,384<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign', window );">Foreign operations</a></td>
<td class="nump">116,277<span></span>
</td>
<td class="nump">59,772<span></span>
</td>
<td class="nump">81,762<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income before income taxes</a></td>
<td class="nump">$ 151,019<span></span>
</td>
<td class="nump">$ 69,349<span></span>
</td>
<td class="nump">$ 105,146<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139983550294328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>The provision for current and deferred income tax expense (benefit) consists of the following: (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">Federal</a></td>
<td class="nump">$ 4,825<span></span>
</td>
<td class="nump">$ 1,685<span></span>
</td>
<td class="nump">$ 3,280<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit', window );">State and local</a></td>
<td class="nump">518<span></span>
</td>
<td class="nump">90<span></span>
</td>
<td class="nump">713<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentForeignTaxExpenseBenefit', window );">Foreign</a></td>
<td class="nump">36,164<span></span>
</td>
<td class="nump">17,024<span></span>
</td>
<td class="nump">27,412<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Current income tax expense</a></td>
<td class="nump">41,507<span></span>
</td>
<td class="nump">18,799<span></span>
</td>
<td class="nump">31,405<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit', window );">Federal</a></td>
<td class="nump">4<span></span>
</td>
<td class="num">(215)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit', window );">State and local</a></td>
<td class="nump">11<span></span>
</td>
<td class="nump">44<span></span>
</td>
<td class="num">(22)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit', window );">Foreign</a></td>
<td class="num">(530)<span></span>
</td>
<td class="nump">753<span></span>
</td>
<td class="num">(2,304)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxesAndTaxCredits', window );">Deferred income tax expense</a></td>
<td class="num">(515)<span></span>
</td>
<td class="nump">582<span></span>
</td>
<td class="num">(2,329)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Total income tax expense</a></td>
<td class="nump">$ 40,992<span></span>
</td>
<td class="nump">$ 19,381<span></span>
</td>
<td class="nump">$ 29,076<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentForeignTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentForeignTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredForeignIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxesAndTaxCredits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) and income tax credits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxesAndTaxCredits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139983477714904">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>The tax effects of temporary differences that give rise to significant portions of the deferred tax assets and deferred tax liabilities are as follows: (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNetAbstract', window );"><strong>Net deferred tax assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign', window );">Foreign net operating loss carry-forwards</a></td>
<td class="nump">$ 1,292<span></span>
</td>
<td class="nump">$ 360<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ipar_DeferredTaxAssetsInventoryAndAccountsReceivable', window );">Inventory and accounts receivable</a></td>
<td class="nump">4,508<span></span>
</td>
<td class="nump">1,928<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsDeferredIncome', window );">Profit sharing</a></td>
<td class="nump">3,787<span></span>
</td>
<td class="nump">2,936<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost', window );">Stock option compensation</a></td>
<td class="nump">732<span></span>
</td>
<td class="nump">718<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsInventory', window );">Effect of inventory profit elimination</a></td>
<td class="nump">5,112<span></span>
</td>
<td class="nump">4,443<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOther', window );">Other</a></td>
<td class="nump">407<span></span>
</td>
<td class="nump">910<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Total gross deferred tax assets, net</a></td>
<td class="nump">15,838<span></span>
</td>
<td class="nump">11,295<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="num">(3,582)<span></span>
</td>
<td class="num">(360)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Net deferred tax assets</a></td>
<td class="nump">12,256<span></span>
</td>
<td class="nump">10,935<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesNetAbstract', window );"><strong>Deferred tax liabilities (long-term):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ipar_DeferredTaxLiabilitiesBuildingExpenses', window );">Building expenses</a></td>
<td class="num">(1,082)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets', window );">Trademarks and licenses</a></td>
<td class="num">(2,551)<span></span>
</td>
<td class="num">(2,894)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ipar_DeferredTaxLiabilitiesUnrealizedGainOnMarketableEquitySecurities', window );">Unrealized gain on marketable equity securities</a></td>
<td class="num">(436)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesOther', window );">Other</a></td>
<td class="num">(251)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilities', window );">Total deferred tax liabilities</a></td>
<td class="num">(4,320)<span></span>
</td>
<td class="num">(2,894)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsLiabilitiesNet', window );">Net deferred tax assets</a></td>
<td class="nump">$ 7,936<span></span>
</td>
<td class="nump">$ 8,041<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ipar_DeferredTaxAssetsInventoryAndAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred tax assets inventory and accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ipar_DeferredTaxAssetsInventoryAndAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ipar_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ipar_DeferredTaxLiabilitiesBuildingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred tax liabilities building expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ipar_DeferredTaxLiabilitiesBuildingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ipar_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ipar_DeferredTaxLiabilitiesUnrealizedGainOnMarketableEquitySecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred tax liabilities unrealized gain on marketable equity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ipar_DeferredTaxLiabilitiesUnrealizedGainOnMarketableEquitySecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ipar_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(15)(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsDeferredIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from deferred income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsDeferredIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from inventory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible foreign operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from long-lived assets other than property, plant, and equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139983550582648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Differences between the United States federal statutory income tax rate and the effective income tax rate were as follows: (Details)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Statutory rates</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes', window );">State and local taxes, net of Federal benefit</a></td>
<td class="nump">0.30%<span></span>
</td>
<td class="nump">0.20%<span></span>
</td>
<td class="nump">0.60%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsEmployeeStockOwnershipPlanDividends', window );">Windfall benefit from exercise of stock options</a></td>
<td class="num">(0.90%)<span></span>
</td>
<td class="num">(0.60%)<span></span>
</td>
<td class="num">(0.70%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential', window );">Benefit of Foreign Derived Intangible Income</a></td>
<td class="num">(0.60%)<span></span>
</td>
<td class="num">(0.40%)<span></span>
</td>
<td class="num">(0.90%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ipar_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate1', window );">U.S. statutory rates</a></td>
<td class="nump">7.40%<span></span>
</td>
<td class="nump">7.50%<span></span>
</td>
<td class="nump">7.50%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments', window );">Other</a></td>
<td class="num">(0.10%)<span></span>
</td>
<td class="nump">0.20%<span></span>
</td>
<td class="nump">0.10%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective rates</a></td>
<td class="nump">27.10%<span></span>
</td>
<td class="nump">27.90%<span></span>
</td>
<td class="nump">27.60%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ipar_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ipar_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ipar_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsEmployeeStockOwnershipPlanDividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to deduction for dividend paid to employee stock ownership plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsEmployeeStockOwnershipPlanDividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139983556905864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit', window );">Deferred Foreign Income Tax Expense (Benefit)</a></td>
<td class="num">$ (530,000)<span></span>
</td>
<td class="nump">$ 753,000<span></span>
</td>
<td class="num">$ (2,304,000)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ipar_ForeignDerivedIntangibleIncomeMember', window );">Foreign Derived Intangible Income [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit', window );">Deferred Foreign Income Tax Expense (Benefit)</a></td>
<td class="nump">$ 900,000<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="nump">$ 900,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredForeignIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ipar_ForeignDerivedIntangibleIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ipar_ForeignDerivedIntangibleIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139983476880872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>The components of accumulated other comprehensive loss consist of the following: (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Cumulative translation adjustments, beginning of year</a></td>
<td class="num">$ (5,997)<span></span>
</td>
<td class="num">$ (39,853)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Cumulative translation adjustments, end of year</a></td>
<td class="num">(38,432)<span></span>
</td>
<td class="num">(5,997)<span></span>
</td>
<td class="num">$ (39,853)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(38,432)<span></span>
</td>
<td class="num">(5,997)<span></span>
</td>
<td class="num">(39,853)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=ipar_AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember', window );">Accumulated Defined Benefit Plans Net Derivative Instruments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Cumulative translation adjustments, beginning of year</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">52<span></span>
</td>
<td class="nump">136<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent', window );">Net derivative instrument gain (loss), net of tax</a></td>
<td class="num">(992)<span></span>
</td>
<td class="num">(52)<span></span>
</td>
<td class="num">(84)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Cumulative translation adjustments, end of year</a></td>
<td class="num">(992)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">52<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(992)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">52<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember', window );">Accumulated Foreign Currency Adjustment Attributable to Parent [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Cumulative translation adjustments, beginning of year</a></td>
<td class="num">(5,997)<span></span>
</td>
<td class="num">(39,905)<span></span>
</td>
<td class="num">(33,786)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Cumulative translation adjustments, end of year</a></td>
<td class="num">(37,440)<span></span>
</td>
<td class="num">(5,997)<span></span>
</td>
<td class="num">(39,905)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax', window );">Translation adjustments</a></td>
<td class="num">(31,443)<span></span>
</td>
<td class="nump">33,908<span></span>
</td>
<td class="num">(6,119)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">$ (37,440)<span></span>
</td>
<td class="num">$ (5,997)<span></span>
</td>
<td class="num">$ (39,905)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments, of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss), attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569643-111683<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit), after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32262-110900<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e640-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=125521441&amp;loc=d3e30755-110894<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=ipar_AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=ipar_AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139983481309432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule of net income attributable to transfers from the noncontrolling interest (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestAbstract', window );"><strong>Noncontrolling Interest [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to Inter Parfums, Inc.</a></td>
<td class="nump">$ 87,411<span></span>
</td>
<td class="nump">$ 38,219<span></span>
</td>
<td class="nump">$ 60,249<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesNet', window );">Decrease in Inter Parfums, Inc.&#8217;s additional paid-in capital for subsidiary share transactions</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(5,167)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNet', window );">&#160;Change from net income attributable to Inter Parfums, Inc. and transfers from noncontrolling interest</a></td>
<td class="nump">$ 87,411<span></span>
</td>
<td class="nump">$ 38,219<span></span>
</td>
<td class="nump">$ 55,082<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the total net income attributable to the parent for the period and the effect of net changes during the period impacting the parent's ownership interest in a subsidiary as it relates to the total (consolidated) equity attributable to the parent. The changes to the parent's ownership interest in a subsidiary represented by this element did not result in a deconsolidation of the subsidiary from the consolidated financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4M<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591554-111686<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the period impacting the parent's ownership interest in a subsidiary as it relates to the total (consolidated) equity attributable to the parent. The changes to the parent's ownership interest in a subsidiary represented by this element did not arise in a deconsolidation of the subsidiary from the consolidated financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4M<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591554-111686<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R82.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139983570390568">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>The following table summarizes cash and cash equivalents as of December 31, 2021: (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ipar_DisclosureReconciliationOfCashAndCashEquivalentsToStatementOfCashFlowsAbstract', window );"><strong>Reconciliation Of Cash And Cash Equivalents To Statement Of Cash Flows</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsAndShortTermInvestments', window );">Cash and cash equivalents per balance sheet</a></td>
<td class="nump">$ 159,613<span></span>
</td>
<td class="nump">$ 169,681<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ipar_CashHeldInEscrowIncludedInOtherAssets', window );">Cash held in escrow included in other assets (see note 3)</a></td>
<td class="nump">8,774<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ipar_CashAndCashEquivalentsPerStatementOfCashFlows', window );">Cash and cash equivalents per statement of cash flows</a></td>
<td class="nump">$ 168,387<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ipar_CashAndCashEquivalentsPerStatementOfCashFlows">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash and cash equivalents per statement of cash flows.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ipar_CashAndCashEquivalentsPerStatementOfCashFlows</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ipar_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ipar_CashHeldInEscrowIncludedInOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash held in escrow included in other assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ipar_CashHeldInEscrowIncludedInOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ipar_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ipar_DisclosureReconciliationOfCashAndCashEquivalentsToStatementOfCashFlowsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ipar_DisclosureReconciliationOfCashAndCashEquivalentsToStatementOfCashFlowsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ipar_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsAndShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the customer may deposit additional funds at any time and effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid Investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Short-term investments, exclusive of cash equivalents, generally consist of marketable securities intended to be sold within one year (or the normal operating cycle if longer) and may include trading securities, available-for-sale securities, or held-to-maturity securities (if maturing within one year), as applicable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsAndShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>g082622_10k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2021"
  xmlns:currency="http://xbrl.sec.gov/currency/2021"
  xmlns:dei="http://xbrl.sec.gov/dei/2021q4"
  xmlns:ipar="http://interparfumsinc.com/20211231"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2021-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="ipar-20211231.xsd" xlink:type="simple"/>
    <context id="From2021-01-01to2021-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-02-25">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
        </entity>
        <period>
            <instant>2022-02-25</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="From2020-01-012020-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2018-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2018-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2018-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2018-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_TreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_us-gaap_TreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2018-12-31_us-gaap_TreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2018-12-31_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2018-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_us-gaap_TreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_us-gaap_TreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_us-gaap_TreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_TreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_MontblancMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ipar:MontblancMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_MontblancMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ipar:MontblancMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_custom_MontblancMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ipar:MontblancMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_JimmyChooMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ipar:JimmyChooMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_JimmyChooMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ipar:JimmyChooMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_custom_JimmyChooMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ipar:JimmyChooMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_CoachMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ipar:CoachMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_CoachMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ipar:CoachMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_custom_CoachMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ipar:CoachMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_GUESSMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ipar:GUESSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_GUESSMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ipar:GUESSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_custom_GUESSMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ipar:GUESSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_InterparfumsSASubsidiaryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">ipar:InterparfumsSASubsidiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_MeasurementInputDiscountRateMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_MeasurementInputDiscountRateMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_us-gaap_ShippingAndHandlingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ShippingAndHandlingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_us-gaap_ShippingAndHandlingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ShippingAndHandlingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_us-gaap_ShippingAndHandlingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ShippingAndHandlingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_us-gaap_SalesRevenueNetMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_us-gaap_SalesRevenueNetMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_us-gaap_SalesRevenueNetMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_srt_MinimumMember_us-gaap_LicensingAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_srt_MaximumMember_us-gaap_LicensingAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_InventoryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">ipar:InventoryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_TrademarksMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_OtherAssetMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">ipar:OtherAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_SwissFederalTaxAdministrationFTAMember_currency_EUR_custom_GlobalSettlementAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:SwissFederalTaxAdministrationFTAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">ipar:GlobalSettlementAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_SwissFederalTaxAdministrationFTAMember_custom_GlobalSettlementAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:SwissFederalTaxAdministrationFTAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">ipar:GlobalSettlementAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_currency_EUR">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-31_currency_EUR_us-gaap_SwissFederalTaxAdministrationFTAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:SwissFederalTaxAdministrationFTAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_currency_EUR">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_AnnaSuiCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ipar:AnnaSuiCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_RochasFashionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ipar:RochasFashionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_STDupontMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ipar:STDupontMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_us-gaap_ProductMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_us-gaap_ProductMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_ForeignExchangeContractMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_BuildingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_BuildingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_EquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_EquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_LeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_LeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_IndefinitelivedIntangibleAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:IndefinitelivedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_FiniteLivedIntangibleAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:FiniteLivedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_LicensesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">ipar:LicensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_OtherIntangibleAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_SubtotalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">ipar:SubtotalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_IndefinitelivedIntangibleAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:IndefinitelivedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_FiniteLivedIntangibleAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:FiniteLivedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_LicensesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">ipar:LicensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_OtherIntangibleAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_SubtotalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">ipar:SubtotalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_us-gaap_TrademarksMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_LicensesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">ipar:LicensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_us-gaap_OtherIntangibleAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_us-gaap_IndefinitelivedIntangibleAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:IndefinitelivedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2019-12-31_us-gaap_MeasurementInputDiscountRateMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_DomesticSubsidiariesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ipar:DomesticSubsidiariesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_LondonInterbankOfferedRateMember_custom_DomesticSubsidiariesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">ipar:LondonInterbankOfferedRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ipar:DomesticSubsidiariesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_LondonInterbankOfferedRateMember_custom_DomesticSubsidiariesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">ipar:LondonInterbankOfferedRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ipar:DomesticSubsidiariesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_ForeignSubsidiariesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ipar:ForeignSubsidiariesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_EuroInterbankOfferedRateMembeMember_custom_ForeignSubsidiariesMember_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">ipar:EuroInterbankOfferedRateMembeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ipar:ForeignSubsidiariesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_EuroInterbankOfferedRateMembeMember_custom_ForeignSubsidiariesMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">ipar:EuroInterbankOfferedRateMembeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ipar:ForeignSubsidiariesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_EuroInterbankOfferedRateMembeMember_custom_ForeignSubsidiariesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">ipar:EuroInterbankOfferedRateMembeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ipar:ForeignSubsidiariesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_LoansPayableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_us-gaap_LoansPayableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_LoansPayableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_LoansPayableOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ipar:LoansPayableOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_LoansPayableOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ipar:LoansPayableOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_LoansPayableOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ipar:LoansPayableOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_LoansPayableTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ipar:LoansPayableTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_LoansPayableTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ipar:LoansPayableTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_LoansPayableTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ipar:LoansPayableTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_LoansPayableThreeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ipar:LoansPayableThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_LoansPayableThreeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ipar:LoansPayableThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-04-30_custom_LoansPayableOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ipar:LoansPayableOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-30</instant>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_srt_MinimumMember_us-gaap_StockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_srt_MaximumMember_us-gaap_StockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_us-gaap_StockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_us-gaap_StockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_us-gaap_StockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_StockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_StockOptionOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ipar:StockOptionOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_us-gaap_StockOptionMember39176796">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2018-12-31_custom_InterparfumsSASubsidiaryMember_custom_EmployeesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ipar:InterparfumsSASubsidiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">ipar:EmployeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="AsOf2018-12-31_custom_InterparfumsSASubsidiaryMember_custom_OfficersAndManagersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ipar:InterparfumsSASubsidiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">ipar:OfficersAndManagersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="From2020-03-012020-03-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
        </entity>
        <period>
            <startDate>2020-03-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-03-31_custom_InterparfumsSASubsidiaryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">ipar:InterparfumsSASubsidiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_InterparfumsSASubsidiaryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">ipar:InterparfumsSASubsidiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2019-10-012019-10-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-10-31</endDate>
        </period>
    </context>
    <context id="AsOf2019-10-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
        </entity>
        <period>
            <instant>2019-10-31</instant>
        </period>
    </context>
    <context id="AsOf2021-02-28_srt_BoardOfDirectorsChairmanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-02-28</instant>
        </period>
    </context>
    <context id="AsOf2022-03-31_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_us-gaap_OperatingIncomeLossMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OperatingIncomeLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_us-gaap_OperatingIncomeLossMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OperatingIncomeLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_us-gaap_OperatingIncomeLossMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OperatingIncomeLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-31_srt_MinimumMember_custom_ExercisePriceRangeOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">ipar:ExercisePriceRangeOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_srt_MaximumMember_custom_ExercisePriceRangeOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">ipar:ExercisePriceRangeOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_ExercisePriceRangeOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">ipar:ExercisePriceRangeOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_srt_MaximumMember_custom_ExercisePriceRangeOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">ipar:ExercisePriceRangeOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-31_srt_MinimumMember_custom_ExercisePriceRangeTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">ipar:ExercisePriceRangeTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_srt_MaximumMember_custom_ExercisePriceRangeThreeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">ipar:ExercisePriceRangeThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_ExercisePriceRangeTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">ipar:ExercisePriceRangeTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_ExercisePriceRangeTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">ipar:ExercisePriceRangeTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-31_srt_MinimumMember_custom_ExercisePriceRangeThreeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">ipar:ExercisePriceRangeThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_srt_MaximumMember_custom_ExercisePriceRangeFourMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">ipar:ExercisePriceRangeFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_ExercisePriceRangeThreeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">ipar:ExercisePriceRangeThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_ExercisePriceRangeThreeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">ipar:ExercisePriceRangeThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_ExercisePriceRangeFourMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">ipar:ExercisePriceRangeFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_ExercisePriceRangeFourMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">ipar:ExercisePriceRangeFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_country_US">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_country_US">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_country_US">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_srt_EuropeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_srt_EuropeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_srt_EuropeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_EliminationsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ipar:EliminationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_EliminationsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ipar:EliminationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_custom_EliminationsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ipar:EliminationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-31_country_US">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_country_US">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_country_US">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_srt_EuropeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_srt_EuropeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_srt_EuropeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_EliminationsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ipar:EliminationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_EliminationsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ipar:EliminationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_custom_EliminationsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ipar:EliminationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_srt_NorthAmericaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_srt_NorthAmericaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_srt_NorthAmericaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_EuropeCountryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ipar:EuropeCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_EuropeCountryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ipar:EuropeCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_custom_EuropeCountryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ipar:EuropeCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_srt_AsiaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_srt_AsiaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_srt_AsiaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_us-gaap_MiddleEastMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:MiddleEastMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_us-gaap_MiddleEastMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:MiddleEastMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_us-gaap_MiddleEastMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:MiddleEastMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_CentralAndSouthAmericaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ipar:CentralAndSouthAmericaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_CentralAndSouthAmericaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ipar:CentralAndSouthAmericaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_custom_CentralAndSouthAmericaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ipar:CentralAndSouthAmericaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_OtherSegmentCountryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ipar:OtherSegmentCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_OtherSegmentCountryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ipar:OtherSegmentCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_custom_OtherSegmentCountryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ipar:OtherSegmentCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_UnitedStatesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ipar:UnitedStatesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_UnitedStatesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ipar:UnitedStatesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_custom_UnitedStatesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ipar:UnitedStatesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_FranceMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ipar:FranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_FranceMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ipar:FranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_custom_FranceMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ipar:FranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_RussiaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ipar:RussiaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_RussiaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ipar:RussiaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_custom_RussiaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ipar:RussiaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_UnitedKingdomMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ipar:UnitedKingdomMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_UnitedKingdomMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ipar:UnitedKingdomMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_custom_UnitedKingdomMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ipar:UnitedKingdomMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_ForeignDerivedIntangibleIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ipar:ForeignDerivedIntangibleIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_ForeignDerivedIntangibleIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ipar:ForeignDerivedIntangibleIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_custom_ForeignDerivedIntangibleIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ipar:ForeignDerivedIntangibleIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ipar:AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_custom_AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ipar:AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2018-12-31_custom_AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ipar:AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ipar:AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ipar:AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_custom_AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ipar:AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ipar:AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_AccumulatedTranslationAdjustmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_us-gaap_AccumulatedTranslationAdjustmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2018-12-31_us-gaap_AccumulatedTranslationAdjustmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_us-gaap_AccumulatedTranslationAdjustmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_us-gaap_AccumulatedTranslationAdjustmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_us-gaap_AccumulatedTranslationAdjustmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_AccumulatedTranslationAdjustmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Pure">
        <measure>pure</measure>
    </unit>
    <unit id="N">
        <measure>ipar:Number</measure>
    </unit>
    <unit id="USDEUR">
        <measure>iso4217:EUR</measure>
    </unit>
    <unit id="USDGBP">
        <measure>iso4217:GBP</measure>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2021-01-01to2021-12-31">0000822663</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2021-01-01to2021-12-31">false</dei:AmendmentFlag>
    <dei:DocumentFiscalYearFocus contextRef="From2021-01-01to2021-12-31">2021</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus contextRef="From2021-01-01to2021-12-31">FY</dei:DocumentFiscalPeriodFocus>
    <dei:CurrentFiscalYearEndDate contextRef="From2021-01-01to2021-12-31">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:TradingSymbol contextRef="From2021-01-01to2021-12-31">IPAR</dei:TradingSymbol>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2021-12-31"
      id="xdx2ixbrl0132"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2020-12-31"
      id="xdx2ixbrl0133"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ImpairmentOfLeasehold
      contextRef="From2020-01-012020-12-31"
      id="xdx2ixbrl0205"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ImpairmentOfLeasehold
      contextRef="From2019-01-012019-12-31"
      id="xdx2ixbrl0206"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherIncome
      contextRef="From2019-01-012019-12-31"
      id="xdx2ixbrl0230"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
      contextRef="From2021-01-01to2021-12-31"
      id="xdx2ixbrl0296"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2021-01-012021-12-31_us-gaap_TreasuryStockMember"
      id="xdx2ixbrl0461"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2020-01-012020-12-31_us-gaap_TreasuryStockMember"
      id="xdx2ixbrl0462"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2019-01-012019-12-31_us-gaap_TreasuryStockMember"
      id="xdx2ixbrl0463"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="From2019-01-012019-12-31"
      id="xdx2ixbrl0564"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments
      contextRef="From2021-01-01to2021-12-31"
      id="xdx2ixbrl0630"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments
      contextRef="From2019-01-012019-12-31"
      id="xdx2ixbrl0632"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="From2019-01-012019-12-31"
      id="xdx2ixbrl0648"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PaymentsToMinorityShareholders
      contextRef="From2021-01-01to2021-12-31"
      id="xdx2ixbrl0662"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PaymentsToMinorityShareholders
      contextRef="From2020-01-012020-12-31"
      id="xdx2ixbrl0663"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="From2021-01-012021-12-31_srt_MinimumMember_us-gaap_LicensingAgreementsMember"
      id="xdx2ixbrl0815">P5Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="From2021-01-012021-12-31_srt_MaximumMember_us-gaap_LicensingAgreementsMember"
      id="xdx2ixbrl0817">P15Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetWeightedAveragePeriodBeforeRenewalOrExtension
      contextRef="From2021-01-012021-12-31_srt_MinimumMember_us-gaap_LicensingAgreementsMember"
      id="xdx2ixbrl0819">P1Y</us-gaap:AcquiredFiniteLivedIntangibleAssetWeightedAveragePeriodBeforeRenewalOrExtension>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetWeightedAveragePeriodBeforeRenewalOrExtension
      contextRef="From2021-01-012021-12-31_srt_MaximumMember_us-gaap_LicensingAgreementsMember"
      id="xdx2ixbrl0821">P12Y</us-gaap:AcquiredFiniteLivedIntangibleAssetWeightedAveragePeriodBeforeRenewalOrExtension>
    <us-gaap:InventoryNet
      contextRef="AsOf2021-12-31"
      decimals="-3"
      id="xdx2ixbrl0863"
      unitRef="USD">198914000</us-gaap:InventoryNet>
    <us-gaap:LongTermDebtTerm contextRef="AsOf2021-12-31" id="xdx2ixbrl0880">P10Y</us-gaap:LongTermDebtTerm>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="AsOf2021-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel1Member"
      id="xdx2ixbrl0926"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="AsOf2021-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel3Member"
      id="xdx2ixbrl0928"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ForeignCurrencyFairValueHedgeAssetAtFairValue
      contextRef="AsOf2021-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel1Member"
      id="xdx2ixbrl0936"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ForeignCurrencyFairValueHedgeAssetAtFairValue
      contextRef="AsOf2021-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel3Member"
      id="xdx2ixbrl0938"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue
      contextRef="AsOf2021-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel1Member"
      id="xdx2ixbrl0941"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue
      contextRef="AsOf2021-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel3Member"
      id="xdx2ixbrl0943"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DerivativeLiabilities
      contextRef="AsOf2021-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel1Member"
      id="xdx2ixbrl0946"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DerivativeLiabilities
      contextRef="AsOf2021-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel3Member"
      id="xdx2ixbrl0948"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2021-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel1Member"
      id="xdx2ixbrl0951"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2021-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel3Member"
      id="xdx2ixbrl0953"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="AsOf2020-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel1Member"
      id="xdx2ixbrl0961"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="AsOf2020-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel3Member"
      id="xdx2ixbrl0963"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue
      contextRef="AsOf2020-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel1Member"
      id="xdx2ixbrl0966"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue
      contextRef="AsOf2020-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel3Member"
      id="xdx2ixbrl0968"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2020-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel1Member"
      id="xdx2ixbrl0971"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2020-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel3Member"
      id="xdx2ixbrl0973"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2020-12-31_us-gaap_BuildingMember"
      id="xdx2ixbrl0994"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2021-12-31_us-gaap_IndefinitelivedIntangibleAssetsMember"
      id="xdx2ixbrl1025"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2020-12-31_us-gaap_IndefinitelivedIntangibleAssetsMember"
      id="xdx2ixbrl1044"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="From2021-01-012021-12-31_us-gaap_TrademarksMember"
      id="xdx2ixbrl1068">P8Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="From2021-01-012021-12-31_custom_LicensesMember"
      id="xdx2ixbrl1069">P15Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="From2021-01-012021-12-31_us-gaap_OtherIntangibleAssetsMember"
      id="xdx2ixbrl1070">P2Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="From2021-01-01to2021-12-31" id="xdx2ixbrl1071">P14Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="From2021-01-012021-12-31_srt_MinimumMember"
      id="xdx2ixbrl1086">P3Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="From2021-01-012021-12-31_srt_MaximumMember"
      id="xdx2ixbrl1088">P20Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:LineOfCreditFacilityExpirationDate1
      contextRef="From2021-01-012021-12-31_custom_LondonInterbankOfferedRateMember_custom_DomesticSubsidiariesMember"
      id="xdx2ixbrl1126">2022-12-16</us-gaap:LineOfCreditFacilityExpirationDate1>
    <us-gaap:LongTermDebt
      contextRef="AsOf2020-12-31_us-gaap_LoansPayableMember"
      id="xdx2ixbrl1155"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:LongTermDebt
      contextRef="AsOf2020-12-31_custom_LoansPayableTwoMember"
      id="xdx2ixbrl1170"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:LongTermDebt
      contextRef="AsOf2021-12-31_custom_LoansPayableThreeMember"
      id="xdx2ixbrl1175"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:LongTermDebtCurrent
      contextRef="AsOf2020-12-31"
      decimals="-3"
      id="xdx2ixbrl1182"
      unitRef="USD">14570000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="AsOf2020-12-31"
      decimals="-3"
      id="xdx2ixbrl1185"
      unitRef="USD">10136000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 contextRef="AsOf2021-12-31" id="xdx2ixbrl1199">P6Y1M6D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="From2021-01-012021-12-31_srt_MinimumMember_us-gaap_StockOptionMember"
      id="xdx2ixbrl1263">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="From2021-01-012021-12-31_srt_MaximumMember_us-gaap_StockOptionMember"
      id="xdx2ixbrl1265">P5Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="From2021-01-012021-12-31_us-gaap_StockOptionMember39176796"
      id="xdx2ixbrl1362">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="From2021-01-01to2021-12-31" id="xdx2ixbrl1376">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="From2020-01-012020-12-31" id="xdx2ixbrl1378">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="From2019-01-012019-12-31" id="xdx2ixbrl1380">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
      contextRef="From2021-01-012021-12-31_srt_MaximumMember_custom_ExercisePriceRangeOneMember"
      id="xdx2ixbrl1411">P0Y11M12D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
      contextRef="From2021-01-012021-12-31_custom_ExercisePriceRangeTwoMember"
      id="xdx2ixbrl1417">P1Y11M8D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
      contextRef="From2021-01-012021-12-31_custom_ExercisePriceRangeThreeMember"
      id="xdx2ixbrl1422">P3Y0M11D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
      contextRef="From2021-01-012021-12-31_custom_ExercisePriceRangeFourMember"
      id="xdx2ixbrl1426">P4Y0M0D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2 contextRef="From2021-01-01to2021-12-31" id="xdx2ixbrl1429">P2Y9M0D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      id="xdx2ixbrl1497"
      unitRef="USD">539009000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="AsOf2021-12-31_custom_EliminationsMember"
      id="xdx2ixbrl1600"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      id="xdx2ixbrl1662"
      unitRef="USD">151019000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <ipar:DeferredTaxLiabilitiesBuildingExpenses
      contextRef="AsOf2020-12-31"
      id="xdx2ixbrl1764"
      unitRef="USD"
      xsi:nil="true"/>
    <ipar:DeferredTaxLiabilitiesUnrealizedGainOnMarketableEquitySecurities
      contextRef="AsOf2020-12-31"
      id="xdx2ixbrl1770"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DeferredTaxLiabilitiesOther
      contextRef="AsOf2020-12-31"
      id="xdx2ixbrl1773"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="AsOf2020-12-31_custom_AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember"
      id="xdx2ixbrl1818"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="AsOf2020-12-31_custom_AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember"
      id="xdx2ixbrl1832"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesNet
      contextRef="From2021-01-01to2021-12-31"
      id="xdx2ixbrl1866"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesNet
      contextRef="From2020-01-012020-12-31"
      id="xdx2ixbrl1867"
      unitRef="USD"
      xsi:nil="true"/>
    <dei:DocumentType contextRef="From2021-01-01to2021-12-31">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport contextRef="From2021-01-01to2021-12-31">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate contextRef="From2021-01-01to2021-12-31">2021-12-31</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport contextRef="From2021-01-01to2021-12-31">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber contextRef="From2021-01-01to2021-12-31">0-16469</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="From2021-01-01to2021-12-31">Inter Parfums, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2021-01-01to2021-12-31">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="From2021-01-01to2021-12-31">13-3275609</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2021-01-01to2021-12-31">551 Fifth Avenue</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="From2021-01-01to2021-12-31">New York</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2021-01-01to2021-12-31">NY</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2021-01-01to2021-12-31">10176</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2021-01-01to2021-12-31">212</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2021-01-01to2021-12-31">983.2640</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="From2021-01-01to2021-12-31">Common Stock, $.001 par value per share</dei:Security12bTitle>
    <dei:SecurityExchangeName contextRef="From2021-01-01to2021-12-31">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer contextRef="From2021-01-01to2021-12-31">Yes</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers contextRef="From2021-01-01to2021-12-31">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus contextRef="From2021-01-01to2021-12-31">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="From2021-01-01to2021-12-31">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="From2021-01-01to2021-12-31">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="From2021-01-01to2021-12-31">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="From2021-01-01to2021-12-31">false</dei:EntityEmergingGrowthCompany>
    <dei:IcfrAuditorAttestationFlag contextRef="From2021-01-01to2021-12-31">true</dei:IcfrAuditorAttestationFlag>
    <dei:EntityShellCompany contextRef="From2021-01-01to2021-12-31">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">1274342976</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding contextRef="AsOf2022-02-25" decimals="INF" unitRef="Shares">31842225</dei:EntityCommonStockSharesOutstanding>
    <dei:AuditorFirmId contextRef="From2021-01-01to2021-12-31">339</dei:AuditorFirmId>
    <dei:AuditorName contextRef="From2021-01-01to2021-12-31">Mazars USA LLP</dei:AuditorName>
    <dei:AuditorLocation contextRef="From2021-01-01to2021-12-31">New York</dei:AuditorLocation>
    <us-gaap:CashCashEquivalentsAndShortTermInvestments contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">159613000</us-gaap:CashCashEquivalentsAndShortTermInvestments>
    <us-gaap:CashCashEquivalentsAndShortTermInvestments contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">169681000</us-gaap:CashCashEquivalentsAndShortTermInvestments>
    <us-gaap:ShortTermInvestments contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">160014000</us-gaap:ShortTermInvestments>
    <us-gaap:ShortTermInvestments contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">126627000</us-gaap:ShortTermInvestments>
    <us-gaap:AccountsReceivableNetCurrent contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">159281000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">124057000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">198914000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">158822000</us-gaap:InventoryNet>
    <us-gaap:OtherReceivablesNetCurrent contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">10308000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:OtherReceivablesNetCurrent contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">1815000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:OtherAssetsCurrent contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">21375000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">16912000</us-gaap:OtherAssetsCurrent>
    <us-gaap:IncomeTaxesReceivable contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">210000</us-gaap:IncomeTaxesReceivable>
    <us-gaap:IncomeTaxesReceivable contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">2806000</us-gaap:IncomeTaxesReceivable>
    <us-gaap:AssetsCurrent contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">709715000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">600720000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">149352000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">19580000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">33728000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">24734000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">214047000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">214108000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:DeferredIncomeTaxAssetsNet contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">7936000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">8041000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:OtherAssetsNoncurrent contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">30586000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">22962000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">1145364000</us-gaap:Assets>
    <us-gaap:Assets contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">890145000</us-gaap:Assets>
    <us-gaap:LongTermDebtCurrent contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">15911000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">14570000</us-gaap:LongTermDebtCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">6014000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">5133000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">81980000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">35576000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">136677000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">95629000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:DividendsPayableCurrent contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">4328000</us-gaap:DividendsPayableCurrent>
    <us-gaap:DividendsPayableCurrent contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">5297000</us-gaap:DividendsPayableCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">244910000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">156205000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermDebtNoncurrent contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">132902000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">10136000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">29220000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">21354000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2021-12-31"
      decimals="INF"
      unitRef="USDPShares">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2020-12-31"
      decimals="INF"
      unitRef="USDPShares">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2021-12-31" decimals="INF" unitRef="Shares">1000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2020-12-31" decimals="INF" unitRef="Shares">1000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued contextRef="AsOf2021-12-31" decimals="INF" unitRef="Shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued contextRef="AsOf2020-12-31" decimals="INF" unitRef="Shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2021-12-31"
      decimals="INF"
      unitRef="USDPShares">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2020-12-31"
      decimals="INF"
      unitRef="USDPShares">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2021-12-31" decimals="INF" unitRef="Shares">100000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2020-12-31" decimals="INF" unitRef="Shares">100000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2021-12-31" decimals="INF" unitRef="Shares">31830420</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2020-12-31" decimals="INF" unitRef="Shares">31608588</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">32000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">32000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">87132000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">75708000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">560663000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">503567000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">-38432000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">-5997000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:TreasuryStockShares contextRef="AsOf2021-12-31" decimals="INF" unitRef="Shares">9864805</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockShares contextRef="AsOf2020-12-31" decimals="INF" unitRef="Shares">9864805</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockValue contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">37475000</us-gaap:TreasuryStockValue>
    <us-gaap:TreasuryStockValue contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">37475000</us-gaap:TreasuryStockValue>
    <us-gaap:StockholdersEquity contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">571920000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">535835000</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">166412000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">166615000</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">738332000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">702450000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">1145364000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">890145000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="USD">879516000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">539009000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="USD">713514000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="USD">322614000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">208278000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="USD">267578000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:GrossProfit
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="USD">556902000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">330731000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="USD">445936000</us-gaap:GrossProfit>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="USD">406459000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">260648000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="USD">341209000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:ImpairmentOfLeasehold
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="USD">2393000</us-gaap:ImpairmentOfLeasehold>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="USD">148050000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">70083000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="USD">104727000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestExpense
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="USD">2825000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">1970000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="USD">2146000</us-gaap:InterestExpense>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="USD">2338000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">-2178000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="USD">-1128000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="USD">3403000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">2865000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="USD">3693000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:OtherIncome
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="USD">53000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">549000</us-gaap:OtherIncome>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="USD">2969000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">-734000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="USD">419000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="USD">151019000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">69349000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="USD">105146000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="USD">40992000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">19381000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="USD">29076000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ProfitLoss
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="USD">110027000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">49968000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="USD">76070000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="USD">22616000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">11749000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="USD">15821000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="USD">87411000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">38219000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="USD">60249000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2021-01-01to2021-12-31"
      decimals="INF"
      unitRef="USDPShares">2.76</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2020-01-012020-12-31"
      decimals="INF"
      unitRef="USDPShares">1.21</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2019-01-012019-12-31"
      decimals="INF"
      unitRef="USDPShares">1.92</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2021-01-01to2021-12-31"
      decimals="INF"
      unitRef="USDPShares">2.75</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2020-01-012020-12-31"
      decimals="INF"
      unitRef="USDPShares">1.21</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2019-01-012019-12-31"
      decimals="INF"
      unitRef="USDPShares">1.90</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2021-01-01to2021-12-31"
      decimals="INF"
      unitRef="Shares">31676796</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2020-01-012020-12-31"
      decimals="INF"
      unitRef="Shares">31536659</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2019-01-012019-12-31"
      decimals="INF"
      unitRef="Shares">31451093</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2021-01-01to2021-12-31"
      decimals="INF"
      unitRef="Shares">31835408</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2020-01-012020-12-31"
      decimals="INF"
      unitRef="Shares">31654544</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2019-01-012019-12-31"
      decimals="INF"
      unitRef="Shares">31688700</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="From2021-01-01to2021-12-31"
      decimals="INF"
      unitRef="USDPShares">1.00</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="From2020-01-012020-12-31"
      decimals="INF"
      unitRef="USDPShares">0.33</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="From2019-01-012019-12-31"
      decimals="INF"
      unitRef="USDPShares">1.16</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:ProfitLoss
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="USD">110027000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">49968000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="USD">76070000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="USD">-1367000</us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">-19000</us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="USD">22000</us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">-52000</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="USD">-136000</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="USD">-42967000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">47912000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="USD">-8712000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTax
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="USD">-44334000</us-gaap:OtherComprehensiveIncomeLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTax
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">47841000</us-gaap:OtherComprehensiveIncomeLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTax
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="USD">-8826000</us-gaap:OtherComprehensiveIncomeLossBeforeTax>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="USD">65693000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">97809000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="USD">67244000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="USD">22616000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">11749000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="USD">15821000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="USD">-375000</us-gaap:OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">-19000</us-gaap:OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="USD">-30000</us-gaap:OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="USD">-11524000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">14004000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="USD">-2593000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="USD">10717000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">25734000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="USD">13198000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="USD">54976000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">72075000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="USD">54046000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2020-12-31_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="USD">32000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2019-12-31_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="USD">31000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2018-12-31_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="USD">31000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2021-01-012021-12-31_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2020-01-012020-12-31_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="USD">1000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2019-01-012019-12-31_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2021-12-31_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="USD">32000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2020-12-31_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="USD">32000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2019-12-31_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="USD">31000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2020-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      unitRef="USD">75708000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2019-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      unitRef="USD">70664000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2018-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      unitRef="USD">69970000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2021-01-012021-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      unitRef="USD">5393000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2020-01-012020-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      unitRef="USD">2771000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2019-01-012019-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      unitRef="USD">4458000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2021-01-012021-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      unitRef="USD">1566000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2020-01-012020-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      unitRef="USD">1711000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2019-01-012019-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      unitRef="USD">1403000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
      contextRef="From2021-01-012021-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      unitRef="USD">-0</us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance>
    <us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
      contextRef="From2020-01-012020-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      unitRef="USD">-0</us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance>
    <us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
      contextRef="From2019-01-012019-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      unitRef="USD">5167000</us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="From2021-01-012021-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      unitRef="USD">5000000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="From2020-01-012020-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="From2020-01-012020-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <ipar:TransferOfSubsidiarySharesPurchasedToTreasuryShares
      contextRef="From2021-01-012021-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      unitRef="USD">-535000</ipar:TransferOfSubsidiarySharesPurchasedToTreasuryShares>
    <ipar:TransferOfSubsidiarySharesPurchasedToTreasuryShares
      contextRef="From2020-01-012020-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      unitRef="USD">562000</ipar:TransferOfSubsidiarySharesPurchasedToTreasuryShares>
    <ipar:TransferOfSubsidiarySharesPurchasedToTreasuryShares
      contextRef="From2019-01-012019-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      unitRef="USD">0</ipar:TransferOfSubsidiarySharesPurchasedToTreasuryShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2021-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      unitRef="USD">87132000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2020-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      unitRef="USD">75708000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2019-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      unitRef="USD">70664000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2020-12-31_us-gaap_RetainedEarningsMember"
      decimals="-3"
      unitRef="USD">503567000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2019-12-31_us-gaap_RetainedEarningsMember"
      decimals="-3"
      unitRef="USD">474637000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2018-12-31_us-gaap_RetainedEarningsMember"
      decimals="-3"
      unitRef="USD">448731000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="From2021-01-012021-12-31_us-gaap_RetainedEarningsMember"
      decimals="-3"
      unitRef="USD">87411000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2020-01-012020-12-31_us-gaap_RetainedEarningsMember"
      decimals="-3"
      unitRef="USD">38219000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2019-01-012019-12-31_us-gaap_RetainedEarningsMember"
      decimals="-3"
      unitRef="USD">60249000</us-gaap:ProfitLoss>
    <us-gaap:DividendsCash
      contextRef="From2021-01-012021-12-31_us-gaap_RetainedEarningsMember"
      decimals="-3"
      unitRef="USD">31690000</us-gaap:DividendsCash>
    <us-gaap:DividendsCash
      contextRef="From2020-01-012020-12-31_us-gaap_RetainedEarningsMember"
      decimals="-3"
      unitRef="USD">10406000</us-gaap:DividendsCash>
    <us-gaap:DividendsCash
      contextRef="From2019-01-012019-12-31_us-gaap_RetainedEarningsMember"
      decimals="-3"
      unitRef="USD">36349000</us-gaap:DividendsCash>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2021-01-012021-12-31_us-gaap_RetainedEarningsMember"
      decimals="-3"
      unitRef="USD">1375000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2020-01-012020-12-31_us-gaap_RetainedEarningsMember"
      decimals="-3"
      unitRef="USD">1117000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2019-01-012019-12-31_us-gaap_RetainedEarningsMember"
      decimals="-3"
      unitRef="USD">2006000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2021-12-31_us-gaap_RetainedEarningsMember"
      decimals="-3"
      unitRef="USD">560663000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2020-12-31_us-gaap_RetainedEarningsMember"
      decimals="-3"
      unitRef="USD">503567000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2019-12-31_us-gaap_RetainedEarningsMember"
      decimals="-3"
      unitRef="USD">474637000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2020-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      unitRef="USD">-5997000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2019-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      unitRef="USD">-39853000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2018-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      unitRef="USD">-33650000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax
      contextRef="From2021-01-012021-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      unitRef="USD">-31443000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax
      contextRef="From2020-01-012020-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      unitRef="USD">33908000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax
      contextRef="From2019-01-012019-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      unitRef="USD">-6119000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax
      contextRef="From2021-01-012021-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      unitRef="USD">0</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax
      contextRef="From2020-01-012020-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      unitRef="USD">-52000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax
      contextRef="From2019-01-012019-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      unitRef="USD">-136000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax>
    <us-gaap:OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="From2021-01-012021-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      unitRef="USD">-992000</us-gaap:OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="From2020-01-012020-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      unitRef="USD">0</us-gaap:OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="From2019-01-012019-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      unitRef="USD">52000</us-gaap:OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2021-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      unitRef="USD">-38432000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2020-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      unitRef="USD">-5997000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2019-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      unitRef="USD">-39853000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2020-12-31_us-gaap_TreasuryStockMember"
      decimals="-3"
      unitRef="USD">-37475000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2019-12-31_us-gaap_TreasuryStockMember"
      decimals="-3"
      unitRef="USD">-37475000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2018-12-31_us-gaap_TreasuryStockMember"
      decimals="-3"
      unitRef="USD">-37475000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2021-12-31_us-gaap_TreasuryStockMember"
      decimals="-3"
      unitRef="USD">-37475000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2020-12-31_us-gaap_TreasuryStockMember"
      decimals="-3"
      unitRef="USD">-37475000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2019-12-31_us-gaap_TreasuryStockMember"
      decimals="-3"
      unitRef="USD">-37475000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2020-12-31_us-gaap_NoncontrollingInterestMember"
      decimals="-3"
      unitRef="USD">166615000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2019-12-31_us-gaap_NoncontrollingInterestMember"
      decimals="-3"
      unitRef="USD">140994000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2018-12-31_us-gaap_NoncontrollingInterestMember"
      decimals="-3"
      unitRef="USD">138139000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="From2021-01-012021-12-31_us-gaap_NoncontrollingInterestMember"
      decimals="-3"
      unitRef="USD">22616000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2020-01-012020-12-31_us-gaap_NoncontrollingInterestMember"
      decimals="-3"
      unitRef="USD">11749000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2019-01-012019-12-31_us-gaap_NoncontrollingInterestMember"
      decimals="-3"
      unitRef="USD">15821000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax
      contextRef="From2021-01-012021-12-31_us-gaap_NoncontrollingInterestMember"
      decimals="-3"
      unitRef="USD">-11524000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax
      contextRef="From2020-01-012020-12-31_us-gaap_NoncontrollingInterestMember"
      decimals="-3"
      unitRef="USD">14004000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax
      contextRef="From2019-01-012019-12-31_us-gaap_NoncontrollingInterestMember"
      decimals="-3"
      unitRef="USD">-2593000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax>
    <us-gaap:OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="From2021-01-012021-12-31_us-gaap_NoncontrollingInterestMember"
      decimals="-3"
      unitRef="USD">-375000</us-gaap:OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="From2020-01-012020-12-31_us-gaap_NoncontrollingInterestMember"
      decimals="-3"
      unitRef="USD">-19000</us-gaap:OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="From2019-01-012019-12-31_us-gaap_NoncontrollingInterestMember"
      decimals="-3"
      unitRef="USD">-30000</us-gaap:OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
      contextRef="From2021-01-012021-12-31_us-gaap_NoncontrollingInterestMember"
      decimals="-3"
      unitRef="USD">-0</us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance>
    <us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
      contextRef="From2020-01-012020-12-31_us-gaap_NoncontrollingInterestMember"
      decimals="-3"
      unitRef="USD">-0</us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance>
    <us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
      contextRef="From2019-01-012019-12-31_us-gaap_NoncontrollingInterestMember"
      decimals="-3"
      unitRef="USD">920000</us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance>
    <us-gaap:DividendsCash
      contextRef="From2021-01-012021-12-31_us-gaap_NoncontrollingInterestMember"
      decimals="-3"
      unitRef="USD">9836000</us-gaap:DividendsCash>
    <us-gaap:DividendsCash
      contextRef="From2020-01-012020-12-31_us-gaap_NoncontrollingInterestMember"
      decimals="-3"
      unitRef="USD">324000</us-gaap:DividendsCash>
    <us-gaap:DividendsCash
      contextRef="From2019-01-012019-12-31_us-gaap_NoncontrollingInterestMember"
      decimals="-3"
      unitRef="USD">9654000</us-gaap:DividendsCash>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2021-01-012021-12-31_us-gaap_NoncontrollingInterestMember"
      decimals="-3"
      unitRef="USD">-293000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2020-01-012020-12-31_us-gaap_NoncontrollingInterestMember"
      decimals="-3"
      unitRef="USD">350000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2019-01-012019-12-31_us-gaap_NoncontrollingInterestMember"
      decimals="-3"
      unitRef="USD">231000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <ipar:TransferOfSubsidiarySharesPurchasedToTreasuryShares
      contextRef="From2021-01-012021-12-31_us-gaap_NoncontrollingInterestMember"
      decimals="-3"
      unitRef="USD">-791000</ipar:TransferOfSubsidiarySharesPurchasedToTreasuryShares>
    <ipar:TransferOfSubsidiarySharesPurchasedToTreasuryShares
      contextRef="From2020-01-012020-12-31_us-gaap_NoncontrollingInterestMember"
      decimals="-3"
      unitRef="USD">-139000</ipar:TransferOfSubsidiarySharesPurchasedToTreasuryShares>
    <ipar:TransferOfSubsidiarySharesPurchasedToTreasuryShares
      contextRef="From2019-01-012019-12-31_us-gaap_NoncontrollingInterestMember"
      decimals="-3"
      unitRef="USD">0</ipar:TransferOfSubsidiarySharesPurchasedToTreasuryShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2021-12-31_us-gaap_NoncontrollingInterestMember"
      decimals="-3"
      unitRef="USD">166412000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2020-12-31_us-gaap_NoncontrollingInterestMember"
      decimals="-3"
      unitRef="USD">166615000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2019-12-31_us-gaap_NoncontrollingInterestMember"
      decimals="-3"
      unitRef="USD">140994000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">702450000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2019-12-31" decimals="-3" unitRef="USD">608998000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2018-12-31" decimals="-3" unitRef="USD">585746000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="USD">110027000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">49968000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="USD">76070000</us-gaap:ProfitLoss>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">738332000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">702450000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2019-12-31" decimals="-3" unitRef="USD">608998000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="USD">110027000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">49968000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="USD">76070000</us-gaap:ProfitLoss>
    <us-gaap:OtherDepreciationAndAmortization
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="USD">12698000</us-gaap:OtherDepreciationAndAmortization>
    <us-gaap:OtherDepreciationAndAmortization
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">9067000</us-gaap:OtherDepreciationAndAmortization>
    <us-gaap:OtherDepreciationAndAmortization
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="USD">8729000</us-gaap:OtherDepreciationAndAmortization>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="USD">853000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">4824000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="USD">1380000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ShareBasedCompensation
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="USD">2853000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">3029000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="USD">3394000</us-gaap:ShareBasedCompensation>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="USD">53000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">549000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:OperatingLeaseImpairmentLoss
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="USD">7302000</us-gaap:OperatingLeaseImpairmentLoss>
    <us-gaap:OperatingLeaseImpairmentLoss
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">5483000</us-gaap:OperatingLeaseImpairmentLoss>
    <us-gaap:OperatingLeaseImpairmentLoss
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="USD">6021000</us-gaap:OperatingLeaseImpairmentLoss>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="USD">-465000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">581000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="USD">-2330000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:UnrealizedGainLossOnDerivatives
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="USD">-65000</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:UnrealizedGainLossOnDerivatives
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">137000</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:UnrealizedGainLossOnDerivatives
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="USD">169000</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="USD">45395000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">-13157000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="USD">-1124000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="USD">49815000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">-19333000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="USD">5925000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="USD">16725000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">-1176000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="USD">4945000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="USD">-7503000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">-5421000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="USD">-4953000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="USD">103046000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">-32239000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="USD">-4960000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedTaxesPayable
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="USD">2698000</us-gaap:IncreaseDecreaseInAccruedTaxesPayable>
    <us-gaap:IncreaseDecreaseInAccruedTaxesPayable
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">-3279000</us-gaap:IncreaseDecreaseInAccruedTaxesPayable>
    <us-gaap:IncreaseDecreaseInAccruedTaxesPayable
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="USD">3016000</us-gaap:IncreaseDecreaseInAccruedTaxesPayable>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="USD">119586000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">64993000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="USD">76452000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireShortTermInvestments
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="USD">55691000</us-gaap:PaymentsToAcquireShortTermInvestments>
    <us-gaap:PaymentsToAcquireShortTermInvestments
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">7582000</us-gaap:PaymentsToAcquireShortTermInvestments>
    <us-gaap:PaymentsToAcquireShortTermInvestments
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="USD">97958000</us-gaap:PaymentsToAcquireShortTermInvestments>
    <us-gaap:ProceedsFromSaleOfShortTermInvestments
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="USD">10644000</us-gaap:ProceedsFromSaleOfShortTermInvestments>
    <us-gaap:ProceedsFromSaleOfShortTermInvestments
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">11513000</us-gaap:ProceedsFromSaleOfShortTermInvestments>
    <us-gaap:ProceedsFromSaleOfShortTermInvestments
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="USD">44814000</us-gaap:ProceedsFromSaleOfShortTermInvestments>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="USD">141274000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">11011000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="USD">5427000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireIntangibleAssets
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="USD">1545000</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:PaymentsToAcquireIntangibleAssets
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">1251000</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:PaymentsToAcquireIntangibleAssets
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="USD">6067000</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">13998000</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="USD">-187866000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">-22329000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="USD">-64638000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="USD">43056000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">13725000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="USD">22321000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="USD">157382000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">13438000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="USD">5393000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">2771000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="USD">4458000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="USD">31690000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">20805000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="USD">34579000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:PaymentsOfDividendsMinorityInterest
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="USD">9836000</us-gaap:PaymentsOfDividendsMinorityInterest>
    <us-gaap:PaymentsOfDividendsMinorityInterest
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">324000</us-gaap:PaymentsOfDividendsMinorityInterest>
    <us-gaap:PaymentsOfDividendsMinorityInterest
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="USD">9654000</us-gaap:PaymentsOfDividendsMinorityInterest>
    <us-gaap:PaymentsToMinorityShareholders
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="USD">6087000</us-gaap:PaymentsToMinorityShareholders>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="USD">78193000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">-18645000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="USD">-68183000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="USD">-11207000</us-gaap:EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations>
    <us-gaap:EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">12245000</us-gaap:EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations>
    <us-gaap:EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="USD">-3350000</us-gaap:EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="USD">-1294000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">36264000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="USD">-59719000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">169681000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2019-12-31" decimals="-3" unitRef="USD">133417000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2018-12-31" decimals="-3" unitRef="USD">193136000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">168387000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">169681000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2019-12-31" decimals="-3" unitRef="USD">133417000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:InterestPaidNet
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="USD">2468000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">1105000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="USD">1764000</us-gaap:InterestPaidNet>
    <us-gaap:IncomeTaxesPaid
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="USD">40497000</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">21772000</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="USD">26332000</us-gaap:IncomeTaxesPaid>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_80C_eus-gaap--SignificantAccountingPoliciesTextBlock_zEvmGVxK25Pf" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.5in; text-align: left"&gt;&lt;b&gt;(1)&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_827_zu7dtXIuY5Nk"&gt;The Company and its Significant Accounting Policies&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_84F_eus-gaap--BusinessDescriptionAndAccountingPoliciesTextBlock_zaqQ1CrlHMM9" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&lt;span id="xdx_867_zFeuUXnmqXK2"&gt;Business of the Company&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Inter Parfums, Inc. and its subsidiaries
(the &#x201c;Company&#x201d;) are in the fragrance business and manufacture and distribute a wide array of fragrances and fragrance
related products.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_899_eus-gaap--SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_zpcXTUGeaJk8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Substantially all of our prestige
fragrance brands are licensed from unaffiliated third parties, and our business is dependent upon the continuation and renewal
of such licenses. &lt;span&gt;With respect to the Company&#x2019;s largest brands, we license the Montblanc, Jimmy Choo, Coach and GUESS brand
names. As a percentage of net sales, product sales for the Company&#x2019;s largest brands were as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;span id="xdx_8BB_zLfZsxXUNYea" style="display: none; visibility: hidden"&gt;Schedule of lanvin brand name for our class&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Year Ended December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2019&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 55%"&gt;Montblanc&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--MontblancMember_zYQdpsEiMHBc" style="width: 12%; text-align: right" title="Concentration risk percentage"&gt;19&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20200101__20201231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--MontblancMember_zByVvYIo3wEk" style="width: 12%; text-align: right"&gt;21&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20190101__20191231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--MontblancMember_z8jeCKYz1uF1" style="width: 12%; text-align: right" title="Concentration risk percentage"&gt;22&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Jimmy Choo&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--JimmyChooMember_zQprf6WWuqpb" style="text-align: right"&gt;18&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20200101__20201231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--JimmyChooMember_zS5aVrWrtb99" style="text-align: right" title="Concentration risk percentage"&gt;16&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20190101__20191231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--JimmyChooMember_zKh8Vx48zKxg" style="text-align: right"&gt;16&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Coach&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--CoachMember_zz272R6gNMCg" style="text-align: right"&gt;16&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20200101__20201231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--CoachMember_zoFqBpv49ldh" style="text-align: right"&gt;17&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20190101__20191231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--CoachMember_z8tyQcKDn2p3" style="text-align: right"&gt;14&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;GUESS&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--GUESSMember_zjFmBtriPnHe" style="text-align: right"&gt;12&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20200101__20201231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--GUESSMember_zs5yKA1qgED6" style="text-align: right"&gt;11&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20190101__20191231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--GUESSMember_zFSzsWYUIFY7" style="text-align: right"&gt;10&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8AB_zhfDGbBby8R8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;No other brand represented 10%
or more of consolidated net sales.&lt;/p&gt;

&lt;p id="xdx_85B_z1C2HfixVkl3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_84E_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zFBXQNTiBWB1" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&lt;span id="xdx_864_zsDymlX0yt0e"&gt;Basis of Preparation&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-size: 10pt; color: windowtext"&gt;The
consolidated financial statements include the accounts of the Company and its subsidiaries, including &lt;span id="xdx_903_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_uPure_c20211231__srt--OwnershipAxis__custom--InterparfumsSASubsidiaryMember_zI2O3snRjMKg" title="Ownership percentage in Interparfums SA"&gt;73&lt;/span&gt;% owned Interparfums SA,
a subsidiary whose stock is publicly traded in France.&lt;/span&gt; &lt;span style="font-size: 10pt"&gt;All material intercompany balances
and transactions have been eliminated&lt;/span&gt;.&lt;/p&gt;

&lt;p id="xdx_85F_zTX5GZVARaz9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_84D_eus-gaap--UseOfEstimates_zbo5NVG30hw9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_862_zrUMUeldlUT8"&gt;Management Estimates&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Management makes assumptions
and estimates to prepare financial statements in conformity with accounting principles generally accepted in the United States
of America. Those assumptions and estimates directly affect the amounts reported and disclosures included in the consolidated financial
statements. Actual results could differ from those assumptions and estimates. Significant estimates for which changes in the near
term are considered reasonably possible and that may have a material impact on the financial statements are disclosed in these
notes to the consolidated financial statements.&lt;/p&gt;

&lt;p id="xdx_853_z7CEYu4MNqR3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_846_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_zE5MUTGyRm4c" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&lt;span id="xdx_86C_z28ilshIsQI2"&gt;Foreign Currency Translation&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;For foreign subsidiaries with
operations denominated in a foreign currency, assets and liabilities are translated to U.S. dollars at year-end exchange rates.
Income and expense items are translated at average rates of exchange prevailing during the year. Gains and losses from translation
adjustments are accumulated in a separate component of shareholders&#x2019; equity.&lt;/p&gt;

&lt;p id="xdx_858_z96YMstlJoXj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_844_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zEpMocWzPs56" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&lt;span id="xdx_86B_zCDC3UyqFj93"&gt;Cash and Cash Equivalents
and Short-Term Investments&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;All highly liquid investments
purchased with a maturity of three months or less are considered to be cash equivalents. The Company also has short-term investments
which consist of certificates of deposit and other contracts with maturities greater than three months and available for sale marketable
equity securities. The Company monitors concentrations of credit risk associated with financial institutions with which the Company
conducts significant business. The Company believes its credit risk is minimal, as the Company primarily conducts business with
large, well-established financial institutions. Substantially all cash and cash equivalents are primarily held at financial institutions
outside the United States and are readily convertible into U.S. dollars.&lt;/p&gt;

&lt;p id="xdx_857_z1JRNnU1Mkqb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;













&lt;p id="xdx_84F_eus-gaap--TradeAndOtherAccountsReceivablePolicy_zOX5N7CtF7sa" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&lt;span id="xdx_86C_zRrOsXXviwH7"&gt;Accounts Receivable&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Accounts receivable represent
payments due to the Company for previously recognized net sales, reduced by allowances for doubtful accounts or balances which
are estimated to be uncollectible, which aggregated $&lt;span id="xdx_908_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_dm_c20211231_zIjlU4KCWMod" title="Allowances for sales returns and doubtful accounts"&gt;2.2 million&lt;/span&gt; and $&lt;span id="xdx_907_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_dm_c20201231_zsvFPBrg2MW8" title="Allowances for sales returns and doubtful accounts"&gt;5.5 million&lt;/span&gt; as of December 31, 2021 and 2020, respectively.
Accounts receivable balances are written-off against the allowance for doubtful accounts when they become uncollectible. Recoveries
of accounts receivable previously recorded against the allowance are recorded in the consolidated statement of income when received.
We generally grant credit based upon our analysis of the customer&#x2019;s financial position, as well as previously established
buying patterns.&lt;/p&gt;

&lt;p id="xdx_853_zDGbMdHX287h" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_84F_eus-gaap--InventoryPolicyTextBlock_ztbdawIs4OD2" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&lt;span id="xdx_86C_zNu6STEIHY4i"&gt;Inventories&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Inventories, including promotional
merchandise, only include inventory considered saleable or usable in future periods, and are stated at the lower of cost and net
realizable value, with cost being determined on the first-in, first-out method.&#160;Cost components include raw materials, direct
labor and overhead (e.g., indirect labor, utilities, depreciation, purchasing, receiving, inspection and warehousing) as well as
inbound freight.&#160;Promotional merchandise is charged to cost of sales at the time the merchandise is shipped to the Company&#x2019;s
customers.&lt;/p&gt;

&lt;p id="xdx_858_z9K5muEB1wti" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_84A_eus-gaap--DerivativesPolicyTextBlock_z9baj96Z3Uch" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&lt;span id="xdx_865_zEB0CQ2uqAGl"&gt;Derivatives&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;All derivative instruments are
recorded as either assets or liabilities and measured at fair value. The Company uses derivative instruments to principally manage
a variety of market risks. For derivatives designated as hedges of the exposure to changes in fair value of the recognized asset
or liability or a firm commitment (referred to as fair value hedges), the gain or loss is recognized in earnings in the period
of change together with the offsetting loss or gain on the hedged item attributable to the risk being hedged. The effect of that
accounting is to include in earnings the extent to which the hedge is not effective in achieving offsetting changes in fair value.
For cash flow hedges, the effective portion of the derivative&#x2019;s gain or loss is initially reported in equity (as a component
of accumulated other comprehensive income) and is subsequently reclassified into earnings in the same period or periods during
which the hedged forecasted transaction affects earnings. The ineffective portion of the gain or loss of a cash flow hedge is reported
in earnings immediately. The Company also holds certain instruments for economic purposes that are not designated for hedge accounting
treatment. For these derivative instruments, changes in their fair value are recorded in earnings immediately.&lt;/p&gt;

&lt;p id="xdx_85F_zBTh2OukoYF5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_84E_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zxLXxkQD6l59" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&lt;span id="xdx_862_ziePjxIBxEIi"&gt;Property, Equipment
and Leasehold Improvements&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Property, equipment and leasehold
improvements are stated at cost less accumulated depreciation and amortization. Depreciation and amortization are provided using
the straight-line method over the estimated useful lives for equipment, which range between three and ten&#160;years and the shorter
of the lease term or estimated useful asset lives for leasehold improvements. Depreciation has not yet begun on property recently
purchased, as it has not yet been put into service. Depreciation provided on equipment used to produce inventory, such as tools
and molds, is included in cost of sales.&lt;/p&gt;

&lt;p id="xdx_851_zsl94Ssv1Lp8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

















&lt;p id="xdx_84B_eus-gaap--GoodwillAndIntangibleAssetsPolicyTextBlock_zMLyGXt7t8gg" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&lt;span id="xdx_86B_zh41q5d3MFDh"&gt;Long-Lived Assets&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Indefinite-lived intangible assets
principally consist of trademarks which are not amortized. The Company evaluates indefinite-lived intangible assets for impairment
at least annually during the fourth quarter, or more frequently when events occur or circumstances change, such as an unexpected
decline in sales, that would more-likely-than-not indicate that the carrying value of an indefinite-lived intangible asset may
not be recoverable. When testing indefinite-lived intangible assets for impairment, the evaluation requires a comparison of the
estimated fair value of the asset to the carrying value of the asset. The fair values used in our evaluations are estimated based
upon discounted future cash flow projections using a weighted average cost of capital of &lt;span id="xdx_905_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_uPure_c20211231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountRateMember_zjI95Q9b1fGj" title="Weighted average cost of capital"&gt;7.47&lt;/span&gt;% and &lt;span id="xdx_906_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_uPure_c20201231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountRateMember_zitEfXDLlzZj" title="Weighted average cost of capital"&gt;6.99&lt;/span&gt;% in 2021 and 2020, respectively.
The cash flow projections are based upon a number of assumptions, including future sales levels, future cost of goods and operating
expense levels, as well as economic conditions, changes to our business model or changes in consumer acceptance of our products
which are more subjective in nature. If the carrying value of an indefinite-lived intangible asset exceeds its fair value, an impairment
charge is recorded.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Intangible assets subject to
amortization are evaluated for impairment testing whenever events or changes in circumstances indicate that the carrying amount
of an amortizable intangible asset may not be recoverable. If impairment indicators exist for an amortizable intangible asset,
the undiscounted future cash flows associated with the expected service potential of the asset are compared to the carrying value
of the asset. If our projection of undiscounted future cash flows is in excess of the carrying value of the intangible asset, no
impairment charge is recorded. If our projection of undiscounted future cash flows is less than the carrying value of the intangible
asset, an impairment charge would be recorded to reduce the intangible asset to its fair value.&lt;/p&gt;

&lt;p id="xdx_859_zvbVB95ePOC6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_846_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_ztLcWRB1tRh4" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&lt;span id="xdx_868_zDcPDuMSob3a"&gt;Revenue Recognition&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Company sells its products
to department stores, perfumeries, specialty stores and domestic and international wholesalers and distributors. Our revenue contracts
represent single performance obligations to sell our products to customers. Sales of such products by our domestic subsidiaries
are denominated in U.S. dollars, and sales of such products by our foreign subsidiaries are primarily denominated in either euro
or U.S. dollars. The Company recognizes revenues when contract terms are met, the price is fixed and determinable, collectability
is reasonably assured, and control of the assets has passed to the customer based on the agreed upon shipping terms. Net sales
are comprised of gross revenues less returns, trade discounts and allowances. The Company does not bill its customers&#x2019; freight
and handling charges. All shipping and handling costs, which aggregated $&lt;span id="xdx_903_eus-gaap--CostOfGoodsAndServicesSold_dm_c20210101__20211231__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_z7kiNCO2jrZd" title="Shipping and handling costs"&gt;10.1 million&lt;/span&gt;, $&lt;span id="xdx_901_eus-gaap--CostOfGoodsAndServicesSold_dm_c20200101__20201231__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_zYpnjFOqQbrf" title="Shipping and handling costs"&gt;5.0 million&lt;/span&gt; and $&lt;span id="xdx_907_eus-gaap--CostOfGoodsAndServicesSold_dm_c20190101__20191231__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_zbv06j8IAt58" title="Shipping and handling costs"&gt;7.7 million&lt;/span&gt; in 2021, 2020
and 2019, respectively, are included in selling, general and administrative expenses in the consolidated statements of income.
The Company grants credit to all qualified customers and does not believe it is exposed significantly to any undue concentration
of credit risk. No one customer represented &lt;span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember_zoLUvQ3mRx5b" title="Concentration risk percentage"&gt;&lt;span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20200101__20201231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember_zhfXNG5EgFo" title="Concentration risk percentage"&gt;&lt;span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20190101__20191231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember_zyOX9TezhAsb" title="Concentration risk percentage"&gt;10&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;% or more of net sales in 2021, 2020 or 2019.&lt;/p&gt;

&lt;p id="xdx_857_zyMuc9mPqZY7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_842_eus-gaap--RevenueRecognitionSalesReturns_zRzspxwoKQok" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86A_z8xvPmwjEzX2"&gt;Sales Returns&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Generally, the Company does not
permit customers to return their unsold products. However, for U.S. based customers, we allow returns if properly requested, authorized
and approved. The Company regularly reviews and revises, as deemed necessary, its estimate of reserves for future sales returns
based primarily upon historic trends and relevant current data including information provided by retailers regarding their inventory
levels. In addition, as necessary, specific accruals may be established for significant future known or anticipated events. The
types of known or anticipated events that we consider include, but are not limited to, the financial condition of our customers,
store closings by retailers, changes in the retail environment and our decision to continue to support new and existing products.
The Company records its estimate of potential sales returns as a reduction of sales and cost of sales with corresponding entries
to accrued expenses, to record the refund liability, and inventory, for the right to recover goods from the customer. The refund
liability associated with estimated returns was $&lt;span id="xdx_908_eus-gaap--ContractWithCustomerRefundLiability_iI_dm_c20211231_znyf5BtratH3" title="Contract with customer, refund liability"&gt;5.1 million&lt;/span&gt; and $&lt;span id="xdx_90C_eus-gaap--ContractWithCustomerRefundLiability_iI_dm_c20201231_zRetSX8A8Xf2" title="Contract with customer, refund liability"&gt;3.6 million&lt;/span&gt; at December 31, 2021 and 2020, respectively, and
the amounts recognized for the rights to recover products was $&lt;span id="xdx_901_eus-gaap--ContractWithCustomerRightToRecoverProduct_iI_dm_c20211231_zeBEEVsuiDj8" title="Contract with customer, right to recover products"&gt;1.9 million&lt;/span&gt; and $&lt;span id="xdx_907_eus-gaap--ContractWithCustomerRightToRecoverProduct_iI_dm_c20201231_z0jjHn77u3ra" title="Contract with customer, right to recover products"&gt;1.4 million&lt;/span&gt; at December 31, 2021 and 2020, respectively.
The physical condition and marketability of returned products are the major factors we consider in estimating realizable value.
Actual returns, as well as estimated realizable values of returned products, may differ significantly, either favorably or unfavorably,
from our estimates, if factors such as economic conditions, inventory levels or competitive conditions differ from our expectations.&lt;/p&gt;

&lt;p id="xdx_85A_zGHAKYOFyFo4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;











&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_848_eus-gaap--RevenueRecognitionAllowances_zIXF944rySMe" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&lt;span id="xdx_868_znLVY5SKtDS2"&gt;Payments to Customers&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Company records revenues
generated from purchase with purchase and gift with purchase promotions as sales and the costs of its purchase with purchase and
gift with purchase promotions as cost of sales. Certain other incentive arrangements require the payment of a fee to customers
based on their attainment of pre-established sales levels.&#160;These fees have been recorded as a reduction of net sales.&lt;/p&gt;

&lt;p id="xdx_852_zWNBQtZ1lOll" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_847_eus-gaap--AdvertisingCostsPolicyTextBlock_zMhsa7dUIP4b" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&lt;span id="xdx_86B_zKwixucqi0Wc"&gt;Advertising and Promotion&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Advertising and promotional costs
are expensed as incurred and recorded as a component of cost of goods sold (in the case of free goods given to customers) or selling,
general and administrative expenses. Advertising and promotional costs included in selling, general and administrative expenses
were $&lt;span id="xdx_90F_eus-gaap--AdvertisingExpense_dm_c20210101__20211231_zO66CJoHkc5i" title="Advertising costs"&gt;171.8 million&lt;/span&gt;, $&lt;span id="xdx_900_eus-gaap--AdvertisingExpense_dm_c20200101__20201231_zmbGZy0nheab" title="Advertising costs"&gt;91.7 million&lt;/span&gt; and $&lt;span id="xdx_906_eus-gaap--AdvertisingExpense_dm_c20190101__20191231_zSBuyQo7SUfj" title="Advertising costs"&gt;144.6 million&lt;/span&gt; for 2021, 2020 and 2019, respectively. Costs relating to purchase with purchase
and gift with purchase promotions that are reflected in cost of sales aggregated $&lt;span id="xdx_90B_eus-gaap--MarketingExpense_dm_c20210101__20211231_zkC5S7wCoKt" title="Customer incentives cost"&gt;37.6 million&lt;/span&gt;, $&lt;span id="xdx_907_eus-gaap--MarketingExpense_dm_c20200101__20201231_zIl6u6IHe97g" title="Customer incentives cost"&gt;26.4 million&lt;/span&gt; and $&lt;span id="xdx_90B_eus-gaap--MarketingExpense_dm_c20190101__20191231_z8Sfs4W9HSo7" title="Customer incentives cost"&gt;38.9 million&lt;/span&gt;
in 2021, 2020 and 2019, respectively.&lt;/p&gt;

&lt;p id="xdx_852_zv0TgE5diP73" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_845_eus-gaap--ResearchAndDevelopmentExpensePolicy_zb6l10DhTTD1" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&lt;span id="xdx_86C_zxubFzrB3ag7"&gt;Package Development
Costs&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Package development costs associated
with new products and redesigns of existing product packaging are expensed as incurred.&lt;/p&gt;

&lt;p id="xdx_850_zDyjh8VrwLea" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_84E_eus-gaap--LessorLeasesPolicyTextBlock_zY4OsnzKpcG1" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&lt;span id="xdx_864_zSwFQL2unLWj"&gt;Operating Leases&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Company leases its offices
and warehouses, vehicles, and certain office equipment, substantially all of which are classified as operating leases. The Company
currently has no material financing leases. The Company determines if an arrangement is a lease at inception. Operating lease assets
and obligations are recognized at the lease commencement date based on the present value of lease payments over the lease term.&lt;/p&gt;

&lt;p id="xdx_851_zBCT9dlLM9yb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_845_eus-gaap--CommitmentsAndContingenciesPolicyTextBlock_zlM20bGen9Pf" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&lt;span id="xdx_86A_zpWo2K9IzHBk"&gt;License Agreements&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Company&#x2019;s license agreements
generally provide the Company with worldwide rights to manufacture, market and sell fragrance and fragrance related products using
the licensors&#x2019; trademarks.&#160;The licenses typically have an initial term of approximately &lt;span id="xdx_905_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtxL_c20210101__20211231__srt--RangeAxis__srt--MinimumMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_zg5oy7vG2Sig" title="License agreement term::XDX::P5Y"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0815"&gt;5&lt;/span&gt;&lt;/span&gt; to &lt;span id="xdx_90B_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtxL_c20210101__20211231__srt--RangeAxis__srt--MaximumMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_zH4FMG4euCva" title="License agreement term::XDX::P15Y"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0817"&gt;15&lt;/span&gt;&lt;/span&gt; years, and are potentially
renewable subject to the Company&#x2019;s compliance with the license agreement provisions.&#160;The remaining terms, excluding
potential renewal periods, range from approximately &lt;span id="xdx_900_eus-gaap--AcquiredFiniteLivedIntangibleAssetWeightedAveragePeriodBeforeRenewalOrExtension_dtxL_c20210101__20211231__srt--RangeAxis__srt--MinimumMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_zZBekVhYz7rl" title="License agreement renewal term::XDX::P1Y"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0819"&gt;1&lt;/span&gt;&lt;/span&gt; to &lt;span id="xdx_90B_eus-gaap--AcquiredFiniteLivedIntangibleAssetWeightedAveragePeriodBeforeRenewalOrExtension_dtxL_c20210101__20211231__srt--RangeAxis__srt--MaximumMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_zPKh8saKEnri" title="License agreement renewal term::XDX::P12Y"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0821"&gt;12&lt;/span&gt;&lt;/span&gt; years.&#160; Under each license, the Company is required to pay royalties
in the range of &lt;span id="xdx_904_ecustom--RoyaltyExpenseNetSalesPercentage_pid_dp_uPure_c20210101__20211231__srt--RangeAxis__srt--MinimumMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_zLpjMvg6tOsh" title="Royalty expense, percentage of net sales"&gt;6&lt;/span&gt;% to &lt;span id="xdx_90C_ecustom--RoyaltyExpenseNetSalesPercentage_pid_dp_uPure_c20210101__20211231__srt--RangeAxis__srt--MaximumMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_ziq3WDdigWN5" title="Royalty expense, percentage of net sales"&gt;10&lt;/span&gt;% to the licensor, at least annually, based on net sales to third parties.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;In certain cases, the Company
may pay an entry fee to acquire, or enter into, a license where the licensor or another licensee was operating a pre-existing fragrance
business.&#160; In those cases, the entry fee is capitalized as an intangible asset and amortized over its useful life.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Most license agreements require
minimum royalty payments, incremental royalties based on net sales levels and minimum spending on advertising and promotional activities.&#160;
Royalty expenses are accrued in the period in which net sales are recognized while advertising and promotional expenses are accrued
at the time these costs are incurred.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;













&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;In addition, the Company is exposed
to certain concentration risk. Most of our prestige fragrance brands are licensed from unaffiliated third parties, and our business
is dependent upon the continuation and renewal of such licenses.&lt;/p&gt;

&lt;p id="xdx_851_zS3es4fIsQH4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&#160;&lt;/p&gt;

&lt;p id="xdx_848_eus-gaap--IncomeTaxPolicyTextBlock_zfkJH3uH7nI3" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&lt;span id="xdx_862_ztuairfRRGmc"&gt;Income Taxes&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Company accounts for income
taxes using an asset and liability approach that requires the recognition of deferred tax assets and liabilities for the expected
future tax consequences of events that have been recognized in its financial statements or tax returns.&#160;The net deferred tax
assets assume sufficient future earnings for their realization, as well as the continued application of currently enacted tax rates.&#160;Included
in net deferred tax assets is a valuation allowance for deferred tax assets, where management believes it is more-likely-than-not
that the deferred tax assets will not be realized in the relevant jurisdiction.&#160;If the Company determines that a deferred
tax asset will not be realizable, an adjustment to the deferred tax asset will result in a reduction of net earnings at that time.
Accrued interest and penalties are included within the related tax asset or liability in the accompanying financial statements.&lt;/p&gt;

&lt;p id="xdx_858_zgWcCsu0X49f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_84B_eus-gaap--ConsolidationSubsidiaryStockIssuancesPolicy_zNn5UAKH97j9" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&lt;span id="xdx_863_z3XeDhRGwgT6"&gt;Issuance of Common Stock
by Consolidated Subsidiary&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The difference between the Company&#x2019;s
share of the proceeds received by the subsidiary and the carrying amount of the portion of the Company&#x2019;s investment deemed
sold, is reflected as an equity adjustment in the consolidated balance sheets.&lt;/p&gt;

&lt;p id="xdx_858_ztrkRACWMHWj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_845_eus-gaap--RepurchaseAgreementsCollateralPolicy_zgFdiS9Lz6vl" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&lt;span id="xdx_86E_zPR2sjlhj6Vi"&gt;Treasury Stock&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Board of Directors may authorize
share repurchases of the Company&#x2019;s common stock (Share Repurchase Authorizations). Share repurchases under Share Repurchase
Authorizations may be made through open market transactions, negotiated purchase or otherwise, at times and in such amounts within
the parameters authorized by the Board. Shares repurchased under Share Repurchase Authorizations are held in treasury for general
corporate purposes, including issuances under various employee stock option plans. Treasury shares are accounted for under the
cost method and reported as a reduction of equity. Share Repurchase Authorizations may be suspended, limited or terminated at any
time without notice.&lt;/p&gt;

&lt;p id="xdx_85B_zl4btBt8GBfd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_846_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zaV2orbuBuQ3" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&lt;span id="xdx_865_zEa8FnNhccEf"&gt;Recent Accounting Pronouncements&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;In June 2016, the Financial Accounting
Standards Board (&#x201c;FASB&#x201d;) issued ASU 2016-13, &#x201c;Financial Instruments - Credit Losses (Topic 326): Measurement
of Credit Losses on Financial Instruments&#x201d;, as updated in 2019 and 2020, which require a financial asset measured at amortized
cost basis to be presented at the net amount expected to be collected. The new rules eliminate the probable initial recognition
threshold and, instead, reflect an entity&#x2019;s current estimate of all expected credit losses. The new rules took effect for
the Company in the first quarter of 2020 and there was no material impact on our consolidated financial statements.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;There are no other recent accounting
pronouncements issued but not yet adopted that would have a material effect on our consolidated financial statements.&lt;/p&gt;

&lt;p id="xdx_85E_zHyHguiqTzx6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_841_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zOY2dqwXvKZ4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_865_zZHMpqe0Xir6"&gt;Reclassifications&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Certain prior year&#x2019;s amounts
in the accompanying consolidated statements of cash flows have been reclassified to conform to current period presentation.&lt;/p&gt;

&lt;p id="xdx_85C_zIPzerqA9kpk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_84F_eus-gaap--BusinessDescriptionAndAccountingPoliciesTextBlock_zaqQ1CrlHMM9" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&lt;span id="xdx_867_zFeuUXnmqXK2"&gt;Business of the Company&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Inter Parfums, Inc. and its subsidiaries
(the &#x201c;Company&#x201d;) are in the fragrance business and manufacture and distribute a wide array of fragrances and fragrance
related products.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_899_eus-gaap--SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_zpcXTUGeaJk8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Substantially all of our prestige
fragrance brands are licensed from unaffiliated third parties, and our business is dependent upon the continuation and renewal
of such licenses. &lt;span&gt;With respect to the Company&#x2019;s largest brands, we license the Montblanc, Jimmy Choo, Coach and GUESS brand
names. As a percentage of net sales, product sales for the Company&#x2019;s largest brands were as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;span id="xdx_8BB_zLfZsxXUNYea" style="display: none; visibility: hidden"&gt;Schedule of lanvin brand name for our class&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Year Ended December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2019&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 55%"&gt;Montblanc&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--MontblancMember_zYQdpsEiMHBc" style="width: 12%; text-align: right" title="Concentration risk percentage"&gt;19&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20200101__20201231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--MontblancMember_zByVvYIo3wEk" style="width: 12%; text-align: right"&gt;21&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20190101__20191231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--MontblancMember_z8jeCKYz1uF1" style="width: 12%; text-align: right" title="Concentration risk percentage"&gt;22&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Jimmy Choo&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--JimmyChooMember_zQprf6WWuqpb" style="text-align: right"&gt;18&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20200101__20201231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--JimmyChooMember_zS5aVrWrtb99" style="text-align: right" title="Concentration risk percentage"&gt;16&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20190101__20191231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--JimmyChooMember_zKh8Vx48zKxg" style="text-align: right"&gt;16&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Coach&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--CoachMember_zz272R6gNMCg" style="text-align: right"&gt;16&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20200101__20201231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--CoachMember_zoFqBpv49ldh" style="text-align: right"&gt;17&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20190101__20191231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--CoachMember_z8tyQcKDn2p3" style="text-align: right"&gt;14&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;GUESS&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--GUESSMember_zjFmBtriPnHe" style="text-align: right"&gt;12&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20200101__20201231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--GUESSMember_zs5yKA1qgED6" style="text-align: right"&gt;11&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20190101__20191231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--GUESSMember_zFSzsWYUIFY7" style="text-align: right"&gt;10&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8AB_zhfDGbBby8R8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;No other brand represented 10%
or more of consolidated net sales.&lt;/p&gt;

</us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock>
    <us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_899_eus-gaap--SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_zpcXTUGeaJk8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Substantially all of our prestige
fragrance brands are licensed from unaffiliated third parties, and our business is dependent upon the continuation and renewal
of such licenses. &lt;span&gt;With respect to the Company&#x2019;s largest brands, we license the Montblanc, Jimmy Choo, Coach and GUESS brand
names. As a percentage of net sales, product sales for the Company&#x2019;s largest brands were as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;span id="xdx_8BB_zLfZsxXUNYea" style="display: none; visibility: hidden"&gt;Schedule of lanvin brand name for our class&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Year Ended December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2019&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 55%"&gt;Montblanc&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--MontblancMember_zYQdpsEiMHBc" style="width: 12%; text-align: right" title="Concentration risk percentage"&gt;19&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20200101__20201231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--MontblancMember_zByVvYIo3wEk" style="width: 12%; text-align: right"&gt;21&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20190101__20191231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--MontblancMember_z8jeCKYz1uF1" style="width: 12%; text-align: right" title="Concentration risk percentage"&gt;22&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Jimmy Choo&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--JimmyChooMember_zQprf6WWuqpb" style="text-align: right"&gt;18&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20200101__20201231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--JimmyChooMember_zS5aVrWrtb99" style="text-align: right" title="Concentration risk percentage"&gt;16&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20190101__20191231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--JimmyChooMember_zKh8Vx48zKxg" style="text-align: right"&gt;16&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Coach&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--CoachMember_zz272R6gNMCg" style="text-align: right"&gt;16&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20200101__20201231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--CoachMember_zoFqBpv49ldh" style="text-align: right"&gt;17&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20190101__20191231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--CoachMember_z8tyQcKDn2p3" style="text-align: right"&gt;14&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;GUESS&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--GUESSMember_zjFmBtriPnHe" style="text-align: right"&gt;12&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20200101__20201231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--GUESSMember_zs5yKA1qgED6" style="text-align: right"&gt;11&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20190101__20191231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--GUESSMember_zFSzsWYUIFY7" style="text-align: right"&gt;10&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2021-01-012021-12-31_custom_MontblancMember"
      decimals="INF"
      unitRef="Pure">0.19</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2020-01-012020-12-31_custom_MontblancMember"
      decimals="INF"
      unitRef="Pure">0.21</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2019-01-012019-12-31_custom_MontblancMember"
      decimals="INF"
      unitRef="Pure">0.22</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2021-01-012021-12-31_custom_JimmyChooMember"
      decimals="INF"
      unitRef="Pure">0.18</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2020-01-012020-12-31_custom_JimmyChooMember"
      decimals="INF"
      unitRef="Pure">0.16</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2019-01-012019-12-31_custom_JimmyChooMember"
      decimals="INF"
      unitRef="Pure">0.16</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2021-01-012021-12-31_custom_CoachMember"
      decimals="INF"
      unitRef="Pure">0.16</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2020-01-012020-12-31_custom_CoachMember"
      decimals="INF"
      unitRef="Pure">0.17</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2019-01-012019-12-31_custom_CoachMember"
      decimals="INF"
      unitRef="Pure">0.14</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2021-01-012021-12-31_custom_GUESSMember"
      decimals="INF"
      unitRef="Pure">0.12</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2020-01-012020-12-31_custom_GUESSMember"
      decimals="INF"
      unitRef="Pure">0.11</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2019-01-012019-12-31_custom_GUESSMember"
      decimals="INF"
      unitRef="Pure">0.10</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_84E_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zFBXQNTiBWB1" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&lt;span id="xdx_864_zsDymlX0yt0e"&gt;Basis of Preparation&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-size: 10pt; color: windowtext"&gt;The
consolidated financial statements include the accounts of the Company and its subsidiaries, including &lt;span id="xdx_903_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_uPure_c20211231__srt--OwnershipAxis__custom--InterparfumsSASubsidiaryMember_zI2O3snRjMKg" title="Ownership percentage in Interparfums SA"&gt;73&lt;/span&gt;% owned Interparfums SA,
a subsidiary whose stock is publicly traded in France.&lt;/span&gt; &lt;span style="font-size: 10pt"&gt;All material intercompany balances
and transactions have been eliminated&lt;/span&gt;.&lt;/p&gt;

</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:MinorityInterestOwnershipPercentageByParent
      contextRef="AsOf2021-12-31_custom_InterparfumsSASubsidiaryMember"
      decimals="INF"
      unitRef="Pure">0.73</us-gaap:MinorityInterestOwnershipPercentageByParent>
    <us-gaap:UseOfEstimates contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_84D_eus-gaap--UseOfEstimates_zbo5NVG30hw9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_862_zrUMUeldlUT8"&gt;Management Estimates&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Management makes assumptions
and estimates to prepare financial statements in conformity with accounting principles generally accepted in the United States
of America. Those assumptions and estimates directly affect the amounts reported and disclosures included in the consolidated financial
statements. Actual results could differ from those assumptions and estimates. Significant estimates for which changes in the near
term are considered reasonably possible and that may have a material impact on the financial statements are disclosed in these
notes to the consolidated financial statements.&lt;/p&gt;

</us-gaap:UseOfEstimates>
    <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_846_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_zE5MUTGyRm4c" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&lt;span id="xdx_86C_z28ilshIsQI2"&gt;Foreign Currency Translation&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;For foreign subsidiaries with
operations denominated in a foreign currency, assets and liabilities are translated to U.S. dollars at year-end exchange rates.
Income and expense items are translated at average rates of exchange prevailing during the year. Gains and losses from translation
adjustments are accumulated in a separate component of shareholders&#x2019; equity.&lt;/p&gt;

</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_844_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zEpMocWzPs56" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&lt;span id="xdx_86B_zCDC3UyqFj93"&gt;Cash and Cash Equivalents
and Short-Term Investments&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;All highly liquid investments
purchased with a maturity of three months or less are considered to be cash equivalents. The Company also has short-term investments
which consist of certificates of deposit and other contracts with maturities greater than three months and available for sale marketable
equity securities. The Company monitors concentrations of credit risk associated with financial institutions with which the Company
conducts significant business. The Company believes its credit risk is minimal, as the Company primarily conducts business with
large, well-established financial institutions. Substantially all cash and cash equivalents are primarily held at financial institutions
outside the United States and are readily convertible into U.S. dollars.&lt;/p&gt;

</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:TradeAndOtherAccountsReceivablePolicy contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_84F_eus-gaap--TradeAndOtherAccountsReceivablePolicy_zOX5N7CtF7sa" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&lt;span id="xdx_86C_zRrOsXXviwH7"&gt;Accounts Receivable&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Accounts receivable represent
payments due to the Company for previously recognized net sales, reduced by allowances for doubtful accounts or balances which
are estimated to be uncollectible, which aggregated $&lt;span id="xdx_908_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_dm_c20211231_zIjlU4KCWMod" title="Allowances for sales returns and doubtful accounts"&gt;2.2 million&lt;/span&gt; and $&lt;span id="xdx_907_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_dm_c20201231_zsvFPBrg2MW8" title="Allowances for sales returns and doubtful accounts"&gt;5.5 million&lt;/span&gt; as of December 31, 2021 and 2020, respectively.
Accounts receivable balances are written-off against the allowance for doubtful accounts when they become uncollectible. Recoveries
of accounts receivable previously recorded against the allowance are recorded in the consolidated statement of income when received.
We generally grant credit based upon our analysis of the customer&#x2019;s financial position, as well as previously established
buying patterns.&lt;/p&gt;

</us-gaap:TradeAndOtherAccountsReceivablePolicy>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">2200000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">5500000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:InventoryPolicyTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_84F_eus-gaap--InventoryPolicyTextBlock_ztbdawIs4OD2" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&lt;span id="xdx_86C_zNu6STEIHY4i"&gt;Inventories&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Inventories, including promotional
merchandise, only include inventory considered saleable or usable in future periods, and are stated at the lower of cost and net
realizable value, with cost being determined on the first-in, first-out method.&#160;Cost components include raw materials, direct
labor and overhead (e.g., indirect labor, utilities, depreciation, purchasing, receiving, inspection and warehousing) as well as
inbound freight.&#160;Promotional merchandise is charged to cost of sales at the time the merchandise is shipped to the Company&#x2019;s
customers.&lt;/p&gt;

</us-gaap:InventoryPolicyTextBlock>
    <us-gaap:DerivativesPolicyTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_84A_eus-gaap--DerivativesPolicyTextBlock_z9baj96Z3Uch" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&lt;span id="xdx_865_zEB0CQ2uqAGl"&gt;Derivatives&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;All derivative instruments are
recorded as either assets or liabilities and measured at fair value. The Company uses derivative instruments to principally manage
a variety of market risks. For derivatives designated as hedges of the exposure to changes in fair value of the recognized asset
or liability or a firm commitment (referred to as fair value hedges), the gain or loss is recognized in earnings in the period
of change together with the offsetting loss or gain on the hedged item attributable to the risk being hedged. The effect of that
accounting is to include in earnings the extent to which the hedge is not effective in achieving offsetting changes in fair value.
For cash flow hedges, the effective portion of the derivative&#x2019;s gain or loss is initially reported in equity (as a component
of accumulated other comprehensive income) and is subsequently reclassified into earnings in the same period or periods during
which the hedged forecasted transaction affects earnings. The ineffective portion of the gain or loss of a cash flow hedge is reported
in earnings immediately. The Company also holds certain instruments for economic purposes that are not designated for hedge accounting
treatment. For these derivative instruments, changes in their fair value are recorded in earnings immediately.&lt;/p&gt;

</us-gaap:DerivativesPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_84E_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zxLXxkQD6l59" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&lt;span id="xdx_862_ziePjxIBxEIi"&gt;Property, Equipment
and Leasehold Improvements&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Property, equipment and leasehold
improvements are stated at cost less accumulated depreciation and amortization. Depreciation and amortization are provided using
the straight-line method over the estimated useful lives for equipment, which range between three and ten&#160;years and the shorter
of the lease term or estimated useful asset lives for leasehold improvements. Depreciation has not yet begun on property recently
purchased, as it has not yet been put into service. Depreciation provided on equipment used to produce inventory, such as tools
and molds, is included in cost of sales.&lt;/p&gt;

</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_84B_eus-gaap--GoodwillAndIntangibleAssetsPolicyTextBlock_zMLyGXt7t8gg" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&lt;span id="xdx_86B_zh41q5d3MFDh"&gt;Long-Lived Assets&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Indefinite-lived intangible assets
principally consist of trademarks which are not amortized. The Company evaluates indefinite-lived intangible assets for impairment
at least annually during the fourth quarter, or more frequently when events occur or circumstances change, such as an unexpected
decline in sales, that would more-likely-than-not indicate that the carrying value of an indefinite-lived intangible asset may
not be recoverable. When testing indefinite-lived intangible assets for impairment, the evaluation requires a comparison of the
estimated fair value of the asset to the carrying value of the asset. The fair values used in our evaluations are estimated based
upon discounted future cash flow projections using a weighted average cost of capital of &lt;span id="xdx_905_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_uPure_c20211231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountRateMember_zjI95Q9b1fGj" title="Weighted average cost of capital"&gt;7.47&lt;/span&gt;% and &lt;span id="xdx_906_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_uPure_c20201231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountRateMember_zitEfXDLlzZj" title="Weighted average cost of capital"&gt;6.99&lt;/span&gt;% in 2021 and 2020, respectively.
The cash flow projections are based upon a number of assumptions, including future sales levels, future cost of goods and operating
expense levels, as well as economic conditions, changes to our business model or changes in consumer acceptance of our products
which are more subjective in nature. If the carrying value of an indefinite-lived intangible asset exceeds its fair value, an impairment
charge is recorded.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Intangible assets subject to
amortization are evaluated for impairment testing whenever events or changes in circumstances indicate that the carrying amount
of an amortizable intangible asset may not be recoverable. If impairment indicators exist for an amortizable intangible asset,
the undiscounted future cash flows associated with the expected service potential of the asset are compared to the carrying value
of the asset. If our projection of undiscounted future cash flows is in excess of the carrying value of the intangible asset, no
impairment charge is recorded. If our projection of undiscounted future cash flows is less than the carrying value of the intangible
asset, an impairment charge would be recorded to reduce the intangible asset to its fair value.&lt;/p&gt;

</us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="AsOf2021-12-31_us-gaap_MeasurementInputDiscountRateMember"
      decimals="INF"
      unitRef="Pure">0.0747</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="AsOf2020-12-31_us-gaap_MeasurementInputDiscountRateMember"
      decimals="INF"
      unitRef="Pure">0.0699</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_846_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_ztLcWRB1tRh4" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&lt;span id="xdx_868_zDcPDuMSob3a"&gt;Revenue Recognition&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Company sells its products
to department stores, perfumeries, specialty stores and domestic and international wholesalers and distributors. Our revenue contracts
represent single performance obligations to sell our products to customers. Sales of such products by our domestic subsidiaries
are denominated in U.S. dollars, and sales of such products by our foreign subsidiaries are primarily denominated in either euro
or U.S. dollars. The Company recognizes revenues when contract terms are met, the price is fixed and determinable, collectability
is reasonably assured, and control of the assets has passed to the customer based on the agreed upon shipping terms. Net sales
are comprised of gross revenues less returns, trade discounts and allowances. The Company does not bill its customers&#x2019; freight
and handling charges. All shipping and handling costs, which aggregated $&lt;span id="xdx_903_eus-gaap--CostOfGoodsAndServicesSold_dm_c20210101__20211231__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_z7kiNCO2jrZd" title="Shipping and handling costs"&gt;10.1 million&lt;/span&gt;, $&lt;span id="xdx_901_eus-gaap--CostOfGoodsAndServicesSold_dm_c20200101__20201231__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_zYpnjFOqQbrf" title="Shipping and handling costs"&gt;5.0 million&lt;/span&gt; and $&lt;span id="xdx_907_eus-gaap--CostOfGoodsAndServicesSold_dm_c20190101__20191231__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_zbv06j8IAt58" title="Shipping and handling costs"&gt;7.7 million&lt;/span&gt; in 2021, 2020
and 2019, respectively, are included in selling, general and administrative expenses in the consolidated statements of income.
The Company grants credit to all qualified customers and does not believe it is exposed significantly to any undue concentration
of credit risk. No one customer represented &lt;span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember_zoLUvQ3mRx5b" title="Concentration risk percentage"&gt;&lt;span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20200101__20201231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember_zhfXNG5EgFo" title="Concentration risk percentage"&gt;&lt;span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20190101__20191231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember_zyOX9TezhAsb" title="Concentration risk percentage"&gt;10&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;% or more of net sales in 2021, 2020 or 2019.&lt;/p&gt;

</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="From2021-01-012021-12-31_us-gaap_ShippingAndHandlingMember"
      decimals="0"
      unitRef="USD">10100000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="From2020-01-012020-12-31_us-gaap_ShippingAndHandlingMember"
      decimals="0"
      unitRef="USD">5000000.0</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="From2019-01-012019-12-31_us-gaap_ShippingAndHandlingMember"
      decimals="0"
      unitRef="USD">7700000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2021-01-012021-12-31_us-gaap_SalesRevenueNetMember"
      decimals="INF"
      unitRef="Pure">0.10</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2020-01-012020-12-31_us-gaap_SalesRevenueNetMember"
      decimals="INF"
      unitRef="Pure">0.10</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2019-01-012019-12-31_us-gaap_SalesRevenueNetMember"
      decimals="INF"
      unitRef="Pure">0.10</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueRecognitionSalesReturns contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_842_eus-gaap--RevenueRecognitionSalesReturns_zRzspxwoKQok" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86A_z8xvPmwjEzX2"&gt;Sales Returns&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Generally, the Company does not
permit customers to return their unsold products. However, for U.S. based customers, we allow returns if properly requested, authorized
and approved. The Company regularly reviews and revises, as deemed necessary, its estimate of reserves for future sales returns
based primarily upon historic trends and relevant current data including information provided by retailers regarding their inventory
levels. In addition, as necessary, specific accruals may be established for significant future known or anticipated events. The
types of known or anticipated events that we consider include, but are not limited to, the financial condition of our customers,
store closings by retailers, changes in the retail environment and our decision to continue to support new and existing products.
The Company records its estimate of potential sales returns as a reduction of sales and cost of sales with corresponding entries
to accrued expenses, to record the refund liability, and inventory, for the right to recover goods from the customer. The refund
liability associated with estimated returns was $&lt;span id="xdx_908_eus-gaap--ContractWithCustomerRefundLiability_iI_dm_c20211231_znyf5BtratH3" title="Contract with customer, refund liability"&gt;5.1 million&lt;/span&gt; and $&lt;span id="xdx_90C_eus-gaap--ContractWithCustomerRefundLiability_iI_dm_c20201231_zRetSX8A8Xf2" title="Contract with customer, refund liability"&gt;3.6 million&lt;/span&gt; at December 31, 2021 and 2020, respectively, and
the amounts recognized for the rights to recover products was $&lt;span id="xdx_901_eus-gaap--ContractWithCustomerRightToRecoverProduct_iI_dm_c20211231_zeBEEVsuiDj8" title="Contract with customer, right to recover products"&gt;1.9 million&lt;/span&gt; and $&lt;span id="xdx_907_eus-gaap--ContractWithCustomerRightToRecoverProduct_iI_dm_c20201231_z0jjHn77u3ra" title="Contract with customer, right to recover products"&gt;1.4 million&lt;/span&gt; at December 31, 2021 and 2020, respectively.
The physical condition and marketability of returned products are the major factors we consider in estimating realizable value.
Actual returns, as well as estimated realizable values of returned products, may differ significantly, either favorably or unfavorably,
from our estimates, if factors such as economic conditions, inventory levels or competitive conditions differ from our expectations.&lt;/p&gt;

</us-gaap:RevenueRecognitionSalesReturns>
    <us-gaap:ContractWithCustomerRefundLiability contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">5100000</us-gaap:ContractWithCustomerRefundLiability>
    <us-gaap:ContractWithCustomerRefundLiability contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">3600000</us-gaap:ContractWithCustomerRefundLiability>
    <us-gaap:ContractWithCustomerRightToRecoverProduct contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">1900000</us-gaap:ContractWithCustomerRightToRecoverProduct>
    <us-gaap:ContractWithCustomerRightToRecoverProduct contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">1400000</us-gaap:ContractWithCustomerRightToRecoverProduct>
    <us-gaap:RevenueRecognitionAllowances contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_848_eus-gaap--RevenueRecognitionAllowances_zIXF944rySMe" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&lt;span id="xdx_868_znLVY5SKtDS2"&gt;Payments to Customers&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Company records revenues
generated from purchase with purchase and gift with purchase promotions as sales and the costs of its purchase with purchase and
gift with purchase promotions as cost of sales. Certain other incentive arrangements require the payment of a fee to customers
based on their attainment of pre-established sales levels.&#160;These fees have been recorded as a reduction of net sales.&lt;/p&gt;

</us-gaap:RevenueRecognitionAllowances>
    <us-gaap:AdvertisingCostsPolicyTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_847_eus-gaap--AdvertisingCostsPolicyTextBlock_zMhsa7dUIP4b" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&lt;span id="xdx_86B_zKwixucqi0Wc"&gt;Advertising and Promotion&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Advertising and promotional costs
are expensed as incurred and recorded as a component of cost of goods sold (in the case of free goods given to customers) or selling,
general and administrative expenses. Advertising and promotional costs included in selling, general and administrative expenses
were $&lt;span id="xdx_90F_eus-gaap--AdvertisingExpense_dm_c20210101__20211231_zO66CJoHkc5i" title="Advertising costs"&gt;171.8 million&lt;/span&gt;, $&lt;span id="xdx_900_eus-gaap--AdvertisingExpense_dm_c20200101__20201231_zmbGZy0nheab" title="Advertising costs"&gt;91.7 million&lt;/span&gt; and $&lt;span id="xdx_906_eus-gaap--AdvertisingExpense_dm_c20190101__20191231_zSBuyQo7SUfj" title="Advertising costs"&gt;144.6 million&lt;/span&gt; for 2021, 2020 and 2019, respectively. Costs relating to purchase with purchase
and gift with purchase promotions that are reflected in cost of sales aggregated $&lt;span id="xdx_90B_eus-gaap--MarketingExpense_dm_c20210101__20211231_zkC5S7wCoKt" title="Customer incentives cost"&gt;37.6 million&lt;/span&gt;, $&lt;span id="xdx_907_eus-gaap--MarketingExpense_dm_c20200101__20201231_zIl6u6IHe97g" title="Customer incentives cost"&gt;26.4 million&lt;/span&gt; and $&lt;span id="xdx_90B_eus-gaap--MarketingExpense_dm_c20190101__20191231_z8Sfs4W9HSo7" title="Customer incentives cost"&gt;38.9 million&lt;/span&gt;
in 2021, 2020 and 2019, respectively.&lt;/p&gt;

</us-gaap:AdvertisingCostsPolicyTextBlock>
    <us-gaap:AdvertisingExpense
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">171800000</us-gaap:AdvertisingExpense>
    <us-gaap:AdvertisingExpense
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">91700000</us-gaap:AdvertisingExpense>
    <us-gaap:AdvertisingExpense
      contextRef="From2019-01-012019-12-31"
      decimals="0"
      unitRef="USD">144600000</us-gaap:AdvertisingExpense>
    <us-gaap:MarketingExpense
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">37600000</us-gaap:MarketingExpense>
    <us-gaap:MarketingExpense
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">26400000</us-gaap:MarketingExpense>
    <us-gaap:MarketingExpense
      contextRef="From2019-01-012019-12-31"
      decimals="0"
      unitRef="USD">38900000</us-gaap:MarketingExpense>
    <us-gaap:ResearchAndDevelopmentExpensePolicy contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_845_eus-gaap--ResearchAndDevelopmentExpensePolicy_zb6l10DhTTD1" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&lt;span id="xdx_86C_zxubFzrB3ag7"&gt;Package Development
Costs&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Package development costs associated
with new products and redesigns of existing product packaging are expensed as incurred.&lt;/p&gt;

</us-gaap:ResearchAndDevelopmentExpensePolicy>
    <us-gaap:LessorLeasesPolicyTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_84E_eus-gaap--LessorLeasesPolicyTextBlock_zY4OsnzKpcG1" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&lt;span id="xdx_864_zSwFQL2unLWj"&gt;Operating Leases&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Company leases its offices
and warehouses, vehicles, and certain office equipment, substantially all of which are classified as operating leases. The Company
currently has no material financing leases. The Company determines if an arrangement is a lease at inception. Operating lease assets
and obligations are recognized at the lease commencement date based on the present value of lease payments over the lease term.&lt;/p&gt;

</us-gaap:LessorLeasesPolicyTextBlock>
    <us-gaap:CommitmentsAndContingenciesPolicyTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_845_eus-gaap--CommitmentsAndContingenciesPolicyTextBlock_zlM20bGen9Pf" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&lt;span id="xdx_86A_zpWo2K9IzHBk"&gt;License Agreements&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Company&#x2019;s license agreements
generally provide the Company with worldwide rights to manufacture, market and sell fragrance and fragrance related products using
the licensors&#x2019; trademarks.&#160;The licenses typically have an initial term of approximately &lt;span id="xdx_905_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtxL_c20210101__20211231__srt--RangeAxis__srt--MinimumMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_zg5oy7vG2Sig" title="License agreement term::XDX::P5Y"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0815"&gt;5&lt;/span&gt;&lt;/span&gt; to &lt;span id="xdx_90B_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtxL_c20210101__20211231__srt--RangeAxis__srt--MaximumMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_zH4FMG4euCva" title="License agreement term::XDX::P15Y"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0817"&gt;15&lt;/span&gt;&lt;/span&gt; years, and are potentially
renewable subject to the Company&#x2019;s compliance with the license agreement provisions.&#160;The remaining terms, excluding
potential renewal periods, range from approximately &lt;span id="xdx_900_eus-gaap--AcquiredFiniteLivedIntangibleAssetWeightedAveragePeriodBeforeRenewalOrExtension_dtxL_c20210101__20211231__srt--RangeAxis__srt--MinimumMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_zZBekVhYz7rl" title="License agreement renewal term::XDX::P1Y"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0819"&gt;1&lt;/span&gt;&lt;/span&gt; to &lt;span id="xdx_90B_eus-gaap--AcquiredFiniteLivedIntangibleAssetWeightedAveragePeriodBeforeRenewalOrExtension_dtxL_c20210101__20211231__srt--RangeAxis__srt--MaximumMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_zPKh8saKEnri" title="License agreement renewal term::XDX::P12Y"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0821"&gt;12&lt;/span&gt;&lt;/span&gt; years.&#160; Under each license, the Company is required to pay royalties
in the range of &lt;span id="xdx_904_ecustom--RoyaltyExpenseNetSalesPercentage_pid_dp_uPure_c20210101__20211231__srt--RangeAxis__srt--MinimumMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_zLpjMvg6tOsh" title="Royalty expense, percentage of net sales"&gt;6&lt;/span&gt;% to &lt;span id="xdx_90C_ecustom--RoyaltyExpenseNetSalesPercentage_pid_dp_uPure_c20210101__20211231__srt--RangeAxis__srt--MaximumMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_ziq3WDdigWN5" title="Royalty expense, percentage of net sales"&gt;10&lt;/span&gt;% to the licensor, at least annually, based on net sales to third parties.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;In certain cases, the Company
may pay an entry fee to acquire, or enter into, a license where the licensor or another licensee was operating a pre-existing fragrance
business.&#160; In those cases, the entry fee is capitalized as an intangible asset and amortized over its useful life.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Most license agreements require
minimum royalty payments, incremental royalties based on net sales levels and minimum spending on advertising and promotional activities.&#160;
Royalty expenses are accrued in the period in which net sales are recognized while advertising and promotional expenses are accrued
at the time these costs are incurred.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;













&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;In addition, the Company is exposed
to certain concentration risk. Most of our prestige fragrance brands are licensed from unaffiliated third parties, and our business
is dependent upon the continuation and renewal of such licenses.&lt;/p&gt;

</us-gaap:CommitmentsAndContingenciesPolicyTextBlock>
    <ipar:RoyaltyExpenseNetSalesPercentage
      contextRef="From2021-01-012021-12-31_srt_MinimumMember_us-gaap_LicensingAgreementsMember"
      decimals="INF"
      unitRef="Pure">0.06</ipar:RoyaltyExpenseNetSalesPercentage>
    <ipar:RoyaltyExpenseNetSalesPercentage
      contextRef="From2021-01-012021-12-31_srt_MaximumMember_us-gaap_LicensingAgreementsMember"
      decimals="INF"
      unitRef="Pure">0.10</ipar:RoyaltyExpenseNetSalesPercentage>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_848_eus-gaap--IncomeTaxPolicyTextBlock_zfkJH3uH7nI3" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&lt;span id="xdx_862_ztuairfRRGmc"&gt;Income Taxes&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Company accounts for income
taxes using an asset and liability approach that requires the recognition of deferred tax assets and liabilities for the expected
future tax consequences of events that have been recognized in its financial statements or tax returns.&#160;The net deferred tax
assets assume sufficient future earnings for their realization, as well as the continued application of currently enacted tax rates.&#160;Included
in net deferred tax assets is a valuation allowance for deferred tax assets, where management believes it is more-likely-than-not
that the deferred tax assets will not be realized in the relevant jurisdiction.&#160;If the Company determines that a deferred
tax asset will not be realizable, an adjustment to the deferred tax asset will result in a reduction of net earnings at that time.
Accrued interest and penalties are included within the related tax asset or liability in the accompanying financial statements.&lt;/p&gt;

</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:ConsolidationSubsidiaryStockIssuancesPolicy contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_84B_eus-gaap--ConsolidationSubsidiaryStockIssuancesPolicy_zNn5UAKH97j9" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&lt;span id="xdx_863_z3XeDhRGwgT6"&gt;Issuance of Common Stock
by Consolidated Subsidiary&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The difference between the Company&#x2019;s
share of the proceeds received by the subsidiary and the carrying amount of the portion of the Company&#x2019;s investment deemed
sold, is reflected as an equity adjustment in the consolidated balance sheets.&lt;/p&gt;

</us-gaap:ConsolidationSubsidiaryStockIssuancesPolicy>
    <us-gaap:RepurchaseAgreementsCollateralPolicy contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_845_eus-gaap--RepurchaseAgreementsCollateralPolicy_zgFdiS9Lz6vl" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&lt;span id="xdx_86E_zPR2sjlhj6Vi"&gt;Treasury Stock&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Board of Directors may authorize
share repurchases of the Company&#x2019;s common stock (Share Repurchase Authorizations). Share repurchases under Share Repurchase
Authorizations may be made through open market transactions, negotiated purchase or otherwise, at times and in such amounts within
the parameters authorized by the Board. Shares repurchased under Share Repurchase Authorizations are held in treasury for general
corporate purposes, including issuances under various employee stock option plans. Treasury shares are accounted for under the
cost method and reported as a reduction of equity. Share Repurchase Authorizations may be suspended, limited or terminated at any
time without notice.&lt;/p&gt;

</us-gaap:RepurchaseAgreementsCollateralPolicy>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_846_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zaV2orbuBuQ3" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&lt;span id="xdx_865_zEa8FnNhccEf"&gt;Recent Accounting Pronouncements&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;In June 2016, the Financial Accounting
Standards Board (&#x201c;FASB&#x201d;) issued ASU 2016-13, &#x201c;Financial Instruments - Credit Losses (Topic 326): Measurement
of Credit Losses on Financial Instruments&#x201d;, as updated in 2019 and 2020, which require a financial asset measured at amortized
cost basis to be presented at the net amount expected to be collected. The new rules eliminate the probable initial recognition
threshold and, instead, reflect an entity&#x2019;s current estimate of all expected credit losses. The new rules took effect for
the Company in the first quarter of 2020 and there was no material impact on our consolidated financial statements.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;There are no other recent accounting
pronouncements issued but not yet adopted that would have a material effect on our consolidated financial statements.&lt;/p&gt;

</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:PriorPeriodReclassificationAdjustmentDescription contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_841_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zOY2dqwXvKZ4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_865_zZHMpqe0Xir6"&gt;Reclassifications&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Certain prior year&#x2019;s amounts
in the accompanying consolidated statements of cash flows have been reclassified to conform to current period presentation.&lt;/p&gt;

</us-gaap:PriorPeriodReclassificationAdjustmentDescription>
    <ipar:ImpactOfCOVID19PandemicTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_802_ecustom--ImpactOfCOVID19PandemicTextBlock_zhjKhOFC7zZf" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;(2)&lt;/td&gt;&lt;td&gt;&lt;span id="xdx_822_zgXMrxJ4zcsd"&gt;Impact of COVID-19 Pandemic&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;A novel strain of coronavirus
(&#x201c;COVID-19&#x201d;) surfaced in late 2019 and has spread around the world, including to the United States and France. In March
2020, the World Health Organization declared COVID-19 a pandemic.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;In response to the COVID-19 pandemic
various national, state, and local governments where we, our suppliers, and our customers operate initially issued decrees prohibiting
certain businesses from continuing to operate and certain classes of workers from reporting to work. In all jurisdictions in which
we operate we have been following guidance from authorities and health officials.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The effects of the COVID-19 pandemic
on the beauty industry began in early March 2020. Retail store closings, event cancellations and a shutdown of international air
travel brought our sales to a virtual standstill and caused a significant unfavorable impact on our results of operations in 2020.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Business significantly improved
in the second half of 2020 and continued to improve throughout 2021, as retail stores reopened, and consumers increased online
purchasing. While we expect this trend to continue, as the luxury fragrance industry has shown continued resilience, the introduction
of variants of COVID-19 in various parts of the world has caused the temporary re-implementation of governmental restrictions to
prevent further spread of the virus. In addition, international air travel has remained curtailed in many jurisdictions due to
both governmental restrictions and consumer health concerns. While COVID-19 has significantly restricted international travel in
the near-term, we continue to believe that global travel retail will once again be a growth opportunity for the long-term. Lastly,
the improved economy has put significant strains on our supply chain causing disruptions affecting the procurement of components,
the ability to transport goods, and related cost increases. These disruptions have come at a time when demand for our product lines
has never been stronger or more sustained. We have been addressing this issue since the beginning of 2021, by ordering well in
advance of need and in larger quantities. Going forward, we aim to carry more inventory overall, source the same components from
multiple suppliers and when possible, manufacture products closer to where they are sold. We do not expect the supply chain bottlenecks
to begin lifting until later in 2022. Therefore, despite recent business improvement, the impact of the COVID-19 pandemic may have
a material adverse effect on our results of our operations, financial position and cash flows through at least the end of 2022.&lt;/p&gt;

</ipar:ImpactOfCOVID19PandemicTextBlock>
    <us-gaap:BusinessCombinationDisclosureTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_809_eus-gaap--BusinessCombinationDisclosureTextBlock_z9lEmzIUSBA1" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;(3)&lt;/td&gt;&lt;td&gt;&lt;span id="xdx_82F_zZ584f55AChe"&gt;Recent Agreements&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Salvatore Ferragamo &lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;In October 2021, we closed on
a transaction agreement with Salvatore Ferragamo S.p.A., whereby an exclusive and worldwide license was granted for the production
and distribution of Ferragamo brand perfumes. Our rights under this license are subject to certain minimum advertising expenditures
and royalty payments as are customary in our industry. The license became effective in October 2021 and will last for 10 years
with a 5-year optional term, subject to certain conditions.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;















&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_897_ecustom--ScheduleOfInventoryCurrentTableTextBlock1_z2moVF6wOGw9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;With respect to the management
and coordination of activities related to the license agreement, the Company operates through a wholly-owned Italian subsidiary
based in Florence, that was acquired from Salvatore Ferragamo on October 1, 2021. The acquisition together with the license agreement
was accounted for as an asset acquisition. The following table summarizes the estimated fair values of the assets acquired and
liabilities assumed on October 1, 2021. &lt;span id="xdx_8BE_z60afETIDPI2"&gt;All amounts have been translated to U.S. dollars at the October 1, 2021 exchange rate.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 40%; margin-right: auto"&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 25%"&gt;Inventories&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--InventoryGross_iI_pn3n3_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--InventoryMember_zBSGsFMZ2Kmk" style="width: 12%; text-align: right" title="Inventories"&gt;17,805&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Trademarks and licenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--InventoryGross_iI_pn3n3_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksMember_zjHRtjDVGIv1" style="text-align: right"&gt;15,880&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Other assets&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--InventoryGross_iI_pn3n3_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--OtherAssetMember_zqiCMi4rBlte" style="border-bottom: Black 1pt solid; text-align: right" title="Inventory gross"&gt;3,033&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in"&gt;Assets acquired&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--FairValueOfAssetsAcquired_pn3n3_c20210101__20211231_zc7pMBCM27j7" style="border-bottom: Black 1pt solid; text-align: right" title="Assets acquired"&gt;36,718&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in"&gt;Liabilities assumed&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--LiabilitiesAssumed1_iN_di_c20210101__20211231_zYAilmIsHA5d" style="border-bottom: Black 1pt solid; text-align: right"&gt;(958&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--InventoryNet_iI_pn3n3_dxL_c20211231_znyKJ10w2TWd" style="border-bottom: Black 2pt double; text-align: right" title="Inventory net::XDX::198%2C914"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0863"&gt;35,760&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;



&lt;p id="xdx_8A0_zuHLOTPrKK3k" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Emanuel Ungaro&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;In October 2021, we also entered into a 10-year exclusive global licensing agreement a with a 5-year optional
term subject to certain conditions, with Emanuel Ungaro Italia S.r.l, for the creation, development and distribution of fragrances
and fragrance-related products, under the Emanuel Ungaro brand. Our rights under this license are subject to certain minimum advertising
expenditures and royalty payments as are customary in our industry.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Donna Karan and DKNY &lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;In September 2021, we entered
into a long-term global licensing agreement for the creation, development and distribution of fragrances and fragrance-related
products under the Donna Karan and DKNY brands. Our rights under this license are subject to certain minimum advertising expenditures
and royalty payments as are customary in our industry. With this agreement, we are gaining several well-established and valuable
fragrance franchises, most notably Donna Karan &lt;i&gt;Cashmere Mist&lt;/i&gt; and DKNY &lt;i&gt;Be Delicious&lt;/i&gt;, as well as a significant loyal
consumer base around the world. In connection with the grant of license, we issued 65,342 shares of Inter Parfums, Inc. common
stock valued at $5.0 million to the licensor. The exclusive license is effective July 1, 2022, and we are planning to launch new
fragrances under these brands in 2023.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;French Tax Settlement &lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The French authorities had considered
that the existence of IP Suisse, a wholly-owned subsidiary of Interparfums SA, does not, in and of itself, constitute a permanent
establishment and therefore Interparfums SA should pay French taxes on all or part of the profits of that entity.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;In June 2021, a global settlement
agreement was reached with the French Tax Authorities, whereby Interparfums SA paid in December 2021, &#x20ac;&lt;span id="xdx_907_eus-gaap--TaxesPayableCurrentAndNoncurrent_iI_dm_uUSDEUR_c20211231__us-gaap--IncomeTaxAuthorityNameAxis__us-gaap--SwissFederalTaxAdministrationFTAMember__srt--CurrencyAxis__currency--EUR__us-gaap--TypeOfArrangementAxis__custom--GlobalSettlementAgreementMember_zgRIBUsoyBNa" title="Taxes Payable"&gt;2.5 million&lt;/span&gt; (approximately
$&lt;span id="xdx_904_eus-gaap--TaxesPayableCurrentAndNoncurrent_iI_dm_uUSD_c20211231__us-gaap--IncomeTaxAuthorityNameAxis__us-gaap--SwissFederalTaxAdministrationFTAMember__us-gaap--TypeOfArrangementAxis__custom--GlobalSettlementAgreementMember_zNa45vnyzqeh" title="Taxes Payable"&gt;2.9 million&lt;/span&gt;) effectively lowering the Lanvin brand royalty rate charged by IP Suisse for the periods from 2017 through 2020. Interparfums
SA also agreed to apply the lower rate in 2021 through 2025 and to transfer the Lanvin brand from IP Suisse to Interparfums SA
by December 31, 2025.&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Land and Building Acquisition
- Future Headquarters in Paris&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;In April 2021, Interparfums SA,
completed the acquisition of its future headquarters at 10 rue de Solf&#xe9;rino in the 7th arrondissement of Paris from the
property developer. This is an office complex combining three buildings connected by two inner courtyards, and consists of approximately
40,000 total sq. ft.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;













&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The $&lt;span id="xdx_902_eus-gaap--PaymentsForPurchaseOfOtherAssets1_pn6n6_uUSD_c20210101__20211231_zKlent8Ofh4k"&gt;142 million&lt;/span&gt; purchase price
includes the complete renovation of the site. As of December 31, 2021, $136.1 million of the purchase price, including approximately
$&lt;span id="xdx_901_eus-gaap--AcquisitionCosts_dm_uUSD_c20210101__20211231__srt--CurrencyAxis__currency--EUR_zGDIfEGVe4h6"&gt;3.1 million&lt;/span&gt; of acquisition costs, is included in property, equipment and leasehold improvements on the accompanying balance sheet
as of December 31, 2021. Approximately $&lt;span id="xdx_903_ecustom--CashHeldInEscrow_iI_dm_c20211231_zcXQAcHk90za"&gt;8.8 million&lt;/span&gt; of cash held in escrow is included in other assets on the accompanying balance
sheet as of December 31, 2021. In addition, the Company borrowed $&lt;span id="xdx_901_eus-gaap--IncomeTaxReceivable_iI_dm_c20211231__srt--CurrencyAxis__currency--EUR__us-gaap--IncomeTaxAuthorityNameAxis__us-gaap--SwissFederalTaxAdministrationFTAMember_zJZHWCo7GE88"&gt;17.0 million&lt;/span&gt; pursuant to a short-term loan equal to the VAT credit,
and in July 2021, the $&lt;span id="xdx_901_eus-gaap--InvestmentTaxCredit_dm_c20210101__20211231__srt--CurrencyAxis__currency--EUR_zykIjumC6No"&gt;17.0 million&lt;/span&gt; VAT credit was reimbursed by the French Tax Authorities and the loan was repaid.&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The acquisition was financed
by a &lt;span id="xdx_909_eus-gaap--LongTermDebtTerm_iI_dtYxL_c20211231_zEMKWpLnF5X5" title="Long-term Debt, Term::XDX::P10Y"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0880"&gt;10&lt;/span&gt;&lt;/span&gt;-year &#x20ac;&lt;span id="xdx_903_eus-gaap--LineOfCredit_iI_pn3n3_uUSDEUR_c20211231__srt--CurrencyAxis__currency--EUR_zznhm4xTa8a2" title="Long-term Line of Credit"&gt;120&lt;/span&gt; million (approximately $&lt;span id="xdx_901_eus-gaap--LineOfCredit_iI_pn3n3_c20211231_zvrHR7gWg4Hd" title="Long-term Line of Credit"&gt;136&lt;/span&gt; million) bank loan which bears interest at &lt;span id="xdx_909_eus-gaap--DebtInstrumentInterestRateTerms_c20210101__20211231_z5oqquTuhvI2" title="Debt Instrument, Interest Rate Terms"&gt;one-month Euribor plus 0.75%&lt;/span&gt;. Approximately
&#x20ac;&lt;span id="xdx_904_eus-gaap--DebtInstrumentFaceAmount_iI_pn3n3_uUSDEUR_c20211231__srt--CurrencyAxis__currency--EUR_zKK7gisjMti" title="Debt Instrument, Face Amount"&gt;80 million&lt;/span&gt; of the variable rate debt was swapped for fixed interest rate debt with a maximum interest rate of 2%.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Anna Sui Corp.&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;In January 2021, we renewed our
license agreement with Anna Sui Corp. for the creation, development and distribution of fragrance products through December&#160;31,
2026, without any material changes in terms and conditions. &lt;span id="xdx_903_ecustom--DiscriptionOfRecentAgreement_c20210101__20211231__dei--LegalEntityAxis__custom--AnnaSuiCorpMember_zUsirhIK94Na" title="Discription of recent agreement"&gt;Our initial 10-year license agreement with Anna Sui Corp. was signed
in 2011. The renewal agreement also allows for an additional 5-year term through 2031 at the option of the Company&lt;/span&gt;.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Rochas Fashion&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Effective January 1, 2021, we
entered into a new license agreement modifying our Rochas fashion business model. The new agreement calls for a reduction in royalties
to be received. As a result, in the first quarter of 2021, we took a $&lt;span id="xdx_902_eus-gaap--ImpairmentChargeOnReclassifiedAssets_dm_c20210101__20211231__dei--LegalEntityAxis__custom--RochasFashionMember_zkCLcfrr2KLe" title="Impairment Charge on Reclassified Assets"&gt;2.4 million&lt;/span&gt; impairment charge on our Rochas fashion trademark.
The new license also contains an option for the licensee to buy-out the Rochas fashion trademarks in June 2025 at its then fair
market value.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;S.T. Dupont&lt;/i&gt;&lt;/b&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;In January 2021, &lt;span id="xdx_900_eus-gaap--BusinessAcquisitionDescriptionOfAcquiredEntity_c20210101__20211231__dei--LegalEntityAxis__custom--STDupontMember_zzie8oIqQBaj" title="License agreements, description"&gt;we renewed our
license agreement with S.T. Dupont for the creation, development and distribution of fragrance products through December&#160;31,
2022, without any material changes in terms and conditions. Our initial 11-year license agreement with S.T. Dupont was signed in
June 1997 and had previously been extended through December 31, 2021.&lt;/span&gt;&lt;/p&gt;

</us-gaap:BusinessCombinationDisclosureTextBlock>
    <ipar:ScheduleOfInventoryCurrentTableTextBlock1 contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_897_ecustom--ScheduleOfInventoryCurrentTableTextBlock1_z2moVF6wOGw9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;With respect to the management
and coordination of activities related to the license agreement, the Company operates through a wholly-owned Italian subsidiary
based in Florence, that was acquired from Salvatore Ferragamo on October 1, 2021. The acquisition together with the license agreement
was accounted for as an asset acquisition. The following table summarizes the estimated fair values of the assets acquired and
liabilities assumed on October 1, 2021. &lt;span id="xdx_8BE_z60afETIDPI2"&gt;All amounts have been translated to U.S. dollars at the October 1, 2021 exchange rate.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 40%; margin-right: auto"&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 25%"&gt;Inventories&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--InventoryGross_iI_pn3n3_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--InventoryMember_zBSGsFMZ2Kmk" style="width: 12%; text-align: right" title="Inventories"&gt;17,805&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Trademarks and licenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--InventoryGross_iI_pn3n3_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksMember_zjHRtjDVGIv1" style="text-align: right"&gt;15,880&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Other assets&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--InventoryGross_iI_pn3n3_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--OtherAssetMember_zqiCMi4rBlte" style="border-bottom: Black 1pt solid; text-align: right" title="Inventory gross"&gt;3,033&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in"&gt;Assets acquired&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--FairValueOfAssetsAcquired_pn3n3_c20210101__20211231_zc7pMBCM27j7" style="border-bottom: Black 1pt solid; text-align: right" title="Assets acquired"&gt;36,718&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in"&gt;Liabilities assumed&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--LiabilitiesAssumed1_iN_di_c20210101__20211231_zYAilmIsHA5d" style="border-bottom: Black 1pt solid; text-align: right"&gt;(958&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--InventoryNet_iI_pn3n3_dxL_c20211231_znyKJ10w2TWd" style="border-bottom: Black 2pt double; text-align: right" title="Inventory net::XDX::198%2C914"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0863"&gt;35,760&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;



</ipar:ScheduleOfInventoryCurrentTableTextBlock1>
    <us-gaap:InventoryGross
      contextRef="AsOf2021-12-31_custom_InventoryMember"
      decimals="-3"
      unitRef="USD">17805000</us-gaap:InventoryGross>
    <us-gaap:InventoryGross
      contextRef="AsOf2021-12-31_us-gaap_TrademarksMember"
      decimals="-3"
      unitRef="USD">15880000</us-gaap:InventoryGross>
    <us-gaap:InventoryGross
      contextRef="AsOf2021-12-31_custom_OtherAssetMember"
      decimals="-3"
      unitRef="USD">3033000</us-gaap:InventoryGross>
    <us-gaap:FairValueOfAssetsAcquired
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="USD">36718000</us-gaap:FairValueOfAssetsAcquired>
    <us-gaap:LiabilitiesAssumed1
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="USD">958000</us-gaap:LiabilitiesAssumed1>
    <us-gaap:TaxesPayableCurrentAndNoncurrent
      contextRef="AsOf2021-12-31_us-gaap_SwissFederalTaxAdministrationFTAMember_currency_EUR_custom_GlobalSettlementAgreementMember"
      decimals="0"
      unitRef="USDEUR">2500000</us-gaap:TaxesPayableCurrentAndNoncurrent>
    <us-gaap:TaxesPayableCurrentAndNoncurrent
      contextRef="AsOf2021-12-31_us-gaap_SwissFederalTaxAdministrationFTAMember_custom_GlobalSettlementAgreementMember"
      decimals="0"
      unitRef="USD">2900000</us-gaap:TaxesPayableCurrentAndNoncurrent>
    <us-gaap:PaymentsForPurchaseOfOtherAssets1
      contextRef="From2021-01-01to2021-12-31"
      decimals="-6"
      unitRef="USD">142000000</us-gaap:PaymentsForPurchaseOfOtherAssets1>
    <us-gaap:AcquisitionCosts
      contextRef="From2021-01-012021-12-31_currency_EUR"
      decimals="0"
      unitRef="USD">3100000</us-gaap:AcquisitionCosts>
    <ipar:CashHeldInEscrow contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">8800000</ipar:CashHeldInEscrow>
    <us-gaap:IncomeTaxReceivable
      contextRef="AsOf2021-12-31_currency_EUR_us-gaap_SwissFederalTaxAdministrationFTAMember"
      decimals="0"
      unitRef="USD">17000000.0</us-gaap:IncomeTaxReceivable>
    <us-gaap:InvestmentTaxCredit
      contextRef="From2021-01-012021-12-31_currency_EUR"
      decimals="0"
      unitRef="USD">17000000.0</us-gaap:InvestmentTaxCredit>
    <us-gaap:LineOfCredit
      contextRef="AsOf2021-12-31_currency_EUR"
      decimals="-3"
      unitRef="USDEUR">120000</us-gaap:LineOfCredit>
    <us-gaap:LineOfCredit contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">136000</us-gaap:LineOfCredit>
    <us-gaap:DebtInstrumentInterestRateTerms contextRef="From2021-01-01to2021-12-31">one-month Euribor plus 0.75%</us-gaap:DebtInstrumentInterestRateTerms>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2021-12-31_currency_EUR"
      decimals="-3"
      unitRef="USDEUR">80000</us-gaap:DebtInstrumentFaceAmount>
    <ipar:DiscriptionOfRecentAgreement contextRef="From2021-01-012021-12-31_custom_AnnaSuiCorpMember">Our initial 10-year license agreement with Anna Sui Corp. was signed
in 2011. The renewal agreement also allows for an additional 5-year term through 2031 at the option of the Company</ipar:DiscriptionOfRecentAgreement>
    <us-gaap:ImpairmentChargeOnReclassifiedAssets
      contextRef="From2021-01-012021-12-31_custom_RochasFashionMember"
      decimals="0"
      unitRef="USD">2400000</us-gaap:ImpairmentChargeOnReclassifiedAssets>
    <us-gaap:BusinessAcquisitionDescriptionOfAcquiredEntity contextRef="From2021-01-012021-12-31_custom_STDupontMember">we renewed our
license agreement with S.T. Dupont for the creation, development and distribution of fragrance products through December&#160;31,
2022, without any material changes in terms and conditions. Our initial 11-year license agreement with S.T. Dupont was signed in
June 1997 and had previously been extended through December 31, 2021.</us-gaap:BusinessAcquisitionDescriptionOfAcquiredEntity>
    <us-gaap:InventoryDisclosureTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_80C_eus-gaap--InventoryDisclosureTextBlock_zbIqYjDHdHx4" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;(4)&lt;/td&gt;&lt;td&gt;&lt;span id="xdx_82A_zPVN2RmbXXAa"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p id="xdx_892_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zrRb4nJddiO5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span id="xdx_8B1_z1kNhe6Jw8G8" style="display: none; visibility: hidden"&gt;Schedule of inventories&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49F_20211231_z7oxjyUrNaij" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_492_20201231_zHh7oxh1Rru7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_407_eus-gaap--InventoryRawMaterials_iI_maINz9tx_zpDlqBeKK311" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 70%; text-align: left"&gt;Raw materials and component parts&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;111,312&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;66,492&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_408_eus-gaap--InventoryFinishedGoods_iI_maINz9tx_zO2JndZo2iN2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Finished goods&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;87,602&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;92,330&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40A_eus-gaap--InventoryNet_iI_mtINz9tx_zwskzoITkwre" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="display: none; padding-bottom: 2pt; visibility: hidden"&gt;Inventories&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2pt double; text-align: right"&gt;198,914&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2pt double; text-align: right"&gt;158,822&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;



&lt;p id="xdx_8AB_zpl8F1Ipqorb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Overhead included in inventory
aggregated $&lt;span id="xdx_90B_eus-gaap--CostOfGoodsAndServicesSoldOverhead_dm_c20210101__20211231__srt--ProductOrServiceAxis__us-gaap--ProductMember_zUYcASZwXUK5" title="Cost of Goods Sold, Overhead"&gt;3.7 million&lt;/span&gt; and $&lt;span id="xdx_902_eus-gaap--CostOfGoodsAndServicesSoldOverhead_dm_c20200101__20201231__srt--ProductOrServiceAxis__us-gaap--ProductMember_zH75RwMS2Wp3"&gt;5.4 million&lt;/span&gt; as of December 31, 2021 and 2020, respectively. Included in inventories is an inventory
reserve, which represents the difference between the cost of the inventory and its estimated realizable value, based upon sales
forecasts and the physical condition of the inventories. In addition, and as necessary, specific reserves for future known or anticipated
events may be established. Inventory reserves aggregated $&lt;span id="xdx_908_eus-gaap--InventoryValuationReserves_iI_dm_c20211231_z3HCyH8yiTr3" title="Inventory Valuation Reserves"&gt;15.8 million&lt;/span&gt; and $&lt;span id="xdx_907_eus-gaap--InventoryValuationReserves_iI_dm_c20201231_zNoSN7RlidSk" title="Inventory Valuation Reserves"&gt;9.4 million&lt;/span&gt; as of December 31, 2021 and 2020, respectively.&lt;/p&gt;

</us-gaap:InventoryDisclosureTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_892_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zrRb4nJddiO5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span id="xdx_8B1_z1kNhe6Jw8G8" style="display: none; visibility: hidden"&gt;Schedule of inventories&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49F_20211231_z7oxjyUrNaij" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_492_20201231_zHh7oxh1Rru7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_407_eus-gaap--InventoryRawMaterials_iI_maINz9tx_zpDlqBeKK311" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 70%; text-align: left"&gt;Raw materials and component parts&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;111,312&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;66,492&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_408_eus-gaap--InventoryFinishedGoods_iI_maINz9tx_zO2JndZo2iN2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Finished goods&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;87,602&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;92,330&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40A_eus-gaap--InventoryNet_iI_mtINz9tx_zwskzoITkwre" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="display: none; padding-bottom: 2pt; visibility: hidden"&gt;Inventories&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2pt double; text-align: right"&gt;198,914&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2pt double; text-align: right"&gt;158,822&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;



</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryRawMaterials contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">111312000</us-gaap:InventoryRawMaterials>
    <us-gaap:InventoryRawMaterials contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">66492000</us-gaap:InventoryRawMaterials>
    <us-gaap:InventoryFinishedGoods contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">87602000</us-gaap:InventoryFinishedGoods>
    <us-gaap:InventoryFinishedGoods contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">92330000</us-gaap:InventoryFinishedGoods>
    <us-gaap:InventoryNet contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">198914000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">158822000</us-gaap:InventoryNet>
    <us-gaap:CostOfGoodsAndServicesSoldOverhead
      contextRef="From2021-01-012021-12-31_us-gaap_ProductMember"
      decimals="0"
      unitRef="USD">3700000</us-gaap:CostOfGoodsAndServicesSoldOverhead>
    <us-gaap:CostOfGoodsAndServicesSoldOverhead
      contextRef="From2020-01-012020-12-31_us-gaap_ProductMember"
      decimals="0"
      unitRef="USD">5400000</us-gaap:CostOfGoodsAndServicesSoldOverhead>
    <us-gaap:InventoryValuationReserves contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">15800000</us-gaap:InventoryValuationReserves>
    <us-gaap:InventoryValuationReserves contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">9400000</us-gaap:InventoryValuationReserves>
    <us-gaap:FairValueDisclosuresTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_806_eus-gaap--FairValueDisclosuresTextBlock_zeSK3KGDx5I1" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;(5)&lt;/td&gt;&lt;td&gt;&lt;span id="xdx_826_zA9SG9OgExr7"&gt;Fair Value of Financial Instruments&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_895_eus-gaap--ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_zpUSsX2tZJt1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The following tables present
our financial assets and liabilities that are measured at fair value on a recurring basis and are categorized using the fair value
hierarchy. The fair value hierarchy has three levels based on the reliability of the inputs used to determine fair value.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span id="xdx_8B5_z08ZA4b1osk4" style="display: none; visibility: hidden"&gt;Schedule of fair value, assets measured on recurring basis&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_499_20211231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zip1pYCzDCQ9" style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49E_20211231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zqW8AlibTaAh" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_498_20211231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zWFQNxn7cvse" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_497_20211231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zcDrb0jEVg1h" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="color: Black"&gt;Fair
    Value Measurements at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="text-align: center; vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: right"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: right"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: right"&gt;&lt;span style="color: Black"&gt;Quoted Prices in&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: right"&gt;&lt;span style="color: Black"&gt;Significant Other&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: right"&gt;&lt;span style="color: Black"&gt;Significant&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="text-align: center; vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: right"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: right"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: right"&gt;&lt;span style="color: Black"&gt;Active Markets for&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: right"&gt;&lt;span style="color: Black"&gt;Observable&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: right"&gt;&lt;span style="color: Black"&gt;Unobservable&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="text-align: center; vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: right"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: right"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: right"&gt;&lt;span style="color: Black"&gt;Identical Assets&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: right"&gt;&lt;span style="color: Black"&gt;Inputs&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: right"&gt;&lt;span style="color: Black"&gt;Inputs&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="text-align: center; vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: right"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt; text-align: right"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="color: Black"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: right"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt; text-align: right"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="color: Black"&gt;(Level 1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: right"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt; text-align: right"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="color: Black"&gt;(Level 2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: right"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt; text-align: right"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="color: Black"&gt;(Level 3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: right"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_406_eus-gaap--AssetsFairValueDisclosureAbstract_iB_zyr2SglTMbYk" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="color: Black"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_407_eus-gaap--InvestmentsFairValueDisclosure_i01I_zoqxLledHNfl" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 38%; text-align: left; padding-bottom: 2pt; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span style="color: Black"&gt;Short-term
    investments&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2pt"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; width: 1%; text-align: left"&gt;&lt;span style="color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2pt double; width: 12%; text-align: right"&gt;&lt;span style="color: Black"&gt;160,014&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2pt; text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2pt"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; width: 1%; text-align: left"&gt;&lt;span style="color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2pt double; width: 14%; text-align: right"&gt;&lt;span style="color: Black"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0926"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2pt; text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2pt"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; width: 1%; text-align: left"&gt;&lt;span style="color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2pt double; width: 12%; text-align: right"&gt;&lt;span style="color: Black"&gt;160,014&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2pt; text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2pt"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; width: 1%; text-align: left"&gt;&lt;span style="color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2pt double; width: 12%; text-align: right"&gt;&lt;span style="color: Black"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0928"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2pt; text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_402_eus-gaap--LiabilitiesAbstract_iB_zm2i0qxAvay6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="color: Black"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_eus-gaap--ForeignCurrencyFairValueHedgeAssetAtFairValue_i01I_zyZJXYtQXuE5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span style="color: Black"&gt;Foreign currency forward
    exchange contracts accounted for using hedge accounting&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="color: Black"&gt;1,982&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="color: Black"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0936"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="color: Black"&gt;1,982&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="color: Black"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0938"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_eus-gaap--ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue_i01I_zeqSL4COBFL7" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0.375in; text-indent: -0.125in"&gt;&lt;span style="color: Black"&gt;Foreign currency forward
    exchange contracts not accounted for using hedge accounting&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="color: Black"&gt;63&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="color: Black"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0941"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="color: Black"&gt;63&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;$&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="color: Black"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0943"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40A_eus-gaap--DerivativeLiabilities_iI_zoek8SC7XOo4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span style="color: Black"&gt;Interest
    rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #FF0000; padding-bottom: 1pt"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #FF0000; text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #FF0000; text-align: right"&gt;&lt;span style="color: Black"&gt;(234&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; color: #FF0000; text-align: left"&gt;&lt;span style="color: Black"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="color: Black"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0946"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #FF0000; padding-bottom: 1pt"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #FF0000; text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #FF0000; text-align: right"&gt;&lt;span style="color: Black"&gt;(234&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; color: #FF0000; text-align: left"&gt;&lt;span style="color: Black"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="color: Black"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0948"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_405_eus-gaap--AssetsFairValueDisclosure_iI_zgWf1xgKXWnd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2pt; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; text-align: left"&gt;&lt;span style="color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2pt double; text-align: right"&gt;&lt;span style="color: Black"&gt;1,811&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; text-align: left"&gt;&lt;span style="color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2pt double; text-align: right"&gt;&lt;span style="color: Black"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0951"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; text-align: left"&gt;&lt;span style="color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2pt double; text-align: right"&gt;&lt;span style="color: Black"&gt;1,811&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; text-align: left"&gt;&lt;span style="color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2pt double; text-align: right"&gt;&lt;span style="color: Black"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0953"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_494_20201231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_z7FyXXMlbJxf" style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49D_20201231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z1vV2kJH9DG3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_490_20201231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zeDZ9U0lgoDj" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49C_20201231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zDh2rS24njTf" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Fair Value Measurements at December 31, 2020&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right; padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: right"&gt;Quoted Prices in&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: right"&gt;Significant Other&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: right"&gt;Significant&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right; padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: right"&gt;Active Markets for&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: right"&gt;Observable&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: right"&gt;Unobservable&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right; padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: right"&gt;Identical Assets&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: right"&gt;Inputs&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: right"&gt;Inputs&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right; padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;(Level 1)&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;(Level 2)&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;(Level 3)&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_406_eus-gaap--AssetsFairValueDisclosureAbstract_iB_zPVcHzGl6kc1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;Assets:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_407_eus-gaap--InvestmentsFairValueDisclosure_i01I_zFWk88u7lgO3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 38%; text-align: left; padding-left: 0.25in; text-indent: -0.125in"&gt;Short-term investments&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;126,627&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0961"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;126,627&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0963"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_eus-gaap--ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue_i01I_zT4hr1fpmTaj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 0.25in; text-indent: -0.125in"&gt;Foreign currency forward exchange contracts not accounted for using hedge accounting&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;253&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0966"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;253&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0968"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_403_eus-gaap--AssetsFairValueDisclosure_i01I_zonVrdkYao88" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="display: none; padding-bottom: 2pt; padding-left: 0.125in; text-indent: -0.125in; visibility: hidden"&gt;&#160;Total Assets&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2pt double; text-align: right"&gt;126,880&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0971"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2pt double; text-align: right"&gt;126,880&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0973"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;



&lt;p id="xdx_8A0_zwDNJddXG2Yl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The carrying amount of cash and
cash equivalents including money market funds, short-term investments including marketable equity securities, accounts receivable,
other receivables, accounts payable and accrued expenses approximates fair value due to the short terms to maturity of these instruments.
The carrying amount of loans payable approximates fair value as the variable interest rates on the Company&#x2019;s indebtedness
approximate current market rates.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

















&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Foreign currency forward exchange
contracts are valued based on quotations from financial institutions and the value of interest rate swaps are the discounted net
present value of the swaps using third party quotes from financial institutions.&lt;/p&gt;

</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_895_eus-gaap--ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_zpUSsX2tZJt1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The following tables present
our financial assets and liabilities that are measured at fair value on a recurring basis and are categorized using the fair value
hierarchy. The fair value hierarchy has three levels based on the reliability of the inputs used to determine fair value.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span id="xdx_8B5_z08ZA4b1osk4" style="display: none; visibility: hidden"&gt;Schedule of fair value, assets measured on recurring basis&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_499_20211231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zip1pYCzDCQ9" style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49E_20211231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zqW8AlibTaAh" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_498_20211231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zWFQNxn7cvse" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_497_20211231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zcDrb0jEVg1h" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="color: Black"&gt;Fair
    Value Measurements at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="text-align: center; vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: right"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: right"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: right"&gt;&lt;span style="color: Black"&gt;Quoted Prices in&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: right"&gt;&lt;span style="color: Black"&gt;Significant Other&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: right"&gt;&lt;span style="color: Black"&gt;Significant&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="text-align: center; vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: right"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: right"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: right"&gt;&lt;span style="color: Black"&gt;Active Markets for&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: right"&gt;&lt;span style="color: Black"&gt;Observable&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: right"&gt;&lt;span style="color: Black"&gt;Unobservable&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="text-align: center; vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: right"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: right"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: right"&gt;&lt;span style="color: Black"&gt;Identical Assets&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: right"&gt;&lt;span style="color: Black"&gt;Inputs&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: right"&gt;&lt;span style="color: Black"&gt;Inputs&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="text-align: center; vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: right"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt; text-align: right"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="color: Black"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: right"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt; text-align: right"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="color: Black"&gt;(Level 1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: right"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt; text-align: right"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="color: Black"&gt;(Level 2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: right"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt; text-align: right"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="color: Black"&gt;(Level 3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: right"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_406_eus-gaap--AssetsFairValueDisclosureAbstract_iB_zyr2SglTMbYk" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="color: Black"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_407_eus-gaap--InvestmentsFairValueDisclosure_i01I_zoqxLledHNfl" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 38%; text-align: left; padding-bottom: 2pt; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span style="color: Black"&gt;Short-term
    investments&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2pt"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; width: 1%; text-align: left"&gt;&lt;span style="color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2pt double; width: 12%; text-align: right"&gt;&lt;span style="color: Black"&gt;160,014&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2pt; text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2pt"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; width: 1%; text-align: left"&gt;&lt;span style="color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2pt double; width: 14%; text-align: right"&gt;&lt;span style="color: Black"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0926"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2pt; text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2pt"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; width: 1%; text-align: left"&gt;&lt;span style="color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2pt double; width: 12%; text-align: right"&gt;&lt;span style="color: Black"&gt;160,014&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2pt; text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2pt"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; width: 1%; text-align: left"&gt;&lt;span style="color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2pt double; width: 12%; text-align: right"&gt;&lt;span style="color: Black"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0928"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2pt; text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_402_eus-gaap--LiabilitiesAbstract_iB_zm2i0qxAvay6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="color: Black"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_eus-gaap--ForeignCurrencyFairValueHedgeAssetAtFairValue_i01I_zyZJXYtQXuE5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span style="color: Black"&gt;Foreign currency forward
    exchange contracts accounted for using hedge accounting&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="color: Black"&gt;1,982&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="color: Black"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0936"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="color: Black"&gt;1,982&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="color: Black"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0938"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_eus-gaap--ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue_i01I_zeqSL4COBFL7" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0.375in; text-indent: -0.125in"&gt;&lt;span style="color: Black"&gt;Foreign currency forward
    exchange contracts not accounted for using hedge accounting&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="color: Black"&gt;63&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="color: Black"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0941"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="color: Black"&gt;63&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;$&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="color: Black"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0943"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40A_eus-gaap--DerivativeLiabilities_iI_zoek8SC7XOo4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span style="color: Black"&gt;Interest
    rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #FF0000; padding-bottom: 1pt"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #FF0000; text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #FF0000; text-align: right"&gt;&lt;span style="color: Black"&gt;(234&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; color: #FF0000; text-align: left"&gt;&lt;span style="color: Black"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="color: Black"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0946"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #FF0000; padding-bottom: 1pt"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #FF0000; text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #FF0000; text-align: right"&gt;&lt;span style="color: Black"&gt;(234&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; color: #FF0000; text-align: left"&gt;&lt;span style="color: Black"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="color: Black"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0948"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_405_eus-gaap--AssetsFairValueDisclosure_iI_zgWf1xgKXWnd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2pt; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; text-align: left"&gt;&lt;span style="color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2pt double; text-align: right"&gt;&lt;span style="color: Black"&gt;1,811&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; text-align: left"&gt;&lt;span style="color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2pt double; text-align: right"&gt;&lt;span style="color: Black"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0951"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; text-align: left"&gt;&lt;span style="color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2pt double; text-align: right"&gt;&lt;span style="color: Black"&gt;1,811&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; text-align: left"&gt;&lt;span style="color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2pt double; text-align: right"&gt;&lt;span style="color: Black"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0953"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_494_20201231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_z7FyXXMlbJxf" style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49D_20201231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z1vV2kJH9DG3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_490_20201231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zeDZ9U0lgoDj" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49C_20201231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zDh2rS24njTf" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Fair Value Measurements at December 31, 2020&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right; padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: right"&gt;Quoted Prices in&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: right"&gt;Significant Other&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: right"&gt;Significant&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right; padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: right"&gt;Active Markets for&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: right"&gt;Observable&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: right"&gt;Unobservable&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right; padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: right"&gt;Identical Assets&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: right"&gt;Inputs&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: right"&gt;Inputs&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right; padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;(Level 1)&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;(Level 2)&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;(Level 3)&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_406_eus-gaap--AssetsFairValueDisclosureAbstract_iB_zPVcHzGl6kc1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;Assets:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_407_eus-gaap--InvestmentsFairValueDisclosure_i01I_zFWk88u7lgO3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 38%; text-align: left; padding-left: 0.25in; text-indent: -0.125in"&gt;Short-term investments&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;126,627&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0961"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;126,627&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0963"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_eus-gaap--ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue_i01I_zT4hr1fpmTaj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 0.25in; text-indent: -0.125in"&gt;Foreign currency forward exchange contracts not accounted for using hedge accounting&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;253&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0966"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;253&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0968"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_403_eus-gaap--AssetsFairValueDisclosure_i01I_zonVrdkYao88" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="display: none; padding-bottom: 2pt; padding-left: 0.125in; text-indent: -0.125in; visibility: hidden"&gt;&#160;Total Assets&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2pt double; text-align: right"&gt;126,880&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0971"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2pt double; text-align: right"&gt;126,880&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0973"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;



</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="AsOf2021-12-31_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-3"
      unitRef="USD">160014000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="AsOf2021-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel2Member"
      decimals="-3"
      unitRef="USD">160014000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:ForeignCurrencyFairValueHedgeAssetAtFairValue
      contextRef="AsOf2021-12-31_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-3"
      unitRef="USD">1982000</us-gaap:ForeignCurrencyFairValueHedgeAssetAtFairValue>
    <us-gaap:ForeignCurrencyFairValueHedgeAssetAtFairValue
      contextRef="AsOf2021-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel2Member"
      decimals="-3"
      unitRef="USD">1982000</us-gaap:ForeignCurrencyFairValueHedgeAssetAtFairValue>
    <us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue
      contextRef="AsOf2021-12-31_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-3"
      unitRef="USD">63000</us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue>
    <us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue
      contextRef="AsOf2021-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel2Member"
      decimals="-3"
      unitRef="USD">63000</us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue>
    <us-gaap:DerivativeLiabilities
      contextRef="AsOf2021-12-31_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-3"
      unitRef="USD">-234000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="AsOf2021-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel2Member"
      decimals="-3"
      unitRef="USD">-234000</us-gaap:DerivativeLiabilities>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2021-12-31_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-3"
      unitRef="USD">1811000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2021-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel2Member"
      decimals="-3"
      unitRef="USD">1811000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="AsOf2020-12-31_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-3"
      unitRef="USD">126627000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="AsOf2020-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel2Member"
      decimals="-3"
      unitRef="USD">126627000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue
      contextRef="AsOf2020-12-31_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-3"
      unitRef="USD">253000</us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue>
    <us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue
      contextRef="AsOf2020-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel2Member"
      decimals="-3"
      unitRef="USD">253000</us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2020-12-31_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-3"
      unitRef="USD">126880000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2020-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel2Member"
      decimals="-3"
      unitRef="USD">126880000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_807_eus-gaap--DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_zn5M6Z8fNke4" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;(6)&lt;/td&gt;&lt;td&gt;&lt;span id="xdx_82E_zfnjnKZXosil"&gt;Derivative Financial Instruments&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Company enters into foreign
currency forward exchange contracts to hedge exposure related to receivables denominated in a foreign currency and occasionally
to manage risks related to future sales expected to be denominated in a foreign currency. Before entering into a derivative transaction
for hedging purposes, it is determined that a high degree of initial effectiveness exists between the change in value of the hedged
item and the change in the value of the derivative instrument from movement in exchange rates. High effectiveness means that the
change in the cash flows of the derivative instrument will effectively offset the change in the cash flows of the hedged item.
The effectiveness of each hedged item is measured throughout the hedged period and is based on the dollar offset methodology and
excludes the portion of the fair value of the foreign currency forward exchange contract attributable to the change in spot-forward
difference which is reported in current period earnings. Any hedge ineffectiveness is also recognized as a gain or loss on foreign
currency in the income statement. For hedge contracts that are no longer deemed highly effective, hedge accounting is discontinued,
and gains and losses accumulated in other comprehensive income are reclassified to earnings.&#160;If it is probable that the forecasted
transaction will no longer occur, then any gains or losses accumulated in other comprehensive income are reclassified to current-period
earnings.&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Gains and losses in derivatives
designated as hedges are accumulated in other comprehensive income (loss) and gains and losses in derivatives not designated as
hedges are included in (gain) loss on foreign currency on the accompanying income statements. Such gains and losses were immaterial
in each of the years in the three-year period ended December 31, 2021. For the year ended December 31, 2021, interest expense
includes a gain of $0.2 million, resulting from an interest rate swap.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;All derivative instruments are
reported as either assets or liabilities on the balance sheet measured at fair value. The valuation of interest rate swap is included
in long-term debt on the accompanying balance sheets. The valuation of foreign currency forward exchange contracts at December
31, 2021 and December 31, 2020, resulted in an asset and is included in other current assets on the accompanying balance sheets.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;At December&#160;31, 2021, the
Company had foreign currency contracts in the form of forward exchange contracts with notional amounts of approximately U.S. $&lt;span id="xdx_902_eus-gaap--ForeignCurrencyContractsLiabilityFairValueDisclosure_iI_dm_uUSD_c20211231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--ForeignExchangeContractMember_zUrDW8nAWuge" title="Foreign currency contracts, liability, fair value disclosure"&gt;64.5 million&lt;/span&gt;
and GB &#xa3;&lt;span id="xdx_90C_eus-gaap--ForeignCurrencyContractsLiabilityFairValueDisclosure_iI_dm_uUSDGBP_c20211231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--ForeignExchangeContractMember_zJaINp4y5hvi" title="Foreign currency contracts, liability, fair value disclosure"&gt;3.5 million&lt;/span&gt;, which all have maturities of less than one year.&lt;/p&gt;

</us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock>
    <us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure
      contextRef="AsOf2021-12-31_us-gaap_ForeignExchangeContractMember"
      decimals="0"
      unitRef="USD">64500000</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure
      contextRef="AsOf2021-12-31_us-gaap_ForeignExchangeContractMember"
      decimals="0"
      unitRef="USDGBP">3500000</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_805_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_zmpCiBz5yz8l" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;(7)&lt;/td&gt;&lt;td&gt;&lt;span id="xdx_828_zi19mCmjwIk4"&gt;Property, Equipment and Leasehold Improvements&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p id="xdx_893_eus-gaap--PropertyPlantAndEquipmentTextBlock_z0bRjPUIflOc" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span id="xdx_8B4_zOApWi6icI86" style="display: none; visibility: hidden"&gt;Schedule of equipment and leasehold improvements&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 70%; text-align: left"&gt;Land and Building (construction in progress)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_zmu1pZyIhen" style="width: 12%; text-align: right" title="Equipment and leasehold improvements"&gt;136,131&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_zOhwooYlLtD9" style="width: 12%; text-align: right" title="Equipment and leasehold improvements"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0994"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Equipment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_zatqLbXfqFpb" style="text-align: right" title="Equipment and leasehold improvements"&gt;52,036&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_zkNXbvmrPpxj" style="text-align: right"&gt;51,060&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Leasehold improvements&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zvYoPZIRifaa" style="border-bottom: Black 1pt solid; text-align: right" title="Equipment and leasehold improvements"&gt;2,082&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zsgKJCxMc6Le" style="border-bottom: Black 1pt solid; text-align: right" title="Equipment and leasehold improvements"&gt;1,989&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20211231_zvVH0RSWRkT8" style="text-align: right"&gt;190,249&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20201231_z3jZry9HRNR7" style="text-align: right"&gt;53,049&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Less accumulated depreciation and amortization&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_c20211231_zDfPC239o3jk" style="border-bottom: Black 1pt solid; text-align: right" title="Less accumulated depreciation and amortization"&gt;40,897&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_c20201231_zSdQ2fOjLqy6" style="border-bottom: Black 1pt solid; text-align: right" title="Less accumulated depreciation and amortization"&gt;33,469&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentNet_iI_c20211231_z5MQFrRc4331" style="border-bottom: Black 2pt double; text-align: right" title="Property, Plant and Equipment, Net, Total"&gt;149,352&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentNet_iI_c20201231_zDkyy5vp5BN7" style="border-bottom: Black 2pt double; text-align: right" title="Property, Plant and Equipment, Net, Total"&gt;19,580&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Depreciation and amortization
expense was $&lt;span id="xdx_903_eus-gaap--DepreciationDepletionAndAmortization_dm_c20210101__20211231_zWBF7I9UTu97" title="Depreciation and amortization expense"&gt;4.4 million&lt;/span&gt;, $&lt;span id="xdx_905_eus-gaap--DepreciationDepletionAndAmortization_dm_c20200101__20201231_znvTPsO5y99e" title="Depreciation and amortization expense"&gt;3.8 million&lt;/span&gt; and $&lt;span id="xdx_904_eus-gaap--DepreciationDepletionAndAmortization_dm_c20190101__20191231_zRKLfsHBp3Gd" title="Depreciation and amortization expense"&gt;3.7 million&lt;/span&gt; in 2021, 2020, and 2019, respectively.&lt;/p&gt;

&lt;p id="xdx_8A8_zZYWZciLiWU7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_893_eus-gaap--PropertyPlantAndEquipmentTextBlock_z0bRjPUIflOc" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span id="xdx_8B4_zOApWi6icI86" style="display: none; visibility: hidden"&gt;Schedule of equipment and leasehold improvements&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 70%; text-align: left"&gt;Land and Building (construction in progress)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_zmu1pZyIhen" style="width: 12%; text-align: right" title="Equipment and leasehold improvements"&gt;136,131&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_zOhwooYlLtD9" style="width: 12%; text-align: right" title="Equipment and leasehold improvements"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0994"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Equipment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_zatqLbXfqFpb" style="text-align: right" title="Equipment and leasehold improvements"&gt;52,036&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_zkNXbvmrPpxj" style="text-align: right"&gt;51,060&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Leasehold improvements&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zvYoPZIRifaa" style="border-bottom: Black 1pt solid; text-align: right" title="Equipment and leasehold improvements"&gt;2,082&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zsgKJCxMc6Le" style="border-bottom: Black 1pt solid; text-align: right" title="Equipment and leasehold improvements"&gt;1,989&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20211231_zvVH0RSWRkT8" style="text-align: right"&gt;190,249&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20201231_z3jZry9HRNR7" style="text-align: right"&gt;53,049&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Less accumulated depreciation and amortization&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_c20211231_zDfPC239o3jk" style="border-bottom: Black 1pt solid; text-align: right" title="Less accumulated depreciation and amortization"&gt;40,897&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_c20201231_zSdQ2fOjLqy6" style="border-bottom: Black 1pt solid; text-align: right" title="Less accumulated depreciation and amortization"&gt;33,469&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentNet_iI_c20211231_z5MQFrRc4331" style="border-bottom: Black 2pt double; text-align: right" title="Property, Plant and Equipment, Net, Total"&gt;149,352&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentNet_iI_c20201231_zDkyy5vp5BN7" style="border-bottom: Black 2pt double; text-align: right" title="Property, Plant and Equipment, Net, Total"&gt;19,580&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Depreciation and amortization
expense was $&lt;span id="xdx_903_eus-gaap--DepreciationDepletionAndAmortization_dm_c20210101__20211231_zWBF7I9UTu97" title="Depreciation and amortization expense"&gt;4.4 million&lt;/span&gt;, $&lt;span id="xdx_905_eus-gaap--DepreciationDepletionAndAmortization_dm_c20200101__20201231_znvTPsO5y99e" title="Depreciation and amortization expense"&gt;3.8 million&lt;/span&gt; and $&lt;span id="xdx_904_eus-gaap--DepreciationDepletionAndAmortization_dm_c20190101__20191231_zRKLfsHBp3Gd" title="Depreciation and amortization expense"&gt;3.7 million&lt;/span&gt; in 2021, 2020, and 2019, respectively.&lt;/p&gt;

</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2021-12-31_us-gaap_BuildingMember"
      decimals="-3"
      unitRef="USD">136131000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2021-12-31_us-gaap_EquipmentMember"
      decimals="-3"
      unitRef="USD">52036000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2020-12-31_us-gaap_EquipmentMember"
      decimals="-3"
      unitRef="USD">51060000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2021-12-31_us-gaap_LeaseholdImprovementsMember"
      decimals="-3"
      unitRef="USD">2082000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2020-12-31_us-gaap_LeaseholdImprovementsMember"
      decimals="-3"
      unitRef="USD">1989000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">190249000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">53049000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">40897000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">33469000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">149352000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">19580000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">4400000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">3800000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="From2019-01-012019-12-31"
      decimals="0"
      unitRef="USD">3700000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:IntangibleAssetsDisclosureTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_80C_eus-gaap--IntangibleAssetsDisclosureTextBlock_zASYfjfS08qk" style="margin-top: 0; margin-bottom: 0"/&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;(8)&lt;/td&gt;&lt;td&gt;&lt;span id="xdx_823_ztId1nKE5Sgb"&gt;Trademarks, Licenses and Other Intangible Assets&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p id="xdx_890_eus-gaap--ScheduleOfImpairedIntangibleAssetsTextBlock_zuBsXwYVrou3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span id="xdx_8B9_zFTNgX7e9xii" style="display: none; visibility: hidden"&gt;Schedule of trademarks, licenses and other intangible assets&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;2021&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Gross&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Accumulated&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Net Book&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Amount&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Amortization&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Value&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 55%; text-align: left; padding-bottom: 1pt"&gt;Trademarks (indefinite lives)&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--IndefinitelivedIntangibleAssetsMember_zu1V8Hk54jCl" style="border-bottom: Black 1pt solid; width: 12%; text-align: right" title="Gross Amount"&gt;119,712&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--IndefinitelivedIntangibleAssetsMember_z4V7kKkHlkBi" style="border-bottom: Black 1pt solid; width: 12%; text-align: right" title="Accumulated Amortization"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1025"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--IndefinitelivedIntangibleAssetsMember_zrketUL9HUY7" style="border-bottom: Black 1pt solid; width: 12%; text-align: right" title="Net Book Value"&gt;119,712&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Trademarks (finite lives)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--FiniteLivedIntangibleAssetsMember_zZCIY8a9jTg" style="text-align: right"&gt;43,820&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--FiniteLivedIntangibleAssetsMember_zqIUcyJ0BHma" style="text-align: right"&gt;68&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--FiniteLivedIntangibleAssetsMember_zmtxuWrqpXn9" style="text-align: right"&gt;43,752&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Licenses (finite lives)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--LicensesMember_zx0fSCvbMOrb" style="text-align: right"&gt;109,682&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--LicensesMember_z8jsBqvtrboj" style="text-align: right"&gt;62,286&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--LicensesMember_z0VnQSfTgOJ7" style="text-align: right"&gt;47,396&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Other intangible assets (finite lives)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_zjSRkZdrdQo9" style="border-bottom: Black 1pt solid; text-align: right"&gt;17,775&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_zJrZNrlcE1S6" style="border-bottom: Black 1pt solid; text-align: right"&gt;14,588&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_ztASP3x639Q5" style="border-bottom: Black 1pt solid; text-align: right"&gt;3,187&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 0.125in"&gt;Subtotal&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20211231__us-gaap--FairValueByAssetClassAxis__custom--SubtotalMember_zjAApMVnkPLe" style="border-bottom: Black 1pt solid; text-align: right"&gt;171,277&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20211231__us-gaap--FairValueByAssetClassAxis__custom--SubtotalMember_z5aaCPnWhZl8" style="border-bottom: Black 1pt solid; text-align: right"&gt;76,942&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20211231__us-gaap--FairValueByAssetClassAxis__custom--SubtotalMember_zeq888yvAzid" style="border-bottom: Black 1pt solid; text-align: right"&gt;94,335&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2pt; padding-left: 0.25in"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20211231_zd8wUtrQItc6" style="border-bottom: Black 2pt double; text-align: right"&gt;290,989&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20211231_zzWg0TC4opf" style="border-bottom: Black 2pt double; text-align: right"&gt;76,942&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20211231_z1ERowanMjXi" style="border-bottom: Black 2pt double; text-align: right"&gt;214,047&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;2020&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Gross&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Accumulated&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Net Book&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Amount&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Amortization&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Value&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 55%; text-align: left; padding-bottom: 1pt"&gt;Trademarks (indefinite lives)&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20201231__us-gaap--FairValueByAssetClassAxis__us-gaap--IndefinitelivedIntangibleAssetsMember_zybGBplDjgM9" style="border-bottom: Black 1pt solid; width: 12%; text-align: right"&gt;131,962&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20201231__us-gaap--FairValueByAssetClassAxis__us-gaap--IndefinitelivedIntangibleAssetsMember_zFwzKYV0hDvc" style="border-bottom: Black 1pt solid; width: 12%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1044"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20201231__us-gaap--FairValueByAssetClassAxis__us-gaap--IndefinitelivedIntangibleAssetsMember_z69xLvALNKe3" style="border-bottom: Black 1pt solid; width: 12%; text-align: right"&gt;131,962&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Trademarks (finite lives)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20201231__us-gaap--FairValueByAssetClassAxis__us-gaap--FiniteLivedIntangibleAssetsMember_ziaV74qg3lCi" style="text-align: right"&gt;47,477&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20201231__us-gaap--FairValueByAssetClassAxis__us-gaap--FiniteLivedIntangibleAssetsMember_zhPRtVWM8tI9" style="text-align: right"&gt;74&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20201231__us-gaap--FairValueByAssetClassAxis__us-gaap--FiniteLivedIntangibleAssetsMember_zq8HaJkzhfVg" style="text-align: right"&gt;47,403&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Licenses (finite lives)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20201231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--LicensesMember_zrAhzOIqgkPe" style="text-align: right"&gt;93,248&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20201231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--LicensesMember_zwz01IMDZW7k" style="text-align: right"&gt;62,262&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20201231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--LicensesMember_zMyp1St5uT12" style="text-align: right"&gt;30,986&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Other intangible assets (finite lives)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20201231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_zGlN5ArnoJh9" style="border-bottom: Black 1pt solid; text-align: right"&gt;18,194&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20201231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_zlfX60VP3edg" style="border-bottom: Black 1pt solid; text-align: right"&gt;14,437&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20201231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_zfKTGxO0jFGd" style="border-bottom: Black 1pt solid; text-align: right"&gt;3,757&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 0.125in"&gt;Subtotal&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20201231__us-gaap--FairValueByAssetClassAxis__custom--SubtotalMember_zWGERQGgcGBg" style="border-bottom: Black 1pt solid; text-align: right"&gt;158,919&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20201231__us-gaap--FairValueByAssetClassAxis__custom--SubtotalMember_zVbjRD3OU4hd" style="border-bottom: Black 1pt solid; text-align: right"&gt;76,773&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20201231__us-gaap--FairValueByAssetClassAxis__custom--SubtotalMember_zoZ4PHhbS7N2" style="border-bottom: Black 1pt solid; text-align: right"&gt;82,146&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2pt; padding-left: 0.25in"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20201231_zlKDRBTRgzJ3" style="border-bottom: Black 2pt double; text-align: right"&gt;290,881&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20201231_znLLbaAQ7M08" style="border-bottom: Black 2pt double; text-align: right"&gt;76,773&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20201231_zLiIvgLQitT7" style="border-bottom: Black 2pt double; text-align: right"&gt;214,108&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;



&lt;p id="xdx_8AC_zDFVvg2vAF1k" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Amortization expense was $&lt;span id="xdx_909_eus-gaap--AmortizationOfIntangibleAssets_dm_c20210101__20211231_zRzN3UNpNi5e"&gt;5.9
million&lt;/span&gt;, $&lt;span id="xdx_90B_eus-gaap--AmortizationOfIntangibleAssets_dm_c20200101__20201231_zPvqgT6L9bEl"&gt;5.3 million&lt;/span&gt; and $&lt;span id="xdx_906_eus-gaap--AmortizationOfIntangibleAssets_dm_c20190101__20191231_zkalSNE8NOt6"&gt;5.0 million&lt;/span&gt; in 2021, 2020 and 2019, respectively. Amortization expense is expected to approximate $&lt;span id="xdx_90D_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_dm_c20211231_zn6kMfoB5nHe"&gt;5.4
million&lt;/span&gt; in 2022, $&lt;span id="xdx_90C_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_dm_c20211231_zYkWq6jGK7U2"&gt;4.4 million&lt;/span&gt; in 2023, $&lt;span id="xdx_90E_ecustom--FiniteLivedIntangibleAssetsAmortizationExpenseAfterTwoYears_iI_dm_c20211231_zjDLtvIn6nv1"&gt;4.2 million&lt;/span&gt; in 2024, 2025 and 2026. The weighted average amortization period for trademarks,
licenses and other intangible assets with finite lives are &lt;span id="xdx_904_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dxL_c20210101__20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksMember_zkGjhOUrG502" title="Amortization period::XDX::P8Y"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1068"&gt;18&lt;/span&gt;&lt;/span&gt; years, &lt;span id="xdx_906_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dxL_c20210101__20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--LicensesMember_zk26A5A30yn8" title="::XDX::P15Y"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1069"&gt;15&lt;/span&gt;&lt;/span&gt; years and &lt;span id="xdx_905_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dxL_c20210101__20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_zSXQI9V2pbu2" title="::XDX::P2Y"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1070"&gt;2&lt;/span&gt;&lt;/span&gt; years, respectively, and &lt;span id="xdx_90F_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dxL_c20210101__20211231_zlBlcV0rOLf2" title="::XDX::P14Y"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1071"&gt;14&lt;/span&gt;&lt;/span&gt; years on average.&lt;/p&gt;



















&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Company reviews intangible
assets with indefinite lives for impairment whenever events or changes in circumstances indicate that the carrying amount may not
be recoverable. There was an impairment charge for trademarks with indefinite useful lives of $&lt;span id="xdx_90E_eus-gaap--AmortizationOfIntangibleAssets_dm_c20210101__20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--IndefinitelivedIntangibleAssetsMember_zwbHZTD4I777"&gt;2.4 million&lt;/span&gt; in 2021 relating to
our Rochas fashion business. The fair values used in our evaluations are estimated based upon discounted future cash flow projections
using a weighted average cost of capital of &lt;span id="xdx_901_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_dp_c20211231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountRateMember_zygYPPsPyuSc" title="Weighted average cost of capital"&gt;7.47&lt;/span&gt;%, &lt;span id="xdx_904_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_dp_c20201231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountRateMember_zVklY56kLe9c"&gt;6.99&lt;/span&gt;%, and &lt;span id="xdx_904_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_dp_c20191231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountRateMember_zZGJVZLsjdC6"&gt;7.94&lt;/span&gt;% as of December 31, 2021, 2020 and 2019, respectively. The cash
flow projections are based upon a number of assumptions, including, future sales levels and future cost of goods and operating
expense levels, as well as economic conditions, changes to our business model or changes in consumer acceptance of our products
which are more subjective in nature. The Company believes that the assumptions it has made in projecting future cash flows for
the evaluations described above are reasonable and currently no other impairment indicators exist for our indefinite-lived assets.
However, if future actual results do not meet our expectations, the Company may be required to record an impairment charge, the
amount of which could be material to our results of operations.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The cost of trademarks, licenses
and other intangible assets with finite lives is being amortized by the straight-line method over the term of the respective license
or the intangible assets estimated useful life which range from &lt;span id="xdx_906_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dxL_c20210101__20211231__srt--RangeAxis__srt--MinimumMember_zsFW3oxRvSE8" title="Amortization period::XDX::P3Y"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1086"&gt;three&lt;/span&gt;&lt;/span&gt; to &lt;span id="xdx_90A_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dxL_c20210101__20211231__srt--RangeAxis__srt--MaximumMember_z50AU7FdbDm" title="Amortization period::XDX::P20Y"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1088"&gt;twenty years&lt;/span&gt;&lt;/span&gt;. If the residual value of a finite life intangible
asset exceeds its carrying value, then the asset is not amortized. The Company reviews intangible assets with finite lives for
impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Trademarks (finite lives) primarily
represent Lanvin brand names and trademarks and in connection with their purchase, Lanvin was granted the right to repurchase the
brand names and trademarks on July 1, 2027 for &#x20ac;70 million (approximately $&lt;span id="xdx_905_eus-gaap--IndefiniteLivedLicenseAgreements_iI_pn6n6_c20211231_zDWDHEBoYp44"&gt;79&lt;/span&gt; million) (residual value) in accordance with
an amendment signed in 2021. Because the residual value of the intangible asset exceeds its carrying value, the asset is not being
amortized.&lt;/p&gt;

</us-gaap:IntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfImpairedIntangibleAssetsTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_890_eus-gaap--ScheduleOfImpairedIntangibleAssetsTextBlock_zuBsXwYVrou3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span id="xdx_8B9_zFTNgX7e9xii" style="display: none; visibility: hidden"&gt;Schedule of trademarks, licenses and other intangible assets&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;2021&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Gross&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Accumulated&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Net Book&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Amount&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Amortization&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Value&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 55%; text-align: left; padding-bottom: 1pt"&gt;Trademarks (indefinite lives)&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--IndefinitelivedIntangibleAssetsMember_zu1V8Hk54jCl" style="border-bottom: Black 1pt solid; width: 12%; text-align: right" title="Gross Amount"&gt;119,712&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--IndefinitelivedIntangibleAssetsMember_z4V7kKkHlkBi" style="border-bottom: Black 1pt solid; width: 12%; text-align: right" title="Accumulated Amortization"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1025"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--IndefinitelivedIntangibleAssetsMember_zrketUL9HUY7" style="border-bottom: Black 1pt solid; width: 12%; text-align: right" title="Net Book Value"&gt;119,712&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Trademarks (finite lives)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--FiniteLivedIntangibleAssetsMember_zZCIY8a9jTg" style="text-align: right"&gt;43,820&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--FiniteLivedIntangibleAssetsMember_zqIUcyJ0BHma" style="text-align: right"&gt;68&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--FiniteLivedIntangibleAssetsMember_zmtxuWrqpXn9" style="text-align: right"&gt;43,752&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Licenses (finite lives)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--LicensesMember_zx0fSCvbMOrb" style="text-align: right"&gt;109,682&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--LicensesMember_z8jsBqvtrboj" style="text-align: right"&gt;62,286&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--LicensesMember_z0VnQSfTgOJ7" style="text-align: right"&gt;47,396&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Other intangible assets (finite lives)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_zjSRkZdrdQo9" style="border-bottom: Black 1pt solid; text-align: right"&gt;17,775&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_zJrZNrlcE1S6" style="border-bottom: Black 1pt solid; text-align: right"&gt;14,588&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_ztASP3x639Q5" style="border-bottom: Black 1pt solid; text-align: right"&gt;3,187&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 0.125in"&gt;Subtotal&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20211231__us-gaap--FairValueByAssetClassAxis__custom--SubtotalMember_zjAApMVnkPLe" style="border-bottom: Black 1pt solid; text-align: right"&gt;171,277&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20211231__us-gaap--FairValueByAssetClassAxis__custom--SubtotalMember_z5aaCPnWhZl8" style="border-bottom: Black 1pt solid; text-align: right"&gt;76,942&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20211231__us-gaap--FairValueByAssetClassAxis__custom--SubtotalMember_zeq888yvAzid" style="border-bottom: Black 1pt solid; text-align: right"&gt;94,335&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2pt; padding-left: 0.25in"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20211231_zd8wUtrQItc6" style="border-bottom: Black 2pt double; text-align: right"&gt;290,989&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20211231_zzWg0TC4opf" style="border-bottom: Black 2pt double; text-align: right"&gt;76,942&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20211231_z1ERowanMjXi" style="border-bottom: Black 2pt double; text-align: right"&gt;214,047&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;2020&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Gross&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Accumulated&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Net Book&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Amount&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Amortization&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Value&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 55%; text-align: left; padding-bottom: 1pt"&gt;Trademarks (indefinite lives)&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20201231__us-gaap--FairValueByAssetClassAxis__us-gaap--IndefinitelivedIntangibleAssetsMember_zybGBplDjgM9" style="border-bottom: Black 1pt solid; width: 12%; text-align: right"&gt;131,962&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20201231__us-gaap--FairValueByAssetClassAxis__us-gaap--IndefinitelivedIntangibleAssetsMember_zFwzKYV0hDvc" style="border-bottom: Black 1pt solid; width: 12%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1044"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20201231__us-gaap--FairValueByAssetClassAxis__us-gaap--IndefinitelivedIntangibleAssetsMember_z69xLvALNKe3" style="border-bottom: Black 1pt solid; width: 12%; text-align: right"&gt;131,962&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Trademarks (finite lives)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20201231__us-gaap--FairValueByAssetClassAxis__us-gaap--FiniteLivedIntangibleAssetsMember_ziaV74qg3lCi" style="text-align: right"&gt;47,477&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20201231__us-gaap--FairValueByAssetClassAxis__us-gaap--FiniteLivedIntangibleAssetsMember_zhPRtVWM8tI9" style="text-align: right"&gt;74&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20201231__us-gaap--FairValueByAssetClassAxis__us-gaap--FiniteLivedIntangibleAssetsMember_zq8HaJkzhfVg" style="text-align: right"&gt;47,403&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Licenses (finite lives)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20201231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--LicensesMember_zrAhzOIqgkPe" style="text-align: right"&gt;93,248&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20201231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--LicensesMember_zwz01IMDZW7k" style="text-align: right"&gt;62,262&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20201231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--LicensesMember_zMyp1St5uT12" style="text-align: right"&gt;30,986&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Other intangible assets (finite lives)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20201231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_zGlN5ArnoJh9" style="border-bottom: Black 1pt solid; text-align: right"&gt;18,194&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20201231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_zlfX60VP3edg" style="border-bottom: Black 1pt solid; text-align: right"&gt;14,437&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20201231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_zfKTGxO0jFGd" style="border-bottom: Black 1pt solid; text-align: right"&gt;3,757&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 0.125in"&gt;Subtotal&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20201231__us-gaap--FairValueByAssetClassAxis__custom--SubtotalMember_zWGERQGgcGBg" style="border-bottom: Black 1pt solid; text-align: right"&gt;158,919&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20201231__us-gaap--FairValueByAssetClassAxis__custom--SubtotalMember_zVbjRD3OU4hd" style="border-bottom: Black 1pt solid; text-align: right"&gt;76,773&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20201231__us-gaap--FairValueByAssetClassAxis__custom--SubtotalMember_zoZ4PHhbS7N2" style="border-bottom: Black 1pt solid; text-align: right"&gt;82,146&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2pt; padding-left: 0.25in"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20201231_zlKDRBTRgzJ3" style="border-bottom: Black 2pt double; text-align: right"&gt;290,881&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20201231_znLLbaAQ7M08" style="border-bottom: Black 2pt double; text-align: right"&gt;76,773&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20201231_zLiIvgLQitT7" style="border-bottom: Black 2pt double; text-align: right"&gt;214,108&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;



</us-gaap:ScheduleOfImpairedIntangibleAssetsTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2021-12-31_us-gaap_IndefinitelivedIntangibleAssetsMember"
      decimals="-3"
      unitRef="USD">119712000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="AsOf2021-12-31_us-gaap_IndefinitelivedIntangibleAssetsMember"
      decimals="-3"
      unitRef="USD">119712000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2021-12-31_us-gaap_FiniteLivedIntangibleAssetsMember"
      decimals="-3"
      unitRef="USD">43820000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2021-12-31_us-gaap_FiniteLivedIntangibleAssetsMember"
      decimals="-3"
      unitRef="USD">68000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="AsOf2021-12-31_us-gaap_FiniteLivedIntangibleAssetsMember"
      decimals="-3"
      unitRef="USD">43752000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2021-12-31_custom_LicensesMember"
      decimals="-3"
      unitRef="USD">109682000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2021-12-31_custom_LicensesMember"
      decimals="-3"
      unitRef="USD">62286000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="AsOf2021-12-31_custom_LicensesMember"
      decimals="-3"
      unitRef="USD">47396000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2021-12-31_us-gaap_OtherIntangibleAssetsMember"
      decimals="-3"
      unitRef="USD">17775000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2021-12-31_us-gaap_OtherIntangibleAssetsMember"
      decimals="-3"
      unitRef="USD">14588000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="AsOf2021-12-31_us-gaap_OtherIntangibleAssetsMember"
      decimals="-3"
      unitRef="USD">3187000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2021-12-31_custom_SubtotalMember"
      decimals="-3"
      unitRef="USD">171277000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2021-12-31_custom_SubtotalMember"
      decimals="-3"
      unitRef="USD">76942000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="AsOf2021-12-31_custom_SubtotalMember"
      decimals="-3"
      unitRef="USD">94335000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">290989000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">76942000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">214047000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2020-12-31_us-gaap_IndefinitelivedIntangibleAssetsMember"
      decimals="-3"
      unitRef="USD">131962000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="AsOf2020-12-31_us-gaap_IndefinitelivedIntangibleAssetsMember"
      decimals="-3"
      unitRef="USD">131962000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2020-12-31_us-gaap_FiniteLivedIntangibleAssetsMember"
      decimals="-3"
      unitRef="USD">47477000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2020-12-31_us-gaap_FiniteLivedIntangibleAssetsMember"
      decimals="-3"
      unitRef="USD">74000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="AsOf2020-12-31_us-gaap_FiniteLivedIntangibleAssetsMember"
      decimals="-3"
      unitRef="USD">47403000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2020-12-31_custom_LicensesMember"
      decimals="-3"
      unitRef="USD">93248000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2020-12-31_custom_LicensesMember"
      decimals="-3"
      unitRef="USD">62262000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="AsOf2020-12-31_custom_LicensesMember"
      decimals="-3"
      unitRef="USD">30986000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2020-12-31_us-gaap_OtherIntangibleAssetsMember"
      decimals="-3"
      unitRef="USD">18194000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2020-12-31_us-gaap_OtherIntangibleAssetsMember"
      decimals="-3"
      unitRef="USD">14437000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="AsOf2020-12-31_us-gaap_OtherIntangibleAssetsMember"
      decimals="-3"
      unitRef="USD">3757000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2020-12-31_custom_SubtotalMember"
      decimals="-3"
      unitRef="USD">158919000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2020-12-31_custom_SubtotalMember"
      decimals="-3"
      unitRef="USD">76773000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="AsOf2020-12-31_custom_SubtotalMember"
      decimals="-3"
      unitRef="USD">82146000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">290881000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">76773000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">214108000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">5900000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">5300000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2019-01-012019-12-31"
      decimals="0"
      unitRef="USD">5000000.0</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">5400000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">4400000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <ipar:FiniteLivedIntangibleAssetsAmortizationExpenseAfterTwoYears contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">4200000</ipar:FiniteLivedIntangibleAssetsAmortizationExpenseAfterTwoYears>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2021-01-012021-12-31_us-gaap_IndefinitelivedIntangibleAssetsMember"
      decimals="0"
      unitRef="USD">2400000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="AsOf2021-12-31_us-gaap_MeasurementInputDiscountRateMember"
      decimals="INF"
      unitRef="Pure">0.0747</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="AsOf2020-12-31_us-gaap_MeasurementInputDiscountRateMember"
      decimals="INF"
      unitRef="Pure">0.0699</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="AsOf2019-12-31_us-gaap_MeasurementInputDiscountRateMember"
      decimals="INF"
      unitRef="Pure">0.0794</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:IndefiniteLivedLicenseAgreements contextRef="AsOf2021-12-31" decimals="-6" unitRef="USD">79000000</us-gaap:IndefiniteLivedLicenseAgreements>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_805_eus-gaap--AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_zkW03kU6fsdd" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;(9)&lt;/td&gt;&lt;td&gt;&lt;span id="xdx_82F_zYjsMSf8W1Cf"&gt;Accrued Expenses&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_893_eus-gaap--ScheduleOfAccruedLiabilitiesTableTextBlock_z2tBzBebFVa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span id="xdx_8B3_zfGhPo3W9388"&gt;Accrued expenses consist of the
following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49B_20211231_zOrca3nEmH29" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49A_20201231_zCaUhWp9ThJh" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_eus-gaap--AccruedAdvertisingCurrent_iI_maALCzkev_zryJtF67WKMd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 70%; text-align: left"&gt;Advertising liabilities&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;31,215&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;12,164&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_402_eus-gaap--AccruedSalariesCurrent_iI_maALCzkev_z5Ky8tSKulA2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Salary (including bonus and related taxes)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;19,993&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;14,605&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_403_eus-gaap--AccruedRoyaltiesCurrent_iI_maALCzkev_zE0TFIWDkX95" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Royalties&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;19,154&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;16,966&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_403_ecustom--DueVendorsNotYetInvoiced_iI_maALCzkev_zreYzpg8bkA" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Due vendors (not yet invoiced)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;45,707&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;31,698&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_402_eus-gaap--PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrent_iI_maALCzkev_zvE6kTpZLRsk" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Retirement reserves&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10,234&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;11,889&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_eus-gaap--CustomerRefundLiabilityCurrent_iI_maALCzkev_zaOmeGtKBpj" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Refund (return) liability&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,128&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,616&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40E_eus-gaap--OtherAccruedLiabilitiesCurrent_iI_maALCzkev_zZcRqnM9d0lg" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Other&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;5,246&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;4,691&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_400_eus-gaap--AccruedLiabilitiesCurrent_iTI_mtALCzkev_z3kdIpeQpYsb" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="display: none; padding-bottom: 2pt; visibility: hidden"&gt;Accrued expenses&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2pt double; text-align: right"&gt;136,677&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2pt double; text-align: right"&gt;95,629&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;



&lt;p id="xdx_8A2_zhGs4I0UOZy2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock>
    <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_893_eus-gaap--ScheduleOfAccruedLiabilitiesTableTextBlock_z2tBzBebFVa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span id="xdx_8B3_zfGhPo3W9388"&gt;Accrued expenses consist of the
following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49B_20211231_zOrca3nEmH29" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49A_20201231_zCaUhWp9ThJh" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_eus-gaap--AccruedAdvertisingCurrent_iI_maALCzkev_zryJtF67WKMd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 70%; text-align: left"&gt;Advertising liabilities&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;31,215&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;12,164&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_402_eus-gaap--AccruedSalariesCurrent_iI_maALCzkev_z5Ky8tSKulA2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Salary (including bonus and related taxes)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;19,993&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;14,605&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_403_eus-gaap--AccruedRoyaltiesCurrent_iI_maALCzkev_zE0TFIWDkX95" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Royalties&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;19,154&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;16,966&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_403_ecustom--DueVendorsNotYetInvoiced_iI_maALCzkev_zreYzpg8bkA" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Due vendors (not yet invoiced)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;45,707&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;31,698&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_402_eus-gaap--PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrent_iI_maALCzkev_zvE6kTpZLRsk" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Retirement reserves&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10,234&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;11,889&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_eus-gaap--CustomerRefundLiabilityCurrent_iI_maALCzkev_zaOmeGtKBpj" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Refund (return) liability&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,128&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,616&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40E_eus-gaap--OtherAccruedLiabilitiesCurrent_iI_maALCzkev_zZcRqnM9d0lg" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Other&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;5,246&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;4,691&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_400_eus-gaap--AccruedLiabilitiesCurrent_iTI_mtALCzkev_z3kdIpeQpYsb" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="display: none; padding-bottom: 2pt; visibility: hidden"&gt;Accrued expenses&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2pt double; text-align: right"&gt;136,677&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2pt double; text-align: right"&gt;95,629&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;



</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
    <us-gaap:AccruedAdvertisingCurrent contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">31215000</us-gaap:AccruedAdvertisingCurrent>
    <us-gaap:AccruedAdvertisingCurrent contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">12164000</us-gaap:AccruedAdvertisingCurrent>
    <us-gaap:AccruedSalariesCurrent contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">19993000</us-gaap:AccruedSalariesCurrent>
    <us-gaap:AccruedSalariesCurrent contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">14605000</us-gaap:AccruedSalariesCurrent>
    <us-gaap:AccruedRoyaltiesCurrent contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">19154000</us-gaap:AccruedRoyaltiesCurrent>
    <us-gaap:AccruedRoyaltiesCurrent contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">16966000</us-gaap:AccruedRoyaltiesCurrent>
    <ipar:DueVendorsNotYetInvoiced contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">45707000</ipar:DueVendorsNotYetInvoiced>
    <ipar:DueVendorsNotYetInvoiced contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">31698000</ipar:DueVendorsNotYetInvoiced>
    <us-gaap:PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrent contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">10234000</us-gaap:PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrent>
    <us-gaap:PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrent contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">11889000</us-gaap:PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrent>
    <us-gaap:CustomerRefundLiabilityCurrent contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">5128000</us-gaap:CustomerRefundLiabilityCurrent>
    <us-gaap:CustomerRefundLiabilityCurrent contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">3616000</us-gaap:CustomerRefundLiabilityCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">5246000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">4691000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">136677000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">95629000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:DebtDisclosureTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_80B_eus-gaap--DebtDisclosureTextBlock_z3so1WY1dNn6" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;(10)&lt;/td&gt;&lt;td&gt;&lt;span id="xdx_821_zPl2YMX39Ffb"&gt;Loans Payable &#x2013; Banks&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Loans payable &#x2013; banks consist
of the following:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Company and its domestic
subsidiaries have available a $&lt;span id="xdx_90A_eus-gaap--LineOfCreditFacilityMaximumBorrowingCapacity_iI_c20211231__dei--LegalEntityAxis__custom--DomesticSubsidiariesMember_zLBYAMwpu2w6" title="Line of credit, maximum borrowing amount"&gt;20 million&lt;/span&gt; unsecured revolving line of credit due on demand, which bears interest at the daily Secured
Overnight Financing Rate (&#x201c;SOFR&#x201d;) plus &lt;span id="xdx_90F_eus-gaap--DebtInstrumentBasisSpreadOnVariableRate1_pid_dp_uPure_c20210101__20211231__us-gaap--VariableRateAxis__custom--LondonInterbankOfferedRateMember__dei--LegalEntityAxis__custom--DomesticSubsidiariesMember_zYMwwLZy6vQi" title="Basis spread over variable interest rate"&gt;2&lt;/span&gt;% (the SOFR was &lt;span id="xdx_90D_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20211231__us-gaap--VariableRateAxis__custom--LondonInterbankOfferedRateMember__dei--LegalEntityAxis__custom--DomesticSubsidiariesMember_zIwllRqe60vg" title="Variable rate"&gt;0.05&lt;/span&gt;% as of December 31, 2021). The line of credit which has
a maturity date of &lt;span id="xdx_908_eus-gaap--LineOfCreditFacilityExpirationDate1_ddpxL_c20210101__20211231__us-gaap--VariableRateAxis__custom--LondonInterbankOfferedRateMember__dei--LegalEntityAxis__custom--DomesticSubsidiariesMember_zi5y8Aw4Cht7" title="::XDX::2022-12-16"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1126"&gt;December&#160;16, 2022&lt;/span&gt;&lt;/span&gt;, is expected to be renewed on an annual basis. Borrowings outstanding pursuant to lines
of credit were zero as of December 31, 2021 and 2020.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Company&#x2019;s foreign subsidiaries
have available credit lines, including several bank overdraft facilities totaling approximately $&lt;span id="xdx_903_eus-gaap--LineOfCreditFacilityMaximumBorrowingCapacity_iI_pn6n6_c20211231__dei--LegalEntityAxis__custom--ForeignSubsidiariesMember_zjSaiZ34pJyk"&gt;28&lt;/span&gt; million. These credit lines
bear interest at EURIBOR plus between &lt;span id="xdx_900_eus-gaap--DebtInstrumentBasisSpreadOnVariableRate1_pid_dp_uPure_c20210101__20211231__us-gaap--VariableRateAxis__custom--EuroInterbankOfferedRateMembeMember__dei--LegalEntityAxis__custom--ForeignSubsidiariesMember__srt--RangeAxis__srt--MinimumMember_zxGu8AsBheC3" title="Basis spread over variable interest rate"&gt;0.5&lt;/span&gt;% and &lt;span id="xdx_90C_eus-gaap--DebtInstrumentBasisSpreadOnVariableRate1_pid_dp_uPure_c20210101__20211231__us-gaap--VariableRateAxis__custom--EuroInterbankOfferedRateMembeMember__dei--LegalEntityAxis__custom--ForeignSubsidiariesMember__srt--RangeAxis__srt--MaximumMember_zryWJs2OjWO1" title="Basis spread over variable interest rate"&gt;0.8&lt;/span&gt;% (EURIBOR was minus &lt;span id="xdx_90A_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20211231__us-gaap--VariableRateAxis__custom--EuroInterbankOfferedRateMembeMember__dei--LegalEntityAxis__custom--ForeignSubsidiariesMember_zq65zFAJJ8U7" title="Variable rate"&gt;0.570&lt;/span&gt;% at December&#160;31, 2021). Borrowings outstanding
pursuant to these bank overdraft facilities were zero as of December 31, 2021 and 2020.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

















&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;As there were no borrowings outstanding
as of December 31, 2021 and 2010, there is no weighted average interest rate on short-term borrowings as of December 31, 2021 and
2020.&lt;/p&gt;

</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="AsOf2021-12-31_custom_DomesticSubsidiariesMember"
      decimals="0"
      unitRef="USD">20</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="From2021-01-012021-12-31_custom_LondonInterbankOfferedRateMember_custom_DomesticSubsidiariesMember"
      decimals="INF"
      unitRef="Pure">0.02</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2021-12-31_custom_LondonInterbankOfferedRateMember_custom_DomesticSubsidiariesMember"
      decimals="INF"
      unitRef="Pure">0.0005</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="AsOf2021-12-31_custom_ForeignSubsidiariesMember"
      decimals="-6"
      unitRef="USD">28000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="From2021-01-012021-12-31_custom_EuroInterbankOfferedRateMembeMember_custom_ForeignSubsidiariesMember_srt_MinimumMember"
      decimals="INF"
      unitRef="Pure">0.005</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="From2021-01-012021-12-31_custom_EuroInterbankOfferedRateMembeMember_custom_ForeignSubsidiariesMember_srt_MaximumMember"
      decimals="INF"
      unitRef="Pure">0.008</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2021-12-31_custom_EuroInterbankOfferedRateMembeMember_custom_ForeignSubsidiariesMember"
      decimals="INF"
      unitRef="Pure">0.00570</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_80A_eus-gaap--LongTermDebtTextBlock_zeDt996wEdyh" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;(11)&lt;/td&gt;&lt;td&gt;&lt;span id="xdx_82F_z4DbqKVC28r3"&gt;Long-Term Debt&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_897_eus-gaap--ScheduleOfDebtInstrumentsTextBlock_zMA0beScaH04" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"&gt;&lt;span id="xdx_8B8_zDtbLqdGeQz3"&gt;Long-term debt consists of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 65%; text-align: left; text-indent: -0.125in; padding-left: 0.125in"&gt;$&lt;span id="xdx_901_eus-gaap--DebtInstrumentFaceAmount_iI_dm_c20211231__us-gaap--LongtermDebtTypeAxis__us-gaap--LoansPayableMember_zr2GjGBCW5Ni" title="Loan payable (in Dollars)"&gt;135.9 million&lt;/span&gt; payable in &lt;span id="xdx_902_ecustom--NumberOfInstallment_iI_pid_uN_c20211231__us-gaap--LongtermDebtTypeAxis__us-gaap--LoansPayableMember_z0VjT2MOZQqa" title="Number of installments"&gt;120&lt;/span&gt; equal monthly installments of $&lt;span id="xdx_904_eus-gaap--DebtInstrumentPeriodicPayment_dm_c20210101__20211231__us-gaap--LongtermDebtTypeAxis__us-gaap--LoansPayableMember_zFFNifrp7ql4" title="Installment amount (in Dollars)"&gt;1.1 million&lt;/span&gt; beginning in April 2021, bearing interest at one-month Euribor plus &lt;span id="xdx_907_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20211231__us-gaap--LongtermDebtTypeAxis__us-gaap--LoansPayableMember_z8NioIBw61Z2" title="Interest per annum"&gt;0.75&lt;/span&gt;%&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--LongTermDebt_iI_c20211231__us-gaap--LongtermDebtTypeAxis__us-gaap--LoansPayableMember_zeY3RkgUJ7Z3" style="width: 12%; text-align: right" title="Loan payable"&gt;124,375&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--LongTermDebt_iI_c20201231__us-gaap--LongtermDebtTypeAxis__us-gaap--LoansPayableMember_zyOOVGWYqHbf" style="width: 12%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1155"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in"&gt;$&lt;span id="xdx_902_eus-gaap--DebtInstrumentFaceAmount_iI_pn6n6_c20211231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableOneMember_zc7fR9ruMpj7"&gt;15&lt;/span&gt;.0 million payable in &lt;span id="xdx_90E_ecustom--NumberOfInstallment_iI_pid_uN_c20211231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableOneMember_zls04tXK2V3i" title="Number of installments"&gt;14&lt;/span&gt; equal annual installments of $&lt;span id="xdx_90A_eus-gaap--DebtInstrumentPeriodicPayment_dm_c20210101__20211231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableOneMember_zIQI3xg3fbsh"&gt;1.1 million&lt;/span&gt; beginning in January 2020 including interest imputed at &lt;span id="xdx_903_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20211231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableOneMember_z7c1VKEfKJcg"&gt;4.1&lt;/span&gt;% per annum&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--LongTermDebt_iI_c20211231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableOneMember_zl6ufcRiHPn1" style="text-align: right"&gt;10,569&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--LongTermDebt_iI_c20201231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableOneMember_zHLrPGY0Cis4" style="text-align: right"&gt;11,208&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in"&gt;$&lt;span id="xdx_90E_eus-gaap--DebtInstrumentFaceAmount_iI_pn6n6_c20211231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableTwoMember_zjWS3GRRDjOc"&gt;17&lt;/span&gt; million payable in &lt;span id="xdx_900_ecustom--NumberOfInstallment_iI_pid_uN_c20211231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableTwoMember_zhDrCItdpwMc" title="Number of installments"&gt;10&lt;/span&gt; equal annual installments of $&lt;span id="xdx_900_eus-gaap--DebtInstrumentPeriodicPayment_dm_c20210101__20211231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableTwoMember_zDQCZr8k366l"&gt;1.7 million&lt;/span&gt; beginning in October 2021 including interest imputed at &lt;span id="xdx_903_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20211231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableTwoMember_zSXZgXMCuGRa" title="Interest per annum"&gt;2.0&lt;/span&gt;% per annum&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--LongTermDebt_iI_c20211231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableTwoMember_zwClsCJGC9Ef" style="text-align: right"&gt;13,869&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--LongTermDebt_iI_c20201231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableTwoMember_zSb2zFa2pWdg" style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1170"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: -0.125in; padding-left: 0.125in"&gt;$&lt;span id="xdx_903_eus-gaap--DebtInstrumentFaceAmount_iI_dm_c20211231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableThreeMember_zI0tfHx4cvw8"&gt;13.4 million&lt;/span&gt; term loan amended such that the loan was repaid in February 2021 plus interest at &lt;span id="xdx_90B_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20211231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableThreeMember_zuP7Ddx97nz3" title="Interest per annum"&gt;0.85&lt;/span&gt;% per annum&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--LongTermDebt_iI_c20211231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableThreeMember_z4H340Co1wo2" style="border-bottom: Black 1pt solid; text-align: right" title="Loan payable"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1175"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--LongTermDebt_iI_c20201231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableThreeMember_zJKDQUnLn4J" style="border-bottom: Black 1pt solid; text-align: right"&gt;13,498&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: -0.125in; padding-left: 0.125in"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--LongTermDebt_iI_c20211231_z0zLZRFstio8" style="text-align: right"&gt;148,813&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--LongTermDebt_iI_c20201231_zXol4Mlgb4ie" style="text-align: right"&gt;24,706&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: -0.125in; padding-left: 0.25in"&gt;Less current maturities&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--LongTermDebtCurrent_iI_c20211231_zFsrVaCUHeEb" style="border-bottom: Black 1pt solid; text-align: right" title="Less current maturities"&gt;15,911&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--LongTermDebtCurrent_iI_dxL_c20201231_zvYm1Uq9Ws7g" style="border-bottom: Black 1pt solid; text-align: right" title="Less current maturities::XDX::14%2C570"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1182"&gt;14,570&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2pt; text-indent: -0.125in; padding-left: 0.375in"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--LongTermDebtNoncurrent_iI_c20211231_zcAIKG3aVVCb" style="border-bottom: Black 2pt double; text-align: right" title="Total"&gt;132,902&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--LongTermDebtNoncurrent_iI_dxL_c20201231_z9kcQMiGz5Lc" style="border-bottom: Black 2pt double; text-align: right" title="::XDX::10%2C136"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1185"&gt;10,136&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;



&lt;p id="xdx_8A5_zaOBx13pgpvg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;In April 2021, to finance the
acquisition of Interparfums SA&#x2019;s future corporate headquarters, the Company entered into a $&lt;span id="xdx_908_eus-gaap--DebtInstrumentFaceAmount_iI_dm_c20210430__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableOneMember_zwYKmCgVtDg8"&gt;135.9 million&lt;/span&gt; (&#x20ac;120 million)
ten-year credit agreement. Approximately $90.6 million (&#x20ac;80.0 million) of the variable rate debt was swapped for variable
interest rate debt with maximum rate of 2% per annum. The swap is a derivative instrument and is therefore recorded at fair value
and changes in fair value are reflected in the accompanying consolidated statements of income.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Maturities of long-term debt
subsequent to December 31, 2021 are approximately $&lt;span id="xdx_903_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_iI_dm_c20211231_zdiE6pGbH5Bg" title="Long-term Debt, Maturities, 2021"&gt;15.9 million&lt;/span&gt; in 2022 and $&lt;span id="xdx_903_eus-gaap--LongTermDebtDescription_c20210101__20211231_zwc9NOyQKt6k" title="Long term debt maturity, description"&gt;16.4 million per year thereafter through 2033.&lt;/span&gt;&lt;/p&gt;

</us-gaap:LongTermDebtTextBlock>
    <us-gaap:ScheduleOfDebtInstrumentsTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_897_eus-gaap--ScheduleOfDebtInstrumentsTextBlock_zMA0beScaH04" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"&gt;&lt;span id="xdx_8B8_zDtbLqdGeQz3"&gt;Long-term debt consists of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 65%; text-align: left; text-indent: -0.125in; padding-left: 0.125in"&gt;$&lt;span id="xdx_901_eus-gaap--DebtInstrumentFaceAmount_iI_dm_c20211231__us-gaap--LongtermDebtTypeAxis__us-gaap--LoansPayableMember_zr2GjGBCW5Ni" title="Loan payable (in Dollars)"&gt;135.9 million&lt;/span&gt; payable in &lt;span id="xdx_902_ecustom--NumberOfInstallment_iI_pid_uN_c20211231__us-gaap--LongtermDebtTypeAxis__us-gaap--LoansPayableMember_z0VjT2MOZQqa" title="Number of installments"&gt;120&lt;/span&gt; equal monthly installments of $&lt;span id="xdx_904_eus-gaap--DebtInstrumentPeriodicPayment_dm_c20210101__20211231__us-gaap--LongtermDebtTypeAxis__us-gaap--LoansPayableMember_zFFNifrp7ql4" title="Installment amount (in Dollars)"&gt;1.1 million&lt;/span&gt; beginning in April 2021, bearing interest at one-month Euribor plus &lt;span id="xdx_907_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20211231__us-gaap--LongtermDebtTypeAxis__us-gaap--LoansPayableMember_z8NioIBw61Z2" title="Interest per annum"&gt;0.75&lt;/span&gt;%&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--LongTermDebt_iI_c20211231__us-gaap--LongtermDebtTypeAxis__us-gaap--LoansPayableMember_zeY3RkgUJ7Z3" style="width: 12%; text-align: right" title="Loan payable"&gt;124,375&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--LongTermDebt_iI_c20201231__us-gaap--LongtermDebtTypeAxis__us-gaap--LoansPayableMember_zyOOVGWYqHbf" style="width: 12%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1155"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in"&gt;$&lt;span id="xdx_902_eus-gaap--DebtInstrumentFaceAmount_iI_pn6n6_c20211231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableOneMember_zc7fR9ruMpj7"&gt;15&lt;/span&gt;.0 million payable in &lt;span id="xdx_90E_ecustom--NumberOfInstallment_iI_pid_uN_c20211231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableOneMember_zls04tXK2V3i" title="Number of installments"&gt;14&lt;/span&gt; equal annual installments of $&lt;span id="xdx_90A_eus-gaap--DebtInstrumentPeriodicPayment_dm_c20210101__20211231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableOneMember_zIQI3xg3fbsh"&gt;1.1 million&lt;/span&gt; beginning in January 2020 including interest imputed at &lt;span id="xdx_903_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20211231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableOneMember_z7c1VKEfKJcg"&gt;4.1&lt;/span&gt;% per annum&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--LongTermDebt_iI_c20211231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableOneMember_zl6ufcRiHPn1" style="text-align: right"&gt;10,569&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--LongTermDebt_iI_c20201231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableOneMember_zHLrPGY0Cis4" style="text-align: right"&gt;11,208&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in"&gt;$&lt;span id="xdx_90E_eus-gaap--DebtInstrumentFaceAmount_iI_pn6n6_c20211231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableTwoMember_zjWS3GRRDjOc"&gt;17&lt;/span&gt; million payable in &lt;span id="xdx_900_ecustom--NumberOfInstallment_iI_pid_uN_c20211231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableTwoMember_zhDrCItdpwMc" title="Number of installments"&gt;10&lt;/span&gt; equal annual installments of $&lt;span id="xdx_900_eus-gaap--DebtInstrumentPeriodicPayment_dm_c20210101__20211231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableTwoMember_zDQCZr8k366l"&gt;1.7 million&lt;/span&gt; beginning in October 2021 including interest imputed at &lt;span id="xdx_903_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20211231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableTwoMember_zSXZgXMCuGRa" title="Interest per annum"&gt;2.0&lt;/span&gt;% per annum&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--LongTermDebt_iI_c20211231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableTwoMember_zwClsCJGC9Ef" style="text-align: right"&gt;13,869&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--LongTermDebt_iI_c20201231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableTwoMember_zSb2zFa2pWdg" style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1170"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: -0.125in; padding-left: 0.125in"&gt;$&lt;span id="xdx_903_eus-gaap--DebtInstrumentFaceAmount_iI_dm_c20211231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableThreeMember_zI0tfHx4cvw8"&gt;13.4 million&lt;/span&gt; term loan amended such that the loan was repaid in February 2021 plus interest at &lt;span id="xdx_90B_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20211231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableThreeMember_zuP7Ddx97nz3" title="Interest per annum"&gt;0.85&lt;/span&gt;% per annum&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--LongTermDebt_iI_c20211231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableThreeMember_z4H340Co1wo2" style="border-bottom: Black 1pt solid; text-align: right" title="Loan payable"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1175"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--LongTermDebt_iI_c20201231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableThreeMember_zJKDQUnLn4J" style="border-bottom: Black 1pt solid; text-align: right"&gt;13,498&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: -0.125in; padding-left: 0.125in"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--LongTermDebt_iI_c20211231_z0zLZRFstio8" style="text-align: right"&gt;148,813&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--LongTermDebt_iI_c20201231_zXol4Mlgb4ie" style="text-align: right"&gt;24,706&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: -0.125in; padding-left: 0.25in"&gt;Less current maturities&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--LongTermDebtCurrent_iI_c20211231_zFsrVaCUHeEb" style="border-bottom: Black 1pt solid; text-align: right" title="Less current maturities"&gt;15,911&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--LongTermDebtCurrent_iI_dxL_c20201231_zvYm1Uq9Ws7g" style="border-bottom: Black 1pt solid; text-align: right" title="Less current maturities::XDX::14%2C570"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1182"&gt;14,570&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2pt; text-indent: -0.125in; padding-left: 0.375in"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--LongTermDebtNoncurrent_iI_c20211231_zcAIKG3aVVCb" style="border-bottom: Black 2pt double; text-align: right" title="Total"&gt;132,902&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--LongTermDebtNoncurrent_iI_dxL_c20201231_z9kcQMiGz5Lc" style="border-bottom: Black 2pt double; text-align: right" title="::XDX::10%2C136"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1185"&gt;10,136&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;



</us-gaap:ScheduleOfDebtInstrumentsTextBlock>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2021-12-31_us-gaap_LoansPayableMember"
      decimals="-3"
      unitRef="USD">135900000000</us-gaap:DebtInstrumentFaceAmount>
    <ipar:NumberOfInstallment
      contextRef="AsOf2021-12-31_us-gaap_LoansPayableMember"
      decimals="INF"
      unitRef="N">120</ipar:NumberOfInstallment>
    <us-gaap:DebtInstrumentPeriodicPayment
      contextRef="From2021-01-012021-12-31_us-gaap_LoansPayableMember"
      decimals="-3"
      unitRef="USD">1100000000</us-gaap:DebtInstrumentPeriodicPayment>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2021-12-31_us-gaap_LoansPayableMember"
      decimals="INF"
      unitRef="Pure">0.0075</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="AsOf2021-12-31_us-gaap_LoansPayableMember"
      decimals="-3"
      unitRef="USD">124375000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2021-12-31_custom_LoansPayableOneMember"
      decimals="-6"
      unitRef="USD">15000000</us-gaap:DebtInstrumentFaceAmount>
    <ipar:NumberOfInstallment
      contextRef="AsOf2021-12-31_custom_LoansPayableOneMember"
      decimals="INF"
      unitRef="N">14</ipar:NumberOfInstallment>
    <us-gaap:DebtInstrumentPeriodicPayment
      contextRef="From2021-01-012021-12-31_custom_LoansPayableOneMember"
      decimals="-3"
      unitRef="USD">1100000000</us-gaap:DebtInstrumentPeriodicPayment>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2021-12-31_custom_LoansPayableOneMember"
      decimals="INF"
      unitRef="Pure">0.041</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="AsOf2021-12-31_custom_LoansPayableOneMember"
      decimals="-3"
      unitRef="USD">10569000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="AsOf2020-12-31_custom_LoansPayableOneMember"
      decimals="-3"
      unitRef="USD">11208000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2021-12-31_custom_LoansPayableTwoMember"
      decimals="-6"
      unitRef="USD">17000000</us-gaap:DebtInstrumentFaceAmount>
    <ipar:NumberOfInstallment
      contextRef="AsOf2021-12-31_custom_LoansPayableTwoMember"
      decimals="INF"
      unitRef="N">10</ipar:NumberOfInstallment>
    <us-gaap:DebtInstrumentPeriodicPayment
      contextRef="From2021-01-012021-12-31_custom_LoansPayableTwoMember"
      decimals="-3"
      unitRef="USD">1700000000</us-gaap:DebtInstrumentPeriodicPayment>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2021-12-31_custom_LoansPayableTwoMember"
      decimals="INF"
      unitRef="Pure">0.020</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="AsOf2021-12-31_custom_LoansPayableTwoMember"
      decimals="-3"
      unitRef="USD">13869000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2021-12-31_custom_LoansPayableThreeMember"
      decimals="-3"
      unitRef="USD">13400000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2021-12-31_custom_LoansPayableThreeMember"
      decimals="INF"
      unitRef="Pure">0.0085</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="AsOf2020-12-31_custom_LoansPayableThreeMember"
      decimals="-3"
      unitRef="USD">13498000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">148813000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">24706000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebtCurrent contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">15911000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtNoncurrent contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">132902000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2021-04-30_custom_LoansPayableOneMember"
      decimals="0"
      unitRef="USD">135900000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">15900000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebtDescription contextRef="From2021-01-01to2021-12-31">16.4 million per year thereafter through 2033.</us-gaap:LongTermDebtDescription>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_805_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zqgwaM2S2mR7" style="margin-top: 0; margin-bottom: 0"/&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;(12)&lt;/td&gt;&lt;td&gt;&lt;span id="xdx_825_zyzysgm6ry98"&gt;Commitments&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;Leases&lt;/p&gt;

&lt;p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Company leases its offices,
warehouses and vehicles, substantially all of which are classified as operating leases. The Company currently has no material financing
leases. The Company determines if an arrangement is a lease at inception. Operating lease assets and obligations are recognized
at the lease commencement date based on the present value of lease payments over the lease term.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;In determining lease asset value,
the Company considers fixed or variable payment terms, prepayments, incentives, and options to extend or terminate, depending on
the lease. Renewal, termination or purchase options affect the lease term used for determining lease asset value only if the option
is reasonably certain to be exercised. The Company generally uses its incremental borrowing rate based on information available
at the lease commencement date for the location in which the lease is held in determining the present value of lease payments.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&#160;&lt;/p&gt;









&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;As of December 31, 2021, the
weighted average remaining lease term was &lt;span id="xdx_903_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtxL_c20211231_zXr3RXHM8Vid" title="Weighted average remaining lease term::XDX::P6Y1M6D"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1199"&gt;6.1&lt;/span&gt;&lt;/span&gt; years and the weighted average discount rate used to determine the operating lease
liability was &lt;span id="xdx_902_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_uPure_c20211231_zGGI7ynjqSoe" title="Operating lease, weighted average discount rate"&gt;2.5&lt;/span&gt;%. Rental expense related to operating leases was $&lt;span id="xdx_90B_eus-gaap--OperatingLeasesRentExpenseNet_dm_c20210101__20211231_zhzkNfylL7uj" title="Operating lease of related to rental expenses"&gt;8.2 million&lt;/span&gt;, $&lt;span id="xdx_904_eus-gaap--OperatingLeasesRentExpenseNet_dm_c20200101__20201231_zgNOlsvEhs37" title="Operating lease of related to rental expenses"&gt;6.2 million&lt;/span&gt;, and $&lt;span id="xdx_90F_eus-gaap--OperatingLeasesRentExpenseNet_dm_c20190101__20191231_zN6YTu1GjGah" title="Operating lease of related to rental expenses"&gt;7.5 million&lt;/span&gt; for the years ended
December 31, 2021, 2020 and 2019, respectively. Operating lease payments included in operating cash flows totaled $&lt;span id="xdx_909_eus-gaap--OperatingLeasePayments_dm_c20210101__20211231_zZKZcRlr63O7" title="Operating lease payments"&gt;7.5 million&lt;/span&gt;
and noncash additions to operating lease assets totaled $&lt;span id="xdx_902_eus-gaap--OperatingLeaseCost_dm_c20210101__20211231_zNDAhX6tEV49" title="Noncash additions to operating lease assets"&gt;12.2 million&lt;/span&gt;.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_89E_eus-gaap--ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_zyF9BNIMPeU5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span id="xdx_8B0_z8Tw1yW0uR54"&gt;Maturities of lease liabilities
subsequent to December&#160;31, 2021 are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"&gt;(In thousands)&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto"&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 85%; text-align: left"&gt;&lt;span style="color: Black"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--OperatingLeasesFutureMinimumPaymentsDueCurrent_iI_c20211231_zgdKcFRfwmI7" style="width: 12%; text-align: right" title="2022"&gt;&lt;span style="color: Black"&gt;6,541&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--OperatingLeasesFutureMinimumPaymentsDueInTwoYears_iI_c20211231_zKxxjLn9srP2" style="text-align: right" title="2023"&gt;&lt;span style="color: Black"&gt;6,776&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--OperatingLeasesFutureMinimumPaymentsDueInThreeYears_iI_c20211231_zyAnOct969U4" style="text-align: right" title="2024"&gt;&lt;span style="color: Black"&gt;5,787&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--OperatingLeasesFutureMinimumPaymentsDueInFourYears_iI_c20211231_zT0E7zKRecuf" style="text-align: right" title="2025"&gt;&lt;span style="color: Black"&gt;4,704&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--OperatingLeasesFutureMinimumPaymentsDueInFiveYears_iI_c20211231_z1JuVgtQyVeb" style="text-align: right" title="2026"&gt;&lt;span style="color: Black"&gt;4,087&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--OperatingLeasesFutureMinimumPaymentsDueThereafter_iI_c20211231_zxf5qxdhJLQd" style="border-bottom: Black 1pt solid; text-align: right" title="Thereafter"&gt;&lt;span style="color: Black"&gt;10,017&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--OperatingLeasesFutureMinimumPaymentsDue_iI_c20211231_zL7HpyRAvjvg" style="border-bottom: Black 1pt solid; text-align: right" title="Gross Total"&gt;&lt;span style="color: Black"&gt;37,912&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="color: Black"&gt;Less imputed interest (based on 2.5%
    weighted-average discount rate)&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #FF0000; padding-bottom: 1pt"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #FF0000; text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_di_c20211231_zeZogE6qFnNa" style="border-bottom: Black 1pt solid; color: #FF0000; text-align: right" title="Less imputed interest (based on 3.0% weighted-average discount rate)"&gt;&lt;span style="color: Black"&gt;(2,679&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; color: #FF0000; text-align: left"&gt;&lt;span style="color: Black"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; text-align: left"&gt;&lt;span style="color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear_iI_c20211231_zIFiIkcyU5ui" style="border-bottom: Black 2pt double; text-align: right" title="Net Total"&gt;&lt;span style="color: Black"&gt;35,233&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;



&lt;p id="xdx_8AB_zhNpFQ1yxWP6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;License Agreements&lt;/p&gt;

&lt;p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_897_esrt--ContractualObligationFiscalYearMaturityScheduleTableTextBlock_zZ3LS5YZ6ke3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span id="xdx_909_eus-gaap--FiniteLivedIntangibleAssetsIntentOrAbilityToRenewOrExtendArrangement_c20210101__20211231_zG1Kv0UMvD25" title="License agreement, expiration description"&gt;The Company is party to a number
of license and other agreements for the use of trademarks and rights in connection with the manufacture and sale of its products
expiring at various dates through 2033.&lt;/span&gt; In connection with certain of these license agreements, the Company is subject to minimum
annual advertising commitments, &lt;span id="xdx_8BA_zRoIaXnWGOPf"&gt;minimum annual royalties and other commitments as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"&gt;(In thousands)&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto"&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 85%; text-align: left"&gt;2022&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--OtherCommitmentDueInNextTwelveMonths_iI_c20211231_zm45FY8fqk6" style="width: 12%; text-align: right" title="2021"&gt;191,422&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--OtherCommitmentDueInSecondYear_iI_c20211231_z0dLRXe8E3tk" style="text-align: right" title="2022"&gt;206,241&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--OtherCommitmentDueInThirdYear_iI_c20211231_zFige0sVO4d6" style="text-align: right" title="2023"&gt;202,774&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;2025&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--OtherCommitmentDueInFourthYear_iI_c20211231_zaqJgioDS9k9" style="text-align: right" title="2024"&gt;199,770&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;2026&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--OtherCommitmentDueInFifthYear_iI_c20211231_zccCQ2llkBg1" style="text-align: right" title="2025"&gt;136,776&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Thereafter&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--OtherCommitmentDueAfterFifthYear_iI_c20211231_zX6A7AQu8all" style="border-bottom: Black 1pt solid; text-align: right" title="Thereafter"&gt;702,780&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--OtherCommitment_iI_c20211231_zYIIHzBGGK3" style="border-bottom: Black 2pt double; text-align: right" title="Total"&gt;1,639,763&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;



&lt;p id="xdx_8A1_zZwkZ0mXFns" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Future advertising commitments
are estimated based on planned future sales for the license terms that were in effect at December 31, 2021, without consideration
for potential renewal periods. The above figures do not reflect the fact that our distributors share our advertising obligations.
Royalty expense included in selling, general, and administrative expenses, aggregated $&lt;span id="xdx_905_eus-gaap--RoyaltyExpense_dm_c20210101__20211231_zv0zwDjibcWk" title="Royalty expense"&gt;69.0 million&lt;/span&gt;, $&lt;span id="xdx_902_eus-gaap--RoyaltyExpense_dm_c20200101__20201231_zRA9yVRRt4Ke" title="Royalty expense"&gt;41.1 million&lt;/span&gt; and $&lt;span id="xdx_90D_eus-gaap--RoyaltyExpense_dm_c20190101__20191231_zNxscyQ0Iszc" title="Royalty expense"&gt;53.0 million&lt;/span&gt;,
in 2021, 2020 and 2019, respectively, and represented &lt;span id="xdx_906_ecustom--RoyaltyExpenseNetSalesPercentage_pid_dp_uPure_c20210101__20211231_zUsXEeOJLdje" title="Royalty expense, percentage of net sales"&gt;7.8&lt;/span&gt;%, &lt;span id="xdx_906_ecustom--RoyaltyExpenseNetSalesPercentage_pid_dp_uPure_c20200101__20201231_zr0biWr1Ldh8" title="Royalty expense, percentage of net sales"&gt;7.6&lt;/span&gt;% and &lt;span id="xdx_90F_ecustom--RoyaltyExpenseNetSalesPercentage_pid_dp_uPure_c20190101__20191231_zlmhlWfFkpe9" title="Royalty expense, percentage of net sales"&gt;7.4&lt;/span&gt;% of net sales for the years ended December 31, 2021, 2020
and 2019, respectively.&lt;/p&gt;

</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent contextRef="AsOf2021-12-31" decimals="INF" unitRef="Pure">0.025</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeasesRentExpenseNet
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">8200000</us-gaap:OperatingLeasesRentExpenseNet>
    <us-gaap:OperatingLeasesRentExpenseNet
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">6200000</us-gaap:OperatingLeasesRentExpenseNet>
    <us-gaap:OperatingLeasesRentExpenseNet
      contextRef="From2019-01-012019-12-31"
      decimals="0"
      unitRef="USD">7500000</us-gaap:OperatingLeasesRentExpenseNet>
    <us-gaap:OperatingLeasePayments
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">7500000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeaseCost
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">12200000</us-gaap:OperatingLeaseCost>
    <us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_89E_eus-gaap--ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_zyF9BNIMPeU5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span id="xdx_8B0_z8Tw1yW0uR54"&gt;Maturities of lease liabilities
subsequent to December&#160;31, 2021 are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"&gt;(In thousands)&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto"&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 85%; text-align: left"&gt;&lt;span style="color: Black"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--OperatingLeasesFutureMinimumPaymentsDueCurrent_iI_c20211231_zgdKcFRfwmI7" style="width: 12%; text-align: right" title="2022"&gt;&lt;span style="color: Black"&gt;6,541&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--OperatingLeasesFutureMinimumPaymentsDueInTwoYears_iI_c20211231_zKxxjLn9srP2" style="text-align: right" title="2023"&gt;&lt;span style="color: Black"&gt;6,776&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--OperatingLeasesFutureMinimumPaymentsDueInThreeYears_iI_c20211231_zyAnOct969U4" style="text-align: right" title="2024"&gt;&lt;span style="color: Black"&gt;5,787&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--OperatingLeasesFutureMinimumPaymentsDueInFourYears_iI_c20211231_zT0E7zKRecuf" style="text-align: right" title="2025"&gt;&lt;span style="color: Black"&gt;4,704&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--OperatingLeasesFutureMinimumPaymentsDueInFiveYears_iI_c20211231_z1JuVgtQyVeb" style="text-align: right" title="2026"&gt;&lt;span style="color: Black"&gt;4,087&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--OperatingLeasesFutureMinimumPaymentsDueThereafter_iI_c20211231_zxf5qxdhJLQd" style="border-bottom: Black 1pt solid; text-align: right" title="Thereafter"&gt;&lt;span style="color: Black"&gt;10,017&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--OperatingLeasesFutureMinimumPaymentsDue_iI_c20211231_zL7HpyRAvjvg" style="border-bottom: Black 1pt solid; text-align: right" title="Gross Total"&gt;&lt;span style="color: Black"&gt;37,912&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="color: Black"&gt;Less imputed interest (based on 2.5%
    weighted-average discount rate)&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #FF0000; padding-bottom: 1pt"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #FF0000; text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_di_c20211231_zeZogE6qFnNa" style="border-bottom: Black 1pt solid; color: #FF0000; text-align: right" title="Less imputed interest (based on 3.0% weighted-average discount rate)"&gt;&lt;span style="color: Black"&gt;(2,679&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; color: #FF0000; text-align: left"&gt;&lt;span style="color: Black"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; text-align: left"&gt;&lt;span style="color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear_iI_c20211231_zIFiIkcyU5ui" style="border-bottom: Black 2pt double; text-align: right" title="Net Total"&gt;&lt;span style="color: Black"&gt;35,233&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;



</us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">6541000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">6776000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInThreeYears contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">5787000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInThreeYears>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFourYears contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">4704000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFourYears>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFiveYears contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">4087000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFiveYears>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDueThereafter contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">10017000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueThereafter>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDue contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">37912000</us-gaap:OperatingLeasesFutureMinimumPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">2679000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">35233000</us-gaap:OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear>
    <srt:ContractualObligationFiscalYearMaturityScheduleTableTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_897_esrt--ContractualObligationFiscalYearMaturityScheduleTableTextBlock_zZ3LS5YZ6ke3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span id="xdx_909_eus-gaap--FiniteLivedIntangibleAssetsIntentOrAbilityToRenewOrExtendArrangement_c20210101__20211231_zG1Kv0UMvD25" title="License agreement, expiration description"&gt;The Company is party to a number
of license and other agreements for the use of trademarks and rights in connection with the manufacture and sale of its products
expiring at various dates through 2033.&lt;/span&gt; In connection with certain of these license agreements, the Company is subject to minimum
annual advertising commitments, &lt;span id="xdx_8BA_zRoIaXnWGOPf"&gt;minimum annual royalties and other commitments as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"&gt;(In thousands)&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto"&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 85%; text-align: left"&gt;2022&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--OtherCommitmentDueInNextTwelveMonths_iI_c20211231_zm45FY8fqk6" style="width: 12%; text-align: right" title="2021"&gt;191,422&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--OtherCommitmentDueInSecondYear_iI_c20211231_z0dLRXe8E3tk" style="text-align: right" title="2022"&gt;206,241&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--OtherCommitmentDueInThirdYear_iI_c20211231_zFige0sVO4d6" style="text-align: right" title="2023"&gt;202,774&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;2025&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--OtherCommitmentDueInFourthYear_iI_c20211231_zaqJgioDS9k9" style="text-align: right" title="2024"&gt;199,770&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;2026&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--OtherCommitmentDueInFifthYear_iI_c20211231_zccCQ2llkBg1" style="text-align: right" title="2025"&gt;136,776&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Thereafter&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--OtherCommitmentDueAfterFifthYear_iI_c20211231_zX6A7AQu8all" style="border-bottom: Black 1pt solid; text-align: right" title="Thereafter"&gt;702,780&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--OtherCommitment_iI_c20211231_zYIIHzBGGK3" style="border-bottom: Black 2pt double; text-align: right" title="Total"&gt;1,639,763&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;



</srt:ContractualObligationFiscalYearMaturityScheduleTableTextBlock>
    <us-gaap:OtherCommitmentDueInNextTwelveMonths contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">191422000</us-gaap:OtherCommitmentDueInNextTwelveMonths>
    <us-gaap:OtherCommitmentDueInSecondYear contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">206241000</us-gaap:OtherCommitmentDueInSecondYear>
    <us-gaap:OtherCommitmentDueInThirdYear contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">202774000</us-gaap:OtherCommitmentDueInThirdYear>
    <us-gaap:OtherCommitmentDueInFourthYear contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">199770000</us-gaap:OtherCommitmentDueInFourthYear>
    <us-gaap:OtherCommitmentDueInFifthYear contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">136776000</us-gaap:OtherCommitmentDueInFifthYear>
    <us-gaap:OtherCommitmentDueAfterFifthYear contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">702780000</us-gaap:OtherCommitmentDueAfterFifthYear>
    <us-gaap:OtherCommitment contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">1639763000</us-gaap:OtherCommitment>
    <us-gaap:RoyaltyExpense
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">69000000.0</us-gaap:RoyaltyExpense>
    <us-gaap:RoyaltyExpense
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">41100000</us-gaap:RoyaltyExpense>
    <us-gaap:RoyaltyExpense
      contextRef="From2019-01-012019-12-31"
      decimals="0"
      unitRef="USD">53000000.0</us-gaap:RoyaltyExpense>
    <ipar:RoyaltyExpenseNetSalesPercentage
      contextRef="From2021-01-01to2021-12-31"
      decimals="INF"
      unitRef="Pure">0.078</ipar:RoyaltyExpenseNetSalesPercentage>
    <ipar:RoyaltyExpenseNetSalesPercentage
      contextRef="From2020-01-012020-12-31"
      decimals="INF"
      unitRef="Pure">0.076</ipar:RoyaltyExpenseNetSalesPercentage>
    <ipar:RoyaltyExpenseNetSalesPercentage
      contextRef="From2019-01-012019-12-31"
      decimals="INF"
      unitRef="Pure">0.074</ipar:RoyaltyExpenseNetSalesPercentage>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_803_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zlyxrfluMVOi" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;(13)&lt;/td&gt;&lt;td&gt;&lt;span id="xdx_824_zVmjzl1ySt49"&gt;Equity&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;Share-Based Payments&lt;/p&gt;

&lt;p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Company maintains
a stock option program for key employees, executives and directors. The plans, all of which have been approved by
shareholder vote, provide for the granting of both nonqualified and incentive options. Options granted under the plans
typically have a six-year term and vest over a &lt;span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_dtxL_c20210101__20211231__srt--RangeAxis__srt--MinimumMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zUGDlh0a2WU6" title="Share-based compensation arrangement by share-based payment award, award vesting period::XDX::P4Y"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1263"&gt;four&lt;/span&gt;&lt;/span&gt;
to &lt;span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_dtxL_c20210101__20211231__srt--RangeAxis__srt--MaximumMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zE2tSj3P95Be" title="Share-based compensation arrangement by share-based payment award, award vesting period::XDX::P5Y"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1265"&gt;five-year&lt;/span&gt;&lt;/span&gt;
period. The fair value of shares vested aggregated $&lt;span id="xdx_90E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_dm_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zfs2A3ks61kd"&gt;1.4
million&lt;/span&gt;, $&lt;span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_dm_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zi9jTldEHxY" title="Fair value of shares vested"&gt;1.7
million&lt;/span&gt; and $&lt;span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_dm_c20190101__20191231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zCCezxtDy292"&gt;1.4 million&lt;/span&gt; in 2021, 2020 and 2019, respectively. &lt;span style="font-family: Times New Roman, Times, Serif"&gt;Compensation
cost, net of estimated forfeitures, is recognized on a straight-line basis over the requisite service period for the
entire award. Forfeitures are estimated based on historic trends. &lt;/span&gt;It is generally the Company&#x2019;s policy to issue
new shares upon exercise of stock options.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_897_eus-gaap--ScheduleOfNonvestedShareActivityTableTextBlock_z8ZrifFxP0t3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span id="xdx_8BC_zMWGswiSqs1h"&gt;The following table sets forth
information with respect to nonvested options for 2021:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Number of Shares&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Weighted Average&lt;br/&gt;
 Grant Date&lt;br/&gt;
Fair Value&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left"&gt;Nonvested options &#x2013; beginning of year&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iS_pid_uShares_c20210101__20211231_zvGsbl79ra63" style="width: 15%; text-align: right" title="Nonvested options - beginning of year"&gt;353,790&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iS_pid_uUSDPShares_c20210101__20211231_zf4XtRrTRhY1" style="width: 15%; text-align: right" title="Weighted Average Grant Date Fair Value, beginning of year"&gt;12.96&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Nonvested options granted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_uShares_c20210101__20211231_zbm3MQRNZLj7" style="text-align: right" title="Nonvested options granted"&gt;9,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_uUSDPShares_c20210101__20211231_zvj55yTKFDL8" style="text-align: right" title="Weighted Average Grant Date Fair Value, granted"&gt;11.35&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Nonvested options vested or forfeited&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_iN_pid_di_uShares_c20210101__20211231_zHoNAdPd7gk1" style="border-bottom: Black 1pt solid; text-align: right" title="Nonvested options vested or forfeited"&gt;(153,280&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_pid_uUSDPShares_c20210101__20211231_zaOodMpx1m63" style="text-align: right" title="Weighted Average Grant Date Fair Value, vested or forfeited"&gt;12.19&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2pt"&gt;Nonvested options &#x2013; end of year&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iE_pid_uShares_c20210101__20211231_zfPUrQ8OE2u2" style="border-bottom: Black 2pt double; text-align: right" title="Nonvested options - end of year"&gt;209,510&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iE_pid_uUSDPShares_c20210101__20211231_zK1Iv0XltGv5" style="text-align: right" title="Weighted Average Grant Date Fair Value, end of year"&gt;13.45&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A8_z9G0XLBK20a4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_89D_eus-gaap--ScheduleOfShareBasedCompensationActivityTableTextBlock_zvleNI06rDEk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span id="xdx_8BB_zB9k0ntXSjdd"&gt;The effect of share-based payment
expenses decreased income statement line items as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Year Ended December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2019&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 55%; text-align: left"&gt;Income before income taxes&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_c20210101__20211231__us-gaap--IncomeStatementLocationAxis__us-gaap--OperatingIncomeLossMember_zPf8FbwkipRc" style="width: 12%; text-align: right" title="Income before income taxes"&gt;2,850&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_c20200101__20201231__us-gaap--IncomeStatementLocationAxis__us-gaap--OperatingIncomeLossMember_zM3RXe1Uzlx5" style="width: 12%; text-align: right"&gt;3,030&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_c20190101__20191231__us-gaap--IncomeStatementLocationAxis__us-gaap--OperatingIncomeLossMember_zLGXk9Bchomf" style="width: 12%; text-align: right"&gt;3,390&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Net income attributable to Inter Parfums, Inc.&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--NetIncomeLoss_c20210101__20211231__us-gaap--IncomeStatementLocationAxis__us-gaap--OperatingIncomeLossMember_zio92kKlNDG1" style="text-align: right" title="Net income attributable to Inter Parfums, Inc."&gt;1,880&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--NetIncomeLoss_c20200101__20201231__us-gaap--IncomeStatementLocationAxis__us-gaap--OperatingIncomeLossMember_zk1fIhwSyAQ8" style="text-align: right"&gt;2,040&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--NetIncomeLoss_c20190101__20191231__us-gaap--IncomeStatementLocationAxis__us-gaap--OperatingIncomeLossMember_znsBRLKCuWb5" style="text-align: right"&gt;2,060&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Diluted earnings per share attributable to Inter Parfums, Inc.&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--EarningsPerShareDiluted_pid_uUSDPShares_c20210101__20211231__us-gaap--IncomeStatementLocationAxis__us-gaap--OperatingIncomeLossMember_zxDcEGuXrfEg" style="text-align: right" title="Diluted earnings per share attributable to Inter Parfums, Inc"&gt;0.06&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--EarningsPerShareDiluted_pid_uUSDPShares_c20200101__20201231__us-gaap--IncomeStatementLocationAxis__us-gaap--OperatingIncomeLossMember_zRLGYRITWUa" style="text-align: right"&gt;0.06&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--EarningsPerShareDiluted_pid_uUSDPShares_c20190101__20191231__us-gaap--IncomeStatementLocationAxis__us-gaap--OperatingIncomeLossMember_zBLJMsKKNzV8" style="text-align: right"&gt;0.07&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p id="xdx_8AE_z0DOdvvSAml7" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_89E_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zDcEFm9k7uh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span id="xdx_8B8_zD54LK3lVHI8"&gt;The following table summarizes stock option activity and related information for the years ended December 31, 2021, 2020 and
2019:&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;
&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="22" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Year ended December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2019&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Options&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Weighted&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Average&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Exercise&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Price&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Options&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Weighted&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Average&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Exercise&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Price&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Options&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Weighted&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Average&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Exercise&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Price&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 28%; text-align: left; text-indent: -0.125in; padding-left: 0.125in"&gt;Shares under option - beginning of year&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_uShares_c20210101__20211231_zA8543b6APh9" style="width: 9%; text-align: right" title="Options shares under option - beginning of year"&gt;713,210&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_uUSDPShares_c20210101__20211231_zC8vapGuY9i" style="width: 9%; text-align: right" title="Weighted average exercise price shares under option - beginning of year"&gt;52.74&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_uShares_c20200101__20201231_z5u6iR8WYkrl" style="width: 9%; text-align: right"&gt;815,800&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_uUSDPShares_c20200101__20201231_zcP0CPxAKP8j" style="width: 9%; text-align: right"&gt;49.89&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_uShares_c20190101__20191231_zU6ybomZKya4" style="width: 9%; text-align: right"&gt;776,171&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_uUSDPShares_c20190101__20191231_zUrKgGW5UtFl" style="width: 9%; text-align: right"&gt;41.33&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in"&gt;Options granted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_uShares_c20210101__20211231_zWaGWhA3y089" style="text-align: right" title="Options granted"&gt;9,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_uUSDPShares_c20210101__20211231_ztWooTqug7se" style="text-align: right" title="Weighted average exercise price options granted"&gt;62.18&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_uShares_c20200101__20201231_zdZYrk8MSQec" style="text-align: right" title="Options granted"&gt;9,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_uUSDPShares_c20200101__20201231_zcTcxSHfjHQe" style="text-align: right"&gt;69.11&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_uShares_c20190101__20191231_zwbAPKXMgHzb" style="text-align: right" title="Options granted"&gt;194,050&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_uUSDPShares_c20190101__20191231_zWRSpCGy5fB4" style="text-align: right"&gt;72.89&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in"&gt;Options exercised&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pid_di_uShares_c20210101__20211231_z8jozSWC3XAb" style="text-align: right" title="Options exercised"&gt;(156,490&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_uUSDPShares_c20210101__20211231_zn6fcE5Pg9Hj" style="text-align: right" title="Weighted average exercise price options exercised"&gt;34.46&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pid_di_uShares_c20200101__20201231_zKMFxZ3Jpyx" style="text-align: right" title="Options exercised"&gt;(95,570&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_uUSDPShares_c20200101__20201231_zt5HTMbsLwL2" style="text-align: right"&gt;28.99&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pid_di_uShares_c20190101__20191231_z2UEaolQPkd8" style="text-align: right" title="Options exercised"&gt;(130,891&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_uUSDPShares_c20190101__20191231_zUqWAhlDcou9" style="text-align: right"&gt;34.06&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: -0.125in; padding-left: 0.125in"&gt;Options forfeited&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_pid_di_uShares_c20210101__20211231_z0823ZeqZ2A6" style="border-bottom: Black 1pt solid; text-align: right" title="Options forfeited"&gt;(40,820&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_uUSDPShares_c20210101__20211231_zgN5rdvufK9b" style="text-align: right" title="Weighted average exercise price options forfeited"&gt;62.57&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_pid_di_uShares_c20200101__20201231_zzKTz6JvbIZc" style="border-bottom: Black 1pt solid; text-align: right" title="Options forfeited"&gt;(16,020&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_uUSDPShares_c20200101__20201231_zjEgBkjyNEn1" style="text-align: right"&gt;58.38&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_pid_di_uShares_c20190101__20191231_zZTaSwGKkgOd" style="border-bottom: Black 1pt solid; text-align: right" title="Options forfeited"&gt;(23,530&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_uUSDPShares_c20190101__20191231_zyiZ3TVFZLNk" style="text-align: right"&gt;45.48&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2pt; text-indent: -0.125in; padding-left: 0.125in"&gt;Shares under option - end of year&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_uShares_c20210101__20211231_zLmY6iaWJ20g" style="border-bottom: Black 2pt double; text-align: right" title="Options shares under option - end of year"&gt;524,900&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_uUSDPShares_c20210101__20211231_zVLAtyPYEs4j" style="text-align: right" title="Weighted average exercise price shares under option - end of year"&gt;57.58&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_uShares_c20200101__20201231_zB9SYPBYrZPg" style="border-bottom: Black 2pt double; text-align: right"&gt;713,210&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_uUSDPShares_c20200101__20201231_zuA5T05mo1V9" style="text-align: right"&gt;52.74&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_uShares_c20190101__20191231_zHnm84lXJmT" style="border-bottom: Black 2pt double; text-align: right"&gt;815,800&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_uUSDPShares_c20190101__20191231_zkHyldwmhiGg" style="text-align: right"&gt;49.89&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8AB_zhbOaxUnAgCa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&#160;&lt;/p&gt;









&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;At December 31, 2021, options
for &lt;span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_pid_uShares_c20211231__us-gaap--DebtInstrumentAxis__us-gaap--StockOptionMember_zmZy7NvXvfW3" title="Number of shares available for grant (in Shares)"&gt;612,535&lt;/span&gt; shares were available for future grant under the plans. The aggregate intrinsic value of options outstanding is $&lt;span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_dm_c20211231__us-gaap--DebtInstrumentAxis__us-gaap--StockOptionMember_zQUIKP2LH6u1" title="Aggregate intrinsic value of options outstanding"&gt;25.9
million&lt;/span&gt; as of December 31, 2021 and unrecognized compensation cost related to stock options outstanding aggregated $&lt;span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_dm_c20211231__us-gaap--DebtInstrumentAxis__custom--StockOptionOneMember_zy9caq77DwYb" title="Aggregate intrinsic value of options outstanding"&gt;2.9 million&lt;/span&gt;,
which will be recognized over the next &lt;span id="xdx_90F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_dxL_c20210101__20211231__us-gaap--DebtInstrumentAxis__us-gaap--StockOptionMember_z2LEBgvlwLGi" title="Term::XDX::P5Y"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1362"&gt;five years&lt;/span&gt;&lt;/span&gt;.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The weighted average fair values
of options granted by Inter Parfums, Inc. during 2021, 2020 and 2019 were $&lt;span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z9ZXJRC5TbIl" title="Weighted average grant date fair value (in Dollars per share)"&gt;11.35&lt;/span&gt;, $&lt;span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z0o2Go7rFK5h" title="Weighted average grant date fair value (in Dollars per share)"&gt;12.16&lt;/span&gt; and $&lt;span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20190101__20191231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_ztP81MAKJyY9" title="Weighted average grant date fair value (in Dollars per share)"&gt;14.14&lt;/span&gt; per share, respectively, on
the date of grant using the Black-Scholes option pricing model to calculate the fair value.&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_894_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zojQBpKqAPSe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span id="xdx_8B8_zqp2yAmXZsBb"&gt;The assumptions used in the Black-Scholes
pricing model are set forth in the following table:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_494_20210101__20211231_zAj1yLhUcnl6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_498_20200101__20201231_zvfM12Hn0mB7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_498_20190101__20191231_zWvzMZGTPlzj" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Year Ended December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2019&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pii_dp_uPure_zJuwuMc5Ckni" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 55%; text-align: left"&gt;Weighted-average expected stock-price volatility&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;25&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;25&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;25&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Weighted-average expected option life&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dxL_c20210101__20211231_zn4UR0StrNI4" style="text-align: right" title="Weighted-average expected option life::XDX::P5Y"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1376"&gt;5.0 years&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dxL_c20200101__20201231_zJXLlFaOMDM7" style="text-align: right" title="Weighted-average expected option life::XDX::P5Y"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1378"&gt;5.0 years&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtxL_c20190101__20191231_zI1qfZ5JrH9l" style="text-align: right" title="Weighted-average expected option life::XDX::P5Y"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1380"&gt;5.0 years&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pii_dp_uPure_zX0zKk2ffFX8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Weighted-average risk-free interest rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0.4&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1.4&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1.7&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_400_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pii_dp_uPure_z7juvhVvP4ri" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Weighted-average dividend yield&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1.6&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2.5&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2.0&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A3_z4RQRU2Koug" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Expected volatility is estimated
based on historic volatility of the Company&#x2019;s common stock. The expected term of the option is estimated based on historic
data. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of the grant of the option and the dividend
yield reflects the assumption that the dividend payout as authorized by the Board of Directors would maintain its current payout
ratio as a percentage of earnings.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_897_eus-gaap--CashProceedsReceivedAndTaxBenefitFromShareBasedPaymentAwardsTableTextBlock_zk2DUKzD1fS5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span id="xdx_8BA_zJjz1GHhyJ9h"&gt;Proceeds, tax benefits and intrinsic
value related to stock options exercised were as follows&lt;/span&gt;:&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49C_20210101__20211231_zIBswFHmbfIg" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_498_20200101__20201231_zRtiSmREtAr9" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_49C_20190101__20191231_zMnqljIvkn5e" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Year Ended December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2019&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40B_eus-gaap--ProceedsFromStockOptionsExercised_z6Rw9FEBmt6h" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 55%; text-align: left; text-indent: -8.1pt; padding-left: 8.1pt"&gt;Proceeds from stock options exercised&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;5,393&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;2,771&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;4,458&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_406_eus-gaap--DeferredTaxExpenseFromStockOptionsExercised_zBKEGaJCuyba" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Tax benefits&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;1,300&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;400&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;690&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_409_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_zQ1YtC1ZC4T5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Intrinsic value of stock options exercised&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;7,800&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;2,873&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;4,520&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8AF_zJo8QVZzWam8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;INTER PARFUMS, INC. AND SUBSIDIARIES&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;Notes to Consolidated Financial Statements&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;December 31, 2021, 2020 and 2019&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;(In thousands except share and per share data)&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_89D_eus-gaap--ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_z2AzDnAS4v3g" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span id="xdx_8B3_zD7zIDewqjl9"&gt;The following table summarizes
additional stock option information as of December&#160;31, 2021:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Exercise prices&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Options&lt;br/&gt; outstanding&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Options outstanding&lt;br/&gt; weighted average remaining&lt;br/&gt; contractual life&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Options&lt;br/&gt; exercisable&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 25%; text-align: center"&gt;&#160;$&lt;span id="xdx_904_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20211231__srt--RangeAxis__srt--MinimumMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_z0SmNLp1UKW8"&gt;32.83&lt;/span&gt; - $&lt;span id="xdx_90C_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20211231__srt--RangeAxis__srt--MaximumMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zxkEFLWonQRc" title="Exercise price range (in Dollars per share)"&gt;33.95&lt;/span&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_uShares_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zghQWgYFZpQ4" style="width: 15%; text-align: right" title="Options outstanding"&gt;81,190&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 32%; text-align: center"&gt;&lt;span id="xdx_907_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtxL_c20210101__20211231__srt--RangeAxis__srt--MaximumMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zbT0vgHJK6z3" title="Options outstanding weighted average remaining contractual life::XDX::P0Y11M12D"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1411"&gt;0.99&lt;/span&gt;&lt;/span&gt; years&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_uShares_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zq3UMvD8Cs77" style="width: 15%; text-align: right" title="Options exercisable"&gt;81,190&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center"&gt;&#160;$&lt;span id="xdx_901_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20211231__srt--RangeAxis__srt--MinimumMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zSK2Hc2JHOs5"&gt;40.15&lt;/span&gt; - $&lt;span id="xdx_90B_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20211231__srt--RangeAxis__srt--MaximumMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_zZl4qG4E9RKk"&gt;46.90&lt;/span&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_uShares_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zo23alIyc0ei" style="text-align: right"&gt;123,130&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span id="xdx_90D_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtxL_c20210101__20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zGo3mr7UDwb2" title="::XDX::P1Y11M8D"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1417"&gt;1.94&lt;/span&gt;&lt;/span&gt; years&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_uShares_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zrOVZVdmeJVf" style="text-align: right"&gt;90,790&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: center"&gt;&#160;$&lt;span id="xdx_90B_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20211231__srt--RangeAxis__srt--MinimumMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_z7PS3EwbWBze"&gt;65.18&lt;/span&gt; - $&lt;span id="xdx_901_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20211231__srt--RangeAxis__srt--MaximumMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_z5DcuTr6jQOk"&gt;69.11&lt;/span&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_uShares_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_z0rt4wLXWj34" style="text-align: right"&gt;164,940&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span id="xdx_901_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtxL_c20210101__20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_zGFPaLhucRG9" title="::XDX::P3Y0M11D"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1422"&gt;3.03&lt;/span&gt;&lt;/span&gt; years&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_uShares_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_zJm6RHjgp7t7" style="text-align: right"&gt;84,790&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center"&gt;$&lt;span id="xdx_90B_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_z1viWAr5GRFa"&gt;73.09&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_uShares_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_zuMRwU8NixE8" style="border-bottom: Black 1pt solid; text-align: right"&gt;155,640&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span id="xdx_906_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtxL_c20210101__20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_zabrABTe8d59" title="::XDX::P4Y0M0D"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1426"&gt;4.00&lt;/span&gt;&lt;/span&gt; years&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_uShares_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_zq5xHhHAiRNd" style="border-bottom: Black 1pt solid; text-align: right"&gt;58,620&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: center"&gt;&#160;Totals&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_uShares_c20211231_zZWPcpK3imjl" style="border-bottom: Black 2pt double; text-align: right"&gt;524,900&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 2pt"&gt;&lt;span id="xdx_907_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtxL_c20210101__20211231_z43En5xnVYij" title="::XDX::P2Y9M0D"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1429"&gt;2.75&lt;/span&gt;&lt;/span&gt; years&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_uShares_c20211231_zoOydnZgWk87" style="border-bottom: Black 2pt double; text-align: right"&gt;315,390&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;



&lt;p id="xdx_8A8_zfHmFJMSTkk5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;As of December 31, 2021, the
weighted average exercise price of options exercisable was $52.23 and the weighted average remaining contractual life of options
exercisable is 2.35 years. The aggregate intrinsic value of options exercisable at December 31, 2021 is $17.2 million.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;In December 2018, Interparfums
SA approved a plan to grant an aggregate of &lt;span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_iI_pid_c20181231__srt--ConsolidatedEntitiesAxis__custom--InterparfumsSASubsidiaryMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_zmeIjpsfFm22" title="Adjusted for stock splits (in Shares)"&gt;26,600&lt;/span&gt; shares of its stock to employees with no performance condition requirement,
and an aggregate of &lt;span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_pid_c20181231__srt--ConsolidatedEntitiesAxis__custom--InterparfumsSASubsidiaryMember__srt--TitleOfIndividualAxis__custom--OfficersAndManagersMember_zFYVOvSAnHy9" title="Aggregate intrinsic value of options outstanding"&gt;133,000&lt;/span&gt; shares to officers and managers, subject to certain corporate performance conditions. The shares, subject
to adjustment for stock splits, will be distributed in June 2022.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;In March 2020, &lt;span id="xdx_900_ecustom--Covid19Description_c20200301__20200331_z6z0qEPsMxh9" title="Covid 19, description"&gt;due to the potential
impact on future net sales and operating results resulting from the COVID-19 pandemic, the estimated number of shares to be distributed,
after forfeited shares, was reduced from&#160;142,571&#160;to&#160;82,162. As the Company had already purchased shares in contemplation
of the higher anticipated distribution, shares purchased in excess of the reduced anticipated distribution were transferred to
treasury shares at the Interparfums SA level.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The fair value of the grant had
been determined based on the quoted stock price of Interparfums SA shares as reported by the NYSE Euronext on the date of grant.&#160;&lt;span id="xdx_90E_ecustom--RevaluationResultedInReductionOfCostDescription_c20200101__20200331__srt--OwnershipAxis__custom--InterparfumsSASubsidiaryMember_z9QGz33uRcDa" title="Revaluation resulted in reduction of cost, description"&gt;The
original cost of the grant was approximately $4.4&#160;million, and the March 2020 revaluation resulted in a reduction of the cost,
to approximately $2.5 million.&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;In June 2020, the performance
conditions were modified affecting 96 employees. As of December 31, 2021, the number of shares to be distributed, after forfeited
shares, increased to&#160;&lt;span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_iI_pid_c20211231__srt--OwnershipAxis__custom--InterparfumsSASubsidiaryMember_zU6v2gsi8Bo3" title="Adjusted for stock splits (in Shares)"&gt;172,343&lt;/span&gt;. The increase in shares anticipated to be distributed were transferred from treasury shares at
the Interparfums SA level. The modification resulted in a revised cost of the grant to approximately $&lt;span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost_dm_c20210101__20211231__srt--OwnershipAxis__custom--InterparfumsSASubsidiaryMember_zNxJlL9c4Lw7" title="Modification resulted revised cost"&gt;4.6 million&lt;/span&gt;.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;In order to avoid dilution of
the Company&#x2019;s ownership of Interparfums SA, all shares distributed or to be distributed pursuant to these plans are pre-existing
shares of Interparfums SA, purchased in the open market by Interparfums SA.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;All share purchases and issuances
have been classified as equity transactions on the accompanying balance sheet.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;Dividends&lt;/p&gt;

&lt;p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;In October 2019, our Board of
Directors authorized a &lt;span id="xdx_90B_ecustom--PercentageOfIncreaseInAnnualDividend_pid_dp_c20191001__20191031_ztVsbdUeAaGk" title="Percentage of increase in annual dividend"&gt;20&lt;/span&gt;% increase in the annual dividend to $&lt;span id="xdx_90F_eus-gaap--DividendsPayableAmountPerShare_iI_pid_c20191031_zxw6vw9fs8a1"&gt;1.32&lt;/span&gt; per share on an annual basis. In April 2020, as a result of
the uncertainties raised by the COVID-19 pandemic, the Board of Directors authorized a temporary suspension of the annual cash
dividend. In February 2021, the Board of Directors authorized a reinstatement of an annual dividend of $1.00 payable quarterly.
In February 2022, the Board of Directors authorized a 100% increase in the annual dividend to $&lt;span id="xdx_907_eus-gaap--DividendsPayableAmountPerShare_iI_pid_c20210228__srt--TitleOfIndividualAxis__srt--BoardOfDirectorsChairmanMember_zb9fHsHC1Kq1" title="Dividends payable, amount per share (in Dollars per share)"&gt;2.00&lt;/span&gt; per share. The next quarterly
cash dividend of $&lt;span id="xdx_90B_eus-gaap--DividendsPayableAmountPerShare_iI_pid_c20220331__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zouOfKzEDI9d" title="Dividends payable, amount per share (in Dollars per share)"&gt;0.50&lt;/span&gt; per share is payable on March 31, 2022 to shareholders of record on March 15, 2022.&lt;/p&gt;

</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
      contextRef="From2021-01-012021-12-31_us-gaap_StockOptionMember"
      decimals="0"
      unitRef="USD">1400000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
      contextRef="From2020-01-012020-12-31_us-gaap_StockOptionMember"
      decimals="0"
      unitRef="USD">1700000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
      contextRef="From2019-01-012019-12-31_us-gaap_StockOptionMember"
      decimals="0"
      unitRef="USD">1400000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
    <us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_897_eus-gaap--ScheduleOfNonvestedShareActivityTableTextBlock_z8ZrifFxP0t3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span id="xdx_8BC_zMWGswiSqs1h"&gt;The following table sets forth
information with respect to nonvested options for 2021:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Number of Shares&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Weighted Average&lt;br/&gt;
 Grant Date&lt;br/&gt;
Fair Value&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left"&gt;Nonvested options &#x2013; beginning of year&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iS_pid_uShares_c20210101__20211231_zvGsbl79ra63" style="width: 15%; text-align: right" title="Nonvested options - beginning of year"&gt;353,790&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iS_pid_uUSDPShares_c20210101__20211231_zf4XtRrTRhY1" style="width: 15%; text-align: right" title="Weighted Average Grant Date Fair Value, beginning of year"&gt;12.96&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Nonvested options granted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_uShares_c20210101__20211231_zbm3MQRNZLj7" style="text-align: right" title="Nonvested options granted"&gt;9,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_uUSDPShares_c20210101__20211231_zvj55yTKFDL8" style="text-align: right" title="Weighted Average Grant Date Fair Value, granted"&gt;11.35&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Nonvested options vested or forfeited&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_iN_pid_di_uShares_c20210101__20211231_zHoNAdPd7gk1" style="border-bottom: Black 1pt solid; text-align: right" title="Nonvested options vested or forfeited"&gt;(153,280&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_pid_uUSDPShares_c20210101__20211231_zaOodMpx1m63" style="text-align: right" title="Weighted Average Grant Date Fair Value, vested or forfeited"&gt;12.19&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2pt"&gt;Nonvested options &#x2013; end of year&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iE_pid_uShares_c20210101__20211231_zfPUrQ8OE2u2" style="border-bottom: Black 2pt double; text-align: right" title="Nonvested options - end of year"&gt;209,510&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iE_pid_uUSDPShares_c20210101__20211231_zK1Iv0XltGv5" style="text-align: right" title="Weighted Average Grant Date Fair Value, end of year"&gt;13.45&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares contextRef="AsOf2020-12-31" decimals="INF" unitRef="Shares">353790</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="AsOf2020-12-31"
      decimals="INF"
      unitRef="USDPShares">12.96</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2021-01-01to2021-12-31"
      decimals="INF"
      unitRef="Shares">9000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="From2021-01-01to2021-12-31"
      decimals="INF"
      unitRef="USDPShares">11.35</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
      contextRef="From2021-01-01to2021-12-31"
      decimals="INF"
      unitRef="Shares">153280</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
      contextRef="From2021-01-01to2021-12-31"
      decimals="INF"
      unitRef="USDPShares">12.19</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares contextRef="AsOf2021-12-31" decimals="INF" unitRef="Shares">209510</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="AsOf2021-12-31"
      decimals="INF"
      unitRef="USDPShares">13.45</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_89D_eus-gaap--ScheduleOfShareBasedCompensationActivityTableTextBlock_zvleNI06rDEk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span id="xdx_8BB_zB9k0ntXSjdd"&gt;The effect of share-based payment
expenses decreased income statement line items as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Year Ended December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2019&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 55%; text-align: left"&gt;Income before income taxes&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_c20210101__20211231__us-gaap--IncomeStatementLocationAxis__us-gaap--OperatingIncomeLossMember_zPf8FbwkipRc" style="width: 12%; text-align: right" title="Income before income taxes"&gt;2,850&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_c20200101__20201231__us-gaap--IncomeStatementLocationAxis__us-gaap--OperatingIncomeLossMember_zM3RXe1Uzlx5" style="width: 12%; text-align: right"&gt;3,030&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_c20190101__20191231__us-gaap--IncomeStatementLocationAxis__us-gaap--OperatingIncomeLossMember_zLGXk9Bchomf" style="width: 12%; text-align: right"&gt;3,390&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Net income attributable to Inter Parfums, Inc.&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--NetIncomeLoss_c20210101__20211231__us-gaap--IncomeStatementLocationAxis__us-gaap--OperatingIncomeLossMember_zio92kKlNDG1" style="text-align: right" title="Net income attributable to Inter Parfums, Inc."&gt;1,880&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--NetIncomeLoss_c20200101__20201231__us-gaap--IncomeStatementLocationAxis__us-gaap--OperatingIncomeLossMember_zk1fIhwSyAQ8" style="text-align: right"&gt;2,040&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--NetIncomeLoss_c20190101__20191231__us-gaap--IncomeStatementLocationAxis__us-gaap--OperatingIncomeLossMember_znsBRLKCuWb5" style="text-align: right"&gt;2,060&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Diluted earnings per share attributable to Inter Parfums, Inc.&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--EarningsPerShareDiluted_pid_uUSDPShares_c20210101__20211231__us-gaap--IncomeStatementLocationAxis__us-gaap--OperatingIncomeLossMember_zxDcEGuXrfEg" style="text-align: right" title="Diluted earnings per share attributable to Inter Parfums, Inc"&gt;0.06&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--EarningsPerShareDiluted_pid_uUSDPShares_c20200101__20201231__us-gaap--IncomeStatementLocationAxis__us-gaap--OperatingIncomeLossMember_zRLGYRITWUa" style="text-align: right"&gt;0.06&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--EarningsPerShareDiluted_pid_uUSDPShares_c20190101__20191231__us-gaap--IncomeStatementLocationAxis__us-gaap--OperatingIncomeLossMember_zBLJMsKKNzV8" style="text-align: right"&gt;0.07&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


</us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="From2021-01-012021-12-31_us-gaap_OperatingIncomeLossMember"
      decimals="-3"
      unitRef="USD">2850000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="From2020-01-012020-12-31_us-gaap_OperatingIncomeLossMember"
      decimals="-3"
      unitRef="USD">3030000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="From2019-01-012019-12-31_us-gaap_OperatingIncomeLossMember"
      decimals="-3"
      unitRef="USD">3390000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-01-012021-12-31_us-gaap_OperatingIncomeLossMember"
      decimals="-3"
      unitRef="USD">1880000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-01-012020-12-31_us-gaap_OperatingIncomeLossMember"
      decimals="-3"
      unitRef="USD">2040000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2019-01-012019-12-31_us-gaap_OperatingIncomeLossMember"
      decimals="-3"
      unitRef="USD">2060000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2021-01-012021-12-31_us-gaap_OperatingIncomeLossMember"
      decimals="INF"
      unitRef="USDPShares">0.06</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2020-01-012020-12-31_us-gaap_OperatingIncomeLossMember"
      decimals="INF"
      unitRef="USDPShares">0.06</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2019-01-012019-12-31_us-gaap_OperatingIncomeLossMember"
      decimals="INF"
      unitRef="USDPShares">0.07</us-gaap:EarningsPerShareDiluted>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_89E_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zDcEFm9k7uh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span id="xdx_8B8_zD54LK3lVHI8"&gt;The following table summarizes stock option activity and related information for the years ended December 31, 2021, 2020 and
2019:&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;
&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="22" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Year ended December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2019&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Options&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Weighted&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Average&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Exercise&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Price&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Options&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Weighted&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Average&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Exercise&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Price&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Options&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Weighted&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Average&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Exercise&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Price&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 28%; text-align: left; text-indent: -0.125in; padding-left: 0.125in"&gt;Shares under option - beginning of year&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_uShares_c20210101__20211231_zA8543b6APh9" style="width: 9%; text-align: right" title="Options shares under option - beginning of year"&gt;713,210&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_uUSDPShares_c20210101__20211231_zC8vapGuY9i" style="width: 9%; text-align: right" title="Weighted average exercise price shares under option - beginning of year"&gt;52.74&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_uShares_c20200101__20201231_z5u6iR8WYkrl" style="width: 9%; text-align: right"&gt;815,800&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_uUSDPShares_c20200101__20201231_zcP0CPxAKP8j" style="width: 9%; text-align: right"&gt;49.89&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_uShares_c20190101__20191231_zU6ybomZKya4" style="width: 9%; text-align: right"&gt;776,171&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_uUSDPShares_c20190101__20191231_zUrKgGW5UtFl" style="width: 9%; text-align: right"&gt;41.33&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in"&gt;Options granted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_uShares_c20210101__20211231_zWaGWhA3y089" style="text-align: right" title="Options granted"&gt;9,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_uUSDPShares_c20210101__20211231_ztWooTqug7se" style="text-align: right" title="Weighted average exercise price options granted"&gt;62.18&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_uShares_c20200101__20201231_zdZYrk8MSQec" style="text-align: right" title="Options granted"&gt;9,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_uUSDPShares_c20200101__20201231_zcTcxSHfjHQe" style="text-align: right"&gt;69.11&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_uShares_c20190101__20191231_zwbAPKXMgHzb" style="text-align: right" title="Options granted"&gt;194,050&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_uUSDPShares_c20190101__20191231_zWRSpCGy5fB4" style="text-align: right"&gt;72.89&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in"&gt;Options exercised&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pid_di_uShares_c20210101__20211231_z8jozSWC3XAb" style="text-align: right" title="Options exercised"&gt;(156,490&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_uUSDPShares_c20210101__20211231_zn6fcE5Pg9Hj" style="text-align: right" title="Weighted average exercise price options exercised"&gt;34.46&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pid_di_uShares_c20200101__20201231_zKMFxZ3Jpyx" style="text-align: right" title="Options exercised"&gt;(95,570&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_uUSDPShares_c20200101__20201231_zt5HTMbsLwL2" style="text-align: right"&gt;28.99&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pid_di_uShares_c20190101__20191231_z2UEaolQPkd8" style="text-align: right" title="Options exercised"&gt;(130,891&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_uUSDPShares_c20190101__20191231_zUqWAhlDcou9" style="text-align: right"&gt;34.06&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: -0.125in; padding-left: 0.125in"&gt;Options forfeited&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_pid_di_uShares_c20210101__20211231_z0823ZeqZ2A6" style="border-bottom: Black 1pt solid; text-align: right" title="Options forfeited"&gt;(40,820&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_uUSDPShares_c20210101__20211231_zgN5rdvufK9b" style="text-align: right" title="Weighted average exercise price options forfeited"&gt;62.57&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_pid_di_uShares_c20200101__20201231_zzKTz6JvbIZc" style="border-bottom: Black 1pt solid; text-align: right" title="Options forfeited"&gt;(16,020&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_uUSDPShares_c20200101__20201231_zjEgBkjyNEn1" style="text-align: right"&gt;58.38&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_pid_di_uShares_c20190101__20191231_zZTaSwGKkgOd" style="border-bottom: Black 1pt solid; text-align: right" title="Options forfeited"&gt;(23,530&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_uUSDPShares_c20190101__20191231_zyiZ3TVFZLNk" style="text-align: right"&gt;45.48&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2pt; text-indent: -0.125in; padding-left: 0.125in"&gt;Shares under option - end of year&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_uShares_c20210101__20211231_zLmY6iaWJ20g" style="border-bottom: Black 2pt double; text-align: right" title="Options shares under option - end of year"&gt;524,900&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_uUSDPShares_c20210101__20211231_zVLAtyPYEs4j" style="text-align: right" title="Weighted average exercise price shares under option - end of year"&gt;57.58&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_uShares_c20200101__20201231_zB9SYPBYrZPg" style="border-bottom: Black 2pt double; text-align: right"&gt;713,210&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_uUSDPShares_c20200101__20201231_zuA5T05mo1V9" style="text-align: right"&gt;52.74&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_uShares_c20190101__20191231_zHnm84lXJmT" style="border-bottom: Black 2pt double; text-align: right"&gt;815,800&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_uUSDPShares_c20190101__20191231_zkHyldwmhiGg" style="text-align: right"&gt;49.89&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="AsOf2020-12-31" decimals="INF" unitRef="Shares">713210</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2020-12-31"
      decimals="INF"
      unitRef="USDPShares">52.74</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="AsOf2019-12-31" decimals="INF" unitRef="Shares">815800</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2019-12-31"
      decimals="INF"
      unitRef="USDPShares">49.89</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="AsOf2018-12-31" decimals="INF" unitRef="Shares">776171</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2018-12-31"
      decimals="INF"
      unitRef="USDPShares">41.33</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2021-01-01to2021-12-31"
      decimals="INF"
      unitRef="Shares">9000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="From2021-01-01to2021-12-31"
      decimals="INF"
      unitRef="USDPShares">62.18</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2020-01-012020-12-31"
      decimals="INF"
      unitRef="Shares">9000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="From2020-01-012020-12-31"
      decimals="INF"
      unitRef="USDPShares">69.11</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2019-01-012019-12-31"
      decimals="INF"
      unitRef="Shares">194050</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="From2019-01-012019-12-31"
      decimals="INF"
      unitRef="USDPShares">72.89</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="From2021-01-01to2021-12-31"
      decimals="INF"
      unitRef="Shares">156490</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="From2021-01-01to2021-12-31"
      decimals="INF"
      unitRef="USDPShares">34.46</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="From2020-01-012020-12-31"
      decimals="INF"
      unitRef="Shares">95570</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="From2020-01-012020-12-31"
      decimals="INF"
      unitRef="USDPShares">28.99</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="From2019-01-012019-12-31"
      decimals="INF"
      unitRef="Shares">130891</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="From2019-01-012019-12-31"
      decimals="INF"
      unitRef="USDPShares">34.06</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="From2021-01-01to2021-12-31"
      decimals="INF"
      unitRef="Shares">40820</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="From2021-01-01to2021-12-31"
      decimals="INF"
      unitRef="USDPShares">62.57</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="From2020-01-012020-12-31"
      decimals="INF"
      unitRef="Shares">16020</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="From2020-01-012020-12-31"
      decimals="INF"
      unitRef="USDPShares">58.38</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="From2019-01-012019-12-31"
      decimals="INF"
      unitRef="Shares">23530</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="From2019-01-012019-12-31"
      decimals="INF"
      unitRef="USDPShares">45.48</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="AsOf2021-12-31" decimals="INF" unitRef="Shares">524900</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2021-12-31"
      decimals="INF"
      unitRef="USDPShares">57.58</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="AsOf2020-12-31" decimals="INF" unitRef="Shares">713210</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2020-12-31"
      decimals="INF"
      unitRef="USDPShares">52.74</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="AsOf2019-12-31" decimals="INF" unitRef="Shares">815800</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2019-12-31"
      decimals="INF"
      unitRef="USDPShares">49.89</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="AsOf2021-12-31_us-gaap_StockOptionMember"
      decimals="INF"
      unitRef="Shares">612535</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="AsOf2021-12-31_us-gaap_StockOptionMember"
      decimals="0"
      unitRef="USD">25900000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="AsOf2021-12-31_custom_StockOptionOneMember"
      decimals="0"
      unitRef="USD">2900000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="From2021-01-012021-12-31_us-gaap_StockOptionMember"
      decimals="INF"
      unitRef="USDPShares">11.35</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="From2020-01-012020-12-31_us-gaap_StockOptionMember"
      decimals="INF"
      unitRef="USDPShares">12.16</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="From2019-01-012019-12-31_us-gaap_StockOptionMember"
      decimals="INF"
      unitRef="USDPShares">14.14</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_894_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zojQBpKqAPSe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span id="xdx_8B8_zqp2yAmXZsBb"&gt;The assumptions used in the Black-Scholes
pricing model are set forth in the following table:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_494_20210101__20211231_zAj1yLhUcnl6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_498_20200101__20201231_zvfM12Hn0mB7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_498_20190101__20191231_zWvzMZGTPlzj" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Year Ended December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2019&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pii_dp_uPure_zJuwuMc5Ckni" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 55%; text-align: left"&gt;Weighted-average expected stock-price volatility&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;25&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;25&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;25&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Weighted-average expected option life&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dxL_c20210101__20211231_zn4UR0StrNI4" style="text-align: right" title="Weighted-average expected option life::XDX::P5Y"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1376"&gt;5.0 years&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dxL_c20200101__20201231_zJXLlFaOMDM7" style="text-align: right" title="Weighted-average expected option life::XDX::P5Y"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1378"&gt;5.0 years&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtxL_c20190101__20191231_zI1qfZ5JrH9l" style="text-align: right" title="Weighted-average expected option life::XDX::P5Y"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1380"&gt;5.0 years&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pii_dp_uPure_zX0zKk2ffFX8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Weighted-average risk-free interest rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0.4&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1.4&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1.7&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_400_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pii_dp_uPure_z7juvhVvP4ri" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Weighted-average dividend yield&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1.6&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2.5&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2.0&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="From2021-01-01to2021-12-31"
      decimals="INF"
      unitRef="Pure">0.25</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="From2020-01-012020-12-31"
      decimals="INF"
      unitRef="Pure">0.25</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="From2019-01-012019-12-31"
      decimals="INF"
      unitRef="Pure">0.25</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="From2021-01-01to2021-12-31"
      decimals="INF"
      unitRef="Pure">0.004</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="From2020-01-012020-12-31"
      decimals="INF"
      unitRef="Pure">0.014</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="From2019-01-012019-12-31"
      decimals="INF"
      unitRef="Pure">0.017</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="From2021-01-01to2021-12-31"
      decimals="INF"
      unitRef="Pure">0.016</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="From2020-01-012020-12-31"
      decimals="INF"
      unitRef="Pure">0.025</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="From2019-01-012019-12-31"
      decimals="INF"
      unitRef="Pure">0.020</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:CashProceedsReceivedAndTaxBenefitFromShareBasedPaymentAwardsTableTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_897_eus-gaap--CashProceedsReceivedAndTaxBenefitFromShareBasedPaymentAwardsTableTextBlock_zk2DUKzD1fS5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span id="xdx_8BA_zJjz1GHhyJ9h"&gt;Proceeds, tax benefits and intrinsic
value related to stock options exercised were as follows&lt;/span&gt;:&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49C_20210101__20211231_zIBswFHmbfIg" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_498_20200101__20201231_zRtiSmREtAr9" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_49C_20190101__20191231_zMnqljIvkn5e" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Year Ended December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2019&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40B_eus-gaap--ProceedsFromStockOptionsExercised_z6Rw9FEBmt6h" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 55%; text-align: left; text-indent: -8.1pt; padding-left: 8.1pt"&gt;Proceeds from stock options exercised&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;5,393&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;2,771&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;4,458&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_406_eus-gaap--DeferredTaxExpenseFromStockOptionsExercised_zBKEGaJCuyba" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Tax benefits&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;1,300&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;400&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;690&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_409_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_zQ1YtC1ZC4T5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Intrinsic value of stock options exercised&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;7,800&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;2,873&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;4,520&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:CashProceedsReceivedAndTaxBenefitFromShareBasedPaymentAwardsTableTextBlock>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="USD">5393000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">2771000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="USD">4458000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:DeferredTaxExpenseFromStockOptionsExercised
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="USD">1300000</us-gaap:DeferredTaxExpenseFromStockOptionsExercised>
    <us-gaap:DeferredTaxExpenseFromStockOptionsExercised
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">400000</us-gaap:DeferredTaxExpenseFromStockOptionsExercised>
    <us-gaap:DeferredTaxExpenseFromStockOptionsExercised
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="USD">690000</us-gaap:DeferredTaxExpenseFromStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="USD">7800000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">2873000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="USD">4520000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_89D_eus-gaap--ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_z2AzDnAS4v3g" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span id="xdx_8B3_zD7zIDewqjl9"&gt;The following table summarizes
additional stock option information as of December&#160;31, 2021:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Exercise prices&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Options&lt;br/&gt; outstanding&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Options outstanding&lt;br/&gt; weighted average remaining&lt;br/&gt; contractual life&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Options&lt;br/&gt; exercisable&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 25%; text-align: center"&gt;&#160;$&lt;span id="xdx_904_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20211231__srt--RangeAxis__srt--MinimumMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_z0SmNLp1UKW8"&gt;32.83&lt;/span&gt; - $&lt;span id="xdx_90C_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20211231__srt--RangeAxis__srt--MaximumMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zxkEFLWonQRc" title="Exercise price range (in Dollars per share)"&gt;33.95&lt;/span&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_uShares_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zghQWgYFZpQ4" style="width: 15%; text-align: right" title="Options outstanding"&gt;81,190&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 32%; text-align: center"&gt;&lt;span id="xdx_907_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtxL_c20210101__20211231__srt--RangeAxis__srt--MaximumMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zbT0vgHJK6z3" title="Options outstanding weighted average remaining contractual life::XDX::P0Y11M12D"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1411"&gt;0.99&lt;/span&gt;&lt;/span&gt; years&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_uShares_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zq3UMvD8Cs77" style="width: 15%; text-align: right" title="Options exercisable"&gt;81,190&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center"&gt;&#160;$&lt;span id="xdx_901_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20211231__srt--RangeAxis__srt--MinimumMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zSK2Hc2JHOs5"&gt;40.15&lt;/span&gt; - $&lt;span id="xdx_90B_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20211231__srt--RangeAxis__srt--MaximumMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_zZl4qG4E9RKk"&gt;46.90&lt;/span&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_uShares_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zo23alIyc0ei" style="text-align: right"&gt;123,130&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span id="xdx_90D_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtxL_c20210101__20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zGo3mr7UDwb2" title="::XDX::P1Y11M8D"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1417"&gt;1.94&lt;/span&gt;&lt;/span&gt; years&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_uShares_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zrOVZVdmeJVf" style="text-align: right"&gt;90,790&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: center"&gt;&#160;$&lt;span id="xdx_90B_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20211231__srt--RangeAxis__srt--MinimumMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_z7PS3EwbWBze"&gt;65.18&lt;/span&gt; - $&lt;span id="xdx_901_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20211231__srt--RangeAxis__srt--MaximumMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_z5DcuTr6jQOk"&gt;69.11&lt;/span&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_uShares_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_z0rt4wLXWj34" style="text-align: right"&gt;164,940&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span id="xdx_901_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtxL_c20210101__20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_zGFPaLhucRG9" title="::XDX::P3Y0M11D"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1422"&gt;3.03&lt;/span&gt;&lt;/span&gt; years&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_uShares_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_zJm6RHjgp7t7" style="text-align: right"&gt;84,790&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center"&gt;$&lt;span id="xdx_90B_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_z1viWAr5GRFa"&gt;73.09&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_uShares_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_zuMRwU8NixE8" style="border-bottom: Black 1pt solid; text-align: right"&gt;155,640&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span id="xdx_906_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtxL_c20210101__20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_zabrABTe8d59" title="::XDX::P4Y0M0D"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1426"&gt;4.00&lt;/span&gt;&lt;/span&gt; years&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_uShares_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_zq5xHhHAiRNd" style="border-bottom: Black 1pt solid; text-align: right"&gt;58,620&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: center"&gt;&#160;Totals&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_uShares_c20211231_zZWPcpK3imjl" style="border-bottom: Black 2pt double; text-align: right"&gt;524,900&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 2pt"&gt;&lt;span id="xdx_907_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtxL_c20210101__20211231_z43En5xnVYij" title="::XDX::P2Y9M0D"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1429"&gt;2.75&lt;/span&gt;&lt;/span&gt; years&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_uShares_c20211231_zoOydnZgWk87" style="border-bottom: Black 2pt double; text-align: right"&gt;315,390&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;



</us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
      contextRef="AsOf2021-12-31_srt_MinimumMember_custom_ExercisePriceRangeOneMember"
      decimals="INF"
      unitRef="USDPShares">32.83</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
      contextRef="AsOf2021-12-31_srt_MaximumMember_custom_ExercisePriceRangeOneMember"
      decimals="INF"
      unitRef="USDPShares">33.95</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="AsOf2021-12-31_custom_ExercisePriceRangeOneMember"
      decimals="INF"
      unitRef="Shares">81190</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="AsOf2021-12-31_custom_ExercisePriceRangeOneMember"
      decimals="INF"
      unitRef="Shares">81190</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
      contextRef="AsOf2021-12-31_srt_MinimumMember_custom_ExercisePriceRangeTwoMember"
      decimals="INF"
      unitRef="USDPShares">40.15</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
      contextRef="AsOf2021-12-31_srt_MaximumMember_custom_ExercisePriceRangeThreeMember"
      decimals="INF"
      unitRef="USDPShares">46.90</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="AsOf2021-12-31_custom_ExercisePriceRangeTwoMember"
      decimals="INF"
      unitRef="Shares">123130</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="AsOf2021-12-31_custom_ExercisePriceRangeTwoMember"
      decimals="INF"
      unitRef="Shares">90790</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
      contextRef="AsOf2021-12-31_srt_MinimumMember_custom_ExercisePriceRangeThreeMember"
      decimals="INF"
      unitRef="USDPShares">65.18</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
      contextRef="AsOf2021-12-31_srt_MaximumMember_custom_ExercisePriceRangeFourMember"
      decimals="INF"
      unitRef="USDPShares">69.11</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="AsOf2021-12-31_custom_ExercisePriceRangeThreeMember"
      decimals="INF"
      unitRef="Shares">164940</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="AsOf2021-12-31_custom_ExercisePriceRangeThreeMember"
      decimals="INF"
      unitRef="Shares">84790</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
      contextRef="AsOf2021-12-31_custom_ExercisePriceRangeFourMember"
      decimals="INF"
      unitRef="USDPShares">73.09</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="AsOf2021-12-31_custom_ExercisePriceRangeFourMember"
      decimals="INF"
      unitRef="Shares">155640</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="AsOf2021-12-31_custom_ExercisePriceRangeFourMember"
      decimals="INF"
      unitRef="Shares">58620</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions contextRef="AsOf2021-12-31" decimals="INF" unitRef="Shares">524900</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions contextRef="AsOf2021-12-31" decimals="INF" unitRef="Shares">315390</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="AsOf2018-12-31_custom_InterparfumsSASubsidiaryMember_custom_EmployeesMember"
      decimals="INF"
      unitRef="Shares">26600</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="AsOf2018-12-31_custom_InterparfumsSASubsidiaryMember_custom_OfficersAndManagersMember"
      decimals="0"
      unitRef="USD">133000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <ipar:Covid19Description contextRef="From2020-03-012020-03-31">due to the potential
impact on future net sales and operating results resulting from the COVID-19 pandemic, the estimated number of shares to be distributed,
after forfeited shares, was reduced from&#160;142,571&#160;to&#160;82,162. As the Company had already purchased shares in contemplation
of the higher anticipated distribution, shares purchased in excess of the reduced anticipated distribution were transferred to
treasury shares at the Interparfums SA level.</ipar:Covid19Description>
    <ipar:RevaluationResultedInReductionOfCostDescription contextRef="From2020-01-012020-03-31_custom_InterparfumsSASubsidiaryMember">The
original cost of the grant was approximately $4.4&#160;million, and the March 2020 revaluation resulted in a reduction of the cost,
to approximately $2.5 million.&#160;</ipar:RevaluationResultedInReductionOfCostDescription>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="AsOf2021-12-31_custom_InterparfumsSASubsidiaryMember"
      decimals="INF"
      unitRef="Shares">172343</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost
      contextRef="From2021-01-012021-12-31_custom_InterparfumsSASubsidiaryMember"
      decimals="0"
      unitRef="USD">4600000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost>
    <ipar:PercentageOfIncreaseInAnnualDividend
      contextRef="From2019-10-012019-10-31"
      decimals="INF"
      unitRef="Pure">0.20</ipar:PercentageOfIncreaseInAnnualDividend>
    <us-gaap:DividendsPayableAmountPerShare
      contextRef="AsOf2019-10-31"
      decimals="INF"
      unitRef="USDPShares">1.32</us-gaap:DividendsPayableAmountPerShare>
    <us-gaap:DividendsPayableAmountPerShare
      contextRef="AsOf2021-02-28_srt_BoardOfDirectorsChairmanMember"
      decimals="INF"
      unitRef="USDPShares">2.00</us-gaap:DividendsPayableAmountPerShare>
    <us-gaap:DividendsPayableAmountPerShare
      contextRef="AsOf2022-03-31_us-gaap_SubsequentEventMember"
      decimals="INF"
      unitRef="USDPShares">0.50</us-gaap:DividendsPayableAmountPerShare>
    <us-gaap:EarningsPerShareTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_800_eus-gaap--EarningsPerShareTextBlock_zpFzO0SNYxZj" style="margin-top: 0; margin-bottom: 0"/&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;b&gt;(14)&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_82B_zJMHuSWwwFd5"&gt;Net Income Attributable to Inter Parfums, Inc. Common Shareholders&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Net income attributable to Inter
Parfums, Inc. per common share (&#x201c;basic EPS&#x201d;) is computed by dividing net income attributable to Inter Parfums, Inc.
by the weighted average number of shares outstanding.&#160;Net income attributable to Inter Parfums, Inc. per share assuming dilution
(&#x201c;diluted EPS&#x201d;), is computed using the weighted average number of shares outstanding, plus the incremental shares outstanding
assuming the exercise of dilutive stock options using the treasury stock method.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_89D_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zlJjlIepIwr5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span id="xdx_8BA_zfyefk7NQKP4"&gt;The reconciliation between the
numerators and denominators of the basic and diluted EPS computations is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Year ended December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2019&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 55%; text-align: left; padding-bottom: 2pt; padding-left: 0.125in; text-indent: -0.125in"&gt;Numerator for diluted earnings per share&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--NetIncomeLoss_c20210101__20211231_zEWwdTlz5Vt2" style="border-bottom: Black 2pt double; width: 12%; text-align: right" title="Numerator for diluted earnings per share (in Dollars)"&gt;87,411&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--NetIncomeLoss_c20200101__20201231_zNxMkoLkjqxj" style="border-bottom: Black 2pt double; width: 12%; text-align: right"&gt;38,219&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--NetIncomeLoss_c20190101__20191231_zDE6DZYY3Mae" style="border-bottom: Black 2pt double; width: 12%; text-align: right"&gt;60,249&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;Denominator:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in"&gt;Weighted average shares&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20210101__20211231_z3w9K3ErW8cl" style="text-align: right" title="Weighted average shares"&gt;31,676,796&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20200101__20201231_zno5RniMDrQ6" style="text-align: right"&gt;31,536,659&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20190101__20191231_zENCLkBFGux6" style="text-align: right"&gt;31,451,093&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in"&gt;Effect of dilutive securities:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 0.375in; text-indent: -0.125in"&gt;Stock options&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pid_c20210101__20211231_z92ryuDbpvDg" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Number Diluted Shares Outstanding Adjustment"&gt;158,612&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pid_c20200101__20201231_zLjAwq7ESuw6" style="border-bottom: Black 1pt solid; text-align: right"&gt;117,885&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pid_c20190101__20191231_zkH1TMDFadK7" style="border-bottom: Black 1pt solid; text-align: right"&gt;237,607&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2pt; padding-left: 0.125in; text-indent: -0.125in"&gt;Denominator for diluted earnings per share&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20210101__20211231_zhHhLvmWNm7k" style="border-bottom: Black 2pt double; text-align: right" title="Denominator for diluted earnings per share"&gt;31,835,408&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20200101__20201231_zaHD7YnDhgK" style="border-bottom: Black 2pt double; text-align: right"&gt;31,654,544&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20190101__20191231_zFHcdezmXLJ9" style="border-bottom: Black 2pt double; text-align: right"&gt;31,688,700&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;Earnings per share:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in"&gt;Net income attributable to Inter Parfums, Inc. common shareholders:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.5in; text-indent: -0.125in"&gt;Basic&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--EarningsPerShareBasic_pid_uUSDPShares_c20210101__20211231_zOAESjXbsdb" style="text-align: right" title="Basic (in Dollars per share)"&gt;2.76&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--EarningsPerShareBasic_pid_uUSDPShares_c20200101__20201231_zYb8TsiOd9sh" style="text-align: right"&gt;1.21&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--EarningsPerShareBasic_pid_uUSDPShares_c20190101__20191231_ztYCFe9bVaud" style="text-align: right"&gt;1.92&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.5in; text-indent: -0.125in"&gt;Diluted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--EarningsPerShareDiluted_pid_uUSDPShares_c20210101__20211231_zwl2wHaUR5d5" style="text-align: right" title="Diluted (in Dollars per share)"&gt;2.75&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--EarningsPerShareDiluted_pid_uUSDPShares_c20200101__20201231_zugRmgPcyZuh" style="text-align: right"&gt;1.21&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--EarningsPerShareDiluted_pid_uUSDPShares_c20190101__20191231_zqFshltCql7" style="text-align: right"&gt;1.90&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;



&lt;p id="xdx_8A9_z9egu375NYqk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Not included in the above computations
is the effect of anti-dilutive potential common shares, which consist of outstanding options to purchase &lt;span id="xdx_901_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210101__20211231_zOBp8fkF9WTe" title="Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount"&gt;175,000&lt;/span&gt;, &lt;span id="xdx_904_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20200101__20201231_z2DnMDmdyJ4j"&gt;450,000&lt;/span&gt;, and
&lt;span id="xdx_90E_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20190101__20191231_zT5RFzadOjRc"&gt;183,000&lt;/span&gt; shares of common stock for 2021, 2020, and 2019, respectively.&lt;/p&gt;

</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_89D_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zlJjlIepIwr5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span id="xdx_8BA_zfyefk7NQKP4"&gt;The reconciliation between the
numerators and denominators of the basic and diluted EPS computations is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Year ended December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2019&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 55%; text-align: left; padding-bottom: 2pt; padding-left: 0.125in; text-indent: -0.125in"&gt;Numerator for diluted earnings per share&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--NetIncomeLoss_c20210101__20211231_zEWwdTlz5Vt2" style="border-bottom: Black 2pt double; width: 12%; text-align: right" title="Numerator for diluted earnings per share (in Dollars)"&gt;87,411&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--NetIncomeLoss_c20200101__20201231_zNxMkoLkjqxj" style="border-bottom: Black 2pt double; width: 12%; text-align: right"&gt;38,219&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--NetIncomeLoss_c20190101__20191231_zDE6DZYY3Mae" style="border-bottom: Black 2pt double; width: 12%; text-align: right"&gt;60,249&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;Denominator:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in"&gt;Weighted average shares&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20210101__20211231_z3w9K3ErW8cl" style="text-align: right" title="Weighted average shares"&gt;31,676,796&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20200101__20201231_zno5RniMDrQ6" style="text-align: right"&gt;31,536,659&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20190101__20191231_zENCLkBFGux6" style="text-align: right"&gt;31,451,093&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in"&gt;Effect of dilutive securities:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 0.375in; text-indent: -0.125in"&gt;Stock options&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pid_c20210101__20211231_z92ryuDbpvDg" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Number Diluted Shares Outstanding Adjustment"&gt;158,612&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pid_c20200101__20201231_zLjAwq7ESuw6" style="border-bottom: Black 1pt solid; text-align: right"&gt;117,885&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pid_c20190101__20191231_zkH1TMDFadK7" style="border-bottom: Black 1pt solid; text-align: right"&gt;237,607&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2pt; padding-left: 0.125in; text-indent: -0.125in"&gt;Denominator for diluted earnings per share&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20210101__20211231_zhHhLvmWNm7k" style="border-bottom: Black 2pt double; text-align: right" title="Denominator for diluted earnings per share"&gt;31,835,408&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20200101__20201231_zaHD7YnDhgK" style="border-bottom: Black 2pt double; text-align: right"&gt;31,654,544&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20190101__20191231_zFHcdezmXLJ9" style="border-bottom: Black 2pt double; text-align: right"&gt;31,688,700&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;Earnings per share:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in"&gt;Net income attributable to Inter Parfums, Inc. common shareholders:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.5in; text-indent: -0.125in"&gt;Basic&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--EarningsPerShareBasic_pid_uUSDPShares_c20210101__20211231_zOAESjXbsdb" style="text-align: right" title="Basic (in Dollars per share)"&gt;2.76&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--EarningsPerShareBasic_pid_uUSDPShares_c20200101__20201231_zYb8TsiOd9sh" style="text-align: right"&gt;1.21&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--EarningsPerShareBasic_pid_uUSDPShares_c20190101__20191231_ztYCFe9bVaud" style="text-align: right"&gt;1.92&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.5in; text-indent: -0.125in"&gt;Diluted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--EarningsPerShareDiluted_pid_uUSDPShares_c20210101__20211231_zwl2wHaUR5d5" style="text-align: right" title="Diluted (in Dollars per share)"&gt;2.75&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--EarningsPerShareDiluted_pid_uUSDPShares_c20200101__20201231_zugRmgPcyZuh" style="text-align: right"&gt;1.21&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--EarningsPerShareDiluted_pid_uUSDPShares_c20190101__20191231_zqFshltCql7" style="text-align: right"&gt;1.90&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;



</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="USD">87411000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">38219000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="USD">60249000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2021-01-01to2021-12-31"
      decimals="INF"
      unitRef="Shares">31676796</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2020-01-012020-12-31"
      decimals="INF"
      unitRef="Shares">31536659</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2019-01-012019-12-31"
      decimals="INF"
      unitRef="Shares">31451093</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="From2021-01-01to2021-12-31"
      decimals="INF"
      unitRef="Shares">158612</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="From2020-01-012020-12-31"
      decimals="INF"
      unitRef="Shares">117885</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="From2019-01-012019-12-31"
      decimals="INF"
      unitRef="Shares">237607</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2021-01-01to2021-12-31"
      decimals="INF"
      unitRef="Shares">31835408</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2020-01-012020-12-31"
      decimals="INF"
      unitRef="Shares">31654544</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2019-01-012019-12-31"
      decimals="INF"
      unitRef="Shares">31688700</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2021-01-01to2021-12-31"
      decimals="INF"
      unitRef="USDPShares">2.76</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2020-01-012020-12-31"
      decimals="INF"
      unitRef="USDPShares">1.21</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2019-01-012019-12-31"
      decimals="INF"
      unitRef="USDPShares">1.92</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2021-01-01to2021-12-31"
      decimals="INF"
      unitRef="USDPShares">2.75</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2020-01-012020-12-31"
      decimals="INF"
      unitRef="USDPShares">1.21</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2019-01-012019-12-31"
      decimals="INF"
      unitRef="USDPShares">1.90</us-gaap:EarningsPerShareDiluted>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2021-01-01to2021-12-31"
      decimals="INF"
      unitRef="Shares">175000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2020-01-012020-12-31"
      decimals="INF"
      unitRef="Shares">450000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2019-01-012019-12-31"
      decimals="INF"
      unitRef="Shares">183000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:SegmentReportingDisclosureTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_809_eus-gaap--SegmentReportingDisclosureTextBlock_zTDjhJtKdnf" style="margin-top: 0; margin-bottom: 0"/&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;b&gt;(15)&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_82F_zfV26WYAai8k"&gt;Segments and Geographic Areas&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Company &lt;span style="font-family: Times New Roman, Times, Serif"&gt;manufactures
and distributes one product line, fragrances and fragrance related products. The Company&lt;/span&gt; manages its business in two segments,
European based operations and United States based operations. The European assets are located, and operations are primarily conducted,
in France. Both European and United States operations primarily represent the sale of prestige brand name fragrances.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;INTER PARFUMS, INC. AND SUBSIDIARIES&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;Notes to Consolidated Financial Statements&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;December 31, 2021, 2020 and 2019&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;(In thousands except share and per share data)&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_899_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_zxd4NvECI4qf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span&gt;&lt;span id="xdx_8B5_zkDY8ZZkiM0h"&gt;Information on the Company&#x2019;s
operations by segments is as follows:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; visibility: visible; font-weight: bold; text-align: center"&gt;Year ended December 31,&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="visibility: visible; vertical-align: bottom"&gt;
    &lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; visibility: visible; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; visibility: visible; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; visibility: visible; font-weight: bold; text-align: center"&gt;2019&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="visibility: visible; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="visibility: visible; text-align: left"&gt;Net sales:&lt;/td&gt;&lt;td style="visibility: visible"&gt;&#160;&lt;/td&gt;
    &lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible"&gt;&#160;&lt;/td&gt;
    &lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible"&gt;&#160;&lt;/td&gt;
    &lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="visibility: visible; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="visibility: visible; width: 55%; text-align: left"&gt;&#160;&#160;&#160;&#160;United States&lt;/td&gt;&lt;td style="visibility: visible; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="visibility: visible; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20210101__20211231__srt--StatementGeographicalAxis__country--US_z5r4PcNAeks3" style="visibility: visible; width: 12%; text-align: right"&gt;216,559&lt;/td&gt;&lt;td style="visibility: visible; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="visibility: visible; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20200101__20201231__srt--StatementGeographicalAxis__country--US_zCfrzosskOG7" style="visibility: visible; width: 12%; text-align: right"&gt;117,489&lt;/td&gt;&lt;td style="visibility: visible; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="visibility: visible; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20190101__20191231__srt--StatementGeographicalAxis__country--US_zWIdVteHZ4Hi" style="visibility: visible; width: 12%; text-align: right"&gt;173,522&lt;/td&gt;&lt;td style="visibility: visible; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="visibility: visible; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="visibility: visible; text-align: left"&gt;&#160;&#160;&#160;&#160;Europe&lt;/td&gt;&lt;td style="visibility: visible"&gt;&#160;&lt;/td&gt;
    &lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20210101__20211231__srt--StatementGeographicalAxis__srt--EuropeMember_zmO13RpnEfAk" style="visibility: visible; text-align: right"&gt;663,290&lt;/td&gt;&lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible"&gt;&#160;&lt;/td&gt;
    &lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20200101__20201231__srt--StatementGeographicalAxis__srt--EuropeMember_ztyL8g0DCNCg" style="visibility: visible; text-align: right"&gt;422,947&lt;/td&gt;&lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible"&gt;&#160;&lt;/td&gt;
    &lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20190101__20191231__srt--StatementGeographicalAxis__srt--EuropeMember_ztcgUX0XX4o3" style="visibility: visible; text-align: right"&gt;542,226&lt;/td&gt;&lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="visibility: visible; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="visibility: visible; text-align: left; padding-bottom: 1pt"&gt;&#160;&#160;&#160;&#160;Eliminations of intercompany sales&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20210101__20211231__srt--StatementGeographicalAxis__custom--EliminationsMember_zwlEf11aFZM2" style="border-bottom: Black 1pt solid; visibility: visible; text-align: right"&gt;(333&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20200101__20201231__srt--StatementGeographicalAxis__custom--EliminationsMember_z5ym2Cf1wVOj" style="border-bottom: Black 1pt solid; visibility: visible; text-align: right"&gt;(1,427&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20190101__20191231__srt--StatementGeographicalAxis__custom--EliminationsMember_zicOjvimpE4k" style="border-bottom: Black 1pt solid; visibility: visible; text-align: right"&gt;(2,234&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="visibility: visible; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="visibility: visible; text-align: left; padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; visibility: visible; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20210101__20211231_zjyV2OjP8sa3" style="border-bottom: Black 2pt double; visibility: visible; text-align: right"&gt;879,516&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; visibility: visible; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20200101__20201231_zeUtsjBlkcec" style="border-bottom: Black 2pt double; visibility: visible; text-align: right"&gt;539,009&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; visibility: visible; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_dxL_c20200101__20201231_zrpOASipOcL" style="border-bottom: Black 2pt double; visibility: visible; text-align: right" title="::XDX::539%2C009"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1497"&gt;713,514&lt;/span&gt;&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="visibility: visible; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="visibility: visible; text-align: left"&gt;Net income attributable to Inter Parfums, Inc.:&lt;/td&gt;&lt;td style="visibility: visible"&gt;&#160;&lt;/td&gt;
    &lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible"&gt;&#160;&lt;/td&gt;
    &lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible"&gt;&#160;&lt;/td&gt;
    &lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="visibility: visible; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="visibility: visible; text-align: left"&gt;&#160;&#160;&#160;&#160;United States&lt;/td&gt;&lt;td style="visibility: visible"&gt;&#160;&lt;/td&gt;
    &lt;td style="visibility: visible; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--NetIncomeLoss_c20210101__20211231__srt--StatementGeographicalAxis__country--US_zJrsX1vBTKh1" style="visibility: visible; text-align: right"&gt;29,359&lt;/td&gt;&lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible"&gt;&#160;&lt;/td&gt;
    &lt;td style="visibility: visible; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--NetIncomeLoss_c20200101__20201231__srt--StatementGeographicalAxis__country--US_zukMU1UqRBab" style="visibility: visible; text-align: right"&gt;7,942&lt;/td&gt;&lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible"&gt;&#160;&lt;/td&gt;
    &lt;td style="visibility: visible; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--NetIncomeLoss_c20190101__20191231__srt--StatementGeographicalAxis__country--US_zfoS7lQBSpQ7" style="visibility: visible; text-align: right"&gt;19,365&lt;/td&gt;&lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="visibility: visible; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="visibility: visible; text-align: left"&gt;&#160;&#160;&#160;&#160;Europe&lt;/td&gt;&lt;td style="visibility: visible"&gt;&#160;&lt;/td&gt;
    &lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--NetIncomeLoss_c20210101__20211231__srt--StatementGeographicalAxis__srt--EuropeMember_z5kifDjPeta6" style="visibility: visible; text-align: right"&gt;57,869&lt;/td&gt;&lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible"&gt;&#160;&lt;/td&gt;
    &lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--NetIncomeLoss_c20200101__20201231__srt--StatementGeographicalAxis__srt--EuropeMember_zytAdG8vtrri" style="visibility: visible; text-align: right"&gt;30,241&lt;/td&gt;&lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible"&gt;&#160;&lt;/td&gt;
    &lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--NetIncomeLoss_c20190101__20191231__srt--StatementGeographicalAxis__srt--EuropeMember_ztQNOn4IdHg8" style="visibility: visible; text-align: right"&gt;40,840&lt;/td&gt;&lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="visibility: visible; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="visibility: visible; text-align: left; padding-bottom: 1pt"&gt;&#160;&#160;&#160;&#160;Eliminations&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--NetIncomeLoss_c20210101__20211231__srt--StatementGeographicalAxis__custom--EliminationsMember_zg9MaKYb0dsc" style="border-bottom: Black 1pt solid; visibility: visible; text-align: right"&gt;183&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--NetIncomeLoss_c20200101__20201231__srt--StatementGeographicalAxis__custom--EliminationsMember_zNVbvBEIifob" style="border-bottom: Black 1pt solid; visibility: visible; text-align: right"&gt;36&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--NetIncomeLoss_c20190101__20191231__srt--StatementGeographicalAxis__custom--EliminationsMember_zykwKqHurgGd" style="border-bottom: Black 1pt solid; visibility: visible; text-align: right"&gt;44&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="visibility: visible; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="visibility: visible; text-align: left; padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; visibility: visible; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--NetIncomeLoss_c20210101__20211231_znQ0YUnY32X3" style="border-bottom: Black 2pt double; visibility: visible; text-align: right"&gt;87,411&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; visibility: visible; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--NetIncomeLoss_c20200101__20201231_zyP62IcvJVSh" style="border-bottom: Black 2pt double; visibility: visible; text-align: right"&gt;38,219&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; visibility: visible; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--NetIncomeLoss_c20190101__20191231_z997kfuIqlMf" style="border-bottom: Black 2pt double; visibility: visible; text-align: right"&gt;60,249&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="visibility: visible; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="visibility: visible; text-align: left; text-indent: -7.75pt; padding-left: 7.75pt"&gt;Depreciation and amortization expense including impairment loss:&lt;/td&gt;&lt;td style="visibility: visible"&gt;&#160;&lt;/td&gt;
    &lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible"&gt;&#160;&lt;/td&gt;
    &lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible"&gt;&#160;&lt;/td&gt;
    &lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="visibility: visible; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="visibility: visible; text-align: left"&gt;&#160;&#160;&#160;&#160;United States&lt;/td&gt;&lt;td style="visibility: visible"&gt;&#160;&lt;/td&gt;
    &lt;td style="visibility: visible; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--DepreciationAndAmortization_c20210101__20211231__srt--StatementGeographicalAxis__country--US_zkF7xuK0rol4" style="visibility: visible; text-align: right"&gt;3,835&lt;/td&gt;&lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible"&gt;&#160;&lt;/td&gt;
    &lt;td style="visibility: visible; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--DepreciationAndAmortization_c20200101__20201231__srt--StatementGeographicalAxis__country--US_zyOCWL2HUBxa" style="visibility: visible; text-align: right"&gt;3,354&lt;/td&gt;&lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible"&gt;&#160;&lt;/td&gt;
    &lt;td style="visibility: visible; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--DepreciationAndAmortization_c20190101__20191231__srt--StatementGeographicalAxis__country--US_zUUVLjx2cPk" style="visibility: visible; text-align: right"&gt;3,088&lt;/td&gt;&lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="visibility: visible; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="visibility: visible; text-align: left; padding-bottom: 1pt"&gt;&#160;&#160;&#160;&#160;Europe&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--DepreciationAndAmortization_c20210101__20211231__srt--StatementGeographicalAxis__srt--EuropeMember_zt8Xwpmj0roa" style="border-bottom: Black 1pt solid; visibility: visible; text-align: right"&gt;8,863&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--DepreciationAndAmortization_c20200101__20201231__srt--StatementGeographicalAxis__srt--EuropeMember_zioukoB7Vgtj" style="border-bottom: Black 1pt solid; visibility: visible; text-align: right"&gt;5,713&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--DepreciationAndAmortization_c20190101__20191231__srt--StatementGeographicalAxis__srt--EuropeMember_z70leSOFQKH9" style="border-bottom: Black 1pt solid; visibility: visible; text-align: right"&gt;5,641&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="visibility: visible; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="visibility: visible; text-align: left; padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; visibility: visible; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--DepreciationAndAmortization_c20210101__20211231_zDXjtc4WPOAg" style="border-bottom: Black 2pt double; visibility: visible; text-align: right"&gt;12,698&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; visibility: visible; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--DepreciationAndAmortization_c20200101__20201231_zqTLCmXoJIdd" style="border-bottom: Black 2pt double; visibility: visible; text-align: right"&gt;9,067&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; visibility: visible; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--DepreciationAndAmortization_c20190101__20191231_z7wvpw82L6q3" style="border-bottom: Black 2pt double; visibility: visible; text-align: right"&gt;8,729&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="visibility: visible; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="visibility: visible; text-align: left"&gt;Interest and investment income:&lt;/td&gt;&lt;td style="visibility: visible"&gt;&#160;&lt;/td&gt;
    &lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible"&gt;&#160;&lt;/td&gt;
    &lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible"&gt;&#160;&lt;/td&gt;
    &lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="visibility: visible; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="visibility: visible; text-align: left"&gt;&#160;&#160;&#160;&#160;United States&lt;/td&gt;&lt;td style="visibility: visible"&gt;&#160;&lt;/td&gt;
    &lt;td style="visibility: visible; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--InvestmentIncomeInterestAndDividend_c20210101__20211231__srt--StatementGeographicalAxis__country--US_zGHaHth6AQv7" style="visibility: visible; text-align: right"&gt;3&lt;/td&gt;&lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible"&gt;&#160;&lt;/td&gt;
    &lt;td style="visibility: visible; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--InvestmentIncomeInterestAndDividend_c20200101__20201231__srt--StatementGeographicalAxis__country--US_z7dyBRe90bJ8" style="visibility: visible; text-align: right"&gt;24&lt;/td&gt;&lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible"&gt;&#160;&lt;/td&gt;
    &lt;td style="visibility: visible; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--InvestmentIncomeInterestAndDividend_c20190101__20191231__srt--StatementGeographicalAxis__country--US_za0FpXMf1CW8" style="visibility: visible; text-align: right"&gt;345&lt;/td&gt;&lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="visibility: visible; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="visibility: visible; text-align: left"&gt;&#160;&#160;&#160;&#160;Europe&lt;/td&gt;&lt;td style="visibility: visible"&gt;&#160;&lt;/td&gt;
    &lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--InvestmentIncomeInterestAndDividend_c20210101__20211231__srt--StatementGeographicalAxis__srt--EuropeMember_zoRhTydjQQed" style="visibility: visible; text-align: right"&gt;3,526&lt;/td&gt;&lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible"&gt;&#160;&lt;/td&gt;
    &lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--InvestmentIncomeInterestAndDividend_c20200101__20201231__srt--StatementGeographicalAxis__srt--EuropeMember_zP5BNsiY3o85" style="visibility: visible; text-align: right"&gt;2,971&lt;/td&gt;&lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible"&gt;&#160;&lt;/td&gt;
    &lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--InvestmentIncomeInterestAndDividend_c20190101__20191231__srt--StatementGeographicalAxis__srt--EuropeMember_zWzfeijv0RZe" style="visibility: visible; text-align: right"&gt;3,501&lt;/td&gt;&lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="visibility: visible; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="visibility: visible; text-align: left; padding-bottom: 1pt"&gt;&#160;&#160;&#160;&#160;Eliminations&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--InvestmentIncomeInterestAndDividend_c20210101__20211231__srt--StatementGeographicalAxis__custom--EliminationsMember_zJm2O7dCPjhc" style="border-bottom: Black 1pt solid; visibility: visible; text-align: right"&gt;(126&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--InvestmentIncomeInterestAndDividend_c20200101__20201231__srt--StatementGeographicalAxis__custom--EliminationsMember_zOPX0UarbiWc" style="border-bottom: Black 1pt solid; visibility: visible; text-align: right"&gt;(130&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--InvestmentIncomeInterestAndDividend_c20190101__20191231__srt--StatementGeographicalAxis__custom--EliminationsMember_zt62G18GMYZ" style="border-bottom: Black 1pt solid; visibility: visible; text-align: right"&gt;(153&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="visibility: visible; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="visibility: visible; text-align: left; padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; visibility: visible; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--InvestmentIncomeInterestAndDividend_c20210101__20211231_z1Scsi8xKcu8" style="border-bottom: Black 2pt double; visibility: visible; text-align: right"&gt;3,403&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; visibility: visible; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--InvestmentIncomeInterestAndDividend_c20200101__20201231_zqQDKSCvhSI9" style="border-bottom: Black 2pt double; visibility: visible; text-align: right"&gt;2,865&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; visibility: visible; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--InvestmentIncomeInterestAndDividend_c20190101__20191231_zEOKYG3INDt8" style="border-bottom: Black 2pt double; visibility: visible; text-align: right"&gt;3,693&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="visibility: visible; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="visibility: visible; text-align: left"&gt;Interest expense:&lt;/td&gt;&lt;td style="visibility: visible"&gt;&#160;&lt;/td&gt;
    &lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible"&gt;&#160;&lt;/td&gt;
    &lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible"&gt;&#160;&lt;/td&gt;
    &lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="visibility: visible; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="visibility: visible; text-align: left"&gt;&#160;&#160;&#160;&#160;United States&lt;/td&gt;&lt;td style="visibility: visible"&gt;&#160;&lt;/td&gt;
    &lt;td style="visibility: visible; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--InterestExpense_c20210101__20211231__srt--StatementGeographicalAxis__country--US_zYxsoG4QjcUa" style="visibility: visible; text-align: right"&gt;636&lt;/td&gt;&lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible"&gt;&#160;&lt;/td&gt;
    &lt;td style="visibility: visible; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--InterestExpense_c20200101__20201231__srt--StatementGeographicalAxis__country--US_z2Ybx7IJsKC3" style="visibility: visible; text-align: right"&gt;604&lt;/td&gt;&lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible"&gt;&#160;&lt;/td&gt;
    &lt;td style="visibility: visible; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--InterestExpense_c20190101__20191231__srt--StatementGeographicalAxis__country--US_zY8KBHWYMCk1" style="visibility: visible; text-align: right"&gt;673&lt;/td&gt;&lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="visibility: visible; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="visibility: visible; text-align: left"&gt;&#160;&#160;&#160;&#160;Europe&lt;/td&gt;&lt;td style="visibility: visible"&gt;&#160;&lt;/td&gt;
    &lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--InterestExpense_c20210101__20211231__srt--StatementGeographicalAxis__srt--EuropeMember_zHgsSFDcKVIf" style="visibility: visible; text-align: right" title="Interest expense"&gt;2,315&lt;/td&gt;&lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible"&gt;&#160;&lt;/td&gt;
    &lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--InterestExpense_c20200101__20201231__srt--StatementGeographicalAxis__srt--EuropeMember_zLmvKN23VR57" style="visibility: visible; text-align: right" title="Interest expense"&gt;1,496&lt;/td&gt;&lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible"&gt;&#160;&lt;/td&gt;
    &lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--InterestExpense_c20190101__20191231__srt--StatementGeographicalAxis__srt--EuropeMember_zNSXrgeFTNAg" style="visibility: visible; text-align: right" title="Interest expense"&gt;1,626&lt;/td&gt;&lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="visibility: visible; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="visibility: visible; text-align: left; padding-bottom: 1pt"&gt;&#160;&#160;&#160;&#160;Eliminations&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--InterestExpense_c20210101__20211231__srt--StatementGeographicalAxis__custom--EliminationsMember_zcrfn5F85JL7" style="border-bottom: Black 1pt solid; visibility: visible; text-align: right" title="Interest expense"&gt;(126&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--InterestExpense_c20200101__20201231__srt--StatementGeographicalAxis__custom--EliminationsMember_zYBXzVtL8SH1" style="border-bottom: Black 1pt solid; visibility: visible; text-align: right" title="Interest expense"&gt;(130&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--InterestExpense_c20190101__20191231__srt--StatementGeographicalAxis__custom--EliminationsMember_zSMQsNKpvAO2" style="border-bottom: Black 1pt solid; visibility: visible; text-align: right" title="Interest expense"&gt;(153&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="visibility: visible; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="visibility: visible; text-align: left; padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; visibility: visible; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--InterestExpense_c20210101__20211231_zYwDrdtfE7qj" style="border-bottom: Black 2pt double; visibility: visible; text-align: right" title="Interest expense"&gt;2,825&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; visibility: visible; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--InterestExpense_c20200101__20201231_zNXV6WHw0F3b" style="border-bottom: Black 2pt double; visibility: visible; text-align: right" title="Interest expense"&gt;1,970&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; visibility: visible; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--InterestExpense_c20190101__20191231_zI8X8gzlNi8c" style="border-bottom: Black 2pt double; visibility: visible; text-align: right" title="Interest expense"&gt;2,146&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="visibility: visible; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="visibility: visible; text-align: left"&gt;Income tax expense:&lt;/td&gt;&lt;td style="visibility: visible"&gt;&#160;&lt;/td&gt;
    &lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible"&gt;&#160;&lt;/td&gt;
    &lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible"&gt;&#160;&lt;/td&gt;
    &lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="visibility: visible; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="visibility: visible; text-align: left"&gt;&#160;&#160;&#160;&#160;United States&lt;/td&gt;&lt;td style="visibility: visible"&gt;&#160;&lt;/td&gt;
    &lt;td style="visibility: visible; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--IncomeTaxExpenseBenefit_c20210101__20211231__srt--StatementGeographicalAxis__country--US_zPqN12BQMkL1" style="visibility: visible; text-align: right"&gt;5,336&lt;/td&gt;&lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible"&gt;&#160;&lt;/td&gt;
    &lt;td style="visibility: visible; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--IncomeTaxExpenseBenefit_c20200101__20201231__srt--StatementGeographicalAxis__country--US_zHU559TDBHrb" style="visibility: visible; text-align: right"&gt;1,590&lt;/td&gt;&lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible"&gt;&#160;&lt;/td&gt;
    &lt;td style="visibility: visible; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--IncomeTaxExpenseBenefit_c20190101__20191231__srt--StatementGeographicalAxis__country--US_ztUs8eqesh7k" style="visibility: visible; text-align: right"&gt;3,945&lt;/td&gt;&lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="visibility: visible; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="visibility: visible; text-align: left"&gt;&#160;&#160;&#160;&#160;Europe&lt;/td&gt;&lt;td style="visibility: visible"&gt;&#160;&lt;/td&gt;
    &lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--IncomeTaxExpenseBenefit_c20210101__20211231__srt--StatementGeographicalAxis__srt--EuropeMember_z0bXvJdCA9qa" style="visibility: visible; text-align: right"&gt;35,607&lt;/td&gt;&lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible"&gt;&#160;&lt;/td&gt;
    &lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--IncomeTaxExpenseBenefit_c20200101__20201231__srt--StatementGeographicalAxis__srt--EuropeMember_z6N7TqsQJgVf" style="visibility: visible; text-align: right"&gt;17,782&lt;/td&gt;&lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible"&gt;&#160;&lt;/td&gt;
    &lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--IncomeTaxExpenseBenefit_c20190101__20191231__srt--StatementGeographicalAxis__srt--EuropeMember_zyNgRnvX3AHa" style="visibility: visible; text-align: right"&gt;25,101&lt;/td&gt;&lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="visibility: visible; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="visibility: visible; text-align: left; padding-bottom: 1pt"&gt;&#160;&#160;&#160;&#160;Eliminations&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--IncomeTaxExpenseBenefit_c20210101__20211231__srt--StatementGeographicalAxis__custom--EliminationsMember_zsxwiXhlQHTb" style="border-bottom: Black 1pt solid; visibility: visible; text-align: right"&gt;49&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--IncomeTaxExpenseBenefit_c20200101__20201231__srt--StatementGeographicalAxis__custom--EliminationsMember_zAQ2F8H0iw26" style="border-bottom: Black 1pt solid; visibility: visible; text-align: right"&gt;9&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--IncomeTaxExpenseBenefit_c20190101__20191231__srt--StatementGeographicalAxis__custom--EliminationsMember_zsfPjVbPoZq9" style="border-bottom: Black 1pt solid; visibility: visible; text-align: right"&gt;30&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="visibility: visible; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="visibility: visible; text-align: left; padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; visibility: visible; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--IncomeTaxExpenseBenefit_c20210101__20211231_zYuwcNGNDjxe" style="border-bottom: Black 2pt double; visibility: visible; text-align: right"&gt;40,992&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; visibility: visible; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--IncomeTaxExpenseBenefit_c20200101__20201231_zK5CansaJlHa" style="border-bottom: Black 2pt double; visibility: visible; text-align: right"&gt;19,381&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; visibility: visible; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--IncomeTaxExpenseBenefit_c20190101__20191231_ziS0Mw2aThV8" style="border-bottom: Black 2pt double; visibility: visible; text-align: right"&gt;29,076&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="margin: 0; visibility: visible"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in"&gt;
&lt;tr style="text-align: center; vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;December 31,&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="text-align: center; vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold"&gt;2019&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; width: 55%"&gt;Total assets:&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; width: 12%"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; width: 12%"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; width: 12%"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&#160;&#160;&#160;&#160;United States&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--Assets_iI_c20211231__srt--StatementGeographicalAxis__country--US_z8zLIQYvfsd3" style="text-align: right"&gt;247,703&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--Assets_iI_c20201231__srt--StatementGeographicalAxis__country--US_z1a1mVWhWgJa" style="text-align: right"&gt;141,316&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--Assets_iI_c20191231__srt--StatementGeographicalAxis__country--US_ze4scNtgijPj" style="text-align: right"&gt;166,180&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&#160;&#160;&#160;&#160;Europe&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--Assets_iI_c20211231__srt--StatementGeographicalAxis__srt--EuropeMember_zFKpIBUvOgqk" style="text-align: right"&gt;931,735&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--Assets_iI_c20201231__srt--StatementGeographicalAxis__srt--EuropeMember_zLoIkfHcmMR6" style="text-align: right"&gt;758,812&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--Assets_iI_c20191231__srt--StatementGeographicalAxis__srt--EuropeMember_zHhR8uZ68Vdi" style="text-align: right"&gt;670,657&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&#160;&#160;&#160;Eliminations&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--Assets_iI_c20211231__srt--StatementGeographicalAxis__custom--EliminationsMember_ziJx0D2ajuXj" style="border-bottom: Black 1pt solid; text-align: right"&gt;(34,074&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--Assets_iI_c20201231__srt--StatementGeographicalAxis__custom--EliminationsMember_zW0wHylpiVnf" style="border-bottom: Black 1pt solid; text-align: right"&gt;(9,983&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--Assets_iI_c20191231__srt--StatementGeographicalAxis__custom--EliminationsMember_ztZSf6TnJ691" style="border-bottom: Black 1pt solid; text-align: right"&gt;(8,005&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--Assets_iI_c20211231_zDp748Hon1k2" style="border-bottom: Black 2pt double; text-align: right"&gt;1,145,364&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--Assets_iI_c20201231_zF0HVpqB8clf" style="border-bottom: Black 2pt double; text-align: right"&gt;890,145&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--Assets_iI_c20191231_zKV32bgh58nd" style="border-bottom: Black 2pt double; text-align: right"&gt;828,832&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Additions to long-lived assets:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&#160;&#160;&#160;&#160;United States&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--AdditionsToOtherAssetsAmount_c20210101__20211231__srt--StatementGeographicalAxis__country--US_zwbljiC2D0T2" style="text-align: right"&gt;2,711&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--AdditionsToOtherAssetsAmount_c20200101__20201231__srt--StatementGeographicalAxis__country--US_zDQwlX504Fj9" style="text-align: right"&gt;1,004&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--AdditionsToOtherAssetsAmount_c20190101__20191231__srt--StatementGeographicalAxis__country--US_zyaItO2G8at2" style="text-align: right"&gt;5,851&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&#160;&#160;&#160;Europe&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--AdditionsToOtherAssetsAmount_c20210101__20211231__srt--StatementGeographicalAxis__srt--EuropeMember_zhE9PE1o3qA5" style="border-bottom: Black 1pt solid; text-align: right"&gt;138,563&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--AdditionsToOtherAssetsAmount_c20200101__20201231__srt--StatementGeographicalAxis__srt--EuropeMember_z7bZHUpdAPbg" style="border-bottom: Black 1pt solid; text-align: right"&gt;11,259&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--AdditionsToOtherAssetsAmount_c20190101__20191231__srt--StatementGeographicalAxis__srt--EuropeMember_znS4FO2uM4K6" style="border-bottom: Black 1pt solid; text-align: right"&gt;5,643&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--AdditionsToOtherAssetsAmount_c20210101__20211231_zHfls6HDBu4k" style="border-bottom: Black 2pt double; text-align: right"&gt;141,274&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--AdditionsToOtherAssetsAmount_c20200101__20201231_zcl7DDjE2QR5" style="border-bottom: Black 2pt double; text-align: right"&gt;12,263&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--AdditionsToOtherAssetsAmount_c20190101__20191231_zXeSTYOabnB4" style="border-bottom: Black 2pt double; text-align: right"&gt;11,494&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Total long-lived assets:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&#160;&#160;&#160;&#160;United States&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--NoncurrentAssets_iI_c20211231__srt--StatementGeographicalAxis__country--US_zQKQz1a0vcYc" style="text-align: right"&gt;63,094&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--NoncurrentAssets_iI_c20201231__srt--StatementGeographicalAxis__country--US_zN6R5bz6TMr6" style="text-align: right"&gt;40,656&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--NoncurrentAssets_iI_c20191231__srt--StatementGeographicalAxis__country--US_zofVpONNxiv8" style="text-align: right"&gt;44,473&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&#160;&#160;&#160;Europe&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--NoncurrentAssets_iI_c20211231__srt--StatementGeographicalAxis__srt--EuropeMember_zr7C4Q02H059" style="border-bottom: Black 1pt solid; text-align: right"&gt;334,033&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--NoncurrentAssets_iI_c20201231__srt--StatementGeographicalAxis__srt--EuropeMember_zgqJ58AYQgJ" style="border-bottom: Black 1pt solid; text-align: right"&gt;217,766&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--NoncurrentAssets_iI_c20191231__srt--StatementGeographicalAxis__srt--EuropeMember_z9wKjWDm19Zg" style="border-bottom: Black 1pt solid; text-align: right"&gt;196,976&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--NoncurrentAssets_iI_c20211231_z6hxmiTCgKSi" style="border-bottom: Black 2pt double; text-align: right"&gt;397,127&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--NoncurrentAssets_iI_c20201231_zJnLsw2O7mc3" style="border-bottom: Black 2pt double; text-align: right"&gt;258,422&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--NoncurrentAssets_iI_c20191231_zGz0VhTFM3Yh" style="border-bottom: Black 2pt double; text-align: right"&gt;241,449&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Deferred tax assets:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&#160;&#160;&#160;&#160;United States&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20211231__srt--StatementGeographicalAxis__country--US_zkvJfows7qFd" style="text-align: right"&gt;870&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20201231__srt--StatementGeographicalAxis__country--US_zP0BCCuOPxBf" style="text-align: right"&gt;886&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20191231__srt--StatementGeographicalAxis__country--US_zVZLmXviCsil" style="text-align: right"&gt;705&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&#160;&#160;&#160;&#160;Europe&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20211231__srt--StatementGeographicalAxis__srt--EuropeMember_z0lncOo7cgB7" style="text-align: right"&gt;7,066&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20201231__srt--StatementGeographicalAxis__srt--EuropeMember_zrlbuGWF38d" style="text-align: right"&gt;7,106&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20191231__srt--StatementGeographicalAxis__srt--EuropeMember_zVMP9IkRSMu4" style="text-align: right"&gt;7,241&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&#160;&#160;&#160;Eliminations&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20211231__srt--StatementGeographicalAxis__custom--EliminationsMember_zJs36H0Si6he" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1600"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20201231__srt--StatementGeographicalAxis__custom--EliminationsMember_znLmrvdF8f1k" style="border-bottom: Black 1pt solid; text-align: right"&gt;49&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20191231__srt--StatementGeographicalAxis__custom--EliminationsMember_zAodDoksCThk" style="border-bottom: Black 1pt solid; text-align: right"&gt;58&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20211231_zEpnN8QYHkOa" style="border-bottom: Black 2pt double; text-align: right"&gt;7,936&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20201231_zkqsKHMhcTOl" style="border-bottom: Black 2pt double; text-align: right"&gt;8,041&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20191231_zisQbqIbzlz4" style="border-bottom: Black 2pt double; text-align: right"&gt;8,004&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8AE_zwGI3qP3PxX8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;INTER PARFUMS, INC. AND SUBSIDIARIES&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;Notes to Consolidated Financial Statements&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;December 31, 2021, 2020 and 2019&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;(In thousands except share and per share data)&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_89E_eus-gaap--ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_zqqPoAQ24U2i" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;United States export sales were
approximately $&lt;span id="xdx_901_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_dm_c20210101__20211231_zOKOIecfTgs"&gt;126.2 million&lt;/span&gt;, $&lt;span id="xdx_909_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_dm_c20200101__20201231_zgHZ9LnNqMH7"&gt;71.5 million&lt;/span&gt; and $&lt;span id="xdx_900_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20190101__20191231_zmGNh1bB8Dsd"&gt;112.0&lt;/span&gt; million in 2021, 2020 and 2019, respectively. &lt;span id="xdx_8BB_z8EKIkonq9Dc"&gt;Consolidated net sales to
customers by region are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Year ended December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2019&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 55%; text-align: left"&gt;North America&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--Revenues_c20210101__20211231__srt--StatementGeographicalAxis__srt--NorthAmericaMember_zAne2nd7s9qb" style="width: 12%; text-align: right" title="Net sales"&gt;354,100&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--Revenues_c20200101__20201231__srt--StatementGeographicalAxis__srt--NorthAmericaMember_zGLPNa5KiEji" style="width: 12%; text-align: right"&gt;193,500&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--Revenues_c20190101__20191231__srt--StatementGeographicalAxis__srt--NorthAmericaMember_zY4PXJenVjHl" style="width: 12%; text-align: right"&gt;235,500&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Europe&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--Revenues_c20210101__20211231__srt--StatementGeographicalAxis__custom--EuropeCountryMember_z4Kj9Q2LPdmi" style="text-align: right"&gt;271,600&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--Revenues_c20200101__20201231__srt--StatementGeographicalAxis__custom--EuropeCountryMember_z9cC9M7ZndHh" style="text-align: right"&gt;180,200&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--Revenues_c20190101__20191231__srt--StatementGeographicalAxis__custom--EuropeCountryMember_zgb1sHloeFD6" style="text-align: right"&gt;240,800&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Asia&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--Revenues_c20210101__20211231__srt--StatementGeographicalAxis__srt--AsiaMember_zW7Z1YghAqd3" style="text-align: right"&gt;128,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--Revenues_c20200101__20201231__srt--StatementGeographicalAxis__srt--AsiaMember_zRNOQ20XH2E3" style="text-align: right"&gt;79,700&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--Revenues_c20190101__20191231__srt--StatementGeographicalAxis__srt--AsiaMember_zV1AsVZ6BVC7" style="text-align: right"&gt;110,900&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Middle East&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--Revenues_c20210101__20211231__srt--StatementGeographicalAxis__us-gaap--MiddleEastMember_zBqHf1TKVNzl" style="text-align: right"&gt;61,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--Revenues_c20200101__20201231__srt--StatementGeographicalAxis__us-gaap--MiddleEastMember_zPX5D2V6erWl" style="text-align: right"&gt;46,800&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--Revenues_c20190101__20191231__srt--StatementGeographicalAxis__us-gaap--MiddleEastMember_z2SSTGEiiOpk" style="text-align: right"&gt;72,600&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Central and South America&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--Revenues_c20210101__20211231__srt--StatementGeographicalAxis__custom--CentralAndSouthAmericaMember_zQ82bJLnqLmc" style="text-align: right"&gt;56,400&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--Revenues_c20200101__20201231__srt--StatementGeographicalAxis__custom--CentralAndSouthAmericaMember_zaQPC0bZbpRd" style="text-align: right"&gt;32,500&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--Revenues_c20190101__20191231__srt--StatementGeographicalAxis__custom--CentralAndSouthAmericaMember_zug9hg2oF66d" style="text-align: right"&gt;46,200&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Other&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--Revenues_c20210101__20211231__srt--StatementGeographicalAxis__custom--OtherSegmentCountryMember_zTIQ1CRJkQvb" style="border-bottom: Black 1pt solid; text-align: right"&gt;8,400&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--Revenues_c20200101__20201231__srt--StatementGeographicalAxis__custom--OtherSegmentCountryMember_zwuHA6VcULmb" style="border-bottom: Black 1pt solid; text-align: right"&gt;6,300&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--Revenues_c20190101__20191231__srt--StatementGeographicalAxis__custom--OtherSegmentCountryMember_zf5C59wEliX7" style="border-bottom: Black 1pt solid; text-align: right"&gt;7,500&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--Revenues_c20210101__20211231_zuLPyqTHRiEf" style="border-bottom: Black 2pt double; text-align: right"&gt;879,500&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--Revenues_c20200101__20201231_za3KlQTe5Msg" style="border-bottom: Black 2pt double; text-align: right"&gt;539,000&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--Revenues_c20190101__20191231_zdyljZT1FLch" style="border-bottom: Black 2pt double; text-align: right"&gt;713,500&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A2_zI94YqJMxfll" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_898_eus-gaap--ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock_zuUa5YDa2a4h" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"&gt;&lt;span id="xdx_8BA_zqXnHQ8BJT6k"&gt;Consolidated net sales to customers in major countries
are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Year Ended December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2019&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 55%; text-align: left"&gt;United States&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20210101__20211231__us-gaap--StatementBusinessSegmentsAxis__custom--UnitedStatesMember_zEKymJV57Qvl" style="width: 12%; text-align: right" title="Revenue from Contract with Customer, Including Assessed Tax"&gt;351,300&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20200101__20201231__us-gaap--StatementBusinessSegmentsAxis__custom--UnitedStatesMember_zxYvGQoLkVMk" style="width: 12%; text-align: right"&gt;187,300&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20190101__20191231__us-gaap--StatementBusinessSegmentsAxis__custom--UnitedStatesMember_ztuDf4UXZh8e" style="width: 12%; text-align: right"&gt;225,300&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;France&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20210101__20211231__us-gaap--StatementBusinessSegmentsAxis__custom--FranceMember_zCRsWORMslv7" style="text-align: right"&gt;44,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20200101__20201231__us-gaap--StatementBusinessSegmentsAxis__custom--FranceMember_zbAfAETODHKk" style="text-align: right"&gt;37,600&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20190101__20191231__us-gaap--StatementBusinessSegmentsAxis__custom--FranceMember_zkP4BXithRv5" style="text-align: right"&gt;43,500&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Russia&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20210101__20211231__us-gaap--StatementBusinessSegmentsAxis__custom--RussiaMember_zcXrJAGJdL37" style="text-align: right"&gt;43,400&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20200101__20201231__us-gaap--StatementBusinessSegmentsAxis__custom--RussiaMember_zYkELQ8N448i" style="text-align: right"&gt;14,100&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20190101__20191231__us-gaap--StatementBusinessSegmentsAxis__custom--RussiaMember_zMwJcPbEQXTj" style="text-align: right"&gt;36,800&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;United Kingdom&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20210101__20211231__us-gaap--StatementBusinessSegmentsAxis__custom--UnitedKingdomMember_z7NvoMSPPB0e" style="text-align: right"&gt;38,500&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20200101__20201231__us-gaap--StatementBusinessSegmentsAxis__custom--UnitedKingdomMember_zmsscOTv6ur1" style="text-align: right"&gt;24,600&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20190101__20191231__us-gaap--StatementBusinessSegmentsAxis__custom--UnitedKingdomMember_zmPhy1xPPQR" style="text-align: right"&gt;35,800&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8AD_zXT9PNXVEmLi" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_899_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_zxd4NvECI4qf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span&gt;&lt;span id="xdx_8B5_zkDY8ZZkiM0h"&gt;Information on the Company&#x2019;s
operations by segments is as follows:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; visibility: visible; font-weight: bold; text-align: center"&gt;Year ended December 31,&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="visibility: visible; vertical-align: bottom"&gt;
    &lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; visibility: visible; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; visibility: visible; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; visibility: visible; font-weight: bold; text-align: center"&gt;2019&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="visibility: visible; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="visibility: visible; text-align: left"&gt;Net sales:&lt;/td&gt;&lt;td style="visibility: visible"&gt;&#160;&lt;/td&gt;
    &lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible"&gt;&#160;&lt;/td&gt;
    &lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible"&gt;&#160;&lt;/td&gt;
    &lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="visibility: visible; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="visibility: visible; width: 55%; text-align: left"&gt;&#160;&#160;&#160;&#160;United States&lt;/td&gt;&lt;td style="visibility: visible; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="visibility: visible; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20210101__20211231__srt--StatementGeographicalAxis__country--US_z5r4PcNAeks3" style="visibility: visible; width: 12%; text-align: right"&gt;216,559&lt;/td&gt;&lt;td style="visibility: visible; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="visibility: visible; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20200101__20201231__srt--StatementGeographicalAxis__country--US_zCfrzosskOG7" style="visibility: visible; width: 12%; text-align: right"&gt;117,489&lt;/td&gt;&lt;td style="visibility: visible; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="visibility: visible; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20190101__20191231__srt--StatementGeographicalAxis__country--US_zWIdVteHZ4Hi" style="visibility: visible; width: 12%; text-align: right"&gt;173,522&lt;/td&gt;&lt;td style="visibility: visible; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="visibility: visible; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="visibility: visible; text-align: left"&gt;&#160;&#160;&#160;&#160;Europe&lt;/td&gt;&lt;td style="visibility: visible"&gt;&#160;&lt;/td&gt;
    &lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20210101__20211231__srt--StatementGeographicalAxis__srt--EuropeMember_zmO13RpnEfAk" style="visibility: visible; text-align: right"&gt;663,290&lt;/td&gt;&lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible"&gt;&#160;&lt;/td&gt;
    &lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20200101__20201231__srt--StatementGeographicalAxis__srt--EuropeMember_ztyL8g0DCNCg" style="visibility: visible; text-align: right"&gt;422,947&lt;/td&gt;&lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible"&gt;&#160;&lt;/td&gt;
    &lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20190101__20191231__srt--StatementGeographicalAxis__srt--EuropeMember_ztcgUX0XX4o3" style="visibility: visible; text-align: right"&gt;542,226&lt;/td&gt;&lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="visibility: visible; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="visibility: visible; text-align: left; padding-bottom: 1pt"&gt;&#160;&#160;&#160;&#160;Eliminations of intercompany sales&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20210101__20211231__srt--StatementGeographicalAxis__custom--EliminationsMember_zwlEf11aFZM2" style="border-bottom: Black 1pt solid; visibility: visible; text-align: right"&gt;(333&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20200101__20201231__srt--StatementGeographicalAxis__custom--EliminationsMember_z5ym2Cf1wVOj" style="border-bottom: Black 1pt solid; visibility: visible; text-align: right"&gt;(1,427&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20190101__20191231__srt--StatementGeographicalAxis__custom--EliminationsMember_zicOjvimpE4k" style="border-bottom: Black 1pt solid; visibility: visible; text-align: right"&gt;(2,234&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="visibility: visible; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="visibility: visible; text-align: left; padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; visibility: visible; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20210101__20211231_zjyV2OjP8sa3" style="border-bottom: Black 2pt double; visibility: visible; text-align: right"&gt;879,516&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; visibility: visible; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20200101__20201231_zeUtsjBlkcec" style="border-bottom: Black 2pt double; visibility: visible; text-align: right"&gt;539,009&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; visibility: visible; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_dxL_c20200101__20201231_zrpOASipOcL" style="border-bottom: Black 2pt double; visibility: visible; text-align: right" title="::XDX::539%2C009"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1497"&gt;713,514&lt;/span&gt;&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="visibility: visible; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="visibility: visible; text-align: left"&gt;Net income attributable to Inter Parfums, Inc.:&lt;/td&gt;&lt;td style="visibility: visible"&gt;&#160;&lt;/td&gt;
    &lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible"&gt;&#160;&lt;/td&gt;
    &lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible"&gt;&#160;&lt;/td&gt;
    &lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="visibility: visible; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="visibility: visible; text-align: left"&gt;&#160;&#160;&#160;&#160;United States&lt;/td&gt;&lt;td style="visibility: visible"&gt;&#160;&lt;/td&gt;
    &lt;td style="visibility: visible; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--NetIncomeLoss_c20210101__20211231__srt--StatementGeographicalAxis__country--US_zJrsX1vBTKh1" style="visibility: visible; text-align: right"&gt;29,359&lt;/td&gt;&lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible"&gt;&#160;&lt;/td&gt;
    &lt;td style="visibility: visible; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--NetIncomeLoss_c20200101__20201231__srt--StatementGeographicalAxis__country--US_zukMU1UqRBab" style="visibility: visible; text-align: right"&gt;7,942&lt;/td&gt;&lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible"&gt;&#160;&lt;/td&gt;
    &lt;td style="visibility: visible; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--NetIncomeLoss_c20190101__20191231__srt--StatementGeographicalAxis__country--US_zfoS7lQBSpQ7" style="visibility: visible; text-align: right"&gt;19,365&lt;/td&gt;&lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="visibility: visible; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="visibility: visible; text-align: left"&gt;&#160;&#160;&#160;&#160;Europe&lt;/td&gt;&lt;td style="visibility: visible"&gt;&#160;&lt;/td&gt;
    &lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--NetIncomeLoss_c20210101__20211231__srt--StatementGeographicalAxis__srt--EuropeMember_z5kifDjPeta6" style="visibility: visible; text-align: right"&gt;57,869&lt;/td&gt;&lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible"&gt;&#160;&lt;/td&gt;
    &lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--NetIncomeLoss_c20200101__20201231__srt--StatementGeographicalAxis__srt--EuropeMember_zytAdG8vtrri" style="visibility: visible; text-align: right"&gt;30,241&lt;/td&gt;&lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible"&gt;&#160;&lt;/td&gt;
    &lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--NetIncomeLoss_c20190101__20191231__srt--StatementGeographicalAxis__srt--EuropeMember_ztQNOn4IdHg8" style="visibility: visible; text-align: right"&gt;40,840&lt;/td&gt;&lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="visibility: visible; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="visibility: visible; text-align: left; padding-bottom: 1pt"&gt;&#160;&#160;&#160;&#160;Eliminations&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--NetIncomeLoss_c20210101__20211231__srt--StatementGeographicalAxis__custom--EliminationsMember_zg9MaKYb0dsc" style="border-bottom: Black 1pt solid; visibility: visible; text-align: right"&gt;183&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--NetIncomeLoss_c20200101__20201231__srt--StatementGeographicalAxis__custom--EliminationsMember_zNVbvBEIifob" style="border-bottom: Black 1pt solid; visibility: visible; text-align: right"&gt;36&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--NetIncomeLoss_c20190101__20191231__srt--StatementGeographicalAxis__custom--EliminationsMember_zykwKqHurgGd" style="border-bottom: Black 1pt solid; visibility: visible; text-align: right"&gt;44&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="visibility: visible; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="visibility: visible; text-align: left; padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; visibility: visible; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--NetIncomeLoss_c20210101__20211231_znQ0YUnY32X3" style="border-bottom: Black 2pt double; visibility: visible; text-align: right"&gt;87,411&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; visibility: visible; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--NetIncomeLoss_c20200101__20201231_zyP62IcvJVSh" style="border-bottom: Black 2pt double; visibility: visible; text-align: right"&gt;38,219&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; visibility: visible; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--NetIncomeLoss_c20190101__20191231_z997kfuIqlMf" style="border-bottom: Black 2pt double; visibility: visible; text-align: right"&gt;60,249&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="visibility: visible; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="visibility: visible; text-align: left; text-indent: -7.75pt; padding-left: 7.75pt"&gt;Depreciation and amortization expense including impairment loss:&lt;/td&gt;&lt;td style="visibility: visible"&gt;&#160;&lt;/td&gt;
    &lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible"&gt;&#160;&lt;/td&gt;
    &lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible"&gt;&#160;&lt;/td&gt;
    &lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="visibility: visible; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="visibility: visible; text-align: left"&gt;&#160;&#160;&#160;&#160;United States&lt;/td&gt;&lt;td style="visibility: visible"&gt;&#160;&lt;/td&gt;
    &lt;td style="visibility: visible; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--DepreciationAndAmortization_c20210101__20211231__srt--StatementGeographicalAxis__country--US_zkF7xuK0rol4" style="visibility: visible; text-align: right"&gt;3,835&lt;/td&gt;&lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible"&gt;&#160;&lt;/td&gt;
    &lt;td style="visibility: visible; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--DepreciationAndAmortization_c20200101__20201231__srt--StatementGeographicalAxis__country--US_zyOCWL2HUBxa" style="visibility: visible; text-align: right"&gt;3,354&lt;/td&gt;&lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible"&gt;&#160;&lt;/td&gt;
    &lt;td style="visibility: visible; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--DepreciationAndAmortization_c20190101__20191231__srt--StatementGeographicalAxis__country--US_zUUVLjx2cPk" style="visibility: visible; text-align: right"&gt;3,088&lt;/td&gt;&lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="visibility: visible; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="visibility: visible; text-align: left; padding-bottom: 1pt"&gt;&#160;&#160;&#160;&#160;Europe&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--DepreciationAndAmortization_c20210101__20211231__srt--StatementGeographicalAxis__srt--EuropeMember_zt8Xwpmj0roa" style="border-bottom: Black 1pt solid; visibility: visible; text-align: right"&gt;8,863&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--DepreciationAndAmortization_c20200101__20201231__srt--StatementGeographicalAxis__srt--EuropeMember_zioukoB7Vgtj" style="border-bottom: Black 1pt solid; visibility: visible; text-align: right"&gt;5,713&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--DepreciationAndAmortization_c20190101__20191231__srt--StatementGeographicalAxis__srt--EuropeMember_z70leSOFQKH9" style="border-bottom: Black 1pt solid; visibility: visible; text-align: right"&gt;5,641&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="visibility: visible; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="visibility: visible; text-align: left; padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; visibility: visible; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--DepreciationAndAmortization_c20210101__20211231_zDXjtc4WPOAg" style="border-bottom: Black 2pt double; visibility: visible; text-align: right"&gt;12,698&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; visibility: visible; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--DepreciationAndAmortization_c20200101__20201231_zqTLCmXoJIdd" style="border-bottom: Black 2pt double; visibility: visible; text-align: right"&gt;9,067&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; visibility: visible; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--DepreciationAndAmortization_c20190101__20191231_z7wvpw82L6q3" style="border-bottom: Black 2pt double; visibility: visible; text-align: right"&gt;8,729&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="visibility: visible; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="visibility: visible; text-align: left"&gt;Interest and investment income:&lt;/td&gt;&lt;td style="visibility: visible"&gt;&#160;&lt;/td&gt;
    &lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible"&gt;&#160;&lt;/td&gt;
    &lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible"&gt;&#160;&lt;/td&gt;
    &lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="visibility: visible; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="visibility: visible; text-align: left"&gt;&#160;&#160;&#160;&#160;United States&lt;/td&gt;&lt;td style="visibility: visible"&gt;&#160;&lt;/td&gt;
    &lt;td style="visibility: visible; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--InvestmentIncomeInterestAndDividend_c20210101__20211231__srt--StatementGeographicalAxis__country--US_zGHaHth6AQv7" style="visibility: visible; text-align: right"&gt;3&lt;/td&gt;&lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible"&gt;&#160;&lt;/td&gt;
    &lt;td style="visibility: visible; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--InvestmentIncomeInterestAndDividend_c20200101__20201231__srt--StatementGeographicalAxis__country--US_z7dyBRe90bJ8" style="visibility: visible; text-align: right"&gt;24&lt;/td&gt;&lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible"&gt;&#160;&lt;/td&gt;
    &lt;td style="visibility: visible; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--InvestmentIncomeInterestAndDividend_c20190101__20191231__srt--StatementGeographicalAxis__country--US_za0FpXMf1CW8" style="visibility: visible; text-align: right"&gt;345&lt;/td&gt;&lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="visibility: visible; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="visibility: visible; text-align: left"&gt;&#160;&#160;&#160;&#160;Europe&lt;/td&gt;&lt;td style="visibility: visible"&gt;&#160;&lt;/td&gt;
    &lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--InvestmentIncomeInterestAndDividend_c20210101__20211231__srt--StatementGeographicalAxis__srt--EuropeMember_zoRhTydjQQed" style="visibility: visible; text-align: right"&gt;3,526&lt;/td&gt;&lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible"&gt;&#160;&lt;/td&gt;
    &lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--InvestmentIncomeInterestAndDividend_c20200101__20201231__srt--StatementGeographicalAxis__srt--EuropeMember_zP5BNsiY3o85" style="visibility: visible; text-align: right"&gt;2,971&lt;/td&gt;&lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible"&gt;&#160;&lt;/td&gt;
    &lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--InvestmentIncomeInterestAndDividend_c20190101__20191231__srt--StatementGeographicalAxis__srt--EuropeMember_zWzfeijv0RZe" style="visibility: visible; text-align: right"&gt;3,501&lt;/td&gt;&lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="visibility: visible; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="visibility: visible; text-align: left; padding-bottom: 1pt"&gt;&#160;&#160;&#160;&#160;Eliminations&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--InvestmentIncomeInterestAndDividend_c20210101__20211231__srt--StatementGeographicalAxis__custom--EliminationsMember_zJm2O7dCPjhc" style="border-bottom: Black 1pt solid; visibility: visible; text-align: right"&gt;(126&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--InvestmentIncomeInterestAndDividend_c20200101__20201231__srt--StatementGeographicalAxis__custom--EliminationsMember_zOPX0UarbiWc" style="border-bottom: Black 1pt solid; visibility: visible; text-align: right"&gt;(130&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--InvestmentIncomeInterestAndDividend_c20190101__20191231__srt--StatementGeographicalAxis__custom--EliminationsMember_zt62G18GMYZ" style="border-bottom: Black 1pt solid; visibility: visible; text-align: right"&gt;(153&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="visibility: visible; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="visibility: visible; text-align: left; padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; visibility: visible; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--InvestmentIncomeInterestAndDividend_c20210101__20211231_z1Scsi8xKcu8" style="border-bottom: Black 2pt double; visibility: visible; text-align: right"&gt;3,403&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; visibility: visible; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--InvestmentIncomeInterestAndDividend_c20200101__20201231_zqQDKSCvhSI9" style="border-bottom: Black 2pt double; visibility: visible; text-align: right"&gt;2,865&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; visibility: visible; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--InvestmentIncomeInterestAndDividend_c20190101__20191231_zEOKYG3INDt8" style="border-bottom: Black 2pt double; visibility: visible; text-align: right"&gt;3,693&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="visibility: visible; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="visibility: visible; text-align: left"&gt;Interest expense:&lt;/td&gt;&lt;td style="visibility: visible"&gt;&#160;&lt;/td&gt;
    &lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible"&gt;&#160;&lt;/td&gt;
    &lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible"&gt;&#160;&lt;/td&gt;
    &lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="visibility: visible; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="visibility: visible; text-align: left"&gt;&#160;&#160;&#160;&#160;United States&lt;/td&gt;&lt;td style="visibility: visible"&gt;&#160;&lt;/td&gt;
    &lt;td style="visibility: visible; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--InterestExpense_c20210101__20211231__srt--StatementGeographicalAxis__country--US_zYxsoG4QjcUa" style="visibility: visible; text-align: right"&gt;636&lt;/td&gt;&lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible"&gt;&#160;&lt;/td&gt;
    &lt;td style="visibility: visible; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--InterestExpense_c20200101__20201231__srt--StatementGeographicalAxis__country--US_z2Ybx7IJsKC3" style="visibility: visible; text-align: right"&gt;604&lt;/td&gt;&lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible"&gt;&#160;&lt;/td&gt;
    &lt;td style="visibility: visible; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--InterestExpense_c20190101__20191231__srt--StatementGeographicalAxis__country--US_zY8KBHWYMCk1" style="visibility: visible; text-align: right"&gt;673&lt;/td&gt;&lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="visibility: visible; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="visibility: visible; text-align: left"&gt;&#160;&#160;&#160;&#160;Europe&lt;/td&gt;&lt;td style="visibility: visible"&gt;&#160;&lt;/td&gt;
    &lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--InterestExpense_c20210101__20211231__srt--StatementGeographicalAxis__srt--EuropeMember_zHgsSFDcKVIf" style="visibility: visible; text-align: right" title="Interest expense"&gt;2,315&lt;/td&gt;&lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible"&gt;&#160;&lt;/td&gt;
    &lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--InterestExpense_c20200101__20201231__srt--StatementGeographicalAxis__srt--EuropeMember_zLmvKN23VR57" style="visibility: visible; text-align: right" title="Interest expense"&gt;1,496&lt;/td&gt;&lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible"&gt;&#160;&lt;/td&gt;
    &lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--InterestExpense_c20190101__20191231__srt--StatementGeographicalAxis__srt--EuropeMember_zNSXrgeFTNAg" style="visibility: visible; text-align: right" title="Interest expense"&gt;1,626&lt;/td&gt;&lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="visibility: visible; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="visibility: visible; text-align: left; padding-bottom: 1pt"&gt;&#160;&#160;&#160;&#160;Eliminations&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--InterestExpense_c20210101__20211231__srt--StatementGeographicalAxis__custom--EliminationsMember_zcrfn5F85JL7" style="border-bottom: Black 1pt solid; visibility: visible; text-align: right" title="Interest expense"&gt;(126&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--InterestExpense_c20200101__20201231__srt--StatementGeographicalAxis__custom--EliminationsMember_zYBXzVtL8SH1" style="border-bottom: Black 1pt solid; visibility: visible; text-align: right" title="Interest expense"&gt;(130&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--InterestExpense_c20190101__20191231__srt--StatementGeographicalAxis__custom--EliminationsMember_zSMQsNKpvAO2" style="border-bottom: Black 1pt solid; visibility: visible; text-align: right" title="Interest expense"&gt;(153&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="visibility: visible; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="visibility: visible; text-align: left; padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; visibility: visible; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--InterestExpense_c20210101__20211231_zYwDrdtfE7qj" style="border-bottom: Black 2pt double; visibility: visible; text-align: right" title="Interest expense"&gt;2,825&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; visibility: visible; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--InterestExpense_c20200101__20201231_zNXV6WHw0F3b" style="border-bottom: Black 2pt double; visibility: visible; text-align: right" title="Interest expense"&gt;1,970&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; visibility: visible; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--InterestExpense_c20190101__20191231_zI8X8gzlNi8c" style="border-bottom: Black 2pt double; visibility: visible; text-align: right" title="Interest expense"&gt;2,146&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="visibility: visible; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="visibility: visible; text-align: left"&gt;Income tax expense:&lt;/td&gt;&lt;td style="visibility: visible"&gt;&#160;&lt;/td&gt;
    &lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible"&gt;&#160;&lt;/td&gt;
    &lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible"&gt;&#160;&lt;/td&gt;
    &lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="visibility: visible; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="visibility: visible; text-align: left"&gt;&#160;&#160;&#160;&#160;United States&lt;/td&gt;&lt;td style="visibility: visible"&gt;&#160;&lt;/td&gt;
    &lt;td style="visibility: visible; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--IncomeTaxExpenseBenefit_c20210101__20211231__srt--StatementGeographicalAxis__country--US_zPqN12BQMkL1" style="visibility: visible; text-align: right"&gt;5,336&lt;/td&gt;&lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible"&gt;&#160;&lt;/td&gt;
    &lt;td style="visibility: visible; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--IncomeTaxExpenseBenefit_c20200101__20201231__srt--StatementGeographicalAxis__country--US_zHU559TDBHrb" style="visibility: visible; text-align: right"&gt;1,590&lt;/td&gt;&lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible"&gt;&#160;&lt;/td&gt;
    &lt;td style="visibility: visible; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--IncomeTaxExpenseBenefit_c20190101__20191231__srt--StatementGeographicalAxis__country--US_ztUs8eqesh7k" style="visibility: visible; text-align: right"&gt;3,945&lt;/td&gt;&lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="visibility: visible; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="visibility: visible; text-align: left"&gt;&#160;&#160;&#160;&#160;Europe&lt;/td&gt;&lt;td style="visibility: visible"&gt;&#160;&lt;/td&gt;
    &lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--IncomeTaxExpenseBenefit_c20210101__20211231__srt--StatementGeographicalAxis__srt--EuropeMember_z0bXvJdCA9qa" style="visibility: visible; text-align: right"&gt;35,607&lt;/td&gt;&lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible"&gt;&#160;&lt;/td&gt;
    &lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--IncomeTaxExpenseBenefit_c20200101__20201231__srt--StatementGeographicalAxis__srt--EuropeMember_z6N7TqsQJgVf" style="visibility: visible; text-align: right"&gt;17,782&lt;/td&gt;&lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible"&gt;&#160;&lt;/td&gt;
    &lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--IncomeTaxExpenseBenefit_c20190101__20191231__srt--StatementGeographicalAxis__srt--EuropeMember_zyNgRnvX3AHa" style="visibility: visible; text-align: right"&gt;25,101&lt;/td&gt;&lt;td style="visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="visibility: visible; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="visibility: visible; text-align: left; padding-bottom: 1pt"&gt;&#160;&#160;&#160;&#160;Eliminations&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--IncomeTaxExpenseBenefit_c20210101__20211231__srt--StatementGeographicalAxis__custom--EliminationsMember_zsxwiXhlQHTb" style="border-bottom: Black 1pt solid; visibility: visible; text-align: right"&gt;49&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--IncomeTaxExpenseBenefit_c20200101__20201231__srt--StatementGeographicalAxis__custom--EliminationsMember_zAQ2F8H0iw26" style="border-bottom: Black 1pt solid; visibility: visible; text-align: right"&gt;9&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; visibility: visible; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--IncomeTaxExpenseBenefit_c20190101__20191231__srt--StatementGeographicalAxis__custom--EliminationsMember_zsfPjVbPoZq9" style="border-bottom: Black 1pt solid; visibility: visible; text-align: right"&gt;30&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="visibility: visible; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="visibility: visible; text-align: left; padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; visibility: visible; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--IncomeTaxExpenseBenefit_c20210101__20211231_zYuwcNGNDjxe" style="border-bottom: Black 2pt double; visibility: visible; text-align: right"&gt;40,992&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; visibility: visible; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--IncomeTaxExpenseBenefit_c20200101__20201231_zK5CansaJlHa" style="border-bottom: Black 2pt double; visibility: visible; text-align: right"&gt;19,381&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; visibility: visible; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--IncomeTaxExpenseBenefit_c20190101__20191231_ziS0Mw2aThV8" style="border-bottom: Black 2pt double; visibility: visible; text-align: right"&gt;29,076&lt;/td&gt;&lt;td style="visibility: visible; padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="margin: 0; visibility: visible"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in"&gt;
&lt;tr style="text-align: center; vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;December 31,&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="text-align: center; vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold"&gt;2019&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; width: 55%"&gt;Total assets:&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; width: 12%"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; width: 12%"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; width: 12%"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&#160;&#160;&#160;&#160;United States&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--Assets_iI_c20211231__srt--StatementGeographicalAxis__country--US_z8zLIQYvfsd3" style="text-align: right"&gt;247,703&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--Assets_iI_c20201231__srt--StatementGeographicalAxis__country--US_z1a1mVWhWgJa" style="text-align: right"&gt;141,316&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--Assets_iI_c20191231__srt--StatementGeographicalAxis__country--US_ze4scNtgijPj" style="text-align: right"&gt;166,180&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&#160;&#160;&#160;&#160;Europe&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--Assets_iI_c20211231__srt--StatementGeographicalAxis__srt--EuropeMember_zFKpIBUvOgqk" style="text-align: right"&gt;931,735&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--Assets_iI_c20201231__srt--StatementGeographicalAxis__srt--EuropeMember_zLoIkfHcmMR6" style="text-align: right"&gt;758,812&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--Assets_iI_c20191231__srt--StatementGeographicalAxis__srt--EuropeMember_zHhR8uZ68Vdi" style="text-align: right"&gt;670,657&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&#160;&#160;&#160;Eliminations&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--Assets_iI_c20211231__srt--StatementGeographicalAxis__custom--EliminationsMember_ziJx0D2ajuXj" style="border-bottom: Black 1pt solid; text-align: right"&gt;(34,074&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--Assets_iI_c20201231__srt--StatementGeographicalAxis__custom--EliminationsMember_zW0wHylpiVnf" style="border-bottom: Black 1pt solid; text-align: right"&gt;(9,983&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--Assets_iI_c20191231__srt--StatementGeographicalAxis__custom--EliminationsMember_ztZSf6TnJ691" style="border-bottom: Black 1pt solid; text-align: right"&gt;(8,005&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--Assets_iI_c20211231_zDp748Hon1k2" style="border-bottom: Black 2pt double; text-align: right"&gt;1,145,364&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--Assets_iI_c20201231_zF0HVpqB8clf" style="border-bottom: Black 2pt double; text-align: right"&gt;890,145&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--Assets_iI_c20191231_zKV32bgh58nd" style="border-bottom: Black 2pt double; text-align: right"&gt;828,832&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Additions to long-lived assets:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&#160;&#160;&#160;&#160;United States&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--AdditionsToOtherAssetsAmount_c20210101__20211231__srt--StatementGeographicalAxis__country--US_zwbljiC2D0T2" style="text-align: right"&gt;2,711&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--AdditionsToOtherAssetsAmount_c20200101__20201231__srt--StatementGeographicalAxis__country--US_zDQwlX504Fj9" style="text-align: right"&gt;1,004&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--AdditionsToOtherAssetsAmount_c20190101__20191231__srt--StatementGeographicalAxis__country--US_zyaItO2G8at2" style="text-align: right"&gt;5,851&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&#160;&#160;&#160;Europe&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--AdditionsToOtherAssetsAmount_c20210101__20211231__srt--StatementGeographicalAxis__srt--EuropeMember_zhE9PE1o3qA5" style="border-bottom: Black 1pt solid; text-align: right"&gt;138,563&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--AdditionsToOtherAssetsAmount_c20200101__20201231__srt--StatementGeographicalAxis__srt--EuropeMember_z7bZHUpdAPbg" style="border-bottom: Black 1pt solid; text-align: right"&gt;11,259&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--AdditionsToOtherAssetsAmount_c20190101__20191231__srt--StatementGeographicalAxis__srt--EuropeMember_znS4FO2uM4K6" style="border-bottom: Black 1pt solid; text-align: right"&gt;5,643&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--AdditionsToOtherAssetsAmount_c20210101__20211231_zHfls6HDBu4k" style="border-bottom: Black 2pt double; text-align: right"&gt;141,274&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--AdditionsToOtherAssetsAmount_c20200101__20201231_zcl7DDjE2QR5" style="border-bottom: Black 2pt double; text-align: right"&gt;12,263&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--AdditionsToOtherAssetsAmount_c20190101__20191231_zXeSTYOabnB4" style="border-bottom: Black 2pt double; text-align: right"&gt;11,494&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Total long-lived assets:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&#160;&#160;&#160;&#160;United States&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--NoncurrentAssets_iI_c20211231__srt--StatementGeographicalAxis__country--US_zQKQz1a0vcYc" style="text-align: right"&gt;63,094&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--NoncurrentAssets_iI_c20201231__srt--StatementGeographicalAxis__country--US_zN6R5bz6TMr6" style="text-align: right"&gt;40,656&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--NoncurrentAssets_iI_c20191231__srt--StatementGeographicalAxis__country--US_zofVpONNxiv8" style="text-align: right"&gt;44,473&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&#160;&#160;&#160;Europe&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--NoncurrentAssets_iI_c20211231__srt--StatementGeographicalAxis__srt--EuropeMember_zr7C4Q02H059" style="border-bottom: Black 1pt solid; text-align: right"&gt;334,033&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--NoncurrentAssets_iI_c20201231__srt--StatementGeographicalAxis__srt--EuropeMember_zgqJ58AYQgJ" style="border-bottom: Black 1pt solid; text-align: right"&gt;217,766&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--NoncurrentAssets_iI_c20191231__srt--StatementGeographicalAxis__srt--EuropeMember_z9wKjWDm19Zg" style="border-bottom: Black 1pt solid; text-align: right"&gt;196,976&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--NoncurrentAssets_iI_c20211231_z6hxmiTCgKSi" style="border-bottom: Black 2pt double; text-align: right"&gt;397,127&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--NoncurrentAssets_iI_c20201231_zJnLsw2O7mc3" style="border-bottom: Black 2pt double; text-align: right"&gt;258,422&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--NoncurrentAssets_iI_c20191231_zGz0VhTFM3Yh" style="border-bottom: Black 2pt double; text-align: right"&gt;241,449&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Deferred tax assets:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&#160;&#160;&#160;&#160;United States&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20211231__srt--StatementGeographicalAxis__country--US_zkvJfows7qFd" style="text-align: right"&gt;870&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20201231__srt--StatementGeographicalAxis__country--US_zP0BCCuOPxBf" style="text-align: right"&gt;886&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20191231__srt--StatementGeographicalAxis__country--US_zVZLmXviCsil" style="text-align: right"&gt;705&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&#160;&#160;&#160;&#160;Europe&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20211231__srt--StatementGeographicalAxis__srt--EuropeMember_z0lncOo7cgB7" style="text-align: right"&gt;7,066&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20201231__srt--StatementGeographicalAxis__srt--EuropeMember_zrlbuGWF38d" style="text-align: right"&gt;7,106&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20191231__srt--StatementGeographicalAxis__srt--EuropeMember_zVMP9IkRSMu4" style="text-align: right"&gt;7,241&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&#160;&#160;&#160;Eliminations&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20211231__srt--StatementGeographicalAxis__custom--EliminationsMember_zJs36H0Si6he" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1600"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20201231__srt--StatementGeographicalAxis__custom--EliminationsMember_znLmrvdF8f1k" style="border-bottom: Black 1pt solid; text-align: right"&gt;49&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20191231__srt--StatementGeographicalAxis__custom--EliminationsMember_zAodDoksCThk" style="border-bottom: Black 1pt solid; text-align: right"&gt;58&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20211231_zEpnN8QYHkOa" style="border-bottom: Black 2pt double; text-align: right"&gt;7,936&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20201231_zkqsKHMhcTOl" style="border-bottom: Black 2pt double; text-align: right"&gt;8,041&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20191231_zisQbqIbzlz4" style="border-bottom: Black 2pt double; text-align: right"&gt;8,004&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="From2021-01-012021-12-31_country_US"
      decimals="-3"
      unitRef="USD">216559000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="From2020-01-012020-12-31_country_US"
      decimals="-3"
      unitRef="USD">117489000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="From2019-01-012019-12-31_country_US"
      decimals="-3"
      unitRef="USD">173522000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="From2021-01-012021-12-31_srt_EuropeMember"
      decimals="-3"
      unitRef="USD">663290000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="From2020-01-012020-12-31_srt_EuropeMember"
      decimals="-3"
      unitRef="USD">422947000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="From2019-01-012019-12-31_srt_EuropeMember"
      decimals="-3"
      unitRef="USD">542226000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="From2021-01-012021-12-31_custom_EliminationsMember"
      decimals="-3"
      unitRef="USD">-333000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="From2020-01-012020-12-31_custom_EliminationsMember"
      decimals="-3"
      unitRef="USD">-1427000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="From2019-01-012019-12-31_custom_EliminationsMember"
      decimals="-3"
      unitRef="USD">-2234000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="USD">879516000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">539009000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-01-012021-12-31_country_US"
      decimals="-3"
      unitRef="USD">29359000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-01-012020-12-31_country_US"
      decimals="-3"
      unitRef="USD">7942000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2019-01-012019-12-31_country_US"
      decimals="-3"
      unitRef="USD">19365000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-01-012021-12-31_srt_EuropeMember"
      decimals="-3"
      unitRef="USD">57869000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-01-012020-12-31_srt_EuropeMember"
      decimals="-3"
      unitRef="USD">30241000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2019-01-012019-12-31_srt_EuropeMember"
      decimals="-3"
      unitRef="USD">40840000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-01-012021-12-31_custom_EliminationsMember"
      decimals="-3"
      unitRef="USD">183000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-01-012020-12-31_custom_EliminationsMember"
      decimals="-3"
      unitRef="USD">36000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2019-01-012019-12-31_custom_EliminationsMember"
      decimals="-3"
      unitRef="USD">44000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="USD">87411000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">38219000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="USD">60249000</us-gaap:NetIncomeLoss>
    <us-gaap:DepreciationAndAmortization
      contextRef="From2021-01-012021-12-31_country_US"
      decimals="-3"
      unitRef="USD">3835000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="From2020-01-012020-12-31_country_US"
      decimals="-3"
      unitRef="USD">3354000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="From2019-01-012019-12-31_country_US"
      decimals="-3"
      unitRef="USD">3088000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="From2021-01-012021-12-31_srt_EuropeMember"
      decimals="-3"
      unitRef="USD">8863000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="From2020-01-012020-12-31_srt_EuropeMember"
      decimals="-3"
      unitRef="USD">5713000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="From2019-01-012019-12-31_srt_EuropeMember"
      decimals="-3"
      unitRef="USD">5641000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="USD">12698000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">9067000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="USD">8729000</us-gaap:DepreciationAndAmortization>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="From2021-01-012021-12-31_country_US"
      decimals="-3"
      unitRef="USD">3000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="From2020-01-012020-12-31_country_US"
      decimals="-3"
      unitRef="USD">24000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="From2019-01-012019-12-31_country_US"
      decimals="-3"
      unitRef="USD">345000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="From2021-01-012021-12-31_srt_EuropeMember"
      decimals="-3"
      unitRef="USD">3526000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="From2020-01-012020-12-31_srt_EuropeMember"
      decimals="-3"
      unitRef="USD">2971000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="From2019-01-012019-12-31_srt_EuropeMember"
      decimals="-3"
      unitRef="USD">3501000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="From2021-01-012021-12-31_custom_EliminationsMember"
      decimals="-3"
      unitRef="USD">-126000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="From2020-01-012020-12-31_custom_EliminationsMember"
      decimals="-3"
      unitRef="USD">-130000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="From2019-01-012019-12-31_custom_EliminationsMember"
      decimals="-3"
      unitRef="USD">-153000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="USD">3403000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">2865000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="USD">3693000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InterestExpense
      contextRef="From2021-01-012021-12-31_country_US"
      decimals="-3"
      unitRef="USD">636000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="From2020-01-012020-12-31_country_US"
      decimals="-3"
      unitRef="USD">604000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="From2019-01-012019-12-31_country_US"
      decimals="-3"
      unitRef="USD">673000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="From2021-01-012021-12-31_srt_EuropeMember"
      decimals="-3"
      unitRef="USD">2315000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="From2020-01-012020-12-31_srt_EuropeMember"
      decimals="-3"
      unitRef="USD">1496000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="From2019-01-012019-12-31_srt_EuropeMember"
      decimals="-3"
      unitRef="USD">1626000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="From2021-01-012021-12-31_custom_EliminationsMember"
      decimals="-3"
      unitRef="USD">-126000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="From2020-01-012020-12-31_custom_EliminationsMember"
      decimals="-3"
      unitRef="USD">-130000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="From2019-01-012019-12-31_custom_EliminationsMember"
      decimals="-3"
      unitRef="USD">-153000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="USD">2825000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">1970000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="USD">2146000</us-gaap:InterestExpense>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2021-01-012021-12-31_country_US"
      decimals="-3"
      unitRef="USD">5336000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2020-01-012020-12-31_country_US"
      decimals="-3"
      unitRef="USD">1590000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2019-01-012019-12-31_country_US"
      decimals="-3"
      unitRef="USD">3945000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2021-01-012021-12-31_srt_EuropeMember"
      decimals="-3"
      unitRef="USD">35607000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2020-01-012020-12-31_srt_EuropeMember"
      decimals="-3"
      unitRef="USD">17782000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2019-01-012019-12-31_srt_EuropeMember"
      decimals="-3"
      unitRef="USD">25101000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2021-01-012021-12-31_custom_EliminationsMember"
      decimals="-3"
      unitRef="USD">49000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2020-01-012020-12-31_custom_EliminationsMember"
      decimals="-3"
      unitRef="USD">9000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2019-01-012019-12-31_custom_EliminationsMember"
      decimals="-3"
      unitRef="USD">30000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="USD">40992000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">19381000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="USD">29076000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:Assets
      contextRef="AsOf2021-12-31_country_US"
      decimals="-3"
      unitRef="USD">247703000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="AsOf2020-12-31_country_US"
      decimals="-3"
      unitRef="USD">141316000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="AsOf2019-12-31_country_US"
      decimals="-3"
      unitRef="USD">166180000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="AsOf2021-12-31_srt_EuropeMember"
      decimals="-3"
      unitRef="USD">931735000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="AsOf2020-12-31_srt_EuropeMember"
      decimals="-3"
      unitRef="USD">758812000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="AsOf2019-12-31_srt_EuropeMember"
      decimals="-3"
      unitRef="USD">670657000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="AsOf2021-12-31_custom_EliminationsMember"
      decimals="-3"
      unitRef="USD">-34074000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="AsOf2020-12-31_custom_EliminationsMember"
      decimals="-3"
      unitRef="USD">-9983000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="AsOf2019-12-31_custom_EliminationsMember"
      decimals="-3"
      unitRef="USD">-8005000</us-gaap:Assets>
    <us-gaap:Assets contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">1145364000</us-gaap:Assets>
    <us-gaap:Assets contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">890145000</us-gaap:Assets>
    <us-gaap:Assets contextRef="AsOf2019-12-31" decimals="-3" unitRef="USD">828832000</us-gaap:Assets>
    <us-gaap:AdditionsToOtherAssetsAmount
      contextRef="From2021-01-012021-12-31_country_US"
      decimals="-3"
      unitRef="USD">2711000</us-gaap:AdditionsToOtherAssetsAmount>
    <us-gaap:AdditionsToOtherAssetsAmount
      contextRef="From2020-01-012020-12-31_country_US"
      decimals="-3"
      unitRef="USD">1004000</us-gaap:AdditionsToOtherAssetsAmount>
    <us-gaap:AdditionsToOtherAssetsAmount
      contextRef="From2019-01-012019-12-31_country_US"
      decimals="-3"
      unitRef="USD">5851000</us-gaap:AdditionsToOtherAssetsAmount>
    <us-gaap:AdditionsToOtherAssetsAmount
      contextRef="From2021-01-012021-12-31_srt_EuropeMember"
      decimals="-3"
      unitRef="USD">138563000</us-gaap:AdditionsToOtherAssetsAmount>
    <us-gaap:AdditionsToOtherAssetsAmount
      contextRef="From2020-01-012020-12-31_srt_EuropeMember"
      decimals="-3"
      unitRef="USD">11259000</us-gaap:AdditionsToOtherAssetsAmount>
    <us-gaap:AdditionsToOtherAssetsAmount
      contextRef="From2019-01-012019-12-31_srt_EuropeMember"
      decimals="-3"
      unitRef="USD">5643000</us-gaap:AdditionsToOtherAssetsAmount>
    <us-gaap:AdditionsToOtherAssetsAmount
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="USD">141274000</us-gaap:AdditionsToOtherAssetsAmount>
    <us-gaap:AdditionsToOtherAssetsAmount
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">12263000</us-gaap:AdditionsToOtherAssetsAmount>
    <us-gaap:AdditionsToOtherAssetsAmount
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="USD">11494000</us-gaap:AdditionsToOtherAssetsAmount>
    <us-gaap:NoncurrentAssets
      contextRef="AsOf2021-12-31_country_US"
      decimals="-3"
      unitRef="USD">63094000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="AsOf2020-12-31_country_US"
      decimals="-3"
      unitRef="USD">40656000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="AsOf2019-12-31_country_US"
      decimals="-3"
      unitRef="USD">44473000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="AsOf2021-12-31_srt_EuropeMember"
      decimals="-3"
      unitRef="USD">334033000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="AsOf2020-12-31_srt_EuropeMember"
      decimals="-3"
      unitRef="USD">217766000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="AsOf2019-12-31_srt_EuropeMember"
      decimals="-3"
      unitRef="USD">196976000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">397127000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">258422000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets contextRef="AsOf2019-12-31" decimals="-3" unitRef="USD">241449000</us-gaap:NoncurrentAssets>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="AsOf2021-12-31_country_US"
      decimals="-3"
      unitRef="USD">870000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="AsOf2020-12-31_country_US"
      decimals="-3"
      unitRef="USD">886000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="AsOf2019-12-31_country_US"
      decimals="-3"
      unitRef="USD">705000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="AsOf2021-12-31_srt_EuropeMember"
      decimals="-3"
      unitRef="USD">7066000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="AsOf2020-12-31_srt_EuropeMember"
      decimals="-3"
      unitRef="USD">7106000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="AsOf2019-12-31_srt_EuropeMember"
      decimals="-3"
      unitRef="USD">7241000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="AsOf2020-12-31_custom_EliminationsMember"
      decimals="-3"
      unitRef="USD">49000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="AsOf2019-12-31_custom_EliminationsMember"
      decimals="-3"
      unitRef="USD">58000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">7936000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">8041000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet contextRef="AsOf2019-12-31" decimals="-3" unitRef="USD">8004000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_89E_eus-gaap--ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_zqqPoAQ24U2i" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;United States export sales were
approximately $&lt;span id="xdx_901_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_dm_c20210101__20211231_zOKOIecfTgs"&gt;126.2 million&lt;/span&gt;, $&lt;span id="xdx_909_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_dm_c20200101__20201231_zgHZ9LnNqMH7"&gt;71.5 million&lt;/span&gt; and $&lt;span id="xdx_900_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20190101__20191231_zmGNh1bB8Dsd"&gt;112.0&lt;/span&gt; million in 2021, 2020 and 2019, respectively. &lt;span id="xdx_8BB_z8EKIkonq9Dc"&gt;Consolidated net sales to
customers by region are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Year ended December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2019&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 55%; text-align: left"&gt;North America&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--Revenues_c20210101__20211231__srt--StatementGeographicalAxis__srt--NorthAmericaMember_zAne2nd7s9qb" style="width: 12%; text-align: right" title="Net sales"&gt;354,100&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--Revenues_c20200101__20201231__srt--StatementGeographicalAxis__srt--NorthAmericaMember_zGLPNa5KiEji" style="width: 12%; text-align: right"&gt;193,500&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--Revenues_c20190101__20191231__srt--StatementGeographicalAxis__srt--NorthAmericaMember_zY4PXJenVjHl" style="width: 12%; text-align: right"&gt;235,500&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Europe&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--Revenues_c20210101__20211231__srt--StatementGeographicalAxis__custom--EuropeCountryMember_z4Kj9Q2LPdmi" style="text-align: right"&gt;271,600&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--Revenues_c20200101__20201231__srt--StatementGeographicalAxis__custom--EuropeCountryMember_z9cC9M7ZndHh" style="text-align: right"&gt;180,200&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--Revenues_c20190101__20191231__srt--StatementGeographicalAxis__custom--EuropeCountryMember_zgb1sHloeFD6" style="text-align: right"&gt;240,800&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Asia&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--Revenues_c20210101__20211231__srt--StatementGeographicalAxis__srt--AsiaMember_zW7Z1YghAqd3" style="text-align: right"&gt;128,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--Revenues_c20200101__20201231__srt--StatementGeographicalAxis__srt--AsiaMember_zRNOQ20XH2E3" style="text-align: right"&gt;79,700&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--Revenues_c20190101__20191231__srt--StatementGeographicalAxis__srt--AsiaMember_zV1AsVZ6BVC7" style="text-align: right"&gt;110,900&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Middle East&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--Revenues_c20210101__20211231__srt--StatementGeographicalAxis__us-gaap--MiddleEastMember_zBqHf1TKVNzl" style="text-align: right"&gt;61,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--Revenues_c20200101__20201231__srt--StatementGeographicalAxis__us-gaap--MiddleEastMember_zPX5D2V6erWl" style="text-align: right"&gt;46,800&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--Revenues_c20190101__20191231__srt--StatementGeographicalAxis__us-gaap--MiddleEastMember_z2SSTGEiiOpk" style="text-align: right"&gt;72,600&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Central and South America&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--Revenues_c20210101__20211231__srt--StatementGeographicalAxis__custom--CentralAndSouthAmericaMember_zQ82bJLnqLmc" style="text-align: right"&gt;56,400&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--Revenues_c20200101__20201231__srt--StatementGeographicalAxis__custom--CentralAndSouthAmericaMember_zaQPC0bZbpRd" style="text-align: right"&gt;32,500&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--Revenues_c20190101__20191231__srt--StatementGeographicalAxis__custom--CentralAndSouthAmericaMember_zug9hg2oF66d" style="text-align: right"&gt;46,200&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Other&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--Revenues_c20210101__20211231__srt--StatementGeographicalAxis__custom--OtherSegmentCountryMember_zTIQ1CRJkQvb" style="border-bottom: Black 1pt solid; text-align: right"&gt;8,400&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--Revenues_c20200101__20201231__srt--StatementGeographicalAxis__custom--OtherSegmentCountryMember_zwuHA6VcULmb" style="border-bottom: Black 1pt solid; text-align: right"&gt;6,300&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--Revenues_c20190101__20191231__srt--StatementGeographicalAxis__custom--OtherSegmentCountryMember_zf5C59wEliX7" style="border-bottom: Black 1pt solid; text-align: right"&gt;7,500&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--Revenues_c20210101__20211231_zuLPyqTHRiEf" style="border-bottom: Black 2pt double; text-align: right"&gt;879,500&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--Revenues_c20200101__20201231_za3KlQTe5Msg" style="border-bottom: Black 2pt double; text-align: right"&gt;539,000&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--Revenues_c20190101__20191231_zdyljZT1FLch" style="border-bottom: Black 2pt double; text-align: right"&gt;713,500&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock>
    <us-gaap:Revenues
      contextRef="From2021-01-012021-12-31_srt_NorthAmericaMember"
      decimals="-3"
      unitRef="USD">354100000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2020-01-012020-12-31_srt_NorthAmericaMember"
      decimals="-3"
      unitRef="USD">193500000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2019-01-012019-12-31_srt_NorthAmericaMember"
      decimals="-3"
      unitRef="USD">235500000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2021-01-012021-12-31_custom_EuropeCountryMember"
      decimals="-3"
      unitRef="USD">271600000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2020-01-012020-12-31_custom_EuropeCountryMember"
      decimals="-3"
      unitRef="USD">180200000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2019-01-012019-12-31_custom_EuropeCountryMember"
      decimals="-3"
      unitRef="USD">240800000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2021-01-012021-12-31_srt_AsiaMember"
      decimals="-3"
      unitRef="USD">128000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2020-01-012020-12-31_srt_AsiaMember"
      decimals="-3"
      unitRef="USD">79700000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2019-01-012019-12-31_srt_AsiaMember"
      decimals="-3"
      unitRef="USD">110900000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2021-01-012021-12-31_us-gaap_MiddleEastMember"
      decimals="-3"
      unitRef="USD">61000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2020-01-012020-12-31_us-gaap_MiddleEastMember"
      decimals="-3"
      unitRef="USD">46800000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2019-01-012019-12-31_us-gaap_MiddleEastMember"
      decimals="-3"
      unitRef="USD">72600000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2021-01-012021-12-31_custom_CentralAndSouthAmericaMember"
      decimals="-3"
      unitRef="USD">56400000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2020-01-012020-12-31_custom_CentralAndSouthAmericaMember"
      decimals="-3"
      unitRef="USD">32500000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2019-01-012019-12-31_custom_CentralAndSouthAmericaMember"
      decimals="-3"
      unitRef="USD">46200000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2021-01-012021-12-31_custom_OtherSegmentCountryMember"
      decimals="-3"
      unitRef="USD">8400000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2020-01-012020-12-31_custom_OtherSegmentCountryMember"
      decimals="-3"
      unitRef="USD">6300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2019-01-012019-12-31_custom_OtherSegmentCountryMember"
      decimals="-3"
      unitRef="USD">7500000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="USD">879500000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">539000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="USD">713500000</us-gaap:Revenues>
    <us-gaap:ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_898_eus-gaap--ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock_zuUa5YDa2a4h" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"&gt;&lt;span id="xdx_8BA_zqXnHQ8BJT6k"&gt;Consolidated net sales to customers in major countries
are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Year Ended December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2019&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 55%; text-align: left"&gt;United States&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20210101__20211231__us-gaap--StatementBusinessSegmentsAxis__custom--UnitedStatesMember_zEKymJV57Qvl" style="width: 12%; text-align: right" title="Revenue from Contract with Customer, Including Assessed Tax"&gt;351,300&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20200101__20201231__us-gaap--StatementBusinessSegmentsAxis__custom--UnitedStatesMember_zxYvGQoLkVMk" style="width: 12%; text-align: right"&gt;187,300&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20190101__20191231__us-gaap--StatementBusinessSegmentsAxis__custom--UnitedStatesMember_ztuDf4UXZh8e" style="width: 12%; text-align: right"&gt;225,300&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;France&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20210101__20211231__us-gaap--StatementBusinessSegmentsAxis__custom--FranceMember_zCRsWORMslv7" style="text-align: right"&gt;44,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20200101__20201231__us-gaap--StatementBusinessSegmentsAxis__custom--FranceMember_zbAfAETODHKk" style="text-align: right"&gt;37,600&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20190101__20191231__us-gaap--StatementBusinessSegmentsAxis__custom--FranceMember_zkP4BXithRv5" style="text-align: right"&gt;43,500&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Russia&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20210101__20211231__us-gaap--StatementBusinessSegmentsAxis__custom--RussiaMember_zcXrJAGJdL37" style="text-align: right"&gt;43,400&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20200101__20201231__us-gaap--StatementBusinessSegmentsAxis__custom--RussiaMember_zYkELQ8N448i" style="text-align: right"&gt;14,100&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20190101__20191231__us-gaap--StatementBusinessSegmentsAxis__custom--RussiaMember_zMwJcPbEQXTj" style="text-align: right"&gt;36,800&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;United Kingdom&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20210101__20211231__us-gaap--StatementBusinessSegmentsAxis__custom--UnitedKingdomMember_z7NvoMSPPB0e" style="text-align: right"&gt;38,500&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20200101__20201231__us-gaap--StatementBusinessSegmentsAxis__custom--UnitedKingdomMember_zmsscOTv6ur1" style="text-align: right"&gt;24,600&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20190101__20191231__us-gaap--StatementBusinessSegmentsAxis__custom--UnitedKingdomMember_zmPhy1xPPQR" style="text-align: right"&gt;35,800&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="From2021-01-012021-12-31_custom_UnitedStatesMember"
      decimals="-3"
      unitRef="USD">351300000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="From2020-01-012020-12-31_custom_UnitedStatesMember"
      decimals="-3"
      unitRef="USD">187300000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="From2019-01-012019-12-31_custom_UnitedStatesMember"
      decimals="-3"
      unitRef="USD">225300000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="From2021-01-012021-12-31_custom_FranceMember"
      decimals="-3"
      unitRef="USD">44000000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="From2020-01-012020-12-31_custom_FranceMember"
      decimals="-3"
      unitRef="USD">37600000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="From2019-01-012019-12-31_custom_FranceMember"
      decimals="-3"
      unitRef="USD">43500000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="From2021-01-012021-12-31_custom_RussiaMember"
      decimals="-3"
      unitRef="USD">43400000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="From2020-01-012020-12-31_custom_RussiaMember"
      decimals="-3"
      unitRef="USD">14100000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="From2019-01-012019-12-31_custom_RussiaMember"
      decimals="-3"
      unitRef="USD">36800000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="From2021-01-012021-12-31_custom_UnitedKingdomMember"
      decimals="-3"
      unitRef="USD">38500000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="From2020-01-012020-12-31_custom_UnitedKingdomMember"
      decimals="-3"
      unitRef="USD">24600000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="From2019-01-012019-12-31_custom_UnitedKingdomMember"
      decimals="-3"
      unitRef="USD">35800000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_80D_eus-gaap--IncomeTaxDisclosureTextBlock_zBeljCq3QZd5" style="margin-top: 0; margin-bottom: 0"/&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;(16)&lt;/td&gt;&lt;td&gt;&lt;span id="xdx_829_zi73uunWhwN8"&gt;Income Taxes&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Company and its subsidiaries
file income tax returns in the U.S. federal, and various states and foreign jurisdictions.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Company assessed its uncertain
tax positions and determined that it has no material uncertain tax position at December 31, 2021.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_89C_eus-gaap--ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_zP7KWJTx3xN4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span id="xdx_8B8_zek4eMr6vwDe"&gt;The components of income before
income taxes consist of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Year ended December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2019&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 55%; text-align: left"&gt;U.S. operations&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_c20210101__20211231_zzpNfdpkgazi" style="width: 12%; text-align: right" title="U.S. operations"&gt;34,742&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_c20200101__20201231_zGARqmS1frAk" style="width: 12%; text-align: right" title="U.S. operations"&gt;9,577&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_c20190101__20191231_zQnEOBvTAa7i" style="width: 12%; text-align: right" title="U.S. operations"&gt;23,384&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Foreign operations&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_c20210101__20211231_zRdQmkhIgTYa" style="border-bottom: Black 1pt solid; text-align: right" title="Foreign operations"&gt;116,277&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_c20200101__20201231_z51CEqt2q3F9" style="border-bottom: Black 1pt solid; text-align: right" title="Foreign operations"&gt;59,772&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_c20190101__20191231_zIeZ60GanUl9" style="border-bottom: Black 1pt solid; text-align: right" title="Foreign operations"&gt;81,762&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_dxL_c20210101__20211231_zrOnVOV5dMj8" style="border-bottom: Black 2pt double; text-align: right" title="Income before income taxes::XDX::151%2C019"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1662"&gt;151,019&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_c20200101__20201231_z3T85frJ6MZ8" style="border-bottom: Black 2pt double; text-align: right" title="Income before income taxes"&gt;69,349&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_c20190101__20191231_zXCUYLNbH8Ei" style="border-bottom: Black 2pt double; text-align: right" title="Income before income taxes"&gt;105,146&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A9_zWk3IgxaIIF5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&#160;&lt;/p&gt;







&lt;p id="xdx_00A" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_896_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zUGiZ2T49aRh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span id="xdx_8BA_zwqhkU3uzkwj"&gt;The provision for current and
deferred income tax expense (benefit) consists of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="color: Black"&gt;Year
    ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="color: Black"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="color: Black"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="color: Black"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="color: Black"&gt;Current:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 55%; padding-left: 0.125in"&gt;&lt;span style="color: Black"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--CurrentFederalTaxExpenseBenefit_c20210101__20211231_zyccVXsRAWgb" style="width: 12%; text-align: right" title="Federal"&gt;&lt;span style="color: Black"&gt;4,825&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--CurrentFederalTaxExpenseBenefit_c20200101__20201231_zQoZuV1w3Dt3" style="width: 12%; text-align: right" title="Federal"&gt;&lt;span style="color: Black"&gt;1,685&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--CurrentFederalTaxExpenseBenefit_c20190101__20191231_zYITiginS8Pj" style="width: 12%; text-align: right" title="Federal"&gt;&lt;span style="color: Black"&gt;3,280&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.125in"&gt;&lt;span style="color: Black"&gt;State and local&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_c20210101__20211231_zeZQt1nhP2qf" style="text-align: right" title="State and local"&gt;&lt;span style="color: Black"&gt;518&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_c20200101__20201231_zIJtWwL6AOM1" style="text-align: right" title="State and local"&gt;&lt;span style="color: Black"&gt;90&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_c20190101__20191231_zuaogGZmmemj" style="text-align: right" title="State and local"&gt;&lt;span style="color: Black"&gt;713&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 0.125in"&gt;&lt;span style="color: Black"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--CurrentForeignTaxExpenseBenefit_c20210101__20211231_zl83A7KS5Ufe" style="border-bottom: Black 1pt solid; text-align: right" title="Foreign"&gt;&lt;span style="color: Black"&gt;36,164&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--CurrentForeignTaxExpenseBenefit_c20200101__20201231_zkZBFCc887yb" style="border-bottom: Black 1pt solid; text-align: right" title="Foreign"&gt;&lt;span style="color: Black"&gt;17,024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--CurrentForeignTaxExpenseBenefit_c20190101__20191231_zQAipynMaS1f" style="border-bottom: Black 1pt solid; text-align: right" title="Foreign"&gt;&lt;span style="color: Black"&gt;27,412&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 0.125in"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--CurrentIncomeTaxExpenseBenefit_c20210101__20211231_zeEvwTxGaul2" style="border-bottom: Black 1pt solid; text-align: right" title="Current income tax expense"&gt;&lt;span style="color: Black"&gt;41,507&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--CurrentIncomeTaxExpenseBenefit_c20200101__20201231_zB7H8NO70fik" style="border-bottom: Black 1pt solid; text-align: right" title="Current income tax expense"&gt;&lt;span style="color: Black"&gt;18,799&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--CurrentIncomeTaxExpenseBenefit_c20190101__20191231_zBWsVBhDhPxd" style="border-bottom: Black 1pt solid; text-align: right" title="Current income tax expense"&gt;&lt;span style="color: Black"&gt;31,405&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0in"&gt;&lt;span style="color: Black"&gt;Deferred:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in"&gt;&lt;span style="color: Black"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_c20210101__20211231_ze6HlfWY8uA8" style="text-align: right" title="Federal"&gt;&lt;span style="color: Black"&gt;4&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #FF0000"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="color: #FF0000; text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_c20200101__20201231_zUhelWURYQZc" style="color: #FF0000; text-align: right" title="Federal"&gt;&lt;span style="color: Black"&gt;(215&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #FF0000; text-align: left"&gt;&lt;span style="color: Black"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #FF0000"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="color: #FF0000; text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_c20190101__20191231_ziUn6oUD2Zyj" style="color: #FF0000; text-align: right" title="Federal"&gt;&lt;span style="color: Black"&gt;(3&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #FF0000; text-align: left"&gt;&lt;span style="color: Black"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0.125in"&gt;&lt;span style="color: Black"&gt;State and local&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_c20210101__20211231_zd2QCvpKnETk" style="text-align: right" title="State and local"&gt;&lt;span style="color: Black"&gt;11&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_c20200101__20201231_zFRLVE8qtbpg" style="text-align: right" title="State and local"&gt;&lt;span style="color: Black"&gt;44&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #FF0000"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="color: #FF0000; text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_c20190101__20191231_zyiKjpMXNJpf" style="color: #FF0000; text-align: right" title="State and local"&gt;&lt;span style="color: Black"&gt;(22&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #FF0000; text-align: left"&gt;&lt;span style="color: Black"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 0.125in"&gt;&lt;span style="color: Black"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #FF0000; padding-bottom: 1pt"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #FF0000; text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--DeferredForeignIncomeTaxExpenseBenefit_c20210101__20211231_ziURehu430v9" style="border-bottom: Black 1pt solid; color: #FF0000; text-align: right" title="Foreign"&gt;&lt;span style="color: Black"&gt;(530&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; color: #FF0000; text-align: left"&gt;&lt;span style="color: Black"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--DeferredForeignIncomeTaxExpenseBenefit_c20200101__20201231_zop73MEig7uh" style="border-bottom: Black 1pt solid; text-align: right" title="Foreign"&gt;&lt;span style="color: Black"&gt;753&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #FF0000; padding-bottom: 1pt"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #FF0000; text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--DeferredForeignIncomeTaxExpenseBenefit_c20190101__20191231_z8JMNNKenST5" style="border-bottom: Black 1pt solid; color: #FF0000; text-align: right" title="Foreign"&gt;&lt;span style="color: Black"&gt;(2,304&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; color: #FF0000; text-align: left"&gt;&lt;span style="color: Black"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 0.125in"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #FF0000; padding-bottom: 1pt"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #FF0000; text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--DeferredIncomeTaxesAndTaxCredits_c20210101__20211231_z5wYD0xIO3L2" style="border-bottom: Black 1pt solid; color: #FF0000; text-align: right" title="Deferred income tax expense"&gt;&lt;span style="color: Black"&gt;(515&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; color: #FF0000; text-align: left"&gt;&lt;span style="color: Black"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--DeferredIncomeTaxesAndTaxCredits_c20200101__20201231_zBOX09o1nzye" style="border-bottom: Black 1pt solid; text-align: right" title="Deferred income tax expense"&gt;&lt;span style="color: Black"&gt;582&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #FF0000; padding-bottom: 1pt"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #FF0000; text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--DeferredIncomeTaxesAndTaxCredits_c20190101__20191231_zysV537hiDga" style="border-bottom: Black 1pt solid; color: #FF0000; text-align: right" title="Deferred income tax expense"&gt;&lt;span style="color: Black"&gt;(2,329&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; color: #FF0000; text-align: left"&gt;&lt;span style="color: Black"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2pt; padding-left: 0.25in"&gt;&lt;span style="color: Black"&gt;Total income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; text-align: left"&gt;&lt;span style="color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--IncomeTaxExpenseBenefit_c20210101__20211231_zYRwkxqLQOXc" style="border-bottom: Black 2pt double; text-align: right" title="Total income tax expense"&gt;&lt;span style="color: Black"&gt;40,992&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; text-align: left"&gt;&lt;span style="color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--IncomeTaxExpenseBenefit_c20200101__20201231_zxFb4ctKogba" style="border-bottom: Black 2pt double; text-align: right" title="Total income tax expense"&gt;&lt;span style="color: Black"&gt;19,381&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; text-align: left"&gt;&lt;span style="color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--IncomeTaxExpenseBenefit_c20190101__20191231_zkeNHgSLd1P2" style="border-bottom: Black 2pt double; text-align: right" title="Total income tax expense"&gt;&lt;span style="color: Black"&gt;29,076&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;



&lt;p id="xdx_8AB_zYpwPMqPmny1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_897_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_z8HkKCVmb7g4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span id="xdx_8B2_zHg3EdUCGBhc"&gt;The tax effects of temporary
differences that give rise to significant portions of the deferred tax assets and deferred tax liabilities are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="color: Black"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_499_20211231_zi4394cUJWsb" style="color: Black; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_490_20201231_zkjjpzRc39bb" style="color: Black; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="color: Black"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="color: Black; font-weight: bold; text-align: center"&gt;December 31,&lt;/td&gt;&lt;td style="color: Black; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="color: Black"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; color: Black; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1pt; color: Black; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; color: Black; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1pt; color: Black; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_eus-gaap--DeferredTaxAssetsNetAbstract_iB_zK1nWOL8gmL2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="color: Black; text-align: left"&gt;Net deferred tax assets:&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsForeign_iI_maDTAGzmCT_zmRBKDLHHch3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 70%; color: Black; text-align: left; padding-left: 0.125in"&gt;Foreign net operating loss carry-forwards&lt;/td&gt;&lt;td style="width: 1%; color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: Black; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; color: Black; text-align: right"&gt;1,292&lt;/td&gt;&lt;td style="width: 1%; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: Black; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; color: Black; text-align: right"&gt;360&lt;/td&gt;&lt;td style="width: 1%; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40F_ecustom--DeferredTaxAssetsInventoryAndAccountsReceivable_maDTAGzmCT_z1s4JlqTUHm6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="color: Black; text-align: left; padding-left: 0.125in"&gt;Inventory and accounts receivable&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: right"&gt;4,508&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: right"&gt;1,928&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_eus-gaap--DeferredTaxAssetsDeferredIncome_iI_maDTAGzmCT_zhDcLYc2jnL1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="color: Black; text-align: left; padding-left: 0.125in"&gt;Profit sharing&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: right"&gt;3,787&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: right"&gt;2,936&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_400_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_iI_maDTAGzmCT_zNImAMKYjB2c" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="color: Black; text-align: left; padding-left: 0.125in"&gt;Stock option compensation&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: right"&gt;732&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: right"&gt;718&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_eus-gaap--DeferredTaxAssetsInventory_iI_maDTAGzmCT_z9f3UtCJGMCk" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="color: Black; text-align: left; padding-left: 0.125in"&gt;Effect of inventory profit elimination&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: right"&gt;5,112&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: right"&gt;4,443&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_408_eus-gaap--DeferredTaxAssetsOther_iI_maDTAGzmCT_z1TnN3770nd4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="color: Black; padding-bottom: 1pt; padding-left: 0.125in"&gt;Other&lt;/td&gt;&lt;td style="color: Black; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: Black; text-align: right"&gt;407&lt;/td&gt;&lt;td style="padding-bottom: 1pt; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: Black; text-align: right"&gt;910&lt;/td&gt;&lt;td style="padding-bottom: 1pt; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_402_eus-gaap--DeferredTaxAssetsGross_iTI_mtDTAGzmCT_maDTANzIZJ_zghQxM5cOPla" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="color: Black; text-align: left; padding-left: 0.25in"&gt;Total gross deferred tax assets, net&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: right"&gt;15,838&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: right"&gt;11,295&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_408_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_di_msDTANzIZJ_zETuZe2V2e2j" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="color: Black; text-align: left; padding-bottom: 1pt; padding-left: 0.25in"&gt;Valuation allowance&lt;/td&gt;&lt;td style="color: Black; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: Black; text-align: right"&gt;(3,582&lt;/td&gt;&lt;td style="padding-bottom: 1pt; color: Black; text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: Black; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: Black; text-align: right"&gt;(360&lt;/td&gt;&lt;td style="padding-bottom: 1pt; color: Black; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40A_eus-gaap--DeferredTaxAssetsNet_iTI_mtDTANzIZJ_zGngeMWftMQd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="color: Black; text-align: left; padding-bottom: 1pt; padding-left: 0.25in"&gt;Net deferred tax assets&lt;/td&gt;&lt;td style="color: Black; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: Black; text-align: right"&gt;12,256&lt;/td&gt;&lt;td style="padding-bottom: 1pt; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: Black; text-align: right"&gt;10,935&lt;/td&gt;&lt;td style="padding-bottom: 1pt; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_eus-gaap--DeferredTaxLiabilitiesNetAbstract_iB_z5kogWajN939" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="color: Black; text-align: left"&gt;Deferred tax liabilities (long-term):&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_ecustom--DeferredTaxLiabilitiesBuildingExpenses_i01I_zsHnfG6XNNjj" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="color: Black; text-align: left; padding-left: 0.125in"&gt;Building expenses&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: right"&gt;(1,082&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1764"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_eus-gaap--DeferredTaxLiabilitiesOtherFiniteLivedAssets_i01NI_di_zSa24pNuTUQh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="color: Black; text-align: left; padding-left: 0.125in"&gt;Trademarks and licenses&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: right"&gt;(2,551&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: right"&gt;(2,894&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40B_ecustom--DeferredTaxLiabilitiesUnrealizedGainOnMarketableEquitySecurities_i01I_zebaeX8IqmS" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="color: Black; text-align: left; padding-left: 0.125in"&gt;Unrealized gain on marketable equity securities&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: right"&gt;(436&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1770"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_eus-gaap--DeferredTaxLiabilitiesOther_i01I_zdjodKSLJgG6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="color: Black; padding-bottom: 1pt; padding-left: 0.125in"&gt;Other&lt;/td&gt;&lt;td style="color: Black; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: Black; text-align: right"&gt;(251&lt;/td&gt;&lt;td style="padding-bottom: 1pt; color: Black; text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: Black; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: Black; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1773"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_400_eus-gaap--DeferredIncomeTaxLiabilities_i01NI_di_zd5vwLFRfw42" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="color: Black; text-align: left; padding-bottom: 1pt; padding-left: 0.25in"&gt;Total deferred tax liabilities&lt;/td&gt;&lt;td style="color: Black; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: Black; text-align: right"&gt;(4,320&lt;/td&gt;&lt;td style="padding-bottom: 1pt; color: Black; text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: Black; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: Black; text-align: right"&gt;(2,894&lt;/td&gt;&lt;td style="padding-bottom: 1pt; color: Black; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_407_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iI_zL18h8AAz5ue" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="color: Black; text-align: left; padding-bottom: 2pt; padding-left: 0.25in"&gt;Net deferred tax assets&lt;/td&gt;&lt;td style="color: Black; padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; color: Black; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2pt double; color: Black; text-align: right"&gt;7,936&lt;/td&gt;&lt;td style="padding-bottom: 2pt; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; color: Black; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2pt double; color: Black; text-align: right"&gt;8,041&lt;/td&gt;&lt;td style="padding-bottom: 2pt; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;



&lt;p id="xdx_8A0_zTf7XmPVN5Q5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Valuation allowances have been
provided for deferred tax assets relating to foreign net operating loss carry-forwards and reserves acquired in connection with
the acquisition of Interparfums Italia srl, as future profitable operations from certain foreign subsidiaries might not be sufficient
to realize the full amount of the deferred tax assets.&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;INTER PARFUMS, INC. AND SUBSIDIARIES&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;Notes to Consolidated Financial Statements&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;December 31, 2021, 2020 and 2019&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;(In thousands except share and per share data)&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;No other valuation allowances
have been provided as management believes that it is more likely than not that the asset will be realized in the reduction of future
taxable income.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Company estimated of the
effect of global intangible low-taxed income (&#x201c;GILTI&#x201d;) and has determined that it has no tax liability related to
GILTI as of December 31, 2021, 2020 and 2019. The Company also estimated the effect of foreign derived intangible income (&#x201c;FDII&#x201d;)
and recorded a tax benefit of approximately $&lt;span id="xdx_90B_eus-gaap--DeferredForeignIncomeTaxExpenseBenefit_dm_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ForeignDerivedIntangibleIncomeMember_zePfhbys0nCd"&gt;0.9 million&lt;/span&gt;, $&lt;span id="xdx_90C_eus-gaap--DeferredForeignIncomeTaxExpenseBenefit_dm_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ForeignDerivedIntangibleIncomeMember_zwK5bpy5kvgk"&gt;0.3 million&lt;/span&gt; and $&lt;span id="xdx_909_eus-gaap--DeferredForeignIncomeTaxExpenseBenefit_dm_c20190101__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ForeignDerivedIntangibleIncomeMember_zexQD05FbtX4"&gt;0.9 million&lt;/span&gt; as of December&#160;31, 2021, 2020 and
2019, respectively.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;French Tax Settlement&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The French authorities had considered
that the existence of IP Suisse, a wholly-owned subsidiary of Interparfums SA, does not, in and of itself, constitute a permanent
establishment and therefore Interparfums, SA should pay French taxes on all or part of the profits of that entity. In June 2021,
a global settlement agreement was reached with the French Tax Authority whereby Interparfums SA paid in December 2021, &#x20ac;2.5
million (approximately $2.9 million) effectively lowering the Lanvin brand royalty rate charged by IP Suisse for the periods from
2017 through 2020. Interparfums SA also agreed to apply the lower rate in 2021 through 2025 and to transfer the Lanvin brand from
IP Suisse to Interparfums, SA by December 31, 2025.&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Company is no longer subject
to U.S. federal, state, and local income tax examinations by tax authorities for years before 2017.&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_89F_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zuxB3yl6LAej" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span id="xdx_8BC_zKFhEewEOfMj"&gt;Differences between the United
States federal statutory income tax rate and the effective income tax rate were as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="color: Black"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: Black; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49B_20210101__20211231_zKfaQdCfQ1tj" style="border-bottom: Black 1pt solid; color: Black; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: Black; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: Black; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: Black; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_498_20200101__20201231_zCryRnAsh2Gc" style="border-bottom: Black 1pt solid; color: Black; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: Black; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: Black; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: Black; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49A_20190101__20191231_zzD1b1MT4mt6" style="border-bottom: Black 1pt solid; color: Black; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; color: Black; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="color: Black"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; color: Black; font-weight: bold; text-align: center"&gt;Year ended December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; color: Black; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="color: Black"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; color: Black; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1pt; color: Black; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; color: Black; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1pt; color: Black; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; color: Black; font-weight: bold; text-align: center"&gt;2019&lt;/td&gt;&lt;td style="padding-bottom: 1pt; color: Black; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40F_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_uPure_zUn273ToAdQi" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 55%; color: Black; text-align: left"&gt;Statutory rates&lt;/td&gt;&lt;td style="width: 1%; color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; color: Black; text-align: right"&gt;21.0&lt;/td&gt;&lt;td style="width: 1%; color: Black; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 1%; color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; color: Black; text-align: right"&gt;21.0&lt;/td&gt;&lt;td style="width: 1%; color: Black; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 1%; color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; color: Black; text-align: right"&gt;21.0&lt;/td&gt;&lt;td style="width: 1%; color: Black; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_pid_dp_uPure_z3TsOQpSz64d" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="color: Black; text-align: left"&gt;State and local taxes, net of Federal benefit&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: right"&gt;0.3&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: right"&gt;0.2&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: right"&gt;0.6&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_eus-gaap--EffectiveIncomeTaxRateReconciliationDeductionsEmployeeStockOwnershipPlanDividends_pid_dp_uPure_zsvSNwGdE5Yg" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="color: Black; text-align: left"&gt;Windfall benefit from exercise of stock options&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: right"&gt;(0.9&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: right"&gt;(0.6&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: right"&gt;(0.7&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_407_eus-gaap--EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_pid_dp_uPure_zQNyQrvXODyf" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="color: Black; text-align: left"&gt;Benefit of Foreign Derived Intangible Income&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: right"&gt;(0.6&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: right"&gt;(0.4&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: right"&gt;(0.9&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="color: Black; text-align: left"&gt;Effect of foreign taxes greater than&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_408_ecustom--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate1_pid_dp_uPure_z0tNlUfNQ9Yk" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="color: Black; text-align: left; padding-left: 0.125in"&gt;U.S. statutory rates&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: right"&gt;7.4&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: right"&gt;7.5&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: right"&gt;7.5&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_402_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherAdjustments_pid_dp_zswJ8pulXbZ7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="color: Black; padding-bottom: 1pt"&gt;Other&lt;/td&gt;&lt;td style="color: Black; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: Black; text-align: right"&gt;(0.1&lt;/td&gt;&lt;td style="padding-bottom: 1pt; color: Black; text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: Black; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: Black; text-align: right"&gt;0.2&lt;/td&gt;&lt;td style="padding-bottom: 1pt; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: Black; text-align: right"&gt;0.1&lt;/td&gt;&lt;td style="padding-bottom: 1pt; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_401_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_pid_dp_zZMCFfSnrETc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="color: Black; text-align: left; padding-bottom: 2pt; padding-left: 0.25in"&gt;Effective rates&lt;/td&gt;&lt;td style="color: Black; padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2pt double; color: Black; text-align: right"&gt;27.1&lt;/td&gt;&lt;td style="padding-bottom: 2pt; color: Black; text-align: left"&gt;%&lt;/td&gt;&lt;td style="color: Black; padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2pt double; color: Black; text-align: right"&gt;27.9&lt;/td&gt;&lt;td style="padding-bottom: 2pt; color: Black; text-align: left"&gt;%&lt;/td&gt;&lt;td style="color: Black; padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2pt double; color: Black; text-align: right"&gt;27.6&lt;/td&gt;&lt;td style="padding-bottom: 2pt; color: Black; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;



&lt;p id="xdx_8AB_zdd6uejOfoTi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;INTER PARFUMS, INC. AND SUBSIDIARIES&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;Notes to Consolidated Financial Statements&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;December 31, 2021, 2020 and 2019&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;(In thousands except share and per share data)&lt;/p&gt;

</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_89C_eus-gaap--ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_zP7KWJTx3xN4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span id="xdx_8B8_zek4eMr6vwDe"&gt;The components of income before
income taxes consist of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Year ended December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2019&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 55%; text-align: left"&gt;U.S. operations&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_c20210101__20211231_zzpNfdpkgazi" style="width: 12%; text-align: right" title="U.S. operations"&gt;34,742&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_c20200101__20201231_zGARqmS1frAk" style="width: 12%; text-align: right" title="U.S. operations"&gt;9,577&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_c20190101__20191231_zQnEOBvTAa7i" style="width: 12%; text-align: right" title="U.S. operations"&gt;23,384&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Foreign operations&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_c20210101__20211231_zRdQmkhIgTYa" style="border-bottom: Black 1pt solid; text-align: right" title="Foreign operations"&gt;116,277&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_c20200101__20201231_z51CEqt2q3F9" style="border-bottom: Black 1pt solid; text-align: right" title="Foreign operations"&gt;59,772&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_c20190101__20191231_zIeZ60GanUl9" style="border-bottom: Black 1pt solid; text-align: right" title="Foreign operations"&gt;81,762&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_dxL_c20210101__20211231_zrOnVOV5dMj8" style="border-bottom: Black 2pt double; text-align: right" title="Income before income taxes::XDX::151%2C019"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1662"&gt;151,019&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_c20200101__20201231_z3T85frJ6MZ8" style="border-bottom: Black 2pt double; text-align: right" title="Income before income taxes"&gt;69,349&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_c20190101__20191231_zXCUYLNbH8Ei" style="border-bottom: Black 2pt double; text-align: right" title="Income before income taxes"&gt;105,146&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="USD">34742000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">9577000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="USD">23384000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="USD">116277000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">59772000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="USD">81762000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">69349000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="USD">105146000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_896_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zUGiZ2T49aRh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span id="xdx_8BA_zwqhkU3uzkwj"&gt;The provision for current and
deferred income tax expense (benefit) consists of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="color: Black"&gt;Year
    ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="color: Black"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="color: Black"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="color: Black"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="color: Black"&gt;Current:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 55%; padding-left: 0.125in"&gt;&lt;span style="color: Black"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--CurrentFederalTaxExpenseBenefit_c20210101__20211231_zyccVXsRAWgb" style="width: 12%; text-align: right" title="Federal"&gt;&lt;span style="color: Black"&gt;4,825&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--CurrentFederalTaxExpenseBenefit_c20200101__20201231_zQoZuV1w3Dt3" style="width: 12%; text-align: right" title="Federal"&gt;&lt;span style="color: Black"&gt;1,685&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--CurrentFederalTaxExpenseBenefit_c20190101__20191231_zYITiginS8Pj" style="width: 12%; text-align: right" title="Federal"&gt;&lt;span style="color: Black"&gt;3,280&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.125in"&gt;&lt;span style="color: Black"&gt;State and local&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_c20210101__20211231_zeZQt1nhP2qf" style="text-align: right" title="State and local"&gt;&lt;span style="color: Black"&gt;518&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_c20200101__20201231_zIJtWwL6AOM1" style="text-align: right" title="State and local"&gt;&lt;span style="color: Black"&gt;90&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_c20190101__20191231_zuaogGZmmemj" style="text-align: right" title="State and local"&gt;&lt;span style="color: Black"&gt;713&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 0.125in"&gt;&lt;span style="color: Black"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--CurrentForeignTaxExpenseBenefit_c20210101__20211231_zl83A7KS5Ufe" style="border-bottom: Black 1pt solid; text-align: right" title="Foreign"&gt;&lt;span style="color: Black"&gt;36,164&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--CurrentForeignTaxExpenseBenefit_c20200101__20201231_zkZBFCc887yb" style="border-bottom: Black 1pt solid; text-align: right" title="Foreign"&gt;&lt;span style="color: Black"&gt;17,024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--CurrentForeignTaxExpenseBenefit_c20190101__20191231_zQAipynMaS1f" style="border-bottom: Black 1pt solid; text-align: right" title="Foreign"&gt;&lt;span style="color: Black"&gt;27,412&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 0.125in"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--CurrentIncomeTaxExpenseBenefit_c20210101__20211231_zeEvwTxGaul2" style="border-bottom: Black 1pt solid; text-align: right" title="Current income tax expense"&gt;&lt;span style="color: Black"&gt;41,507&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--CurrentIncomeTaxExpenseBenefit_c20200101__20201231_zB7H8NO70fik" style="border-bottom: Black 1pt solid; text-align: right" title="Current income tax expense"&gt;&lt;span style="color: Black"&gt;18,799&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--CurrentIncomeTaxExpenseBenefit_c20190101__20191231_zBWsVBhDhPxd" style="border-bottom: Black 1pt solid; text-align: right" title="Current income tax expense"&gt;&lt;span style="color: Black"&gt;31,405&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0in"&gt;&lt;span style="color: Black"&gt;Deferred:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in"&gt;&lt;span style="color: Black"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_c20210101__20211231_ze6HlfWY8uA8" style="text-align: right" title="Federal"&gt;&lt;span style="color: Black"&gt;4&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #FF0000"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="color: #FF0000; text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_c20200101__20201231_zUhelWURYQZc" style="color: #FF0000; text-align: right" title="Federal"&gt;&lt;span style="color: Black"&gt;(215&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #FF0000; text-align: left"&gt;&lt;span style="color: Black"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #FF0000"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="color: #FF0000; text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_c20190101__20191231_ziUn6oUD2Zyj" style="color: #FF0000; text-align: right" title="Federal"&gt;&lt;span style="color: Black"&gt;(3&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #FF0000; text-align: left"&gt;&lt;span style="color: Black"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0.125in"&gt;&lt;span style="color: Black"&gt;State and local&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_c20210101__20211231_zd2QCvpKnETk" style="text-align: right" title="State and local"&gt;&lt;span style="color: Black"&gt;11&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_c20200101__20201231_zFRLVE8qtbpg" style="text-align: right" title="State and local"&gt;&lt;span style="color: Black"&gt;44&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #FF0000"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="color: #FF0000; text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_c20190101__20191231_zyiKjpMXNJpf" style="color: #FF0000; text-align: right" title="State and local"&gt;&lt;span style="color: Black"&gt;(22&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #FF0000; text-align: left"&gt;&lt;span style="color: Black"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 0.125in"&gt;&lt;span style="color: Black"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #FF0000; padding-bottom: 1pt"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #FF0000; text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--DeferredForeignIncomeTaxExpenseBenefit_c20210101__20211231_ziURehu430v9" style="border-bottom: Black 1pt solid; color: #FF0000; text-align: right" title="Foreign"&gt;&lt;span style="color: Black"&gt;(530&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; color: #FF0000; text-align: left"&gt;&lt;span style="color: Black"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--DeferredForeignIncomeTaxExpenseBenefit_c20200101__20201231_zop73MEig7uh" style="border-bottom: Black 1pt solid; text-align: right" title="Foreign"&gt;&lt;span style="color: Black"&gt;753&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #FF0000; padding-bottom: 1pt"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #FF0000; text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--DeferredForeignIncomeTaxExpenseBenefit_c20190101__20191231_z8JMNNKenST5" style="border-bottom: Black 1pt solid; color: #FF0000; text-align: right" title="Foreign"&gt;&lt;span style="color: Black"&gt;(2,304&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; color: #FF0000; text-align: left"&gt;&lt;span style="color: Black"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 0.125in"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #FF0000; padding-bottom: 1pt"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #FF0000; text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--DeferredIncomeTaxesAndTaxCredits_c20210101__20211231_z5wYD0xIO3L2" style="border-bottom: Black 1pt solid; color: #FF0000; text-align: right" title="Deferred income tax expense"&gt;&lt;span style="color: Black"&gt;(515&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; color: #FF0000; text-align: left"&gt;&lt;span style="color: Black"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--DeferredIncomeTaxesAndTaxCredits_c20200101__20201231_zBOX09o1nzye" style="border-bottom: Black 1pt solid; text-align: right" title="Deferred income tax expense"&gt;&lt;span style="color: Black"&gt;582&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #FF0000; padding-bottom: 1pt"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #FF0000; text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--DeferredIncomeTaxesAndTaxCredits_c20190101__20191231_zysV537hiDga" style="border-bottom: Black 1pt solid; color: #FF0000; text-align: right" title="Deferred income tax expense"&gt;&lt;span style="color: Black"&gt;(2,329&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; color: #FF0000; text-align: left"&gt;&lt;span style="color: Black"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2pt; padding-left: 0.25in"&gt;&lt;span style="color: Black"&gt;Total income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; text-align: left"&gt;&lt;span style="color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--IncomeTaxExpenseBenefit_c20210101__20211231_zYRwkxqLQOXc" style="border-bottom: Black 2pt double; text-align: right" title="Total income tax expense"&gt;&lt;span style="color: Black"&gt;40,992&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; text-align: left"&gt;&lt;span style="color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--IncomeTaxExpenseBenefit_c20200101__20201231_zxFb4ctKogba" style="border-bottom: Black 2pt double; text-align: right" title="Total income tax expense"&gt;&lt;span style="color: Black"&gt;19,381&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; text-align: left"&gt;&lt;span style="color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--IncomeTaxExpenseBenefit_c20190101__20191231_zkeNHgSLd1P2" style="border-bottom: Black 2pt double; text-align: right" title="Total income tax expense"&gt;&lt;span style="color: Black"&gt;29,076&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;



</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="USD">4825000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">1685000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="USD">3280000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="USD">518000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">90000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="USD">713000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="USD">36164000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">17024000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="USD">27412000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="USD">41507000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">18799000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="USD">31405000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="USD">4000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">-215000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="USD">-3000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="USD">11000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">44000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="USD">-22000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="USD">-530000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">753000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="USD">-2304000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxesAndTaxCredits
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="USD">-515000</us-gaap:DeferredIncomeTaxesAndTaxCredits>
    <us-gaap:DeferredIncomeTaxesAndTaxCredits
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">582000</us-gaap:DeferredIncomeTaxesAndTaxCredits>
    <us-gaap:DeferredIncomeTaxesAndTaxCredits
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="USD">-2329000</us-gaap:DeferredIncomeTaxesAndTaxCredits>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="USD">40992000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">19381000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="USD">29076000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_897_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_z8HkKCVmb7g4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span id="xdx_8B2_zHg3EdUCGBhc"&gt;The tax effects of temporary
differences that give rise to significant portions of the deferred tax assets and deferred tax liabilities are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="color: Black"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_499_20211231_zi4394cUJWsb" style="color: Black; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_490_20201231_zkjjpzRc39bb" style="color: Black; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="color: Black"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="color: Black; font-weight: bold; text-align: center"&gt;December 31,&lt;/td&gt;&lt;td style="color: Black; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="color: Black"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; color: Black; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1pt; color: Black; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; color: Black; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1pt; color: Black; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_eus-gaap--DeferredTaxAssetsNetAbstract_iB_zK1nWOL8gmL2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="color: Black; text-align: left"&gt;Net deferred tax assets:&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsForeign_iI_maDTAGzmCT_zmRBKDLHHch3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 70%; color: Black; text-align: left; padding-left: 0.125in"&gt;Foreign net operating loss carry-forwards&lt;/td&gt;&lt;td style="width: 1%; color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: Black; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; color: Black; text-align: right"&gt;1,292&lt;/td&gt;&lt;td style="width: 1%; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: Black; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; color: Black; text-align: right"&gt;360&lt;/td&gt;&lt;td style="width: 1%; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40F_ecustom--DeferredTaxAssetsInventoryAndAccountsReceivable_maDTAGzmCT_z1s4JlqTUHm6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="color: Black; text-align: left; padding-left: 0.125in"&gt;Inventory and accounts receivable&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: right"&gt;4,508&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: right"&gt;1,928&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_eus-gaap--DeferredTaxAssetsDeferredIncome_iI_maDTAGzmCT_zhDcLYc2jnL1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="color: Black; text-align: left; padding-left: 0.125in"&gt;Profit sharing&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: right"&gt;3,787&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: right"&gt;2,936&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_400_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_iI_maDTAGzmCT_zNImAMKYjB2c" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="color: Black; text-align: left; padding-left: 0.125in"&gt;Stock option compensation&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: right"&gt;732&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: right"&gt;718&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_eus-gaap--DeferredTaxAssetsInventory_iI_maDTAGzmCT_z9f3UtCJGMCk" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="color: Black; text-align: left; padding-left: 0.125in"&gt;Effect of inventory profit elimination&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: right"&gt;5,112&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: right"&gt;4,443&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_408_eus-gaap--DeferredTaxAssetsOther_iI_maDTAGzmCT_z1TnN3770nd4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="color: Black; padding-bottom: 1pt; padding-left: 0.125in"&gt;Other&lt;/td&gt;&lt;td style="color: Black; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: Black; text-align: right"&gt;407&lt;/td&gt;&lt;td style="padding-bottom: 1pt; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: Black; text-align: right"&gt;910&lt;/td&gt;&lt;td style="padding-bottom: 1pt; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_402_eus-gaap--DeferredTaxAssetsGross_iTI_mtDTAGzmCT_maDTANzIZJ_zghQxM5cOPla" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="color: Black; text-align: left; padding-left: 0.25in"&gt;Total gross deferred tax assets, net&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: right"&gt;15,838&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: right"&gt;11,295&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_408_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_di_msDTANzIZJ_zETuZe2V2e2j" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="color: Black; text-align: left; padding-bottom: 1pt; padding-left: 0.25in"&gt;Valuation allowance&lt;/td&gt;&lt;td style="color: Black; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: Black; text-align: right"&gt;(3,582&lt;/td&gt;&lt;td style="padding-bottom: 1pt; color: Black; text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: Black; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: Black; text-align: right"&gt;(360&lt;/td&gt;&lt;td style="padding-bottom: 1pt; color: Black; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40A_eus-gaap--DeferredTaxAssetsNet_iTI_mtDTANzIZJ_zGngeMWftMQd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="color: Black; text-align: left; padding-bottom: 1pt; padding-left: 0.25in"&gt;Net deferred tax assets&lt;/td&gt;&lt;td style="color: Black; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: Black; text-align: right"&gt;12,256&lt;/td&gt;&lt;td style="padding-bottom: 1pt; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: Black; text-align: right"&gt;10,935&lt;/td&gt;&lt;td style="padding-bottom: 1pt; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_eus-gaap--DeferredTaxLiabilitiesNetAbstract_iB_z5kogWajN939" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="color: Black; text-align: left"&gt;Deferred tax liabilities (long-term):&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_ecustom--DeferredTaxLiabilitiesBuildingExpenses_i01I_zsHnfG6XNNjj" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="color: Black; text-align: left; padding-left: 0.125in"&gt;Building expenses&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: right"&gt;(1,082&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1764"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_eus-gaap--DeferredTaxLiabilitiesOtherFiniteLivedAssets_i01NI_di_zSa24pNuTUQh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="color: Black; text-align: left; padding-left: 0.125in"&gt;Trademarks and licenses&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: right"&gt;(2,551&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: right"&gt;(2,894&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40B_ecustom--DeferredTaxLiabilitiesUnrealizedGainOnMarketableEquitySecurities_i01I_zebaeX8IqmS" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="color: Black; text-align: left; padding-left: 0.125in"&gt;Unrealized gain on marketable equity securities&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: right"&gt;(436&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1770"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_eus-gaap--DeferredTaxLiabilitiesOther_i01I_zdjodKSLJgG6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="color: Black; padding-bottom: 1pt; padding-left: 0.125in"&gt;Other&lt;/td&gt;&lt;td style="color: Black; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: Black; text-align: right"&gt;(251&lt;/td&gt;&lt;td style="padding-bottom: 1pt; color: Black; text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: Black; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: Black; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1773"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_400_eus-gaap--DeferredIncomeTaxLiabilities_i01NI_di_zd5vwLFRfw42" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="color: Black; text-align: left; padding-bottom: 1pt; padding-left: 0.25in"&gt;Total deferred tax liabilities&lt;/td&gt;&lt;td style="color: Black; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: Black; text-align: right"&gt;(4,320&lt;/td&gt;&lt;td style="padding-bottom: 1pt; color: Black; text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: Black; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: Black; text-align: right"&gt;(2,894&lt;/td&gt;&lt;td style="padding-bottom: 1pt; color: Black; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_407_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iI_zL18h8AAz5ue" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="color: Black; text-align: left; padding-bottom: 2pt; padding-left: 0.25in"&gt;Net deferred tax assets&lt;/td&gt;&lt;td style="color: Black; padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; color: Black; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2pt double; color: Black; text-align: right"&gt;7,936&lt;/td&gt;&lt;td style="padding-bottom: 2pt; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; color: Black; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2pt double; color: Black; text-align: right"&gt;8,041&lt;/td&gt;&lt;td style="padding-bottom: 2pt; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;



</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">1292000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">360000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign>
    <ipar:DeferredTaxAssetsInventoryAndAccountsReceivable contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">4508000</ipar:DeferredTaxAssetsInventoryAndAccountsReceivable>
    <ipar:DeferredTaxAssetsInventoryAndAccountsReceivable contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">1928000</ipar:DeferredTaxAssetsInventoryAndAccountsReceivable>
    <us-gaap:DeferredTaxAssetsDeferredIncome contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">3787000</us-gaap:DeferredTaxAssetsDeferredIncome>
    <us-gaap:DeferredTaxAssetsDeferredIncome contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">2936000</us-gaap:DeferredTaxAssetsDeferredIncome>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">732000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">718000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsInventory contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">5112000</us-gaap:DeferredTaxAssetsInventory>
    <us-gaap:DeferredTaxAssetsInventory contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">4443000</us-gaap:DeferredTaxAssetsInventory>
    <us-gaap:DeferredTaxAssetsOther contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">407000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsOther contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">910000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsGross contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">15838000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">11295000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">3582000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">360000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsNet contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">12256000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxAssetsNet contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">10935000</us-gaap:DeferredTaxAssetsNet>
    <ipar:DeferredTaxLiabilitiesBuildingExpenses contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">-1082000</ipar:DeferredTaxLiabilitiesBuildingExpenses>
    <us-gaap:DeferredTaxLiabilitiesOtherFiniteLivedAssets contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">2551000</us-gaap:DeferredTaxLiabilitiesOtherFiniteLivedAssets>
    <us-gaap:DeferredTaxLiabilitiesOtherFiniteLivedAssets contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">2894000</us-gaap:DeferredTaxLiabilitiesOtherFiniteLivedAssets>
    <ipar:DeferredTaxLiabilitiesUnrealizedGainOnMarketableEquitySecurities contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">-436000</ipar:DeferredTaxLiabilitiesUnrealizedGainOnMarketableEquitySecurities>
    <us-gaap:DeferredTaxLiabilitiesOther contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">-251000</us-gaap:DeferredTaxLiabilitiesOther>
    <us-gaap:DeferredIncomeTaxLiabilities contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">4320000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredIncomeTaxLiabilities contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">2894000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">7936000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">8041000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="From2021-01-012021-12-31_custom_ForeignDerivedIntangibleIncomeMember"
      decimals="0"
      unitRef="USD">900000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="From2020-01-012020-12-31_custom_ForeignDerivedIntangibleIncomeMember"
      decimals="0"
      unitRef="USD">300000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="From2019-01-012019-12-31_custom_ForeignDerivedIntangibleIncomeMember"
      decimals="0"
      unitRef="USD">900000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_89F_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zuxB3yl6LAej" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span id="xdx_8BC_zKFhEewEOfMj"&gt;Differences between the United
States federal statutory income tax rate and the effective income tax rate were as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="color: Black"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: Black; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49B_20210101__20211231_zKfaQdCfQ1tj" style="border-bottom: Black 1pt solid; color: Black; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: Black; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: Black; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: Black; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_498_20200101__20201231_zCryRnAsh2Gc" style="border-bottom: Black 1pt solid; color: Black; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: Black; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: Black; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: Black; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49A_20190101__20191231_zzD1b1MT4mt6" style="border-bottom: Black 1pt solid; color: Black; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; color: Black; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="color: Black"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; color: Black; font-weight: bold; text-align: center"&gt;Year ended December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; color: Black; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="color: Black"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; color: Black; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1pt; color: Black; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; color: Black; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1pt; color: Black; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; color: Black; font-weight: bold; text-align: center"&gt;2019&lt;/td&gt;&lt;td style="padding-bottom: 1pt; color: Black; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40F_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_uPure_zUn273ToAdQi" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 55%; color: Black; text-align: left"&gt;Statutory rates&lt;/td&gt;&lt;td style="width: 1%; color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; color: Black; text-align: right"&gt;21.0&lt;/td&gt;&lt;td style="width: 1%; color: Black; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 1%; color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; color: Black; text-align: right"&gt;21.0&lt;/td&gt;&lt;td style="width: 1%; color: Black; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 1%; color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; color: Black; text-align: right"&gt;21.0&lt;/td&gt;&lt;td style="width: 1%; color: Black; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_pid_dp_uPure_z3TsOQpSz64d" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="color: Black; text-align: left"&gt;State and local taxes, net of Federal benefit&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: right"&gt;0.3&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: right"&gt;0.2&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: right"&gt;0.6&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_eus-gaap--EffectiveIncomeTaxRateReconciliationDeductionsEmployeeStockOwnershipPlanDividends_pid_dp_uPure_zsvSNwGdE5Yg" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="color: Black; text-align: left"&gt;Windfall benefit from exercise of stock options&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: right"&gt;(0.9&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: right"&gt;(0.6&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: right"&gt;(0.7&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_407_eus-gaap--EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_pid_dp_uPure_zQNyQrvXODyf" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="color: Black; text-align: left"&gt;Benefit of Foreign Derived Intangible Income&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: right"&gt;(0.6&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: right"&gt;(0.4&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: right"&gt;(0.9&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="color: Black; text-align: left"&gt;Effect of foreign taxes greater than&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_408_ecustom--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate1_pid_dp_uPure_z0tNlUfNQ9Yk" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="color: Black; text-align: left; padding-left: 0.125in"&gt;U.S. statutory rates&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: right"&gt;7.4&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: right"&gt;7.5&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: right"&gt;7.5&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_402_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherAdjustments_pid_dp_zswJ8pulXbZ7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="color: Black; padding-bottom: 1pt"&gt;Other&lt;/td&gt;&lt;td style="color: Black; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: Black; text-align: right"&gt;(0.1&lt;/td&gt;&lt;td style="padding-bottom: 1pt; color: Black; text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: Black; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: Black; text-align: right"&gt;0.2&lt;/td&gt;&lt;td style="padding-bottom: 1pt; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: Black; text-align: right"&gt;0.1&lt;/td&gt;&lt;td style="padding-bottom: 1pt; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_401_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_pid_dp_zZMCFfSnrETc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="color: Black; text-align: left; padding-bottom: 2pt; padding-left: 0.25in"&gt;Effective rates&lt;/td&gt;&lt;td style="color: Black; padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2pt double; color: Black; text-align: right"&gt;27.1&lt;/td&gt;&lt;td style="padding-bottom: 2pt; color: Black; text-align: left"&gt;%&lt;/td&gt;&lt;td style="color: Black; padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2pt double; color: Black; text-align: right"&gt;27.9&lt;/td&gt;&lt;td style="padding-bottom: 2pt; color: Black; text-align: left"&gt;%&lt;/td&gt;&lt;td style="color: Black; padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2pt double; color: Black; text-align: right"&gt;27.6&lt;/td&gt;&lt;td style="padding-bottom: 2pt; color: Black; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;



</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="From2021-01-01to2021-12-31"
      decimals="INF"
      unitRef="Pure">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="From2020-01-012020-12-31"
      decimals="INF"
      unitRef="Pure">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="From2019-01-012019-12-31"
      decimals="INF"
      unitRef="Pure">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="From2021-01-01to2021-12-31"
      decimals="INF"
      unitRef="Pure">0.003</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="From2020-01-012020-12-31"
      decimals="INF"
      unitRef="Pure">0.002</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="From2019-01-012019-12-31"
      decimals="INF"
      unitRef="Pure">0.006</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationDeductionsEmployeeStockOwnershipPlanDividends
      contextRef="From2021-01-01to2021-12-31"
      decimals="INF"
      unitRef="Pure">-0.009</us-gaap:EffectiveIncomeTaxRateReconciliationDeductionsEmployeeStockOwnershipPlanDividends>
    <us-gaap:EffectiveIncomeTaxRateReconciliationDeductionsEmployeeStockOwnershipPlanDividends
      contextRef="From2020-01-012020-12-31"
      decimals="INF"
      unitRef="Pure">-0.006</us-gaap:EffectiveIncomeTaxRateReconciliationDeductionsEmployeeStockOwnershipPlanDividends>
    <us-gaap:EffectiveIncomeTaxRateReconciliationDeductionsEmployeeStockOwnershipPlanDividends
      contextRef="From2019-01-012019-12-31"
      decimals="INF"
      unitRef="Pure">-0.007</us-gaap:EffectiveIncomeTaxRateReconciliationDeductionsEmployeeStockOwnershipPlanDividends>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
      contextRef="From2021-01-01to2021-12-31"
      decimals="INF"
      unitRef="Pure">-0.006</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
      contextRef="From2020-01-012020-12-31"
      decimals="INF"
      unitRef="Pure">-0.004</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
      contextRef="From2019-01-012019-12-31"
      decimals="INF"
      unitRef="Pure">-0.009</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <ipar:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate1
      contextRef="From2021-01-01to2021-12-31"
      decimals="INF"
      unitRef="Pure">0.074</ipar:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate1>
    <ipar:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate1
      contextRef="From2020-01-012020-12-31"
      decimals="INF"
      unitRef="Pure">0.075</ipar:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate1>
    <ipar:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate1
      contextRef="From2019-01-012019-12-31"
      decimals="INF"
      unitRef="Pure">0.075</ipar:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate1>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="From2021-01-01to2021-12-31"
      decimals="INF"
      unitRef="Pure">-0.001</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="From2020-01-012020-12-31"
      decimals="INF"
      unitRef="Pure">0.002</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="From2019-01-012019-12-31"
      decimals="INF"
      unitRef="Pure">0.001</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="From2021-01-01to2021-12-31"
      decimals="INF"
      unitRef="Pure">0.271</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="From2020-01-012020-12-31"
      decimals="INF"
      unitRef="Pure">0.279</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="From2019-01-012019-12-31"
      decimals="INF"
      unitRef="Pure">0.276</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:ComprehensiveIncomeNoteTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_801_eus-gaap--ComprehensiveIncomeNoteTextBlock_zekB4W6nwU4d" style="margin-top: 0; margin-bottom: 0"/&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;(17)&lt;/td&gt;&lt;td&gt;&lt;span id="xdx_82A_zMDiheg1qEY"&gt;Accumulated Other Comprehensive Loss&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_891_eus-gaap--ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_zT2ahtPkK5pg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&lt;span id="xdx_8BD_z2018wLiyWrk"&gt;The components of accumulated other
comprehensive loss consist of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="color: Black"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; color: Black; font-weight: bold; text-align: center"&gt;Year ended December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; color: Black; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="color: Black"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; color: Black; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1pt; color: Black; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; color: Black; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1pt; color: Black; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; color: Black; font-weight: bold; text-align: center"&gt;2019&lt;/td&gt;&lt;td style="padding-bottom: 1pt; color: Black; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="color: Black"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="color: Black; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="color: Black; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="color: Black; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 55%; color: Black; text-align: left"&gt;Net derivative instruments, beginning of year&lt;/td&gt;&lt;td style="width: 1%; color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: Black; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iS_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember_z8NwCIV0OFgi" style="width: 12%; color: Black; text-align: right" title="Net derivative instruments, beginning of year"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1818"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: Black; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iS_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__custom--AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember_zVLnjObU6Ota" style="width: 12%; color: Black; text-align: right" title="Net derivative instruments, beginning of year"&gt;52&lt;/td&gt;&lt;td style="width: 1%; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: Black; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iS_c20190101__20191231__us-gaap--StatementEquityComponentsAxis__custom--AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember_zcO40Katkn9e" style="width: 12%; color: Black; text-align: right" title="Net derivative instruments, beginning of year"&gt;136&lt;/td&gt;&lt;td style="width: 1%; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="color: Black; text-align: left; padding-bottom: 1pt"&gt;Net derivative instrument loss, net of tax&lt;/td&gt;&lt;td style="color: Black; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember_znaE0XRI0M8i" style="border-bottom: Black 1pt solid; color: Black; text-align: right" title="Net derivative instrument gain (loss), net of tax"&gt;(992&lt;/td&gt;&lt;td style="padding-bottom: 1pt; color: Black; text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: Black; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__custom--AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember_zpWsCwwmm9K5" style="border-bottom: Black 1pt solid; color: Black; text-align: right" title="Net derivative instrument gain (loss), net of tax"&gt;(52&lt;/td&gt;&lt;td style="padding-bottom: 1pt; color: Black; text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: Black; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent_c20190101__20191231__us-gaap--StatementEquityComponentsAxis__custom--AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember_zulD6iHEI5a6" style="border-bottom: Black 1pt solid; color: Black; text-align: right" title="Net derivative instrument gain (loss), net of tax"&gt;(84&lt;/td&gt;&lt;td style="padding-bottom: 1pt; color: Black; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="color: Black; text-align: left; padding-bottom: 1pt"&gt;Net derivative instruments, end of year&lt;/td&gt;&lt;td style="color: Black; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iE_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember_zi0dEX2OAb1e" style="border-bottom: Black 1pt solid; color: Black; text-align: right" title="Net derivative instruments, end of year"&gt;(992&lt;/td&gt;&lt;td style="padding-bottom: 1pt; color: Black; text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: Black; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iE_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__custom--AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember_zmSt4N8sPGl2" style="border-bottom: Black 1pt solid; color: Black; text-align: right" title="Net derivative instruments, end of year"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1832"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iE_c20190101__20191231__us-gaap--StatementEquityComponentsAxis__custom--AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember_zlAFjDVhRoaa" style="border-bottom: Black 1pt solid; color: Black; text-align: right" title="Net derivative instruments, end of year"&gt;52&lt;/td&gt;&lt;td style="padding-bottom: 1pt; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="color: Black"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="color: Black; text-align: left"&gt;Cumulative translation adjustments, beginning of year&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iS_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedTranslationAdjustmentMember_zZtL9OD2C5Tg" style="color: Black; text-align: right" title="Cumulative translation adjustments, beginning of year"&gt;(5,997&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iS_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedTranslationAdjustmentMember_zx08Us77Xpv" style="color: Black; text-align: right" title="Cumulative translation adjustments, beginning of year"&gt;(39,905&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iS_c20190101__20191231__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedTranslationAdjustmentMember_zEaBJn0ox5Ja" style="color: Black; text-align: right" title="Cumulative translation adjustments, beginning of year"&gt;(33,786&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="color: Black; text-align: left; padding-bottom: 1pt"&gt;Translation adjustments&lt;/td&gt;&lt;td style="color: Black; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedTranslationAdjustmentMember_zVfsua6Vt5c5" style="border-bottom: Black 1pt solid; color: Black; text-align: right" title="Translation adjustments"&gt;(31,443&lt;/td&gt;&lt;td style="padding-bottom: 1pt; color: Black; text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: Black; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedTranslationAdjustmentMember_z2zWJIkxmuT9" style="border-bottom: Black 1pt solid; color: Black; text-align: right" title="Translation adjustments"&gt;33,908&lt;/td&gt;&lt;td style="padding-bottom: 1pt; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_c20190101__20191231__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedTranslationAdjustmentMember_zsSrjNLPOCfl" style="border-bottom: Black 1pt solid; color: Black; text-align: right" title="Translation adjustments"&gt;(6,119&lt;/td&gt;&lt;td style="padding-bottom: 1pt; color: Black; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="color: Black; text-align: left; padding-bottom: 1pt"&gt;Cumulative translation adjustments, end of year&lt;/td&gt;&lt;td style="color: Black; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iE_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedTranslationAdjustmentMember_zRPbbUho5b1l" style="border-bottom: Black 1pt solid; color: Black; text-align: right" title="Cumulative translation adjustments, end of year"&gt;(37,440&lt;/td&gt;&lt;td style="padding-bottom: 1pt; color: Black; text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: Black; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iE_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedTranslationAdjustmentMember_zMO8dc2L7wp6" style="border-bottom: Black 1pt solid; color: Black; text-align: right" title="Cumulative translation adjustments, end of year"&gt;(5,997&lt;/td&gt;&lt;td style="padding-bottom: 1pt; color: Black; text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: Black; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iE_c20190101__20191231__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedTranslationAdjustmentMember_zxkqgm5CvTZ1" style="border-bottom: Black 1pt solid; color: Black; text-align: right" title="Cumulative translation adjustments, end of year"&gt;(39,905&lt;/td&gt;&lt;td style="padding-bottom: 1pt; color: Black; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="color: Black"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="color: Black; text-align: left; padding-bottom: 2pt"&gt;Accumulated other comprehensive loss&lt;/td&gt;&lt;td style="color: Black; padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; color: Black; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iI_c20211231_z9lfBa14i2V1" style="border-bottom: Black 2pt double; color: Black; text-align: right" title="Accumulated other comprehensive loss"&gt;(38,432&lt;/td&gt;&lt;td style="padding-bottom: 2pt; color: Black; text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: Black; padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; color: Black; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iI_c20201231_zrepYmMBCj0k" style="border-bottom: Black 2pt double; color: Black; text-align: right"&gt;(5,997&lt;/td&gt;&lt;td style="padding-bottom: 2pt; color: Black; text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: Black; padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; color: Black; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iI_c20191231_zXZBNJmdo7Of" style="border-bottom: Black 2pt double; color: Black; text-align: right"&gt;(39,853&lt;/td&gt;&lt;td style="padding-bottom: 2pt; color: Black; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A0_zE2lWp6Gzvc7" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;



</us-gaap:ComprehensiveIncomeNoteTextBlock>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_891_eus-gaap--ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_zT2ahtPkK5pg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&lt;span id="xdx_8BD_z2018wLiyWrk"&gt;The components of accumulated other
comprehensive loss consist of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="color: Black"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; color: Black; font-weight: bold; text-align: center"&gt;Year ended December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; color: Black; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="color: Black"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; color: Black; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1pt; color: Black; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; color: Black; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1pt; color: Black; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; color: Black; font-weight: bold; text-align: center"&gt;2019&lt;/td&gt;&lt;td style="padding-bottom: 1pt; color: Black; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="color: Black"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="color: Black; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="color: Black; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="color: Black; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 55%; color: Black; text-align: left"&gt;Net derivative instruments, beginning of year&lt;/td&gt;&lt;td style="width: 1%; color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: Black; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iS_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember_z8NwCIV0OFgi" style="width: 12%; color: Black; text-align: right" title="Net derivative instruments, beginning of year"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1818"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: Black; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iS_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__custom--AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember_zVLnjObU6Ota" style="width: 12%; color: Black; text-align: right" title="Net derivative instruments, beginning of year"&gt;52&lt;/td&gt;&lt;td style="width: 1%; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: Black; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iS_c20190101__20191231__us-gaap--StatementEquityComponentsAxis__custom--AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember_zcO40Katkn9e" style="width: 12%; color: Black; text-align: right" title="Net derivative instruments, beginning of year"&gt;136&lt;/td&gt;&lt;td style="width: 1%; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="color: Black; text-align: left; padding-bottom: 1pt"&gt;Net derivative instrument loss, net of tax&lt;/td&gt;&lt;td style="color: Black; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember_znaE0XRI0M8i" style="border-bottom: Black 1pt solid; color: Black; text-align: right" title="Net derivative instrument gain (loss), net of tax"&gt;(992&lt;/td&gt;&lt;td style="padding-bottom: 1pt; color: Black; text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: Black; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__custom--AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember_zpWsCwwmm9K5" style="border-bottom: Black 1pt solid; color: Black; text-align: right" title="Net derivative instrument gain (loss), net of tax"&gt;(52&lt;/td&gt;&lt;td style="padding-bottom: 1pt; color: Black; text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: Black; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent_c20190101__20191231__us-gaap--StatementEquityComponentsAxis__custom--AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember_zulD6iHEI5a6" style="border-bottom: Black 1pt solid; color: Black; text-align: right" title="Net derivative instrument gain (loss), net of tax"&gt;(84&lt;/td&gt;&lt;td style="padding-bottom: 1pt; color: Black; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="color: Black; text-align: left; padding-bottom: 1pt"&gt;Net derivative instruments, end of year&lt;/td&gt;&lt;td style="color: Black; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iE_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember_zi0dEX2OAb1e" style="border-bottom: Black 1pt solid; color: Black; text-align: right" title="Net derivative instruments, end of year"&gt;(992&lt;/td&gt;&lt;td style="padding-bottom: 1pt; color: Black; text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: Black; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iE_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__custom--AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember_zmSt4N8sPGl2" style="border-bottom: Black 1pt solid; color: Black; text-align: right" title="Net derivative instruments, end of year"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1832"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iE_c20190101__20191231__us-gaap--StatementEquityComponentsAxis__custom--AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember_zlAFjDVhRoaa" style="border-bottom: Black 1pt solid; color: Black; text-align: right" title="Net derivative instruments, end of year"&gt;52&lt;/td&gt;&lt;td style="padding-bottom: 1pt; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="color: Black"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="color: Black; text-align: left"&gt;Cumulative translation adjustments, beginning of year&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iS_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedTranslationAdjustmentMember_zZtL9OD2C5Tg" style="color: Black; text-align: right" title="Cumulative translation adjustments, beginning of year"&gt;(5,997&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iS_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedTranslationAdjustmentMember_zx08Us77Xpv" style="color: Black; text-align: right" title="Cumulative translation adjustments, beginning of year"&gt;(39,905&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iS_c20190101__20191231__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedTranslationAdjustmentMember_zEaBJn0ox5Ja" style="color: Black; text-align: right" title="Cumulative translation adjustments, beginning of year"&gt;(33,786&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="color: Black; text-align: left; padding-bottom: 1pt"&gt;Translation adjustments&lt;/td&gt;&lt;td style="color: Black; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedTranslationAdjustmentMember_zVfsua6Vt5c5" style="border-bottom: Black 1pt solid; color: Black; text-align: right" title="Translation adjustments"&gt;(31,443&lt;/td&gt;&lt;td style="padding-bottom: 1pt; color: Black; text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: Black; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedTranslationAdjustmentMember_z2zWJIkxmuT9" style="border-bottom: Black 1pt solid; color: Black; text-align: right" title="Translation adjustments"&gt;33,908&lt;/td&gt;&lt;td style="padding-bottom: 1pt; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_c20190101__20191231__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedTranslationAdjustmentMember_zsSrjNLPOCfl" style="border-bottom: Black 1pt solid; color: Black; text-align: right" title="Translation adjustments"&gt;(6,119&lt;/td&gt;&lt;td style="padding-bottom: 1pt; color: Black; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="color: Black; text-align: left; padding-bottom: 1pt"&gt;Cumulative translation adjustments, end of year&lt;/td&gt;&lt;td style="color: Black; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iE_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedTranslationAdjustmentMember_zRPbbUho5b1l" style="border-bottom: Black 1pt solid; color: Black; text-align: right" title="Cumulative translation adjustments, end of year"&gt;(37,440&lt;/td&gt;&lt;td style="padding-bottom: 1pt; color: Black; text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: Black; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iE_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedTranslationAdjustmentMember_zMO8dc2L7wp6" style="border-bottom: Black 1pt solid; color: Black; text-align: right" title="Cumulative translation adjustments, end of year"&gt;(5,997&lt;/td&gt;&lt;td style="padding-bottom: 1pt; color: Black; text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: Black; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iE_c20190101__20191231__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedTranslationAdjustmentMember_zxkqgm5CvTZ1" style="border-bottom: Black 1pt solid; color: Black; text-align: right" title="Cumulative translation adjustments, end of year"&gt;(39,905&lt;/td&gt;&lt;td style="padding-bottom: 1pt; color: Black; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="color: Black"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="color: Black; text-align: left; padding-bottom: 2pt"&gt;Accumulated other comprehensive loss&lt;/td&gt;&lt;td style="color: Black; padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; color: Black; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iI_c20211231_z9lfBa14i2V1" style="border-bottom: Black 2pt double; color: Black; text-align: right" title="Accumulated other comprehensive loss"&gt;(38,432&lt;/td&gt;&lt;td style="padding-bottom: 2pt; color: Black; text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: Black; padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; color: Black; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iI_c20201231_zrepYmMBCj0k" style="border-bottom: Black 2pt double; color: Black; text-align: right"&gt;(5,997&lt;/td&gt;&lt;td style="padding-bottom: 2pt; color: Black; text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: Black; padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; color: Black; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iI_c20191231_zXZBNJmdo7Of" style="border-bottom: Black 2pt double; color: Black; text-align: right"&gt;(39,853&lt;/td&gt;&lt;td style="padding-bottom: 2pt; color: Black; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="AsOf2019-12-31_custom_AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember"
      decimals="-3"
      unitRef="USD">52000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="AsOf2018-12-31_custom_AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember"
      decimals="-3"
      unitRef="USD">136000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent
      contextRef="From2021-01-012021-12-31_custom_AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember"
      decimals="-3"
      unitRef="USD">-992000</us-gaap:OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent
      contextRef="From2020-01-012020-12-31_custom_AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember"
      decimals="-3"
      unitRef="USD">-52000</us-gaap:OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent
      contextRef="From2019-01-012019-12-31_custom_AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember"
      decimals="-3"
      unitRef="USD">-84000</us-gaap:OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="AsOf2021-12-31_custom_AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember"
      decimals="-3"
      unitRef="USD">-992000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="AsOf2019-12-31_custom_AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember"
      decimals="-3"
      unitRef="USD">52000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="AsOf2020-12-31_us-gaap_AccumulatedTranslationAdjustmentMember"
      decimals="-3"
      unitRef="USD">-5997000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="AsOf2019-12-31_us-gaap_AccumulatedTranslationAdjustmentMember"
      decimals="-3"
      unitRef="USD">-39905000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="AsOf2018-12-31_us-gaap_AccumulatedTranslationAdjustmentMember"
      decimals="-3"
      unitRef="USD">-33786000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
      contextRef="From2021-01-012021-12-31_us-gaap_AccumulatedTranslationAdjustmentMember"
      decimals="-3"
      unitRef="USD">-31443000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
      contextRef="From2020-01-012020-12-31_us-gaap_AccumulatedTranslationAdjustmentMember"
      decimals="-3"
      unitRef="USD">33908000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
      contextRef="From2019-01-012019-12-31_us-gaap_AccumulatedTranslationAdjustmentMember"
      decimals="-3"
      unitRef="USD">-6119000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="AsOf2021-12-31_us-gaap_AccumulatedTranslationAdjustmentMember"
      decimals="-3"
      unitRef="USD">-37440000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="AsOf2020-12-31_us-gaap_AccumulatedTranslationAdjustmentMember"
      decimals="-3"
      unitRef="USD">-5997000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="AsOf2019-12-31_us-gaap_AccumulatedTranslationAdjustmentMember"
      decimals="-3"
      unitRef="USD">-39905000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">-38432000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">-5997000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="AsOf2019-12-31" decimals="-3" unitRef="USD">-39853000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:MinorityInterestDisclosureTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_806_eus-gaap--MinorityInterestDisclosureTextBlock_zByigvtYnxki" style="margin-top: 0; margin-bottom: 0"/&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;(18)&lt;/td&gt;&lt;td&gt;&lt;span id="xdx_826_zfNvBoYHth0k"&gt;Net Income Attributable to Inter Parfums, Inc. and Transfers from the Noncontrolling Interest&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p id="xdx_892_eus-gaap--ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock_z6bQSfK2HVW7" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span id="xdx_8B3_zT1VWmcDFA85" style="display: none; visibility: hidden"&gt;Schedule of net income attributable to transfers from the noncontrolling interest&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_494_20210101__20211231_zmj7rP5v3rye" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_492_20200101__20201231_zwVHY0pR8ec5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_499_20190101__20191231_z0DwhBQWU0dk" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="color: Black"&gt;Year
    ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="color: Black"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="color: Black"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="color: Black"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_407_eus-gaap--NetIncomeLoss_z7p5PdToESgh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 55%; text-align: left; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="color: Black"&gt;Net income attributable to Inter Parfums, Inc.&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="color: Black"&gt;87,411&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="color: Black"&gt;38,219&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="color: Black"&gt;60,249&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_402_eus-gaap--ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesNet_z6sJRoHhgHQ2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="color: Black"&gt;Decrease in Inter Parfums, Inc.&#x2019;s additional
    paid-in capital for subsidiary share transactions&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="color: Black"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1866"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="color: Black"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1867"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #FF0000; padding-bottom: 1pt"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #FF0000; text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #FF0000; text-align: right"&gt;&lt;span style="color: Black"&gt;(5,167&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; color: #FF0000; text-align: left"&gt;&lt;span style="color: Black"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_400_eus-gaap--ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNet_z88EJYfrzncb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2pt; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"/&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;span style="color: Black"&gt;Change from net income attributable to Inter Parfums, Inc. and transfers from noncontrolling interest&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; text-align: left"&gt;&lt;span style="color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2pt double; text-align: right"&gt;&lt;span style="color: Black"&gt;87,411&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; text-align: left"&gt;&lt;span style="color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2pt double; text-align: right"&gt;&lt;span style="color: Black"&gt;38,219&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; text-align: left"&gt;&lt;span style="color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2pt double; text-align: right"&gt;&lt;span style="color: Black"&gt;55,082&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;



&lt;p id="xdx_8AD_zGaZYBR2EsGg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;

</us-gaap:MinorityInterestDisclosureTextBlock>
    <us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_892_eus-gaap--ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock_z6bQSfK2HVW7" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span id="xdx_8B3_zT1VWmcDFA85" style="display: none; visibility: hidden"&gt;Schedule of net income attributable to transfers from the noncontrolling interest&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_494_20210101__20211231_zmj7rP5v3rye" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_492_20200101__20201231_zwVHY0pR8ec5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_499_20190101__20191231_z0DwhBQWU0dk" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="color: Black"&gt;Year
    ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="color: Black"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="color: Black"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="color: Black"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_407_eus-gaap--NetIncomeLoss_z7p5PdToESgh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 55%; text-align: left; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="color: Black"&gt;Net income attributable to Inter Parfums, Inc.&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="color: Black"&gt;87,411&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="color: Black"&gt;38,219&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="color: Black"&gt;60,249&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_402_eus-gaap--ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesNet_z6sJRoHhgHQ2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="color: Black"&gt;Decrease in Inter Parfums, Inc.&#x2019;s additional
    paid-in capital for subsidiary share transactions&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="color: Black"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1866"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="color: Black"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1867"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="color: #FF0000; padding-bottom: 1pt"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: #FF0000; text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; color: #FF0000; text-align: right"&gt;&lt;span style="color: Black"&gt;(5,167&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; color: #FF0000; text-align: left"&gt;&lt;span style="color: Black"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_400_eus-gaap--ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNet_z88EJYfrzncb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2pt; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"/&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;span style="color: Black"&gt;Change from net income attributable to Inter Parfums, Inc. and transfers from noncontrolling interest&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; text-align: left"&gt;&lt;span style="color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2pt double; text-align: right"&gt;&lt;span style="color: Black"&gt;87,411&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; text-align: left"&gt;&lt;span style="color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2pt double; text-align: right"&gt;&lt;span style="color: Black"&gt;38,219&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; text-align: left"&gt;&lt;span style="color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2pt double; text-align: right"&gt;&lt;span style="color: Black"&gt;55,082&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&lt;span style="color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;



</us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="USD">87411000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">38219000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="USD">60249000</us-gaap:NetIncomeLoss>
    <us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesNet
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="USD">-5167000</us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesNet>
    <us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNet
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="USD">87411000</us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNet>
    <us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNet
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">38219000</us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNet>
    <us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNet
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="USD">55082000</us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNet>
    <ipar:ReconciliationOfCashAndCashEquivalentsToTheStatementOfCashFlowsTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_80D_ecustom--ReconciliationOfCashAndCashEquivalentsToTheStatementOfCashFlowsTextBlock_z3A1PtU4iC4e" style="margin-top: 0; margin-bottom: 0"/&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;(19)&lt;/td&gt;&lt;td&gt;&lt;span id="xdx_828_zwupbeSFx0qk"&gt;Reconciliation of Cash and Cash Equivalents to the Statement of Cash Flows&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_893_eus-gaap--ScheduleOfCashAndCashEquivalentsTableTextBlock_zp6EmKT6Xtp4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span id="xdx_8BD_zpQue6aL6gP9"&gt;The following table summarizes
cash and cash equivalents as of December 31, 2021:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-family: Courier New, Courier, Monospace; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49D_20211231_zPehRo7p78A2" style="border-bottom: Black 1pt solid; text-align: center"&gt;December 31, 2021&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_409_eus-gaap--CashCashEquivalentsAndShortTermInvestments_iI_zX1rKjbN7Yn5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 85%; text-align: left"&gt;Cash and cash equivalents per balance sheet&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;159,613&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40E_ecustom--CashHeldInEscrowIncludedInOtherAssets_iI_zgfaoIKvSPUl" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Cash held in escrow included in other assets (see note 3)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;8,774&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_ecustom--CashAndCashEquivalentsPerStatementOfCashFlows_iI_z3NGxqJWTH9i" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2pt"&gt;Cash and cash equivalents per statement of cash flows&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2pt double; text-align: right"&gt;168,387&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8AE_zUUhc8uvTUeg" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

</ipar:ReconciliationOfCashAndCashEquivalentsToTheStatementOfCashFlowsTextBlock>
    <us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_893_eus-gaap--ScheduleOfCashAndCashEquivalentsTableTextBlock_zp6EmKT6Xtp4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span id="xdx_8BD_zpQue6aL6gP9"&gt;The following table summarizes
cash and cash equivalents as of December 31, 2021:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-family: Courier New, Courier, Monospace; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49D_20211231_zPehRo7p78A2" style="border-bottom: Black 1pt solid; text-align: center"&gt;December 31, 2021&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_409_eus-gaap--CashCashEquivalentsAndShortTermInvestments_iI_zX1rKjbN7Yn5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 85%; text-align: left"&gt;Cash and cash equivalents per balance sheet&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;159,613&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40E_ecustom--CashHeldInEscrowIncludedInOtherAssets_iI_zgfaoIKvSPUl" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Cash held in escrow included in other assets (see note 3)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;8,774&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_ecustom--CashAndCashEquivalentsPerStatementOfCashFlows_iI_z3NGxqJWTH9i" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2pt"&gt;Cash and cash equivalents per statement of cash flows&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2pt double; text-align: right"&gt;168,387&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock>
    <us-gaap:CashCashEquivalentsAndShortTermInvestments contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">159613000</us-gaap:CashCashEquivalentsAndShortTermInvestments>
    <ipar:CashHeldInEscrowIncludedInOtherAssets contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">8774000</ipar:CashHeldInEscrowIncludedInOtherAssets>
    <ipar:CashAndCashEquivalentsPerStatementOfCashFlows contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">168387000</ipar:CashAndCashEquivalentsPerStatementOfCashFlows>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>103
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M4_PGZ\VU[7:#A+FQ*BV#@2"-L\VO>"D3L1\0' A@90![$T /W8&7 ?QM0.=
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MZ,EZ\ZU@LV/5LE@]GRIK55IL+J2(I'87P/F94G:[XVZP^V)S_1]02P,$%
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M8#Q34S%^6&")9Q/.#H!K:86F7XPSC;:B7U =]T?)U;^%TI.S.:."E46&)<G
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M4HU,YC578S#A6D#]OV9,OBST >U@/?L?4$L#!!0    ( !6#852NAE>_$@<
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MG5 HK]#-AM=B(XM,U.IG=/GO+M>?T11]N%F@9S\]1S\UFO<;N5.\RM393)O
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M&-\ 0<!XA##,[!W+E6$<!"2&9X/VI$']I.&E( H\>:"8I7:Y0[HT&7M$07N
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M(1ITX_XV0A>7YJT-ZC?DPX_X]0;F#1N(BE_OH!Y//U#&KKH;E_:FX=D!(T/
MV@93N'M^6AU&C]-23%33*6<XZW"G)LX[!]LJ$!+WW0I(F,LO;F6%'TB0FPA:
MSJ%/&WK(,>RCD"AJ4!(1-8:+!F'"VL&M4[GBE<"3]Z$9U,N+)Z C)T94>4M4
M4VJVT"@B)2A0-S\!9UO>J*62457I'3#7?W0#?ZN4T;B9=5QM?@ZLTPR]I[WH
MZ)^3B)-B\ ($^B9\I#CW:T4I0MRD79"9H1E&G27/].B%+Z%'$M!D0F%A$JR9
MT[."6W W-#*T804%\'50.=BDELHU<U4PX#AP VG(&V7,)*HKX(%0IFV?XH;
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MS=C.<P">;_I^2%^X07Z=_O4_ %!+ P04    "  5@V%45]VVV+8&  "Z#@
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MS+&596D0)[+VPILJ?+U:&8_!*?SDOB$M+\#SW!C?7O !W>?,Z_\ 4$L#!!0
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MO=#U Z1+3^% %(\MIL@%1[[(N%:G^"!%,J_VQ3@A@,UER$0YVVXK[#[[UAK
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M'_:NNTKQ8K58XRBG->IHCEQ['" YPCBOI=G9X#$M?"<;]#*J[>"PC>1FXSQ
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ME\K2%FC%#:U=U,Z![E=*V9/B$O2+?/834$L#!!0    ( !6#851C%\K!Y (
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M]",(78(D!Z5IT)$L!FZ5.UE*824ZJ,4:0:R%5"& @-=\"?P$E?+=E$$R3$Z
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M)[%LCA_>=.']NC$>K^&P;/#OA[ D@/.M 5&'#[I@^(?FZA]02P,$%     @
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MQ43#MWNNFX1]VNEB"/F>%0N'#"A<2:R^EC6S6G1-6,JE:E$]*?Z6+UI2!O1
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M^!Q<8Q\_R(@HAB'6SP<_C?50@9YBFUT\"%U+(]AG34G[?QX7A93R!2]$XOA
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M6##9WJ LYX4IF4JYU(+IE!<Z?6J-*!13AFD=@7(M!(2H@DM!4@T=+),+BS1
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MS#_>LL^*.CTD?(".JI0%"FO!KI%654X-V5;:C>VOSSJP[_H$>9-Z!1O-:;#
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M[NW@OQ2:JFJ@PB5!PY/1T /=#M-V8]7:#;"%LC0.G5G0_P<U.]#[I5)VM^$
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MJ1&*B1E,)ZQ;BL&0>UO#L)?DGZ!A=+0^Y&.#?,UY8*Q&._E(QO QLB&/P06
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MJQ6([W7%5A1B94N/W8G#,;@J:&93$XLO"(R4926I;01T:6=LOC>PU.NUI4#
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M&7ZJZ/DI7QYJ,RW)PCX8$<W-)'38L2J6M3X%>%[&KB;]Z:XK "$6C85$GXS
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MUIMP%4*!)>N$?5#]KSCR63J\7 GC?Z$??>,0\LY8U8S!5$'#Y?#/GD<=_DM
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M/]ZQ?VGO3G=9,(WG4OSDA5E/G-2! I>L$>96;K[B]CZ)Y<NET.T_;+K<9.1
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MPW*#SZ8P?@/:5UJ[!\$#'![BV3]02P,$%     @ %8-A5-*"1DG> @  X@4
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M=RD8#\#[M=;NZ/@$W7:>_P502P,$%     @ %8-A5+,F:[F# P  [P<  !D
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MT*BQUJSQ40-I''"]$D*?!R;!^$RN?@%02P,$%     @ %8-A5 YA8>@W!@
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MJ:"R!G2>26F>%C9 ]YN:_P902P,$%     @ %8-A5'-U&TR1 @  &P8  !D
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M!.C[,\[5PXGYXMI\89_\#U!+ P04    "  5@V%44:IOXD\"   3!0  &0
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M'4O^N=!-)0ACH-=GG*O-P+0M99LZ^ -02P,$%     @ %8-A5(%2&)EA @
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M7AUN"4X(4P+Y_X92\7RBWN8T;^^6OP%02P,$%     @ %8-A5-:'N2,[!
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M0-'BSX0=Y<D],$-9<O[%/-RN9QXTC%C*5LI 4'UY9#<L30V2YO%/!>K5?9K
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M&NCO&\[5TX/IH#YUG/\+4$L#!!0    ( !6#850:841)?@,  +0-   9
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MPH:*RBVPWV=2FLW$.6@N:J._ 5!+ P04    "  5@V%4E:2]1*T"   &!P
M&0   'AL+W=O<FMS:&5E=',O<VAE970U.2YX;6RU5<ENVS 0_15"Z"$!'&OS
MUL 6X*5! \2MD33M(>B!EL:6$%)422J._[Y#RE:=0%9.]<'BD/,>WPR'P_%.
MR&>5 FCRREFN)DZJ=7'MNBI.@5/5%07DN+(1DE.-IMRZJI! $POBS T\;^!R
MFN5.-+9S*QF-1:E9EL-*$E5R3N5^!DSL)H[O'"?NLVVJS80;C0NZA0?0C\5*
MHN76+$G&(5>9R(F$S<29^M?SD?&W#C\SV*F3,3&1K(5X-L9M,G$\(P@8Q-HP
M4/R\P!P8,T0HX\^!TZFW-,#3\9']QL:.L:RI@KE@O[)$IQ-GY) $-K1D^E[L
MOL(AGK[ABP53]I_L*M]>WR%QJ;3@!S JX%E>?>GK(0^G@.$90'  !.\ ?N\,
M(#P 0AMHI<R&M:":1F,I=D0:;V0S YL;B\9HLMR<XH.6N)HA3D=W(M]>_0#)
MR0+6FEPL0-.,*?*-2DE-AB_)%7E\6)"+3Y=C5^..!N?&!_99Q1Z<8?<#LA2Y
M3A7YDB>0O"5P46JM-SCJG06MC N(NR3T.R3P K]!T+P=/BTDPKTF^!LY89V^
MT/*%9^5@TFYSI66)I:W)TQTZD%L-7/UNH>_5]#U+WVL['7T\G0Y94EW*3&>@
MSB9@5C'V+:.YPR^1W__LF=_8?6G0TJ^U]#_40JR6Q 3-*RG[#IHJEEEA;F63
MGG96?]#M85TS9NYT 9+L@4JB4\"6M,'=<"A%N4TQW##LMJ1T4(<Q^" ,FBNR
MHGNZ9D"^XVD]+8&O0;:=U[ F'_Z/<AC5]*-6[>_H.^2&QD"F7)2Y;DK]J*$4
MO+>E4%V:!L>PN6C<DU;#06YM!U8D-A*JKE//UDU^:GN;^\^]>B&65&XS/ L&
M&X1ZW2'N+ZNN6QE:%+9QK87&-FB'*3Y4((T#KF^$T$?#;% _?=%?4$L#!!0
M   ( !6#8506G?8GWP(  ,L'   9    >&PO=V]R:W-H965T<R]S:&5E=#8P
M+GAM;(65:V^;,!2&_XJ%-JF5UG(+D%1)I#;1+M(Z5;UL'Z9]<. 0K!J<VB;I
M_OV.#679 LF78!N_YWE?",?3G9#/J@#0Y+7DE9HYA=:;*]=5:0$E59=B Q7>
MR84LJ<:I7+MJ(X%F5E1R-_"\V"TIJYSYU*[=R?E4U)JS"NXD47594OG[!KC8
MS1S?>5NX9^M"FP5W/MW0-3R ?MK<29RY796,E5 I)BHB(9\YU_[5C6\%=L=W
M!CNU-R8FRDJ(9S/YDLT<SS@"#JDV)2A>MK  SDTE]/'2%G4ZIA'NC]^J?[3A
M,<R**E@(_H-ENI@Y8X=DD-.:ZWNQ^PQMH,C42P57]I?LVKV>0])::5&V8G10
MLJJYTM?V0>P) G] $+2"P/IN0-;EDFHZGTJQ(]+LQFIF8*-:-9ICE7DK#UKB
M788Z/;^ENI9,,U!$Y(0#!B2<T17CS:*J5PI>:J@TT8(L(85R!9*$_@<2>(%/
MJ 1"%<D%Q_>KKLC9$C1E7)V3=X15Y+$0M:)5IJ:N1K>&Z::MLYO&63#@#%F7
M'>?I84G.WIW_6\7%K%W@H L<V++A0-F%*$NF\7^E%4%C9"$JS:HU5*F)NV0J
MY4+5F.KG]4IIB?^:7T>H84<-+74T0,4,0=\C:%2159D/:#N/HY$_=;<]K%''
M&IUBA7VL1A7OLY(D[F=%'2LZQ1KUL:(#5I2,DWY6W+'B4ZRHCQ4?L$:)-^IG
M)1TK.<6*^UC)(<L;RC7N6..CK,<"L)_F&F0?<7Q ]#W/'T!..N3D*/*3%$J1
M1Z$I[V-.#IAA,O&#?J;O_6TUWE'J5T H*S>UA@R; P8&I<F9::H9P0X=7GKO
MR<[V4<@NZ!8DG@LDPT]2U-A_)-5PWMM'O ._%T&<3 ;\[K5&_ZC?;W@H#CZC
M5KO_Z891$(;_0=V]UFR.N5LJUZQ2V&ESU'F7"1:0S<G13+38V&Z]$AI[OQT6
M>-J"-!OP?BZ$?IN8 Z [O^=_ %!+ P04    "  5@V%46DR-R'L"  "7!@
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MX% [ _H^5\KN)\Y!W1-._P%02P,$%     @ %8-A5&-P\+D7 P  /@H  !D
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MU E%AF_!<VE_T::.]1RT6$G%BQJL%1245?_DM39B!X#['0"_!OC[@+ #$-2
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MD$: SPLA]*%C)N@JS]6_4$L#!!0    ( !6#852@ZO4RS ,  /L-   9
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M$+6$R&:F"<7F(2&*3,>";T 8M%8S YM,R];AT\J4_4D)O4LU3TWG@J>(F;P
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MH/*LA%N!Y*$HF'B^AIP?%R,\>GEPEVUWRCP(EO,]V\)G4'_L;X6^"YHH:59
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M%_3W&\[5RXT!: Y?E_\#4$L#!!0    ( !6#853H++(560<  /T?   9
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M:2; [TLA].[!&-C?^%_]#U!+ P04    "  5@V%4C6 \UX<#  "&"@  &0
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MK&#=8M D8..B((Z)Q0"P )$2]\A!0:LV\ZOVJXP5L]66L#BP"P. (]1<>R8
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MQ/M!LU](MM>CUX9)-<CIRU(-Y\ [@+J_94R^++H$X[B_^@U02P,$%     @
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MBT_]N,&[*2AK@-\+*<W[P-Y^VMON\C]02P,$%     @ %8-A5,KE;91A P
M6@P  !D   !X;"]W;W)K<VAE971S+W-H965T-S@N>&ULG5==;],P%/TK5B0D
MD%#ST:Y=I[;2VH#8 V*B#!X0#VYRTUIS[&*[=/OW7#M9:%GB#%Z:^.,<WW-L
MW]S.CE+=ZQV (0\E%WH>[(S97X6ASG904CV0>Q X4DA54H--M0WU7@'-':CD
M81)%X["D3 2+F>N[58N9/!C.!-PJH@]E2=7C$K@\SH,X>.KXS+8[8SO"Q6Q/
MM[ &<[>_5=@*&Y:<E2 TDX(H*.;!=7R5QI$%N!E?&1SUR3NQ4C92WMO&33X/
M(AL1<,B,I:#X^ 4KX-PR81P_:]*@6=,"3]^?V-\[\2AF0S6L)/_&<K.;!Y<!
MR:&@!VX^R^,'J 5=6+Y,<NU^R;&>&P4D.V@CRQJ,$91,5$_Z4!MQ HC''8"D
M!B1_ T8=@&$-&+X4,*H!(^=,)<7YD%)#%S,ECT39V<AF7YR9#HWRF;#[OC8*
M1QGBS")E10$*1 ::;, < 00Q.R!W@AG(R=I0@R,%Y* H)QJ;!R/5(V$BDR40
M0Q^(PBF$BMSA .G<5CZ;<<1E"$4NR?&PZ2OR.@5#&==O9J%!)3:>,*NC7E91
M)QU1QPGY*(79:?).Y)"?$X1H0>-#\N3#,O$RII -R#!^2Y(HB5L"6KT<'K7
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MFHEK]!%]>8S0U8=K] &E%#TEK!"$QF)H2Q6X=F\OZR"G59#NA2"QBQX8E8E
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M9PN>IDP^."E8>D.G]@^!>_SV^91E="G,=0..2#O^R%*^S)/FJ4M(1/U4._X
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M&@1>Z:71\'UI A)Y3(@\YA5Y#OJJT ?N^\WYV9O96W$)8E6K*R3P+2'P+:_
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M;W!S+V%P<"YX;6Q02P$"% ,4    "  5@V%4KFP[E^X    K @  $0
M        @ &O    9&]C4')O<',O8V]R92YX;6Q02P$"% ,4    "  5@V%4
MF5R<(Q &  "<)P  $P              @ ', 0  >&PO=&AE;64O=&AE;64Q
M+GAM;%!+ 0(4 Q0    ( !6#850\W:6O\P4  +T9   8              "
M@0T(  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q02P$"% ,4    "  5@V%4
M943C>M8&  !'&P  &               @($V#@  >&PO=V]R:W-H965T<R]S
M:&5E=#(N>&UL4$L! A0#%     @ %8-A5.SEJ?C& @  H0@  !@
M     ("!0A4  'AL+W=O<FMS:&5E=',O<VAE970S+GAM;%!+ 0(4 Q0    (
M !6#850"EN]=]04  )07   8              " @3X8  !X;"]W;W)K<VAE
M971S+W-H965T-"YX;6Q02P$"% ,4    "  5@V%4XX[^,$<$  !D#P  &
M            @(%I'@  >&PO=V]R:W-H965T<R]S:&5E=#4N>&UL4$L! A0#
M%     @ %8-A5*Z&5[\2!P  X"$  !@              ("!YB(  'AL+W=O
M<FMS:&5E=',O<VAE970V+GAM;%!+ 0(4 Q0    ( !6#850]+EF!=P@  +4D
M   8              " @2XJ  !X;"]W;W)K<VAE971S+W-H965T-RYX;6Q0
M2P$"% ,4    "  5@V%42=:UD# 7  !:/P  &               @(';,@
M>&PO=V]R:W-H965T<R]S:&5E=#@N>&UL4$L! A0#%     @ %8-A5%?=MMBV
M!@  N@X  !@              ("!04H  'AL+W=O<FMS:&5E=',O<VAE970Y
M+GAM;%!+ 0(4 Q0    ( !6#852]$7E:/ @  -H4   9              "
M@2U1  !X;"]W;W)K<VAE971S+W-H965T,3 N>&UL4$L! A0#%     @ %8-A
M5-FEN?%X @  1 4  !D              ("!H%D  'AL+W=O<FMS:&5E=',O
M<VAE970Q,2YX;6Q02P$"% ,4    "  5@V%4+3+CC,T$  "Q#   &0
M        @(%/7   >&PO=V]R:W-H965T<R]S:&5E=#$R+GAM;%!+ 0(4 Q0
M   ( !6#850';%3!MP4  +8.   9              " @5-A  !X;"]W;W)K
M<VAE971S+W-H965T,3,N>&UL4$L! A0#%     @ %8-A5/A1%$C. @  008
M !D              ("!06<  'AL+W=O<FMS:&5E=',O<VAE970Q-"YX;6Q0
M2P$"% ,4    "  5@V%4L70M&: $   <"P  &0              @(%&:@
M>&PO=V]R:W-H965T<R]S:&5E=#$U+GAM;%!+ 0(4 Q0    ( !6#853BI;68
MV0(  -0%   9              " @1UO  !X;"]W;W)K<VAE971S+W-H965T
M,38N>&UL4$L! A0#%     @ %8-A5&,7RL'D @  508  !D
M ("!+7(  'AL+W=O<FMS:&5E=',O<VAE970Q-RYX;6Q02P$"% ,4    "  5
M@V%4\+'RORP#  "?!@  &0              @(%(=0  >&PO=V]R:W-H965T
M<R]S:&5E=#$X+GAM;%!+ 0(4 Q0    ( !6#852U;P*TT04  -P,   9
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M970R,RYX;6Q02P$"% ,4    "  5@V%40,P-4^T"  #=!@  &0
M    @($2G@  >&PO=V]R:W-H965T<R]S:&5E=#(T+GAM;%!+ 0(4 Q0    (
M !6#853%HAH<SP(  !@'   9              " @3:A  !X;"]W;W)K<VAE
M971S+W-H965T,C4N>&UL4$L! A0#%     @ %8-A5)+C[J20 @  6P8  !D
M             ("!/*0  'AL+W=O<FMS:&5E=',O<VAE970R-BYX;6Q02P$"
M% ,4    "  5@V%4LSL.+9<8  "72@  &0              @($#IP  >&PO
M=V]R:W-H965T<R]S:&5E=#(W+GAM;%!+ 0(4 Q0    ( !6#853P5,$], ,
M ,0&   9              " @=&_  !X;"]W;W)K<VAE971S+W-H965T,C@N
M>&UL4$L! A0#%     @ %8-A5!>(GGMK P  80<  !D              ("!
M.,,  'AL+W=O<FMS:&5E=',O<VAE970R.2YX;6Q02P$"% ,4    "  5@V%4
M'^^1^U\"   "!0  &0              @(':Q@  >&PO=V]R:W-H965T<R]S
M:&5E=#,P+GAM;%!+ 0(4 Q0    ( !6#850PT-B*U0,  /P)   9
M      " @7#)  !X;"]W;W)K<VAE971S+W-H965T,S$N>&UL4$L! A0#%
M  @ %8-A5'TK2(+" @   P8  !D              ("!?,T  'AL+W=O<FMS
M:&5E=',O<VAE970S,BYX;6Q02P$"% ,4    "  5@V%4) 6Z13D#  "4!P
M&0              @(%UT   >&PO=V]R:W-H965T<R]S:&5E=#,S+GAM;%!+
M 0(4 Q0    ( !6#8532@D9)W@(  .(%   9              " @>73  !X
M;"]W;W)K<VAE971S+W-H965T,S0N>&UL4$L! A0#%     @ %8-A5(-7[C.K
M @  J04  !D              ("!^M8  'AL+W=O<FMS:&5E=',O<VAE970S
M-2YX;6Q02P$"% ,4    "  5@V%4LR9KN8,#  #O!P  &0
M@('<V0  >&PO=V]R:W-H965T<R]S:&5E=#,V+GAM;%!+ 0(4 Q0    ( !6#
M852F#+N6^@4  / 1   9              " @9;=  !X;"]W;W)K<VAE971S
M+W-H965T,S<N>&UL4$L! A0#%     @ %8-A5,DT!/=  P  ,@<  !D
M         ("!Q^,  'AL+W=O<FMS:&5E=',O<VAE970S."YX;6Q02P$"% ,4
M    "  5@V%4#F%AZ#<&   9#P  &0              @($^YP  >&PO=V]R
M:W-H965T<R]S:&5E=#,Y+GAM;%!+ 0(4 Q0    ( !6#850IAW%UV@4  %0/
M   9              " @:SM  !X;"]W;W)K<VAE971S+W-H965T-# N>&UL
M4$L! A0#%     @ %8-A5!I#K+_> @  T@8  !D              ("!O?,
M 'AL+W=O<FMS:&5E=',O<VAE970T,2YX;6Q02P$"% ,4    "  5@V%4_O#I
M.-$"  "R!@  &0              @('2]@  >&PO=V]R:W-H965T<R]S:&5E
M=#0R+GAM;%!+ 0(4 Q0    ( !6#851S=1M,D0(  !L&   9
M  " @=KY  !X;"]W;W)K<VAE971S+W-H965T-#,N>&UL4$L! A0#%     @
M%8-A5#WW'9GJ @  A0L  !D              ("!HOP  'AL+W=O<FMS:&5E
M=',O<VAE970T-"YX;6Q02P$"% ,4    "  5@V%4R$]$;%L%  ">%P  &0
M            @('#_P  >&PO=V]R:W-H965T<R]S:&5E=#0U+GAM;%!+ 0(4
M Q0    ( !6#852#1\%N(P,  !@*   9              " @54% 0!X;"]W
M;W)K<VAE971S+W-H965T-#8N>&UL4$L! A0#%     @ %8-A5/\=:IAI!0
MYQ$  !D              ("!KP@! 'AL+W=O<FMS:&5E=',O<VAE970T-RYX
M;6Q02P$"% ,4    "  5@V%4#;*U-E<"  "S!0  &0              @(%/
M#@$ >&PO=V]R:W-H965T<R]S:&5E=#0X+GAM;%!+ 0(4 Q0    ( !6#852>
M-,#14@(  *T%   9              " @=T0 0!X;"]W;W)K<VAE971S+W-H
M965T-#DN>&UL4$L! A0#%     @ %8-A5,="0)M+!   ;1<  !D
M     ("!9A,! 'AL+W=O<FMS:&5E=',O<VAE970U,"YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( !6#8536A[DC.P0  +T3   9              "
M@<0D 0!X;"]W;W)K<VAE971S+W-H965T-34N>&UL4$L! A0#%     @ %8-A
M5'5Z2(P; P    D  !D              ("!-BD! 'AL+W=O<FMS:&5E=',O
M<VAE970U-BYX;6Q02P$"% ,4    "  5@V%4=UN3O7@$  "!%   &0
M        @(&(+ $ >&PO=V]R:W-H965T<R]S:&5E=#4W+GAM;%!+ 0(4 Q0
M   ( !6#850:841)?@,  +0-   9              " @3<Q 0!X;"]W;W)K
M<VAE971S+W-H965T-3@N>&UL4$L! A0#%     @ %8-A5)6DO42M @  !@<
M !D              ("![#0! 'AL+W=O<FMS:&5E=',O<VAE970U.2YX;6Q0
M2P$"% ,4    "  5@V%4%IWV)]\"  #+!P  &0              @('0-P$
M>&PO=V]R:W-H965T<R]S:&5E=#8P+GAM;%!+ 0(4 Q0    ( !6#851:3(W(
M>P(  )<&   9              " @>8Z 0!X;"]W;W)K<VAE971S+W-H965T
M-C$N>&UL4$L! A0#%     @ %8-A5)>F7\\\ P  'PH  !D
M ("!F#T! 'AL+W=O<FMS:&5E=',O<VAE970V,BYX;6Q02P$"% ,4    "  5
M@V%48W#PN1<#   ^"@  &0              @($+00$ >&PO=V]R:W-H965T
M<R]S:&5E=#8S+GAM;%!+ 0(4 Q0    ( !6#853"%@2M5 ,  (4*   9
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M970V."YX;6Q02P$"% ,4    "  5@V%4Z"RR%5D'  #]'P  &0
M    @(%[5@$ >&PO=V]R:W-H965T<R]S:&5E=#8Y+GAM;%!+ 0(4 Q0    (
M !6#852-8#S7AP,  (8*   9              " @0M> 0!X;"]W;W)K<VAE
M971S+W-H965T-S N>&UL4$L! A0#%     @ %8-A5-,!]/F# @  " 8  !D
M             ("!R6$! 'AL+W=O<FMS:&5E=',O<VAE970W,2YX;6Q02P$"
M% ,4    "  5@V%4E2>''+@'   C)P  &0              @(&#9 $ >&PO
M=V]R:W-H965T<R]S:&5E=#<R+GAM;%!+ 0(4 Q0    ( !6#85060D"FQ0,
M - /   9              " @7)L 0!X;"]W;W)K<VAE971S+W-H965T-S,N
M>&UL4$L! A0#%     @ %8-A5$S]_BYQ P  \0P  !D              ("!
M;G ! 'AL+W=O<FMS:&5E=',O<VAE970W-"YX;6Q02P$"% ,4    "  5@V%4
M4IL_WKX"  !J!P  &0              @($6= $ >&PO=V]R:W-H965T<R]S
M:&5E=#<U+GAM;%!+ 0(4 Q0    ( !6#851G/'<H@P,  /H+   9
M      " @0MW 0!X;"]W;W)K<VAE971S+W-H965T-S8N>&UL4$L! A0#%
M  @ %8-A5$C9VJA/!   ^0X  !D              ("!Q7H! 'AL+W=O<FMS
M:&5E=',O<VAE970W-RYX;6Q02P$"% ,4    "  5@V%4RN5ME&$#  !:#
M&0              @(%+?P$ >&PO=V]R:W-H965T<R]S:&5E=#<X+GAM;%!+
M 0(4 Q0    ( !6#851MZW1GFP(  (0'   9              " @>." 0!X
M;"]W;W)K<VAE971S+W-H965T-SDN>&UL4$L! A0#%     @ %8-A5+6\#!$Q
M!   1Q$  !D              ("!M84! 'AL+W=O<FMS:&5E=',O<VAE970X
M,"YX;6Q02P$"% ,4    "  5@V%498D\2!$#  "0"   &0
M@($=B@$ >&PO=V]R:W-H965T<R]S:&5E=#@Q+GAM;%!+ 0(4 Q0    ( !6#
M853A[$[[B@(  "8&   9              " @66- 0!X;"]W;W)K<VAE971S
M+W-H965T.#(N>&UL4$L! A0#%     @ %8-A5$D#$  [ P  *A,   T
M         ( !)I ! 'AL+W-T>6QE<RYX;6Q02P$"% ,4    "  5@V%4EXJ[
M',     3 @  "P              @ &,DP$ 7W)E;',O+G)E;'-02P$"% ,4
M    "  5@V%4)[%\L\<&   +-@  #P              @ %UE $ >&PO=V]R
M:V)O;VLN>&UL4$L! A0#%     @ %8-A5&;-$3IT @  ;3   !H
M     ( !:9L! 'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#%
M  @ %8-A5!(!8E A @  ("\  !,              ( !%9X! %M#;VYT96YT
A7U1Y<&5S72YX;6Q02P4&     %H 6@"M&   9Z !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>237</ContextCount>
  <ElementCount>463</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>77</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>7</UnitCount>
  <MyReports>
    <Report instance="g082622_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="g082622_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>00000002 - Statement - Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/BalanceSheets</Role>
      <ShortName>Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="g082622_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>00000003 - Statement - Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/BalanceSheetsParenthetical</Role>
      <ShortName>Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="g082622_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>00000004 - Statement - Consolidated Statements of Income</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/StatementsOfIncome</Role>
      <ShortName>Consolidated Statements of Income</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="g082622_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>00000005 - Statement - Consolidated Statements of Comprehensive Income</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/StatementsOfComprehensiveIncome</Role>
      <ShortName>Consolidated Statements of Comprehensive Income</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="g082622_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>00000006 - Statement - Consolidated Statements of Changes in Shareholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/StatementsOfChangesInShareholdersEquity</Role>
      <ShortName>Consolidated Statements of Changes in Shareholders' Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="g082622_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>00000007 - Statement - Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/StatementsOfCashFlows</Role>
      <ShortName>Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="g082622_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>00000008 - Disclosure - The Company and its Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPolicies</Role>
      <ShortName>The Company and its Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="g082622_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>00000009 - Disclosure - Impact of COVID-19 Pandemic</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/ImpactOfCovid-19Pandemic</Role>
      <ShortName>Impact of COVID-19 Pandemic</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="g082622_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>00000010 - Disclosure - Recent Agreements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/RecentAgreements</Role>
      <ShortName>Recent Agreements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="g082622_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>00000011 - Disclosure - Inventories</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/Inventories</Role>
      <ShortName>Inventories</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="g082622_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>00000012 - Disclosure - Fair Value of Financial Instruments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/FairValueOfFinancialInstruments</Role>
      <ShortName>Fair Value of Financial Instruments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="g082622_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>00000013 - Disclosure - Derivative Financial Instruments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/DerivativeFinancialInstruments</Role>
      <ShortName>Derivative Financial Instruments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="g082622_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>00000014 - Disclosure - Property, Equipment and Leasehold Improvements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/PropertyEquipmentAndLeaseholdImprovements</Role>
      <ShortName>Property, Equipment and Leasehold Improvements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="g082622_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>00000015 - Disclosure - Trademarks, Licenses and Other Intangible Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssets</Role>
      <ShortName>Trademarks, Licenses and Other Intangible Assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="g082622_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>00000016 - Disclosure - Accrued Expenses</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/AccruedExpenses</Role>
      <ShortName>Accrued Expenses</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="g082622_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>00000017 - Disclosure - Loans Payable ??? Banks</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/LoansPayableBanks</Role>
      <ShortName>Loans Payable ??? Banks</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="g082622_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>00000018 - Disclosure - Long-Term Debt</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/Long-termDebt</Role>
      <ShortName>Long-Term Debt</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="g082622_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>00000019 - Disclosure - Commitments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/Commitments</Role>
      <ShortName>Commitments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="g082622_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>00000020 - Disclosure - Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/Equity</Role>
      <ShortName>Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="g082622_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>00000021 - Disclosure - Net Income Attributable to Inter Parfums, Inc. Common Shareholders</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.CommonShareholders</Role>
      <ShortName>Net Income Attributable to Inter Parfums, Inc. Common Shareholders</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="g082622_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>00000022 - Disclosure - Segments and Geographic Areas</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/SegmentsAndGeographicAreas</Role>
      <ShortName>Segments and Geographic Areas</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="g082622_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>00000023 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="g082622_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>00000024 - Disclosure - Accumulated Other Comprehensive Loss</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/AccumulatedOtherComprehensiveLoss</Role>
      <ShortName>Accumulated Other Comprehensive Loss</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="g082622_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>00000025 - Disclosure - Net Income Attributable to Inter Parfums, Inc. and Transfers from the Noncontrolling Interest</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.AndTransfersFromNoncontrollingInterest</Role>
      <ShortName>Net Income Attributable to Inter Parfums, Inc. and Transfers from the Noncontrolling Interest</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="g082622_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>00000026 - Disclosure - Reconciliation of Cash and Cash Equivalents to the Statement of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/ReconciliationOfCashAndCashEquivalentsToStatementOfCashFlows</Role>
      <ShortName>Reconciliation of Cash and Cash Equivalents to the Statement of Cash Flows</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="g082622_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>00000027 - Disclosure - The Company and its Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesPolicies</Role>
      <ShortName>The Company and its Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPolicies</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="g082622_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>00000028 - Disclosure - The Company and its Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesTables</Role>
      <ShortName>The Company and its Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPolicies</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="g082622_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>00000029 - Disclosure - Recent Agreements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/RecentAgreementsTables</Role>
      <ShortName>Recent Agreements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://interparfumsinc.com/role/RecentAgreements</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="g082622_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>00000030 - Disclosure - Inventories (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/InventoriesTables</Role>
      <ShortName>Inventories (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://interparfumsinc.com/role/Inventories</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="g082622_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>00000031 - Disclosure - Fair Value of Financial Instruments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/FairValueOfFinancialInstrumentsTables</Role>
      <ShortName>Fair Value of Financial Instruments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://interparfumsinc.com/role/FairValueOfFinancialInstruments</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="g082622_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>00000032 - Disclosure - Property, Equipment and Leasehold Improvements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/PropertyEquipmentAndLeaseholdImprovementsTables</Role>
      <ShortName>Property, Equipment and Leasehold Improvements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://interparfumsinc.com/role/PropertyEquipmentAndLeaseholdImprovements</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="g082622_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>00000033 - Disclosure - Trademarks, Licenses and Other Intangible Assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssetsTables</Role>
      <ShortName>Trademarks, Licenses and Other Intangible Assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssets</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="g082622_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>00000034 - Disclosure - Accrued Expenses (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/AccruedExpensesTables</Role>
      <ShortName>Accrued Expenses (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://interparfumsinc.com/role/AccruedExpenses</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="g082622_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>00000035 - Disclosure - Long-Term Debt (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/Long-termDebtTables</Role>
      <ShortName>Long-Term Debt (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://interparfumsinc.com/role/Long-termDebt</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="g082622_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>00000036 - Disclosure - Commitments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/CommitmentsTables</Role>
      <ShortName>Commitments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://interparfumsinc.com/role/Commitments</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="g082622_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>00000037 - Disclosure - Equity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/EquityTables</Role>
      <ShortName>Equity (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://interparfumsinc.com/role/Equity</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="g082622_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>00000038 - Disclosure - Net Income Attributable to Inter Parfums, Inc. Common Shareholders (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.CommonShareholdersTables</Role>
      <ShortName>Net Income Attributable to Inter Parfums, Inc. Common Shareholders (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.CommonShareholders</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="g082622_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>00000039 - Disclosure - Segments and Geographic Areas (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/SegmentsAndGeographicAreasTables</Role>
      <ShortName>Segments and Geographic Areas (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://interparfumsinc.com/role/SegmentsAndGeographicAreas</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="g082622_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>00000040 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/IncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://interparfumsinc.com/role/IncomeTaxes</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="g082622_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>00000041 - Disclosure - Accumulated Other Comprehensive Loss (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/AccumulatedOtherComprehensiveLossTables</Role>
      <ShortName>Accumulated Other Comprehensive Loss (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://interparfumsinc.com/role/AccumulatedOtherComprehensiveLoss</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="g082622_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>00000042 - Disclosure - Net Income Attributable to Inter Parfums, Inc. and Transfers from the Noncontrolling Interest (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.AndTransfersFromNoncontrollingInterestTables</Role>
      <ShortName>Net Income Attributable to Inter Parfums, Inc. and Transfers from the Noncontrolling Interest (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.AndTransfersFromNoncontrollingInterest</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="g082622_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>00000043 - Disclosure - Reconciliation of Cash and Cash Equivalents to the Statement of Cash Flows (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/ReconciliationOfCashAndCashEquivalentsToStatementOfCashFlowsTables</Role>
      <ShortName>Reconciliation of Cash and Cash Equivalents to the Statement of Cash Flows (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://interparfumsinc.com/role/ReconciliationOfCashAndCashEquivalentsToStatementOfCashFlows</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="g082622_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>00000044 - Disclosure - Schedule of lanvin brand name for our class (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/ScheduleOfLanvinBrandNameForOurClassDetails</Role>
      <ShortName>Schedule of lanvin brand name for our class (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="g082622_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>00000045 - Disclosure - The Company and its Significant Accounting Policies (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesDetailsNarrative</Role>
      <ShortName>The Company and its Significant Accounting Policies (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesTables</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="g082622_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>00000046 - Disclosure - All amounts have been translated to U.S. dollars at the October 1, 2021 exchange rate. (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/AllAmountsHaveBeenTranslatedToU.s.DollarsAtOctober12021ExchangeRate.Details</Role>
      <ShortName>All amounts have been translated to U.S. dollars at the October 1, 2021 exchange rate. (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="g082622_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>00000047 - Disclosure - Recent Agreements (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative</Role>
      <ShortName>Recent Agreements (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://interparfumsinc.com/role/RecentAgreementsTables</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="g082622_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>00000048 - Disclosure - Schedule of inventories (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/ScheduleOfInventoriesDetails</Role>
      <ShortName>Schedule of inventories (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="g082622_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>00000049 - Disclosure - Inventories (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/InventoriesDetailsNarrative</Role>
      <ShortName>Inventories (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://interparfumsinc.com/role/InventoriesTables</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="g082622_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>00000050 - Disclosure - Schedule of fair value, assets measured on recurring basis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/ScheduleOfFairValueAssetsMeasuredOnRecurringBasisDetails</Role>
      <ShortName>Schedule of fair value, assets measured on recurring basis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="g082622_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>00000051 - Disclosure - Derivative Financial Instruments (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/DerivativeFinancialInstrumentsDetailsNarrative</Role>
      <ShortName>Derivative Financial Instruments (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://interparfumsinc.com/role/DerivativeFinancialInstruments</ParentRole>
      <Position>51</Position>
    </Report>
    <Report instance="g082622_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>00000052 - Disclosure - Schedule of equipment and leasehold improvements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/ScheduleOfEquipmentAndLeaseholdImprovementsDetails</Role>
      <ShortName>Schedule of equipment and leasehold improvements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="g082622_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>00000053 - Disclosure - Property, Equipment and Leasehold Improvements (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/PropertyEquipmentAndLeaseholdImprovementsDetailsNarrative</Role>
      <ShortName>Property, Equipment and Leasehold Improvements (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://interparfumsinc.com/role/PropertyEquipmentAndLeaseholdImprovementsTables</ParentRole>
      <Position>53</Position>
    </Report>
    <Report instance="g082622_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>00000054 - Disclosure - Schedule of trademarks, licenses and other intangible assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/ScheduleOfTrademarksLicensesAndOtherIntangibleAssetsDetails</Role>
      <ShortName>Schedule of trademarks, licenses and other intangible assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="g082622_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>00000055 - Disclosure - Trademarks, Licenses and Other Intangible Assets (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssetsDetailsNarrative</Role>
      <ShortName>Trademarks, Licenses and Other Intangible Assets (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssetsTables</ParentRole>
      <Position>55</Position>
    </Report>
    <Report instance="g082622_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>00000056 - Disclosure - Accrued expenses consist of the following: (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/AccruedExpensesConsistOfFollowingDetails</Role>
      <ShortName>Accrued expenses consist of the following: (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="g082622_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>00000057 - Disclosure - Long-term debt consists of the following: (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/Long-termDebtConsistsOfFollowingDetails</Role>
      <ShortName>Long-term debt consists of the following: (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="g082622_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>00000058 - Disclosure - Loans Payable ??? Banks (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/LoansPayableBanksDetailsNarrative</Role>
      <ShortName>Loans Payable ??? Banks (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://interparfumsinc.com/role/LoansPayableBanks</ParentRole>
      <Position>58</Position>
    </Report>
    <Report instance="g082622_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>00000059 - Disclosure - Long-Term Debt (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/Long-termDebtDetailsNarrative</Role>
      <ShortName>Long-Term Debt (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://interparfumsinc.com/role/Long-termDebtTables</ParentRole>
      <Position>59</Position>
    </Report>
    <Report instance="g082622_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>00000060 - Disclosure - Maturities of lease liabilities subsequent to December 31, 2021 are as follows: (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/MaturitiesOfLeaseLiabilitiesSubsequentToDecember312021AreAsFollowsDetails</Role>
      <ShortName>Maturities of lease liabilities subsequent to December 31, 2021 are as follows: (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="g082622_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>00000061 - Disclosure - minimum annual royalties and other commitments as follows: (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/MinimumAnnualRoyaltiesAndOtherCommitmentsAsFollowsDetails</Role>
      <ShortName>minimum annual royalties and other commitments as follows: (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="g082622_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>00000062 - Disclosure - Commitments (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/CommitmentsDetailsNarrative</Role>
      <ShortName>Commitments (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://interparfumsinc.com/role/CommitmentsTables</ParentRole>
      <Position>62</Position>
    </Report>
    <Report instance="g082622_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>00000063 - Disclosure - The following table sets forth information with respect to nonvested options for 2021: (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/FollowingTableSetsForthInformationWithRespectToNonvestedOptionsFor2021Details</Role>
      <ShortName>The following table sets forth information with respect to nonvested options for 2021: (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="g082622_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>00000064 - Disclosure - The effect of share-based payment expenses decreased income statement line items as follows: (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/EffectOfShare-basedPaymentExpensesDecreasedIncomeStatementLineItemsAsFollowsDetails</Role>
      <ShortName>The effect of share-based payment expenses decreased income statement line items as follows: (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="g082622_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>00000065 - Disclosure - The following table summarizes stock option activity and related information for the years ended December 31, 2021, 2020 and 2019: (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/FollowingTableSummarizesStockOptionActivityAndRelatedInformationForYearsEndedDecember3120212020And2019Details</Role>
      <ShortName>The following table summarizes stock option activity and related information for the years ended December 31, 2021, 2020 and 2019: (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="g082622_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>00000066 - Disclosure - The assumptions used in the Black-Scholes pricing model are set forth in the following table: (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/AssumptionsUsedInBlack-scholesPricingModelAreSetForthInFollowingTableDetails</Role>
      <ShortName>The assumptions used in the Black-Scholes pricing model are set forth in the following table: (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="g082622_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>00000067 - Disclosure - Proceeds, tax benefits and intrinsic value related to stock options exercised were as follows (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/ProceedsTaxBenefitsAndIntrinsicValueRelatedToStockOptionsExercisedWereAsFollowsDetails</Role>
      <ShortName>Proceeds, tax benefits and intrinsic value related to stock options exercised were as follows (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="g082622_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>00000068 - Disclosure - The following table summarizes additional stock option information as of December 31, 2021: (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/FollowingTableSummarizesAdditionalStockOptionInformationAsOfDecember312021Details</Role>
      <ShortName>The following table summarizes additional stock option information as of December 31, 2021: (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="g082622_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>00000069 - Disclosure - Equity (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/EquityDetailsNarrative</Role>
      <ShortName>Equity (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://interparfumsinc.com/role/EquityTables</ParentRole>
      <Position>69</Position>
    </Report>
    <Report instance="g082622_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>00000070 - Disclosure - The reconciliation between the numerators and denominators of the basic and diluted EPS computations is as follows: (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/ReconciliationBetweenNumeratorsAndDenominatorsOfBasicAndDilutedEpsComputationsIsAsFollowsDetails</Role>
      <ShortName>The reconciliation between the numerators and denominators of the basic and diluted EPS computations is as follows: (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="g082622_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>00000071 - Disclosure - Net Income Attributable to Inter Parfums, Inc. Common Shareholders (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.CommonShareholdersDetailsNarrative</Role>
      <ShortName>Net Income Attributable to Inter Parfums, Inc. Common Shareholders (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.CommonShareholdersTables</ParentRole>
      <Position>71</Position>
    </Report>
    <Report instance="g082622_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>00000072 - Disclosure - Information on the Company???s operations by segments is as follows: (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/InformationOnCompanysOperationsBySegmentsIsAsFollowsDetails</Role>
      <ShortName>Information on the Company???s operations by segments is as follows: (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report instance="g082622_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>00000073 - Disclosure - Consolidated net sales to customers by region are as follows: (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/NetSalesToCustomersByRegionAreAsFollowsDetails</Role>
      <ShortName>Consolidated net sales to customers by region are as follows: (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>73</Position>
    </Report>
    <Report instance="g082622_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>00000074 - Disclosure - Consolidated net sales to customers in major countries are as follows: (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/NetSalesToCustomersInMajorCountriesAreAsFollowsDetails</Role>
      <ShortName>Consolidated net sales to customers in major countries are as follows: (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report instance="g082622_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>00000075 - Disclosure - The components of income before income taxes consist of the following: (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/ComponentsOfIncomeBeforeIncomeTaxesConsistOfFollowingDetails</Role>
      <ShortName>The components of income before income taxes consist of the following: (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>75</Position>
    </Report>
    <Report instance="g082622_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>00000076 - Disclosure - The provision for current and deferred income tax expense (benefit) consists of the following: (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/ProvisionForCurrentAndDeferredIncomeTaxExpenseBenefitConsistsOfFollowingDetails</Role>
      <ShortName>The provision for current and deferred income tax expense (benefit) consists of the following: (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>76</Position>
    </Report>
    <Report instance="g082622_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>00000077 - Disclosure - The tax effects of temporary differences that give rise to significant portions of the deferred tax assets and deferred tax liabilities are as follows: (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/TaxEffectsOfTemporaryDifferencesThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndDeferredTaxLiabilitiesAreAsFollowsDetails</Role>
      <ShortName>The tax effects of temporary differences that give rise to significant portions of the deferred tax assets and deferred tax liabilities are as follows: (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>77</Position>
    </Report>
    <Report instance="g082622_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>00000078 - Disclosure - Differences between the United States federal statutory income tax rate and the effective income tax rate were as follows: (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/DifferencesBetweenUnitedStatesFederalStatutoryIncomeTaxRateAndEffectiveIncomeTaxRateWereAsFollowsDetails</Role>
      <ShortName>Differences between the United States federal statutory income tax rate and the effective income tax rate were as follows: (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>78</Position>
    </Report>
    <Report instance="g082622_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>00000079 - Disclosure - Income Taxes (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/IncomeTaxesDetailsNarrative</Role>
      <ShortName>Income Taxes (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://interparfumsinc.com/role/IncomeTaxesTables</ParentRole>
      <Position>79</Position>
    </Report>
    <Report instance="g082622_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>00000080 - Disclosure - The components of accumulated other comprehensive loss consist of the following: (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/ComponentsOfAccumulatedOtherComprehensiveLossConsistOfFollowingDetails</Role>
      <ShortName>The components of accumulated other comprehensive loss consist of the following: (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>80</Position>
    </Report>
    <Report instance="g082622_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>00000081 - Disclosure - Schedule of net income attributable to transfers from the noncontrolling interest (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/ScheduleOfNetIncomeAttributableToTransfersFromNoncontrollingInterestDetails</Role>
      <ShortName>Schedule of net income attributable to transfers from the noncontrolling interest (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>81</Position>
    </Report>
    <Report instance="g082622_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R82.htm</HtmlFileName>
      <LongName>00000082 - Disclosure - The following table summarizes cash and cash equivalents as of December 31, 2021: (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/FollowingTableSummarizesCashAndCashEquivalentsAsOfDecember312021Details</Role>
      <ShortName>The following table summarizes cash and cash equivalents as of December 31, 2021: (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>82</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-K" original="g082622_10k.htm">g082622_10k.htm</File>
    <File>g082622_ex21.htm</File>
    <File>g082622_ex23.htm</File>
    <File>g082622_ex3-10.htm</File>
    <File>g082622_ex3-101.htm</File>
    <File>g082622_ex3-102.htm</File>
    <File>g082622_ex3-103.htm</File>
    <File>g082622_ex3-8.htm</File>
    <File>g082622_ex31-1.htm</File>
    <File>g082622_ex31-2.htm</File>
    <File>g082622_ex32-1.htm</File>
    <File>g082622_ex32-2.htm</File>
    <File>g082622_ex4-33.htm</File>
    <File>ipar-20211231.xsd</File>
    <File>ipar-20211231_cal.xml</File>
    <File>ipar-20211231_def.xml</File>
    <File>ipar-20211231_lab.xml</File>
    <File>ipar-20211231_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>img001_v1.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="1">http://fasb.org/srt/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy items="1068">http://fasb.org/us-gaap/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy items="36">http://xbrl.sec.gov/dei/2021q4</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>109
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "g082622_10k.htm": {
   "axisCustom": 0,
   "axisStandard": 27,
   "contextCount": 237,
   "dts": {
    "calculationLink": {
     "local": [
      "ipar-20211231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "ipar-20211231_def.xml"
     ]
    },
    "inline": {
     "local": [
      "g082622_10k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "ipar-20211231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "ipar-20211231_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "ipar-20211231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.sec.gov/currency/2021/currency-2021.xsd",
      "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"
     ]
    }
   },
   "elementCount": 601,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2021-01-31": 72,
    "http://interparfumsinc.com/20211231": 2,
    "http://xbrl.sec.gov/dei/2021q4": 6,
    "total": 80
   },
   "keyCustom": 19,
   "keyStandard": 444,
   "memberCustom": 37,
   "memberStandard": 38,
   "nsprefix": "ipar",
   "nsuri": "http://interparfumsinc.com/20211231",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00000001 - Document - Cover",
     "role": "http://interparfumsinc.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000010 - Disclosure - Recent Agreements",
     "role": "http://interparfumsinc.com/role/RecentAgreements",
     "shortName": "Recent Agreements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000011 - Disclosure - Inventories",
     "role": "http://interparfumsinc.com/role/Inventories",
     "shortName": "Inventories",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000012 - Disclosure - Fair Value of Financial Instruments",
     "role": "http://interparfumsinc.com/role/FairValueOfFinancialInstruments",
     "shortName": "Fair Value of Financial Instruments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000013 - Disclosure - Derivative Financial Instruments",
     "role": "http://interparfumsinc.com/role/DerivativeFinancialInstruments",
     "shortName": "Derivative Financial Instruments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000014 - Disclosure - Property, Equipment and Leasehold Improvements",
     "role": "http://interparfumsinc.com/role/PropertyEquipmentAndLeaseholdImprovements",
     "shortName": "Property, Equipment and Leasehold Improvements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000015 - Disclosure - Trademarks, Licenses and Other Intangible Assets",
     "role": "http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssets",
     "shortName": "Trademarks, Licenses and Other Intangible Assets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000016 - Disclosure - Accrued Expenses",
     "role": "http://interparfumsinc.com/role/AccruedExpenses",
     "shortName": "Accrued Expenses",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000017 - Disclosure - Loans Payable \u2013 Banks",
     "role": "http://interparfumsinc.com/role/LoansPayableBanks",
     "shortName": "Loans Payable \u2013 Banks",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000018 - Disclosure - Long-Term Debt",
     "role": "http://interparfumsinc.com/role/Long-termDebt",
     "shortName": "Long-Term Debt",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000019 - Disclosure - Commitments",
     "role": "http://interparfumsinc.com/role/Commitments",
     "shortName": "Commitments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashCashEquivalentsAndShortTermInvestments",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000002 - Statement - Consolidated Balance Sheets",
     "role": "http://interparfumsinc.com/role/BalanceSheets",
     "shortName": "Consolidated Balance Sheets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:ShortTermInvestments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000020 - Disclosure - Equity",
     "role": "http://interparfumsinc.com/role/Equity",
     "shortName": "Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000021 - Disclosure - Net Income Attributable to Inter Parfums, Inc. Common Shareholders",
     "role": "http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.CommonShareholders",
     "shortName": "Net Income Attributable to Inter Parfums, Inc. Common Shareholders",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000022 - Disclosure - Segments and Geographic Areas",
     "role": "http://interparfumsinc.com/role/SegmentsAndGeographicAreas",
     "shortName": "Segments and Geographic Areas",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000023 - Disclosure - Income Taxes",
     "role": "http://interparfumsinc.com/role/IncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000024 - Disclosure - Accumulated Other Comprehensive Loss",
     "role": "http://interparfumsinc.com/role/AccumulatedOtherComprehensiveLoss",
     "shortName": "Accumulated Other Comprehensive Loss",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MinorityInterestDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000025 - Disclosure - Net Income Attributable to Inter Parfums, Inc. and Transfers from the Noncontrolling Interest",
     "role": "http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.AndTransfersFromNoncontrollingInterest",
     "shortName": "Net Income Attributable to Inter Parfums, Inc. and Transfers from the Noncontrolling Interest",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MinorityInterestDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ipar:ReconciliationOfCashAndCashEquivalentsToTheStatementOfCashFlowsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000026 - Disclosure - Reconciliation of Cash and Cash Equivalents to the Statement of Cash Flows",
     "role": "http://interparfumsinc.com/role/ReconciliationOfCashAndCashEquivalentsToStatementOfCashFlows",
     "shortName": "Reconciliation of Cash and Cash Equivalents to the Statement of Cash Flows",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ipar:ReconciliationOfCashAndCashEquivalentsToTheStatementOfCashFlowsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000027 - Disclosure - The Company and its Significant Accounting Policies (Policies)",
     "role": "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesPolicies",
     "shortName": "The Company and its Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000028 - Disclosure - The Company and its Significant Accounting Policies (Tables)",
     "role": "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesTables",
     "shortName": "The Company and its Significant Accounting Policies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ipar:ScheduleOfInventoryCurrentTableTextBlock1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000029 - Disclosure - Recent Agreements (Tables)",
     "role": "http://interparfumsinc.com/role/RecentAgreementsTables",
     "shortName": "Recent Agreements (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ipar:ScheduleOfInventoryCurrentTableTextBlock1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USDPShares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000003 - Statement - Consolidated Balance Sheets (Parenthetical)",
     "role": "http://interparfumsinc.com/role/BalanceSheetsParenthetical",
     "shortName": "Consolidated Balance Sheets (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USDPShares",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:InventoryDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000030 - Disclosure - Inventories (Tables)",
     "role": "http://interparfumsinc.com/role/InventoriesTables",
     "shortName": "Inventories (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:InventoryDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:FairValueDisclosuresTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000031 - Disclosure - Fair Value of Financial Instruments (Tables)",
     "role": "http://interparfumsinc.com/role/FairValueOfFinancialInstrumentsTables",
     "shortName": "Fair Value of Financial Instruments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:FairValueDisclosuresTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000032 - Disclosure - Property, Equipment and Leasehold Improvements (Tables)",
     "role": "http://interparfumsinc.com/role/PropertyEquipmentAndLeaseholdImprovementsTables",
     "shortName": "Property, Equipment and Leasehold Improvements (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfImpairedIntangibleAssetsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000033 - Disclosure - Trademarks, Licenses and Other Intangible Assets (Tables)",
     "role": "http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssetsTables",
     "shortName": "Trademarks, Licenses and Other Intangible Assets (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfImpairedIntangibleAssetsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000034 - Disclosure - Accrued Expenses (Tables)",
     "role": "http://interparfumsinc.com/role/AccruedExpensesTables",
     "shortName": "Accrued Expenses (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:LongTermDebtTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000035 - Disclosure - Long-Term Debt (Tables)",
     "role": "http://interparfumsinc.com/role/Long-termDebtTables",
     "shortName": "Long-Term Debt (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:LongTermDebtTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000036 - Disclosure - Commitments (Tables)",
     "role": "http://interparfumsinc.com/role/CommitmentsTables",
     "shortName": "Commitments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000037 - Disclosure - Equity (Tables)",
     "role": "http://interparfumsinc.com/role/EquityTables",
     "shortName": "Equity (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000038 - Disclosure - Net Income Attributable to Inter Parfums, Inc. Common Shareholders (Tables)",
     "role": "http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.CommonShareholdersTables",
     "shortName": "Net Income Attributable to Inter Parfums, Inc. Common Shareholders (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000039 - Disclosure - Segments and Geographic Areas (Tables)",
     "role": "http://interparfumsinc.com/role/SegmentsAndGeographicAreasTables",
     "shortName": "Segments and Geographic Areas (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000004 - Statement - Consolidated Statements of Income",
     "role": "http://interparfumsinc.com/role/StatementsOfIncome",
     "shortName": "Consolidated Statements of Income",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:GrossProfit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000040 - Disclosure - Income Taxes (Tables)",
     "role": "http://interparfumsinc.com/role/IncomeTaxesTables",
     "shortName": "Income Taxes (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:ComprehensiveIncomeNoteTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000041 - Disclosure - Accumulated Other Comprehensive Loss (Tables)",
     "role": "http://interparfumsinc.com/role/AccumulatedOtherComprehensiveLossTables",
     "shortName": "Accumulated Other Comprehensive Loss (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:ComprehensiveIncomeNoteTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:MinorityInterestDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000042 - Disclosure - Net Income Attributable to Inter Parfums, Inc. and Transfers from the Noncontrolling Interest (Tables)",
     "role": "http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.AndTransfersFromNoncontrollingInterestTables",
     "shortName": "Net Income Attributable to Inter Parfums, Inc. and Transfers from the Noncontrolling Interest (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:MinorityInterestDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "ipar:ReconciliationOfCashAndCashEquivalentsToTheStatementOfCashFlowsTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000043 - Disclosure - Reconciliation of Cash and Cash Equivalents to the Statement of Cash Flows (Tables)",
     "role": "http://interparfumsinc.com/role/ReconciliationOfCashAndCashEquivalentsToStatementOfCashFlowsTables",
     "shortName": "Reconciliation of Cash and Cash Equivalents to the Statement of Cash Flows (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ipar:ReconciliationOfCashAndCashEquivalentsToTheStatementOfCashFlowsTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock",
       "us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "From2021-01-012021-12-31_custom_MontblancMember",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000044 - Disclosure - Schedule of lanvin brand name for our class (Details)",
     "role": "http://interparfumsinc.com/role/ScheduleOfLanvinBrandNameForOurClassDetails",
     "shortName": "Schedule of lanvin brand name for our class (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock",
       "us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "From2021-01-012021-12-31_custom_MontblancMember",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Pure",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:TradeAndOtherAccountsReceivablePolicy",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000045 - Disclosure - The Company and its Significant Accounting Policies (Details Narrative)",
     "role": "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesDetailsNarrative",
     "shortName": "The Company and its Significant Accounting Policies (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:TradeAndOtherAccountsReceivablePolicy",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ipar:ScheduleOfInventoryCurrentTableTextBlock1",
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:FairValueOfAssetsAcquired",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000046 - Disclosure - All amounts have been translated to U.S. dollars at the October 1, 2021 exchange rate. (Details)",
     "role": "http://interparfumsinc.com/role/AllAmountsHaveBeenTranslatedToU.s.DollarsAtOctober12021ExchangeRate.Details",
     "shortName": "All amounts have been translated to U.S. dollars at the October 1, 2021 exchange rate. (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ipar:ScheduleOfInventoryCurrentTableTextBlock1",
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:FairValueOfAssetsAcquired",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:PaymentsForPurchaseOfOtherAssets1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000047 - Disclosure - Recent Agreements (Details Narrative)",
     "role": "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative",
     "shortName": "Recent Agreements (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:PaymentsForPurchaseOfOtherAssets1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "us-gaap:InventoryDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:InventoryRawMaterials",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000048 - Disclosure - Schedule of inventories (Details)",
     "role": "http://interparfumsinc.com/role/ScheduleOfInventoriesDetails",
     "shortName": "Schedule of inventories (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "us-gaap:InventoryDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:InventoryRawMaterials",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:InventoryDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:InventoryValuationReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000049 - Disclosure - Inventories (Details Narrative)",
     "role": "http://interparfumsinc.com/role/InventoriesDetailsNarrative",
     "shortName": "Inventories (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:InventoryDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:InventoryValuationReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000005 - Statement - Consolidated Statements of Comprehensive Income",
     "role": "http://interparfumsinc.com/role/StatementsOfComprehensiveIncome",
     "shortName": "Consolidated Statements of Comprehensive Income",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "us-gaap:FairValueDisclosuresTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "AsOf2021-12-31_us-gaap_FairValueMeasurementsRecurringMember",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:InvestmentsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000050 - Disclosure - Schedule of fair value, assets measured on recurring basis (Details)",
     "role": "http://interparfumsinc.com/role/ScheduleOfFairValueAssetsMeasuredOnRecurringBasisDetails",
     "shortName": "Schedule of fair value, assets measured on recurring basis (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "us-gaap:FairValueDisclosuresTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "AsOf2021-12-31_us-gaap_FairValueMeasurementsRecurringMember",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:InvestmentsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "AsOf2021-12-31_us-gaap_ForeignExchangeContractMember",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000051 - Disclosure - Derivative Financial Instruments (Details Narrative)",
     "role": "http://interparfumsinc.com/role/DerivativeFinancialInstrumentsDetailsNarrative",
     "shortName": "Derivative Financial Instruments (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "AsOf2021-12-31_us-gaap_ForeignExchangeContractMember",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000052 - Disclosure - Schedule of equipment and leasehold improvements (Details)",
     "role": "http://interparfumsinc.com/role/ScheduleOfEquipmentAndLeaseholdImprovementsDetails",
     "shortName": "Schedule of equipment and leasehold improvements (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000053 - Disclosure - Property, Equipment and Leasehold Improvements (Details Narrative)",
     "role": "http://interparfumsinc.com/role/PropertyEquipmentAndLeaseholdImprovementsDetailsNarrative",
     "shortName": "Property, Equipment and Leasehold Improvements (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfImpairedIntangibleAssetsTextBlock",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000054 - Disclosure - Schedule of trademarks, licenses and other intangible assets (Details)",
     "role": "http://interparfumsinc.com/role/ScheduleOfTrademarksLicensesAndOtherIntangibleAssetsDetails",
     "shortName": "Schedule of trademarks, licenses and other intangible assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfImpairedIntangibleAssetsTextBlock",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000055 - Disclosure - Trademarks, Licenses and Other Intangible Assets (Details Narrative)",
     "role": "http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssetsDetailsNarrative",
     "shortName": "Trademarks, Licenses and Other Intangible Assets (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AccruedAdvertisingCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000056 - Disclosure - Accrued expenses consist of the following: (Details)",
     "role": "http://interparfumsinc.com/role/AccruedExpensesConsistOfFollowingDetails",
     "shortName": "Accrued expenses consist of the following: (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AccruedAdvertisingCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "us-gaap:LongTermDebtTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:LongTermDebt",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000057 - Disclosure - Long-term debt consists of the following: (Details)",
     "role": "http://interparfumsinc.com/role/Long-termDebtConsistsOfFollowingDetails",
     "shortName": "Long-term debt consists of the following: (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "us-gaap:LongTermDebtTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:LongTermDebt",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:DebtDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "AsOf2021-12-31_custom_DomesticSubsidiariesMember",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000058 - Disclosure - Loans Payable \u2013 Banks (Details Narrative)",
     "role": "http://interparfumsinc.com/role/LoansPayableBanksDetailsNarrative",
     "shortName": "Loans Payable \u2013 Banks (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:DebtDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "AsOf2021-12-31_custom_DomesticSubsidiariesMember",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:LongTermDebtTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000059 - Disclosure - Long-Term Debt (Details Narrative)",
     "role": "http://interparfumsinc.com/role/Long-termDebtDetailsNarrative",
     "shortName": "Long-Term Debt (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:LongTermDebtTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "AsOf2018-12-31_us-gaap_CommonStockMember",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000006 - Statement - Consolidated Statements of Changes in Shareholders' Equity",
     "role": "http://interparfumsinc.com/role/StatementsOfChangesInShareholdersEquity",
     "shortName": "Consolidated Statements of Changes in Shareholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "AsOf2018-12-31_us-gaap_CommonStockMember",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000060 - Disclosure - Maturities of lease liabilities subsequent to December 31, 2021 are as follows: (Details)",
     "role": "http://interparfumsinc.com/role/MaturitiesOfLeaseLiabilitiesSubsequentToDecember312021AreAsFollowsDetails",
     "shortName": "Maturities of lease liabilities subsequent to December 31, 2021 are as follows: (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "srt:ContractualObligationFiscalYearMaturityScheduleTableTextBlock",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:OtherCommitmentDueInNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000061 - Disclosure - minimum annual royalties and other commitments as follows: (Details)",
     "role": "http://interparfumsinc.com/role/MinimumAnnualRoyaltiesAndOtherCommitmentsAsFollowsDetails",
     "shortName": "minimum annual royalties and other commitments as follows: (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "srt:ContractualObligationFiscalYearMaturityScheduleTableTextBlock",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:OtherCommitmentDueInNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent",
      "reportCount": 1,
      "unitRef": "Pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000062 - Disclosure - Commitments (Details Narrative)",
     "role": "http://interparfumsinc.com/role/CommitmentsDetailsNarrative",
     "shortName": "Commitments (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:OperatingLeasesRentExpenseNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "AsOf2020-12-31",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares",
      "reportCount": 1,
      "unitRef": "Shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000063 - Disclosure - The following table sets forth information with respect to nonvested options for 2021: (Details)",
     "role": "http://interparfumsinc.com/role/FollowingTableSetsForthInformationWithRespectToNonvestedOptionsFor2021Details",
     "shortName": "The following table sets forth information with respect to nonvested options for 2021: (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Shares",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "From2020-01-012020-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000064 - Disclosure - The effect of share-based payment expenses decreased income statement line items as follows: (Details)",
     "role": "http://interparfumsinc.com/role/EffectOfShare-basedPaymentExpensesDecreasedIncomeStatementLineItemsAsFollowsDetails",
     "shortName": "The effect of share-based payment expenses decreased income statement line items as follows: (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "From2021-01-012021-12-31_us-gaap_OperatingIncomeLossMember",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "AsOf2020-12-31",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unitRef": "Shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000065 - Disclosure - The following table summarizes stock option activity and related information for the years ended December 31, 2021, 2020 and 2019: (Details)",
     "role": "http://interparfumsinc.com/role/FollowingTableSummarizesStockOptionActivityAndRelatedInformationForYearsEndedDecember3120212020And2019Details",
     "shortName": "The following table summarizes stock option activity and related information for the years ended December 31, 2021, 2020 and 2019: (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "AsOf2018-12-31",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Shares",
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000066 - Disclosure - The assumptions used in the Black-Scholes pricing model are set forth in the following table: (Details)",
     "role": "http://interparfumsinc.com/role/AssumptionsUsedInBlack-scholesPricingModelAreSetForthInFollowingTableDetails",
     "shortName": "The assumptions used in the Black-Scholes pricing model are set forth in the following table: (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Pure",
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ProceedsFromStockOptionsExercised",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000067 - Disclosure - Proceeds, tax benefits and intrinsic value related to stock options exercised were as follows (Details)",
     "role": "http://interparfumsinc.com/role/ProceedsTaxBenefitsAndIntrinsicValueRelatedToStockOptionsExercisedWereAsFollowsDetails",
     "shortName": "Proceeds, tax benefits and intrinsic value related to stock options exercised were as follows (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:CashProceedsReceivedAndTaxBenefitFromShareBasedPaymentAwardsTableTextBlock",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:DeferredTaxExpenseFromStockOptionsExercised",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000068 - Disclosure - The following table summarizes additional stock option information as of December 31, 2021: (Details)",
     "role": "http://interparfumsinc.com/role/FollowingTableSummarizesAdditionalStockOptionInformationAsOfDecember312021Details",
     "shortName": "The following table summarizes additional stock option information as of December 31, 2021: (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Shares",
      "xsiNil": "false"
     }
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
      "reportCount": 1,
      "unitRef": "USDPShares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000069 - Disclosure - Equity (Details Narrative)",
     "role": "http://interparfumsinc.com/role/EquityDetailsNarrative",
     "shortName": "Equity (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "From2020-03-012020-03-31",
      "decimals": null,
      "lang": "en-US",
      "name": "ipar:Covid19Description",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000007 - Statement - Consolidated Statements of Cash Flows",
     "role": "http://interparfumsinc.com/role/StatementsOfCashFlows",
     "shortName": "Consolidated Statements of Cash Flows",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:OtherDepreciationAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000070 - Disclosure - The reconciliation between the numerators and denominators of the basic and diluted EPS computations is as follows: (Details)",
     "role": "http://interparfumsinc.com/role/ReconciliationBetweenNumeratorsAndDenominatorsOfBasicAndDilutedEpsComputationsIsAsFollowsDetails",
     "shortName": "The reconciliation between the numerators and denominators of the basic and diluted EPS computations is as follows: (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Shares",
      "xsiNil": "false"
     }
    },
    "R71": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000071 - Disclosure - Net Income Attributable to Inter Parfums, Inc. Common Shareholders (Details Narrative)",
     "role": "http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.CommonShareholdersDetailsNarrative",
     "shortName": "Net Income Attributable to Inter Parfums, Inc. Common Shareholders (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Shares",
      "xsiNil": "false"
     }
    },
    "R72": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000072 - Disclosure - Information on the Company\u2019s operations by segments is as follows: (Details)",
     "role": "http://interparfumsinc.com/role/InformationOnCompanysOperationsBySegmentsIsAsFollowsDetails",
     "shortName": "Information on the Company\u2019s operations by segments is as follows: (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:DepreciationAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R73": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000073 - Disclosure - Consolidated net sales to customers by region are as follows: (Details)",
     "role": "http://interparfumsinc.com/role/NetSalesToCustomersByRegionAreAsFollowsDetails",
     "shortName": "Consolidated net sales to customers by region are as follows: (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R74": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000074 - Disclosure - Consolidated net sales to customers in major countries are as follows: (Details)",
     "role": "http://interparfumsinc.com/role/NetSalesToCustomersInMajorCountriesAreAsFollowsDetails",
     "shortName": "Consolidated net sales to customers in major countries are as follows: (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "From2021-01-012021-12-31_custom_UnitedStatesMember",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R75": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000075 - Disclosure - The components of income before income taxes consist of the following: (Details)",
     "role": "http://interparfumsinc.com/role/ComponentsOfIncomeBeforeIncomeTaxesConsistOfFollowingDetails",
     "shortName": "The components of income before income taxes consist of the following: (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R76": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000076 - Disclosure - The provision for current and deferred income tax expense (benefit) consists of the following: (Details)",
     "role": "http://interparfumsinc.com/role/ProvisionForCurrentAndDeferredIncomeTaxExpenseBenefitConsistsOfFollowingDetails",
     "shortName": "The provision for current and deferred income tax expense (benefit) consists of the following: (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R77": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000077 - Disclosure - The tax effects of temporary differences that give rise to significant portions of the deferred tax assets and deferred tax liabilities are as follows: (Details)",
     "role": "http://interparfumsinc.com/role/TaxEffectsOfTemporaryDifferencesThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndDeferredTaxLiabilitiesAreAsFollowsDetails",
     "shortName": "The tax effects of temporary differences that give rise to significant portions of the deferred tax assets and deferred tax liabilities are as follows: (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R78": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000078 - Disclosure - Differences between the United States federal statutory income tax rate and the effective income tax rate were as follows: (Details)",
     "role": "http://interparfumsinc.com/role/DifferencesBetweenUnitedStatesFederalStatutoryIncomeTaxRateAndEffectiveIncomeTaxRateWereAsFollowsDetails",
     "shortName": "Differences between the United States federal statutory income tax rate and the effective income tax rate were as follows: (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Pure",
      "xsiNil": "false"
     }
    },
    "R79": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:DeferredForeignIncomeTaxExpenseBenefit",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000079 - Disclosure - Income Taxes (Details Narrative)",
     "role": "http://interparfumsinc.com/role/IncomeTaxesDetailsNarrative",
     "shortName": "Income Taxes (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "From2021-01-012021-12-31_custom_ForeignDerivedIntangibleIncomeMember",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:DeferredForeignIncomeTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000008 - Disclosure - The Company and its Significant Accounting Policies",
     "role": "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPolicies",
     "shortName": "The Company and its Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R80": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "AsOf2020-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000080 - Disclosure - The components of accumulated other comprehensive loss consist of the following: (Details)",
     "role": "http://interparfumsinc.com/role/ComponentsOfAccumulatedOtherComprehensiveLossConsistOfFollowingDetails",
     "shortName": "The components of accumulated other comprehensive loss consist of the following: (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "us-gaap:ComprehensiveIncomeNoteTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "AsOf2018-12-31_custom_AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R81": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000081 - Disclosure - Schedule of net income attributable to transfers from the noncontrolling interest (Details)",
     "role": "http://interparfumsinc.com/role/ScheduleOfNetIncomeAttributableToTransfersFromNoncontrollingInterestDetails",
     "shortName": "Schedule of net income attributable to transfers from the noncontrolling interest (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock",
       "us-gaap:MinorityInterestDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "From2019-01-012019-12-31",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R82": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashCashEquivalentsAndShortTermInvestments",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000082 - Disclosure - The following table summarizes cash and cash equivalents as of December 31, 2021: (Details)",
     "role": "http://interparfumsinc.com/role/FollowingTableSummarizesCashAndCashEquivalentsAsOfDecember312021Details",
     "shortName": "The following table summarizes cash and cash equivalents as of December 31, 2021: (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock",
       "ipar:ReconciliationOfCashAndCashEquivalentsToTheStatementOfCashFlowsTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "-3",
      "lang": null,
      "name": "ipar:CashHeldInEscrowIncludedInOtherAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ipar:ImpactOfCOVID19PandemicTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000009 - Disclosure - Impact of COVID-19 Pandemic",
     "role": "http://interparfumsinc.com/role/ImpactOfCovid-19Pandemic",
     "shortName": "Impact of COVID-19 Pandemic",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "g082622_10k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ipar:ImpactOfCOVID19PandemicTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 77,
   "tag": {
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED STATES"
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2021",
     "presentation": [
      "http://interparfumsinc.com/role/InformationOnCompanysOperationsBySegmentsIsAsFollowsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_AllCurrenciesDomain": {
     "auth_ref": [],
     "localname": "AllCurrenciesDomain",
     "nsuri": "http://xbrl.sec.gov/currency/2021",
     "presentation": [
      "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_EUR": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Euro Member Countries, Euro"
       }
      }
     },
     "localname": "EUR",
     "nsuri": "http://xbrl.sec.gov/currency/2021",
     "presentation": [
      "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://interparfumsinc.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://interparfumsinc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r684"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://interparfumsinc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r684"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://interparfumsinc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditorFirmId": {
     "auth_ref": [
      "r681",
      "r683",
      "r684"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PCAOB issued Audit Firm Identifier",
        "label": "Auditor Firm ID"
       }
      }
     },
     "localname": "AuditorFirmId",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://interparfumsinc.com/role/Cover"
     ],
     "xbrltype": "nonemptySequenceNumberItemType"
    },
    "dei_AuditorLocation": {
     "auth_ref": [
      "r681",
      "r683",
      "r684"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location"
       }
      }
     },
     "localname": "AuditorLocation",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://interparfumsinc.com/role/Cover"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_AuditorName": {
     "auth_ref": [
      "r681",
      "r683",
      "r684"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name"
       }
      }
     },
     "localname": "AuditorName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://interparfumsinc.com/role/Cover"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://interparfumsinc.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://interparfumsinc.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://interparfumsinc.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r683"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://interparfumsinc.com/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r681",
      "r683",
      "r684"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://interparfumsinc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://interparfumsinc.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://interparfumsinc.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://interparfumsinc.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://interparfumsinc.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r682"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://interparfumsinc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r670"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://interparfumsinc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r683"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://interparfumsinc.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r683"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://interparfumsinc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r685"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://interparfumsinc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://interparfumsinc.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r673"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://interparfumsinc.com/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://interparfumsinc.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://interparfumsinc.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://interparfumsinc.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://interparfumsinc.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://interparfumsinc.com/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://interparfumsinc.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://interparfumsinc.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r676"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://interparfumsinc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r672"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://interparfumsinc.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://interparfumsinc.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://interparfumsinc.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains."
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://interparfumsinc.com/role/LoansPayableBanksDetailsNarrative",
      "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r672"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://interparfumsinc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r704"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Elected Not To Use the Extended Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://interparfumsinc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://interparfumsinc.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r672"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://interparfumsinc.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://interparfumsinc.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r687"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://interparfumsinc.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r684"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://interparfumsinc.com/role/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://interparfumsinc.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r672"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://interparfumsinc.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r672"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://interparfumsinc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r672"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://interparfumsinc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r672"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://interparfumsinc.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://interparfumsinc.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r702"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://interparfumsinc.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://interparfumsinc.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_IcfrAuditorAttestationFlag": {
     "auth_ref": [
      "r681",
      "r683",
      "r684"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "localname": "IcfrAuditorAttestationFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://interparfumsinc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://interparfumsinc.com/role/LoansPayableBanksDetailsNarrative",
      "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://interparfumsinc.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://interparfumsinc.com/role/Cover"
     ],
     "xbrltype": "trueItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r683"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://interparfumsinc.com/role/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r677"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://interparfumsinc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r678"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://interparfumsinc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r671"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://interparfumsinc.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r675"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://interparfumsinc.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r674"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://interparfumsinc.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r679"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://interparfumsinc.com/role/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r680"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://interparfumsinc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://interparfumsinc.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r703"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://interparfumsinc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "ipar_AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The member accumulated defined benefit plans net derivative instruments.",
        "label": "Accumulated Defined Benefit Plans Net Derivative Instruments [Member]"
       }
      }
     },
     "localname": "AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember",
     "nsuri": "http://interparfumsinc.com/20211231",
     "presentation": [
      "http://interparfumsinc.com/role/ComponentsOfAccumulatedOtherComprehensiveLossConsistOfFollowingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ipar_AnnaSuiCorpMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stans for anna SuiCorp.",
        "label": "Anna Sui Corp [Member]"
       }
      }
     },
     "localname": "AnnaSuiCorpMember",
     "nsuri": "http://interparfumsinc.com/20211231",
     "presentation": [
      "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "ipar_CashAndCashEquivalentsPerStatementOfCashFlows": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash and cash equivalents per statement of cash flows.",
        "label": "Cash and cash equivalents per statement of cash flows"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPerStatementOfCashFlows",
     "nsuri": "http://interparfumsinc.com/20211231",
     "presentation": [
      "http://interparfumsinc.com/role/FollowingTableSummarizesCashAndCashEquivalentsAsOfDecember312021Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ipar_CashHeldInEscrow": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash held in escrow.",
        "label": "[custom:CashHeldInEscrow-0]"
       }
      }
     },
     "localname": "CashHeldInEscrow",
     "nsuri": "http://interparfumsinc.com/20211231",
     "presentation": [
      "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ipar_CashHeldInEscrowIncludedInOtherAssets": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash held in escrow included in other assets.",
        "label": "Cash held in escrow included in other assets (see note 3)"
       }
      }
     },
     "localname": "CashHeldInEscrowIncludedInOtherAssets",
     "nsuri": "http://interparfumsinc.com/20211231",
     "presentation": [
      "http://interparfumsinc.com/role/FollowingTableSummarizesCashAndCashEquivalentsAsOfDecember312021Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ipar_CentralAndSouthAmericaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stans for central and south america.",
        "label": "Central And South America [Member]"
       }
      }
     },
     "localname": "CentralAndSouthAmericaMember",
     "nsuri": "http://interparfumsinc.com/20211231",
     "presentation": [
      "http://interparfumsinc.com/role/NetSalesToCustomersByRegionAreAsFollowsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ipar_CoachMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The member coach.",
        "label": "Coach [Member]"
       }
      }
     },
     "localname": "CoachMember",
     "nsuri": "http://interparfumsinc.com/20211231",
     "presentation": [
      "http://interparfumsinc.com/role/ScheduleOfLanvinBrandNameForOurClassDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ipar_Covid19Description": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Covid 19 description.",
        "label": "Covid 19, description"
       }
      }
     },
     "localname": "Covid19Description",
     "nsuri": "http://interparfumsinc.com/20211231",
     "presentation": [
      "http://interparfumsinc.com/role/EquityDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "ipar_DeferredTaxAssetsInventoryAndAccountsReceivable": {
     "auth_ref": [],
     "calculation": {
      "http://interparfumsinc.com/role/TaxEffectsOfTemporaryDifferencesThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndDeferredTaxLiabilitiesAreAsFollowsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred tax assets inventory and accounts receivable.",
        "label": "Inventory and accounts receivable"
       }
      }
     },
     "localname": "DeferredTaxAssetsInventoryAndAccountsReceivable",
     "nsuri": "http://interparfumsinc.com/20211231",
     "presentation": [
      "http://interparfumsinc.com/role/TaxEffectsOfTemporaryDifferencesThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndDeferredTaxLiabilitiesAreAsFollowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ipar_DeferredTaxLiabilitiesBuildingExpenses": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred tax liabilities building expenses.",
        "label": "Building expenses"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesBuildingExpenses",
     "nsuri": "http://interparfumsinc.com/20211231",
     "presentation": [
      "http://interparfumsinc.com/role/TaxEffectsOfTemporaryDifferencesThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndDeferredTaxLiabilitiesAreAsFollowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ipar_DeferredTaxLiabilitiesUnrealizedGainOnMarketableEquitySecurities": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred tax liabilities unrealized gain on marketable equity securities.",
        "label": "Unrealized gain on marketable equity securities"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesUnrealizedGainOnMarketableEquitySecurities",
     "nsuri": "http://interparfumsinc.com/20211231",
     "presentation": [
      "http://interparfumsinc.com/role/TaxEffectsOfTemporaryDifferencesThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndDeferredTaxLiabilitiesAreAsFollowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ipar_DisclosureImpactOfCovid19PandemicAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Impact Of Covid-19 Pandemic"
       }
      }
     },
     "localname": "DisclosureImpactOfCovid19PandemicAbstract",
     "nsuri": "http://interparfumsinc.com/20211231",
     "xbrltype": "stringItemType"
    },
    "ipar_DisclosureReconciliationOfCashAndCashEquivalentsToStatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reconciliation Of Cash And Cash Equivalents To Statement Of Cash Flows",
        "verboseLabel": "Following Table Summarizes Cash And Cash Equivalents As Of December 31 2021"
       }
      }
     },
     "localname": "DisclosureReconciliationOfCashAndCashEquivalentsToStatementOfCashFlowsAbstract",
     "nsuri": "http://interparfumsinc.com/20211231",
     "xbrltype": "stringItemType"
    },
    "ipar_DiscriptionOfRecentAgreement": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discription of recent agreement.",
        "label": "Discription of recent agreement"
       }
      }
     },
     "localname": "DiscriptionOfRecentAgreement",
     "nsuri": "http://interparfumsinc.com/20211231",
     "presentation": [
      "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "ipar_DomesticSubsidiariesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stans for domestic subsidiaries.",
        "label": "Domestic Subsidiaries [Member]"
       }
      }
     },
     "localname": "DomesticSubsidiariesMember",
     "nsuri": "http://interparfumsinc.com/20211231",
     "presentation": [
      "http://interparfumsinc.com/role/LoansPayableBanksDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "ipar_DueVendorsNotYetInvoiced": {
     "auth_ref": [],
     "calculation": {
      "http://interparfumsinc.com/role/AccruedExpensesConsistOfFollowingDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Due vendors not yet invoiced.",
        "label": "Due vendors (not yet invoiced)"
       }
      }
     },
     "localname": "DueVendorsNotYetInvoiced",
     "nsuri": "http://interparfumsinc.com/20211231",
     "presentation": [
      "http://interparfumsinc.com/role/AccruedExpensesConsistOfFollowingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ipar_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).",
        "label": "U.S. statutory rates"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate1",
     "nsuri": "http://interparfumsinc.com/20211231",
     "presentation": [
      "http://interparfumsinc.com/role/DifferencesBetweenUnitedStatesFederalStatutoryIncomeTaxRateAndEffectiveIncomeTaxRateWereAsFollowsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ipar_EliminationsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stans for eliminations.",
        "label": "Eliminations [Member]"
       }
      }
     },
     "localname": "EliminationsMember",
     "nsuri": "http://interparfumsinc.com/20211231",
     "presentation": [
      "http://interparfumsinc.com/role/InformationOnCompanysOperationsBySegmentsIsAsFollowsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ipar_EmployeesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stans for employees.",
        "label": "Employees [Member]"
       }
      }
     },
     "localname": "EmployeesMember",
     "nsuri": "http://interparfumsinc.com/20211231",
     "presentation": [
      "http://interparfumsinc.com/role/EquityDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "ipar_EuroInterbankOfferedRateMembeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stans for euro interbank offered rate membe.",
        "label": "Euro Interbank Offered Rate Membe [Member]"
       }
      }
     },
     "localname": "EuroInterbankOfferedRateMembeMember",
     "nsuri": "http://interparfumsinc.com/20211231",
     "presentation": [
      "http://interparfumsinc.com/role/LoansPayableBanksDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "ipar_EuropeCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stans for europe country.",
        "label": "Europe Country [Member]"
       }
      }
     },
     "localname": "EuropeCountryMember",
     "nsuri": "http://interparfumsinc.com/20211231",
     "presentation": [
      "http://interparfumsinc.com/role/NetSalesToCustomersByRegionAreAsFollowsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ipar_ExercisePriceRangeFourMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price Range Four [Member]"
       }
      }
     },
     "localname": "ExercisePriceRangeFourMember",
     "nsuri": "http://interparfumsinc.com/20211231",
     "presentation": [
      "http://interparfumsinc.com/role/FollowingTableSummarizesAdditionalStockOptionInformationAsOfDecember312021Details"
     ],
     "xbrltype": "domainItemType"
    },
    "ipar_ExercisePriceRangeOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stans for exercise price range one.",
        "label": "Exercise Price Range One [Member]"
       }
      }
     },
     "localname": "ExercisePriceRangeOneMember",
     "nsuri": "http://interparfumsinc.com/20211231",
     "presentation": [
      "http://interparfumsinc.com/role/FollowingTableSummarizesAdditionalStockOptionInformationAsOfDecember312021Details"
     ],
     "xbrltype": "domainItemType"
    },
    "ipar_ExercisePriceRangeThreeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stans for exercise price range three.",
        "label": "Exercise Price Range Three [Member]"
       }
      }
     },
     "localname": "ExercisePriceRangeThreeMember",
     "nsuri": "http://interparfumsinc.com/20211231",
     "presentation": [
      "http://interparfumsinc.com/role/FollowingTableSummarizesAdditionalStockOptionInformationAsOfDecember312021Details"
     ],
     "xbrltype": "domainItemType"
    },
    "ipar_ExercisePriceRangeTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price Range Two [Member]"
       }
      }
     },
     "localname": "ExercisePriceRangeTwoMember",
     "nsuri": "http://interparfumsinc.com/20211231",
     "presentation": [
      "http://interparfumsinc.com/role/FollowingTableSummarizesAdditionalStockOptionInformationAsOfDecember312021Details"
     ],
     "xbrltype": "domainItemType"
    },
    "ipar_FiniteLivedIntangibleAssetsAmortizationExpenseAfterTwoYears": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount finite lived intangible assets amortization expense after two years.",
        "label": "[custom:FiniteLivedIntangibleAssetsAmortizationExpenseAfterTwoYears-0]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAfterTwoYears",
     "nsuri": "http://interparfumsinc.com/20211231",
     "presentation": [
      "http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssetsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ipar_ForeignDerivedIntangibleIncomeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stans for foreign derived intangible income.",
        "label": "Foreign Derived Intangible Income [Member]"
       }
      }
     },
     "localname": "ForeignDerivedIntangibleIncomeMember",
     "nsuri": "http://interparfumsinc.com/20211231",
     "presentation": [
      "http://interparfumsinc.com/role/IncomeTaxesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "ipar_ForeignSubsidiariesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stans for foreign subsidiaries.",
        "label": "Foreign Subsidiaries [Member]"
       }
      }
     },
     "localname": "ForeignSubsidiariesMember",
     "nsuri": "http://interparfumsinc.com/20211231",
     "presentation": [
      "http://interparfumsinc.com/role/LoansPayableBanksDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "ipar_FranceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stans for france.",
        "label": "France [Member]"
       }
      }
     },
     "localname": "FranceMember",
     "nsuri": "http://interparfumsinc.com/20211231",
     "presentation": [
      "http://interparfumsinc.com/role/NetSalesToCustomersInMajorCountriesAreAsFollowsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ipar_GUESSMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The member GUESS.",
        "label": "G U E S S [Member]"
       }
      }
     },
     "localname": "GUESSMember",
     "nsuri": "http://interparfumsinc.com/20211231",
     "presentation": [
      "http://interparfumsinc.com/role/ScheduleOfLanvinBrandNameForOurClassDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ipar_GlobalSettlementAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stans for global settlement agreement.",
        "label": "Global Settlement Agreement [Member]"
       }
      }
     },
     "localname": "GlobalSettlementAgreementMember",
     "nsuri": "http://interparfumsinc.com/20211231",
     "presentation": [
      "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "ipar_ImpactOfCOVID19PandemicTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for impact of COVID 19 pandemic.",
        "label": "Impact of COVID-19 Pandemic"
       }
      }
     },
     "localname": "ImpactOfCOVID19PandemicTextBlock",
     "nsuri": "http://interparfumsinc.com/20211231",
     "presentation": [
      "http://interparfumsinc.com/role/ImpactOfCovid-19Pandemic"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ipar_InterparfumsSASubsidiaryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The member interparfums s a subsidiary.",
        "label": "Interparfums S A Subsidiary [Member]"
       }
      }
     },
     "localname": "InterparfumsSASubsidiaryMember",
     "nsuri": "http://interparfumsinc.com/20211231",
     "presentation": [
      "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesDetailsNarrative",
      "http://interparfumsinc.com/role/EquityDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "ipar_InventoryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stans for inventory.",
        "label": "Inventory [Member]"
       }
      }
     },
     "localname": "InventoryMember",
     "nsuri": "http://interparfumsinc.com/20211231",
     "presentation": [
      "http://interparfumsinc.com/role/AllAmountsHaveBeenTranslatedToU.s.DollarsAtOctober12021ExchangeRate.Details"
     ],
     "xbrltype": "domainItemType"
    },
    "ipar_JimmyChooMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The member jimmy choo.",
        "label": "Jimmy Choo [Member]"
       }
      }
     },
     "localname": "JimmyChooMember",
     "nsuri": "http://interparfumsinc.com/20211231",
     "presentation": [
      "http://interparfumsinc.com/role/ScheduleOfLanvinBrandNameForOurClassDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ipar_LicensesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stans for licenses.",
        "label": "Licenses [Member]"
       }
      }
     },
     "localname": "LicensesMember",
     "nsuri": "http://interparfumsinc.com/20211231",
     "presentation": [
      "http://interparfumsinc.com/role/ScheduleOfTrademarksLicensesAndOtherIntangibleAssetsDetails",
      "http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssetsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "ipar_LoansPayableOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stans for loans payable one.",
        "label": "Loans Payable One [Member]"
       }
      }
     },
     "localname": "LoansPayableOneMember",
     "nsuri": "http://interparfumsinc.com/20211231",
     "presentation": [
      "http://interparfumsinc.com/role/Long-termDebtConsistsOfFollowingDetails",
      "http://interparfumsinc.com/role/Long-termDebtDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "ipar_LoansPayableThreeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stans for loans payable three.",
        "label": "Loans Payable Three [Member]"
       }
      }
     },
     "localname": "LoansPayableThreeMember",
     "nsuri": "http://interparfumsinc.com/20211231",
     "presentation": [
      "http://interparfumsinc.com/role/Long-termDebtConsistsOfFollowingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ipar_LoansPayableTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stans for loans payable two.",
        "label": "Loans Payable Two [Member]"
       }
      }
     },
     "localname": "LoansPayableTwoMember",
     "nsuri": "http://interparfumsinc.com/20211231",
     "presentation": [
      "http://interparfumsinc.com/role/Long-termDebtConsistsOfFollowingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ipar_LondonInterbankOfferedRateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stans for london interbank offered rate.",
        "label": "London Interbank Offered Rate [Member]"
       }
      }
     },
     "localname": "LondonInterbankOfferedRateMember",
     "nsuri": "http://interparfumsinc.com/20211231",
     "presentation": [
      "http://interparfumsinc.com/role/LoansPayableBanksDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "ipar_MontblancMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The member montblanc.",
        "label": "Montblanc [Member]"
       }
      }
     },
     "localname": "MontblancMember",
     "nsuri": "http://interparfumsinc.com/20211231",
     "presentation": [
      "http://interparfumsinc.com/role/ScheduleOfLanvinBrandNameForOurClassDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ipar_NumberOfInstallment": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of installment.",
        "label": "Number of installments"
       }
      }
     },
     "localname": "NumberOfInstallment",
     "nsuri": "http://interparfumsinc.com/20211231",
     "presentation": [
      "http://interparfumsinc.com/role/Long-termDebtConsistsOfFollowingDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "ipar_OfficersAndManagersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stans for officers and managers.",
        "label": "Officers And Managers [Member]"
       }
      }
     },
     "localname": "OfficersAndManagersMember",
     "nsuri": "http://interparfumsinc.com/20211231",
     "presentation": [
      "http://interparfumsinc.com/role/EquityDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "ipar_OtherAssetMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stans for other asset.",
        "label": "Other Asset [Member]"
       }
      }
     },
     "localname": "OtherAssetMember",
     "nsuri": "http://interparfumsinc.com/20211231",
     "presentation": [
      "http://interparfumsinc.com/role/AllAmountsHaveBeenTranslatedToU.s.DollarsAtOctober12021ExchangeRate.Details"
     ],
     "xbrltype": "domainItemType"
    },
    "ipar_OtherSegmentCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stans for other segment country.",
        "label": "Other Segment Country [Member]"
       }
      }
     },
     "localname": "OtherSegmentCountryMember",
     "nsuri": "http://interparfumsinc.com/20211231",
     "presentation": [
      "http://interparfumsinc.com/role/NetSalesToCustomersByRegionAreAsFollowsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ipar_PercentageOfIncreaseInAnnualDividend": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of increase in annual dividend.",
        "label": "Percentage of increase in annual dividend"
       }
      }
     },
     "localname": "PercentageOfIncreaseInAnnualDividend",
     "nsuri": "http://interparfumsinc.com/20211231",
     "presentation": [
      "http://interparfumsinc.com/role/EquityDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "ipar_ReconciliationOfCashAndCashEquivalentsToTheStatementOfCashFlowsTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reconciliation of cash and cash equivalents to the statement of cash flows.",
        "label": "Reconciliation of Cash and Cash Equivalents to the Statement of Cash Flows"
       }
      }
     },
     "localname": "ReconciliationOfCashAndCashEquivalentsToTheStatementOfCashFlowsTextBlock",
     "nsuri": "http://interparfumsinc.com/20211231",
     "presentation": [
      "http://interparfumsinc.com/role/ReconciliationOfCashAndCashEquivalentsToStatementOfCashFlows"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ipar_RevaluationResultedInReductionOfCostDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revaluation resulted in reduction of cost description.",
        "label": "Revaluation resulted in reduction of cost, description"
       }
      }
     },
     "localname": "RevaluationResultedInReductionOfCostDescription",
     "nsuri": "http://interparfumsinc.com/20211231",
     "presentation": [
      "http://interparfumsinc.com/role/EquityDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "ipar_RochasFashionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stans for rochas fashion.",
        "label": "Rochas Fashion [Member]"
       }
      }
     },
     "localname": "RochasFashionMember",
     "nsuri": "http://interparfumsinc.com/20211231",
     "presentation": [
      "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "ipar_RoyaltyExpenseNetSalesPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Royalty expense net sales percentage.",
        "label": "Royalty expense, percentage of net sales"
       }
      }
     },
     "localname": "RoyaltyExpenseNetSalesPercentage",
     "nsuri": "http://interparfumsinc.com/20211231",
     "presentation": [
      "http://interparfumsinc.com/role/CommitmentsDetailsNarrative",
      "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "ipar_RussiaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stans for russia.",
        "label": "Russia [Member]"
       }
      }
     },
     "localname": "RussiaMember",
     "nsuri": "http://interparfumsinc.com/20211231",
     "presentation": [
      "http://interparfumsinc.com/role/NetSalesToCustomersInMajorCountriesAreAsFollowsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ipar_STDupontMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The member stand for STDupont.",
        "label": "S T Dupont [Member]"
       }
      }
     },
     "localname": "STDupontMember",
     "nsuri": "http://interparfumsinc.com/20211231",
     "presentation": [
      "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "ipar_ScheduleOfInventoryCurrentTableTextBlock1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of inventory current table text block1.",
        "label": "All amounts have been translated to U.S. dollars at the October 1, 2021 exchange rate."
       }
      }
     },
     "localname": "ScheduleOfInventoryCurrentTableTextBlock1",
     "nsuri": "http://interparfumsinc.com/20211231",
     "presentation": [
      "http://interparfumsinc.com/role/RecentAgreementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ipar_StockOptionOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stans for stock option one.",
        "label": "Stock Option One [Member]"
       }
      }
     },
     "localname": "StockOptionOneMember",
     "nsuri": "http://interparfumsinc.com/20211231",
     "presentation": [
      "http://interparfumsinc.com/role/EquityDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "ipar_SubtotalMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stans for subtotal.",
        "label": "Subtotal [Member]"
       }
      }
     },
     "localname": "SubtotalMember",
     "nsuri": "http://interparfumsinc.com/20211231",
     "presentation": [
      "http://interparfumsinc.com/role/ScheduleOfTrademarksLicensesAndOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ipar_SupplementalDisclosureOfCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental disclosures of cash flow information:"
       }
      }
     },
     "localname": "SupplementalDisclosureOfCashFlowInformationAbstract",
     "nsuri": "http://interparfumsinc.com/20211231",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "ipar_TransferOfSubsidiarySharesPurchasedToTreasuryShares": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Transfer of subsidiary shares purchased to treasury shares.",
        "label": "Transfer of subsidiary shares purchased"
       }
      }
     },
     "localname": "TransferOfSubsidiarySharesPurchasedToTreasuryShares",
     "nsuri": "http://interparfumsinc.com/20211231",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfChangesInShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ipar_UnitedKingdomMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stans for united kingdom.",
        "label": "United Kingdom [Member]"
       }
      }
     },
     "localname": "UnitedKingdomMember",
     "nsuri": "http://interparfumsinc.com/20211231",
     "presentation": [
      "http://interparfumsinc.com/role/NetSalesToCustomersInMajorCountriesAreAsFollowsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ipar_UnitedStatesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stans for united states.",
        "label": "United States [Member]"
       }
      }
     },
     "localname": "UnitedStatesMember",
     "nsuri": "http://interparfumsinc.com/20211231",
     "presentation": [
      "http://interparfumsinc.com/role/NetSalesToCustomersInMajorCountriesAreAsFollowsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_AsiaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Continent of Asia.",
        "label": "Asia [Member]"
       }
      }
     },
     "localname": "AsiaMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/NetSalesToCustomersByRegionAreAsFollowsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_BoardOfDirectorsChairmanMember": {
     "auth_ref": [
      "r219"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Leader of board of directors.",
        "label": "Board of Directors Chairman [Member]"
       }
      }
     },
     "localname": "BoardOfDirectorsChairmanMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/EquityDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ConsolidatedEntitiesAxis": {
     "auth_ref": [
      "r141",
      "r276",
      "r280",
      "r285",
      "r464",
      "r465",
      "r473",
      "r474",
      "r560",
      "r667",
      "r689",
      "r699",
      "r700",
      "r701"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by consolidated entity or group of entities.",
        "label": "Consolidated Entities [Axis]"
       }
      }
     },
     "localname": "ConsolidatedEntitiesAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/EquityDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidatedEntitiesDomain": {
     "auth_ref": [
      "r141",
      "r276",
      "r280",
      "r285",
      "r464",
      "r465",
      "r473",
      "r474",
      "r560",
      "r667",
      "r689",
      "r699",
      "r700",
      "r701"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Entity or group of entities consolidated into reporting entity."
       }
      }
     },
     "localname": "ConsolidatedEntitiesDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/EquityDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock": {
     "auth_ref": [
      "r686"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of contractual obligation by timing of payment due. Includes, but is not limited to, long-term debt obligation, lease obligation, and purchase obligation.",
        "label": "minimum annual royalties and other commitments as follows:"
       }
      }
     },
     "localname": "ContractualObligationFiscalYearMaturityScheduleTableTextBlock",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/CommitmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "srt_CurrencyAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by currency.",
        "label": "Currency [Axis]"
       }
      }
     },
     "localname": "CurrencyAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_EuropeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Continent of Europe.",
        "label": "Europe [Member]"
       }
      }
     },
     "localname": "EuropeMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/InformationOnCompanysOperationsBySegmentsIsAsFollowsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r290",
      "r323",
      "r376",
      "r377",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r575",
      "r640",
      "r643",
      "r668",
      "r669"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Upper limit of the provided range.",
        "label": "Maximum [Member]"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesDetailsNarrative",
      "http://interparfumsinc.com/role/EquityDetailsNarrative",
      "http://interparfumsinc.com/role/FollowingTableSummarizesAdditionalStockOptionInformationAsOfDecember312021Details",
      "http://interparfumsinc.com/role/LoansPayableBanksDetailsNarrative",
      "http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssetsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r290",
      "r323",
      "r376",
      "r377",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r575",
      "r640",
      "r643",
      "r668",
      "r669"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lower limit of the provided range.",
        "label": "Minimum [Member]"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesDetailsNarrative",
      "http://interparfumsinc.com/role/EquityDetailsNarrative",
      "http://interparfumsinc.com/role/FollowingTableSummarizesAdditionalStockOptionInformationAsOfDecember312021Details",
      "http://interparfumsinc.com/role/LoansPayableBanksDetailsNarrative",
      "http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssetsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_NorthAmericaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Continent of North America.",
        "label": "North America [Member]"
       }
      }
     },
     "localname": "NorthAmericaMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/NetSalesToCustomersByRegionAreAsFollowsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_OwnershipAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of entity in which ownership interest is disclosed. Excludes equity method investee and named security investment.",
        "label": "Ownership [Axis]"
       }
      }
     },
     "localname": "OwnershipAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesDetailsNarrative",
      "http://interparfumsinc.com/role/EquityDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_OwnershipDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of entity in which ownership interest is disclosed. Excludes equity method investee and named security investment."
       }
      }
     },
     "localname": "OwnershipDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesDetailsNarrative",
      "http://interparfumsinc.com/role/EquityDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r213",
      "r354",
      "r356",
      "r577",
      "r639",
      "r641"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by product and service, or group of similar products and similar services.",
        "label": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesDetailsNarrative",
      "http://interparfumsinc.com/role/InventoriesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r213",
      "r354",
      "r356",
      "r577",
      "r639",
      "r641"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Product or service, or a group of similar products or similar services."
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesDetailsNarrative",
      "http://interparfumsinc.com/role/InventoriesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r290",
      "r323",
      "r362",
      "r376",
      "r377",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r575",
      "r640",
      "r643",
      "r668",
      "r669"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.",
        "label": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesDetailsNarrative",
      "http://interparfumsinc.com/role/EquityDetailsNarrative",
      "http://interparfumsinc.com/role/FollowingTableSummarizesAdditionalStockOptionInformationAsOfDecember312021Details",
      "http://interparfumsinc.com/role/LoansPayableBanksDetailsNarrative",
      "http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssetsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r290",
      "r323",
      "r362",
      "r376",
      "r377",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r575",
      "r640",
      "r643",
      "r668",
      "r669"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median."
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesDetailsNarrative",
      "http://interparfumsinc.com/role/EquityDetailsNarrative",
      "http://interparfumsinc.com/role/FollowingTableSummarizesAdditionalStockOptionInformationAsOfDecember312021Details",
      "http://interparfumsinc.com/role/LoansPayableBanksDetailsNarrative",
      "http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssetsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r214",
      "r215",
      "r354",
      "r357",
      "r642",
      "r658",
      "r659",
      "r660",
      "r661",
      "r662",
      "r663",
      "r664",
      "r665",
      "r666",
      "r688",
      "r691",
      "r692",
      "r693",
      "r694",
      "r695",
      "r696",
      "r697",
      "r698"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Geographical area."
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/InformationOnCompanysOperationsBySegmentsIsAsFollowsDetails",
      "http://interparfumsinc.com/role/NetSalesToCustomersByRegionAreAsFollowsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r214",
      "r215",
      "r354",
      "r357",
      "r642",
      "r651",
      "r658",
      "r659",
      "r660",
      "r661",
      "r662",
      "r663",
      "r664",
      "r665",
      "r666",
      "r688",
      "r690"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by geographical components.",
        "label": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/InformationOnCompanysOperationsBySegmentsIsAsFollowsDetails",
      "http://interparfumsinc.com/role/NetSalesToCustomersByRegionAreAsFollowsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualAxis": {
     "auth_ref": [
      "r219",
      "r558"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by title of individual or nature of relationship to individual or group of individuals.",
        "label": "Title of Individual [Axis]"
       }
      }
     },
     "localname": "TitleOfIndividualAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/EquityDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of individual, or nature of relationship to individual or group of individuals."
       }
      }
     },
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/EquityDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock": {
     "auth_ref": [
      "r44"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.",
        "label": "Accrued Expenses"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/AccruedExpenses"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r43",
      "r563"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/BalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts payable - trade"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r7",
      "r26",
      "r220",
      "r221"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/BalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts receivable, net"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedAdvertisingCurrent": {
     "auth_ref": [
      "r9",
      "r11",
      "r12",
      "r47"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/AccruedExpensesConsistOfFollowingDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for advertising of the entity's goods and services. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Advertising liabilities"
       }
      }
     },
     "localname": "AccruedAdvertisingCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/AccruedExpensesConsistOfFollowingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r47"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/AccruedExpensesConsistOfFollowingDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://interparfumsinc.com/role/BalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued expenses",
        "totalLabel": "Accrued expenses"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/AccruedExpensesConsistOfFollowingDetails",
      "http://interparfumsinc.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedRoyaltiesCurrent": {
     "auth_ref": [
      "r11",
      "r12",
      "r47"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/AccruedExpensesConsistOfFollowingDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for royalties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Royalties"
       }
      }
     },
     "localname": "AccruedRoyaltiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/AccruedExpensesConsistOfFollowingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedSalariesCurrent": {
     "auth_ref": [
      "r11",
      "r12",
      "r47"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/AccruedExpensesConsistOfFollowingDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of the obligations incurred through that date and payable for employees' services provided. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Salary (including bonus and related taxes)"
       }
      }
     },
     "localname": "AccruedSalariesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/AccruedExpensesConsistOfFollowingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r41",
      "r261"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Less accumulated depreciation and amortization"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/ScheduleOfEquipmentAndLeaseholdImprovementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/ComponentsOfAccumulatedOtherComprehensiveLossConsistOfFollowingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r29",
      "r68",
      "r70",
      "r71",
      "r624",
      "r648",
      "r649"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/BalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated other comprehensive loss",
        "periodEndLabel": "Cumulative translation adjustments, end of year",
        "periodStartLabel": "Cumulative translation adjustments, beginning of year"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/BalanceSheets",
      "http://interparfumsinc.com/role/ComponentsOfAccumulatedOtherComprehensiveLossConsistOfFollowingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": {
     "auth_ref": [
      "r80",
      "r81",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r529"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).",
        "label": "Accumulated Other Comprehensive Income (Loss) [Table]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/ComponentsOfAccumulatedOtherComprehensiveLossConsistOfFollowingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r67",
      "r71",
      "r80",
      "r81",
      "r82",
      "r143",
      "r144",
      "r145",
      "r471",
      "r644",
      "r645",
      "r705"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfChangesInShareholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedTranslationAdjustmentMember": {
     "auth_ref": [
      "r65",
      "r71",
      "r80",
      "r81",
      "r82",
      "r471",
      "r523",
      "r524",
      "r525",
      "r526",
      "r529"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent.",
        "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]"
       }
      }
     },
     "localname": "AccumulatedTranslationAdjustmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/ComponentsOfAccumulatedOtherComprehensiveLossConsistOfFollowingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AcquiredFiniteLivedIntangibleAssetWeightedAveragePeriodBeforeRenewalOrExtension": {
     "auth_ref": [
      "r245"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average period before the next renewal or extension for intangible assets with renewal or extension terms, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "License agreement renewal term"
       }
      }
     },
     "localname": "AcquiredFiniteLivedIntangibleAssetWeightedAveragePeriodBeforeRenewalOrExtension",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Acquired Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "AcquiredFiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/AllAmountsHaveBeenTranslatedToU.s.DollarsAtOctober12021ExchangeRate.Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": {
     "auth_ref": [
      "r244"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "License agreement term"
       }
      }
     },
     "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_AcquisitionCosts": {
     "auth_ref": [
      "r580",
      "r581"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The capitalized costs incurred during the period (excluded from amortization) to purchase, lease or otherwise acquire an unproved property, including costs of lease bonuses and options to purchase or lease properties, the portion of costs applicable to minerals when land including mineral rights is purchased in fee, brokers' fees, recording fees, legal costs, and other costs incurred in acquiring properties.",
        "label": "Acquisition Costs, Period Cost"
       }
      }
     },
     "localname": "AcquisitionCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r27",
      "r409",
      "r563"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/BalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
        "label": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r143",
      "r144",
      "r145",
      "r406",
      "r407",
      "r408",
      "r496"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfChangesInShareholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionsToOtherAssetsAmount": {
     "auth_ref": [
      "r42"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of significant additions in the period in other assets (current, noncurrent, or unclassified).",
        "label": "Additions to Other Assets, Amount"
       }
      }
     },
     "localname": "AdditionsToOtherAssetsAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/InformationOnCompanysOperationsBySegmentsIsAsFollowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to reconcile net income to net cash provided by operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdvertisingCostsPolicyTextBlock": {
     "auth_ref": [
      "r411"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for advertising cost.",
        "label": "Advertising and Promotion"
       }
      }
     },
     "localname": "AdvertisingCostsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AdvertisingExpense": {
     "auth_ref": [
      "r412"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line.",
        "label": "Advertising costs"
       }
      }
     },
     "localname": "AdvertisingExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "auth_ref": [
      "r33",
      "r226",
      "r234"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.",
        "label": "Allowances for sales returns and doubtful accounts"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r121",
      "r242",
      "r250"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssetsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r163"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.CommonShareholdersDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ArrangementsAndNonarrangementTransactionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "localname": "ArrangementsAndNonarrangementTransactionsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r135",
      "r195",
      "r202",
      "r209",
      "r232",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r464",
      "r473",
      "r514",
      "r561",
      "r563",
      "r594",
      "r621"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/BalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets [Default Label]",
        "totalLabel": "Total assets",
        "verboseLabel": "Assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/BalanceSheets",
      "http://interparfumsinc.com/role/InformationOnCompanysOperationsBySegmentsIsAsFollowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/BalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r8",
      "r10",
      "r60",
      "r135",
      "r232",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r464",
      "r473",
      "r514",
      "r561",
      "r563"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/BalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/BalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "auth_ref": [
      "r500"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Total Assets"
       }
      }
     },
     "localname": "AssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/ScheduleOfFairValueAssetsMeasuredOnRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsFairValueDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets:"
       }
      }
     },
     "localname": "AssetsFairValueDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/ScheduleOfFairValueAssetsMeasuredOnRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Preparation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BuildingMember": {
     "auth_ref": [
      "r260"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities.",
        "label": "Building [Member]"
       }
      }
     },
     "localname": "BuildingMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/ScheduleOfEquipmentAndLeaseholdImprovementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionDescriptionOfAcquiredEntity": {
     "auth_ref": [
      "r449"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "With respect to a business combination completed during the period, this element provides a description of the business, other than the name, which may include the industry, size, products and other important information.",
        "label": "License agreements, description"
       }
      }
     },
     "localname": "BusinessAcquisitionDescriptionOfAcquiredEntity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination and Asset Acquisition [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationAndAssetAcquisitionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationDisclosureTextBlock": {
     "auth_ref": [
      "r455"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).",
        "label": "Recent Agreements"
       }
      }
     },
     "localname": "BusinessCombinationDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/RecentAgreements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r142",
      "r182"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the business description and accounting policies concepts.  Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Accounting policies describe all significant accounting policies of the reporting entity.",
        "label": "Business of the Company"
       }
      }
     },
     "localname": "BusinessDescriptionAndAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r5",
      "r38",
      "r123"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "periodEndLabel": "Cash and cash equivalents \u2013 end of year",
        "periodStartLabel": "Cash and cash equivalents \u2013 beginning of year"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "auth_ref": [
      "r15",
      "r124"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.",
        "label": "Cash and Cash Equivalents and Short-Term Investments"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsAndShortTermInvestments": {
     "auth_ref": [
      "r38"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/BalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the customer may deposit additional funds at any time and effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid Investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Short-term investments, exclusive of cash equivalents, generally consist of marketable securities intended to be sold within one year (or the normal operating cycle if longer) and may include trading securities, available-for-sale securities, or held-to-maturity securities (if maturing within one year), as applicable.",
        "label": "Cash and cash equivalents",
        "verboseLabel": "Cash and cash equivalents per balance sheet"
       }
      }
     },
     "localname": "CashCashEquivalentsAndShortTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/BalanceSheets",
      "http://interparfumsinc.com/role/FollowingTableSummarizesCashAndCashEquivalentsAsOfDecember312021Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r115",
      "r521"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/StatementsOfCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net increase (decrease) in cash and cash equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashProceedsReceivedAndTaxBenefitFromShareBasedPaymentAwardsTableTextBlock": {
     "auth_ref": [
      "r405"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of cash received from exercise of stock options and similar instruments granted under share-based payment arrangements and tax benefit from exercise of stock options.",
        "label": "Proceeds, tax benefits and intrinsic value related to stock options exercised were as follows"
       }
      }
     },
     "localname": "CashProceedsReceivedAndTaxBenefitFromShareBasedPaymentAwardsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/EquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r269",
      "r270",
      "r271",
      "r272",
      "r653"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/Commitments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommitmentsAndContingenciesPolicyTextBlock": {
     "auth_ref": [
      "r273",
      "r654"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies.",
        "label": "License Agreements"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockDividendsPerShareDeclared": {
     "auth_ref": [
      "r340"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding.",
        "label": "Dividends declared per share"
       }
      }
     },
     "localname": "CommonStockDividendsPerShareDeclared",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfIncome"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r143",
      "r144",
      "r496"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfChangesInShareholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r25"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common stock, par value (in Dollars per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/BalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r25"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common stock, authorized"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/BalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r25",
      "r335"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common stock, outstanding"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/BalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r25",
      "r563"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/BalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common stock, $0.001 par value. Authorized 100,000,000 shares; outstanding, 31,830,420 and 31,608,588 shares at December 31, 2021 and 2020, respectively"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r75",
      "r77",
      "r78",
      "r91",
      "r609",
      "r635"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/StatementsOfComprehensiveIncome": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive income attributable to Inter Parfums Inc."
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r75",
      "r77",
      "r90",
      "r460",
      "r461",
      "r477",
      "r608",
      "r634"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/StatementsOfComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest",
        "totalLabel": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterestAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Comprehensive income attributable to noncontrolling interests:"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterestAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfComprehensiveIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r75",
      "r77",
      "r89",
      "r459",
      "r477",
      "r607",
      "r633"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/StatementsOfComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive income"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNoteTextBlock": {
     "auth_ref": [
      "r88",
      "r102",
      "r606",
      "r632"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.",
        "label": "Accumulated Other Comprehensive Loss"
       }
      }
     },
     "localname": "ComprehensiveIncomeNoteTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/AccumulatedOtherComprehensiveLoss"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "auth_ref": [
      "r176",
      "r177",
      "r217",
      "r511",
      "r512",
      "r652"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage."
       }
      }
     },
     "localname": "ConcentrationRiskBenchmarkDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesDetailsNarrative",
      "http://interparfumsinc.com/role/ScheduleOfLanvinBrandNameForOurClassDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "auth_ref": [
      "r176",
      "r177",
      "r217",
      "r511",
      "r512",
      "r650",
      "r652"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by benchmark of concentration risk.",
        "label": "Concentration Risk Benchmark [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesDetailsNarrative",
      "http://interparfumsinc.com/role/ScheduleOfLanvinBrandNameForOurClassDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "auth_ref": [
      "r176",
      "r177",
      "r217",
      "r511",
      "r512"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.",
        "label": "Concentration risk percentage"
       }
      }
     },
     "localname": "ConcentrationRiskPercentage1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesDetailsNarrative",
      "http://interparfumsinc.com/role/ScheduleOfLanvinBrandNameForOurClassDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNet": {
     "auth_ref": [
      "r341",
      "r472",
      "r478"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the total net income attributable to the parent for the period and the effect of net changes during the period impacting the parent's ownership interest in a subsidiary as it relates to the total (consolidated) equity attributable to the parent. The changes to the parent's ownership interest in a subsidiary represented by this element did not result in a deconsolidation of the subsidiary from the consolidated financial statements.",
        "label": "Change from net income attributable to Inter Parfums, Inc. and transfers from noncontrolling interest"
       }
      }
     },
     "localname": "ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/ScheduleOfNetIncomeAttributableToTransfersFromNoncontrollingInterestDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesNet": {
     "auth_ref": [
      "r341",
      "r472",
      "r478"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the period impacting the parent's ownership interest in a subsidiary as it relates to the total (consolidated) equity attributable to the parent. The changes to the parent's ownership interest in a subsidiary represented by this element did not arise in a deconsolidation of the subsidiary from the consolidated financial statements.",
        "label": "Decrease in Inter Parfums, Inc.\u2019s additional paid-in capital for subsidiary share transactions"
       }
      }
     },
     "localname": "ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/ScheduleOfNetIncomeAttributableToTransfersFromNoncontrollingInterestDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock": {
     "auth_ref": [
      "r472",
      "r478"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The tabular disclosure of the effects of any changes in a parent's ownership interest in a subsidiary on the equity attributable to the parent if the ownership interests in a subsidiary changes during the period. The changes represented by this element did not result in the deconsolidation of the subsidiary.",
        "label": "Schedule of net income attributable to transfers from the noncontrolling interest"
       }
      }
     },
     "localname": "ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.AndTransfersFromNoncontrollingInterestTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConsolidationSubsidiaryStockIssuancesPolicy": {
     "auth_ref": [
      "r462",
      "r463"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for income statement treatment in consolidation for issuances of stock by a subsidiary.",
        "label": "Issuance of Common Stock by Consolidated Subsidiary"
       }
      }
     },
     "localname": "ConsolidationSubsidiaryStockIssuancesPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContractWithCustomerRefundLiability": {
     "auth_ref": [
      "r355"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability for consideration received or receivable from customer which is not included in transaction price, when consideration is expected to be refunded to customer.",
        "label": "Contract with customer, refund liability"
       }
      }
     },
     "localname": "ContractWithCustomerRefundLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerRightToRecoverProduct": {
     "auth_ref": [
      "r355"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of right to recover product from customer on settling refund liability.",
        "label": "Contract with customer, right to recover products"
       }
      }
     },
     "localname": "ContractWithCustomerRightToRecoverProduct",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r97",
      "r577"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/StatementsOfIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of sales",
        "verboseLabel": "Shipping and handling costs"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesDetailsNarrative",
      "http://interparfumsinc.com/role/StatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSoldOverhead": {
     "auth_ref": [
      "r94"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indirect cost incurred related to good produced and service rendered.",
        "label": "Cost of Goods Sold, Overhead"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSoldOverhead",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/InventoriesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentFederalTaxExpenseBenefit": {
     "auth_ref": [
      "r136",
      "r432",
      "r439"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Federal"
       }
      }
     },
     "localname": "CurrentFederalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/ProvisionForCurrentAndDeferredIncomeTaxExpenseBenefitConsistsOfFollowingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentForeignTaxExpenseBenefit": {
     "auth_ref": [
      "r136",
      "r432"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Foreign"
       }
      }
     },
     "localname": "CurrentForeignTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/ProvisionForCurrentAndDeferredIncomeTaxExpenseBenefitConsistsOfFollowingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r136",
      "r432",
      "r439",
      "r441"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.",
        "label": "Current income tax expense"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/ProvisionForCurrentAndDeferredIncomeTaxExpenseBenefitConsistsOfFollowingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": {
     "auth_ref": [
      "r136",
      "r432",
      "r439"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "State and local"
       }
      }
     },
     "localname": "CurrentStateAndLocalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/ProvisionForCurrentAndDeferredIncomeTaxExpenseBenefitConsistsOfFollowingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CustomerRefundLiabilityCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://interparfumsinc.com/role/AccruedExpensesConsistOfFollowingDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Current regulatory liabilities generally represent obligations to make refunds to customers for various reasons including overpayment.",
        "label": "Refund (return) liability"
       }
      }
     },
     "localname": "CustomerRefundLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/AccruedExpensesConsistOfFollowingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r132",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r298",
      "r299",
      "r304",
      "r311",
      "r312",
      "r314",
      "r320"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Loans Payable \u2013 Banks"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/LoansPayableBanks"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r18",
      "r20",
      "r21",
      "r134",
      "r141",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r294",
      "r300",
      "r301",
      "r302",
      "r303",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r316",
      "r317",
      "r318",
      "r319",
      "r536",
      "r595",
      "r598",
      "r619"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/EquityDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.",
        "label": "Basis spread over variable interest rate"
       }
      }
     },
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/LoansPayableBanksDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r287",
      "r316",
      "r317",
      "r534",
      "r536",
      "r537"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "verboseLabel": "Loan payable (in Dollars)"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/Long-termDebtConsistsOfFollowingDetails",
      "http://interparfumsinc.com/role/Long-termDebtDetailsNarrative",
      "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r49",
      "r288"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Interest per annum",
        "verboseLabel": "Variable rate"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/LoansPayableBanksDetailsNarrative",
      "http://interparfumsinc.com/role/Long-termDebtConsistsOfFollowingDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentInterestRateTerms": {
     "auth_ref": [
      "r49"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of the interest rate as being fixed or variable, and, if variable, identification of the index or rate on which the interest rate is based and the number of points or percentage added to that index or rate to set the rate, and other pertinent information, such as frequency of rate resets.",
        "label": "Debt Instrument, Interest Rate Terms"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateTerms",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/LoansPayableBanksDetailsNarrative",
      "http://interparfumsinc.com/role/Long-termDebtConsistsOfFollowingDetails",
      "http://interparfumsinc.com/role/Long-termDebtDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r50",
      "r134",
      "r141",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r294",
      "r300",
      "r301",
      "r302",
      "r303",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r316",
      "r317",
      "r318",
      "r319",
      "r536"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities."
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/EquityDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentPeriodicPayment": {
     "auth_ref": [
      "r50",
      "r615"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the required periodic payments including both interest and principal payments.",
        "label": "Installment amount (in Dollars)"
       }
      }
     },
     "localname": "DebtInstrumentPeriodicPayment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/Long-termDebtConsistsOfFollowingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r50",
      "r134",
      "r141",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r294",
      "r300",
      "r301",
      "r302",
      "r303",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r313",
      "r316",
      "r317",
      "r318",
      "r319",
      "r336",
      "r337",
      "r338",
      "r339",
      "r533",
      "r534",
      "r536",
      "r537",
      "r616"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/LoansPayableBanksDetailsNarrative",
      "http://interparfumsinc.com/role/Long-termDebtConsistsOfFollowingDetails",
      "http://interparfumsinc.com/role/Long-termDebtDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r136",
      "r433",
      "r439"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Federal Income Tax Expense (Benefit)",
        "verboseLabel": "Federal"
       }
      }
     },
     "localname": "DeferredFederalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/ProvisionForCurrentAndDeferredIncomeTaxExpenseBenefitConsistsOfFollowingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredForeignIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r136",
      "r433",
      "r439"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Foreign Income Tax Expense (Benefit)",
        "verboseLabel": "Foreign"
       }
      }
     },
     "localname": "DeferredForeignIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/IncomeTaxesDetailsNarrative",
      "http://interparfumsinc.com/role/ProvisionForCurrentAndDeferredIncomeTaxExpenseBenefitConsistsOfFollowingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxAssetsNet": {
     "auth_ref": [
      "r416",
      "r417"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/BalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.",
        "label": "Deferred tax assets",
        "verboseLabel": "Deferred Income Tax Assets, Net"
       }
      }
     },
     "localname": "DeferredIncomeTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/BalanceSheets",
      "http://interparfumsinc.com/role/InformationOnCompanysOperationsBySegmentsIsAsFollowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r121",
      "r136",
      "r433",
      "r439",
      "r440",
      "r441"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/StatementsOfCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred tax expense (benefit)"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilities": {
     "auth_ref": [
      "r22",
      "r23",
      "r424",
      "r597",
      "r618"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences.",
        "label": "Deferred Tax Liabilities, Gross",
        "negatedLabel": "Total deferred tax liabilities"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/TaxEffectsOfTemporaryDifferencesThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndDeferredTaxLiabilitiesAreAsFollowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxesAndTaxCredits": {
     "auth_ref": [
      "r122"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) and income tax credits.",
        "label": "Deferred income tax expense"
       }
      }
     },
     "localname": "DeferredIncomeTaxesAndTaxCredits",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/ProvisionForCurrentAndDeferredIncomeTaxExpenseBenefitConsistsOfFollowingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r136",
      "r433",
      "r439"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred State and Local Income Tax Expense (Benefit)",
        "verboseLabel": "State and local"
       }
      }
     },
     "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/ProvisionForCurrentAndDeferredIncomeTaxExpenseBenefitConsistsOfFollowingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsDeferredIncome": {
     "auth_ref": [
      "r430",
      "r431"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/TaxEffectsOfTemporaryDifferencesThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndDeferredTaxLiabilitiesAreAsFollowsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from deferred income.",
        "label": "Profit sharing"
       }
      }
     },
     "localname": "DeferredTaxAssetsDeferredIncome",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/TaxEffectsOfTemporaryDifferencesThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndDeferredTaxLiabilitiesAreAsFollowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "auth_ref": [
      "r425"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/TaxEffectsOfTemporaryDifferencesThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndDeferredTaxLiabilitiesAreAsFollowsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Gross",
        "totalLabel": "Total gross deferred tax assets, net"
       }
      }
     },
     "localname": "DeferredTaxAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/TaxEffectsOfTemporaryDifferencesThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndDeferredTaxLiabilitiesAreAsFollowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsInventory": {
     "auth_ref": [
      "r430",
      "r431"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/TaxEffectsOfTemporaryDifferencesThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndDeferredTaxLiabilitiesAreAsFollowsDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from inventory.",
        "label": "Effect of inventory profit elimination"
       }
      }
     },
     "localname": "DeferredTaxAssetsInventory",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/TaxEffectsOfTemporaryDifferencesThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndDeferredTaxLiabilitiesAreAsFollowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsLiabilitiesNet": {
     "auth_ref": [
      "r427"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.",
        "label": "Net deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/TaxEffectsOfTemporaryDifferencesThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndDeferredTaxLiabilitiesAreAsFollowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsNet": {
     "auth_ref": [
      "r427"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/TaxEffectsOfTemporaryDifferencesThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndDeferredTaxLiabilitiesAreAsFollowsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Net of Valuation Allowance",
        "totalLabel": "Net deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/TaxEffectsOfTemporaryDifferencesThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndDeferredTaxLiabilitiesAreAsFollowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net deferred tax assets:"
       }
      }
     },
     "localname": "DeferredTaxAssetsNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/TaxEffectsOfTemporaryDifferencesThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndDeferredTaxLiabilitiesAreAsFollowsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign": {
     "auth_ref": [
      "r430",
      "r431"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/TaxEffectsOfTemporaryDifferencesThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndDeferredTaxLiabilitiesAreAsFollowsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible foreign operating loss carryforwards.",
        "label": "Foreign net operating loss carry-forwards"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwardsForeign",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/TaxEffectsOfTemporaryDifferencesThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndDeferredTaxLiabilitiesAreAsFollowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOther": {
     "auth_ref": [
      "r430",
      "r431"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/TaxEffectsOfTemporaryDifferencesThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndDeferredTaxLiabilitiesAreAsFollowsDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.",
        "label": "Deferred Tax Assets, Other",
        "verboseLabel": "Other"
       }
      }
     },
     "localname": "DeferredTaxAssetsOther",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/TaxEffectsOfTemporaryDifferencesThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndDeferredTaxLiabilitiesAreAsFollowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost": {
     "auth_ref": [
      "r430",
      "r431"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/TaxEffectsOfTemporaryDifferencesThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndDeferredTaxLiabilitiesAreAsFollowsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.",
        "label": "Stock option compensation"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/TaxEffectsOfTemporaryDifferencesThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndDeferredTaxLiabilitiesAreAsFollowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r426"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/TaxEffectsOfTemporaryDifferencesThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndDeferredTaxLiabilitiesAreAsFollowsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "negatedLabel": "Valuation allowance"
       }
      }
     },
     "localname": "DeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/TaxEffectsOfTemporaryDifferencesThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndDeferredTaxLiabilitiesAreAsFollowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxExpenseFromStockOptionsExercised": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax expense from write-off of the deferred tax asset related to deductible stock options at exercise.",
        "label": "Tax benefits"
       }
      }
     },
     "localname": "DeferredTaxExpenseFromStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/ProceedsTaxBenefitsAndIntrinsicValueRelatedToStockOptionsExercisedWereAsFollowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred tax liabilities (long-term):"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/TaxEffectsOfTemporaryDifferencesThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndDeferredTaxLiabilitiesAreAsFollowsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesOther": {
     "auth_ref": [
      "r430",
      "r431"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences classified as other.",
        "label": "Deferred Tax Liabilities, Other",
        "verboseLabel": "Other"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesOther",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/TaxEffectsOfTemporaryDifferencesThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndDeferredTaxLiabilitiesAreAsFollowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets": {
     "auth_ref": [
      "r430",
      "r431"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from long-lived assets other than property, plant, and equipment.",
        "label": "Deferred Tax Liabilities, Other Finite-Lived Assets",
        "negatedLabel": "Trademarks and licenses"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesOtherFiniteLivedAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/TaxEffectsOfTemporaryDifferencesThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndDeferredTaxLiabilitiesAreAsFollowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanDisclosureLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Defined Benefit Plan Disclosure [Line Items]"
       }
      }
     },
     "localname": "DefinedBenefitPlanDisclosureLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/IncomeTaxesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DepreciationAndAmortization": {
     "auth_ref": [
      "r121",
      "r259"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.",
        "label": "Depreciation, Depletion and Amortization, Nonproduction"
       }
      }
     },
     "localname": "DepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/InformationOnCompanysOperationsBySegmentsIsAsFollowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r121",
      "r190"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation and amortization expense"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/PropertyEquipmentAndLeaseholdImprovementsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset."
       }
      }
     },
     "localname": "DerivativeContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/DerivativeFinancialInstrumentsDetailsNarrative",
      "http://interparfumsinc.com/role/EquityDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r63",
      "r485",
      "r486",
      "r488",
      "r490"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/DerivativeFinancialInstrumentsDetailsNarrative",
      "http://interparfumsinc.com/role/EquityDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r495",
      "r499"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.",
        "label": "Derivative Financial Instruments"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/DerivativeFinancialInstruments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable": {
     "auth_ref": [
      "r482",
      "r485",
      "r488",
      "r490",
      "r491",
      "r493",
      "r494"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) [Table]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/DerivativeFinancialInstrumentsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative Instruments, Gain (Loss) [Line Items]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/DerivativeFinancialInstrumentsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeLiabilities": {
     "auth_ref": [
      "r61",
      "r62",
      "r63",
      "r510"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.",
        "label": "Interest rate swaps"
       }
      }
     },
     "localname": "DerivativeLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/ScheduleOfFairValueAssetsMeasuredOnRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativesPolicyTextBlock": {
     "auth_ref": [
      "r140",
      "r480",
      "r481",
      "r482",
      "r484",
      "r492"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities.",
        "label": "Derivatives"
       }
      }
     },
     "localname": "DerivativesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DividendsCash": {
     "auth_ref": [
      "r340",
      "r614"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of paid and unpaid cash dividends declared for classes of stock, for example, but not limited to, common and preferred.",
        "label": "Dividends, Cash",
        "negatedLabel": "Dividends"
       }
      }
     },
     "localname": "DividendsCash",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfChangesInShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DividendsPayableAmountPerShare": {
     "auth_ref": [
      "r126"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The per share amount of a dividend declared, but not paid, as of the financial reporting date.",
        "label": "Dividends payable, amount per share (in Dollars per share)"
       }
      }
     },
     "localname": "DividendsPayableAmountPerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/EquityDetailsNarrative"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_DividendsPayableCurrent": {
     "auth_ref": [
      "r12",
      "r47"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/BalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Income taxes payable"
       }
      }
     },
     "localname": "DividendsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r92",
      "r148",
      "r149",
      "r150",
      "r151",
      "r152",
      "r156",
      "r158",
      "r160",
      "r161",
      "r162",
      "r166",
      "r167",
      "r497",
      "r498",
      "r610",
      "r636"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Basic",
        "verboseLabel": "Basic (in Dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/ReconciliationBetweenNumeratorsAndDenominatorsOfBasicAndDilutedEpsComputationsIsAsFollowsDetails",
      "http://interparfumsinc.com/role/StatementsOfIncome"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareBasicAndDilutedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net income attributable to Inter Parfums, Inc. common shareholders:"
       }
      }
     },
     "localname": "EarningsPerShareBasicAndDilutedAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r92",
      "r148",
      "r149",
      "r150",
      "r151",
      "r152",
      "r158",
      "r160",
      "r161",
      "r162",
      "r166",
      "r167",
      "r497",
      "r498",
      "r610",
      "r636"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Diluted",
        "terseLabel": "Diluted (in Dollars per share)",
        "verboseLabel": "Diluted earnings per share attributable to Inter Parfums, Inc"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/EffectOfShare-basedPaymentExpensesDecreasedIncomeStatementLineItemsAsFollowsDetails",
      "http://interparfumsinc.com/role/ReconciliationBetweenNumeratorsAndDenominatorsOfBasicAndDilutedEpsComputationsIsAsFollowsDetails",
      "http://interparfumsinc.com/role/StatementsOfIncome"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r163",
      "r164",
      "r165",
      "r168"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Net Income Attributable to Inter Parfums, Inc. Common Shareholders"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.CommonShareholders"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations": {
     "auth_ref": [
      "r521"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/StatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The effect of exchange rate changes on cash balances in continuing operations held in foreign currencies.",
        "label": "Effect of exchange rate changes on cash"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r419"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective rates"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/DifferencesBetweenUnitedStatesFederalStatutoryIncomeTaxRateAndEffectiveIncomeTaxRateWereAsFollowsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r138",
      "r419",
      "r443"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).",
        "label": "Statutory rates"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/DifferencesBetweenUnitedStatesFederalStatutoryIncomeTaxRateAndEffectiveIncomeTaxRateWereAsFollowsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsEmployeeStockOwnershipPlanDividends": {
     "auth_ref": [
      "r419",
      "r443"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to deduction for dividend paid to employee stock ownership plan.",
        "label": "Windfall benefit from exercise of stock options"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationDeductionsEmployeeStockOwnershipPlanDividends",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/DifferencesBetweenUnitedStatesFederalStatutoryIncomeTaxRateAndEffectiveIncomeTaxRateWereAsFollowsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential": {
     "auth_ref": [
      "r419",
      "r443"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile.",
        "label": "Benefit of Foreign Derived Intangible Income"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/DifferencesBetweenUnitedStatesFederalStatutoryIncomeTaxRateAndEffectiveIncomeTaxRateWereAsFollowsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments": {
     "auth_ref": [
      "r419",
      "r443"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.",
        "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Percent",
        "verboseLabel": "Other"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationOtherAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/DifferencesBetweenUnitedStatesFederalStatutoryIncomeTaxRateAndEffectiveIncomeTaxRateWereAsFollowsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes": {
     "auth_ref": [
      "r419",
      "r443"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).",
        "label": "State and local taxes, net of Federal benefit"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/DifferencesBetweenUnitedStatesFederalStatutoryIncomeTaxRateAndEffectiveIncomeTaxRateWereAsFollowsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tangible personal property used to produce goods and services.",
        "label": "Equipment [Member]"
       }
      }
     },
     "localname": "EquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/ScheduleOfEquipmentAndLeaseholdImprovementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity:",
        "verboseLabel": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/BalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r0",
      "r80",
      "r81",
      "r82",
      "r143",
      "r144",
      "r145",
      "r147",
      "r153",
      "r155",
      "r170",
      "r233",
      "r335",
      "r340",
      "r406",
      "r407",
      "r408",
      "r435",
      "r436",
      "r496",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r529",
      "r644",
      "r645",
      "r646",
      "r705"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/ComponentsOfAccumulatedOtherComprehensiveLossConsistOfFollowingDetails",
      "http://interparfumsinc.com/role/StatementsOfChangesInShareholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/ScheduleOfFairValueAssetsMeasuredOnRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r500",
      "r501",
      "r502",
      "r508"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/ScheduleOfFairValueAssetsMeasuredOnRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain": {
     "auth_ref": [
      "r506"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Class of asset."
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/ScheduleOfTrademarksLicensesAndOtherIntangibleAssetsDetails",
      "http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssetsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueByAssetClassAxis": {
     "auth_ref": [
      "r500",
      "r508"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by class of asset.",
        "label": "Asset Class [Axis]"
       }
      }
     },
     "localname": "FairValueByAssetClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/ScheduleOfTrademarksLicensesAndOtherIntangibleAssetsDetails",
      "http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssetsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r302",
      "r316",
      "r317",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r375",
      "r501",
      "r565",
      "r566",
      "r567"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/ScheduleOfFairValueAssetsMeasuredOnRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r500",
      "r501",
      "r504",
      "r505",
      "r509"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/ScheduleOfFairValueAssetsMeasuredOnRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r507"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value of Financial Instruments"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/FairValueOfFinancialInstruments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r302",
      "r363",
      "r364",
      "r369",
      "r375",
      "r501",
      "r565"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/ScheduleOfFairValueAssetsMeasuredOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r302",
      "r316",
      "r317",
      "r363",
      "r364",
      "r369",
      "r375",
      "r501",
      "r566"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/ScheduleOfFairValueAssetsMeasuredOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r302",
      "r316",
      "r317",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r375",
      "r501",
      "r567"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/ScheduleOfFairValueAssetsMeasuredOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement frequency."
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/ScheduleOfFairValueAssetsMeasuredOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r302",
      "r316",
      "r317",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r375",
      "r565",
      "r566",
      "r567"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value."
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/ScheduleOfFairValueAssetsMeasuredOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "auth_ref": [
      "r507",
      "r509"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
        "label": "Fair Value, Recurring [Member]"
       }
      }
     },
     "localname": "FairValueMeasurementsRecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/ScheduleOfFairValueAssetsMeasuredOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueOfAssetsAcquired": {
     "auth_ref": [
      "r126",
      "r127",
      "r128"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fair value of assets acquired in noncash investing or financing activities.",
        "label": "Assets acquired"
       }
      }
     },
     "localname": "FairValueOfAssetsAcquired",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/AllAmountsHaveBeenTranslatedToU.s.DollarsAtOctober12021ExchangeRate.Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Amortization period"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssetsDetailsNarrative"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r249"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Accumulated Amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/ScheduleOfTrademarksLicensesAndOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable": {
     "auth_ref": [
      "r243"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table containing detailed characteristics of finite-lived intangible assets acquired during a business combination. Finite-lived intangible assets are assets that have no physical form, but have expected future economic benefit, and are expected to be used over a defined period. Acquired finite-lived intangible assets are disclosed by major class (assets that can be grouped together because they are similar, either by their nature or by their use in operations of the Entity) and in total. Additionally, any significant residual value (the expected value of the asset at the end of its useful life) and the weighted-average amortization period are also disclosed.",
        "label": "Finite-Lived Intangible Assets Acquired as Part of Business Combination [Table]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/AllAmountsHaveBeenTranslatedToU.s.DollarsAtOctober12021ExchangeRate.Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "auth_ref": [
      "r251"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssetsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "auth_ref": [
      "r251"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssetsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r243",
      "r245",
      "r249",
      "r253",
      "r578",
      "r579"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/AllAmountsHaveBeenTranslatedToU.s.DollarsAtOctober12021ExchangeRate.Details",
      "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesDetailsNarrative",
      "http://interparfumsinc.com/role/ScheduleOfTrademarksLicensesAndOtherIntangibleAssetsDetails",
      "http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssetsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r249",
      "r579"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Gross Amount"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/ScheduleOfTrademarksLicensesAndOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/ScheduleOfTrademarksLicensesAndOtherIntangibleAssetsDetails",
      "http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssetsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r243",
      "r248"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company."
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/AllAmountsHaveBeenTranslatedToU.s.DollarsAtOctober12021ExchangeRate.Details",
      "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesDetailsNarrative",
      "http://interparfumsinc.com/role/ScheduleOfTrademarksLicensesAndOtherIntangibleAssetsDetails",
      "http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssetsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assets, excluding financial assets, that lack physical substance, having a limited useful life.",
        "label": "Finite-Lived Intangible Assets [Member]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/ScheduleOfTrademarksLicensesAndOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r249",
      "r578"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Net Book Value"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/ScheduleOfTrademarksLicensesAndOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of liability contracts related to the exchange of different currencies, including, but not limited to, foreign currency options, forward (delivery or nondelivery) contracts, and swaps entered into.",
        "label": "Foreign currency contracts, liability, fair value disclosure"
       }
      }
     },
     "localname": "ForeignCurrencyContractsLiabilityFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/DerivativeFinancialInstrumentsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue": {
     "auth_ref": [
      "r487"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value as of the balance sheet date of all foreign currency derivative liabilities not designated as hedging instruments.",
        "label": "Foreign currency forward exchange contracts not accounted for using hedge accounting"
       }
      }
     },
     "localname": "ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/ScheduleOfFairValueAssetsMeasuredOnRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyFairValueHedgeAssetAtFairValue": {
     "auth_ref": [
      "r486"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value as of the balance sheet date of all derivative assets designated as foreign currency fair value hedging instruments.",
        "label": "Foreign currency forward exchange contracts accounted for using hedge accounting"
       }
      }
     },
     "localname": "ForeignCurrencyFairValueHedgeAssetAtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/ScheduleOfFairValueAssetsMeasuredOnRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyTransactionGainLossBeforeTax": {
     "auth_ref": [
      "r515",
      "r517",
      "r518",
      "r520"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/StatementsOfIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement.",
        "label": "Foreign Currency Transaction Gain (Loss), before Tax",
        "negatedLabel": "(Gain) loss on foreign currency"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionGainLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": {
     "auth_ref": [
      "r531"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.",
        "label": "Foreign Currency Translation"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ForeignExchangeContractMember": {
     "auth_ref": [
      "r63",
      "r363",
      "r489"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument whose primary underlying risk is tied to foreign exchange rates.",
        "label": "Foreign Exchange Contract [Member]"
       }
      }
     },
     "localname": "ForeignExchangeContractMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/DerivativeFinancialInstrumentsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock": {
     "auth_ref": [
      "r240",
      "r246"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.",
        "label": "Long-Lived Assets"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r96",
      "r135",
      "r195",
      "r201",
      "r205",
      "r208",
      "r211",
      "r232",
      "r276",
      "r277",
      "r278",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r514"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/StatementsOfIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "totalLabel": "Gross margin"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentChargeOnReclassifiedAssets": {
     "auth_ref": [
      "r256",
      "r258"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the asset that is reclassified back to held and used from held-for-sale, the amount of impairment charge that is recognized on the reclassification date.",
        "label": "Impairment Charge on Reclassified Assets"
       }
      }
     },
     "localname": "ImpairmentChargeOnReclassifiedAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentOfLeasehold": {
     "auth_ref": [
      "r121",
      "r257"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/StatementsOfIncome": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The adjustment to reduce the value of existing agreements that specify the lessee's rights to use the leased property. This expense is charged when the estimates of future profits generated by the leased property are reduced.",
        "label": "Impairment loss"
       }
      }
     },
     "localname": "ImpairmentOfLeasehold",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": {
     "auth_ref": [
      "r137",
      "r442"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.",
        "label": "U.S. operations"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/ComponentsOfIncomeBeforeIncomeTaxesConsistOfFollowingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign": {
     "auth_ref": [
      "r137",
      "r442"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.",
        "label": "Foreign operations"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/ComponentsOfIncomeBeforeIncomeTaxesConsistOfFollowingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r195",
      "r201",
      "r205",
      "r208",
      "r211"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/StatementsOfIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.",
        "label": "Income before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/ComponentsOfIncomeBeforeIncomeTaxesConsistOfFollowingDetails",
      "http://interparfumsinc.com/role/EffectOfShare-basedPaymentExpensesDecreasedIncomeStatementLineItemsAsFollowsDetails",
      "http://interparfumsinc.com/role/StatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r86",
      "r121",
      "r192",
      "r230",
      "r604",
      "r630"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/StatementsOfCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss).",
        "label": "Income (Loss) from Equity Method Investments",
        "negatedLabel": "Share of income of equity investment"
       }
      }
     },
     "localname": "IncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r263",
      "r266"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/EffectOfShare-basedPaymentExpensesDecreasedIncomeStatementLineItemsAsFollowsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r266"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement."
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/EffectOfShare-basedPaymentExpensesDecreasedIncomeStatementLineItemsAsFollowsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxAuthorityNameAxis": {
     "auth_ref": [
      "r421"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of taxing authority.",
        "label": "Income Tax Authority, Name [Axis]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Named agency, division or body that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes."
       }
      }
     },
     "localname": "IncomeTaxAuthorityNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r138",
      "r420",
      "r422",
      "r429",
      "r437",
      "r444",
      "r446",
      "r447",
      "r448"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r139",
      "r154",
      "r155",
      "r193",
      "r418",
      "r438",
      "r445",
      "r637"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/StatementsOfIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income taxes",
        "terseLabel": "Total income tax expense",
        "verboseLabel": "Income Tax Expense (Benefit)"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/InformationOnCompanysOperationsBySegmentsIsAsFollowsDetails",
      "http://interparfumsinc.com/role/ProvisionForCurrentAndDeferredIncomeTaxExpenseBenefitConsistsOfFollowingDetails",
      "http://interparfumsinc.com/role/StatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r79",
      "r414",
      "r415",
      "r422",
      "r423",
      "r428",
      "r434"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income Tax, Policy [Policy Text Block]",
        "verboseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxReceivable": {
     "auth_ref": [
      "r37",
      "r617"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of income taxes previously overpaid to tax authorities (such as U.S. Federal, state and local tax authorities) representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes. Also called income tax refund receivable.",
        "label": "Income Taxes Receivable"
       }
      }
     },
     "localname": "IncomeTaxReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesPaid": {
     "auth_ref": [
      "r117",
      "r125"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.",
        "label": "Income Taxes Paid",
        "verboseLabel": "Income taxes"
       }
      }
     },
     "localname": "IncomeTaxesPaid",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesReceivable": {
     "auth_ref": [
      "r53",
      "r603",
      "r629"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/BalanceSheets": {
       "order": 7.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount due within one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes.",
        "label": "Income taxes receivable"
       }
      }
     },
     "localname": "IncomeTaxesReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "auth_ref": [
      "r120"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/StatementsOfCashFlows": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.",
        "label": "Accounts payable and accrued expenses"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r120"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/StatementsOfCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "Accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedTaxesPayable": {
     "auth_ref": [
      "r120"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/StatementsOfCashFlows": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period of all taxes owed but not paid, including income, property and other taxes.",
        "label": "Income taxes, net"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedTaxesPayable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r120"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/StatementsOfCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedLabel": "Inventories"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changes in:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingLeaseLiability": {
     "auth_ref": [
      "r120",
      "r547"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/StatementsOfCashFlows": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in obligation for operating lease.",
        "label": "Operating lease liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingAssets": {
     "auth_ref": [
      "r120"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/StatementsOfCashFlows": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating assets classified as other.",
        "label": "Increase (Decrease) in Other Operating Assets",
        "negatedLabel": "Other assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IndefiniteLivedLicenseAgreements": {
     "auth_ref": [
      "r252"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount (original costs adjusted for previously recognized amortization and impairment) as of the balance sheet date for the capitalized costs to acquire rights under a license arrangement (for example, to sell specified products in a specified territory) having an indefinite period of benefit.",
        "label": "Indefinite-Lived License Agreements"
       }
      }
     },
     "localname": "IndefiniteLivedLicenseAgreements",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssetsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IndefinitelivedIntangibleAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assets, excluding financial assets and goodwill, that lack physical substance, having a projected indefinite period of benefit.",
        "label": "Indefinite-lived Intangible Assets [Member]"
       }
      }
     },
     "localname": "IndefinitelivedIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/ScheduleOfTrademarksLicensesAndOtherIntangibleAssetsDetails",
      "http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssetsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r255"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all or part of the information related to intangible assets.",
        "label": "Trademarks, Licenses and Other Intangible Assets"
       }
      }
     },
     "localname": "IntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssets"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r241",
      "r247"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/BalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Trademarks, licenses and other intangible assets, net"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r84",
      "r189",
      "r532",
      "r535",
      "r611"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/StatementsOfIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/InformationOnCompanysOperationsBySegmentsIsAsFollowsDetails",
      "http://interparfumsinc.com/role/StatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r112",
      "r116",
      "r125"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory Disclosure [Abstract]"
       }
      }
     },
     "localname": "InventoryDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InventoryDisclosureTextBlock": {
     "auth_ref": [
      "r239"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.",
        "label": "Inventory Disclosure [Text Block]",
        "verboseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/Inventories"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryFinishedGoods": {
     "auth_ref": [
      "r55"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/ScheduleOfInventoriesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.",
        "label": "Finished goods"
       }
      }
     },
     "localname": "InventoryFinishedGoods",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/ScheduleOfInventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryGross": {
     "auth_ref": [
      "r57"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross amount, as of the balance sheet date, of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Inventory gross"
       }
      }
     },
     "localname": "InventoryGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/AllAmountsHaveBeenTranslatedToU.s.DollarsAtOctober12021ExchangeRate.Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r6",
      "r57",
      "r563"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/BalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://interparfumsinc.com/role/ScheduleOfInventoriesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventories",
        "verboseLabel": "Inventory net"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/AllAmountsHaveBeenTranslatedToU.s.DollarsAtOctober12021ExchangeRate.Details",
      "http://interparfumsinc.com/role/BalanceSheets",
      "http://interparfumsinc.com/role/ScheduleOfInventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryPolicyTextBlock": {
     "auth_ref": [
      "r14",
      "r58",
      "r130",
      "r169",
      "r236",
      "r237",
      "r239",
      "r576"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.",
        "label": "Inventory, Policy [Policy Text Block]",
        "verboseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryRawMaterials": {
     "auth_ref": [
      "r56"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/ScheduleOfInventoriesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Raw materials and component parts"
       }
      }
     },
     "localname": "InventoryRawMaterials",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/ScheduleOfInventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryValuationReserves": {
     "auth_ref": [
      "r57",
      "r238"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of valuation reserve for inventory.",
        "label": "Inventory Valuation Reserves"
       }
      }
     },
     "localname": "InventoryValuationReserves",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/InventoriesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentIncomeInterestAndDividend": {
     "auth_ref": [
      "r100"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/StatementsOfIncome": {
       "order": 3.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income and dividend income on nonoperating securities.",
        "label": "Investment Income, Interest and Dividend",
        "negatedLabel": "Interest and investment income"
       }
      }
     },
     "localname": "InvestmentIncomeInterestAndDividend",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/InformationOnCompanysOperationsBySegmentsIsAsFollowsDetails",
      "http://interparfumsinc.com/role/StatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentTaxCredit": {
     "auth_ref": [
      "r122"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount deducted from an entities' taxes, reflecting a percentage of an amount invested in certain assets spread over the useful life of those assets; includes deferred investment tax credits.",
        "label": "Investment Tax Credit"
       }
      }
     },
     "localname": "InvestmentTaxCredit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentsFairValueDisclosure": {
     "auth_ref": [
      "r500"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.",
        "label": "Investments, Fair Value Disclosure",
        "verboseLabel": "Short-term investments"
       }
      }
     },
     "localname": "InvestmentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/ScheduleOfFairValueAssetsMeasuredOnRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "auth_ref": [
      "r260"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additions or improvements to assets held under a lease arrangement.",
        "label": "Leasehold Improvements [Member]"
       }
      }
     },
     "localname": "LeaseholdImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/ScheduleOfEquipmentAndLeaseholdImprovementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r550"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "negatedLabel": "Less imputed interest (based on 3.0% weighted-average discount rate)"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/MaturitiesOfLeaseLiabilitiesSubsequentToDecember312021AreAsFollowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LessorLeasesPolicyTextBlock": {
     "auth_ref": [
      "r552",
      "r553",
      "r554",
      "r555"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for leasing arrangements entered into by lessor.",
        "label": "Operating Leases"
       }
      }
     },
     "localname": "LessorLeasesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities:"
       }
      }
     },
     "localname": "LiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/ScheduleOfFairValueAssetsMeasuredOnRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r32",
      "r135",
      "r232",
      "r514",
      "r563",
      "r600",
      "r627"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/BalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity [Default Label]",
        "totalLabel": "Total liabilities and equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/BalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesAssumed1": {
     "auth_ref": [
      "r126",
      "r127",
      "r128"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fair value of liabilities assumed in noncash investing or financing activities.",
        "label": "Liabilities Assumed",
        "negatedLabel": "Liabilities Assumed"
       }
      }
     },
     "localname": "LiabilitiesAssumed1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/AllAmountsHaveBeenTranslatedToU.s.DollarsAtOctober12021ExchangeRate.Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r48",
      "r135",
      "r232",
      "r276",
      "r277",
      "r278",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r465",
      "r473",
      "r474",
      "r514",
      "r561",
      "r562",
      "r563"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/BalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/BalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LicensingAgreementsMember": {
     "auth_ref": [
      "r451"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights, generally of limited duration, under a license arrangement (for example, to sell or otherwise utilize specified products or processes in a specified territory).",
        "label": "Licensing Agreements [Member]"
       }
      }
     },
     "localname": "LicensingAgreementsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LineOfCredit": {
     "auth_ref": [
      "r21",
      "r598",
      "r619"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.",
        "label": "Long-term Line of Credit"
       }
      }
     },
     "localname": "LineOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityExpirationDate1": {
     "auth_ref": [
      "r45"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date the credit facility terminates, in YYYY-MM-DD format.",
        "label": "Line of Credit Facility, Expiration Date"
       }
      }
     },
     "localname": "LineOfCreditFacilityExpirationDate1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/LoansPayableBanksDetailsNarrative"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r45"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of credit, maximum borrowing amount"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/LoansPayableBanksDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LoansPayableMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Borrowing supported by a written promise to pay an obligation.",
        "label": "Loans Payable [Member]"
       }
      }
     },
     "localname": "LoansPayableMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/Long-termDebtConsistsOfFollowingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r21",
      "r301",
      "r315",
      "r316",
      "r317",
      "r598",
      "r623"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Loan payable"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/Long-termDebtConsistsOfFollowingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtCurrent": {
     "auth_ref": [
      "r46"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/BalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Current portion of long-term debt",
        "verboseLabel": "Less current maturities"
       }
      }
     },
     "localname": "LongTermDebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/BalanceSheets",
      "http://interparfumsinc.com/role/Long-termDebtConsistsOfFollowingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtDescription": {
     "auth_ref": [
      "r50",
      "r336"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of long-term debt arrangements, which are debt arrangements that originally require full repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer, and disclosures pertaining to the underlying arrangements, including repayment terms, conversion features, interest rates, restrictions on assets and activities, debt covenants, and other matters important to users of the financial statements. Types of long-term debt arrangements include borrowing under notes payable, bonds payable, debentures, term loans, and other contractual obligations for payment.",
        "label": "Long term debt maturity, description"
       }
      }
     },
     "localname": "LongTermDebtDescription",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/Long-termDebtDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": {
     "auth_ref": [
      "r141",
      "r274",
      "r306"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-term Debt, Maturities, 2021"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/Long-termDebtDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "auth_ref": [
      "r50"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/BalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long\u2013term debt, less current portion",
        "verboseLabel": "Total"
       }
      }
     },
     "localname": "LongTermDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/BalanceSheets",
      "http://interparfumsinc.com/role/Long-termDebtConsistsOfFollowingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtTerm": {
     "auth_ref": [
      "r505"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period between issuance and maturity of long-term debt, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Long-term Debt, Term"
       }
      }
     },
     "localname": "LongTermDebtTerm",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LongTermDebtTextBlock": {
     "auth_ref": [
      "r320"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-term debt.",
        "label": "Long-Term Debt"
       }
      }
     },
     "localname": "LongTermDebtTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/Long-termDebt"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r50"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/Long-termDebtConsistsOfFollowingDetails",
      "http://interparfumsinc.com/role/Long-termDebtDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r50",
      "r275"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer."
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/Long-termDebtConsistsOfFollowingDetails",
      "http://interparfumsinc.com/role/Long-termDebtDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MarketingExpense": {
     "auth_ref": [
      "r99"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expenditures for planning and executing the conception, pricing, promotion, and distribution of ideas, goods, and services. Costs of public relations and corporate promotions are typically considered to be marketing costs.",
        "label": "Customer incentives cost"
       }
      }
     },
     "localname": "MarketingExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MeasurementInputDiscountRateMember": {
     "auth_ref": [
      "r503"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using interest rate to determine present value of future cash flows.",
        "label": "Measurement Input, Discount Rate [Member]"
       }
      }
     },
     "localname": "MeasurementInputDiscountRateMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesDetailsNarrative",
      "http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssetsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputTypeAxis": {
     "auth_ref": [
      "r503"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Axis]"
       }
      }
     },
     "localname": "MeasurementInputTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesDetailsNarrative",
      "http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssetsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MeasurementInputTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input used to determine value of asset and liability."
       }
      }
     },
     "localname": "MeasurementInputTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesDetailsNarrative",
      "http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssetsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MiddleEastMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region of Middle East.",
        "label": "Middle East [Member]"
       }
      }
     },
     "localname": "MiddleEastMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/NetSalesToCustomersByRegionAreAsFollowsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MinorityInterest": {
     "auth_ref": [
      "r54",
      "r135",
      "r232",
      "r276",
      "r280",
      "r281",
      "r282",
      "r285",
      "r286",
      "r514",
      "r599",
      "r626"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/BalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).",
        "label": "Noncontrolling interest"
       }
      }
     },
     "localname": "MinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestDisclosureTextBlock": {
     "auth_ref": [
      "r479"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for noncontrolling interest in consolidated subsidiaries, which could include the name of the subsidiary, the ownership percentage held by the parent, the ownership percentage held by the noncontrolling owners, the amount of the noncontrolling interest, the location of this amount on the balance sheet (when not reported separately), an explanation of the increase or decrease in the amount of the noncontrolling interest, the noncontrolling interest share of the net Income or Loss of the subsidiary, the location of this amount on the income statement (when not reported separately), the nature of the noncontrolling interest such as background information and terms, the amount of the noncontrolling interest represented by preferred stock, a description of the preferred stock, and the dividend requirements of the preferred stock.",
        "label": "Net Income Attributable to Inter Parfums, Inc. and Transfers from the Noncontrolling Interest"
       }
      }
     },
     "localname": "MinorityInterestDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.AndTransfersFromNoncontrollingInterest"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_MinorityInterestOwnershipPercentageByParent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The parent entity's interest in net assets of the subsidiary, expressed as a percentage.",
        "label": "Ownership percentage in Interparfums SA"
       }
      }
     },
     "localname": "MinorityInterestOwnershipPercentageByParent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r115"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/StatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by (used in) financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows from financing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r115"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/StatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows from investing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r115",
      "r119",
      "r122"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/StatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows from operating activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r4",
      "r74",
      "r76",
      "r82",
      "r87",
      "r122",
      "r135",
      "r146",
      "r148",
      "r149",
      "r150",
      "r151",
      "r154",
      "r155",
      "r159",
      "r195",
      "r201",
      "r205",
      "r208",
      "r211",
      "r232",
      "r276",
      "r277",
      "r278",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r498",
      "r514",
      "r605",
      "r631"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/StatementsOfIncome": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net income attributable to Inter Parfums, Inc.",
        "terseLabel": "Net Income (Loss) Attributable to Parent",
        "totalLabel": "Net income attributable to Inter Parfums, Inc.",
        "verboseLabel": "Numerator for diluted earnings per share (in Dollars)"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/EffectOfShare-basedPaymentExpensesDecreasedIncomeStatementLineItemsAsFollowsDetails",
      "http://interparfumsinc.com/role/InformationOnCompanysOperationsBySegmentsIsAsFollowsDetails",
      "http://interparfumsinc.com/role/ReconciliationBetweenNumeratorsAndDenominatorsOfBasicAndDilutedEpsComputationsIsAsFollowsDetails",
      "http://interparfumsinc.com/role/ScheduleOfNetIncomeAttributableToTransfersFromNoncontrollingInterestDetails",
      "http://interparfumsinc.com/role/StatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r74",
      "r76",
      "r82",
      "r154",
      "r155",
      "r467",
      "r476"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/StatementsOfComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
       "weight": 1.0
      },
      "http://interparfumsinc.com/role/StatementsOfIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.",
        "label": "Less: Net income attributable to the noncontrolling interest",
        "verboseLabel": "Net income"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfComprehensiveIncome",
      "http://interparfumsinc.com/role/StatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "Recent Accounting Pronouncements"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncontrollingInterestAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Noncontrolling Interest [Abstract]"
       }
      }
     },
     "localname": "NoncontrollingInterestAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance": {
     "auth_ref": [
      "r341",
      "r463",
      "r469"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in noncontrolling interest from subsidiary issuance of equity interests to noncontrolling interest holders.",
        "label": "Noncontrolling Interest, Increase from Subsidiary Equity Issuance",
        "negatedLabel": "Purchase of subsidiary shares from noncontrolling interests"
       }
      }
     },
     "localname": "NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfChangesInShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NoncontrollingInterestMember": {
     "auth_ref": [
      "r143",
      "r144",
      "r145",
      "r340",
      "r457"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.",
        "label": "Noncontrolling Interest [Member]"
       }
      }
     },
     "localname": "NoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfChangesInShareholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NoncurrentAssets": {
     "auth_ref": [
      "r215"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets.",
        "label": "Long-Lived Assets [Default Label]",
        "verboseLabel": "Long-Lived Assets"
       }
      }
     },
     "localname": "NoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/InformationOnCompanysOperationsBySegmentsIsAsFollowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "auth_ref": [
      "r101"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/StatementsOfIncome": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "Nonoperating Income (Expense)",
        "negatedTotalLabel": "Other expenses (income)"
       }
      }
     },
     "localname": "NonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NonoperatingIncomeExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other expenses (income):"
       }
      }
     },
     "localname": "NonoperatingIncomeExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r195",
      "r201",
      "r205",
      "r208",
      "r211"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/StatementsOfIncome": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Income from operations"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingIncomeLossMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing operating income (loss).",
        "label": "Operating Income (Loss) [Member]"
       }
      }
     },
     "localname": "OperatingIncomeLossMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/EffectOfShare-basedPaymentExpensesDecreasedIncomeStatementLineItemsAsFollowsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OperatingLeaseCost": {
     "auth_ref": [
      "r546",
      "r551"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.",
        "label": "Noncash additions to operating lease assets"
       }
      }
     },
     "localname": "OperatingLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/CommitmentsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseImpairmentLoss": {
     "auth_ref": [
      "r542"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/StatementsOfCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss from impairment of right-of-use asset from operating lease.",
        "label": "Lease expense"
       }
      }
     },
     "localname": "OperatingLeaseImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r544"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/BalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Current portion of lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r544"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/BalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Lease liabilities, less current portion"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasePayments": {
     "auth_ref": [
      "r545",
      "r547"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
        "label": "Operating lease payments"
       }
      }
     },
     "localname": "OperatingLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/CommitmentsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r543"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/BalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Right-of-use assets, net"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r549",
      "r551"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Weighted average cost of capital",
        "verboseLabel": "Operating lease, weighted average discount rate"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/CommitmentsDetailsNarrative",
      "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesDetailsNarrative",
      "http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssetsDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r548",
      "r551"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Weighted average remaining lease term"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/CommitmentsDetailsNarrative"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsDue": {
     "auth_ref": [
      "r538",
      "r540"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of required minimum rental payments for leases having an initial or remaining non-cancelable letter-terms in excess of one year.",
        "label": "Gross Total"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/MaturitiesOfLeaseLiabilitiesSubsequentToDecember312021AreAsFollowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent": {
     "auth_ref": [
      "r538",
      "r540"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "2022"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsDueCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/MaturitiesOfLeaseLiabilitiesSubsequentToDecember312021AreAsFollowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears": {
     "auth_ref": [
      "r538",
      "r540"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "2026"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsDueInFiveYears",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/MaturitiesOfLeaseLiabilitiesSubsequentToDecember312021AreAsFollowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears": {
     "auth_ref": [
      "r538",
      "r540"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "2025"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsDueInFourYears",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/MaturitiesOfLeaseLiabilitiesSubsequentToDecember312021AreAsFollowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears": {
     "auth_ref": [
      "r538",
      "r540"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "2024"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsDueInThreeYears",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/MaturitiesOfLeaseLiabilitiesSubsequentToDecember312021AreAsFollowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears": {
     "auth_ref": [
      "r538",
      "r540"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "2023"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsDueInTwoYears",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/MaturitiesOfLeaseLiabilitiesSubsequentToDecember312021AreAsFollowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter": {
     "auth_ref": [
      "r538",
      "r540"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due after the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Thereafter"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsDueThereafter",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/MaturitiesOfLeaseLiabilitiesSubsequentToDecember312021AreAsFollowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the remainder of the fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Net Total"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/MaturitiesOfLeaseLiabilitiesSubsequentToDecember312021AreAsFollowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasesRentExpenseNet": {
     "auth_ref": [
      "r539"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rental expense for the reporting period incurred under operating leases, including minimum and any contingent rent expense, net of related sublease income.",
        "label": "Operating lease of related to rental expenses"
       }
      }
     },
     "localname": "OperatingLeasesRentExpenseNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/CommitmentsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r11",
      "r12",
      "r13",
      "r47"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/AccruedExpensesConsistOfFollowingDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/AccruedExpensesConsistOfFollowingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsCurrent": {
     "auth_ref": [
      "r59",
      "r563"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/BalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current assets classified as other.",
        "label": "Other current assets"
       }
      }
     },
     "localname": "OtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r42"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/BalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCommitment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum amount of other commitment not otherwise specified in the taxonomy. Excludes commitments explicitly modeled in the taxonomy, including but not limited to, long-term and short-term purchase commitments, recorded and unrecorded purchase obligations, supply commitments, registration payment arrangements, leases, debt, product warranties, guarantees, environmental remediation obligations, and pensions.",
        "label": "Total"
       }
      }
     },
     "localname": "OtherCommitment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/MinimumAnnualRoyaltiesAndOtherCommitmentsAsFollowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCommitmentDueAfterFifthYear": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of commitment classified as other to be paid after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Other Commitment, to be Paid, after Year Five",
        "verboseLabel": "Thereafter"
       }
      }
     },
     "localname": "OtherCommitmentDueAfterFifthYear",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/MinimumAnnualRoyaltiesAndOtherCommitmentsAsFollowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCommitmentDueInFifthYear": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of commitment classified as other to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Other Commitment, to be Paid, Year Five",
        "verboseLabel": "2025"
       }
      }
     },
     "localname": "OtherCommitmentDueInFifthYear",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/MinimumAnnualRoyaltiesAndOtherCommitmentsAsFollowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCommitmentDueInFourthYear": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of commitment classified as other to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Other Commitment, to be Paid, Year Four",
        "verboseLabel": "2024"
       }
      }
     },
     "localname": "OtherCommitmentDueInFourthYear",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/MinimumAnnualRoyaltiesAndOtherCommitmentsAsFollowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCommitmentDueInNextTwelveMonths": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of commitment classified as other to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "2021"
       }
      }
     },
     "localname": "OtherCommitmentDueInNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/MinimumAnnualRoyaltiesAndOtherCommitmentsAsFollowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCommitmentDueInSecondYear": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of commitment classified as other to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Other Commitment, to be Paid, Year Two",
        "verboseLabel": "2022"
       }
      }
     },
     "localname": "OtherCommitmentDueInSecondYear",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/MinimumAnnualRoyaltiesAndOtherCommitmentsAsFollowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCommitmentDueInThirdYear": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of commitment classified as other to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Other Commitment, to be Paid, Year Three",
        "verboseLabel": "2023"
       }
      }
     },
     "localname": "OtherCommitmentDueInThirdYear",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/MinimumAnnualRoyaltiesAndOtherCommitmentsAsFollowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r459",
      "r460",
      "r470"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/StatementsOfComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments, of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss), attributable to noncontrolling interests.",
        "label": "Net derivative instrument loss, net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfChangesInShareholdersEquity",
      "http://interparfumsinc.com/role/StatementsOfComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r459",
      "r460",
      "r470"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments, of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss), attributable to parent entity.",
        "label": "Net derivative instrument gain (loss), net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/ComponentsOfAccumulatedOtherComprehensiveLossConsistOfFollowingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r459",
      "r460",
      "r470"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/StatementsOfComprehensiveIncome": {
       "order": 3.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to noncontrolling interests.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Noncontrolling Interest",
        "verboseLabel": "Translation adjustments, net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax": {
     "auth_ref": [
      "r64",
      "r69",
      "r516",
      "r519",
      "r528"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit), before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Foreign currency translation adjustment, net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfChangesInShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeTax": {
     "auth_ref": [
      "r80",
      "r81",
      "r88",
      "r231",
      "r522",
      "r527",
      "r529",
      "r606",
      "r632"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax, after reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), before Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax": {
     "auth_ref": [
      "r66"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments, of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss).",
        "label": "Net derivative instrument income (loss), net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r64"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Translation adjustments, net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax": {
     "auth_ref": [
      "r64",
      "r69",
      "r519",
      "r528"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit), after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Translation adjustments"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/ComponentsOfAccumulatedOtherComprehensiveLossConsistOfFollowingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other comprehensive income:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfComprehensiveIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax": {
     "auth_ref": [
      "r68",
      "r72",
      "r73",
      "r483"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of reclassification adjustment from accumulated other comprehensive income of accumulated gain (loss) realized from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's deferred hedging gain (loss).",
        "label": "Transfer from other comprehensive income into earnings"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfChangesInShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherDepreciationAndAmortization": {
     "auth_ref": [
      "r98",
      "r121",
      "r259"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/StatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense charged against earnings to allocate the cost of tangible and intangible assets over their remaining economic lives, classified as other.",
        "label": "Depreciation and amortization including impairment loss"
       }
      }
     },
     "localname": "OtherDepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherIncome": {
     "auth_ref": [
      "r638"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/StatementsOfIncome": {
       "order": 4.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue and income classified as other.",
        "label": "Other Income",
        "negatedLabel": "Other income"
       }
      }
     },
     "localname": "OtherIncome",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherIntangibleAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intangible assets classified as other.",
        "label": "Other Intangible Assets [Member]"
       }
      }
     },
     "localname": "OtherIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/ScheduleOfTrademarksLicensesAndOtherIntangibleAssetsDetails",
      "http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssetsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherReceivablesNetCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://interparfumsinc.com/role/BalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.",
        "label": "Receivables, other"
       }
      }
     },
     "localname": "OtherReceivablesNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PayablesAndAccrualsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payables and Accruals [Abstract]"
       }
      }
     },
     "localname": "PayablesAndAccrualsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PaymentsForPurchaseOfOtherAssets1": {
     "auth_ref": [
      "r113",
      "r118"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid to purchase other assets as part of operating activities.",
        "label": "Payments for Purchase of Other Assets"
       }
      }
     },
     "localname": "PaymentsForPurchaseOfOtherAssets1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDividendsCommonStock": {
     "auth_ref": [
      "r109"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/StatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.",
        "label": "Payments of Ordinary Dividends, Common Stock",
        "negatedLabel": "Dividends paid"
       }
      }
     },
     "localname": "PaymentsOfDividendsCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDividendsMinorityInterest": {
     "auth_ref": [
      "r109"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/StatementsOfCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow in the form of ordinary dividends provided by the non-wholly owned subsidiary to noncontrolling interests.",
        "label": "Payments of Ordinary Dividends, Noncontrolling Interest",
        "negatedLabel": "Dividends paid to noncontrolling interests"
       }
      }
     },
     "localname": "PaymentsOfDividendsMinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireEquityMethodInvestments": {
     "auth_ref": [
      "r104"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/StatementsOfCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.",
        "label": "Payments to Acquire Equity Method Investments",
        "negatedLabel": "Purchase of equity investment"
       }
      }
     },
     "localname": "PaymentsToAcquireEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireIntangibleAssets": {
     "auth_ref": [
      "r105"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/StatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.",
        "label": "Payments to Acquire Intangible Assets",
        "negatedLabel": "Payment for intangible assets acquired"
       }
      }
     },
     "localname": "PaymentsToAcquireIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireProductiveAssets": {
     "auth_ref": [
      "r105",
      "r452",
      "r453",
      "r454"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/StatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets.",
        "label": "Payments to Acquire Productive Assets",
        "negatedLabel": "Purchase of property, equipment and leasehold improvements"
       }
      }
     },
     "localname": "PaymentsToAcquireProductiveAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireShortTermInvestments": {
     "auth_ref": [
      "r106"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/StatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for securities or other assets acquired, which qualify for treatment as an investing activity and are to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.",
        "label": "Payments to Acquire Short-term Investments",
        "negatedLabel": "Purchases of short-term investments"
       }
      }
     },
     "localname": "PaymentsToAcquireShortTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToMinorityShareholders": {
     "auth_ref": [
      "r111"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/StatementsOfCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to a noncontrolling interest. Includes, but not limited to, reduction of noncontrolling interest ownership. Excludes dividends paid to the noncontrolling interest.",
        "label": "Payments to Noncontrolling Interests",
        "negatedLabel": "Purchase of subsidiary shares from noncontrolling interests"
       }
      }
     },
     "localname": "PaymentsToMinorityShareholders",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrent": {
     "auth_ref": [
      "r20",
      "r359",
      "r360",
      "r361"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/AccruedExpensesConsistOfFollowingDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability, recognized in statement of financial position, for pension, other postretirement and postemployment benefits, classified as current.",
        "label": "Retirement reserves"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/AccruedExpensesConsistOfFollowingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r24",
      "r321"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred stock, par value (in Dollars per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/BalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r24"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred stock, authorized"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/BalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r24",
      "r321"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred stock, issued"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/BalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r24",
      "r563"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/BalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred stock, $0.001 par value. Authorized 1,000,000 shares; none issued"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PriorPeriodReclassificationAdjustmentDescription": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.",
        "label": "Reclassifications"
       }
      }
     },
     "localname": "PriorPeriodReclassificationAdjustmentDescription",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfLongTermDebt": {
     "auth_ref": [
      "r108"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/StatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.",
        "label": "Proceeds from issuance of long-term debt"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfShortTermInvestments": {
     "auth_ref": [
      "r103"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/StatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from sales of all investments, including securities and other assets, having ready marketability and intended by management to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.",
        "label": "Proceeds from sale of short-term investments"
       }
      }
     },
     "localname": "ProceedsFromSaleOfShortTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "auth_ref": [
      "r107",
      "r405"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/StatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.",
        "label": "Proceeds from exercise of options",
        "verboseLabel": "Proceeds from stock options exercised"
       }
      }
     },
     "localname": "ProceedsFromStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/ProceedsTaxBenefitsAndIntrinsicValueRelatedToStockOptionsExercisedWereAsFollowsDetails",
      "http://interparfumsinc.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Product Information [Line Items]"
       }
      }
     },
     "localname": "ProductInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesDetailsNarrative",
      "http://interparfumsinc.com/role/ScheduleOfLanvinBrandNameForOurClassDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ProductMember": {
     "auth_ref": [
      "r356"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Article or substance produced by nature, labor or machinery.",
        "label": "Product [Member]"
       }
      }
     },
     "localname": "ProductMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/InventoriesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r4",
      "r74",
      "r76",
      "r82",
      "r114",
      "r135",
      "r146",
      "r154",
      "r155",
      "r195",
      "r201",
      "r205",
      "r208",
      "r211",
      "r232",
      "r276",
      "r277",
      "r278",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r459",
      "r466",
      "r468",
      "r476",
      "r477",
      "r498",
      "r514",
      "r612"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/StatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://interparfumsinc.com/role/StatementsOfIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net income",
        "totalLabel": "Net income"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfCashFlows",
      "http://interparfumsinc.com/role/StatementsOfChangesInShareholdersEquity",
      "http://interparfumsinc.com/role/StatementsOfComprehensiveIncome",
      "http://interparfumsinc.com/role/StatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r41",
      "r262"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/ScheduleOfEquipmentAndLeaseholdImprovementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "auth_ref": [
      "r265",
      "r655",
      "r656",
      "r657"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Equipment and Leasehold Improvements"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/PropertyEquipmentAndLeaseholdImprovements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r40",
      "r260"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Equipment and leasehold improvements"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/ScheduleOfEquipmentAndLeaseholdImprovementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/ScheduleOfEquipmentAndLeaseholdImprovementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r16",
      "r17",
      "r262",
      "r563",
      "r613",
      "r628"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/BalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, equipment and leasehold improvements, net",
        "verboseLabel": "Property, Plant and Equipment, Net, Total"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/BalanceSheets",
      "http://interparfumsinc.com/role/ScheduleOfEquipmentAndLeaseholdImprovementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "auth_ref": [
      "r39",
      "r262",
      "r655",
      "r656"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "verboseLabel": "Property, Equipment and Leasehold Improvements"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r16",
      "r262"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Schedule of equipment and leasehold improvements"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/PropertyEquipmentAndLeaseholdImprovementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r16",
      "r260"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software."
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/ScheduleOfEquipmentAndLeaseholdImprovementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProvisionForDoubtfulAccounts": {
     "auth_ref": [
      "r93",
      "r235"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/StatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.",
        "label": "Provision for doubtful accounts"
       }
      }
     },
     "localname": "ProvisionForDoubtfulAccounts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent": {
     "auth_ref": [
      "r71",
      "r83"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss) attributable to parent.",
        "label": "Transfer of OCI into earnings"
       }
      }
     },
     "localname": "ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyDomain": {
     "auth_ref": [
      "r370",
      "r556",
      "r557"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests."
       }
      }
     },
     "localname": "RelatedPartyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/IncomeTaxesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "auth_ref": [
      "r370",
      "r556",
      "r559",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/IncomeTaxesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RepaymentsOfLongTermDebt": {
     "auth_ref": [
      "r110"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/StatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.",
        "label": "Repayments of Long-term Debt",
        "negatedLabel": "Repayment of long-term debt"
       }
      }
     },
     "localname": "RepaymentsOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepurchaseAgreementsCollateralPolicy": {
     "auth_ref": [
      "r574"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy with regard to collateral required and collateral rights on securities sold under agreements to repurchase.",
        "label": "Treasury Stock"
       }
      }
     },
     "localname": "RepurchaseAgreementsCollateralPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpensePolicy": {
     "auth_ref": [
      "r413"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.",
        "label": "Package Development Costs"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpensePolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r28",
      "r340",
      "r409",
      "r563",
      "r625",
      "r647",
      "r649"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/BalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r0",
      "r143",
      "r144",
      "r145",
      "r147",
      "r153",
      "r155",
      "r233",
      "r406",
      "r407",
      "r408",
      "r435",
      "r436",
      "r496",
      "r644",
      "r646"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfChangesInShareholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax": {
     "auth_ref": [
      "r186",
      "r187",
      "r200",
      "r206",
      "r207",
      "r213",
      "r214",
      "r217",
      "r353",
      "r354",
      "r577"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/StatementsOfIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.",
        "label": "Net sales",
        "verboseLabel": "Revenue from Contract with Customer, Including Assessed Tax"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerIncludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/InformationOnCompanysOperationsBySegmentsIsAsFollowsDetails",
      "http://interparfumsinc.com/role/NetSalesToCustomersInMajorCountriesAreAsFollowsDetails",
      "http://interparfumsinc.com/role/StatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "auth_ref": [
      "r131",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r358"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue from contract with customer.",
        "label": "Revenue Recognition"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueRecognitionAllowances": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue recognition for sales allowances.",
        "label": "Payments to Customers"
       }
      }
     },
     "localname": "RevenueRecognitionAllowances",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueRecognitionSalesReturns": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for sales returns.",
        "label": "Sales Returns"
       }
      }
     },
     "localname": "RevenueRecognitionSalesReturns",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Revenues": {
     "auth_ref": [
      "r85",
      "r135",
      "r186",
      "r187",
      "r200",
      "r206",
      "r207",
      "r213",
      "r214",
      "r217",
      "r232",
      "r276",
      "r277",
      "r278",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r514",
      "r612"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).",
        "label": "Revenues",
        "verboseLabel": "Net sales"
       }
      }
     },
     "localname": "Revenues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/NetSalesToCustomersByRegionAreAsFollowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Revenues from External Customers and Long-Lived Assets [Line Items]"
       }
      }
     },
     "localname": "RevenuesFromExternalCustomersAndLongLivedAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/InformationOnCompanysOperationsBySegmentsIsAsFollowsDetails",
      "http://interparfumsinc.com/role/NetSalesToCustomersByRegionAreAsFollowsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RoyaltyExpense": {
     "auth_ref": [
      "r98"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense related to royalty payments under a contractual arrangement such as payment for mineral and drilling rights and use of technology or intellectual property.",
        "label": "Royalty expense"
       }
      }
     },
     "localname": "RoyaltyExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/CommitmentsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SalesRevenueNetMember": {
     "auth_ref": [
      "r176",
      "r217"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.",
        "label": "Revenue Benchmark [Member]"
       }
      }
     },
     "localname": "SalesRevenueNetMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accrued liabilities.",
        "label": "Accrued expenses consist of the following:"
       }
      }
     },
     "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/AccruedExpensesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r71",
      "r527",
      "r529"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).",
        "label": "The components of accumulated other comprehensive loss consist of the following:"
       }
      }
     },
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/AccumulatedOtherComprehensiveLossTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of cash and cash equivalents.",
        "label": "The following table summarizes cash and cash equivalents as of December 31, 2021:"
       }
      }
     },
     "localname": "ScheduleOfCashAndCashEquivalentsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/ReconciliationOfCashAndCashEquivalentsToStatementOfCashFlowsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "auth_ref": [
      "r434"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.",
        "label": "The provision for current and deferred income tax expense (benefit) consists of the following:"
       }
      }
     },
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtInstrumentsTextBlock": {
     "auth_ref": [
      "r50",
      "r141",
      "r316",
      "r318",
      "r336",
      "r337",
      "r338",
      "r339",
      "r533",
      "r534",
      "r537",
      "r616"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.",
        "label": "Long-term debt consists of the following:"
       }
      }
     },
     "localname": "ScheduleOfDebtInstrumentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/Long-termDebtTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "auth_ref": [
      "r427"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.",
        "label": "The tax effects of temporary differences that give rise to significant portions of the deferred tax assets and deferred tax liabilities are as follows:"
       }
      }
     },
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": {
     "auth_ref": [
      "r371",
      "r372",
      "r373",
      "r374",
      "r375"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosures about an individual defined benefit pension plan or an other postretirement defined benefit plan. It may be appropriate to group certain similar plans.  Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Defined Benefit Plans Disclosures [Table]"
       }
      }
     },
     "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/IncomeTaxesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r162"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "The reconciliation between the numerators and denominators of the basic and diluted EPS computations is as follows:"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.CommonShareholdersTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "auth_ref": [
      "r419"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Differences between the United States federal statutory income tax rate and the effective income tax rate were as follows:"
       }
      }
     },
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "auth_ref": [
      "r500",
      "r501"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of fair value, assets measured on recurring basis"
       }
      }
     },
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/FairValueOfFinancialInstrumentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r243",
      "r248",
      "r578"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/ScheduleOfTrademarksLicensesAndOtherIntangibleAssetsDetails",
      "http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssetsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock": {
     "auth_ref": [
      "r541"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of future minimum payments required in the aggregate and for each of the five succeeding fiscal years for operating leases having initial or remaining noncancelable lease terms in excess of one year and the total minimum rentals to be received in the future under noncancelable subleases as of the balance sheet date.",
        "label": "Maturities of lease liabilities subsequent to December 31, 2021 are as follows:"
       }
      }
     },
     "localname": "ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/CommitmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfImpairedIntangibleAssetsTextBlock": {
     "auth_ref": [
      "r254"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of impaired intangible assets excluding goodwill. This may include a description of the facts and circumstances leading to the recording of impairment charges of intangible assets in the period, the amount of the impairment charges, the methods of determining fair value of the associated assets, the caption in the income statement in which the impairment losses are aggregated, and the segment in which the impaired intangible assets are reported.",
        "label": "Schedule of trademarks, licenses and other intangible assets"
       }
      }
     },
     "localname": "ScheduleOfImpairedIntangibleAssetsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock": {
     "auth_ref": [
      "r136"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of income before income tax between domestic and foreign jurisdictions.",
        "label": "The components of income before income taxes consist of the following:"
       }
      }
     },
     "localname": "ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "auth_ref": [
      "r14",
      "r34",
      "r35",
      "r36"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Schedule of inventories"
       }
      }
     },
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/InventoriesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock": {
     "auth_ref": [
      "r389"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the changes in outstanding nonvested shares.",
        "label": "The following table sets forth information with respect to nonvested options for 2021:"
       }
      }
     },
     "localname": "ScheduleOfNonvestedShareActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/EquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfProductInformationTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule detailing quantitative information concerning products or product lines by product or product line.",
        "label": "Schedule of Product Information [Table]"
       }
      }
     },
     "localname": "ScheduleOfProductInformationTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesDetailsNarrative",
      "http://interparfumsinc.com/role/ScheduleOfLanvinBrandNameForOurClassDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r41",
      "r262"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/ScheduleOfEquipmentAndLeaseholdImprovementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the extent of the entity's reliance on its major customers, if revenues from transactions with a single external customer amount to 10 percent or more of entity revenues, including the disclosure of that fact, the total amount of revenues from each such customer, and the identity of the reportable segment or segments reporting the revenues. The entity need not disclose the identity of a major customer or the amount of revenues that each segment reports from that customer. For these purposes, a group of companies known to the entity to be under common control is considered a single customer, and the federal government, a state government, a local government such as a county or municipality, or a foreign government is each considered a single customer.",
        "label": "Consolidated net sales to customers in major countries are as follows:"
       }
      }
     },
     "localname": "ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/SegmentsAndGeographicAreasTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock": {
     "auth_ref": [
      "r95",
      "r216"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information concerning material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material.  An entity may also provide subtotals of geographic information about groups of countries.",
        "label": "Consolidated net sales to customers by region are as follows:"
       }
      }
     },
     "localname": "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/SegmentsAndGeographicAreasTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable": {
     "auth_ref": [
      "r85",
      "r216"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material.  An entity may also provide subtotals of geographic information about groups of countries.",
        "label": "Schedule of Revenues from External Customers and Long-Lived Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/InformationOnCompanysOperationsBySegmentsIsAsFollowsDetails",
      "http://interparfumsinc.com/role/NetSalesToCustomersByRegionAreAsFollowsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r195",
      "r198",
      "r204",
      "r240"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/NetSalesToCustomersInMajorCountriesAreAsFollowsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "auth_ref": [
      "r195",
      "r198",
      "r204",
      "r240"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Information on the Company\u2019s operations by segments is as follows:"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/SegmentsAndGeographicAreasTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock": {
     "auth_ref": [
      "r389",
      "r391",
      "r394"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of activity for award under share-based payment arrangement. Includes, but is not limited to, outstanding award at beginning and end of year, granted, exercised, forfeited, and weighted-average grant date fair value.",
        "label": "The effect of share-based payment expenses decreased income statement line items as follows:"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/EquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock": {
     "auth_ref": [
      "r404"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms.",
        "label": "The following table summarizes additional stock option information as of December 31, 2021:"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/EquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r383",
      "r391",
      "r394"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "The following table summarizes stock option activity and related information for the years ended December 31, 2021, 2020 and 2019:"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/EquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r397"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "The assumptions used in the Black-Scholes pricing model are set forth in the following table:"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/EquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of subsidiary's sales of previously unissued stock made to investors outside the consolidated group. This includes stock issued in a business combination in exchange for shares of an acquired entity.",
        "label": "Schedule of Subsidiary or Equity Method Investee [Table]"
       }
      }
     },
     "localname": "ScheduleOfSubsidiaryOrEquityMethodInvesteeTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/EquityDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock": {
     "auth_ref": [
      "r175",
      "r176",
      "r177",
      "r178",
      "r511",
      "r513"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.",
        "label": "Schedule of lanvin brand name for our class"
       }
      }
     },
     "localname": "SchedulesOfConcentrationOfRiskByRiskFactorTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r183",
      "r186",
      "r187",
      "r188",
      "r189",
      "r190",
      "r191",
      "r192",
      "r193",
      "r194",
      "r195",
      "r196",
      "r197",
      "r200",
      "r201",
      "r202",
      "r203",
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r211",
      "r217",
      "r267",
      "r268",
      "r639"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity."
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/NetSalesToCustomersInMajorCountriesAreAsFollowsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r183",
      "r184",
      "r185",
      "r195",
      "r199",
      "r205",
      "r209",
      "r210",
      "r211",
      "r212",
      "r213",
      "r216",
      "r217",
      "r218"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segments and Geographic Areas"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/SegmentsAndGeographicAreas"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/NetSalesToCustomersInMajorCountriesAreAsFollowsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r99"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/StatementsOfIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, general, and administrative expenses"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r120"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/StatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Noncash stock compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r379"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Share-based compensation arrangement by share-based payment award, award vesting period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/EquityDetailsNarrative"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "auth_ref": [
      "r400"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.",
        "label": "Weighted-average dividend yield"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/AssumptionsUsedInBlack-scholesPricingModelAreSetForthInFollowingTableDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "auth_ref": [
      "r399"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Weighted-average expected stock-price volatility"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/AssumptionsUsedInBlack-scholesPricingModelAreSetForthInFollowingTableDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "auth_ref": [
      "r401"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Weighted-average risk-free interest rate"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/AssumptionsUsedInBlack-scholesPricingModelAreSetForthInFollowingTableDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": {
     "auth_ref": [
      "r381"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares authorized for issuance under share-based payment arrangement.",
        "label": "Adjusted for stock splits (in Shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/EquityDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "auth_ref": [
      "r404"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.",
        "label": "Number of shares available for grant (in Shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/EquityDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": {
     "auth_ref": [
      "r393"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.",
        "label": "Intrinsic value of stock options exercised"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/ProceedsTaxBenefitsAndIntrinsicValueRelatedToStockOptionsExercisedWereAsFollowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "auth_ref": [
      "r388"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period",
        "negatedLabel": "Options forfeited"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/FollowingTableSummarizesStockOptionActivityAndRelatedInformationForYearsEndedDecember3120212020And2019Details"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Nonvested options granted",
        "verboseLabel": "Options granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/FollowingTableSetsForthInformationWithRespectToNonvestedOptionsFor2021Details",
      "http://interparfumsinc.com/role/FollowingTableSummarizesStockOptionActivityAndRelatedInformationForYearsEndedDecember3120212020And2019Details"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r392"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.",
        "label": "Weighted Average Grant Date Fair Value, granted",
        "verboseLabel": "Weighted average grant date fair value (in Dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/EquityDetailsNarrative",
      "http://interparfumsinc.com/role/FollowingTableSetsForthInformationWithRespectToNonvestedOptionsFor2021Details"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "auth_ref": [
      "r404"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.",
        "label": "Aggregate intrinsic value of options outstanding"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/EquityDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r385",
      "r404"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Options shares under option - end of year",
        "periodStartLabel": "Options shares under option - beginning of year"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/FollowingTableSummarizesStockOptionActivityAndRelatedInformationForYearsEndedDecember3120212020And2019Details"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r384"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Weighted average exercise price shares under option - end of year",
        "periodStartLabel": "Weighted average exercise price shares under option - beginning of year"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/FollowingTableSummarizesStockOptionActivityAndRelatedInformationForYearsEndedDecember3120212020And2019Details"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost": {
     "auth_ref": [
      "r403"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An excess of the fair value of the modified award over the fair value of the award immediately before the modification.",
        "label": "Modification resulted revised cost"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/EquityDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Weighted average exercise price options exercised"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/FollowingTableSummarizesStockOptionActivityAndRelatedInformationForYearsEndedDecember3120212020And2019Details"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.",
        "label": "Weighted average exercise price options forfeited"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/FollowingTableSummarizesStockOptionActivityAndRelatedInformationForYearsEndedDecember3120212020And2019Details"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Weighted average exercise price options granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/FollowingTableSummarizesStockOptionActivityAndRelatedInformationForYearsEndedDecember3120212020And2019Details"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis": {
     "auth_ref": [
      "r396"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by range of option prices pertaining to options granted.",
        "label": "Exercise Price Range [Axis]"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/FollowingTableSummarizesAdditionalStockOptionInformationAsOfDecember312021Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain": {
     "auth_ref": [
      "r402"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding options by ranges of exercise prices."
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/FollowingTableSummarizesAdditionalStockOptionInformationAsOfDecember312021Details"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions": {
     "auth_ref": [
      "r390"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied.",
        "label": "Options exercisable"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/FollowingTableSummarizesAdditionalStockOptionInformationAsOfDecember312021Details"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions": {
     "auth_ref": [
      "r385"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares reserved for issuance pertaining to the outstanding stock options as of the balance sheet date for all option plans in the customized range of exercise prices.",
        "label": "Options outstanding"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/FollowingTableSummarizesAdditionalStockOptionInformationAsOfDecember312021Details"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": {
     "auth_ref": [
      "r380"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Term"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/EquityDetailsNarrative"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r398",
      "r410"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Weighted-average expected option life"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/AssumptionsUsedInBlack-scholesPricingModelAreSetForthInFollowingTableDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of non-vested options outstanding.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares",
        "periodEndLabel": "Nonvested options - end of year",
        "periodStartLabel": "Nonvested options - beginning of year"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/FollowingTableSetsForthInformationWithRespectToNonvestedOptionsFor2021Details"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of non-vested options forfeited.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Number of Shares",
        "negatedLabel": "Nonvested options vested or forfeited"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/FollowingTableSetsForthInformationWithRespectToNonvestedOptionsFor2021Details"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average grant-date fair value of non-vested options forfeited.",
        "label": "Weighted Average Grant Date Fair Value, vested or forfeited"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/FollowingTableSetsForthInformationWithRespectToNonvestedOptionsFor2021Details"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average grant-date fair value of non-vested options outstanding.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price",
        "periodEndLabel": "Weighted Average Grant Date Fair Value, end of year",
        "periodStartLabel": "Weighted Average Grant Date Fair Value, beginning of year"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/FollowingTableSetsForthInformationWithRespectToNonvestedOptionsFor2021Details"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1": {
     "auth_ref": [
      "r382"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.",
        "label": "Fair value of shares vested"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/EquityDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1": {
     "auth_ref": [
      "r386"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average exercise price as of the balance sheet date for those equity-based payment arrangements exercisable and outstanding.",
        "label": "Exercise price range (in Dollars per share)"
       }
      }
     },
     "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/FollowingTableSummarizesAdditionalStockOptionInformationAsOfDecember312021Details"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r395"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term of outstanding stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Options outstanding weighted average remaining contractual life"
       }
      }
     },
     "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/FollowingTableSummarizesAdditionalStockOptionInformationAsOfDecember312021Details"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShippingAndHandlingMember": {
     "auth_ref": [
      "r356"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Packing and transport of product.",
        "label": "Shipping and Handling [Member]"
       }
      }
     },
     "localname": "ShippingAndHandlingMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShortTermInvestments": {
     "auth_ref": [
      "r19",
      "r601",
      "r602",
      "r620"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/BalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.",
        "label": "Short-term investments"
       }
      }
     },
     "localname": "ShortTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r129",
      "r142"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "The Company and its Significant Accounting Policies"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r3",
      "r183",
      "r186",
      "r187",
      "r188",
      "r189",
      "r190",
      "r191",
      "r192",
      "r193",
      "r194",
      "r195",
      "r196",
      "r197",
      "r200",
      "r201",
      "r202",
      "r203",
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r211",
      "r217",
      "r240",
      "r264",
      "r267",
      "r268",
      "r639"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/NetSalesToCustomersInMajorCountriesAreAsFollowsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r0",
      "r52",
      "r80",
      "r81",
      "r82",
      "r143",
      "r144",
      "r145",
      "r147",
      "r153",
      "r155",
      "r170",
      "r233",
      "r335",
      "r340",
      "r406",
      "r407",
      "r408",
      "r435",
      "r436",
      "r496",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r529",
      "r644",
      "r645",
      "r646",
      "r705"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/ComponentsOfAccumulatedOtherComprehensiveLossConsistOfFollowingDetails",
      "http://interparfumsinc.com/role/StatementsOfChangesInShareholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/EffectOfShare-basedPaymentExpensesDecreasedIncomeStatementLineItemsAsFollowsDetails",
      "http://interparfumsinc.com/role/FollowingTableSummarizesAdditionalStockOptionInformationAsOfDecember312021Details",
      "http://interparfumsinc.com/role/InventoriesDetailsNarrative",
      "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative",
      "http://interparfumsinc.com/role/StatementsOfChangesInShareholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r143",
      "r144",
      "r145",
      "r170",
      "r577"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/EffectOfShare-basedPaymentExpensesDecreasedIncomeStatementLineItemsAsFollowsDetails",
      "http://interparfumsinc.com/role/FollowingTableSummarizesAdditionalStockOptionInformationAsOfDecember312021Details",
      "http://interparfumsinc.com/role/InventoriesDetailsNarrative",
      "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative",
      "http://interparfumsinc.com/role/StatementsOfChangesInShareholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r24",
      "r25",
      "r335",
      "r340",
      "r387"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period",
        "negatedLabel": "Options exercised"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/FollowingTableSummarizesStockOptionActivityAndRelatedInformationForYearsEndedDecember3120212020And2019Details"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueAcquisitions": {
     "auth_ref": [
      "r52",
      "r335",
      "r340"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued pursuant to acquisitions during the period.",
        "label": "Shares issued for license acquisition"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueAcquisitions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfChangesInShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "auth_ref": [
      "r24",
      "r25",
      "r340",
      "r378",
      "r392"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Share-based compensation (adjustment)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfChangesInShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "auth_ref": [
      "r52",
      "r335",
      "r340"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of stock options.",
        "label": "Shares issued upon exercise of stock options"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfChangesInShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contracts conveying rights, but not obligations, to buy or sell a specific quantity of stock at a specified price during a specified period (an American option) or at a specified date (a European option).",
        "label": "Equity Option [Member]"
       }
      }
     },
     "localname": "StockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/EquityDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r25",
      "r30",
      "r31",
      "r135",
      "r228",
      "r232",
      "r514",
      "r563"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/BalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "totalLabel": "Total Inter Parfums, Inc. shareholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inter Parfums, Inc. shareholders\u2019 equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/BalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r0",
      "r1",
      "r81",
      "r135",
      "r143",
      "r144",
      "r145",
      "r147",
      "r153",
      "r232",
      "r233",
      "r340",
      "r406",
      "r407",
      "r408",
      "r435",
      "r436",
      "r457",
      "r458",
      "r475",
      "r496",
      "r514",
      "r522",
      "r523",
      "r529",
      "r645",
      "r646",
      "r705"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/BalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "periodEndLabel": "Ending Balance",
        "periodStartLabel": "Beginning Balance",
        "totalLabel": "Total equity"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/BalanceSheets",
      "http://interparfumsinc.com/role/StatementsOfChangesInShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r133",
      "r322",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r340",
      "r344"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Equity"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/Equity"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r530",
      "r564"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/EquityDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r530",
      "r564"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/EquityDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r530",
      "r564"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/EquityDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Subsidiary or Equity Method Investee [Line Items]"
       }
      }
     },
     "localname": "SubsidiaryOrEquityMethodInvesteeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/EquityDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash paid for:"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SwissFederalTaxAdministrationFTAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of the government of Switzerland.",
        "label": "Swiss Federal Tax Administration (FTA) [Member]"
       }
      }
     },
     "localname": "SwissFederalTaxAdministrationFTAMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TaxesPayableCurrentAndNoncurrent": {
     "auth_ref": [
      "r20",
      "r596",
      "r622"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes.",
        "label": "Taxes Payable"
       }
      }
     },
     "localname": "TaxesPayableCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TradeAndOtherAccountsReceivablePolicy": {
     "auth_ref": [
      "r222",
      "r223",
      "r224",
      "r225",
      "r227",
      "r229"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for accounts receivable.",
        "label": "Accounts Receivable"
       }
      }
     },
     "localname": "TradeAndOtherAccountsReceivablePolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_TrademarksMember": {
     "auth_ref": [
      "r450"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style.",
        "label": "Trademarks [Member]"
       }
      }
     },
     "localname": "TrademarksMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/AllAmountsHaveBeenTranslatedToU.s.DollarsAtOctober12021ExchangeRate.Details",
      "http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssetsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockMember": {
     "auth_ref": [
      "r51",
      "r342"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Treasury Stock [Member]"
       }
      }
     },
     "localname": "TreasuryStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfChangesInShareholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockShares": {
     "auth_ref": [
      "r51",
      "r342"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.",
        "label": "Treasury Stock, Shares"
       }
      }
     },
     "localname": "TreasuryStockShares",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/BalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockValue": {
     "auth_ref": [
      "r51",
      "r342",
      "r343"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/BalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.",
        "label": "Treasury Stock, Value",
        "negatedLabel": "Treasury stock, at cost, 9,864,805 common shares at December 31, 2021 and 2020"
       }
      }
     },
     "localname": "TreasuryStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TypeOfArrangementAxis": {
     "auth_ref": [
      "r456"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]"
       }
      }
     },
     "localname": "TypeOfArrangementAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_UnrealizedGainLossOnDerivatives": {
     "auth_ref": [
      "r121"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/StatementsOfCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net change in the difference between the fair value and the carrying value, or in the comparative fair values, of derivative instruments, including options, swaps, futures, and forward contracts, held at each balance sheet date, that was included in earnings for the period.",
        "label": "Unrealized Gain (Loss) on Derivatives",
        "negatedLabel": "Change in fair value of derivatives"
       }
      }
     },
     "localname": "UnrealizedGainLossOnDerivatives",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r171",
      "r172",
      "r173",
      "r174",
      "r179",
      "r180",
      "r181"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Management Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_VariableRateAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of variable rate.",
        "label": "Variable Rate [Axis]"
       }
      }
     },
     "localname": "VariableRateAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/LoansPayableBanksDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index."
       }
      }
     },
     "localname": "VariableRateDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/LoansPayableBanksDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment": {
     "auth_ref": [
      "r162"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.",
        "label": "Weighted Average Number Diluted Shares Outstanding Adjustment"
       }
      }
     },
     "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/ReconciliationBetweenNumeratorsAndDenominatorsOfBasicAndDilutedEpsComputationsIsAsFollowsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r157",
      "r162"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Denominator for diluted earnings per share",
        "verboseLabel": "Diluted"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/ReconciliationBetweenNumeratorsAndDenominatorsOfBasicAndDilutedEpsComputationsIsAsFollowsDetails",
      "http://interparfumsinc.com/role/StatementsOfIncome"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average number of shares outstanding:"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r156",
      "r162"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted average shares",
        "verboseLabel": "Basic"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://interparfumsinc.com/role/ReconciliationBetweenNumeratorsAndDenominatorsOfBasicAndDilutedEpsComputationsIsAsFollowsDetails",
      "http://interparfumsinc.com/role/StatementsOfIncome"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 7
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(a),(b))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "220",
   "URI": "http://asc.fasb.org/topic&trid=2134417"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6911-107765"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3367-108585"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3367-108585"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3000-108585"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4273-108586"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4297-108586"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4304-108586"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4313-108586"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4332-108586"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18726-107790"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e7018-107765"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(c))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(n))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1448-109256"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1505-109256"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e3842-109258"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e4984-109258"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "http://asc.fasb.org/topic&trid=2144383"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "270",
   "URI": "http://asc.fasb.org/extlink&oid=124437754&loc=d3e543-108305"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6327-108592"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6442-108592"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "http://asc.fasb.org/topic&trid=2134479"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8657-108599"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(2))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8844-108599"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=124429488&loc=d3e326-107755"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8981-108599"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "http://asc.fasb.org/topic&trid=2134510"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e4975-111524"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=SL6953423-111524"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5212-111524"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5033-111524"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5093-111524"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=109237563&loc=d3e33775-111570"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4556-108314"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.BB)",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "330",
   "URI": "http://asc.fasb.org/topic&trid=2126998"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "http://asc.fasb.org/topic&trid=2144416"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "44",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=29634951&loc=d3e1756-110224"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=123351718&loc=d3e2420-110228"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=123351718&loc=d3e2459-110228"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "360",
   "URI": "http://asc.fasb.org/topic&trid=2155823"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=123368208&loc=d3e12565-110249"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123465755&loc=d3e1835-112601"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "http://asc.fasb.org/topic&trid=2208564"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496180-112644"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21521-112644"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21538-112644"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "http://asc.fasb.org/topic&trid=2208762"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130561-203045"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130563-203045"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130563-203045"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130564-203045"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130543-203045"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "27",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130611-203046-203046"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "http://asc.fasb.org/topic&trid=49130388"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123453770&loc=d3e1703-114919"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123453770&loc=d3e1731-114919"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2410-114920"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2439-114920"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.14)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "35",
   "Subparagraph": "(a)",
   "Topic": "720",
   "URI": "http://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "35",
   "Subparagraph": "(b)",
   "Topic": "720",
   "URI": "http://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a),20,24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5419-128473"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123385561&loc=d3e9135-128495"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123362884&loc=d3e9212-128498"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123362884&loc=d3e9215-128498"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "http://asc.fasb.org/topic&trid=2303972"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "808",
   "URI": "http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4568447-111683"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4568740-111683"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569616-111683"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569643-111683"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4613674-111683"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569618-111683"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569655-111683"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4M",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591554-111686"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "http://asc.fasb.org/topic&trid=2197479"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "c",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624181-113959"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41675-113959"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "182",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123421605&loc=SL5629052-113961"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "25",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123477628&loc=d3e90205-114008"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "815",
   "URI": "http://asc.fasb.org/topic&trid=2229140"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19279-110258"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=SL6742756-110258"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29,30)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=120253306&loc=d3e28228-110885"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=120253306&loc=d3e28129-110885"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123602790&loc=d3e30226-110892"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=125521441&loc=d3e30690-110894"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=125521441&loc=d3e30755-110894"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=124440516&loc=d3e30840-110895"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32262-110900"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.3(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "830",
   "URI": "http://asc.fasb.org/topic&trid=2175825"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(Note 3)",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=123403562&loc=d3e38371-112697"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=123406913&loc=d3e41499-112717"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=123406913&loc=d3e41502-112717"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=123406913&loc=d3e41502-112717"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123399704&loc=SL77918431-209957"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918701-209980"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=124258985&loc=SL77919352-209981"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=124258985&loc=SL119206284-209981"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=124258985&loc=SL117410129-209981"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=124258985&loc=SL117410129-209981"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124437977&loc=d3e55792-112764"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=109249958&loc=SL6224234-111729"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "330",
   "Topic": "912",
   "URI": "http://asc.fasb.org/extlink&oid=6471895&loc=d3e55923-109411"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-10(c)(3)(ii)(A))",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123726172&loc=d3e511914-122862"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-10(c)(7)(ii))",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123726172&loc=d3e511914-122862"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61929-109447"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61929-109447"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62059-109447"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62059-109447"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62395-109447"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62395-109447"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62479-109447"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62479-109447"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.8)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=SL6807758-109447"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=SL6807758-109447"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(1)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61872-109447"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(2)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61872-109447"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(4))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(5))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.10)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(13)(f))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(24))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(25))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "405",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6957935&loc=d3e64057-112817"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Subparagraph": "(c)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(10))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(15)(b)(2))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226008-175313"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(1)(g))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(15))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.5(c))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(10))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r631": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r632": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(20))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(21))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r638": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04.4)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r642": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819544-158441"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r646": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r647": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r648": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r649": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(b),(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r650": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195"
  },
  "r651": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r652": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=123364037&loc=d3e3115-115594"
  },
  "r653": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629"
  },
  "r654": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "450",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491354&loc=d3e6049-115624"
  },
  "r655": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99779-112916"
  },
  "r656": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99893-112916"
  },
  "r657": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=SL120174063-112916"
  },
  "r658": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r659": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r660": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r661": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r662": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r663": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r664": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r665": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r666": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r667": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 4))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r668": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "http://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663"
  },
  "r669": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "http://asc.fasb.org/extlink&oid=123360121&loc=d3e27327-108691"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r670": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12"
  },
  "r671": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r672": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r673": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r674": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r675": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g"
  },
  "r676": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d"
  },
  "r677": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r678": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r679": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e637-108580"
  },
  "r680": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r681": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  },
  "r682": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r683": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r684": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r685": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r686": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "303",
   "Subparagraph": "(5)"
  },
  "r687": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r688": {
   "Footnote": "2",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r689": {
   "Footnote": "4",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e640-108580"
  },
  "r690": {
   "Footnote": "4",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "29"
  },
  "r691": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column B",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r692": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column C",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r693": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column D",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r694": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column E",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r695": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column F",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r696": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column G",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r697": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column H",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r698": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column I",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r699": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(i)",
   "Subsection": "01"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e681-108580"
  },
  "r700": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iv)",
   "Subsection": "01"
  },
  "r701": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iv)",
   "Subsection": "02"
  },
  "r702": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r703": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  },
  "r704": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  },
  "r705": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669686-108580"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e689-108580"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL34724391-108580"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e557-108580"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(12))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(22))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e7054-107765"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(23))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(5))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(b)(2))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.3)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>110
<FILENAME>0001753926-22-000273-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001753926-22-000273-xbrl.zip
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M8R\<T]^8__E^X9E.VM.-IS!9S2S>#!L'GVQCG\ "N@C3G;2[3V"0?%X^]7S
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MQSP3,H/=$_V7G!%?]$1 NSO!<K99G;^VFT\MP/T104SPX%K "W549#(G'MK
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M88 \:;>%RU78#+PO+& =^+.$YC- <^*Z+RM(4[V]8?5V^*M1>S&<S4?+;3Q
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MS);5?WSV7<FA?V1<)6@GJ*<:#!?L]M XNEP"Q%W,_6JSU3X^@IYB/C<>,&$
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M%J*RGB$JS:)3%3V9,Q%>.0?,C:0J&F6IUTO24I*6)2$M&QG2\JGHI$5/YFN
MMV/ZU]Q#*TF[[:![I8"6DD:CI#,EG5D2.K.9TIEZT<F,GLNIDGT<%B_IRH*<
MZ4480TE7GO<L;J5TI5%TNJ+G<L0[S'> NKB<,MP+1U[62_)2DI<E(2_;*7E9
M+SIYT7/Y C\XYZS-HX&S)T(,H(M5\628DLB41&8!B<Q#O<@[&2]RZ49^($W8
M*&G"DFYMH6G"0PA"K9H*'AL%%SS,7+[HS!E,8QUS7XLI^[YOTE'.N$^1VA03
MWY4^IB)^P4Q(%5(.A2YXZ9S&RNVRD%,^@'XW4WNO:#)-2;]*^K4L]*N6TJ_-
M!:)?HT,\VS_?/_MS?T^/<?&AU-@JJ41))9:$2M13*K&U0%3B$7/Y,EJ: :TL
M<1@*4\^A&3!_$ H260Z2:AV[,O!TN0]\YHR'L1_1(R=]KGLNG#A3$JJ24"T+
MH<J$]6X5/0+/3.9?6/Y'8#F1:TY$![[P[>>,9=AIMF0<F3N4'(S;*Q@AVBC]
MW24A6A9"E D%WBXZ'=)S266@-*>1Z-%YW._[]!GK-6!A\Z(1GM))51*>92$\
MF4#AG:(3'CV77:IOB#7QB-R R,,ZBAL"] WK*S9UF3J&7X!FUDRKUN$+*>%*
MI:620BT&=5B$,904ZGE/=2;$>*?P.IJ>S*ZNTJGE(0H)] H8K%-2F9+*+ V5
MR00<[Q0]8<I,YH0*G!X&NI@<O% T^E(ZSDOZLH#TY8'!@+7M3##@GV4PX(.
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MM5!%G"$"MQM%_??OWMW<W*R%W%WKR.LD4(C^>?O&N(K,.++6.U3[T?>EY.W
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MDC2!NGA!/F7?ES=T$#/'$_"<,Q*B')DU$9+[)V-Q9;A<'6V<2XYK3P+5]SB
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MU^(.'+TSYV':4_%48RK,8:N79VW<64.E^14<EQ*@!09HM01H"= %!FAMYQ4
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MCWWX0"</B:("-1>@@A*EDG&G"V-RFJ%@9OPGUV9C^PS>]KAK!=$NT_BZTGP
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ML<:BA1.?'F-.A4F3:J@52M Y@.)HJP'O87 *K!*Y,5!R,[(YSX'C/&Z%Q.A
M1_)1%U4:0*DQ4PME// QPL7+T+B4'!*![BL1DLQCGH^$0M\.DMD,BBMY55JW
ME-&=]40\CK22)@] AU9 N*N:]8APH5!_R2C6N@&8#)#^2 N:U(0VW1A'T4$B
M)-[D),T^B(G 0ZQHK*W&9,@D&@Y/\%1T3*>?WSMX 4A]0G[ZQFR(CU^P/BP\
M:FJ@%?%$G"\\12;.G:F!,Z2YIU4Y</G'^550\5BE<"K- PWSQDV;D^:>(X6K
M=W#MS#3HI;T_CO\RVU0QF(S8%;2H0QF&W)QUK59/T8BG&+H@I%;R>,!51Y-9
M%D4BBKV<*=/9!2)<(3-=7]YP1?@A_FXMF;GYT2  8,EB6N:@AP J'L@'VO1]
MB^5J:?T\&WIOU*)$>P2Y17N;T;9O=T.[4F$\'8:FS$ZB,:+LL0K=L9:QM>+(
MKD&IH+JY*:5HXS_0),(LYW[)KAW2!9@@,!#N?('-371J6E#X]1.L-0>PH)G!
MJ)4958OHJ&@C\XD 8P.&3MP@C-'XUT(7-J-X*ZL^^MZ:\Q5MAO^3>DZY9:@8
M@2V[AFBS<UA/FF>),(81"7JT5T!'J2%DK]IX-^1X2G"7-JRI5,.(%&.11&UG
MZ,KGU</#P^4D*KH(4L8QH=U[P @SU)LD-3I&B3XPXH^ '09YC[<&^-83.";,
M2(TYL.!K?Z>(#4O8]-M(O>V<C742_SV2@8>D.0T.X=?21_L_T3J6"-Y=ILBQ
MT8+]HC^LGD9$?\@#F%I.>Q)T&-BI,&-QK56K.O,LTRO*\4: =R40@;]3T[J'
MPD^@+6K8N!T1V?ZSC%P+Q*0AK"5SC=#ADC5V6O42P*=#<5#6,8XESS:2 &8U
M1[%AKCS0UM<Q,^Y) %< FQ5HKI)TD'?<])C'TX @- *CLN$C;T1JD%-4,FVC
MNT6 X*2(0KF^0,/=4@+W(G,\,PQ(>W=X@'Y!%B(_98ZVUBG%R.TS(F8;/YRA
M L/._B&!5GL!$M?0H8L6QC248$\!G=)61J>9YPN.-P@8K$WJNTZVU\X#+:>)
MDI W6AH!0SL?4$@F =BH#SM:P_6\H6"('@EHUJ:<'&STEEG;I]:#X?2?H8D9
MF%[D_"9]G&[H'(D>X-);(%-FK31EDBESNS1E/BD9TI7Z<T7ZAM0?FS:?*#]D
MUAG2@&SAL%2"N4,3(FJ0[_,IM:-*1LP9ZM5(.]G+%G*6N,T-_/>4 <O6,H$6
M4H=:$>06P6@>')=Q5"K>!L$@&7V7H63FRA@IGC9E69<3J3:"+@U1P$336(.,
MBU*K*$&HK7<@^<4*[5K072A\&!2/4!YL^ZS7 CT!^NPK@>X\8P*QC!>4,[1G
M: N 1U95-)UP%B)';Y,M@CY4AN?H,=QMC$U (S#:]%"+TLNF;6XXQ#B 20 I
MAT<'/+(CID#=+@^U<$^AN)0B$NK7=2@'#E<CH\5AK40[]E')[$.S(#Z0U&*A
MDM$_^ET,^Z"( S08H:*F^V&QQQ+37VJ8M.[+-/@#A0T=/4,"% 6!*)*W!$)<
M"UIHUM8O4T0N[A/70;T4(D(6*M2@= I56[HH$H4DJAM)"Y=N@K@^&N*1=\DF
MJB5R77'-UH@-?^)PA(/4+M2@LXDJ&W:E;3_&+I3U-;I2H?&4Q%08@XK[.IV!
M!#XX=,35D4N:H!1"6PC2"4P1*+1OES1K7BVZU$4TT-0 '/;<;-\=LU%QMN^/
MV2!4:\UB%?5VSZ'.YA7+H1LS<1PH+)HAI0/HDNJ 3A93E ]V#Q8*@T/A&/,;
M.*(Z*Q#6K"^)1) CAV1#S\9^V(GIZES#>88;14?!6-E;J^M'+%9TWO52GWS:
MUV$-QHI,$G@P,"RC6C&/)3H</"=<8DF GA#HA$O\D")=@.CJHXAF&$^SL@[O
MA9$,-"&#U4821T11'SW%E#V%$6QZ2 X)O4<]C5 *R&,N1;+U!7=U2Q2UHP;:
MH].3UYKR=#E:8HBT14(#"H;H(Y*2@#>4PC$P [0S],$-\C.$Z?/4!D71LUQ;
MH9-9H<>'1EV!;0!UE@R$%N 8/(V>%&<?;<YVE/90()%.U%$=WQ;$;>8B'R4N
M34-)2*<^9@ZF8PBN*MIJ N^0G=WHDK EO-?W)5:5<[N!CG: 98,O849 ^S5)
MUBL.0^=D"X>#<"T\9&>T.?JHV:W7/"!,H^ZL7:!".G[(-5$]P,,K848TZ(JS
MVQ6\[>S?<C<F,GS2;L,A4TMYE-#>8::-ELW;56)OV3 <A(R)Y<&8&^"QGH"S
M!V,(6,87PKV4_F+X*>AQH/*2'S3+$[\P!=NF_2TF3!&TYEB1L413MHRHA<]I
MHROP]MA/;),P>P_3T4T" @;2AJ0R9N)!Z4 A75W33 /E9&:S#4PX)L:\XK,M
ME$1LS,\7X7D@^^T#.BN:2_A:$;5VEQS]1\-V8 +\24[)<*&X;_O1KG+HRN=H
M94H&A(([J<W1C22IP%@$+!,:N^*9W2DZ)C63UZ599V;RTT1FTOY1!_^O NVZ
M:W/C[]CF$AMF]S/>%F*AVP!7,VDZ+70L_\>!U27TUMI(M94(A'(T/X+* ,<#
MX_L"JY>.=R$9,U%NLS2/06\.'23,-$I$=,V6D]L=6::]?!3A<'0"YH3@K@>B
M5X'Q!EZ+=="%QB*WB\O6EC*ZX2;>7(?W6>TU\?18-7;-K$G.>)J.,25E-$44
M,NEQ&VN32?)!95%E0W2(^P]E6HTZEY8B1GLL K]Q@S0;8:"7+J>&&0/DMB&I
MM9WAL^F DNU>(>O7P0LD,FN/&M$&HR)B-IJ)OM0"MZ;[NJO,^?<DU;NUPK?6
M+'OB-NF?:)89=E<032%!"P@Y'B&0A$*G&72 "X796-[S)$;Z6 JEV2H%7R11
M$RCQ9(ZDU4(U#T5#OT^AH]: C.<MZBZ0Z;1>FD[)=+I3FDX7A+X<Z]@?K8)K
M5Y^1 'OLB@)TTN J%,U:OG2O0(/(QP9] N+$G#]%-"0,6S$C2XOH1 ,)0>NA
M2[J\]M?E+%JYU',;0$%=[5-PB$[Q82,!IG#B=48(Q@H-N9@S_' T%Q:[@M:_
MRIXTT0XC;6<<7*@OX)0HLXR;?$<2<G5C]:)+0R22)I7B%S"'.QG;LV5M9Y(>
MM/J4#B$7!)S-[38,<7-"M.*4H=$P&$G8_X8A&0A/S?!\;;:9%%,((_4$FH73
MZ,.\BQ8]XIAJAR?QFOE95KP+DBR<D_W097W*:BDZH">ZKT$T A2'H;8L)MG2
M&E5&TS:B>H2F$BO\5C+[C^G9*'NT;-X*GH 6-[9LS&H5B=8.NKV/01G0"(K0
M C;+,XG29+HYS&3![L(<@-8$@J7V=R8\K&>5!+-EQI$&/6-*+3=BN#50:0>)
M3QFCPK@4,+YA@'@$O:2BC1QHE,+0#]0C3#P>/%'T[2=ZEA:MST0]Z2-:W;DO
M ;+^Q F04U.^=!8:I$,AS#B+U((TUAI Q".0-XZ*@S3+:J0Z7]'W?.R1SZQ>
M/CZ%<MAYE*089,.&C /C6SZ2O"OA)QL#3@97Q>TI-_NF4PQTG#-&XM)93Y7M
ML >R3CYA KYTF;K&:?(!URD(+>ZCEI.B8SB>BH:RED4&A:)8NJ7-@P&/,)$O
MG3;2IIY4.K\ ST"6_YD\4\2+E0>U_S')/;U72T^.2FYD0X';NZROQ$BTB]T$
M&]&%U?OZ2XG';"F7S"JE>SVF;(NVX>83&5(+M3&&' 8F) _S_K4=V!9[J0PC
M1=NEB$&0QX3\Q3I-WIH)3,4/- BD\?R&:EGY(TD'4+R##AYT3&O]?3@C-I-@
M:Q+X)X@^.K[+^89Q SC<RH12-O6:'LJ$] -,!$ZG_(7I:"XS\*QHAX4NL)%\
MK\L@ !$'S%_1,2K6U\>)]?7JE!;F?.O.I[4_UW1HRK!REZ1^Y4)/DM-.D2R5
MV<J<I/QQ:!3+:YS^FDPYJ=+A@>286'RUE2\:7I&*K>:2F$_SY5Q$T/9C*PTC
M)]"E@)*"+A53"L\N<%+.#"O8:9:!O,>$V&;SX++23X7BDDS>&XV\(R+B52A#
MVX0-R\$:FU48 *+-Y+9I@J9X&S6Q)/B8!IC,!FF:R=Q#]D2>XR%P:'QYF2CH
ME/":[$*D<IB?@0JF]@%L;=M@'199ZRA5"+CM:^LV)NI1O"I/ D%M9G\/\R5'
MW(O6J8CA7.VX%P*%BL0__U%OU#\@([6AK;0]6/4%@T;I'9K.+G /Q!(]-I0+
MYK0Y,@GLFNLJ,T3>;/:+B9(R462_L5XK5MK]?R&O!M*0:22WML[7 AE3&Z4Q
ME8RIM6II37TQ?FKOPAOEI?=HE)4[$NM'^*KM94J#FJET,H-2F>G"2'HV+"'3
M](0L^O$NNOL3Z#-]CJEOJ,DQZ%^P"\@7$EMSYC5+QO)&9VCZ=Q;$Z.<<+QBB
M601MRACIE B!)C>/<DR745HX3Y(63+X<\;*=AJG^.N0M#L6MDQK%4HTUL_B9
M?'[8-ZG7&&/U, 4=! 93B@V#,!U32RT7WIKS@)LH+V36.HZ91I7V.Y24;R*Q
M4B]UQ>F(-BK)7=1?L+I3H_$!%'(3.8MQS:?2> TY(^FRBU:/B&)Y=;2Q$3FT
MX )ZN.QW:29T9DP"( 4'F[,^=/A);T&_M,X#A^46?72,>A1M#0WG@JK#02"#
M00_U:)KJ_R0L4RK1&2D'>L0=&Y+OI,HN93YAREHA\>NV\(B&4'U'L\T#D+6[
M.&EME5S+[NAKRJG6I9Q'J'956]"H]K/BF1 #HL\4(![:%/4)U:!SRDZV;#,9
M:8D\[5)UZ$9E3*EHS%@RV,#O,E7&TDCQ3.=#*E,[DR&PO;V#-N3?.18'-<]7
M4B&5&%+>-X+MUG;JU<+O\%@":%<LG;)TW;@_($4$ V,B2DZ0IN2W60_MZ]%G
M+V.[3;U]!\9.L4]QG(&S'RO9U_0,BS%63+U&;8VPZH!/=4#2!#!H)Z\<Y?+=
M@)I5:Q\ )Y%C=;6FZFO]H,.3-#@SP2/S2*8R&IH_\C#XHK6S4R13Z(TP*@:6
M6&LZGX6BS%.RS>DTN@L=AG?W2*@5[7AUJ:JE5C:83XK+1O7'X3)KV.0O89\%
M%@*T;1YWI0Y!>8^%34#^-;=V@ ;ER1M\ABIJH\)TX/.8+$]F9CB"7]YADQ_I
M3YI]HA>UH1GFCW4)5W2E2-AMBH+WM,Z4J1?997[[GB(7B>\MK6^1%(2?:AN7
M0OH@\OIE]\M#).)I+4V?N>IAJ:&\E5CS*>AZ7N&-V%0V*@]/03YU@3GK=Z<M
M/#QK8;WH0!A+A7%)4?A[^\9L7AJOJ M&D;2>V] L4]O9VDRO*[#E/+2$11Y3
MVO38CV(\Y__A(NIP+(ADB]H8W'1A EA>^.T;(Q7IM"@TE\0ZXI_YN:),*3FF
MFE=&%HPCM':O<J_#,^'Z&6E7.]:P8V#Q$A2D]/J$'D#>K;Q] _)6!3G_M:G0
M3>T N>M  [A6264K$O@DFN\4;V$LH*TLRE"2,^(&2 ]:(K=KQ =4]Y3L8TE*
ME98@,)\*AO_V#1P6JJ7:A9VB/K6!@M9#88T!.B3B;YW,CHXC:PW4W;31>JME
M?JP$I@#JL B6 I!=46 EE,!:%#^#./H?3(,3:*=X^P;P@!4[N?(I*X%18" Z
MP'I4DL4D5\#.R #-@W:O5>P;D:M%A3S1NK649^: _#8:?:8BI@[8M"EUML8R
MO*J85 !45'XS)&VD@':B4:3!";!AP\%>>3<,W>F,#'42I]0O?@?-.]*EYTG]
MCO!.$.C-)"F",G*#H\GD8YH8:11]K38N$H&T+_J<9 JKPF>+J;(D*\&6C\*(
M,DXA+)30 5]FJHVB72%'^!-K<]87C$? !@<EA7_'1PDEY;Y,1HZMNV]C9T''
MY1*6$#1)-R4R6BZDFNNZ@)MN3$N."V1@72\-K-K 6BL-K"\B1\[GZC2G>H><
MJF\A'Y)5?P?B9-.S@#_=(;%.FWS#4C'0OI-J"_2$&<FHZ/KVS<-D5].>B5VQ
M'Y%V6X$*J/ 7S.6,!!QBCZ_NP@-8? 1S*'D@6SY,T*BWP*11^MJHV^"05'?M
M<N89FJ^%M,.(^8,U)[E_@***LQ8K%)R3&QFT[$=+0/P=E?!$",( 8<QZXY@P
M!\)2&&H;2@M%Z3Y7.O>!N90-CE(2<(HK[8%+LSYMNAQJI" \:&76KH>,8=R4
MYY(M PKH40-3]RI2'$V*'-/MPK=OH#43=V$JQT@C#6+B*PJS"0$O].F;&*PR
M[":U>,WAS>A&J?2(\LC1_EZ2S&^+'0"_#Z]6PR[K<XH,CWQN,T5L@Z<HDXS4
M?<_^2M]G:\'CH#J<#MT-ND)\:-I&K^C@85(4,V>?(G#]/LH92DI3C:@/ ^<4
MOI582R^H +_/!MBHEDK)J)LJ"R!*8#V^D,1^C')0>JL DC>*"EV@>R9$:9U*
M.00R,K[FT,5,3$(TGB2?<J%"*[[#KQA^:L$LE(*%URN6=9CD X= /EG-!<IL
M5&WTLDG#3.U<J97#2&[&= 7-]'B4:A1)74,XEWTX+&2RQ/RV))$4J63N[KE&
MI5JM.IZ4*DRS3).BH\L1+ ]HBEH@O;HC5_W<=[?&*,O(>/FRUZ<\LHY>,D++
M$VP!\)&8T5EC1>O+66$A73 B9VY7\&NZV9#XRFH2Q31L,S:6C9!W,C5VDG($
M#"OD7/.!)!4IA4%:$T@ON@ENT67Q$B+%;Y';85D&S9 T_86Y4E"Y):_H2A#)
M943Y$@.FKK8MHJ!=@E08@<K8V<D094"*9:YFBE3<,]EV.D54)Y[F8U=A#CU!
M@:4Z]8ZHC)17U%8NPB_QX.7=)<81C&X]JKN3,Z+8"%:L'Y?$K6Y6,]<Q:84-
M;Q1#>X"N[F!#<8W)0J=#FEI%^1W.A$%FBXYF3M?R!I-E;R4;DZF"UH!TL?)V
M@2.Z;Z6224P92C?%9K"8T:K-81TNZIP<D0Z5^*$BUQ1ZB!'97:D82;DVS#3G
M&]&=.\?HF<O*!^;[<\VWZ9=LYE)NBH;W#8]*IYOU@)GWDA L7UQI)SIP5H_K
M"/',<]1/!ST"=@XCUQ;F<F23VQ/_/WMOVARWD6V+?E>$_@/"KWW#OE&J)JG)
M:I_C")H:K&[+TA'E]NMX\>(&6)551 L%5&,@1?_ZN]<>,A,H%$G9&D@*]\1M
MBV05D,/.G7M<*ZPMGO5NG9-\:P>L+&G %K1UF'3KP88?D?R:DRX@S[QUG42.
M+(_B*&C^>*)U&3ZUP1!21UR^R6=("B8DD<)CF'1?JFO^VLUO3,'L2U3C([V4
MIS0O\A_BSI%.Z@HOOB,(*W^[Z-7\6:"YR$AQ^F[?(J&X>VE2P(] !7C[5C 5
M-J;=-1D>3?IF I<_]G!+-AI*)B%TKQV=2,;1Q-@A)M>*,R;G)$PB"VG+.QZ0
M,<I8<0UWKPJ*;=]?WH9J=OM6-Q_NM84=  DL/NE$62'J[,GX(*W K6PNH>^3
M_1$'1D!,HIHE!OM -#XPLOIOO"[K-$8XE=\^J07JS?Y0EP+% I!MAER*>G-_
M+%NZ(!M1 H][N/V\?Y T)12X?:N+S2;5_ORT_3P[RF)^/>@(NLK5M(E9 Z)>
M6$W(7FM],.P1;^QR8,O<K*]6]M8._C$NV)6RKEH]FT*Q&:((GZX^$LF#^XJ@
MV.EB8C^,KU005G0LKJBA:0*LPSGH8\FFS>=5]"DIIHHN^ C=BVNKU-++B@[;
M5\:>Y)8J_]"JTAT1%W7AV[WXR]#AV234]-6(*.K C"\H2:23?'HZ+?'D.:D^
M1*_2Z0S(V4706:?')1G2*=!3A%2WOD+Q^/MC/%[B\7MC//XSV4.O2SH7]1"+
MV$;9G'Q4#6"&J(>*>U65,]P0PB;]+(79G!R(HD-EC0?"!T::R^TIK/+V[L=1
MY B J5LO( 9W7.:F]=#56:ARN[]CH9&?I%@TET*<P@:N6BJTU%QW>_:"B&[W
MQD=40=9!4K\H8BPS^&^V/N*<'*>(AP20JZBX&.W(^"]S5ED\ H3U F(E>,2^
MG?5PS:%YGS0H:*S)@L:DV0-4HANHB#F"0C$0 R'!.DM;7!QAD#YBO#D'\5G7
M.=*R"&-8 2?;8N=XPIN>HHHI!Z:!2$M?BO+.L,+.?L=<^T9?8%ZR8>J34(/'
M'\X\;%_1Z5/21/E"HL!JB G>91^,9$N#8Z=04&<PE0*Z:RWHK*@.T_PDY;[G
MIZXBL4Y7%X*' S\16PW28$8O397/NYO*&WAR<CA=3_>G$T^$TO':I.O5/#>K
M<3,/[I0#3VD1P^6HL6/QN[[_$MXKFM#:/7S1@688Q9]BX(IJE60+NH@K9,#@
M\ALE$=-<N&9ZSK2,ZF_--I.W2M7"'?K>,[1KG]-GJ.'&7KR4-%/+]>;2?\)Y
M-6[_J),YBM09]H*$FRZ"A]-$>0'!@ZOPX%ECJ<U.?;Q0U,:]B1S'.7&U%8SY
M)I. T3TPJRFN+TGW>-YXVV0%/ ^U^D+H&PI5>/W0=#AK$KKQ!%J$)7\2P5FK
M^HE22<HYK ,UAD2>5KL&O70OK&OKS4O]X/L77-:O*5F[T;PRGFCQ:D3*R+"[
M9%5+Q?KV+?9;Z>UR10*7;6% @DD_.NQ1!^LL?QM9]!Y@L$_5TNT9O^9J:?#^
M[820Q'R/ZYR3W76C-=!KZ5C2P3+ KZ3@.X1,A6O7UGS*U]$A2'U0_$?#;-(8
M-JO;\+/ #2?$ '.0FZ^R @6&90X\8V#,"@DTX.NK1O&0(_#V.@E<.15M<@3,
M3K<M"-E\::#<9&"M/&*]4/ YP2E,6#6A+D#++@-K43=GREVT-##7& B@^,^A
MBC">72;8G(C(SOU4NY$>_I4 _[,1&K-%K$IZ5\VL<D6@E>,4LC\%V*L,O4M:
M6$J^,2;&Z,QT4\\80GH#N-#T7U"<@5?<&H@9GTG_;,!DO9T+,]$S,S$.&]KZ
M]%)?4FAC!=M]T];8G@/39"PTM9/(@7YF7X:CO_;&B4*HL5TE?[HAT9]/4HUT
M.'T#.JPU/;>'4+3[Z)%T)@F8$[B2SXT+]VV6\."!VO@(MGS0WNA\._":WK[U
M9A!?"#Z!,?RZTX@-J<E\CU0M.67]0%H4K?!88+0H(8"!81J#0S%+;5$B2T8>
M$6P8&D@\0FXM5*:33J!MLYK\NX=[EE^A;PG5AK$1<TAI,/^9(]=DSH)><;=O
M*9G9\%K%QSG^Q+I3VS(9_#.;YY/D%>U.!RPU^EQ@J8KL]VM>@,0'XI]00[ES
M"XT7[%=KE]>;G26"DFWBQ!GM072N;NH!3:X"><F'9/AEY_>23,XOR M&SD;"
M@MR.>U*X8_ _!C&VY0QO&=YI6JM2$'=OY\$5BE@^&".6$K&\.T8LKXC%O>V4
M=^Q!,ZT[!UMU^-_8)N,@3)21"RHXB?*#&1K/\:G#5 L;U4C:^G'?!J@4WZAR
MY3:9T.AMN-9]'D*&/XU)G7S:DNW]#@TQAK%E)2X<'7J9?)[%+NY.4<;+=BY)
M3KG5) P5(EP2<&5J)T:Z 0T*/AD#\;Y"D5'9YEEXD,4A!B=ST:B!JT>6=YN[
M  :AT;F85NV[1P\FVQ9FP+#PC# 6$[DTD>.U/51\+Z-OE__W1^.8/;1.&C%
MCGX(_[W^TWUJG3O]?A\!1, TI\FKP;]Q@,UW.J%<HRRL-"/BT!90%9A[BEF/
ML^P;AM3@,&HFB4KC)PL(Q1T Y(A*K][6?&R$6#!-?CQ+&":"YNJIG\H"%Z#"
MU\;PCR@V$E8VC3!KC:,Z@.2H9HV$;X3<B"N_PCJPA6W$?TPL1,]'Q1ZFCV([
MAGZ4F/M TYK3>H>XA"/T8$LJ0FF@.+S6STI@N@<: K64D8<UB\)08H"A6)E4
M$,*00IF7,CI&X1B1<Y9R%VA;6?(J@'&"I<F*P%M64%RUN#*.'E1$6U!PY=O<
M?)5BZ/6@WW%S?AR^1[E:F!?M$=E+(&*N;H9B>4;2'T5!5';,>&9LHX&%DB)7
M""0)E)Q&.CXX2?ZKL07?-=&-K3@ 9RLEAK1_, O8,J*0[U#73Y,G0&Y.)-Y>
M@<%H$FC0K5I.WK 9=N'XD +B;#P8"J 2X&XN<K"[7%@PM96VW_X85WN)U-"#
M#+33GF'L'HZIK"N8>GAWS*$8[ [NWTQ;M#B3 IE'] "L #BYJ\Q5_FDA^*ZH
M>0S^I\R<?@<]!CGF7LT%@VF5OJ,I_6ZL(M)D62ZR)I2%\=+X(Z^G@3.-49UB
M+YUIK_JF;H_NR%Y.? Y-]Y8VQ%*+W\:T*);!3J%T:RB1IS)AG&BAMJS*5:ET
MF8CRE^@R%T7%FVHW0QA08%GQ$@KEF',ON>?WP@I/%)Z(PR1I?E9GWH[,5AQJ
MQ!+YYC+CA O+/U%<(]6S6$U:+_& 8W3&;B%VQ_+MU<)<;Q5S$%G(9$8*JX7J
MF;)["">W;\6JQ[,L(9(P$^):CH]^L#K0$"P]^F'CJ9=9@Z]HY8(A$F[>&)^:
M9=IS "H\#7:_F,=K,FSK;*Q1E+-?IW5S^];=G2AGS\?TJ,W 6A=_B\O32#O=
MD:#;NC=D6_5XE7FDT3:$^$C-&D%F0#M6>H6$%\^M63Y2%)L'4C5-6]6MZ^XU
M'QZI:^F)2@V%N*07F>J6@7*KI%SIW064\PQX"#%MN&A>?:,HMJN7ALURL+^.
M)\QDU[[D)DV0L@&1)0: "F+&<DU RWM4OK,X)ZVV>%$O.>GIZCMKQ1PM"W8[
MUWG:0(%-DWV8/*?NB.F909/I6(%K=0B0RP,X4J]%HJ:3L_$"]I_>NC/SH=!&
MQPP(DH25UW?6BBT;LI%_5Z>-\ZMTE,N5L9%!,)#VE&[0K';:HA<)#OIWCPT&
MP74N0<PJ,*!V\VC^[I'X74RC0">D8KM,:@S)@@^4:-*6H[L&?M!(C]Z^I8I4
MA<KHJEA\#  WLFO4/WTL" L?H$X!@?)+%RI\A *%Z>U;'=+' ;9VI,SO<+W"
M.2SM?P;>!ZF3\RC9HX:YQV51I( ,3F6:C__QR[\, T_$;+.)3YJ\Z"],4X2_
ME.@GIXM7.N7V: WV^0;O]]#MJL)$;K0^GO#_)F3_@9K%NUCU,6E069^L.*$C
M[KG5NAV7?[F[M\.P*P)M96">1Z">/7&W;]6(K0 [!@7;\%*R0G;";"?9N/C&
M*]OFCC"DQUI95*\ZD -ZG%TX3O7J%@F:R^U;<L+#QG/E,MYY B"7^::5*,Y>
MQDUEE>+MH#T\V$UR8'$:\/O(A%T*9@PW R )A7L]?>LWK>,1A[N'Q@/278G;
ML4^\;GK!_Y Y8XX'[X-LR& W"WH50O,/Q]"\A.;OC:'YSV2)/^$BW>!CQ]4/
MC3 !XV9><D3)N_7>Z$"#(7DO<[._>I0KI'/.2JN9#(A_\D#Q<OFC&O0YIX5:
MKS#QNF<PIWN71<VD&6)9]R(&/&15NS!!CS?&B?9Z,G6\75,X9S!H:L9&AJ;_
M5%Z>H;?A!GAD'[^L(O;XQ"50VZ)KG/FF8Q&UEY&;U,$K/L=WFFV\B4.ZFV\+
M'<[<4\>JEEV7=)ZN!0 @*GI@VK"3K"H+;^!TG;A>-PY'<\@$HP>(?:#AQJR:
M<PPS8N]&E-,Z:>A:5'1L#4^@S;P#E]62,S#/&&D-)@%HYVOK%9>0Q;]1@A0J
MO/'+7PL.41TV($>;;!1]LS77W0GNVMYPT?@HK=*S1#O*V='CX# :WIKNC,U%
MKWK K9*IX0BU1GCXB,$ML6$W9"='#916--L/YOCS?8S*+]YM*54[=[MCD&7N
M,??VKF&1">80Y@E-(#&QMV$8<_(X9,VE2<S@08)A* K$@N0J(QT]Q&89TISZ
MS)7Q2I_ B2+C25S(9>7#I64?.<UZ\3%.M,N'4E]:2G:/=6\,"& 1!\OEZ# Z
MBE6MLF[LBH$:J1)+UU"Z,D37KCH1O\DTHF_8D.G3K/)R%K4;L,O%AXL#\=:B
MSM4339L:[L\9PFVTB@&(]<_6T5RL_*ZS]HYR@:^Z3N%ANU[G9S<N'8B:MQHU
MGOZ(]7W/R#FV#(X%3.)X$XKM:FT;KO_V*=>EX?,D]OU_?[7S%5#C<W)/$#CW
M/VN],?^L8SK-YLTQ!K7S]5=R9S<5/V_>^\1=-GM-F=@2T@B_^FC;TIG@7YOY
MX+AVO_L,XWKTX.&CK0/[I&,YS% XG1:.V?NRFE1G2'A9D*:7$>40"XR$;WQ5
M>9R&H+OPV 'YE?6Y+Q:75-%$D[K)C*X=ND^4B4EC>W03KUJX\*(Q-!/Q;7>E
M_LH2-B!I@PNW&8B/@^LF(NJ(7VHK/O\3=0GH/SBUNACC ?XB#_"!!*%0EI"A
MEW \*>-)&4_*T%A>:;'$JIR]O=.NQ0);<),?\B[KQO+SACG)AELZ>YLNN81D
M/%GCR1I/UM!87KN90UKK* -V#=KA$%(A_Q_(Z'#Y,IB.WRR9U0B1"U0"K.DG
M6(GJ#Y7\NXK3U,#Y;V;3;[LG,,1IQK,XGL7Q+&ZQ!Z4\U1^[\:R,9V4\*UN"
M']K^T:]=N<CH\[+SD6-SET[<?S<F[B5Q?W],W(^!WE'7#8SE>8TRUF"7K]L*
MX$Y.\LS;S(3/HNE&$?TR150XS7P#&W?%E;DXB/.VT@:9#."FY@ZR+).:3@%<
M/4KP*,%70H)#R$+:N$Y(2,MJ2**GGUEJ/V96_-!'?DZ/RZBL6#*+ RU[FDV<
M)$= >T%O1=GX;K:F_*^C'_[VJ<L%QH/\91[DY\7<K1V#1$1(L4H7$NK%OMF7
M9#?)[$%:50)BD/P(Y.UFDKQZGCQ6\I4#/.BQ6]*1WY;-'B^J4;X_72Y,99I$
M^/G3IY/D67:2MG,\Z6E6D3+.9L>3V[=> PRU@2B_2=^F=;HL)\F+M'#?:O>(
M[VB.V=,+QONWCB,I?P;40>H[]B92;*BE4N&[PU4F0\?%2]LG%J*;_+K>RGX6
ML3S_Z'ZQI_4IN+)Q5O]9GJ7H,3IX]?35\TGR<N66:?+*K$UZ8CG+Z#8"B,[C
M;+%H:X&S2#CU+:! ]'$Y^AE=6F\.7R0_<LWR>"N-M])GE_,?N? BZJ!CH7]5
MSLC$2N9M<D"WR0DH2OZ)5N:98S(2^G<E@*,_5B497I/DQ[):966>)3^WV3*C
M]S>ERW_/ 2Q5%YE@^C/YQT\N*W[_%FV5:WK/_R#N0$(V2?9__O')_B1Y_>J
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MOMWI!HL>,0EE#!MOWOKT7Z>'TV1>@IV,@;NW#S $D/U(!E% \";-EBAKS0K
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M\J0LHE(U3PYB+.42$MWEDCP:&)>^Y0O3N@@JW$@58$[#=H2#4]<U[27.S.>
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M#A&=8[.E6\&_3;^/$  C!, 7KS1^.Z]P?$M)I=1&;G:V%F5AW;V;%<YQ]'R
M_&R@/I-+<Q?T4BF \:5<6]PNS@D:XNDVHU)-Q4[I^J@<1N4P*H>AL>S7[,%S
MA?2V(R6MV'E.WZJR>FY>WD"C4\C':H21F:.EN1VA"7I&VN7>4V1]*;'CI#@'
M%B3N6W(S?YK7.@!Y)#=2N'3%$?HEZ9Q6,Z9(<U@Q.'^U$]:=Z'NYA<-5-9KC
M<BZ=1^!BE1J=A<_O<LL5^:"SG'[%:?,Z;I*?&/F%]-#S!P*VQ"PG3]UZZ^H4
M( 0*@U25;2-,VDT\TLTF//&K>I4@BF=A\!;<#N&W0\TA)$W/['E5NU::G&Z7
M7!@';6*NM1YAMR3G&%SZ'I/XJ%-'G3KJU.Y8<K<@T3A0AG3>^S@R*"<()VF9
M5MJ9E-4=)6N&U+;<E<%L]-6E%A](&&Y=@ME.0Y,AYKW/H>$XL;0J22N1(^7U
M?817LD&+T@O$^7KM253D(41"/F=F@4@9OB]#BX? %446!;193Y-#A._T-E*R
M0CR-/]VO@(X:%T-256.C%7/;%IZ9%I4C5ISEGZMP&G6KR#&"X"*54!*5#U1'
MG958^)4;M>&H#4=MN,W"# <X4@<<ASKC'S@*-'>SK+;D0<!^M%-J. KS3'IB
MY'M<5 I59"'BK4ZAX#M9'^ L3S,IJ8LK5+4HLKT8!>\J9 L>C=D"R18\&+,%
MGZG2*C2>R?%"9S9<CAFY8O""JC/KWAI(KZ==QS.UIOL0#YYKY=J-YLT,V7]4
M]R;'V?*8="$8B+$JR[P\BI>DDVF.X2;-AO*)TU!N-AAWUS@Z6VQKJ0K7:M).
MA?5I;X#^6?8EO.#(D3UZ%M5J<&%[WDIF'R57_9V-,A1F56DEM)3WTLR[8B3Y
MA!X^W*8W7--:I]QT+1W:+'5Q#D+RQ]K)'7UF0^8XZ2$%?=IBYZ<>-22N&::O
MJ'MUZ6$[MLIT[T*RSQNZ05.EL$:M'L*;V%I$1N)95JX.-=X<H<%S)]%#[6&%
M:W3B&@*0@A1Y2'BVM-A[8]SJ%WV$P1=G1#GX$>STW$I43+_A2\908R6X1,*-
MA-8D<>M,@]95Y BBAH;Y*ZM>'61SC.H2*Z_P4)EF[DPNV)7SFS[#+FWLAI0*
M;>[=C2U![>W<>^_7A1M%7UD@[&A=1^1=,5*+PCQN //4PZJW<Z-^F,V__!%-
M?L[>:LE:: N;EQT*NJCB#7>9XTI:OB(DM&&P<Y;=(?5.&O\DJ]I:0<$XGLQ)
M[+9X6W!Z./4(5:3)?1NUE/KH]<'+GC6M_-6'J?$LE.9A837\@9LO&8B"-Q4W
M#M*%(MA<4L^VHUW8',*0V(@TBC?E/#WS;HHOP#)(4+HPI#J1C&_.:M'KYX[[
M$4-R.Y7V+MIV>XOL>'0;@)6V/B[7:PLM-R5B\H!4IJ=X)!89:BA8EQ*ZO)R]
MY02[ /08LA<7#YC#)?5OW SFT5],=!;]+=HF33$V:U=UQ) S''F1!DV&)96:
MO/."4-WMYCIJ&Y4=U\GPA8EWT5-8)B$[897-0NVU3W6C/;[^+"Y,M(^$V?E*
M/B1+:& B=Q ZV'7Y6;#?M);?NCII*DBK,/SB6)%]4R(?[]/%\TPL_9<^:_T>
M_3H?<?R_B<Z,&O\D&!I1>#!@DF(.QATL@ID3,E!F/W9!O;NEOL/H%IVT55>?
M!'/Q9AHBOX74*N.%J4-X1/X'(NRHSD@[#9O Q(P0/(/MSUB+KE%7*JH1)\V)
MA,50U;%VI@0,:"Z\DA820-$X5B"JN-6#_2.#L1C\)09%=_5YKT![U$2:I)#L
M/:&W>1QPW&QZH14G=/=*_IF'K5=_!&3F(<$T\7G>@&IM9H>1PGVL4C%-,M "
MODZ\S4V,U6@_ >,GC>N]T\:&3\@_!/\_Z^2VQT:>,9#_T<<2 4B:O@<<[&2C
M^06EJ+.N@&[V!Z!6;*(@OOPMX#=4C16.=8I$U!Q+:: +#1FE[UA!A:*2:'1=
M,,]!3@)A?X!96?K)\)"T.<+TP_<CO]28W1N5PO:Q*/"IY.IFS&:!CJJ"_,.2
MNX40_3R1W^)S;SLEH7EZQ!!I];IE@R.N5T*X-C8.&=B/G4=A!'&SXZ+,R^49
M2%5J-B:[3'%O&:0MOH/KK''!ZI0J!2.I,:! 93R9*')?1\<4*3U(D"]38(1#
M VEX19O+H] V/0&(L_2D3IW^TI5#I?I1]Y>KJE)\^J9)9RBF/46DR)!'5HB1
M(RB>SD)PAO\"AYY96PPT%RU;FQ3E.L/KD.6\NS-F.27+^7#,<GZ.*+Z@CHH!
M_L=2'J1?N'I^&]3#.;'U:^W."ESPIBZSVBG5:3UMANR#Z-'L),O)WX'=R-QN
M?=4KN;D-($QZ(4=UW18B!E\9QO \ P&&]XJ W]2PP\:^1;W)9>VBEONX,_T5
M&>CTXJ?">"7D'W;O8(E] _.Q2^?:4 Z)6)7D:#=F$I2S3@2I:=R*$?@'[D4O
M/%;V*,'=S0\.WIPUIV%"7[,O-^H74@JDL(^"& GDQHOX>1W!I063!=(, J('
M+[+YG$SE)R3&D^37MT"Z%:]C?T$.4CHH[)-A:5]7#FGS3B]@,"D,,UDI &8]
M,/33LGJ+'/ :EP1K)TD7#R2:0F)Z6_^=OBH.W@=DO;82N(-3!% BS<?\O]98
MZ(,<$\T):(I+4.]6Z9*<NA8NH\V#JTVZ(:5PL,?T].6PW,5R7@A0<3]2VPE7
MD4VI5.@??7%OK%K]S1DW9GYF.4)!@MBVU+03HC4GR<$Q+6 ?]2$FW[&]U(;?
M1IOK[%D=3X936P44 T@-N1)$P47Z7S(.A9@;D[82O^).$/:VHA&STN;VOGY5
MC%[\S\IY<'9HC1#C&72?-J]\FWR.Q#,BT9N:7N&W198WI3CJ"DR$A$V3<#J;
MS6_,4@0QM)\F+!D#.S8D$JA$ NW1'>?KQU>  A?.SD)F:B3#HUJZ1%7A9IBQ
M2=_AJCF1"F%!0TGGY=JNXH)>B,_DX.[*]8:N/")LC_:7/YE)K5E09Y$I2*]:
M@(PS0,Q^ :AKT5D5(%4.F(1,!*U::I?#0*IH,W6AN9T0GN"8;:")L\WM-!4*
MT*<<A(R+Q=\QT4X7WC\@P/1-(JDDL5BP]0+Z<T+GND4P"&9$$#-&7LK>":U2
M8(*)>.R09Q.^&WD*:2;6 C:\>N-YZ&?VIN+<T3>Y[YH^K[W/@K?KI;#[ $BH
MA:VY\"&KF1GIS*0]CH3I&X''&KB)>632$4E6XCK5P@D2[1E3Y#WMTT%/[)0!
MPR$7HJ(,@2(Q_$KI^4%G4ZC6Z0;:#\B,KUSMF5O\:00R5SG/NF>ZVTNJU:5\
M$ %+&YU&6V,Y]L.L4@,++*R);16$+UYND;.^)L"<H]>'B9*+TA:-=% ):Q 3
M=MEM$ ">)S&G5UM(W^FLHIOY3CQAX6\LZ@5WFF8S_EC4*4\^CX(VT15AJ47^
M1FKG9#_4^AHHE5=\=!<PUI5"<F0F)OP4K%!+!WU8XLHJ%FK=R0AVERY%Y@;>
MLNJZAQ%-5&\GO1J?Q G@KHZ5BE@^Z%JC>W5H*.[NCA%)B4A^-T8D/Z/CI@SM
MUFUNG$8;- "H8H3IW-;QW;S(<0WZZ\-3AK)S,D--O>@&);D3TS=^H>1*-2,[
M28Y(*V=FH1M.?DCXWER/[MQB%!_O"EZ'U2.&N,4WG*2YO_/UMV) E3D[8K].
M#Z?)O,SSM%)'JH!9Q."$I44_\)+8R-V^C]&&B[$F=2J)$C%P0BAW#&Z^K-(5
MPU:"*B& ^LL5+0E])PYD*^8&R5=V(C=1\%302E>U"O$ [/K<X YU<-ZNZL=H
M050 .$*%)/"QNG@*EQ%:*U6*5G(2P7[2U=0'MV%X&=JSB^KHNW[:0/SBE4+M
M:WG#1&L;)GI@8IN8SY$=GR[CUI'S8)9#]M8@**3/$D;LOTQ<P&;-'YW0-3^Y
MP:WDIITAH+1+=)5_896'!UU_9CN\G(#)Q<F6D'1W$Z'\*ZN8";#3M3"$LJKE
MT![0\X]4A':#3U'JS>7.5$KEF,%TWJXB[O4P4W66%+Y."[<W)MSM:JPZTT>D
M"PJ],W]C<1.HV!Y&A&%#')>G0AO*(#IQCB)45PU6-F&]1 _&Y5=]55?3:NDB
M:"F5P ^?.*N>6)9D=\>.S2QEC%BI\'+E&N4^KCE%4T-0-D&SK;@W3D.3H;\
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M=X!U\2K>1X,B?V'4[Q=#IYR/S*P'9J"9ZAP(_LV^%YO4S;P48K_\]JUN@*)
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M"?@H=/>#+5L2UH'?8<(N(+H5I &$G0);^0:E%XU!IP?P6-H)4#9;16JX/@,
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MOOT.^64+_KK'.K:DT+J'"HB:6$KT/Z5+.M:!9?:4]NNX1,W 4O/%T:YY*/N
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M%:"I=05QJX1^UD49EL#=G0?31SOC FU=H(?WI]\]>N]C^=MQUKCQ+.X(WB\
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MV]OY&BGWBJE1M))-(>DMWXY,\%]VIW?W J[E('9]3.*Q,^D38>+!X"*M0'_
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MGQA&#)O5'OU;\4"\EJJA96O F^$++(EESF)Z1.M.VPG)9H63TM0JD)8+XD<
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MK 4<.^,0Z2RMZ CR8!%&(X><?BPY- NC2>++K/+2E=N(+J_HDLCHZ :3B<?
M"[<N:8)TLTPZ<5R?G< ]B%!MJ<87O>/,(U_S<FF0W*LWUQ4>7!DY:<W9VUJD
M?HFI9PN6G99FGK.17NFMM<>[7K&#.*%=K==DA'/HFT0KA/5%I"%O7L;51QJV
M!GR2)4V :5\A[L&YK-I%29;^E=H)N$ZBD(D$OA2SF;G4%D!Q#9$:DCR285D.
M95CCR=V@R"7[IJ]E8Y[[%,H3"&=]L_W2'JG72<H6HT=C_[)XO +-)-3?J5C.
M; K=OI7&Q%H!_U[R"T,K=SA=3_>G$]$UB"07" KF+5)VHK)@HS!WBP&;GY)N
MAZF$^\,NPI#HHC'$7!MJM807:N;#@:$$"I@C[UC(6EDV6.][JHUNRL47:I"3
MN6I7<7*<U2$8BA# E4%4Y1G9&&>@511O-I7(L/BL2KT"E6,6G^2P[=V(H:],
M67&POKOVLCRP&'(H'BS%[@XGHNG]DF1*[M_!S\K/!7.#[9*!&<V,7>D316$O
M$N+SPK)[GR(L.S# 3QBG'7K['PG</OH,@=MS5V[+Q7(U8KJ?MR!I@.XARO"(
M\T*"G17>%X.:/9& D!G4^L4-JJ!)#%%O@:<XT71Z7.;YV1UAAWI.OE.&HL+
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M9GEZX:/V14@K\=U0[=W:H'D(?H3TV<8B,M>_6\!=,7'VOY,_M_RI7,O[%MA
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M11<C]* '>>"D2/K<#@#D7:"?YP]DD?FR-8S[W+&>/])16*\T6(]&M+WTA;-
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M@*+%[(<Q5S$&Z$041G3[H]W#[H%5D!U2EP?=/:<O\=E'NT?=8_>;9>Y!1^T
M.M&EX6*5O>XNW:F]KI: [>-&A?Y XQZM^VZ_-AEW=+CD@L%!#L+EZ!1$N[Y
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MK9"4N^B-[D(FNB6%1582JWXX*;D^,^Q_U!+1N$#<(A;Y1;NBM05\NL/:7QE
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M4SE=2%?/1[L[M1Y_^'KG.FSM3;T5<RN,E,F>#-U>**]%'9MC;B5 ,R3Q00O
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M=2QJ%%Y./J1CB*S[%_Y@AP5RA:N!T^]C8+3$%4(?>+#[@PZQ&4+%?,7X7>=
M*5E2)Z0&4KWO3>01UC$UMM%5Z)C9;E<2%Q^9>*#&!G Z"/P4I&!HFS[FZ?"_
M_VMG=_<IG<;<WNA#=D4+1'G*4J(7]$!&4/D&S8B@&B1H](B80H.,'.FWFRY#
M_(+_GEI7%9+PM$I2',G2!B 4BG>!060L_,A&NHP+!&XEB,0"F$597>[M;7>
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M@GR%,RE8+(,$(+\(55,=6TH:[-&NVR,@W7!&+&^JKV28Y#88%D]Q.E*A4_&
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M?DW2),YF+N+,0.:_/GASZ7GQ'9VE33N$M@+LG(A[D6D4&S^"JR2 N3\KXO\
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M C%6>R)]V21:+HBB0Y(K8#;CXIDHGB)(0DX0S=C)&Q?N1BISQ.4T J).,CS
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M[+"F%@A;Y3$;J&*&*QQE$P[*[=AU9>70H<M\-[Z#DTDQ9%]Y@4Q^39K%9Z,
M,Z.K]CS/SHL!Q#9_^DGBRQB6EZ#L/D].))]IM'T*06LVCY$9XZQN>.)PT7Z(
MVYIQ:2D H4HVPTBS.+P(:++5,WI@U)-F0=R"VIIDQ(S63+P,C)AF8E#JU/VH
M,FLFU!)3]CC,3M-LRT0)-0_V-$TW^:-JI]2ZSP^I,RMU1U/-F)9+D'ARE;L@
M1\X,D-27D"Y%VI4_M:V 2M)34?LDW4P*E+^'CD!ITJJ#W"#'U5CZD)S,MTE[
MP]CN47:R=-XRY;Q-"JNA=0/*"QD,TI>E7#^=-&#0FVN03?>X?>3VSK'?T'>.
M\LZQK^\<\R]J+Q+>;BQ6M4QDC51 )NY05G\6<0##42]=0>*$1.E\Y8UF;',-
MI"\DD8990125C8 %C 0I+^K)I&RGRI#*RK3(1TWRI=EO&>U.6TK'M/<Z'BNP
M,*A'B:,Y42B#)^#(\+&21E0(),!!0F\6CR$5I?G31S9"E6X5 I7)U3&1-,^3
MBA&NU<2JDDH]DH<4RKRL>Z53[T5AK,]-15H19AEK!K*@K,H0CVYGG$0/EX<7
M^OSA^.$#V_+'TO\XCS4*^%9G;D:!SCSX*?R.!/!!982#J51G!RHV_N+RTX<H
M&GY>)P$FX5/T$20/)Q]&+\D"S_A>5#I;S7!#@:7J(GM^:Q1H)!L=4PI+1)VH
MQ\O^$(9ZZ%;>M9!K.K[>CJ*_HH7%P\?="+PH^)_N6./%TB7:Q/(\O,@(8AU$
M?CX/W;0J9=O1Z0^B8DY3ZK2,9J<133@= S^XDV@E:H(D1SFZ](UK1B3W)[*I
M3O0 7<V3S,&TG'6C%T?]V*-M? +B29B6%&M7N+SGZ"K SE%IHYWXT4_2&51"
MEA3J\D&>!AQMQ*<@@>N3*SPW\5_,1Y+= M!?2<^D]64*XDR/$M4\H'A)JHN2
MZL9"MC6M\$Y%]M#E+;T0'3HP)TB8N)&M\FR@0(D\#7B?A2MDU*&*!J>MUMD?
M8VM] Q29#X]9'D-7R&NR>8ML^=BPG4#[&C;+O%<"-1Q3NH. *IXAS_Z1(N_4
MO:RARC,@C64R4!292<Z.B=9+ !D["Y:WG4SY\>Y_@E<2F2*S!>>F5QRS+Z\=
M0TFH;F%3'=O"@6\-+8H$3ZL#!M57&4=@&5,+3,!8()T0(/9(N5OA"*/XG;EX
MG&?(RE_)T9N&SC-DYB1A;[YB2KJR_^J:*<!5[L0=(%O&5W RV+)E]/N=9TA6
M7US%=U_OL2_-V)JR7T.P*6SL6/0,*>R/^$10/E[9F,UR*%@B#KU2.E8,L\&,
MGG-7-2.6[>0RS2S6A%>C[Q3'H=95?J#""BA_,GTE'F6)T[;\^*)3WAHK%S9E
M#:>2=0?**1*54%XAZ:D ,CH_7(?"0J2'8ZNT\ 1?:U/[6J6O]5#[6A\@HSVI
MW8&Z'9)=T;#:7Z3-/$^9&B?;<=9I- ^^O4X"^E8G19Y2H*HIZWHQ588-I2@6
M[\#06MD#DE1:R_.Q?$;D]<G$7\7E2B.?5%2=A93^^805DI!SZ:2WLG^3C+A.
M%9T7JE&0'Z*<MV0UYS@>@(QXVK6,[$8'>N(S_[HBSC %JJDBG!A6F>+0N(GE
M\94R)252D62QN;E4@A7ZD_&TTG.D.O5!=6H;]$.7*OQ178V>@:5PY[(CXL9&
ML3]B&#ES,Q"/R[25EU- 4 Q05LB_5\257U&E&BDRX+GXW[("9:T%'S=X4U53
ME4%(3"DOU%5QI[DP_8_RT:C/PXG#[1DE2J#WW(_J'@]$T@:3R!2>4*G[$@M4
MX 1SSIN-VC^(&T<PL$H:9[(=\<(-6!Q3B+<[,ZD!QIYE_#R<FAAK&)=^PNI-
MU(,N&_TH^^ -9?E\RX_,]10D*,3Q/A7?'P69#EPLMTA);?!=('WW_ EP6KAO
M>2JLYC(0?A84Y25_,'"Q$8 +X(S;X^YFWDN._J5OZ5:M0 .[F?MW ?NT0'7-
M-&_-BZW1TK:&M#6."FQKI DI'N>%.D@7OU0@701>EFY6D.<))GP9P,'V'0@P
MDY-.Y=>6<<9C#L%&O6LYL%9_RIVGT@@5>*]6DCP#RG#$"A@4_4SY@WXXF:BZ
MP8M]D=1M:N :I)-)11.+M*G2=NA>4)>KJXIM&^JZM5K!+)W(M1&76%G6.C7[
MP"@N'N6FJVNG&Q!$R3Y@ V"!$WN6;".]IFIE/M$G*OLOTW\E=$R\.O/5K;"J
MZ9C4P)"%&E-'O[_J[#<66]%4*[(+=.9CS"T\5YE-F;FB#C=@Z02X(CSI;141
M(._?%>JRU@IN0H'(]L6];'!"?_/IU :"Q.]A)7@BJ[HH4>ZJ 'LD==LN2UJK
M@)G?ZM=U-@1*PBU'9?U4$3]/7>:+[[*8(8V%^%&A]4B[2[AM@TRSA$%JU+EU
M]O8A,4K/^M9_A%Q*Q.,1IV?7KD@$U!GX'$W3O[YHO*#?IYCYKGY_ZO[NK6$P
MQB<;KU[@@11XT1 (?RP %&U7BJ(7D< +T'#"I3A_?='JOUAQ)@WH3&HF9]+B
M0;%)^(%)<_W;Y\\G5_^4JSS]^OGR[,OUR<W%UR_LYN3#IS-IQ2C(!L-D-QO'
M8GH6^,M[*G0?"5"%_)HM1BBREPKLGX$GGL9R4>10BF7CI6K/M1*@T0*VB_%%
M6#\9@ELGR7^"*,HQF!(VSA$74[XH 6W@L3?1:@?O#UZ^UJ!\$BBI,*"&Y":(
MD@)9%!3E4D^H\:&&[@:@*Y/@'@_>@Z:&\!./<M>IG5$2<Q;*<1*FC'+.1GHL
M!7U+@_YIH#\EXT2NT8J)/+Z?(S]/_"GZOZ*? 6?8>8F2(.(//RJ_:/Q!!F71
MAV?J*D-+IPT@\,2VY0(I&FHYX)?S2EN#^FF@OL&Z%@4AVL<:=L=L &"\I2J*
M-0"ZZ[UEOYR>GIV=GR^Q^2*C_.C5@GU7;[:6.^5^>%-_QUM@F5*Y%K31HE[M
MV'Q3\_9>;9OTT'.69PCD!?)T/[7)I32-EJR)GV<HE!;ZM48MS_O7<-=PUW#?
M_KQ'&NX:[AKN&NY%E^^YTB:W8Q]NW28\'7,+*W+(4*Q=WY;NV*K'\(@];G)_
MH-PQZVEP;N@$T8#4@-2 U(#4@-2 U(#,&R#WJ 05UMI8VL,@9X2R#<.C>:1Y
M;A/S][39H4^"W &RV3XTVMJWL)GYV]VVT3AJ:6!J%M> U(#4@%QI?C1;3:/3
MW(.D_(DLIZW;&+E$_DYC/<LTRTXX:>^[U+ LVBP:EAJ6>9Q%PU+#,H^S:%AJ
M6);Y9N,*"\79=M(K9'F*39DLD)59-"6@PMWR6K^E+S4V!TP-2^VKTX#4@-2
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MJM3.I]S.HM%5J%DTN@HUBT97H70=?0&K+V!S-XN^@"W<+%KL%TOL[_$"]DW
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M-S,3IU>(2X_%PH[H\C%X@]<*QC3O!N_?6>^_3E%"PP'P77BFY:.\!ZEQ';A
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MR>RLN5>:+:/?[Z@>6GB+!S#]-QW);AP1C-$MLNF:;V*\"_8I4I0R($J!7X:
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MQ<C.]/O6FZDUZX_FV"W,?B6FGO"%$_CL%AN=$46)[\(S+9\:6/M8YSUJJFG
M5Z8 \$<=<R.S/NKLBTV#+3^@)J*<O51"O%J9\ADUXYWPH<"F!=2&.]4_#1N>
MP;N!Y]JV;*Z:'AW?@&\=;%(*OU&G5VJ5:OX96KZ5;K#[$1[C[!_< _C8EBD<
M7]1A\Z):P9ZNK<;QN9 MTZ(F?'&K5]5WC1YK'N.4%X&8,&R-?*JZP%U1YS?8
MXMB:RO:S] DL^ ;F\[FI@$0-2M7X[,(9BBEV!G=,850KU-#-\J,VKYZ8NEZ
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MR]K&X^O+(>:)";>P[2,^XH,&+J=')\I*CPP<X:&'NY=/\=C-XMX[2SPL,)6
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M"@!FY EC=MP5FB!"")=7IA,QM) &9/8L.SW[RGQNT\T^P68J1#1]5!DJ^8W
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MO$"@C-PH@P_E!!7'\%0X%M !#$"P)64IJ:-!P:%6$$:]"V('AT?S@)8%X[D
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MG'Z]_OJZ)-+FPF%NZ#%72AR#-IWFD01Y&6Y)$1'C \ R X[QT3X:<<NS@3$
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M7H>XOEF&9MBT)R,=2KV%A+ 0;UXJ2V=3N3T1YG;=BDZCS&S&ND6MTA/DPS>
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M0?^_,Q=B*:#]6N.[M ?%ZYIF+*@MR&YLUZJUI!M>J^B<M)G@(G[0.LNQ^QS
MY+CG?&_4G$K9%-?W<8"="4N.X)O33C700X2=0M]' W(4K+;E1&YLMO.)X&G
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MS-*%O57B CAS5F?/"1XE0<BBYK)OGHU)N^ _]"NKP;/"WZV97'DZ'4A]?O\
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M^J5E7W4TQ)ND2^V,R\&@VG3V)\"KVM<O %H]@IWX(3QB97]HL\:4)('80@C
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M)&2W8'N5&@$<-YV8H%,0)$#US/V.D'606OO =V%?TA^D5)JE4TS8MMQQ4O<
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MR$C\[39TUB%  S^S,Z]FKN[:9[/;4;IW.+.ZW)FG\J*D#>O:33UU\MN$A[(
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MBU(0$"DX_K H)#)+YC3[\82JT%S8A*DEM" H5U%-N)5@"*EFQ\E'(^B=0'Q
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M8>:V&X[BG#@W0PB+UVJN69A4U5/#\2Y;*7^VDD65L:4-YGUC;D]@9 K+=S1
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M*"V&SQP*\(9G"MC8V3Y3[%MX) D9B/<F@(G#W4F@X?4>.E5]E'S,EM9''/A
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MS[XN,UJ7#A9U_DM^OK&9RJ:7.BKLOCF@AG9$#(D1+K$:85+M$WONJF.[MHQ
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M18!,^N=M2W0"(94K)HKIU85V/("Q%=#DY6(]U1B^J5H[+A?@MH-KER#-$+7
M4_IB]WA'.*B>)O9(,>M,0+_B$J%8AW79)==$61%@*F.I(^I-L*>L$1;7*US1
MP-"EQA[UU:.P/]LY24^=<O-Y\GAWZF1[XPS0W4GF@'@+0H*SQE[&U,MG'S*
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M)/&3)!,72:*!4+^Z[QR;1W+^M9/Z"!#J-DXZRX5;MF4^)EGPZZK0V%_JQ9$
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MME2W#[^U/_'5?W.!_.P=CN05>D;<WW,-25W#=+R?^*J__4?7$49,XN$)(TH
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M(/ 5JK.$<[966^9K?I*YEF_X]ZO^MO,@%L:3BW/CR5%'C3]\;+BT6FSXPT2
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MU4-ISBGFMS"<$_"K_3:;VJNB(\S?E)K[[:G\0=9)8 +.)&*02 N^"W.#'\%
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M=@-$D>]QF/+ZE&"3_K.C=@;$XNVAXX% 4RFWJ'G,1MY8B1S1L@68NJ#V75#
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MB]L%2B$*N'KY[J->:KZ],-%@(#Q)=R(82.^'@3 %8+;\4%$>'ZOSUP.4G!U
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MIA,HYJ,R_P_4@9SX>:LW1KF[&=7-)DZ6RP2$'SN721%^/%9Q*MO:USBT]-O
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M,U #UA2H$=FL:'-]'4;I7U]9E-476N3:L@:_M+3TO%XD<[RH6%-5X.<8Q^6
M/_T/?HMA8 \ZX9!O\!(@*879[?75VFL)?Z\%MW<_L*;V 2O0I@F"WA[]T7^G
M+_NINUATKL_PT )?M+],=^^5^QS^^(TOF,QB%=;Q )#H"[$!:[\FS;M?&*@:
M$S=@J[!D>OMF#KY3Q.V6@,UBDX9QIKL&%ZBYOH+87<77MCBC?SH3AB=P:;$!
M$T"?8:46QN /./S*H/:F3RQZ.6E/W<=Y(5]*L_$D-&$Z#LU'M%SW<3"-@0K@
M@\8P+\1B#9(5(S(=3@2\Q?JG^D#M@8$[0&T 2$EFEY_%*70M=K8ETPBGP#VL
M*F/IHU)C*Y%G&FV=)$==)LE9D^22)SI)+@Y&RF5XW&5XW,D/CUOEE?^%#(*]
MR8"K_6MQS6R_M__:X"4P91L2R_AT"*/H"HP,\RH52\YNF" '\QH6ZL+&[[3F
MH^+\"6M4/Z:?7S]6F9#)=)WL]<?OL">961VA,=MPLJ4(<&/W6^INP!>-:6;K
M#:=U3J?SF[_QQ#\&/]E<F[\<7]=>GV!'9%OSA\J]UGB;3(HL!>XTIP+#IB,-
M.22C&LY _:# +=>==4#BZ-XZF)[9N87^QZ%D1FA,?6,1.+06!7.;5R;8!B%,
MW4XR:I\,/"O>."O&[:RNKU8/"S*"CG%@IO(*_;8$]@M:OAVD4&OH_\9__0,5
M/.C9T\RPOZZY0Q^?Z/'*5?)<7YE&L2/)V1&/M.7+F0%AK]TASLV9/$]1M"%<
MK.6MOKZR-JK_!"S#ME5T9:^:H@].W'7)*#(2-"/AAE_&-EP^>'VU6)V>'F1E
MC8.G&JL=<RN3&17;BI8Q,OT#0P[P?/9X?M8P1X6N<]TL!&A&9/,&_9H0"+O-
M_]SIB:VY\/ EE+A1:2*';V^L#_7,M.;=&=<=I*K/C[6$D>T##2B@U B\$;YK
M<^H$.NKU6@01DH Q7"Y W .[4@( ,WY@>I","Z[_=GD#3-0S!LYX/=?'&!ZJ
MG.N<3Q]#/<FEW#3&@9JR;K^AGE8ICO4HG'#Z\V_,'X<[=!/'@I[(^,$Q,L*!
M3; K62<1SF.,]8$'/@$3LM$8#30-=:/8'[)1:!N>ZG7Q?5HNA9J;GW2"#XYD
M>BRU/BH)DLRU'GOY0W]4K5KZ@Y[]9BD(G*DP+17K+<.'@B]EWCK9Z#\N!<WV
M.!$P'0P;LBPIBGO1=^%MPC:%.?6J+LO4_!Z$W>G_C_]Z96M+Z_/L?-4NKVQI
M6Y+4JKKM*QQP0RZBS^1Z!A2=0A.N77%WP<(>HP%C@:G\5DS9\M$-3%6GE8%4
M'GQ]3[]B@PI[YGE0F("\"G?K3?<G8(+<A@D\;6$"3QN8R!>2^<^/#[+"<''!
M!)ZV, '3+0+"1!)#B438F BAI>=NHC*_M*U_!M,QUZ_"$4W'\7->3;A:VCJ.
MML+H;=VW:#@*@^[!;&\&M]8G9[7DP%9!K/O%;&DT:VH3.4D_D@7YC>X("[5I
MPV[V[W&\TUH#UH4V=5Y!DZDDFDH[T\'C,!)@/^(Z]!=1HNHB7\G+S\EC$F]?
ME64CZ2@RB28I;^%T,J1SJAF%:JX\R!;OM.DQ2;>W9K&1= D*1[&T6PU2C%J!
MKUKBOB1 02_B6PW[<!U-UCM<7%2+$UM-= TLW9T^N)O3ATQM V##'F2,:P=;
M5X9D1NP<7"FS:.*Q67U)$_),R[='XWS/J;Z8;T&,UR#F>\SJ3\3V)F3YJO!:
MRNZY]TC4(1SV@L7=$NS/I"V]IX3> 80.-:O\E9E\IPH-;9(\#?@$JY#A> JE
M:;>9W&<"GDQPX'$J>H-[O%G)%QGVT:-39DS $[!*2) I-(FE8M:%.ACG4GSU
MF\MJXJO[[1'PLWDQ=PSY';5E<=K;;-[$HS9KA/W[?GD\?*L.4\LJ4O_G$V*S
MXAUW&)4;C"8I-(&Y#74]N =Q3&"&!P SA\['W.=3'V*^WWN,.60"=[XEJ01*
M)1)G#!CL<, X];SB?8?EYL/W\D,ZWH@)WN>7I&DT%<XPA(N.=R):5;Q6$VWH
M<#N""@XEY.(N/K'57+C0B1 J7JLYEJ7I*Z"U8[66O0S-K-N[L+$36TT$;&P;
MXO0H])[GXI;81VRI^EU&W[5EMPQWA\)3IM#X>F\K;'OA3]"_O:E3R-[1>M<U
MANH&6&T&DXH\%\:-:O1>5'/8YQ]MNJGP3VQ:Z4=!D6"L[-6&5X1WEG8$],CO
M0P^G^:M^Y(I<NOW*:&P$] C(AEVE1]H[/AHGJV.KP]CP!P0CA)9826[!BOE*
M?SQW(A"3>^:E3K&4K7F3X;0-F^V:[XF2\7K'3J/*9"/WI*"#_VJ]^K!7Z\P^
MM0#Y[S;2G <'WDB8;6QX"V&<C/B[J/0%-?<MI"*A2SB<V-N7Z(L3[S(=,=V:
MI[F>1J:HZL?WX.RF(U8EW=P3-';96YEI2V-NI:G ]15O-,7@%NF.L#G\S2+G
M<3&$9\4@A -O^GRG#_&A\$8+=UL/C45K#&!;6LV,'9UF[5&<#'B%]<K&(LNR
M,#66#X&76R[:V2K":,ZW0=O/CNCNH)A^:W++80*VUR'+]R'6"XV.][97POTM
MW'K@K4;*&8H8+_:Z78'L+IJTL12U;>B7<\!4(A0B.H0/D1<K^2$[>TA\'>^P
M@PV\)2AL^U&#JP3XA'- 3_#G[90I3:I>G#/LTU>]<[3S#CALA=.^YMGI\X,,
M1J?GW\+L@F6_.'31, Z%'8='<,S+F!-F_KID%EOSZH I\V(^<=?A(Y8XL>_]
MUN!Z,$6MKL^R A#)\TI'D!1M<Q>XE9DVWM\&L,Y_]1_41U;L_LGMX*B#VL$!
M$'=?B>3;1X;A:4 1\^"-SD9WG-23F1%0#1"(G3^HTUO3-LEO912]WABDRPQY
M8?9S^RM__ 8_TKIPG+0,IST8S:"L>1MPH@.<JR'! 5Z(P(M _>C*#!R:TS$G
M12S^"7B3H'?:-#]N#M8TUV=Q/&-4IZ*/J6W#)F9P)B#4%"<2HIA41:^OX!RY
M$0<V9(ZH,V8M0NT.OO-%U,<@ZHT\%<='C/<NGL H"J<: T+ A62,F5;BZC/U
MX2& D\O@P/31H&#]^N1%L+*BOKM;)"NI?=M3'<NP/6_Y+)D;@6.%+=6AO@N'
M1T)F#W^F\CT.:<OP.9 EV8[UJ+W;.$.&_M[>WSAYZ6]L]3=.G6A_8UUIL*A]
M:78<PDHBV>ZEV7&LFAV'VOYR7=TLB89I F1.=F;^<H/:FDZ[MK_<Z8FM^91-
M5,>%7"GQW0W=D/C74.+6FF!2K?D@_T%_?@[X"M:'\X<6"[:&3ZW-'KN^L@GF
M]FRA9&SJ;'EI<!E$@TN_.0=C7N';O,"K0$_5_P[S52/O;.EW%6Z,QV>[2]=7
M!-/4S^W)O@GE^NT84,]_4\5#B.?6.S,P2IW7.3E:;U[.R>V<G)T[8W'S]\P&
M\,D=8)8?M&V7R7I;'K"] B-X?N0[K2WH5U\V>H(;#?J2;4II='WLMIZNUC*=
M?ZZXH7P=P:+=WAZ4V[DSHCWD6N?&G*AQ1H!&5&$XY(U7^SE]^"<GE_30,2P>
M5Q0._(]M,M,M4[ 7MNW2 VQ-\>O  (\\N[EY:;3FE)RH=:H9;J"0/WSM;:\&
MBWOLS>]4:V,SK9=& !T9"3R)4CZZ7NU._!WN8*0 3 8 P/7@\&X S'7EN:0H
M@Z>[U D T!%R#A: L-%'@OZ3 )@^'(".:/EN 'PKL:\J=_^9N.?C#T!G##Y@
M *9(E"*\TW / V!\M?5->H01VSJ2ON>>/!J9OJ#_WC@ :_3K\ DGZR.QT,T,
MMM^9&&D*<-RO?1=!='!.DBCA(U7R%(P*][$ D>D$+B!39V6ZA^5SU5POIB!S
M:@,A@"Q!$&@ZX=V_Z;1 1A]#[KN!K--[><?>WQ.2A_T3(XD? LBH!($2A'=Y
MVJEY#3:7Z+KX1UW$OL#K78WT )G417CHRNR8646Z5V]?C^9AK?4.O7W%H_@=
M]">""V@[5.L:3H1"%\>9XF?E0&>TRS7]^VB^"?T1+>=^][JP"M@3^)ECL@CI
MW>K9OYO=B:%_3A/A^:,X-K8@G)H-B5P7G[P^>4RZB2_"79P?42 <1Q/$GNK/
M>6/\.+Z3+1CG.T]?8WXX*B0&)XIQ-_]*%!@'VA?IW? M (S'U?7B/:AJUW,X
MO*&=S_OIU6,A* 5K_C5[)9Z^:K3"D-NOUTZ;.(9;)O")>VF4PO>T7@[JHAA_
M).9"4(3FW(NJ?&6%08?KG"H2PYCR1Y%I%,/V#-^<.0X3!^*0G9;=L2B/GC(-
M?O34*2_*B7_^?,^___P)R/$7D0,$"0&C]HJB&X7KW/#3FS[/LASX#-@PP4_;
MLH GTJD?OU,X";A38I$^&PX68N5FV;6YV24WZK+1T]YH7/7JX%*C J&65Q<Y
M[S'4NP7W'V3E'1]GFX]]/&#WON_ITJ$E*Z51<M]<I6-?6J]4)._)T;O!0!M4
M7O"7[WJ6:4<.@Y!3AE)H.K%GOD8<4;!U?OB!F3Y=J9$2GK.-T;-'JEGP* @]
M;P<P@Z1WD[,8"+8#]<J8)^BD@I5E+@%K:L!W\U\U3F62,9!H882B4RB=/%&Y
MYBO=(0#AYH*+F9IA[^BQ*LL>:8R1B+@0<$%B*)'P;A=X6KC8JOL&D^#R7'T2
M$R7VOD?'0.B%D1^%H70BE!R\N-IT!R2QG&:@LQ"PA;@EA-E+5YC'CS;&*AZ>
M[3U"F"$8E('&)M=42CK<Q)(#'-E'!V0B8%MU"R"KK^UQME#BNU([=H ,.R%D
M30$(*,!WAGC<JEX&F^,Q&TP>O^\UN7?'Q@V/H2=OK"D>X29LQ-8(/[-4#7PG
MY6(N/F,?+^('2;Q'GH3A6T,(/+T"3>![6EYG'M7>S6D]G]621*DS?GAM].,'
MGC R(J"E@U\2(MR@D]U)9L_3Z=2@JY6^A4HW=M#9NS/TUN(ZZ.^)#CKQ-?;U
MGRPFS*1N4Y1S?KGQ4]AI<"2#TS6:OL'F?LP0=J^;&S_@IB-.5#AS# &<"\ /
M1PPO0RT0$0!Q+WD8EXV>]D9CI2F?0/*%/3W4SCPR(INQL8X 4C$&Q=14>\1D
M24@$[(C>LNYC)&:0*$V&$HH]?GJ.%T(.R]*8/>7>RL3]2W;*'!DA(>=LD"A)
M[>D\B"-"*/\(.3"#X^7EM?PU)3JUH-M.[ B0L-,Y2!2CZ4M(Z_!LCQCZ:A-A
M2ERW ##]/AD-OX#@92)VV!XNET,(%],HG;P$MOPT!@A<V+N DY>T@91-O?;4
MX*NBPU8)PLA]0E/X!9Q^ZIT#US-<P)G"!*[Q5'Q^O/>H(#HV."/J$8,F]\V_
MNH2\8N5ZI@]00>;Y]R^UDWBK/65Z43NB]U0H @Z'X02:3.^IG9]Y3"-U@/HP
M_VZ6<\-WZ:'$>F06'!]8883*TBB6#*C-R9FABCQ [L]3D_%H0A/EY'?D\?J#
MI7@@YDZ*N 31X# DE8.3!?6@&"^.P5_UJ)=1HWR)>UTV>MH;C96Z? )Q+[L*
M7%JP R/-P>(5@&?G^3'/<B(;0/SK[IZY5_O)S/,XZ.I#'^L_2ASL?"(<Q!YH
M.2P6EF)GV3J7QMH/09?M[(N6D&-BQ!D%Q!*[P^7 P!B#%4?OE2Z>>XL)7$*/
MD"5.HMKYCYE,D(M"GKKX:*5ZOSECOYZ?.38>P(\FB@6G=(32K3LFM?.A"5D7
M"-6H;%7A/TB)IF("H4AB302:3IU;.?4>$ HD4O0V[W+\UQBK?W+Q@% T$2'
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MA4)N@J2")7> <;W?X60<DH&)AT6T6%]GSL@5M2"3>/Q*/Q/E&CL\8&;5CD+
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MX3!-RI*B6)8T+VK@#)\6JUH3M)QBB5KW<K;YJ-IE1X,>,^<7R8UK^PPF%>B
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M)$*ZRMN;MA_>_&(G=]5'?3*8?I>?G]Z7R0J;SBVXZ1&["*'C1\82&)I.[RV
M-O13#RJ)^910FO.)4H>R-"VV$QWU4>JUF3- :2B)]FF4I'U'<"\8]>4OW<F?
M-."J][U&F<5KQ.EC-)RBP32*I=P&4D2'4>?D"L_I%5D@)$>36N6[-A1G!_=V
MWV.>0&@=RBVE%R BHRB<"E7>,L^T>8%7>4[9VIT\Y=J=?*<GMN;T_> Q]SIL
MIWJ)R#N3$ZWY?8\LL"^YNVR_8W0FUV]HM\MUS-[BW' DR8P\N[YB>?!C&0[!
M4!"USZA(CQ]SX$(J')PF %5XO@OT85%%P#?T@3%6<_)%2W/X<$8_%#T@O_)S
M87E&B-X>7S&;FBN7EN8'MC3?SAI<C7O],ZZ-=K<-:/+X\O;9&"L/M$":2*?M
M@>4$F4YT7A[>E/9Z'D< [_P#'[@\9LS>E^+K:S2O=\AT.[ACWA-B?LWN2-'>
ML=K_)@\[GM5F^J=Z2!L<@-M/SG]W\;U.UFAW[]]!Y.^83_U(L."/9(F\!2O!
M\B[^TX4V5.743%M1H>+;XH%>^8B+;T]ENC<L+_<?J&=M=3M.Y1DLR$U!^;F-
MY+NP9^<;_4#*Q>;9]6M^7W:BFW%#7F(;\LQ!AF(/3B?,,;(\ ];<A)'9Q?AM
MOM0:,OEFYFX^S#5;\V$]^Y@OW]]W^N0>T/3HL9["_EJ_:KX+&:SIWR* KF3M
M"A' MI .W->-M;'U\[5UJ_6/@ U?VCYM<^V[Q-8O^YI/N3L]5XWZC/+4#;98
M "5</:*^CMS_5;K0+$ 7(9ET2Z\,A&)N_*C8XCK II2&+NP(SD,554F>940V
MT^D UJ$J=: 0\F-H;:XP(EQ)/ C?S9?[8?(8,G(C'UIL0;?F&7,3B+S81>S$
MCCM<^1$C.[&ZG4 A,Y<$2F%N/9?/0OB'3(4@IPVDB6"IL+/6LAJ57U=1^OE.
M^:-#?(EE/$ 594]V4).E+F],MP2_/1'4;115JP<?\G4GT13MUMGLC*_[(0<?
MW TGT#3I/1_\T!N.;;OAX"_6S\R@%!QP"OZK3UT';,^,42D-."@VRR@<:_]
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M"3+AFQ^7YK_7K>_:M0LRY9NUUR@Q41FV:7%Q?OXN6$I@6V-E<^$)EP)0WED
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MZX<#IS% .IA(CM7-)72<NSXP?_8Q5*/K1Q-VFE[+01T$[)'?'4H^M)T^&@8
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MAZ1'.T4)U&1F)% IE'1F;/-!.2$)S- >*H6R7F-"!+?0[-G:PS@W<BP5MK]
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MW;,U2O-%2=C0 >P00.G&A8?2)4;55SC 7H79\0:T'C08%4,BU[KC6&T$?"4
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M_TP78KP3C\U/+=,9SVO]"IY)>^KW9EVZO+P1%CP="UX3%IQ?\@E8!:S"@F]
M4$E);/@[_VP7DF)7BHF'X',+0^=VA=Z2*8I*"125,K'Q*S>""F.?@K&ORL+8
M\TL^ :N 51C[S<8^J=7D_+-=J+%?51Z7E;$_1R8PVP@8PMBG:^Q58>SY)9^
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M,D\FD12!-?><UQYSFY,C.CU)B$VJ!/\Q4<QGL>Y#LF:CPF3[X.^*YFPNASC
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M7W@M9K7FOVS!Z-;U+SPEK4=BE220,&U@S<T]YR[D+VOHPG@= 2>4DB4H&5)
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M)MQ$1AR\&!&&#81Q2M7MF,#C*?8D%P' F-(+2;F8V'@DCX:'"Y0IK(H\+E1
M!; $N6!)E$9:&I9Q3D%!K4F]1-M+F$YZ4=8#3G4W0<<(M<$LW0UI'6$SL$E_
MJPNT;/"P!9+=;2AFDUG&UXQP+P2,K%DNY=+*ZK:"M6C?8$.] R$7V8I<!NQ!
M_Z]PMW(5BG9;)#N9\+TLG#$:CT9HIE:ZMSCB)CLJ]^Q19&_RIG+QN5C[' CA
M!(C[FKZT859N# CT^IX8KNKAU?H2ZHS0R?%]<(L_NT3ABWV)PKY$X3_%WV]/
M;\/O2&:];/MY _IYGT]9E]1@W0EJM7>_&+F8P7R]*9TVD, &R%6AA#AY4_6H
M 0S*=0+I!L)5&8"[>X_O!BS4+G)A(0KS6D:D&HHY&2H..3#3*Q=##IJ'@! 1
M:I1&X2?!=8U>3?M%6*\2#(K;Q6L&H=GAQ/Z4&HZ_3J%A<[Q0T3M/WXW(XE1K
M';#UI?5KK-G<U5)#)YU?6;"G.7*OH*(:[DB/'&2_UC?05).0F/+CT!A,A#[T
MX1)0L' E"8]G(O%B))@L:QVW7_ ^9PBW^1;!;EJT65S\I1/^QO4!B([S.AD<
MCD :L493M25C"UO%:=EH/?;-4+;6&_DTFZ&D,IB,G]RH%9A#WLX-$$6=0P",
MB+XUU\?Y"R)#[U+_DJ&L01UM/WV%X F=9+<4KL'=^N%.$<K\3Y(7L]Z9S&!H
M%5&Q%P-;NQ$^13$@I:I@)O-T- C$VJ%X6'G3;4T*(#\1K+=2^BKE%NJTJ/A6
M*8>$@QB"J8+MK&!J>C*(7&+ 8'*G9R$#[$Q7*[P[V:E=X?*V7Y86O/M&NV."
MI*)H%6(DMNA1TO7IB&R"#T= _1?()DXZ*8EW0>ZRFBM>9&G9*XD89]?.#5I'
MLH@R-X$L1.(%F(6TORW5%,*"2/<FK=N%X5=I<+CDF ![Z5/;W5A;C1IG"IQ4
M=.HFP;@7?EN[TSY!X3?B*S]^!&8QU),"GF,74]-<UKY([7T^\U)^..(P^ZAS
MY$U&X=<R$:CT>]?ZI$78UTG>]X>9[XI8BQQ06?'2YI?*EV^+MWW#7I;Z:#*/
M\\C_A%0<,[L$_L,>XM2R(O$FW%*>X CVH_"J"SRN9>#VPFIK]\\G**R.2Z;X
MLGG=9$MZ"!<SSF[AN.V.DZ9G6(C.ZELZ:>]US]J]?W9']L"G>.J#<4&'>-:O
M<T-[FV/41!E)]CJ/[Y+SM>);2>;6" .J/&Z=VLY5_SN6.I/:3O+\QX^^TX&=
MGA_=%>%R(CZ-O;;(2L[3T$WG)<\D<J44HUEIV7EH0J:@/@_6RXPW=+YSMZ.E
M"0!!ST*WESQ;NT$^1<D3RD.9+"%V;Z9VC69$@2#H+=9P#G 3A^5=D0GJDGAP
M1\A@B71PK(K"J:B1EW<1*^[L3MF?Y.U^/[$-X0,::XA_6 KU%*Q99@CB#5P[
MSFQPYUQHATS%C5[)'YE*B(.CKHV+85P6"P[:+NW,V0MSD-ER7U09T%T1"D-#
M@7V*$+"($LL.J:5R48EK.-[0:^,-"><"9Z5(W"1&(4%8-3ER6!C@DF6R<F[8
MX!=<N!-Y)+3"0%MGE>G"B!Q0D$>YETQ;N[<^0<DT%H!]#$!**CHN4;[D"FW&
M79--@*;SR%(![0U[)B._#S1G8]%;.#P&)0DRA(BL6=-EKKYSA/0,QE/QELD]
MLKFYKJ5=],P_>M7#L3#MS"JI=P0]X@16^!E_"HB30_^BXHC61LK=6X21I7/V
M9=,O)0T79LM=N)G37(C5H!*X(M55MMYJ57T@V\./=7XQ? L: *1B# ]C-MR0
MQ-.4G%F+NW]S\'GD.&9WY-#&@6SLW%]DJP9W4*1]@ @'"#NG]MQE(V8F6EQW
MTD1;H$9M!+N=<,2J7=9]*V1[V#ZF4D@P;1#\C5+_"4K7R!/%'@(QIL*;6'U4
MV@K;M]Z^;.I^R:VVH['5S40"\R'4QD.3O"":E) ,X:2D!-S.<>/V"A2\,!=Z
M32!F]^F]/J#'!7Q58Q=:_L;HK8,,I<#O6I*9:1K4P-1]1W9WT_9&NM=%&4Z
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M#S+QKF!]]<F$PZ/I5M/25!^087%KY".V3NQ&I51K+"QEGILO"L:31KOS%&:
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MBE\WFO0D<!UOF+)RXLH7/.\C;>X;:9O#VM<OE4OJ<.FJRZO/7)0B,H<:KBI
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MQ<KK\^O1U[M>V3#8KVY _=+[_[\CJ,/.?[5RIG7:_8)>%2=22[+#\I5#[;#
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MY14O>^V[U[ZI7/Z2Q,I3VYI1#:MS(0%S&S7;.I(D_;GP*6E4LHT;@'#;X[P
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MYC* %=4(O2,-B@=X731=+Z@H=$MM-5#N*?]W0ZT<5BO=YZZOUTAP3:)["5W
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MHFMI+<@G>=7[@':.3]2W4@^) ^+]LGP?./^N[!/ "&(!,R+QA!AVUGG".'3
MX*JLJQ76#-6$6@3!*^MCQ0/\+2X+PB=MDK;8LQ!M]S[917DR9N=^+27\U_7,
MH+\AJG86=1ZLR_%6TVD3R-O8M=D_ZA3_*I$+-.62#E\HCVI'*>8V6</O)Y=7
M.H8P.9C@;+U*@5.P6W4:P2Y6 Q-.^MR47<(XWM+7[A>I@)ZD33%)AG;HUDW;
M!$7/N:L/[D"33IZ%%!<CKRGUP1RVJ2=RE<KRAPM3E%E>T/8I\GJMB2??U1NO
M$^T48D8:B<>4K]*FNK!TB_O?I$W(5UCAW S0QM?N3^@0>39SK18=%X@K+:M4
M<3>F<EEGVB71VW!=QA )BSN\M>QHI!RVR7+'[<M)&=E&Z\Q0U9Z1'NP6[MI.
M--B0$3<FPF6VO]HU%J"=N9'"<)5=U]IUW56SQ_U/8W\N21AKE]*&8Y!S<\T5
M[%'@CWNE)N]L0?><>2V>UV7MHI38>?+N=0PFWJ7OV)]FN#</F/9K?*IT>6XC
M]D1N.L -\R9T3*:#S9!;;:FWUC0O/<([H0AB1^IK#@IP V^8#6 H"9EKSRPH
M4_UG Y+Z"EM(VX)7=>B)FCI2HTRX[W2M7#H[\50TIN<\N:KNJYGDH5'@X_TN
MA!>Y/WI(H\M-4\>+?G9C5@*_5A%&-RLMZ*.R2(AI2YO9ZZJ^*6U^&9B'F2)R
M9HME-U$Z*@MA-N$B>,<0&1?PNU!@N0H]U%MFT64I959<"&GR:X9P,E+<+82+
M9S()5[ER,+H2?=5YLI[WN%&804*PQT'.L=[PY+S.W2H/J)/'FBDTKK]]I]M@
MT)D1VX9V!![!&[_UQ9^N]2T*[C6<2D*DT89$E72SE4?*.- "HNXOT4U(7PJ=
M'7I6Z]N@RPBB]YZ\80WF2J?&(89AV7>0D+5O]J@M'ASO=F=#8]QA'\B]4;NM
MLFP7C=KCQ&I[AT)TV-JAQ2;J-0IAFI;U&'3\1/(E<144@IJF))UH,DD=1NUO
M5L(S$\=#V0.?&K0YUU1(\2KZWE/3* LHK)+FVKKZ_I4P^C2U$'@Z7%Y=]CN)
M[X]%U;I"(O$#/09O?!)#>4E0YXD(52+'RV+8I9P,%O/:9;<BJ5VI[DQ9YWW3
M8B5:!.N84CNZ3'--[K\I@Q"7=^,P'DJU^'&0'%_ND1P;D1Q[0,8'D[WO\\&=
MQQ#WXV87BKPC=E+ ><8.H%2M&@ 2\-2NX623I\EBMWURFUB#T*#@$6L5LRR.
M(V>7@PDN)"#P8LO1" N:7^<J J5<5Y=,MG);73-0,RZ: ,>N &N7Z]S)>3DA
MN0=I"_0$U^OVJUI"'DHF5<\&T8J8,4P\,+>L@U8OY'.21) !W'_\5>KMM\5E
M7XA/KOFZKDC"-CN'V=C4<<VQ:C$Z8>(= 'K+*(!%!I/4@6UH3^;"=PDW93+F
M!'A$!.,<G&H UT(*^U4$A%-ZND7&G#.],HE;1[=E^E';NHIA[2>JWLJXFR1#
M*^8=6,1D5Y 45L]QWGDL--]W;]!OZV;>18/^G(NP%D57#(QNM<;6E$L2<NUL
MZ<0BW9G9&4@"U^)-,PWE)!'OH=O(+-CQRJQ8.T'9<$.P)GR@Q2T!%QU'SW9B
M9SU/C%\2*PMKE$K=EG9Y1<H*(BA=7-4R3LB0&*QOP(M(AC(NS <!'T0ZKJP1
MJYJ%$F0IPD2()G#$8R]ZMG6#[*;H"2(GR7BL9S.<71O,4:2P&([B6_ V]KI(
M$U 3S91,V!! RH3O"G$B@@BVH,M43+2<K=+6QZ8J%L)-*SDY)WYV,NR^H6FK
MMZTTSJLA7B=WA.+5"+$(?Y<&?],8K_8G&GF,+';=MXA$HV(,00/?)G8?Y]SR
MS;.+LNG4(''P1U+H&B-S?P^* < TU4&T:>ZVH@FYG&D5@IKP/VOQ?HU4&I R
MGY&U);!8QEMN\HEE .]VC#-F%X\0F^]UJO\@HG8R$H&H7-"WM5&>-<W3OR]'
M'S>J"R'@T62N[ZW./.>=A<!WWKFOFG:5QX@I@KW51,EE[D'1,PWZU YP%:>#
MYZ>;@BL[VMZ%GAM,IR81=VE2L@A.=$L$P 6;DYKN-*20%_8M>8V/WAU+F,-9
M39HZM5IDTW") K9?+1 -7K)D;]/TW6XL.Q+%88X@=,"-QWZE*K=*MSIKY5"E
M'< * <@Q7#"W5O3*>&ER._JZ=T?7&E<7W3*W6"7)OAM-8J-I@(;)6<4JOX[F
MOXV#LXGE7U?ERJMHT;]5'2G76LFYKIPLZ1'J>W=Z.LT$.,\KH.LV_BC ^L1T
M0/=XWC:==1GH]Z=UR2499L!=M,;+B<DP#VY=.:C/@1?<?*$0OG=:SRF,%6FV
M!*G0^2%$+R.B,O, _5#6HX&A$: R1WT8>^!-IJ)M>YNG+Q;OE,XM:NOY'=,-
MG5D4TXA*KUT.%3T:#Q652)97M0A0]AF!K6:2>I?M]Y?%7&^2@99-L*DM#+]8
MP9L7;1A\0*SK#'BZP"L,9["WU+95].RBI;9_/5O]>L90L-\PX6P]8)SQYD^(
M,]XF_02B',##!S<++2>YR&LG]D<,CL,:CD&BO"X+\EK6IW/-&:5CX=JJW/VM
MMI<$6_UZ4F Y@\J+YK8.9>*\M=:Q1 6O:H0NRDP9'N)K;"+H4,!&KU)LM#)C
M[6"([W:%A&K,J? (AK%/,@2V)6?WZ>JQJ/%KF?2*FM=(3:@E'GB9FK[<T,?H
M[F[RO0S:ZM=S"PC-A+.;QJ-(' T>\^1I?(*K#)@038&$G%)@4E #H,EG7SS@
M#*I0^ZTA3I+R!='.#6=A#5^AQ2;@7C$.R=+5:"B(.T6]M*T4GQS5BR(25]DQ
MN; ]FNEEM5P2L>9',O )/YCK08 %GW&81GCN8])D'TQK7'CPDM98#;:N']AB
MP%OB/H.18O&$I3YE8BZ=M%X46"PN\[,[%.<9L="\),7VD48 L,X<R-'M@G)%
MPUSX?B'/I<VT^O7';^0-,\?) NZY5<H2310OT-2:R4P@=</#/2#&"6.6P1#=
M&JR3T(B+C 3+\2#[V7&:A _3Z G_Z*:6WMWN%+P+R^]6PH<>/@YT\ZL]='-/
MPO6?HNOTRK]:QDAL?MT!7L5\(2IR03 E34HBLUG)[97HZ\H@$]'VV@4E<= W
M=4#Y4WBF_G31G,HQ'PGUL$3?PXG4)]J\D #%B\Y=^X^+AO2:KL9?CYOYN)ON
MP]JXNVC%?MSW<R09M[YRV!;7\]G9O68S=+RUQI/Q!8R>GI4<AB0YWV2X&.8M
M79FX/:9U=B=;IM=%T_6,S.$"7!\"[/JRGHPF#.NH[-B5PN/\*=T:TU9WC96\
M^(K==$<W*&QZ,>H= $)#\FZ*44NB4NQJC2O>;CEN;_2GYKX#%7'"/BRC@5 Q
MG(Z.QVJF-*/*"I@\,RU'1AP_3VG&,M'"#^Y1FHW&+0:8!?=X6;WTH>@]V=!B
MF(8Q[T#D5U@0PVP<QM<>_VG1D#_U%* LO*R;[[/_^IS_][>__Y/SE:Z:<Y!]
ME'E$Q;%MU!?JZ/@,-K7U1C>VO(133:O), "6BH7T1O+UHUW1(3%:*/\?\-WT
MA,QX_D#2--V-=;DUW$ KGMA?!/V@<%XO:'FT5U537P<P^ZA[H3U*PW9UB3HR
MSA^J<:Y>A0.MR_/AL.3K1+D1CPJZ;_=,AL@##25;OBT6GB794#_'D!%U.PZ+
M"H(IW*6R;S+G9+*G4%1]%_JJML*]N%>P6WK./DD%.Y;3^E:878 SG16,PX$4
M3=B\(WC/'Z,F;'MMV_!'XN:BHOC LGJ6<:S247AVEK*TUW$X'<T6L]-"C(?L
M<-:)4J>?<)]&GFAT>3*]T)%">DLP_&R]@P5#FT@OM;Y[AB*99BE!CON,Z4^&
M=+JZ#$QI0H_I-3+%XVG)='<%P07'N4K7BWM0^.MKMZPPU:P,[Z19T3DS2%_K
MBJ_#@TJ9H9H"HG=Q+\%+U<.UB^R="!V6U\X<B2%Y7)+&/,!M/8+#FWBKI,">
MF/:V$@LO)BH9O4?$3G)'A$N<\<0)>YIJAQ$D3B R&L59O4MQ>BU5]KE#[K@'
M_E37K[6V*_I$?@1-9W!UG#O)Z645)?;*I5&:7RA%NF:=PV02CU,S+!/EZW4J
M,^JTP8.7[VG#+QB0-8_ULT-H,P1)*4P&Y=6*?&+5CA;ICLG8<1*[N)W45*<E
M;^%7WER1$^'?BW!N^+)MA/>$TB(P(:O=I.\CAI;%]7<Q39S:-0ZY=J]I?^_K
M']HAT8;_7(RE04N8G==->]MAN]\/2;2+>R>B"2Y>GIYE)_\@N7;\V_&+HY.C
MD[/L_.SHY/#T0T)6_H()G5R<'LM$?CYY=O@,,\C^=7SXXB-@3/:G;W_Z_ICE
M_AW.G^]<AI 2ZXR?=)K'<5\S^3:SBV5AWW+[\L=LE%>([JRX]7%1\>=?\!<Y
M_0J1H#MI<&%A?J;I5#SGE37-@3>LYNYS=2M05^H<_4NRA<C&>)S]9JK>L4<C
MA$ ??O'XQ_.7S__>=C]^AO^R"69G'(;8Z^FMW15[20%)\>4C'(BZ6?3E &WJ
M2D/;[*@'D*S-#FGGEZYCUV@/V;8+[G,]I7FP/VFX,( >T*B[O2S-VSKSY>YO
M4)R#\AC<X_X7X)UH/=D5.R)R%S;W&PG\%R"VXW\.!=ED;,SL+IYP\03'HW]!
M/X X\+Q6ML0U(",L-&7PE,$L[\EE$&U.'=1X&*MW/Q_>>,W<V@BOGZZ/GV.G
MTD-ER-1=9C^9$FR&S%4KO^-6$P[:0LY/SD/XQ8A\XZ !^6D+J2>VPEJ52_^>
MQLY+6E(E\%Y,B]H%29;(CRSJBE:ZLET=%B2\@56T -%] 5TN>PGL6,E!ULPE
MBF"#<@ BE('G8XF,8(!0UFSRR;#P#EF0QN:&LPYMR&G,:(-IF]%%C4W98)K%
MPERB_*B@X>3)+"8N$U ,$#^J!]#'8N7"*,/PB.\*Y8L#$U"5=)Q I'I6Y*XU
M:8G,:GK,C"LUNH.ZE$7'\T;('-4!/ZRP7[/#V:SNR9>.(A?# NPE_U#8U0:_
MF@1-G-$B"GA,O?D%-S-B: [=H&ZT79'PJ)'OG4,<%5-'H.8B8S.&'35XE0"$
M5CG7>C5VC<#4GT3$!<:&P8H_N6IM2*[:R=!7)-OZA8=!%74NX034@[.DH_6]
MPNGN.2OCFQS-:*#611[F WLEL57BH;GZM K9-J%=G8IL<&1WUG;,I3$O!-N*
M]4C6N*HY%%4-'CQ\#?RW)G)88LPZWXZUNK2M2YV0H,B0(8HZN:[/:.*H01TW
M7_0(^D& +<S+^H:GWP;N4$?5-VA$!7W1TN$HK=LG,@"7=:(-;)IRE05H+\;
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M8-5NI9=7N;3I5LGY5F261P3^T28(_(U5VO<=V:17^/P[??3JW[]02P,$%
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MU)I)KIWY?<QW-/"QKS#5;;>[1:1(:/)9QGQA=H5;"<M0 ([U,+5%HP5389X
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MYO]"'=CI-!;!.?&W=*O$O,RUYG@"O%.<2SR\-L=IX6WYO+WW'U"EI\KW NL
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M[*)8XV8WTX=DSJ_?=]75!R7:3H9Q.,#$(ME=Y[O/\[]=_>/'I^/1^=]>7KR
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MOJ:,C096:)V;LJIYS],H2$AK&R2-@\Q4!L*U*NGFNU'Q_WW"0?&D =O@W>0
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M38O+J=8SR]U0H6398 7I.DO_[^#1H.GB.=C.8NLL.C>/MN'Z*CME@_Q)$MV
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MU[PA[7+?6=U8M(F'<[+,]CI24 &YQSGG,M[< ;D%$D.IP8_Y5S'=?'OL+,/
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MCB2!*V!K*("<7WE;,Y2T4PG\IB425,(D&)YEH4"/.X+N9[^+U?P"\"OI_EK
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MK]<#B_BKM=T;"E+L3VTG1U0Z_ *A2\7X#';UU="PIU:1@^95+LO\Y%ZY>YP
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MZUJS&A[" DG0?7JWX$Y2L-C+#2-@H%UO/L5UEG0;(R)72Y&=PZCBU]N9'ID
M-E/F*Z[G"6//.\\.4JD^[8,I[#C=L.0]<@B02K^?2,N8Y6*1QZ\1Z9^7HB?T
M,"J_75B^<5T0\^BY*77O7X(U:' 1W4!NC)\CDA]\$-5O6G1QK\"&).M9<>Y.
MK=Q1>/:TE:;6#Q<QNSM,75@C2%II$^[SND+*L@?1E,L.0QRPT$>JV4#('?;
M!SC+OI*R1 M"R+K?%$T5T7[::R-NZE OKC.5QN?S1_VH[<XVMPHP.$=VXLUJ
MJN3TGQ)SO:@?7*G&2CB$:U^>=<F[NF>J+@"SL@]#;'<G2N'=%:'X0&N*W;VB
M:]MNDRON#JY,GL:2"OAA^ @H;01Y=W)N].1DF#3 KFB8]=P]#0%30<4P/B@0
M,\7H.M#@F3;V2\.,RVB,ZQ=D0OT%0DNXG,EU/0I\CA%-*M(C ^8Z,^#0G-%!
MC460"X*_5.:&^<0Y =1A,\L!*%1@KDK?L.\'>@ ^79KGYG3C-BR2"US,]@7R
M!8%!;;\A5*?F<9,8E:VECN^^(;5\3(8Y7O5 50=3^K/(R$X4KNNX,[(S*![H
M&NY6-FN)?;A?XXBEK=/0*:5^UX9_$:\!D&95 ]MEU]QUBXU&M%5A32)F>[B8
MI8\L(B[A!=3YV.)Z@7#(D0LRX?OV,!^D[K*Z>V1]J^=6(ABM(E$7<%3%X:G5
MJM:^M[(;EU@&.RS+1Z+/H7$JM2$A"R/ Q0=#G__%O-(7BGHF&!YH=*_*,0K*
M10K.::?K&.+%9,**YSP/ZSR\650@.RAGKE=_7D-D1"K9SG*+*)[%CP%;E$P<
MBC^VX\& ^9*4&NL59=VX>) Z< >/TYE;=J+B01PA^5LV#4.PP9AV/M?C3F"*
M[H)A1AUN<-L]4QCD%Y,;GQOC%'#H@JS%'3;:V36[IL3*[C"_F$P)2&[19W^F
MH#NZ?Q>L(ME5X*8(OX3!>95@@,8^I.X;'6<)$D:DQLE0EK()6O31LW9+(U9T
MA8#R"X=<IZ(\9TG4ZGZ!=><OM6LOO41.4QGPM(]A<>T?SAMJ3!EYO1:7A&OP
MG^7YFYG^=:2'S8?A,2^_[L0 QR95\TRTKZX)UCH1-#'"#;/K>#Z08V.QZX@6
M0?RAAW5E[YX0CA9>SCIHNKOF'0_Y.8* U!9UGYH=.B2'[GC7%[Y ?$SS!T+A
MG!F+@J:?'I<;B;%#R&,S@L.RA>.^W.]<,57Y>=6\VM@A>]6ZG-C;U>3>[N.@
MVPY!RG38B6XU=G@VXFMKX9YLG2;9<SE2S56Y29XQUT[)0?*S(9+@:2BB-L'7
M9IEL& BO"V[RA[>@M[LK;?B!V5ZN/= %:C:#7\G-TQ8KV3S+XHIR9^Q*C5$B
M^ =FQWKAL<KE/HE/QHJADFB6MT[G(U?YEDL/ABQLK*SP<.,RT)04">OI;H@@
M\$S!=N.2R18*^4YE$UX1XS;/VZ2.0\[N=(=08SI**1($VX$=3. H-9?8Z*/S
M)T*2;/UU71T7:'X3?=4.IQ8+:Y>J=KN*$D;!/[H26*4^?"IXT=VOY0,0*"OQ
M'?G&O]_WM%CS3N/WX^$-@5MNG;L!N<VH4K9URG350C(& Z $DC_\_3^1N'^7
MNJ7+TUQ!J-_CVY4N@R1[L;RRP 0@$<]57J[5JIGZ3R%W+'PL/&6_IB5KPY&9
MNUZS^1*C9S%%&Y(-**_?0R:3#>W+ ;!EM" .$*N=[KIHXOK_TY=."0P IS:W
M*\BWL3C9.WB CDZ.=JJC!!"ZNC5)9M_6OK5H8'22'[-')4WKOE2\XQAK1WV&
M\ RR<!KM#->6]$#Q#FII=S2? @ IC=.BURJ*$FX+$B[UG"80<=!>7"(E_^@T
M62V*6514E)R<N0ZZ;G2EO+T2726DW5/$TKI\2UDA:')J2-JB:]*HR-,*2\S[
MZ"F A(I*YZA-5M<S/&[ !CM2L)77W6?GOA!_/.Q$Q) T@QT\,6_PLJB;<% 0
MO$  Q"J!@+/F78S#?D%^>^-I:+:D-D+=NF7:#@:[/GX _-Z:-3\0EL_ZTJGV
MQMT< CYLDTUH[N=S;W>+^QTB"G#K_(W;T,A)>6\1@#!V4,H:&HDS%^9)?*HF
M>E)QG0]];OEX%(&,%7?[8,&<Q4C5R"$.+Z,Y %SF4>#J1"0K>NWO5'%09+YO
MOGJ,=*Y/QEDG."=ONBR[2TX$ X@' =UCZ<[I%'WY;NM^SGD'69"R-C4POP6L
M*Y\I9H,7IXMS6^^NF#?I;6H\H7:L)YX5;RH7S%LL-G*<'23!1"2,U*EL8"<$
M?VN_3#CK?T]>U#4,3Q$#W .CW-2<&/GBQC:HE0Q3N)AA.:$_^5#9[3)Q,<U[
M1"^R-Y%:"0*L4(*YL0>6]1Y']$^%8^ "*<9Y?T09%1)LJHP%.>$H-P>MO9X?
MQN+F(3B*M(M.3D]&/&AZ/K%X?O\&Q(L=])+PEN'/=85+!/-O\$UO. "=FKB.
MVYU5?2N;+(0^U.U9N-0:^ 08]K6K))*W,/!^K7%K]S=9)FFM"7%G%Q=/ME3H
M5IV'87N+34Q%+5@[@]TS5"H>/6>U'OJS]VZ21@3]UB3M8T8S_P@JIEA?O,4F
M<E\0WMWFV?O[QSI6-6$O"3UUTF5GBMH//JH\+%M !$-=_;%G8L;N=,YR('*W
MZ-O1V1:X6E26<SQR +:Q,X6>=00"_/PL+-@UDZI!_W+=@IB=\78L*2S3^B?8
M53NIO&P[*?/1X[D#P^96('@9S4RF+DGCMGW,KY4A\8/US=L76P-3S8AA1?4[
MKZ>SLFP->QA4X\>6ATT')_Q"@1+8D+\$NY>[&&@UTKYN/EA^I+A/%5JCL.F+
MVD6N,G3\)2#49_8X<_30!QDJ]?FY)O(L>Z\<'S]2CF"$5?CG0MS50$;]5<K3
MT?4R1X02W;3</'+"6).0I5L!6'L&=&72I>^N7$A9Q2R+LC/\_4 $8_L2>05V
M\A490FK+R^6C]:+.XRT$4K.+L<?\/Y 8"/T[$X/?R^I9[>F/TK@N0)+5-+NT
MB[?ZU$*PU8\&_EJ,>7\N0S2981G9E[O.''ESB%^S7/YKI[M$=E Q$=+1R!6H
M! /5@W3/A'YXY@;WFIO:\ CX-W>5BJ[_8J67X$VCJN&R8X"Q?K!N#L)<L+N@
M>KA*-7XJU'OYMYR%>YO3T+JSSM[QJ4M94@=R_6#R!YX/6N 28A<5L)"7#S_"
M&%F9AE_0G8BKC%R_9/B)Q]B%0 Y=!^4'!=?3E/X29&2,)]25@MUDGL3;6>?[
MPH9FMCB>OJ[1BM9FXV&++4Y68O_G0+Z8^9@:738></^$YEK5,U%M@:KJ9#I1
M<&Z]>:^JM<VNW5\,P.,#"*FX37!MXM?%/N4+]:+G8HI"P0H:C2O3G8PY;GZI
MC0)<L@^+VWWD_-EFT%/)[B;+[J9S4+'K(<U_:6JKI,P<_@G\QJMZ?K6SZW5
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M]E2P!MALVIB-!E;GUD30.P\@!MTK?GF:H=3R:N.<;56"6C*S*XA*YLS7/?C
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MSGU_9^ZK>U[MOOK-[LS.;S^[\YU]V%C8>C^Y%-6X7#!Q4!M@!9$DR;-.1V6
MLXZKVZUPCH=,Q/B5<O!QZ?IY*(TSTBR5245!_&BD^R%M1Z?8) ,W'BU[?Y.U
M[*O%2-6:E[WMXN85U9NWSOMW$Q=5>Q'_[)+<EC[29.EIYL>^AXN_^],2?5VR
M2/7]_HTB%']Y6+D\6[,I=5*)3W7R3!<9P(,R<6H0'ZVYW.^/-2=%BS0W',>?
MK>/38(!'C1ZE*>N+JXLNT=0'=<(9CB+]!GT#)AG))?Z%Q>&G%])HP_Z*!D=D
MVH9@+700VF&5]OG_" N$1,^6&J]I+ 1\;&#[QT0J&TZDN_S)NBCN;'+/"IJL
M80T&E2DWO5L?PQ)Q0!$W_[M:ME0Y@E8S]V3%/_VP3,BM_;8=Z\+4MY<NK)X!
M.<U?[(M\,72@*Q'I,8(:Y:RO%&H8K3P3M*%,7JJ'9\/7-3@H@<YW;!J#%,D)
M)IG^ES("<S)-:,N:R__"S^'$)E<?627Q,'9 6\M*3#EKF?0/7$P.^)Z9ZNE\
MT -/)6K$)LK5O,2>I<GX%R5*K]);S&$?#-2"')5,O--V#5#!;I.V5?I\7+9(
M4*X4!+OW9;[*>$W:[6DU-I!4J2A;WUATCOHEA])R==N#&P^7^:%K'1H/I=)7
MSO704 *PQ28^:GHJ#.S8VSAR$0 <?VY@("C5;Y?<?98VHSPZ@NLH?[Y< F[K
M120%Y)J+X#*GKZB6V1KKSO#II13Z^*UZIDA%_GOB>]HO"-Y,;$%?]UIR5F#Z
ME3"F4QJY$A3*I"HWYU?%XPGV5VU+"RL+7X@JS_Z>NP-7% (2G;*FN@-(2G0:
M-5,833>"S6+Z/2CGR%"#>7CEC-5V7^HIZ$5:2D1,;^"W][MP+WA(SNQ^,"=,
MG;K==-=;2',&\PN A0<AC-60)J@PDE6**GP/T"?NNP^I&6U1DF4$$ Z> G[?
MK 2(O3D16E/B5/5\OH@E[QB765]18=8/CQ?EB=1: N)CSM46"9%OAC/Z8.RZ
MK&<2KH:%7@KZF3FZ!H1]2,?[^>QO%$0+$^'D_CWZ(M-JZQ;-1CL"'../I@XU
MQNP!I$6[H?:%:[(K8@%.1[OI]5:=AHK! :FSTM5_]J,BV]]WJR/18) -;L.(
M1!%YX>2110XH+QT_E_)_U,/W?\GC_P5Y3#&A.;+><F84F%>X\2GTI6Y>8E:+
M\D>%FA!>_6T#)P$I9"A9T/8\]QK!:F9PK47/&EU \7:MPG'&/XK#MK<1= $R
M7X)\\.Y^,]^#^4@RE,U&4EISFHR)3(XY9?V_MCG:EN YNMTO2V)M.$/0*ZJG
MS1:L&5C\2V@GMB;-,4#B>F-O(MBEDBA .AU9T'17J8F-@ISB9F(I%$'!<C?T
M!QO%IO7L',ZV,F7@!^3;>^E+ETSTIYJR9NL8"/S+.5-=[XG9T)].,'\SV0H'
MBK4?1*Y!,SP6DURF3>0S O30WJ;19LA*_+#NN$AW155]X4-FK2;]FB=K0>M'
MQU"BT)>99''K+YXPQRB/' ]ASHEA1"_=U).-K !%.8OAH 3D"&EU^<@M\!/$
M:3?:&=THC+<BJ:#$28>\!909@*H(($]5Q"OE)*.^XO]3N=__=?]_X3Y(R3D/
MW:,5'A@&'[&$SL6#<2]GA'1,O+J"_/PJJ)/Z'?+<5>ZF#B6:Q-[EZ+1/Q0^%
M:[O>F?OGQ]WA5_]J/O@YRWZ.=X5<8HFM5U323=^NJ#:DJ=!CRREC[;]<#S[4
MDIK?:D&2B*<3B.&=-^Q(Q>QJ0^%R%;RG\*+#^JI%$:^6%5U$6J.4&Q?7ANX_
M#G#&+UT,']G;P$G0'W(^3'ZMR^1["L]H577].4W-VK>F,S%Z/7.7,HU1([N:
M2W4K6KSW]!6;\]!^<4NB?R2\R[XSZP;:#\:7V_N\4%8K'A+B7OCR443I).LO
MYL(!%7+IXL=Q137N_,_OP/]^]<16UH-[E(%1D4HHD]D!']U%FDZ?28XJ?O35
M,FF!H7DV^N3CP5W&CMAG"9VD[ZGM!41FE?N:KA'Z&OFP^XL'*Y%75#7-TK&-
M>[]08_(^AC. *=/!R4LY_1 6^F:Z1@1/0!*L"!2!#.[JUSC U&[E6DE;'S1N
M%+8?5Z$XSX<8P3LG7&T2JK)]DJI]JONIB@&F?5]*R[YY_4%FZ;]:UM[Q,=-_
MBG$T^M3J^16Z/^.;4W:-8 8AEDC.IXJ)TD$FU)[H1,6(1=]P:I+5C^[6.WM!
MK=CLG+J<0G)L"<8B.@?<GP*5SA,0&?XB>+58N@GZ;"W0\ZTIQN60V!O$-A,)
M#YQQFRX 89C)Y)K5F)Y:6]9N?^(T<.H)3CC!9R%1UB56@?ZRVH ::?M:N9F4
M=&A8AI]SME>?>*G3LBAS;4EI?*$NS.B^==\TN]/+=1ZX .[M<4<MLB+Y2<[H
M0P!&%VE*SQGM6)G'<ZUF5=O'6 O9N'[J0]]H.)S5W1>@/B">=<;95"*S 77<
MFQ(:C1H;Q;5X^F[5 EUR.U"21'5(;1=A[G C,(1]H9KDZI_E##U!GM7@XR1A
M=&J"!*:90H>, YNM0J%*"6'CP-7ZO7-4X/GOUV \8@Z0R>4[ 8K5W"U2[,EK
MFAJ+8A*YO9: GOY*O)'Q2O8U+LOF7//E7X*@]NYP _^ NX:A=>'0'->XD3-.
M1_92]]O?G9T2E[#4)>^=+*UA.V3-W*^CZ?;P], 383#:OMY*V"J=V18FF,:B
M9#UY_,*]T4M2VVVZ*:.AP./^H?Z$8OHR3K9TF62@$=]SAM9E324[6C5 ZSL7
M<O\TY@3SGJGWPMT,0[<>+]+$J&N.JX\D*UU2I0#:V72=/# ;F%])UW\IUUSC
MSB/4W4A-->9SN> )>S]8VWWFE;34G>8&"XFN%Q5 F//6?J_U5FVI0TXMZ0>4
MH<JD80XGB8B3-Y0@V43B0#]T#5V\L['^=66J*W4?*$IY,9ZL+6C436].M %I
M.89&,K?ZFJM8I0X&=LHNASF?>BTI'?M(Q!W!LMV:?7QG:1E_YE5(0X-^QWCM
M"C9]KN4VVI>A'J#Y@:2.<$HW8_DX3IHXRO[A<;CXMR8@Z%0H1T&7\V!>R*\4
M'5F.]@;V]'L6IE6KW_A2>W)+,T65!-BO]-*\]/L9U&(S>J$'[JB>DEQ%;1G]
M-^FWR/D>ACG7$W?)EKL2F=471@'6K=*.0.&*F=*0TP^:+F^#OD+Z]/!-D$ A
M"Q^L-M!IR*%L)30!01+[Q];]@]:&9^+UX/(8? =/5]0+;>IQ8F0BO?:^7.8/
M.BR<Q$7;>7I%Q=/3Y[,UY[,CLP\:[D%9+JXC2QN^MC1@Q4>VMW>"A0=W*[!R
M-::/O"7-HN67%!6+KJ@.TC$+Q>4S[66PNG'$(<P!799COC94  *0@UX(2 _!
M888M1>.L<A,^2/P#=)?0V $[R#M,%2>6W&8_O=],T;IF8RJR[#-A+D.;"O5L
ME?VY_.Y9SB&Q'*[MM6-&PU2=]\IUA-/U7<%-THX#I77<ORY8;UYS.T,,4#)D
M;AW1&DL Z7F.[E&CVK7 !PM$T]&6*2:2B_U"X85\*/RBJ?7 YDR#27_D_.L
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M'MFJ?NM8HK5Z?>"[WG BZ+M?HB?#IDLP&+/3L-LI>)ZZWJHP*M@H5&J'KE8
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M)]FXVV&UDC3TCZ]IW>X:^W>E7U@>T00/J34M9XXUFU>H%M4\:X#7IQS7X7K
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MY6XW5S=M8<I=W'",-T5]+Z K(("UC@;N7%&YQ>,*B?6BL'C[$!;2@P0G,"G
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MB:#;;C-/P5&.YT@>,QN?0BKQ0JBE.[X"S,U_:U.;0YCLB8I)3,2YS7)9<U4
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M31\V*I)JE;:!5+"]$>S=@A)7RZ5M(/54@%\6<2];+GB9PTZ(-@SA0H0^WM"
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M4?(-<X4F'#RD<9"MM\V;M=7F55[L/XYYX(/BI*]Z5PS;#=U6>U@]@"\AZ&C
M?V?^)\K#J_"2RJ],W_ R3RR.\#.P&M+-B$9XVLJBZHOTQ>W#(')>Q\\\[@WA
M:H6E*+NH0&40^VBXEP<R59T_6P?<4JM0O3D$NUZU-<R/N4FCEHZ](D$)"KPR
MB9F':4, -7DG,)SJ+RVI\SB*)4L^NI-\LT&!0SL,1_RAX-H_I6%K;=F7FY+@
M<@5MD-*7T6DIWY(K^/<2^&'/7'J!G_\/4$L#!!0    ( !6#8522C5?B[!P
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M.P/^_TEO:^GN22<&7"9<\/QJN+1^NU+\=XP#.ENIH[A?B?]$\J3=7C(MQ\/
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MHEG(41ASY$G Z)L4M%.>:(K39\R35YKKZ:X>CVSCDZ9CH7RP,=;+()@L5/6
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MXWDN*0D[S4(K25!^7@P&-D]_B\<N%0%\XH72-M7CEJ;V-H^.*CBMGYD%W,[
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M-G2#2[IUXUA+7)K56R7Y#&#X2/6(1[ +Q7JU6R7X!J,5P-&:K7DKU@V=L5>
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MKNDJ??\$@D?PC2[9B]TB;C3:'>(@:(-CX5P?TB#Y;^#B^R?4UMA(FWOY0Z+
M:-M'7H*S_684CF<18"0R2NOF/FMRCQ8'!7$KO%KJ)13S]9V 61Q<P9GL"0^-
MVH."NC%?_=C1S>-%5H!%KX=SG@_O=P#G"W:WXY%^.@=Y3\P-P)XTOV;3EH8(
M]VX\BJ W_/SJ]L")RR(-<AK/,4AR(>H<V]77'"*T>CR)H#3[V.K8\W ,_'1/
M(:<H))!$D]D%"@+T1(>K-%ODQ_)=F+0Y!Z3M.5[2(,\>N0#.+&OVYUQNR*Z3
M9%ZA<'Y$OUN>@8<HY9#HLOBIS.*F-<>GS64,$BF'1M^W>XBV[TE5AG+=TW:"
M"F9?Z<L3I7S3M::P-;=R%(!47M\3,CZ0&S=LOF233WVL7U_:X#.H8O$C#<(M
MM<#+Q*J.@D7ES9S72T4M1\7V<_IV@+'RL*4M\*P^E[]";DANW#5;*)2O?U3*
M&LI7J)@D95#JJ&Y[G1/='<EU/@G%$N8W+^K*FDJ)HB=B.=G",=^AD.^?D+:0
M-V5-7?S83<A%LH566I="IB7UQW*NM*F')G84=(EPD:B_&'_$/:_S7;@>&"^9
M<T;7X-C6,.;,V,?&*)/?]DFC8$)<QXPC=MQ)(FI>"1[D845K2MHN:"G9EMH(
M1=9N (;(AQZ=R_*WDJ35;,=)GX>V#]0Z >V2><0 X6[ENXAE7DJ=R^Y<VWTB
M:V.0<*H9LO08C>VZ]^FN*[<(LU(#P:=*LJ4G7GE"3V.,I0MA3>$!XE&@W-+3
MJ#R]URCTFB"S+3] <,K$VWG$E+<!3MSPAV:>M<_5@Q?:CI,VY/S];Y^I"OE/
MA[=H6TJUPZ'+X="E!>@(\%[/T>,;'T".VI_OV8]'R8\<*OKK] K,W> \I+-G
M+3A;H:4JA6P^4JFCMU,K24_0"3E"ESPM4BS1\^F(1&I(0&&WQR!=2-7*HXW&
MDN\UWSOMDIH[T+N+'PCTH8NA(OF2N$+?!Q2B 8MTB>WI7.("80#GH;:$A>5[
M/Y_0D+"<V-9/)5I27GZCA+*]A9GY\I"#:DF;]T8AT99ZI/*$JDZSZ\J:"3$0
MBE>,@NVA!?L!8>6^NR]8_3Z[@D(?A=S[^$!MULEL!C#PI1?VDQ,T>353+]Q)
MACYJ2+UPDVYYESZ/,1*2(@5!HZ:IC*!Z..@R('2\'C(E[+A?ZZ5$:/=HX9 2
MX9 2X9 2H4;ZQ90#?:_8#3,B2-=C PM&XWP(?6=M;I@.09J+V?19+PS!9'9*
M=VG( G)@0"WTE/H3A#&_8'+JKN@WT5IRT-6@%5,YGQJ>?C7E2 2P86.LR#5/
M!GFWPL#U)V%>H1OIGK>(6Q@&KHVXZ?0H8#"Q-P/$5<F/I3ZLNE7G_'D%,;^/
M?R:?J!J5AX&E+B,:-HZ1*(3<)5"]"(0OM5<_6?"%PQHY!!UTS\4AZ$"PU1UN
M>AYN>AYN>FH0;NMQS.&FIQYS_1W/['NU<$AWL0I46[ITM7@/:Q"1O5+J+?5C
MY*.1O[E1C*E  ;D%J^2N#)G,;C!5P^GP"RY#_72/>S4[#+3W9]'2:9MG[ P0
M#\-5E%.\Y&#G*@P/QC+Q&MX, X;P=K!-9CP7V15T'Y@Q3S]A,5[@SY@IP.@,
M>%Q0[T8,Z#$&8Y)D3"*R?$D?WY:-YFU_+$52P'IT@FV7#MGTZ43(R7IUWHU^
M<EC'CDM;<4F:5XGTF3<J/8X9AV'L!K=H[0:,X.SU^%.T7,*(SU4]R8S*DEDF
M[3LN[\#!60_\\7C$'X_WMIT8$D*.32VOR<?C,INY%FI=)EUSL,GSQ8VZ.Q!1
MM'"TN QG""^Y[^IW&"UN 5D!CX[[:Q0^ A(!?\)G,BO,QJ$4VG=EGN_SF<"<
MB-]88:GDZ(>T:P=N^W:>:.<.3GIG,R#,^G=00@"KPZ="G["?SV:4GLGL;D'G
MW]$#G;1^>O\U2Q5'9RIFD]F_#&FMQ)];6#'U9L7[.M$!WCM;+\BV?R?=&K?)
MY?R,!"I01H-#,B+H"A,"!S(R!//&X Y9%95X<ZPK:W)WW]"C\,R5RUGCE!,+
MO[2SUW,Z$%=<>4ZRKIBLI1XY:25SK]'4XU!.P:GDUSI%64"SRA&DJ&;&4:<C
M?RW$;'?;=0&:S4Z\EH&U.GG;)D5SPL(5(NKGST55#'D#]6:5(#-U'0]6KYV,
MU LJ@E,ZJ&$84Q927JC6? *HV@R2<O?N,R#4FD/4#EUG00C4CBNV<OYGS**)
M0+1 ]!NF@W.;136I>R'"E#-$6UOJ6Q:6^D.O0;3E03QR"L6LQ[9*K:6KPKF+
M0SKFR W W&X]@T$<;2W?*@Z""M8C(J/;3J]CR0D3+Y<NAO\&Y"Y"WH_$TS+V
M(OC([D^'_BT(6'18SD5S@3!_Z.2<=5UT3=+_W](ZQV]'7Z2>A@]:3IH-90YA
MI*5.&,=-B>.^.9R05W#C,"<-R_^^9E0Z7$)59R;_^RUO@Y';IT-G3"AKB4/I
M.W?:G 2N]^.(> OZ+;G!T*-"^(9\$(PQ<Y*E/K(B;E+Y5AX#8/)UM]TZ<>*I
MX6)*>K]+>G=62??.DO7//;X$1!M?63&O?@)4GZ*[P<@#P"=TUSH!(6T](GRO
MBC"D2K;''WI/1^P]R@UH<OY,K5Q(N?X=Z+K/*\\-9)W_1/E^=A[2_OD0@AD%
MSB,C83,L(U08NW0T9G0X3Z#@3>]1B*(%8.S[O!LWR$DN-_''9#(KSG>I_"I9
M@Q23W-UT7YSO^:GM\I.+RF0^>!,/WL1!>A-?RNU+N6=0[^*EJ7NMAXN7AXN7
M.PI^^!<OK;L76*;.HM6B^2O4UDFW0IY0O(;]!]R6/F$'RJ=HR<Z8N?['/R7C
M.%H@IC/ZWZGRBW/*ZDW@AN1DG2G[S)0"LMTSV[VZZ,S2O;A+EC7\'0,;2U5.
M5<=+G71FYB2QRS'2VFA4(63?N>70AZ.5.MM+&+*]7K*H$J&Z:B&I8>B(M<ME
M VDSWO:NIPV8ZD4H20UCQRJF$"MR+H+L??>8*1^8DM;I/9&+<=Q*O(N0^] Y
M<A<HQ@V!VU8Q]3R8,=Q*K(M@^V*#:?#0DGS23_BEON2XI_2V?*&*)$^%2:JF
MHT^6G[B;EXZE$2^M3O;LC;1)')'(#7T>0,0%U).Q(29@($.T+T%8&@'4ZC2M
M\EZ:IK>  <A2CE&+$;M>%+L!NPQXW-,JNSN! QG-M@CJK^!CS&9\=7/J>>VM
M$C"0T=J7((3>&J,1?DFTKMX=T4IFK:2R;1FU-D]>K">X&HP,0&54U,P0_2:,
MKB3> O@Q'6<S%<&J2)VF#=D3RM,4[/(2L)L(#R% >QT[[BCT0XS0(49(*E0K
MSYL.,4*'&*%#C)#IK&08/G+5=)LDZ!:2'_)@'WFMH6Z?6LQ9:CMOB<Y,?ITL
MC/):9B)FM,0O0DS,O'TQ+.U#9N4NWPVL5M^\S_E$5#?N*T4-A8%H3:'R'9 :
MTJU='O-9\%2;6[7LX+<T$?M2MYMYI*[=I<:***IA:@,3"EN&2I55&[>LML"Q
M>ZO:$\"7NSD9"IU2SA35SB0->VKY7<Y<[ZIPT+JBTX]VRUA*MTC&'PVX$:@B
M0U  ?7:)G#\*SK*="MV_XM)#W?NE3(F >F\'3L)M1<"4H1U?1\1R-'K>\7L&
MQ,I=OBW0>KUJ<)D[I[X;;]<#Z?8BK]3[,UUZ4P UHE\D_\\&-IQ[%A0PF5V&
M/GR$?NP&XMU&4'3 6XV4^1JERP)XDCS909+/;0%7]X@/R;5LK6O<2/\[DAP)
M"6)Z\K!CCS(!IJV[64> ]WN5;KD*T!H <8I2?D>B6,K$#K;KK$%R+H3[6,MW
M<B:S&?0 9AF_OKFA.Z<_2B4N+-_[;9QV9"_G1X1"RU=LM%:X$^1B?S([@QAX
MM%URNG A7KIBIPVM)*\S'?7M6M@?,TVF1,"-3#@>)D\A'5:4-;'^5RHR8+VO
MEMD:!Y!!&&0J0*50__I:O01K)&RC'K:+D&W5HQH",7C[?V0@;DHTF/6M_I$\
MG,KTC:W-\U_GCRQ]T%KU;K"PPE#W!!5?(N@^60><,B^,N(JA9$,*F2L1LOW\
MN4V0K-R%V@72[G/H(M7*L^BZXN9NTBGGCA2B//7"K>R3Z:VL]A+@&&,6^LR&
M[\EZ6R1]36_\1&TU_M=O=(> X?P&8(A\59Z&EGJ9CDRE"-GWLE7K0A"-*M.3
MOO8:=)71AS*CZ8W1W_A3DI=APNN%"S%/5]\X#\C^/0Y[K'4F$.%J9L&XVV6"
M99>7T[O/CRX,F-)[@?!76E?R>'M7/0Y[W'4F$*'&.M!QETZV7*:'X@,='0P\
M59=_O9&G)Q&A@FW!T-MEG3]_7L'DD;-DB>]@;RUW,>RAU9X$1$.IW:B\WE<Q
MODZ33&4HY:KA7YZY$=BH$MVM;0T)&?:P[%M.HL';;JB/,=5OD_:F>YUOT]5?
M;P#*)='VZ:+@L.44/4*?/;]'/ SYC! <L%0+#@\Q&1]M^^H%\KX%[,4W/D1N
M 8D#;E_> C_V^ V#V2DBD1J,AJT,$ZF=F!3!^'F@*S-+-/8-^7 &D_>@+T,/
M\PIND&^)R:*#Q;I![\,;8[T+1S0VO[2[Q%!-QF-4S'DL$J6)$GX9CL,P=H,S
M%ID$PKJ-G=75J3H\H)MQ)G3KF;Z0FE))Z!AD3J'Q$L5AE+TC+)[\\GK#0[,!
M6^+0":/Y%F^!AT(/!I"O#R<@>@(@I-H@>V\=\7C-,Q"B)0SYKY,977F@QSY-
MWHH^7Q&VOL11$E=X2;3>I_WTMNY]55P@Q7E(:.'/]H8;@OB3M7Z.)/:H*BOR
MP A+ODU(<\YO[APO1YP#2>[1VCZ?_MT\?3Z.(@P?8OY^[#WB$3<W27GZ_6LJ
MR66:[G.! CHZB%8>S$^CLC1I?T[2H9/OD3WIR_MTTDY_8J5>.TF_3K[CVAR:
M78LI]U[O)&3#R@W79+("B<.&T+TO.;_7'F;'9<'D>G!0,K32?O[^M\_'HT__
MI,-ITY_SL';2B ')V#&X"E.E%(0Q(!=T/3NG$L<AW>UC$E'<^<R]0N'\BB+G
MCPD!$:FL8M7U>?<6[4@[VI!^[2RDN[5K35+2?0>*,$?I/O*V.&7I)F'S5X#F
MV%TMJ%8MN54H*6Y!-.%>&"$=)OLY?-9#+ID)>1IE$=*2XOT'I*LEC'0(%Q[)
M&@A3;PL.*X,&VX*LAW!! KS7<_3XQF-V"5XGP*6_<-PX8ND'T^]W-?"D7WZ_
M,Y!353W:40V1%BU+YS&F>J7L"EF^Q+0.=%M$7$>K</"VG.+G/(#<[&/:N?S"
M:J5@[^E]FLA40K+PZ,5P9%>J53"E(LM<R&X89HH%M2N#F$5N,*6"_N??N\]*
MLZ-)8]-C0SFQ6M:E=V9=-# ,>P8WKHXK1"2&9J'82\&RAJE^]J =$@JN,/ 2
M1QOE<[Q$.(+_=@6G?)M,9<)*+P5!)8M"Y=HLGHFCFFTVR0#D7C[Z"7?4"D]9
MTMH:E5\*OMJL"C4:TS@G])X_LR,]B>NJ5/#EX%?#E@@KP]%[R0BC^W5*[ D(
MJ;PE)^.""B\'.PE[(@P-![$EG(DA2[Y_*0CEN1':'88!\7TN4G*/)M$"X(3D
MY+Q5 I.DUHL!3\FC"%+#-\"O4>C%&+-(%L5L*Y=\*=#5\R6"RW#TV!F8 4JK
MOUG.$YJI[2.S'$1U7@J$*@Y%8.;"K0P$?U#R[MP T"5CP_K)^A;,N>"!WAG[
MN_(9>S[7J!."R"&L"Q9[X&6=L)-US+MQ7%KG<+!^.%@_'*P?#M8KAR*'@_4^
MO(>'@_7#P?KA8+T/U*X1CA9CNCQ0&F6'P=5R-A^Z"PEN>_D2G0KSX^C3Y.A?
M?BQ<+6GU6;N,YM;/W/<8UV,"I>-Y^[W5Q_!52FT]??\&?3\ YRY1YN\JES21
M/UH; !G-0@NZY=7D%+!3^(#J;W<H5J_6_!JGI,IT5*<>V")P/>J%Z_AQR[+G
MCLN4>)WU7%A^.NK;K=14Z@K2A2+?^=6TEETC:E?']+COD=]IA$[*CPB8M[8Y
M\B[#;^X?""=CB[VSI.O0>[^+0P^&SI)UYWA9?W9Z]M(9=PM6++*#)1;:7 C2
M\.+IU;;#8R>A=7.12MM-UZ Q:WQS3: 6^N$:2]&,\ZWY.,GLZY.8KB2 D.QJ
MG2)KMKR:!4ZYYH"5WS#5$(QU\7PID<JDS,5BAK)E:TD8R0COR1/7"PQ6>N#:
M@JK7MQJ^4XD!G],LOQU0+=BW>TTZK)&*TI[\:A?8#3WY0\KY(KU[TG2%6"&R
M==>9*+]23&2.,9Y7*%?$U O42@%6B&S=+2:=T?^7;N.4$XTI72C9NZ>KV:2N
MTMJZA^NE7/49F5U9=K$@=F;33O\"2Y*!0K;S\XQ%E(430&4!-N%.@# O 231
M9);X&"AO4B_#A[H,,-ZF&Y;5!2893!YX3]EO$>N+%N2=9;E?9EF7?29UN<'H
M$3(UZP+ATS1\CV7+*06"%:.=4RD173%]K!/3*NN9,HZ=-'0P38R3])Z3E@,2
M IQ_/"0D_$<F/6)4?$PTLQGPF"SN <4=NWA]!NE'E!L/D/N%&WV%C^ 6$G"/
M[N \Y,G-PNB&34:6'GJ6R7H3;I>3/_WL"KH/,$@>&==U?GVJDS>78D(K%UE&
MK>-OR:6"="-G3@EV,*68><?(EF9GE1*=B7P#%&O;Y<07 62?!UL&)-ZTKH'*
M89*FA\IKI1> +D]NP'Z)Z0:TWHS[6_HMQ2/!F(JE\,7O0!>0SV5 <N044D0E
M1#D)5<XL(<LA&5WY&8%I$2YM5@]D!%9*/ %C,L^MJWHIH+Y4,QUQ9G@3M<F<
MS(80T^W33Y=$EKIP2[J&%U:SNAUNV"JQ9$NM?IRD5C/6N%X; 2STO380W4"\
MKOS]79:X$T?K>VJ5$M=+,YOEOY&[8)NT88$_M@F(916ZJ;"L<\OF"54Y!>O*
MFG'0[B!X,7*VNVSW@\AFYVT',/;JSJ5F%: :]!G [*S^,HS<< [I<I%H-G*W
MI$950RY?R=Q S1FP=-W+C+"4C<8WH?7J3]^;@7 ?[:8!9_9[@L:>%R]C/IYY
M.!/[#H,%6[\>>0Z49CZAS[59@8L^(7?;I8-8G_S[3:<.K:KG'3)YAUDFMFT"
M&0U+J'E+1N]NZU&KL(F:M6*-2;0KZ.5;WCO(<"#&T>:P.<G OEUH-$-2ZJL9
M,X%V0DH0BR*3B'6;?XE8E5(M*&XX-D4J<:3#@*T&3QOPV&SVM 9AK\9.;K6H
M\9A<@XB; F[B2"=TL>9A.%(C:)\F#1E'\JF$VN/-TJ4SQQ:WV(,D$9W_1YPD
M+5-=]M&K/_UD,;K-.1%A^<D>,&4* !VLDYDT9*)A0]/19S/X]JOB%MG5,)9-
MC $1 ]OEB?Q7[ 9PMN:Q(+\"?PXVG*4'W<4W8VY<#&2IKKKJ<>BCJENY6+J?
MR 26>J"2R!5O7;O*2I>E%AI_J8.JL0B$:J917]_V%$_P@!5G:@8POVK'LIBQ
M4#<4!,F+[3Q3I]3A5WFX*NN1N>[83;,T),,M/6(59?TZ#-GDA;!"[PY,N^\Q
M9F/CX^0F_5V\7+KL"5URZI+%./39/TP#>G0#;HWP^"6/#]-W(S9_I9*JO&1U
MGW=L.HEDR*9/QZ.]\1 7_@/8]LL"6JAPLZZ==Z.?'-9[);HE'6_L+_:*.OWD
M_P-02P,$%     @ %8-A5$^0%,-\?   4/8& !4   !I<&%R+3(P,C$Q,C,Q
M7VQA8BYX;6SDO7ES)+F1)_K_,]OO@-=Z3U9M1G;7H=&H6S.[EKQ:W&$5.22K
M^^G)QMJ"$<@D5)$1J3A83'WZ!1!WX(S(3,"S9P]U5:6[Q\^!'VZ'X]_^U^LZ
M1B\XRTF:_/LW[[Y[^PW"29A&)%G]^S>?'TX7#^?7U]^@O B2*(C3!/_[-TGZ
MS?_ZG__C_T+T__S;_WUZBJX(CJ,?T44:GEXGR_3/Z%.PQC^BGW""LZ!(LS^C
MGX.X9/^27I$89^@\76]B7&#Z0_7A']&_?/?N?8!.3RWL_HR3*,T^WU^W=I^+
M8I/_^/WW7[]^_2Y)7X*O:?8E_RY,UW8&'XJ@*//6VMO7M_7_J=3_+2;)EQ_9
M_SP%.4:TO)+\Q]><_/LW[+OU9[]^^"[-5M^_?_OVW??_W\>;A_ 9KX-3DK!R
M"_$WC1:S(M-[]\,//WS/?VU$!<G7IRQNOO'A^P9.:YG^2C3R/20Y^3'G\&[2
M,"AXM1L_@Y02[&^GC=@I^Z?3=^]//[S[[C6/OFD*GY=@EL;X'B\1=_/'8KNA
M5,H)8\(W];\]9W@I!Q-GV?=,__L$KX("1^Q#/[ /O?LC^]#OZG^^"9YP_ UB
MDI0?2K]^&-BJE;YW#?8.9R2-+I-YJ,?:GN#3MI,5.SC0UW?NPF-:!/$L\'U-
MY[ _X7DEWNFY+VG:S^-Y)=W3/ CL0H0\N7CEY1JS?[RA?QI Q*\%'<!PU(!D
M)C0],/\"'QAJVZWU-!S8C5EOGF:B[VQDY#:70?[$#9?YZ2H(-O0#[]]]C^,B
M;_[EE/W+Z=MW=?_]N_J??V4C)%[CI+C\1TF*+1N_Z4P@*?+%*\F;+W)W__T;
M2YWOQ^XP[476^!1DH:%@:HGOPY0.:YOB-*ZJH%)?9NG:&DI=BJFEPJ_Q4_N=
MJN@I%(5# [$,YVF9A7A2S?>]FE+"-<IU3+785 XGIY\?OOF?E2CJ9-'?F/1_
M_=OWW1<\$HWB6J?)0Y&&7S[B]1/.%*Y+Y%P22@FS3R)!" QQ5,C&9*GD$!=$
M?ZM$H3!E$46$35Z#^"X@T75R'FP('9.UK#'HN&20%?P^F[0*8)AE@W+,LDX'
M,26Z:$*U&C3.W>,B( F.+H,LH>OC7$LVE;!+END!]^DEEP3#*RV\,:$:8=1(
M0^/1(@S+=1FSZ>UM\8PS-AIG^!DG.7G!UTF8KK&^'[/7=]JG375KT+_9*H/A
MY%3$0K]W>WZ-%D61D:>R")YBC(J4]H 9G95!(^QCAH.\S+;FB9E4TB4)-5#[
M=).(@2&6&MN80HTDS"G:)UI;:5)0?ZGMU7528%I2A98^>A67/+(!WR>43AX,
MLRQ CBDV5$&-#C2NG;,:I3#YAO8]R;^<;<]P$CZO@^R+9I/"K.9V66GGQ'"5
MJ=<!PSU+H.(:M*>&F!YJU?:T=T$V0<9Y]>Y]S2KV+[]^I+1_HEA":8\E%W'!
M%ATXQ@S9[]Y9H $UKO%6:F]]C**"_S=9K[?GSVFJKF!!Q%D%*\"U%3SZ'48%
MRT&-*YA+(29VZ!H^3X/P65V[@Y^=U:P$5%NKO=]@U*@(2.R@J<2A*_*GSY</
M#^J*'/SLK"(EH-J*[/T&HR)%0..*_ E]1I?H@?[?P\[M\JSHS>OHW\9S.OI/
MO]Y^37"6/Y.-9/(F^=U%G2MAL4H7?O1>ZRI$XVIO90X[F^(+!_J'9;G.'Q8/
MY5-.(A)D6W6C-FDX:^=VT-NFKQ?WS@M[C&.F])5H+[% G1ZTY>!'OB_"#T>O
MDTU9/-(O:I:!:G&7RS\3Z/ZR3R7KG5Z6 (5)?R>.N#QB"K .I\<N79 \3,ND
MN \*_7Z]C:)/HJD=T5%.U )+/B54(PU/4*.+F#*$J=%=ED9E6-QF#SA[(:&L
M7U.+N9HHZ4 V\R69C'<*&8"-"5.+HB")4"T-J]-ZH#.[#4E6BR3Z"P5)/[#2
M]E4:>:<A6R;8@W ME;!W-MDB'-.JD>>\:C2@3;(>@ACG]_@%)R7^A/4'.PI9
MIY32P1W0228(ATH:=&(D!!?K[YC['[_N*4+5H-7[S=5()<!IAJ?V!^]5+T,C
M]!A%4)"\(&$0H_XLYI"#D55U?R0)69=K:>\@^=U5M4MA-54_^!%$]<L0"9/7
M2@;:,'%%817XAKS@Z#HI*&#R%.-%GN,B/]M^#/Z>9N=QD.M"R2=9<#FDS'"M
M/]!,4/=.POF8QS2M+)QR$ZBS@2HCZ&F+N!G$[<":3-_0Z7V2LWG<*L.\?]7'
M@&KD7=+4"+M/2J4P& J:$(X)U\JC3@'"1.AC\*H?&8>_.QL99;#:D;'_HW=&
MJ! )(V,E<^A3RNN$3K>IL/908R3B\!1#"JYW;#'XW7O=:D")!Q.U%+2ISV,6
M1)BMN_3#A"CF-F)6#G(8+CN4\<X. S Q4+81.W0?P$/!^51&W0F(,LYZ 16\
MMAL8"WBO:1TJX2R;B54326A=074AX#%X793%<YJ18LN23V@6/3H%E]V#&7B_
MHU!+>R>2-41Q>&$*B&J@5N6$YPZ!M3IY^$KR_ I'. MBYEZTIBNMO Z=O7I<
MZ#=H+96=[MA.<FBPA6NE"8:2D^ *.W],&=7:%4L'^N@-M? MA 7/>9EE. FW
MBLW?X<^NECLR4,UJI_^;=[(H  GQF+7((?JF'(??K=*7[\/Z&U65-W_C5<XK
MN_F77R\_WX^\&/[DHI)E8%@%]__=>^5*P BI&\HL154C1N<L(B$C.#]![)^!
M#$ L9.=VN<@R=E;!MEDTTQN%K-.%CP[N8/4C$_1.&1MT8K!V3+53-C"\8-33
MX0?-_;]74^GB.4C04.F@4:(_Q>E3$#_@HH@K5YH-.TWLMTG%73RX'?@N1EPO
M[YU@$T *L>1<"W5JW=;K828BS<@48<+[JW_\@?WQM/HCYQ?]ZZ\W>!7$ETE!
M)_"2KDDJX8(]&FB,+)*?O7-#C4G8?6=2J!([;.>Q2)+@H23G:;91=Q<2(6<=
MA!)@VR4($MXK6@M+2&E Y1 51$SRT#MM]VGX'.170?Y,%SGJ"I>*.:MR#<BV
MTB4R,*I=#4P(-.*2J!8]=,T_/%Z4FU0W*1A+.*MO.;2VJH<_PZAE*29ADP$]
MHDH,VL9J'8&KW=P:R;A<9$CA]1<7 P'OC-"A4L4^ R/$54 RGLKY;-L+A+O*
M\#]*Q>;3)$VG\47VK@SBBLQJ8(AFCU5W5Z.5A[4CWSK7PYK?8[;98XK#MU/U
M0D8+9Z1LU.C!HZ,9K!#71E6K'/(GJ-4 W#FV?_P+P1DM[N?M#7ZA[+'J'[7*
MGKI("X<4O:1&$QXS;>"JN8E:';[E]VGQ,] NDU^_R[EC[^QZ2IF&%RJJH4OY
M)XK#(YT2HZX7K)1.$%=#[\#VA3WGWD^FVGLH5'L_C6KOCX!J[V=2[?TQ4.W#
M9*I]@$*U#].H]N$(J/9A)M4^0*/:!<[("S^JNT[R(BO9#):ES=/,Z_0J+LEF
M [[/-IT\&+I9@!SSK5-!G0ZPB5J:8;)*+E_#9W9H?,Z2A :&?3B#CM-NS0;^
MH&/3*8#AF@U*H7.K=%"CA!HM:%W;799N<%9L[RC\8I%$[#&3#6L99UM#@A\K
M3<?;PK:NC#:+36I@J&B/53@R3I-5?3_P<7 [$%8/>%:2.#+MXXV%7)),#K#/
MIZ$$&.I(88U9T@A!ZZ5:GFMY(4BY)(8"8I\9(Q$PU)#CDCUSM3E<M-$.-XAQ
MD./G-(ZNUYLL?;&Y0ZS3<'J+V Q]<(]8+0Z&3&:,8C13K8'Z*M!8UMLKYN.F
M,<&"6M[37KX<MF+[?B@,AETFA$+T%)_B $Q[<)U$>,FS-L2RO _:[LM2U^V-
MM@GN#"^W62B"H=\4M.*5MT;W-%;DZ8#6Y:GSDNBW),QZ0#+*:+8F3$I@.&F+
M=&+.F /'&U8)1+"<2%()9_&&<FAMO.'P9^\T4&.2YVS!X+H9?BUF4@>CU7#9
MM5A [W<J&G'O/++'*,\0X+P'>2B?BE3U/*U4PEW$LA1:%[$\^-E[S:LQ"1'+
MM="AJ_8B76.6=[%-AD]T X5.VEF5FR&WU:\6A4$%(S[A9*U60'T-:*/,SQ05
M>Q&4I1S7+-M%,9?CB0ID?Q 9RW@GC0'8F"V-6)W\_9"WUV[2)$H3_L;&4Y!\
MN5TN<88CY=L"ECKN)J*6\+NIJ4'!.U6FH)2<8%$UU.JA6G&_CP@HF%2?Y]H-
M2!IA9]PQ FY)HY2$P183/-7)^T'&(@4[6+X()9_5/+%2<\:8"4ZTW+'0@<$B
M>Z#2%"&*3H<K0IOHL)-^BG9]@9],;S3)19T>@&G #DZ^)'+>F64!3AJ&P601
M$SX!^"+331HD^5VP95,T_2&J1- M=51 A\092P&BC0*:2!HJB&K)@V_,]E#=
M)MJ)LE30X>Q8 [0W)99(>:> $9J> E3:)0T>OVJ><U8(>J&! %1*@U8*'@W&
MT/0TH-).:4 E+?N#@:@?*HA@Y63HY #200!G( 23AS8??2C2\,OMIE!EE-'(
M.4V,JH(YR($Z%O+.&1,R611?L465)#2JL#EQ=S=#>[M&%'1[IT8%='B39BP%
MABY*:.*MF:=B__=E5$=Z'8FU4T^YG+OC/0W,[I!/(N2]^DW(Q!?0J&C36>QS
MUKE+QN,TR=.81$&!(YX"CV!9'*9>U%DF9 /8-BNR0LX[8RS B0E1.W'4R/M_
M-.^1%'2=M;Q.(O)"HC*09>70R+EBC!9F0Q>I$ BNZ) )+X@P690N42=]V/'E
M<KV)TRW6G=T((N[VW^7@NKWVX>_>:UL#2IAT-E('?REFN20ASO)%$GT,DF!%
M_ZBN:HVPN[=C3("[1V14DC"(8((G!(W5\H@JH$8#PO3B+ VRZ'9Y03(<4KOY
M^7- LG4@7[O:*+@:..R -R.(7MH[IZPA"C<8F1(;4UHUU.A!6^VR$VJ>8J^X
M9&^M&<[JE-).-TGTD =;)7)1[\RRPR>)?*RE$1<'>' W<DB_UR:7]4@ES9Z;
M3! JC4SALT,2 >N0JD>YV*OG_ KF#?L47?@;'U13:+A_44T+77Q232H.AEEF
MC(I'U5H5U.C ZJAN-YB]>Y*L*KPW:6ZX[:&6=WK7PP1[<--#)0R&7B:$PH2]
MD4<US=XPE4._@39]%'P.,GP6Y#@Z3]<;G.2\ ?!_S>N7!O^)H\])A+/>/BC+
MIY*?;2]?<1:2'-]E=&URS_+VZ"9DA_B2TQ'X<$4U&+_W_QDPC>APO@E;*+4P
MXM*(BQ]XLTR ISV3T8J[VT0S@^XVU-2RW@EF"="*)0ZBA42DVI@AK;A'KJCC
MAS2R4+EBBB62<L5!2)$$J3ZPR*#@DR^:(".M-%C.& ..Y*S9:]R1-6^N:%%,
MH4U?WB-K1-@:TG3"4#DC(+2B#-."L-W?+I9_PNDJ"S;/)%2>#&MD76WR&^$V
M^_M*0>\TLD$GO'W9$SOH(\S\#>#F#>;J+[TGF*M_^)4B&KK4_\')\\L"$/[X
M<ONOWNM8@#*NT,^?KA\O+]##X^+Q\L%C\V>WNS;RN8?XLZM&+@/5M.O^;]ZK
M60%(=H5N<_CY04S6).$+<%U\AT3*W5Q ";&; 0@BWFM9CTNH[)X@A '^4YH5
MSXLUIG./0-G.94*N6KL:8-/F10GOG-#"&E.""Z):TL5=[ T^KP8@_=UK0<SI
M76L%R,'=ZI&,]VHW %-T_+4HA-Y@D1-U+]#_T57K%P$UK;[[Q7NU2^&(J5;)
M_AKWGDZ#/I(HBO%ED.O#(40QE^<P*I#]0Y2QC'=*&( )#XMR,<3D#CT G&/V
MTD:\2**'M-0/_1;RSH8$&]CMV* 3]DX-6X3"O8%*A4>$<B574P:>P/ !K]B&
MA''BH!%V%S5L MQ%#:LD8;#$!$^>:K)6<#2OF''AM=[<.BMSDN \K_'JLL4;
M=-Q>A+6 /[P4JU'PSK,I*(6 O5KDL ?MGUD>YHCCTVQ<R*2<=3AJB&U/(XIX
MKWH]+F%+D@M6T7,'OZARE06TQ-6U/?S=7=8X":PN45SO1QAU*T$DI(/C(H>N
MSOLR5RTL);\[JTX9K+8Z^S_"J$X)HG%U5B*'KLZJ*_@/DJRB=&WJDD=BCOMD
M*<A1ISR0@5'5:F"*;KD6A3;7N\<QN^9\%V3%]I%V-7D0\IWOLVW_%\W$;XH!
ME[/ Z8[UIX3VVM[I.!NRT#558HC+'7;&6.<XY2_:]E_]J"*S-;,**SW7.6JM
MW!BGJ]4J>2?55*2J)+:U;O]QA3KZ_L CX"(,RW7)"7W!7BW"T1E.Z!\*'KO\
M"1>R!Y@UJY?=[#ECY#[<;IFZBS$8#-Z#!\(I06<2U391;11QJXB:1=*WNL$]
M*=#SA8\8<75!*_I[F1?&QTIME5T.^M,<Z@_X=IK>63T+KH["34=]7F893L(M
MZFR@15%DY*DL>&J^(F43@X-=^FP"V"),.'__\0?VQ]/JCYRT]*^_GJ<O.%L\
MY?PE\E'12'YW03TE+,8NX4?O!%(A$G,@41DZ":RE?%3V11KR;I/=5)=X,?S9
M557+0#4UW?\-1$5+ (E/WU0B/!^ ATI>T(]'#,!5'*PD+HQ^=U7-4EA-/0]^
M!%'1,D1"K]_((";DLZHO<!YFA-\DU/DR$'->\1*00OWW9&#10 2F9D-/UF,G
M?X]7A TU_/II<]*EZ=(4\JZ' 2WL\;@@%09!'!N$RI&CK]3E;O#(I462E$%\
MCS=IIJ/04,PU<V0@QX3IRX#BB028DAZ5+*J$/;+B/\L@*W 6;XW$$"1=<T,!
M=4R/D1@HALBQ*4G2BOOG"5]/$]:9&8DBBCI?ABC "DN2D1PHKBC J9<JK;Q_
MMCP\XSAFN3."Q-RQR(1=,T8->,P941(4:Y3PE+SA&JA6@44=GD[M@DZ=+!WN
MR?LDD !;QZ%6&"R-Q@@MF53EPF-Z'METAS.2LC"QS,0C0=(U@Q10Q]P9B8%B
MC1R;DB^5..+R,(ARF416-&GE_)!D!%-.D5H(($&&R$STH-*^R7%%\C"(*SQ7
M]-_&43\&6=<D4<(=$T40!$46%3HE82J%AC=<Q3MI_HJ#S(XR/4D_A!&@RNG2
MB@$DRQB;B2I,WAM1JL/E'G+UZ*,6=7:8:P#;GNLJY$"0Q0!...VMQ =D\3@:
M7;(W=[97),:?2DD$BES$%3]4X!I>C'\'P0<%*.&^.Q=#3 Y5@MYJOSE52(I/
MP5K64\C%W+) #G+(A*$,(#9(@2D8T<DB)NR-%?45V^LDPJ__@;=*WP0YM[Q0
MP!P28R0$B!ER9 IJ-+>>N32BXM[(<9>1=9!M'TAH&#9$0;?T4 $=\F,L!8@@
M"F@*AM32Z.'ZW/>H\AB\7D>4L&1)JI<%#$Q1RKLEC 'VD#<*84#TT2-4L(@J
MH:&6;S*QFPS9)NV%2]07^L_32#UC,6BY)9:5"T-Z:54 D<P&IX)J ]63*J8%
MI5F;KX%9\,:Z1131PLKK_]R0!+]3EH%4UBW#-'"'O)(( F*3&IV"0[7D2?,'
MQ'18*GM Q'D_P=WW_HGSWI8X[T$3Y_T<XCQ^30$1Y\,$=S_X)\X'6^)\ $V<
M#[.(PU+;^Z;..?WC;?:8?I4%?"LEO=!&A"HE32<&CS("-A-AF *;WS 5WU3A
MDZW;["Y+7T@2JJ?1*G$OI%& EC)G) N//G* )@ZUD^1&SS>1ZLFZL;$T8GYZ
MFR%(>5=3YZ('1Y0A,&,G4TG[IL5=FA=!_/^3C7:1+A?V0A$I8"E1!I+PZ"*#
M9R)-I8.HDJ]%=TU;=@ BO:XV^MW=E6,)K.[*<>]'$$20(1*O'%>[*Y60CZIF
M7,UPH.@9AC\[JV@)J+:>>[_!J&81D%#+O'U3&5\-FKTI'-\]IXDZN$ 4<57;
M*G!-C8]_!U'K"E#CFN=BB,MYW+E_+7"2R[ORWF_.1OHQG'9@;WX 4<-C-.(+
M:?7O'FKTEXP4].OGZ7I=)O7)D"P&42'GJJ:U,)M:EPJ!8( .V9@-M2P:"GN@
MQD,:DY"P-[\_TL5I1@*99S(A5Z10 VP8(4J H(,2EI"!NA5$C:0'(MQEF)$1
MT\K@%PXQ>]#Z=KF4COXZ85?$, -N"**6!$$4([PQ8:C":=C30)4*XCK^J7.=
MYR7.)A%(HN*)1DKP"C()\A II0)I)%:EZ)M?#S@LZ7BY???^Z9$4L6SA*8HX
M&Y\4X-K1:?0["'XH0(WYP']#Z1*]>__FZ5O4:'F@P*?T,0LB.D0^;-=/::S(
MA"65<D4$#<2&"Q(1$'10XQ*?^4.U**ID?67*&@"6N#3ZW14)I+":ZA_\"*+B
M98B$3F!0WQZ[_\O7\)F]*ZZX[" 7<ST,R$".AX*^# @::(")S^54HJB1]779
MH1O"5N9)P<K;I&!EF!2L($X*5K:3@I7724'SZ2I-">VC;I]BL@H421.UTJZ)
MH8$\YHA$%!1=U/B4?4>K@CH=']DV>=JUZV299FN.X8K^0>*I0LY9ODT=S#;A
MIDP(!$]TR(24FU4BO)XPR[Z]]L&-,F)OTE2 KD@2)"$)XC9UHVSWW*SBC#&6
MX%OR&.1A\,@.I$"I2JW)L=@J=FDX?6R[5T$<O^ X_H\D_9H\X"!/$QQ5^RVR
MTR6]O-NH&P/L8>"-0A@$I6P0*L)OF-+I%Z:%&K5ZM\P;FWY.XS(I@HS?8<]D
M/91"SBU[%#"'K!D) 6*+')F"):TPJJ3]70JOLE>T$R_6^4G3T.C%'5\1UX(>
MW127R@+BC1:@ZMYXG7.DFR]76AZO<Q:8O75!7O!%4 0U/J7/*G'7%SAUH,<W
M-V6R@&BD!:B\J]GJL'0U0<,KKVEKLG,Z_5JEFNCSD93[Y#4"1#%_32L"B"(R
M7)HL-AEJ9+WQX6$=Q''S9K?2KY&46SY((0[Y,! !Q <9+@4?N"AJ9+WQX7*-
MLQ4=[G[*TJ_%<YU#5NF?0MHM/[20ASR1B@+BBPZ?@C>-"JITFK2__@CTVB5
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MP:8LJMM/B #?",(K-M6XQQLZ(>>O\+9=P=FV_G'"^#C-FJ=!;X[+BI%LBBF
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M/6G/")#TC !D3Y;?4P_;9^4L@\+'.AZW^N7P-=OY0P6@O8\<I8%_[$98^RA
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M*:0N3XL@AC^K[P?X+)YR?FG%0$ZYBH\^0 =>UOYE\N#:O@:D+-0F:MH^XUC
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MLB8#I)6<ITF>QB2JWBS%=$7Z'"2_/*=QO&711=%#^923B 39MAH8VI"CZZ3
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M_.A6_"8^UA^)_V [4GSR/U!+ P04    "  5@V%4"Z5W!.];  "TTP4 %0
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M@H%J-8@;/P:&2,_A'/DT,)SZCC>F?P.#7-MI/*<"!IRFRU@.!E@==W<8P=F
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ME9TX@AK4'!!Z Y9N$C>:0(GKQ /L1,>A?JB*0*LS([I;0HGLQ"/4(>=4%\]
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MA5&Y](Y1BK3A2F4'YS4Q^[!<B;@G["F"J_H(2;V-\QJ8=DQHH[?_ 1&4K?7
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MGKU$\J&\6R[$UZF@PB2-Q0\1+7L*$[%R3DB:X33GA"A/XK4U3;<?&2I8XQ=
MAD<&AJ*G)[:G@+@!]2W?."F.N*XKL=K\H-:RJ%_73NXIB__4252032U,NX8#
M*GKC5V"&BYX;7NV]!NQ>FQ.^$U JBIO)BL5ZR01TAPJ43U%.*\H<R-,.NY &
MB_)M'\:O##VP/(Q8IVV(>N!W^>-C(O$.DU/,HH2PG*(U#2[2*:&+@@WJXPXQ
M5*^1H&P?O_ T@.V]L?3*A*EC8,?EBF30 :#,'3Y$NBVG2#^$O>)S%=013RUR
M1T[-SU9#*-_&*RQM2?!F]GPGXMZPI2P*(!+YL>8,HM407#3)5[9T(MY[5WQ"
M]($PY$?M4E'])TR7W!JXR-@=GJ6R"'6:E9=T9&G7!$?U2,E&0=.?@S?!6DGQ
M/^[G*"@'#<(T#G#&@MJXP7K@8#6RV\<X&W@""@IJ^CC=('7LN^?R<9QHSYF@
M_1W7,#6SK+D-6M&E0]TZ6INBX(X(09V(*.:;HX\W?#VA!8ZZ5^+'YDHLNLM2
MPM>_7)SR 8+5" ,:XNLY-^!=@VLPORWZ#^D_K"83M%E/IELFHI^YFZO584G+
MMH< I8@_"T14G^!K>D81VLS\K"^,H^^:"Z/H%M3Z.53:QSG'"3%QSOV TU59
M39'R7'M=R[PIV8[C<J/J@'7-(,!&!>WO>*/JQ]K&YF5'*W_69E=ID(UE>=3:
MKVH]G/HY!1C+-7"0PE":3FZ]MA9@@ 6F[^5X60$8U/+@S$0X#'?N/,141F^O
MI^5A=YA<I)PXN6:#?-]<B6*40 XCK,?50$%])(<RO4)R#33 :]/W<KE&NR #
M+%)#-\>K%,*DQC(%T<&?'6Y=)A&^U#XTE]IZ$/_6V1JV&D#<@A%O1&TDT=CL
ME%L-ZK;"K#7@@$6\W:B.U_@  M*J0+L]D?W1$#>4/"*:R0>S'P4J'!-9]DKD
M*G)WFY(GG>/Z?5-95.-]&ZQ&E#'6U9C!QJ!NKS!(2&^24&*]IH!100"Z.KZ<
MT0V>U;*W&\7Q,@<SLWT_PYI4_BS>>QK&:!'2K^P21Z(*MM!#LKRA\F;ZQNK]
MH74RLAKPVZ :4BY?.6BP'C4HAW4HY9\(B9]QDHASH0:V-IN]Y3".3YT5\('\
M94!GQZNX%TO;)]10(OFSD,L2=&4M>\5J_;&Y6LM>P:J;VSLAHG >JTHEA@G
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MVV] !5BBFBZNEZ2!*<TK]B;<_5F,=VA6[;R?$)G1\'&.HXFX6MV]VEHI-=4
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MP%;%7\K22R@4EF,LX[0YI3B='8<,:Z-C/WRGBXY-^03!DYCAVR"4<P2+<I*
MI &MI@D>Q#Q^!-!61%ECQ<R.C;Z7%R6/ROH^Z[=0N%/9P?(B?9%N2("IC.YP
M4_AA1$)D0%5(:7L:^.*+#8$2P(T;>!K/)&BH53>"N(WO=_87N>-EB80\8J?H
M]UQS=;Q)$UWG/YEXZ$CA22F.%:Q=D!IK\4(Z>\9SLVRKN*E#T@_'N0M4MA)C
MDS\-Z^W:*[ 06  C5=3QQ*6K2>WJUW]@1#E@\^4E>D()6"EK^WNV1L?7RUIJ
M#%I&9.#5W :\CY+6#..9*( $'[+0U1A[IKLOTL<\8Q+'([#*[NKD^D"YE_RJ
M6*FFBF^JN@;I^S[\>^]-G?"1^/=^;_CWH0__/ECR;[0[4F/Q[X.7_"MLAH[8
MD3E\".CJ^-!BE&!0\P8HE(">,'Q]F:P+:/V1AZZ?:P<'S@?5Y3H=/08N;NVZ
M&KUQ;7<V]L8R&G$Y:ZCDR0(^)Q3A65I5'%SO3"B>%9299*L/-7NPW3"NK2H=
M7\@VB/G,VU-$\9/,FEQ?W6)7)#M%C+<23R!,F$"+"W>M046J91\Y&')*UY9<
M;YD9GNZ>R-<:L1IMU+*A:.[ZXOPN]@$MI3SAIM+DZ6&SN[^'[]18]R_C92V
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MY>WURMOKE3>[6/^N+EDYOL4V^B6KU[LI.[N;XEHO5;F3G\,LI[+DQ2UZ+&X
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MHAIP 6:UE_Q\>7\GI*)H%JLD!% Y1]G#I4*X0AE7762!+@G3I&@TFKE^ML]
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MGZU6@: ^UA-.(N!9 @M1WYKV4'H/?Q1@2V\CTIZHFLHH-OMV!YJF-%90UY^
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M,E]E>#(Q+FAT;5!+ 0(4 Q0    ( !6#8510>.#FW0,  ,P.   0
M      "  20; P!G,#@R-C(R7V5X,C,N:'1M4$L! A0#%     @ %8-A5/F"
MW!'(#@  ]6T  !(              ( !+Q\# &<P.#(V,C)?97@S+3$P+FAT
M;5!+ 0(4 Q0    ( !6#850<SUG3P X  'EL   3              "  2<N
M P!G,#@R-C(R7V5X,RTQ,#$N:'1M4$L! A0#%     @ %8-A5-EW_5\H#0
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M,S$M,2YH=&U02P$"% ,4    "  5@V%44*]1K#P'   !*   $@
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M,5]V,2YJ<&=02P$"% ,4    "  5@V%4/I5+3CL5   ST0  $0
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MHP4 :7!A<BTR,#(Q,3(S,5]P<F4N>&UL4$L%!@     3 !, P00  "__!0
!  $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
